PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Jaworski, A; Tessier-Lavigne, M				Jaworski, Alexander; Tessier-Lavigne, Marc			Autocrine/juxtaparacrine regulation of axon fasciculation by Slit-Robo signaling	NATURE NEUROSCIENCE			English	Article							NEURONAL GROWTH CONES; GRASSHOPPER EMBRYOS; DROSOPHILA	Axons travel to their targets in bundles or fascicles, but the molecules regulating fasciculation remain incompletely characterized. We found that Slit2 and its Robo receptors are expressed by motor axons, and that inactivation of Slit2 or Robo1 and Robo2 in mice caused axons to defasciculate prematurely at muscle targets. In vitro, Slit2 secreted by motoneurons regulated fasciculation through Robo1 and Robo2. These results support the idea that Slit2 promotes axon fasciculation via an autocrine and/or juxtaparacrine mechanism.	[Jaworski, Alexander; Tessier-Lavigne, Marc] Genentech Inc, Div Res, San Francisco, CA 94080 USA; [Jaworski, Alexander; Tessier-Lavigne, Marc] Rockefeller Univ, Lab Brain Dev & Repair, New York, NY 10021 USA	Roche Holding; Genentech; Rockefeller University	Tessier-Lavigne, M (corresponding author), Genentech Inc, Div Res, San Francisco, CA 94080 USA.	marctl@mail.rockefeller.edu		Jaworski, Alexander/0000-0002-4596-5450	Genentech; The Rockefeller University	Genentech(Roche HoldingGenentech); The Rockefeller University	We thank N. Velarde for technical assistance, A. Koch and colleagues (Genentech) for expression and purification of Slit2, Robo1-Fc and Robo1-AP, S. Pfaff (Salk Institute) and J. Lewcock (Genentech) for sharing the HB9 antibody, and D. Simon for thoughtful comments on the manuscript. This work was supported by Genentech and The Rockefeller University.	Brose K, 1999, CELL, V96, P795, DOI 10.1016/S0092-8674(00)80590-5; Cloutier JF, 2002, NEURON, V33, P877, DOI 10.1016/S0896-6273(02)00635-9; Huber AB, 2005, NEURON, V48, P949, DOI 10.1016/j.neuron.2005.12.003; KLOSE M, 1989, SCIENCE, V245, P982, DOI 10.1126/science.2772651; KUWADA JY, 1986, SCIENCE, V233, P740, DOI 10.1126/science.3738507; LIN DM, 1994, NEURON, V13, P1055, DOI 10.1016/0896-6273(94)90045-0; Liu JM, 2003, MECH DEVELOP, V120, P1059, DOI 10.1016/S0925-4773(03)00161-8; RAPER JA, 1984, J NEUROSCI, V4, P2329; RAPER JA, 1983, J NEUROSCI, V3, P31; Rhee J, 2002, NAT CELL BIOL, V4, P798, DOI 10.1038/ncb858; Sabatier C, 2004, CELL, V117, P157, DOI 10.1016/S0092-8674(04)00303-4; Santiago-Martinez E, 2008, J CELL BIOL, V182, P241, DOI 10.1083/jcb.200804120; Shiau CE, 2009, DEVELOPMENT, V136, P4155, DOI 10.1242/dev.034355; Yuan WL, 2003, P NATL ACAD SCI USA, V100, P5217, DOI 10.1073/pnas.0730709100	14	66	72	0	13	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2012	15	3					367	369		10.1038/nn.3037	http://dx.doi.org/10.1038/nn.3037			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	899CY	22306607				2022-12-28	WOS:000300793100008
J	Poulet, JFA; Fernandez, LMJ; Crochet, S; Petersen, CCH				Poulet, James F. A.; Fernandez, Laura M. J.; Crochet, Sylvain; Petersen, Carl C. H.			Thalamic control of cortical states	NATURE NEUROSCIENCE			English	Article							BEHAVING MICE; BARREL CORTEX; RESPONSES; MODULATION; MECHANISMS; NETWORKS; DYNAMICS	We investigated the impact of thalamus on ongoing cortical activity in the awake, behaving mouse. We demonstrate that the desynchronized cortical state during active behavior is driven by a centrally generated increase in thalamic action potential firing, which can also be mimicked by optogenetic stimulation of the thalamus. The thalamus therefore is key in controlling cortical states.	[Poulet, James F. A.; Fernandez, Laura M. J.; Crochet, Sylvain; Petersen, Carl C. H.] Ecole Polytech Fed Lausanne EPFL, Fac Life Sci, Brain Mind Inst, Lab Sensory Proc, Lausanne, Switzerland; [Poulet, James F. A.] Max Delbruck Ctr Mol Med MDC, Dept Neurosci, Berlin, Germany; [Poulet, James F. A.] Charite Univ Med Berlin, Neurosci Res Ctr, Berlin, Germany; [Poulet, James F. A.] Charite Univ Med Berlin, Cluster Excellence NeuroCure, Berlin, Germany; [Fernandez, Laura M. J.; Crochet, Sylvain] INSERM, U1028, F-69008 Lyon, France; [Fernandez, Laura M. J.; Crochet, Sylvain] Ctr Natl Rech Sci CNRS, UMR5292, Lyon, France; [Fernandez, Laura M. J.; Crochet, Sylvain] Integrat Physiol Brain Arousal Syst Team, Lyon Neurosci Res Ctr, Lyon, France	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm)	Crochet, S (corresponding author), Ecole Polytech Fed Lausanne EPFL, Fac Life Sci, Brain Mind Inst, Lab Sensory Proc, Lausanne, Switzerland.	sylvain.crochet@univ-lyon1.fr; carl.petersen@epfl.ch	Fernandez, Laura MJ/K-4717-2012; Petersen, Carl/M-5123-2017	Fernandez, Laura MJ/0000-0002-7942-3369; Petersen, Carl/0000-0003-3344-4495; Crochet, Sylvain/0000-0002-2965-8899; Poulet, James/0000-0003-0296-5415	Swiss National Science Foundation; Human Frontiers in Science Program; SystemsX.ch; Deutsche Forschungsgemeinschaft [Exc 257 NeuroCure]; European Research Council; Region Rhone-Alpes Exploradoc; Agence Nationale de la Recherche France [ANR-09-JCJC-0028-01]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Human Frontiers in Science Program(Human Frontier Science Program); SystemsX.ch; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Research Council(European Research Council (ERC)European Commission); Region Rhone-Alpes Exploradoc(Region Auvergne-Rhone-Alpes); Agence Nationale de la Recherche France(French National Research Agency (ANR))	We would like to thank K. Svoboda (Howard Hughes Medical Institute Janelia Farm; Addgene plasmid 20071) and C. Luscher (University of Geneva; virus) for AAV-ChR2. This work was funded by grants from the Swiss National Science Foundation (C.C.H.P.), Human Frontiers in Science Program (J.F.A.P. and C. C. H. P.), SystemsX.ch (C. C. H. P.), Deutsche Forschungsgemeinschaft (Exc 257 NeuroCure) (J.F.A.P.), a European Research Council starting grant (J.F.A.P.), Region Rhone-Alpes Exploradoc (L.M.J.F.) and Agence Nationale de la Recherche France (project AWAKE CX, ANR-09-JCJC-0028-01) (S.C.).	Berger H, 1929, ARCH PSYCHIAT NERVEN, V87, P527, DOI 10.1007/BF01797193; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Castro-Alamancos MA, 2004, NEURON, V41, P455, DOI 10.1016/S0896-6273(03)00853-5; Constantinople CM, 2011, NEURON, V69, P1061, DOI 10.1016/j.neuron.2011.02.040; Crochet S, 2006, NAT NEUROSCI, V9, P608, DOI 10.1038/nn1690; Fanselow EE, 1999, J NEUROSCI, V19, P7603, DOI 10.1523/JNEUROSCI.19-17-07603.1999; Fee MS, 1997, J NEUROPHYSIOL, V78, P1144, DOI 10.1152/jn.1997.78.2.1144; Ferezou I, 2007, NEURON, V56, P907, DOI 10.1016/j.neuron.2007.10.007; Haider B, 2009, NEURON, V62, P171, DOI 10.1016/j.neuron.2009.04.008; Niell CM, 2010, NEURON, V65, P472, DOI 10.1016/j.neuron.2010.01.033; Okun M, 2010, J NEUROSCI, V30, P4440, DOI 10.1523/JNEUROSCI.5062-09.2010; Otazu GH, 2009, NAT NEUROSCI, V12, P646, DOI 10.1038/nn.2306; Poulet JFA, 2008, NATURE, V454, P881, DOI 10.1038/nature07150; Steriade M, 2004, PROG BRAIN RES, V145, P179, DOI 10.1016/S0079-6123(03)45013-9	15	203	204	1	42	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2012	15	3					370	372		10.1038/nn.3035	http://dx.doi.org/10.1038/nn.3035			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	899CY	22267163				2022-12-28	WOS:000300793100009
J	Clarke, LE; Attwell, D				Clarke, Laura E.; Attwell, David			An astrocyte TRP switch for inhibition	NATURE NEUROSCIENCE			English	Editorial Material							RECEPTOR POTENTIAL A1; CHANNEL; RELEASE		[Clarke, Laura E.; Attwell, David] UCL, Dept Neurosci Physiol & Pharmacol, London, England	University of London; University College London	Clarke, LE (corresponding author), UCL, Dept Neurosci Physiol & Pharmacol, London, England.	d.attwell@ucl.ac.uk	Attwell, David/ABE-6750-2020					Andersson DA, 2008, J NEUROSCI, V28, P2485, DOI 10.1523/JNEUROSCI.5369-07.2008; Attwell D, 2010, NATURE, V468, P232, DOI 10.1038/nature09613; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Di Castro MA, 2011, NAT NEUROSCI, V14, P1276, DOI 10.1038/nn.2929; Doerner JF, 2007, J BIOL CHEM, V282, P13180, DOI 10.1074/jbc.M607849200; Golovina VA, 2005, J PHYSIOL-LONDON, V564, P737, DOI 10.1113/jphysiol.2005.085035; Gourine AV, 2010, SCIENCE, V329, P571, DOI 10.1126/science.1190721; Hamilton NB, 2010, NAT REV NEUROSCI, V11, P227, DOI 10.1038/nrn2803; Nilius B, 2011, J PHYSIOL-LONDON, V589, P1543, DOI 10.1113/jphysiol.2010.200717; Panatier A, 2011, CELL, V146, P785, DOI 10.1016/j.cell.2011.07.022; Semyanov A, 2003, NAT NEUROSCI, V6, P484, DOI 10.1038/nn1043; Shigetomi E, 2012, NAT NEUROSCI, V15, P70, DOI 10.1038/nn.3000; Takahashi N, 2008, CHANNELS, V2, P287, DOI 10.4161/chan.2.4.6745; Wang YYY, 2010, J NEUROSCI, V30, P12958, DOI 10.1523/JNEUROSCI.2715-10.2010; Zhang XF, 2008, EUR J NEUROSCI, V27, P605, DOI 10.1111/j.1460-9568.2008.06030.x	15	7	7	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2012	15	1					2	3						2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	866VO	22193248				2022-12-28	WOS:000298414400002
J	Huang, H; Trussell, LO				Huang, Hai; Trussell, Laurence O.			KCNQ5 channels control resting properties and release probability of a synapse	NATURE NEUROSCIENCE			English	Article							AUDITORY BRAIN-STEM; PROTEIN-KINASE-C; POTASSIUM CHANNEL; TRANSMITTER RELEASE; MUSCARINIC MODULATION; K+ CHANNELS; INNER-EAR; ACTIVATION; SUBUNITS; OSCILLATIONS	Little is known about which ion channels determine the resting electrical properties of presynaptic membranes. In recordings made from the rat calyx of Held, a giant mammalian terminal, we found resting potential to be controlled by KCNQ (Kv7) K+ channels, most probably KCNQ5 (Kv7.5) homomers. Unlike most KCNQ channels, which are activated only by depolarizing stimuli, the presynaptic channels began to activate just below the resting potential. As a result, blockers and activators of KCNQ5 depolarized or hyperpolarized nerve terminals, respectively, markedly altering resting conductance. Moreover, the background conductance set by KCNQ5 channels, together with Na+ and hyperpolarization-activated and cyclic nucleotide-gated (HCN) channels, determined the size and time course of the response to subthreshold stimuli. Signaling pathways known to directly affect exocytic machinery also regulated KCNQ5 channels, and increase or decrease of KCNQ5 channel activity controlled release probability through alterations in resting potential. Thus, ion channel determinants of presynaptic resting potential also control synaptic strength.	[Huang, Hai; Trussell, Laurence O.] Oregon Hlth & Sci Univ, Oregon Hearing Res Ctr, Portland, OR 97201 USA; [Huang, Hai; Trussell, Laurence O.] Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97201 USA	Oregon Health & Science University; Oregon Health & Science University	Huang, H (corresponding author), Oregon Hlth & Sci Univ, Oregon Hearing Res Ctr, Portland, OR 97201 USA.	huanghai@ohsu.edu	Huang, Hai/N-2330-2017; Huang, Hai/E-5588-2011	Huang, Hai/0000-0002-6928-3198; Huang, Hai/0000-0002-6928-3198	US National Institutes of Health [DC004450, NS028901]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS028901, R37NS028901] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004450] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank V. Balakrishnan and P. Brehm for comments, K. Bender and S. Kuo for technical advice and B. Kachar (National Institute on Deafness and Other Communication Disorders) for KCNQ4 antibody. L.O.T. is supported by US National Institutes of Health grants DC004450 and NS028901.	Alle H, 2008, CURR OPIN NEUROBIOL, V18, P314, DOI 10.1016/j.conb.2008.08.006; Awatramani GB, 2005, NEURON, V48, P109, DOI 10.1016/j.neuron.2005.08.038; Brown DA, 2009, BRIT J PHARMACOL, V156, P1185, DOI 10.1111/j.1476-5381.2009.00111.x; Brueggemann LI, 2011, MOL PHARMACOL, V79, P10, DOI 10.1124/mol.110.067496; Caminos E, 2007, J COMP NEUROL, V505, P363, DOI 10.1002/cne.21497; Chambard JM, 2005, PFLUG ARCH EUR J PHY, V450, P34, DOI 10.1007/s00424-004-1366-2; COCHET C, 1986, BIOCHEM J, V237, P25, DOI 10.1042/bj2370025; Cooper EC, 2001, J NEUROSCI, V21, P9529, DOI 10.1523/JNEUROSCI.21-24-09529.2001; Devaux JJ, 2004, J NEUROSCI, V24, P1236, DOI 10.1523/JNEUROSCI.4512-03.2004; Dodson PD, 2004, TRENDS NEUROSCI, V27, P210, DOI 10.1016/j.tins.2004.02.012; Dodson PD, 2002, J NEUROSCI, V22, P6953; Elmedyb P, 2007, BASIC CLIN PHARMACOL, V100, P316, DOI 10.1111/j.1742-7843.2007.00048.x; FORSYTHE ID, 1994, J PHYSIOL-LONDON, V479, P381, DOI 10.1113/jphysiol.1994.sp020303; Garcia-Pino E, 2010, J COMP NEUROL, V518, P1301, DOI 10.1002/cne.22276; Goldman AM, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000289; HAY JC, 1995, NATURE, V374, P173, DOI 10.1038/374173a0; Hermann J, 2007, J NEUROPHYSIOL, V98, P807, DOI 10.1152/jn.00355.2007; Holz RW, 2000, J BIOL CHEM, V275, P17878, DOI 10.1074/jbc.M000925200; Hoshi N, 2003, NAT NEUROSCI, V6, P564, DOI 10.1038/nn1062; Huang H, 2008, NEURON, V60, P975, DOI 10.1016/j.neuron.2008.10.052; Ishikawa T, 2003, J NEUROSCI, V23, P10445; Kharkovets T, 2000, P NATL ACAD SCI USA, V97, P4333, DOI 10.1073/pnas.97.8.4333; Kim JH, 2007, NAT NEUROSCI, V10, P196, DOI 10.1038/nn1839; Leao RN, 2009, J NEUROSCI, V29, P13353, DOI 10.1523/JNEUROSCI.1463-09.2009; Lerche C, 2000, J BIOL CHEM, V275, P22395, DOI 10.1074/jbc.M002378200; Martire M, 2004, J NEUROSCI, V24, P592, DOI 10.1523/JNEUROSCI.3143-03.2004; Miceli F, 2009, CHANNELS, V3, P274; Micheva KD, 2001, J CELL BIOL, V154, P355, DOI 10.1083/jcb.200102098; Nakajo K, 2005, J PHYSIOL-LONDON, V569, P59, DOI 10.1113/jphysiol.2005.094995; Oliver D, 2003, J NEUROSCI, V23, P2141; Peretz A, 2007, J NEUROPHYSIOL, V97, P283, DOI 10.1152/jn.00634.2006; Rhee JS, 2002, CELL, V108, P121, DOI 10.1016/S0092-8674(01)00635-3; Roura-Ferrer M, 2009, CELL PHYSIOL BIOCHEM, V24, P325, DOI 10.1159/000257425; Saitoh N, 2001, P NATL ACAD SCI USA, V98, P14017, DOI 10.1073/pnas.241333598; Schroeder BC, 2000, J BIOL CHEM, V275, P24089, DOI 10.1074/jbc.M003245200; Shah MM, 2008, P NATL ACAD SCI USA, V105, P7869, DOI 10.1073/pnas.0802805105; Shapiro MS, 2000, J NEUROSCI, V20, P1710; Soh H, 2010, MOL PHARMACOL, V78, P1088, DOI 10.1124/mol.110.066100; Song P, 2005, NAT NEUROSCI, V8, P1335, DOI 10.1038/nn1533; Suh BC, 2002, NEURON, V35, P507, DOI 10.1016/S0896-6273(02)00790-0; Taschenberger H, 2000, J NEUROSCI, V20, P9162; Tatulian L, 2001, J NEUROSCI, V21, P5535, DOI 10.1523/JNEUROSCI.21-15-05535.2001; Torborg CL, 2006, J NEUROSCI, V26, P7362, DOI 10.1523/JNEUROSCI.1257-06.2006; Trussell LO, 1999, ANNU REV PHYSIOL, V61, P477, DOI 10.1146/annurev.physiol.61.1.477; Turecek R, 2002, P NATL ACAD SCI USA, V99, P13884, DOI 10.1073/pnas.212419699; Turecek R, 2001, NATURE, V411, P587, DOI 10.1038/35079084; Vervaeke K, 2006, J PHYSIOL-LONDON, V576, P235, DOI 10.1113/jphysiol.2006.111336; Wang HS, 1998, SCIENCE, V282, P1890, DOI 10.1126/science.282.5395.1890; Wiedemann C, 1996, EMBO J, V15, P2094, DOI 10.1002/j.1460-2075.1996.tb00563.x; Xu TH, 2007, J BIOL CHEM, V282, P23899, DOI 10.1074/jbc.M702108200	50	59	60	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2011	14	7					840	U51		10.1038/nn.2830	http://dx.doi.org/10.1038/nn.2830			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	783KR	21666672	Green Accepted			2022-12-28	WOS:000292081700011
J	Charlesworth, JD; Tumer, EC; Warren, TL; Brainard, MS				Charlesworth, Jonathan D.; Tumer, Evren C.; Warren, Timothy L.; Brainard, Michael S.			Learning the microstructure of successful behavior	NATURE NEUROSCIENCE			English	Article							GANGLIA-FOREBRAIN CIRCUIT; ZEBRA FINCH SONG; MOVEMENT VARIABILITY; ADULT BIRDSONG; EYE-MOVEMENTS; MOTOR; BRAIN; RESPONSES; TIME; PERTURBATION	Reinforcement signals indicating success or failure are known to alter the probability of selecting between distinct actions. However, successful performance of many motor skills, such as speech articulation, also requires learning behavioral trajectories that vary continuously over time. Here, we investigated how temporally discrete reinforcement signals shape a continuous behavioral trajectory, the fundamental frequency of adult Bengalese finch song. We provided reinforcement contingent on fundamental frequency performance only at one point in the song. Learned changes to fundamental frequency were maximal at this point, but also extended both earlier and later in the fundamental frequency trajectory. A simple principle predicted the detailed structure of learning: birds learned to produce the average of the behavioral trajectories associated with successful outcomes. This learning rule accurately predicted the structure of learning at a millisecond timescale, demonstrating that the nervous system records fine-grained details of successful behavior and uses this information to guide learning.	[Charlesworth, Jonathan D.; Tumer, Evren C.; Warren, Timothy L.; Brainard, Michael S.] Univ Calif San Francisco, WM Keck Ctr Integrat Neurosci, San Francisco, CA 94143 USA; [Charlesworth, Jonathan D.; Tumer, Evren C.; Warren, Timothy L.; Brainard, Michael S.] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; [Charlesworth, Jonathan D.; Warren, Timothy L.; Brainard, Michael S.] Univ Calif San Francisco, Grad Program Neurosci, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Charlesworth, JD (corresponding author), Univ Calif San Francisco, WM Keck Ctr Integrat Neurosci, San Francisco, CA 94143 USA.	jcharles@phy.ucsf.edu		Brainard, Michael/0000-0002-9425-9907; Warren, Timothy/0000-0002-4429-4106	US National Institutes of Health; US National Institute on Deafness and Other Communication Disorders; Sloan-Swartz Foundation; US National Science Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH077970] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006636] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Sloan-Swartz Foundation; US National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank P. Sabes, S. Sober, L. Frank, A. Doupe and S. Lisberger for discussion and comments on the manuscript and J. Wong and C. Brown for animal care. This work was supported by US National Institutes of Health R01 and P50 grants. E. C. T. was supported by a National Research Service Award postdoctoral fellowship from the US National Institute on Deafness and Other Communication Disorders and by the Sloan-Swartz Foundation. J. D. C. and T. L. W. were supported by US National Science Foundation graduate fellowships.	Andalman AS, 2009, P NATL ACAD SCI USA, V106, P12518, DOI 10.1073/pnas.0903214106; Aronov D, 2008, SCIENCE, V320, P630, DOI 10.1126/science.1155140; Ashmore RC, 2005, J NEUROSCI, V25, P8543, DOI 10.1523/JNEUROSCI.1668-05.2005; Balleine BW, 2007, ANN NY ACAD SCI, V1104, P147, DOI 10.1196/annals.1390.006; BOTTJER SW, 1984, SCIENCE, V224, P901, DOI 10.1126/science.6719123; Catania A., 1984, LEARNING; Chi ZY, 2001, NEURON, V32, P899, DOI 10.1016/S0896-6273(01)00524-4; Churchland MM, 2006, NEURON, V52, P1085, DOI 10.1016/j.neuron.2006.10.034; Cohen JD, 2007, PHILOS T R SOC B, V362, P933, DOI 10.1098/rstb.2007.2098; Doya Kenji, 2000, P469; Elemans CPH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002581; Elemans CPH, 2004, NATURE, V431, P146, DOI 10.1038/431146a; Faisal AA, 2008, NAT REV NEUROSCI, V9, P292, DOI 10.1038/nrn2258; Fee MS, 2004, ANN NY ACAD SCI, V1016, P153, DOI 10.1196/annals.1298.022; FETZ EB, 1971, SCIENCE, V174, P431, DOI 10.1126/science.174.4007.431; Fiete IR, 2007, J NEUROPHYSIOL, V98, P2038, DOI 10.1152/jn.01311.2006; Franz M, 2002, J NEUROBIOL, V51, P129, DOI 10.1002/neu.10043; Gardner TJ, 2006, P NATL ACAD SCI USA, V103, P6094, DOI 10.1073/pnas.0601707103; Glaze CM, 2007, J NEUROSCI, V27, P7631, DOI 10.1523/JNEUROSCI.1065-07.2007; Glaze CM, 2006, J NEUROSCI, V26, P991, DOI 10.1523/JNEUROSCI.3387-05.2006; Hampton CM, 2009, J NEUROPHYSIOL, V101, P3235, DOI 10.1152/jn.91089.2008; Hermes D.J., 2006, METHODS EMPIRICAL PR, P29; Hessler NA, 1999, NAT NEUROSCI, V2, P209, DOI 10.1038/6306; Hira R, 2009, J NEUROSCI METH, V179, P258, DOI 10.1016/j.jneumeth.2009.02.001; House D., 1990, TONAL PERCEPTION SPE; Jarvis ED, 1998, NEURON, V21, P775, DOI 10.1016/S0896-6273(00)80594-2; Kao MH, 2005, NATURE, V433, P638, DOI 10.1038/nature03127; Leonardo A, 2005, J NEUROSCI, V25, P652, DOI 10.1523/JNEUROSCI.3036-04.2005; Leonardo A, 1999, NATURE, V399, P466, DOI 10.1038/20933; MAUK MD, 1992, BEHAV NEUROSCI, V106, P666, DOI 10.1037/0735-7044.106.4.666; Mauk MD, 2004, ANNU REV NEUROSCI, V27, P307, DOI 10.1146/annurev.neuro.27.070203.144247; Medina JF, 2005, NEURON, V45, P157, DOI 10.1016/j.neuron.2004.12.017; Mendez JM, 2010, J NEUROPHYSIOL, V104, P984, DOI 10.1152/jn.01031.2009; Olveczky BP, 2005, PLOS BIOL, V3, P902, DOI 10.1371/journal.pbio.0030153; ROSENFELD JP, 1971, PHYSIOL BEHAV, V7, P489, DOI 10.1016/0031-9384(71)90099-0; ROSENFELD JP, 1973, SCIENCE, V181, P767, DOI 10.1126/science.181.4101.767; SCHARFF C, 1991, J NEUROSCI, V11, P2896; Schoppik D, 2008, NEURON, V58, P248, DOI 10.1016/j.neuron.2008.02.015; SKINNER BF, 1948, J EXP PSYCHOL, V38, P168, DOI 10.1037//0096-3445.121.3.273; Skinner BF., 1953, SCI HUMAN BEHAV; Sober SJ, 2008, J NEUROSCI, V28, P10370, DOI 10.1523/JNEUROSCI.2448-08.2008; Staddon JE., 1983, ADAPTIVE BEHAV LEARN; Tchernichovski O, 2001, SCIENCE, V291, P2564, DOI 10.1126/science.1058522; Tchernichovski O, 2004, ANN NY ACAD SCI, V1016, P348, DOI 10.1196/annals.1298.031; Thorndike E. L., 1911, ANIMAL INTELLIGENCE; Todorov E, 2004, NAT NEUROSCI, V7, P907, DOI 10.1038/nn1309; Todorov E, 2002, NAT NEUROSCI, V5, P1226, DOI 10.1038/nn963; Tumer EC, 2007, NATURE, V450, P1240, DOI 10.1038/nature06390; van Beers RJ, 2004, J NEUROPHYSIOL, V91, P1050, DOI 10.1152/jn.00652.2003; van Beers RJ, 2007, J NEUROSCI, V27, P8757, DOI 10.1523/JNEUROSCI.2311-07.2007	50	50	50	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2011	14	3					373	380		10.1038/nn.2748	http://dx.doi.org/10.1038/nn.2748			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	725MW	21278732	Green Accepted			2022-12-28	WOS:000287650100019
J	Szuts, TA; Fadeyev, V; Kachiguine, S; Sher, A; Grivich, MV; Agrochao, M; Hottowy, P; Dabrowski, W; Lubenov, EV; Siapas, AG; Uchida, N; Litke, AM; Meister, M				Szuts, Tobi A.; Fadeyev, Vitaliy; Kachiguine, Sergei; Sher, Alexander; Grivich, Matthew V.; Agrochao, Margarida; Hottowy, Pawel; Dabrowski, Wladyslaw; Lubenov, Evgueniy V.; Siapas, Athanassios G.; Uchida, Naoshige; Litke, Alan M.; Meister, Markus			A wireless multi-channel neural amplifier for freely moving animals	NATURE NEUROSCIENCE			English	Article							MOUSE VISUAL-CORTEX; INTEGRATED-CIRCUIT; RECORDING-SYSTEM; SCALE; RAT; TECHNOLOGY; RESPONSES; NEURONS; CELLS	Conventional neural recording systems restrict behavioral experiments to a flat indoor environment compatible with the cable that tethers the subject to recording instruments. To overcome these constraints, we developed a wireless multi-channel system for recording neural signals from rats. The device takes up to 64 voltage signals from implanted electrodes, samples each at 20 kHz, time-division multiplexes them into one signal and transmits that output by radio frequency to a receiver up to 60 m away. The system introduces <4 mu V of electrode-referred noise, comparable to wired recording systems, and outperforms existing rodent telemetry systems in channel count, weight and transmission range. This allows effective recording of brain signals in freely behaving animals. We report measurements of neural population activity taken outdoors and in tunnels. Neural firing in the visual cortex was relatively sparse, correlated even across large distances and was strongly influenced by locomotor activity.	[Szuts, Tobi A.] Harvard Univ, Program Biophys, Cambridge, MA 02138 USA; [Fadeyev, Vitaliy; Kachiguine, Sergei; Sher, Alexander; Grivich, Matthew V.; Litke, Alan M.] Univ Calif Santa Cruz, Santa Cruz Inst Particle Phys, Santa Cruz, CA 95064 USA; [Agrochao, Margarida; Uchida, Naoshige; Meister, Markus] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Agrochao, Margarida] Inst Gulbenkian Ciencias, Champalimaud Neurosci Programme, Oeiras, Portugal; [Hottowy, Pawel; Dabrowski, Wladyslaw] AGH Univ Sci & Technol, Fac Phys & Appl Comp Sci, Krakow, Poland; [Lubenov, Evgueniy V.; Siapas, Athanassios G.] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Lubenov, Evgueniy V.; Siapas, Athanassios G.] CALTECH, Div Engn & Appl Sci, Pasadena, CA 91125 USA; [Uchida, Naoshige; Meister, Markus] Harvard Univ, Ctr Brain Sci, Cambridge, MA 02138 USA	Harvard University; University of California System; University of California Santa Cruz; Harvard University; Fundacao Champalimaud; Instituto Gulbenkian de Ciencia; AGH University of Science & Technology; California Institute of Technology; California Institute of Technology; Harvard University	Szuts, TA (corresponding author), Harvard Univ, Program Biophys, Cambridge, MA 02138 USA.	szuts@fas.harvard.edu; meister@fas.harvard.edu	Hottowy, Pawel/R-4981-2019; Dabrowski, Wladyslaw/AAS-6369-2020	Dabrowski, Wladyslaw/0000-0001-9061-9568; Sher, Alexander/0000-0001-6655-6456; Meister, Markus/0000-0003-2136-6506; Uchida, Naoshige/0000-0002-5755-9409	McKnight Foundation; Gordon and Betty Moore Foundation; Polish Ministry of Science and Higher Education; National Science Foundation; Burroughs Wellcome Fund Career Award at the Scientific Interface	McKnight Foundation; Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); National Science Foundation(National Science Foundation (NSF)); Burroughs Wellcome Fund Career Award at the Scientific Interface(Burroughs Wellcome Fund)	We thank A. Leifer and E. Soucy for technical assistance and O. Mazor and A. Biewener for advice. Funding was provided by the McKnight Foundation (M. M., T. A. S.) the Gordon and Betty Moore Foundation (M. M.), the Polish Ministry of Science and Higher Education (W. D., P. H.), the National Science Foundation (PHY-0750525, A. M. L.) and the Burroughs Wellcome Fund Career Award at the Scientific Interface (A. S.).	Barlow H. B., 1961, SENS COMMUN, P217, DOI DOI 10.7551/MITPRESS/9780262518420.003.0013; Bartho P, 2004, J NEUROPHYSIOL, V92, P600, DOI 10.1152/jn.01170.2003; BORTON DA, 2009, EMBC 2009 ANN INT C, P5531; Brun VH, 2008, HIPPOCAMPUS, V18, P1200, DOI 10.1002/hipo.20504; Calhoun J. B, 1963, ECOLOGY SOCIOLOGY NO; Chalupa LM, 2008, EYE RETINA VISUAL SY; Chestek CA, 2009, IEEE T NEUR SYS REH, V17, P330, DOI 10.1109/TNSRE.2009.2023293; Dabrowski W, 2005, NUCL INSTRUM METH A, V541, P405, DOI 10.1016/j.nima.2005.01.082; Dabrowski W, 2004, BIOSENS BIOELECTRON, V19, P749, DOI 10.1016/j.bios.2003.08.005; Feierstein CE, 2006, NEURON, V51, P495, DOI 10.1016/j.neuron.2006.06.032; Felsen G, 2005, NAT NEUROSCI, V8, P1643, DOI 10.1038/nn1608; Gray CM, 1995, J NEUROSCI METH, V63, P43, DOI 10.1016/0165-0270(95)00085-2; GREGORY JA, 2009, EMBC 2009 ANN INT C, P3833; Grybos P, 2006, P 5 INT M SUBSTR INT, P208; Hampson RE, 2009, J NEUROSCI METH, V182, P195, DOI 10.1016/j.jneumeth.2009.06.007; Harrison RR, 2009, IEEE T NEUR SYS REH, V17, P322, DOI 10.1109/TNSRE.2009.2023298; Hottowy P, 2008, P 6 INT M SUBSTR INT, P261; Jermakowicz WJ, 2009, J NEUROPHYSIOL, V101, P2279, DOI 10.1152/jn.91207.2008; Ji DY, 2007, NAT NEUROSCI, V10, P100, DOI 10.1038/nn1825; Jog MS, 2002, J NEUROSCI METH, V117, P141, DOI 10.1016/S0165-0270(02)00092-4; Kohn A, 2009, CURR OPIN NEUROBIOL, V19, P434, DOI 10.1016/j.conb.2009.06.007; Laughlin SB, 2003, SCIENCE, V301, P1870, DOI 10.1126/science.1089662; Lewen GD, 2001, NETWORK-COMP NEURAL, V12, P317, DOI 10.1088/0954-898X/12/3/305; Lin LN, 2006, J NEUROSCI METH, V155, P28, DOI 10.1016/j.jneumeth.2005.12.032; MCCORMICK DA, 1985, J NEUROPHYSIOL, V54, P782, DOI 10.1152/jn.1985.54.4.782; Miranda H, 2010, IEEE T BIOMED CIRC S, V4, P181, DOI 10.1109/TBCAS.2010.2044573; Niell CM, 2008, J NEUROSCI, V28, P7520, DOI 10.1523/JNEUROSCI.0623-08.2008; Niell CM, 2010, NEURON, V65, P472, DOI 10.1016/j.neuron.2010.01.033; Pouzat C, 2002, J NEUROSCI METH, V122, P43, DOI 10.1016/S0165-0270(02)00276-5; Reid RC, 1997, VISUAL NEUROSCI, V14, P1015, DOI 10.1017/S0952523800011743; Reppas JB, 2002, NEURON, V35, P961, DOI 10.1016/S0896-6273(02)00823-1; Sawinski J, 2009, P NATL ACAD SCI USA, V106, P19557, DOI 10.1073/pnas.0903680106; Siapas AG, 2005, NEURON, V46, P141, DOI 10.1016/j.neuron.2005.02.028; SINNAMON HM, 1984, PHYSIOL BEHAV, V33, P185, DOI 10.1016/0031-9384(84)90098-2; Uchida N, 2003, NAT NEUROSCI, V6, P1224, DOI 10.1038/nn1142; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520; Yamamoto J, 2008, J NEUROPHYSIOL, V100, P2430, DOI 10.1152/jn.90687.2008; YIN M, 2009, EMBC 2009 ANN INT C, P1608	38	132	138	1	36	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2011	14	2					263	U363		10.1038/nn.2730	http://dx.doi.org/10.1038/nn.2730			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	711MJ	21240274				2022-12-28	WOS:000286595400026
J	Guo, T; Mandai, K; Condie, BG; Wickramasinghe, SR; Capecchi, MR; Ginty, DD				Guo, Ting; Mandai, Kenji; Condie, Brian G.; Wickramasinghe, S. Rasika; Capecchi, Mario R.; Ginty, David D.			An evolving NGF-Hoxd1 signaling pathway mediates development of divergent neural circuits in vertebrates	NATURE NEUROSCIENCE			English	Article							NERVE GROWTH-FACTOR; SACRAL SPINAL-CORD; EVO-DEVO; SENSORY NEURONS; AXON GUIDANCE; IN-VIVO; PROJECTIONS; RAT; NEUROTROPHINS; EXPRESSION	Species are endowed with unique sensory capabilities that are encoded by divergent neural circuits. One potential explanation for how divergent circuits have evolved is that conserved extrinsic signals are differentially interpreted by developing neurons of different species to yield unique patterns of axonal connections. Although nerve growth factor (NGF) controls survival, maturation and axonal projections of nociceptors of different vertebrates, whether the NGF signal is differentially transduced in different species to yield unique features of nociceptor circuits is unclear. We identified a species-specific signaling module induced by NGF and mediated by a rapidly evolving Hox transcription factor, Hoxd1. NGF promoted robust expression of Hoxd1 in mice, but not chickens, both in vivo and in vitro. Mice lacking Hoxd1 displayed altered nociceptor circuitry that resembles that normally found in chicks. Conversely, ectopic expression of Hoxd1 in developing chick nociceptors promoted a pattern of axonal projections reminiscent of the mouse. Thus, conserved growth factors control divergent neuronal transcriptional events that mediate interspecies differences in neural circuits and the behaviors that they control.	[Guo, Ting; Mandai, Kenji; Wickramasinghe, S. Rasika; Ginty, David D.] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA; [Condie, Brian G.] Univ Georgia, Dept Genet, Athens, GA 30602 USA; [Capecchi, Mario R.] Univ Utah, Sch Med, Dept Human Genet, Howard Hughes Med Inst, Salt Lake City, UT 84132 USA	Howard Hughes Medical Institute; Johns Hopkins University; University System of Georgia; University of Georgia; Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah	Ginty, DD (corresponding author), Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA.	dginty@jhmi.edu		Mandai, Kenji/0000-0002-0115-6635	US National Institutes of Health [NS34814]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM021168] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R29NS034814, R37NS034814, R01NS034814] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank T. Sanger for green anole embryos, cDNA and assistance with staging, N. Marsh-Armstrong for frog embryos, F. Lefcort for antibodies, S. Sockanathan, B. Zhuang and C. Lee for reagents and technical assistance with chick electroporation, A. Kolodkin, M. Li, X. Dong and H. Song for helpful discussions and members of the Ginty laboratory for comments on the manuscript, discussions and assistance throughout the course of the project. This work was supported by US National Institutes of Health grant NS34814 (D.D.G.). M.R.C. and D.D.G. are investigators of the Howard Hughes Medical Institute.	Chang C, 2009, INT J DEV BIOL, V53, P813, DOI 10.1387/ijdb.072556cc; Chen AI, 2006, NEURON, V49, P395, DOI 10.1016/j.neuron.2005.12.028; CHUNG K, 1993, J COMP NEUROL, V337, P63, DOI 10.1002/cne.903370104; Chuong CM, 2000, CURR OPIN GENET DEV, V10, P449, DOI 10.1016/S0959-437X(00)00111-8; Deppmann CD, 2008, SCIENCE, V320, P369, DOI 10.1126/science.1152677; Di-Poi N, 2009, GENOME RES, V19, P602, DOI 10.1101/gr.087932.108; DODD J, 1988, SCIENCE, V242, P692, DOI 10.1126/science.3055291; Eide AL, 1997, ANAT EMBRYOL, V195, P237, DOI 10.1007/s004290050043; FROHMAN MA, 1992, MECH DEVELOP, V38, P55, DOI 10.1016/0925-4773(92)90038-L; GUNDERSEN RW, 1979, SCIENCE, V206, P1079, DOI 10.1126/science.493992; HEMMING FJ, 1994, CELL TISSUE RES, V277, P519, DOI 10.1007/s004410050180; HONDA CN, 1985, J NEUROPHYSIOL, V53, P1059, DOI 10.1152/jn.1985.53.4.1059; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Huber AB, 2003, ANNU REV NEUROSCI, V26, P509, DOI 10.1146/annurev.neuro.26.010302.081139; Kardong K., 2006, VERTEBRATES COMP ANA; KEMP TS, 2005, ORIGIN EVOLUTION MAM; Kim SJ, 2005, MOL PAIN, V1, DOI 10.1186/1744-8069-1-11; KOLM PJ, 1995, DEV BIOL, V167, P34, DOI 10.1006/dbio.1995.1005; LEVIMONTALCINI R, 1987, SCIENCE, V237, P1154, DOI 10.1126/science.3306916; Liu Q, 2007, NAT NEUROSCI, V10, P946, DOI 10.1038/nn1937; Liu Q, 2009, CELL, V139, P1353, DOI 10.1016/j.cell.2009.11.034; Lonze BE, 2002, NEURON, V34, P371, DOI 10.1016/S0896-6273(02)00686-4; Lucas AM, 1972, AVIAN ANATOMY INTEGU, V2; Luo WQ, 2007, NEURON, V54, P739, DOI 10.1016/j.neuron.2007.04.027; Mandai K, 2009, NEURON, V63, P614, DOI 10.1016/j.neuron.2009.07.031; Martinez-Garcia F, 2002, J COMP NEUROL, V447, P99, DOI 10.1002/cne.10200; MIRNICS K, 1995, J COMP NEUROL, V355, P601, DOI 10.1002/cne.903550409; NADELHAFT I, 1983, J COMP NEUROL, V216, P36, DOI 10.1002/cne.902160105; Nakamura H, 2001, METHODS, V24, P43, DOI 10.1006/meth.2001.1155; Patel TD, 2000, NEURON, V25, P345, DOI 10.1016/S0896-6273(00)80899-5; Pearson JC, 2005, NAT REV GENET, V6, P893, DOI 10.1038/nrg1726; PROTHERO D. R., 1992, EOCENE OLIGOCENE CLI; Rice FL, 2008, SENSES COMPREHENSIVE, P1, DOI 10.1016/B978-0-12-805408-6.00340-7; Saxod R., 1978, HDB SENSORY PHYSL, VIX, P338; SNIDER WD, 1994, CELL, V77, P627, DOI 10.1016/0092-8674(94)90048-5; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Tvrdik P, 2006, DEV CELL, V11, P239, DOI 10.1016/j.devcel.2006.06.016; von During M., 1979, BIOL REPTILIA, P407; Wall PD, 2002, J COMP NEUROL, V449, P298, DOI 10.1002/cne.10294; Werner T, 2007, NUCLEIC ACIDS RES, V35, P6526, DOI 10.1093/nar/gkm727; Wu P, 2004, INT J DEV BIOL, V48, P249, DOI 10.1387/ijdb.15272390; Zanazzi A, 2007, NATURE, V445, P639, DOI 10.1038/nature05551; Zhuang BQ, 2009, NEURON, V61, P359, DOI 10.1016/j.neuron.2008.12.022; Zylka MJ, 2005, NEURON, V45, P17, DOI 10.1016/j.neuron.2004.12.015	44	40	41	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2011	14	1					31	U47		10.1038/nn.2710	http://dx.doi.org/10.1038/nn.2710			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	699TE	21151121	Green Accepted			2022-12-28	WOS:000285684900011
J	Bouvier, J; Thoby-Brisson, M; Renier, N; Dubreuil, V; Ericson, J; Champagnat, J; Pierani, A; Chedotal, A; Fortin, G				Bouvier, Julien; Thoby-Brisson, Muriel; Renier, Nicolas; Dubreuil, Veronique; Ericson, Johan; Champagnat, Jean; Pierani, Alessandra; Chedotal, Alain; Fortin, Gilles			Hindbrain interneurons and axon guidance signaling critical for breathing	NATURE NEUROSCIENCE			English	Article							PRE-BOTZINGER COMPLEX; RESPIRATORY RHYTHM GENERATION; PREBOTZINGER COMPLEX; SPINAL-CORD; IN-VITRO; GENETIC IDENTIFICATION; EXPRESSING NEURONS; PACEMAKER NEURONS; MOTOR-NEURON; IDENTITY	Breathing is a bilaterally synchronous behavior that relies on a respiratory rhythm generator located in the brainstem. An essential component of this generator is the preBotzinger complex (preBotC), which paces inspirations. Little is known about the developmental origin of the interneuronal populations forming the preBotC oscillator network. We found that the homeobox gene Dbx1 controls the fate of glutamatergic interneurons required for preBotC rhythm generation in the mouse embryo. We also found that a conditional inactivation in Dbx1-derived cells of the roundabout homolog 3 (Robo3) gene, which is necessary for axonal midline crossing, resulted in left-right de-synchronization of the preBotC oscillator. Together, these findings identify Dbx1-derived interneurons as the core rhythmogenic elements of the preBotC oscillator and indicate that Robo3-dependent guidance signaling in these cells is required for bilaterally synchronous activity.	[Pierani, Alessandra] Univ Paris Diderot, CNRS, UMR 7592, Inst Jacques Monod, Paris, France; [Bouvier, Julien; Thoby-Brisson, Muriel; Champagnat, Jean; Fortin, Gilles] CNRS UPR 3294, Inst Neurobiol Alfred Fessard, Gif Sur Yvette, France; [Renier, Nicolas; Chedotal, Alain] INSERM, U968, Paris, France; [Renier, Nicolas; Chedotal, Alain] UPMC Univ Paris 06, UMR S968, Inst Vis, Paris, France; [Renier, Nicolas; Chedotal, Alain] CNRS, UMR 7210, Paris, France; [Dubreuil, Veronique] Univ Paris Diderot, CNRS, UMR 7216, Paris, France; [Ericson, Johan] Karolinska Inst, Stockholm, Sweden	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Karolinska Institutet	Pierani, A (corresponding author), Univ Paris Diderot, CNRS, UMR 7592, Inst Jacques Monod, Paris, France.	pierani.alessandra@ijm.univ-paris-diderot.fr; alain.chedotal@inserm.fr; gilles.fortin@inaf.cnrs-gif.fr	Chedotal, Alain/F-2750-2017; Bouvier, Julien/C-1018-2017; Thoby-Brisson, Muriel/E-1167-2014; Renier, Nicolas/E-1855-2018; Pierani, Alessandra/O-6136-2017	Chedotal, Alain/0000-0001-7577-3794; Bouvier, Julien/0000-0002-1307-4426; Thoby-Brisson, Muriel/0000-0003-3214-1724; Renier, Nicolas/0000-0003-2642-4402; Pierani, Alessandra/0000-0002-4872-4791; Dubreuil, Veronique/0000-0001-8060-3597; Ericson, Johan/0000-0002-8019-7127; Fortin, Gilles/0000-0002-2123-8603	Region Ile-de-France; Fondation pour la Recherche Medicale; Fondation pour la Recherche Medicale Equipe; Association Francaise contre les Myopathies [ASS-SUB06-00123]; Ville de Paris [2006 ASES 102]; Agence Nationale de la Recherche [ANR-05-NEUR-007-01, ANR-08-MNPS-030-01, ANR-07-NEUR-007-01]; Centre National de la Recherche Scientifique; Institut de la Sante et de la Recherche Medicale	Region Ile-de-France(Region Ile-de-France); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Fondation pour la Recherche Medicale Equipe(Fondation pour la Recherche Medicale); Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); Ville de Paris; Agence Nationale de la Recherche(French National Research Agency (ANR)); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Institut de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm))	We thank J.-F. Brunet, C. Goridis and A. Lumsden for comments on the manuscript; M. Tessier-Lavigne for providing the Robo3 knockout; S. Karaz for providing specimens; and S. Autran and V. Mezieres for technical assistance with genotyping. J.B. is supported by Region Ile-de-France and the Fondation pour la Recherche Medicale. This work was supported by grants from Fondation pour la Recherche Medicale Equipe (A.C.), the Association Francaise contre les Myopathies (ASS-SUB06-00123, A.C.), the Ville de Paris (2006 ASES 102, A. P.) and the Agence Nationale de la Recherche (ANR-05-NEUR-007-01 BIS to A. P., ANR-08-MNPS-030-01 to A. C. and ANR-07-NEUR-007-01 to G. F.). This work benefited from the facilities and expertise of the Imagif Cell Biology Unit and the Anicampus mouse facility of the Gif-sur-Yvette campus. This work was supported by Centre National de la Recherche Scientifique and the Institut de la Sante et de la Recherche Medicale.	BIANCHI AL, 1995, PHYSIOL REV, V75, P1, DOI 10.1152/physrev.1995.75.1.1; Bielle F, 2005, NAT NEUROSCI, V8, P1002, DOI 10.1038/nn1511; Blanchi B, 2003, NAT NEUROSCI, V6, P1091, DOI 10.1038/nn1129; Bouvier J, 2008, EUR J NEUROSCI, V28, P510, DOI 10.1111/j.1460-9568.2008.06345.x; Briscoe J, 2001, CURR OPIN NEUROBIOL, V11, P43, DOI 10.1016/S0959-4388(00)00172-0; Briscoe J, 1999, NATURE, V398, P622, DOI 10.1038/19315; Cheng LP, 2004, NAT NEUROSCI, V7, P510, DOI 10.1038/nn1221; Cohen-Tannoudji M, 1998, MOL CELL BIOL, V18, P1444, DOI 10.1128/MCB.18.3.1444; Del Negro CA, 2001, J NEUROPHYSIOL, V86, P59, DOI 10.1152/jn.2001.86.1.59; Dubreuil V, 2009, J NEUROSCI, V29, P14836, DOI 10.1523/JNEUROSCI.2623-09.2009; Ericson J, 1997, CELL, V90, P169, DOI 10.1016/S0092-8674(00)80323-2; Feldman JL, 2006, NAT REV NEUROSCI, V7, P232, DOI 10.1038/nrn1871; FUNK GD, 1993, J NEUROPHYSIOL, V70, P1497, DOI 10.1152/jn.1993.70.4.1497; Garcia-Campmany L, 2010, CURR OPIN NEUROBIOL, V20, P116, DOI 10.1016/j.conb.2010.01.002; Geisen MJ, 2008, PLOS BIOL, V6, P1178, DOI 10.1371/journal.pbio.0060142; Gray PA, 2001, NAT NEUROSCI, V4, P927, DOI 10.1038/nn0901-927; Gray PA, 1999, SCIENCE, V286, P1566, DOI 10.1126/science.286.5444.1566; Jen JC, 2004, SCIENCE, V304, P1509, DOI 10.1126/science.1096437; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Johnson SM, 2001, J NEUROPHYSIOL, V85, P1772, DOI 10.1152/jn.2001.85.4.1772; Keller C, 2004, GENE DEV, V18, P2608, DOI 10.1101/gad.1243904; Kiehn O, 2006, ANNU REV NEUROSCI, V29, P279, DOI 10.1146/annurev.neuro.29.051605.112910; Koizumi H, 2008, J NEUROSCI, V28, P2353, DOI 10.1523/JNEUROSCI.3553-07.2008; Koshiya N, 1999, NATURE, V400, P360, DOI 10.1038/22540; Lanuza GM, 2004, NEURON, V42, P375, DOI 10.1016/S0896-6273(04)00249-1; Liu YY, 2003, EUR J NEUROSCI, V17, P41, DOI 10.1046/j.1460-9568.2003.02418.x; Lumsden A, 1996, SCIENCE, V274, P1109, DOI 10.1126/science.274.5290.1109; Marillat V, 2004, NEURON, V43, P69, DOI 10.1016/j.neuron.2004.06.018; McKay LC, 2005, NAT NEUROSCI, V8, P1142, DOI 10.1038/nn1517; Moran-Rivard L, 2001, NEURON, V29, P385, DOI 10.1016/S0896-6273(01)00213-6; Morgado-Valle C, 2010, J NEUROSCI, V30, P3634, DOI 10.1523/JNEUROSCI.3040-09.2010; Pattyn A, 2000, DEVELOPMENT, V127, P1349; Pattyn A, 2003, DEVELOPMENT, V130, P4149, DOI 10.1242/dev.00641; Pattyn A, 2003, GENE DEV, V17, P729, DOI 10.1101/gad.255803; Pierani A, 2001, NEURON, V29, P367, DOI 10.1016/S0896-6273(01)00212-4; Pierani A, 1999, CELL, V97, P903, DOI 10.1016/S0092-8674(00)80802-8; Rekling JC, 1998, ANNU REV PHYSIOL, V60, P385, DOI 10.1146/annurev.physiol.60.1.385; Renier N, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000325; Rose MF, 2009, P NATL ACAD SCI USA, V106, P22462, DOI 10.1073/pnas.0911579106; Sabatier C, 2004, CELL, V117, P157, DOI 10.1016/S0092-8674(04)00303-4; SMITH JC, 1991, SCIENCE, V254, P726, DOI 10.1126/science.1683005; Srour M, 2010, SCIENCE, V328, P592, DOI 10.1126/science.1186463; Stornetta RL, 2003, J COMP NEUROL, V455, P499, DOI 10.1002/cne.10504; Tan WB, 2008, NAT NEUROSCI, V11, P538, DOI 10.1038/nn.2104; Tan WB, 2010, J COMP NEUROL, V518, P1862, DOI 10.1002/cne.22308; Thoby-Brisson M, 2005, J NEUROSCI, V25, P4307, DOI 10.1523/JNEUROSCI.0551-05.2005; Thoby-Brisson M, 2009, NAT NEUROSCI, V12, P1028, DOI 10.1038/nn.2354; Wallen-Mackenzie A, 2006, J NEUROSCI, V26, P12294, DOI 10.1523/JNEUROSCI.3855-06.2006; Wilson SI, 2008, NEURON, V59, P413, DOI 10.1016/j.neuron.2008.07.020; Zhang Y, 2008, NEURON, V60, P84, DOI 10.1016/j.neuron.2008.09.027	50	149	150	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2010	13	9					1066	U55		10.1038/nn.2622	http://dx.doi.org/10.1038/nn.2622			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	643XC	20680010	Green Submitted			2022-12-28	WOS:000281332600011
J	Liu, K; Lu, Y; Lee, JK; Samara, R; Willenberg, R; Sears-Kraxberger, I; Tedeschi, A; Park, KK; Jin, D; Cai, B; Xu, BG; Connolly, L; Steward, O; Zheng, BH; He, ZG				Liu, Kai; Lu, Yi; Lee, Jae K.; Samara, Ramsey; Willenberg, Rafer; Sears-Kraxberger, Ilse; Tedeschi, Andrea; Park, Kevin Kyungsuk; Jin, Duo; Cai, Bin; Xu, Bengang; Connolly, Lauren; Steward, Oswald; Zheng, Binhai; He, Zhigang			PTEN deletion enhances the regenerative ability of adult corticospinal neurons	NATURE NEUROSCIENCE			English	Article							SPINAL-CORD-INJURY; CENTRAL-NERVOUS-SYSTEM; NEURITE GROWTH-INHIBITORS; NOGO-DEFICIENT MICE; AXON REGENERATION; FUNCTIONAL RECOVERY; TRACT AXONS; IN-VIVO; RAT; PLASTICITY	Despite the essential role of the corticospinal tract (CST) in controlling voluntary movements, successful regeneration of large numbers of injured CST axons beyond a spinal cord lesion has never been achieved. We found that PTEN/mTOR are critical for controlling the regenerative capacity of mouse corticospinal neurons. After development, the regrowth potential of CST axons was lost and this was accompanied by a downregulation of mTOR activity in corticospinal neurons. Axonal injury further diminished neuronal mTOR activity in these neurons. Forced upregulation of mTOR activity in corticospinal neurons by conditional deletion of Pten, a negative regulator of mTOR, enhanced compensatory sprouting of uninjured CST axons and enabled successful regeneration of a cohort of injured CST axons past a spinal cord lesion. Furthermore, these regenerating CST axons possessed the ability to reform synapses in spinal segments distal to the injury. Thus, modulating neuronal intrinsic PTEN/mTOR activity represents a potential therapeutic strategy for promoting axon regeneration and functional repair after adult spinal cord injury.	[Liu, Kai; Lu, Yi; Tedeschi, Andrea; Park, Kevin Kyungsuk; Jin, Duo; Cai, Bin; Xu, Bengang; Connolly, Lauren; He, Zhigang] Childrens Hosp, FM Kirby Neurobiol Ctr, Boston, MA 02115 USA; [Liu, Kai; Lu, Yi; Tedeschi, Andrea; Park, Kevin Kyungsuk; Jin, Duo; Cai, Bin; Xu, Bengang; Connolly, Lauren; He, Zhigang] Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; [Lee, Jae K.; Samara, Ramsey; Zheng, Binhai] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Willenberg, Rafer; Sears-Kraxberger, Ilse; Steward, Oswald] Univ Calif Irvine, Coll Med, Reeve Irvine Res Ctr, Irvine, CA 92717 USA; [Willenberg, Rafer; Sears-Kraxberger, Ilse; Steward, Oswald] Univ Calif Irvine, Coll Med, Dept Anat & Neurobiol Neurobiol & Behav & Neurosu, Irvine, CA 92717 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; University of California System; University of California San Diego; University of California System; University of California Irvine; University of California System; University of California Irvine	He, ZG (corresponding author), Childrens Hosp, FM Kirby Neurobiol Ctr, 300 Longwood Ave, Boston, MA 02115 USA.	zhigang.he@childrens.harvard.edu	Lu, Yi/AEV-5561-2022	Liu, Kai/0000-0001-9351-1640; Steward, Oswald/0000-0001-7069-8756	Wings for Life; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; Craig H. Neilson Foundation; National Institute of Neurological Disorders and Stroke; International Spinal Research Trust; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS068128, F31NS070558, R01NS054734] Funding Source: NIH RePORTER	Wings for Life; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; Craig H. Neilson Foundation; National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); International Spinal Research Trust; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank F. Wang for providing Rosa-stop-PLAP mice and M. Greenberg, M. Tessier-Lavigne and C. Woolf for reading the manuscript. This work was supported by grants from Wings for Life (K.L. and Z.H.), the Dr. Miriam and Sheldon G. Adelson Medical Research Foundation (Z.H.), the Craig H. Neilson Foundation (Y.L. and K.K.P.), the National Institute of Neurological Disorders and Stroke (Z.H., B.Z. and O.S.), the International Spinal Research Trust (Z.H.) and a private contribution to the Reeve-Irvine Research Center (O.S.). R.W. is the recipient of a predoctoral fellowship from the National Institute of Neurological Disorders and Stroke.	Alto LT, 2009, NAT NEUROSCI, V12, P1106, DOI 10.1038/nn.2365; Arlotta P, 2005, NEURON, V45, P207, DOI 10.1016/j.neuron.2004.12.036; Bareyre FM, 2005, NAT MED, V11, P1355, DOI 10.1038/nm1331; Bareyre FM, 2004, NAT NEUROSCI, V7, P269, DOI 10.1038/nn1195; Berger W, 1998, NEUROSCI BIOBEHAV R, V22, P579, DOI 10.1016/S0149-7634(97)00047-X; BERNSTEI.JJ, 1973, EXP NEUROL, V41, P402, DOI 10.1016/0014-4886(73)90282-3; Blesch A, 2009, TRENDS NEUROSCI, V32, P41, DOI 10.1016/j.tins.2008.09.008; BREGMAN BS, 1989, J COMP NEUROL, V282, P355, DOI 10.1002/cne.902820304; Bundesen LQ, 2003, J NEUROSCI, V23, P7789; Cafferty WBJ, 2006, J NEUROSCI, V26, P12242, DOI 10.1523/JNEUROSCI.3827-06.2006; Case LC, 2005, CURR BIOL, V15, pR749, DOI 10.1016/j.cub.2005.09.008; Courtine G, 2008, NAT MED, V14, P69, DOI 10.1038/nm1682; DAVID S, 1981, SCIENCE, V214, P931, DOI 10.1126/science.6171034; Deumens R, 2005, PROG NEUROBIOL, V77, P57, DOI 10.1016/j.pneurobio.2005.10.004; Fujiki M, 1996, J COMP NEUROL, V371, P469; Garcia-Alias G, 2009, NAT NEUROSCI, V12, P1145, DOI 10.1038/nn.2377; Groszer M, 2001, SCIENCE, V294, P2186, DOI 10.1126/science.1065518; Hasegawa H, 2008, J COMP NEUROL, V511, P543, DOI 10.1002/cne.21862; Hiebert GW, 2002, J NEUROSCI RES, V69, P160, DOI 10.1002/jnr.10275; Hollis ER, 2009, EXP NEUROL, V215, P53, DOI 10.1016/j.expneurol.2008.09.014; Houle JD, 2006, J NEUROSCI, V26, P7405, DOI 10.1523/JNEUROSCI.1166-06.2006; Inman DM, 2003, J COMP NEUROL, V462, P431, DOI 10.1002/cne.10768; Kennard MA, 1936, AM J PHYSIOL, V115, P138, DOI 10.1152/ajplegacy.1936.115.1.138; Kim JE, 2003, NEURON, V38, P187, DOI 10.1016/S0896-6273(03)00147-8; Leaver SG, 2006, GENE THER, V13, P1328, DOI 10.1038/sj.gt.3302791; Lee JK, 2009, J NEUROSCI, V29, P8649, DOI 10.1523/JNEUROSCI.1864-09.2009; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Maier IC, 2008, J NEUROSCI, V28, P9386, DOI 10.1523/JNEUROSCI.1697-08.2008; Park KK, 2010, EXP NEUROL, V223, P45, DOI 10.1016/j.expneurol.2009.12.032; Park KK, 2008, SCIENCE, V322, P963, DOI 10.1126/science.1161566; Pearse DD, 2004, NAT MED, V10, P610, DOI 10.1038/nm1056; Persson S, 2006, J COMP NEUROL, V497, P683, DOI 10.1002/cne.20987; Raineteau O, 2001, NAT REV NEUROSCI, V2, P263, DOI 10.1038/35067570; RICHARDSON PM, 1984, J NEUROCYTOL, V13, P165, DOI 10.1007/BF01148324; SAVIO T, 1990, P NATL ACAD SCI USA, V87, P4130, DOI 10.1073/pnas.87.11.4130; SCHNELL L, 1990, NATURE, V343, P269, DOI 10.1038/343269a0; SCHNELL L, 1994, NATURE, V367, P170, DOI 10.1038/367170a0; Simonen M, 2003, NEURON, V38, P201, DOI 10.1016/S0896-6273(03)00226-5; Steward O, 2008, J NEUROSCI, V28, P6836, DOI 10.1523/JNEUROSCI.5372-07.2008; Thallmair M, 1998, NAT NEUROSCI, V1, P124, DOI 10.1038/373; Tom VJ, 2004, J NEUROSCI, V24, P6531, DOI 10.1523/JNEUROSCI.0994-04.2004; Varoqui H, 2002, J NEUROSCI, V22, P142, DOI 10.1523/JNEUROSCI.22-01-00142.2002; Weidner N, 2001, P NATL ACAD SCI USA, V98, P3513, DOI 10.1073/pnas.051626798; YIN HS, 1983, J NEUROSCI, V3, P1135; Zhao M, 2006, NATURE, V442, P457, DOI 10.1038/nature04925; Zheng BH, 2003, NEURON, V38, P213, DOI 10.1016/S0896-6273(03)00225-3; Zheng BH, 2006, TRENDS NEUROSCI, V29, P640, DOI 10.1016/j.tins.2006.09.005; Zhou FQ, 2004, NEURON, V42, P897, DOI 10.1016/j.neuron.2004.05.011	48	643	679	5	117	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2010	13	9					1075	U64		10.1038/nn.2603	http://dx.doi.org/10.1038/nn.2603			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	643XC	20694004	Green Submitted, Green Accepted			2022-12-28	WOS:000281332600012
J	Schlosburg, JE; Blankman, JL; Long, JZ; Nomura, DK; Pan, B; Kinsey, SG; Nguyen, PT; Ramesh, D; Booker, L; Burston, JJ; Thomas, EA; Selley, DE; Sim-Selley, LJ; Liu, QS; Lichtman, AH; Cravatt, BF				Schlosburg, Joel E.; Blankman, Jacqueline L.; Long, Jonathan Z.; Nomura, Daniel K.; Pan, Bin; Kinsey, Steven G.; Nguyen, Peter T.; Ramesh, Divya; Booker, Lamont; Burston, James J.; Thomas, Elizabeth A.; Selley, Dana E.; Sim-Selley, Laura J.; Liu, Qing-song; Lichtman, Aron H.; Cravatt, Benjamin F.			Chronic monoacylglycerol lipase blockade causes functional antagonism of the endocannabinoid system	NATURE NEUROSCIENCE			English	Article							ACID AMIDE HYDROLASE; CANNABINOID RECEPTOR ADAPTATION; PRECIPITATED WITHDRAWAL; BRAIN; DELTA(9)-TETRAHYDROCANNABINOL; ANANDAMIDE; TOLERANCE; ENZYMES; IDENTIFICATION; INHIBITION	Prolonged exposure to drugs of abuse, such as cannabinoids and opioids, leads to pharmacological tolerance and receptor desensitization in the nervous system. We found that a similar form of functional antagonism was produced by sustained inactivation of monoacylglycerol lipase (MAGL), the principal degradative enzyme for the endocannabinoid 2-arachidonoylglycerol. After repeated administration, the MAGL inhibitor JZL184 lost its analgesic activity and produced cross-tolerance to cannabinoid receptor (CB1) agonists in mice, effects that were phenocopied by genetic disruption of Mgll (encoding MAGL). Chronic MAGL blockade also caused physical dependence, impaired endocannabinoid-dependent synaptic plasticity and desensitized brain CB1 receptors. These data contrast with blockade of fatty acid amide hydrolase, an enzyme that degrades the other major endocannabinoid anandamide, which produced sustained analgesia without impairing CB1 receptors. Thus, individual endocannabinoids generate distinct analgesic profiles that are either sustained or transitory and associated with agonism and functional antagonism of the brain cannabinoid system, respectively.	[Schlosburg, Joel E.; Kinsey, Steven G.; Nguyen, Peter T.; Ramesh, Divya; Booker, Lamont; Burston, James J.; Selley, Dana E.; Sim-Selley, Laura J.; Lichtman, Aron H.] Virginia Commonwealth Univ, Dept Pharmacol & Toxicol, Richmond, VA 23284 USA; [Blankman, Jacqueline L.; Long, Jonathan Z.; Nomura, Daniel K.; Cravatt, Benjamin F.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Blankman, Jacqueline L.; Long, Jonathan Z.; Nomura, Daniel K.; Cravatt, Benjamin F.] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA; [Pan, Bin; Liu, Qing-song] Med Coll Wisconsin, Dept Pharmacol & Toxicol, Milwaukee, WI 53226 USA; [Thomas, Elizabeth A.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA	Virginia Commonwealth University; Scripps Research Institute; Scripps Research Institute; Medical College of Wisconsin; Scripps Research Institute	Lichtman, AH (corresponding author), Virginia Commonwealth Univ, Dept Pharmacol & Toxicol, Richmond, VA 23284 USA.	alichtma@vcu.edu; cravatt@scripps.edu	Pan, Bin/D-5626-2011; Pan, Bin/C-9630-2011	Long, Jonathan/0000-0003-2631-7463; Pan, Bin/0000-0002-5134-2508	US National Institutes of Health [DA017259, DA009789, DA025285, DA005274, DA015683, DA03672, DA07027, DA014277, DA023758, DA024741]; Ruth L. Kirschstein US National Institutes of Health [DA023758, DA026261, DA026279, DA028333]; American Cancer Society; Skaggs Institute for Chemical Biology; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA014277, P50DA005274, R01DA025285, R01DA003672, F31DA026261, F31DA028333, P01DA017259, R37DA003672, R01DA024741, P01DA009789, T32DA007027, R01DA015683, F31DA026279, F30DA023758] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ruth L. Kirschstein US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Skaggs Institute for Chemical Biology; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank S. Niessen and H. Hoover for assistance with proteomics studies, I. Beletskaya and R. Abdullah for technical support and the Cravatt and Lichtman laboratories for critical reading of the manuscript. This work was supported by the US National Institutes of Health (grants DA017259, DA009789, DA025285, DA005274, DA015683, DA03672, DA005274, DA07027, DA014277, DA023758 and DA024741), Ruth L. Kirschstein US National Institutes of Health Predoctoral Fellowships (DA026261 to J.L.B., DA026279 to J.E.S., DA028333 to L.B. and DA023758 to P.T.N.), the American Cancer Society (D.K.N.) and the Skaggs Institute for Chemical Biology.	ACETO MD, 1995, EUR J PHARMACOL, V282, pR1, DOI 10.1016/0014-2999(95)00447-S; Ahn K, 2008, CHEM REV, V108, P1687, DOI 10.1021/cr0782067; Ahn K, 2009, CHEM BIOL, V16, P411, DOI 10.1016/j.chembiol.2009.02.013; Blankman JL, 2007, CHEM BIOL, V14, P1347, DOI 10.1016/j.chembiol.2007.11.006; Caille S, 2007, J NEUROSCI, V27, P3695, DOI 10.1523/JNEUROSCI.4403-06.2007; Cravatt BF, 1996, NATURE, V384, P83, DOI 10.1038/384083a0; Cravatt BF, 2001, P NATL ACAD SCI USA, V98, P9371, DOI 10.1073/pnas.161191698; DEUTSCH DG, 1993, BIOCHEM PHARMACOL, V46, P791, DOI 10.1016/0006-2952(93)90486-G; DEVANE WA, 1992, SCIENCE, V258, P1946, DOI 10.1126/science.1470919; Falenski KW, 2010, NEUROPSYCHOPHARMACOL, V35, P1775, DOI 10.1038/npp.2010.44; FAN F, 1994, J PHARMACOL EXP THER, V271, P1383; Fowler CJ, 2006, FUND CLIN PHARMACOL, V20, P549, DOI 10.1111/j.1472-8206.2006.00442.x; Gao Y, 2010, J NEUROSCI, V30, P2017, DOI 10.1523/JNEUROSCI.5693-09.2010; Haller J, 2009, PSYCHOPHARMACOLOGY, V204, P607, DOI 10.1007/s00213-009-1494-7; Hillard CJ, 2000, PROSTAG OTH LIPID M, V61, P3, DOI 10.1016/S0090-6980(00)00051-4; Jhaveri MD, 2006, J NEUROSCI, V26, P13318, DOI 10.1523/JNEUROSCI.3326-06.2006; Kathuria S, 2003, NAT MED, V9, P76, DOI 10.1038/nm803; Kinsey SG, 2009, J PHARMACOL EXP THER, V330, P902, DOI 10.1124/jpet.109.155465; Kreitzer AC, 2002, CURR OPIN NEUROBIOL, V12, P324, DOI 10.1016/S0959-4388(02)00328-8; Lanoir J, 2006, J COMP NEUROL, V495, P607, DOI 10.1002/cne.20916; Lichtman AH, 2002, J PHARMACOL EXP THER, V302, P73, DOI 10.1124/jpet.302.1.73; Lichtman AH, 2004, PAIN, V109, P319, DOI 10.1016/j.pain.2004.01.022; Lichtman AH, 2004, J PHARMACOL EXP THER, V311, P441, DOI 10.1124/jpet.104.069401; Lichtman AH, 2005, HANDB EXP PHARMACOL, V168, P691; Lichtman AH, 1996, J PHARMACOL EXP THER, V276, P585; Liu YS, 1999, P NATL ACAD SCI USA, V96, P14694, DOI 10.1073/pnas.96.26.14694; Long JZ, 2009, P NATL ACAD SCI USA, V106, P20270, DOI 10.1073/pnas.0909411106; Long JZ, 2009, CHEM BIOL, V16, P744, DOI 10.1016/j.chembiol.2009.05.009; Long JZ, 2009, NAT CHEM BIOL, V5, P37, DOI 10.1038/nchembio.129; Luk T, 2004, BRIT J PHARMACOL, V142, P495, DOI 10.1038/sj.bjp.0705792; Mackie K, 2006, ANNU REV PHARMACOL, V46, P101, DOI 10.1146/annurev.pharmtox.46.120604.141254; Marsicano G, 2003, SCIENCE, V302, P84, DOI 10.1126/science.1088208; MECHOULAM R, 1995, BIOCHEM PHARMACOL, V50, P83, DOI 10.1016/0006-2952(95)00109-D; Monory K, 2007, PLOS BIOL, V5, P2354, DOI 10.1371/journal.pbio.0050269; Nomura DK, 2008, NAT CHEM BIOL, V4, P373, DOI 10.1038/nchembio.86; Ohno-Shosaku T, 2001, NEURON, V29, P729, DOI 10.1016/S0896-6273(01)00247-1; Pacher P, 2006, PHARMACOL REV, V58, P389, DOI 10.1124/pr.58.3.2; Pan B, 2009, J PHARMACOL EXP THER, V331, P591, DOI 10.1124/jpet.109.158162; PERTWEE RG, 1991, NEUROPHARMACOLOGY, V30, P237, DOI 10.1016/0028-3908(91)90150-A; Romero J, 1997, MOL BRAIN RES, V46, P100, DOI 10.1016/S0169-328X(96)00277-X; Schlosburg JE, 2009, AAPS J, V11, P342, DOI 10.1208/s12248-009-9110-7; Sim LJ, 1996, J NEUROSCI, V16, P8057; Sim-Selley LJ, 2002, J PHARMACOL EXP THER, V303, P36, DOI 10.1124/jpet.102.035618; Straiker A, 2009, MOL PHARMACOL, V76, P1220, DOI 10.1124/mol.109.059030; SUGIURA T, 1995, BIOCHEM BIOPH RES CO, V215, P89, DOI 10.1006/bbrc.1995.2437; Sun M, 2007, J PHYSIOL-LONDON, V578, P751, DOI 10.1113/jphysiol.2006.120147; Tanimura A, 2010, NEURON, V65, P320, DOI 10.1016/j.neuron.2010.01.021; Thomas EA, 2001, J NEUROCHEM, V76, P789, DOI 10.1046/j.1471-4159.2001.00027.x; Wilson RI, 2001, NEURON, V31, P453, DOI 10.1016/S0896-6273(01)00372-5; Wilson RI, 2002, SCIENCE, V296, P678, DOI 10.1126/science.1063545	50	449	461	0	50	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2010	13	9					1113	U111		10.1038/nn.2616	http://dx.doi.org/10.1038/nn.2616			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	643XC	20729846	Green Accepted			2022-12-28	WOS:000281332600017
J	Jazayeri, M; Shadlen, MN				Jazayeri, Mehrdad; Shadlen, Michael N.			Temporal context calibrates interval timing	NATURE NEUROSCIENCE			English	Article							FRONTAL-CORTEX; NEURAL BASIS; TIME; REPRESENTATION; DECISION; CUES; DISCRIMINATION; INTEGRATION; PERCEPTION; JUDGMENT	We use our sense of time to identify temporal relationships between events and to anticipate actions. The degree to which we can exploit temporal contingencies depends on the variability of our measurements of time. We asked humans to reproduce time intervals drawn from different underlying distributions. As expected, production times were more variable for longer intervals. However, production times exhibited a systematic regression toward the mean. Consequently, estimates for a sample interval differed depending on the distribution from which it was drawn. A performance-optimizing Bayesian model that takes the underlying distribution of samples into account provided an accurate description of subjects' performance, variability and bias. This finding suggests that the CNS incorporates knowledge about temporal uncertainty to adapt internal timing mechanisms to the temporal statistics of the environment.	[Jazayeri, Mehrdad] Helen Hay Whitney Fdn, New York, NY USA; [Jazayeri, Mehrdad; Shadlen, Michael N.] Univ Washington, Dept Physiol & Biophys, Natl Primate Res Ctr, Howard Hughes Med Inst, Seattle, WA 98195 USA	Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Jazayeri, M (corresponding author), Helen Hay Whitney Fdn, New York, NY USA.	mjaz@u.washington.edu	Shadlen, Michael Neil/AAL-1870-2020	Shadlen, Michael/0000-0002-2002-2210	Helen Hay Whitney Foundation; Howard Hughes Medical Institute; US National Institutes of Health [EY11378, RR000166]; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000166] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY011378] Funding Source: NIH RePORTER	Helen Hay Whitney Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We are grateful to G. Horwitz for sharing resources and to both G. Horwitz and V. de Lafuente for their feedback on the manuscript. This work was supported by a fellowship from Helen Hay Whitney Foundation, the Howard Hughes Medical Institute and research grants EY11378 and RR000166 from the US National Institutes of Health.	AHRENS M, 2008, ADV NEURAL INFORM PR; ALLAN LG, 1979, PERCEPT PSYCHOPHYS, V26, P340, DOI 10.3758/BF03204158; Bernardo JM, 1994, BAYESIAN THEORY; Brannon EM, 2008, J COGNITIVE NEUROSCI, V20, P193, DOI 10.1162/jocn.2008.20016; Buonomano DV, 2009, NAT REV NEUROSCI, V10, P113, DOI 10.1038/nrn2558; CREELMAN CD, 1962, J ACOUST SOC AM, V34, P582, DOI 10.1121/1.1918172; Cui X, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000167; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; Gallistel CR, 2000, PSYCHOL REV, V107, P289, DOI 10.1037/0033-295X.107.2.289; GIBBON J, 1992, J EXP ANAL BEHAV, V57, P393, DOI 10.1901/jeab.1992.57-393; Gold JI, 2008, J NEUROPHYSIOL, V100, P2653, DOI 10.1152/jn.90629.2008; Graf EW, 2005, VISION RES, V45, P3050, DOI 10.1016/j.visres.2005.08.007; HELSON H, 1948, PSYCHOL REV, V55, P297, DOI 10.1037/h0056721; HOLLINGWORTH HL, 1913, ARCH PSYCHOL, V4, P44; Hudson TE, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000130; Jacobs RA, 1999, VISION RES, V39, P3621, DOI 10.1016/S0042-6989(99)00088-7; Janssen P, 2005, NAT NEUROSCI, V8, P234, DOI 10.1038/nn1386; Kersten D, 2004, ANNU REV PSYCHOL, V55, P271, DOI 10.1146/annurev.psych.55.090902.142005; Knill DC, 1996, PERCEPTION BAYESIAN; Kording KP, 2004, P NATL ACAD SCI USA, V101, P9839, DOI 10.1073/pnas.0308394101; Kording KP, 2004, NATURE, V427, P244, DOI 10.1038/nature02169; Lauwereyns J, 2002, NEURON, V33, P463, DOI 10.1016/S0896-6273(02)00571-8; Lee IH, 2003, J NEUROPHYSIOL, V89, P2528, DOI 10.1152/jn.01055.2002; Lewis PA, 2009, PHILOS T R SOC B, V364, P1897, DOI 10.1098/rstb.2009.0020; Maimon G, 2006, NAT NEUROSCI, V9, P948, DOI 10.1038/nn1716; Mamassian P, 2002, NEU INF PRO, P13; Mamassian P, 2008, PSYCHOL SCI, V19, P601, DOI 10.1111/j.1467-9280.2008.02129.x; Matell MS, 2004, COGNITIVE BRAIN RES, V21, P139, DOI 10.1016/j.cogbrainres.2004.06.012; Mauk MD, 2004, ANNU REV NEUROSCI, V27, P307, DOI 10.1146/annurev.neuro.27.070203.144247; Meck WH, 2008, CURR OPIN NEUROBIOL, V18, P145, DOI 10.1016/j.conb.2008.08.002; Mita A, 2009, NAT NEUROSCI, V12, P502, DOI 10.1038/nn.2272; Miyazaki M, 2005, J NEUROPHYSIOL, V94, P395, DOI 10.1152/jn.01168.2004; Nobrel AC, 2007, CURR OPIN NEUROBIOL, V17, P465, DOI 10.1016/j.conb.2007.07.006; OKANO K, 1987, EXP BRAIN RES, V66, P155; PARDUCCI A, 1965, PSYCHOL REV, V72, P407, DOI 10.1037/h0022602; Rakitin BC, 1998, J EXP PSYCHOL-ANIM B, V24, P15, DOI 10.1037/0097-7403.24.1.15; Rao SM, 2001, NAT NEUROSCI, V4, P317, DOI 10.1038/85191; Raphan M., 2006, NEURAL INFORM PROCES, V19, P1145; Reutimann J, 2004, J NEUROSCI, V24, P3295, DOI 10.1523/JNEUROSCI.4098-03.2004; SCHULTZ W, 1992, EXP BRAIN RES, V91, P363; Shadlen MN, 2001, J NEUROPHYSIOL, V86, P1916, DOI 10.1152/jn.2001.86.4.1916; Stocker AA, 2006, NAT NEUROSCI, V9, P578, DOI 10.1038/nn1669; Tanaka M, 2006, NAT NEUROSCI, V9, P20, DOI 10.1038/nn1617; Tanaka M, 2007, J NEUROSCI, V27, P12109, DOI 10.1523/JNEUROSCI.1873-07.2007; Tassinari H, 2006, J NEUROSCI, V26, P10154, DOI 10.1523/JNEUROSCI.2779-06.2006; Toth LJ, 2002, NATURE, V415, P165, DOI 10.1038/415165a; TREISMAN M, 1963, PSYCHOL MONOGR, V77, P1, DOI 10.1037/h0093864; Trommershauser J, 2003, J OPT SOC AM A, V20, P1419, DOI 10.1364/JOSAA.20.001419	48	391	393	4	55	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2010	13	8					1020	U152		10.1038/nn.2590	http://dx.doi.org/10.1038/nn.2590			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	632DK	20581842	Green Accepted			2022-12-28	WOS:000280400600022
J	Johansen, JP; Tarpley, JW; LeDoux, JE; Blair, HT				Johansen, Joshua P.; Tarpley, Jason W.; LeDoux, Joseph E.; Blair, Hugh T.			Neural substrates for expectation-modulated fear learning in the amygdala and periaqueductal gray	NATURE NEUROSCIENCE			English	Article							ANTERIOR CINGULATE CORTEX; LATERAL AMYGDALA; POTENTIATED STARTLE; SYNAPTIC PLASTICITY; CONDITIONED FEAR; RAT; PROJECTIONS; RESPONSES; NUCLEUS; NEURONS	A form of aversively motivated learning called fear conditioning occurs when a neutral conditioned stimulus is paired with an aversive unconditioned stimulus (UCS). UCS-evoked depolarization of amygdala neurons may instruct Hebbian plasticity that stores memories of the conditioned stimulus-unconditioned stimulus association, but the origin of UCS inputs to the amygdala is unknown. Theory and evidence suggest that instructive UCS inputs to the amygdala will be inhibited when the UCS is expected, but this has not been found during fear conditioning. We investigated neural pathways that relay information about the UCS to the amygdala by recording neurons in the amygdala and periaqueductal gray (PAG) of rats during fear conditioning. UCS-evoked responses in both amygdala and PAG were inhibited by expectation. Pharmacological inactivation of the PAG attenuated UCS-evoked responses in the amygdala and impaired acquisition of fear conditioning, indicating that PAG may be an important part of the pathway that relays instructive signals to the amygdala.	[Johansen, Joshua P.; Tarpley, Jason W.; Blair, Hugh T.] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA USA; [Johansen, Joshua P.; Tarpley, Jason W.] Univ Calif Los Angeles, Interdept Program Neurosci, Los Angeles, CA USA; [LeDoux, Joseph E.] NYU, Ctr Neural Sci, New York, NY 10003 USA; [LeDoux, Joseph E.] Nathan S Kline Inst Psychiat Res, Emot Brain Inst, Orangeburg, NY 10962 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; New York University; Nathan Kline Institute for Psychiatric Research	Blair, HT (corresponding author), Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA USA.	jtarpley@ucla.edu; blair@psych.ucla.edu	Johansen, Joshua/N-8010-2015	Johansen, Joshua/0000-0003-4240-1550; Blair, Hugh/0000-0001-8256-5109	National Science Foundation; National Alliance for Research on Schizophrenia and Depression; US National Institutes of Health [R01 MH073700-01]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH073700] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Alliance for Research on Schizophrenia and Depression(NARSAD); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We are grateful to S. Nicola and A. Welday for comments on an earlier version of the manuscript and M. Fanselow, D. Buonomano, R. Thompson, D. Schiller and Y. Niv for valuable discussions. This work was supported by a National Science Foundation Graduate Research Fellowship to J.P.J. and a National Alliance for Research on Schizophrenia and Depression Young Investigator Award and US National Institutes of Health grant (R01 MH073700-01) to H. T. B.	ASTONJONES G, 1991, PROG BRAIN RES, V88, P47; Belova MA, 2007, NEURON, V55, P970, DOI 10.1016/j.neuron.2007.08.004; Blair HT, 2005, J NEUROSCI, V25, P4198, DOI 10.1523/JNEUROSCI.0674-05.2005; Blair HT, 2001, LEARN MEMORY, V8, P229, DOI 10.1101/lm.30901; BOLLES RC, 1980, BEHAV BRAIN SCI, V3, P291, DOI 10.1017/S0140525X0000491X; Borszcz GS, 2006, PAIN, V123, P155, DOI 10.1016/j.pain.2006.02.026; Brunzell DH, 2001, BEHAV NEUROSCI, V115, P365, DOI 10.1037//0735-7044.115.2.365; CASSELL MD, 1986, BRAIN RES BULL, V17, P321, DOI 10.1016/0361-9230(86)90237-6; Collins DR, 2000, LEARN MEMORY, V7, P97, DOI 10.1101/lm.7.2.97; DISCALA G, 1987, PHYSIOL BEHAV, V40, P55, DOI 10.1016/0031-9384(87)90185-5; ENNIS M, 1991, J COMP NEUROL, V306, P480, DOI 10.1002/cne.903060311; Fanselow M.S., 1991, MIDBRAIN PERIAQUEDUC; Fanselow MS, 1998, NEURON, V20, P625, DOI 10.1016/S0896-6273(00)81002-8; Fanselow MS, 2005, ANNU REV PSYCHOL, V56, P207, DOI 10.1146/annurev.psych.56.091103.070213; Gauriau C, 2004, J COMP NEUROL, V468, P24, DOI 10.1002/cne.10873; Goosens KA, 2003, NEURON, V40, P1013, DOI 10.1016/S0896-6273(03)00728-1; Han JH, 2007, SCIENCE, V316, P457, DOI [10.1126/science.1139438, 10.1126/science.1134697]; HELMSTETTER FJ, 1994, J NEUROSCI, V14, P7099; Helmstetter FJ, 2008, NEUROBIOL LEARN MEM, V89, P324, DOI 10.1016/j.nlm.2007.09.002; HERRERO MT, 1991, BRAIN RES, V543, P201, DOI 10.1016/0006-8993(91)90029-U; Herry C, 2007, J NEUROSCI, V27, P5958, DOI 10.1523/JNEUROSCI.5218-06.2007; Johansen JP, 2004, NAT NEUROSCI, V7, P398, DOI 10.1038/nn1207; Kamin L. J., 1968, MIAMI S PREDICTION B, P9; Keay KA, 1997, J COMP NEUROL, V385, P207, DOI 10.1002/(SICI)1096-9861(19970825)385:2<207::AID-CNE3>3.0.CO;2-5; KIM JJ, 1993, BEHAV NEUROSCI, V107, P1093, DOI 10.1037/0735-7044.107.6.1093; Knudsen EI, 2002, NATURE, V417, P322, DOI 10.1038/417322a; Lang PJ, 2006, PROG BRAIN RES, V156, P3, DOI 10.1016/S0079-6123(06)56001-7; Lanuza E, 2004, NEUROSCIENCE, V125, P305, DOI 10.1016/j.neuroscience.2003.12.034; LEDOUX JE, 1988, J NEUROSCI, V8, P2517; Maren S, 2004, NAT REV NEUROSCI, V5, P844, DOI 10.1038/nrn1535; McNally GP, 2006, LEARN MEMORY, V13, P245, DOI 10.1101/lm.196606; McNally GP, 2006, BEHAV NEUROSCI, V120, P313, DOI 10.1037/0735-7044.120.2.313; OTTERSEN OP, 1981, J COMP NEUROL, V202, P335, DOI 10.1002/cne.902020304; QUIRK GJ, 1995, NEURON, V15, P1029, DOI 10.1016/0896-6273(95)90092-6; Repa JC, 2001, NAT NEUROSCI, V4, P724, DOI 10.1038/89512; Rescorla R. A., 1972, CLASSICAL CONDITIONI; ROMANSKI LM, 1993, BEHAV NEUROSCI, V107, P444, DOI 10.1037/0735-7044.107.3.444; Rosenkranz JA, 2002, NATURE, V417, P282, DOI 10.1038/417282a; Rumpel S, 2005, SCIENCE, V308, P83, DOI 10.1126/science.1103944; Sah P, 2008, ANN NY ACAD SCI, V1129, P88, DOI 10.1196/annals.1417.020; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; Shi CJ, 1999, J NEUROSCI, V19, P420, DOI 10.1523/JNEUROSCI.19-01-00420.1999; SWANSON LW, 1982, BRAIN RES BULL, V9, P321, DOI 10.1016/0361-9230(82)90145-9; Tang JR, 2005, MOL PAIN, V1, DOI 10.1186/1744-8069-1-6; Thompson RF, 1998, NEUROBIOL LEARN MEM, V70, P150, DOI 10.1006/nlme.1998.3845; UWANO T, 1995, NEUROSCIENCE, V68, P339, DOI 10.1016/0306-4522(95)00125-3; Yacubian J, 2006, J NEUROSCI, V26, P9530, DOI 10.1523/JNEUROSCI.2915-06.2006; YOUNG SL, 1992, J EXP PSYCHOL ANIM B, V18, P400, DOI 10.1037/0097-7403.18.4.400; Zhao ZW, 2004, J NEUROSCI, V24, P10326, DOI 10.1523/JNEUROSCI.2758-04.2004	50	184	184	2	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2010	13	8					979	U102		10.1038/nn.2594	http://dx.doi.org/10.1038/nn.2594			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	632DK	20601946	Green Accepted			2022-12-28	WOS:000280400600017
J	Wyllie, DJA; Traynelis, SF				Wyllie, David J. A.; Traynelis, Stephen F.			NMDA receptor permeation: a light in the tunnel	NATURE NEUROSCIENCE			English	Editorial Material							D-ASPARTATE RECEPTORS; CHANNEL PORE; GLUTAMATE; NEURONS; CELLS; BLOCK	A single amino acid residue determines single-channel conductance, ion permeation and channel block in the NMDA receptor, three of the key features of this ligand-gated ion channel.	[Wyllie, David J. A.] Univ Edinburgh, Ctr Integrat Physiol, Edinburgh, Midlothian, Scotland; [Traynelis, Stephen F.] Emory Univ, Dept Pharmacol, Atlanta, GA 30322 USA	University of Edinburgh; Emory University	Wyllie, DJA (corresponding author), Univ Edinburgh, Ctr Integrat Physiol, Edinburgh, Midlothian, Scotland.	dwyllie1@staffmail.ed.ac.uk; strayne@emory.edu	Wyllie, David J A/AAK-4678-2021	Wyllie, David J A/0000-0002-4957-6049	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036654, R37NS036654, R01NS065371] Funding Source: NIH RePORTER; NINDS NIH HHS [NS065371, NS036654] Funding Source: Medline; Wellcome Trust [R41653, R42176] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Wellcome Trust(Wellcome TrustEuropean Commission)		BURNASHEV N, 1992, SCIENCE, V257, P1415, DOI 10.1126/science.1382314; CULLCANDY SG, 1987, NATURE, V325, P525, DOI 10.1038/325525a0; GIBB AJ, 1992, J PHYSIOL-LONDON, V456, P143, DOI 10.1113/jphysiol.1992.sp019331; HOWE JR, 1991, J PHYSIOL-LONDON, V432, P143, DOI 10.1113/jphysiol.1991.sp018381; JAHR CE, 1987, NATURE, V325, P522, DOI 10.1038/325522a0; Kashiwagi K, 2002, MOL PHARMACOL, V61, P533, DOI 10.1124/mol.61.3.533; Kuner T, 1996, J NEUROSCI, V16, P3549; MAYER ML, 1984, NATURE, V309, P261, DOI 10.1038/309261a0; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; O'Leary T, 2009, BIOCHEM SOC T, V37, P1347, DOI 10.1042/BST0371347; Ogden KK, 2011, TRENDS PHARMACOL SCI, V32, P726, DOI 10.1016/j.tips.2011.08.003; Retchless BS, 2012, NAT NEUROSCI, V15, P406, DOI 10.1038/nn.3025; Schneggenburger R, 1997, NEURON, V18, P167, DOI 10.1016/S0896-6273(01)80055-6; Sobolevsky AI, 2009, NATURE, V462, P745, DOI 10.1038/nature08624; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451	15	3	3	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2012	15	3					343	344		10.1038/nn.3058	http://dx.doi.org/10.1038/nn.3058			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	899CY	22362102				2022-12-28	WOS:000300793100003
J	Fu, J; Bottegoni, G; Sasso, O; Bertorelli, R; Rocchia, W; Masetti, M; Guijarro, A; Lodola, A; Armirotti, A; Garau, G; Bandiera, T; Reggiani, A; Mor, M; Cavalli, A; Piomelli, D				Fu, Jin; Bottegoni, Giovanni; Sasso, Oscar; Bertorelli, Rosalia; Rocchia, Walter; Masetti, Matteo; Guijarro, Ana; Lodola, Alessio; Armirotti, Andrea; Garau, Gianpiero; Bandiera, Tiziano; Reggiani, Angelo; Mor, Marco; Cavalli, Andrea; Piomelli, Daniele			A catalytically silent FAAH-1 variant drives anandamide transport in neurons	NATURE NEUROSCIENCE			English	Article							ACID AMIDE HYDROLASE; CANNABINOID RECEPTOR; FORCE-FIELDS; INHIBITORS; INACTIVATION; ACCUMULATION; CELLS; 2-ARACHIDONOYLGLYCEROL; IDENTIFICATION; MODULATION	The endocannabinoid anandamide is removed from the synaptic space by a selective transport system, expressed in neurons and astrocytes, that remains molecularly uncharacterized. Here we describe a partly cytosolic variant of the intracellular anandamide-degrading enzyme fatty acid amide hydrolase-1 (FAAH-1), termed FAAH-like anandamide transporter (FLAT), that lacked amidase activity but bound anandamide with low micromolar affinity and facilitated its translocation into cells. Known anandamide transport inhibitors, such as AM404 and OMDM-1, blocked these effects. We also identified a competitive antagonist of the interaction of anandamide with FLAT, the phthalazine derivative ARN272, that prevented anandamide internalization in vitro, interrupted anandamide deactivation in vivo and exerted profound analgesic effects in rodent models of nociceptive and inflammatory pain, which were mediated by CB1 cannabinoid receptors. The results identify FLAT as a critical molecular component of anandamide transport in neural cells and a potential target for therapeutic drugs.	[Fu, Jin; Guijarro, Ana; Piomelli, Daniele] Univ Calif Irvine, Dept Pharmacol, Irvine, CA 92717 USA; [Bottegoni, Giovanni; Sasso, Oscar; Bertorelli, Rosalia; Rocchia, Walter; Masetti, Matteo; Armirotti, Andrea; Garau, Gianpiero; Bandiera, Tiziano; Reggiani, Angelo; Cavalli, Andrea; Piomelli, Daniele] Italian Inst Technol, Genoa, Italy; [Lodola, Alessio; Mor, Marco] Univ Parma, Dept Pharmaceut, I-43100 Parma, Italy; [Cavalli, Andrea] Univ Bologna, Dept Pharmaceut Sci, I-40126 Bologna, Italy	University of California System; University of California Irvine; Istituto Italiano di Tecnologia - IIT; University of Parma; University of Bologna	Piomelli, D (corresponding author), Univ Calif Irvine, Dept Pharmacol, Irvine, CA 92717 USA.	piomelli@uci.edu	Garau, Gianpiero/A-2800-2012; Garau, Gianpiero/AAM-4234-2021; Mor, Marco/D-2394-2009; Armirotti, Andrea/AAB-3284-2019; Lodola, Alessio/H-9078-2013; Fu, Jin/A-3510-2012; Rocchia, Walter/H-3784-2012; bertorelli, rosalia/A-2989-2012	Garau, Gianpiero/0000-0001-9473-5814; Garau, Gianpiero/0000-0001-9473-5814; Mor, Marco/0000-0003-0199-1849; Lodola, Alessio/0000-0002-8675-1002; Rocchia, Walter/0000-0003-2480-7151; CAVALLI, ANDREA/0000-0002-6370-1176; Armirotti, Andrea/0000-0002-3766-8755; Masetti, Matteo/0000-0002-3757-7802; GUIJARRO ANTON, Ana Isabel/0000-0002-1595-2173; Bottegoni, Giovanni/0000-0003-1251-583X; BERTORELLI, Rosalia/0000-0002-7913-3564	US National Institute on Drug Abuse; US National Institute on Alcohol Abuse and Alcoholism [DA-012413]; US National Institute on General Medicine [1R01GM093937-01]; Agilent/University of California Irvine Analytical Discovery Facility; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM093937] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA012413] Funding Source: NIH RePORTER	US National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); US National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); US National Institute on General Medicine; Agilent/University of California Irvine Analytical Discovery Facility; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank G. Colombano, J. Kim, S. Mandrup-Bertozzi, D. Thongkham, G. Moreno-Sanz and R. Scarpelli for help with experiments and discussions about the project. This research was supported by grants from the US National Institute on Drug Abuse and the US National Institute on Alcohol Abuse and Alcoholism (DA-012413 to D. P.) and the US National Institute on General Medicine (1R01GM093937-01 to W. R.). The support provided by the Agilent/University of California Irvine Analytical Discovery Facility is gratefully acknowledged.	ABAGYAN R, 1994, J MOL BIOL, V235, P983, DOI 10.1006/jmbi.1994.1052; Alexander JP, 2005, CHEM BIOL, V12, P1179, DOI 10.1016/j.chembiol.2005.08.011; Beltramo M, 1997, SCIENCE, V277, P1094, DOI 10.1126/science.277.5329.1094; Beltramo M, 2000, NEUROREPORT, V11, P1231, DOI 10.1097/00001756-200004270-00018; Bisogno T, 2001, EUR J BIOCHEM, V268, P1982, DOI 10.1046/j.1432-1327.2001.02072.x; Bojesen IN, 2003, J LIPID RES, V44, P1790, DOI 10.1194/jlr.M300170-JLR200; Bracey MH, 2002, SCIENCE, V298, P1793, DOI 10.1126/science.1076535; Cravatt BF, 2001, P NATL ACAD SCI USA, V98, P9371, DOI 10.1073/pnas.161191698; DEVANE WA, 1992, SCIENCE, V258, P1946, DOI 10.1126/science.1470919; Di Marzo V, 2008, NAT REV DRUG DISCOV, V7, P438, DOI 10.1038/nrd2553; Evans MS, 1998, J NEUROSCI METH, V79, P37, DOI 10.1016/S0165-0270(97)00159-3; Fu J, 2007, J BIOL CHEM, V282, P1518, DOI 10.1074/jbc.M607809200; Glaser ST, 2003, P NATL ACAD SCI USA, V100, P4269, DOI 10.1073/pnas.0730816100; Gulyas AI, 2004, EUR J NEUROSCI, V20, P441, DOI 10.1111/j.1460-9568.2004.03428.x; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Hillard CJ, 2007, J MOL NEUROSCI, V33, P18, DOI 10.1007/s12031-007-0045-0; Hillard CJ, 2003, BRIT J PHARMACOL, V140, P802, DOI 10.1038/sj.bjp.0705468; Hillard CJ, 1997, J NEUROCHEM, V69, P631, DOI 10.1046/j.1471-4159.1997.69020631.x; Jacobsson SOP, 2001, BRIT J PHARMACOL, V132, P1743, DOI 10.1038/sj.bjp.0704029; Kaczocha M, 2009, P NATL ACAD SCI USA, V106, P6375, DOI 10.1073/pnas.0901515106; KANAI N, 1995, SCIENCE, V268, P866, DOI 10.1126/science.7754369; Kathuria S, 2003, NAT MED, V9, P76, DOI 10.1038/nm803; La Rana G, 2006, J PHARMACOL EXP THER, V317, P1365, DOI 10.1124/jpet.105.100792; Li XQ, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-11; Lichtman AH, 2004, J PHARMACOL EXP THER, V311, P441, DOI 10.1124/jpet.104.069401; Ligresti A, 2004, BIOCHEM J, V380, P265, DOI 10.1042/BJ20031812; Maccarrone M, 2010, TRENDS BIOCHEM SCI, V35, P601, DOI 10.1016/j.tibs.2010.05.008; Maione S, 2008, BRIT J PHARMACOL, V155, P775, DOI 10.1038/bjp.2008.308; Matlin AJ, 2005, NAT REV MOL CELL BIO, V6, P386, DOI 10.1038/nrm1645; McKinney MK, 2005, ANNU REV BIOCHEM, V74, P411, DOI 10.1146/annurev.biochem.74.082803.133450; Niot I, 2009, PROG LIPID RES, V48, P101, DOI 10.1016/j.plipres.2009.01.001; Oddi S, 2009, CHEM BIOL, V16, P624, DOI 10.1016/j.chembiol.2009.05.004; Ortar G, 2003, BIOCHEM PHARMACOL, V65, P1473, DOI 10.1016/S0006-2952(03)00109-6; Ortega-Gutierrez S, 2004, BIOCHEMISTRY-US, V43, P8184, DOI 10.1021/bi049395f; Patricelli MP, 1999, BIOCHEMISTRY-US, V38, P14125, DOI 10.1021/bi991876p; PEARSON GDN, 1982, P NATL ACAD SCI-BIOL, V79, P2976, DOI 10.1073/pnas.79.9.2976; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Piomelli D, 1999, P NATL ACAD SCI USA, V96, P5802, DOI 10.1073/pnas.96.10.5802; Piomelli D, 2007, NAT REV NEUROSCI, V8, P743, DOI 10.1038/nrn2233; Reese-Wagoner A, 1999, BBA-MOL CELL BIOL L, V1441, P106, DOI 10.1016/S1388-1981(99)00154-7; Rocchia W, 2001, J PHYS CHEM B, V105, P6507, DOI 10.1021/jp010454y; Rosso L, 2008, J COMPUT CHEM, V29, P24, DOI 10.1002/jcc.20675; Russo R, 2007, J PHARMACOL EXP THER, V322, P236, DOI 10.1124/jpet.107.119941; Schwartz GJ, 2008, CELL METAB, V8, P281, DOI 10.1016/j.cmet.2008.08.005; Seierstad M, 2008, J MED CHEM, V51, P7327, DOI 10.1021/jm800311k; Speers AE, 2007, CHEM REV, V107, P3687, DOI 10.1021/cr068286z; Wei BQQ, 2006, J BIOL CHEM, V281, P36569, DOI 10.1074/jbc.M606646200; Yates ML, 2009, MOL PHARMACOL, V76, P11, DOI 10.1124/mol.109.055251	49	126	131	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2012	15	1					64	U82		10.1038/nn.2986	http://dx.doi.org/10.1038/nn.2986			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	866VO	22101642	Green Submitted, Green Accepted			2022-12-28	WOS:000298414400015
J	Baumgartner, T; Knoch, D; Hotz, P; Eisenegger, C; Fehr, E				Baumgartner, Thomas; Knoch, Daria; Hotz, Philine; Eisenegger, Christoph; Fehr, Ernst			Dorsolateral and ventromedial prefrontal cortex orchestrate normative choice	NATURE NEUROSCIENCE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; DECISION-MAKING; ORBITOFRONTAL CORTEX; COGNITIVE CONTROL; SOCIAL COGNITION; NEURAL CIRCUITRY; SELF-CONTROL; NEUROBIOLOGY; PREFERENCES; MODULATION	Humans are noted for their capacity to over-ride self-interest in favor of normatively valued goals. We examined the neural circuitry that is causally involved in normative, fairness-related decisions by generating a temporarily diminished capacity for costly normative behavior, a 'deviant' case, through non-invasive brain stimulation (repetitive transcranial magnetic stimulation) and compared normal subjects' functional magnetic resonance imaging signals with those of the deviant subjects. When fairness and economic self-interest were in conflict, normal subjects (who make costly normative decisions at a much higher frequency) displayed significantly higher activity in, and connectivity between, the right dorsolateral prefrontal cortex (DLPFC) and the posterior ventromedial prefrontal cortex (pVMPFC). In contrast, when there was no conflict between fairness and economic self-interest, both types of subjects displayed identical neural patterns and behaved identically. These findings suggest that a parsimonious prefrontal network, the activation of right DLPFC and pVMPFC, and the connectivity between them, facilitates subjects' willingness to incur the cost of normative decisions.	[Baumgartner, Thomas; Hotz, Philine; Eisenegger, Christoph; Fehr, Ernst] Univ Zurich, Dept Econ, Lab Social & Neural Syst Res, Zurich, Switzerland; [Baumgartner, Thomas; Knoch, Daria] Univ Basel, Dept Psychol, Lab Social & Affect Neurosci, Basel, Switzerland; [Eisenegger, Christoph] Univ Cambridge, Dept Expt Psychol, Behav & Clin Neurosci Inst, Cambridge CB2 3EB, England	University of Zurich; University of Basel; University of Cambridge	Baumgartner, T (corresponding author), Univ Zurich, Dept Econ, Lab Social & Neural Syst Res, Zurich, Switzerland.	t.baumgartner@unibas.ch; daria.knoch@unibas.ch; ernst.fehr@econ.uzh.ch	Knoch, Daria/H-7324-2012	Baumgartner, Thomas/0000-0001-5966-7377	Neurochoice Project of SystemsX; Swiss Initiative for Systems Biology; Swiss National Science Foundation [PP00P1-123381]	Neurochoice Project of SystemsX; Swiss Initiative for Systems Biology; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	We thank C. Ruff, K. E. Stephan and A. Rangel for their helpful comments. This study is a part of the project on the foundations of norm compliance in the National Center of Competence in Affective Sciences. E. F. also acknowledges support from the Neurochoice Project of SystemsX, the Swiss Initiative for Systems Biology. D. K. acknowledges support from the Swiss National Science Foundation (grant no. PP00P1-123381).	BAUMGARTNER T, 2011, HUM BRAIN MAPP  0513, DOI DOI 10.1002/HBM.21298; Baumgartner T, 2008, NEURON, V58, P639, DOI 10.1016/j.neuron.2008.04.009; Baumgartner T, 2009, NEURON, V64, P756, DOI 10.1016/j.neuron.2009.11.017; BLOUNT S, 1995, ORGAN BEHAV HUM DEC, V63, P131, DOI 10.1006/obhd.1995.1068; Boorman ED, 2009, NEURON, V62, P733, DOI 10.1016/j.neuron.2009.05.014; Boyd R, 2005, ORIGIN EVOLUTION CUL; Carter CS, 1998, SCIENCE, V280, P747, DOI 10.1126/science.280.5364.747; Chib VS, 2009, J NEUROSCI, V29, P12315, DOI 10.1523/JNEUROSCI.2575-09.2009; Damasio A, 1995, DESCARTES ERROR EMOT; de Quervain DJF, 2004, SCIENCE, V305, P1254, DOI 10.1126/science.1100735; Eisenegger C, 2008, NEUROIMAGE, V42, P379, DOI 10.1016/j.neuroimage.2008.04.172; Fehr E, 2003, NATURE, V425, P785, DOI 10.1038/nature02043; Friston KJ, 1997, NEUROIMAGE, V6, P218, DOI 10.1006/nimg.1997.0291; Frith U, 2003, PHILOS T R SOC B, V358, P459, DOI 10.1098/rstb.2002.1218; Griskova I, 2007, NEUROSCI LETT, V419, P162, DOI 10.1016/j.neulet.2007.04.030; GUTH W, 1982, J ECON BEHAV ORGAN, V3, P367, DOI 10.1016/0167-2681(82)90011-7; Harbaugh WT, 2007, SCIENCE, V316, P1622, DOI 10.1126/science.1140738; Hare TA, 2008, J NEUROSCI, V28, P5623, DOI 10.1523/JNEUROSCI.1309-08.2008; Hare TA, 2010, J NEUROSCI, V30, P583, DOI 10.1523/JNEUROSCI.4089-09.2010; Hare TA, 2009, SCIENCE, V324, P646, DOI 10.1126/science.1168450; Henrich J, 2001, AM ECON REV, V91, P73, DOI 10.1257/aer.91.2.73; Herwig U, 2007, NEUROIMAGE, V37, P652, DOI 10.1016/j.neuroimage.2007.05.023; Kable JW, 2007, NAT NEUROSCI, V10, P1625, DOI 10.1038/nn2007; Kable JW, 2009, NEURON, V63, P733, DOI 10.1016/j.neuron.2009.09.003; Knoch D, 2008, CEREB CORTEX, V18, P1987, DOI 10.1093/cercor/bhm237; Knoch D, 2006, SCIENCE, V314, P829, DOI 10.1126/science.1129156; Knoch D, 2010, PSYCHOL SCI, V21, P337, DOI 10.1177/0956797609360750; Knoch D, 2009, P NATL ACAD SCI USA, V106, P20895, DOI 10.1073/pnas.0911619106; Koch G, 2005, NEUROIMAGE, V24, P34, DOI 10.1016/j.neuroimage.2004.09.042; Lieberman MD, 2009, SOC COGN AFFECT NEUR, V4, P423, DOI 10.1093/scan/nsp052; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Miller BL, 1997, BRIT J PSYCHIAT, V170, P150, DOI 10.1192/bjp.170.2.150; Moll J, 2006, P NATL ACAD SCI USA, V103, P15623, DOI 10.1073/pnas.0604475103; Montague PR, 2002, NEURON, V36, P265, DOI 10.1016/S0896-6273(02)00974-1; Neary D, 1998, NEUROLOGY, V51, P1546, DOI 10.1212/WNL.51.6.1546; Phillips ML, 1997, NATURE, V389, P495, DOI 10.1038/39051; Plassmann H, 2007, J NEUROSCI, V27, P9984, DOI 10.1523/JNEUROSCI.2131-07.2007; Pruessmann KP, 1999, MAGNET RESON MED, V42, P952, DOI 10.1002/(SICI)1522-2594(199911)42:5<952::AID-MRM16>3.0.CO;2-S; Ridderinkhof KR, 2004, SCIENCE, V306, P443, DOI 10.1126/science.1100301; Robertson EM, 2003, J COGNITIVE NEUROSCI, V15, P948, DOI 10.1162/089892903770007344; Rossi S, 2009, CLIN NEUROPHYSIOL, V120, P2008, DOI 10.1016/j.clinph.2009.08.016; Sanfey AG, 2003, SCIENCE, V300, P1755, DOI 10.1126/science.1082976; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; Singer T, 2004, SCIENCE, V303, P1157, DOI 10.1126/science.1093535; Smith DV, 2010, J NEUROSCI, V30, P2490, DOI 10.1523/JNEUROSCI.3319-09.2010; Tabibnia G, 2008, PSYCHOL SCI, V19, P339, DOI 10.1111/j.1467-9280.2008.02091.x; Tricomi E, 2010, NATURE, V463, P1089, DOI 10.1038/nature08785; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Van Overwalle F, 2009, HUM BRAIN MAPP, V30, P829, DOI 10.1002/hbm.20547; van't Wout M, 2005, NEUROREPORT, V16, P1849, DOI 10.1097/01.wnr.0000183907.08149.14	50	195	204	6	66	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2011	14	11					1468	U149		10.1038/nn.2933	http://dx.doi.org/10.1038/nn.2933			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	841NI	21964488	Green Accepted, Green Published			2022-12-28	WOS:000296518600024
J	Prinz, M; Priller, J; Sisodia, SS; Ransohoff, RM				Prinz, Marco; Priller, Josef; Sisodia, Sangram S.; Ransohoff, Richard M.			Heterogeneity of CNS myeloid cells and their roles in neurodegeneration	NATURE NEUROSCIENCE			English	Review							CENTRAL-NERVOUS-SYSTEM; AMYOTROPHIC-LATERAL-SCLEROSIS; MARROW-DERIVED MICROGLIA; TUMOR-NECROSIS-FACTOR; BETA-AMYLOID DEPOSITION; BLOOD-BRAIN-BARRIER; ALZHEIMERS-DISEASE; PARKINSONS-DISEASE; BONE-MARROW; MOUSE MODEL	The diseased brain hosts a heterogeneous population of myeloid cells, including parenchymal microglia, perivascular cells, meningeal macrophages and blood-borne monocytes. To date, the different types of brain myeloid cells have been discriminated solely on the basis of their localization, morphology and surface epitope expression. However, recent data suggest that resident microglia may be functionally distinct from bone marrow-or blood-derived phagocytes, which invade the CNS under pathological conditions. During the last few years, research on brain myeloid cells has been markedly changed by the advent of new tools in imaging, genetics and immunology. These methodologies have yielded unexpected results, which challenge the traditional view of brain macrophages. On the basis of these new studies, we differentiate brain myeloid subtypes with regard to their origin, function and fate in the brain and illustrate the divergent features of these cells during neurodegeneration.	[Ransohoff, Richard M.] Cleveland Clin, Neuroinflammat Res Ctr, Dept Neurosci, Lerner Res Inst, Cleveland, OH 44106 USA; [Ransohoff, Richard M.] Cleveland Clin, Mellen Ctr MS Treatment & Res, Neurol Inst, Cleveland, OH 44106 USA; [Prinz, Marco] Univ Hosp Freiburg, Dept Neuropathol, Freiburg, Germany; [Priller, Josef] Charite, Dept Neuropsychiat, D-13353 Berlin, Germany; [Priller, Josef] Charite, Lab Mol Psychiat, D-13353 Berlin, Germany; [Sisodia, Sangram S.] Univ Chicago, Dept Neurobiol, Chicago, IL 60637 USA; [Sisodia, Sangram S.] Univ Chicago, Comm Neurobiol, Chicago, IL 60637 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; University of Freiburg; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Chicago; University of Chicago	Ransohoff, RM (corresponding author), Cleveland Clin, Neuroinflammat Res Ctr, Dept Neurosci, Lerner Res Inst, Cleveland, OH 44106 USA.	marco.prinz@uniklinik-freiburg.de; ransohr@ccf.org	Priller, Josef/ABW-3835-2022	Priller, Josef/0000-0001-7596-0979	BMBF; Competence Network of Multiple Sclerosis (KKNMS); Competence Network of Neurodegenerative Disorders (DZNE); Centre of Chronic Immunodeficiency; Centre for Biological Signaling Studies; DFG [SFB 620, FOR1336]; Hertie-Foundation (Gemeinnutzige Hertie-Stiftung); BMBF (Berlin-Brandenburger Center fur Regenerative Therapien); Deutsche Forschungsgemeinschaft [FOR1336, SFB-TRR43]; National Institutes on Aging; Adler Foundation; Cure Alzheimer's Fund; US National Institutes of Health; National Multiple Sclerosis Society; Williams Family Fund for Multiple Sclerosis Research; Nancy Davis Center Without Walls	BMBF(Federal Ministry of Education & Research (BMBF)); Competence Network of Multiple Sclerosis (KKNMS); Competence Network of Neurodegenerative Disorders (DZNE); Centre of Chronic Immunodeficiency; Centre for Biological Signaling Studies; DFG(German Research Foundation (DFG)); Hertie-Foundation (Gemeinnutzige Hertie-Stiftung); BMBF (Berlin-Brandenburger Center fur Regenerative Therapien)(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); National Institutes on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Adler Foundation; Cure Alzheimer's Fund; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Multiple Sclerosis Society(National Multiple Sclerosis Society); Williams Family Fund for Multiple Sclerosis Research; Nancy Davis Center Without Walls	The authors wish to thank F. F. Klett for Figure 1, K. Bhaskar and B. Lamb for Figure 2, and K. Kierdorf for fruitful discussion. M. P. was supported by the BMBF-funded Competence Network of Multiple Sclerosis (KKNMS), the Competence Network of Neurodegenerative Disorders (DZNE), the Centre of Chronic Immunodeficiency, the Centre for Biological Signaling Studies, the DFG (SFB 620, FOR1336) and the Hertie-Foundation (Gemeinnutzige Hertie-Stiftung). J.P. was supported by the BMBF (Berlin-Brandenburger Center fur Regenerative Therapien) and the Deutsche Forschungsgemeinschaft (SFB-TRR43, FOR1336 and the excellence cluster NeuroCure). Research in the S. S. S. laboratory is supported by the National Institutes on Aging, the Adler Foundation and Cure Alzheimer's Fund. The R. M. R. laboratory is supported by the US National Institutes of Health, the National Multiple Sclerosis Society, the Williams Family Fund for Multiple Sclerosis Research and the Nancy Davis Center Without Walls.	Ajami B, 2007, NAT NEUROSCI, V10, P1538, DOI 10.1038/nn2014; Alliot F, 1999, DEV BRAIN RES, V117, P145, DOI 10.1016/S0165-3806(99)00113-3; Appel SH, 2008, NEUROLOGY, V71, P1326, DOI 10.1212/01.wnl.0000327668.43541.22; Armulik A, 2010, NATURE, V468, P557, DOI 10.1038/nature09522; ASHWELL K, 1991, DEV BRAIN RES, V58, P1, DOI 10.1016/0165-3806(91)90231-7; Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; Bechmann I, 2001, EXP NEUROL, V168, P242, DOI 10.1006/exnr.2000.7618; Beers DR, 2006, P NATL ACAD SCI USA, V103, P16021, DOI 10.1073/pnas.0607423103; Bell RD, 2010, NEURON, V68, P409, DOI 10.1016/j.neuron.2010.09.043; Bhaskar K, 2010, NEURON, V68, P19, DOI 10.1016/j.neuron.2010.08.023; Biju KC, 2010, MOL THER, V18, P1536, DOI 10.1038/mt.2010.107; Bjorkqvist M, 2008, J EXP MED, V205, P1869, DOI 10.1084/jem.20080178; Boillee S, 2006, SCIENCE, V312, P1389, DOI 10.1126/science.1123511; Cardona AE, 2006, NAT NEUROSCI, V9, P917, DOI 10.1038/nn1715; Chapman GA, 2000, J NEUROSCI, V20, DOI 10.1523/JNEUROSCI.20-15-j0004.2000; Chen HL, 2005, ANN NEUROL, V58, P963, DOI 10.1002/ana.20682; Chinnery HR, 2010, J NEUROPATH EXP NEUR, V69, P896, DOI 10.1097/NEN.0b013e3181edbc1a; Choi SH, 2008, NEURON, V59, P568, DOI 10.1016/j.neuron.2008.07.033; Corneveaux JJ, 2010, HUM MOL GENET, V19, P3295, DOI 10.1093/hmg/ddq221; Cuadros MA, 1998, PROG NEUROBIOL, V56, P173, DOI 10.1016/S0301-0082(98)00035-5; Daneman R, 2010, NATURE, V468, P562, DOI 10.1038/nature09513; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; Djukic M, 2006, BRAIN, V129, P2394, DOI 10.1093/brain/awl206; El Khoury J, 2007, NAT MED, V13, P432, DOI 10.1038/nm1555; Engelhardt B, 2008, J NEUROL SCI, V274, P23, DOI 10.1016/j.jns.2008.05.019; Firuzi O, 2006, ANN NEUROL, V59, P219, DOI 10.1002/ana.20774; Fuhrmann M, 2010, NAT NEUROSCI, V13, P411, DOI 10.1038/nn.2511; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Gerhard A, 2006, NEUROBIOL DIS, V21, P404, DOI 10.1016/j.nbd.2005.08.002; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Giorgini F, 2005, NAT GENET, V37, P526, DOI 10.1038/ng1542; Gowing G, 2009, EXP NEUROL, V220, P267, DOI 10.1016/j.expneurol.2009.08.021; Grathwohl SA, 2009, NAT NEUROSCI, V12, P1361, DOI 10.1038/nn.2432; Gu XF, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-8; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hawkes CA, 2009, P NATL ACAD SCI USA, V106, P1261, DOI 10.1073/pnas.0805453106; Heneka MT, 2010, J NEURAL TRANSM, V117, P919, DOI 10.1007/s00702-010-0438-z; HICKEY WF, 1992, J NEUROPATH EXP NEUR, V51, P246, DOI 10.1097/00005072-199205000-00002; Holmes C, 2003, J NEUROL NEUROSUR PS, V74, P788, DOI 10.1136/jnnp.74.6.788; Hunot S, 1999, J NEUROSCI, V19, P3440; in 't Veld BA, 2001, NEW ENGL J MED, V345, P1515, DOI 10.1056/NEJMoa010178; Keshet GI, 2007, J COMP NEUROL, V504, P690, DOI 10.1002/cne.21483; Kim WK, 2006, AM J PATHOL, V168, P822, DOI 10.2353/ajpath.2006.050215; King IL, 2009, BLOOD, V113, P3190, DOI 10.1182/blood-2008-07-168575; Klunemann HH, 2005, NEUROLOGY, V64, P1502, DOI 10.1212/01.WNL.0000160304.00003.CA; Koenigsknecht-Talboo J, 2008, J NEUROSCI, V28, P14156, DOI 10.1523/JNEUROSCI.4147-08.2008; Kokovay E, 2005, NEUROBIOL DIS, V19, P471, DOI 10.1016/j.nbd.2005.01.023; LaFerla FM, 2010, BIOCHEM SOC T, V38, P993, DOI 10.1042/BST0380993; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; Lee S, 2010, AM J PATHOL, V177, P2549, DOI 10.2353/ajpath.2010.100265; Liberatore GT, 1999, NAT MED, V5, P1403; Lichanska AM, 2000, EXP HEMATOL, V28, P601, DOI 10.1016/S0301-472X(00)00157-0; Liu ZQ, 2010, J NEUROSCI, V30, P17091, DOI 10.1523/JNEUROSCI.4403-10.2010; Lobsiger CS, 2007, NAT NEUROSCI, V10, P1355, DOI 10.1038/nn1988; Malm TM, 2005, NEUROBIOL DIS, V18, P134, DOI 10.1016/j.nbd.2004.09.009; Marin-Teva JL, 2004, NEURON, V41, P535, DOI 10.1016/S0896-6273(04)00069-8; Massengale M, 2005, J EXP MED, V201, P1579, DOI 10.1084/jem.20050030; Mawuenyega KG, 2010, SCIENCE, V330, P1774, DOI 10.1126/science.1197623; Mccoy MK, 2006, J NEUROSCI, V26, P9365, DOI 10.1523/JNEUROSCI.1504-06.2006; MCGEER PL, 1988, NEUROLOGY, V38, P1285, DOI 10.1212/WNL.38.8.1285; McKercher SR, 1996, EMBO J, V15, P5647, DOI 10.1002/j.1460-2075.1996.tb00949.x; Mildner A, 2007, NAT NEUROSCI, V10, P1544, DOI 10.1038/nn2015; Mildner A, 2011, J NEUROSCI, V31, P11159, DOI 10.1523/JNEUROSCI.6209-10.2011; Mildner A, 2009, BRAIN, V132, P2487, DOI 10.1093/brain/awp144; Mueller-Steiner S, 2006, NEURON, V51, P703, DOI 10.1016/j.neuron.2006.07.027; Nadeau S, 2000, J NEUROSCI, V20, P3456, DOI 10.1523/JNEUROSCI.20-09-03456.2000; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Perry VH, 2010, NAT REV NEUROL, V6, P193, DOI 10.1038/nrneurol.2010.17; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Price DL, 2000, ANN NY ACAD SCI, V920, P179; Priller J, 2001, NAT MED, V7, P1356, DOI 10.1038/nm1201-1356; Priller J, 2006, J NEUROSCI, V26, P11753, DOI 10.1523/JNEUROSCI.2275-06.2006; Prinz M, 2011, GLIA, V59, P177, DOI 10.1002/glia.21104; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; Ransohoff RM, 2010, NATURE, V468, P253, DOI 10.1038/nature09615; Ransohoff RM, 2009, IMMUNITY, V31, P711, DOI 10.1016/j.immuni.2009.09.010; Ransohoff RM, 2009, ANNU REV IMMUNOL, V27, P119, DOI 10.1146/annurev.immunol.021908.132528; Rodriguez M, 2007, NEUROBIOL DIS, V28, P316, DOI 10.1016/j.nbd.2007.07.024; Roumier A, 2004, J NEUROSCI, V24, P11421, DOI 10.1523/JNEUROSCI.2251-04.2004; Saederup N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013693; Schulz Martina, 2005, Cerebrospinal Fluid Res, V2, P8, DOI 10.1186/1743-8454-2-8; Schwab C, 2010, BBA-MOL BASIS DIS, V1802, P889, DOI 10.1016/j.bbadis.2009.10.013; Serbina NV, 2006, NAT IMMUNOL, V7, P311, DOI 10.1038/ni1309; Shaftel SS, 2007, J CLIN INVEST, V117, P1595, DOI 10.1172/JCI31450; SHOJI H, 1993, J NEUROL, V240, P59, DOI 10.1007/BF00838449; Simard AR, 2006, NEURON, V49, P489, DOI 10.1016/j.neuron.2006.01.022; Solomon JN, 2006, GLIA, V53, P744, DOI 10.1002/glia.20331; Stalder AK, 2005, J NEUROSCI, V25, P11125, DOI 10.1523/JNEUROSCI.2545-05.2005; Stalder M, 2001, NEUROBIOL AGING, V22, P427, DOI 10.1016/S0197-4580(01)00209-3; Sun BG, 2008, NEURON, V60, P247, DOI 10.1016/j.neuron.2008.10.001; Thevandavakkam MA, 2010, CNS NEUROL DISORD-DR, V9, P791; Tremblay ME, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000527; UNGER ER, 1993, J NEUROPATH EXP NEUR, V52, P460, DOI 10.1097/00005072-199309000-00004; Wilcock DM, 2004, J NEUROSCI, V24, P6144, DOI 10.1523/JNEUROSCI.1090-04.2004; Wu DC, 2003, P NATL ACAD SCI USA, V100, P6145, DOI 10.1073/pnas.0937239100; Zhang W, 2005, FASEB J, V19, P533, DOI 10.1096/fj.04-2751com	98	486	502	0	73	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2011	14	10					1227	1235		10.1038/nn.2923	http://dx.doi.org/10.1038/nn.2923			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	825EQ	21952260				2022-12-28	WOS:000295254200006
J	Hayman, R; Verriotis, MA; Jovalekic, A; Fenton, AA; Jeffery, KJ				Hayman, Robin; Verriotis, Madeleine A.; Jovalekic, Aleksandar; Fenton, Andre A.; Jeffery, Kathryn J.			Anisotropic encoding of three-dimensional space by place cells and grid cells	NATURE NEUROSCIENCE			English	Article							ENTORHINAL CORTEX; PATH-INTEGRATION; REPRESENTATION; HIPPOCAMPUS; DIRECTION; FIELDS; INPUTS; MAP	The subjective sense of space may result in part from the combined activity of place cells in the hippocampus and grid cells in posterior cortical regions such as the entorhinal cortex and pre- and parasubiculum. In horizontal planar environments, place cells provide focal positional information, whereas grid cells supply odometric (distance measuring) information. How these cells operate in three dimensions is unknown, even though the real world is three-dimensional. We investigated this issue in rats exploring two different kinds of apparatus: a climbing wall (the 'pegboard') and a helix. Place and grid cell firing fields had normal horizontal characteristics but were elongated vertically, with grid fields forming stripes. It seems that grid cell odometry (and by implication path integration) is impaired or absent in the vertical domain, at least when the rat itself remains horizontal. These findings suggest that the mammalian encoding of three-dimensional space is anisotropic.	[Hayman, Robin; Verriotis, Madeleine A.; Jovalekic, Aleksandar; Jeffery, Kathryn J.] UCL, Inst Behav Neurosci, Dept Cognit Perceptual & Brain Sci, Div Psychol & Language Sci, London, England; [Fenton, Andre A.] NYU, Ctr Neural Sci, New York, NY 10003 USA; [Fenton, Andre A.] SUNY, Dept Physiol & Pharmacol, Brooklyn, NY USA	University of London; University College London; New York University; State University of New York (SUNY) System; SUNY Maritime College	Jeffery, KJ (corresponding author), UCL, Inst Behav Neurosci, Dept Cognit Perceptual & Brain Sci, Div Psychol & Language Sci, London, England.	k.jeffery@ucl.ac.uk	Jeffery, Kathryn J/C-2409-2008	Jeffery, Kathryn J/0000-0002-9495-0378; Fenton, Andre/0000-0002-5063-1156; Verriotis, Madeleine/0000-0003-3019-0370; Hayman, Robin/0000-0003-1075-0430	Wellcome Trust; European Commission; Axona Ltd; National Science Foundation [IOS-0725001]	Wellcome Trust(Wellcome TrustEuropean Commission); European Commission(European CommissionEuropean Commission Joint Research Centre); Axona Ltd; National Science Foundation(National Science Foundation (NSF))	The work was supported by grants from the Wellcome Trust to K.J.J., the European Commission Framework 7 ('Spacebrain') to K.J.J. and Axona Ltd, and a National Science Foundation grant (no. IOS-0725001) to A.A.F. We thank E. Kelemen for help designing and M. Shkop for constructing the helical track, E. Leeper for building the pegboard arena, M. Witter for advice on histology and C. Barry and F. Cacucci for comments on the manuscript.	Barry C, 2007, NAT NEUROSCI, V10, P682, DOI 10.1038/nn1905; Boccara CN, 2010, NAT NEUROSCI, V13, P987, DOI 10.1038/nn.2602; Burgess N, 2008, ANN NY ACAD SCI, V1124, P77, DOI 10.1196/annals.1440.002; Derdikman D, 2009, NAT NEUROSCI, V12, P1325, DOI 10.1038/nn.2396; Fuhs MC, 2006, J NEUROSCI, V26, P4266, DOI 10.1523/JNEUROSCI.4353-05.2006; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Hartley T, 2000, HIPPOCAMPUS, V10, P369, DOI 10.1002/1098-1063(2000)10:4<369::AID-HIPO3>3.0.CO;2-0; JEFFERY K, ANIMAL THIN IN PRESS; Jeffery KJ, 2007, HIPPOCAMPUS, V17, P775, DOI 10.1002/hipo.20322; Jeffery KJ, 2006, EXP BRAIN RES, V169, P218, DOI 10.1007/s00221-005-0138-3; Knierim JJ, 2000, NAT NEUROSCI, V3, P209, DOI 10.1038/72910; Knierim JJ, 2001, J NEUROPHYSIOL, V85, P105, DOI 10.1152/jn.2001.85.1.105; Leutgeb JK, 2007, SCIENCE, V315, P961, DOI 10.1126/science.1135801; McNaughton BL, 2006, NAT REV NEUROSCI, V7, P663, DOI 10.1038/nrn1932; Moser EI, 2008, ANNU REV NEUROSCI, V31, P69, DOI 10.1146/annurev.neuro.31.061307.090723; Nitz DA, 2011, J NEUROPHYSIOL, V105, P1815, DOI 10.1152/jn.00573.2010; O'Keefe J, 2005, HIPPOCAMPUS, V15, P853, DOI 10.1002/hipo.20115; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; Sargolini F, 2006, SCIENCE, V312, P758, DOI 10.1126/science.1125572; Skaggs W. E., 1993, ADV NEURAL INF PROCE, V5, P1031; Stackman RW, 2000, J NEUROPHYSIOL, V83, P393, DOI 10.1152/jn.2000.83.1.393; TAFFORIN C, 1994, ADV SPACE RES, V14, P415, DOI 10.1016/0273-1177(94)90433-2	22	102	103	0	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2011	14	9					1182	U244		10.1038/nn.2892	http://dx.doi.org/10.1038/nn.2892			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	812ID	21822271	Green Accepted			2022-12-28	WOS:000294284900019
J	Mizuseki, K; Diba, K; Pastalkova, E; Buzsaki, G				Mizuseki, Kenji; Diba, Kamran; Pastalkova, Eva; Buzsaki, Gyoergy			Hippocampal CA1 pyramidal cells form functionally distinct sublayers	NATURE NEUROSCIENCE			English	Article							PHASE PRECESSION; ENTORHINAL CORTEX; CORTICAL-NEURONS; RAT HIPPOCAMPUS; BEHAVING RAT; FIELD CA1; OSCILLATIONS; MORPHOLOGY; NEOCORTEX; NETWORKS	Hippocampal CA1 pyramidal neurons have frequently been regarded as a homogeneous cell population in biophysical, pharmacological and modeling studies. We found robust differences between pyramidal neurons residing in the deep and superficial CA1 sublayers in rats. Compared with their superficial peers, deep pyramidal cells fired at higher rates, burst more frequently, were more likely to have place fields and were more strongly modulated by slow oscillations of sleep. Both deep and superficial pyramidal cells fired preferentially at the trough of theta oscillations during maze exploration, whereas deep pyramidal cells shifted their preferred phase of firing to the peak of theta during rapid eye movement (REM) sleep. Furthermore, although the majority of REM theta phase-shifting cells fired at the ascending phase of gamma oscillations during waking, nonshifting cells preferred the trough. Thus, CA1 pyramidal cells in adjacent sublayers can address their targets jointly or differentially, depending on brain states.	[Mizuseki, Kenji; Diba, Kamran; Pastalkova, Eva; Buzsaki, Gyoergy] Rutgers State Univ, Ctr Mol & Behav Neurosci, Newark, NJ 07102 USA	Rutgers State University Newark; Rutgers State University New Brunswick	Buzsaki, G (corresponding author), Rutgers State Univ, Ctr Mol & Behav Neurosci, Newark, NJ 07102 USA.	buzsaki@axon.rutgers.edu	Mizuseki, Kenji/A-9214-2011	Mizuseki, Kenji/0000-0002-1456-2149; Diba, Kamran/0000-0001-5128-4478; Buzsaki, Gyorgy/0000-0002-3100-4800	US National Institutes of Health [NS034994, MH54671]; National Science Foundation; J.D. McDonnell Foundation; Uehara Memorial Foundation; Astellas Foundation for Research on Metabolic Disorders; Japan Society of Promotion for Sciences; Robert Leet and Clara Guthrie Patterson Trust; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH054671] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034994] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC009947] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); J.D. McDonnell Foundation; Uehara Memorial Foundation(Uehara Memorial Foundation); Astellas Foundation for Research on Metabolic Disorders; Japan Society of Promotion for Sciences(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Robert Leet and Clara Guthrie Patterson Trust; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank E. Cela, S. Fujisawa, P. M. Hiche, S. Ozen, A. Sirota, E. Stark and Y. Wang for comments on the manuscript, and D. Sullivan for valuable suggestions. This work was supported by the US National Institutes of Health (NS034994, MH54671), the National Science Foundation, the J.D. McDonnell Foundation, the Uehara Memorial Foundation, the Astellas Foundation for Research on Metabolic Disorders, the Japan Society of Promotion for Sciences, and the Robert Leet and Clara Guthrie Patterson Trust.	Amaral DaL P, 2007, HIPPOCAMPUS BOOK, P37; BAIMBRIDGE KG, 1991, SYNAPSE, V7, P269, DOI 10.1002/syn.890070404; BANNISTER NJ, 1995, J COMP NEUROL, V360, P150, DOI 10.1002/cne.903600111; BILKEY DK, 1990, BRAIN RES, V514, P77, DOI 10.1016/0006-8993(90)90437-G; BRAGIN A, 1995, J NEUROSCI, V15, P47; CHAGNACAMITAL Y, 1990, J COMP NEUROL, V296, P598, DOI 10.1002/cne.902960407; CONNORS BW, 1982, J NEUROPHYSIOL, V48, P1302, DOI 10.1152/jn.1982.48.6.1302; Csicsvari J, 2003, J NEUROPHYSIOL, V90, P1314, DOI 10.1152/jn.00116.2003; Csicsvari J, 2003, NEURON, V37, P311, DOI 10.1016/S0896-6273(02)01169-8; de No RL, 1934, J PSYCHOL NEUROL, V46, P113; Deguchi Y, 2011, NAT NEUROSCI, V14, P495, DOI 10.1038/nn.2768; Dong HW, 2009, P NATL ACAD SCI USA, V106, P11794, DOI 10.1073/pnas.0812608106; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Golding NL, 2001, J NEUROPHYSIOL, V86, P2998, DOI 10.1152/jn.2001.86.6.2998; Hafting T, 2008, NATURE, V453, P1248, DOI 10.1038/nature06957; Harris KD, 2002, NATURE, V417, P738, DOI 10.1038/nature00808; Harris KD, 2001, NEURON, V32, P141, DOI 10.1016/S0896-6273(01)00447-0; Henriksen EJ, 2010, NEURON, V68, P127, DOI 10.1016/j.neuron.2010.08.042; Isomura Y, 2006, NEURON, V52, P871, DOI 10.1016/j.neuron.2006.10.023; Jarsky T, 2008, J COMP NEUROL, V506, P535, DOI 10.1002/cne.21564; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; MARKUS EJ, 1994, HIPPOCAMPUS, V4, P410, DOI 10.1002/hipo.450040404; MASON A, 1990, J NEUROSCI, V10, P1415; Mehta MR, 2002, NATURE, V417, P741, DOI 10.1038/nature00807; Mizuseki K, 2009, NEURON, V64, P267, DOI 10.1016/j.neuron.2009.08.037; Molinari S, 1996, P NATL ACAD SCI USA, V93, P8028, DOI 10.1073/pnas.93.15.8028; MULLER RU, 1989, J NEUROSCI, V9, P4101; Nelson SB, 2006, TRENDS NEUROSCI, V29, P339, DOI 10.1016/j.tins.2006.05.004; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; Pace-Schott EF, 2002, NAT REV NEUROSCI, V3, P591, DOI 10.1038/nrn895; PETERS S, 1987, SCIENCE, V236, P589, DOI 10.1126/science.2883728; Poe GR, 2000, BRAIN RES, V855, P176, DOI 10.1016/S0006-8993(99)02310-0; Senior TJ, 2008, J NEUROSCI, V28, P2274, DOI 10.1523/JNEUROSCI.4669-07.2008; Skaggs W., 1993, ADV NEURAL INFORM PR, V5, P1030; Skaggs WE, 1996, HIPPOCAMPUS, V6, P149, DOI 10.1002/(SICI)1098-1063(1996)6:2<149::AID-HIPO6>3.0.CO;2-K; SLOMIANKA L, 1992, NEUROSCIENCE, V48, P325, DOI 10.1016/0306-4522(92)90494-M; Song S, 2005, PLOS BIOL, V3, P507, DOI 10.1371/journal.pbio.0030068; SORENSEN JC, 1993, ANAT EMBRYOL, V188, P107; STERIADE M, 1993, J NEUROSCI, V13, P3252, DOI 10.1523/jneurosci.13-08-03252.1993; TAMAMAKI N, 1995, J COMP NEUROL, V353, P379, DOI 10.1002/cne.903530306; Thompson CL, 2008, NEURON, V60, P1010, DOI 10.1016/j.neuron.2008.12.008; Thomson AM, 2002, CEREB CORTEX, V12, P936, DOI 10.1093/cercor/12.9.936; Varga C, 2010, NAT NEUROSCI, V13, P822, DOI 10.1038/nn.2570; Wang Y, 2006, NAT NEUROSCI, V9, P534, DOI 10.1038/nn1670; WHITTINGTON MA, 1995, NATURE, V373, P612, DOI 10.1038/373612a0; YLINEN A, 1995, J NEUROSCI, V15, P30; Yoshimura Y, 2005, NATURE, V433, P868, DOI 10.1038/nature03252; Yu YC, 2009, NATURE, V458, P501, DOI 10.1038/nature07722	50	227	231	2	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2011	14	9					1174	U235		10.1038/nn.2894	http://dx.doi.org/10.1038/nn.2894			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	812ID	21822270	Green Published, Green Accepted			2022-12-28	WOS:000294284900018
J	Sanuki, R; Onishi, A; Koike, C; Muramatsu, R; Watanabe, S; Muranishi, Y; Irie, S; Uneo, S; Koyasu, T; Matsui, R; Cherasse, Y; Urade, Y; Watanabe, D; Kondo, M; Yamashita, T; Furukawa, T				Sanuki, Rikako; Onishi, Akishi; Koike, Chieko; Muramatsu, Rieko; Watanabe, Satoshi; Muranishi, Yuki; Irie, Shoichi; Uneo, Shinji; Koyasu, Toshiyuki; Matsui, Ryosuke; Cherasse, Yoan; Urade, Yoshihiro; Watanabe, Dai; Kondo, Mineo; Yamashita, Toshihide; Furukawa, Takahisa			miR-124a is required for hippocampal axogenesis and retinal cone survival through Lhx2 suppression	NATURE NEUROSCIENCE			English	Article							DEVELOPING MOUSE RETINA; HOMEOBOX GENE; CELL FATE; TRANSCRIPTION FACTORS; EARLY NEUROGENESIS; MICRORNA TARGETS; TRANSGENIC MICE; MESSENGER-RNAS; DIFFERENTIATION; EXPRESSION	MicroRNA-124a (miR-124a) is the most abundant microRNA expressed in the vertebrate CNS. Despite past investigations into the role of miR-124a, inconsistent results have left the in vivo function of miR-124a unclear. We examined the in vivo function of miR-124a by targeted disruption of Rncr3 (retinal non-coding RNA 3), the dominant source of miR-124a. Rncr3(-/-) mice exhibited abnormalities in the CNS, including small brain size, axonal mis-sprouting of dentate gyrus granule cells and retinal cone cell death. We found that Lhx2 is an in vivo target mRNA of miR-124a. We also observed that LHX2 downregulation by miR-124a is required for the prevention of apoptosis in the developing retina and proper axonal development of hippocampal neurons. These results suggest that miR-124a is essential for the maturation and survival of dentate gyrus neurons and retinal cones, as it represses Lhx2 translation.	[Sanuki, Rikako; Onishi, Akishi; Koike, Chieko; Watanabe, Satoshi; Muranishi, Yuki; Irie, Shoichi; Furukawa, Takahisa] Osaka Biosci Inst, Dept Dev Biol, Osaka, Japan; [Sanuki, Rikako; Onishi, Akishi; Watanabe, Satoshi; Irie, Shoichi; Furukawa, Takahisa] Japan Sci & Technol Agcy, Osaka Biosci Inst, Osaka, Japan; [Muramatsu, Rieko; Yamashita, Toshihide] Osaka Univ, Grad Sch Med, Dept Mol Neurosci, Osaka, Japan; [Uneo, Shinji; Koyasu, Toshiyuki; Kondo, Mineo] Nagoya Univ, Dept Ophthalmol, Grad Sch Med, Showa Ku, Nagoya, Aichi 4648601, Japan; [Matsui, Ryosuke; Watanabe, Dai] Kyoto Univ, Dept Biol Sci, Fac Med, Grad Sch Biostudies,Sakyo Ku, Kyoto, Japan; [Cherasse, Yoan; Urade, Yoshihiro] Osaka Biosci Inst, Dept Mol Behav Biol, Osaka, Japan	Japan Science & Technology Agency (JST); Osaka University; Nagoya University; Kyoto University	Furukawa, T (corresponding author), Osaka Biosci Inst, Dept Dev Biol, Osaka, Japan.	furukawa@obi.or.jp	Sanuki, Rikako/AAV-7143-2021; Cherasse, Yoan/AAD-6442-2020	Sanuki, Rikako/0000-0001-9862-9840; Cherasse, Yoan/0000-0002-6139-8193; Yamashita, Toshihide/0000-0003-4559-7018; Watanabe, Satoshi/0000-0002-8129-6223	Japan Science and Technology Agency (JST), Core Research for Evolutional Science and Technology (CREST); Ministry of Education, Culture, Sports, Science and Technology; Takeda Science Foundation; Uehara Memorial Foundation; Mochida Memorial Foundation; Naito Foundation; Grants-in-Aid for Scientific Research [23592603] Funding Source: KAKEN	Japan Science and Technology Agency (JST), Core Research for Evolutional Science and Technology (CREST)(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Uehara Memorial Foundation(Uehara Memorial Foundation); Mochida Memorial Foundation; Naito Foundation(Naito Memorial Foundation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank T. Maniatis for RIPmiR-124a-2, M. Kilimann for Synapsin 1 promoter, Y. Omori, K. Terada, M. Ueno, N. Nagata, K. Aritake, Y. Oishi, T. Hamasaki, and H. Abe for critical comments and technical advice, and A. Tani, M. Kadowaki, Y. Kawakami, A. Ishimaru, H. Tsujii, T. Saioka, K. Sone, H. Abe, and S. Kennedy for technical assistance. This work was supported by Japan Science and Technology Agency (JST), Core Research for Evolutional Science and Technology (CREST), Grant-in-Aid for Scientific Research (B), Grant-in-Aid for Young Scientists (B), a Grant for Molecular Brain Science from the Ministry of Education, Culture, Sports, Science and Technology, the Takeda Science Foundation, the Uehara Memorial Foundation, the Mochida Memorial Foundation, and the Naito Foundation.	BABB TL, 1991, NEUROSCIENCE, V42, P351, DOI 10.1016/0306-4522(91)90380-7; Baulac S, 2008, ARCH NEUROL-CHICAGO, V65, P943, DOI 10.1001/archneur.65.7.943; Blackshaw S, 2004, PLOS BIOL, V2, P1411, DOI 10.1371/journal.pbio.0020247; Cao XW, 2007, GENE DEV, V21, P531, DOI 10.1101/gad.1519207; Cepko CL, 1996, P NATL ACAD SCI USA, V93, P589, DOI 10.1073/pnas.93.2.589; Chen SM, 1997, NEURON, V19, P1017, DOI 10.1016/S0896-6273(00)80394-3; Cheng LC, 2009, NAT NEUROSCI, V12, P399, DOI 10.1038/nn.2294; Chow RL, 2001, ANNU REV CELL DEV BI, V17, P255, DOI 10.1146/annurev.cellbio.17.1.255; Conaco C, 2006, P NATL ACAD SCI USA, V103, P2422, DOI 10.1073/pnas.0511041103; COTE F, 1993, CELL, V73, P35, DOI 10.1016/0092-8674(93)90158-M; Damiani D, 2008, J NEUROSCI, V28, P4878, DOI 10.1523/JNEUROSCI.0828-08.2008; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Edbauer D, 2010, NEURON, V65, P373, DOI 10.1016/j.neuron.2010.01.005; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Furukawa A, 2002, J NEUROSCI, V22, P1640, DOI 10.1523/JNEUROSCI.22-05-01640.2002; Furukawa T, 1997, CELL, V91, P531, DOI 10.1016/S0092-8674(00)80439-0; Georgi SA, 2010, J NEUROSCI, V30, P4048, DOI 10.1523/JNEUROSCI.4982-09.2010; Glancy M, 2009, EUR J HUM GENET, V17, P37, DOI 10.1038/ejhg.2008.133; Gray PA, 2004, SCIENCE, V306, P2255, DOI 10.1126/science.1104935; Hackler L, 2010, INVEST OPHTH VIS SCI, V51, P1823, DOI 10.1167/iovs.09-4657; He SM, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-236; HOESCHE C, 1993, J BIOL CHEM, V268, P26494; Holmes GL, 1999, J COMP NEUROL, V404, P537, DOI 10.1002/(SICI)1096-9861(19990222)404:4<537::AID-CNE9>3.0.CO;2-#; Koike C, 2010, P NATL ACAD SCI USA, V107, P332, DOI 10.1073/pnas.0912730107; Koyama R, 2004, CURR NEUROVASC RES, V1, P3, DOI 10.2174/1567202043480242; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Liu KL, 2011, NUCLEIC ACIDS RES, V39, P2869, DOI 10.1093/nar/gkq904; Makeyev EV, 2007, MOL CELL, V27, P435, DOI 10.1016/j.molcel.2007.07.015; Mangale VS, 2008, SCIENCE, V319, P304, DOI 10.1126/science.1151695; Ng L, 2001, NAT GENET, V27, P94, DOI 10.1038/83829; Nishida A, 2003, NAT NEUROSCI, V6, P1255, DOI 10.1038/nn1155; Ohsawa R, 2008, BRAIN RES, V1192, P90, DOI 10.1016/j.brainres.2007.04.014; OKAZAKI MM, 1995, J COMP NEUROL, V352, P515, DOI 10.1002/cne.903520404; Onishi A, 2009, NEURON, V61, P234, DOI 10.1016/j.neuron.2008.12.006; Porter FD, 1997, DEVELOPMENT, V124, P2935; Qiu R, 2009, MECH DEVELOP, V126, P804, DOI 10.1016/j.mod.2009.08.002; Rajasethupathy P, 2009, NEURON, V63, P803, DOI 10.1016/j.neuron.2009.05.029; Sanuki R, 2010, FEBS LETT, V584, P753, DOI 10.1016/j.febslet.2009.12.030; Siegel G, 2009, NAT CELL BIOL, V11, P705, DOI 10.1038/ncb1876; Silber J, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-14; Tabares-Seisdedos R, 2009, MOL PSYCHIATR, V14, P563, DOI 10.1038/mp.2009.2; Tonelli DD, 2008, DEVELOPMENT, V135, P3911, DOI 10.1242/dev.025080; Visvanathan J, 2007, GENE DEV, V21, P744, DOI 10.1101/gad.1519107; Weiler IJ, 1997, P NATL ACAD SCI USA, V94, P5395, DOI 10.1073/pnas.94.10.5395; Wilson SI, 2008, NEURON, V59, P413, DOI 10.1016/j.neuron.2008.07.020; Xu XL, 2008, J NEUROSCI, V28, P11883, DOI 10.1523/JNEUROSCI.4114-08.2008; Yoo AS, 2009, NATURE, V460, P642, DOI 10.1038/nature08139	50	212	216	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2011	14	9					1125	U177		10.1038/nn.2897	http://dx.doi.org/10.1038/nn.2897			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	812ID	21857657				2022-12-28	WOS:000294284900012
J	Shusterman, R; Smear, MC; Koulakov, AA; Rinberg, D				Shusterman, Roman; Smear, Matthew C.; Koulakov, Alexei A.; Rinberg, Dmitry			Precise olfactory responses tile the sniff cycle	NATURE NEUROSCIENCE			English	Article							BULB UNIT-ACTIVITY; ODOR REPRESENTATIONS; TEMPORAL PRECISION; SPIKE TRAINS; TUFTED CELLS; CORTEX; RAT; INFORMATION; INHIBITION; ACCURACY	In terrestrial vertebrates, sniffing controls odorant access to receptors, and therefore sets the timescale of olfactory stimuli. We found that odorants evoked precisely sniff-locked activity in mitral/tufted cells in the olfactory bulb of awake mouse. The trial-to-trial response jitter averaged 12 ms, a precision comparable to other sensory systems. Individual cells expressed odor-specific temporal patterns of activity and, across the population, onset times tiled the duration of the sniff cycle. Responses were more tightly time-locked to the sniff phase than to the time after inhalation onset. The spikes of single neurons carried sufficient information to discriminate odors. In addition, precise locking to sniff phase may facilitate ensemble coding by making synchrony relationships across neurons robust to variation in sniff rate. The temporal specificity of mitral/tufted cell output provides a potentially rich source of information for downstream olfactory areas.	[Shusterman, Roman; Smear, Matthew C.; Rinberg, Dmitry] Howard Hughes Med Inst, Ashburn, VA USA; [Smear, Matthew C.] Northwestern Univ, Dept Neurobiol & Physiol, Evanston, IL 60208 USA; [Koulakov, Alexei A.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Howard Hughes Medical Institute; Northwestern University; Cold Spring Harbor Laboratory	Rinberg, D (corresponding author), Howard Hughes Med Inst, Janelia Farm Res Campus, Ashburn, VA USA.	rinbergd@janelia.hhmi.org	Shusterman, Roman/B-9514-2008	Shusterman, Roman/0000-0002-1081-2884	Howard Hughes Medical Institute; US National Institutes of Health [R01 EY018068]; NATIONAL EYE INSTITUTE [R01EY018068] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank J. Osborne and T. Tabachnik for design and fabrication of experimental equipment, S. Royer for help with electrophysiological setup, J. Nunez-Iglesias for help with statistical analysis, P. Ahammad, D.B. Chklovskii and S. Druckmann for discussions and A. Resulaj, J.T. Dudman, V. Jayaraman, E. Pastalkova and K. Svoboda for comments on the manuscript. R.S., M.C.S. and D.R. are supported by the Howard Hughes Medical Institute. A.A.K. was supported by US National Institutes of Health grant R01 EY018068.	Abraham NM, 2004, NEURON, V44, P865, DOI 10.1016/j.neuron.2004.11.017; ADRIAN ED, 1950, ELECTROEN CLIN NEURO, V2, P377, DOI 10.1016/0013-4694(50)90075-7; Assisi C, 2007, NAT NEUROSCI, V10, P1176, DOI 10.1038/nn1947; Bair W, 1996, NEURAL COMPUT, V8, P1185, DOI 10.1162/neco.1996.8.6.1185; Barlow H B, 1972, Perception, V1, P371, DOI 10.1068/p010371; Bathellier B, 2008, NEURON, V57, P586, DOI 10.1016/j.neuron.2008.02.011; Bhalla US, 1997, J COMPUT NEUROSCI, V4, P221, DOI 10.1023/A:1008819818970; Bishop C.M., 2006, PATTERN RECOGN; Brody CD, 2003, NEURON, V37, P843, DOI 10.1016/S0896-6273(03)00120-X; Buonviso N, 2003, EUR J NEUROSCI, V17, P1811, DOI 10.1046/j.1460-9568.2003.02619.x; Butts DA, 2007, NATURE, V449, P92, DOI [10.1038/nature06105, 10.1038/natureO6105]; Cang JH, 2003, J NEUROSCI, V23, P4108; Cassenaer S, 2007, NATURE, V448, P709, DOI 10.1038/nature05973; CHAPUT MA, 1986, PHYSIOL BEHAV, V36, P319, DOI 10.1016/0031-9384(86)90023-5; Cury KM, 2010, NEURON, V68, P570, DOI 10.1016/j.neuron.2010.09.040; Doucette W, 2008, PLOS BIOL, V6, P2266, DOI 10.1371/journal.pbio.0060258; Fantana AL, 2008, NEURON, V59, P802, DOI 10.1016/j.neuron.2008.07.039; Franks KM, 2006, NEURON, V49, P357, DOI 10.1016/j.neuron.2005.12.026; Fuentes RA, 2008, J NEUROPHYSIOL, V100, P422, DOI 10.1152/jn.00095.2008; HABERLY LB, 1977, BRAIN RES, V129, P152, DOI 10.1016/0006-8993(77)90978-7; HOPFIELD JJ, 1995, NATURE, V376, P33, DOI 10.1038/376033a0; Kay LM, 1999, NAT NEUROSCI, V2, P1003, DOI 10.1038/14801; Kepecs A, 2006, CHEM SENSES, V31, P167, DOI 10.1093/chemsce/bjj016; Laurent G, 1996, J NEUROSCI, V16, P3837; Laurent G, 2002, NAT REV NEUROSCI, V3, P884, DOI 10.1038/nrn964; Llinas R.R., 2004, SYNAPTIC ORG BRAIN; Margrie TW, 2003, J PHYSIOL-LONDON, V546, P363, DOI 10.1113/jphysiol.2002.031245; Miyamichi K, 2011, NATURE, V472, P191, DOI 10.1038/nature09714; Nagel KI, 2011, NAT NEUROSCI, V14, P208, DOI 10.1038/nn.2725; PAGER J, 1985, BEHAV BRAIN RES, V16, P81, DOI 10.1016/0166-4328(85)90084-1; Perez-Orive J, 2002, SCIENCE, V297, P359, DOI 10.1126/science.1070502; Poo C, 2009, NEURON, V62, P850, DOI 10.1016/j.neuron.2009.05.022; Raman B, 2010, J NEUROSCI, V30, P1994, DOI 10.1523/JNEUROSCI.5639-09.2010; Rieke F., 1997, SPIKES EXPLORING NEU; Rinberg D, 2006, J NEUROSCI, V26, P8857, DOI 10.1523/JNEUROSCI.0884-06.2006; Rinberg D, 2006, NEURON, V51, P351, DOI 10.1016/j.neuron.2006.07.013; SOBEL EC, 1993, J NEUROPHYSIOL, V69, P1331, DOI 10.1152/jn.1993.69.4.1331; Spors H, 2006, J NEUROSCI, V26, P1247, DOI 10.1523/JNEUROSCI.3100-05.2006; Stettler DD, 2009, NEURON, V63, P854, DOI 10.1016/j.neuron.2009.09.005; Uchida N, 2003, NAT NEUROSCI, V6, P1224, DOI 10.1038/nn1142; Verhagen JV, 2007, NAT NEUROSCI, V10, P631, DOI 10.1038/nn1892; Vetter RS, 2006, CHEM SENSES, V31, P359, DOI 10.1093/chemse/bjj040; Wehr M, 2003, NATURE, V426, P442, DOI 10.1038/nature02116	44	246	251	0	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2011	14	8					1039	U136		10.1038/nn.2877	http://dx.doi.org/10.1038/nn.2877			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	797KC	21765422				2022-12-28	WOS:000293123700018
J	Sugi, T; Nishida, Y; Mori, I				Sugi, Takuma; Nishida, Yukuo; Mori, Ikue			Regulation of behavioral plasticity by systemic temperature signaling in Caenorhabditis elegans	NATURE NEUROSCIENCE			English	Article							HEAT-SHOCK-FACTOR; C-ELEGANS; LIFE-SPAN; MOLECULAR CHAPERONES; OLFACTORY NEURON; NERVOUS-SYSTEM; THERMOTAXIS; DROSOPHILA; ESTROGEN; PROTEIN	Animals cope with environmental changes by altering behavioral strategy. Environmental information is generally received by sensory neurons in the neural circuit that generates behavior. However, although environmental temperature inevitably influences an animal's entire body, the mechanism of systemic temperature perception remains largely unknown. We show here that systemic temperature signaling induces a change in a memory-based behavior in C. elegans. During behavioral conditioning, non-neuronal cells as well as neuronal cells respond to cultivation temperature through a heat-shock transcription factor that drives newly identified gene expression dynamics. This systemic temperature signaling regulates thermosensory neurons non-cell-autonomously through the estrogen signaling pathway, producing thermotactic behavior. We provide a link between systemic environmental recognition and behavioral plasticity in the nervous system.	[Sugi, Takuma; Nishida, Yukuo; Mori, Ikue] Nagoya Univ, Grp Mol Neurobiol, Grad Sch Sci, Nagoya, Aichi 4648601, Japan; [Mori, Ikue] Japan Sci & Technol Agcy, CREST, Tokyo, Japan; [Mori, Ikue] Nagoya Univ, Inst Adv Res, Nagoya, Aichi 4648601, Japan	Nagoya University; Japan Science & Technology Agency (JST); Nagoya University	Mori, I (corresponding author), Nagoya Univ, Grp Mol Neurobiol, Grad Sch Sci, Nagoya, Aichi 4648601, Japan.	m46920a@nucc.cc.nagoya-u.ac.jp	Sugi, Takuma/O-7429-2015		Japan Science and Technology (JST) agency	Japan Science and Technology (JST) agency(Japan Science & Technology Agency (JST))	We thank N. Hisamoto (Nagoya University), T. Mizuno (Nagoya University) and K. Matsumoto (Nagoya University) for sharing strains; A. Fire (Stanford University School of Medicine) for pPD plasmids; Y. Iino (University of Tokyo) for the gcy-5 and gcy-7 promoters; Caenorhabditis Genetic Center, C. elegans Knockout Consortium and S. Mitani at the National Bioresource Project, Japan, for strains; K. Terauchi and T. Kondo for kindly sharing the microarray apparatus; T. Inada for kindly sharing the quantitative PCR apparatus; C. Bargmann, S. Takagi, N. Hisamoto, A. Kuhara, P. Jurado, H. Sasakura, N. Ohnishi, T. Kimata, M. Nonomura and members of the Mori laboratory for comments on this manuscript and discussion. I.M. is a Scholar of the Institute for Advanced Research in Nagoya University, Japan. This work was supported by the Core Research for Evolutional Science and Technology (CREST) Program of the Japan Science and Technology (JST) agency (to I.M.).	Akerfelt M, 2010, NAT REV MOL CELL BIO, V11, P545, DOI 10.1038/nrm2938; Altun-Gultekin Z, 2001, DEVELOPMENT, V128, P1951; BARGMANN CI, 1993, CELL, V74, P515, DOI 10.1016/0092-8674(93)80053-H; Bear M.F., 2007, NEUROSCIENCE, Vthird; Biron D, 2008, P NATL ACAD SCI USA, V105, P11002, DOI 10.1073/pnas.0805004105; Biron D, 2006, NAT NEUROSCI, V9, P1499, DOI 10.1038/nn1796; Chatzigeorgiou M, 2010, NAT NEUROSCI, V13, P861, DOI 10.1038/nn.2581; CLOS J, 1993, NATURE, V364, P252, DOI 10.1038/364252a0; Conti B, 2006, SCIENCE, V314, P825, DOI 10.1126/science.1132191; Devaney E, 2006, INT J PARASITOL, V36, P641, DOI 10.1016/j.ijpara.2006.02.006; GOODSON ML, 1995, J BIOL CHEM, V270, P2447, DOI 10.1074/jbc.270.6.2447; Hajdu-Cronin YM, 2004, GENETICS, V168, P1937, DOI 10.1534/genetics.104.028423; Hamada FN, 2008, NATURE, V454, P217, DOI 10.1038/nature07001; HEDGECOCK EM, 1975, P NATL ACAD SCI USA, V72, P4061, DOI 10.1073/pnas.72.10.4061; Hobert O, 1997, NEURON, V19, P345, DOI 10.1016/S0896-6273(00)80944-7; Hsu AL, 2003, SCIENCE, V300, P1142, DOI 10.1126/science.1083701; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Ito H, 2006, J NEUROSCI METH, V154, P45, DOI 10.1016/j.jneumeth.2005.11.011; Kimura KD, 2004, CURR BIOL, V14, P1291, DOI 10.1016/j.cub.2004.06.060; Kuhara A, 2008, SCIENCE, V320, P803, DOI 10.1126/science.1148922; Lee SJ, 2009, CURR BIOL, V19, P715, DOI 10.1016/j.cub.2009.03.041; Liu F, 2008, NAT NEUROSCI, V11, P334, DOI 10.1038/nn2057; Lumpkin EA, 2007, NATURE, V445, P858, DOI 10.1038/nature05662; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Mimoto A, 2007, BIOCHEM BIOPH RES CO, V364, P883, DOI 10.1016/j.bbrc.2007.10.089; Mohri A, 2005, GENETICS, V169, P1437, DOI 10.1534/genetics.104.036111; MORI I, 1995, NATURE, V376, P344, DOI 10.1038/376344a0; Mori I, 2007, CURR OPIN NEUROBIOL, V17, P712, DOI 10.1016/j.conb.2007.11.010; Morimoto RI, 1998, GENE DEV, V12, P3788, DOI 10.1101/gad.12.24.3788; Morley JF, 2004, MOL BIOL CELL, V15, P657, DOI 10.1091/mbc.E03-07-0532; MOSSER DD, 1990, P NATL ACAD SCI USA, V87, P3748, DOI 10.1073/pnas.87.10.3748; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Okochi Y, 2005, EMBO J, V24, P2127, DOI 10.1038/sj.emboj.7600697; Prahlad V, 2008, SCIENCE, V320, P811, DOI 10.1126/science.1156093; Von Stetina SE, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r135; Watson JD, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-84; Woolley CS, 2007, ANNU REV PHARMACOL, V47, P657, DOI 10.1146/annurev.pharmtox.47.120505.105219; Wu MV, 2009, CELL, V139, P61, DOI 10.1016/j.cell.2009.07.036; Xiang Y, 2010, NATURE, V468, P921, DOI 10.1038/nature09576; Zariwala HA, 2003, J NEUROSCI, V23, P4369; ZIMARINO V, 1987, NATURE, V327, P727, DOI 10.1038/327727a0	41	52	56	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2011	14	8					984	U69		10.1038/nn.2854	http://dx.doi.org/10.1038/nn.2854			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	797KC	21706021				2022-12-28	WOS:000293123700011
J	Bero, AW; Yan, P; Roh, JH; Cirrito, JR; Stewart, FR; Raichle, ME; Lee, JM; Holtzman, DM				Bero, Adam W.; Yan, Ping; Roh, Jee Hoon; Cirrito, John R.; Stewart, Floy R.; Raichle, Marcus E.; Lee, Jin-Moo; Holtzman, David M.			Neuronal activity regulates the regional vulnerability to amyloid-beta deposition	NATURE NEUROSCIENCE			English	Article							ALZHEIMERS-DISEASE; TRANSGENIC MICE; MESSENGER-RNA; IN-VIVO; AEROBIC GLYCOLYSIS; FUNCTIONAL CONNECTIVITY; INTERSTITIAL FLUID; DEFAULT NETWORK; GAMMA-SECRETASE; HUMAN-BRAIN	Amyloid-beta (A beta) plaque deposition in specific brain regions is a pathological hallmark of Alzheimer's disease. However, the mechanism underlying the regional vulnerability to A beta deposition in Alzheimer's disease is unknown. Herein, we provide evidence that endogenous neuronal activity regulates the regional concentration of interstitial fluid (ISF) A beta, which drives local A beta aggregation. Using in vivo microdialysis, we show that ISF A beta concentrations in several brain regions of APP transgenic mice before plaque deposition were commensurate with the degree of subsequent plaque deposition and with the concentration of lactate, a marker of neuronal activity. Furthermore, unilateral vibrissal stimulation increased ISF A beta, and unilateral vibrissal deprivation decreased ISF A beta and lactate, in contralateral barrel cortex. Long-term unilateral vibrissal deprivation decreased amyloid plaque formation and growth. Our results suggest a mechanism to account for the vulnerability of specific brain regions to A beta deposition in Alzheimer's disease.	[Bero, Adam W.; Yan, Ping; Roh, Jee Hoon; Cirrito, John R.; Stewart, Floy R.; Raichle, Marcus E.; Lee, Jin-Moo; Holtzman, David M.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Bero, Adam W.; Roh, Jee Hoon; Stewart, Floy R.; Holtzman, David M.] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO 63110 USA; [Bero, Adam W.; Yan, Ping; Roh, Jee Hoon; Cirrito, John R.; Stewart, Floy R.; Lee, Jin-Moo; Holtzman, David M.] Washington Univ, Sch Med, Hope Ctr Neurol Disorders, St Louis, MO 63110 USA; [Bero, Adam W.; Yan, Ping; Roh, Jee Hoon; Cirrito, John R.; Stewart, Floy R.; Lee, Jin-Moo; Holtzman, David M.] Washington Univ, Sch Med, Charles F & Joanne Knight Alzheimers Dis Res Ctr, St Louis, MO 63110 USA; [Raichle, Marcus E.] Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA; [Raichle, Marcus E.] Washington Univ, Sch Med, Dept Biomed Engn, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Holtzman, DM (corresponding author), Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA.	holtzman@neuro.wustl.edu	JH, Roh/F-4078-2014; Lee, Jin-Moo/K-2024-2015	JH, Roh/0000-0002-3243-0529; Lee, Jin-Moo/0000-0002-3979-0906	US National Institutes of Health [AG033452, AG029524, AG568127, NS06833, NS67905, NS32636, AG13956, P30NS057105]; Cure Alzheimer's Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS032636, P01NS006833, P30NS057105, P50NS006833, R01NS067905] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F31AG033452, R37AG013956, K01AG029524, R01AG013956] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cure Alzheimer's Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank R.H. Mach (Washington University School of Medicine, St. Louis) for generously providing methoxy-X04 and X-34. We thank K.H. Ashe (University of Minnesota) for generously providing Tg2576 mice. We thank Eli Lilly and Co. for generously providing m266 and biotinylated 3D6 anti-A beta antibodies. This work was supported by US National Institutes of Health grants AG033452 (A.W.B.), AG029524 (J.R.C.), AG568127 (J.R.C.), NS06833 (M.E.R.), NS67905 (J.-M.L.), NS32636 (J.-M.L.), AG13956 (D.M.H.), P30NS057105 (D.M.H.) and the Cure Alzheimer's Fund (D.M.H.).	BAHMANYAR S, 1987, SCIENCE, V237, P77, DOI 10.1126/science.3299701; Bigl M, 2000, NEUROSCI LETT, V292, P107, DOI 10.1016/S0304-3940(00)01452-X; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Buckner RL, 2009, J NEUROSCI, V29, P1860, DOI 10.1523/JNEUROSCI.5062-08.2009; Buckner RL, 2005, J NEUROSCI, V25, P7709, DOI 10.1523/JNEUROSCI.2177-05.2005; Cirrito JR, 2008, NEURON, V58, P42, DOI 10.1016/j.neuron.2008.02.003; Cirrito JR, 2005, NEURON, V48, P913, DOI 10.1016/j.neuron.2005.10.028; Cirrito JR, 2003, J NEUROSCI, V23, P8844; DURHAM D, 1978, J COMP NEUROL, V178, P629, DOI 10.1002/cne.901780403; Eisele YS, 2010, SCIENCE, V330, P980, DOI 10.1126/science.1194516; Filippini N, 2009, P NATL ACAD SCI USA, V106, P7209, DOI 10.1073/pnas.0811879106; Flicker L, 2010, J ALZHEIMERS DIS, V20, P803, DOI 10.3233/JAD-2010-091624; Franklin K. B. J., 1996, MOUSE BRAIN STEREOTA; Gilestro GF, 2009, SCIENCE, V324, P109, DOI 10.1126/science.1166673; GOEDERT M, 1987, EMBO J, V6, P3627, DOI 10.1002/j.1460-2075.1987.tb02694.x; Goldstein ME, 2007, J PHARMACOL EXP THER, V323, P102, DOI 10.1124/jpet.107.125492; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Harris JA, 2010, NEURON, V68, P428, DOI 10.1016/j.neuron.2010.10.020; Hedden T, 2009, J NEUROSCI, V29, P12686, DOI 10.1523/JNEUROSCI.3189-09.2009; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Hyder F, 2006, J CEREBR BLOOD F MET, V26, P865, DOI 10.1038/sj.jcbfm.9600263; Irizarry MC, 1997, J NEUROPATH EXP NEUR, V56, P965, DOI 10.1097/00005072-199709000-00002; Irizarry MC, 2001, AM J PATHOL, V158, P173, DOI 10.1016/S0002-9440(10)63955-7; Jankowsky JL, 2004, HUM MOL GENET, V13, P159, DOI 10.1093/hmg/ddh019; Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7; Kang JE, 2009, SCIENCE, V326, P1005, DOI 10.1126/science.1180962; Kim J, 2009, NEURON, V64, P632, DOI 10.1016/j.neuron.2009.11.013; Kim J, 2009, NEURON, V63, P287, DOI 10.1016/j.neuron.2009.06.026; Klunk WE, 2002, J NEUROPATH EXP NEUR, V61, P797, DOI 10.1093/jnen/61.9.797; Lazarov O, 2002, J NEUROSCI, V22, P9785; MELZER P, 1985, BRAIN RES, V348, P229, DOI 10.1016/0006-8993(85)90441-X; Meyer-Luehmann M, 2003, NAT NEUROSCI, V6, P370, DOI 10.1038/nn1022; Meyer-Luehmann M, 2006, SCIENCE, V313, P1781, DOI 10.1126/science.1131864; Olney JW, 1997, ARCH NEUROL-CHICAGO, V54, P1234, DOI 10.1001/archneur.1997.00550220042012; Page K, 1996, P NATL ACAD SCI USA, V93, P14020, DOI 10.1073/pnas.93.24.14020; PELLERIN L, 1994, P NATL ACAD SCI USA, V91, P10625, DOI 10.1073/pnas.91.22.10625; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Riedner BA, 2007, SLEEP, V30, P1643, DOI 10.1093/sleep/30.12.1643; Rojas MJ, 2006, AM J PHYSIOL-REG I, V291, pR189, DOI 10.1152/ajpregu.00409.2005; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Sperling RA, 2009, NEURON, V63, P178, DOI 10.1016/j.neuron.2009.07.003; Uehara T, 2008, PHARMACOL BIOCHEM BE, V90, P273, DOI 10.1016/j.pbb.2008.04.001; Vaishnavi SN, 2010, P NATL ACAD SCI USA, V107, P17757, DOI 10.1073/pnas.1010459107; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Vlassenko AG, 2010, P NATL ACAD SCI USA, V107, P17763, DOI 10.1073/pnas.1010461107; Vyazovskiy VV, 2008, NAT NEUROSCI, V11, P200, DOI 10.1038/nn2035; Wei W, 2010, NAT NEUROSCI, V13, P190, DOI 10.1038/nn.2476; WOOLSEY TA, 1970, BRAIN RES, V17, P205, DOI 10.1016/0006-8993(70)90079-X; Yan P, 2009, J NEUROSCI, V29, P10706, DOI 10.1523/JNEUROSCI.2637-09.2009	49	576	590	1	76	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2011	14	6					750	U353		10.1038/nn.2801	http://dx.doi.org/10.1038/nn.2801			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	768SH	21532579	Green Accepted			2022-12-28	WOS:000290958000018
J	Piet, R; Manzoni, OJ				Piet, Richard; Manzoni, Olivier J.			Prime time for stress	NATURE NEUROSCIENCE			English	Editorial Material							LONG-TERM POTENTIATION; SYNAPTIC PLASTICITY; SYNAPSES; RELEASE; BRAIN		[Piet, Richard] Univ Otago, Ctr Neuroendocrinol, Dunedin, New Zealand; [Piet, Richard] Univ Otago, Dept Physiol, Dunedin, New Zealand; [Manzoni, Olivier J.] Univ Aix Marseille 2, Inst Neurobiol Mediterranee, INSERM, U901, Marseille, France	University of Otago; University of Otago; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Piet, R (corresponding author), Univ Otago, Ctr Neuroendocrinol, Dunedin, New Zealand.	richard.piet@otago.ac.nz; olivier.manzoni@inserm.fr	Piet, Richard/H-7958-2019; Manzoni, Olivier/M-7899-2016	Piet, Richard/0000-0001-5160-6027; Manzoni, Olivier/0000-0002-5579-6208				Armario A, 2008, NEUROSCI BIOBEHAV R, V32, P1121, DOI 10.1016/j.neubiorev.2008.04.003; Bender VA, 2009, J NEUROSCI, V29, P10974, DOI 10.1523/JNEUROSCI.2123-09.2009; Feder A, 2009, NAT REV NEUROSCI, V10, P446, DOI 10.1038/nrn2649; Joels M, 2009, NAT REV NEUROSCI, V10, P459, DOI 10.1038/nrn2632; Koob GF, 2008, NEURON, V59, P11, DOI 10.1016/j.neuron.2008.06.012; Kuzmiski JB, 2010, NAT NEUROSCI, V13, P1257, DOI 10.1038/nn.2629; Lau CG, 2007, NAT REV NEUROSCI, V8, P413, DOI 10.1038/nrn2153; Lledo PM, 1998, SCIENCE, V279, P399, DOI 10.1126/science.279.5349.399; Ludwig M, 2006, NAT REV NEUROSCI, V7, P126, DOI 10.1038/nrn1845; Lupien SJ, 2009, NAT REV NEUROSCI, V10, P434, DOI 10.1038/nrn2639; Regehr WG, 2009, NEURON, V63, P154, DOI 10.1016/j.neuron.2009.06.021; Schierloh A, 2007, NEUROSCI LETT, V416, P82, DOI 10.1016/j.neulet.2007.01.047; Selye H., 1975, STRESS DISTRESS; Sheng H, 2008, ENDOCRINOLOGY, V149, P1389, DOI 10.1210/en.2007-1378; Ulrich-Lai YM, 2009, NAT REV NEUROSCI, V10, P397, DOI 10.1038/nrn2647	15	3	3	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2010	13	10					1156	1158		10.1038/nn1010-1156	http://dx.doi.org/10.1038/nn1010-1156			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	654MB	20877277				2022-12-28	WOS:000282171300004
J	Dupret, D; O'Neill, J; Pleydell-Bouverie, B; Csicsvari, J				Dupret, David; O'Neill, Joseph; Pleydell-Bouverie, Barty; Csicsvari, Jozsef			The reorganization and reactivation of hippocampal maps predict spatial memory performance	NATURE NEUROSCIENCE			English	Article							NMDA-RECEPTOR BLOCKADE; PLACE CELLS; NEURONAL ENSEMBLES; CONSOLIDATION; SLEEP; PATTERNS; TRACE; RAT; TASK; IMPAIRMENT	The hippocampus is an important brain circuit for spatial memory and the spatially selective spiking of hippocampal neuronal assemblies is thought to provide a mnemonic representation of space. We found that remembering newly learnt goal locations required NMDA receptor-dependent stabilization and enhanced reactivation of goal-related hippocampal assemblies. During spatial learning, place-related firing patterns in the CA1, but not CA3, region of the rat hippocampus were reorganized to represent new goal locations. Such reorganization did not occur when goals were marked by visual cues. The stabilization and successful retrieval of these newly acquired CA1 representations of behaviorally relevant places was NMDAR dependent and necessary for subsequent memory retention performance. Goal-related assembly patterns associated with sharp wave/ripple network oscillations, during both learning and subsequent rest periods, predicted memory performance. Together, these results suggest that the reorganization and reactivation of assembly firing patterns in the hippocampus represent the formation and expression of new spatial memory traces.	[Dupret, David; O'Neill, Joseph; Pleydell-Bouverie, Barty; Csicsvari, Jozsef] Univ Oxford, Dept Pharmacol, Anat Neuropharmacol Unit, MRC, Oxford OX1 3QT, England	University of Oxford	Dupret, D (corresponding author), Univ Oxford, Dept Pharmacol, Anat Neuropharmacol Unit, MRC, S Parks Rd, Oxford OX1 3QT, England.	david.dupret@pharm.ox.ac.uk; jozsef.csicsvari@pharm.ox.ac.uk		Dupret, David/0000-0002-0040-1766	Medical Research Council; Institut de France-Fondation Louis D.; International Brain Research Organization; Saint Edmund Hall College, University of Oxford; Medical Research Council [MC_U138169944, MC_U138197111] Funding Source: researchfish; MRC [MC_U138197111, MC_U138169944] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Institut de France-Fondation Louis D.; International Brain Research Organization; Saint Edmund Hall College, University of Oxford; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank J.N.P. Rawlins and D. M. Bannerman for discussions about the behavioral procedures; J.R. Huxter and K. Allen for discussions about data analysis and the manuscript; P. Somogyi, M. Capogna, C. Lever, O. Paulsen and T. Bienvenu for comments on a previous version of the manuscript and N. Campo-Urriza for technical assistance. This work was supported by the Medical Research Council. D. D. was successively funded by fellowships from the Institut de France-Fondation Louis D. and the International Brain Research Organization (Research Fellowship), and currently holds a Junior Research Fellowship in Neurosciences from Saint Edmund Hall College, University of Oxford.	BUZSAKI G, 1986, BRAIN RES, V398, P242, DOI 10.1016/0006-8993(86)91483-6; BUZSAKI G, 1989, NEUROSCIENCE, V31, P551, DOI 10.1016/0306-4522(89)90423-5; Cheng S, 2008, NEURON, V57, P303, DOI 10.1016/j.neuron.2007.11.035; Csicsvari J, 2000, NEURON, V28, P585, DOI 10.1016/S0896-6273(00)00135-5; Csicsvari J, 1999, J NEUROSCI, V19, P274, DOI 10.1523/JNEUROSCI.19-01-00274.1999; Ego-Stengel V, 2010, HIPPOCAMPUS, V20, P1, DOI 10.1002/hipo.20707; Ekstrom AD, 2003, NATURE, V425, P184, DOI 10.1038/nature01964; Gerrard JL, 2008, J NEUROSCI, V28, P7883, DOI 10.1523/JNEUROSCI.1265-08.2008; Girardeau G, 2009, NAT NEUROSCI, V12, P1222, DOI 10.1038/nn.2384; GLICKMAN SE, 1961, PSYCHOL BULL, V58, P218, DOI 10.1037/h0044212; Hebb Donald O., 1949, ORG BEHAV; Hok V, 2007, J NEUROSCI, V27, P472, DOI 10.1523/JNEUROSCI.2864-06.2007; Hollup SA, 2001, J NEUROSCI, V21, P1635, DOI 10.1523/JNEUROSCI.21-05-01635.2001; Kentros C, 1998, SCIENCE, V280, P2121, DOI 10.1126/science.280.5372.2121; King C, 1999, J PHYSIOL-LONDON, V521, P159, DOI 10.1111/j.1469-7793.1999.00159.x; Kudrimoti HS, 1999, J NEUROSCI, V19, P4090; Lansink CS, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000173; Leutgeb S, 2005, SCIENCE, V309, P619, DOI 10.1126/science.1114037; Leutgeb S, 2004, SCIENCE, V305, P1295, DOI 10.1126/science.1100265; Losonczy A, 2008, NATURE, V452, P436, DOI 10.1038/nature06725; Maquet P, 2001, SCIENCE, V294, P1048, DOI 10.1126/science.1062856; MARKUS EJ, 1995, J NEUROSCI, V15, P7079; MARR D, 1971, PHILOS T ROY SOC B, V262, P23, DOI 10.1098/rstb.1971.0078; Marshall U, 2007, TRENDS COGN SCI, V11, P442, DOI 10.1016/j.tics.2007.09.001; MCCLELLAND JL, 1995, PSYCHOL REV, V102, P419, DOI 10.1037/0033-295X.102.3.419; McDonald RJ, 2005, EUR J NEUROSCI, V22, P1201, DOI 10.1111/j.1460-9568.2005.04272.x; MCGAUGH JL, 1966, SCIENCE, V153, P1351, DOI 10.1126/science.153.3742.1351; Morris RGM, 2006, EUR J NEUROSCI, V23, P2829, DOI 10.1111/j.1460-9568.2006.04888.x; MORRIS RGM, 1986, NATURE, V319, P774, DOI 10.1038/319774a0; MULLER RU, 1987, J NEUROSCI, V7, P1951; MULLER RU, 1989, J NEUROSCI, V9, P4101; Nakashiba T, 2009, NEURON, V62, P781, DOI 10.1016/j.neuron.2009.05.013; Nakazawa K, 2004, NAT REV NEUROSCI, V5, P361, DOI 10.1038/nrn1385; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; O'Neill J, 2006, NEURON, V49, P143, DOI 10.1016/j.neuron.2005.10.037; O'Neill J, 2008, NAT NEUROSCI, V11, P209, DOI 10.1038/nn2037; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; Pennartz CMA, 2004, J NEUROSCI, V24, P6446, DOI 10.1523/JNEUROSCI.0575-04.2004; Peyrache A, 2009, NAT NEUROSCI, V12, P919, DOI 10.1038/nn.2337; Rasch B, 2007, CURR OPIN NEUROBIOL, V17, P698, DOI 10.1016/j.conb.2007.11.007; Rasch B, 2007, SCIENCE, V315, P1426, DOI 10.1126/science.1138581; Riedel G, 1999, NAT NEUROSCI, V2, P898, DOI 10.1038/13202; Shimizu E, 2000, SCIENCE, V290, P1170, DOI 10.1126/science.290.5494.1170; Skaggs WE, 1996, HIPPOCAMPUS, V6, P149, DOI 10.1002/(SICI)1098-1063(1996)6:2<149::AID-HIPO6>3.0.CO;2-K; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; Steele RJ, 1999, HIPPOCAMPUS, V9, P118, DOI 10.1002/(SICI)1098-1063(1999)9:2<118::AID-HIPO4>3.0.CO;2-8; Sutherland GR, 2000, CURR OPIN NEUROBIOL, V10, P180, DOI 10.1016/S0959-4388(00)00079-9; Tatsuno M, 2006, J NEUROSCI, V26, P10727, DOI 10.1523/JNEUROSCI.3317-06.2006; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520	50	384	389	2	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2010	13	8					995	U122		10.1038/nn.2599	http://dx.doi.org/10.1038/nn.2599			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	632DK	20639874	Green Accepted			2022-12-28	WOS:000280400600019
J	Gandhi, S; Wood, NW				Gandhi, Sonia; Wood, Nicholas W.			Genome-wide association studies: the key to unlocking neurodegeneration?	NATURE NEUROSCIENCE			English	Article							AMYLOID-BETA-PEPTIDE; FAMILIAL ALZHEIMERS-DISEASE; PARKINSONS-DISEASE; PRECURSOR-PROTEIN; APOLIPOPROTEIN-E; IDENTIFIES VARIANTS; MISSENSE MUTATIONS; COMPLEX TRAITS; RISK-FACTORS; GENE	The successful discovery of genes that cause rare monogenic disorders has dominated our understanding of the genetic basis of neurodegenerative disease. The emergence of robust genome-wide association methodologies promises to explain the genetic etiology of the common sporadic forms of complex diseases. In addition to revealing the genetic susceptibility of neurodegenerative disease, genome-wide association studies (GWASs) should also be an unbiased generator of molecules that are relevant in disease pathogenesis. Despite this exciting potential, GWAS results have varied in their consistency and their ability to deliver these aims. The largest challenge that faces neuroscientists is the interpretation of the results of GWASs and the translation of the genetic findings into functional mechanisms that are biologically important in disease pathogenesis and, ultimately, treatment design. We examine recent results from GWASs of Alzheimer's disease and Parkinson's disease and explore their use and limitations. We further reflect on how these results may expedite progress in understanding and influencing the molecular pathogenesis of neurodegeneration.	[Gandhi, Sonia; Wood, Nicholas W.] UCL, Inst Neurol, Dept Mol Neurosci, London, England	University of London; University College London	Wood, NW (corresponding author), UCL, Inst Neurol, Dept Mol Neurosci, London, England.	n.wood@ion.ucl.ac.uk	Wood, Nicholas W/C-2505-2009	Wood, Nicholas W/0000-0002-9500-3348	Wellcome Trust; Medical Research Council; Parkinson's UK; MRC [MC_G1000735, MC_PC_09003, MC_G0901330] Funding Source: UKRI; Medical Research Council [MC_PC_09003, MC_G1000735, MC_G0901330] Funding Source: researchfish; Parkinson&quot;s UK [J-0804] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Parkinson's UK(Parkinson's UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Parkinson&quot;s UK(Parkinson&apos;s UK)	The authors acknowledge the support of the Wellcome Trust, the Medical Research Council (Neurodegeneration strategic award) and Parkinson's UK.	Bales KR, 1997, NAT GENET, V17, P263, DOI 10.1038/ng1197-263; Bell RD, 2007, J CEREBR BLOOD F MET, V27, P909, DOI 10.1038/sj.jcbfm.9600419; Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209; Brouwers N, 2008, ANN MED, V40, P562, DOI 10.1080/07853890802186905; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Carey RM, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-30; DeMattos RB, 2002, P NATL ACAD SCI USA, V99, P10843, DOI 10.1073/pnas.162228299; Dickson SP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000294; Edwards TL, 2010, ANN HUM GENET, V74, P97, DOI 10.1111/j.1469-1809.2009.00560.x; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Frazer KA, 2009, NAT REV GENET, V10, P241, DOI 10.1038/nrg2554; Gilks WP, 2005, LANCET, V365, P415, DOI 10.1016/S0140-6736(05)17830-1; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; Hardy J, 2006, NEURON, V52, P3, DOI 10.1016/j.neuron.2006.09.016; Harel A, 2008, TRAFFIC, V9, P417, DOI 10.1111/j.1600-0854.2007.00694.x; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; Healy DG, 2008, LANCET NEUROL, V7, P583, DOI 10.1016/S1474-4422(08)70117-0; Holmes C, 2008, LANCET, V372, P216, DOI 10.1016/S0140-6736(08)61075-2; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; Lee HC, 2004, CURR MOL MED, V4, P227, DOI 10.2174/1566524043360753; Lesage S, 2006, NEW ENGL J MED, V354, P422, DOI 10.1056/NEJMc055540; Lesage S, 2009, HUM MOL GENET, V18, pR48, DOI 10.1093/hmg/ddp012; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; MCGEER PL, 1992, BRAIN RES, V579, P337, DOI 10.1016/0006-8993(92)90071-G; Michel D, 1997, BIOCHEM J, V328, P45, DOI 10.1042/bj3280045; Neumann J, 2009, BRAIN, V132, P1783, DOI 10.1093/brain/awp044; Ng PC, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000160; NORDSTEDT C, 1993, J BIOL CHEM, V268, P608; Nuutinen T, 2009, BRAIN RES REV, V61, P89, DOI 10.1016/j.brainresrev.2009.05.007; Paisan-Ruiz C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023; Pittman AM, 2006, HUM MOL GENET, V15, pR188, DOI 10.1093/hmg/ddl190; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; ROGAEV EI, 1995, NATURE, V376, P775, DOI 10.1038/376775a0; Rogers J, 2006, NEUROBIOL AGING, V27, P1733, DOI 10.1016/j.neurobiolaging.2005.09.043; Satake W, 2009, NAT GENET, V41, P1303, DOI 10.1038/ng.485; Schork NJ, 2009, CURR OPIN GENET DEV, V19, P212, DOI 10.1016/j.gde.2009.04.010; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; Simon-Sanchez J, 2008, LANCET NEUROL, V7, P1067, DOI 10.1016/S1474-4422(08)70241-2; Simon-Sanchez J, 2009, NAT GENET, V41, P1308, DOI 10.1038/ng.487; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Small SA, 2008, NEURON, V60, P534, DOI 10.1016/j.neuron.2008.11.007; Surmeier DJ, 2010, CELL CALCIUM, V47, P175, DOI 10.1016/j.ceca.2009.12.003; TSAI MS, 1994, AM J HUM GENET, V54, P643; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Wang WYS, 2005, NAT REV GENET, V6, P109, DOI 10.1038/nrg1522; Webster S, 1997, J NEUROCHEM, V69, P388; Zhou J, 2008, J NEUROCHEM, V106, P2080, DOI 10.1111/j.1471-4159.2008.05558.x	48	70	77	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2010	13	7					789	794		10.1038/nn.2584	http://dx.doi.org/10.1038/nn.2584			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	615YF	20581814				2022-12-28	WOS:000279173900007
J	Li, KX; Lu, YM; Xu, ZH; Zhang, J; Zhu, JM; Zhang, JM; Cao, SX; Chen, XJ; Chen, Z; Luo, JH; Duan, SM; Li, XM				Li, Ke-Xin; Lu, Ying-Mei; Xu, Zheng-Hao; Zhang, Jing; Zhu, Jun-Ming; Zhang, Jian-Ming; Cao, Shu-Xia; Chen, Xiao-Juan; Chen, Zhong; Luo, Jian-Hong; Duan, Shumin; Li, Xiao-Ming			Neuregulin 1 regulates excitability of fast-spiking neurons through Kv1.1 and acts in epilepsy	NATURE NEUROSCIENCE			English	Article							PARVALBUMIN-POSITIVE INTERNEURONS; LONG-TERM POTENTIATION; PRIMARY VISUAL-CORTEX; GABAERGIC INTERNEURONS; POTASSIUM CHANNELS; NEURAL DEVELOPMENT; TYROSINE KINASE; NMDA RECEPTORS; K+ CHANNELS; ERBB4	Dysfunction of fast-spiking, parvalbumin-positive (FS-PV) interneurons is implicated in the pathogenesis of epilepsy. ErbB4, a key Neuregulin 1 (NRG1) receptor, is mainly expressed in this type of interneurons, and recent studies suggest that parvalbumin interneurons are a major target of NRG1-ErbB4 signaling in adult brain. Thus, we hypothesized that downregulation of NRG1-ErbB4 signaling in FS-PV interneurons is involved in epilepsy. We found that NRG1, through its receptor ErbB4, increased the intrinsic excitability of FS-PV interneurons. This effect was mediated by increasing the near-threshold responsiveness and decreasing the voltage threshold for action potentials through Kv1.1, a voltage-gated potassium channel. Furthermore, mice with specific deletion of ErbB4 in parvalbumin interneurons were more susceptible to pentylenetetrazole- and pilocarpine-induced models of epilepsy. Exogenous NRG1 delayed the onset of seizures and decreased their incidence and stage. Moreover, expression of ErbB4, but not ErbB2, was downregulated in human epileptogenic tissue. Together, our findings suggest that NRG1-ErbB4 signaling contributes to human epilepsy through regulating the excitability of FS-PV interneurons. ErbB4 may be a new target for anticonvulsant drugs in epilepsy.	[Li, Ke-Xin; Lu, Ying-Mei; Xu, Zheng-Hao; Zhang, Jing; Cao, Shu-Xia; Chen, Xiao-Juan; Chen, Zhong; Luo, Jian-Hong; Duan, Shumin; Li, Xiao-Ming] Zhejiang Univ, Sch Med, Zhejiang Prov Key Lab Neurobiol, Key Lab Med Neurobiol,Minist Hlth China,Dept Neur, Hangzhou 310003, Zhejiang, Peoples R China; [Zhu, Jun-Ming; Zhang, Jian-Ming] Zhejiang Univ, Sch Med, Dept Neurosurg, Affiliated Hosp 2, Hangzhou 310003, Zhejiang, Peoples R China; [Luo, Jian-Hong; Duan, Shumin; Li, Xiao-Ming] Zhejiang Univ, Soft Matter Res Ctr, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University	Li, XM (corresponding author), Zhejiang Univ, Sch Med, Zhejiang Prov Key Lab Neurobiol, Key Lab Med Neurobiol,Minist Hlth China,Dept Neur, Hangzhou 310003, Zhejiang, Peoples R China.	lixm@zju.edu.cn	Luo, jian/HGE-7331-2022	Xu, Zhenghao/0000-0003-0033-525X; Li, Ke-Xin/0000-0003-3879-294X	National Natural Science Foundation of China [30970916, 31070926, 30725047]; state Ministry of Science and Technology of China [2010CB912004, 2010CB912002]; Zhejiang Provincial Natural Science Foundation of China [Z2090127]; Foundation for the Author of National Excellent Doctoral Dissertation of China [200937]; Science Foundation of Chinese Universities [JD09023]; Zhejiang Provincial Qianjiang Talent Plan [2010R10057]; Fundamental Research Funds for the Central Universities [2011XZZX002]; Zhejiang Province Key Technology Innovation Team [2010R50049]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); state Ministry of Science and Technology of China(Ministry of Science and Technology, China); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); Foundation for the Author of National Excellent Doctoral Dissertation of China(Foundation for the Author of National Excellent Doctoral Dissertation of China); Science Foundation of Chinese Universities; Zhejiang Provincial Qianjiang Talent Plan; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Zhejiang Province Key Technology Innovation Team	We thank L. Mei (Georgia Health Sciences University) for advice. We are grateful to T.M. Gao (Southern Medical University), Z.J. Huang (Cold Spring Harbor), X.H. Zhang (Institute of Neuroscience, Chinese Academy of Sciences) and L. Bao (Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences) for providing reagents and/or mice. We express our gratitude to the subjects and their families for their participation. We also thank T.M. Gao and I.C. Bruce for critical reading of this manuscript, and Q.L. Miao for technical assistance. This work was supported by grants from the National Natural Science Foundation of China (30970916, 31070926 and 30725047), the Major Research Program from the state Ministry of Science and Technology of China (2010CB912004, 2010CB912002), the Zhejiang Provincial Natural Science Foundation of China (Z2090127), the Foundation for the Author of National Excellent Doctoral Dissertation of China (200937), the Science Foundation of Chinese Universities (JD09023), the Zhejiang Provincial Qianjiang Talent Plan (2010R10057), the Fundamental Research Funds for the Central Universities (2011XZZX002) and Zhejiang Province Key Technology Innovation Team (2010R50049).	Arber S, 2000, CELL, V101, P485, DOI 10.1016/S0092-8674(00)80859-4; Bjarnadottir M, 2007, J NEUROSCI, V27, P4519, DOI 10.1523/JNEUROSCI.4314-06.2007; Buonanno A, 2010, BRAIN RES BULL, V83, P122, DOI 10.1016/j.brainresbull.2010.07.012; Cascella NG, 2009, NEUROSCI RES, V63, P227, DOI 10.1016/j.neures.2009.01.002; Chattopadhyaya B, 2004, J NEUROSCI, V24, P9598, DOI 10.1523/JNEUROSCI.1851-04.2004; Chen YJ, 2010, P NATL ACAD SCI USA, V107, P21818, DOI 10.1073/pnas.1010669107; Coetzee WA, 1999, ANN NY ACAD SCI, V868, P233, DOI 10.1111/j.1749-6632.1999.tb11293.x; Cook KK, 2002, J BIOL CHEM, V277, P13268, DOI 10.1074/jbc.M108898200; Corfas G, 2004, NAT NEUROSCI, V7, P575, DOI 10.1038/nn1258; Di Cristo G, 2004, NAT NEUROSCI, V7, P1184, DOI 10.1038/nn1334; Dreyfus J, 1998, REMARKABLE MED HAS B; Fazzari P, 2010, NATURE, V464, P1376, DOI 10.1038/nature08928; Fisahn A, 2009, CEREB CORTEX, V19, P612, DOI 10.1093/cercor/bhn107; Fukazawa R, 2003, J MOL CELL CARDIOL, V35, P1473, DOI 10.1016/j.yjmcc.2003.09.012; Garcia-Rivello H, 2005, AM J PHYSIOL-HEART C, V289, pH1153, DOI 10.1152/ajpheart.00048.2005; Gibson JR, 1999, NATURE, V402, P75, DOI 10.1038/47035; Goldberg EM, 2008, NEURON, V58, P387, DOI 10.1016/j.neuron.2008.03.003; Gu ZL, 2005, J NEUROSCI, V25, P4974, DOI 10.1523/JNEUROSCI.1086-05.2005; Guan D, 2006, J PHYSIOL-LONDON, V571, P371, DOI 10.1113/jphysiol.2005.097006; Hippenmeyer S, 2005, PLOS BIOL, V3, P878, DOI 10.1371/journal.pbio.0030159; Holmes TC, 1996, SCIENCE, V274, P2089, DOI 10.1126/science.274.5295.2089; Huang YZ, 2000, NEURON, V26, P443, DOI 10.1016/S0896-6273(00)81176-9; Kawaguchi Y, 1997, CEREB CORTEX, V7, P476, DOI 10.1093/cercor/7.6.476; Kwon OB, 2005, J NEUROSCI, V25, P9378, DOI 10.1523/JNEUROSCI.2100-05.2005; LAI C, 1991, NEURON, V6, P691, DOI 10.1016/0896-6273(91)90167-X; Lau D, 2000, J NEUROSCI, V20, P9071; Law AJ, 2004, NEUROSCIENCE, V127, P125, DOI 10.1016/j.neuroscience.2004.04.026; Li B, 2007, NEURON, V54, P583, DOI 10.1016/j.neuron.2007.03.028; Liguori R, 2001, MUSCLE NERVE, V24, P630, DOI 10.1002/mus.1048; Mei L, 2008, NAT REV NEUROSCI, V9, P437, DOI 10.1038/nrn2392; Neddens J, 2010, HIPPOCAMPUS, V20, P724, DOI 10.1002/hipo.20675; Ogiwara I, 2007, J NEUROSCI, V27, P5903, DOI 10.1523/JNEUROSCI.5270-06.2007; Perucca E, 2002, CNS DRUGS, V16, P695, DOI 10.2165/00023210-200216100-00004; Perucca E, 2007, LANCET, V370, P313, DOI 10.1016/S0140-6736(07)61149-0; Pitcher GM, 2011, NAT MED, V17, P470, DOI 10.1038/nm.2315; Robertson B, 1996, FEBS LETT, V383, P26, DOI 10.1016/0014-5793(96)00211-6; Schulte U, 2006, NEURON, V49, P697, DOI 10.1016/j.neuron.2006.01.033; Smart SL, 1998, NEURON, V20, P809, DOI 10.1016/S0896-6273(00)81018-1; Strauss KA, 2006, NEW ENGL J MED, V354, P1370, DOI 10.1056/NEJMoa052773; TANOUYE MA, 1981, P NATL ACAD SCI-BIOL, V78, P6548, DOI 10.1073/pnas.78.10.6548; Ting AK, 2011, J NEUROSCI, V31, P15, DOI 10.1523/JNEUROSCI.2538-10.2011; Tucker K, 2002, J PHYSIOL-LONDON, V542, P413, DOI 10.1113/jphysiol.2002.017376; Vullhorst D, 2009, J NEUROSCI, V29, P12255, DOI 10.1523/JNEUROSCI.2454-09.2009; WANG H, 1994, J NEUROSCI, V14, P4588; Wen L, 2010, P NATL ACAD SCI USA, V107, P1211, DOI 10.1073/pnas.0910302107; Woo RS, 2007, NEURON, V54, P599, DOI 10.1016/j.neuron.2007.04.009; Yau HJ, 2003, CEREB CORTEX, V13, P252, DOI 10.1093/cercor/13.3.252; Ziyatdinova S, 2011, EPILEPSY RES, V94, P75, DOI 10.1016/j.eplepsyres.2011.01.003; Zuberi SM, 1999, BRAIN, V122, P817, DOI 10.1093/brain/122.5.817	49	122	125	3	58	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2012	15	2					267	273		10.1038/nn.3006	http://dx.doi.org/10.1038/nn.3006			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	882ZX	22158511				2022-12-28	WOS:000299603500018
J	Livneh, Y; Mizrahi, A				Livneh, Yoav; Mizrahi, Adi			Experience-dependent plasticity of mature adult-born neurons	NATURE NEUROSCIENCE			English	Article							OLFACTORY-BULB; SYNAPTIC PLASTICITY; CRITICAL PERIOD; NEUROGENESIS; BRAIN; SYNAPTOGENESIS	The adult olfactory bulb and hippocampus are continuously supplied with newborn neurons that are thought to possess a capacity for plasticity only at a young neuronal age, mainly during the early stages of integration into the network. We find that the two main types of adult-born neurons in the mouse olfactory bulb undergo experience-dependent plasticity long after maturation and integration, as evidenced by stabilization of synaptic turnover rates. Thus, the potential time window for plasticity of adult-born neurons extends well into maturity.	[Livneh, Yoav; Mizrahi, Adi] Hebrew Univ Jerusalem, Inst Life Sci, Dept Neurobiol, IL-91904 Jerusalem, Israel; [Mizrahi, Adi] Hebrew Univ Jerusalem, Edmond & Lily Safra Ctr Brain Sci, IL-91904 Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem	Mizrahi, A (corresponding author), Hebrew Univ Jerusalem, Inst Life Sci, Dept Neurobiol, Edmond J Safra Campus, IL-91904 Jerusalem, Israel.	mizrahia@cc.huji.ac.il	Livneh, Yoav/AAA-4007-2021	Livneh, Yoav/0000-0002-0434-4201	European Research Council [203994]; ERA-NET [0398216]; Israel Academy of Sciences and Humanities	European Research Council(European Research Council (ERC)European Commission); ERA-NET; Israel Academy of Sciences and Humanities	We thank H. Spors (Max Planck Institute of Biophysics, Frankfurt, Germany) for the analysis software for the intrinsic signals. We thank Y. Adam for assistance with surgical procedures. We thank members of the Mizrahi laboratory and D. Nachmani for discussions and for commenting on the manuscript. This work was supported by European Research Council (203994) and ERA-NET (0398216) grants to A. M. Y. L. is supported by the Adams Fellowship Program of the Israel Academy of Sciences and Humanities.	ALTMAN J, 1969, J COMP NEUROL, V137, P433, DOI 10.1002/cne.901370404; Alvarez-Buylla A, 2002, J NEUROSCI, V22, P629, DOI 10.1523/JNEUROSCI.22-03-00629.2002; Bhatt DH, 2009, ANNU REV PHYSIOL, V71, P261, DOI 10.1146/annurev.physiol.010908.163140; Ge SY, 2007, NEURON, V54, P559, DOI 10.1016/j.neuron.2007.05.002; Hofer SB, 2009, NATURE, V457, P313, DOI 10.1038/nature07487; Holtmaat A, 2009, NAT REV NEUROSCI, V10, P647, DOI 10.1038/nrn2699; Kelsch W, 2010, ANNU REV NEUROSCI, V33, P131, DOI 10.1146/annurev-neuro-060909-153252; Kelsch W, 2009, J NEUROSCI, V29, P11852, DOI 10.1523/JNEUROSCI.2406-09.2009; Lazarini F, 2011, TRENDS NEUROSCI, V34, P20, DOI 10.1016/j.tins.2010.09.006; Livneh Y, 2009, J NEUROSCI, V29, P86, DOI 10.1523/JNEUROSCI.4105-08.2009; Mandairon N, 2009, J NEUROPHYSIOL, V101, P2204, DOI 10.1152/jn.00076.2009; Mizrahi A, 2007, NAT NEUROSCI, V10, P444, DOI 10.1038/nn1875; Moreno MM, 2009, P NATL ACAD SCI USA, V106, P17980, DOI 10.1073/pnas.0907063106; Nissant A, 2009, NAT NEUROSCI, V12, P728, DOI 10.1038/nn.2298; Yang G, 2009, NATURE, V462, P920, DOI 10.1038/nature08577	15	44	47	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2012	15	1					26	28		10.1038/nn.2980	http://dx.doi.org/10.1038/nn.2980			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	866VO	22081159				2022-12-28	WOS:000298414400010
J	Domingos, AI; Vaynshteyn, J; Voss, HU; Ren, XY; Gradinaru, V; Zang, F; Deisseroth, K; de Araujo, IE; Friedman, J				Domingos, Ana I.; Vaynshteyn, Jake; Voss, Henning U.; Ren, Xueying; Gradinaru, Viviana; Zang, Feng; Deisseroth, Karl; de Araujo, Ivan E.; Friedman, Jeffrey			Leptin regulates the reward value of nutrient	NATURE NEUROSCIENCE			English	Article							SWEET TASTE; ORBITOFRONTAL CORTEX; WANTING FOOD; WEIGHT-LOSS; DOPAMINE; NEURONS; BRAIN; SUCROSE; RESTRICTION; CIRCUITRY	We developed an assay for quantifying the reward value of nutrient and used it to analyze the effects of metabolic state and leptin. In this assay, mice chose between two sippers, one of which dispensed water and was coupled to optogenetic activation of dopaminergic (DA) neurons and the other of which dispensed natural or artificial sweeteners. This assay measured the reward value of sweeteners relative to lick-induced optogenetic activation of DA neurons. Mice preferred optogenetic stimulation of DA neurons to sucralose, but not to sucrose. However, the mice preferred sucralose plus optogenetic stimulation versus sucrose. We found that food restriction increased the value of sucrose relative to sucralose plus optogenetic stimulation, and that leptin decreased it. Our data suggest that leptin suppresses the ability of sucrose to drive taste-independent DA neuronal activation and provide new insights into the mechanism of leptin's effects on food intake.	[Domingos, Ana I.; Vaynshteyn, Jake; Friedman, Jeffrey] Rockefeller Univ, Mol Genet Lab, New York, NY 10021 USA; [Voss, Henning U.] Weill Cornell Med Coll, Dept Radiol, New York, NY USA; [Ren, Xueying; de Araujo, Ivan E.] Yale Univ, Sch Med, JB Pierce Lab, New Haven, CT USA; [Ren, Xueying] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT USA; [Gradinaru, Viviana; Zang, Feng; Deisseroth, Karl] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, CNC Program, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [Friedman, Jeffrey] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA	Rockefeller University; Cornell University; Yale University; The John B Pierce Laboratory, Inc; Yale University; Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University; Howard Hughes Medical Institute; Rockefeller University	Friedman, J (corresponding author), Rockefeller Univ, Mol Genet Lab, 1230 York Ave, New York, NY 10021 USA.	friedj@mail.rockefeller.edu	Ren, Xueying/AAA-9464-2020; Ren, Xueying/ABF-8967-2021	Ren, Xueying/0000-0002-6503-0425; De Araujo, Ivan/0000-0003-3081-3339; Domingos, Ana/0000-0002-7938-4814	Klarman Family Foundation for Eating Disorders (KFFfED); Fundacao para a Ciencia e Tecnologia (Portugal); US National Institutes of Health [DC009997, MH075957]; Gatsby Foundation; Defense Advanced Research Projects Agency; Nancy M. and Samuel C. Fleming Research Scholar Award in Intercampus Collaborations; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH075957, R37MH075957] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC009997] Funding Source: NIH RePORTER	Klarman Family Foundation for Eating Disorders (KFFfED); Fundacao para a Ciencia e Tecnologia (Portugal)(Portuguese Foundation for Science and Technology); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gatsby Foundation; Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Nancy M. and Samuel C. Fleming Research Scholar Award in Intercampus Collaborations; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank F. Pestilli for helping with the bootstrap analysis. We thank the Klarman Family Foundation for Eating Disorders (KFFfED) for supporting this work. A.I.D. was supported by Fundacao para a Ciencia e Tecnologia (Portugal) and KFFfED. J.V. was supported by KFFfED. X.R. and I.E.d.A. were supported by US National Institutes of Health grant DC009997 to I.E.d.A. F.Z., V.G. and K.D. were supported by the US National Institutes of Health (grant MH075957), the Gatsby Foundation and Defense Advanced Research Projects Agency. H.U.V. was partially supported by the Nancy M. and Samuel C. Fleming Research Scholar Award in Intercampus Collaborations.	Abizaid A, 2006, J CLIN INVEST, V116, P3229, DOI 10.1172/JCI29867; BARTOSHUK LM, 1979, SCIENCE, V205, P934, DOI 10.1126/science.472717; Bellisle F, 2007, EUR J CLIN NUTR, V61, P691, DOI 10.1038/sj.ejcn.1602649; Berridge KC, 2000, NEUROSCI BIOBEHAV R, V24, P173, DOI 10.1016/S0149-7634(99)00072-X; Berridge KC, 2007, PSYCHOPHARMACOLOGY, V191, P391, DOI 10.1007/s00213-006-0578-x; Berridge KC, 2009, PHYSIOL BEHAV, V97, P537, DOI 10.1016/j.physbeh.2009.02.044; BUKOWIECKI LJ, 1983, AM J PHYSIOL, V244, pR500, DOI 10.1152/ajpregu.1983.244.4.R500; Cameron JD, 2008, PHYSIOL BEHAV, V94, P474, DOI 10.1016/j.physbeh.2008.02.014; de Araujo IE, 2008, NEURON, V57, P930, DOI 10.1016/j.neuron.2008.01.032; Epstein LH, 2003, PHYSIOL BEHAV, V78, P221, DOI 10.1016/S0031-9384(02)00978-2; Eric Walters D., 1991, SWEETENERS DISCOVERY; Farooqi IS, 2007, SCIENCE, V317, P1355, DOI 10.1126/science.1144599; Figlewicz DP, 2006, PHYSIOL BEHAV, V89, P611, DOI 10.1016/j.physbeh.2006.07.023; Figlewicz DP, 2001, PHYSIOL BEHAV, V73, P229, DOI 10.1016/S0031-9384(01)00486-3; Finlayson G, 2007, NEUROSCI BIOBEHAV R, V31, P987, DOI 10.1016/j.neubiorev.2007.03.004; Friedman JM, 2004, NAT MED, V10, P563, DOI 10.1038/nm0604-563; Fulton S, 2000, SCIENCE, V287, P125, DOI 10.1126/science.287.5450.125; Fulton S, 2004, BEHAV BRAIN RES, V155, P319, DOI 10.1016/j.bbr.2004.05.021; Fulton S, 2006, NEURON, V51, P811, DOI 10.1016/j.neuron.2006.09.006; Glencoe C, 2002, GLENCOE CHEM MATTER; Glimcher PW, 2004, SCIENCE, V306, P447, DOI 10.1126/science.1102566; Haley S, 2005, SWEETENER CONSUMPTIO, P1; HODOS W, 1961, SCIENCE, V134, P943, DOI 10.1126/science.134.3483.943; Hommel JD, 2006, NEURON, V51, P801, DOI 10.1016/j.neuron.2006.08.023; Lee JH, 2010, NATURE, V465, P788, DOI 10.1038/nature09108; Lewis SR, 2006, PHYSIOL BEHAV, V87, P595, DOI 10.1016/j.physbeh.2005.12.002; Li XD, 2002, P NATL ACAD SCI USA, V99, P4692, DOI 10.1073/pnas.072090199; Lydall ES, 2010, PSYCHOPHARMACOLOGY, V209, P153, DOI 10.1007/s00213-010-1779-x; Nelson G, 2001, CELL, V106, P381, DOI 10.1016/S0092-8674(01)00451-2; Nie Y, 2005, CURR BIOL, V15, P1948, DOI 10.1016/j.cub.2005.09.037; Padoa-Schioppa C, 2006, NATURE, V441, P223, DOI 10.1038/nature04676; Padoa-Schioppa C, 2008, NAT NEUROSCI, V11, P95, DOI 10.1038/nn2020; Ren XY, 2010, J NEUROSCI, V30, P8012, DOI 10.1523/JNEUROSCI.5749-09.2010; Roesch MR, 2007, NAT NEUROSCI, V10, P1615, DOI 10.1038/nn2013; ROZIN P, 1980, INT J OBESITY, V4, P356; Sclafani A, 2001, APPETITE, V36, P79, DOI 10.1006/appe.2000.0370; Servant G, 2010, P NATL ACAD SCI USA, V107, P4746, DOI 10.1073/pnas.0911670107; Shigemura N, 2003, ARCH HISTOL CYTOL, V66, P253, DOI 10.1679/aohc.66.253; Sugrue LP, 2005, NAT REV NEUROSCI, V6, P363, DOI 10.1038/nrn1666; Tsai HC, 2009, SCIENCE, V324, P1080, DOI 10.1126/science.1168878; Umabiki M, 2010, TOHOKU J EXP MED, V220, P267, DOI 10.1620/tjem.220.267; Ventura E.E., 2010, OBESITY SILVER SPRIN, V19, P687; WEIJNEN JAWM, 1989, PHYSIOL BEHAV, V46, P923, DOI 10.1016/0031-9384(89)90192-3; Wise RA, 2008, NEUROTOX RES, V14, P169, DOI 10.1007/BF03033808; Zhang F, 2006, NAT METHODS, V3, P785, DOI 10.1038/nmeth936	45	171	176	1	60	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2011	14	12					1562	U92		10.1038/nn.2977	http://dx.doi.org/10.1038/nn.2977			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	855EJ	22081158	Green Accepted			2022-12-28	WOS:000297546300016
J	Puente, N; Cui, YH; Lassalle, O; Lafourcade, M; Georges, F; Venance, L; Grandes, P; Manzoni, OJ				Puente, Nagore; Cui, Yihui; Lassalle, Olivier; Lafourcade, Mathieu; Georges, Francois; Venance, Laurent; Grandes, Pedro; Manzoni, Olivier J.			Polymodal activation of the endocannabinoid system in the extended amygdala	NATURE NEUROSCIENCE			English	Article							LONG-TERM DEPRESSION; BED NUCLEUS; ENDOGENOUS CANNABINOIDS; TRPV1; LOCALIZATION; ANANDAMIDE; RECEPTORS; SYNAPSES; CHANNELS; 2-ARACHIDONOYL-GLYCEROL	The reason why neurons synthesize more than one endocannabinoid (eCB) and how this is involved in the regulation of synaptic plasticity in a single neuron is not known. We found that 2-arachidonoylglycerol (2-AG) and anandamide mediate different forms of plasticity in the extended amygdala of rats. Dendritic L-type Ca2+ channels and the subsequent release of 2-AG acting on presynaptic CB1 receptors triggered retrograde short-term depression. Long-term depression was mediated by postsynaptic mGluR5-dependent release of anandamide acting on postsynaptic TRPV1 receptors. In contrast, 2-AG/CB1R-mediated retrograde signaling mediated both forms of plasticity in the striatum. These data illustrate how the eCB system can function as a polymodal signal integrator to allow the diversification of synaptic plasticity in a single neuron.	[Cui, Yihui; Venance, Laurent] Coll France, Ctr Interdisciplinary Res Biol, CNRS, INSERM,U1050,UMR 7241, F-75231 Paris, France; [Puente, Nagore; Lassalle, Olivier; Lafourcade, Mathieu; Georges, Francois; Manzoni, Olivier J.] INSERM, U862, Bordeaux, France; [Puente, Nagore; Lassalle, Olivier; Lafourcade, Mathieu; Georges, Francois; Manzoni, Olivier J.] Univ Bordeaux, Bordeaux, France; [Puente, Nagore; Grandes, Pedro] Univ Basque Country, Fac Med & Dent, Dept Neurosci, Leioa, Spain; [Puente, Nagore; Lassalle, Olivier; Manzoni, Olivier J.] INSERM, U901, F-13258 Marseille, France; [Puente, Nagore; Lassalle, Olivier] Univ Mediterranee UMR S901, Marseille, France; [Puente, Nagore; Lassalle, Olivier; Manzoni, Olivier J.] INMED, Marseille, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; College de France; Ecole Normale Superieure (ENS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; University of Basque Country; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Venance, L (corresponding author), Coll France, Ctr Interdisciplinary Res Biol, CNRS, INSERM,U1050,UMR 7241, F-75231 Paris, France.	laurent.venance@college-de-france.fr; pedro.grandes@ehu.es; olivier.manzoni@inserm.fr	Manzoni, Olivier/M-7899-2016; Puente, Nagore/H-7054-2015; Lafourcade, Mathieu/GQZ-7267-2022; Cui, Yihui/AAB-9328-2022; Grandes, Pedro/H-7494-2015; Grandes, Pedro/AAA-1627-2019; Venance, Laurent/E-5840-2016	Manzoni, Olivier/0000-0002-5579-6208; Puente, Nagore/0000-0003-0866-5747; Grandes, Pedro/0000-0003-3947-4230; Lafourcade, Mathieu/0000-0001-6117-1194; Venance, Laurent/0000-0003-0738-1662; Cui, Yihui/0000-0002-7362-6237; GEORGES, Francois/0000-0002-2628-2638	INSERM; Agence National pour la Recherche Neurosciences (Neurologie et Psychiatrie) [ANR-06-NEURO-043-01]; Region Aquitaine; Basque Country University; Basque Country Government [ANR-06-NEURO-043-01, GIC07/70-IT-432-07]; Ministerio de Ciencia e Innovacion [SAF2009-07065]; Neuroscience School of Paris; Agence National pour la Recherche Neurosciences "Mobil,"; "Red de Trastornos Adictivos," RETICS, Instituto de Salud Carlos III, MICINN [RD07/0001/2001]; College de France	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Agence National pour la Recherche Neurosciences (Neurologie et Psychiatrie)(French National Research Agency (ANR)); Region Aquitaine(Region Nouvelle-Aquitaine); Basque Country University; Basque Country Government(Basque Government); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Neuroscience School of Paris; Agence National pour la Recherche Neurosciences "Mobil,"(French National Research Agency (ANR)); "Red de Trastornos Adictivos," RETICS, Instituto de Salud Carlos III, MICINN(Instituto de Salud Carlos IIIMinistry of Science and Innovation, Spain (MICINN)Spanish Government); College de France	The authors thank N. Stella, M. Sepers and P. Chavis for critical reading of the manuscript, and R. Martinez for invaluable help in setting up the Manzoni laboratory. Work in the Manzoni laboratory was supported by INSERM, Agence National pour la Recherche Neurosciences (Neurologie et Psychiatrie ANR-06-NEURO-043-01) and Region Aquitaine. N. P. was supported by Basque Country Government Postdoctoral grant BFI05.185 and by a Basque Country University grant for PhD Researcher's Specialization. P.G. was supported by Basque Country Government grant GIC07/70-IT-432-07, by Ministerio de Ciencia e Innovacion (SAF2009-07065) and by "Red de Trastornos Adictivos," RETICS, Instituto de Salud Carlos III, MICINN, grant RD07/0001/2001. Y.C. was supported by the Neuroscience School of Paris, Agence National pour la Recherche Neurosciences "Mobil," INSERM and College de France.	Almasi R, 2008, LIFE SCI, V82, P644, DOI 10.1016/j.lfs.2007.12.022; Bisogno T, 1999, BIOCHEM BIOPH RES CO, V256, P377, DOI 10.1006/bbrc.1999.0254; Cavanaugh DJ, 2011, J NEUROSCI, V31, P5067, DOI 10.1523/JNEUROSCI.6451-10.2011; Chavez AE, 2010, NAT NEUROSCI, V13, P1511, DOI 10.1038/nn.2684; Chevaleyre V, 2003, NEURON, V38, P461, DOI 10.1016/S0896-6273(03)00235-6; Cristino L, 2006, NEUROSCIENCE, V139, P1405, DOI 10.1016/j.neuroscience.2006.02.074; Di Marzo V, 2002, PROSTAG LEUKOTR ESS, V66, P377, DOI 10.1054/plef.2001.0349; Di Marzo V, 2001, TRENDS PHARMACOL SCI, V22, P346, DOI 10.1016/S0165-6147(00)01712-0; Di Marzo V, 2008, TRENDS PHARMACOL SCI, V29, P594, DOI 10.1016/j.tips.2008.09.004; Dumont EC, 2004, J NEUROSCI, V24, P8198, DOI 10.1523/JNEUROSCI.0425-04.2004; Fagni L, 2000, TRENDS NEUROSCI, V23, P80, DOI 10.1016/S0166-2236(99)01492-7; Gaetani S, 2009, INT REV NEUROBIOL, V85, P57, DOI 10.1016/S0074-7742(09)85005-8; Gibson HE, 2008, NEURON, V57, P746, DOI 10.1016/j.neuron.2007.12.027; Grueter BA, 2010, NAT NEUROSCI, V13, P1519, DOI 10.1038/nn.2685; Heifets BD, 2009, ANNU REV PHYSIOL, V71, P283, DOI 10.1146/annurev.physiol.010908.163149; Herman JP, 1997, TRENDS NEUROSCI, V20, P78, DOI 10.1016/S0166-2236(96)10069-2; Jalabert M, 2009, PROG NEURO-PSYCHOPH, V33, P1336, DOI 10.1016/j.pnpbp.2009.07.010; Jung KM, 2005, MOL PHARMACOL, V68, P1196, DOI 10.1124/mol.105.013961; Kano M, 2009, PHYSIOL REV, V89, P309, DOI 10.1152/physrev.00019.2008; Karbarz MJ, 2009, ANESTH ANALG, V108, P316, DOI 10.1213/ane.0b013e31818c7cbd; Katona I, 2008, NAT MED, V14, P923, DOI 10.1038/nm.f.1869; Katona I, 2006, J NEUROSCI, V26, P5628, DOI 10.1523/JNEUROSCI.0309-06.2006; Kauer JA, 2009, TRENDS NEUROSCI, V32, P215, DOI 10.1016/j.tins.2008.12.006; Kawamura Y, 2006, J NEUROSCI, V26, P2991, DOI 10.1523/JNEUROSCI.4872-05.2006; Koob GF, 2008, NEURON, V59, P11, DOI 10.1016/j.neuron.2008.06.012; Kreitzer AC, 2001, NEURON, V29, P717, DOI 10.1016/S0896-6273(01)00246-X; Lafourcade M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000709; Long JZ, 2009, NAT CHEM BIOL, V5, P37, DOI 10.1038/nchembio.129; Lujan R, 1996, EUR J NEUROSCI, V8, P1488, DOI 10.1111/j.1460-9568.1996.tb01611.x; Maccarrone M, 2008, NAT NEUROSCI, V11, P152, DOI 10.1038/nn2042; Maione S, 2009, J PHYSIOL-LONDON, V587, P2521, DOI 10.1113/jphysiol.2009.171900; Marrs WR, 2010, NAT NEUROSCI, V13, P951, DOI 10.1038/nn.2601; Marsch R, 2007, J NEUROSCI, V27, P832, DOI 10.1523/JNEUROSCI.3303-06.2007; Massi L, 2008, J NEUROSCI, V28, P10496, DOI 10.1523/JNEUROSCI.2291-08.2008; Mato S, 2008, NEUROPHARMACOLOGY, V54, P87, DOI 10.1016/j.neuropharm.2007.04.014; McElligott ZA, 2009, PROG NEURO-PSYCHOPH, V33, P1329, DOI 10.1016/j.pnpbp.2009.05.022; Nyilas R, 2009, EUR J NEUROSCI, V29, P1964, DOI 10.1111/j.1460-9568.2009.06751.x; Petrosino S, 2010, CURR OPIN INVEST DR, V11, P51; Piomelli D, 2003, NAT REV NEUROSCI, V4, P873, DOI 10.1038/nrn1247; Puente N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008869; Robbe D, 2002, P NATL ACAD SCI USA, V99, P8384, DOI 10.1073/pnas.122149199; Robbe D, 2001, J NEUROSCI, V21, P109, DOI 10.1523/JNEUROSCI.21-01-00109.2001; Ross RA, 2003, BRIT J PHARMACOL, V140, P790, DOI 10.1038/sj.bjp.0705467; Rubino T, 2008, CEREB CORTEX, V18, P1292, DOI 10.1093/cercor/bhm161; Starowicz K, 2008, CURR PHARM DESIGN, V14, P42; Starowicz K, 2007, J NEUROSCI, V27, P13739, DOI 10.1523/JNEUROSCI.3258-07.2007; Tippens AL, 2008, J COMP NEUROL, V506, P569, DOI 10.1002/cne.21567; Uchigashima M, 2007, J NEUROSCI, V27, P3663, DOI 10.1523/JNEUROSCI.0448-07.2007; Valenti M, 2004, CELL MOL LIFE SCI, V61, P945, DOI 10.1007/s00018-003-3453-5; Yoshida T, 2006, J NEUROSCI, V26, P4740, DOI 10.1523/JNEUROSCI.0054-06.2006	50	125	125	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2011	14	12					1542	U67		10.1038/nn.2974	http://dx.doi.org/10.1038/nn.2974			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	855EJ	22057189				2022-12-28	WOS:000297546300013
J	Paz, JT; Bryant, AS; Peng, K; Fenno, L; Yizhar, O; Frankel, WN; Deisseroth, K; Huguenard, JR				Paz, Jeanne T.; Bryant, Astra S.; Peng, Kathy; Fenno, Lief; Yizhar, Ofer; Frankel, Wayne N.; Deisseroth, Karl; Huguenard, John R.			A new mode of corticothalamic transmission revealed in the Gria4(-/-) model of absence epilepsy	NATURE NEUROSCIENCE			English	Article							SELECTIVE GLUTAMATE RECEPTORS; THALAMIC RETICULAR NUCLEUS; SOMATOSENSORY THALAMUS; IN-VITRO; SYNAPTIC DISTRIBUTION; CORTICAL-NEURONS; WAVE DISCHARGES; BARREL CORTEX; RELAY CELLS; RAT	Cortico-thalamo-cortical circuits mediate sensation and generate neural network oscillations associated with slow-wave sleep and various epilepsies. Cortical input to sensory thalamus is thought to mainly evoke feed-forward synaptic inhibition of thalamocortical (TC) cells via reticular thalamic nucleus (nRT) neurons, especially during oscillations. This relies on a stronger synaptic strength in the cortico-nRT pathway than in the cortico-TC pathway, allowing the feed-forward inhibition of TC cells to overcome direct cortico-TC excitation. We found a systemic and specific reduction in strength in GluA4-deficient (Gria4(-/-)) mice of one excitatory synapse of the rhythmogenic cortico-thalamo-cortical system, the cortico-nRT projection, and observed that the oscillations could still be initiated by cortical inputs via the cortico-TC-nRT-TC pathway. These results reveal a previously unknown mode of cortico-thalamo-cortical transmission, bypassing direct cortico-nRT excitation, and describe a mechanism for pathological oscillation generation. This mode could be active under other circumstances, representing a previously unknown channel of cortico-thalamo-cortical information processing.	[Paz, Jeanne T.; Bryant, Astra S.; Peng, Kathy; Huguenard, John R.] Stanford Univ, Dept Neurol & Neurol Sci, Sch Med, Stanford, CA 94305 USA; [Fenno, Lief; Yizhar, Ofer; Deisseroth, Karl] Stanford Univ, Sch Med, Dept Bioengn, Stanford, CA 94305 USA; [Frankel, Wayne N.] Jackson Lab, Bar Harbor, ME 04609 USA	Stanford University; Stanford University; Jackson Laboratory	Huguenard, JR (corresponding author), Stanford Univ, Dept Neurol & Neurol Sci, Sch Med, Stanford, CA 94305 USA.	john.huguenard@stanford.edu	YIZHAR, OFER/AAV-8497-2021; Huguenard, John/I-5016-2012; Fenno, Lief/AAF-9638-2019; Huguenard, John/K-6429-2019; Fenno, Lief/AAK-2924-2020; Ritter, Stefanie L/D-9312-2012	Huguenard, John/0000-0002-6950-1191; Huguenard, John/0000-0002-6950-1191; Bryant, Astra/0000-0002-0887-2044; Yizhar, Ofer/0000-0003-4228-1448	US National Institutes of Health; National Institute of Neurological Disorders and Stroke [NS34774, NS06477, NS031348]; DARPA; Epilepsy Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH020016] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS034774, R01NS034774, R01NS006477, R37NS031348, R01NS031348] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Epilepsy Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank I. Parada for her expert histology technical support and A. Herbert and S. Jin for their help with animal husbandry. We also thank T. Davidson for insightful discussions on the optogenetic approach and C. Lee for a generous help during virus injections. This work was supported by grants from the US National Institutes of Health and the National Institute of Neurological Disorders and Stroke (NS34774, NS06477 and NS031348), the DARPA REPAIR program and the Epilepsy Foundation.	AGMON A, 1993, J NEUROSCI, V13, P5365, DOI 10.1523/JNEUROSCI.13-12-05365.1993; BAL T, 1995, J PHYSIOL-LONDON, V483, P665, DOI 10.1113/jphysiol.1995.sp020613; Bal T, 2000, J NEUROSCI, V20, P7478; Beenhakker MP, 2009, NEURON, V62, P612, DOI 10.1016/j.neuron.2009.05.015; BERNARDO KL, 1987, J COMP NEUROL, V258, P542, DOI 10.1002/cne.902580406; Beyer B, 2008, HUM MOL GENET, V17, P1738, DOI 10.1093/hmg/ddn064; Blumenfeld H, 2000, J NEUROSCI, V20, P5153; BOURASSA J, 1995, EUR J NEUROSCI, V7, P19, DOI 10.1111/j.1460-9568.1995.tb01016.x; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Bryant AS, 2009, J NEUROPHYSIOL, V102, P2880, DOI 10.1152/jn.00476.2009; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; Cruikshank SJ, 2010, NEURON, V65, P230, DOI 10.1016/j.neuron.2009.12.025; Destexhe A, 1998, J NEUROPHYSIOL, V79, P999; Dittgen T, 2004, P NATL ACAD SCI USA, V101, P18206, DOI 10.1073/pnas.0407976101; Dobrunz LE, 1997, NEURON, V18, P995, DOI 10.1016/S0896-6273(00)80338-4; GEIGER JRP, 1995, NEURON, V15, P193, DOI 10.1016/0896-6273(95)90076-4; Gentet LJ, 2003, J PHYSIOL-LONDON, V546, P801, DOI 10.1113/jphysiol.2002.032730; Golshani P, 2001, P NATL ACAD SCI USA, V98, P4172, DOI 10.1073/pnas.061013698; HOOGLAND PV, 1987, EXP BRAIN RES, V68, P73, DOI 10.1007/BF00255235; HUGUENARD JR, 1994, J NEUROSCI, V14, P5485; JONES EG, 1969, PROC R SOC SER B-BIO, V172, P173, DOI 10.1098/rspb.1969.0018; KEINANEN K, 1990, SCIENCE, V249, P556, DOI 10.1126/science.2166337; Lee JH, 2010, NATURE, V465, P788, DOI 10.1038/nature09108; LIU XB, 1995, J COMP NEUROL, V352, P187, DOI 10.1002/cne.903520203; Liu XB, 1999, J COMP NEUROL, V414, P67; Meeren HKM, 2002, J NEUROSCI, V22, P1480, DOI 10.1523/JNEUROSCI.22-04-01480.2002; Mineff EM, 2000, NEUROSCIENCE, V101, P969, DOI 10.1016/S0306-4522(00)00421-8; MOSBACHER J, 1994, SCIENCE, V266, P1059, DOI 10.1126/science.7973663; Mountcastle V.B., 1998, PERCEPTUAL NEUROSCIE; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; OHARA PT, 1985, J NEUROCYTOL, V14, P365, DOI 10.1007/BF01217752; Paz JT, 2010, J NEUROSCI, V30, P5465, DOI 10.1523/JNEUROSCI.5083-09.2010; Paz JT, 2007, J NEUROSCI, V27, P929, DOI 10.1523/JNEUROSCI.4677-06.2007; PETRALIA RS, 1992, J COMP NEUROL, V318, P329, DOI 10.1002/cne.903180309; Petreanu L, 2007, NAT NEUROSCI, V10, P663, DOI 10.1038/nn1891; Pinault D, 1998, J PHYSIOL-LONDON, V509, P449, DOI 10.1111/j.1469-7793.1998.449bn.x; Pinault D, 2003, J PHYSIOL-LONDON, V552, P881, DOI 10.1113/jphysiol.2003.046573; PINAULT D, 1995, EUR J NEUROSCI, V7, P31, DOI 10.1111/j.1460-9568.1995.tb01017.x; Polack PO, 2007, J NEUROSCI, V27, P6590, DOI 10.1523/JNEUROSCI.0753-07.2007; Schofield CM, 2009, P NATL ACAD SCI USA, V106, P7630, DOI 10.1073/pnas.0811326106; Sherman SM, 1998, P NATL ACAD SCI USA, V95, P7121, DOI 10.1073/pnas.95.12.7121; Sillito AM, 2002, PHILOS T R SOC B, V357, P1739, DOI 10.1098/rstb.2002.1170; Sohal VS, 2009, NATURE, V459, P698, DOI 10.1038/nature07991; Steriade M, 1998, Adv Neurol, V77, P105; Steriade M, 2005, TRENDS NEUROSCI, V28, P317, DOI 10.1016/j.tins.2005.03.007; STERIADE M, 1995, J NEUROSCI, V15, P623; Von Krosigk M, 1999, NEUROSCIENCE, V91, P7, DOI 10.1016/S0306-4522(98)00557-0; VONKROSIGK M, 1993, SCIENCE, V261, P361, DOI 10.1126/science.8392750; WARREN RA, 1994, J NEUROPHYSIOL, V72, P1993, DOI 10.1152/jn.1994.72.4.1993; WONGRILEY MTT, 1976, BRAIN RES, V108, P257, DOI 10.1016/0006-8993(76)90185-2	50	129	129	1	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2011	14	9					1167	U225		10.1038/nn.2896	http://dx.doi.org/10.1038/nn.2896			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	812ID	21857658	Green Accepted			2022-12-28	WOS:000294284900017
J	Li, HD; Zhong, XF; Chau, KF; Williams, EC; Chang, Q				Li, Hongda; Zhong, Xiaofen; Chau, Kevin Fongching; Williams, Emily Cunningham; Chang, Qiang			Loss of activity-induced phosphorylation of MeCP2 enhances synaptogenesis, LTP and spatial memory	NATURE NEUROSCIENCE			English	Article							CPG-BINDING PROTEIN-2; RETT-SYNDROME; DNA METHYLATION; BDNF TRANSCRIPTION; NEURONAL MECP2; CHROMATIN; MUTATIONS	DNA methylation-dependent epigenetic mechanisms underlie the development and function of the mammalian brain. MeCP2 is highly expressed in neurons and functions as a molecular linker between DNA methylation, chromatin remodeling and transcription regulation. Previous in vitro studies have shown that neuronal activity-induced phosphorylation (NAIP) of methyl CpG-binding protein 2 (MeCP2) precedes its release from the Bdnf promoter and the ensuing Bdnf transcription. However, the in vivo function of this phosphorylation event remains elusive. We generated knock-in mice that lack NAIP of MeCP2 and found that they performed better in hippocampus-dependent memory tests, presented enhanced long-term potentiation at two synapses in the hippocampus and showed increased excitatory synaptogenesis. At the molecular level, the phospho-mutant MeCP2 protein bound more tightly to several MeCP2 target gene promoters and altered the expression of these genes. Our results suggest that NAIP of MeCP2 is required for modulating dynamic functions of the adult mouse brain.	[Li, Hongda; Williams, Emily Cunningham; Chang, Qiang] Univ Wisconsin, Genet Training Program, Madison, WI 53706 USA; [Li, Hongda; Zhong, Xiaofen; Chau, Kevin Fongching; Williams, Emily Cunningham; Chang, Qiang] Univ Wisconsin, Waisman Ctr, Madison, WI 53705 USA; [Chang, Qiang] Univ Wisconsin, Dept Genet & Neurol, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Chang, Q (corresponding author), Univ Wisconsin, Genet Training Program, Madison, WI 53706 USA.	qchang@waisman.wisc.edu	Li, Hongda/F-3034-2017	Li, Hongda/0000-0001-6754-5150; Chau, Kevin Fongching/0000-0002-7899-3247	Stem Cell and Regenerative Medicine Center at the University of Wisconsin, Madison; Friends of the Waisman Center [5T32GM07133]; National Alliance for Research on Schizophrenia and Depression; National Institute of Child Health and Human Development [R01 HD064743, R21 HD066560, P30 HD03352]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD064743, P30HD003352] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD066560] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007133] Funding Source: NIH RePORTER	Stem Cell and Regenerative Medicine Center at the University of Wisconsin, Madison; Friends of the Waisman Center; National Alliance for Research on Schizophrenia and Depression(NARSAD); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	;We thank A. Messing, J. Svaren and J. Yin for critically reading the manuscript, S. Marwaha for assistance with mouse work, and M. Andrzejewski for assistance with statistical analysis. H.L. was supported by a pre-doctoral fellowship from the Stem Cell and Regenerative Medicine Center at the University of Wisconsin, Madison. E.C.W. was supported by a predoctoral training grant (5T32GM07133) and a graduate student fellowship from the Friends of the Waisman Center. Q.C. was supported by a Young Investigator Award from the National Alliance for Research on Schizophrenia and Depression. This work was partially supported by grants from the National Institute of Child Health and Human Development (R01 HD064743 and R21 HD066560 to Q.C., and P30 HD03352 to the Waisman Center).	Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Bird AP, 1999, CELL, V99, P451, DOI 10.1016/S0092-8674(00)81532-9; Chahrour M, 2008, SCIENCE, V320, P1224, DOI 10.1126/science.1153252; Chao HT, 2007, NEURON, V56, P58, DOI 10.1016/j.neuron.2007.08.018; Chen WG, 2003, SCIENCE, V302, P885, DOI 10.1126/science.1086446; Collins AL, 2004, HUM MOL GENET, V13, P2679, DOI 10.1093/hmg/ddh282; Deng JV, 2010, NAT NEUROSCI, V13, P1128, DOI 10.1038/nn.2614; Feng J, 2010, NAT NEUROSCI, V13, P423, DOI 10.1038/nn.2514; Hagberg B, 1997, EUR CHILD ADOLES PSY, V6, P5; HAGBERG B, 1985, ACTA PAEDIATR SCAND, V74, P405, DOI 10.1111/j.1651-2227.1985.tb10993.x; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; LEWIS JD, 1992, CELL, V69, P905, DOI 10.1016/0092-8674(92)90610-O; Martinowich K, 2003, SCIENCE, V302, P890, DOI 10.1126/science.1090842; Miller CA, 2007, NEURON, V53, P857, DOI 10.1016/j.neuron.2007.02.022; Miller CA, 2010, NAT NEUROSCI, V13, P664, DOI 10.1038/nn.2560; Nan XS, 1997, CELL, V88, P471, DOI 10.1016/S0092-8674(00)81887-5; Skene PJ, 2010, MOL CELL, V37, P457, DOI 10.1016/j.molcel.2010.01.030; Tao JF, 2009, P NATL ACAD SCI USA, V106, P4882, DOI 10.1073/pnas.0811648106; Van den Veyver IB, 2000, CURR OPIN GENET DEV, V10, P275, DOI 10.1016/S0959-437X(00)00083-6; Wan MM, 1999, AM J HUM GENET, V65, P1520, DOI 10.1086/302690; Xiang FQ, 2000, J MED GENET, V37, P250, DOI 10.1136/jmg.37.4.250; Yasui DH, 2007, P NATL ACAD SCI USA, V104, P19416, DOI 10.1073/pnas.0707442104; Zhou ZL, 2006, NEURON, V52, P255, DOI 10.1016/j.neuron.2006.09.037	23	116	121	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2011	14	8					1001	U89		10.1038/nn.2866	http://dx.doi.org/10.1038/nn.2866			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	797KC	21765426	Green Accepted			2022-12-28	WOS:000293123700013
J	Chen, JL; Lin, WC; Cha, JW; So, PT; Kubota, Y; Nedivi, E				Chen, Jerry L.; Lin, Walter C.; Cha, Jae Won; So, Peter T.; Kubota, Yoshiyuki; Nedivi, Elly			Structural basis for the role of inhibition in facilitating adult brain plasticity	NATURE NEUROSCIENCE			English	Article							OCULAR DOMINANCE PLASTICITY; EXPERIENCE-DEPENDENT PLASTICITY; PRIMARY VISUAL-CORTEX; CRITICAL PERIOD; MONOCULAR DEPRIVATION; MOUSE MODEL; INTERNEURONS; RESPONSES; NEURONS; CONNECTIONS	Although inhibition has been implicated in mediating plasticity in the adult brain, the underlying mechanism remains unclear. Here we present a structural mechanism for the role of inhibition in experience-dependent plasticity. Using chronic in vivo two-photon microscopy in the mouse neocortex, we show that experience drives structural remodeling of superficial layer 2/3 interneurons in an input- and circuit-specific manner, with up to 16% of branch tips undergoing remodeling. Visual deprivation initially induces dendritic branch retractions, and this is accompanied by a loss of inhibitory inputs onto neighboring pyramidal cells. The resulting decrease in inhibitory tone, also achievable pharmacologically using the antidepressant fluoxetine, provides a permissive environment for further structural adaptation, including addition of new synapse-bearing branch tips. Our findings suggest that therapeutic approaches that reduce inhibition, when combined with an instructive stimulus, could facilitate restructuring of mature circuits impaired by damage or disease, improving function and perhaps enhancing cognitive abilities.	[Chen, Jerry L.; Lin, Walter C.; Nedivi, Elly] MIT, Picower Inst Learning & Memory, Cambridge, MA 02139 USA; [Chen, Jerry L.; Nedivi, Elly] MIT, Dept Biol, Cambridge, MA 02139 USA; [Lin, Walter C.] Harvard Univ, Sch Med, Harvard MIT Div Hlth Sci & Technol, Cambridge, MA 02138 USA; [Cha, Jae Won; So, Peter T.] MIT, Dept Mech Engn, Cambridge, MA 02139 USA; [So, Peter T.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Kubota, Yoshiyuki] Japan Sci & Technol Agcy, Tokyo, Japan; [Kubota, Yoshiyuki] Natl Inst Physiol Sci, Div Cerebral Circuitry, Okazaki, Aichi 444, Japan; [Kubota, Yoshiyuki] Grad Univ Adv Studies SOKENDAI, Dept Physiol Sci, Okazaki, Aichi, Japan; [Nedivi, Elly] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Northwell Health; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Japan Science & Technology Agency (JST); National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Graduate University for Advanced Studies - Japan; Massachusetts Institute of Technology (MIT)	Nedivi, E (corresponding author), MIT, Picower Inst Learning & Memory, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	nedivi@mit.edu	Nedivi, Elly/ABC-9923-2021	Kubota, Yoshiyuki/0000-0002-0950-7460; Chen, Jerry/0000-0002-7409-7859; /0000-0002-1710-0767	US National Eye Institute [R01 EY017656]; Stanley Center for Psychiatric Research; MIT-Portugal; Singapore-MIT Alliance-2; Singapore-MIT Alliance for Research and Technology; Ministry of Education, Culture, Sports, Science and Technology of Japan [20500300, 22120518]; NATIONAL EYE INSTITUTE [R01EY017656] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [22120518] Funding Source: KAKEN	US National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Stanley Center for Psychiatric Research; MIT-Portugal; Singapore-MIT Alliance-2; Singapore-MIT Alliance for Research and Technology; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank J. Leslie, R. Schecter and J. Hoch for comments on the manuscript; M. F. Bear for helpful discussions; M. Kozberg for assistance in data analysis; J. Coleman, H. B. Yu, S. Horng and C. McCurry for assistance with optical intrinsic imaging; Y. Yamamoto (Yokohama Demonstration Laboratory, SII NanoTecnnology Inc.) for data collection assistance by Zeiss NVision40; S. Hatada and H. Kita (National Institute of Physiological Sciences) for serial electron microscopy reconstruction; and Y. Kawaguchi for valuable discussions regarding EM reconstructions. This work was sponsored by grants to E.N. from the US National Eye Institute (R01 EY017656) and from the Stanley Center for Psychiatric Research. J. L. C. was supported in part by the MIT-Portugal program. J. W. C. was supported in part by the Singapore-MIT Alliance-2 and Singapore-MIT Alliance for Research and Technology. Y. K. was supported by a grant-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (20500300, 22120518).	Antonini A, 1999, J NEUROSCI, V19, P4388; Buhl EH, 1997, J PHYSIOL-LONDON, V500, P689, DOI 10.1113/jphysiol.1997.sp022053; Bullier J, 2001, PROG BRAIN RES, V134, P193; Chattopadhyaya B, 2004, J NEUROSCI, V24, P9598, DOI 10.1523/JNEUROSCI.1851-04.2004; Chaudhry FA, 1998, J NEUROSCI, V18, P9733; Chklovskii DB, 2004, NATURE, V431, P782, DOI 10.1038/nature03012; Dan Y, 2004, NEURON, V44, P23, DOI 10.1016/j.neuron.2004.09.007; Dani VS, 2005, P NATL ACAD SCI USA, V102, P12560, DOI 10.1073/pnas.0506071102; DAW NW, 1992, J NEUROPHYSIOL, V67, P197, DOI 10.1152/jn.1992.67.1.197; De Paola V, 2006, NEURON, V49, P861, DOI 10.1016/j.neuron.2006.02.017; Dong HW, 2004, J COMP NEUROL, V475, P361, DOI 10.1002/cne.20164; Fernandez F, 2007, NAT NEUROSCI, V10, P411, DOI 10.1038/nn1860; Frenkel MY, 2006, NEURON, V51, P339, DOI 10.1016/j.neuron.2006.06.026; Frenkel MY, 2004, NEURON, V44, P917, DOI 10.1016/j.neuron.2004.12.003; Froemke RC, 2007, NATURE, V450, P425, DOI 10.1038/nature06289; Gandhi SP, 2008, P NATL ACAD SCI USA, V105, P16797, DOI 10.1073/pnas.0806159105; Gordon JA, 1996, J NEUROSCI, V16, P3274; Hanover JL, 1999, J NEUROSCI, V19, part. no.; Harauzov A, 2010, J NEUROSCI, V30, P361, DOI 10.1523/JNEUROSCI.2233-09.2010; He HY, 2006, J NEUROSCI, V26, P2951, DOI 10.1523/JNEUROSCI.5554-05.2006; HENDRY SHC, 1994, J NEUROSCI, V14, P2383; HENDRY SHC, 1990, J NEUROSCI, V10, P2438; HENDRY SHC, 1986, NATURE, V320, P750, DOI 10.1038/320750a0; HENDRY SHC, 1988, NEURON, V1, P701, DOI 10.1016/0896-6273(88)90169-9; Hensch TK, 1998, SCIENCE, V282, P1504, DOI 10.1126/science.282.5393.1504; HIRSCH JA, 1993, J PHYSIOL-LONDON, V461, P247, DOI 10.1113/jphysiol.1993.sp019512; Hofer SB, 2006, NAT NEUROSCI, V9, P127, DOI 10.1038/nn1610; Hofer SB, 2009, NATURE, V457, P313, DOI 10.1038/nature07487; Huang ZJ, 1999, CELL, V98, P739, DOI 10.1016/S0092-8674(00)81509-3; Kaiser KMM, 2004, J NEUROSCI, V24, P1319, DOI 10.1523/JNEUROSCI.2852-03.2004; Kalatsky VA, 2003, NEURON, V38, P529, DOI 10.1016/S0896-6273(03)00286-1; Kameyama K, 2010, J NEUROSCI, V30, P1551, DOI 10.1523/JNEUROSCI.5025-09.2010; Kleschevnikov AM, 2004, J NEUROSCI, V24, P8153, DOI 10.1523/JNEUROSCI.1766-04.2004; Kubota Y, 2009, FRONT NEURAL CIRCUIT, V3, DOI 10.3389/neuro.04.004.2009; Lee WCA, 2006, PLOS BIOL, V4, P271, DOI 10.1371/journal.pbio.0040029; Lee WCA, 2008, P NATL ACAD SCI USA, V105, P19968, DOI 10.1073/pnas.0810149105; LEVAY S, 1980, J COMP NEUROL, V191, P1, DOI 10.1002/cne.901910102; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; MAUNSELL JHR, 1983, J NEUROSCI, V3, P2563; Maya-Vetencourt JF, 2008, SCIENCE, V320, P385, DOI 10.1126/science.1150516; Nassi JJ, 2009, NAT REV NEUROSCI, V10, P360, DOI 10.1038/nrn2619; Rubenstein JLR, 2003, GENES BRAIN BEHAV, V2, P255, DOI 10.1034/j.1601-183X.2003.00037.x; Sale A, 2007, NAT NEUROSCI, V10, P679, DOI 10.1038/nn1899; Sato M, 2008, J NEUROSCI, V28, P10278, DOI 10.1523/JNEUROSCI.2451-08.2008; Sawtell NB, 2003, NEURON, V38, P977, DOI 10.1016/S0896-6273(03)00323-4; Silberberg G, 2005, TRENDS NEUROSCI, V28, P541, DOI 10.1016/j.tins.2005.08.004; Stepanyants A, 2002, NEURON, V34, P275, DOI 10.1016/S0896-6273(02)00652-9; WIESEL TN, 1965, J NEUROPHYSIOL, V28, P1029, DOI 10.1152/jn.1965.28.6.1029; Yamashita A, 2003, J COMP NEUROL, V464, P426, DOI 10.1002/cne.10810	49	149	150	0	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2011	14	5					587	U73		10.1038/nn.2799	http://dx.doi.org/10.1038/nn.2799			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	754VU	21478885	Green Accepted, Green Published			2022-12-28	WOS:000289886600014
J	Ghiasvand, NM; Rudolph, DD; Mashayekhi, M; Brzezinski, JA; Goldman, D; Glaser, T				Ghiasvand, Noor M.; Rudolph, Dellaney D.; Mashayekhi, Mohammad; Brzezinski, Joseph A.; Goldman, Daniel; Glaser, Tom			Deletion of a remote enhancer near ATOH7 disrupts retinal neurogenesis, causing NCRNA disease	NATURE NEUROSCIENCE			English	Article							GANGLION-CELL; GENE-EXPRESSION; NON-ATTACHMENT; MATH5; RETINOPATHY; COMPETENCE; RESPONSES; NETWORK; MICE; SIZE	Individuals with nonsyndromic congenital retinal nonattachment (NCRNA) are totally blind from birth. The disease afflicts similar to 1% of Kurdish people living in a group of neighboring villages in North Khorasan, Iran. We found that NCRNA is caused by a 6,523-bp deletion that spans a remote cis regulatory element 20 kb upstream from ATOH7 (Math5), a bHLH transcription factor gene that is required for retinal ganglion cell (RGC) and optic nerve development. In humans, the absence of RGCs stimulates massive neovascular growth of fetal blood vessels in the vitreous and early retinal detachment. The remote ATOH7 element appears to act as a secondary or 'shadow' transcriptional enhancer. It has minimal sequence similarity to the primary enhancer, which is close to the Atoh7 promoter, but drives transgene expression with an identical spatiotemporal pattern in the mouse retina. The human transgene also functions appropriately in zebrafish, reflecting deep evolutionary conservation. These dual enhancers may reinforce Atoh7 expression during early critical stages of eye development when retinal neurogenesis is initiated.	[Rudolph, Dellaney D.; Brzezinski, Joseph A.; Glaser, Tom] Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; [Rudolph, Dellaney D.; Brzezinski, Joseph A.; Glaser, Tom] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Ghiasvand, Noor M.] Shahid Beheshti Univ Med Sci, Neurosci Res Ctr, Sch Med, Tehran, Iran; [Ghiasvand, Noor M.] Shahid Beheshti Univ Med Sci, Dept Med Genet, Sch Med, Tehran, Iran; [Ghiasvand, Noor M.] Grand Valley State Univ, Dept Biol, Allendale, MI 49401 USA; [Mashayekhi, Mohammad] Emam Ali Hosp, Ophthalmol Ward, Bojnourd, N Khorasan, Iran; Univ Michigan, Mol & Behav Neurosci Inst, Dept Biochem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Shahid Beheshti University Medical Sciences; Shahid Beheshti University Medical Sciences; Grand Valley State University; North Khorasan University of Medical Sciences; University of Michigan System; University of Michigan	Glaser, T (corresponding author), Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA.	tglaser@umich.edu	Brzezinski, Joseph/AAM-4699-2021	Brzezinski, Joseph/0000-0001-5854-0315	Glaucoma Foundation; University of Michigan Center for Genetics in Health and Medicine; US National Institutes of Health [EY14259, EY18132, T32 EY13934]; NATIONAL EYE INSTITUTE [T32EY013934, R01EY018132, R01EY014259] Funding Source: NIH RePORTER	Glaucoma Foundation; University of Michigan Center for Genetics in Health and Medicine(University of Michigan System); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The authors are grateful to A. Swaroop for facilitating this collaborative project, A. Aledavood for logistical support and encouragement, H. Parmar, J. Trobe and E. Oliver for help interpreting MRI studies, L. Prasov for assistance with mouse tissue cDNAs and retinal dissections, J. Johnson for pBGn-Cherry plasmid DNA, N. Brown for Math5-GFP transgenic mice, I. Masai for ath5:GFP transgenic fish, M. Pihalja and M. Chiang for flow cytometry advice, S. Philips and T. Masud for screening candidate genes, S. Dagenais and R. Lyons for SNP genotyping analysis, S. Barolo, N. Brown, L. Prasov, C. Chou, M. Meisler and B. Link for helpful suggestions, and to T. Saunders, M. van Keuren and the University of Michigan transgenic animal, flow cytometry and DNA sequencing cores for technical support. We are profoundly grateful to NCRNA family members for their involvement and dedication to this study over many years. The research was funded by grants from the Glaucoma Foundation and the University of Michigan Center for Genetics in Health and Medicine to T. G., and from the US National Institutes of Health to T. G. (EY14259), D. G. (EY18132) and J.A.B. (T32 EY13934).	BRODRICK JD, 1972, BRIT J OPHTHALMOL, V56, P589, DOI 10.1136/bjo.56.8.589; Brodsky MC, 2010, PEDIATRIC NEURO-OPHTHALMOLOGY, SECOND EDITION, P383, DOI 10.1007/978-0-387-69069-8_8; Brown NL, 2002, MAMM GENOME, V13, P95, DOI 10.1007/s00335-001-2101-3; Brown NL, 1998, DEVELOPMENT, V125, P4821; Brown NL, 2001, DEVELOPMENT, V128, P2497; Brzezinski JA, 2005, INVEST OPHTH VIS SCI, V46, P2540, DOI 10.1167/iovs.04-1123; BRZEZINSKI JA, 2004, INVEST OPHTH VIS SCI, V45, P3422; BRZEZINSKI JA, 2011, DEV BIOL IN PRESS; Chen Jing, 2007, Angiogenesis, V10, P133, DOI 10.1007/s10456-007-9066-0; Frankel N, 2010, NATURE, V466, P490, DOI 10.1038/nature09158; Fruttiger Marcus, 2007, Angiogenesis, V10, P77, DOI 10.1007/s10456-007-9065-1; Gariano RF, 2005, NATURE, V438, P960, DOI 10.1038/nature04482; Ghiasvand NM, 2000, AM J MED GENET, V92, P220, DOI 10.1002/(SICI)1096-8628(20000529)92:3<220::AID-AJMG11>3.3.CO;2-P; Ghiasvand NM, 1998, AM J MED GENET, V78, P226, DOI 10.1002/(SICI)1096-8628(19980707)78:3<226::AID-AJMG3>3.3.CO;2-F; Ghiasvand NM, 2000, AM J MED GENET, V90, P165, DOI 10.1002/(SICI)1096-8628(20000117)90:2<165::AID-AJMG15>3.0.CO;2-O; Hobert O, 2010, CURR BIOL, V20, pR697, DOI 10.1016/j.cub.2010.07.035; Hoffmann EM, 2007, SURV OPHTHALMOL, V52, P32, DOI 10.1016/j.survophthal.2006.10.002; Hong JW, 2008, SCIENCE, V321, P1314, DOI 10.1126/science.1160631; Hsiung F, 2002, HUM MOL GENET, V11, P1207, DOI 10.1093/hmg/11.10.1207; Hufnagel RB, 2007, MOL CELL NEUROSCI, V36, P435, DOI 10.1016/j.mcn.2007.08.006; Hufnagel RB, 2010, DEV BIOL, V340, P490, DOI 10.1016/j.ydbio.2010.02.002; Hutcheson DA, 2005, DEVELOPMENT, V132, P829, DOI 10.1242/dev.01653; Kay JN, 2005, DEVELOPMENT, V132, P2573, DOI 10.1242/dev.01831; Kay JN, 2001, NEURON, V30, P725, DOI 10.1016/S0896-6273(01)00312-9; Kleinjan DA, 2005, AM J HUM GENET, V76, P8, DOI 10.1086/426833; Lee BL, 1996, AM J OPHTHALMOL, V122, P131, DOI 10.1016/S0002-9394(14)71982-8; Lin B, 2004, NEURON, V43, P475, DOI 10.1016/j.neuron.2004.08.002; Livesey FJ, 2001, NAT REV NEUROSCI, V2, P109, DOI 10.1038/35053522; Macgregor S, 2010, HUM MOL GENET, V19, P2716, DOI 10.1093/hmg/ddq144; Mu XQ, 2005, DEV BIOL, V280, P467, DOI 10.1016/j.ydbio.2005.01.028; PALMER EA, 1991, OPHTHALMOLOGY, V98, P1628; Perry J.R., 1975, IRAN STUD-UK, V8, P199, DOI [10.1080/00210867508701499, DOI 10.1080/00210867508701499]; Perry MW, 2010, CURR BIOL, V20, P1562, DOI 10.1016/j.cub.2010.07.043; PHILLIPS CI, 1979, J PEDIAT OPHTH STRAB, V16, P358; Poggi L, 2005, J CELL BIOL, V171, P991, DOI 10.1083/jcb.200509098; PRASOV L, 2009, INVEST OPHTH VIS SCI, V50, P1310; Prasov L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012315; Provis JM, 2001, PROG RETIN EYE RES, V20, P799, DOI 10.1016/S1350-9462(01)00012-X; Ramdas WD, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000978; Riesenberg AN, 2009, GENESIS, V47, P175, DOI 10.1002/dvg.20479; Skowronska-Krawczyk D, 2009, DEVELOPMENT, V136, P3767, DOI 10.1242/dev.033449; Swaroop A, 2010, NAT REV NEUROSCI, V11, P563, DOI 10.1038/nrn2880; Van Gelder RN, 2003, SCIENCE, V299, P222, DOI 10.1126/science.1079536; Wang SW, 2001, GENE DEV, V15, P24, DOI 10.1101/gad.855301; WARBURG M, 1979, T OPHTHAL SOC UK, V99, P272; West H, 2005, DEVELOPMENT, V132, P1855, DOI 10.1242/dev.01732; Willardsen MI, 2009, DEV BIOL, V326, P471, DOI 10.1016/j.ydbio.2008.10.046; Williams RW, 1998, J NEUROSCI, V18, P138; Wright AF, 2010, NAT REV GENET, V11, P273, DOI 10.1038/nrg2717; Yang ZY, 2003, DEV BIOL, V264, P240, DOI 10.1016/j.ydbio.2003.08.005	50	100	105	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2011	14	5					578	U63		10.1038/nn.2798	http://dx.doi.org/10.1038/nn.2798			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	754VU	21441919	Green Submitted, Green Accepted			2022-12-28	WOS:000289886600013
J	Zanto, TP; Rubens, MT; Thangavel, A; Gazzaley, A				Zanto, Theodore P.; Rubens, Michael T.; Thangavel, Arul; Gazzaley, Adam			Causal role of the prefrontal cortex in top-down modulation of visual processing and working memory	NATURE NEUROSCIENCE			English	Article							FEATURE-BASED ATTENTION; SELECTIVE ATTENTION; SPATIAL ATTENTION; FUNCTIONAL CONNECTIVITY; EXTRASTRIATE CORTEX; COGNITIVE TASK; INFORMATION; SUPPRESSION; PERFORMANCE; BRAIN	Selective attention filters information to limit what is encoded and maintained in working memory. Although the prefrontal cortex (PFC) is central to both selective attention and working memory, the underlying neural processes that link these cognitive abilities remain elusive. Using functional magnetic resonance imaging to guide repetitive transcranial magnetic stimulation with electroencephalographic recordings in humans, we perturbed PFC function at the inferior frontal junction in participants before they performed a selective-attention, delayed-recognition task. This resulted in diminished top-down modulation of activity in posterior cortex during early encoding stages, which predicted a subsequent decrement in working memory accuracy. Participants with stronger fronto-posterior functional connectivity displayed greater disruptive effects. Our data further suggests that broad alpha-band (7-14 Hz) phase coherence subserved this long-distance top-down modulation. These results suggest that top-down modulation mediated by the prefrontal cortex is a causal link between early attentional processes and subsequent memory performance.	[Zanto, Theodore P.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Physiol & Psychiat, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Zanto, TP (corresponding author), Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA.	theodore.zanto@ucsf.edu; adam.gazzaley@ucsf.edu			US National Institutes of Health [1F32AG030249-01A2, 5R01AG030395]; NATIONAL INSTITUTE ON AGING [R01AG030395, F32AG030249] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We would like to thank V. Barres and C. Gruson-Daniel for their assistance. This work was supported by US National Institutes of Health grants 1F32AG030249-01A2 (T.P.Z.) and 5R01AG030395 (A.G.).	AnlloVento L, 1996, PERCEPT PSYCHOPHYS, V58, P191, DOI 10.3758/BF03211875; Awh E, 2006, NEUROSCIENCE, V139, P201, DOI 10.1016/j.neuroscience.2005.08.023; Awh E, 2001, TRENDS COGN SCI, V5, P119, DOI 10.1016/S1364-6613(00)01593-X; Baddeley A.D., 1986, WORKING MEMORY THOUG; Barcelo F, 2000, NAT NEUROSCI, V3, P399, DOI 10.1038/73975; Bollinger J, 2010, J NEUROSCI, V30, P14399, DOI 10.1523/JNEUROSCI.1547-10.2010; Capotosto P, 2009, J NEUROSCI, V29, P5863, DOI 10.1523/JNEUROSCI.0539-09.2009; Chawla D, 1999, NAT NEUROSCI, V2, P671, DOI 10.1038/10230; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Derrfuss J, 2004, NEUROIMAGE, V23, P604, DOI 10.1016/j.neuroimage.2004.06.007; Desimone Robert, 1994, P75; DUNCAN J, 1989, PSYCHOL REV, V96, P433, DOI 10.1037/0033-295X.96.3.433; Fuggetta G, 2006, J NEUROPHYSIOL, V95, P3277, DOI 10.1152/jn.01273.2005; FUSTER JM, 1985, BRAIN RES, V330, P299, DOI 10.1016/0006-8993(85)90689-4; Gazzaley A, 2005, J COGNITIVE NEUROSCI, V17, P507, DOI 10.1162/0898929053279522; Gazzaley A, 2008, P NATL ACAD SCI USA, V105, P13122, DOI 10.1073/pnas.0806074105; Gazzaley A, 2007, CEREB CORTEX, V17, pI125, DOI 10.1093/cercor/bhm113; Gazzaley Adam, 2004, Cognitive Affective & Behavioral Neuroscience, V4, P580, DOI 10.3758/CABN.4.4.580; Kastner S, 2000, ANNU REV NEUROSCI, V23, P315, DOI 10.1146/annurev.neuro.23.1.315; Klimesch W, 2010, NEUROSCI BIOBEHAV R, V34, P1002, DOI 10.1016/j.neubiorev.2009.10.004; LaBar KS, 1999, NEUROIMAGE, V10, P695, DOI 10.1006/nimg.1999.0503; Lachaux JP, 1999, HUM BRAIN MAPP, V8, P194, DOI 10.1002/(SICI)1097-0193(1999)8:4<194::AID-HBM4>3.0.CO;2-C; Menendez RGD, 2004, NEUROIMAGE, V21, P527, DOI 10.1016/j.neuroimage.2003.09.051; Miller BT, 2011, J COGNITIVE NEUROSCI, V23, P1, DOI 10.1162/jocn.2010.21516; MORAN J, 1985, SCIENCE, V229, P782, DOI 10.1126/science.4023713; Morishima Y, 2009, NAT NEUROSCI, V12, P85, DOI 10.1038/nn.2237; NAATANEN R, 1982, PSYCHOL BULL, V92, P605; Pascual-Leone A, 1998, J CLIN NEUROPHYSIOL, V15, P333, DOI 10.1097/00004691-199807000-00005; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; Rainer G, 1998, NATURE, V393, P577, DOI 10.1038/31235; Rissman J, 2004, NEUROIMAGE, V23, P752, DOI 10.1016/j.neuroimage.2004.06.035; Rossi AF, 2009, EXP BRAIN RES, V192, P489, DOI 10.1007/s00221-008-1642-z; Ruff CC, 2008, CEREB CORTEX, V18, P817, DOI 10.1093/cercor/bhm128; Rutman AM, 2010, J COGNITIVE NEUROSCI, V22, P1224, DOI 10.1162/jocn.2009.21257; Sauseng P, 2005, INT J PSYCHOPHYSIOL, V57, P97, DOI 10.1016/j.ijpsycho.2005.03.018; Sauseng P, 2008, NEUROSCI BIOBEHAV R, V32, P1001, DOI 10.1016/j.neubiorev.2008.03.014; Schoenfeld MA, 2007, CEREB CORTEX, V17, P2468, DOI 10.1093/cercor/bhl154; Silver MA, 2009, TRENDS COGN SCI, V13, P488, DOI 10.1016/j.tics.2009.08.005; Taylor PCJ, 2007, CEREB CORTEX, V17, P391, DOI 10.1093/cercor/bhj156; Thut G, 2006, J NEUROSCI, V26, P9494, DOI 10.1523/JNEUROSCI.0875-06.2006; Thut G, 2010, BRAIN TOPOGR, V22, P219, DOI 10.1007/s10548-009-0115-4; UNGERLEIDER LG, 1989, EXP BRAIN RES, V76, P473, DOI 10.1007/BF00248903; Ungerleider LG, 1998, P NATL ACAD SCI USA, V95, P883, DOI 10.1073/pnas.95.3.883; WEBSTER MJ, 1994, CEREB CORTEX, V4, P470, DOI 10.1093/cercor/4.5.470; Zanto TP, 2010, NEUROIMAGE, V53, P736, DOI 10.1016/j.neuroimage.2010.06.012; Zanto TP, 2010, NEUROPSYCHOLOGIA, V48, P13, DOI 10.1016/j.neuropsychologia.2009.08.003; Zanto TP, 2009, J NEUROSCI, V29, P3059, DOI 10.1523/JNEUROSCI.4621-08.2009; ZEKI S, 1991, J NEUROSCI, V11, P641; Zhang WW, 2009, NAT NEUROSCI, V12, P24, DOI 10.1038/nn.2223	50	438	444	7	130	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2011	14	5					656	U156		10.1038/nn.2773	http://dx.doi.org/10.1038/nn.2773			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	754VU	21441920	Green Accepted			2022-12-28	WOS:000289886600023
J	Penzes, P; Cahill, ME; Jones, KA; VanLeeuwen, JE; Woolfrey, KM				Penzes, Peter; Cahill, Michael E.; Jones, Kelly A.; VanLeeuwen, Jon-Eric; Woolfrey, Kevin M.			Dendritic spine pathology in neuropsychiatric disorders	NATURE NEUROSCIENCE			English	Review							AUTISM SPECTRUM DISORDERS; FRAGILE-X-SYNDROME; ALZHEIMERS-DISEASE; AMYLOID-BETA; MOUSE MODEL; SYNAPTIC PLASTICITY; PREFRONTAL CORTEX; BEHAVIORAL PHENOTYPES; MENTAL-RETARDATION; SOCIAL-INTERACTION	Substantial progress has been made toward understanding the genetic architecture, cellular substrates, brain circuits and endophenotypic profiles of neuropsychiatric disorders, including autism spectrum disorders (ASD), schizophrenia and Alzheimer's disease. Recent evidence implicates spiny synapses as important substrates of pathogenesis in these disorders. Although synaptic perturbations are not the only alterations relevant for these diseases, understanding the molecular underpinnings of spine pathology may provide insight into their etiologies and may reveal new drug targets. Here we discuss recent neuropathological, genetic, molecular and animal model studies that implicate structural alterations at spiny synapses in the pathogenesis of major neurological disorders, focusing on ASD, schizophrenia and Alzheimer's disease as representatives of these categories across different ages of onset. We stress the importance of reverse translation, collaborative and multidisciplinary approaches, and the study of the spatio-temporal roles of disease molecules in the context of synaptic regulatory pathways and neuronal circuits that underlie disease endophenotypes.	[Penzes, Peter; Cahill, Michael E.; Jones, Kelly A.; VanLeeuwen, Jon-Eric; Woolfrey, Kevin M.] Northwestern Univ, Dept Physiol, Feinberg Sch Med, Chicago, IL 60611 USA; [Penzes, Peter] Northwestern Univ, Dept Psychiat & Behav Sci, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Penzes, P (corresponding author), Northwestern Univ, Dept Physiol, Feinberg Sch Med, Chicago, IL 60611 USA.	p-penzes@northwestern.edu	Penzes, Peter/L-3987-2016	Penzes, Peter/0000-0001-5449-1640; Cahill, Michael/0000-0003-0574-2655	US National Institutes of Health (NIH) National Institute of Mental Health [MH071316, MH071533]; National Alliance for Research on Schizophrenia and Depression and Alzheimer's Association; NIH [1F31AG031621, 1F31MH085362, 1F31MH087043]; American Heart Association; NATIONAL INSTITUTE OF MENTAL HEALTH [F31MH087043, F31MH085362, R01MH071316, R01MH071533] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F31AG031621] Funding Source: NIH RePORTER	US National Institutes of Health (NIH) National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Alliance for Research on Schizophrenia and Depression and Alzheimer's Association; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grants from the US National Institutes of Health (NIH) National Institute of Mental Health (MH071316, MH071533), National Alliance for Research on Schizophrenia and Depression and Alzheimer's Association (to P.P.), NIH 1F31AG031621 (M.E.C.), NIH 1F31MH085362 (K.A.J.), NIH 1F31MH087043 (J.V.) and a predoctoral American Heart Association fellowship (K.M.W.).	Abrahams BS, 2008, NAT REV GENET, V9, P341, DOI 10.1038/nrg2346; Arendt T, 2009, ACTA NEUROPATHOL, V118, P167, DOI 10.1007/s00401-009-0536-x; Ashe KH, 2010, NEURON, V66, P631, DOI 10.1016/j.neuron.2010.04.031; Ayhan Y, 2011, MOL PSYCHIATR, V16, P293, DOI 10.1038/mp.2009.144; Bacchelli E, 2003, MOL PSYCHIATR, V8, P916, DOI 10.1038/sj.mp.4001340; Bagni C, 2005, NAT REV NEUROSCI, V6, P376, DOI 10.1038/nrn1667; Barros CS, 2009, P NATL ACAD SCI USA, V106, P4507, DOI 10.1073/pnas.0900355106; Berkel S, 2010, NAT GENET, V42, P489, DOI 10.1038/ng.589; Bertram L, 2008, NAT REV NEUROSCI, V9, P768, DOI 10.1038/nrn2494; BOURGEOIS JP, 1994, CEREB CORTEX, V4, P78, DOI 10.1093/cercor/4.1.78; Bourgeron T, 2009, CURR OPIN NEUROBIOL, V19, P231, DOI 10.1016/j.conb.2009.06.003; Butler MG, 2005, J MED GENET, V42, P318, DOI 10.1136/jmg.2004.024646; Cahill ME, 2009, P NATL ACAD SCI USA, V106, P13058, DOI 10.1073/pnas.0904636106; Chadman KK, 2008, AUTISM RES, V1, P147, DOI 10.1002/aur.22; Chao HT, 2007, NEURON, V56, P58, DOI 10.1016/j.neuron.2007.08.018; Chen YJJ, 2008, J NEUROSCI, V28, P6872, DOI 10.1523/JNEUROSCI.1815-08.2008; Chih B, 2004, HUM MOL GENET, V13, P1471, DOI 10.1093/hmg/ddh158; Cook EH, 1997, AM J HUM GENET, V60, P928; Coyle JT, 2006, CELL MOL NEUROBIOL, V26, P365, DOI 10.1007/s10571-006-9062-8; DEKOSKY ST, 1990, ANN NEUROL, V27, P457, DOI 10.1002/ana.410270502; Dindot SV, 2008, HUM MOL GENET, V17, P111, DOI 10.1093/hmg/ddm288; Dolen G, 2007, NEURON, V56, P955, DOI 10.1016/j.neuron.2007.12.001; Dudanova I, 2007, J COMP NEUROL, V502, P261, DOI 10.1002/cne.21305; Dumanis SB, 2009, J NEUROSCI, V29, P15317, DOI 10.1523/JNEUROSCI.4026-09.2009; Durand CM, 2007, NAT GENET, V39, P25, DOI 10.1038/ng1933; Fiala JC, 2002, BRAIN RES REV, V39, P29, DOI 10.1016/S0165-0173(02)00158-3; Fraser MM, 2008, NEUROSCIENCE, V151, P476, DOI 10.1016/j.neuroscience.2007.10.048; Garcia RAG, 2000, P NATL ACAD SCI USA, V97, P3596, DOI 10.1073/pnas.070042497; Geschwind DH, 2007, CURR OPIN NEUROBIOL, V17, P103, DOI 10.1016/j.conb.2007.01.009; Glantz LA, 2000, ARCH GEN PSYCHIAT, V57, P65, DOI 10.1001/archpsyc.57.1.65; Gogtay N, 2008, SCHIZOPHRENIA BULL, V34, P30, DOI 10.1093/schbul/sbm103; Guy J, 2007, SCIENCE, V315, P1143, DOI 10.1126/science.1138389; Hayashi-Takagi A, 2010, NAT NEUROSCI, V13, P327, DOI 10.1038/nn.2487; Hill JJ, 2006, MOL PSYCHIATR, V11, P557, DOI 10.1038/sj.mp.4001792; Holtmaat A, 2009, NAT REV NEUROSCI, V10, P647, DOI 10.1038/nrn2699; Hsieh H, 2006, NEURON, V52, P831, DOI 10.1016/j.neuron.2006.10.035; Hutsler JJ, 2010, BRAIN RES, V1309, P83, DOI 10.1016/j.brainres.2009.09.120; Irwin SA, 2002, AM J MED GENET, V111, P140, DOI 10.1002/ajmg.10500; Irwin SA, 2001, AM J MED GENET, V98, P161, DOI 10.1002/1096-8628(20010115)98:2<161::AID-AJMG1025>3.0.CO;2-B; Jacobsen JS, 2006, P NATL ACAD SCI USA, V103, P5161, DOI 10.1073/pnas.0600948103; Jamain S, 2008, P NATL ACAD SCI USA, V105, P1710, DOI 10.1073/pnas.0711555105; Ji Y, 2003, NEUROSCIENCE, V122, P305, DOI 10.1016/j.neuroscience.2003.08.007; Kasai H, 2010, TRENDS NEUROSCI, V33, P121, DOI 10.1016/j.tins.2010.01.001; Kaufmann WE, 2000, CEREB CORTEX, V10, P981, DOI 10.1093/cercor/10.10.981; Knafo S, 2009, CEREB CORTEX, V19, P586, DOI 10.1093/cercor/bhn111; Knobloch M, 2008, MOL NEUROBIOL, V37, P73, DOI 10.1007/s12035-008-8018-z; Kolluri N, 2005, AM J PSYCHIAT, V162, P1200, DOI 10.1176/appi.ajp.162.6.1200; Kolomeets NS, 2005, SYNAPSE, V57, P47, DOI 10.1002/syn.20153; Kristiansen LV, 2006, MOL PSYCHIATR, V11, P737, DOI 10.1038/sj.mp.4001844; Kushima I, 2012, SCHIZOPHRENIA BULL, V38, P552, DOI 10.1093/schbul/sbq118; Kvajo M, 2008, P NATL ACAD SCI USA, V105, P7076, DOI 10.1073/pnas.0802615105; Kwon CH, 2006, NEURON, V50, P377, DOI 10.1016/j.neuron.2006.03.023; Lanz TA, 2003, NEUROBIOL DIS, V13, P246, DOI 10.1016/S0969-9961(03)00079-2; Li B, 2007, NEURON, V54, P583, DOI 10.1016/j.neuron.2007.03.028; Li SM, 2009, NEURON, V62, P788, DOI 10.1016/j.neuron.2009.05.012; Lipska BK, 2006, HUM MOL GENET, V15, P1245, DOI 10.1093/hmg/ddl040; McClellan J, 2010, CELL, V141, P210, DOI 10.1016/j.cell.2010.03.032; Mei L, 2008, NAT REV NEUROSCI, V9, P437, DOI 10.1038/nrn2392; Mukai J, 2008, NAT NEUROSCI, V11, P1302, DOI 10.1038/nn.2204; Norris CM, 2005, J NEUROSCI, V25, P4649, DOI 10.1523/JNEUROSCI.0365-05.2005; Palop JJ, 2010, NAT NEUROSCI, V13, P812, DOI 10.1038/nn.2583; Penzes P, 2003, NEURON, V37, P263, DOI 10.1016/S0896-6273(02)01168-6; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Roussignol G, 2005, J NEUROSCI, V25, P3560, DOI 10.1523/JNEUROSCI.4354-04.2005; Schumacher J, 2009, HUM MOL GENET, V18, P2719, DOI 10.1093/hmg/ddp204; Selemon LD, 1999, BIOL PSYCHIAT, V45, P17, DOI 10.1016/S0006-3223(98)00281-9; Selkoe DJ, 2008, BEHAV BRAIN RES, V192, P106, DOI 10.1016/j.bbr.2008.02.016; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Silverman JL, 2010, NAT REV NEUROSCI, V11, P490, DOI 10.1038/nrn2851; Sleegers K, 2010, TRENDS GENET, V26, P84, DOI 10.1016/j.tig.2009.12.004; Smith DL, 2009, P NATL ACAD SCI USA, V106, P16877, DOI 10.1073/pnas.0908706106; Snyder EM, 2005, NAT NEUROSCI, V8, P1051, DOI 10.1038/nn1503; Spence SJ, 2009, PEDIATR RES, V65, P599, DOI 10.1203/PDR.0b013e31819e7168; Stark KL, 2008, NAT GENET, V40, P751, DOI 10.1038/ng.138; STCLAIR D, 1990, LANCET, V336, P13, DOI 10.1016/0140-6736(90)91520-K; Steen RG, 2006, BRIT J PSYCHIAT, V188, P510, DOI 10.1192/bjp.188.6.510; Steiner P, 2008, NEURON, V60, P788, DOI 10.1016/j.neuron.2008.10.014; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Sweet RA, 2009, NEUROPSYCHOPHARMACOL, V34, P374, DOI 10.1038/npp.2008.67; Tabuchi K, 2007, SCIENCE, V318, P71, DOI 10.1126/science.1146221; Tackenberg C, 2009, CURR ALZHEIMER RES, V6, P261, DOI 10.2174/156720509788486554; Tackenberg C, 2009, J NEUROSCI, V29, P14439, DOI 10.1523/JNEUROSCI.3590-09.2009; Tan HY, 2007, CEREB CORTEX, V17, pI171, DOI [10.1093/cercor/bhm069, 10.1093/cercor/hhm069]; Tavazoie SF, 2005, NAT NEUROSCI, V8, P1727, DOI 10.1038/nn1566; Toro R, 2010, TRENDS GENET, V26, P363, DOI 10.1016/j.tig.2010.05.007; Tsai J, 2004, NAT NEUROSCI, V7, P1181, DOI 10.1038/nn1335; Walsh DM, 2004, NEURON, V44, P181, DOI 10.1016/j.neuron.2004.09.010; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Woolfrey KM, 2009, NAT NEUROSCI, V12, P1275, DOI 10.1038/nn.2386; Wu HY, 2010, J NEUROSCI, V30, P2636, DOI 10.1523/JNEUROSCI.4456-09.2010; Xie Z, 2007, NEURON, V56, P640, DOI 10.1016/j.neuron.2007.10.005; Xie Z, 2010, MOL CELL NEUROSCI, V43, P81, DOI 10.1016/j.mcn.2009.09.006; Yashiro K, 2009, NAT NEUROSCI, V12, P777, DOI 10.1038/nn.2327; Yoshida T, 2009, SCHIZOPHR RES, V113, P84, DOI 10.1016/j.schres.2009.05.004; Youn HS, 2007, J ALZHEIMERS DIS, V11, P385; Zhao LX, 2006, NAT NEUROSCI, V9, P234, DOI 10.1038/nn1630; Zhou J, 2009, J NEUROSCI, V29, P1773, DOI 10.1523/JNEUROSCI.5685-08.2009; Zhou ZL, 2006, NEURON, V52, P255, DOI 10.1016/j.neuron.2006.09.037	100	966	988	6	184	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2011	14	3					285	293		10.1038/nn.2741	http://dx.doi.org/10.1038/nn.2741			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	725MW	21346746	Green Accepted			2022-12-28	WOS:000287650100006
J	Asadollahi, A; Mysore, SP; Knudsen, EI				Asadollahi, Ali; Mysore, Shreesh P.; Knudsen, Eric I.			Stimulus-driven competition in a cholinergic midbrain nucleus	NATURE NEUROSCIENCE			English	Article							OWL OPTIC TECTUM; ISTHMI PARS PARVOCELLULARIS; LATERAL INTRAPARIETAL AREA; FRONTAL EYE FIELD; TOP-DOWN CONTROL; SUPERIOR COLLICULUS; BARN OWL; VISUAL-ATTENTION; TARGET SELECTION; INHIBITION	The mechanisms by which the brain selects a particular stimulus as the next target for gaze are poorly understood. A cholinergic nucleus in the owl's midbrain exhibits functional properties that suggest its role in bottom-up stimulus selection. Neurons in the nucleus isthmi pars parvocellularis (Ipc) responded to wide ranges of visual and auditory features, but they were not tuned to particular values of those features. Instead, they encoded the relative strengths of stimuli across the entirety of space. Many neurons exhibited switch-like properties, abruptly increasing their responses to a stimulus in their receptive field when it became the strongest stimulus. This information propagates directly to the optic tectum, a structure involved in gaze control and stimulus selection, as periodic (25-50 Hz) bursts of cholinergic activity. The functional properties of Ipc neurons resembled those of a salience map, a core component in computational models for spatial attention and gaze control.	[Asadollahi, Ali; Mysore, Shreesh P.; Knudsen, Eric I.] Stanford Sch Med, Dept Neurobiol, Stanford, CA USA	Stanford University	Asadollahi, A (corresponding author), Stanford Sch Med, Dept Neurobiol, Stanford, CA USA.	asad@stanford.edu	Asadollahi, Ali/AAV-4971-2021	Asadollahi, Ali/0000-0002-7915-6846; Mysore, Shreesh/0000-0002-7781-8252	US National Institutes of Health [R01 EY019179]; NATIONAL EYE INSTITUTE [R01EY019179] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank P. Knudsen for technical support, C. Goddard and S. Devarajan for helpful discussions and T. Moore, B. Noudoost and N. Steinmets for reviewing the manuscript. This work was supported by grants from the US National Institutes of Health (R01 EY019179) to E.I.K.	Bisley JW, 2003, SCIENCE, V299, P81, DOI 10.1126/science.1077395; Buschman TJ, 2007, SCIENCE, V315, P1860, DOI 10.1126/science.1138071; CARANDINI M, 1994, SCIENCE, V264, P1333, DOI 10.1126/science.8191289; Endo T, 2005, J NEUROPHYSIOL, V94, P3893, DOI 10.1152/jn.00211.2005; Fecteau JH, 2006, TRENDS COGN SCI, V10, P382, DOI 10.1016/j.tics.2006.06.011; Goldberg ME, 2002, ANN NY ACAD SCI, V956, P205, DOI 10.1111/j.1749-6632.2002.tb02820.x; GOLDBERG ME, 1972, J NEUROPHYSIOL, V35, P560, DOI 10.1152/jn.1972.35.4.560; Itti L, 2001, NAT REV NEUROSCI, V2, P194, DOI 10.1038/35058500; Itti L, 2000, VISION RES, V40, P1489, DOI 10.1016/S0042-6989(99)00163-7; KARTEN HJ, 1969, ANN NY ACAD SCI, V167, P164, DOI 10.1111/j.1749-6632.1969.tb20442.x; KNUDSEN EI, 1995, J NEUROSCI, V15, P5139; KNUDSEN EI, 1982, J NEUROSCI, V2, P1177; Knudsen EI, 1996, EXP BRAIN RES, V108, P23; Lakatos P, 2008, SCIENCE, V320, P110, DOI 10.1126/science.1154735; Maczko KA, 2006, J NEUROSCI, V26, P12799, DOI 10.1523/JNEUROSCI.3946-06.2006; Marin G, 2005, J NEUROSCI, V25, P7081, DOI 10.1523/JNEUROSCI.1379-05.2005; Marin G, 2007, J NEUROSCI, V27, P8112, DOI 10.1523/JNEUROSCI.1420-07.2007; Marino J, 2005, NAT NEUROSCI, V8, P194, DOI 10.1038/nn1391; McPeek RM, 2002, J NEUROPHYSIOL, V88, P2019, DOI 10.1152/jn.2002.88.4.2019; Muller JR, 2005, P NATL ACAD SCI USA, V102, P524, DOI 10.1073/pnas.0408311101; Mysore SP, 2010, J NEUROSCI, V30, P1727, DOI 10.1523/JNEUROSCI.3740-09.2010; Parkhurst D, 2002, VISION RES, V42, P107, DOI 10.1016/S0042-6989(01)00250-4; Reynolds JH, 2004, ANNU REV NEUROSCI, V27, P611, DOI 10.1146/annurev.neuro.26.041002.131039; RIZZOLATTI G, 1974, J NEUROPHYSIOL, V37, P1262, DOI 10.1152/jn.1974.37.6.1262; Sarter M, 2005, BRAIN RES REV, V48, P98, DOI 10.1016/j.brainresrev.2004.08.006; SCHILLER PH, 1987, J NEUROPHYSIOL, V57, P1033, DOI 10.1152/jn.1987.57.4.1033; SERENO MI, 1987, J COMP NEUROL, V261, P319, DOI 10.1002/cne.902610302; Shipp S, 2004, TRENDS COGN SCI, V8, P223, DOI 10.1016/j.tics.2004.03.004; Sommer MA, 2000, J NEUROPHYSIOL, V83, P1979, DOI 10.1152/jn.2000.83.4.1979; SORENSON EM, 1989, J COMP NEUROL, V281, P641, DOI 10.1002/cne.902810412; Sparks DL, 2002, NAT REV NEUROSCI, V3, P952, DOI 10.1038/nrn986; Stein BE., 1993, MERGING SENSES; Wang SR, 2003, BRAIN RES REV, V41, P13, DOI 10.1016/S0165-0173(02)00217-5; Wang Y, 2006, J COMP NEUROL, V494, P7, DOI 10.1002/cne.20821; Winkowski DE, 2007, J NEUROSCI, V27, P13279, DOI 10.1523/JNEUROSCI.3937-07.2007; Winkowski DE, 2008, NEURON, V60, P698, DOI 10.1016/j.neuron.2008.09.013; Witten IB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010396; YAN K, 1986, NEUROSCI LETT, V64, P340, DOI 10.1016/0304-3940(86)90352-6; Yu CJ, 2003, NEUROSCIENCE, V118, P135, DOI 10.1016/S0306-4522(02)00768-6	39	51	51	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2010	13	7					889	U138		10.1038/nn.2573	http://dx.doi.org/10.1038/nn.2573			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	615YF	20526331	Green Accepted			2022-12-28	WOS:000279173900023
J	Wichterle, H; Przedborski, S				Wichterle, Hynek; Przedborski, Serge			What can pluripotent stem cells teach us about neurodegenerative diseases?	NATURE NEUROSCIENCE			English	Article							PARKINSONS-DISEASE; DIRECTED DIFFERENTIATION; MOTOR-NEURONS; GLIAL-CELLS; EXPRESSION; NEUROGENESIS; MECHANISMS; INDUCTION; GENES; BRAIN	Neurodegenerative diseases represent a growing public health challenge. Current medications treat symptoms, but none halt or retard neurodegeneration. The recent advent of pluripotent cell biology has opened new avenues for neurodegenerative disease research. The greatest potential for induced pluripotent cells derived from affected individuals is likely to be their utility for modeling and understanding the mechanisms underlying neurodegenerative processes, and for searching for new treatments, including cell replacement therapies. However, much work remains to be done before pluripotent cells can be used for preclinical and clinical applications. Here we discuss the challenges of generating specific neural cell subtypes from pluripotent stem cells, the use of pluripotent stem cells to model both cell-autonomous and non-cell-autonomous mechanisms of neurodegeneration, whether adult-onset neurodegeneration can be emulated in short-term cultures and the hurdles of cell replacement therapy. Progress in these four areas will substantially accelerate effective application of pluripotent stem cells.	[Wichterle, Hynek; Przedborski, Serge] Columbia Univ, Dept Neurol, New York, NY 10027 USA; [Wichterle, Hynek; Przedborski, Serge] Columbia Univ, Dept Pathol & Cell Biol, New York, NY USA; [Wichterle, Hynek] Columbia Univ, Dept Neurosci, New York, NY USA; [Wichterle, Hynek; Przedborski, Serge] Columbia Univ, Ctr Motor Neuron Biol & Dis, New York, NY USA	Columbia University; Columbia University; Columbia University; Columbia University	Przedborski, S (corresponding author), Columbia Univ, Dept Neurol, New York, NY 10027 USA.	sp30@columbia.edu		Wichterle, Hynek/0000-0002-7817-0080	US National Institutes of Health [AG021617, NS042269, NS062180, NS064191, NS38370, NS058502, NS055923]; US Department of Defense [W81XWH-08-1-0522, W81XWH-08-1-0465, DAMD 17-03-1]; Parkinson Disease Foundation (New York); Thomas Hartman Foundation For Parkinson's Research; A.L.S. foundation; Muscular Dystrophy Association/Wings-over-Wall Street; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS055923, R21NS064191, R21NS062180, R01NS058502, P50NS038370, R01NS042269] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG021617] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Defense(United States Department of Defense); Parkinson Disease Foundation (New York); Thomas Hartman Foundation For Parkinson's Research; A.L.S. foundation; Muscular Dystrophy Association/Wings-over-Wall Street(Muscular Dystrophy Association); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors are supported by US National Institutes of Health grants AG021617, NS042269, NS062180, NS064191, NS38370, NS058502 and NS055923; US Department of Defense grants W81XWH-08-1-0522, W81XWH-08-1-0465 and DAMD 17-03-1; the Parkinson Disease Foundation (New York); the Thomas Hartman Foundation For Parkinson's Research; the Project A.L.S. foundation; and the Muscular Dystrophy Association/Wings-over-Wall Street.	Abujarour R, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-5-220; Amabile G, 2009, TRENDS MOL MED, V15, P59, DOI 10.1016/j.molmed.2008.12.003; Andersson E, 2006, CELL, V124, P393, DOI [10.1016/j.cell.2005.10.037, 10.1016/J.CELL.2005.10.037]; Bel-Vialar S, 2002, DEVELOPMENT, V129, P5103; Cafferty WBJ, 2006, J NEUROSCI, V26, P12242, DOI 10.1523/JNEUROSCI.3827-06.2006; Custer SK, 2006, NAT NEUROSCI, V9, P1302, DOI 10.1038/nn1750; Dasen JS, 2003, NATURE, V425, P926, DOI 10.1038/nature02051; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Deierborg T, 2008, PROG NEUROBIOL, V85, P407, DOI 10.1016/j.pneurobio.2008.05.001; di Sanguinetto SADT, 2008, CURR OPIN NEUROBIOL, V18, P36, DOI 10.1016/j.conb.2008.04.002; Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799; Ebert AD, 2009, NATURE, V457, P277, DOI 10.1038/nature07677; FRAICHARD A, 1995, J CELL SCI, V108, P3181; Friling S, 2009, P NATL ACAD SCI USA, V106, P7613, DOI 10.1073/pnas.0902396106; Hanna J, 2007, SCIENCE, V318, P1920, DOI 10.1126/science.1152092; Hockemeyer D, 2009, NAT BIOTECHNOL, V27, P851, DOI 10.1038/nbt.1562; Irioka T, 2005, DEV BRAIN RES, V154, P63, DOI 10.1016/j.devbrainres.2004.10.004; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Kanning KC, 2010, ANNU REV NEUROSCI, V33, P409, DOI 10.1146/annurev.neuro.051508.135722; Karumbayaram S, 2009, STEM CELLS, V27, P806, DOI 10.1002/stem.31; Kazuki Y, 2010, MOL THER, V18, P386, DOI 10.1038/mt.2009.274; Kempermann G, 1999, SCI AM, V280, P48, DOI 10.1038/scientificamerican0599-48; Lau D, 2008, CELL STEM CELL, V3, P591, DOI 10.1016/j.stem.2008.11.001; Lee G, 2009, NATURE, V461, P402, DOI 10.1038/nature08320; Li JY, 2008, NAT MED, V14, P501, DOI 10.1038/nm1746; Lin TX, 2009, NAT METHODS, V6, P805, DOI [10.1038/NMETH.1393, 10.1038/nmeth.1393]; Lindvall O, 2010, J CLIN INVEST, V120, P29, DOI 10.1172/JCI40543; Liu JP, 2001, NEURON, V32, P997, DOI 10.1016/S0896-6273(01)00544-X; Lobsiger CS, 2007, NAT NEUROSCI, V10, P1355, DOI 10.1038/nn1988; Magavi SS, 2000, NATURE, V405, P951, DOI 10.1038/35016083; Maherali N, 2009, CURR BIOL, V19, P1718, DOI 10.1016/j.cub.2009.08.025; Marchetto MCN, 2008, CELL STEM CELL, V3, P649, DOI 10.1016/j.stem.2008.10.001; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; Mizuseki K, 2003, P NATL ACAD SCI USA, V100, P5828, DOI 10.1073/pnas.1037282100; Nagai M, 2007, NAT NEUROSCI, V10, P615, DOI 10.1038/nn1876; Nakatomi H, 2002, CELL, V110, P429, DOI 10.1016/S0092-8674(02)00862-0; Organization WH, 2006, NEUR DIS PUBL HLTH C, DOI 10.1001/archneurol.2007.19; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Placantonakis DG, 2009, STEM CELLS, V27, P521, DOI 10.1634/stemcells.2008-0884; Przedborski S, 2003, J CLIN INVEST, V111, P3, DOI 10.1172/JCI200317522; Rodriguez-Gomez JA, 2007, STEM CELLS, V25, P918, DOI 10.1634/stemcells.2006-0386; Sermon KD, 2009, HUM REPROD, V24, P1556, DOI 10.1093/humrep/dep062; Soldner F, 2009, CELL, V136, P964, DOI 10.1016/j.cell.2009.02.013; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Wernig M, 2008, P NATL ACAD SCI USA, V105, P5856, DOI 10.1073/pnas.0801677105; Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	48	35	38	3	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2010	13	7					800	804		10.1038/nn.2577	http://dx.doi.org/10.1038/nn.2577			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	615YF	20581816	Green Accepted			2022-12-28	WOS:000279173900009
J	Liu, J; Ward, A; Gao, JW; Dong, YM; Nishio, N; Inada, H; Kang, LJ; Yu, Y; Ma, D; Xu, T; Mori, I; Xie, ZX; Xu, XZS				Liu, Jie; Ward, Alex; Gao, Jingwei; Dong, Yongming; Nishio, Nana; Inada, Hitoshi; Kang, Lijun; Yu, Yong; Ma, Di; Xu, Tao; Mori, Ikue; Xie, Zhixiong; Xu, X. Z. Shawn			C-elegans phototransduction requires a G protein-dependent cGMP pathway and a taste receptor homolog	NATURE NEUROSCIENCE			English	Article							NUCLEOTIDE-GATED CHANNEL; OLFACTORY RECEPTORS; SUGAR PERCEPTION; PHOTORECEPTORS; EXPRESSION; SUBUNIT; FAMILY; ALPHA; SENSITIVITY; NEURONS	The eyeless animal C. elegans is able to sense light and engages in phototaxis behavior that is mediated by photoreceptor cells. However, the molecular and cellular mechanisms underlying phototransduction in C. elegans remain largely unclear. By recording the photoreceptor neuron ASJ in wild-type and various mutant worms, we found that phototransduction in ASJ is a G protein-mediated process and requires membrane-associated guanylate cyclases, but not typical phosphodiesterases. In addition, we found that C. elegans phototransduction requires LITE-1, a candidate photoreceptor protein known to be a member of the invertebrate taste receptor family. Our genetic, pharmacological and electrophysiological data suggest a model in which LITE-1 transduces light signals in ASJ via G protein signaling, which leads to upregulation of the second messenger cGMP, followed by opening of cGMP-sensitive CNG channels and stimulation of photoreceptor cells. Our results identify a phototransduction cascade in C. elegans and implicate the function of a 'taste receptor' in phototransduction.	[Liu, Jie; Ward, Alex; Gao, Jingwei; Dong, Yongming; Kang, Lijun; Yu, Yong; Ma, Di; Xu, X. Z. Shawn] Univ Michigan, Inst Life Sci, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Liu, Jie; Ward, Alex; Gao, Jingwei; Dong, Yongming; Kang, Lijun; Yu, Yong; Ma, Di; Xu, X. Z. Shawn] Univ Michigan, Neurosci Program, Ann Arbor, MI 48109 USA; [Gao, Jingwei; Xie, Zhixiong] Wuhan Univ, Coll Life Sci, Wuhan 430072, Hubei, Peoples R China; [Nishio, Nana; Inada, Hitoshi; Mori, Ikue] Nagoya Univ, Grp Mol Neurobiol, Nagoya, Aichi 4648601, Japan; [Nishio, Nana; Inada, Hitoshi; Mori, Ikue] Nagoya Univ, Grad Sch Sci, CREST JST, Nagoya, Aichi 4648601, Japan; [Inada, Hitoshi] Harvard Univ, Dept Mol & Cell Biol, Cambridge, MA 02138 USA; [Yu, Yong; Xu, Tao] Chinese Acad Sci, Inst Biophys, Beijing 100080, Peoples R China	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Wuhan University; Nagoya University; Japan Science & Technology Agency (JST); Nagoya University; Harvard University; Chinese Academy of Sciences; Institute of Biophysics, CAS	Xu, XZS (corresponding author), Univ Michigan, Inst Life Sci, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA.	shawnxu@umich.edu	Dong, Yongming/H-9502-2013; Inada, Hitoshi/GQH-1084-2022; Inada, Hitoshi/T-2773-2019; liu, jie/B-4901-2011	Dong, Yongming/0000-0002-6510-0913; Inada, Hitoshi/0000-0002-6121-3830; Inada, Hitoshi/0000-0002-6121-3830; liu, jie/0000-0002-1215-5814; KANG, Lijun/0000-0001-9939-5134	National Eye Institute [T32EY13934]; Chinese 111 project [CB06081]; National Institute of General Medical Sciences; Pew scholar award; NATIONAL EYE INSTITUTE [T32EY013934] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078276, R01GM083241] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Chinese 111 project(Ministry of Education, China - 111 Project); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Pew scholar award; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank P. Hu, A. Kumar and B. Ye for comments, M. Koelle for PTX plasmid and B. Decaluwe and S. Gu for technical assistance. Some strains were obtained from the Caenorhabditis Genetics Center, the Oklahoma Knockout Consortium and S. Mitani. A.W. was supported by a predoctoral training grant from the National Eye Institute (T32EY13934 to The University of Michigan). J.G. and Z.X. received support from the Chinese 111 project (CB06081). This work was supported by grants from the National Institute of General Medical Sciences and a Pew scholar award to X.Z.S.X.	Bargmann CI., 2006, WORMBOOK, P1, DOI [10.1895/wormbook.1.123.1, DOI 10.1895/WORMBOOK.1.123.1]; Benton R, 2006, PLOS BIOL, V4, P240, DOI 10.1371/journal.pbio.0040020; Berson DM, 2007, PFLUG ARCH EUR J PHY, V454, P849, DOI 10.1007/s00424-007-0242-2; Birnby DA, 2000, GENETICS, V155, P85; Bounoutas A, 2007, PFLUG ARCH EUR J PHY, V454, P691, DOI 10.1007/s00424-006-0187-x; BOWES C, 1990, NATURE, V347, P677, DOI 10.1038/347677a0; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Clyne PJ, 2000, SCIENCE, V287, P1830, DOI 10.1126/science.287.5459.1830; Coburn CM, 1996, NEURON, V17, P695, DOI 10.1016/S0896-6273(00)80201-9; Darby C, 2001, INFECT IMMUN, V69, P6271, DOI 10.1128/IAI.69.10.6271-6275.2001; Ebbs ML, 2007, PFLUG ARCH EUR J PHY, V454, P735, DOI 10.1007/s00424-007-0246-y; Edwards SL, 2008, PLOS BIOL, V6, P1715, DOI 10.1371/journal.pbio.0060198; Feng ZY, 2006, CELL, V127, P621, DOI 10.1016/j.cell.2006.09.035; Fu YB, 2007, PFLUG ARCH EUR J PHY, V454, P805, DOI 10.1007/s00424-006-0194-y; Gardiner A, 2009, BIOL LETTERS, V5, P244, DOI 10.1098/rsbl.2008.0723; Gomez MD, 2000, J NEUROSCI, V20, P5254, DOI 10.1523/JNEUROSCI.20-14-05254.2000; Goodman MB, 1998, NEURON, V20, P763, DOI 10.1016/S0896-6273(00)81014-4; Gotow T, 2008, BRAIN RES, V1225, P3, DOI 10.1016/j.brainres.2008.04.059; Goubaeva F, 2003, J BIOL CHEM, V278, P19634, DOI 10.1074/jbc.M300052200; Gray JM, 2004, NATURE, V430, P317, DOI 10.1038/nature02714; Hallem EA, 2006, ANNU REV ENTOMOL, V51, P113, DOI 10.1146/annurev.ento.51.051705.113646; Inada H, 2006, GENETICS, V172, P2239, DOI 10.1534/genetics.105.050013; Ishimoto H, 2005, EMBO J, V24, P3259, DOI 10.1038/sj.emboj.7600796; Jansen G, 1999, NAT GENET, V21, P414, DOI 10.1038/7753; Komatsu H, 1996, NEURON, V17, P707, DOI 10.1016/S0896-6273(00)80202-0; L'Etoile ND, 2000, NEURON, V25, P575, DOI 10.1016/S0896-6273(00)81061-2; LEYTE A, 1992, EMBO J, V11, P4795, DOI 10.1002/j.1460-2075.1992.tb05585.x; Li W, 2006, NATURE, V440, P684, DOI 10.1038/nature04538; Miranda-Vizuete A, 2006, FEBS LETT, V580, P484, DOI 10.1016/j.febslet.2005.12.046; Murakami M, 2001, MECH DEVELOP, V109, P27, DOI 10.1016/S0925-4773(01)00507-X; Nagel G, 2005, CURR BIOL, V15, P2279, DOI 10.1016/j.cub.2005.11.032; O'Halloran DM, 2006, J MOL EVOL, V63, P87, DOI 10.1007/s00239-005-0215-z; Omori K, 2007, CIRC RES, V100, P309, DOI 10.1161/01.RES.0000256354.95791.f1; PALCZEWSKI K, 1994, NEURON, V13, P395, DOI 10.1016/0896-6273(94)90355-7; Ramot D, 2008, NAT NEUROSCI, V11, P908, DOI 10.1038/nn.2157; Roayaie K, 1998, NEURON, V20, P55, DOI 10.1016/S0896-6273(00)80434-1; Rogers C, 2006, CURR BIOL, V16, P649, DOI 10.1016/j.cub.2006.03.023; Sato K, 2008, NATURE, V452, P1002, DOI 10.1038/nature06850; Scott K, 2005, NEURON, V48, P455, DOI 10.1016/j.neuron.2005.10.015; Scott K, 2001, CELL, V104, P661, DOI 10.1016/S0092-8674(01)00263-X; STERN JH, 1986, P NATL ACAD SCI USA, V83, P1163, DOI 10.1073/pnas.83.4.1163; Tanis JE, 2008, GENETICS, V178, P157, DOI 10.1534/genetics.107.079780; Terakita A, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-213; Thorne N, 2008, J COMP NEUROL, V506, P548, DOI 10.1002/cne.21547; Tremblay J, 2002, MOL CELL BIOCHEM, V230, P31, DOI 10.1023/A:1014260204524; TROEMEL ER, 1995, CELL, V83, P207, DOI 10.1016/0092-8674(95)90162-0; Ueno K, 2006, J NEUROSCI, V26, P6143, DOI 10.1523/JNEUROSCI.0857-06.2006; Ueno K, 2008, EUR J NEUROSCI, V28, P1956, DOI 10.1111/j.1460-9568.2008.06507.x; Ward A, 2008, NAT NEUROSCI, V11, P916, DOI 10.1038/nn.2155; Xiong WH, 1998, NAT NEUROSCI, V1, P359, DOI 10.1038/nn0998_359	50	128	148	2	52	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2010	13	6					715	U88		10.1038/nn.2540	http://dx.doi.org/10.1038/nn.2540			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	600QY	20436480	Green Accepted			2022-12-28	WOS:000278003300016
J	Oren, I; Kullmann, DM				Oren, Iris; Kullmann, Dimitri M.			Mapping out hippocampal inhibition	NATURE NEUROSCIENCE			English	Editorial Material							CA1 PYRAMIDAL NEURONS; GABAERGIC INTERNEURONS	A synthesis of opto- and pharmacogenetics is beginning to reveal how various interneuron types direct incoming traffic in the hippocampus to help create a map of the environment.	[Oren, Iris; Kullmann, Dimitri M.] UCL, Inst Neurol, London, England	University of London; University College London	Oren, I (corresponding author), UCL, Inst Neurol, London, England.	d.kullmann@ucl.ac.uk	Kullmann, Dimitri M/A-3162-2009	Kullmann, Dimitri M/0000-0001-6696-3545; Oren, Iris/0000-0003-1427-1402	Action Medical Research [1725] Funding Source: researchfish; MRC [G116/147, G0802158, G0801316] Funding Source: UKRI; Medical Research Council [G0801316, G116/147, G0802158] Funding Source: Medline; Wellcome Trust [095580] Funding Source: Medline	Action Medical Research; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		COBB SR, 1995, NATURE, V378, P75, DOI 10.1038/378075a0; Freund TF, 1997, CAN J PHYSIOL PHARM, V75, P479, DOI 10.1139/y97-033; Gasparini S, 2004, J NEUROSCI, V24, P11046, DOI 10.1523/JNEUROSCI.2520-04.2004; Hefft S, 2005, NAT NEUROSCI, V8, P1319, DOI 10.1038/nn1542; Isaacson JS, 2011, NEURON, V72, P231, DOI 10.1016/j.neuron.2011.09.027; Katona I, 1999, NEUROSCIENCE, V88, P37, DOI 10.1016/S0306-4522(98)00302-9; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; Losonczy A, 2006, NEURON, V50, P291, DOI 10.1016/j.neuron.2006.03.016; Lovett-Barron M, 2012, NAT NEUROSCI, V15, P423, DOI 10.1038/nn.3024; Magnus CJ, 2011, SCIENCE, V333, P1292, DOI 10.1126/science.1206606; Miles R, 1996, NEURON, V16, P815, DOI 10.1016/S0896-6273(00)80101-4; Oren I, 2010, J PHYSIOL-LONDON, V588, P785, DOI 10.1113/jphysiol.2009.180851; Pavlov I, 2009, J NEUROSCI, V29, P15341, DOI 10.1523/JNEUROSCI.2747-09.2009; Pouille F, 2004, NATURE, V429, P717, DOI 10.1038/nature02615; Taniguchi H, 2011, NEURON, V71, P995, DOI 10.1016/j.neuron.2011.07.026	15	1	1	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2012	15	3					346	347		10.1038/nn.3056	http://dx.doi.org/10.1038/nn.3056			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	899CY	22362104				2022-12-28	WOS:000300793100005
J	Mitra, A; Mitra, SS; Tsien, RW				Mitra, Ananya; Mitra, Siddhartha S.; Tsien, Richard W.			Heterogeneous reallocation of presynaptic efficacy in recurrent excitatory circuits adapting to inactivity	NATURE NEUROSCIENCE			English	Article							HOMEOSTATIC SYNAPTIC PLASTICITY; NEUROTRANSMITTER RELEASE; NEURONS; CDK5; NETWORK; CULTURES; CORTEX; CA3; DEPRIVATION; ROSCOVITINE	Recurrent excitatory circuits face extreme challenges in balancing efficacy and stability. We recorded from CA3 pyramidal neuron pairs in rat hippocampal slice cultures to characterize synaptic and circuit-level changes in recurrent synapses resulting from long-term inactivity. Chronic tetrodotoxin treatment greatly reduced the percentage of connected CA3-CA3 neurons, but enhanced the strength of the remaining connections; presynaptic release probability sharply increased, whereas quantal size was unaltered. Connectivity was decreased in activity-deprived circuits by functional silencing of synapses, whereas three-dimensional anatomical analysis revealed no change in spine or bouton density or aggregate dendrite length. The silencing arose from enhanced Cdk5 activity and could be reverted by acute Cdk5 inhibition with roscovitine. Our results suggest that recurrent circuits adapt to chronic inactivity by reallocating presynaptic weights heterogeneously, strengthening certain connections while silencing others. This restricts synaptic output and input, preserving signaling efficacy among a subset of neuronal ensembles while protecting network stability.	[Mitra, Ananya; Tsien, Richard W.] Stanford Univ, Dept Mol & Cellular Physiol, Sch Med, Stanford, CA 94305 USA; [Mitra, Siddhartha S.] Stanford Univ, Inst Stem Cell Biol & Regenerat Med, Sch Med, Stanford, CA 94305 USA; [Tsien, Richard W.] NYU, Inst Neurosci, New York, NY USA	Stanford University; Stanford University; New York University	Tsien, RW (corresponding author), Stanford Univ, Dept Mol & Cellular Physiol, Sch Med, Stanford, CA 94305 USA.	rwtsien@stanford.edu			National Institute of Mental Health [5R37MH071739]; Mather Foundation Burnett Family Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH071739] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Mather Foundation Burnett Family Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank M. Pathak, Dhani and S. Owen for comments on the manuscript, A.Y. Olson for help with spine density analysis, I. Prada for advice on immunostaining techniques, and Stanford Neuroscience Microscope Core. We also thank members of the Tsien laboratory for helpful discussions throughout the project. This work was supported by National Institute of Mental Health grant 5R37MH071739 and grants from the Mather Foundation Burnett Family Foundation to R.W.T.	Aoki C, 2009, J COMP NEUROL, V517, P105, DOI 10.1002/cne.22137; Bacci A, 2001, J NEUROSCI, V21, P6588, DOI 10.1523/JNEUROSCI.21-17-06588.2001; Beique JC, 2011, P NATL ACAD SCI USA, V108, P816, DOI 10.1073/pnas.1017914108; Buonomano DV, 2005, J NEUROPHYSIOL, V94, P2275, DOI 10.1152/jn.01250.2004; Burrone J, 2002, NATURE, V420, P414, DOI 10.1038/nature01242; Bushey D, 2011, SCIENCE, V332, P1576, DOI 10.1126/science.1202839; Butz M, 2009, FRONT COMPUT NEUROSC, V3, DOI 10.3389/neuro.10.010.2009; BUZSAKI G, 2006, RHYTHMS BRAIN, P464; Costa ACS, 2010, BEHAV BRAIN RES, V206, P52, DOI 10.1016/j.bbr.2009.08.034; Darcy KJ, 2006, NAT NEUROSCI, V9, P315, DOI 10.1038/nn1640; De Simoni A, 2003, J PHYSIOL-LONDON, V550, P135, DOI 10.1113/jphysiol.2003.039099; Desai NS, 1999, NAT NEUROSCI, V2, P515, DOI 10.1038/9165; Fu WY, 2007, NAT NEUROSCI, V10, P67, DOI 10.1038/nn1811; Graf ER, 2009, NEURON, V64, P663, DOI 10.1016/j.neuron.2009.11.002; Guzowski JF, 2004, NEURON, V44, P581, DOI 10.1016/j.neuron.2004.11.003; Hanson JE, 2007, J PHYSIOL-LONDON, V579, P53, DOI 10.1113/jphysiol.2006.114868; Hanson JE, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-96; Hardingham NR, 2010, J NEUROSCI, V30, P1441, DOI 10.1523/JNEUROSCI.3244-09.2010; Houweling AR, 2005, CEREB CORTEX, V15, P834, DOI 10.1093/cercor/bhh184; Jakawich SK, 2010, NEURON, V68, P1143, DOI 10.1016/j.neuron.2010.11.034; Kim J, 2008, NEURON, V58, P925, DOI 10.1016/j.neuron.2008.05.009; Kim SH, 2010, NEURON, V67, P797, DOI 10.1016/j.neuron.2010.08.003; Krystof V, 2010, CURR DRUG TARGETS, V11, P291, DOI 10.2174/138945010790711950; Lai KO, 2009, BBA-MOL BASIS DIS, V1792, P741, DOI 10.1016/j.bbadis.2009.05.001; Lefort S, 2009, NEURON, V61, P301, DOI 10.1016/j.neuron.2008.12.020; Lindskog M, 2010, P NATL ACAD SCI USA, V107, P21806, DOI 10.1073/pnas.1016399107; Ma L, 1999, NAT NEUROSCI, V2, P24, DOI 10.1038/4525; Maffei A, 2008, J NEUROSCI, V28, P4377, DOI 10.1523/JNEUROSCI.5298-07.2008; Maffei A, 2006, NATURE, V443, P81, DOI 10.1038/nature05079; Meijer L, 1997, EUR J BIOCHEM, V243, P527, DOI 10.1111/j.1432-1033.1997.t01-2-00527.x; Moulder KL, 2008, J NEUROSCI, V28, P5159, DOI 10.1523/JNEUROSCI.5317-07.2008; MULLER D, 1993, DEV BRAIN RES, V71, P93, DOI 10.1016/0165-3806(93)90109-N; O'Brien RJ, 1998, NEURON, V21, P1067, DOI 10.1016/S0896-6273(00)80624-8; Ou CY, 2010, CELL, V141, P846, DOI 10.1016/j.cell.2010.04.011; Park M, 2011, NEURON, V70, P742, DOI 10.1016/j.neuron.2011.04.002; Rolls ET, 2006, PROG NEUROBIOL, V79, P1, DOI 10.1016/j.pneurobio.2006.04.005; Saviane Chiara, 2007, V403, P303, DOI 10.1007/978-1-59745-529-9_19; Silberberg G, 2005, TRENDS NEUROSCI, V28, P541, DOI 10.1016/j.tins.2005.08.004; Song S, 2005, PLOS BIOL, V3, P507, DOI 10.1371/journal.pbio.0030068; Su SC, 2011, ANNU REV CELL DEV BI, V27, P465, DOI 10.1146/annurev-cellbio-092910-154023; Tan TC, 2003, NAT CELL BIOL, V5, P701, DOI 10.1038/ncb1020; Tao L, 2006, P NATL ACAD SCI USA, V103, P12911, DOI 10.1073/pnas.0605415103; Thiagarajan TC, 2005, NEURON, V47, P725, DOI 10.1016/j.neuron.2005.06.037; Tomizawa K, 2002, J NEUROSCI, V22, P2590, DOI 10.1523/JNEUROSCI.22-07-02590.2002; Trasande CA, 2007, J CLIN NEUROPHYSIOL, V24, P154, DOI 10.1097/WNP.0b013e318033787f; TSAI LH, 1994, NATURE, V371, P419, DOI 10.1038/371419a0; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; Turrigiano GG, 2000, CURR OPIN NEUROBIOL, V10, P358, DOI 10.1016/S0959-4388(00)00091-X; Wittner L, 2007, BRAIN STRUCT FUNCT, V212, P75, DOI 10.1007/s00429-007-0148-y; Yan Z, 2002, J PHYSIOL-LONDON, V540, P761	50	57	57	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2012	15	2					250	257		10.1038/nn.3004	http://dx.doi.org/10.1038/nn.3004			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	882ZX	22179109	Green Accepted			2022-12-28	WOS:000299603500016
J	Fetsch, CR; Pouget, A; DeAngelis, GC; Angelaki, DE				Fetsch, Christopher R.; Pouget, Alexandre; DeAngelis, Gregory C.; Angelaki, Dora E.			Neural correlates of reliability-based cue weighting during multisensory integration	NATURE NEUROSCIENCE			English	Article							STOCHASTIC MOTION SIGNALS; SUPERIOR TEMPORAL AREA; MACAQUE MONKEY; OPTIC FLOW; BAYESIAN INTEGRATION; HEADING PERCEPTION; POPULATION CODES; CORTICAL AREAS; SELF-MOTION; MST NEURONS	Integration of multiple sensory cues is essential for precise and accurate perception and behavioral performance, yet the reliability of sensory signals can vary across modalities and viewing conditions. Human observers typically employ the optimal strategy of weighting each cue in proportion to its reliability, but the neural basis of this computation remains poorly understood. We trained monkeys to perform a heading discrimination task from visual and vestibular cues, varying cue reliability randomly. The monkeys appropriately placed greater weight on the more reliable cue, and population decoding of neural responses in the dorsal medial superior temporal area closely predicted behavioral cue weighting, including modest deviations from optimality. We found that the mathematical combination of visual and vestibular inputs by single neurons is generally consistent with recent theories of optimal probabilistic computation in neural circuits. These results provide direct evidence for a neural mechanism mediating a simple and widespread form of statistical inference.	[Fetsch, Christopher R.; DeAngelis, Gregory C.; Angelaki, Dora E.] Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA; [Pouget, Alexandre; DeAngelis, Gregory C.] Univ Rochester, Dept Brain & Cognit Sci, Rochester, NY USA; [Pouget, Alexandre] Univ Geneva, Dept Basic Neurosci, Geneva, Switzerland; [Angelaki, Dora E.] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA	Washington University (WUSTL); University of Rochester; University of Geneva; Baylor College of Medicine	Fetsch, CR (corresponding author), Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA.	crfetsch@u.washington.edu		DeAngelis, Gregory/0000-0002-1635-1273; Pouget, Alexandre/0000-0003-3054-6365	US National Institutes of Health [EY019087, EY016178]; US National Institutes of Health Institutional National Research Service [5-T32-EY13360-07]; National Science Foundation [BCS0446730]; Multidisciplinary University Research Initiative [N00014-07-1-0937]; James McDonnell Foundation; NATIONAL EYE INSTITUTE [R01EY016178, T32EY013360, R01EY019087] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Institutes of Health Institutional National Research Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Multidisciplinary University Research Initiative(MURI); James McDonnell Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank A. Turner, J. Arand, H. Schoknecht, B. Adeyemo and J. Lin for animal care and technical help, and V. Rao, S. Nelson and M. Jazayeri for discussions and comments on the manuscript. We are indebted to Y. Guan and S. Liu for generously contributing data to this project. This work was supported by grants from the US National Institutes of Health (EY019087 to D. E. A. and EY016178 to G. C. D.) and a US National Institutes of Health Institutional National Research Service Award (5-T32-EY13360-07 supporting C. R. F.). A. P. was supported by grants from the National Science Foundation (BCS0446730), Multidisciplinary University Research Initiative (N00014-07-1-0937) and the James McDonnell Foundation.	Alais D, 2004, CURR BIOL, V14, P257, DOI 10.1016/j.cub.2004.01.029; Battaglia PW, 2003, J OPT SOC AM A, V20, P1391, DOI 10.1364/JOSAA.20.001391; Bremmer F, 2002, EUR J NEUROSCI, V16, P1569, DOI 10.1046/j.1460-9568.2002.02206.x; BRITTEN KH, 1993, VISUAL NEUROSCI, V10, P1157, DOI 10.1017/S0952523800010269; Chen AH, 2011, J NEUROSCI, V31, P12036, DOI 10.1523/JNEUROSCI.0395-11.2011; Cheng K, 2007, PSYCHOL BULL, V133, P625, DOI 10.1037/0033-2909.133.4.625; Clark J.J., 1990, DATA FUSION SENSORY; COCHRAN W. G., 1937, J. Roy. Statist. Soc. 1937., (Suppl.), V4, P102; Dayan P, 2001, COMPUTATIONAL NEUROS; Duffy CJ, 1998, J NEUROPHYSIOL, V80, P1816, DOI 10.1152/jn.1998.80.4.1816; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Fetsch CR, 2010, J NEUROPHYSIOL, V104, P1506, DOI 10.1152/jn.91247.2008; Fetsch CR, 2009, J NEUROSCI, V29, P15601, DOI 10.1523/JNEUROSCI.2574-09.2009; FOLDIAK P, 1993, COMPUTATION AND NEURAL SYSTEMS, P55; Fukushima K, 1997, EXP BRAIN RES, V117, P1, DOI 10.1007/PL00005786; Fukushima K, 2008, NEURAL NETWORKS, V21, P774, DOI 10.1016/j.neunet.2007.12.049; Gu Y, 2006, J NEUROSCI, V26, P73, DOI 10.1523/JNEUROSCI.2356-05.2006; Gu Y, 2008, NAT NEUROSCI, V11, P1201, DOI 10.1038/nn.2191; Gu Y, 2007, NAT NEUROSCI, V10, P1038, DOI 10.1038/nn1935; Gu Y, 2010, NEURON, V66, P596, DOI 10.1016/j.neuron.2010.04.026; Heuer HW, 2007, J NEUROPHYSIOL, V98, P1115, DOI 10.1152/jn.00083.2007; Hillis JM, 2004, J VISION, V4, P967, DOI 10.1167/4.12.1; Jacobs RA, 1999, VISION RES, V39, P3621, DOI 10.1016/S0042-6989(99)00088-7; Jazayeri M, 2006, NAT NEUROSCI, V9, P690, DOI 10.1038/nn1691; Knill DC, 2007, J VISION, V7, DOI 10.1167/7.5.i; Knill DC, 2003, VISION RES, V43, P2539, DOI 10.1016/S0042-6989(03)00458-9; Knill DC, 2004, TRENDS NEUROSCI, V27, P712, DOI 10.1016/j.tins.2004.10.007; Knill DC, 1996, PERCEPTION BAYESIAN; Kording KP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000943; KOMATSU H, 1988, J NEUROPHYSIOL, V60, P580, DOI 10.1152/jn.1988.60.2.580; Landy M.S., 2011, SENSORY CUE INTEGRAT, P5, DOI [10.1093/acprof:oso/9780195387247.003.0001, DOI 10.1093/ACPROF:OSO/9780195387247.003.0001]; LANDY MS, 1995, VISION RES, V35, P389, DOI 10.1016/0042-6989(94)00176-M; Lappe M, 1996, J NEUROSCI, V16, P6265; Lewis JW, 2000, J COMP NEUROL, V428, P112, DOI 10.1002/1096-9861(20001204)428:1<112::AID-CNE8>3.0.CO;2-9; Ma WJ, 2006, NAT NEUROSCI, V9, P1432, DOI 10.1038/nn1790; MAUNSELL JHR, 1983, J NEUROSCI, V3, P2563; Morgan ML, 2008, NEURON, V59, P662, DOI 10.1016/j.neuron.2008.06.024; Ohshiro T, 2011, NAT NEUROSCI, V14, P775, DOI 10.1038/nn.2815; Perrone JA, 1998, J NEUROSCI, V18, P5958; Rosas P, 2005, J OPT SOC AM A, V22, P801, DOI 10.1364/JOSAA.22.000801; Sanger TD, 1996, J NEUROPHYSIOL, V76, P2790, DOI 10.1152/jn.1996.76.4.2790; STANTON GB, 1995, J COMP NEUROL, V353, P291, DOI 10.1002/cne.903530210; Stein BE., 1993, MERGING SENSES; Takahashi K, 2007, J NEUROSCI, V27, P9742, DOI 10.1523/JNEUROSCI.0817-07.2007; TANAKA K, 1989, J NEUROPHYSIOL, V62, P626, DOI 10.1152/jn.1989.62.3.626; van Beers RJ, 2002, CURR BIOL, V12, P834, DOI 10.1016/S0960-9822(02)00836-9; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1293, DOI 10.3758/BF03194544; Xiao Q, 2006, VISUAL NEUROSCI, V23, P49, DOI 10.1017/S0952523806231055; YOUNG MJ, 1993, VISION RES, V33, P2685, DOI 10.1016/0042-6989(93)90228-O	50	250	252	1	67	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2012	15	1					146	U185		10.1038/nn.2983	http://dx.doi.org/10.1038/nn.2983			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	866VO	22101645	Green Accepted			2022-12-28	WOS:000298414400025
J	Maniar, TA; Kaplan, M; Wang, GJ; Shen, K; Wei, L; Shaw, JE; Koushika, SP; Bargmann, CI				Maniar, Tapan A.; Kaplan, Miriam; Wang, George J.; Shen, Kang; Wei, Li; Shaw, Jocelyn E.; Koushika, Sandhya P.; Bargmann, Cornelia I.			UNC-33 (CRMP) and ankyrin organize microtubules and localize kinesin to polarize axon-dendrite sorting	NATURE NEUROSCIENCE			English	Article							CAENORHABDITIS-ELEGANS; INITIAL SEGMENT; HIPPOCAMPAL-NEURONS; NEURITE OUTGROWTH; OLFACTORY CILIA; C-ELEGANS; TRANSPORT; TUBULIN; PROTEIN; VESICLES	The polarized distribution of neuronal proteins to axons and dendrites relies on microtubule-binding proteins such as CRMP, directed motors such as the kinesin UNC-104 (Kif1A) and diffusion barriers such as ankyrin. The causative relationships among these molecules are unknown. We show here that Caenorhabditis elegans CRMP (UNC-33) acts early in neuronal development, together with ankyrin (UNC-44), to organize microtubule asymmetry and axon-dendrite sorting. In unc-33 and unc-44 mutants, axonal proteins were mislocalized to dendrites and vice versa, suggesting bidirectional failures of axon-dendrite identity. unc-44 directed UNC-33 localization to axons, where it was enriched in a region that resembled the axon initial segment. unc-33 and unc-44 were both required to establish the asymmetric dynamics of axonal and dendritic microtubules; in their absence, microtubules were disorganized, the axonal kinesin UNC-104 invaded dendrites, and inappropriate UNC-104 activity randomized axonal protein sorting. We suggest that UNC-44 and UNC-33 direct polarized sorting through their global effects on neuronal microtubule organization.	[Maniar, Tapan A.; Kaplan, Miriam; Bargmann, Cornelia I.] Rockefeller Univ, Howard Hughes Med Inst, Lab Neural Circuits & Behav, New York, NY 10021 USA; [Wang, George J.; Shen, Kang] Stanford Univ, Howard Hughes Med Inst, Dept Biol, Stanford, CA 94305 USA; [Wei, Li; Shaw, Jocelyn E.] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN USA; [Koushika, Sandhya P.] Tata Inst Fundamental Res, Natl Ctr Biol Sci, Bangalore, Karnataka, India	Howard Hughes Medical Institute; Rockefeller University; Howard Hughes Medical Institute; Stanford University; University of Minnesota System; University of Minnesota Twin Cities; Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS)	Bargmann, CI (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Lab Neural Circuits & Behav, New York, NY 10021 USA.	cori@rockefeller.edu		Koushika, Sandhya/0000-0002-1742-7356; Bargmann, Cornelia/0000-0002-8484-0618	Howard Hughes Medical Institute	Howard Hughes Medical Institute(Howard Hughes Medical Institute)	We thank C. Ghenoiu, P. Nurse, Y. Saheki, S. Shaham, M. Tsunozaki, M. Heiman, A. Kelly, T. Starich and members of our labs for advice and comments on the manuscript, C. Janke (Institut Curie) and B. Edde (Universite Pierre et Marie Curie) for antibodies, and Y. Saheki (Rockefeller University) and the Caenorhabditis Genetics Center for strains. C. I. B. and K. S. are Investigators of the Howard Hughes Medical Institute. This work was supported by the Howard Hughes Medical Institute.	Adler CE, 2006, NAT NEUROSCI, V9, P511, DOI 10.1038/nn1666; Albeg A, 2011, MOL CELL NEUROSCI, V46, P308, DOI 10.1016/j.mcn.2010.10.001; Arimura N, 2007, NAT REV NEUROSCI, V8, P194, DOI 10.1038/nrn2056; Arimura N, 2009, DEV CELL, V16, P675, DOI 10.1016/j.devcel.2009.03.005; BAAS PW, 1988, P NATL ACAD SCI USA, V85, P8335, DOI 10.1073/pnas.85.21.8335; Barnes AP, 2009, ANNU REV NEUROSCI, V32, P347, DOI 10.1146/annurev.neuro.31.060407.125536; BRENNER S, 1974, GENETICS, V77, P71; Brot S, 2010, J NEUROSCI, V30, P10639, DOI 10.1523/JNEUROSCI.0059-10.2010; BURTON PR, 1985, J COMP NEUROL, V242, P147, DOI 10.1002/cne.902420202; BURTON PR, 1981, P NATL ACAD SCI-BIOL, V78, P3269, DOI 10.1073/pnas.78.5.3269; Crump JG, 2001, NEURON, V29, P115, DOI 10.1016/S0896-6273(01)00184-2; Dwyer ND, 2001, NEURON, V31, P277, DOI 10.1016/S0896-6273(01)00361-0; Dwyer ND, 1998, CELL, V93, P455, DOI 10.1016/S0092-8674(00)81173-3; Fukata Y, 2002, NAT CELL BIOL, V4, P583, DOI 10.1038/ncb825; Grubb MS, 2010, CURR OPIN NEUROBIOL, V20, P481, DOI 10.1016/j.conb.2010.04.012; HALL DH, 1991, CELL, V65, P837, DOI 10.1016/0092-8674(91)90391-B; HEDGECOCK EM, 1985, DEV BIOL, V111, P158, DOI 10.1016/0012-1606(85)90443-9; Hedstrom KL, 2008, J CELL BIOL, V183, P635, DOI 10.1083/jcb.200806112; HEIDEMANN SR, 1981, J CELL BIOL, V91, P661, DOI 10.1083/jcb.91.3.661; Hirokawa N, 2005, NAT REV NEUROSCI, V6, P201, DOI 10.1038/nrn1624; Inagaki N, 2001, NAT NEUROSCI, V4, P781, DOI 10.1038/90476; Jenkins SM, 2001, J CELL BIOL, V155, P739, DOI 10.1083/jcb.200109026; Kawano Y, 2005, MOL CELL BIOL, V25, P9920, DOI 10.1128/MCB.25.22.9920-9935.2005; Kimura T, 2005, J NEUROCHEM, V93, P1371, DOI 10.1111/j.1471-4159.2005.03063.x; LI W, 1992, GENETICS, V132, P675; Mello C, 1995, METHOD CELL BIOL, V48, P451; MEYRAND P, 1992, J NEUROSCI, V12, P2803; Mimori-Kiyosue Y, 2000, CURR BIOL, V10, P865, DOI 10.1016/S0960-9822(00)00600-X; Nonet ML, 1997, J NEUROSCI, V17, P8061; Ogawa Y, 2006, J NEUROSCI, V26, P5230, DOI 10.1523/JNEUROSCI.0425-06.2006; OTSUKA AJ, 1995, J CELL BIOL, V129, P1081, DOI 10.1083/jcb.129.4.1081; Ou CY, 2010, CELL, V141, P846, DOI 10.1016/j.cell.2010.04.011; PALAY SL, 1968, J CELL BIOL, V38, P193, DOI 10.1083/jcb.38.1.193; Quinn CC, 2003, J NEUROSCI, V23, P2815; Rolls MM, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-7; RUVKUN G, 1989, NATURE, V338, P313, DOI 10.1038/338313a0; SIDDIQUI SS, 1989, J NEUROSCI, V9, P2963; Sobotzik JM, 2009, P NATL ACAD SCI USA, V106, P17564, DOI 10.1073/pnas.0909267106; Song AH, 2009, CELL, V136, P1148, DOI 10.1016/j.cell.2009.01.016; Srayko M, 2005, DEV CELL, V9, P223, DOI 10.1016/j.devcel.2005.07.003; Treinin M, 1998, P NATL ACAD SCI USA, V95, P15492, DOI 10.1073/pnas.95.26.15492; Tsuboi D, 2005, J NEUROCHEM, V95, P1629, DOI 10.1111/j.1471-4159.2005.03490.x; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Wicks SR, 2001, NAT GENET, V28, P160, DOI 10.1038/88878; Winckler B, 1999, NATURE, V397, P698, DOI 10.1038/17789; Witte H, 2008, J CELL BIOL, V180, P619, DOI 10.1083/jcb.200707042; WOLFF A, 1992, EUR J CELL BIOL, V59, P425; Yi JJ, 2010, CELL, V142, P144, DOI 10.1016/j.cell.2010.06.010; Yonekawa Y, 1998, J CELL BIOL, V141, P431, DOI 10.1083/jcb.141.2.431; Zhou HM, 2001, J NEUROSCI, V21, P3749, DOI 10.1523/JNEUROSCI.21-11-03749.2001	50	113	120	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2012	15	1					48	U66		10.1038/nn.2970	http://dx.doi.org/10.1038/nn.2970			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	866VO	22101643	Green Accepted			2022-12-28	WOS:000298414400013
J	Tymianski, M				Tymianski, Michael			Emerging mechanisms of disrupted cellular signaling in brain ischemia	NATURE NEUROSCIENCE			English	Article							NMDA RECEPTOR ACTIVATION; HIPPOCAMPAL-NEURONS; TRPM7 CHANNELS; DEATH; PROTEIN; STROKE; CURRENTS; SUBUNITS; CALCIUM; PSD-95	Recent findings have provided insights into pathogenic mechanism(s) that may complement and add to the traditional glutamatergic mechanisms to which ischemic brain injury is ascribed. The discovery of mechanisms leading to ionic imbalance and signaling cascades that mediate cross-talk between redundant pathways of cell death, as well as mechanisms that operate downstream of, upstream of and in parallel with excitotoxicity, has spurred new research into therapeutics ranging from proof of concept in animals to human clinical trials. This Perspective presents an integrated consideration of new molecular pathogenic mechanisms underlying ischemic damage in the brain, and how our combined knowledge of these mechanisms and our existing knowledge of excitotoxicity may establish new targets for therapy, by allowing clearer boundaries on what might be expected of a given intervention, and may yield advances that will benefit patients.	[Tymianski, Michael] Univ Hlth Network, Toronto Western Res Inst, Toronto, ON, Canada; [Tymianski, Michael] Univ Toronto, Div Neurosurg, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto	Tymianski, M (corresponding author), Univ Hlth Network, Toronto Western Res Inst, Toronto, ON, Canada.	miketym2@rogers.com		Tymianski, Mike/0000-0002-6311-9565				Aarts M, 2003, CELL, V115, P863, DOI 10.1016/S0092-8674(03)01017-1; Aarts M, 2002, SCIENCE, V298, P846, DOI 10.1126/science.1072873; Allen NJ, 2002, J PHYSIOL-LONDON, V543, P521, DOI 10.1113/jphysiol.2002.020297; Andrade-Rozental AF, 2000, BRAIN RES REV, V32, P308, DOI 10.1016/S0165-0173(99)00099-5; Askwith CC, 2004, J BIOL CHEM, V279, P18296, DOI 10.1074/jbc.M312145200; Besancon E, 2008, TRENDS PHARMACOL SCI, V29, P268, DOI 10.1016/j.tips.2008.02.003; Christopherson KS, 1999, J BIOL CHEM, V274, P27467, DOI 10.1074/jbc.274.39.27467; Contreras JE, 2004, BRAIN RES REV, V47, P290, DOI 10.1016/j.brainresrev.2004.08.002; Fonfria E, 2006, J RECEPT SIG TRANSD, V26, P179, DOI 10.1080/10799890600637522; GIFFARD RG, 1990, BRAIN RES, V506, P339, DOI 10.1016/0006-8993(90)91276-M; Guo SZ, 2009, STROKE, V40, pS4, DOI 10.1161/STROKEAHA.108.534388; Hara Y, 2002, MOL CELL, V9, P163, DOI 10.1016/S1097-2765(01)00438-5; Hardingham GE, 2006, BIOCHEM SOC T, V34, P936, DOI 10.1042/BST0340936; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; Hardingham GE, 2010, NAT REV NEUROSCI, V11, P682, DOI 10.1038/nrn2911; Husi H, 2000, NAT NEUROSCI, V3, P661, DOI 10.1038/76615; Immke DC, 2001, NAT NEUROSCI, V4, P869, DOI 10.1038/nn0901-869; Ivanov A, 2006, J PHYSIOL-LONDON, V572, P789, DOI 10.1113/jphysiol.2006.105510; Jia J, 2011, J CEREBR BLOOD F MET, V31, P2160, DOI 10.1038/jcbfm.2011.77; Jin J, 2008, SCIENCE, V322, P756, DOI 10.1126/science.1163493; Kaneko S, 2006, J PHARMACOL SCI, V101, P66, DOI 10.1254/jphs.FP0060128; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; Krishtal O, 2003, TRENDS NEUROSCI, V26, P477, DOI 10.1016/S0166-2236(03)00210-8; Lau A, 2010, PFLUG ARCH EUR J PHY, V460, P525, DOI 10.1007/s00424-010-0809-1; Lipton P, 1999, PHYSIOL REV, V79, P1431, DOI 10.1152/physrev.1999.79.4.1431; Liu YT, 2007, J NEUROSCI, V27, P2846, DOI 10.1523/JNEUROSCI.0116-07.2007; MacDonald JF, 2006, TRENDS NEUROSCI, V29, P75, DOI 10.1016/j.tins.2005.12.001; MacVicar BA, 2010, TRENDS NEUROSCI, V33, P93, DOI 10.1016/j.tins.2009.11.007; McNulty S, 2005, PFLUG ARCH EUR J PHY, V451, P235, DOI 10.1007/s00424-005-1440-4; McShane R, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003154.pub5; Nadler MJS, 2001, NATURE, V411, P590, DOI 10.1038/35079092; Ning K, 2004, J NEUROSCI, V24, P4052, DOI 10.1523/JNEUROSCI.5449-03.2004; Olah ME, 2009, J PHYSIOL-LONDON, V587, P965, DOI 10.1113/jphysiol.2008.162289; Perraud AL, 2001, NATURE, V411, P595, DOI 10.1038/35079100; Petralia RS, 2010, NEUROSCIENCE, V167, P68, DOI 10.1016/j.neuroscience.2010.01.022; Sattler R, 1999, SCIENCE, V284, P1845, DOI 10.1126/science.284.5421.1845; Sheng M, 1999, ANN NY ACAD SCI, V868, P483, DOI 10.1111/j.1749-6632.1999.tb11317.x; SILVER IA, 1990, J GEN PHYSIOL, V95, P837, DOI 10.1085/jgp.95.5.837; Soriano FX, 2008, J NEUROSCI, V28, P10696, DOI 10.1523/JNEUROSCI.1207-08.2008; Thompson RJ, 2006, SCIENCE, V312, P924, DOI 10.1126/science.1126241; Tu WH, 2010, CELL, V140, P222, DOI 10.1016/j.cell.2009.12.055; Venkatachalam K, 2007, ANNU REV BIOCHEM, V76, P387, DOI 10.1146/annurev.biochem.75.103004.142819; Wei WL, 2007, P NATL ACAD SCI USA, V104, P16323, DOI 10.1073/pnas.0701149104; Xia P, 2010, J NEUROSCI, V30, P11246, DOI 10.1523/JNEUROSCI.2488-10.2010; Xie Yu-Feng, 2010, Int J Physiol Pathophysiol Pharmacol, V2, P95; Xiong ZG, 2004, CELL, V118, P687, DOI 10.1016/j.cell.2004.08.026; Yamamoto S, 2008, NAT MED, V14, P738, DOI 10.1038/nm1758; Yen MR, 2007, PROG BIOPHYS MOL BIO, V94, P5, DOI 10.1016/j.pbiomolbio.2007.03.006; Yermolaieva O, 2004, P NATL ACAD SCI USA, V101, P6752, DOI 10.1073/pnas.0308636100; Zhang SJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000604	50	98	100	3	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2011	14	11					1369	1373		10.1038/nn.2951	http://dx.doi.org/10.1038/nn.2951			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	841NI	22030547				2022-12-28	WOS:000296518600008
J	Nieuwenhuis, S; Forstmann, BU; Wagenmakers, EJ				Nieuwenhuis, Sander; Forstmann, Birte U.; Wagenmakers, Eric-Jan			Erroneous analyses of interactions in neuroscience: a problem of significance	NATURE NEUROSCIENCE			English	Article								In theory, a comparison of two experimental effects requires a statistical test on their difference. In practice, this comparison is often based on an incorrect procedure involving two separate tests in which researchers conclude that effects differ when one effect is significant (P < 0.05) but the other is not (P > 0.05). We reviewed 513 behavioral, systems and cognitive neuroscience articles in five top-ranking journals (Science, Nature, Nature Neuroscience, Neuron and The Journal of Neuroscience) and found that 78 used the correct procedure and 79 used the incorrect procedure. An additional analysis suggests that incorrect analyses of interactions are even more common in cellular and molecular neuroscience. We discuss scenarios in which the erroneous procedure is particularly beguiling.	[Nieuwenhuis, Sander] Leiden Univ, Dept Psychol, Leiden, Netherlands; [Nieuwenhuis, Sander] Leiden Inst Brain & Cognit, Leiden, Netherlands; [Forstmann, Birte U.; Wagenmakers, Eric-Jan] Univ Amsterdam, Cognit Sci Ctr Amsterdam, Amsterdam, Netherlands	Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); University of Amsterdam	Nieuwenhuis, S (corresponding author), Leiden Univ, Dept Psychol, Leiden, Netherlands.	s.nieuwenhuis@fsw.leidenuiv.nl	Wagenmakers, Eric-Jan/AAH-7065-2019; Forstmann, Birte/AAS-8515-2020	Wagenmakers, Eric-Jan/0000-0003-1596-1034; 				Cumming G, 2007, J CELL BIOL, V177, P7, DOI 10.1083/jcb.200611141; Gelman A, 2006, AM STAT, V60, P328, DOI 10.1198/000313006X152649; Henson R, 2005, Q J EXP PSYCHOL-A, V58, P193, DOI 10.1080/02724980443000502; LOFTUS GR, 1994, PSYCHON B REV, V1, P476, DOI 10.3758/BF03210951; Poldrack RA, 2008, NEUROIMAGE, V40, P409, DOI 10.1016/j.neuroimage.2007.11.048; ROSENTHAL R, 1963, J PSYCHOL, V55, P33, DOI 10.1080/00223980.1963.9916596; ROSNOW RL, 1989, AM PSYCHOL, V44, P1276, DOI 10.1037/0003-066X.44.10.1276	7	512	515	1	127	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2011	14	9					1105	1107		10.1038/nn.2886	http://dx.doi.org/10.1038/nn.2886			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	812ID	21878926	Bronze			2022-12-28	WOS:000294284900006
J	Fitzgerald, JK; Freedman, DJ; Assad, JA				Fitzgerald, Jamie K.; Freedman, David J.; Assad, John A.			Generalized associative representations in parietal cortex	NATURE NEUROSCIENCE			English	Article							LATERAL INTRAPARIETAL AREA; PRIMATE POSTERIOR PARIETAL; NEURONAL REPRESENTATIONS; PERCEPTUAL DECISION; PREFRONTAL CORTEX; NEURAL BASIS; MACAQUE; MEMORY; MONKEY; ORGANIZATION	Making associations between sensory stimuli is a critical aspect of behavior. We previously found that neurons in the lateral intraparietal area (LIP) of Macaca mulatta reflect learned associations between directions of moving visual stimuli. Individual LIP neurons might encode associations only for specific stimuli, such as motion directions; alternatively, they may encode more general associations whenever animals must decide between discrete alternatives. To test this, we asked whether LIP neurons encode learned associations between pairs of arbitrarily chosen static shapes and, in a separate task, whether the same neurons also encode associations between motion directions. Our experimental design dissociated the visual associations from the movements used to report those associations. We found robust encoding of the learned pair associations between shapes, and shape-pair-selective neurons tended to be selective for direction associations. These findings suggest that representing generic categorical outcomes may be a fundamental role of parietal neurons.	[Fitzgerald, Jamie K.; Freedman, David J.; Assad, John A.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Freedman, David J.] Univ Chicago, Dept Neurobiol, Chicago, IL 60637 USA; [Assad, John A.] Ctr Neurosci & Cognit Syst UniTn, Ist Italiano Tecnol, Rovereto, Italy	Harvard University; Harvard Medical School; University of Chicago; Istituto Italiano di Tecnologia - IIT	Assad, JA (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA.	jassad@hms.harvard.edu			National Eye Institute [EY-12106, EY-12196]; National Institute of Mental Health Predoctoral National Research Service [F31 MH085439]; The Edward R. and Anne G. Lefler Center for the Study of Neurodegenerative Disorders; Charles H. Hood Postdoctoral Fellowship; NATIONAL EYE INSTITUTE [R01EY012106, P30EY012196] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [F31MH085439] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Institute of Mental Health Predoctoral National Research Service; The Edward R. and Anne G. Lefler Center for the Study of Neurodegenerative Disorders; Charles H. Hood Postdoctoral Fellowship; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank J. Maunsell, M. Livingstone, R. Born, R. Wilson, D. Zaksas, D. Ruff, G. Kreiman, J. Ware and the Harvard Catalyst Program for comments and discussions, and K. Irwin, J. LeBlanc, T. Lafratta and C. Ponce for technical assistance. This work was supported by National Eye Institute grant EY-12106 (J.A.A.), Vision Core grant EY-12196, a National Institute of Mental Health Predoctoral National Research Service Award (F31 MH085439, J.K.F.), The Edward R. and Anne G. Lefler Center for the Study of Neurodegenerative Disorders Predoctoral Fellowship (J.K.F.) and a Charles H. Hood Postdoctoral Fellowship (D.J.F.).	Andersen RA, 2002, ANNU REV NEUROSCI, V25, P189, DOI 10.1146/annurev.neuro.25.112701.142922; Bennur S, 2011, J NEUROSCI, V31, P913, DOI 10.1523/JNEUROSCI.4417-10.2011; BLATT GJ, 1990, J COMP NEUROL, V299, P421, DOI 10.1002/cne.902990404; Born RT, 2005, ANNU REV NEUROSCI, V28, P157, DOI 10.1146/annurev.neuro.26.041002.131052; Churchland AK, 2008, NAT NEUROSCI, V11, P693, DOI 10.1038/nn.2123; Fanini A, 2009, J NEUROPHYSIOL, V101, P289, DOI 10.1152/jn.00400.2007; Ferrera VP, 2006, NAT NEUROSCI, V9, P1207, DOI 10.1038/nn1006-1207; Freedman DJ, 2006, NATURE, V443, P85, DOI 10.1038/nature05078; Freedman DJ, 2011, NAT NEUROSCI, V14, P143, DOI 10.1038/nn.2740; Freedman DJ, 2009, J NEUROSCI, V29, P5671, DOI 10.1523/JNEUROSCI.2878-08.2009; GNADT JW, 1988, EXP BRAIN RES, V70, P216; Gold JI, 2007, ANNU REV NEUROSCI, V30, P535, DOI 10.1146/annurev.neuro.29.051605.113038; Goldberg ME, 2006, PROG BRAIN RES, V155, P157, DOI 10.1016/S0079-6123(06)55010-1; Herrington TM, 2009, J NEUROSCI, V29, P5793, DOI 10.1523/JNEUROSCI.4412-08.2009; Janssen P, 2008, J NEUROSCI, V28, P6679, DOI 10.1523/JNEUROSCI.0499-08.2008; Lewis JW, 2000, J COMP NEUROL, V428, P112, DOI 10.1002/1096-9861(20001204)428:1<112::AID-CNE8>3.0.CO;2-9; Maunsell JHR, 2004, TRENDS COGN SCI, V8, P261, DOI 10.1016/j.tics.2004.04.003; Messinger A, 2001, P NATL ACAD SCI USA, V98, P12239, DOI 10.1073/pnas.211431098; Miller EK, 2002, PHILOS T R SOC B, V357, P1123, DOI 10.1098/rstb.2002.1099; MISHKIN M, 1983, TRENDS NEUROSCI, V6, P414, DOI 10.1016/0166-2236(83)90190-X; Naya Y, 2003, EUR J NEUROSCI, V18, P2915, DOI 10.1111/j.1460-9568.2003.03020.x; Nieder A, 2006, SCIENCE, V313, P1431, DOI 10.1126/science.1130308; Osada T, 2008, PHILOS T R SOC B, V363, P2187, DOI 10.1098/rstb.2008.2271; Platt ML, 1999, NATURE, V400, P233, DOI 10.1038/22268; Rainer G, 1999, J NEUROSCI, V19, P5493; Roitman JD, 2002, J NEUROSCI, V22, P9475; SAKAI K, 1991, NATURE, V354, P152, DOI 10.1038/354152a0; Schlack A, 2007, NEURON, V53, P881, DOI 10.1016/j.neuron.2007.02.028; Sereno AB, 1998, NATURE, V395, P500, DOI 10.1038/26752; Shadlen MN, 2001, J NEUROPHYSIOL, V86, P1916, DOI 10.1152/jn.2001.86.4.1916; Shadlen MN, 2008, BETTER CONSCIOUS DEC, P71, DOI 10.7551/mitpress/9780262195805.003.0004; Toth LJ, 2002, NATURE, V415, P165, DOI 10.1038/415165a; Tudusciuc O, 2007, P NATL ACAD SCI USA, V104, P14513, DOI 10.1073/pnas.0705495104; Tudusciuc O, 2009, J NEUROPHYSIOL, V101, P2984, DOI 10.1152/jn.90713.2008; Vallentin D, 2010, EUR J NEUROSCI, V32, P1380, DOI 10.1111/j.1460-9568.2010.07427.x	35	60	60	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2011	14	8					1075	U179		10.1038/nn.2878	http://dx.doi.org/10.1038/nn.2878			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	797KC	21765425	Green Accepted			2022-12-28	WOS:000293123700023
J	Chadick, JZ; Gazzaley, A				Chadick, James Z.; Gazzaley, Adam			Differential coupling of visual cortex with default or frontal-parietal network based on goals	NATURE NEUROSCIENCE			English	Article							WORKING-MEMORY PERFORMANCE; TOP-DOWN MODULATION; FUNCTIONAL INTERACTIONS; COGNITIVE TASK; HUMAN BRAIN; SUPPRESSION; ATTENTION	The relationship between top-down enhancement and suppression of sensory cortical activity and large-scale neural networks remains unclear. Functional connectivity analysis of human functional magnetic resonance imaging data revealed that visual cortical areas that selectively process relevant information are functionally connected with the frontal-parietal network, whereas those that process irrelevant information are simultaneously coupled with the default network. This indicates that sensory cortical regions are differentially and dynamically coupled with distinct networks on the basis of task goals.	[Chadick, James Z.; Gazzaley, Adam] Univ Calif San Francisco, WM Keck Fdn Ctr Integrat Neurosci, Dept Neurol Physiol & Psychiat, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Gazzaley, A (corresponding author), Univ Calif San Francisco, WM Keck Fdn Ctr Integrat Neurosci, Dept Neurol Physiol & Psychiat, San Francisco, CA 94143 USA.	adam.gazzaley@ucsf.edu			US National Institutes of Health [5R01AG030395]; Larry L. Hillblom Center for the Biology of Aging; NATIONAL INSTITUTE ON AGING [R01AG030395] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Larry L. Hillblom Center for the Biology of Aging; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We would like to thank A. Rutman, M. Ruben, J.A. Anguera, E. Morsella and T. Zanto for their assistance. This work was supported by the grants from the US National Institutes of Health, including 5R01AG030395 (A.G.), and Larry L. Hillblom Center for the Biology of Aging Graduate Fellowship (J.Z.C.).	Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Buckner RL, 2007, TRENDS COGN SCI, V11, P49, DOI 10.1016/j.tics.2006.11.004; Corbetta M, 1998, P NATL ACAD SCI USA, V95, P831, DOI 10.1073/pnas.95.3.831; Corbetta M, 2008, NEURON, V58, P306, DOI 10.1016/j.neuron.2008.04.017; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fuster JM, 1997, TRENDS NEUROSCI, V20, P451, DOI 10.1016/S0166-2236(97)01128-4; FUSTER JM, 1985, BRAIN RES, V330, P299, DOI 10.1016/0006-8993(85)90689-4; Gazzaley A, 2005, J COGNITIVE NEUROSCI, V17, P507, DOI 10.1162/0898929053279522; Gazzaley A, 2005, NAT NEUROSCI, V8, P1298, DOI 10.1038/nn1543; Gazzaley A, 2007, CEREB CORTEX, V17, pI125, DOI 10.1093/cercor/bhm113; MORAN J, 1985, SCIENCE, V229, P782, DOI 10.1126/science.4023713; Rissman J, 2004, NEUROIMAGE, V23, P752, DOI 10.1016/j.neuroimage.2004.06.035; Rissman J, 2009, NEUROPSYCHOLOGIA, V47, P1637, DOI 10.1016/j.neuropsychologia.2009.01.036; Rutman AM, 2010, J COGNITIVE NEUROSCI, V22, P1224, DOI 10.1162/jocn.2009.21257; Zanto TP, 2009, J NEUROSCI, V29, P3059, DOI 10.1523/JNEUROSCI.4621-08.2009	15	158	161	1	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2011	14	7					830	832		10.1038/nn.2823	http://dx.doi.org/10.1038/nn.2823			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	783KR	21623362	Green Accepted			2022-12-28	WOS:000292081700009
J	Hua, YF; Sinha, R; Thiel, CS; Schmidt, R; Huve, J; Martens, H; Hell, SW; Egner, A; Klingauf, J				Hua, Yunfeng; Sinha, Raunak; Thiel, Cora S.; Schmidt, Roman; Hueve, Jana; Martens, Henrik; Hell, Stefan W.; Egner, Alexander; Klingauf, Jurgen			A readily retrievable pool of synaptic vesicles	NATURE NEUROSCIENCE			English	Article							CLATHRIN-MEDIATED ENDOCYTOSIS; ACTIVE ZONES; MEMBRANE; TRANSMITTER; EXOCYTOSIS; SYNAPSES; MODES; SYNAPTOBREVIN; LOCALIZATION; TRAFFICKING	Although clathrin-mediated endocytosis is thought to be the predominant mechanism of synaptic vesicle recycling, it seems to be too slow for fast recycling. Therefore, it was suggested that a presorted and preassembled pool of synaptic vesicle proteins on the presynaptic membrane might support a first wave of fast clathrin-mediated endocytosis. In this study we monitored the temporal dynamics of such a 'readily retrievable pool' of synaptic vesicle proteins in rat hippocampal neurons using a new type of probe. By applying cypHer5E, a new cyanine dye-based pH-sensitive exogenous marker, coupled to antibodies to luminal domains of synaptic vesicle proteins, we could reliably monitor synaptic vesicle recycling and demonstrate the preferential recruitment of a surface pool of synaptic vesicle proteins upon stimulated endocytosis. By using fluorescence nanoscopy of surface-labeled synaptotagmin 1, we could resolve the spatial distribution of the surface pool at the periactive zone in hippocampal boutons, which represent putative sites of endocytosis.	[Hua, Yunfeng; Sinha, Raunak; Thiel, Cora S.; Klingauf, Jurgen] Max Planck Inst Biophys Chem, Dept Membrane Biophys, Gottingen, Germany; [Hua, Yunfeng; Sinha, Raunak; Thiel, Cora S.; Hueve, Jana; Klingauf, Jurgen] Univ Munster, Inst Med Phys & Biophys, Dept Cellular Biophys, Munster, Germany; [Schmidt, Roman; Hell, Stefan W.; Egner, Alexander] Max Planck Inst Biophys Chem, Dept NanoBiophoton, D-37077 Gottingen, Germany; [Hueve, Jana; Klingauf, Jurgen] Ctr Nanotechnol CeNTech, Fluorescence Microscopy Facil Muenster, Munster, Germany; [Martens, Henrik] Synapt Syst GmbH, Gottingen, Germany	Max Planck Society; University of Munster; Max Planck Society	Klingauf, J (corresponding author), Max Planck Inst Biophys Chem, Dept Membrane Biophys, Gottingen, Germany.	klingauf@uni-muenster.de		Hua, Yunfeng/0000-0003-0072-7122; Egner, Alexander/0000-0001-5248-3858	European Science Foundation/Deutsche Forschungsgemeinschaft (DFG) [CRP FP-020]; DFG [Kl 1334/1-1, SFB 944, CMPB, SFB755]; Max-Planck Foundation; International Max Planck Research School in Neurosciences at the University of Goettingen	European Science Foundation/Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)European Science Foundation (ESF)); DFG(German Research Foundation (DFG)); Max-Planck Foundation(Foundation CELLEX); International Max Planck Research School in Neurosciences at the University of Goettingen	We thank M. Pilot and I. Herfort for the preparation of primary cell cultures of hippocampal neurons and E. Neher and R. H. Chow for critical reading of the manuscript. We acknowledge D. Boening and M. Martineau for experimental support and we are grateful to K. Kolmakov and V. Belov (Max Planck Institute for Biophysical Chemistry, Goettingen) for providing us with the new fluorescent dye KK114. We thank G. Miesenbock (Oxford University) for providing superecliptic spH. We would also like to thank M. Hoon and N. Glyvuk for suggestions. This work was supported by grants from the European Science Foundation/Deutsche Forschungsgemeinschaft (DFG) (EUROMEMBRANE programme, EuroSynapse CRP FP-020 to J.K.) as well as from the DFG (Kl 1334/1-1 to C. S. T. and J.K., SFB 944 to J.K., CMPB to A. E. and S. W. H., and SFB755 to A. E. and S. W. H.). Y.H. is supported by a stipend from the Max-Planck Foundation and R. Sinha is supported by a stipend from the International Max Planck Research School in Neurosciences at the University of Goettingen.	Adie EJ, 2003, ASSAY DRUG DEV TECHN, V1, P251, DOI 10.1089/15406580360545062; Balaji J, 2007, P NATL ACAD SCI USA, V104, P20576, DOI 10.1073/pnas.0707574105; Brodin L, 2006, CELL TISSUE RES, V326, P301, DOI 10.1007/s00441-006-0216-2; CECCARELLI B, 1973, J CELL BIOL, V57, P499, DOI 10.1083/jcb.57.2.499; Dittman JS, 2006, P NATL ACAD SCI USA, V103, P11399, DOI 10.1073/pnas.0600784103; Fernandez-Alfonso T, 2004, NEURON, V41, P943, DOI 10.1016/S0896-6273(04)00113-8; Fernandez-Alfonso T, 2006, NEURON, V51, P179, DOI 10.1016/j.neuron.2006.06.008; Fredj NB, 2009, NAT NEUROSCI, V12, P751, DOI 10.1038/nn.2317; Gandhi SP, 2003, NATURE, V423, P607, DOI 10.1038/nature01677; Glyvuk N, 2010, EMBO J, V29, P1318, DOI 10.1038/emboj.2010.15; Goslin K., 1991, CULTURING NERVE CELL, P251; Granseth B, 2006, NEURON, V51, P773, DOI 10.1016/j.neuron.2006.08.029; Groemer TW, 2007, NAT NEUROSCI, V10, P145, DOI 10.1038/nn1831; Gundelfinger ED, 2003, NAT REV MOL CELL BIO, V4, P127, DOI 10.1038/nrm1016; He LM, 2006, NATURE, V444, P102, DOI 10.1038/nature05250; HEUSER JE, 1973, J CELL BIOL, V57, P315, DOI 10.1083/jcb.57.2.315; Hosoi N, 2009, NEURON, V63, P216, DOI 10.1016/j.neuron.2009.06.010; Hua YF, 2010, NAT NEUROSCI, V13, P1451, DOI 10.1038/nn.2695; Huve J, 2008, BIOPHYS J, V95, P877, DOI 10.1529/biophysj.107.127449; Kano H, 2002, ULTRAMICROSCOPY, V90, P207, DOI 10.1016/S0304-3991(01)00132-2; Kim SH, 2009, J NEUROSCI, V29, P3865, DOI 10.1523/JNEUROSCI.5639-08.2009; Koenig JH, 1998, P NATL ACAD SCI USA, V95, P12677, DOI 10.1073/pnas.95.21.12677; Martens H, 2008, J NEUROSCI, V28, P13125, DOI 10.1523/JNEUROSCI.3887-08.2008; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; MILLER TM, 1984, J CELL BIOL, V98, P685, DOI 10.1083/jcb.98.2.685; Mueller VJ, 2004, J NEUROSCI, V24, P2004, DOI 10.1523/JNEUROSCI.4080-03.2004; Murthy VN, 1999, NAT NEUROSCI, V2, P503, DOI 10.1038/9149; RICHARDSON WH, 1972, J OPT SOC AM, V62, P55, DOI 10.1364/JOSA.62.000055; Roos J, 1999, CURR BIOL, V9, P1411, DOI 10.1016/S0960-9822(00)80087-1; Sankaranarayanan S, 2000, BIOPHYS J, V79, P2199, DOI 10.1016/S0006-3495(00)76468-X; Sankaranarayanan S, 2000, NAT CELL BIOL, V2, P197, DOI 10.1038/35008615; Sara Y, 2005, NEURON, V45, P563, DOI 10.1016/j.neuron.2004.12.056; Schikorski T, 2001, NAT NEUROSCI, V4, P391, DOI 10.1038/86042; Schikorski T, 1997, J NEUROSCI, V17, P5858; Schmidt R, 2008, NAT METHODS, V5, P539, DOI 10.1038/nmeth.1214; Shupliakov O, 2002, P NATL ACAD SCI USA, V99, P14476, DOI 10.1073/pnas.212381799; Staras K, 2010, NEURON, V66, P37, DOI 10.1016/j.neuron.2010.03.020; Staudt T, 2007, MICROSC RES TECHNIQ, V70, P1, DOI 10.1002/jemt.20396; Tabares L, 2007, J NEUROSCI, V27, P5422, DOI 10.1523/JNEUROSCI.0670-07.2007; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; Taubenblatt P, 1999, J CELL SCI, V112, P3559; Teng HB, 1999, J NEUROSCI, V19, P4855; Teng HB, 2000, J NEUROSCI, V20, P7986; Vanden Berghe P, 2006, J PHYSIOL-LONDON, V572, P707, DOI 10.1113/jphysiol.2005.100842; Wienisch M, 2006, NAT NEUROSCI, V9, P1019, DOI 10.1038/nn1739; Willig KI, 2006, NATURE, V440, P935, DOI 10.1038/nature04592; Wu LG, 2007, J NEUROSCI, V27, P11793, DOI 10.1523/JNEUROSCI.3471-07.2007; Wu XS, 2009, NAT NEUROSCI, V12, P1003, DOI 10.1038/nn.2355; Yao CK, 2009, CELL, V138, P947, DOI 10.1016/j.cell.2009.06.033; Zhang Q, 2009, SCIENCE, V323, P1448, DOI 10.1126/science.1167373	50	110	111	0	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2011	14	7					833	U42		10.1038/nn.2838	http://dx.doi.org/10.1038/nn.2838			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	783KR	21666673	Green Published			2022-12-28	WOS:000292081700010
J	Rebola, N; Carta, M; Lanore, F; Blanchet, C; Mulle, C				Rebola, Nelson; Carta, Mario; Lanore, Frederic; Blanchet, Christophe; Mulle, Christophe			NMDA receptor-dependent metaplasticity at hippocampal mossy fiber synapses	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; SYNAPTIC PLASTICITY; CELLS; AMPA	Hippocampal mossy fiber synapses have been reported to lack NMDA receptor (NMDAR)-dependent long-term potentiation (LTP) of AMPA excitatory postsynaptic currents (EPSCs), unlike conventional glutamatergic synapses. An explanation for this difference may reside in the relatively low number of NMDARs at these synapses. Because mossy fiber synapses display LTP selective for NMDARs, we examined whether this would affect the plasticity rules at mossy fiber-CA3 synapses in mouse hippocampal slices. We found that LTP of NMDARs serves as a metaplastic switch making mossy fiber synapses competent for generating NMDAR-dependent LTP of AMPA EPSCs.	[Rebola, Nelson; Carta, Mario; Lanore, Frederic; Blanchet, Christophe; Mulle, Christophe] Univ Bordeaux, Interdisciplinary Inst Neurosci, Bordeaux, France; [Rebola, Nelson; Carta, Mario; Lanore, Frederic; Blanchet, Christophe; Mulle, Christophe] CNRS, UMR 5297, Interdisciplinary Inst Neurosci, Bordeaux, France	UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux	Mulle, C (corresponding author), Univ Bordeaux, Interdisciplinary Inst Neurosci, Bordeaux, France.	mulle@u-bordeaux2.fr		Mulle, Christophe/0000-0003-2709-6615; Lanore, Frederic/0000-0003-4316-6855; Carta, Mario/0000-0003-1225-2742	Centre National de la Recherche Scientifique; Conseil Regional d'Aquitaine; European Commission [LSHM-CT-2005-019055]; EMBO; Fondation pour la Recherche Medicale	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Conseil Regional d'Aquitaine(Region Nouvelle-Aquitaine); European Commission(European CommissionEuropean Commission Joint Research Centre); EMBO(European Molecular Biology Organization (EMBO)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	We thank N. Grosjean, E. Normand and A. Lacquemant for mouse breeding and J. Lourenco, D. Perrais and B. Srikumar for comments. This study was supported by grants from the Centre National de la Recherche Scientifique, the Conseil Regional d'Aquitaine and the European Commission (EUSynapse Project, contract no. LSHM-CT-2005-019055). N.R. was financed by an EMBO long-term fellowship, M.C. by a Marie Curie grant and F.L. by a fellowship from the Fondation pour la Recherche Medicale.	Debanne D, 1998, J PHYSIOL-LONDON, V507, P237, DOI 10.1111/j.1469-7793.1998.237bu.x; Henze DA, 2002, NAT NEUROSCI, V5, P790, DOI 10.1038/nn887; Kakegawa W, 2004, EUR J NEUROSCI, V20, P101, DOI 10.1111/j.1460-9568.2004.03461.x; Kishimoto Y, 2006, J NEUROSCI, V26, P1562, DOI 10.1523/JNEUROSCI.4142-05.2006; Kwon HB, 2008, NEURON, V57, P108, DOI 10.1016/j.neuron.2007.11.024; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Nakazawa K, 2002, SCIENCE, V297, P211, DOI 10.1126/science.1071795; Nicoll RA, 2005, NAT REV NEUROSCI, V6, P863, DOI 10.1038/nrn1786; Rajji T, 2006, J NEUROSCI, V26, P908, DOI 10.1523/JNEUROSCI.4194-05.2006; Rebola N, 2008, NEURON, V57, P121, DOI 10.1016/j.neuron.2007.11.023; Takumi Y, 1999, NAT NEUROSCI, V2, P618, DOI 10.1038/10172; ZALUTSKY RA, 1990, SCIENCE, V248, P1619, DOI 10.1126/science.2114039	12	37	37	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2011	14	6					691	693		10.1038/nn.2809	http://dx.doi.org/10.1038/nn.2809			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	768SH	21532578	Green Submitted			2022-12-28	WOS:000290958000009
J	Bossert, JM; Stern, AL; Theberge, FRM; Cifani, C; Koya, E; Hope, BT; Shaham, Y				Bossert, Jennifer M.; Stern, Anna L.; Theberge, Florence R. M.; Cifani, Carlo; Koya, Eisuke; Hope, Bruce T.; Shaham, Yavin			Ventral medial prefrontal cortex neuronal ensembles mediate context-induced relapse to heroin	NATURE NEUROSCIENCE			English	Article							NUCLEUS-ACCUMBENS; SEEKING; RATS; REINSTATEMENT; EXTINCTION; FEAR	In a rat model of context-induced relapse to heroin, we identified sparsely distributed ventral medial prefrontal cortex (mPFC) neurons that were activated by the heroin-associated context. Selective pharmacogenetic inactivation of these neurons inhibited context-induced drug relapse. A small subset of ventral mPFC neurons formed neuronal ensembles that encode the learned associations between heroin reward and heroin-associated contexts; re-activation of these neuronal ensembles by drug-associated contexts during abstinence provoked drug relapse.	[Bossert, Jennifer M.; Stern, Anna L.; Theberge, Florence R. M.; Cifani, Carlo; Koya, Eisuke; Hope, Bruce T.; Shaham, Yavin] NIDA, Behav Neurosci Branch, Intramural Res Program, US Natl Inst Hlth,Dept Hlth & Human Serv, Baltimore, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA)	Shaham, Y (corresponding author), NIDA, Behav Neurosci Branch, Intramural Res Program, US Natl Inst Hlth,Dept Hlth & Human Serv, Baltimore, MD USA.	yshaham@intra.nida.nih.gov	Cifani, Carlo/AAC-5456-2022; Hope, Bruce T/A-9223-2010; Theberge, Florence/T-2916-2019; shaham, yavin/G-1306-2014	Cifani, Carlo/0000-0001-6180-828X; Hope, Bruce T/0000-0001-5804-7061; Koya, Eisuke/0000-0002-5039-4875	National Institute on Drug Abuse (US National Institutes of Health, Department of Health and Human Services); NATIONAL INSTITUTE ON DRUG ABUSE [ZIADA000467, ZIADA000434] Funding Source: NIH RePORTER	National Institute on Drug Abuse (US National Institutes of Health, Department of Health and Human Services)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank B. Navarre and K. Wihbey for their help in conducting the experiments and thank M. van den Oever for the CamKII and GAD67 immunofluorescence protocol. We also thank M. Heilig for helpful comments on the manuscript. This work was supported by the Intramural Research Program of the National Institute on Drug Abuse (US National Institutes of Health, Department of Health and Human Services).	Bossert JM, 2007, J NEUROSCI, V27, P12655, DOI 10.1523/JNEUROSCI.3926-07.2007; BOUTON ME, 1979, LEARN MOTIV, V10, P445, DOI 10.1016/0023-9690(79)90057-2; Celentano M, 2009, PSYCHOPHARMACOLOGY, V204, P349, DOI 10.1007/s00213-009-1467-x; Crombag HS, 2008, PHILOS T R SOC B, V363, P3233, DOI 10.1098/rstb.2008.0090; EICHENBAUM H, 1993, SCIENCE, V261, P993, DOI 10.1126/science.8351525; ETTENBERG A, 1982, PSYCHOPHARMACOLOGY, V78, P204, DOI 10.1007/BF00428151; Hebb Donald O., 1949, ORG BEHAV; KASOF GM, 1995, J NEUROSCI, V15, P4238; Koya E, 2009, NAT NEUROSCI, V12, P1069, DOI 10.1038/nn.2364; PENNARTZ CMA, 1994, PROG NEUROBIOL, V42, P719, DOI 10.1016/0301-0082(94)90025-6; Peters J, 2008, J NEUROSCI, V28, P6046, DOI 10.1523/JNEUROSCI.1045-08.2008; Peters J, 2009, LEARN MEMORY, V16, P279, DOI 10.1101/lm.1041309; Rogers JL, 2008, NEUROSCIENCE, V151, P579, DOI 10.1016/j.neuroscience.2007.10.012; Van den Oever MC, 2008, NAT NEUROSCI, V11, P1053, DOI 10.1038/nn.2165; WIKLER A, 1973, ARCH GEN PSYCHIAT, V28, P611	15	210	223	2	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2011	14	4					420	422		10.1038/nn.2758	http://dx.doi.org/10.1038/nn.2758			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	741FQ	21336273	Green Accepted, Green Submitted			2022-12-28	WOS:000288849400010
J	Huang, Z; Lujan, R; Kadurin, I; Uebele, VN; Renger, JJ; Dolphin, AC; Shah, MM				Huang, Zhuo; Lujan, Rafael; Kadurin, Ivan; Uebele, Victor N.; Renger, John J.; Dolphin, Annette C.; Shah, Mala M.			Presynaptic HCN1 channels regulate Ca(V)3.2 activity and neurotransmission at select cortical synapses	NATURE NEUROSCIENCE			English	Article							ACTIVATED CATION CHANNELS; T-TYPE; I-H; DENDRITIC INTEGRATION; SYNAPTIC-TRANSMISSION; DISTAL DENDRITES; CA1; PLASTICITY; LOCALIZATION; RELEASE	The hyperpolarization-activated cyclic nucleotide-gated (HCN) channels are subthreshold, voltage-gated ion channels that are highly expressed in hippocampal and cortical pyramidal cell dendrites, where they are important for regulating synaptic potential integration and plasticity. We found that HCN1 subunits are also localized to the active zone of mature asymmetric synaptic terminals targeting mouse entorhinal cortical layer III pyramidal neurons. HCN channels inhibited glutamate synaptic release by suppressing the activity of low-threshold voltage-gated T-type (Ca(V)3.2) Ca2+ channels. Consistent with this, electron microscopy revealed colocalization of presynaptic HCN1 and Ca(V)3.2 subunit. This represents a previously unknown mechanism by which HCN channels regulate synaptic strength and thereby neural information processing and network excitability.	[Huang, Zhuo; Shah, Mala M.] Univ London, Sch Pharm, Dept Pharmacol, London WC1N 1AX, England; [Lujan, Rafael] Univ Castilla La Mancha, Ctr Invest Discapacidades Neurol, Dept Ciencias Med, Albacete, Spain; [Kadurin, Ivan; Dolphin, Annette C.] UCL, Dept Neurosci Physiol & Pharmacol, London, England; [Uebele, Victor N.; Renger, John J.] Merck Res Labs, Dept Depress & Circadian Rhythms, Rahway, PA USA	University of London; University College London; University of London School of Pharmacy; Universidad de Castilla-La Mancha; University of London; University College London; Merck & Company	Shah, MM (corresponding author), Univ London, Sch Pharm, Dept Pharmacol, London WC1N 1AX, England.	mala.shah@pharmacy.ac.uk	Lujan, Rafael/G-2555-2015; Dolphin, Annette C/F-7416-2010; Kadurin, Ivan/F-7759-2012	Dolphin, Annette C/0000-0003-4626-4856; Kadurin, Ivan/0000-0002-7720-367X; Lujan Miras, Rafael/0000-0003-2001-9545; Shah, Mala/0000-0002-8323-4739	MRC [G0700369, G0801756]; Wellcome Trust [WT087363MA]; European Research Council [ERC_2010_StG_20091118]; Spanish Ministry of Science and Innovation [BFU-2009-08404/BFI]; CONSOLIDER-Ingenio [CSD2008-00005]; Junta de Comunidades de Castilla-La Mancha [PAI08-0174-6967]; Epilepsy Research UK [0803]; US National Institutes of Health [U24NS050606]; Medical Research Council [G0700369, G0801756] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [P01CA095616] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U24NS050606] Funding Source: NIH RePORTER	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); European Research Council(European Research Council (ERC)European Commission); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); CONSOLIDER-Ingenio(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Junta de Comunidades de Castilla-La Mancha(Junta de Comunidades de Castilla-La Mancha); Epilepsy Research UK; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank D. A. Brown (University College London), D. Johnston (University of Texas), M. C. Walker (University College London) and A. Constanti (University of London) for helpful discussions. We are also grateful to S. Martin (University College London) for genotyping the transgenic mice, K. Venner (University College London) for help with processing some samples for electron microscopy, D. McCarthy (University of London) for assistance with acquisition of some electron micrographs and H. Beck (University of Bonn) and K. P. Campbell (University of Iowa) for providing Ca<INF>V</INF>3.2<SUP>+/-</SUP> breeding pairs. This work was supported by an MRC New Investigator Award (G0700369, M. M. S.), a Wellcome Trust project grant (WT087363MA, M. M. S.), a European Research Council Starter Independent Grant (ERC_2010_StG_20091118, M. M. S.), the Spanish Ministry of Science and Innovation (BFU-2009-08404/BFI and CONSOLIDER-Ingenio CSD2008-00005, R. L.), the Junta de Comunidades de Castilla-La Mancha (PAI08-0174-6967, R. L.), an Epilepsy Research UK Grant (0803, A. C. D.) and an MRC Project Grant (G0801756, A. C. D.). The monoclonal antibodies HCN1 (Clone N70/28) and Ca<INF>V</INF>3.2 (Clone N55/10) were developed by and obtained from the University of California at Davis/US National Institutes of Health NeuroMab Facility, supported by US National Institutes of Health grant U24NS050606 and maintained by the University of California at Davis.	Aponte Y, 2006, J PHYSIOL-LONDON, V574, P229, DOI 10.1113/jphysiol.2005.104042; Beaumont V, 2002, NEURON, V33, P601, DOI 10.1016/S0896-6273(02)00581-0; Beaumont V, 2000, NAT NEUROSCI, V3, P133, DOI 10.1038/72072; Bender RA, 2007, J NEUROSCI, V27, P4697, DOI 10.1523/JNEUROSCI.4699-06.2007; Biel M, 2009, PHYSIOL REV, V89, P847, DOI 10.1152/physrev.00029.2008; Bourinet E, 2001, BIOPHYS J, V81, P79, DOI 10.1016/S0006-3495(01)75681-0; Boyes J, 2007, EUR J NEUROSCI, V25, P2081, DOI 10.1111/j.1460-9568.2007.05463.x; Brager DH, 2007, J NEUROSCI, V27, P13926, DOI 10.1523/JNEUROSCI.3520-07.2007; Brun VH, 2008, NEURON, V57, P290, DOI 10.1016/j.neuron.2007.11.034; Campanac E, 2008, J NEUROSCI, V28, P8635, DOI 10.1523/JNEUROSCI.1411-08.2008; Catterall WA, 1998, CELL CALCIUM, V24, P307, DOI 10.1016/S0143-4160(98)90055-0; Chen CC, 2003, SCIENCE, V302, P1416, DOI 10.1126/science.1089268; Chevaleyre V, 2002, P NATL ACAD SCI USA, V99, P9538, DOI 10.1073/pnas.142213199; Cossart R, 2001, NAT NEUROSCI, V4, P52, DOI 10.1038/82900; Crunelli V, 2005, J PHYSIOL-LONDON, V562, P121, DOI 10.1113/jphysiol.2004.076273; Cuttle MF, 2001, J PHYSIOL-LONDON, V534, P733, DOI 10.1111/j.1469-7793.2001.00733.x; Daw MI, 2009, J NEUROSCI, V29, P11112, DOI 10.1523/JNEUROSCI.5760-08.2009; Dreyfus FM, 2010, J NEUROSCI, V30, P99, DOI 10.1523/JNEUROSCI.4305-09.2010; Evans DI, 2000, J NEUROPHYSIOL, V83, P2519, DOI 10.1152/jn.2000.83.5.2519; Fan Y, 2005, NAT NEUROSCI, V8, P1542, DOI 10.1038/nn1568; George MS, 2009, NAT NEUROSCI, V12, P577, DOI 10.1038/nn.2307; Gill CH, 2004, BRIT J PHARMACOL, V143, P411, DOI 10.1038/sj.bjp.0705945; Groffen AJ, 2010, SCIENCE, V327, P1614, DOI 10.1126/science.1183765; Hefft S, 2005, NAT NEUROSCI, V8, P1319, DOI 10.1038/nn1542; Huang Z, 2009, J NEUROSCI, V29, P10979, DOI 10.1523/JNEUROSCI.1531-09.2009; Lorincz A, 2002, NAT NEUROSCI, V5, P1185, DOI 10.1038/nn962; Lujan R, 2006, EUR J NEUROSCI, V23, P1479, DOI 10.1111/j.1460-9568.2006.04669.x; Lujan R, 2005, EUR J NEUROSCI, V21, P2073, DOI 10.1111/j.1460-9568.2005.04043.x; Lujan R, 1996, EUR J NEUROSCI, V8, P1488, DOI 10.1111/j.1460-9568.1996.tb01611.x; Magee JC, 1999, NAT NEUROSCI, V2, pU9; Magee JC, 2000, NAT REV NEUROSCI, V1, P181, DOI 10.1038/35044552; Neher E, 2008, NEURON, V59, P861, DOI 10.1016/j.neuron.2008.08.019; Nolan MF, 2004, CELL, V119, P719, DOI 10.1016/S0092-8674(04)01055-4; Nolan MF, 2003, CELL, V115, P551, DOI 10.1016/S0092-8674(03)00884-5; Notomi T, 2004, J COMP NEUROL, V471, P241, DOI 10.1002/cne.11039; PAPE HC, 1994, NEUROSCIENCE, V59, P363, DOI 10.1016/0306-4522(94)90602-5; Randall AD, 1997, NEUROPHARMACOLOGY, V36, P879, DOI 10.1016/S0028-3908(97)00086-5; Remondes M, 2004, NATURE, V431, P699, DOI 10.1038/nature02965; Shah MM, 2004, NEURON, V44, P495, DOI 10.1016/j.neuron.2004.10.011; Shipe WD, 2008, J MED CHEM, V51, P3692, DOI 10.1021/jm800419w; Southan AP, 2000, J PHYSIOL-LONDON, V526, P91, DOI 10.1111/j.1469-7793.2000.t01-1-00091.x; Stevens CF, 2004, CURR OPIN NEUROBIOL, V14, P341, DOI 10.1016/j.conb.2004.04.004; Sun J, 2007, NATURE, V450, P676, DOI 10.1038/nature06308; Talavera K, 2006, CELL CALCIUM, V40, P97, DOI 10.1016/j.ceca.2006.04.013; Tsay D, 2007, NEURON, V56, P1076, DOI 10.1016/j.neuron.2007.11.015; TSIEN RW, 1991, TRENDS PHARMACOL SCI, V12, P349, DOI 10.1016/0165-6147(91)90595-J; Uebele VN, 2009, NEUROREPORT, V20, P257, DOI 10.1097/WNR.0b013e3283200111; Wang M, 2007, CELL, V129, P397, DOI 10.1016/j.cell.2007.03.015; Williams SR, 2008, NAT NEUROSCI, V11, P790, DOI 10.1038/nn.2137	49	118	123	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2011	14	4					478	U114		10.1038/nn.2757	http://dx.doi.org/10.1038/nn.2757			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	741FQ	21358644	Green Accepted			2022-12-28	WOS:000288849400019
J	Koon, AC; Ashley, J; Barria, R; DasGupta, S; Brain, R; Waddell, S; Alkema, MJ; Budnik, V				Koon, Alex C.; Ashley, James; Barria, Romina; DasGupta, Shamik; Brain, Ruth; Waddell, Scott; Alkema, Mark J.; Budnik, Vivian			Autoregulatory and paracrine control of synaptic and behavioral plasticity by octopaminergic signaling	NATURE NEUROSCIENCE			English	Article							ELEMENT-BINDING PROTEIN; DROSOPHILA-MELANOGASTER; NEUROMUSCULAR-JUNCTIONS; IN-VIVO; FUNCTIONAL COMPONENTS; GENETIC DISSECTION; K+ CHANNEL; TYRAMINE; RECEPTOR; NEURONS	Adrenergic signaling has important roles in synaptic plasticity and metaplasticity. However, the underlying mechanisms of these functions remain poorly understood. We investigated the role of octopamine, the invertebrate counterpart of adrenaline and noradrenaline, in synaptic and behavioral plasticity in Drosophila. We found that an increase in locomotor speed induced by food deprivation was accompanied by an activity- and octopamine-dependent extension of octopaminergic arbors and that the formation and maintenance of these arbors required electrical activity. Growth of octopaminergic arbors was controlled by a cAMP- and CREB-dependent positive-feedback mechanism that required Oct beta 2R octopamine autoreceptors. Notably, this autoregulation was necessary for the locomotor response. In addition, octopamine neurons regulated the expansion of excitatory glutamatergic neuromuscular arbors through Oct beta 2Rs on glutamatergic motor neurons. Our results provide a mechanism for global regulation of excitatory synapses, presumably to maintain synaptic and behavioral plasticity in a dynamic range.	[Koon, Alex C.; Ashley, James; Barria, Romina; DasGupta, Shamik; Brain, Ruth; Waddell, Scott; Alkema, Mark J.; Budnik, Vivian] Univ Massachusetts, Sch Med, Dept Neurobiol, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Budnik, V (corresponding author), Univ Massachusetts, Sch Med, Dept Neurobiol, Worcester, MA 01605 USA.	vivian.budnik@umassmed.edu		Koon, Alex/0000-0002-4274-7052; DasGupta, Shamik/0000-0001-5803-8982; Ashley, James/0000-0002-6693-1014; DasGupta, Shamik/0000-0001-5566-7548	US National Institutes of Health [R01 MH0700000, MH09883, MH081982, GM084491]; Bill & Melinda Gates Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH070000, R01MH069883, R01MH081982, F31MH009883] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank M. Yoshihara, S. Speese, Y. Fuentes-Medel and C. Korkut for comments on the manuscript, C. Brewer for assistance with data analysis and the UMass Amherst antibody facility for production of the TBH antibody. This work was supported by US National Institutes of Health grants R01 MH0700000 to V. B., MH09883 to S. W., MH081982 to S. W. and GM084491 to M.J.A. M.J.A. was also supported by the Bill & Melinda Gates Foundation.	Aamodt S M, 1999, Adv Neurol, V79, P133; Ataman B, 2008, NEURON, V57, P705, DOI 10.1016/j.neuron.2008.01.026; Balfanz S, 2005, J NEUROCHEM, V93, P440, DOI 10.1111/j.1471-4159.2005.03034.x; Benito E, 2010, TRENDS NEUROSCI, V33, P230, DOI 10.1016/j.tins.2010.02.001; BREEN CA, 1983, NATURE, V303, P716, DOI 10.1038/303716a0; BUDNIK V, 1990, J NEUROSCI, V10, P3754; Cheung US, 1999, J NEUROBIOL, V40, P1, DOI 10.1002/(SICI)1097-4695(199907)40:1<1::AID-NEU1>3.0.CO;2-1; Crocker A, 2010, NEURON, V65, P670, DOI 10.1016/j.neuron.2010.01.032; DAVENPORT AP, 1984, PHYSIOL ENTOMOL, V9, P269, DOI 10.1111/j.1365-3032.1984.tb00709.x; Floresco SB, 2003, NAT NEUROSCI, V6, P968, DOI 10.1038/nn1103; Fouquet W, 2009, J CELL BIOL, V186, P129, DOI 10.1083/jcb.200812150; Hammer M, 1998, LEARN MEMORY, V5, P146; Han KA, 1998, J NEUROSCI, V18, P3650; Hardie SL, 2007, DEV NEUROBIOL, V67, P1396, DOI 10.1002/dneu.20459; Howell KMR, 1998, J EXP BIOL, V201, P2053; Hu HL, 2007, CELL, V131, P160, DOI 10.1016/j.cell.2007.09.017; Kitamoto T, 2001, J NEUROBIOL, V47, P81, DOI 10.1002/neu.1018; Kittel RJ, 2006, SCIENCE, V312, P1051, DOI 10.1126/science.1126308; Korkut C, 2009, NAT REV NEUROSCI, V10, P627, DOI 10.1038/nrn2681; Kutsukake M, 2000, GENE, V245, P31, DOI 10.1016/S0378-1119(99)00569-7; Kuzmiski JB, 2009, NEURON, V62, P839, DOI 10.1016/j.neuron.2009.05.027; Landgraf M, 1997, J NEUROSCI, V17, P9642; Lee HG, 2003, DEV BIOL, V264, P179, DOI 10.1016/j.ydbio.2003.07.018; Marques G, 2006, INT REV NEUROBIOL, V75, P267, DOI 10.1016/S0074-7742(06)75012-7; MCGUIRE SE, 2004, SCI STKE, pPL6; McNabb SL, 1997, NEURON, V19, P813, DOI 10.1016/S0896-6273(00)80963-0; Monastirioti M, 1996, J NEUROSCI, V16, P3900; MONASTIRIOTI M, 1995, J COMP NEUROL, V356, P275, DOI 10.1002/cne.903560210; Mosca TJ, 2005, P NATL ACAD SCI USA, V102, P3477, DOI 10.1073/pnas.0406164102; Murchison CF, 2004, CELL, V117, P131, DOI 10.1016/S0092-8674(04)00259-4; Nagaya Y, 2002, NEUROSCI LETT, V329, P324, DOI 10.1016/S0304-3940(02)00596-7; Nishikawa K, 1999, BRAIN RES, V837, P67, DOI 10.1016/S0006-8993(99)01676-5; O'Dell TJ, 2010, CELL SIGNAL, V22, P728, DOI 10.1016/j.cellsig.2009.12.004; Paradis S, 2001, NEURON, V30, P737, DOI 10.1016/S0896-6273(01)00326-9; Perazzona B, 2004, J NEUROSCI, V24, P8823, DOI 10.1523/JNEUROSCI.4542-03.2004; Rasse TM, 2005, NAT NEUROSCI, V8, P898, DOI 10.1038/nn1484; Roeder T, 2005, ANNU REV ENTOMOL, V50, P447, DOI 10.1146/annurev.ento.50.071803.130404; Saraswati S, 2004, J NEUROBIOL, V58, P425, DOI 10.1002/neu.10298; Schroder-Lang S, 2007, NAT METHODS, V4, P39, DOI 10.1038/NMETH975; Schroll C, 2006, CURR BIOL, V16, P1741, DOI 10.1016/j.cub.2006.07.023; Schuster CM, 1996, NEURON, V17, P655, DOI 10.1016/S0896-6273(00)80198-1; Schuster CM, 1996, NEURON, V17, P641, DOI 10.1016/S0896-6273(00)80197-X; Schwaerzel M, 2003, J NEUROSCI, V23, P10495, DOI 10.1523/jneurosci.23-33-10495.2003; Sigrist SJ, 2003, J NEUROSCI, V23, P6546; Steinert JR, 2006, NEURON, V50, P723, DOI 10.1016/j.neuron.2006.04.025; Suo S, 2006, J NEUROSCI, V26, P10082, DOI 10.1523/JNEUROSCI.0819-06.2006; Takizawa E, 2007, ZOOL SCI, V24, P504, DOI 10.2108/zsj.24.504; White BH, 2001, NEURON, V31, P699, DOI 10.1016/S0896-6273(01)00415-9; ZHONG Y, 1992, J NEUROSCI, V12, P644; Zhou C, 2008, NAT NEUROSCI, V11, P1059, DOI 10.1038/nn.2164	50	91	92	1	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2011	14	2					190	U275		10.1038/nn.2716	http://dx.doi.org/10.1038/nn.2716			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	711MJ	21186359	Green Accepted, Green Published			2022-12-28	WOS:000286595400016
J	Voss, JL; Gonsalves, BD; Federmeier, KD; Tranel, D; Cohen, NJ				Voss, Joel L.; Gonsalves, Brian D.; Federmeier, Kara D.; Tranel, Daniel; Cohen, Neal J.			Hippocampal brain-network coordination during volitional exploratory behavior enhances learning	NATURE NEUROSCIENCE			English	Article							PARIETAL CORTEX; MEMORY; REPRESENTATION; MOVEMENT; FMRI	Exploratory behaviors during learning determine what is studied and when, helping to optimize subsequent memory performance. To elucidate the cognitive and neural determinants of exploratory behaviors, we manipulated the control that human subjects had over the position of a moving window through which they studied objects and their locations. Our behavioral, neuropsychological and neuroimaging data indicate that volitional control benefits memory performance and is linked to a brain network that is centered on the hippocampus. Increases in correlated activity between the hippocampus and other areas were associated with specific aspects of memory, which suggests that volitional control optimizes interactions among specialized neural systems through the hippocampus. Memory is therefore an active process that is intrinsically linked to behavior. Furthermore, brain structures that are typically seen as passive participants in memory encoding (for example, the hippocampus) are actually part of an active network that controls behavior dynamically as it unfolds.	[Voss, Joel L.; Gonsalves, Brian D.; Federmeier, Kara D.; Cohen, Neal J.] Univ Illinois, Beckman Inst Adv Sci & Technol, Urbana, IL 61801 USA; [Tranel, Daniel] Univ Iowa, Dept Neurol, Div Cognit Neurosci, Carver Coll Med, Iowa City, IA 52242 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Iowa	Voss, JL (corresponding author), Univ Illinois, Beckman Inst Adv Sci & Technol, Urbana, IL 61801 USA.	joelvoss@illinois.edu		Voss, Joel/0000-0003-4180-9335; Federmeier, Kara/0000-0002-7815-1808; Tranel, Daniel/0000-0002-1338-1389	US National Institutes of Health (NIH) [K99-NS069788]; Beckman Institute; Kiwanis Foundation; NIH [MH062500, NS19632]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH062500] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS019632, P01NS019632, K99NS069788] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [P50DC003189] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Beckman Institute; Kiwanis Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	Research was supported by a US National Institutes of Health (NIH) Pathway to Independence award (K99-NS069788) and a Beckman Institute Postdoctoral Fellowship Award to J.L.V., by funds from the Kiwanis Foundation to D.T.T., and by NIH grants MH062500 to N.J.C. and NS19632 to D.T.T.	Allen JS, 2006, J CLIN EXP NEUROPSYC, V28, P457, DOI 10.1080/13803390590949287; Bellebaum C, 2007, CEREBELLUM, V6, P184, DOI 10.1080/14734220601169707; Bird CM, 2008, NAT REV NEUROSCI, V9, P182, DOI 10.1038/nrn2335; Buckner RL, 2010, ANNU REV PSYCHOL, V61, P27, DOI 10.1146/annurev.psych.60.110707.163508; Cabeza R, 2008, NAT REV NEUROSCI, V9, P613, DOI 10.1038/nrn2459; Chua EF, 2009, J COGNITIVE NEUROSCI, V21, P1751, DOI 10.1162/jocn.2009.21123; Chun MM, 2007, CURR OPIN NEUROBIOL, V17, P177, DOI 10.1016/j.conb.2007.03.005; COHEN NJ, 1980, SCIENCE, V210, P207, DOI 10.1126/science.7414331; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Custers R, 2010, SCIENCE, V329, P47, DOI 10.1126/science.1188595; Eichenbaum H, 2004, CONDITIONING CONSCIO, DOI [10.1093/acprof:oso/, DOI 10.1093/ACPROF:OSO]; Epstein RA, 2008, TRENDS COGN SCI, V12, P388, DOI 10.1016/j.tics.2008.07.004; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; FOSTER TC, 1989, SCIENCE, V244, P1580, DOI 10.1126/science.2740902; Friston Karl J., 1994, Human Brain Mapping, V2, P56, DOI 10.1002/hbm.460020107; Gibson J.J., 1986, ECOLOGICAL APPROACH; Gupta R, 2009, NEUROPSYCHOLOGIA, V47, P1686, DOI 10.1016/j.neuropsychologia.2009.02.007; Habas C, 2009, J NEUROSCI, V29, P8586, DOI 10.1523/JNEUROSCI.1868-09.2009; Harman KL, 1999, CURR BIOL, V9, P1315, DOI 10.1016/S0960-9822(00)80053-6; HELD R, 1965, SCI AM, V213, P84, DOI 10.1038/scientificamerican1165-84; HELD R, 1963, J COMP PHYSIOL PSYCH, V56, P872, DOI 10.1037/h0040546; Insausti R, 1998, AM J NEURORADIOL, V19, P659; Jonides J, 2008, ANNU REV PSYCHOL, V59, P193, DOI 10.1146/annurev.psych.59.103006.093615; Kennedy PJ, 2009, P NATL ACAD SCI USA, V106, P10805, DOI 10.1073/pnas.0903259106; Kesner RP, 2009, NEUROBIOL LEARN MEM, V91, P197, DOI 10.1016/j.nlm.2008.09.004; Kesner RP, 2004, NEUROBIOL LEARN MEM, V82, P199, DOI 10.1016/j.nlm.2004.05.007; Koechlin E, 2007, SCIENCE, V318, P594, DOI 10.1126/science.1142995; Konkel A, 2008, FRONT HUM NEUROSCI, V2, DOI 10.3389/neuro.09.015.2008; Krienen FM, 2009, CEREB CORTEX, V19, P2485, DOI 10.1093/cercor/bhp135; MACKWORTH NH, 1967, PERCEPT PSYCHOPHYS, V2, P547, DOI 10.3758/BF03210264; Martin A, 2007, ANNU REV PSYCHOL, V58, P25, DOI 10.1146/annurev.psych.57.102904.190143; Metcalfe J, 2010, BEHAV PROCESS, V83, P213, DOI 10.1016/j.beproc.2009.12.011; Metcalfe J, 2009, CURR DIR PSYCHOL SCI, V18, P159, DOI 10.1111/j.1467-8721.2009.01628.x; National Research Council, 1999, PEOPL LEARN; Neisser U., 1976, COGNITION REALITY PR; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; Piaget J, 1953, ORIGINS INTELLIGENCE; Reber PJ, 2002, HIPPOCAMPUS, V12, P363, DOI 10.1002/hipo.10018; Rossion B, 2004, PERCEPTION, V33, P217, DOI 10.1068/p5117; Sakagami M, 2007, ANN NY ACAD SCI, V1104, P89, DOI 10.1196/annals.1390.010; Shimamura AP, 2009, PSYCHOL REV, V116, P1, DOI 10.1037/a0014500; Simons JS, 2003, NAT REV NEUROSCI, V4, P637, DOI 10.1038/nrn1178; Smith EE, 1999, SCIENCE, V283, P1657, DOI 10.1126/science.283.5408.1657; Song EY, 2005, HIPPOCAMPUS, V15, P8, DOI 10.1002/hipo.20023; SQUIRE LR, 1991, SCIENCE, V253, P1380, DOI 10.1126/science.1896849; Tanji J, 2008, PHYSIOL REV, V88, P37, DOI 10.1152/physrev.00014.2007; Tolman E.C., 1932, PURPOSIVE BEHAV ANIM; Uncapher MR, 2009, NEUROBIOL LEARN MEM, V91, P139, DOI 10.1016/j.nlm.2008.10.011; VANHOESEN GW, 1979, SCIENCE, V205, P608, DOI 10.1126/science.109926; Voss JL, 2009, HIPPOCAMPUS, V19, P773, DOI 10.1002/hipo.20608	50	110	110	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2011	14	1					115	U152		10.1038/nn.2693	http://dx.doi.org/10.1038/nn.2693			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	699TE	21102449	Green Accepted			2022-12-28	WOS:000285684900022
J	Wilhelm, BG; Groemer, TW; Rizzoli, SO				Wilhelm, Benjamin G.; Groemer, Teja W.; Rizzoli, Silvio O.			The same synaptic vesicles drive active and spontaneous release	NATURE NEUROSCIENCE			English	Article							NEUROMUSCULAR-JUNCTION; NEUROTRANSMISSION; POOL	Synaptic vesicles release neurotransmitter both actively (on stimulation) and spontaneously (at rest). It has been assumed that identical vesicles use both modes of release; however, recent evidence has challenged this view. Using several assays (FM dye imaging, pHluorin imaging and antibody-labeling of synaptotagmin) in neuromuscular preparations from Drosophila, frog and mouse, as well as rat cultured neurons, we found that the same vesicles participate in active and spontaneous release.	[Wilhelm, Benjamin G.; Rizzoli, Silvio O.] Deutsch Forsch Gemeinschaft Ctr Mol Physiol Brain, European Neurosci Inst, STED Microscopy Grp, Gottingen, Germany; [Wilhelm, Benjamin G.] Int Max Planck Res Sch Neurosci, Gottingen, Germany; [Groemer, Teja W.] Univ Erlangen Nurnberg, Dept Psychiat & Psychotherapy, Erlangen, Germany	Max Planck Society; University of Erlangen Nuremberg	Rizzoli, SO (corresponding author), Deutsch Forsch Gemeinschaft Ctr Mol Physiol Brain, European Neurosci Inst, STED Microscopy Grp, Excellence Cluster 171, Gottingen, Germany.	s.rizzoli@eni-g.de	Rizzoli, Silvio/ABG-2227-2020	Rizzoli, Silvio/0000-0002-1667-7839; Groemer, Teja/0000-0003-3854-716X	European Research Council; Interdisciplinary Center of Clinical Research at the University Hospital of the University of Erlangen-Nuremberg	European Research Council(European Research Council (ERC)European Commission); Interdisciplinary Center of Clinical Research at the University Hospital of the University of Erlangen-Nuremberg	We thank R. Schmidt, A. Egner and U. Bohm (Max Planck Institute for Biophysical Chemistry) for isoSTED imaging. We thank K. Ebert, C. Schafer and K. Krohnert for expert technical assistance. The work was supported by a Starting Grant from the European Research Council, Program FP7 to S.O.R. (NANOMAP). T.W.G. acknowledges the support of the Interdisciplinary Center of Clinical Research at the University Hospital of the University of Erlangen-Nuremberg.	Chung C, 2010, J NEUROSCI, V30, P1363, DOI 10.1523/JNEUROSCI.3427-09.2010; DELCASTILLO J, 1954, J PHYSIOL-LONDON, V124, P560, DOI 10.1113/jphysiol.1954.sp005129; Fredj NB, 2009, NAT NEUROSCI, V12, P751, DOI 10.1038/nn.2317; Groemer TW, 2007, NAT NEUROSCI, V10, P145, DOI 10.1038/nn1831; Harata N, 2001, P NATL ACAD SCI USA, V98, P12748, DOI 10.1073/pnas.171442798; Harata NC, 2006, NEURON, V49, P243, DOI 10.1016/j.neuron.2005.12.018; Heerssen H, 2008, CURR BIOL, V18, P401, DOI 10.1016/j.cub.2008.02.055; Ikeda K, 2009, P NATL ACAD SCI USA, V106, P2945, DOI 10.1073/pnas.0811017106; Mathew SS, 2008, J NEUROSCI, V28, P725, DOI 10.1523/JNEUROSCI.3625-07.2008; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Rizzoli SO, 2002, J NEUROSCI, V22, P10680; Sara Y, 2005, NEURON, V45, P563, DOI 10.1016/j.neuron.2004.12.056; Schmidt R, 2009, NANO LETT, V9, P2508, DOI 10.1021/nl901398t; Zhu YL, 2008, P NATL ACAD SCI USA, V105, P18018, DOI 10.1073/pnas.0809714105	14	67	68	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2010	13	12					1454	1456		10.1038/nn.2690	http://dx.doi.org/10.1038/nn.2690			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	684CW	21102450				2022-12-28	WOS:000284525800007
J	Ma, DKK; Marchetto, MC; Guo, JJU; Ming, GL; Gage, FH; Song, HJ				Ma, Dengke K.; Marchetto, Maria Carolina; Guo, Junjie U.; Ming, Guo-li; Gage, Fred H.; Song, Hongjun			Epigenetic choreographers of neurogenesis in the adult mammalian brain	NATURE NEUROSCIENCE			English	Review							NEURAL STEM-CELLS; METHYL-CPG BINDING-PROTEIN-1; CENTRAL-NERVOUS-SYSTEM; SELF-RENEWAL; HIPPOCAMPAL NEUROGENESIS; DNA METHYLATION; PROGENITOR CELLS; GENE-EXPRESSION; L1 RETROTRANSPOSITION; STEM/PROGENITOR CELLS	Epigenetic mechanisms regulate cell differentiation during embryonic development and also serve as important interfaces between genes and the environment in adulthood. Neurogenesis in adults, which generates functional neural cell types from adult neural stem cells, is dynamically regulated by both intrinsic state-specific cell differentiation cues and extrinsic neural niche signals. Epigenetic regulation by DNA and histone modifiers, non-coding RNAs and other self-sustained mechanisms can lead to relatively long-lasting biological effects and maintain functional neurogenesis throughout life in discrete regions of the mammalian brain. Here, we review recent evidence that epigenetic mechanisms carry out diverse roles in regulating specific aspects of adult neurogenesis and highlight the implications of such epigenetic regulation for neural plasticity and disorders.	[Guo, Junjie U.; Ming, Guo-li; Song, Hongjun] Johns Hopkins Univ Sch Med, Inst Cell Engn, Baltimore, MD USA; [Marchetto, Maria Carolina; Gage, Fred H.] Salk Inst Biol Studies, Genet Lab, La Jolla, CA 92037 USA; [Ma, Dengke K.] MIT, Dept Biol, Cambridge, MA USA; [Guo, Junjie U.; Ming, Guo-li; Song, Hongjun] Johns Hopkins Univ Sch Med, Solomon Snyder Dept Neurosci, Baltimore, MD USA; [Ming, Guo-li; Song, Hongjun] Johns Hopkins Univ Sch Med, Dept Neurol, Baltimore, MD USA	Johns Hopkins University; Salk Institute; Massachusetts Institute of Technology (MIT); Johns Hopkins University; Johns Hopkins University	Song, HJ (corresponding author), Johns Hopkins Univ Sch Med, Inst Cell Engn, Baltimore, MD USA.	shongju1@jhmi.edu	Ming, Guo-li/J-7880-2013	Ming, Guo-li/0000-0002-2517-6075	National Institutes of Health [NS048271, HD069184, MH088485, MH090258, AG024984, NS047344, MH087874]; Brain Science Institute at Johns Hopkins; National Alliance for Research on Schizophrenia and Depression; Mathers Foundation; Lookout Fund; J.S.McDonnell Foundation; Helen Hay Whitney Foundation; Foundation for Advanced Research in the Medical Sciences; Dr. Richard and Mavis Fowler; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD069184] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH088485, R01MH090258, R21MH087874, R33MH087874] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048271, R01NS047344] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG024984] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Brain Science Institute at Johns Hopkins; National Alliance for Research on Schizophrenia and Depression(NARSAD); Mathers Foundation; Lookout Fund; J.S.McDonnell Foundation; Helen Hay Whitney Foundation; Foundation for Advanced Research in the Medical Sciences; Dr. Richard and Mavis Fowler; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank M. L. Gage and K. Christian for comments on the manuscript and J. Simon for illustrations. This work was supported by the National Institutes of Health grants NS048271 and HD069184 (G.-l. M.), MH088485 and MH090258 (F. H. G.), and AG024984, NS047344 and MH087874 (H. S.), the Brain Science Institute at Johns Hopkins and National Alliance for Research on Schizophrenia and Depression (G.-l. M.), the Mathers Foundation, the Lookout Fund and the J.S.McDonnell Foundation (F. H. G.), a Helen Hay Whitney Foundation postdoctoral fellowship (D. K. M.), and the Dr. Richard and Mavis Fowler and the Foundation for Advanced Research in the Medical Sciences Fellowship (J.U.G.).	Allan AM, 2008, HUM MOL GENET, V17, P2047, DOI 10.1093/hmg/ddn102; ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; Alvarez-Buylla A, 2004, NEURON, V41, P683, DOI 10.1016/S0896-6273(04)00111-4; Ball MP, 2009, NAT BIOTECHNOL, V27, P361, DOI 10.1038/nbt.1533; Banasr Mounira, 2007, CNS & Neurological Disorders-Drug Targets, V6, P311, DOI 10.2174/187152707783220929; Bath KG, 2008, J NEUROSCI, V28, P2383, DOI 10.1523/JNEUROSCI.4387-07.2008; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Caballero IM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004315; Cameron HA, 2001, J COMP NEUROL, V435, P406, DOI 10.1002/cne.1040; Capela A, 2002, NEURON, V35, P865, DOI 10.1016/S0896-6273(02)00835-8; Cedar H, 2009, NAT REV GENET, V10, P295, DOI 10.1038/nrg2540; Chen ZY, 2006, SCIENCE, V314, P140, DOI 10.1126/science.1129663; Cheng LC, 2009, NAT NEUROSCI, V12, P399, DOI 10.1038/nn.2294; Christian K, 2010, CELL CYCLE, V9, P636, DOI 10.4161/cc.9.4.10932; Coufal NG, 2009, NATURE, V460, P1127, DOI 10.1038/nature08248; Covic M, 2010, HEREDITY, V105, P122, DOI 10.1038/hdy.2010.27; Crepaldi L, 2009, EPIGENETICS-US, V4, P23, DOI 10.4161/epi.4.1.7604; Deng W, 2010, NAT REV NEUROSCI, V11, P339, DOI 10.1038/nrn2822; Dirks P, 2007, CANCER CELL, V12, P295, DOI 10.1016/j.ccr.2007.10.003; Duan X, 2008, CURR OPIN NEUROBIOL, V18, P108, DOI 10.1016/j.conb.2008.04.001; Encinas JM, 2008, METHOD CELL BIOL, V85, P243, DOI 10.1016/S0091-679X(08)85011-X; Episkopou V, 2005, TRENDS NEUROSCI, V28, P219, DOI 10.1016/j.tins.2005.03.003; Fasano CA, 2007, CELL STEM CELL, V1, P87, DOI 10.1016/j.stem.2007.04.001; Fasano CA, 2009, GENE DEV, V23, P561, DOI 10.1101/gad.1743709; Feng J, 2010, NAT NEUROSCI, V13, P423, DOI 10.1038/nn.2514; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Goldberg AD, 2007, CELL, V128, P635, DOI 10.1016/j.cell.2007.02.006; Goren A, 2010, NAT METHODS, V7, P47, DOI [10.1038/NMETH.1404, 10.1038/nmeth.1404]; He DY, 2010, J BIOL CHEM, V285, P19043, DOI 10.1074/jbc.M110.100693; He S, 2009, DEV BIOL, V328, P257, DOI 10.1016/j.ydbio.2009.01.020; Heiman M, 2008, CELL, V135, P738, DOI 10.1016/j.cell.2008.10.028; Hobert O, 2008, SCIENCE, V319, P1785, DOI 10.1126/science.1151651; Holliday R, 1993, EXS, V64, P452; HOLLIDAY R, 1990, BIOL REV, V65, P431, DOI 10.1111/j.1469-185X.1990.tb01233.x; Holliday R, 2006, EPIGENETICS-US, V1, P76, DOI 10.4161/epi.1.2.2762; Hsieh J, 2004, P NATL ACAD SCI USA, V101, P16659, DOI 10.1073/pnas.0407643101; Hsieh J, 2010, NEUROBIOL DIS, V39, P73, DOI 10.1016/j.nbd.2010.01.008; Hu QK, 2010, STEM CELLS, V28, P279, DOI 10.1002/stem.246; Iorio MV, 2010, BBA-GENE REGUL MECH, V1799, P694, DOI 10.1016/j.bbagrm.2010.05.005; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Jawerka M, 2010, NEURON GLIA BIOL, V6, P93, DOI 10.1017/S1740925X10000049; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jepsen K, 2007, NATURE, V450, P415, DOI 10.1038/nature06270; Jin SG, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq223; Juliandi B, 2010, CURR OPIN NEUROBIOL, V20, P408, DOI 10.1016/j.conb.2010.04.001; Kanki H, 2010, MOL BRAIN, V3, DOI 10.1186/1756-6606-3-5; Kempermann G, 2004, CURR OPIN NEUROBIOL, V14, P186, DOI 10.1016/j.conb.2004.03.001; Kitabatake Y, 2007, NEUROSURG CLIN N AM, V18, P105, DOI 10.1016/j.nec.2006.10.008; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; Kuwabara T, 2004, CELL, V116, P779, DOI 10.1016/S0092-8674(04)00248-X; Kuwabara T, 2009, NAT NEUROSCI, V12, P1097, DOI 10.1038/nn.2360; KUZUMAKI N, 2010, HIPPOCAMPUS     0315, DOI DOI 10.1002/HIPO.20775; Li XK, 2008, J BIOL CHEM, V283, P27644, DOI 10.1074/jbc.M804899200; Li Y, 2008, NEURON, V59, P399, DOI 10.1016/j.neuron.2008.06.023; Lim DA, 2009, NATURE, V458, P529, DOI 10.1038/nature07726; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Liu CM, 2010, CELL STEM CELL, V6, P433, DOI 10.1016/j.stem.2010.02.017; Lledo PM, 2006, NAT REV NEUROSCI, V7, P179, DOI 10.1038/nrn1867; Ma DKK, 2009, ANN NY ACAD SCI, V1170, P664, DOI 10.1111/j.1749-6632.2009.04373.x; Ma DK, 2009, CELL RES, V19, P672, DOI 10.1038/cr.2009.56; Ma DKK, 2009, CELL CYCLE, V8, P1526, DOI 10.4161/cc.8.10.8500; Ma DK, 2009, SCIENCE, V323, P1074, DOI 10.1126/science.1166859; Ma DK, 2005, CURR OPIN NEUROBIOL, V15, P514, DOI 10.1016/j.conb.2005.08.003; Martinowich K, 2003, SCIENCE, V302, P890, DOI 10.1126/science.1090842; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; Morris KV, 2009, RNA BIOL, V6, P242, DOI 10.4161/rna.6.3.8353; Mu YL, 2010, CURR OPIN NEUROBIOL, V20, P416, DOI 10.1016/j.conb.2010.04.010; Muotri AR, 2006, NATURE, V441, P1087, DOI 10.1038/nature04959; Muotri AR, 2009, HIPPOCAMPUS, V19, P1002, DOI 10.1002/hipo.20564; Muotri AR, 2005, NATURE, V435, P903, DOI 10.1038/nature03663; Nagarajan RP, 2009, SEMIN CANCER BIOL, V19, P188, DOI 10.1016/j.semcancer.2009.02.005; Nelson ED, 2008, J NEUROSCI, V28, P395, DOI 10.1523/JNEUROSCI.3796-07.2008; Ng RK, 2008, CELL CYCLE, V7, P1173, DOI 10.4161/cc.7.9.5791; O'Neill LP, 2006, NAT GENET, V38, P835, DOI 10.1038/ng1820; Pastrana E, 2009, P NATL ACAD SCI USA, V106, P6387, DOI 10.1073/pnas.0810407106; Ptashne M, 2007, CURR BIOL, V17, pR233, DOI 10.1016/j.cub.2007.02.030; Qiu Z, 2008, NEURON, V60, P775, DOI 10.1016/j.neuron.2008.09.040; Ringrose L, 2007, DEVELOPMENT, V134, P223, DOI 10.1242/dev.02723; Roh TY, 2004, NAT BIOTECHNOL, V22, P1013, DOI 10.1038/nbt990; Roth TL, 2011, HORM BEHAV, V59, P315, DOI 10.1016/j.yhbeh.2010.05.005; Sahay A, 2007, NAT NEUROSCI, V10, P1110, DOI 10.1038/nn1969; Serio TR, 2000, TRENDS CELL BIOL, V10, P98, DOI 10.1016/S0962-8924(99)01711-0; Smrt RD, 2007, NEUROBIOL DIS, V27, P77, DOI 10.1016/j.nbd.2007.04.005; Smrt RD, 2010, STEM CELLS, V28, P1060, DOI 10.1002/stem.431; Suh H, 2007, CELL STEM CELL, V1, P515, DOI 10.1016/j.stem.2007.09.002; Sun GQ, 2007, P NATL ACAD SCI USA, V104, P15282, DOI 10.1073/pnas.0704089104; Szulwach KE, 2010, J CELL BIOL, V189, P127, DOI 10.1083/jcb.200908151; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Waddington C. R., 1966, PRINCIPLES DEV DIFFE; Wang ZB, 2009, CELL, V138, P1019, DOI 10.1016/j.cell.2009.06.049; Yoo AS, 2009, NATURE, V460, P642, DOI 10.1038/nature08139; Zhang TY, 2010, ANNU REV PSYCHOL, V61, P439, DOI 10.1146/annurev.psych.60.110707.163625; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033; Zhao XY, 2003, P NATL ACAD SCI USA, V100, P6777, DOI 10.1073/pnas.1131928100; Zhou ZL, 2006, NEURON, V52, P255, DOI 10.1016/j.neuron.2006.09.037; Zocchi L, 2010, CURR OPIN NEUROBIOL, V20, P432, DOI 10.1016/j.conb.2010.04.005	100	242	250	0	44	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2010	13	11					1338	1344		10.1038/nn.2672	http://dx.doi.org/10.1038/nn.2672			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	673KI	20975758	Green Accepted			2022-12-28	WOS:000283658200011
J	Meaney, MJ; Ferguson-Smith, AC				Meaney, Michael J.; Ferguson-Smith, Anne C.			Epigenetic regulation of the neural transcriptome: the meaning of the marks	NATURE NEUROSCIENCE			English	Article							DNA METHYLATION; HUMAN BRAIN; HISTONE H3; CHROMATIN-STRUCTURE; MECP2; CPG; HETEROCHROMATIN; PROMOTER; DISEASE; COMPLEX	The field of epigenetics provides neurobiologists with candidate mechanisms for experience-dependent changes in gene transcription. The ability to realize the potential of epigenetics in defining the causal pathways lying between environmental signals, transcriptional regulation and neural function will depend on moving beyond correlational studies focusing on individual epigenetic marks. Here we attempt to provide a conceptual framework for integrative research on nucleotide sequence, chromatin modifications, RNA signaling and their interactions in understanding experience-dependent phenotypic plasticity. Studies in genomic imprinting may serve as an existing model for such approaches.	[Meaney, Michael J.] McGill Univ, Douglas Hosp Mental Hlth Univ Inst, Sackler Program Epigenet & Psychobiol, Montreal, PQ, Canada; [Ferguson-Smith, Anne C.] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, England; [Meaney, Michael J.; Ferguson-Smith, Anne C.] Singapore Inst Clin Sci, Singapore, Singapore	McGill University; University of Cambridge; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Institute for Clinical Sciences (SICS)	Meaney, MJ (corresponding author), McGill Univ, Douglas Hosp Mental Hlth Univ Inst, Sackler Program Epigenet & Psychobiol, Montreal, PQ, Canada.	michael.meaney@mcgill.ca	Meaney, Michael/N-5931-2019; Ferguson-Smith, Anne C/G-7534-2011	Ferguson-Smith, Anne/0000-0002-7608-5894	MRC [G0800784] Funding Source: UKRI; Medical Research Council [G0800784B] Funding Source: researchfish; Medical Research Council [G0800784] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Akbarian S, 2009, BIOL PSYCHIAT, V65, P198, DOI 10.1016/j.biopsych.2008.08.015; Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Angrisano T, 2006, NUCLEIC ACIDS RES, V34, P364, DOI 10.1093/nar/gkj400; Babak T, 2008, CURR BIOL, V18, P1735, DOI 10.1016/j.cub.2008.09.044; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bird A, 2007, NATURE, V447, P396, DOI 10.1038/nature05913; Borrelli E, 2008, NEURON, V60, P961, DOI 10.1016/j.neuron.2008.10.012; Chahrour M, 2008, SCIENCE, V320, P1224, DOI 10.1126/science.1153252; Chen M, 2009, CELL METAB, V9, P548, DOI 10.1016/j.cmet.2009.05.004; Chen WG, 2003, SCIENCE, V302, P885, DOI 10.1126/science.1086446; Ciccone DN, 2009, NATURE, V461, P415, DOI 10.1038/nature08315; Davies W, 2008, ADV EXP MED BIOL, V626, P62; Doi M, 2006, CELL, V125, P497, DOI 10.1016/j.cell.2006.03.033; Edwards CA, 2008, PLOS BIOL, V6, P1292, DOI 10.1371/journal.pbio.0060135; Elgin SCR, 2003, CURR BIOL, V13, pR895, DOI 10.1016/j.cub.2003.11.006; Fujita H, 2003, MOL CELL BIOL, V23, P2645, DOI 10.1128/MCB.23.8.2645-2657.2003; Gregg C, 2010, SCIENCE, V329, P643, DOI 10.1126/science.1190830; Hake SB, 2006, P NATL ACAD SCI USA, V103, P6428, DOI 10.1073/pnas.0600803103; Hall SE, 2010, CURR BIOL, V20, P149, DOI 10.1016/j.cub.2009.11.035; He F, 2005, NAT NEUROSCI, V8, P616, DOI 10.1038/nn1440; Hendrich B, 2003, TRENDS GENET, V19, P269, DOI 10.1016/S0168-9525(03)00080-5; Horsthemke B, 2008, AM J MED GENET A, V146A, P2041, DOI 10.1002/ajmg.a.32364; Jirtle RL, 2007, NAT REV GENET, V8, P253, DOI 10.1038/nrg2045; Keogh MC, 2005, CELL, V123, P593, DOI 10.1016/j.cell.2005.10.025; Kim MS, 2009, NATURE, V461, P1007, DOI 10.1038/nature08456; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; Klose RJ, 2005, MOL CELL, V19, P667, DOI 10.1016/j.molcel.2005.07.021; Koerner MV, 2009, DEVELOPMENT, V136, P1771, DOI 10.1242/dev.030403; Kong A, 2009, NATURE, V462, P868, DOI 10.1038/nature08625; Li F, 2008, CELL, V135, P272, DOI 10.1016/j.cell.2008.08.036; Luo SW, 2009, EMBO J, V28, P2568, DOI 10.1038/emboj.2009.178; McEwen KR, 2010, EPIGENET CHROMATIN, V3, DOI 10.1186/1756-8935-3-2; McGowan PO, 2009, NAT NEUROSCI, V12, P342, DOI 10.1038/nn.2270; Metivier R, 2008, NATURE, V452, P45, DOI 10.1038/nature06544; Murgatroyd C, 2009, NAT NEUROSCI, V12, P1559, DOI 10.1038/nn.2436; Nagano T, 2008, SCIENCE, V322, P1717, DOI 10.1126/science.1163802; Ooi SKT, 2007, NATURE, V448, P714, DOI 10.1038/nature05987; Plagge A, 2006, CYTOGENET GENOME RES, V113, P178, DOI 10.1159/000090830; Renthal W, 2008, TRENDS MOL MED, V14, P341, DOI 10.1016/j.molmed.2008.06.004; Roth TL, 2009, CURR OPIN NEUROBIOL, V19, P336, DOI 10.1016/j.conb.2009.05.011; Sanz LA, 2008, EMBO J, V27, P2523, DOI 10.1038/emboj.2008.142; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; Segal E, 2009, TRENDS GENET, V25, P335, DOI 10.1016/j.tig.2009.06.002; Sims RJ, 2008, NAT REV MOL CELL BIO, V9, P815, DOI 10.1038/nrm2502; Skene PJ, 2010, MOL CELL, V37, P457, DOI 10.1016/j.molcel.2010.01.030; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; Thomson JP, 2010, NATURE, V464, P1082, DOI 10.1038/nature08924; Vakoc CR, 2005, MOL CELL, V19, P381, DOI 10.1016/j.molcel.2005.06.011; Wang XH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002557; Weaver ICG, 2007, J NEUROSCI, V27, P1756, DOI 10.1523/JNEUROSCI.4164-06.2007; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Weiss A, 1997, GENES CELLS, V2, P481, DOI 10.1046/j.1365-2443.1997.1390337.x; Yamazawa K, 2010, AM J MED GENET C, V154C, P329, DOI 10.1002/ajmg.c.30270; Zhang DD, 2010, AM J HUM GENET, V86, P411, DOI 10.1016/j.ajhg.2010.02.005; Zhang TY, 2010, J NEUROSCI, V30, P13130, DOI 10.1523/JNEUROSCI.1039-10.2010; Zhang Y, 2001, GENE DEV, V15, P2343, DOI 10.1101/gad.927301	58	160	165	0	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2010	13	11					1313	1318		10.1038/nn1110-1313	http://dx.doi.org/10.1038/nn1110-1313			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	673KI	20975754				2022-12-28	WOS:000283658200007
J	Pearson, J; Platt, ML				Pearson, John; Platt, Michael L.			Dynamic decision making in the brain	NATURE NEUROSCIENCE			English	Editorial Material							PARIETAL CORTEX; ORBITOFRONTAL CORTEX; PERCEPTUAL DECISION; CHOICE; INTEGRATION; BEHAVIOR; MONKEY; MODEL; LIP	How do we make decisions? A study uses MEG to provide the spatial as well as the temporal resolution needed to answer this question, together with computational modeling, which allows for complex non-linear decision models. This work helps resolve some of the seemingly contradictory results from previous work.	[Pearson, John; Platt, Michael L.] Duke Univ, Med Ctr, Dept Neurobiol, Duke Inst Brain Sci, Durham, NC 27710 USA	Duke University	Pearson, J (corresponding author), Duke Univ, Med Ctr, Dept Neurobiol, Duke Inst Brain Sci, Durham, NC 27710 USA.	platt@neuro.duke.edu		Pearson, John/0000-0002-9876-7837				Blair K, 2006, J NEUROSCI, V26, P11379, DOI 10.1523/JNEUROSCI.1640-06.2006; Hunt LT, 2012, NAT NEUROSCI, V15, P470, DOI 10.1038/nn.3017; Kable JW, 2007, NAT NEUROSCI, V10, P1625, DOI 10.1038/nn2007; Kable JW, 2009, NEURON, V63, P733, DOI 10.1016/j.neuron.2009.09.003; Noonan MP, 2010, P NATL ACAD SCI USA, V107, P20547, DOI 10.1073/pnas.1012246107; Plassmann H, 2007, J NEUROSCI, V27, P9984, DOI 10.1523/JNEUROSCI.2131-07.2007; Platt ML, 1999, NATURE, V400, P233, DOI 10.1038/22268; Rorie AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009308; Shadlen MN, 2001, J NEUROPHYSIOL, V86, P1916, DOI 10.1152/jn.2001.86.4.1916; Soltani A, 2006, J NEUROSCI, V26, P3731, DOI 10.1523/JNEUROSCI.5159-05.2006; Sugrue LP, 2004, SCIENCE, V304, P1782, DOI 10.1126/science.1094765; Usher M, 2001, PSYCHOL REV, V108, P550, DOI 10.1037//0033-295X.108.3.550; Wang XJ, 2002, NEURON, V36, P955, DOI 10.1016/S0896-6273(02)01092-9; Wong KF, 2006, J NEUROSCI, V26, P1314, DOI 10.1523/JNEUROSCI.3733-05.2006; Wong KF, 2007, FRONT COMPUT NEUROSC, V1, DOI 10.3389/neuro.10.006.2007	15	8	9	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2012	15	3					341	342		10.1038/nn.3049	http://dx.doi.org/10.1038/nn.3049			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	899CY	22362101				2022-12-28	WOS:000300793100002
J	Shinohara, R; Thumkeo, D; Kamijo, H; Kaneko, N; Sawamoto, K; Watanabe, K; Takebayashi, H; Kiyonari, H; Ishizaki, T; Furuyashiki, T; Narumiya, S				Shinohara, Ryota; Thumkeo, Dean; Kamijo, Hiroshi; Kaneko, Naoko; Sawamoto, Kazunobu; Watanabe, Keisuke; Takebayashi, Hirohide; Kiyonari, Hiroshi; Ishizaki, Toshimasa; Furuyashiki, Tomoyuki; Narumiya, Shuh			A role for mDia, a Rho-regulated actin nucleator, in tangential migration of interneuron precursors	NATURE NEUROSCIENCE			English	Article							NEURONAL MIGRATION; CENTROSOME SEPARATION; CEREBRAL-CORTEX; CELL-MIGRATION; ADULT BRAIN; NEUROGENESIS; MOVEMENT; CYTOSKELETON; PROTEIN; DIFFERENTIATION	In brain development, distinct types of migration, radial migration and tangential migration, are shown by excitatory and inhibitory neurons, respectively. Whether these two types of migration operate by similar cellular mechanisms remains unclear. We examined neuronal migration in mice deficient in mDia1 (also known as Diap1) and mDia3 (also known as Diap2), which encode the Rho-regulated actin nucleators mammalian diaphanous homolog 1 (mDia1) and mDia3. mDia deficiency impaired tangential migration of cortical and olfactory inhibitory interneurons, whereas radial migration and consequent layer formation of cortical excitatory neurons were unaffected. mDia-deficient neuroblasts exhibited reduced separation of the centrosome from the nucleus and retarded nuclear translocation. Concomitantly, anterograde F-actin movement and F-actin condensation at the rear, which occur during centrosomal and nuclear movement of wild-type cells, respectively, were impaired in mDia-deficient neuroblasts. Blockade of Rho-associated protein kinase (ROCK), which regulates myosin II, also impaired nuclear translocation. These results suggest that Rho signaling via mDia and ROCK critically regulates nuclear translocation through F-actin dynamics in tangential migration, whereas this mechanism is dispensable in radial migration.	[Shinohara, Ryota; Thumkeo, Dean; Kamijo, Hiroshi; Ishizaki, Toshimasa; Furuyashiki, Tomoyuki; Narumiya, Shuh] Kyoto Univ, Dept Pharmacol, Grad Sch Med, Kyoto, Japan; [Kaneko, Naoko; Sawamoto, Kazunobu] Nagoya City Univ, Grad Sch Med Sci, Dept Dev & Regenerat Biol, Inst Mol Med, Nagoya, Aichi, Japan; [Watanabe, Keisuke; Takebayashi, Hirohide] Kumamoto Univ, Grad Sch Med Sci, Dept Morphol Neural Sci, Kumamoto, Japan; [Kiyonari, Hiroshi] RIKEN Ctr Dev Biol, Lab Anim Resources & Genet Engn, Kobe, Hyogo, Japan; [Furuyashiki, Tomoyuki; Narumiya, Shuh] Core Res Evolut Sci & Technol, Tokyo, Japan	Kyoto University; Nagoya City University; Kumamoto University; RIKEN; Japan Science & Technology Agency (JST)	Narumiya, S (corresponding author), Kyoto Univ, Dept Pharmacol, Grad Sch Med, Kyoto, Japan.	snaru@mfour.med.kyoto-u.ac.jp	Kiyonari, Hiroshi/N-7936-2015; Takebayashi, Hirohide/AAO-1693-2020; Furuyashiki, Tomoyuki/AAG-5283-2019; Furuyashiki, Tomoyuki/B-8760-2014; Kaneko, Naoko/P-2054-2019; Shinohara, Ryota/AAN-1274-2021	Furuyashiki, Tomoyuki/0000-0001-8089-8399; Furuyashiki, Tomoyuki/0000-0001-8089-8399; Shinohara, Ryota/0000-0001-5279-2642; Sawamoto, Kazunobu/0000-0003-1984-5129; Kaneko, Naoko/0000-0003-3121-7117	Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Science and Technology Agency; Grants-in-Aid for Scientific Research [23680041] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank M. Okabe for providing pCX-EGFP, F. Matsuzaki for providing pCAG-EGFP-C1 and pCAG-PACT-mKO1, Y. Yanagawa for providing GAD65 and GAD67 antisense probes, Y. Deguchi for providing mDia3 riboprobes, A. Mizutani for animal care, K. Tohyama for supporting genotyping and plasmid construction, T. Arai and A. Washimi for secretarial help, and K. Nonomura for technical assistance. R. S. thanks A. Kakizuka for providing the opportunity to work in Kyoto University Graduate School of Medicine. R. S. was supported by the Japan Society for the Promotion of Science Research Fellowship. This work was supported in part by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan and a Core Research for Evolutional Science and Technology (CREST) grant from Japan Science and Technology Agency.	Alvarez-Buylla A, 2002, J NEUROSCI, V22, P629, DOI 10.1523/JNEUROSCI.22-03-00629.2002; Baudoin JP, 2008, DEV NEUROSCI-BASEL, V30, P132, DOI 10.1159/000109858; Bellion A, 2005, J NEUROSCI, V25, P5691, DOI 10.1523/JNEUROSCI.1030-05.2005; Campellone KG, 2010, NAT REV MOL CELL BIO, V11, P237, DOI 10.1038/nrm2867; Cao J, 2010, CURR BIOL, V20, P770, DOI 10.1016/j.cub.2010.02.060; Ge WH, 2006, P NATL ACAD SCI USA, V103, P1319, DOI 10.1073/pnas.0510419103; Ghashghaei HT, 2007, NAT REV NEUROSCI, V8, P141, DOI 10.1038/nrn2074; Govek EE, 2005, GENE DEV, V19, P1, DOI 10.1101/gad.1256405; Govek EE, 2011, DEV NEUROBIOL, V71, P528, DOI 10.1002/dneu.20850; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Higashida C, 2004, SCIENCE, V303, P2007, DOI 10.1126/science.1093923; Ishizaki T, 2001, NAT CELL BIOL, V3, P8; Ishizaki T, 1997, FEBS LETT, V404, P118, DOI 10.1016/S0014-5793(97)00107-5; Kawauchi T, 2008, DEV NEUROSCI-BASEL, V30, P36, DOI 10.1159/000109850; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; Konno D, 2008, NAT CELL BIOL, V10, P93, DOI 10.1038/ncb1673; Lledo PM, 2008, TRENDS NEUROSCI, V31, P392, DOI 10.1016/j.tins.2008.05.006; Marin O, 2003, ANNU REV NEUROSCI, V26, P441, DOI 10.1146/annurev.neuro.26.041002.131058; Marin O, 2001, NAT REV NEUROSCI, V2, P780, DOI 10.1038/35097509; Marin O, 2006, TRENDS NEUROSCI, V29, P655, DOI 10.1016/j.tins.2006.10.001; Martini FJ, 2010, J NEUROSCI, V30, P8660, DOI 10.1523/JNEUROSCI.1962-10.2010; Masahira N, 2006, DEV BIOL, V293, P358, DOI 10.1016/j.ydbio.2006.02.029; Metin C, 2008, J NEUROSCI, V28, P11746, DOI 10.1523/JNEUROSCI.3860-08.2008; Narumiya S, 1997, FEBS LETT, V410, P68, DOI 10.1016/S0014-5793(97)00317-7; Nguyen L, 2006, CELL CYCLE, V5, P2314, DOI 10.4161/cc.5.20.3381; Nguyen L, 2006, GENE DEV, V20, P1511, DOI 10.1101/gad.377106; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; OROURKE NA, 1992, SCIENCE, V258, P299, DOI 10.1126/science.1411527; Pacary E, 2011, NEURON, V69, P1069, DOI 10.1016/j.neuron.2011.02.018; Palazzo AF, 2001, NAT CELL BIOL, V3, P723, DOI 10.1038/35087035; Patel BN, 2002, CURR OPIN CELL BIOL, V14, P221, DOI 10.1016/S0955-0674(02)00308-3; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Rosenblatt J, 2004, CELL, V117, P361, DOI 10.1016/S0092-8674(04)00341-1; Saito T, 2001, DEV BIOL, V240, P237, DOI 10.1006/dbio.2001.0439; Sakata D, 2007, J EXP MED, V204, P2031, DOI 10.1084/jem.20062647; Sawamoto K, 2006, SCIENCE, V311, P629, DOI 10.1126/science.1119133; Schaar BT, 2005, P NATL ACAD SCI USA, V102, P13652, DOI 10.1073/pnas.0506008102; Solecki DJ, 2004, NAT NEUROSCI, V7, P1195, DOI 10.1038/nn1332; Tsai JW, 2007, NAT NEUROSCI, V10, P970, DOI 10.1038/nn1934; Umeshima H, 2007, P NATL ACAD SCI USA, V104, P16182, DOI 10.1073/pnas.0708047104; Vaughan S, 2011, TRENDS CELL BIOL, V21, P57, DOI 10.1016/j.tcb.2010.09.004; Watanabe N, 1997, EMBO J, V16, P3044, DOI 10.1093/emboj/16.11.3044; Watanabe N, 1999, NAT CELL BIOL, V1, P136, DOI 10.1038/11056; Watanabe S, 2008, MOL BIOL CELL, V19, P2328, DOI 10.1091/mbc.E07-10-1086; Wen Y, 2004, NAT CELL BIOL, V6, P820, DOI 10.1038/ncb1160; Westermann S, 2003, NAT REV MOL CELL BIO, V4, P938, DOI 10.1038/nrm1260; Wichterle H, 1997, NEURON, V18, P779, DOI 10.1016/S0896-6273(00)80317-7; Xie ZG, 2003, CELL, V114, P469, DOI 10.1016/S0092-8674(03)00605-6; YAGI T, 1993, ANAL BIOCHEM, V214, P70, DOI 10.1006/abio.1993.1458; Yasuda S, 2004, NATURE, V428, P767, DOI 10.1038/nature02452	50	91	94	1	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2012	15	3					373	U193		10.1038/nn.3020	http://dx.doi.org/10.1038/nn.3020			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	899CY	22246438	Green Submitted			2022-12-28	WOS:000300793100010
J	Lee, S; Ahmed, T; Lee, S; Kim, H; Choi, S; Kim, DS; Kim, SJ; Cho, J; Shin, HS				Lee, Sukchan; Ahmed, Touqeer; Lee, Soojung; Kim, Huisu; Choi, Sukwoo; Kim, Duk-Soo; Kim, Sang Jeong; Cho, Jeiwon; Shin, Hee-Sup			Bidirectional modulation of fear extinction by mediodorsal thalamic firing in mice	NATURE NEUROSCIENCE			English	Article							MEDIAL PREFRONTAL CORTEX; POSTTRAUMATIC-STRESS-DISORDER; CONDITIONED FEAR; THALAMOCORTICAL RELAY; NUCLEUS; AMYGDALA; LESIONS; MEMORY; RATS; ATTENTION	The mediodorsal thalamic nucleus has been implicated in the control of memory processes. However, the underlying neural mechanism remains unclear. Here we provide evidence for bidirectional modulation of fear extinction by the mediodorsal thalamic nucleus. Mice with a knockout or mediodorsal thalamic nucleus-specific knockdown of phospholipase C beta 4 exhibited impaired fear extinction. Mutant mediodorsal thalamic nucleus neurons in slices showed enhanced burst firing accompanied by increased T-type Ca2+ currents; blocking of T channels in vivo rescued the fear extinction. Tetrode recordings in freely moving mice revealed that, during extinction, the single-spike (tonic) frequency of mediodorsal thalamic nucleus neurons increased in wild-type mice, but was static in mutant mice. Furthermore, tonic-evoking microstimulations of the mediodorsal thalamic nucleus, contemporaneous with the extinction tones, rescued fear extinction in mutant mice and facilitated it in wild-type mice. In contrast, burst-evoking microstimulation suppressed extinction in wild-type mice, mimicking the mutation. These results suggest that the firing mode of the mediodorsal thalamic nucleus is critical for the modulation of fear extinction.	[Lee, Sukchan; Ahmed, Touqeer; Lee, Soojung; Kim, Huisu; Cho, Jeiwon; Shin, Hee-Sup] Korea Inst Sci & Technol, Brain Sci Inst, Seoul, South Korea; [Lee, Sukchan; Kim, Sang Jeong] Seoul Natl Univ, Coll Med, Dept Physiol, Seoul, South Korea; [Kim, Huisu; Shin, Hee-Sup] Univ Sci & Technol, Dept Neurosci, Taejon, South Korea; [Choi, Sukwoo] Seoul Natl Univ, Sch Biol Sci, Coll Nat Sci, Seoul, South Korea; [Kim, Duk-Soo] Soonchunhyang Univ, Dept Anat, Coll Med, Cheonan Si, South Korea	Korea Institute of Science & Technology (KIST); Seoul National University (SNU); Seoul National University (SNU); Soonchunhyang University	Shin, HS (corresponding author), Korea Inst Sci & Technol, Brain Sci Inst, Seoul, South Korea.	shin@kist.re.kr	Ahmed, Touqeer/AAP-2195-2021; Kim, Sang Jeong/J-2740-2012	Kim, Sang Jeong/0000-0001-8931-3713; Ahmed, Touqeer/0000-0003-0322-8169	National Honor Scientist Program of Korea; Ministry of Education, Science and Technology, Korea	National Honor Scientist Program of Korea; Ministry of Education, Science and Technology, Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea)	We thank J. Park for assistance with animal care and I. Hong for behavioral tests in the beginning of this work. This work was supported by a grant from the National Honor Scientist Program of Korea and a grant from the 21C Frontier Proteomics Program of the Ministry of Education, Science and Technology, Korea.	Bremner JD, 1999, BIOL PSYCHIAT, V45, P806, DOI 10.1016/S0006-3223(98)00297-2; Cheong E, 2009, P NATL ACAD SCI USA, V106, P21912, DOI 10.1073/pnas.0912204106; Cheong EJ, 2008, J NEUROSCI, V28, P13331, DOI 10.1523/JNEUROSCI.3013-08.2008; Fanselow MS, 2005, ANNU REV PSYCHOL, V56, P207, DOI 10.1146/annurev.psych.56.091103.070213; Garcia R, 2006, LEARN MEMORY, V13, P14, DOI 10.1101/lm.60406; Herry C, 2002, J NEUROSCI, V22, P577, DOI 10.1523/JNEUROSCI.22-02-00577.2002; Hugues S, 2007, LEARN MEMORY, V14, P520, DOI 10.1101/lm.625407; Hunt PR, 1998, J NEUROSCI, V18, P10045; Inoue T, 2004, EUR J PHARMACOL, V497, P311, DOI 10.1016/j.ejphar.2004.06.061; Jiang HP, 1996, P NATL ACAD SCI USA, V93, P14598, DOI 10.1073/pnas.93.25.14598; Jones E.G., 2007, THALAMUS, VVolume 1, P575; LABERGE D, 1990, J NEUROSCI, V10, P613; LaBerge D, 1997, CONSCIOUS COGN, V6, P149, DOI 10.1006/ccog.1997.0305; Lanius RA, 2003, BIOL PSYCHIAT, V53, P204, DOI 10.1016/S0006-3223(02)01466-X; Li XB, 2004, BRAIN RES, V1008, P261, DOI 10.1016/j.brainres.2004.02.038; Likhtik E, 2005, J NEUROSCI, V25, P7429, DOI 10.1523/JNEUROSCI.2314-05.2005; Liu XB, 1998, J COMP NEUROL, V395, P450, DOI 10.1002/(SICI)1096-9861(19980615)395:4<450::AID-CNE3>3.0.CO;2-0; LLINAS R, 1982, NATURE, V297, P406, DOI 10.1038/297406a0; Llinas R, 1998, PHILOS T ROY SOC B, V353, P1841, DOI 10.1098/rstb.1998.0336; Martin RL, 2000, J PHARMACOL EXP THER, V295, P302; McCormick DA, 1997, ANNU REV NEUROSCI, V20, P185, DOI 10.1146/annurev.neuro.20.1.185; MCCORMICK DA, 1990, J PHYSIOL-LONDON, V431, P291, DOI 10.1113/jphysiol.1990.sp018331; MCCORMICK DA, 1992, P NATL ACAD SCI USA, V89, P2774, DOI 10.1073/pnas.89.7.2774; Mitchell AS, 2008, J NEUROSCI, V28, P258, DOI 10.1523/JNEUROSCI.4922-07.2008; Mitchell AS, 2005, EUR J NEUROSCI, V22, P973, DOI 10.1111/j.1460-9568.2005.04199.x; Miyata M, 2003, J NEUROSCI, V23, P8098; Nakamura M, 2004, EUR J NEUROSCI, V20, P2929, DOI 10.1111/j.1460-9568.2004.03768.x; Pare D, 2004, J NEUROPHYSIOL, V92, P1, DOI 10.1152/jn.00153.2004; Portas CM, 1998, J NEUROSCI, V18, P8979; RAY JP, 1993, J COMP NEUROL, V337, P1, DOI 10.1002/cne.903370102; RAY JP, 1992, J COMP NEUROL, V323, P167, DOI 10.1002/cne.903230204; Riban V, 2004, EXP NEUROL, V188, P452, DOI 10.1016/j.expneurol.2004.04.020; Sherman SM, 2001, TRENDS NEUROSCI, V24, P122, DOI 10.1016/S0166-2236(00)01714-8; Sotres-Bayon F, 2010, CURR OPIN NEUROBIOL, V20, P231, DOI 10.1016/j.conb.2010.02.005; STERIADE M, 1988, PHYSIOL REV, V68, P649, DOI 10.1152/physrev.1988.68.3.649; Swadlow HA, 2001, NAT NEUROSCI, V4, P402, DOI 10.1038/86054; Van der Werf YD, 2000, NEUROPSYCHOLOGIA, V38, P613, DOI 10.1016/S0028-3932(99)00104-9; Van der Werf YD, 2002, BRAIN RES REV, V39, P107, DOI 10.1016/S0165-0173(02)00181-9; VERGNES M, 1990, BRAIN RES, V523, P87, DOI 10.1016/0006-8993(90)91638-W; Vertes RP, 2002, J COMP NEUROL, V442, P163, DOI 10.1002/cne.10083; WINOCUR G, 1990, BEHAV BRAIN RES, V38, P145, DOI 10.1016/0166-4328(90)90012-4; Zhang DX, 2002, J NEUROSCI, V22, P3277, DOI 10.1523/JNEUROSCI.22-08-03277.2002; Zoppelt D, 2003, NEUROPSYCHOLOGIA, V41, P1160, DOI 10.1016/S0028-3932(03)00019-8	43	54	54	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2012	15	2					308	314		10.1038/nn.2999	http://dx.doi.org/10.1038/nn.2999			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	882ZX	22197828				2022-12-28	WOS:000299603500023
J	Swaminathan, SK; Freedman, DJ				Swaminathan, Sruthi K.; Freedman, David J.			Preferential encoding of visual categories in parietal cortex compared with prefrontal cortex	NATURE NEUROSCIENCE			English	Article							LATERAL INTRAPARIETAL AREA; SINGLE NEURONS; RHESUS-MONKEYS; MACAQUE MONKEY; DECISION; REPRESENTATIONS; INFORMATION; INTENTION; IMAGES; LOBE	The ability to recognize the behavioral relevance, or category membership, of sensory stimuli is critical for interpreting the meaning of events in our environment. Neurophysiological studies of visual categorization have found categorical representations of stimuli in prefrontal cortex (PFC), an area that is closely associated with cognitive and executive functions. Recent studies have also identified neuronal category signals in parietal areas that are typically associated with visual-spatial processing. It has been proposed that category-related signals in parietal cortex and other visual areas may result from 'top-down' feedback from PFC. We directly compared neuronal activity in the lateral intraparietal (LIP) area and PFC in monkeys performing a visual motion categorization task. We found that LIP showed stronger, more reliable and shorter latency category signals than PFC. These findings suggest that LIP is strongly involved in visual categorization and argue against the idea that parietal category signals arise as a result of feedback from PFC during this task.	[Swaminathan, Sruthi K.; Freedman, David J.] Univ Chicago, Dept Neurobiol, Chicago, IL 60637 USA	University of Chicago	Freedman, DJ (corresponding author), Univ Chicago, Dept Neurobiol, Chicago, IL 60637 USA.	dfreedman@uchicago.edu			US National Institutes of Health [R01 EY019041, 5T32GM007839]; NATIONAL EYE INSTITUTE [R01EY019041] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007839] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. McClellan for animal training and technical assistance, G. Huang, C. Rishel and S. Thomas for technical assistance, and the staff of The University of Chicago Animal Resources Center for expert veterinary assistance. We also thank J. Assad, J. Fitzgerald, T. Herrington, G. Ibos, J. McKee, E. Miller, C. Pack, M. Riesenhuber and A. Sarma for helpful discussions and/or comments on an earlier version of this manuscript. This work was supported by US National Institutes of Health grant R01 EY019041. Additional support was provided by a National Science Foundation Faculty Early Career Development Award, the Alfred P. Sloan Foundation, the Brain Research Foundation and US National Institutes of Health Training Grant 5T32GM007839.	Ashby EG, 2005, ANNU REV PSYCHOL, V56, P149, DOI 10.1146/annurev.psych.56.091103.070217; Bennur S, 2011, J NEUROSCI, V31, P913, DOI 10.1523/JNEUROSCI.4417-10.2011; Bisley JW, 2010, ANNU REV NEUROSCI, V33, P1, DOI 10.1146/annurev-neuro-060909-152823; Born RT, 2005, ANNU REV NEUROSCI, V28, P157, DOI 10.1146/annurev.neuro.26.041002.131052; Cook EP, 2002, J NEUROSCI, V22, P1994, DOI 10.1523/JNEUROSCI.22-05-01994.2002; Fabre-Thorpe M, 1998, NEUROREPORT, V9, P303, DOI 10.1097/00001756-199801260-00023; Ferrera VP, 2006, NAT NEUROSCI, V9, P1207, DOI 10.1038/nn1006-1207; Ferrera VP, 2009, NAT NEUROSCI, V12, P1458, DOI 10.1038/nn.2434; Fitzgerald JK, 2011, NAT NEUROSCI, V14, P1075, DOI 10.1038/nn.2878; Freedman DJ, 2006, NATURE, V443, P85, DOI 10.1038/nature05078; Freedman DJ, 2011, NAT NEUROSCI, V14, P143, DOI 10.1038/nn.2740; Freedman DJ, 2009, J NEUROSCI, V29, P5671, DOI 10.1523/JNEUROSCI.2878-08.2009; Freedman DJ, 2001, SCIENCE, V291, P312, DOI 10.1126/science.291.5502.312; Freedman DJ, 2003, J NEUROSCI, V23, P5235; Gold JI, 2007, ANNU REV NEUROSCI, V30, P535, DOI 10.1146/annurev.neuro.29.051605.113038; Gottlieb J, 2010, CURR OPIN NEUROBIOL, V20, P731, DOI 10.1016/j.conb.2010.09.015; Jiang X, 2007, NEURON, V53, P891, DOI 10.1016/j.neuron.2007.02.015; Lewis JW, 2000, J COMP NEUROL, V428, P112, DOI 10.1002/1096-9861(20001204)428:1<112::AID-CNE8>3.0.CO;2-9; Merchant H, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00069; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Nieder A, 2006, SCIENCE, V313, P1431, DOI 10.1126/science.1130308; Oristaglio J, 2006, J NEUROSCI, V26, P8310, DOI 10.1523/JNEUROSCI.1779-06.2006; ROBERTS WA, 1988, J EXP PSYCHOL ANIM B, V14, P247, DOI 10.1037/0097-7403.14.3.247; Roy JE, 2010, J NEUROSCI, V30, P8519, DOI 10.1523/JNEUROSCI.4837-09.2010; Shadlen MN, 2008, BETTER CONSCIOUS DEC, P71, DOI 10.7551/mitpress/9780262195805.003.0004; Snyder LH, 2000, VISION RES, V40, P1433, DOI 10.1016/S0042-6989(00)00052-3; Stoet G, 2004, NEURON, V42, P1003, DOI 10.1016/j.neuron.2004.06.003; Vogels R, 1999, EUR J NEUROSCI, V11, P1223, DOI 10.1046/j.1460-9568.1999.00530.x; Wallis JD, 2001, NATURE, V411, P953, DOI 10.1038/35082081; Williams ZM, 2003, NAT NEUROSCI, V6, P616, DOI 10.1038/nn1055; Wyttenbach RA, 1996, SCIENCE, V273, P1542, DOI 10.1126/science.273.5281.1542	31	124	124	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2012	15	2					315	320		10.1038/nn.3016	http://dx.doi.org/10.1038/nn.3016			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	882ZX	22246435	Green Accepted			2022-12-28	WOS:000299603500024
J	Economides, JR; Sincich, LC; Adams, DL; Horton, JC				Economides, John R.; Sincich, Lawrence C.; Adams, Daniel L.; Horton, Jonathan C.			Orientation tuning of cytochrome oxidase patches in macaque primary visual cortex	NATURE NEUROSCIENCE			English	Article							MONKEY STRIATE CORTEX; OCULAR-DOMINANCE; FUNCTIONAL-ORGANIZATION; RECORDING CAPABILITIES; CHROMATIC MECHANISMS; OWL MONKEY; COLOR; V1; V2; SELECTIVITY	The abundant concentration of cytochrome oxidase in patches or blobs of primate striate cortex has never been explained. Patches are thought to contain unoriented, color-opponent neurons. Lacking orientation selectivity, these cells might endow patches with high metabolic activity because they respond to all contours in visual scenes. To test this idea, we measured orientation tuning in layer 2/3 of macaque cortical area V1 using acutely implanted 100-electrode arrays. Each electrode recording site was identified and assigned to the patch or interpatch compartment. The mean orientation bandwidth of cells was 28.4 degrees in patches and 25.8 degrees in interpatches. Neurons in patches were indeed less orientation selective, but the difference was subtle, indicating that the processing of form and color is not strictly segregated in V1. The most conspicuous finding was that patch cells had a 49% greater overall firing rate. This global difference in neuronal responsiveness, rather than an absence of orientation tuning, may account for the rich mitochondrial enzyme activity that defines patches.	[Economides, John R.; Adams, Daniel L.; Horton, Jonathan C.] Univ Calif San Francisco, Beckman Vis Ctr, San Francisco, CA 94143 USA; [Sincich, Lawrence C.] Univ Alabama, Dept Visual Sci, Birmingham, AL USA; [Adams, Daniel L.] Univ Trent, Ctr Mind Brain Sci, Rovereto, Italy	University of California System; University of California San Francisco; University of Alabama System; University of Alabama Birmingham; University of Trento	Horton, JC (corresponding author), Univ Calif San Francisco, Beckman Vis Ctr, San Francisco, CA 94143 USA.	hortonj@vision.ucsf.edu	Economides, John/AAV-7631-2020; Adams, Daniel L/A-5229-2009	Economides, John/0000-0002-9236-2441; Adams, Daniel L/0000-0003-0376-4949; Horton, Jonathan/0000-0002-3952-435X	US National Eye Institute [EY10217, EY10217-16A1S1, EY13676, EY02162]; US National Institutes of Health [R00169]; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000169] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY002162, R01EY010217, R56EY010217, F32EY013676] Funding Source: NIH RePORTER	US National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by grants EY10217, EY10217-16A1S1 (J.C.H.), EY13676 (L.C.S.) and EY02162 (Beckman Vision Center) from the US National Eye Institute and by Research to Prevent Blindness. The California Regional Primate Research Center is supported by US National Institutes of Health Base Grant RR00169. C.M. Jocson provided technical assistance and M.K. Feusner assisted with computer programming.	BARTFELD E, 1992, P NATL ACAD SCI USA, V89, P11905, DOI 10.1073/pnas.89.24.11905; BLASDEL GG, 1986, NATURE, V321, P579, DOI 10.1038/321579a0; BLASDEL GG, 1992, J NEUROSCI, V12, P3139, DOI 10.1523/JNEUROSCI.12-08-03139.1992; BONHOEFFER T, 1991, NATURE, V353, P429, DOI 10.1038/353429a0; Chatterjee S, 2003, NATURE, V426, P668, DOI 10.1038/nature02163; DEYOE EA, 1995, VISUAL NEUROSCI, V12, P629, DOI 10.1017/S0952523800008920; Eliades SJ, 2008, J NEUROSCI METH, V172, P201, DOI 10.1016/j.jneumeth.2008.04.029; Engel SA, 2005, NEURON, V45, P613, DOI 10.1016/j.neuron.2005.01.014; Farias MF, 1997, J COMP NEUROL, V386, P217, DOI 10.1002/(SICI)1096-9861(19970922)386:2<217::AID-CNE4>3.0.CO;2-4; Friedman HS, 2003, J PHYSIOL-LONDON, V548, P593, DOI 10.1113/jphysiol.2002.033555; Henze DA, 2000, J NEUROPHYSIOL, V84, P390, DOI 10.1152/jn.2000.84.1.390; Heywood CA, 2003, NEUROL CLIN, V21, P483, DOI 10.1016/S0733-8619(02)00102-0; HORTON JC, 1984, PHILOS T ROY SOC B, V304, P199, DOI 10.1098/rstb.1984.0021; HORTON JC, 1981, NATURE, V292, P762, DOI 10.1038/292762a0; Horwitz GD, 2007, J NEUROPHYSIOL, V97, P3070, DOI 10.1152/jn.00965.2006; Johnson EN, 2008, J NEUROSCI, V28, P8096, DOI 10.1523/JNEUROSCI.1404-08.2008; Johnson EN, 2001, NAT NEUROSCI, V4, P409, DOI 10.1038/86061; Kaufman L., 1990, FINDING GROUPS DATA, DOI 10.1002/9780470316801; Kelly RC, 2007, J NEUROSCI, V27, P261, DOI 10.1523/JNEUROSCI.4906-06.2007; KENNEDY C, 1976, P NATL ACAD SCI USA, V73, P4230, DOI 10.1073/pnas.73.11.4230; Kim SJ, 2006, ANN BIOMED ENG, V34, P300, DOI 10.1007/s10439-005-9037-9; Landisman CE, 2002, J NEUROPHYSIOL, V87, P3126, DOI 10.1152/jn.2002.87.6.3126; Landisman CE, 2002, J NEUROPHYSIOL, V87, P3138, DOI 10.1152/jn.00957.1999; LENNIE P, 1990, J NEUROSCI, V10, P649; LEVENTHAL AG, 1995, J NEUROSCI, V15, P1808, DOI 10.1523/JNEUROSCI.15-03-01808.1995; LIVINGSTONE MS, 1984, J NEUROSCI, V4, P309; Lu HD, 2008, CEREB CORTEX, V18, P516, DOI 10.1093/cercor/bhm081; MARTIN KAC, 1988, TRENDS NEUROSCI, V11, P380, DOI 10.1016/0166-2236(88)90072-0; McDonald JS, 2010, J VISION, V10, DOI 10.1167/10.12.34; Nauhaus I, 2008, NEURON, V57, P673, DOI 10.1016/j.neuron.2008.01.020; Nauhaus I, 2007, J NEUROPHYSIOL, V97, P3781, DOI 10.1152/jn.00120.2007; Nordhausen CT, 1996, BRAIN RES, V726, P129; NORDHAUSEN CT, 1994, BRAIN RES, V637, P27, DOI 10.1016/0006-8993(94)91213-0; O'Keefe LP, 1998, J NEUROPHYSIOL, V80, P594, DOI 10.1152/jn.1998.80.2.594; Polimeni JR, 2005, P NATL ACAD SCI USA, V102, P4158, DOI 10.1073/pnas.0500291102; PURVES D, 1993, J COMP NEUROL, V334, P169, DOI 10.1002/cne.903340202; Ringach DL, 2002, J NEUROSCI, V22, P5639; SCHILLER PH, 1976, J NEUROPHYSIOL, V39, P1320; Seymour K, 2010, CEREB CORTEX, V20, P1946, DOI 10.1093/cercor/bhp265; Sincich LC, 2005, J NEUROSCI, V25, P10087, DOI 10.1523/JNEUROSCI.3313-05.2005; Sincich LC, 2005, ANNU REV NEUROSCI, V28, P303, DOI 10.1146/annurev.neuro.28.061604.135731; Sincich LC, 2002, SCIENCE, V295, P1734, DOI 10.1126/science.1067902; Smith MA, 2008, J NEUROSCI, V28, P12591, DOI 10.1523/JNEUROSCI.2929-08.2008; Sumner P, 2008, NEUROIMAGE, V39, P814, DOI 10.1016/j.neuroimage.2007.09.013; Swindale NV, 1998, BIOL CYBERN, V78, P45, DOI 10.1007/s004220050411; TOOTELL RBH, 1988, J NEUROSCI, V8, P1500; TSO DY, 1988, J NEUROSCI, V8, P1712; WONGRILEY M, 1984, NATURE, V307, P262, DOI 10.1038/307262a0; Xu XM, 2004, J NEUROSCI, V24, P6237, DOI 10.1523/JNEUROSCI.1144-04.2004; Yoshioka T, 1996, BEHAV BRAIN RES, V76, P71, DOI 10.1016/0166-4328(95)00184-0	50	28	29	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	2011	14	12					1574	U108		10.1038/nn.2958	http://dx.doi.org/10.1038/nn.2958			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	855EJ	22057193	Green Submitted, Green Accepted			2022-12-28	WOS:000297546300018
J	Mellios, N; Sugihara, H; Castro, J; Banerjee, A; Le, C; Kumar, A; Crawford, B; Strathmann, J; Tropea, D; Levine, SS; Edbauer, D; Sur, M				Mellios, Nikolaos; Sugihara, Hiroki; Castro, Jorge; Banerjee, Abhishek; Le, Chuong; Kumar, Arooshi; Crawford, Benjamin; Strathmann, Julia; Tropea, Daniela; Levine, Stuart S.; Edbauer, Dieter; Sur, Mriganka			miR-132, an experience-dependent microRNA, is essential for visual cortex plasticity	NATURE NEUROSCIENCE			English	Article							MONOCULAR DEPRIVATION; MORPHOGENESIS	Using quantitative analyses, we identified microRNAs (miRNAs) that were abundantly expressed in visual cortex and that responded to dark rearing and/or monocular deprivation. The most substantially altered miRNA, miR-132, was rapidly upregulated after eye opening and was delayed by dark rearing. In vivo inhibition of miR-132 in mice prevented ocular dominance plasticity in identified neurons following monocular deprivation and affected the maturation of dendritic spines, demonstrating its critical role in the plasticity of visual cortex circuits.	[Mellios, Nikolaos; Sugihara, Hiroki; Castro, Jorge; Banerjee, Abhishek; Le, Chuong; Kumar, Arooshi; Crawford, Benjamin; Tropea, Daniela; Sur, Mriganka] MIT, Dept Brain & Cognit Sci, Picower Inst Learning & Memory, Cambridge, MA 02139 USA; [Strathmann, Julia; Edbauer, Dieter] DZNE German Ctr Neurodegenerat Dis, Munich, Germany; [Levine, Stuart S.] MIT, Biomicro Ctr, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Northwell Health; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Massachusetts Institute of Technology (MIT)	Sur, M (corresponding author), MIT, Dept Brain & Cognit Sci, Picower Inst Learning & Memory, E25-618, Cambridge, MA 02139 USA.	msur@mit.edu	Edbauer, Dieter/M-9906-2019; Tropea, Daniela/AAX-8147-2020	Edbauer, Dieter/0000-0002-7186-4653; Levine, Stuart/0000-0001-7363-562X; Tropea, Daniela/0000-0001-9730-6636; Sugihara, Hiroki/0000-0002-0637-3700	US National Eye Institute [1F32EY020066-01]; Helmholtz Young Investigator program [HZ-NG-607]; Simons Foundation; US National Institutes of Health [EY017098, EY007023]; NATIONAL EYE INSTITUTE [R01EY007023, R01EY017098, F32EY020066] Funding Source: NIH RePORTER	US National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Helmholtz Young Investigator program; Simons Foundation; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank J. Sharma and C. Runyan for feedback, G. Kreiman for assistance with data analysis, M. Constantine-Paton and her laboratory for sharing equipment and B. Karki for technical assistance. Supported by US National Eye Institute Ruth L. Kirschstein Postdoctoral Fellowship 1F32EY020066-01 (N.M.), Helmholtz Young Investigator program HZ-NG-607 (D. E.), a Simons Foundation postdoctoral fellowship (A. B.) and US National Institutes of Health EY017098 and EY007023 to M.S.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079; Edbauer D, 2010, NEURON, V65, P373, DOI 10.1016/j.neuron.2010.01.005; Frenkel MY, 2004, NEURON, V44, P917, DOI 10.1016/j.neuron.2004.12.003; Giraldez AJ, 2005, SCIENCE, V308, P833, DOI 10.1126/science.1109020; Gordon JA, 1996, J NEUROSCI, V16, P3274; Hensch TK, 2005, NAT REV NEUROSCI, V6, P877, DOI 10.1038/nrn1787; Impey S, 2010, MOL CELL NEUROSCI, V43, P146, DOI 10.1016/j.mcn.2009.10.005; Mataga N, 2004, NEURON, V44, P1031, DOI 10.1016/j.neuron.2004.11.028; Oray S, 2004, NEURON, V44, P1021, DOI 10.1016/j.neuron.2004.12.001; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; Trachtenberg JT, 2000, SCIENCE, V287, P2029, DOI 10.1126/science.287.5460.2029; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vo N, 2005, P NATL ACAD SCI USA, V102, P16426, DOI 10.1073/pnas.0508448102; Wayman GA, 2008, P NATL ACAD SCI USA, V105, P9093, DOI 10.1073/pnas.0803072105	15	141	148	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2011	14	10					1240	1242		10.1038/nn.2909	http://dx.doi.org/10.1038/nn.2909			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	825EQ	21892155	Green Accepted, Green Submitted			2022-12-28	WOS:000295254200008
J	Awasaki, T; Huang, YL; O'Connor, MB; Lee, T				Awasaki, Takeshi; Huang, Yaling; O'Connor, Michael B.; Lee, Tzumin			Glia instruct developmental neuronal remodeling through TGF-beta signaling	NATURE NEUROSCIENCE			English	Article							DROSOPHILA METAMORPHOSIS; RECEPTOR; REQUIREMENT; MYOGLIANIN; EXPRESSION; SYSTEM; BRAIN	We found that glia secrete myoglianin, a TGF-beta ligand, to instruct developmental neural remodeling in Drosophila. Glial myoglianin upregulated neuronal expression of an ecdysone nuclear receptor that triggered neurite remodeling following the late-larval ecdysone peak. Thus glia orchestrate developmental neural remodeling not only by engulfment of unwanted neurites but also by enabling neuron remodeling.	[Awasaki, Takeshi; Huang, Yaling; Lee, Tzumin] Univ Massachusetts, Dept Neurobiol, Worcester, MA 01605 USA; [Awasaki, Takeshi; Huang, Yaling; Lee, Tzumin] Howard Hughes Med Inst, Ashburn, VA USA; [O'Connor, Michael B.] Univ Minnesota, Howard Hughes Med Inst, Minneapolis, MN USA; [O'Connor, Michael B.] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN USA	University of Massachusetts System; University of Massachusetts Worcester; Howard Hughes Medical Institute; Howard Hughes Medical Institute; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Awasaki, T (corresponding author), Univ Massachusetts, Dept Neurobiol, Worcester, MA 01605 USA.	awasakit@janelia.hhmi.org; leet@janelia.hhmi.org	O'Connor, Michael B/C-9977-2014; AWASAKI, Takeshi/AAO-7579-2021	O'Connor, Michael B/0000-0002-3067-5506; AWASAKI, Takeshi/0000-0003-2662-6389	US National Institutes of Health [NS42049, MH83607]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095746] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH083607] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042049] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Y. Nakanishi, C. Hama, K. Ito, M. R. Freeman, the Bloomington Stock Center, the Vienna Drosophila RNAi Center, the Exelixis stock collection at Harvard Medical School and the Developmental Studies Hybridoma Bank for fly stocks and antibodies, M. A. Logan and C.-F. Kao for critical reading of the manuscript and members of the Lee laboratory for fruitful discussion. This work was supported by the US National Institutes of Health (NS42049 and MH83607 to T. L.).	Awasaki T, 2006, NEURON, V50, P855, DOI 10.1016/j.neuron.2006.04.027; Awasaki T, 2004, CURR BIOL, V14, P668, DOI 10.1016/j.cub.2004.04.001; Awasaki T, 2011, NAT NEUROSCI, V14, P6, DOI 10.1038/nn0111-6; Jensen PA, 2009, MECH DEVELOP, V126, P950, DOI 10.1016/j.mod.2009.09.003; Lee T, 1999, DEVELOPMENT, V126, P4065; Lee T, 2000, NEURON, V28, P807, DOI 10.1016/S0896-6273(00)00155-0; Lee-Hoeflich ST, 2005, FEBS LETT, V579, P4615, DOI 10.1016/j.febslet.2005.06.088; Lo PCH, 1999, MECH DEVELOP, V86, P171, DOI 10.1016/S0925-4773(99)00108-2; Marin EC, 2005, DEVELOPMENT, V132, P725, DOI 10.1242/dev.01614; TRUMAN JW, 1990, J NEUROBIOL, V21, P1072, DOI 10.1002/neu.480210711; Watts RJ, 2003, NEURON, V38, P871, DOI 10.1016/S0896-6273(03)00295-2; Watts RJ, 2004, CURR BIOL, V14, P678, DOI 10.1016/j.cub.2004.03.035; Zheng XY, 2006, EMBO J, V25, P615, DOI 10.1038/sj.emboj.7600962; Zheng XY, 2003, CELL, V112, P303, DOI 10.1016/S0092-8674(03)00072-2; Zhu CC, 2008, DEVELOPMENT, V135, P513, DOI 10.1242/dev.010876	15	88	88	1	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2011	14	7					821	823		10.1038/nn.2833	http://dx.doi.org/10.1038/nn.2833			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	783KR	21685919	Green Accepted			2022-12-28	WOS:000292081700006
J	Girshick, AR; Landy, MS; Simoncelli, EP				Girshick, Ahna R.; Landy, Michael S.; Simoncelli, Eero P.			Cardinal rules: visual orientation perception reflects knowledge of environmental statistics	NATURE NEUROSCIENCE			English	Article							ANISOTROPY; DISCRIMINATION; INFORMATION; SELECTIVITY; INTEGRATION; MODELS	Humans are good at performing visual tasks, but experimental measurements have revealed substantial biases in the perception of basic visual attributes. An appealing hypothesis is that these biases arise through a process of statistical inference, in which information from noisy measurements is fused with a probabilistic model of the environment. However, such inference is optimal only if the observer's internal model matches the environment. We found this to be the case. We measured performance in an orientation-estimation task and found that orientation judgments were more accurate at cardinal (horizontal and vertical) orientations. Judgments made under conditions of uncertainty were strongly biased toward cardinal orientations. We estimated observers' internal models for orientation and found that they matched the local orientation distribution measured in photographs. In addition, we determined how a neural population could embed probabilistic information responsible for such biases.	[Girshick, Ahna R.; Landy, Michael S.; Simoncelli, Eero P.] NYU, Dept Psychol, New York, NY 10003 USA; [Girshick, Ahna R.; Landy, Michael S.; Simoncelli, Eero P.] NYU, Ctr Neural Sci, New York, NY 10003 USA; [Simoncelli, Eero P.] NYU, Howard Hughes Med Inst, New York, NY USA; [Simoncelli, Eero P.] NYU, Courant Inst Math Sci, New York, NY USA	New York University; New York University; Howard Hughes Medical Institute; New York University; New York University	Girshick, AR (corresponding author), NYU, Dept Psychol, 6 Washington Pl, New York, NY 10003 USA.	ahna.girshick@gmail.com		Landy, Michael/0000-0002-2079-4552; Simoncelli, Eero/0000-0002-1206-527X	US National Institutes of Health [EY019451, EY16165]; Howard Hughes Medical Institute; NATIONAL EYE INSTITUTE [F32EY019451, R01EY016165] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We wish to thank D. Ganguli for helpful discussions on image statistics and population coding, T. Saarela for the monitor calibration and N. Solomon for assisting with the experiments. This work was funded by US National Institutes of Health grants EY019451 (A.R.G.) and EY16165 (M.S.L.), and the Howard Hughes Medical Institute (E.P.S.).	APPELLE S, 1972, PSYCHOL BULL, V78, P266, DOI 10.1037/h0033117; BIRCH EE, 1983, VISION RES, V23, P1019, DOI 10.1016/0042-6989(83)90012-3; BLAKEMORE C, 1970, NATURE, V228, P477, DOI 10.1038/228477a0; Brainard DH, 2006, J VISION, V6, P1267, DOI 10.1167/6.11.10; Burge J, 2010, J NEUROSCI, V30, P7269, DOI 10.1523/JNEUROSCI.5551-09.2010; BURT PJ, 1983, IEEE T COMMUN, V31, P532, DOI 10.1109/TCOM.1983.1095851; CAMPBELL FW, 1968, J PHYSIOL-LONDON, V197, P551, DOI 10.1113/jphysiol.1968.sp008574; Chapman B, 1998, P NATL ACAD SCI USA, V95, P2609, DOI 10.1073/pnas.95.5.2609; Cohen EH, 2007, J NEUROSCI, V27, P12540, DOI 10.1523/JNEUROSCI.4496-07.2007; Coppola DM, 1998, P NATL ACAD SCI USA, V95, P4002, DOI 10.1073/pnas.95.7.4002; Dakin SC, 2001, J OPT SOC AM A, V18, P1016, DOI 10.1364/JOSAA.18.001016; DEVALOIS RL, 1982, VISION RES, V22, P531, DOI 10.1016/0042-6989(82)90112-2; El-Bizri N., 2005, ARAB SCI PHILOS, V15, P189, DOI 10.1017/S0957423905000172; Farid H, 2004, IEEE T IMAGE PROCESS, V13, P496, DOI 10.1109/TIP.2004.823819; FISCHER BJ, 2010, INT JT C NEUR NETW, P1; Furmanski CS, 2000, NAT NEUROSCI, V3, P535, DOI 10.1038/75702; Ganguli D., 2010, ADV NEURAL INFORM PR, V23; Geisler WS, 2001, VISION RES, V41, P711, DOI 10.1016/S0042-6989(00)00277-7; GEORGOPOULOS AP, 1986, SCIENCE, V233, P1416, DOI 10.1126/science.3749885; Granlund Gosta H., 1995, SIGNAL PROCESSING CO; Green DM, 1966, SIGNAL DETECTION THE; Griffiths TL, 2008, CAMB HANDB PSYCHOL, P59; HELMHOLTZ H, 2000, TREATISE PHYSL OPTIC; Ho YX, 2007, J VISION, V7, DOI 10.1167/7.1.1; Jazayeri M, 2006, NAT NEUROSCI, V9, P690, DOI 10.1038/nn1691; Knill DC, 1996, PERCEPTION BAYESIAN; Kording KP, 2004, NATURE, V427, P244, DOI 10.1038/nature02169; Li BW, 2003, J NEUROPHYSIOL, V90, P204, DOI 10.1152/jn.00954.2002; Ma WJ, 2006, NAT NEUROSCI, V9, P1432, DOI 10.1038/nn1790; Maloney LT, 2009, VISUAL NEUROSCI, V26, P147, DOI 10.1017/S0952523808080905; Mamassian P, 2001, COGNITION, V81, pB1, DOI 10.1016/S0010-0277(01)00116-0; MAYER MJ, 1977, VISION RES, V17, P703, DOI 10.1016/S0042-6989(77)80006-0; MITCHELL DE, 1973, VISION RES, V13, P535, DOI 10.1016/0042-6989(73)90023-0; ORBAN GA, 1984, VISION RES, V24, P121, DOI 10.1016/0042-6989(84)90097-X; Ringach DL, 2002, J NEUROSCI, V22, P5639; Schwartz O, 2007, NAT REV NEUROSCI, V8, P522, DOI 10.1038/nrn2155; SEUNG HS, 1993, P NATL ACAD SCI USA, V90, P10749, DOI 10.1073/pnas.90.22.10749; Shadlen MN, 1996, J NEUROSCI, V16, P1486; Simoncelli E, 1993, THESIS MIT; Stocker AA, 2006, NAT NEUROSCI, V9, P578, DOI 10.1038/nn1669; Stocker AA, 2009, J VISION, V9, DOI 10.1167/9.9.9; Swindale NV, 1998, BIOL CYBERN, V78, P45, DOI 10.1007/s004220050411; SWITKES E, 1978, VISION RES, V18, P1393, DOI 10.1016/0042-6989(78)90232-8; Tassinari H, 2006, J NEUROSCI, V26, P10154, DOI 10.1523/JNEUROSCI.2779-06.2006; TIMNEY BN, 1976, SCIENCE, V193, P699, DOI 10.1126/science.948748; Tomassini A, 2010, VISION RES, V50, P541, DOI 10.1016/j.visres.2009.12.005; Weiss Y, 2002, NAT NEUROSCI, V5, P598, DOI 10.1038/nn858; Zhang KC, 1998, J NEUROPHYSIOL, V79, P1017, DOI 10.1152/jn.1998.79.2.1017	50	313	313	2	50	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2011	14	7					926	U156		10.1038/nn.2831	http://dx.doi.org/10.1038/nn.2831			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	783KR	21642976	Green Accepted			2022-12-28	WOS:000292081700022
J	Resnik, J; Sobel, N; Paz, R				Resnik, Jennifer; Sobel, Noam; Paz, Rony			Auditory aversive learning increases discrimination thresholds	NATURE NEUROSCIENCE			English	Article							TOP-DOWN INFLUENCES; CONDITIONED FEAR; RESPONSE PROPERTIES; TASK-DIFFICULTY; CORTEX; AMYGDALA; MEMORY; STIMULUS; NEUROSCIENCE; MECHANISMS	Animal studies of discriminative fear conditioning traditionally use stimuli that are distant in physical features and thus easily distinguished perceptually. Independently, human studies have shown that training mostly improves discrimination thresholds. We found that aversive learning actually induced an increase in discrimination thresholds in humans and that subjective aversion during conditioning predicted the individual threshold change. This counterintuitive performance deterioration occurred when using odors or sounds as aversive reinforcers and was not a result of attentional distraction or decision bias. In contrast, positive reinforcement or mere exposure induced the typically reported decrease in thresholds. Our findings indicate that aversive outcomes induce wider stimulus generalization by modulating perceptual thresholds, suggesting the engagement of low-level mechanisms. We suggest that for risk- or loss-related stimuli, less specificity could be a benefit, as it invokes the same mechanisms that respond quickly and efficiently in the face of danger.	[Resnik, Jennifer; Sobel, Noam; Paz, Rony] Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Paz, R (corresponding author), Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel.	rony.paz@weizmann.ac.il	Resnik, Jennifer/AAA-5644-2020	Resnik, Jennifer/0000-0002-0573-0008; Sobel, Noam/0000-0002-3232-9391	Minerva Foundation; Israel Science Foundation	Minerva Foundation; Israel Science Foundation(Israel Science Foundation)	We thank D. Sagi for discussions. This work was supported by a Minerva Foundation and an Israel Science Foundation Grant to R.P., an Alon and Marie-Curie Fellow.	Ahissar M, 1997, NATURE, V387, P401, DOI 10.1038/387401a0; Ahissar M, 2009, PHILOS T R SOC B, V364, P285, DOI 10.1098/rstb.2008.0253; Amitay S, 2006, NAT NEUROSCI, V9, P1446, DOI 10.1038/nn1787; Antunes R, 2010, J NEUROSCI, V30, P9782, DOI 10.1523/JNEUROSCI.1037-10.2010; Armony JL, 1997, CEREB CORTEX, V7, P157, DOI 10.1093/cercor/7.2.157; BORDI F, 1994, EXP BRAIN RES, V98, P261, DOI 10.1007/BF00228414; BORDI F, 1992, J NEUROSCI, V12, P2493; Buonomano DV, 1998, ANNU REV NEUROSCI, V21, P149, DOI 10.1146/annurev.neuro.21.1.149; Chavez CM, 2009, NEUROBIOL LEARN MEM, V91, P382, DOI 10.1016/j.nlm.2008.10.010; Davis M, 2001, MOL PSYCHIATR, V6, P13, DOI 10.1038/sj.mp.4000812; Dunsmoor JE, 2011, NEUROIMAGE, V55, P1878, DOI 10.1016/j.neuroimage.2011.01.041; Dunsmoor JE, 2009, LEARN MEMORY, V16, P460, DOI 10.1101/lm.1431609; Duvarci S, 2009, J NEUROSCI, V29, P10357, DOI 10.1523/JNEUROSCI.2119-09.2009; Fahle M, 2002, PERCEPTUAL LEARNING; Fanselow MS, 2005, ANNU REV PSYCHOL, V56, P207, DOI 10.1146/annurev.psych.56.091103.070213; Gilbert CD, 2007, NEURON, V54, P677, DOI 10.1016/j.neuron.2007.05.019; Haddad R, 2008, NAT METHODS, V5, P425, DOI [10.1038/nmeth.1197, 10.1038/NMETH.1197]; Han JH, 2008, LEARN MEMORY, V15, P443, DOI 10.1101/lm.993608; Hawkey DJC, 2004, NAT NEUROSCI, V7, P1055, DOI 10.1038/nn1315; Johnson BN, 2007, J NEUROSCI METH, V160, P231, DOI 10.1016/j.jneumeth.2006.09.008; KARNI A, 1993, NATURE, V365, P250, DOI 10.1038/365250a0; Kurt S, 2010, P NATL ACAD SCI USA, V107, P8481, DOI 10.1073/pnas.0912357107; Laxmi TR, 2003, BEHAV BRAIN RES, V145, P89, DOI 10.1016/S0166-4328(03)00101-3; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; LEVITT H, 1971, J ACOUST SOC AM, V49, P467, DOI 10.1121/1.1912375; Li W, 2008, SCIENCE, V319, P1842, DOI 10.1126/science.1152837; Lissek S, 2010, AM J PSYCHIAT, V167, P47, DOI 10.1176/appi.ajp.2009.09030410; Livneh U, 2010, J NEUROSCI METH, V192, P90, DOI 10.1016/j.jneumeth.2010.07.027; Macmillan N. A., 2004, DETECTION THEORY USE; Marcell ME, 2000, J CLIN EXP NEUROPSYC, V22, P830, DOI 10.1076/jcen.22.6.830.949; Maren S, 2004, NAT REV NEUROSCI, V5, P844, DOI 10.1038/nrn1535; McLaren IPL, 2002, ANIM LEARN BEHAV, V30, P177, DOI 10.3758/BF03192828; Morris JS, 1998, P ROY SOC B-BIOL SCI, V265, P649, DOI 10.1098/rspb.1998.0343; Neumann DL, 2006, BIOL PSYCHOL, V73, P175, DOI 10.1016/j.biopsycho.2006.03.004; Paz R, 2004, TRENDS NEUROSCI, V27, P496, DOI 10.1016/j.tins.2004.04.013; Pearce J. M., 2008, ANIMAL LEARNING COGN, V3rd; Polley DB, 2004, P NATL ACAD SCI USA, V101, P16351, DOI 10.1073/pnas.0407586101; Polley DB, 2006, J NEUROSCI, V26, P4970, DOI 10.1523/JNEUROSCI.3771-05.2006; Quirk GJ, 1997, NEURON, V19, P613, DOI 10.1016/S0896-6273(00)80375-X; Roelfsema PR, 2010, TRENDS COGN SCI, V14, P64, DOI 10.1016/j.tics.2009.11.005; Schechtman E, 2010, J NEUROSCI, V30, P10460, DOI 10.1523/JNEUROSCI.2377-10.2010; Shaban H, 2006, NAT NEUROSCI, V9, P1028, DOI 10.1038/nn1732; SHEPARD RN, 1987, SCIENCE, V237, P1317, DOI 10.1126/science.3629243; Watanabe T, 2001, NATURE, V413, P844, DOI 10.1038/35101601; Weinberger NM, 2004, NAT REV NEUROSCI, V5, P279, DOI 10.1038/nrn1366; Weinberger NM, 2007, LEARN MEMORY, V14, P1, DOI 10.1101/lm.421807; Wesson DW, 2010, J NEUROSCI, V30, P3013, DOI 10.1523/JNEUROSCI.6003-09.2010; Wright BA, 2009, PHILOS T R SOC B, V364, P301, DOI 10.1098/rstb.2008.0262; Yehuda R, 2007, NEURON, V56, P19, DOI 10.1016/j.neuron.2007.09.006; Yeshurun Y, 2008, BEHAV NEUROSCI, V122, P1031, DOI 10.1037/a0012806	50	82	85	0	40	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2011	14	6					791	U157		10.1038/nn.2802	http://dx.doi.org/10.1038/nn.2802			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	768SH	21552275				2022-12-28	WOS:000290958000024
J	Wang, LM; Han, XQ; Mehren, J; Hiroi, M; Billeter, JC; Miyamoto, T; Amrein, H; Levine, JD; Anderson, DJ				Wang, Liming; Han, Xiaoqing; Mehren, Jennifer; Hiroi, Makoto; Billeter, Jean-Christophe; Miyamoto, Tetsuya; Amrein, Hubert; Levine, Joel D.; Anderson, David J.			Hierarchical chemosensory regulation of male-male social interactions in Drosophila	NATURE NEUROSCIENCE			English	Article							CUTICULAR HYDROCARBONS; GUSTATORY RECEPTORS; PHEROMONE RECEPTOR; MALE-AGGRESSION; MALE COURTSHIP; SEX-PHEROMONE; MUTANT MICE; BEHAVIOR; TASTE; MELANOGASTER	Pheromones regulate male social behaviors in Drosophila, but the identities and behavioral role(s) of these chemosensory signals, and how they interact, are incompletely understood. We found that (z)-7-tricosene, a male-enriched cuticular hydrocarbon that was previously shown to inhibit male-male courtship, was essential for normal levels of aggression. The mechanisms by which (z)-7-tricosene induced aggression and suppressed courtship were independent, but both required the gustatory receptor Gr32a. Sensitivity to (z)-7-tricosene was required for the aggression-promoting effect of 11-cis-vaccenyl acetate (cVA), an olfactory pheromone, but (z)-7-tricosene sensitivity was independent of cVA. (z)-7-tricosene and cVA therefore regulate aggression in a hierarchical manner. Furthermore, the increased courtship caused by depletion of male cuticular hydrocarbons was suppressed by a mutation in the olfactory receptor Or47b. Thus, male social behaviors are controlled by gustatory pheromones that promote aggression and suppress courtship, and whose influences are dominant to olfactory pheromones that enhance these behaviors.	[Wang, Liming; Han, Xiaoqing; Anderson, David J.] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Han, Xiaoqing; Anderson, David J.] CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA; [Mehren, Jennifer] Rockefeller Univ, Lab Neurogenet & Behav, New York, NY 10021 USA; [Hiroi, Makoto] Univ Calif Berkeley, Helen Wills Neurosci Inst, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Billeter, Jean-Christophe; Levine, Joel D.] Univ Toronto, Dept Biol, Mississauga, ON L5L 1C6, Canada; [Miyamoto, Tetsuya; Amrein, Hubert] Texas A&M Hlth Sci Ctr, Dept Mol & Cellular Med, College Stn, TX USA	California Institute of Technology; California Institute of Technology; Howard Hughes Medical Institute; Rockefeller University; University of California System; University of California Berkeley; University of Toronto; University Toronto Mississauga; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Wang, LM (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	lmwang@caltech.edu; wuwei@caltech.edu	Amrein, Hubert/AAG-9480-2021; Wang, Liming/C-8402-2011; Billeter, Jean-Christophe/G-5399-2012; Hiroi, Makoto/B-6834-2008; han, xiao/HDN-9782-2022	Amrein, Hubert/0000-0001-8799-7250; Hiroi, Makoto/0000-0002-0136-5891; Billeter, Jean-Christophe/0000-0001-7796-4068	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005606, R01DC009014] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA031389] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIDA NIH HHS [R01 DA031389] Funding Source: Medline; NIDCD NIH HHS [R01 DC005606, R01 DC009014] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Billeter JC, 2009, NATURE, V461, P987, DOI 10.1038/nature08495; BUTTERWORTH FM, 1969, SCIENCE, V163, P1356, DOI 10.1126/science.163.3873.1356; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Chamero P, 2007, NATURE, V450, P899, DOI 10.1038/nature05997; Chen S, 2002, P NATL ACAD SCI USA, V99, P5664, DOI 10.1073/pnas.082102599; Couto A, 2005, CURR BIOL, V15, P1535, DOI 10.1016/j.cub.2005.07.034; Dankert H, 2009, NAT METHODS, V6, P297, DOI [10.1038/NMETH.1310, 10.1038/nmeth.1310]; DAVIS TL, 1989, SYNTHESIS-STUTTGART, P936, DOI 10.1055/s-1989-27435; Fernandez MD, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000541; DOW MA, 1975, NATURE, V254, P511, DOI 10.1038/254511a0; Dulac C, 2003, NAT REV NEUROSCI, V4, P551, DOI 10.1038/nrn1140; Ejima A, 2007, CURR BIOL, V17, P599, DOI 10.1016/j.cub.2007.01.053; Everaerts C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009607; Ferveur JF, 2005, BEHAV GENET, V35, P279, DOI 10.1007/s10519-005-3220-5; Fishilevich E, 2005, CURR BIOL, V15, P1548, DOI 10.1016/j.cub.2005.07.066; Gong WJ, 2003, P NATL ACAD SCI USA, V100, P2556, DOI 10.1073/pnas.0535280100; Ha TS, 2006, J NEUROSCI, V26, P8727, DOI 10.1523/JNEUROSCI.0876-06.2006; Hoyer SC, 2008, CURR BIOL, V18, P159, DOI 10.1016/j.cub.2007.12.052; Issa FA, 2006, CURR BIOL, V16, P2217, DOI 10.1016/j.cub.2006.08.065; JALLON JM, 1984, BEHAV GENET, V14, P441, DOI 10.1007/BF01065444; Koganezawa M, 2010, CURR BIOL, V20, P1, DOI 10.1016/j.cub.2009.11.038; Krstic D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004457; Krupp JJ, 2008, CURR BIOL, V18, P1373, DOI 10.1016/j.cub.2008.07.089; Kurtovic A, 2007, NATURE, V446, P542, DOI 10.1038/nature05672; Lacaille F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000661; Lee Y, 2010, NEURON, V67, P555, DOI 10.1016/j.neuron.2010.07.006; Lee Y, 2009, P NATL ACAD SCI USA, V106, P4495, DOI 10.1073/pnas.0811744106; Leypold BG, 2002, P NATL ACAD SCI USA, V99, P6376, DOI 10.1073/pnas.082127599; Mandiyan VS, 2005, NAT NEUROSCI, V8, P1660, DOI 10.1038/nn1589; Marella S, 2006, NEURON, V49, P285, DOI 10.1016/j.neuron.2005.11.037; McGuire SE, 2003, SCIENCE, V302, P1765, DOI 10.1126/science.1089035; Miyamoto T, 2008, NAT NEUROSCI, V11, P874, DOI 10.1038/nn.2161; Mombaerts P, 2004, NAT REV NEUROSCI, V5, P263, DOI 10.1038/nrn1365; Moon SJ, 2009, CURR BIOL, V19, P1623, DOI 10.1016/j.cub.2009.07.061; Root CM, 2008, NEURON, V59, P311, DOI 10.1016/j.neuron.2008.07.003; Savarit F, 1999, P NATL ACAD SCI USA, V96, P9015, DOI 10.1073/pnas.96.16.9015; Stowers L, 2002, SCIENCE, V295, P1493, DOI 10.1126/science.1069259; Thorne N, 2004, CURR BIOL, V14, P1065, DOI 10.1016/j.cub.2004.05.019; Touhara K, 2009, ANNU REV PHYSIOL, V71, P307, DOI 10.1146/annurev.physiol.010908.163209; van Naters WVG, 2007, CURR BIOL, V17, P606, DOI 10.1016/j.cub.2007.02.043; Vrontou E, 2006, NAT NEUROSCI, V9, P1469, DOI 10.1038/nn1809; Wang LM, 2008, P NATL ACAD SCI USA, V105, P5657, DOI 10.1073/pnas.0801327105; Wang LM, 2010, NATURE, V463, P227, DOI 10.1038/nature08678; Wang ZR, 2004, CELL, V117, P981, DOI 10.1016/j.cell.2004.06.011; Weiss LA, 2011, NEURON, V69, P258, DOI 10.1016/j.neuron.2011.01.001; WENKERT E, 1985, J ORG CHEM, V50, P719, DOI 10.1021/jo00205a042; Wolff Nancy, 2009, J Correct Health Care, V15, P58, DOI 10.1177/1078345808326622; Yew JY, 2009, CURR BIOL, V19, P1245, DOI 10.1016/j.cub.2009.06.037; Yoon HY, 2005, CELL, V123, P669, DOI 10.1016/j.cell.2005.08.039; Zhou L, 1997, P NATL ACAD SCI USA, V94, P5131, DOI 10.1073/pnas.94.10.5131	50	139	141	1	61	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2011	14	6					757	U392		10.1038/nn.2800	http://dx.doi.org/10.1038/nn.2800			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	768SH	21516101	Green Accepted			2022-12-28	WOS:000290958000019
J	Esteve, P; Sandonis, A; Cardozo, M; Malapeira, J; Ibanez, C; Crespo, I; Marcos, S; Gonzalez-Garcia, S; Toribio, ML; Arribas, J; Shimono, A; Guerrero, I; Bovolenta, P				Esteve, Pilar; Sandonis, Africa; Cardozo, Marcos; Malapeira, Jordi; Ibanez, Carmen; Crespo, Inmaculada; Marcos, Severine; Gonzalez-Garcia, Sara; Luisa Toribio, Maria; Arribas, Joaquin; Shimono, Akihiko; Guerrero, Isabel; Bovolenta, Paola			SFRPs act as negative modulators of ADAM10 to regulate retinal neurogenesis	NATURE NEUROSCIENCE			English	Article							FRIZZLED-RELATED PROTEIN-2; AMYLOID PRECURSOR PROTEIN; ALPHA-SECRETASE; MYOCARDIAL-INFARCTION; BETA-CATENIN; CELL-FATE; NOTCH; INHIBITORS; MOUSE; METALLOPROTEINASES	It is well established that retinal neurogenesis in mouse embryos requires the activation of Notch signaling, but is independent of the Wnt signaling pathway. We found that genetic inactivation of Sfrp1 and Sfrp2, two postulated Wnt antagonists, perturbs retinal neurogenesis. In retinas from Sfrp1(-/-); Sfrp2(-/-) embryos, Notch signaling was transiently upregulated because Sfrps bind ADAM10 metalloprotease and downregulate its activity, an important step in Notch activation. The proteolysis of other ADAM10 substrates, including APP, was consistently altered in Sfrp mutants, whereas pharmacological inhibition of ADAM10 partially rescued the Sfrp1(-/-); Sfrp2(-/-) retinal phenotype. Conversely, ectopic Sfrp1 expression in the Drosophila wing imaginal disc prevented the expression of Notch targets, and this was restored by the coexpression of Kuzbanian, the Drosophila ADAM10 homolog. Together, these data indicate that Sfrps inhibit the ADAM10 metalloprotease, which might have important implications in pathological events, including cancer and Alzheimer's disease.	[Esteve, Pilar; Sandonis, Africa; Cardozo, Marcos; Ibanez, Carmen; Crespo, Inmaculada; Marcos, Severine; Gonzalez-Garcia, Sara; Luisa Toribio, Maria; Guerrero, Isabel; Bovolenta, Paola] Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa, Consejo Super Invest Cient CSIC, Madrid, Spain; [Esteve, Pilar; Sandonis, Africa; Cardozo, Marcos; Crespo, Inmaculada; Marcos, Severine; Bovolenta, Paola] Ctr Invest Biomed Red Enfermedades Raras, Madrid, Spain; [Esteve, Pilar; Sandonis, Africa; Cardozo, Marcos; Crespo, Inmaculada; Marcos, Severine; Bovolenta, Paola] CSIC, Inst Cajal, E-28002 Madrid, Spain; [Malapeira, Jordi; Arribas, Joaquin] Vall dHebron Inst Oncol, Barcelona, Spain; [Malapeira, Jordi; Arribas, Joaquin] Univ Autonoma Barcelona, Dept Biochem & Mol Biol, Bellaterra, Spain; [Malapeira, Jordi; Arribas, Joaquin] Inst Catalana Recerca & Estudis Avancats, Barcelona, Spain; [Shimono, Akihiko] Natl Univ Singapore, Can Sci Inst Singapore, Singapore 117548, Singapore	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Cajal (IC); Vall d'Hebron Institut d'Oncologia (VHIO); Autonomous University of Barcelona; ICREA; National University of Singapore	Esteve, P (corresponding author), Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa, Consejo Super Invest Cient CSIC, Madrid, Spain.	pesteve@cbm.uam.es; pbovolenta@cbm.uam.es	Arribas, Joaquin/M-4482-2014; González-García, Sara/Y-9913-2019; Crespo, Inmaculada/AAB-5451-2019; Guerrero, Isabel/K-2518-2014; Toribio, Maria L/C-2039-2017; Malapeira, Jordi/I-7956-2014	Arribas, Joaquin/0000-0002-0504-0664; González-García, Sara/0000-0002-0315-2136; Crespo, Inmaculada/0000-0003-3086-9762; Guerrero, Isabel/0000-0001-6761-1218; Toribio, Maria L/0000-0002-8637-0373; Cardozo, Marcos J/0000-0003-2246-2946; Malapeira, Jordi/0000-0003-3503-1272	Spanish MICINN [BFU2007-61774]; Fundacion Mutual Madrilena [2006-0916]; Comunidad Autonoma de Madrid [P-SAL-0190-2006]; CSIC; Spanish Ministerio de Ciencia e Innovacion [BFU2008-03320/BMC, CSD2007-00008]; Fundacion Areces; CIBERER; ICREA Funding Source: Custom	Spanish MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Fundacion Mutual Madrilena; Comunidad Autonoma de Madrid(Comunidad de Madrid); CSIC; Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Fundacion Areces; CIBERER; ICREA(ICREA)	We thank J.M. Ruiz for help with initial experiments and I. Dompablo for technical assistance, H. Bellen (Jan and Dan Duncan Neurological Research Institute), T. Tabata (University of Tokyo), S. Campuzano (CSIC-Universidad Autonoma de Madrid) and the Developmental Studies Hybridoma Bank for Drosophila antibodies and stocks, and A. Ludwig (RWTH Aachen University) for the G1254023X compound. This work was supported by grants from the Spanish MICINN (BFU2007-61774), Fundacion Mutual Madrilena (2006-0916), Comunidad Autonoma de Madrid (P-SAL-0190-2006), Programa Intramural Especial-CSIC and CIBERER intramural funds to P. B.; CSIC intramural funds to P. E.; grants BFU2008-03320/BMC and CSD2007-00008 from the Spanish Ministerio de Ciencia e Innovacion to I. G. and an institutional grant from Fundacion Areces given to the Centro de Biologia Molecular "Severo Ochoa" to I.G. and M.L.T.	Amour A, 2000, FEBS LETT, V473, P275, DOI 10.1016/S0014-5793(00)01528-3; Bovolenta P, 2008, J CELL SCI, V121, P737, DOI 10.1242/jcs.026096; Caille I, 2004, DEVELOPMENT, V131, P2173, DOI 10.1242/dev.01103; Campbell C, 2008, CURR OPIN HEMATOL, V15, P319, DOI 10.1097/MOH.0b013e328303b9df; Cho SH, 2006, DEVELOPMENT, V133, P3167, DOI 10.1242/dev.02474; Del Monte G, 2007, DEV DYNAM, V236, P2594, DOI 10.1002/dvdy.21246; Donmez G, 2010, CELL, V142, P320, DOI 10.1016/j.cell.2010.06.020; Edwards DR, 2008, MOL ASPECTS MED, V29, P258, DOI 10.1016/j.mam.2008.08.001; Esteve P, 2006, CURR OPIN NEUROBIOL, V16, P13, DOI 10.1016/j.conb.2006.01.001; Fu XY, 2006, DEV BIOL, V299, P424, DOI 10.1016/j.ydbio.2006.08.015; Gavert N, 2007, CANCER RES, V67, P7703, DOI 10.1158/0008-5472.CAN-07-0991; Hartmann D, 2002, HUM MOL GENET, V11, P2615, DOI 10.1093/hmg/11.21.2615; Hayward P, 2008, DEVELOPMENT, V135, P411, DOI 10.1242/dev.000505; He W, 2010, P NATL ACAD SCI USA, V107, P21110, DOI 10.1073/pnas.1004708107; Jorissen E, 2010, J NEUROSCI, V30, P4833, DOI 10.1523/JNEUROSCI.5221-09.2010; Kim AS, 2001, MECH DEVELOP, V103, P167, DOI 10.1016/S0925-4773(01)00342-2; Kobayashi K, 2009, NAT CELL BIOL, V11, P46, DOI 10.1038/ncb1811; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Kubo F, 2009, DEVELOPMENT, V136, P1823, DOI 10.1242/dev.029272; Kuhn PH, 2010, EMBO J, V29, P3020, DOI 10.1038/emboj.2010.167; Langton KP, 1998, J BIOL CHEM, V273, P16778, DOI 10.1074/jbc.273.27.16778; Lee HX, 2006, CELL, V124, P147, DOI 10.1016/j.cell.2005.12.018; Lichtenthaler SF, 2011, J NEUROCHEM, V116, P10, DOI 10.1111/j.1471-4159.2010.07081.x; Liu CQ, 2008, DEVELOPMENT, V135, P3567, DOI 10.1242/dev.028076; Liu H, 2003, DEV DYNAM, V227, P323, DOI 10.1002/dvdy.10315; Liu H, 2007, DEV BIOL, V308, P54, DOI 10.1016/j.ydbio.2007.04.052; Livesey FJ, 2001, NAT REV NEUROSCI, V2, P109, DOI 10.1038/35053522; Lopez-Rios J, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-19; Ludwig A, 2005, COMB CHEM HIGH T SCR, V8, P161, DOI 10.2174/1386207053258488; Matsuda Y, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2317; Micchelli CA, 1997, DEVELOPMENT, V124, P1485; Mii Y, 2009, DEVELOPMENT, V136, P4083, DOI 10.1242/dev.032524; Misra K, 2010, DEV BIOL, V337, P74, DOI 10.1016/j.ydbio.2009.10.015; Morcillo J, 2006, DEVELOPMENT, V133, P3179, DOI 10.1242/dev.02493; Mott JD, 2000, J BIOL CHEM, V275, P1384, DOI 10.1074/jbc.275.2.1384; Muraguchi T, 2007, NAT NEUROSCI, V10, P838, DOI 10.1038/nn1922; Muraoka O, 2006, NAT CELL BIOL, V8, P329, DOI 10.1038/ncb1379; Nolo R, 2000, CELL, V102, P349, DOI 10.1016/S0092-8674(00)00040-4; Reiss K, 2005, EMBO J, V24, P742, DOI 10.1038/sj.emboj.7600548; Riedle S, 2009, BIOCHEM J, V420, P391, DOI 10.1042/BJ20081625; Rodriguez J, 2005, NAT NEUROSCI, V8, P1301, DOI 10.1038/nn1547; Satoh W, 2006, DEVELOPMENT, V133, P989, DOI 10.1242/dev.02274; Satoh W, 2008, GENESIS, V46, P92, DOI 10.1002/dvg.20369; Stetler-Stevenson WG, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.127re6; Tanimoto H, 2000, MOL CELL, V5, P59, DOI 10.1016/S1097-2765(00)80403-7; Tokunaga A, 2004, J NEUROCHEM, V90, P142, DOI 10.1111/j.1471-4159.2004.02470.x; Torroja C, 2004, DEVELOPMENT, V131, P2395, DOI 10.1242/dev.01102; Trevant B, 2008, J CELL PHYSIOL, V217, P113, DOI 10.1002/jcp.21482; Uren A, 2000, J BIOL CHEM, V275, P4374, DOI 10.1074/jbc.275.6.4374; Wall DS, 2009, J CELL BIOL, V184, P101, DOI 10.1083/jcb.200805155	50	68	69	1	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2011	14	5					562	U43		10.1038/nn.2794	http://dx.doi.org/10.1038/nn.2794			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	754VU	21478884				2022-12-28	WOS:000289886600011
J	Murray, AJ; Sauer, JF; Riedel, G; McClure, C; Ansel, L; Cheyne, L; Bartos, M; Wisden, W; Wulff, P				Murray, Andrew J.; Sauer, Jonas-Frederic; Riedel, Gernot; McClure, Christina; Ansel, Laura; Cheyne, Lesley; Bartos, Marlene; Wisden, William; Wulff, Peer			Parvalbumin-positive CA1 interneurons are required for spatial working but not for reference memory	NATURE NEUROSCIENCE			English	Article							HIPPOCAMPAL; SCHIZOPHRENIA; INHIBITION; BEHAVIOR; NEURONS	Parvalbumin-positive GABAergic interneurons in cortical circuits are hypothesized to control cognitive function. To test this idea directly, we functionally removed parvalbumin-positive interneurons selectively from hippocampal CA1 in mice. We found that parvalbumin-positive interneurons are dispensable for spatial reference, but are essential for spatial working memory.	[Murray, Andrew J.; Sauer, Jonas-Frederic; Riedel, Gernot; McClure, Christina; Ansel, Laura; Cheyne, Lesley; Bartos, Marlene; Wisden, William; Wulff, Peer] Univ Aberdeen, Inst Med Sci, Aberdeen, Scotland	University of Aberdeen	Wulff, P (corresponding author), Univ Aberdeen, Inst Med Sci, Foresterhill, Aberdeen, Scotland.	w.wisden@imperial.ac.uk; p.wulff@abdn.ac.uk	Wisden, William/A-4071-2011	Wisden, William/0000-0003-4743-0334; McClure, Christina/0000-0002-8207-450X; Ansel Bollepalli, Laura/0000-0003-2324-7228; Bollepalli, Laura/0000-0001-5902-059X; Sauer, Jonas-Frederic/0000-0002-6854-7294; Bartos, Marlene/0000-0001-9741-1946; Wulff, Peer/0000-0002-0282-7832	Northern Research Partnership; Biotechnology and Biological Sciences Research Council [BB/H001123/1]; Royal Society; University of Aberdeen; J. Ernest Tait Estate; Lichtenberg Award; Medical Research Council [G0800401, G0601498]; BBSRC [BB/H001123/1] Funding Source: UKRI; MRC [G0601498, G0800401, G0800399] Funding Source: UKRI; Medical Research Council [G0800399] Funding Source: researchfish	Northern Research Partnership; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Royal Society(Royal Society of London); University of Aberdeen; J. Ernest Tait Estate; Lichtenberg Award; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank M. Klugmann and T. Kuner for AAV plasmids and technical advice, E. Fuchs and H. Monyer for Pvalb-cre mice, R. Yu for tetanus toxin light chain cDNA, D. Kuhl for the Arc/Arg3.1 cDNA, T. Goetz for bringing the FLEX system to our attention, C. Black for participation in the initial cloning of AAV vectors, P. Teismann and the microscopy core facility at the University of Aberdeen for the use of microscopy equipment, and L. Strachan, A. Plano and S. Deiana for help with surgeries and behavioral testing. We were supported by the Northern Research Partnership (J.-F.S.), Biotechnology and Biological Sciences Research Council grant BB/H001123/1 (P. W.), the Royal Society (M. B. and P. W.), the University of Aberdeen (M. B., W. W. and P. W.), the J. Ernest Tait Estate (W. W.), the Lichtenberg Award (M. B.) and Medical Research Council grants G0800401 (G.R.) and G0601498 (W.W. and P.W.).	Atasoy D, 2008, J NEUROSCI, V28, P7025, DOI 10.1523/JNEUROSCI.1954-08.2008; Baude A, 2007, CEREB CORTEX, V17, P2094, DOI 10.1093/cercor/bhl117; Behrens MM, 2007, SCIENCE, V318, P1645, DOI 10.1126/science.1148045; Fuchs EC, 2007, NEURON, V53, P591, DOI 10.1016/j.neuron.2007.01.031; Glickfeld LL, 2008, J NEUROSCI, V28, P1824, DOI 10.1523/JNEUROSCI.4700-07.2008; Hampson RE, 1999, J NEUROSCI, V19, P1492; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; Lewis DA, 2005, NAT REV NEUROSCI, V6, P312, DOI 10.1038/nrn1648; Morris BJ, 2005, CURR OPIN PHARMACOL, V5, P101, DOI 10.1016/j.coph.2004.08.008; OLTON DS, 1979, BEHAV BRAIN SCI, V2, P313, DOI 10.1017/S0140525X00062713; Reisel D, 2002, NAT NEUROSCI, V5, P868, DOI 10.1038/nn910; Riedel G, 1999, NAT NEUROSCI, V2, P898, DOI 10.1038/13202; Wulff P, 2009, P NATL ACAD SCI USA, V106, P3561, DOI 10.1073/pnas.0813176106; Yamamoto M, 2003, J NEUROSCI, V23, P6759; Zhang ZJ, 2002, SCHIZOPHR RES, V55, P1, DOI 10.1016/S0920-9964(01)00188-8	15	199	202	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2011	14	3					297	299		10.1038/nn.2751	http://dx.doi.org/10.1038/nn.2751			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	725MW	21278730	Green Accepted, Green Submitted			2022-12-28	WOS:000287650100008
J	Fu, AKY; Hung, KW; Fu, WY; Shen, C; Chen, Y; Xia, J; Lai, KO; Ip, NY				Fu, Amy K. Y.; Hung, Kwok-Wang; Fu, Wing-Yu; Shen, Chong; Chen, Yu; Xia, Jun; Lai, Kwok-On; Ip, Nancy Y.			APC(Cdh1) mediates EphA4-dependent downregulation of AMPA receptors in homeostatic plasticity	NATURE NEUROSCIENCE			English	Article							DENDRITIC SPINE MORPHOGENESIS; UBIQUITIN-PROTEASOME SYSTEM; ANAPHASE-PROMOTING COMPLEX; POSTSYNAPTIC DENSITY; GLUTAMATE RECEPTORS; SYNAPTIC PLASTICITY; PROTEIN-DEGRADATION; EXPRESSION; MODULATION; TRAFFICKING	Homeostatic plasticity is crucial for maintaining neuronal output by counteracting unrestrained changes in synaptic strength. Chronic elevation of synaptic activity by bicuculline reduces the amplitude of miniature excitatory postsynaptic currents (mEPSCs), but the underlying mechanisms of this effect remain unclear. We found that activation of EphA4 resulted in a decrease in synaptic and surface GluR1 and attenuated mEPSC amplitude through a degradation pathway that requires the ubiquitin proteasome system (UPS). Elevated synaptic activity resulted in increased tyrosine phosphorylation of EphA4, which associated with the ubiquitin ligase anaphase-promoting complex (APC) and its activator Cdh1 in neurons in a ligand-dependent manner. APC(Cdh1) interacted with and targeted GluR1 for proteasomal degradation in vitro, whereas depletion of Cdh1 in neurons abolished the EphA4-dependent downregulation of GluR1. Knockdown of EphA4 or Cdh1 prevented the reduction in mEPSC amplitude in neurons that was a result of chronic elevated activity. Our results define a mechanism by which EphA4 regulates homeostatic plasticity through an APC(Cdh1)-dependent degradation pathway.	[Fu, Amy K. Y.; Hung, Kwok-Wang; Fu, Wing-Yu; Shen, Chong; Chen, Yu; Xia, Jun; Lai, Kwok-On; Ip, Nancy Y.] Hong Kong Univ Sci & Technol, Ctr Neurosci, State Key Lab Mol Neurosci & Mol, Dept Biochem, Hong Kong, Peoples R China	Hong Kong University of Science & Technology	Ip, NY (corresponding author), Hong Kong Univ Sci & Technol, Ctr Neurosci, State Key Lab Mol Neurosci & Mol, Dept Biochem, Hong Kong, Peoples R China.	boip@ust.hk	Lai, Kwok On/ABC-8046-2021; Lai, Kwok-On/E-5182-2011; Lai, Kwok-On/L-7468-2019; shen, chong/J-7256-2015; Xia, Jun/C-7234-2009	Lai, Kwok-On/0000-0002-4069-054X; shen, chong/0000-0002-6222-4304; Fu, Kit Yu/0000-0003-4085-6201; Ip, Nancy Yuk-Yu/0000-0002-2763-8907; Xia, Jun/0000-0001-9308-2188	Research Grants Council of Hong Kong SAR (HKUST) [6444/06M, 661007, 661109, 1/06C, 6/CRF/08]; Area of Excellence Scheme of the University Grants Committee [AoE/B-15/01]; Hong Kong Jockey Club; Croucher Foundation	Research Grants Council of Hong Kong SAR (HKUST)(Hong Kong Research Grants Council); Area of Excellence Scheme of the University Grants Committee; Hong Kong Jockey Club; Croucher Foundation	We thank P. Bartlett for EphA4<SUP>-/-</SUP> mice, R. Huganir for GluR1 antibodies and the GluR1 4KR mutant expression construct, R. Malinow for the GluR1-GFP construct, J. Chamberlain for the mouse muscle cDNA library, L. Shi, W. Chau, K. Kong, X.-N. Li, W. Fang, E. Cheung, B. Butt and C. Kwong for technical assistance, and members of the Ip laboratory for discussions. This study was supported in part by the Research Grants Council of Hong Kong SAR (HKUST, 6444/06M, 661007, 661109, 1/06C and 6/CRF/08), the Area of Excellence Scheme of the University Grants Committee (AoE/B-15/01) and the Hong Kong Jockey Club. N.Y. Ip and K.-O. Lai were recipients of the Croucher Foundation Senior Research Fellowship and Croucher Foundation Fellowship, respectively.	Ang XL, 2008, J BIOL CHEM, V283, P29424, DOI 10.1074/jbc.M802475200; Bingol B, 2005, CURR OPIN NEUROBIOL, V15, P536, DOI 10.1016/j.conb.2005.08.016; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Burbea M, 2002, NEURON, V35, P107, DOI 10.1016/S0896-6273(02)00749-3; Burrone J, 2002, NATURE, V420, P414, DOI 10.1038/nature01242; Castro A, 2005, ONCOGENE, V24, P314, DOI 10.1038/sj.onc.1207973; Cheng K, 2002, J BIOL CHEM, V277, P31988, DOI 10.1074/jbc.M201161200; Ciechanover A, 2005, CELL DEATH DIFFER, V12, P1178, DOI 10.1038/sj.cdd.4401692; Colledge M, 2003, NEURON, V40, P595, DOI 10.1016/S0896-6273(03)00687-1; Dalva MB, 2000, CELL, V103, P945, DOI 10.1016/S0092-8674(00)00197-5; Deininger K, 2008, P NATL ACAD SCI USA, V105, P12539, DOI 10.1073/pnas.0801174105; Ehlers MD, 2003, NAT NEUROSCI, V6, P231, DOI 10.1038/nn1013; Fu WY, 2007, NAT NEUROSCI, V10, P67, DOI 10.1038/nn1811; Gieffers C, 1999, P NATL ACAD SCI USA, V96, P11317, DOI 10.1073/pnas.96.20.11317; Haglund K, 2003, TRENDS BIOCHEM SCI, V28, P598, DOI 10.1016/j.tibs.2003.09.005; Helton TD, 2008, P NATL ACAD SCI USA, V105, P19492, DOI 10.1073/pnas.0802280105; Henkemeyer M, 2003, J CELL BIOL, V163, P1313, DOI 10.1083/jcb.200306033; Jordan BA, 2004, MOL CELL PROTEOMICS, V3, P857, DOI 10.1074/mcp.M400045-MCP200; Juo P, 2004, CURR BIOL, V14, P2057, DOI 10.1016/j.cub.2004.11.010; Kato A, 2005, P NATL ACAD SCI USA, V102, P5600, DOI 10.1073/pnas.0501769102; Klein R, 2009, NAT NEUROSCI, V12, P15, DOI 10.1038/nn.2231; Konishi Y, 2004, SCIENCE, V303, P1026, DOI 10.1126/science.1093712; Kraft C, 2005, MOL CELL, V18, P543, DOI 10.1016/j.molcel.2005.04.023; Li KW, 2004, J BIOL CHEM, V279, P987, DOI 10.1074/jbc.M303116200; Lim KL, 2005, J NEUROSCI, V25, P2002, DOI 10.1523/JNEUROSCI.4474-04.2005; Lissin DV, 1998, P NATL ACAD SCI USA, V95, P7097, DOI 10.1073/pnas.95.12.7097; Listovsky T, 2004, EMBO J, V23, P1619, DOI 10.1038/sj.emboj.7600149; Malinow R, 2003, PHILOS T ROY SOC B, V358, P707, DOI 10.1098/rstb.2002.1233; Matyskiela Mary E., 2009, Journal of Biology (London), V8, P92, DOI 10.1186/jbiol184; Murai KK, 2003, NAT NEUROSCI, V6, P153, DOI 10.1038/nn994; Murthy VN, 2001, NEURON, V32, P673, DOI 10.1016/S0896-6273(01)00500-1; O'Brien RJ, 1998, NEURON, V21, P1067, DOI 10.1016/S0896-6273(00)80624-8; O'Brien RJ, 1998, CURR OPIN NEUROBIOL, V8, P364, DOI 10.1016/S0959-4388(98)80062-7; Pasquale EB, 2008, CELL, V133, P38, DOI 10.1016/j.cell.2008.03.011; Patrick GN, 2003, CURR BIOL, V13, P2073, DOI 10.1016/j.cub.2003.10.028; Penzes P, 2003, NEURON, V37, P263, DOI 10.1016/S0896-6273(02)01168-6; Pozo K, 2010, NEURON, V66, P337, DOI 10.1016/j.neuron.2010.04.028; Sala C, 2003, J NEUROSCI, V23, P6327; Sala C, 2001, NEURON, V31, P115, DOI 10.1016/S0896-6273(01)00339-7; Seeburg DP, 2008, NEURON, V58, P571, DOI 10.1016/j.neuron.2008.03.021; Shepherd JD, 2006, NEURON, V52, P475, DOI 10.1016/j.neuron.2006.08.034; Stellwagen D, 2006, NATURE, V440, P1054, DOI 10.1038/nature04671; Takasu MA, 2002, SCIENCE, V295, P491, DOI 10.1126/science.1065983; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; Turrigiano GG, 2008, CELL, V135, P422, DOI 10.1016/j.cell.2008.10.008; van Roessel P, 2004, CELL, V119, P707, DOI 10.1016/j.cell.2004.11.028; Wierenga CJ, 2005, J NEUROSCI, V25, P2895, DOI 10.1523/JNEUROSCI.5217-04.2005; Yi JJ, 2005, NEURON, V47, P629, DOI 10.1016/j.neuron.2005.07.008; Zhang DW, 2009, J NEUROSCI, V29, P4498, DOI 10.1523/JNEUROSCI.6094-08.2009; Zhao YL, 2003, CURR BIOL, V13, P887, DOI 10.1016/S0960-9822(03)00332-4	50	127	128	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2011	14	2					181	U263		10.1038/nn.2715	http://dx.doi.org/10.1038/nn.2715			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	711MJ	21186356				2022-12-28	WOS:000286595400015
J	Rosenzweig, ES; Courtine, G; Jindrich, DL; Brock, JH; Ferguson, AR; Strand, SC; Nout, YS; Roy, RR; Miller, DM; Beattie, MS; Havton, LA; Bresnahan, JC; Edgerton, VR; Tuszynski, MH				Rosenzweig, Ephron S.; Courtine, Gregoire; Jindrich, Devin L.; Brock, John H.; Ferguson, Adam R.; Strand, Sarah C.; Nout, Yvette S.; Roy, Roland R.; Miller, Darren M.; Beattie, Michael S.; Havton, Leif A.; Bresnahan, Jacqueline C.; Edgerton, V. Reggie; Tuszynski, Mark H.			Extensive spontaneous plasticity of corticospinal projections after primate spinal cord injury	NATURE NEUROSCIENCE			English	Article							SAMPLE-SIZE; BROWN-SEQUARD; MOTOR CORTEX; RECOVERY; REGENERATION; AXONS; ORGANIZATION; CONNECTIONS; SYSTEM; GROWTH	Although axonal regeneration after CNS injury is limited, partial injury is frequently accompanied by extensive functional recovery. To investigate mechanisms underlying spontaneous recovery after incomplete spinal cord injury, we administered C7 spinal cord hemisections to adult rhesus monkeys and analyzed behavioral, electrophysiological and anatomical adaptations. We found marked spontaneous plasticity of corticospinal projections, with reconstitution of fully 60% of pre-lesion axon density arising from sprouting of spinal cord midline-crossing axons. This extensive anatomical recovery was associated with improvement in coordinated muscle recruitment, hand function and locomotion. These findings identify what may be the most extensive natural recovery of mammalian axonal projections after nervous system injury observed to date, highlighting an important role for primate models in translational disease research.	[Rosenzweig, Ephron S.; Brock, John H.; Miller, Darren M.; Tuszynski, Mark H.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Courtine, Gregoire; Jindrich, Devin L.; Roy, Roland R.; Havton, Leif A.; Edgerton, V. Reggie] Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90024 USA; [Courtine, Gregoire; Jindrich, Devin L.; Roy, Roland R.; Havton, Leif A.; Edgerton, V. Reggie] Univ Calif Los Angeles, Dept Physiol Sci, Los Angeles, CA 90024 USA; [Courtine, Gregoire] Univ Zurich, Dept Neurol, Zurich, Switzerland; [Ferguson, Adam R.; Nout, Yvette S.; Beattie, Michael S.; Bresnahan, Jacqueline C.] Univ Calif San Francisco, Dept Neurosurg, San Francisco, CA 94143 USA; [Strand, Sarah C.] Univ Calif Davis, Calif Natl Primate Res Ctr, Davis, CA 95616 USA; [Tuszynski, Mark H.] Vet Adm Med Ctr, La Jolla, CA 90034 USA	University of California System; University of California San Diego; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of Zurich; University of California System; University of California San Francisco; University of California System; University of California Davis; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Tuszynski, MH (corresponding author), Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA.	mtuszynski@ucsd.edu	courtine, gregoire/AAJ-1694-2020; Rosenzweig, Ephron/AAI-7541-2020	courtine, gregoire/0000-0002-5744-4142; Rosenzweig, Ephron/0000-0002-0370-9643; Ferguson, Adam/0000-0001-7102-1608	US National Institutes of Health [NS42291, NS049881, NS053059]; Veterans Administration; California Roman-Reed funds; Bernard and Anne Spitzer Charitable Trust; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS053059, R01NS049041, R01NS042291, R01NS049881, R01NS067092] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Administration(US Department of Veterans Affairs); California Roman-Reed funds; Bernard and Anne Spitzer Charitable Trust; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors thank H. Yang, S. Zdunowski, M. Culbertson, H. Zhong, R. Moseanko, S. Hawbecker, H. McKay and T. Bernot for valuable experimental assistance. This work was supported by the US National Institutes of Health (NS42291, NS049881 and NS053059), the Veterans Administration, California Roman-Reed funds, the Bernard and Anne Spitzer Charitable Trust and the Dr. Miriam and Sheldon G. Adelson Medical Research Foundation.	Anderson KD, 2005, EXP NEUROL, V194, P161, DOI 10.1016/j.expneurol.2005.02.006; Bareyre FM, 2004, NAT NEUROSCI, V7, P269, DOI 10.1038/nn1195; Blesch A, 2009, TRENDS NEUROSCI, V32, P41, DOI 10.1016/j.tins.2008.09.008; Bradbury EJ, 2006, NAT REV NEUROSCI, V7, P644, DOI 10.1038/nrn1964; Brock JH, 2010, J NEUROSCI, V30, P9728, DOI 10.1523/JNEUROSCI.1924-10.2010; Brus-Ramer M, 2007, J NEUROSCI, V27, P13793, DOI 10.1523/JNEUROSCI.3489-07.2007; BUNGE RP, 1993, ADV NEUROL, V59, P75; CATTELL RB, 1966, MULTIVAR BEHAV RES, V1, P245, DOI 10.1207/s15327906mbr0102_10; CATTELL RB, 1969, EDUC PSYCHOL MEAS, V29, P781, DOI 10.1177/001316446902900405; Courtine G, 2005, BRAIN, V128, P2338, DOI 10.1093/brain/awh604; Courtine G, 2008, NAT MED, V14, P69, DOI 10.1038/nm1682; Courtine G, 2007, NAT MED, V13, P561, DOI 10.1038/nm1595; Courtine G, 2009, NAT NEUROSCI, V12, P1333, DOI 10.1038/nn.2401; Dancause N, 2005, J NEUROSCI, V25, P10167, DOI 10.1523/JNEUROSCI.3256-05.2005; Fawcett JW, 2007, SPINAL CORD, V45, P190, DOI 10.1038/sj.sc.3102007; Ghosh A, 2009, J NEUROSCI, V29, P12210, DOI 10.1523/JNEUROSCI.1828-09.2009; GUADAGNOLI E, 1988, PSYCHOL BULL, V103, P265, DOI 10.1037/0033-2909.103.2.265; HAVTON L, 1987, NATURE, V325, P711, DOI 10.1038/325711a0; HEPPREYMOND MC, 1974, EXP BRAIN RES, V21, P519; Hogarty KY, 2005, EDUC PSYCHOL MEAS, V65, P202, DOI 10.1177/0013164404267287; Hollis ER, 2009, EXP NEUROL, V215, P53, DOI 10.1016/j.expneurol.2008.09.014; Isa T, 2007, PHYSIOLOGY, V22, P145, DOI 10.1152/physiol.00045.2006; JENNY AB, 1983, J NEUROSCI, V3, P567; KAISER HF, 1960, EDUC PSYCHOL MEAS, V20, P141, DOI 10.1177/001316446002000116; Kakulas B A, 1999, J Spinal Cord Med, V22, P119; Lacroix S, 2004, J COMP NEUROL, V473, P147, DOI 10.1002/cne.20051; LAWRENCE DG, 1968, BRAIN, V91, P1, DOI 10.1093/brain/91.1.1; LITTLE JW, 1985, PARAPLEGIA, V23, P39, DOI 10.1038/sc.1985.7; MacCallum RC, 1999, PSYCHOL METHODS, V4, P84, DOI 10.1037/1082-989x.4.1.84; Maier IC, 2008, J NEUROSCI, V28, P9386, DOI 10.1523/JNEUROSCI.1697-08.2008; NATHAN PW, 1973, BRAIN, V96, P471, DOI 10.1093/brain/96.3.471; RAISMAN G, 1969, BRAIN RES, V14, P25, DOI 10.1016/0006-8993(69)90029-8; Reader TA, 1999, NEUROCHEM INT, V34, P1, DOI 10.1016/S0197-0186(98)00048-5; Rosenzweig ES, 2009, J COMP NEUROL, V513, P151, DOI 10.1002/cne.21940; ROTH EJ, 1991, PARAPLEGIA, V29, P582, DOI 10.1038/sc.1991.86; Sasaki S, 2004, J NEUROPHYSIOL, V92, P3142, DOI 10.1152/jn.00342.2004; Steward O, 2008, EXP NEUROL, V209, P446, DOI 10.1016/j.expneurol.2007.12.010; Turner W.A., 1891, BRAIN, V14, P496; Weidner N, 2001, P NATL ACAD SCI USA, V98, P3513, DOI 10.1073/pnas.051626798	39	258	263	1	41	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2010	13	12					1505	U90		10.1038/nn.2691	http://dx.doi.org/10.1038/nn.2691			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	684CW	21076427	Green Accepted, Green Submitted			2022-12-28	WOS:000284525800015
J	Constantino, SM; Daw, ND				Constantino, Sara M.; Daw, Nathaniel D.			A closer look at choice	NATURE NEUROSCIENCE			English	Editorial Material							DECISION; REPRESENTATION		[Constantino, Sara M.; Daw, Nathaniel D.] NYU, Dept Psychol, New York, NY 10003 USA; [Daw, Nathaniel D.] NYU, Ctr Neural Sci, New York, NY 10003 USA	New York University; New York University	Constantino, SM (corresponding author), NYU, Dept Psychol, 6 Washington Pl, New York, NY 10003 USA.	nathaniel.daw@nyu.edu		Constantino, Sara/0000-0001-5533-5885				Armel KC, 2008, JUDGM DECIS MAK, V3, P396; Balleine BW, 2009, NEUROECONOMICS: DECISION MAKING AND THE BRAIN, P367, DOI 10.1016/B978-0-12-374176-9.00024-5; Daw ND, 2005, NAT NEUROSCI, V8, P1704, DOI 10.1038/nn1560; Erev I, 2008, J BEHAV DECIS MAKING, V21, P575, DOI 10.1002/bdm.602; Glimcher PW, 2009, NEUROECONOMICS: DECISION MAKING AND THE BRAIN, P503, DOI 10.1016/B978-0-12-374176-9.00032-4; Gold JI, 2002, NEURON, V36, P299, DOI 10.1016/S0896-6273(02)00971-6; Krajbich I, 2010, NAT NEUROSCI, V13, P1292, DOI 10.1038/nn.2635; Niv Y, 2006, TRENDS COGN SCI, V10, P375, DOI 10.1016/j.tics.2006.06.010; PAYNE JW, 1992, ANNU REV PSYCHOL, V43, P87, DOI 10.1146/annurev.ps.43.020192.000511; Platt ML, 1999, NATURE, V400, P233, DOI 10.1038/22268; Ratcliff R, 2004, PSYCHOL REV, V111, P333, DOI 10.1037/0033-295X.111.2.333; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Stewart N, 2006, COGNITIVE PSYCHOL, V53, P1, DOI 10.1016/j.cogpsych.2005.10.003; Sugrue LP, 2004, SCIENCE, V304, P1782, DOI 10.1126/science.1094765; Thier P, 1996, P NATL ACAD SCI USA, V93, P4962, DOI 10.1073/pnas.93.10.4962	15	5	5	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2010	13	10					1153	1154		10.1038/nn1010-1153	http://dx.doi.org/10.1038/nn1010-1153			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	654MB	20877275				2022-12-28	WOS:000282171300002
J	Fritz, JB; David, SV; Radtke-Schuller, S; Yin, PB; Shamma, SA				Fritz, Jonathan B.; David, Stephen V.; Radtke-Schuller, Susanne; Yin, Pingbo; Shamma, Shihab A.			Adaptive, behaviorally gated, persistent encoding of task-relevant auditory information in ferret frontal cortex	NATURE NEUROSCIENCE			English	Article							PRIMATE PREFRONTAL CORTEX; RECEPTIVE-FIELDS; SELECTIVE REPRESENTATION; TOP-DOWN; ATTENTION; MEMORY; PLASTICITY; PREMOTOR; NEURONS; ORGANIZATION	Top-down signals from frontal cortex are thought to be important in cognitive control of sensory processing. To explore this interaction, we compared activity in ferret frontal cortex and primary auditory cortex (A1) during auditory and visual tasks requiring discrimination between classes of reference and target stimuli. Frontal cortex responses were behaviorally gated, selectively encoded the timing and invariant behavioral meaning of target stimuli, could be rapid in onset, and sometimes persisted for hours following behavior. These results are consistent with earlier findings in A1 that attention triggered rapid, selective, persistent, task-related changes in spectrotemporal receptive fields. Simultaneously recorded local field potentials revealed behaviorally gated changes in inter-areal coherence that were selectively modulated between frontal cortex and focal regions of A1 that were responsive to target sounds. These results suggest that A1 and frontal cortex dynamically establish a functional connection during auditory behavior that shapes the flow of sensory information and maintains a persistent trace of recent task-relevant stimulus features.	[Fritz, Jonathan B.; David, Stephen V.; Yin, Pingbo; Shamma, Shihab A.] Univ Maryland, Syst Res Inst, College Pk, MD 20742 USA; [Radtke-Schuller, Susanne] Univ Munich, Bioctr, Div Neurobiol, Munich, Germany	University System of Maryland; University of Maryland College Park; University of Munich	Fritz, JB (corresponding author), Univ Maryland, Syst Res Inst, College Pk, MD 20742 USA.	ripple@umd.edu	Fritz, Jonathan/AAK-4863-2020; Shamma, Shihab A/F-9852-2012	David, Stephen/0000-0003-4135-3104; Fritz, Jonathan/0000-0002-0625-172X	US National Institutes of Health [R03DC005938, R01DC005779, F32DC008453]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [F32DC008453, R01DC005779, R01DC007657, R03DC005938] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We would like to thank A. Duque, J. Bizley, V. Bajo, F. Nodal and A. King for discussion and for generously sharing their unpublished neuroanatomical data on the ferret frontal cortex and its connectivity with auditory cortex, N. Mesgarani for assistance with customized MATLAB software development, M. Elhilali for discussion and for analysis of memory effects in A1, S. Gotts for discussion of LFP coherence, C. Carr for cheerfully sharing laboratory resources for neuroanatomical studies and A. Israelson, A. Rubin, K. Donaldson and D. Levitt for assistance in training the ferrets in this study. This research was funded by grants from the US National Institutes of Health (R03DC005938 to J. B. F., R01DC005779 to S. A. S. and J. B. F. and F32DC008453 to S. V. D.).	Anton-Erxleben K, 2009, CEREB CORTEX, V19, P2466, DOI 10.1093/cercor/bhp002; Baddeley A.D., 1986, WORKING MEMORY THOUG; Bizley JK, 2005, CEREB CORTEX, V15, P1637, DOI 10.1093/cercor/bhi042; Bodner M, 1996, NEUROREPORT, V7, P1905, DOI 10.1097/00001756-199608120-00006; Buschman TJ, 2007, SCIENCE, V315, P1860, DOI 10.1126/science.1138071; David SV, 2009, J NEUROSCI, V29, P3374, DOI 10.1523/JNEUROSCI.5249-08.2009; DIPELLEGRINO G, 1993, SOMATOSENS MOT RES, V10, P245; Duncan J, 2001, NAT REV NEUROSCI, V2, P820, DOI 10.1038/35097575; Duque A, 2010, CEREB CORTEX, V20, P1020, DOI 10.1093/cercor/bhp164; Ehlis AC, 2009, NEUROSCIENCE, V159, P1032, DOI 10.1016/j.neuroscience.2009.01.015; Engel AK, 2010, CURR OPIN NEUROBIOL, V20, P156, DOI 10.1016/j.conb.2010.02.015; Everling S, 2006, EUR J NEUROSCI, V23, P2197, DOI 10.1111/j.1460-9568.2006.04736.x; Freedman DJ, 2001, SCIENCE, V291, P312, DOI 10.1126/science.291.5502.312; Frey S, 2008, PROG BRAIN RES, V169, P117, DOI 10.1016/S0079-6123(07)00007-6; Fritz J, 2003, NAT NEUROSCI, V6, P1216, DOI 10.1038/nn1141; Fritz JB, 2005, J NEUROSCI, V25, P7623, DOI 10.1523/JNEUROSCI.1318-05.2005; Fritz JB, 2007, CURR OPIN NEUROBIOL, V17, P437, DOI 10.1016/j.conb.2007.07.011; Fritz JB, 2007, J NEUROPHYSIOL, V98, P2337, DOI 10.1152/jn.00552.2007; Fujisawa S, 2008, NAT NEUROSCI, V11, P823, DOI 10.1038/nn.2134; Funahashi S, 2006, NEUROSCIENCE, V139, P251, DOI 10.1016/j.neuroscience.2005.07.003; Fusi S, 2007, NEURON, V54, P319, DOI 10.1016/j.neuron.2007.03.017; Gold JI, 2007, ANNU REV NEUROSCI, V30, P535, DOI 10.1146/annurev.neuro.29.051605.113038; Goldman MS, 2009, NEURON, V61, P621, DOI 10.1016/j.neuron.2008.12.012; Golmayo L, 2003, NEUROSCIENCE, V119, P597, DOI 10.1016/S0306-4522(03)00031-9; Gregoriou GG, 2009, SCIENCE, V324, P1207, DOI 10.1126/science.1171402; Haider B, 2006, J NEUROSCI, V26, P4535, DOI 10.1523/JNEUROSCI.5297-05.2006; Jung MW, 2008, REV NEUROSCIENCE, V19, P29; Klein DJ, 2000, J COMPUT NEUROSCI, V9, P85, DOI 10.1023/A:1008990412183; Knight RT, 1999, ACTA PSYCHOL, V101, P159, DOI 10.1016/S0001-6918(99)00004-9; Lemus L, 2009, P NATL ACAD SCI USA, V106, P14640, DOI 10.1073/pnas.0907505106; Messinger A, 2009, J NEUROSCI, V29, P5640, DOI 10.1523/JNEUROSCI.3857-08.2009; Meyers EM, 2008, J NEUROPHYSIOL, V100, P1407, DOI 10.1152/jn.90248.2008; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Mitra P., 2007, OBSERVED BRAIN DYNAM; Morishima Y, 2009, NAT NEUROSCI, V12, P85, DOI 10.1038/nn.2237; Morris RGM, 2006, EUR J NEUROSCI, V23, P2829, DOI 10.1111/j.1460-9568.2006.04888.x; Murthy A, 2001, J NEUROPHYSIOL, V86, P2634, DOI 10.1152/jn.2001.86.5.2634; Polley DB, 2006, J NEUROSCI, V26, P4970, DOI 10.1523/JNEUROSCI.3771-05.2006; Rainer G, 1998, NATURE, V393, P577, DOI 10.1038/31235; Rasmusson DD, 2007, NEUROSCIENCE, V149, P232, DOI 10.1016/j.neuroscience.2007.06.057; Roelfsema PR, 2010, TRENDS COGN SCI, V14, P64, DOI 10.1016/j.tics.2009.11.005; Romanski Lizabeth M., 2004, Cognitive Affective & Behavioral Neuroscience, V4, P421, DOI 10.3758/CABN.4.4.421; Russ BE, 2007, HEARING RES, V229, P204, DOI 10.1016/j.heares.2006.10.010; Salinas E, 2009, J NEUROSCI, V29, P4369, DOI 10.1523/JNEUROSCI.0164-09.2009; Shima K, 2000, J NEUROPHYSIOL, V84, P2148, DOI 10.1152/jn.2000.84.4.2148; Sugihara T, 2006, J NEUROSCI, V26, P11138, DOI 10.1523/JNEUROSCI.3550-06.2006; Theunissen FE, 2001, NETWORK-COMP NEURAL, V12, P289, DOI 10.1088/0954-898X/12/3/304; Wallis JD, 2003, J NEUROPHYSIOL, V90, P1790, DOI 10.1152/jn.00086.2003; Wise SP, 2008, TRENDS NEUROSCI, V31, P599, DOI 10.1016/j.tins.2008.08.008; Woodman GF, 2007, CEREB CORTEX, V17, pI118, DOI 10.1093/cercor/bhm065	50	163	163	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2010	13	8					1011	U143		10.1038/nn.2598	http://dx.doi.org/10.1038/nn.2598			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	632DK	20622871	Green Accepted			2022-12-28	WOS:000280400600021
J	Lucantonio, F; Stalnaker, TA; Shaham, Y; Niv, Y; Schoenbaum, G				Lucantonio, Federica; Stalnaker, Thomas A.; Shaham, Yavin; Niv, Yael; Schoenbaum, Geoffrey			The impact of orbitofrontal dysfunction on cocaine addiction	NATURE NEUROSCIENCE			English	Review							ORBITAL PREFRONTAL CORTEX; DECISION-MAKING; DRUG-ADDICTION; BASOLATERAL AMYGDALA; NEURONAL-ACTIVITY; METHAMPHETAMINE ABUSERS; AMPHETAMINE EXPOSURE; BEHAVIORAL-CONTROL; REWARD PREFERENCE; EXPERIENCED RATS	Cocaine addiction is characterized by poor judgment and maladaptive decision-making. Here we review evidence implicating the orbitofrontal cortex in such behavior. This evidence suggests that cocaine-induced changes in orbitofrontal cortex disrupt the representation of states and transition functions that form the basis of flexible and adaptive 'model-based' behavioral control. By impairing this function, cocaine exposure leads to an overemphasis on less flexible, maladaptive 'model-free' control systems. We propose that such an effect accounts for the complex pattern of maladaptive behaviors associated with cocaine addiction.	[Lucantonio, Federica; Schoenbaum, Geoffrey] Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA; [Stalnaker, Thomas A.; Shaham, Yavin; Schoenbaum, Geoffrey] Natl Inst Drug Abuse, Intramural Res Program, Baltimore, MD USA; [Niv, Yael] Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA; [Niv, Yael] Princeton Univ, Inst Neurosci, Princeton, NJ 08544 USA	University System of Maryland; University of Maryland Baltimore; National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA); Princeton University; Princeton University	Schoenbaum, G (corresponding author), Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA.	schoenbg@schoenbaumlab.org	shaham, yavin/G-1306-2014		US National Institute on Drug Abuse; NATIONAL INSTITUTE ON DRUG ABUSE [ZIADA000434, ZIADA000587] Funding Source: NIH RePORTER	US National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This review is dedicated to the family of Jacob Peter Waletzky. The work of writing it was supported by funding from the intramural and extramural programs of the US National Institute on Drug Abuse, including time while G. S. and T. A. S. were employed at the University of Maryland, Baltimore. The opinions expressed in this article are the author's own and do not reflect the view of the US National Institutes of Health, the Department of Health and Human Services, or the United States government.	Adinoff R, 2001, AM J PSYCHIAT, V158, P390, DOI 10.1176/appi.ajp.158.3.390; Bechara A, 2005, NAT NEUROSCI, V8, P1458, DOI 10.1038/nn1584; Bechara A, 2001, NEUROPSYCHOLOGIA, V39, P376, DOI 10.1016/S0028-3932(00)00136-6; Breiter HC, 2001, NEURON, V30, P619, DOI 10.1016/S0896-6273(01)00303-8; Burke KA, 2007, FRONT INTEGR NEUROSC, V1, DOI [10.3389/neuro.07.002.2007, 10.3389/neuro.07/002.2007]; Burke KA, 2009, EUR J NEUROSCI, V30, P1941, DOI 10.1111/j.1460-9568.2009.06992.x; Calu DJ, 2007, LEARN MEMORY, V14, P325, DOI 10.1101/lm.534807; Camille N, 2004, SCIENCE, V304, P1167, DOI 10.1126/science.1094550; Cardinal RN, 2002, NEUROSCI BIOBEHAV R, V26, P321, DOI 10.1016/S0149-7634(02)00007-6; Coffey SF, 2003, EXP CLIN PSYCHOPHARM, V11, P18, DOI 10.1037/1064-1297.11.1.18; Cousens GA, 2003, INTEGR PHYS BEH SCI, V38, P272, DOI 10.1007/BF02688858; Critchley HD, 1996, J NEUROPHYSIOL, V75, P1673, DOI 10.1152/jn.1996.75.4.1673; Crombag HS, 2005, CEREB CORTEX, V15, P341, DOI 10.1093/cercor/bhh136; Daw ND, 2011, NEURON, V69, P1204, DOI 10.1016/j.neuron.2011.02.027; Daw ND, 2005, NAT NEUROSCI, V8, P1704, DOI 10.1038/nn1560; Deroche-Gamonet V, 2004, SCIENCE, V305, P1014, DOI 10.1126/science.1099020; Ersche KD, 2008, PSYCHOPHARMACOLOGY, V197, P421, DOI 10.1007/s00213-007-1051-1; Ersche KD, 2011, BRAIN, V134, P2013, DOI 10.1093/brain/awr138; Everitt BJ, 2008, PHILOS T R SOC B, V363, P3125, DOI 10.1098/rstb.2008.0089; Everitt BJ, 2005, NAT NEUROSCI, V8, P1481, DOI 10.1038/nn1579; Everitt BJ, 2002, J NEUROSCI, V22, P3312; Fellows LK, 2003, BRAIN, V126, P1830, DOI 10.1093/brain/awg180; Fillmore MT, 2006, J PSYCHOPHARMACOL, V20, P24, DOI 10.1177/0269881105057000; Franklin TR, 2002, BIOL PSYCHIAT, V51, P134, DOI 10.1016/S0006-3223(01)01269-0; Fuchs RA, 2004, J NEUROSCI, V24, P6600, DOI 10.1523/JNEUROSCI.1924-04.2004; Gallagher M, 1999, J NEUROSCI, V19, P6610; Gottfried JA, 2003, SCIENCE, V301, P1104, DOI 10.1126/science.1087919; Grant S, 2000, NEUROPSYCHOLOGIA, V38, P1180, DOI 10.1016/S0028-3932(99)00158-X; Heil SH, 2006, ADDICT BEHAV, V31, P1290, DOI 10.1016/j.addbeh.2005.09.005; Hikosaka K, 2004, EUR J NEUROSCI, V19, P1046, DOI 10.1111/j.0953-816X.2004.03120.x; Homayoun H, 2006, J NEUROSCI, V26, P8025, DOI 10.1523/JNEUROSCI.0842-06.2006; Im HI, 2010, NAT NEUROSCI, V13, P1120, DOI 10.1038/nn.2615; Izquierdo A, 2004, J NEUROSCI, V24, P7540, DOI 10.1523/JNEUROSCI.1921-04.2004; Izquierdo A, 2010, NEUROPSYCHOPHARMACOL, V35, P505, DOI 10.1038/npp.2009.155; Jentsch JD, 2002, NEUROPSYCHOPHARMACOL, V26, P183, DOI 10.1016/S0893-133X(01)00355-4; Jentsch JD, 1999, PSYCHOPHARMACOLOGY, V146, P373, DOI 10.1007/PL00005483; Kalivas PW, 2008, NEUROPSYCHOPHARMACOL, V33, P166, DOI 10.1038/sj.npp.1301564; Kantak KM, 2005, PSYCHOPHARMACOLOGY, V181, P227, DOI 10.1007/s00213-005-2243-1; Kim SJ, 2005, NEUROPSYCHOPHARMACOL, V30, P1383, DOI 10.1038/sj.npp.1300699; Kirby KN, 2004, ADDICTION, V99, P461, DOI 10.1111/j.1360-0443.2003.00669.x; Kolb B, 2004, BRAIN COGNITION, V55, P104, DOI 10.1016/s0278-2626(03)00278-1; KREMER EF, 1978, J EXP PSYCHOL ANIM B, V4, P22, DOI 10.1037/0097-7403.4.1.22; Krueger DD, 2009, BEHAV PHARMACOL, V20, P695, DOI 10.1097/FBP.0b013e328333a2bb; Lasseter HC, 2009, EUR J NEUROSCI, V30, P1370, DOI 10.1111/j.1460-9568.2009.06906.x; Liu X, 2007, J NEUROSCI, V27, P4587, DOI 10.1523/JNEUROSCI.5227-06.2007; LONDON ED, 1990, ARCH GEN PSYCHIAT, V47, P567; Lu L, 2005, NAT NEUROSCI, V8, P212, DOI 10.1038/nn1383; Lyoo IK, 2004, PSYCHIAT RES-NEUROIM, V131, P135, DOI 10.1016/j.pscychresns.2004.04.001; McDannald MA, 2011, J NEUROSCI, V31, P2700, DOI 10.1523/JNEUROSCI.5499-10.2011; Mendelson JH, 1996, NEW ENGL J MED, V334, P965, DOI 10.1056/NEJM199604113341507; Mobini S, 2002, PSYCHOPHARMACOLOGY, V160, P290, DOI 10.1007/s00213-001-0983-0; Nelson A, 2006, J NEUROSCI, V26, P3805, DOI 10.1523/JNEUROSCI.4305-05.2006; Nestler EJ, 2002, NEUROBIOL LEARN MEM, V78, P637, DOI 10.1006/nlme.2002.4084; Nestler EJ, 2001, NAT REV NEUROSCI, V2, P119, DOI 10.1038/35053570; Noonan MP, 2010, P NATL ACAD SCI USA, V107, P20547, DOI 10.1073/pnas.1012246107; O'Doherty J, 2001, NAT NEUROSCI, V4, P95, DOI 10.1038/82959; O'Doherty J, 2000, NEUROREPORT, V11, P399, DOI 10.1097/00001756-200002070-00035; O'Doherty J, 2001, J NEUROPHYSIOL, V85, P1315, DOI 10.1152/jn.2001.85.3.1315; O'Neill J, 2001, ALCOHOL CLIN EXP RES, V25, P1673; O'Neill J, 2001, ADDICT BIOL, V6, P347, DOI 10.1080/13556210020077073; Ostlund SB, 2007, J NEUROSCI, V27, P4819, DOI 10.1523/JNEUROSCI.5443-06.2007; Padoa-Schioppa C, 2006, NATURE, V441, P223, DOI 10.1038/nature04676; Pears A, 2003, J NEUROSCI, V23, P11189; Pickens CL, 2003, J NEUROSCI, V23, P11078; Porter JN, 2011, J NEUROSCI, V31, P4926, DOI 10.1523/JNEUROSCI.5426-10.2011; Robbins TW, 1999, NATURE, V398, P567, DOI 10.1038/19208; Roesch MR, 2007, J NEUROSCI, V27, P245, DOI 10.1523/JNEUROSCI.4080-06.2007; Roesch MR, 2005, J NEUROPHYSIOL, V94, P2457, DOI 10.1152/jn.00373.2005; ROLLS ET, 1994, J NEUROSCI, V14, P5437; Schoenbaum G, 2005, CEREB CORTEX, V15, P1162, DOI 10.1093/cercor/bhh216; Schoenbaum G, 2004, EUR J NEUROSCI, V19, P1997, DOI 10.1111/j.1460-9568.2004.03274.x; Schoenbaum G, 1998, NAT NEUROSCI, V1, P155, DOI 10.1038/407; Schoenbaum G, 2008, BIOL PSYCHIAT, V63, P256, DOI 10.1016/j.biopsych.2007.06.003; Schoenbaum G, 2009, NAT REV NEUROSCI, V10, P885, DOI 10.1038/nrn2753; Shaham Y, 2005, NAT NEUROSCI, V8, P1437, DOI 10.1038/nn1105-1437; Simon NW, 2007, BEHAV NEUROSCI, V121, P543, DOI 10.1037/0735-7044.121.3.543; Stalnaker TA, 2006, EUR J NEUROSCI, V24, P2643, DOI 10.1111/j.1460-9568.2006.05128.x; Sul JH, 2010, NEURON, V66, P449, DOI 10.1016/j.neuron.2010.03.033; Takahashi YK, 2009, NEURON, V62, P269, DOI 10.1016/j.neuron.2009.03.005; Taylor JR, 2001, BIOL PSYCHIAT, V50, P137, DOI 10.1016/S0006-3223(01)01106-4; Thompson PM, 2004, J NEUROSCI, V24, P6028, DOI 10.1523/JNEUROSCI.0713-04.2004; THORPE SJ, 1983, EXP BRAIN RES, V49, P93; Tremblay L, 1999, NATURE, V398, P704, DOI 10.1038/19525; Tsuchida A, 2010, J NEUROSCI, V30, P16868, DOI 10.1523/JNEUROSCI.1958-10.2010; Vanderschuren LJMJ, 2004, SCIENCE, V305, P1017, DOI 10.1126/science.1098975; Volkow N D, 1990, NIDA Res Monogr, V105, P47; Volkow ND, 2000, CEREB CORTEX, V10, P318, DOI 10.1093/cercor/10.3.318; VOLKOW ND, 1988, J NEURORADIOLOGY, V15, P288; VOLKOW ND, 1993, SYNAPSE, V14, P169, DOI 10.1002/syn.890140210; VOLKOW ND, 1991, AM J PSYCHIAT, V148, P621; Volkow ND, 2001, AM J PSYCHIAT, V158, P383, DOI 10.1176/appi.ajp.158.3.383; Volkow ND, 2001, AM J PSYCHIAT, V158, P2015, DOI 10.1176/appi.ajp.158.12.2015; Voorn P, 2004, TRENDS NEUROSCI, V27, P468, DOI 10.1016/j.tins.2004.06.006; Wallis JD, 2003, EUR J NEUROSCI, V18, P2069, DOI 10.1046/j.1460-9568.2003.02922.x; Walton ME, 2010, NEURON, V65, P927, DOI 10.1016/j.neuron.2010.02.027; Winstanley CA, 2004, J NEUROSCI, V24, P4718, DOI 10.1523/JNEUROSCI.5606-03.2004; Winstanley CA, 2007, J NEUROSCI, V27, P10497, DOI 10.1523/JNEUROSCI.2566-07.2007; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406; Wolf ME, 2004, NEUROPHARMACOLOGY, V47, P61, DOI 10.1016/j.neuropharm.2004.07.006; Wyvell CL, 2001, J NEUROSCI, V21, P7831, DOI 10.1523/JNEUROSCI.21-19-07831.2001	100	143	147	1	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2012	15	3					358	366		10.1038/nn.3014	http://dx.doi.org/10.1038/nn.3014			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	899CY	22267164	Green Accepted			2022-12-28	WOS:000300793100007
J	Nandy, AS; Tjan, BS				Nandy, Anirvan S.; Tjan, Bosco S.			Saccade-confounded image statistics explain visual crowding	NATURE NEUROSCIENCE			English	Article							HORIZONTAL CONNECTIONS; OBJECT RECOGNITION; PERCEPTION; RESOLUTION; EMERGENCE; ATTENTION; CONTEXT; CORTEX; V1; V4	Processing of shape information in human peripheral visual fields is impeded beyond what can be expected by poor spatial resolution. Visual crowding, the inability to identify objects in clutter, has been shown to be the primary factor limiting shape perception in peripheral vision. Despite the well-documented effects of crowding, its underlying causes remain poorly understood. Given that spatial attention both facilitates learning of image statistics and directs saccadic eye movements, we propose that the acquisition of image statistics in peripheral visual fields is confounded by eye-movement artifacts. Specifically, the image statistics acquired under a peripherally deployed spotlight of attention are systematically biased by saccade-induced image displacements. These erroneously represented image statistics lead to inappropriate contextual interactions in the periphery and cause crowding.	[Nandy, Anirvan S.; Tjan, Bosco S.] Univ So Calif, Dept Psychol, Los Angeles, CA 90089 USA; [Tjan, Bosco S.] Univ So Calif, Neurosci Grad Program, Los Angeles, CA USA	University of Southern California; University of Southern California	Nandy, AS (corresponding author), Salk Inst Biol Studies, Syst Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	nandy@salk.edu; btjan@usc.edu		Nandy, Anirvan/0000-0002-4225-5349	US National Institutes of Health [EY017707]; NATIONAL EYE INSTITUTE [R01EY017707] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The authors would like to thank I. Biederman, A. Disney, J. Hirsch, M. Jadi, R. Millin and J. Reynolds for helpful comments on the manuscript. This research was supported by US National Institutes of Health grant EY017707 (B.S.T.).	Bahill A.T., 1975, INVEST OPHTH VIS SCI, V14, P68; Ben-Shahar O, 2004, NEURAL COMPUT, V16, P445, DOI 10.1162/089976604772744866; Bosking WH, 1997, J NEUROSCI, V17, P2112; BOUMA H, 1970, NATURE, V226, P177, DOI 10.1038/226177a0; Bruce NDB, 2006, NEUROCOMPUTING, V69, P1301, DOI 10.1016/j.neucom.2005.12.096; CAMPBELL FW, 1978, VISION RES, V18, P1297, DOI 10.1016/0042-6989(78)90219-5; Castet E, 2002, P NATL ACAD SCI USA, V99, P15159, DOI 10.1073/pnas.232377199; De Pisapia N, 2010, CURR BIOL, V20, P613, DOI 10.1016/j.cub.2010.01.056; Deubel H, 1996, VISION RES, V36, P1827, DOI 10.1016/0042-6989(95)00294-4; Diamond MR, 2000, J NEUROSCI, V20, P3449, DOI 10.1523/JNEUROSCI.20-09-03449.2000; Freeman J, 2011, NAT NEUROSCI, V14, P1195, DOI 10.1038/nn.2889; Garcia-Perez MA, 2001, J NEUROSCI, V21, P7313, DOI 10.1523/JNEUROSCI.21-18-07313.2001; GATTASS R, 1981, J COMP NEUROL, V201, P519, DOI 10.1002/cne.902010405; Geisler WS, 2008, ANNU REV PSYCHOL, V59, P167, DOI 10.1146/annurev.psych.58.110405.085632; Geisler WS, 2001, VISION RES, V41, P711, DOI 10.1016/S0042-6989(00)00277-7; Gilbert C, 2000, VISION RES, V40, P1217, DOI 10.1016/S0042-6989(99)00234-5; Greenwood JA, 2010, CURR BIOL, V20, P496, DOI 10.1016/j.cub.2010.01.023; Greenwood JA, 2009, P NATL ACAD SCI USA, V106, P13130, DOI 10.1073/pnas.0901352106; He S, 1996, NATURE, V383, P334, DOI 10.1038/383334a0; Ito M, 1999, NEURON, V22, P593, DOI 10.1016/S0896-6273(00)80713-8; Itti L, 2001, NAT REV NEUROSCI, V2, P194, DOI 10.1038/35058500; KAPADIA MK, 1995, NEURON, V15, P843, DOI 10.1016/0896-6273(95)90175-2; Karklin Y, 2009, NATURE, V457, P83, DOI 10.1038/nature07481; Larsson J, 2006, J NEUROSCI, V26, P13128, DOI 10.1523/JNEUROSCI.1657-06.2006; Lebedev S, 1996, INVEST OPHTH VIS SCI, V37, P2750; Levi DM, 2007, J VISION, V7, DOI 10.1167/7.2.21; Levi DM, 2008, VISION RES, V48, P635, DOI 10.1016/j.visres.2007.12.009; Levi DM, 2009, CURR BIOL, V19, P1988, DOI 10.1016/j.cub.2009.09.056; Levi DM, 2002, J VISION, V2, P167, DOI 10.1167/2.2.3; Motter B. C., 2002, J VISION, V2, P274, DOI DOI 10.1167/2.7.274; Motter BC, 2007, J VISION, V7, DOI 10.1167/7.2.6; Motter BC, 2009, J NEUROSCI, V29, P5749, DOI 10.1523/JNEUROSCI.4496-08.2009; Nandy AS, 2007, J VISION, V7, DOI 10.1167/7.2.5; Neri P, 2006, J NEUROPHYSIOL, V96, P142, DOI 10.1152/jn.01261.2005; Olshausen BA, 1996, NATURE, V381, P607, DOI 10.1038/381607a0; Parkes L, 2001, NAT NEUROSCI, V4, P739, DOI 10.1038/89532; Pelli DG, 2008, CURR OPIN NEUROBIOL, V18, P445, DOI 10.1016/j.conb.2008.09.008; Pelli DG, 2004, J VISION, V4, P1136, DOI 10.1167/4.12.12; Petrov Y, 2007, J VISION, V7, DOI 10.1167/7.2.12; Pinon MC, 1998, CEREB CORTEX, V8, P685, DOI 10.1093/cercor/8.8.685; Sigman M, 2001, P NATL ACAD SCI USA, V98, P1935, DOI 10.1073/pnas.031571498; Stettler DD, 2002, NEURON, V36, P739, DOI 10.1016/S0896-6273(02)01029-2; TOET A, 1992, VISION RES, V32, P1349, DOI 10.1016/0042-6989(92)90227-A; van den Berg R, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000646; Watson TL, 2009, CURR BIOL, V19, P1040, DOI 10.1016/j.cub.2009.04.052; WHITE JM, 1990, INVEST OPHTH VIS SCI, V31, P1149; Whitney D, 2011, TRENDS COGN SCI, V15, P160, DOI 10.1016/j.tics.2011.02.005; WILSON JR, 1976, J NEUROPHYSIOL, V39, P512, DOI 10.1152/jn.1976.39.3.512; Wurtz RH, 2008, VISION RES, V48, P2070, DOI 10.1016/j.visres.2008.03.021	49	80	83	0	36	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2012	15	3					463	U159		10.1038/nn.3021	http://dx.doi.org/10.1038/nn.3021			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	899CY	22231425	Green Accepted			2022-12-28	WOS:000300793100021
J	Retchless, BS; Gao, W; Johnson, JW				Retchless, Beth Siegler; Gao, Wei; Johnson, Jon W.			A single GluN2 subunit residue controls NMDA receptor channel properties via intersubunit interaction	NATURE NEUROSCIENCE			English	Article							D-ASPARTATE RECEPTOR; GLUTAMATE-RECEPTOR; K+ CHANNEL; EXTRACELLULAR VESTIBULE; SUBSTITUTED CYSTEINES; XENOPUS-OOCYTES; EXTERNAL MG2+; MUTANT CYCLES; ION CHANNELS; BLOCK	NMDA receptors (NMDARs) are glutamate-gated ion channels that are present at most excitatory mammalian synapses. The four GluN2 subunits (GluN2A-D) contribute to four diheteromeric NMDAR subtypes that have divergent physiological and pathological roles. Channel properties that are fundamental to NMDAR function vary among subtypes. We investigated the amino acid residues responsible for variations in channel properties by creating and examining NMDARs containing mutant GluN2 subunits. We found that the NMDAR subtype specificity of three crucial channel properties, Mg2+ block, selective permeability to Ca2+ and single-channel conductance, were all controlled primarily by the residue at a single GluN2 site in the M3 transmembrane region. Mutant cycle analysis guided by molecular modeling revealed that a GluN2-GluN1 subunit interaction mediates the site's effects. We conclude that a single GluN2 subunit residue couples with the pore-forming loop of the GluN1 subunit to create naturally occurring variations in NMDAR properties that are critical to synaptic plasticity and learning.	[Retchless, Beth Siegler; Gao, Wei; Johnson, Jon W.] Univ Pittsburgh, Dept Neurosci, Pittsburgh, PA 15260 USA; [Retchless, Beth Siegler; Gao, Wei; Johnson, Jon W.] Univ Pittsburgh, Ctr Neurosci, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Johnson, JW (corresponding author), Univ Pittsburgh, Dept Neurosci, Pittsburgh, PA 15260 USA.	jjohnson@pitt.edu			US National Institutes of Health [R01 MH045817, F31 MH079755]; NATIONAL INSTITUTE OF MENTAL HEALTH [F31MH079755, R01MH045817] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The authors thank A. Qian for valuable contributions to and advice on initial experiments, K. Bouch and C. Shiber for excellent technical assistance, M. Pellegrino for generous help with statistical analyses, M. Casio and A. Retchless for helpful discussions and comments on the manuscript, S. Meriney, M. Grabe, D. Wood and members of the Johnson laboratory for helpful discussions, and D. Colquhoun for making available the DC Analysis programs for single-channel analysis. This work was supported by US National Institutes of Health grants R01 MH045817 and associated S1 supplement (J.W.J.) and F31 MH079755 (B.S.R.).	Alam A, 2007, P NATL ACAD SCI USA, V104, P15334, DOI 10.1073/pnas.0707324104; [Anonymous], 2004, STAT ANAL DATA DISPL; Antonov SM, 1999, P NATL ACAD SCI USA, V96, P14571, DOI 10.1073/pnas.96.25.14571; Beck C, 1999, NEURON, V22, P559, DOI 10.1016/S0896-6273(00)80710-2; BURNASHEV N, 1995, J PHYSIOL-LONDON, V485, P403, DOI 10.1113/jphysiol.1995.sp020738; Chen GQ, 1999, NATURE, V402, P817, DOI 10.1038/45568; Chiu JC, 2002, MOL BIOL EVOL, V19, P1066, DOI 10.1093/oxfordjournals.molbev.a004165; Clarke RJ, 2006, J NEUROSCI, V26, P5825, DOI 10.1523/JNEUROSCI.0577-06.2006; Clinton SM, 2004, NEUROPSYCHOPHARMACOL, V29, P1353, DOI 10.1038/sj.npp.1300451; Colquhoun D, 1998, BRIT J PHARMACOL, V125, P924; Colquhoun David, 1995, P483; Cuello LG, 2010, NATURE, V466, P203, DOI 10.1038/nature09153; Cull-Candy SG, 1998, NEUROPHARMACOLOGY, V37, P1369, DOI 10.1016/S0028-3908(98)00119-1; Cull-Candy Stuart G, 2004, Sci STKE, V2004, pre16, DOI 10.1126/stke.2552004re16; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; FARRANT M, 1994, NATURE, V368, P335, DOI 10.1038/368335a0; FLEMING WW, 1972, J PHARMACOL-PARIS, V181, P339; Gielen M, 2009, NATURE, V459, P703, DOI 10.1038/nature07993; HIDALGO P, 1995, SCIENCE, V268, P307, DOI 10.1126/science.7716527; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; ISHII T, 1993, J BIOL CHEM, V268, P2836; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; Jones KS, 2002, J NEUROSCI, V22, P2044, DOI 10.1523/JNEUROSCI.22-06-02044.2002; Kuner T, 1996, NEURON, V17, P343, DOI 10.1016/S0896-6273(00)80165-8; Kuner T, 1996, J NEUROSCI, V16, P3549; LEWIS CA, 1979, J PHYSIOL-LONDON, V286, P417, DOI 10.1113/jphysiol.1979.sp012629; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Lynch MA, 2004, PHYSIOL REV, V84, P87, DOI 10.1152/physrev.00014.2003; Madhusudhan M.S., 2007, CURR PROTOC PROTEIN, V2; MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217; Panchenko VA, 2001, J GEN PHYSIOL, V117, P345, DOI 10.1085/jgp.117.4.345; Qian A, 2005, J PHYSIOL-LONDON, V562, P319, DOI 10.1113/jphysiol.2004.076737; Qian AQ, 2006, J NEUROSCI, V26, P10899, DOI 10.1523/JNEUROSCI.3453-06.2006; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Schneggenburger R, 1996, BIOPHYS J, V70, P2165, DOI 10.1016/S0006-3495(96)79782-5; SCHREIBER G, 1995, J MOL BIOL, V248, P478, DOI 10.1006/jmbi.1995.0235; Shi N, 2006, NATURE, V440, P570, DOI 10.1038/nature04508; Sobolevsky AI, 2002, NEURON, V33, P75, DOI 10.1016/S0896-6273(01)00560-8; Sobolevsky AI, 2009, NATURE, V462, P745, DOI 10.1038/nature08624; Sprengel R, 2001, TRENDS PHARMACOL SCI, V22, P7, DOI 10.1016/S0165-6147(00)01588-1; STERN P, 1994, J PHYSIOL-LONDON, V476, P391, DOI 10.1113/jphysiol.1994.sp020140; Tikhonov DB, 2002, BIOPHYS J, V82, P1884, DOI 10.1016/S0006-3495(02)75538-0; Tikhonov DB, 2007, MOL MEMBR BIOL, V24, P135, DOI 10.1080/09687860601008806; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Williams K, 1998, MOL PHARMACOL, V53, P933; Wollmuth LP, 1998, J GEN PHYSIOL, V112, P623, DOI 10.1085/jgp.112.5.623; WOOD MW, 1995, P NATL ACAD SCI USA, V92, P4882, DOI 10.1073/pnas.92.11.4882; Wrighton DC, 2008, J PHYSIOL-LONDON, V586, P211, DOI 10.1113/jphysiol.2007.143164; Wyllie DJA, 1996, P ROY SOC B-BIOL SCI, V263, P1079, DOI 10.1098/rspb.1996.0159; Yuan HJ, 2009, J NEUROSCI, V29, P12045, DOI 10.1523/JNEUROSCI.1365-09.2009	50	62	63	1	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2012	15	3					406	U89		10.1038/nn.3025	http://dx.doi.org/10.1038/nn.3025			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	899CY	22246434	Green Accepted			2022-12-28	WOS:000300793100014
J	Subramaniam, S; Napolitano, F; Mealer, RG; Kim, S; Errico, F; Barrow, R; Shahani, N; Tyagi, R; Snyder, SH; Usiello, A				Subramaniam, Srinivasa; Napolitano, Francesco; Mealer, Robert G.; Kim, Seyun; Errico, Francesco; Barrow, Roxanne; Shahani, Neelam; Tyagi, Richa; Snyder, Solomon H.; Usiello, Alessandro			Rhes, a striatal-enriched small G protein, mediates mTOR signaling and L-DOPA-induced dyskinesia	NATURE NEUROSCIENCE			English	Article							GTP-BINDING PROTEIN	L-DOPA-induced dyskinesia, the rate-limiting side effect in the therapy of Parkinson's disease, is mediated by activation of mammalian target of rapamycin (mTOR) signaling in the striatum. We found that Ras homolog enriched in striatum (Rhes), a striatal-specific protein, binds to and activates mTOR. Moreover, Rhes(-/-) mice showed reduced striatal mTOR signaling and diminished dyskinesia, but maintained motor improvement on L-DOPA treatment, suggesting a therapeutic benefit for Rhes-binding drugs.	[Subramaniam, Srinivasa; Mealer, Robert G.; Kim, Seyun; Barrow, Roxanne; Tyagi, Richa; Snyder, Solomon H.] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21218 USA; [Napolitano, Francesco; Errico, Francesco; Usiello, Alessandro] Ceinge Biotecnol Avanzate, Lab Behav Neurosci, Naples, Italy; [Shahani, Neelam; Snyder, Solomon H.] Johns Hopkins Univ, Sch Med, Dept Psychiat, Baltimore, MD 21205 USA; [Snyder, Solomon H.] Johns Hopkins Univ, Sch Med, Dept Pharmacol, Baltimore, MD 21205 USA; [Usiello, Alessandro] Univ Naples 2, Dept Environm Sci, Naples, Italy	Johns Hopkins University; CEINGE Biotecnologie Avanzate; Johns Hopkins University; Johns Hopkins University; Universita della Campania Vanvitelli	Snyder, SH (corresponding author), Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21218 USA.	ssnyder@jhmi.edu	tyagi, richa/A-7261-2015; usiello, alessandro/B-2368-2012; Napolitano, Francesco/F-8691-2012; Errico, Francesco/C-2787-2012; Kim, Seyun/B-3387-2012	Usiello, Alessandro/0000-0001-9203-853X; Napolitano, Francesco/0000-0003-0884-1851; ERRICO, Francesco/0000-0002-3636-7395	United States Public Health Service [MH18501]; Cure for Huntington's Disease Initiative; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH018501, R37MH018501] Funding Source: NIH RePORTER	United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Cure for Huntington's Disease Initiative; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank R. Romano, D. Vitucci, V. Marsili, P. Scherer and S. Korde for valuable technical assistance, and R. DiLauro (University of Naples) for providing the Rhes<SUP>-/-</SUP> mice. This work was supported by United States Public Health Service grant MH18501 (S.H.S.) and a grant of the Cure for Huntington's Disease Initiative (S.H.S.).	Errico F, 2008, MOL CELL NEUROSCI, V37, P335, DOI 10.1016/j.mcn.2007.10.007; Long X, 2005, CURR BIOL, V15, P702, DOI 10.1016/j.cub.2005.02.053; Malagelada C, 2010, J NEUROSCI, V30, P1166, DOI 10.1523/JNEUROSCI.3944-09.2010; Quintero GC, 2008, NEUROREPORT, V19, P1563, DOI 10.1097/WNR.0b013e3283118434; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Santini E, 2007, J NEUROSCI, V27, P6995, DOI 10.1523/JNEUROSCI.0852-07.2007; Santini E, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000308; Seredenina T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022231; Subramaniam S, 2010, J BIOL CHEM, V285, P20428, DOI 10.1074/jbc.C110.127191; Subramaniam S, 2009, SCIENCE, V324, P1327, DOI 10.1126/science.1172871; Vargiu P, 2004, ONCOGENE, V23, P559, DOI 10.1038/sj.onc.1207161	11	71	74	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2012	15	2					191	193		10.1038/nn.2994	http://dx.doi.org/10.1038/nn.2994			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	882ZX	22179112	Green Accepted			2022-12-28	WOS:000299603500008
J	Storkebaum, E; Quaegebeur, A; Vikkula, M; Carmeliet, P				Storkebaum, Erik; Quaegebeur, Annelies; Vikkula, Miikka; Carmeliet, Peter			Cerebrovascular disorders: molecular insights and therapeutic opportunities	NATURE NEUROSCIENCE			English	Review							AMYOTROPHIC-LATERAL-SCLEROSIS; ENDOTHELIAL GROWTH-FACTOR; HEREDITARY HEMORRHAGIC TELANGIECTASIA; CEREBRAL CAVERNOUS MALFORMATIONS; AMYLOID-BETA-PEPTIDE; MOTOR-NEURON DEGENERATION; BLOOD-BRAIN-BARRIER; VASCULAR COGNITIVE IMPAIRMENT; ALZHEIMERS-DISEASE; NEUROVASCULAR DYSFUNCTION	Blood vessels in the nervous system have traditionally been considered neutral bystanders that only passively adapt their structure and function in response to the needs of neural cells. Emerging evidence suggests, however, that vessels and angiogenic molecules actively participate in the pathogenesis of neurological disorders. Here we will discuss molecular insights into neurological disorders resulting either from excessive vessel growth (cerebral vascular malformations) or improper vessel regression (neurodegeneration and white matter lesions). These genetic insights offer alternative therapeutic options, some of which are being evaluated in the clinic.	[Quaegebeur, Annelies; Carmeliet, Peter] Katholieke Univ Leuven, Vesalius Res Ctr, Lab Angiogenesis & Neurovasc Link, Louvain, Belgium; [Storkebaum, Erik] Max Planck Inst Mol Biomed, Mol Neurogenet Lab, Munster, Germany; [Quaegebeur, Annelies; Carmeliet, Peter] Katholieke Univ Leuven VIB, Vesalius Res Ctr, Lab Angiogenesis & Neurovasc Link, Louvain, Belgium; [Vikkula, Miikka] Catholic Univ Louvain, de Duve Inst, WELBIO Walloon Excellence Lifesci & Biotechnol, B-1200 Brussels, Belgium; [Vikkula, Miikka] Catholic Univ Louvain, de Duve Inst, Lab Human Mol Genet, B-1200 Brussels, Belgium	Flanders Institute for Biotechnology (VIB); KU Leuven; Max Planck Society; Flanders Institute for Biotechnology (VIB); KU Leuven; Universite Catholique Louvain; WELBIO; Universite Catholique Louvain	Carmeliet, P (corresponding author), Katholieke Univ Leuven, Vesalius Res Ctr, Lab Angiogenesis & Neurovasc Link, Louvain, Belgium.	peter.carmeliet@vib-kuleuven.be	Carmeliet, Peter/AAQ-5140-2020; Storkebaum, Erik/B-5389-2017; Vikkula, Miikka/Q-1038-2018	Carmeliet, Peter/0000-0001-7961-1821; Storkebaum, Erik/0000-0002-9519-5642; Vikkula, Miikka/0000-0002-6236-338X; Quaegebeur, Annelies/0000-0001-5357-9341	Interuniversity Attraction Poles; FNRS (Fonds de la Recherche Scientifique); ARC (Actions de Recherche Concertees-Communaute francaise de Belgique); Flemish Government, the Fund for Scientific Research-Flemish Government [G.0677.09, G.0676.09]; Belgian Science Policy [IUAP-P6/30]; Association Francaise contre les Myopathies (AFM); Geneeskundige stichting Koningin Elisabeth; Motor Neurone Disease Association [70/130]	Interuniversity Attraction Poles(Belgian Federal Science Policy Office); FNRS (Fonds de la Recherche Scientifique)(Fonds de la Recherche Scientifique - FNRS); ARC (Actions de Recherche Concertees-Communaute francaise de Belgique); Flemish Government, the Fund for Scientific Research-Flemish Government; Belgian Science Policy(Belgian Federal Science Policy Office); Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies); Geneeskundige stichting Koningin Elisabeth; Motor Neurone Disease Association	We thank L. Notebaert, A. Truyens and B. Sass for help with the figures. E. S. is a fellow of FWO-Flanders, funded by the state North Rhine Westphalia and supported by a grant from the Frick Foundation for ALS Research. A. Q. is a fellow of the Fund for Scientific Research (FWO), Flanders. M. V. is supported by grants from the Interuniversity Attraction Poles initiated by the Belgian Science Policy, Network 5/25, the F.R.S.-FNRS (Fonds de la Recherche Scientifique), and the ARC (Actions de Recherche Concertees-Communaute francaise de Belgique). P. C. is supported by Long-term structural Methusalem funding by the Flemish Government, the Fund for Scientific Research-Flemish Government (FWO) (G.0677.09, G.0676.09), the Belgian Science Policy (IUAP-P6/30), the Association Francaise contre les Myopathies (AFM), Geneeskundige stichting Koningin Elisabeth and Motor Neurone Disease Association grant 70/130.	Anand S, 2010, NAT MED, V16, P909, DOI 10.1038/nm.2186; ASSAREH A, 2010, CNS NEUROSCI TH 0707, P604, DOI DOI 10.1111/J.1755-5949.2010.00181.X; Ayata C, 2010, STROKE, V41, pS129, DOI 10.1161/STROKEAHA.110.595207; Azzouz M, 2004, NATURE, V429, P413, DOI 10.1038/nature02544; Bell RD, 2010, NEURON, V68, P409, DOI 10.1016/j.neuron.2010.09.043; Bell RD, 2009, NAT CELL BIOL, V11, P143, DOI 10.1038/ncb1819; Boon LM, 2005, CURR OPIN GENET DEV, V15, P265, DOI 10.1016/j.gde.2005.03.004; Bose P, 2009, NEW ENGL J MED, V360, P2143, DOI 10.1056/NEJMc0901421; BRUN A, 1986, ANN NEUROL, V19, P253, DOI 10.1002/ana.410190306; Candelario-Jalil E, 2011, STROKE, V42, P1345, DOI 10.1161/STROKEAHA.110.600825; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Carrano A, 2011, ANTIOXID REDOX SIGN, V15, P1167, DOI 10.1089/ars.2011.3895; Chabriat H, 2009, LANCET NEUROL, V8, P643, DOI 10.1016/S1474-4422(09)70127-9; Chan AC, 2010, FEBS J, V277, P1076, DOI 10.1111/j.1742-4658.2009.07536.x; Chow N, 2007, P NATL ACAD SCI USA, V104, P823, DOI 10.1073/pnas.0608251104; Chrissobolis S, 2011, FRONT BIOSCI-LANDMRK, V16, P1733, DOI 10.2741/3816; Corti P, 2011, DEVELOPMENT, V138, P1573, DOI 10.1242/dev.060467; Cunnane S, 2011, NUTRITION, V27, P3, DOI 10.1016/j.nut.2010.07.021; Cunningham K, 2011, HUM MOL GENET, V20, P3198, DOI 10.1093/hmg/ddr225; De Almodovar CR, 2009, PHYSIOL REV, V89, P607, DOI 10.1152/physrev.00031.2008; de la Torre JC, 2004, LANCET NEUROL, V3, P184, DOI 10.1016/S1474-4422(04)00683-0; Deane R, 2003, NAT MED, V9, P907, DOI 10.1038/nm890; Derejko M, 2006, NUCL MED COMMUN, V27, P945, DOI 10.1097/01.mnm.0000243370.18883.62; Dodge JC, 2010, MOL THER, V18, P2075, DOI 10.1038/mt.2010.206; Dupuis-Girod S, 2010, J THROMB HAEMOST, V8, P1447, DOI 10.1111/j.1538-7836.2010.03860.x; Emerich DF, 2010, NEUROTOX RES, V17, P66, DOI 10.1007/s12640-009-9079-0; Faurobert E, 2010, FEBS J, V277, P1084, DOI 10.1111/j.1742-4658.2009.07537.x; Gao P, 2009, J CEREBR BLOOD F MET, V29, P1482, DOI 10.1038/jcbfm.2009.67; Garbuzova-Davis S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001205; Garbuzova-Davis S, 2011, BRAIN RES, V1398, P113, DOI 10.1016/j.brainres.2011.04.049; Girouard H, 2006, J APPL PHYSIOL, V100, P328, DOI 10.1152/japplphysiol.00966.2005; Grammas P, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-26; Greenberg SA, 2004, STROKE, V35, P2616, DOI 10.1161/01.str.0000143224.36527.44; Greenway MJ, 2006, NAT GENET, V38, P411, DOI 10.1038/ng1742; Gridley T, 2010, CURR TOP DEV BIOL, V92, P277, DOI 10.1016/S0070-2153(10)92009-7; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hamilton Nicola B, 2010, Front Neuroenergetics, V2, DOI 10.3389/fnene.2010.00005; Harris GJ, 1999, BRAIN, V122, P1667, DOI 10.1093/brain/122.9.1667; Hauptman Jason S, 2010, Surg Neurol Int, V1, P63, DOI 10.4103/2152-7806.70962; He Y, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000722; Henkel JS, 2009, NEUROLOGY, V72, P1614, DOI 10.1212/WNL.0b013e3181a41228; Iadecola C, 2004, NAT REV NEUROSCI, V5, P347, DOI 10.1038/nrn1387; Iadecola C, 2010, ACTA NEUROPATHOL, V120, P287, DOI 10.1007/s00401-010-0718-6; Joutel A, 2010, J CLIN INVEST, V120, P433, DOI 10.1172/JCI39733; Kalaria RN, 2010, NUTR REV, V68, pS74, DOI 10.1111/j.1753-4887.2010.00352.x; KEW JJM, 1993, BRAIN, V116, P655, DOI 10.1093/brain/116.3.655; Kieran D, 2008, J NEUROSCI, V28, P14056, DOI 10.1523/JNEUROSCI.3399-08.2008; Kim H, 2009, STROKE, V40, pS95, DOI 10.1161/STROKEAHA.108.533216; Lambrechts D, 2009, J MED GENET, V46, P840, DOI 10.1136/jmg.2008.058222; Leblanc GG, 2009, STROKE, V40, pE694, DOI 10.1161/STROKEAHA.109.563692; Lebrin F, 2010, NAT MED, V16, P420, DOI 10.1038/nm.2131; Leen WG, 2010, BRAIN, V133, P655, DOI 10.1093/brain/awp336; Lewandowska E, 2010, FOLIA NEUROPATHOL, V48, P104; Li X, 2006, EUR J NEUROSCI, V23, P2078, DOI 10.1111/j.1460-9568.2006.04735.x; Liu J, 2009, NAT MED, V15, P940, DOI 10.1038/nm.1994; Liu Y, 2008, FEBS LETT, V582, P359, DOI 10.1016/j.febslet.2007.12.035; Lu L, 2009, J BIOL CHEM, V284, P33989, DOI 10.1074/jbc.M109.067918; Mawuenyega KG, 2010, SCIENCE, V330, P1774, DOI 10.1126/science.1197623; McDonald DA, 2011, HUM MOL GENET, V20, P211, DOI 10.1093/hmg/ddq433; Merlini M, 2011, ACTA NEUROPATHOL, V122, P293, DOI 10.1007/s00401-011-0834-y; Nicaise C, 2009, BRAIN RES, V1301, P152, DOI 10.1016/j.brainres.2009.09.018; Oosthuyse B, 2001, NAT GENET, V28, P131, DOI 10.1038/88842; Oosting S, 2009, NEW ENGL J MED, V361, P931, DOI 10.1056/NEJMc091271; Pardali E, 2010, TRENDS CELL BIOL, V20, P556, DOI 10.1016/j.tcb.2010.06.006; Park L, 2011, P NATL ACAD SCI USA, V108, P5063, DOI 10.1073/pnas.1015413108; Park SO, 2009, J CLIN INVEST, V119, P3487, DOI 10.1172/JCI39482; Pasinelli P, 2006, NAT REV NEUROSCI, V7, P710, DOI 10.1038/nrn1971; Patel NS, 2010, J NEUROCHEM, V112, P66, DOI 10.1111/j.1471-4159.2009.06426.x; Peppiatt CM, 2006, NATURE, V443, P700, DOI 10.1038/nature05193; Poesen K, 2008, J NEUROSCI, V28, P10451, DOI 10.1523/JNEUROSCI.1092-08.2008; Quaegebeur A, 2010, CURR TOP MICROBIOL, V345, P71, DOI 10.1007/82_2010_83; Riant F, 2010, FEBS J, V277, P1070, DOI 10.1111/j.1742-4658.2009.07535.x; Ricard N, 2010, BLOOD, V116, P1604, DOI 10.1182/blood-2010-03-276881; Rizzo MT, 2010, MOL NEUROBIOL, V42, P52, DOI 10.1007/s12035-010-8132-6; Ruiz DS, 2009, ANN NEUROL, V66, P271, DOI 10.1002/ana.21754; Rule RR, 2010, NEUROLOGY, V74, P821, DOI 10.1212/WNL.0b013e3181d3e2dd; Sagare A, 2007, NAT MED, V13, P1029, DOI 10.1038/nm1635; Shovlin CL, 2010, BLOOD REV, V24, P203, DOI 10.1016/j.blre.2010.07.001; Soucek T, 2003, NEURON, V39, P43, DOI 10.1016/S0896-6273(03)00367-2; Spuch C, 2010, BIOMATERIALS, V31, P5608, DOI 10.1016/j.biomaterials.2010.03.042; Stewart CR, 2010, NAT IMMUNOL, V11, P155, DOI 10.1038/ni.1836; Storkebaum E, 2005, NAT NEUROSCI, V8, P85, DOI 10.1038/nn1360; Storkebaum E, 2010, CIRCULATION, V122, P273, DOI 10.1161/CIRCULATIONAHA.109.929364; Sutedja NA, 2011, J NEUROL NEUROSUR PS, V82, P638, DOI 10.1136/jnnp.2010.236752; Tesseur Ina, 2006, Current Alzheimer Research, V3, P505, DOI 10.2174/156720506779025297; Thomas T, 1996, NATURE, V380, P168, DOI 10.1038/380168a0; Town T, 2008, NAT MED, V14, P681, DOI 10.1038/nm1781; van Blitterswijk M, 2010, NEUROGENETICS, V11, P275, DOI 10.1007/s10048-010-0239-4; Walker EJ, 2011, ANN NEUROL, V69, P954, DOI 10.1002/ana.22348; Wang YM, 2007, J NEUROSCI, V27, P304, DOI 10.1523/JNEUROSCI.4433-06.2007; Whitehead KJ, 2009, NAT MED, V15, P177, DOI 10.1038/nm.1911; Winkler EA, 2011, NAT NEUROSCI, V14, P1398, DOI 10.1038/nn.2946; Wu ZH, 2005, NAT MED, V11, P959, DOI 10.1038/nm1287; Xiong N, 2011, GENE THER, V18, P394, DOI 10.1038/gt.2010.152; Xu J, 2001, J CEREBR BLOOD F MET, V21, P702, DOI 10.1097/00004647-200106000-00008; Yamamoto Y, 2011, NEUROPATH APPL NEURO, V37, P94, DOI 10.1111/j.1365-2990.2010.01147.x; Yang SP, 2004, NEUROBIOL AGING, V25, P283, DOI 10.1016/S0197-4580(03)00111-8; Yemisci M, 2009, NAT MED, V15, P1031, DOI 10.1038/nm.2022; Zhong ZH, 2008, NAT NEUROSCI, V11, P420, DOI 10.1038/nn2073; Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003	100	68	68	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2011	14	11					1390	1397		10.1038/nn.2947	http://dx.doi.org/10.1038/nn.2947			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	841NI	22030550				2022-12-28	WOS:000296518600011
J	Ala-Laurila, P; Greschner, M; Chichilnisky, EJ; Rieke, F				Ala-Laurila, Petri; Greschner, Martin; Chichilnisky, E. J.; Rieke, Fred			Cone photoreceptor contributions to noise and correlations in the retinal output	NATURE NEUROSCIENCE			English	Article							MIDGET GANGLION-CELLS; PRIMATE RETINA; ABSOLUTE THRESHOLD; Y-CELL; X-CELL; RESPONSES; LIGHT; SENSITIVITY; POPULATION; PARASOL	Transduction and synaptic noise generated in retinal cone photoreceptors determine the fidelity with which light inputs are encoded, and the readout of cone signals by downstream circuits determines whether this fidelity is used for vision. We examined the effect of cone noise on visual signals by measuring its contribution to correlated noise in primate retinal ganglion cells. Correlated noise was strong in the responses of dissimilar cell types with shared cone inputs. The dynamics of cone noise could account for rapid correlations in ganglion cell activity, and the extent of shared cone input could explain correlation strength. Furthermore, correlated noise limited the fidelity with which visual signals were encoded by populations of ganglion cells. Thus, a simple picture emerges: cone noise, traversing the retina through diverse pathways, accounts for most of the noise and correlations in the retinal output and constrains how higher centers exploit signals carried by parallel visual pathways.	[Ala-Laurila, Petri; Rieke, Fred] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; [Ala-Laurila, Petri; Rieke, Fred] Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA; [Greschner, Martin; Chichilnisky, E. J.] Salk Inst Biol Studies, La Jolla, CA USA	Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Salk Institute	Rieke, F (corresponding author), Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA.	rieke@u.washington.edu	Ala-Laurila, Petri/AAE-1203-2019	Ala-Laurila, Petri/0000-0002-6139-6825; Chichilnisky, E.J./0000-0002-5613-0248	Howard Hughes Medical Institute; US National Institutes of Health [EY-11850, EY-13150]; Academy of Finland [123231]; McKnight Foundation; Pioneer Postdoctoral Fellowship Award; NATIONAL EYE INSTITUTE [R01EY013150, R01EY017992, R01EY011850, P30EY001730] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Academy of Finland(Academy of Finland); McKnight Foundation; Pioneer Postdoctoral Fellowship Award; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank G. Horwitz, G. Murphy, L. Paninski and M. Vidne for detailed comments on the manuscript and helpful discussions, D. Carleton, E. Martinson and P. Newman for excellent technical assistance, G. D. Field, J.L. Gauthier, J. Shlens and A. Sher for experimental assistance, A. M. Litke, M. I. Grivich, D. Petrusca, W. Dabrowski, A. Grillo, P. Grybos, P. Hottowy and S. Kachiguine for technical development, and J. Crook, D. Dacey, T. Haun, M. Manookin, O. Packer, B. Peterson, H. Fox, K. Osborn and the Tissue Distribution Program of the Regional Primate Research Center at the University of Washington for providing primate tissue. This work was supported by the Howard Hughes Medical Institute (F. R.), the US National Institutes of Health (EY-11850 to F. R. and EY-13150 to E. J. C.), the Academy of Finland (grant 123231 to P. A.-L.), the McKnight Foundation (E. J. C.) and a Pioneer Postdoctoral Fellowship Award (M.G.).	AHO AC, 1987, J OPT SOC AM A, V4, P2321, DOI 10.1364/JOSAA.4.002321; BARLOW HB, 1956, J OPT SOC AM, V46, P634, DOI 10.1364/JOSA.46.000634; BARLOW HB, 1957, NATURE, V179, P255, DOI 10.1038/179255b0; BAYLOR DA, 1977, J PHYSIOL-LONDON, V271, P425, DOI 10.1113/jphysiol.1977.sp012007; BIALEK W, 1991, SCIENCE, V252, P1854, DOI 10.1126/science.2063199; Borghuis BG, 2009, J NEUROSCI, V29, P3045, DOI 10.1523/JNEUROSCI.5071-08.2009; BOYCOTT BB, 1991, EUR J NEUROSCI, V3, P1069, DOI 10.1111/j.1460-9568.1991.tb00043.x; Brivanlou IH, 1998, NEURON, V20, P527, DOI 10.1016/S0896-6273(00)80992-7; Chichilnisky EJ, 2001, NETWORK-COMP NEURAL, V12, P199, DOI 10.1088/0954-898X/12/2/306; Choi SY, 2005, NEURON, V48, P555, DOI 10.1016/j.neuron.2005.09.011; COHEN E, 1992, EUR J NEUROSCI, V4, P506, DOI 10.1111/j.1460-9568.1992.tb00901.x; Dacey DM, 2003, CURR OPIN NEUROBIOL, V13, P421, DOI 10.1016/S0959-4388(03)00103-X; DACEY DM, 1992, VISUAL NEUROSCI, V9, P279, DOI 10.1017/S0952523800010695; DeVries SH, 1999, J NEUROPHYSIOL, V81, P908, DOI 10.1152/jn.1999.81.2.908; DONNER K, 1992, VISION RES, V32, P853, DOI 10.1016/0042-6989(92)90028-H; Dunn FA, 2007, NATURE, V449, P603, DOI 10.1038/nature06150; Field GD, 2007, ANNU REV NEUROSCI, V30, P1, DOI 10.1146/annurev.neuro.30.051606.094252; Field GD, 2005, ANNU REV PHYSIOL, V67, P491, DOI 10.1146/annurev.physiol.67.031103.151256; Field GD, 2007, J NEUROSCI, V27, P13261, DOI 10.1523/JNEUROSCI.3437-07.2007; Fu YB, 2008, NAT NEUROSCI, V11, P565, DOI 10.1038/nn.2110; Gauthier JL, 2009, J NEUROSCI, V29, P4675, DOI 10.1523/JNEUROSCI.5294-08.2009; Gollisch T, 2008, SCIENCE, V319, P1108, DOI 10.1126/science.1149639; Goodchild AK, 1996, J COMP NEUROL, V366, P55, DOI 10.1002/(SICI)1096-9861(19960226)366:1<55::AID-CNE5>3.0.CO;2-J; Hamer RD, 2003, J GEN PHYSIOL, V122, P419, DOI 10.1085/jgp.200308832; Hidaka S, 2004, J NEUROSCI, V24, P10553, DOI 10.1523/JNEUROSCI.3319-04.2004; Hu EH, 2003, J NEUROSCI, V23, P6768; Jackman SL, 2009, NAT NEUROSCI, V12, P303, DOI 10.1038/nn.2267; LAMB TD, 1977, J PHYSIOL-LONDON, V272, P435, DOI 10.1113/jphysiol.1977.sp012053; MASTRONARDE DN, 1983, J NEUROPHYSIOL, V49, P303, DOI 10.1152/jn.1983.49.2.303; MASTRONARDE DN, 1983, J NEUROPHYSIOL, V49, P325, DOI 10.1152/jn.1983.49.2.325; MASTRONARDE DN, 1989, TRENDS NEUROSCI, V12, P75, DOI 10.1016/0166-2236(89)90140-9; Meister M, 1996, P NATL ACAD SCI USA, V93, P609, DOI 10.1073/pnas.93.2.609; MOLLON JD, 1992, VISION RES, V32, P745, DOI 10.1016/0042-6989(92)90189-P; Naarendorp F, 2010, J NEUROSCI, V30, P12495, DOI 10.1523/JNEUROSCI.2186-10.2010; Pillow JW, 2008, NATURE, V454, P995, DOI 10.1038/nature07140; Puchalla JL, 2005, NEURON, V46, P493, DOI 10.1016/j.neuron.2005.03.026; Renteria RC, 2006, J NEUROSCI, V26, P11857, DOI 10.1523/JNEUROSCI.1718-06.2006; Rieke F., 1997, SPIKES EXPLORING NEU; Schneeweis DM, 1999, J NEUROSCI, V19, P1203; Shadlen MN, 1996, J NEUROSCI, V16, P1486; Shlens J, 2008, CURR OPIN NEUROBIOL, V18, P396, DOI 10.1016/j.conb.2008.09.010; SLAUGHTER MM, 1981, SCIENCE, V211, P182, DOI 10.1126/science.6255566; Trong PK, 2008, NAT NEUROSCI, V11, P1343, DOI 10.1038/nn.2199; VANEY DI, 1991, NEUROSCI LETT, V125, P187, DOI 10.1016/0304-3940(91)90024-N; Warland DK, 1997, J NEUROPHYSIOL, V78, P2336, DOI 10.1152/jn.1997.78.5.2336; WERBLIN FS, 1969, J NEUROPHYSIOL, V32, P339, DOI 10.1152/jn.1969.32.3.339; Westheimer G., 1981, PROGR SENSORY PHYSL, P1, DOI DOI 10.1007/978-3-642-66744-2; Xu Y, 2008, J COMP NEUROL, V507, P1871, DOI 10.1002/cne.21644; Zaghloul KA, 2003, J NEUROSCI, V23, P2645	49	64	64	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2011	14	10					1309	U127		10.1038/nn.2927	http://dx.doi.org/10.1038/nn.2927			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	825EQ	21926983	Green Accepted			2022-12-28	WOS:000295254200020
J	Egner, T				Egner, Tobias			Surprise! A unifying model of dorsal anterior cingulate function?	NATURE NEUROSCIENCE			English	Editorial Material							ERROR LIKELIHOOD; PREDICTION ERRORS; COGNITIVE CONTROL; CORTEX; CONFLICT; REWARD; TIME; TASK		[Egner, Tobias] Duke Univ, Dept Psychol & Neurosci, Durham, NC 27706 USA; [Egner, Tobias] Duke Univ, Ctr Cognit Neurosci, Durham, NC USA	Duke University; Duke University	Egner, T (corresponding author), Duke Univ, Dept Psychol & Neurosci, Durham, NC 27706 USA.	tobias.egner@duke.edu	Egner, Tobias/A-5237-2009; Egner, Tobias/AAD-5864-2022	Egner, Tobias/0000-0001-7956-3241; Egner, Tobias/0000-0001-7956-3241				Alexander WH, 2011, NAT NEUROSCI, V14, P1338, DOI 10.1038/nn.2921; Behrens TEJ, 2007, NAT NEUROSCI, V10, P1214, DOI 10.1038/nn1954; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Brown JW, 2011, NEUROIMAGE, V57, P314, DOI 10.1016/j.neuroimage.2011.04.028; Brown JW, 2005, SCIENCE, V307, P1118, DOI 10.1126/science.1105783; Egner T, 2010, J NEUROSCI, V30, P16601, DOI 10.1523/JNEUROSCI.2770-10.2010; GEHRING WJ, 1993, PSYCHOL SCI, V4, P385, DOI 10.1111/j.1467-9280.1993.tb00586.x; Grinband J, 2011, NEUROIMAGE, V57, P303, DOI 10.1016/j.neuroimage.2010.12.027; Hayden BY, 2011, J NEUROSCI, V31, P4178, DOI 10.1523/JNEUROSCI.4652-10.2011; Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI 10.1037/0033-295X.109.4.679; Jessup RK, 2010, J NEUROSCI, V30, P3467, DOI 10.1523/JNEUROSCI.4130-09.2010; Kennerley SW, 2006, NAT NEUROSCI, V9, P940, DOI 10.1038/nn1724; Matsumoto M, 2007, NAT NEUROSCI, V10, P647, DOI 10.1038/nn1890; Rudebeck PH, 2006, NAT NEUROSCI, V9, P1161, DOI 10.1038/nn1756; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593	15	32	33	1	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2011	14	10					1219	1220		10.1038/nn.2932	http://dx.doi.org/10.1038/nn.2932			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	825EQ	21952261				2022-12-28	WOS:000295254200001
J	Kastner, DB; Baccus, SA				Kastner, David B.; Baccus, Stephen A.			Coordinated dynamic encoding in the retina using opposing forms of plasticity	NATURE NEUROSCIENCE			English	Article							SLOW CONTRAST ADAPTATION; GANGLION-CELLS; VARIANCE ADAPTATION; SALAMANDER RETINA; VISUAL-ADAPTATION; TEMPORAL CONTRAST; NATURAL IMAGES; SPATIAL SCALE; BIPOLAR CELLS; INFORMATION	The range of natural inputs encoded by a neuron often exceeds its dynamic range. To overcome this limitation, neural populations divide their inputs among different cell classes, as with rod and cone photoreceptors, and adapt by shifting their dynamic range. We report that the dynamic behavior of retinal ganglion cells in salamanders, mice and rabbits is divided into two opposing forms of short-term plasticity in different cell classes. One population of cells exhibited sensitization-a persistent elevated sensitivity following a strong stimulus. This newly observed dynamic behavior compensates for the information loss caused by the known process of adaptation occurring in a separate cell population. The two populations divide the dynamic range of inputs, with sensitizing cells encoding weak signals and adapting cells encoding strong signals. In the two populations, the linear, threshold and adaptive properties are linked to preserve responsiveness when stimulus statistics change, with one population maintaining the ability to respond when the other fails.	[Baccus, Stephen A.] Stanford Univ, Dept Neurobiol, Sch Med, Stanford, CA 94305 USA; [Kastner, David B.] Stanford Univ, Neurosci Program, Sch Med, Stanford, CA 94305 USA	Stanford University; Stanford University	Baccus, SA (corresponding author), Stanford Univ, Dept Neurobiol, Sch Med, Stanford, CA 94305 USA.	baccus@stanford.edu		Kastner, David/0000-0001-9681-425X	US National Eye Institute; Pew Charitable Trusts; McKnight Endowment Fund for Neuroscience; Karl Kirchgessner Foundation; Alfred P. Sloan Foundation; Stanford Medical Scientist Training Program; US National Science Foundation; NATIONAL EYE INSTITUTE [R01EY022933, R01EY016842] Funding Source: NIH RePORTER	US National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Pew Charitable Trusts; McKnight Endowment Fund for Neuroscience; Karl Kirchgessner Foundation; Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); Stanford Medical Scientist Training Program; US National Science Foundation(National Science Foundation (NSF)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank E. Knudsen and W. T. Newsome for comments on the manuscript; D. Baylor, R. W. Tsien, B. Wandell, P. Jadzinsky, A. L. Fairhall, F. Rieke, D. S. Fisher and K. D. Miller for discussions; and Y. Ozuysal and A. Huberman for technical assistance. This work was supported by grants from the US National Eye Institute, Pew Charitable Trusts, McKnight Endowment Fund for Neuroscience, Karl Kirchgessner Foundation and Alfred P. Sloan Foundation (S. A. B.); and by the Stanford Medical Scientist Training Program and a US National Science Foundation Integrative Graduate Education and Research Traineeship (D. B. K.). Rabbit experiments were performed in the laboratory of M. Meister at Harvard University.	Abbott LF, 1999, NEURAL COMPUT, V11, P91, DOI 10.1162/089976699300016827; Baccus SA, 2007, ANNU REV PHYSIOL, V69, P271, DOI 10.1146/annurev.physiol.69.120205.124451; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Brown SP, 2001, NAT NEUROSCI, V4, P44, DOI 10.1038/82888; Butts DA, 2003, NETWORK-COMP NEURAL, V14, P177, DOI 10.1088/0954-898X/14/2/301; Chichilnisky EJ, 2001, NETWORK-COMP NEURAL, V12, P199, DOI 10.1088/0954-898X/12/2/306; DAYAN P, 2009, THEORETICAL NEUROSCI, V460; DeWeese M, 1998, NEURAL COMPUT, V10, P1179, DOI 10.1162/089976698300017403; ENROTHCUGELL C, 1966, J PHYSIOL-LONDON, V187, P517, DOI 10.1113/jphysiol.1966.sp008107; Fairhall AL, 2001, NATURE, V412, P787, DOI 10.1038/35090500; Field GD, 2002, NEURON, V34, P773, DOI 10.1016/S0896-6273(02)00700-6; Frazor RA, 2006, VISION RES, V46, P1585, DOI 10.1016/j.visres.2005.06.038; Gollisch T, 2008, SCIENCE, V319, P1108, DOI 10.1126/science.1149639; Huberman AD, 2008, NEURON, V59, P425, DOI 10.1016/j.neuron.2008.07.018; Kim KJ, 2003, J NEUROSCI, V23, P1506, DOI 10.1523/JNEUROSCI.23-04-01506.2003; LAUGHLIN S, 1981, Z NATURFORSCH C, V36, P910; Li GL, 2007, J NEUROSCI, V27, P7377, DOI 10.1523/JNEUROSCI.0410-07.2007; MAGUIRE G, 1989, P NATL ACAD SCI USA, V86, P10144, DOI 10.1073/pnas.86.24.10144; Manookin MB, 2006, NEURON, V50, P453, DOI 10.1016/j.neuron.2006.03.039; Maravall M, 2007, PLOS BIOL, V5, P323, DOI 10.1371/journal.pbio.0050019; Mennerick S, 1996, NEURON, V17, P1241, DOI 10.1016/S0896-6273(00)80254-8; Nagel KI, 2006, NEURON, V51, P845, DOI 10.1016/j.neuron.2006.08.030; Olveczky BP, 2003, NATURE, V423, P401, DOI 10.1038/nature01652; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; PINSKER HM, 1973, SCIENCE, V182, P1039, DOI 10.1126/science.182.4116.1039; Reinagel P, 2000, J NEUROSCI, V20, P5392, DOI 10.1523/JNEUROSCI.20-14-05392.2000; Rieke F, 2001, J NEUROSCI, V21, P9445, DOI 10.1523/JNEUROSCI.21-23-09445.2001; Rieke F, 2009, NEURON, V64, P605, DOI 10.1016/j.neuron.2009.11.028; Segev R, 2006, J NEUROPHYSIOL, V95, P2277, DOI 10.1152/jn.00928.2005; Snippe HP, 2003, J OPT SOC AM A, V20, P1321, DOI 10.1364/JOSAA.20.001321; Solomon SG, 2004, NEURON, V42, P155, DOI 10.1016/S0896-6273(04)00178-3; SRINIVASAN MV, 1982, PROC R SOC SER B-BIO, V216, P427, DOI 10.1098/rspb.1982.0085; Strong SP, 1998, PHYS REV LETT, V80, P197, DOI 10.1103/PhysRevLett.80.197; Wark B, 2009, NEURON, V61, P750, DOI 10.1016/j.neuron.2009.01.019; Wessel R, 1996, J NEUROPHYSIOL, V75, P2280, DOI 10.1152/jn.1996.75.6.2280	38	61	62	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2011	14	10					1317	U135		10.1038/nn.2906	http://dx.doi.org/10.1038/nn.2906			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	825EQ	21909086	Green Accepted			2022-12-28	WOS:000295254200021
J	Rao-Ruiz, P; Rotaru, DC; van der Loo, RJ; Mansvelder, HD; Stiedl, O; Smit, AB; Spijker, S				Rao-Ruiz, Priyanka; Rotaru, Diana C.; van der Loo, Rolinka J.; Mansvelder, Huibert D.; Stiedl, Oliver; Smit, August B.; Spijker, Sabine			Retrieval-specific endocytosis of GluA2-AMPARs underlies adaptive reconsolidation of contextual fear	NATURE NEUROSCIENCE			English	Article							AMPA RECEPTOR TRAFFICKING; LONG-TERM DEPRESSION; MEMORY RECONSOLIDATION; SYNAPTIC PLASTICITY; EXTINCTION; CONSOLIDATION; MECHANISMS; ERASURE; POTENTIATION; REACTIVATION	Upon retrieval, fear memories are rendered labile and prone to modification, necessitating a restabilization process of reconsolidation to persist further. This process is also crucial for modulating both strength and content of an existing memory and forms a promising therapeutic target for fear-related disorders. However, the molecular and cellular mechanism of adaptive reconsolidation still remains obscure. Here we show that retrieval of fear memory induces a biphasic temporal change in GluA2-containing AMPA-type glutamate receptor (AMPAR) membrane expression and synaptic strength in the mouse dorsal hippocampus. Blockade of retrieval-induced, regulated, GluA2-dependent endocytosis enhanced subsequent expression of fear. In addition, this blockade prevented the loss of fear response after reconsolidation-update of fear memory content in the long-term. Thus, endocytosis of GluA2-containing AMPARs allows plastic changes at the synaptic level that exerts an inhibitory constraint on memory strengthening and underlies the loss of fear response by reinterpretation of memory content during adaptive reconsolidation.	[Rao-Ruiz, Priyanka; Rotaru, Diana C.; van der Loo, Rolinka J.; Stiedl, Oliver; Smit, August B.; Spijker, Sabine] VU Univ Vrije Univ, Dept Mol & Cellular Neurobiol, Ctr Neurogenom & Cognit Res, Amsterdam, Netherlands; [Rotaru, Diana C.; Mansvelder, Huibert D.] Vrije Univ Amsterdam, Dept Integrat Neurophysiol, Ctr Neurogenom & Cognit Res, Amsterdam, Netherlands; [Stiedl, Oliver] Vrije Univ Amsterdam, Dept Funct Genom, Ctr Neurogenom & Cognit Res, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	Spijker, S (corresponding author), VU Univ Vrije Univ, Dept Mol & Cellular Neurobiol, Ctr Neurogenom & Cognit Res, Neurosci Campus Amsterdam, Amsterdam, Netherlands.	sabine.spijker@cncr.vu.nl	Spijker, Sabine/F-2300-2011; Mansvelder, Huibert/N-6138-2018; Rotaru, Diana/AAZ-9058-2020; Stiedl, Oliver/AAB-5004-2021	Mansvelder, Huibert/0000-0003-1365-5340; Stiedl, Oliver/0000-0002-4427-9221; Rao-Ruiz, Priyanka/0000-0001-9504-1427; Spijker, Sabine/0000-0002-6814-2019; Rotaru, Diana/0000-0002-0724-3596	Neuromics Marie Curie Early Stage Training grant [MEST-CT-2005-020919]	Neuromics Marie Curie Early Stage Training grant	The authors thank J. Peters, M. van den Oever, R. van Kesteren and S. A. Kushner for critical reading of previous versions of this manuscript, and K. W. Li for technical advice in relation to biotinylation experiments. P.R.-R. was supported by a Neuromics Marie Curie Early Stage Training grant (MEST-CT-2005-020919).	Alberini CM, 2005, TRENDS NEUROSCI, V28, P51, DOI 10.1016/j.tins.2004.11.001; Brebner K, 2005, SCIENCE, V310, P1340, DOI 10.1126/science.1116894; Carroll RC, 1999, NAT NEUROSCI, V2, P454, DOI 10.1038/8123; Chan Wan Yee Macy, 2010, Learn Mem, V17, P512, DOI 10.1101/lm.1912510; Clem RL, 2010, SCIENCE, V330, P1108, DOI 10.1126/science.1195298; Counotte DS, 2011, NAT NEUROSCI, V14, P417, DOI 10.1038/nn.2770; FANSELOW MS, 1986, LEARN MOTIV, V17, P16, DOI 10.1016/0023-9690(86)90018-4; Frankland PW, 2006, LEARN MEMORY, V13, P451, DOI 10.1101/lm.183406; Franklin K. B., 1997, MOUSE BRAIN STEREOTA; GORDON WC, 1973, PHYSIOL BEHAV, V10, P1071, DOI 10.1016/0031-9384(73)90190-X; Han JH, 2009, SCIENCE, V323, P1492, DOI 10.1126/science.1164139; Jonas P, 2000, NEWS PHYSIOL SCI, V15, P83; Kessels HW, 2009, NEURON, V61, P340, DOI 10.1016/j.neuron.2009.01.015; Kida S, 2002, NAT NEUROSCI, V5, P348, DOI 10.1038/nn819; Kindt M, 2009, NAT NEUROSCI, V12, P256, DOI 10.1038/nn.2271; Lee JLC, 2004, SCIENCE, V304, P839, DOI 10.1126/science.1095760; Lee JLC, 2008, NAT NEUROSCI, V11, P1264, DOI 10.1038/nn.2205; Lee JLC, 2006, J NEUROSCI, V26, P10051, DOI 10.1523/JNEUROSCI.2466-06.2006; Lee JLC, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00168; Lee JLC, 2009, TRENDS NEUROSCI, V32, P413, DOI 10.1016/j.tins.2009.05.002; Lee SH, 2002, NEURON, V36, P661, DOI 10.1016/S0896-6273(02)01024-3; Lee SH, 2008, SCIENCE, V319, P1253, DOI 10.1126/science.1150541; Lu W, 2009, NEURON, V62, P254, DOI 10.1016/j.neuron.2009.02.027; MALENKA RC, 1994, CELL, V78, P535, DOI 10.1016/0092-8674(94)90517-7; Malenka RC, 2003, ANN NY ACAD SCI, V1003, P1, DOI 10.1196/annals.1300.001; Mamiya N, 2009, J NEUROSCI, V29, P402, DOI 10.1523/JNEUROSCI.4639-08.2009; Man HY, 2000, NEURON, V25, P649, DOI 10.1016/S0896-6273(00)81067-3; Maren S, 2011, NEURON, V70, P830, DOI 10.1016/j.neuron.2011.04.023; Matsuo N, 2008, SCIENCE, V319, P1104, DOI 10.1126/science.1149967; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; Migues PV, 2010, NAT NEUROSCI, V13, P630, DOI 10.1038/nn.2531; MISANIN JR, 1968, SCIENCE, V160, P554, DOI 10.1126/science.160.3827.554; Monfils MH, 2009, SCIENCE, V324, P951, DOI 10.1126/science.1167975; Nader K, 2003, TRENDS NEUROSCI, V26, P65, DOI 10.1016/S0166-2236(02)00042-5; Nader K, 2000, NATURE, V406, P722, DOI 10.1038/35021052; Nader K, 2009, NAT REV NEUROSCI, V10, P224, DOI 10.1038/nrn2590; Plant K, 2006, NAT NEUROSCI, V9, P602, DOI 10.1038/nn1678; Przybyslawski J, 1999, J NEUROSCI, V19, P6623; Qiu SF, 2006, J NEUROSCI, V26, P12943, DOI 10.1523/JNEUROSCI.2561-06.2006; Rescorla RA, 2004, LEARN MEMORY, V11, P501, DOI 10.1101/lm.77504; Robertson SD, 2010, J NEUROSCI, V30, P11305, DOI 10.1523/JNEUROSCI.0126-10.2010; Rumpel S, 2005, SCIENCE, V308, P83, DOI 10.1126/science.1103944; Schafe GE, 2001, TRENDS NEUROSCI, V24, P540, DOI 10.1016/S0166-2236(00)01969-X; Schiller D, 2010, NATURE, V463, P49, DOI 10.1038/nature08637; Serrano P, 2008, PLOS BIOL, V6, P2698, DOI 10.1371/journal.pbio.0060318; Suzuki A, 2004, J NEUROSCI, V24, P4787, DOI 10.1523/JNEUROSCI.5491-03.2004; Tronson NC, 2007, NAT REV NEUROSCI, V8, P262, DOI 10.1038/nrn2090; Tronson NC, 2006, NAT NEUROSCI, V9, P167, DOI 10.1038/nn1628; Van den Oever MC, 2008, NAT NEUROSCI, V11, P1053, DOI 10.1038/nn.2165; Wang SH, 2009, NAT NEUROSCI, V12, P905, DOI 10.1038/nn.2350	50	152	154	1	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2011	14	10					1302	U117		10.1038/nn.2907	http://dx.doi.org/10.1038/nn.2907			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	825EQ	21909089				2022-12-28	WOS:000295254200019
J	Sul, JH; Jo, S; Lee, D; Jung, MW				Sul, Jung Hoon; Jo, Suhyun; Lee, Daeyeol; Jung, Min Whan			Role of rodent secondary motor cortex in value-based action selection	NATURE NEUROSCIENCE			English	Article							MEDIAL PREFRONTAL CORTEX; ORBITOFRONTAL CORTEX; DECISION-MAKING; AFFERENT CONNECTIONS; MATCHING BEHAVIOR; NEURONAL-ACTIVITY; AGRANULAR CORTEX; EYE FIELDS; REWARD; RAT	Despite widespread neural activity related to reward values, signals related to upcoming choice have not been clearly identified in the rodent brain. Here we examined neuronal activity in the lateral (AGl) and medial (AGm) agranular cortex, corresponding to the primary and secondary motor cortex, respectively, in rats performing a dynamic foraging task. Choice signals, before behavioral manifestation of the rat's choice, arose in the AGm earlier than in any other areas of the rat brain previously studied under free-choice conditions. The AGm also conveyed neural signals for decision value and chosen value. By contrast, upcoming choice signals arose later, and value signals were weaker, in the AGl. We also found that AGm lesions made the rats' choices less dependent on dynamically updated values. These results suggest that rodent secondary motor cortex might be uniquely involved in both representing and reading out value signals for flexible action selection.	[Sul, Jung Hoon; Jo, Suhyun; Jung, Min Whan] Ajou Univ, Neurosci Lab, Inst Med Sci, Sch Med, Suwon 441749, South Korea; [Jo, Suhyun; Jung, Min Whan] Ajou Univ, Grad Program Neurosci, Sch Med, Suwon 441749, South Korea; [Lee, Daeyeol] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT USA	Ajou University; Ajou University; Yale University	Jung, MW (corresponding author), Ajou Univ, Neurosci Lab, Inst Med Sci, Sch Med, Suwon 441749, South Korea.	min@ajou.ac.kr	Lee, Daeyeol/A-6794-2008; Jung, Min Whan/GXF-5216-2022	Lee, Daeyeol/0000-0003-3474-019X; Jo, Suhyun/0000-0002-6538-8240	Brain Research Center; Korea National Research Foundation [2011-0015618]; Cognitive Neuroscience Program; Ministry of Education, Science and Technology, Korea [2011-0019209]; US National Institutes of Health; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA029330] Funding Source: NIH RePORTER	Brain Research Center; Korea National Research Foundation(National Research Foundation of Korea); Cognitive Neuroscience Program; Ministry of Education, Science and Technology, Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank C. Lee for discussion, P. Nachev for commenting on the manuscript, J.W. Ghim for helping with analysis and E. Seuter for proofreading the manuscript. This work was supported by a grant from the Brain Research Center of the 21st Century Frontier Research Program, a Korea National Research Foundation grant (2011-0015618), the Cognitive Neuroscience Program, and the Original Technology Research Program for Brain Science (2011-0019209) funded by the Ministry of Education, Science and Technology, Korea (to M.W.J.), and the US National Institutes of Health (to D.L.).	AKINTUNDE A, 1992, BRAIN RES, V575, P86, DOI 10.1016/0006-8993(92)90427-B; Baeg EH, 2001, CEREB CORTEX, V11, P441, DOI 10.1093/cercor/11.5.441; Baeg EH, 2003, NEURON, V40, P177, DOI 10.1016/S0896-6273(03)00597-X; Balleine BW, 2007, J NEUROSCI, V27, P8161, DOI 10.1523/JNEUROSCI.1554-07.2007; Barraclough DJ, 2004, NAT NEUROSCI, V7, P404, DOI 10.1038/nn1209; Buschman TJ, 2007, SCIENCE, V315, P1860, DOI 10.1126/science.1138071; Coe B, 2002, J NEUROSCI, V22, P5081, DOI 10.1523/JNEUROSCI.22-12-05081.2002; DONOGHUE JP, 1982, J COMP NEUROL, V212, P76, DOI 10.1002/cne.902120106; DONOGHUE JP, 1983, J COMP NEUROL, V217, P390, DOI 10.1002/cne.902170404; Felsen G, 2008, NEURON, V60, P137, DOI 10.1016/j.neuron.2008.09.019; Hoshi E, 2007, CURR OPIN NEUROBIOL, V17, P234, DOI 10.1016/j.conb.2007.02.003; Huh N, 2009, LEARN MEMORY, V16, P315, DOI 10.1101/lm.1295509; Kable JW, 2009, NEURON, V63, P733, DOI 10.1016/j.neuron.2009.09.003; Kargo WJ, 2007, J NEUROSCI, V27, P3548, DOI 10.1523/JNEUROSCI.3604-06.2007; Kennerley SW, 2009, J COGNITIVE NEUROSCI, V21, P1162, DOI 10.1162/jocn.2009.21100; Kim H, 2009, J NEUROSCI, V29, P14701, DOI 10.1523/JNEUROSCI.2728-09.2009; Kim YB, 2007, J NEUROPHYSIOL, V98, P3548, DOI 10.1152/jn.00310.2007; Lau B, 2005, J EXP ANAL BEHAV, V84, P555, DOI 10.1901/jeab.2005.110-04; Lau B, 2008, NEURON, V58, P451, DOI 10.1016/j.neuron.2008.02.021; Louie K, 2010, J NEUROSCI, V30, P5498, DOI 10.1523/JNEUROSCI.5742-09.2010; MILLER MW, 1987, EXP BRAIN RES, V67, P339; Nachev P, 2008, NAT REV NEUROSCI, V9, P856, DOI 10.1038/nrn2478; NEAFSEY EJ, 1986, BRAIN RES REV, V11, P77, DOI 10.1016/0165-0173(86)90011-1; Padoa-Schioppa C, 2006, NATURE, V441, P223, DOI 10.1038/nature04676; PASSINGHAM RE, 1988, BEHAV NEUROSCI, V102, P101, DOI 10.1037/0735-7044.102.1.101; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Pesaran B, 2008, NATURE, V453, P406, DOI 10.1038/nature06849; Platt ML, 1999, NATURE, V400, P233, DOI 10.1038/22268; Ragozzino ME, 2007, ANN NY ACAD SCI, V1121, P355, DOI 10.1196/annals.1401.013; REEP RL, 1990, J COMP NEUROL, V294, P262, DOI 10.1002/cne.902940210; REEP RL, 1984, NEUROSCI LETT, V44, P247, DOI 10.1016/0304-3940(84)90030-2; REEP RL, 1987, BRAIN RES BULL, V19, P203, DOI 10.1016/0361-9230(87)90086-4; Roesch MR, 2006, NEURON, V51, P509, DOI 10.1016/j.neuron.2006.06.027; Roesch MR, 2003, J NEUROPHYSIOL, V90, P1766, DOI 10.1152/jn.00019.2003; Roesch MR, 2004, SCIENCE, V304, P307, DOI 10.1126/science.1093223; Samejima K, 2005, SCIENCE, V310, P1337, DOI 10.1126/science.1115270; SANDERSON KJ, 1984, BRAIN RES, V292, P251, DOI 10.1016/0006-8993(84)90761-3; Schoenbaum G, 2006, TRENDS NEUROSCI, V29, P116, DOI 10.1016/j.tins.2005.12.006; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; Seo H, 2007, J NEUROSCI, V27, P8366, DOI 10.1523/JNEUROSCI.2369-07.2007; Seo H, 2009, J NEUROSCI, V29, P7278, DOI 10.1523/JNEUROSCI.1479-09.2009; Seo H, 2009, J NEUROSCI, V29, P3627, DOI 10.1523/JNEUROSCI.4726-08.2009; Sohn JW, 2007, J NEUROSCI, V27, P13655, DOI 10.1523/JNEUROSCI.2982-07.2007; STADDON JER, 1981, J EXP ANAL BEHAV, V35, P397, DOI 10.1901/jeab.1981.35-397; Sugrue LP, 2004, SCIENCE, V304, P1782, DOI 10.1126/science.1094765; Sul JH, 2010, NEURON, V66, P449, DOI 10.1016/j.neuron.2010.03.033; TANJI J, 1994, NEUROSCI RES, V19, P251, DOI 10.1016/0168-0102(94)90038-8; Thevarajah D, 2009, J NEUROSCI, V29, P1998, DOI 10.1523/JNEUROSCI.4764-08.2009; UYLINGS HBM, 1990, PROG BRAIN RES, V85, P31, DOI [DOI 10.1016/j.bbr.2003.09.028, DOI 10.1016/j.pscychresns.2017.01.006]; Wang Y, 1998, BRAIN RES, V781, P137, DOI 10.1016/S0006-8993(97)01223-7	50	133	133	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2011	14	9					1202	U139		10.1038/nn.2881	http://dx.doi.org/10.1038/nn.2881			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	812ID	21841777	Green Accepted			2022-12-28	WOS:000294284900022
J	Shipman, SL; Schnell, E; Hirai, T; Chen, BS; Roche, KW; Nicoll, RA				Shipman, Seth L.; Schnell, Eric; Hirai, Takaaki; Chen, Bo-Shiun; Roche, Katherine W.; Nicoll, Roger A.			Functional dependence of neuroligin on a new non-PDZ intracellular domain	NATURE NEUROSCIENCE			English	Article							INHIBITORY SYNAPSE FORMATION; CELL-ADHESION MOLECULE; AMPA RECEPTORS; NEUREXIN; AUTISM; MUTATION; PROTEIN; EXPRESSION; PSD-95; MECHANISMS	Neuroligins, a family of postsynaptic adhesion molecules, are important in synaptogenesis through a well-characterized transsynaptic interaction with neurexin. In addition, neuroligins are thought to drive postsynaptic assembly through binding of their intracellular domain to PSD-95. However, there is little direct evidence to support the functional necessity of the neuroligin intracellular domain in postsynaptic development. We found that presence of endogenous neuroligin obscured the study of exogenous mutated neuroligin. We therefore used chained microRNAs in rat organotypic hippocampal slices to generate a reduced background of endogenous neuroligin. On this reduced background, we found that neuroligin function was critically dependent on the cytoplasmic tail. However, this function required neither the PDZ ligand nor any other previously described cytoplasmic binding domain, but rather required a previously unknown conserved region. Mutation of a single critical residue in this region inhibited neuroligin-mediated excitatory synaptic potentiation. Finally, we found a functional distinction between neuroligins 1 and 3.	[Shipman, Seth L.; Nicoll, Roger A.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA; [Shipman, Seth L.; Nicoll, Roger A.] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; [Shipman, Seth L.] Univ Calif San Francisco, Neurosci Grad Program, San Francisco, CA 94143 USA; [Schnell, Eric] Univ Calif San Francisco, Dept Anesthesia & Perioperat Care, San Francisco, CA 94143 USA; [Hirai, Takaaki; Chen, Bo-Shiun; Roche, Katherine W.] NINDS, US Natl Inst Hlth, Bethesda, MD 20892 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Nicoll, RA (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA.	nicoll@cmp.ucsf.edu	Roche, Katherine/W-9893-2019; Chen, Bo-Shiun/H-4633-2012; Shipman, Seth/G-2562-2011	Schnell, Eric/0000-0002-5623-5015; Roche, Katherine/0000-0001-7282-6539	US National Institute of Mental Health; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH038256] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS002994] Funding Source: NIH RePORTER	US National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank A.M. Craig, T. Sudhof and F. Varoqueaux for neuroligin constructs. We are grateful to K. Bjorgan for technical assistance and all members of the Nicoll laboratory and E. Dreyfuss for discussion of and comments on the manuscript. This work was supported by grants from the US National Institute of Mental Health.	Arac D, 2007, NEURON, V56, P992, DOI 10.1016/j.neuron.2007.12.002; Barrow SL, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-17; Blundell J, 2010, J NEUROSCI, V30, P2115, DOI 10.1523/JNEUROSCI.4517-09.2010; Bolliger MF, 2008, P NATL ACAD SCI USA, V105, P6421, DOI 10.1073/pnas.0801383105; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Budreck EC, 2007, EUR J NEUROSCI, V26, P1738, DOI 10.1111/j.1460-9568.2007.05842.x; Chen SX, 2010, NEURON, V67, P967, DOI 10.1016/j.neuron.2010.08.016; Chih B, 2005, SCIENCE, V307, P1324, DOI 10.1126/science.1107470; Chubykin AA, 2007, NEURON, V54, P919, DOI 10.1016/j.neuron.2007.05.029; Comoletti D, 2004, J NEUROSCI, V24, P4889, DOI 10.1523/JNEUROSCI.0468-04.2004; Daoud H, 2009, BIOL PSYCHIAT, V66, P906, DOI 10.1016/j.biopsych.2009.05.008; de Wit J, 2009, NEURON, V64, P799, DOI 10.1016/j.neuron.2009.12.019; Dean C, 2003, NAT NEUROSCI, V6, P708, DOI 10.1038/nn1074; Dean C, 2006, TRENDS NEUROSCI, V29, P21, DOI 10.1016/j.tins.2005.11.003; Dresbach T, 2004, MOL CELL NEUROSCI, V27, P227, DOI 10.1016/j.mcn.2004.06.013; Fabrichny IP, 2007, NEURON, V56, P979, DOI 10.1016/j.neuron.2007.11.013; Fu ZY, 2003, J NEUROPHYSIOL, V90, P3950, DOI 10.1152/jn.00647.2003; Futai K, 2007, NAT NEUROSCI, V10, P186, DOI 10.1038/nn1837; Graf ER, 2004, CELL, V119, P1013, DOI 10.1016/j.cell.2004.11.035; Gutierrez RC, 2009, NEUROSCIENCE, V162, P208, DOI 10.1016/j.neuroscience.2009.04.062; Heine M, 2008, P NATL ACAD SCI USA, V105, P20947, DOI 10.1073/pnas.0804007106; Irie M, 1997, SCIENCE, V277, P1511, DOI 10.1126/science.277.5331.1511; Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136; Kerchner GA, 2008, NAT REV NEUROSCI, V9, P813, DOI 10.1038/nrn2501; Kim J, 2008, P NATL ACAD SCI USA, V105, P9087, DOI 10.1073/pnas.0803448105; Ko J, 2009, NEURON, V64, P791, DOI 10.1016/j.neuron.2009.12.012; Ko J, 2009, EMBO J, V28, P3244, DOI 10.1038/emboj.2009.249; Lawson-Yuen A, 2008, EUR J HUM GENET, V16, P614, DOI 10.1038/sj.ejhg.5202006; Levinson JN, 2005, NEURON, V48, P171, DOI 10.1016/j.neuron.2005.09.017; Levinson JN, 2005, J BIOL CHEM, V280, P17312, DOI 10.1074/jbc.M413812200; Lida J, 2004, MOL CELL NEUROSCI, V27, P497, DOI 10.1016/j.mcn.2004.08.006; Linhoff MW, 2009, NEURON, V61, P734, DOI 10.1016/j.neuron.2009.01.017; Nam CI, 2005, P NATL ACAD SCI USA, V102, P6137, DOI 10.1073/pnas.0502038102; Petralia RS, 1999, NAT NEUROSCI, V2, P31, DOI 10.1038/4532; Poulopoulos A, 2009, NEURON, V63, P628, DOI 10.1016/j.neuron.2009.08.023; Prange O, 2004, P NATL ACAD SCI USA, V101, P13915, DOI 10.1073/pnas.0405939101; Radyushkin K, 2009, GENES BRAIN BEHAV, V8, P416, DOI 10.1111/j.1601-183X.2009.00487.x; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Song JY, 1999, P NATL ACAD SCI USA, V96, P1100, DOI 10.1073/pnas.96.3.1100; Stan A, 2010, P NATL ACAD SCI USA, V107, P11116, DOI 10.1073/pnas.0914233107; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Suh YH, 2010, NAT NEUROSCI, V13, P338, DOI 10.1038/nn.2488; Tabuchi K, 2007, SCIENCE, V318, P71, DOI 10.1126/science.1146221; Varoqueaux F, 2004, EUR J CELL BIOL, V83, P449, DOI 10.1078/0171-9335-00410; Varoqueaux F, 2006, NEURON, V51, P741, DOI 10.1016/j.neuron.2006.09.003; Washbourne P, 2004, J NEUROSCI, V24, P9244, DOI 10.1523/JNEUROSCI.3339-04.2004; Wittenmayer N, 2009, P NATL ACAD SCI USA, V106, P13564, DOI 10.1073/pnas.0905819106; Yamagata M, 2003, CURR OPIN CELL BIOL, V15, P621, DOI 10.1016/S0955-0674(03)00107-8; Zhang C, 2009, J NEUROSCI, V29, P10843, DOI 10.1523/JNEUROSCI.1248-09.2009	50	76	77	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2011	14	6					718	U388		10.1038/nn.2825	http://dx.doi.org/10.1038/nn.2825			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	768SH	21532576	Green Accepted			2022-12-28	WOS:000290958000014
J	Kakegawa, W; Miyoshi, Y; Hamase, K; Matsuda, S; Matsuda, K; Kohda, K; Emi, K; Motohashi, J; Konno, R; Zaitsu, K; Yuzaki, M				Kakegawa, Wataru; Miyoshi, Yurika; Hamase, Kenji; Matsuda, Shinji; Matsuda, Keiko; Kohda, Kazuhisa; Emi, Kyoichi; Motohashi, Junko; Konno, Ryuichi; Zaitsu, Kiyoshi; Yuzaki, Michisuke			D-Serine regulates cerebellar LTD and motor coordination through the delta 2 glutamate receptor	NATURE NEUROSCIENCE			English	Article							LONG-TERM DEPRESSION; D-ASPARTATE RECEPTORS; AMINO-ACID OXIDASE; SYNAPTIC PLASTICITY; IN-VIVO; MAMMALIAN BRAIN; GRANULE CELLS; RAT-BRAIN; RACEMASE; GLIA	D-Serine (D-Ser) is an endogenous co-agonist for NMDA receptors and regulates neurotransmission and synaptic plasticity in the forebrain. D-Ser is also found in the cerebellum during the early postnatal period. Although D-Ser binds to the delta 2 glutamate receptor (GluD2, Grid2) in vitro, its physiological significance has remained unclear. Here we show that D-Ser serves as an endogenous ligand for GluD2 to regulate long-term depression (LTD) at synapses between parallel fibers and Purkinje cells in the immature cerebellum. D-Ser was released mainly from Bergmann glia after the burst stimulation of parallel fibers in immature, but not mature, cerebellum. D-Ser rapidly induced endocytosis of AMPA receptors and mutually occluded LTD in wild-type, but not Grid2-null, Purkinje cells. Moreover, mice expressing mutant GluD2 in which the binding site for D-Ser was disrupted showed impaired LTD and motor dyscoordination during development. These results indicate that glial D-Ser regulates synaptic plasticity and cerebellar functions by interacting with GluD2.	[Kakegawa, Wataru; Matsuda, Shinji; Matsuda, Keiko; Kohda, Kazuhisa; Emi, Kyoichi; Motohashi, Junko; Yuzaki, Michisuke] Keio Univ, Sch Med, Dept Physiol, Shinjuku Ku, Tokyo 160, Japan; [Kakegawa, Wataru; Matsuda, Shinji; Matsuda, Keiko; Kohda, Kazuhisa; Emi, Kyoichi; Motohashi, Junko; Yuzaki, Michisuke] Japan Sci & Technol Corp, Core Res Evolut Sci & Technol, Kawaguchi, Saitama, Japan; [Miyoshi, Yurika; Hamase, Kenji] Kyushu Univ, Grad Sch Pharmaceut Sci, Higashi Ku, Fukuoka 812, Japan; [Konno, Ryuichi] Int Univ Hlth & Welf Grad Sch, Ctr Med Sci, Ohtawara, Tochigi, Japan	Keio University; Japan Science & Technology Agency (JST); Kyushu University; International University of Health & Welfare	Yuzaki, M (corresponding author), Keio Univ, Sch Med, Dept Physiol, Shinjuku Ku, Tokyo 160, Japan.	myuzaki@a5.keio.jp	Matsuda, Shinji/L-4727-2013; Kakegawa, Wataru/L-4900-2013; Kakegawa, Wataru/G-5569-2016; Kohda, Kazuhisa/L-4731-2013; Yuzaki, Michisuke/K-5328-2013; Matsuda, Shinji/GRR-5226-2022; Matsuda, Keiko/L-5778-2013	Yuzaki, Michisuke/0000-0002-5750-3544; 	Ministry of Education, Culture, Sports, Science and Technology of Japan; Japanese Science and Technology Agency; Keio Gijuku Academic Development Funds; Research Grants for Life Science and Medicine; Naito Foundation; Takeda Science Foundation	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japanese Science and Technology Agency(Japan Science & Technology Agency (JST)); Keio Gijuku Academic Development Funds; Research Grants for Life Science and Medicine; Naito Foundation(Naito Memorial Foundation); Takeda Science Foundation(Takeda Science Foundation (TSF))	We appreciate Shiseido Co., Ltd. for their technical support concerning the 2D-HPLC analysis of D-Ser. We thank M. Watanabe for the antibodies to GluD2 and 3-PGDH, S. Nakanishi for the GFP-TeNT cDNA, M. Mishina for the Grid2-null mouse, and T. Takahashi, S. Jitsuki and T. Nishikawa for comments. This work was supported by a Grant-in-Aid for the Ministry of Education, Culture, Sports, Science and Technology of Japan (M.Y. and W. K.), Core Research for Evolutional Science and Technology from the Japanese Science and Technology Agency (M.Y.), Keio Gijuku Academic Development Funds (W. K.), the Keio University Medical Science Fund, Research Grants for Life Science and Medicine (W. K.), the Naito Foundation Subsidy for Promotion of Specific Research Projects (W. K.) and the Takeda Science Foundation (M.Y.).	Billard JM, 2008, J CELL MOL MED, V12, P1872, DOI 10.1111/j.1582-4934.2008.00315.x; Casado M, 2002, NEURON, V33, P123, DOI 10.1016/S0896-6273(01)00568-2; Hansen KB, 2009, J NEUROSCI, V29, P907, DOI 10.1523/JNEUROSCI.4081-08.2009; Hashimoto A, 1997, PROG NEUROBIOL, V52, P325, DOI 10.1016/S0301-0082(97)00019-1; HASHIMOTO A, 1995, NEUROSCIENCE, V66, P635, DOI 10.1016/0306-4522(94)00597-X; Henneberger C, 2010, NATURE, V463, P232, DOI 10.1038/nature08673; Hirai H, 2005, NAT NEUROSCI, V8, P1534, DOI 10.1038/nn1576; Hirai H, 2005, EMBO REP, V6, P90, DOI 10.1038/sj.embor.7400312; Hirai H, 2003, NAT NEUROSCI, V6, P869, DOI 10.1038/nn1086; Jurado S, 2003, J CELL SCI, V116, P3165, DOI 10.1242/jcs.00620; Kakegawa W, 2008, J NEUROSCI, V28, P1460, DOI 10.1523/JNEUROSCI.2553-07.2008; Kakegawa W, 2007, J PHYSIOL-LONDON, V584, P89, DOI 10.1113/jphysiol.2007.141291; Kakegawa W, 2009, J NEUROSCI, V29, P5738, DOI 10.1523/JNEUROSCI.6013-08.2009; KASHIWABUCHI N, 1995, CELL, V81, P245, DOI 10.1016/0092-8674(95)90334-8; Kim PM, 2005, P NATL ACAD SCI USA, V102, P2105, DOI 10.1073/pnas.0409723102; Lee SH, 2002, NEURON, V36, P661, DOI 10.1016/S0896-6273(02)01024-3; Lehre KP, 2002, BIOPHYS J, V83, P125, DOI 10.1016/S0006-3495(02)75154-0; LevRam V, 1997, NEURON, V18, P1025, DOI 10.1016/S0896-6273(00)80340-2; Lino M, 2001, SCIENCE, V292, P926, DOI 10.1126/science.1058827; Matsuda K, 2010, SCIENCE, V328, P363, DOI 10.1126/science.1185152; Matsuda S, 2000, EMBO J, V19, P2765, DOI 10.1093/emboj/19.12.2765; Miya K, 2008, J COMP NEUROL, V510, P641, DOI 10.1002/cne.21822; Miyoshi Y, 2009, J CHROMATOGR B, V877, P2506, DOI 10.1016/j.jchromb.2009.06.028; Mothet JP, 2005, P NATL ACAD SCI USA, V102, P5606, DOI 10.1073/pnas.0408483102; Naur P, 2007, P NATL ACAD SCI USA, V104, P14116, DOI 10.1073/pnas.0703718104; NICHOLSON C, 1978, J NEUROPHYSIOL, V41, P1026, DOI 10.1152/jn.1978.41.4.1026; Oliet SHR, 2009, NEUROSCIENCE, V158, P275, DOI 10.1016/j.neuroscience.2008.01.071; Panatier A, 2006, CELL, V125, P775, DOI 10.1016/j.cell.2006.02.051; SCHELL MJ, 1995, P NATL ACAD SCI USA, V92, P3948, DOI 10.1073/pnas.92.9.3948; Schell MJ, 1997, J NEUROSCI, V17, P1604; Shin JH, 2005, J NEUROPHYSIOL, V94, P4281, DOI 10.1152/jn.00661.2005; Tanaka K, 2008, NEURON, V59, P608, DOI 10.1016/j.neuron.2008.06.026; Tregnago M, 1998, BRAIN RES, V793, P54, DOI 10.1016/S0006-8993(98)00161-9; Wang LZ, 2003, ACTA PHARMACOL SIN, V24, P965; Wang W, 1998, DEV BRAIN RES, V111, P65, DOI 10.1016/S0165-3806(98)00123-0; Williams SM, 2006, GLIA, V53, P401, DOI 10.1002/glia.20300; Wolosker H, 1999, P NATL ACAD SCI USA, V96, P13409, DOI 10.1073/pnas.96.23.13409; Xia J, 2000, NEURON, V28, P499, DOI 10.1016/S0896-6273(00)00128-8; Yamamoto M, 2003, J NEUROSCI, V23, P6759; Yang YL, 2003, P NATL ACAD SCI USA, V100, P15194, DOI 10.1073/pnas.2431073100; Yao Y, 2008, EMBO J, V27, P2158, DOI 10.1038/emboj.2008.140; Yuzaki M, 2009, NEUROSCIENCE, V162, P633, DOI 10.1016/j.neuroscience.2008.12.002; ZAFRA F, 1995, J NEUROSCI, V15, P3952; Zhang Z, 2008, CEREB CORTEX, V18, P2391, DOI 10.1093/cercor/bhn008; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	45	120	121	2	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2011	14	5					603	U93		10.1038/nn.2791	http://dx.doi.org/10.1038/nn.2791			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	754VU	21460832				2022-12-28	WOS:000289886600016
J	Chua, HF; Ho, SS; Jasinska, AJ; Polk, TA; Welsh, RC; Liberzon, I; Strecher, VJ				Chua, Hannah Faye; Ho, S. Shaun; Jasinska, Agnes J.; Polk, Thad A.; Welsh, Robert C.; Liberzon, Israel; Strecher, Victor J.			Self-related neural response to tailored smoking-cessation messages predicts quitting	NATURE NEUROSCIENCE			English	Article							METAANALYSIS; EDUCATION; BRAIN	Tailored health interventions can be more effective in eliciting positive behavior change than generic interventions, but the underlying neural mechanisms are not yet understood. Here, 91 smokers participated in a functional magnetic resonance imaging session and a tailored smoking-cessation program. We found that increases in activation in self-related processing regions, particularly dorsomedial prefrontal cortex, to tailored messages predicted quitting during a 4-month follow-up.	[Chua, Hannah Faye; Jasinska, Agnes J.] Univ Michigan, Neurosci Program, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Chua, HF (corresponding author), Univ Michigan, Neurosci Program, Ann Arbor, MI 48109 USA.	hchua@umich.edu	Welsh, Robert/ABH-3526-2021	Ho, Shao-Hsuan/0000-0003-2617-1628; Liberzon, Israel/0000-0002-4990-556X	National Institute of Drug Abuse [R21-DA024429-01]; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA024429] Funding Source: NIH RePORTER	National Institute of Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institute of Drug Abuse grant R21DA024429-01 to H.F.C. and V.J.S.	Brug J, 1999, PATIENT EDUC COUNS, V36, P145, DOI 10.1016/S0738-3991(98)00131-1; Chua HF, 2009, BIOL PSYCHIAT, V65, P165, DOI 10.1016/j.biopsych.2008.08.030; Dijkstra A, 2005, HEALTH EDUC RES, V20, P527, DOI 10.1093/her/cyh014; Lancaster T, 2005, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001292.pub2, 10.1002/14651858.CD001292.pub3]; Northoff G, 2004, TRENDS COGN SCI, V8, P102, DOI 10.1016/j.tics.2004.01.004; Northoff G, 2006, NEUROIMAGE, V31, P440, DOI 10.1016/j.neuroimage.2005.12.002; Schmitz TW, 2006, NEUROIMAGE, V30, P1050, DOI 10.1016/j.neuroimage.2005.10.030; Strecher V, 2007, ANNU REV CLIN PSYCHO, V3, P53, DOI 10.1146/annurev.clinpsy.3.022806.091428; Strecher VJ, 2008, AM J PREV MED, V34, P373, DOI 10.1016/j.amepre.2007.12.024; Symons CS, 1997, PSYCHOL BULL, V121, P371, DOI 10.1037/0033-2909.121.3.371; van der Meer L, 2010, NEUROSCI BIOBEHAV R, V34, P935, DOI 10.1016/j.neubiorev.2009.12.004; Velicer WF, 2004, ADDICT BEHAV, V29, P51, DOI 10.1016/S0306-4603(03)00084-4	12	126	126	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2011	14	4					426	427		10.1038/nn.2761	http://dx.doi.org/10.1038/nn.2761			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	741FQ	21358641	Green Accepted			2022-12-28	WOS:000288849400012
J	Lafourcade, M; Larrieu, T; Mato, S; Duffaud, A; Sepers, M; Matias, I; De Smedt-Peyrusse, V; Labrousse, VF; Bretillon, L; Matute, C; Rodriguez-Puertas, R; Laye, S; Manzoni, OJ				Lafourcade, Mathieu; Larrieu, Thomas; Mato, Susana; Duffaud, Anais; Sepers, Marja; Matias, Isabelle; De Smedt-Peyrusse, Veronique; Labrousse, Virginie F.; Bretillon, Lionel; Matute, Carlos; Rodriguez-Puertas, Rafael; Laye, Sophie; Manzoni, Olivier J.			Nutritional omega-3 deficiency abolishes endocannabinoid-mediated neuronal functions	NATURE NEUROSCIENCE			English	Article							POLYUNSATURATED FATTY-ACIDS; LONG-TERM DEPRESSION; NUCLEUS-ACCUMBENS; SYNAPTIC PLASTICITY; PREFRONTAL CORTEX; MOOD DISORDERS; BEHAVIOR; MICE; RECEPTORS; BRAIN	The corollaries of the obesity epidemic that plagues developed societies are malnutrition and resulting biochemical imbalances. Low levels of essential n-3 polyunsaturated fatty acids (n-3 PUFAs) have been linked to neuropsychiatric diseases, but the underlying synaptic alterations are mostly unknown. We found that lifelong n-3 PUFAs dietary insufficiency specifically ablates long-term synaptic depression mediated by endocannabinoids in the prelimbic prefrontal cortex and accumbens. In n-3-deficient mice, presynaptic cannabinoid CB1 receptors (CB(1)Rs) normally responding to endocannabinoids were uncoupled from their effector G(i/o) proteins. Finally, the dietary-induced reduction of CB1R functions in mood-controlling structures was associated with impaired emotional behavior. These findings identify a plausible synaptic substrate for the behavioral alterations caused by the n-3 PUFAs deficiency that is often observed in western diets.	[Lafourcade, Mathieu; Larrieu, Thomas; Duffaud, Anais; Sepers, Marja; Matias, Isabelle; De Smedt-Peyrusse, Veronique; Labrousse, Virginie F.; Laye, Sophie; Manzoni, Olivier J.] INRA, CNRS, UMR 1286, UMR 5226, Bordeaux, France; [Lafourcade, Mathieu; Sepers, Marja; Matias, Isabelle; Manzoni, Olivier J.] INSERM, U862, Physiopathol Synapt Plast Grp, Neuroctr Magendie, Bordeaux, France; [Larrieu, Thomas; Duffaud, Anais; De Smedt-Peyrusse, Veronique; Labrousse, Virginie F.; Laye, Sophie] Univ Bordeaux, Bordeaux, France; [Mato, Susana; Matute, Carlos] Univ Basque Country, Dept Neurosci, Bizkaia, Spain; [Bretillon, Lionel] INRA, CGSA, UMR1324, F-21034 Dijon, France; [Rodriguez-Puertas, Rafael] Univ Basque Country, Dept Pharmacol, Bizkaia, Spain; [Manzoni, Olivier J.] INSERM, U901, F-13258 Marseille, France; [Manzoni, Olivier J.] Univ Aix Marseille 2, UMR S901, Marseille, France; [Manzoni, Olivier J.] INMED, Marseille, France	Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Universite de Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; University of Basque Country; INRAE; Institut Agro; AgroSup Dijon; Universite de Bourgogne; University of Basque Country; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Laye, S (corresponding author), INRA, CNRS, UMR 1286, UMR 5226, Bordeaux, France.	sophie.laye@bordeaux.inra.fr; olivier.manzoni@inserm.fr	Laye, Sophie/AAX-2501-2020; Matute, Carlos/N-5559-2014; Rodriguez-Puertas, Rafael/A-1127-2010; Mato, Susana/AAU-3129-2020; Manzoni, Olivier/M-7899-2016; Lafourcade, Mathieu/GQZ-7267-2022	Laye, Sophie/0000-0002-3843-1012; Matute, Carlos/0000-0001-8672-711X; Rodriguez-Puertas, Rafael/0000-0003-4517-5114; Mato, Susana/0000-0002-2005-9793; Manzoni, Olivier/0000-0002-5579-6208; Sepers, Marja/0000-0002-6510-2804; Lafourcade, Mathieu/0000-0001-6117-1194; Larrieu, Thomas/0000-0003-2406-356X; Bretillon, Lionel/0000-0002-6957-100X	INSERM; Institut National de la Recherche Agronomique; Region Aquitaine; Centro de Investigacion Biomedica en Red en Enfermedades Neurodegenerativas (CIBERNED); Spanish Ministry of Health [FIS 070628]	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Institut National de la Recherche Agronomique; Region Aquitaine(Region Nouvelle-Aquitaine); Centro de Investigacion Biomedica en Red en Enfermedades Neurodegenerativas (CIBERNED); Spanish Ministry of Health(Instituto de Salud Carlos IIISpanish Government)	The authors thank O. Lassalle for helping with illustrations, P. Chavis and M. Darnaudery for helpful discussions, P. Birac and C. Tridon for taking care of the mice and S. Gregoire for technical help. This work was supported by INSERM (O.J.M.), Institut National de la Recherche Agronomique (S.L.), Region Aquitaine (O.J.M. and S.L.), Centro de Investigacion Biomedica en Red en Enfermedades Neurodegenerativas (CIBERNED) and the Spanish Ministry of Health (FIS 070628, ISCIII, C.M.M., R.R.P. and S.M.).	Bambico FR, 2007, J NEUROSCI, V27, P11700, DOI 10.1523/JNEUROSCI.1636-07.2007; Berger A, 2001, P NATL ACAD SCI USA, V98, P6402, DOI 10.1073/pnas.101119098; Bourre JM, 2005, J NUTR HEALTH AGING, V9, P31; Chalon S, 2006, PROSTAG LEUKOTR ESS, V75, P259, DOI 10.1016/j.plefa.2006.07.005; DeMar JC, 2006, J LIPID RES, V47, P172, DOI 10.1194/jlr.M500362-JLR200; Evans DL, 2005, BIOL PSYCHIAT, V58, P175, DOI 10.1016/j.biopsych.2005.05.001; Haller J, 2004, EUR J NEUROSCI, V19, P1906, DOI 10.1111/j.1460-9568.2004.03293.x; Hayton SJ, 2010, J NEUROSCI, V30, P11493, DOI 10.1523/JNEUROSCI.1550-10.2010; Heifets BD, 2009, ANNU REV PHYSIOL, V71, P283, DOI 10.1146/annurev.physiol.010908.163149; Hill MN, 2009, TRENDS PHARMACOL SCI, V30, P484, DOI 10.1016/j.tips.2009.06.006; Jacob W, 2009, GENES BRAIN BEHAV, V8, P685, DOI 10.1111/j.1601-183X.2009.00512.x; Kauer JA, 2006, NAT NEUROSCI, V9, P593, DOI 10.1038/nn0506-593; Krishnan V, 2008, NATURE, V455, P894, DOI 10.1038/nature07455; Lafourcade M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000709; Lauritzen L, 2001, PROG LIPID RES, V40, P1, DOI 10.1016/S0163-7827(00)00017-5; Leweke FM, 2008, ADDICT BIOL, V13, P264, DOI 10.1111/j.1369-1600.2008.00106.x; Liperoti R, 2009, CURR PHARM DESIGN, V15, P4165, DOI 10.2174/138161209789909683; Lutz B, 2009, CURR OPIN PHARMACOL, V9, P46, DOI 10.1016/j.coph.2008.12.001; Mackie K, 2008, MOL CELL ENDOCRINOL, V286, pS60, DOI 10.1016/j.mce.2008.01.022; Martin BR, 2004, TRENDS PHARMACOL SCI, V25, P325, DOI 10.1016/j.tips.2004.04.005; Matias I, 2008, BBA-MOL CELL BIOL L, V1781, P52, DOI 10.1016/j.bbalip.2007.11.001; Mato S, 2005, J NEUROSCI, V25, P11619, DOI 10.1523/JNEUROSCI.2294-05.2005; Mato S, 2004, NAT NEUROSCI, V7, P585, DOI 10.1038/nn1251; Mato S, 2008, NEUROPHARMACOLOGY, V54, P87, DOI 10.1016/j.neuropharm.2007.04.014; Mikasova L, 2008, P NATL ACAD SCI USA, V105, P18596, DOI 10.1073/pnas.0805959105; Mingam R, 2008, EUR J NEUROSCI, V28, P1877, DOI 10.1111/j.1460-9568.2008.06470.x; Nestler EJ, 2006, BIOL PSYCHIAT, V59, P1151, DOI 10.1016/j.biopsych.2005.09.018; Parker G, 2006, AM J PSYCHIAT, V163, P969, DOI 10.1176/appi.ajp.163.6.969; PORSOLT RD, 2001, CURR PROTOC NEUROSCI, V10; Rapoport SI, 2007, PROSTAG LEUKOTR ESS, V77, P251, DOI 10.1016/j.plefa.2007.10.023; Robbe D, 2002, P NATL ACAD SCI USA, V99, P8384, DOI 10.1073/pnas.122149199; Robbe D, 2002, J NEUROSCI, V22, P4346, DOI 10.1523/JNEUROSCI.22-11-04346.2002; SAMAT A, 2008, DRUG DISCOV, V3, P187; Schlosburg JE, 2010, NAT NEUROSCI, V13, P1113, DOI 10.1038/nn.2616; SIMON P, 1994, BEHAV BRAIN RES, V61, P59, DOI 10.1016/0166-4328(94)90008-6; Simopoulos AP, 2009, WORLD REV NUTR DIET, V100, P1, DOI 10.1159/000235706; Steiner MA, 2008, PHARMACOGENOMICS J, V8, P196, DOI 10.1038/sj.tpj.6500466; Steiner MA, 2008, PSYCHONEUROENDOCRINO, V33, P1165, DOI 10.1016/j.psyneuen.2008.06.004; Uriguen L, 2004, NEUROPHARMACOLOGY, V46, P966, DOI 10.1016/j.neuropharm.2004.01.003; Vinod KY, 2006, TRENDS PHARMACOL SCI, V27, P539, DOI 10.1016/j.tips.2006.08.006; Watanabe S, 2003, PROSTAG LEUKOTR ESS, V69, P51, DOI 10.1016/S0952-3278(03)00056-5	41	225	233	3	36	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2011	14	3					345	350		10.1038/nn.2736	http://dx.doi.org/10.1038/nn.2736			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	725MW	21278728	Green Submitted			2022-12-28	WOS:000287650100015
J	Larsen, RS; Corlew, RJ; Henson, MA; Roberts, AC; Mishina, M; Watanabe, M; Lipton, SA; Nakanishi, N; Perez-Otano, I; Weinberg, RJ; Philpot, BD				Larsen, Rylan S.; Corlew, Rebekah J.; Henson, Maile A.; Roberts, Adam C.; Mishina, Masayoshi; Watanabe, Masahiko; Lipton, Stuart A.; Nakanishi, Nobuki; Perez-Otano, Isabel; Weinberg, Richard J.; Philpot, Benjamin D.			NR3A-containing NMDARs promote neurotransmitter release and spike timing-dependent plasticity	NATURE NEUROSCIENCE			English	Article							RECEPTOR SUBUNIT NR3A; LONG-TERM DEPRESSION; PRESYNAPTIC NMDA; SOMATOSENSORY CORTEX; VISUAL-CORTEX; TONIC FACILITATION; ENTORHINAL CORTEX; GLUTAMATE RELEASE; EXPRESSION; AUTORECEPTORS	Recent evidence suggests that presynaptic-acting NMDA receptors (preNMDARs) are important for neocortical synaptic transmission and plasticity. We found that unique properties of the NR3A subunit enable preNMDARs to enhance spontaneous and evoked glutamate release and that NR3A is required for spike timing-dependent long-term depression in the juvenile mouse visual cortex. In the mature cortex, NR2B-containing preNMDARs enhanced neurotransmission in the absence of magnesium, indicating that presynaptic NMDARs may function under depolarizing conditions throughout life. Our findings indicate that NR3A relieves preNMDARs from the dual-activation requirement of ligand-binding and depolarization; the developmental removal of NR3A limits preNMDAR functionality by restoring this associative property.	[Larsen, Rylan S.; Roberts, Adam C.; Philpot, Benjamin D.] Univ N Carolina, Dept Cell & Mol Physiol, Chapel Hill, NC 27515 USA; [Corlew, Rebekah J.; Henson, Maile A.; Philpot, Benjamin D.] Univ N Carolina, Curriculum Neurobiol, Chapel Hill, NC USA; [Roberts, Adam C.; Weinberg, Richard J.; Philpot, Benjamin D.] Univ N Carolina, Ctr Neurosci, Chapel Hill, NC USA; [Roberts, Adam C.; Philpot, Benjamin D.] Univ N Carolina, Carolina Inst Dev Disabil, Chapel Hill, NC USA; [Mishina, Masayoshi] Univ Tokyo, Grad Sch Med, Dept Mol Neurobiol & Pharmacol, Tokyo, Japan; [Watanabe, Masahiko] Hokkaido Univ, Sch Med, Dept Anat, Sapporo, Hokkaido 060, Japan; [Lipton, Stuart A.; Nakanishi, Nobuki] Sanford Burnham Med Res Inst, Del E Webb Ctr Neurosci Aging & Stem Cell Res, La Jolla, CA USA; [Perez-Otano, Isabel] Ctr Invest Med Aplicada, Dept Neurociencias, Pamplona, Spain; [Perez-Otano, Isabel] Univ Navarra, E-31080 Pamplona, Spain; [Weinberg, Richard J.] Univ N Carolina, Dept Cell & Dev Biol, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Tokyo; Hokkaido University; Sanford Burnham Prebys Medical Discovery Institute; University of Navarra; University of North Carolina; University of North Carolina Chapel Hill	Philpot, BD (corresponding author), Univ N Carolina, Dept Cell & Mol Physiol, Chapel Hill, NC 27515 USA.	bphilpot@med.unc.edu	Weinberg, Richard/AAC-1898-2020; WATANABE, Masahiko/A-4055-2012; Watanabe, Masahiko/S-3614-2019; Perez-Otano, Isabel/S-9613-2017	WATANABE, Masahiko/0000-0001-5037-7138; Watanabe, Masahiko/0000-0001-5037-7138; Perez-Otano, Isabel/0000-0002-7222-8202; Larsen, Rylan/0000-0002-7136-1175; Roberts, Adam/0000-0001-8596-8552; Lipton, Stuart/0000-0002-3490-1259; Weinberg, Richard/0000-0001-9689-7278; Corlew, Rebekah/0000-0001-7000-8209	National Alliance for Research on Schizophrenia and Depression; Marie Curie International Program, UTE project Centro de Investigacion Medica Aplicada; Spanish Ministry of Education and Science [SAF2006-10025, CSD2008-00005]; National Research Service Award [F31 GM080162]; University of North Carolina; National Institute of Child Health and Human Development [T32 HD40127]; NARSAD; US National Institutes of Health [RO1 NS39444]; NARSAD, NEI [R01 EY018323]; National Science Foundation [0822969, P01 HD29587, R01 EY05477, R01 EY09024]; Grants-in-Aid for Scientific Research [19100005] Funding Source: KAKEN; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD029587, T32HD040127] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY005477, R01EY018323, R01EY009024] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F31GM080162] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [F31MH091817] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039444] Funding Source: NIH RePORTER	National Alliance for Research on Schizophrenia and Depression(NARSAD); Marie Curie International Program, UTE project Centro de Investigacion Medica Aplicada; Spanish Ministry of Education and Science(Spanish Government); National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of North Carolina; National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NARSAD(NARSAD); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NARSAD, NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)NARSAD); National Science Foundation(National Science Foundation (NSF)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank K. Phend and S. Burette for processing electron microscopic materials and P. McCoy and T. Riday for preparing fixed tissue for this process. We also thank J. Miriyala, J. Berrios and K. Williams for mouse colony maintenance and genotyping. We thank D. J. Brasier, T. Kash, N. Calakos and D. Corlew for early critical readings of the manuscript and R. Chitwood for technical assistance. This work was supported by National Alliance for Research on Schizophrenia and Depression, the Marie Curie International Program, UTE project Centro de Investigacion Medica Aplicada, and Spanish Ministry of Education and Science grants SAF2006-10025, CSD2008-00005 (to I.P.-O.), National Research Service Award predoctoral fellowship F31 GM080162 (to R. J. C.), a University of North Carolina dissertation completion fellowship (to M. A. H.), a National Institute of Child Health and Human Development training grant (T32 HD40127) and NARSAD Fellowships (to A. C. R.), US National Institutes of Health grant RO1 NS39444 (to R. J. W.), NARSAD, NEI R01 EY018323, and National Science Foundation grant 0822969 (to B. D. P.), and P01 HD29587, R01 EY05477 and R01 EY09024 (to S.A.L.).	Banerjee A, 2009, CEREB CORTEX, V19, P2959, DOI 10.1093/cercor/bhp067; Bender VA, 2006, J NEUROSCI, V26, P4166, DOI 10.1523/JNEUROSCI.0176-06.2006; Berretta N, 1996, NEUROSCIENCE, V75, P339, DOI 10.1016/0306-4522(96)00301-6; Brasier DJ, 2008, J NEUROSCI, V28, P2199, DOI 10.1523/JNEUROSCI.3915-07.2008; Charton JP, 1999, BRAIN RES, V816, P609, DOI 10.1016/S0006-8993(98)01243-8; Chatterton JE, 2002, NATURE, V415, P793, DOI 10.1038/nature715; Cheetham CEJ, 2010, J NEUROSCI, V30, P12566, DOI 10.1523/JNEUROSCI.2544-10.2010; Christie JM, 2008, NEURON, V60, P298, DOI 10.1016/j.neuron.2008.08.028; Christie JM, 2009, J NEUROSCI, V29, P11441, DOI 10.1523/JNEUROSCI.2387-09.2009; Corlew R, 2007, J NEUROSCI, V27, P9835, DOI 10.1523/JNEUROSCI.5494-06.2007; Corlew R, 2008, NEUROSCIENTIST, V14, P609, DOI 10.1177/1073858408322675; Costa BM, 2009, J PHARMACOL EXP THER, V331, P618, DOI 10.1124/jpet.109.156752; Cull-Candy Stuart G, 2004, Sci STKE, V2004, pre16, DOI 10.1126/stke.2552004re16; Das S, 1998, NATURE, V393, P377, DOI 10.1038/30748; DeBiasi S, 1996, NEUROREPORT, V7, P2773, DOI 10.1097/00001756-199611040-00073; DUDEK SM, 1993, J NEUROSCI, V13, P2910; Froemke RC, 2005, NATURE, V434, P221, DOI 10.1038/nature03366; Hatton CJ, 2005, NEURON, V46, P261, DOI 10.1016/j.neuron.2005.03.005; Hensch TK, 2005, NAT REV NEUROSCI, V6, P877, DOI 10.1038/nrn1787; Henson MA, 2010, PROG NEUROBIOL, V91, P23, DOI 10.1016/j.pneurobio.2010.01.004; Herkert M, 1998, EUR J NEUROSCI, V10, P1553, DOI 10.1046/j.1460-9568.1998.00164.x; Karavanova I, 2007, MOL CELL NEUROSCI, V34, P468, DOI 10.1016/j.mcn.2006.12.001; Kemp JA, 2002, NAT NEUROSCI, V5, P1039, DOI 10.1038/nn936; LARSEN RS, 2010, FRONT SYNAPTIC NEURO, V2, P12; Laube B, 1997, NEURON, V18, P493, DOI 10.1016/S0896-6273(00)81249-0; LAURIE DJ, 1994, EUR J PHARM-MOLEC PH, V268, P335, DOI 10.1016/0922-4106(94)90058-2; Li YH, 2009, CURR NEUROVASC RES, V6, P104, DOI 10.2174/156720209788185632; Lin H, 2010, P NATL ACAD SCI USA, V107, P16661, DOI 10.1073/pnas.1007397107; Mameli M, 2005, J NEUROSCI, V25, P2285, DOI 10.1523/JNEUROSCI.3877-04.2005; Mayford M, 1996, SCIENCE, V274, P1678, DOI 10.1126/science.274.5293.1678; McGuinness L, 2010, NEURON, V68, P1109, DOI 10.1016/j.neuron.2010.11.023; McKinney RA, 1999, NAT NEUROSCI, V2, P44, DOI 10.1038/4548; Nishi M, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-23-j0003.2001; Perez-Otano I, 2006, NAT NEUROSCI, V9, P611, DOI 10.1038/nn1680; Perez-Otano I, 2001, J NEUROSCI, V21, P1228; Philpot BD, 2001, NEURON, V29, P157, DOI 10.1016/S0896-6273(01)00187-8; Pina-Crespo JC, 2010, J NEUROSCI, V30, P11501, DOI 10.1523/JNEUROSCI.1593-10.2010; Roberts AC, 2009, NEURON, V63, P342, DOI 10.1016/j.neuron.2009.06.016; Rodriguez-Moreno A, 2008, NAT NEUROSCI, V11, P744, DOI 10.1038/nn.2125; RODRIGUEZMORENO A, 2010, FRONT SYNAPTIC NEURO, V2, P12; Sjostrom PJ, 2003, NEURON, V39, P641, DOI 10.1016/S0896-6273(03)00476-8; Smith SL, 2007, NAT NEUROSCI, V10, P370, DOI 10.1038/nn1844; Smothers CT, 2003, BRAIN RES, V987, P117, DOI 10.1016/S0006-8993(03)03315-8; Wong HK, 2002, J COMP NEUROL, V450, P303, DOI 10.1002/cne.10314; Yang J, 2006, J NEUROSCI, V26, P406, DOI 10.1523/JNEUROSCI.4413-05.2006; Yao YN, 2006, J NEUROSCI, V26, P4559, DOI 10.1523/JNEUROSCI.0560-06.2006	46	107	113	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2011	14	3					338	344		10.1038/nn.2750	http://dx.doi.org/10.1038/nn.2750			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	725MW	21297630	Green Accepted			2022-12-28	WOS:000287650100014
J	Baig, SM; Koschak, A; Lieb, A; Gebhart, M; Dafinger, C; Nurnberg, G; Ali, A; Ahmad, I; Sinnegger-Brauns, MJ; Brandt, N; Engel, J; Mangoni, ME; Farooq, M; Khan, HU; Nurnberg, P; Striessnig, J; Bolz, HJ				Baig, Shahid M.; Koschak, Alexandra; Lieb, Andreas; Gebhart, Mathias; Dafinger, Claudia; Nuernberg, Gudrun; Ali, Amjad; Ahmad, Ilyas; Sinnegger-Brauns, Martina J.; Brandt, Niels; Engel, Jutta; Mangoni, Matteo E.; Farooq, Muhammad; Khan, Habib U.; Nuernberg, Peter; Striessnig, Joerg; Bolz, Hanno J.			Loss of Ca(v)1.3 (CACNA1D) function in a human channelopathy with bradycardia and congenital deafness	NATURE NEUROSCIENCE			English	Article							CA2+ CHANNELS; CALCIUM-CHANNELS; POTASSIUM CHANNEL; GATING CURRENT; IONIC CURRENT; GENE; CELL; MODULATION; MUTATION; JERVELL	Deafness is genetically very heterogeneous and forms part of several syndromes. So far, delayed rectifier potassium channels have been linked to human deafness associated with prolongation of the QT interval on electrocardiograms and ventricular arrhythmia in Jervell and Lange-Nielsen syndrome. Ca(v)1.3 voltage-gated L-type calcium channels (LTCCs) translate sound-induced depolarization into neurotransmitter release in auditory hair cells and control diastolic depolarization in the mouse sinoatrial node (SAN). Human deafness has not previously been linked to defects in LTCCs. We used positional cloning to identify a mutation in CACNA1D, which encodes the pore-forming alpha 1 subunit of Ca(v)1.3 LTCCs, in two consanguineous families with deafness. All deaf subjects showed pronounced SAN dysfunction at rest. The insertion of a glycine residue in a highly conserved, alternatively spliced region near the channel pore resulted in nonconducting calcium channels that had abnormal voltage-dependent gating. We describe a human channelopathy (termed SANDD syndrome, sinoatrial node dysfunction and deafness) with a cardiac and auditory phenotype that closely resembles that of Cacna1d(-/-) mice.	[Dafinger, Claudia; Bolz, Hanno J.] Univ Hosp Cologne, Inst Human Genet, Cologne, Germany; [Baig, Shahid M.; Ali, Amjad; Ahmad, Ilyas; Farooq, Muhammad] Natl Inst Biotechnol & Genet Engn, Human Mol Genet Lab, Hlth Biotechnol Div, Faisalabad, Pakistan; [Koschak, Alexandra; Lieb, Andreas; Gebhart, Mathias; Sinnegger-Brauns, Martina J.; Striessnig, Joerg] Univ Innsbruck, Ctr Mol Biosci, Inst Pharm, A-6020 Innsbruck, Austria; [Nuernberg, Gudrun; Nuernberg, Peter] Univ Cologne, Cologne Ctr Genom, Cologne, Germany; [Nuernberg, Gudrun; Nuernberg, Peter] Univ Cologne, Inst Genet, Cologne, Germany; [Brandt, Niels; Engel, Jutta] Univ Tubingen, Inst Physiol 2, Tubingen, Germany; [Brandt, Niels; Engel, Jutta] Univ Tubingen, Tubingen Hearing Res Ctr, Tubingen, Germany; [Brandt, Niels; Engel, Jutta] Univ Saarland, Dept Biophys, D-6650 Homburg, Germany; [Mangoni, Matteo E.] Univ Montpellier 1 & 2, CNRS, Inst Genom Fonct,Dept Physiol,UMR 5203,U661, Montpellier, France; [Khan, Habib U.] Khyber Teaching Hosp, Dept Pathol, Peshawar, Pakistan; [Nuernberg, Peter] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, Cologne, Germany; [Bolz, Hanno J.] Bioscientia, Ctr Human Genet, Ingelheim, Germany	University of Cologne; Pakistan Institute of Engineering & Applied Science; University of Innsbruck; University of Cologne; University of Cologne; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Saarland University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; University of Cologne	Bolz, HJ (corresponding author), Univ Hosp Cologne, Inst Human Genet, Cologne, Germany.	joerg.striessnig@uibk.ac.at; hanno.bolz@uk-koeln.de	Tuluc, Petronel/C-2527-2011; Mangoni, Matteo E/E-6025-2015; Baig, Shahid Mahmood/I-7309-2015; BAig, Shahid Mahmood/AAS-8365-2020; Striessnig, Joerg/S-9334-2017; Ahmad, Ilyas/AAT-6577-2021; Ali, Amjad/AAG-4441-2021	Mangoni, Matteo E/0000-0002-8892-3373; Striessnig, Joerg/0000-0002-9406-7120; Ahmad, Ilyas/0000-0003-4845-9227; Ali, Amjad/0000-0002-0486-4661; Lieb, Andreas/0000-0001-9567-649X; Brauns, Martina/0000-0002-0547-2731	Geers-Stiftung, Bonn; Imhoff-Stiftung, Koln; Koln Fortune, University Hospital of Cologne, Deutsche Forschungsgemeinschaft [BO2954/1-2]; Forschung contra Blindheit: Initiative Usher-Syndrom e.V.; Austrian Science Fund [P-20670]; Agence Nationale pour la Recherche [ANR-06-PHYSIO-004-01]; Fondation de France; Marie Curie Research Training Network CavNET [MRTN-CT-2006-035367]; University of Innsbruck; Austrian Science Fund (FWF) [P 20670] Funding Source: researchfish	Geers-Stiftung, Bonn; Imhoff-Stiftung, Koln; Koln Fortune, University Hospital of Cologne, Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Forschung contra Blindheit: Initiative Usher-Syndrom e.V.; Austrian Science Fund(Austrian Science Fund (FWF)); Agence Nationale pour la Recherche(French National Research Agency (ANR)); Fondation de France(Fondation de France); Marie Curie Research Training Network CavNET(European Commission); University of Innsbruck; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	We thank the families who have participated in this study, K. Beam and W. Sandtner for discussion on gating currents, M. Thoenes, K. Zimmermann, S. Blick, G. Gajic and S. Kasperek for technical assistance, B. Ali for help with ECG recordings, K. Boss for discussion of the manuscript and C. Striessnig for artwork. This work was supported by the Geers-Stiftung, Bonn; Imhoff-Stiftung, Koln; Koln Fortune, University Hospital of Cologne, Deutsche Forschungsgemeinschaft (BO2954/1-2); Forschung contra Blindheit: Initiative Usher-Syndrom e.V. (to H.J.B.); the Austrian Science Fund (P-20670); the Agence Nationale pour la Recherche (ANR-06-PHYSIO-004-01 to M.E.M.); the Fondation de France; the Marie Curie Research Training Network CavNET (MRTN-CT-2006-035367); and the University of Innsbruck (to J.S. and A.K.).	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Abecasis GR, 2001, BIOINFORMATICS, V17, P742, DOI 10.1093/bioinformatics/17.8.742; Bangalore R, 1996, AM J PHYSIOL-HEART C, V270, pH1521, DOI 10.1152/ajpheart.1996.270.5.H1521; Bitner-Glindzicz M, 2000, ADV OTO-RHINO-LARYNG, V56, P45; Brandt A, 2005, J NEUROSCI, V25, P11577, DOI 10.1523/JNEUROSCI.3411-05.2005; Brandt N, 2007, J NEUROSCI, V27, P3174, DOI 10.1523/JNEUROSCI.3965-06.2007; Busquet P, 2010, INT J NEUROPSYCHOPH, V13, P499, DOI 10.1017/S1461145709990368; Chan CS, 2007, NATURE, V447, P1081, DOI 10.1038/nature05865; Cohen M, 2007, INT J AUDIOL, V46, P82, DOI 10.1080/14992020600975279; Dou HV, 2004, JARO-J ASSOC RES OTO, V5, P215, DOI 10.1007/s10162-003-4020-3; FUKUSHIMA K, 1995, GENOME RES, V5, P305, DOI 10.1101/gr.5.3.305; Gudbjartsson DF, 2000, NAT GENET, V25, P12, DOI 10.1038/75514; Guzman JN, 2009, J NEUROSCI, V29, P11011, DOI 10.1523/JNEUROSCI.2519-09.2009; Hilgert N, 2009, MUTAT RES-REV MUTAT, V681, P189, DOI 10.1016/j.mrrev.2008.08.002; Hoda JC, 2005, J NEUROSCI, V25, P252, DOI 10.1523/JNEUROSCI.3054-04.2005; Jones LP, 1997, J PHYSIOL-LONDON, V498, P601, DOI 10.1113/jphysiol.1997.sp021886; Kamp TJ, 1996, J PHYSIOL-LONDON, V492, P89, DOI 10.1113/jphysiol.1996.sp021291; Knirsch M, 2007, J NEUROSCI, V27, P6442, DOI 10.1523/JNEUROSCI.5364-06.2007; Koschak A, 2001, J BIOL CHEM, V276, P22100, DOI 10.1074/jbc.M101469200; Lakatta EG, 2010, CIRC RES, V106, P659, DOI 10.1161/CIRCRESAHA.109.206078; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Mangoni ME, 2008, PHYSIOL REV, V88, P919, DOI 10.1152/physrev.00018.2007; Mangoni ME, 2003, P NATL ACAD SCI USA, V100, P5543, DOI 10.1073/pnas.0935295100; McDonough SI, 2005, BIOPHYS J, V88, P211, DOI 10.1529/biophysj.104.051714; McKinney BC, 2006, LEARN MEMORY, V13, P584, DOI 10.1101/lm.279006; Naz S, 2002, AM J HUM GENET, V71, P632, DOI 10.1086/342193; Neyroud N, 1997, NAT GENET, V15, P186, DOI 10.1038/ng0297-186; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Olson PA, 2005, J NEUROSCI, V25, P1050, DOI 10.1523/JNEUROSCI.3327-04.2005; Platzer J, 2000, CELL, V102, P89, DOI 10.1016/S0092-8674(00)00013-1; Raybaud A, 2006, J BIOL CHEM, V281, P39424, DOI 10.1074/jbc.M607405200; Ruschendorf F, 2005, BIOINFORMATICS, V21, P2123, DOI 10.1093/bioinformatics/bti264; Safayhi H, 1997, MOL ENDOCRINOL, V11, P619, DOI 10.1210/me.11.5.619; SEINO S, 1992, P NATL ACAD SCI USA, V89, P584, DOI 10.1073/pnas.89.2.584; Singh A, 2008, J BIOL CHEM, V283, P20733, DOI 10.1074/jbc.M802254200; Singh A, 2006, NAT NEUROSCI, V9, P1108, DOI 10.1038/nn1751; Sinnegger-Brauns MJ, 2004, J CLIN INVEST, V113, P1430, DOI 10.1172/JCI200420208; Splawski I, 1997, NEW ENGL J MED, V336, P1562, DOI 10.1056/NEJM199705293362204; Splawski I, 2004, CELL, V119, P19, DOI 10.1016/j.cell.2004.09.011; Splawski I, 2005, P NATL ACAD SCI USA, V102, P8089, DOI 10.1073/pnas.0502506102; Stary A, 2008, CHANNELS, V2, P210, DOI 10.4161/chan.2.3.6158; Striessnig J, 2008, CHANNELS, V2, P233, DOI 10.4161/chan.2.4.5847; Striessnig J, 2010, PFLUG ARCH EUR J PHY, V460, P361, DOI 10.1007/s00424-010-0800-x; Thiele H, 2005, BIOINFORMATICS, V21, P1730, DOI 10.1093/bioinformatics/bth488; Tyson J, 1997, HUM MOL GENET, V6, P2179, DOI 10.1093/hmg/6.12.2179; Woods CG, 2006, AM J HUM GENET, V78, P889, DOI 10.1086/503875	46	184	193	0	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2011	14	1					77	U107		10.1038/nn.2694	http://dx.doi.org/10.1038/nn.2694			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	699TE	21131953				2022-12-28	WOS:000285684900017
J	Huang, JK; Jarjour, AA; Nait Oumesmar, B; Kerninon, C; Williams, A; Krezel, W; Kagechika, H; Bauer, J; Zhao, C; Baron-Van Evercooren, A; Chambon, P; Ffrench-Constant, C; Franklin, RJM				Huang, Jeffrey K.; Jarjour, Andrew A.; Nait Oumesmar, Brahim; Kerninon, Christophe; Williams, Anna; Krezel, Wojciech; Kagechika, Hiroyuki; Bauer, Julien; Zhao, Chao; Baron-Van Evercooren, Anne; Chambon, Pierre; Ffrench-Constant, Charles; Franklin, Robin J. M.			Retinoid X receptor gamma signaling accelerates CNS remyelination	NATURE NEUROSCIENCE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; MULTIPLE-SCLEROSIS; THYROID-HORMONE; SPINAL-CORD; EXPRESSION; CELLS; OLIGODENDROCYTES; DIFFERENTIATION; DEMYELINATION; DISEASE	The molecular basis of CNS myelin regeneration (remyelination) is poorly understood. We generated a comprehensive transcriptional profile of the separate stages of spontaneous remyelination that follow focal demyelination in the rat CNS and found that transcripts that encode the retinoid acid receptor RXR-gamma were differentially expressed during remyelination. Cells of the oligodendrocyte lineage expressed RXR-gamma in rat tissues that were undergoing remyelination and in active and remyelinated multiple sclerosis lesions. Knockdown of RXR-gamma by RNA interference or RXR-specific antagonists severely inhibited oligodendrocyte differentiation in culture. In mice that lacked RXR-gamma, adult oligodendrocyte precursor cells efficiently repopulated lesions after demyelination, but showed delayed differentiation into mature oligodendrocytes. Administration of the RXR agonist 9-cis-retinoic acid to demyelinated cerebellar slice cultures and to aged rats after demyelination caused an increase in remyelinated axons. Our results indicate that RXR-gamma is a positive regulator of endogenous oligodendrocyte precursor cell differentiation and remyelination and might be a pharmacological target for regenerative therapy in the CNS.	[Jarjour, Andrew A.; Williams, Anna; Ffrench-Constant, Charles] Univ Edinburgh, Ctr Translat Res, Ctr Inflammat Res, Queens Med Res Inst,MRC Ctr Regenerat Med, Edinburgh, Midlothian, Scotland; [Jarjour, Andrew A.; Williams, Anna; Ffrench-Constant, Charles] Univ Edinburgh, Ctr Translat Res, Ctr Inflammat Res, Queens Med Res Inst,Multiple Sclerosis Soc, Edinburgh, Midlothian, Scotland; [Huang, Jeffrey K.; Zhao, Chao; Franklin, Robin J. M.] Univ Cambridge, MRC Ctr Stem Cell Biol & Regenerat Med, Cambridge, England; [Huang, Jeffrey K.; Zhao, Chao; Franklin, Robin J. M.] Univ Cambridge, Dept Vet Med, Cambridge, England; [Nait Oumesmar, Brahim; Kerninon, Christophe; Baron-Van Evercooren, Anne] Ctr Rech, Inst Cerveau & Moelle Epiniere, INSERM, U975, Paris 13, France; [Nait Oumesmar, Brahim; Kerninon, Christophe; Baron-Van Evercooren, Anne] Univ Paris 06, UMR S975, Paris 13, France; [Nait Oumesmar, Brahim; Kerninon, Christophe; Baron-Van Evercooren, Anne] CNRS, UMR 7225, Paris 13, France; [Nait Oumesmar, Brahim; Kerninon, Christophe; Baron-Van Evercooren, Anne] Grp Hosp Pitie Salpetriere, AP HP, F-75634 Paris 13, France; [Krezel, Wojciech; Chambon, Pierre] Inst Genet Biol Mol & Cellulaire, Dept Cell Biol & Dev, Illkirch Graffenstaden, France; [Kagechika, Hiroyuki] Tokyo Med & Dent Univ, Grad Sch Biomed Sci, Inst Biomat & Bioengn, Chiyoda Ku, Tokyo, Japan; [Bauer, Julien] Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England	University of Edinburgh; University of Edinburgh; University of Cambridge; University of Cambridge; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Tokyo Medical & Dental University (TMDU); University of Cambridge	Ffrench-Constant, C (corresponding author), Univ Edinburgh, Ctr Translat Res, Ctr Inflammat Res, Queens Med Res Inst,MRC Ctr Regenerat Med, Edinburgh, Midlothian, Scotland.	cffc@ed.ac.uk; rjf1000@cam.ac.uk	KREZEL, Wojciech/S-8331-2019; Krezel, Wojciech/I-7886-2016; Oumesmar, Brahim Nait/E-5365-2017; Evercooren, Anne S Baron-Van/G-3632-2013; Messier, Claude/A-2322-2008; Huang, Jeffrey K./AAH-2418-2021; Krezel, Wojciech/H-9080-2017; OUMESMAR, Brahim NAIT/AAX-4135-2020; Huang, Jeffrey/J-5248-2017	Krezel, Wojciech/0000-0003-1605-3185; Oumesmar, Brahim Nait/0000-0002-1646-6281; Messier, Claude/0000-0002-4791-1763; Huang, Jeffrey K./0000-0003-0996-9451; Krezel, Wojciech/0000-0003-1605-3185; OUMESMAR, Brahim NAIT/0000-0002-1646-6281; Huang, Jeffrey/0000-0003-0996-9451; Jarjour, Andrew/0000-0002-1550-1778; Baron-Van Evercooren, Anne/0000-0002-4150-2205; Williams, Anna/0000-0002-6329-382X; Franklin, Robin/0000-0001-6522-2104; Kagechika, Hiroyuki/0000-0002-6747-1013	United Kingdom Multiple Sclerosis Society; Wellcome Trust; French Multiple Sclerosis foundation ARSEP; Biotechnology and Biological Sciences Research Council of the United Kingdom; National Multiple Sclerosis Society; AP-HP Hopital Pitie-Salpetriere, Service d'Anatomopathologie Neurologique et des Maladies du Systeme Nerveux; Multiple Sclerosis Society of Canada; Medical Research Council [G0700711B] Funding Source: researchfish	United Kingdom Multiple Sclerosis Society; Wellcome Trust(Wellcome TrustEuropean Commission); French Multiple Sclerosis foundation ARSEP; Biotechnology and Biological Sciences Research Council of the United Kingdom(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Multiple Sclerosis Society(National Multiple Sclerosis Society); AP-HP Hopital Pitie-Salpetriere, Service d'Anatomopathologie Neurologique et des Maladies du Systeme Nerveux; Multiple Sclerosis Society of Canada; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank D. Seilhean (Service d'Anatomopathologie Neurologique, G-H Pitie-Salpetriere, Paris) for classification of multiple sclerosis lesions, the French Brain Bank GIE NeuroCEB (Hopital Pitie-Salpetriere, Paris, France) and the United Kingdom Multiple Sclerosis Society Brain Bank (R. Reynolds, Imperial College, London) for multiple sclerosis tissue. All tissues were collected with the approval of the French and London Multicentre Research Ethics committees. Animal procedures were performed under a UK Home Office Project License. This work was supported by grants from the United Kingdom Multiple Sclerosis Society (R.J.M.F., C.ff.-C.), the Wellcome Trust (C.ff.-C.), the French Multiple Sclerosis foundation ARSEP (B.N.O.), the Biotechnology and Biological Sciences Research Council of the United Kingdom (C.ff.-C., J.B.), National Multiple Sclerosis Society (C.ff.-C., R.J.M.F., A.B.-V.E., B.N.O.), AP-HP Hopital Pitie-Salpetriere, Service d'Anatomopathologie Neurologique (B.N.O.) et des Maladies du Systeme Nerveux (A.B.-V.E.). A.W. holds a Wellcome Trust Intermediate Fellowship. A.A.J. holds a Fellowship from Multiple Sclerosis Society of Canada.	Almad A, 2010, J COMP NEUROL, V518, P785, DOI 10.1002/cne.22242; Altucci L, 2007, NAT REV DRUG DISCOV, V6, P793, DOI 10.1038/nrd2397; Birgbauer E, 2004, J NEUROSCI RES, V78, P157, DOI 10.1002/jnr.20248; Brown NS, 2000, J CLIN INVEST, V106, P73, DOI 10.1172/JCI9422; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Chang A, 2002, NEW ENGL J MED, V346, P165, DOI 10.1056/NEJMoa010994; Diab A, 2004, J NEUROIMMUNOL, V148, P116, DOI 10.1016/j.jneuroim.2003.11.010; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Fancy SPJ, 2009, GENE DEV, V23, P1571, DOI 10.1101/gad.1806309; Franklin RJM, 2002, NAT REV NEUROSCI, V3, P705, DOI 10.1038/nrn917; Franklin RJM, 2008, NAT REV NEUROSCI, V9, P839, DOI 10.1038/nrn2480; Georgiades P, 1997, DEV DYNAM, V210, P227; Germain P, 2006, PHARMACOL REV, V58, P760, DOI 10.1124/pr.58.4.7; Goldschmidt T, 2009, NEUROLOGY, V72, P1914, DOI 10.1212/WNL.0b013e3181a8260a; Granneman J, 1998, J NEUROSCI RES, V51, P563, DOI 10.1002/(SICI)1097-4547(19980301)51:5<563::AID-JNR3>3.0.CO;2-D; Haugen BR, 2004, ENDOCRINOLOGY, V145, P3679, DOI 10.1210/en.2003-1401; HEYMAN RA, 1992, CELL, V68, P397, DOI 10.1016/0092-8674(92)90479-V; Kagechika H, 2005, J MED CHEM, V48, P5875, DOI 10.1021/jm0581821; Klemann C, 2009, AM J PATHOL, V174, P2234, DOI 10.2353/ajpath.2009.081084; Krezel W, 1996, P NATL ACAD SCI USA, V93, P9010, DOI 10.1073/pnas.93.17.9010; Krzyzosiak A, 2010, NEURON, V66, P908, DOI 10.1016/j.neuron.2010.05.004; Kuhlmann T, 2008, BRAIN, V131, P1749, DOI 10.1093/brain/awn096; Laursen LS, 2009, J NEUROSCI, V29, P9174, DOI 10.1523/JNEUROSCI.5942-08.2009; Lefebvre P, 2010, TRENDS ENDOCRIN MET, V21, P676, DOI 10.1016/j.tem.2010.06.009; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; Miller RH, 2007, NAT NEUROSCI, V10, P1351, DOI 10.1038/nn1995; Moreno S, 2004, NEUROSCIENCE, V123, P131, DOI 10.1016/j.neuroscience.2003.08.064; Nave KA, 2008, ANNU REV NEUROSCI, V31, P535, DOI 10.1146/annurev.neuro.30.051606.094309; Nishimaki-Mogami T, 2008, BIOCHEM PHARMACOL, V76, P1006, DOI 10.1016/j.bcp.2008.08.005; Patani R, 2007, NEUROPATH APPL NEURO, V33, P277, DOI 10.1111/j.1365-2990.2007.00805.x; Pombo PMG, 1999, MOL BRAIN RES, V64, P92, DOI 10.1016/S0169-328X(98)00311-8; PRINEAS JW, 1979, ANN NEUROL, V5, P22, DOI 10.1002/ana.410050105; RAINE CS, 1993, J NEUROPATH EXP NEUR, V52, P199, DOI 10.1097/00005072-199305000-00003; Schrage K, 2006, EUR J NEUROSCI, V23, P285, DOI 10.1111/j.1460-9568.2005.04534.x; Sim FJ, 2002, J NEUROSCI, V22, P2451, DOI 10.1523/JNEUROSCI.22-07-02451.2002; Sirn FJ, 2006, ANN NEUROL, V59, P763, DOI 10.1002/ana.20812; Takahashi B, 2002, J MED CHEM, V45, P3327, DOI 10.1021/jm0255320; Trousson A, 2009, J NEUROCHEM, V109, P945, DOI 10.1111/j.1471-4159.2009.06009.x; Wolswijk G, 1998, J NEUROSCI, V18, P601; Woodruff RH, 1999, GLIA, V25, P216, DOI 10.1002/(SICI)1098-1136(19990201)25:3<216::AID-GLIA2>3.0.CO;2-L	40	367	394	1	43	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2011	14	1					45	U68		10.1038/nn.2702	http://dx.doi.org/10.1038/nn.2702			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	699TE	21131950	Green Accepted, Green Submitted			2022-12-28	WOS:000285684900013
J	Andrade, A; Denome, S; Jiang, YQ; Marangoudakis, S; Lipscombe, D				Andrade, Arturo; Denome, Sylvia; Jiang, Yu-Qiu; Marangoudakis, Spiro; Lipscombe, Diane			Opioid inhibition of N-type Ca2+ channels and spinal analgesia couple to alternative splicing	NATURE NEUROSCIENCE			English	Article							RAT SYMPATHETIC NEURONS; CALCIUM-CHANNELS; NEUROPATHIC PAIN; BINDING PROTEINS; SUBSTANCE-P; T-TYPE; MODULATION; MECHANISMS; ANTINOCICEPTION; TRANSMISSION	Alternative pre-mRNA splicing occurs extensively in the nervous systems of complex organisms, including humans, considerably expanding the potential size of the proteome. Cell-specific alternative pre-mRNA splicing is thought to optimize protein function for specialized cellular tasks, but direct evidence for this is limited. Transmission of noxious thermal stimuli relies on the activity of N-type Ca(V)2.2 calcium channels in nociceptors. Using an exon-replacement strategy in mice, we show that mutually exclusive splicing patterns in the Ca(V)2.2 gene modulate N-type channel function in nociceptors, leading to a change in morphine analgesia. Exon 37a (e37a) enhances mu-opioid receptor-mediated inhibition of N-type calcium channels by promoting activity-independent inhibition. In the absence of e37a, spinal morphine analgesia is weakened in vivo but the basal response to noxious thermal stimuli is not altered. Our data suggest that highly specialized, discrete cellular responsiveness in vivo can be attributed to alternative splicing events regulated at the level of individual neurons.	[Andrade, Arturo; Denome, Sylvia; Jiang, Yu-Qiu; Marangoudakis, Spiro; Lipscombe, Diane] Brown Univ, Dept Neurosci, Providence, RI 02912 USA	Brown University	Lipscombe, D (corresponding author), Brown Univ, Dept Neurosci, Providence, RI 02912 USA.	diane_lipscombe@brown.edu			US National Institutes of Health (Transgenic Facility at Brown University) [RO1NS055251, F31NS066702, P20RR015578]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015578] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS055251, F31NS066702, R01NS029967] Funding Source: NIH RePORTER	US National Institutes of Health (Transgenic Facility at Brown University)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank J. Kysik and E. Paul in the mouse transgenic facility at Brown University, R. Burwell for advice on animal behavior, T.D. Helton for help with image analyses and C.G. Phillips and S.E. Allen for helpful comments on the manuscript. This work was supported by US National Institutes of Health grants RO1NS055251 (D.L.), F31NS066702 (S.M.) and P20RR015578 (Transgenic Facility at Brown University).	Adams PJ, 2009, CHANNELS, V3, P110, DOI 10.4161/chan.3.2.7932; Altier C, 2004, TRENDS PHARMACOL SCI, V25, P465, DOI 10.1016/j.tips.2004.07.004; Altier C, 2007, J NEUROSCI, V27, P6363, DOI 10.1523/JNEUROSCI.0307-07.2007; Bao JP, 1998, J NEUROSCI, V18, P8740; Bell TJ, 2004, NEURON, V41, P127, DOI 10.1016/S0896-6273(03)00801-8; Bourinet E, 1999, NAT NEUROSCI, V2, P407, DOI 10.1038/8070; Boutz PL, 2007, GENE DEV, V21, P1636, DOI 10.1101/gad.1558107; Bowersox SS, 1996, J PHARMACOL EXP THER, V279, P1243; Castiglioni AJ, 2006, J PHYSIOL-LONDON, V576, P119, DOI 10.1113/jphysiol.2006.115030; Chen M, 2009, NAT REV MOL CELL BIO, V10, P741, DOI 10.1038/nrm2777; Costigan M, 2009, ANNU REV NEUROSCI, V32, P1, DOI 10.1146/annurev.neuro.051508.135531; Dredge BK, 2001, NAT REV NEUROSCI, V2, P43, DOI 10.1038/35049061; Elmslie KS, 2003, J BIOENERG BIOMEMBR, V35, P477, DOI 10.1023/B:JOBB.0000008021.55853.18; GLAUM SR, 1994, J NEUROSCI, V14, P4965; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; HILLE B, 1995, LIFE SCI, V56, P989, DOI 10.1016/0024-3205(95)00038-8; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; HYLDEN JLK, 1980, EUR J PHARMACOL, V67, P313, DOI 10.1016/0014-2999(80)90515-4; Ikeda SR, 1999, ADV SEC MESS PHOSPH, V33, P131; Ikeda SR, 2007, NAT NEUROSCI, V10, P269, DOI 10.1038/nn0307-269; Kammermeier PJ, 2000, J NEUROSCI, V20, P5623, DOI 10.1523/JNEUROSCI.20-15-05623.2000; Li Q, 2007, NAT REV NEUROSCI, V8, P819, DOI 10.1038/nrn2237; Liao P, 2009, PFLUG ARCH EUR J PHY, V458, P481, DOI 10.1007/s00424-009-0635-5; Licatalosi DD, 2008, NATURE, V456, P464, DOI 10.1038/nature07488; Lipscombe D, 2005, CURR OPIN NEUROBIOL, V15, P358, DOI 10.1016/j.conb.2005.04.002; LUEBKE JI, 1994, PFLUG ARCH EUR J PHY, V428, P499, DOI 10.1007/BF00374571; MALMBERG AB, 1995, PAIN, V60, P83, DOI 10.1016/0304-3959(94)00094-U; Marker CL, 2005, J NEUROSCI, V25, P3551, DOI 10.1523/JNEUROSCI.4899-04.2005; Matthews EA, 2001, PAIN, V92, P235, DOI 10.1016/S0304-3959(01)00255-X; Mich PM, 2008, MOL PHARMACOL, V74, P904, DOI 10.1124/mol.108.045153; Mu YY, 2003, NEURON, V40, P581, DOI 10.1016/S0896-6273(03)00676-7; NAGY JI, 1982, NEUROSCIENCE, V7, P89, DOI 10.1016/0306-4522(82)90155-5; Nelson MT, 2005, J NEUROSCI, V25, P8766, DOI 10.1523/JNEUROSCI.2527-05.2005; Pan JQ, 2000, J NEUROSCI, V20, P4769; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Raingo J, 2007, NAT NEUROSCI, V10, P285, DOI 10.1038/nn1848; Saegusa H, 2002, NEUROSCI RES, V43, P1, DOI 10.1016/S0168-0102(02)00017-2; Scherrer G, 2009, CELL, V137, P1148, DOI 10.1016/j.cell.2009.04.019; Scott DA, 2002, EUR J PHARMACOL, V451, P279, DOI 10.1016/S0014-2999(02)02247-1; SHAPIRO MS, 1993, NEURON, V10, P11, DOI 10.1016/0896-6273(93)90237-L; SILVERMAN JD, 1990, J NEUROCYTOL, V19, P789, DOI 10.1007/BF01188046; TADDESE A, 1995, SCIENCE, V270, P1366, DOI 10.1126/science.270.5240.1366; Tedford HW, 2006, PHARMACOL REV, V58, P837, DOI 10.1124/pr.58.4.11; Ule J, 2006, CURR OPIN NEUROBIOL, V16, P102, DOI 10.1016/j.conb.2006.01.003; Wang YX, 2000, PAIN, V84, P151, DOI 10.1016/S0304-3959(99)00197-9; Williams JT, 2001, PHYSIOL REV, V81, P299, DOI 10.1152/physrev.2001.81.1.299; Wilson SG, 2001, BEHAV BRAIN RES, V125, P65, DOI 10.1016/S0166-4328(01)00281-9; Xie JY, 2001, NATURE, V410, P936, DOI 10.1038/35073593; Zhang CL, 2008, GENE DEV, V22, P2550, DOI 10.1101/gad.1703108; Zhong XL, 2006, HUM MOL GENET, V15, P1497, DOI 10.1093/hmg/ddl068	50	68	70	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2010	13	10					1249	1256		10.1038/nn.2643	http://dx.doi.org/10.1038/nn.2643			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	654MB	20852623	Green Accepted			2022-12-28	WOS:000282171300017
J	Muguruma, K; Nishiyama, A; Ono, Y; Miyawaki, H; Mizuhara, E; Hori, S; Kakizuka, A; Obata, K; Yanagawa, Y; Hirano, T; Sasai, Y				Muguruma, Keiko; Nishiyama, Ayaka; Ono, Yuichi; Miyawaki, Hiroyuki; Mizuhara, Eri; Hori, Seiji; Kakizuka, Akira; Obata, Kunihiko; Yanagawa, Yuchio; Hirano, Tomoo; Sasai, Yoshiki			Ontogeny-recapitulating generation and tissue integration of ES cell-derived Purkinje cells	NATURE NEUROSCIENCE			English	Article							CEREBELLAR GRANULE; ISTHMIC ORGANIZER; RHOMBIC-LIP; MIDBRAIN; FGF8; DIFFERENTIATION; PRECURSORS; GENES; TRANSPLANTATION; SYNAPSES	Purkinje cells are the sole output neurons of the cerebellar cortex and their dysfunction causes severe ataxia. We found that Purkinje cells could be robustly generated from mouse embryonic stem (ES) cells by recapitulating the self-inductive signaling microenvironments of the isthmic organizer. The cell-surface marker Neph3 enabled us to carry out timed prospective selection of Purkinje cell progenitors, which generated morphologically characteristic neurons with highly arborized dendrites that expressed mature Purkinje cell-specific markers such as the glutamate receptor subunit GluR delta 2. Similar to mature Purkinje cells, these neurons also showed characteristic spontaneous and repeated action potentials and their postsynaptic excitatory potentials were generated exclusively through nonNMDA glutamate receptors. Fetal transplantation of precursors isolated by fluorescence-activated cell sorting showed orthotopic integration of the grafted neurons into the Purkinje cell layer with their axons extending to the deep cerebellar nuclei and dendrites receiving climbing and parallel fibers. This selective preparation of bona fide Purkinje cells should aid future investigation of this important neuron.	[Muguruma, Keiko; Nishiyama, Ayaka; Sasai, Yoshiki] RIKEN, Organogenesis & Neurogenesis Grp, Ctr Dev Biol, Kobe, Hyogo, Japan; [Ono, Yuichi; Mizuhara, Eri] KAN Inst, Grp Neuronal Differentiat, Kobe, Hyogo, Japan; [Miyawaki, Hiroyuki; Hirano, Tomoo] Kyoto Univ, Grad Sch Sci, Dept Biophys, Kyoto, Japan; [Hori, Seiji; Kakizuka, Akira] Kyoto Univ, Grad Sch Biostudies, Lab Funct Biol, Kyoto, Japan; [Obata, Kunihiko] RIKEN, Obata Res Unit, Brain Sci Inst, Wako, Saitama, Japan; [Yanagawa, Yuchio] Gunma Univ, Sch Med, Dept Genet & Behav Neurosci, Maebashi, Gunma 371, Japan; [Yanagawa, Yuchio] Japan Sci & Technol Agcy, CREST, Tokyo, Japan	RIKEN; Kyoto University; Kyoto University; RIKEN; Gunma University; Japan Science & Technology Agency (JST)	Sasai, Y (corresponding author), RIKEN, Organogenesis & Neurogenesis Grp, Ctr Dev Biol, Kobe, Hyogo, Japan.	yoshikisasai@cdb.riken.jp	Miyawaki, Hiroyuki/CAA-0525-2022	Muguruma, Keiko/0000-0002-3149-4408; Miyawaki, Hiroyuki/0000-0003-1556-1348	Ministry of Education, Culture, Sports, Science and Technology (Japan); Kobe Cluster Project; Leading Project; National Center of Neurology and Psychiatry	Ministry of Education, Culture, Sports, Science and Technology (Japan)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Kobe Cluster Project; Leading Project; National Center of Neurology and Psychiatry(National Center for Neurology & Psychiatry - Japan)	We thank H. Enomoto and M. Eiraku for comments, T. Wataya for help in tissue preparation and members of the Sasai laboratory for discussion and advice. This work was supported by grants-in-aid from the Ministry of Education, Culture, Sports, Science and Technology (Japan), the Kobe Cluster Project, the Leading Project (Y.S.) and the National Center of Neurology and Psychiatry (K.M.).	Alder J, 1999, NAT NEUROSCI, V2, P535, DOI 10.1038/9189; Altman J, 1997, DEV CEREBELLAR SYSTE; ANG SL, 1993, DEVELOPMENT, V118, P139; BAPTISTA CA, 1994, NEURON, V12, P243, DOI 10.1016/0896-6273(94)90268-2; BenArie N, 1997, NATURE, V390, P169, DOI 10.1038/36579; Cendelin J, 2009, CEREBELLUM, V8, P35, DOI 10.1007/s12311-008-0061-9; Crossley PH, 1996, NATURE, V380, P66, DOI 10.1038/380066a0; DAVIS CA, 1988, GENE DEV, V2, P1736, DOI 10.1101/gad.2.12b.1736; Eiraku M, 2008, CELL STEM CELL, V3, P519, DOI 10.1016/j.stem.2008.09.002; Fink AJ, 2006, J NEUROSCI, V26, P3066, DOI 10.1523/JNEUROSCI.5203-05.2006; Frontali M, 2001, BRAIN RES BULL, V56, P227, DOI 10.1016/S0361-9230(01)00574-3; Garin N, 2001, NEUROSCIENCE, V105, P431, DOI 10.1016/S0306-4522(01)00127-0; HIRANO T, 1988, P NATL ACAD SCI USA, V85, P934, DOI 10.1073/pnas.85.3.934; HIRANO T, 1993, J NEUROPHYSIOL, V70, P1316, DOI 10.1152/jn.1993.70.4.1316; Hoshino M, 2005, NEURON, V47, P201, DOI 10.1016/j.neuron.2005.06.007; Ikeda H, 1996, NAT GENET, V13, P196, DOI 10.1038/ng0696-196; Joyner AL, 1996, TRENDS GENET, V12, P15, DOI 10.1016/0168-9525(96)81383-7; Liu AM, 1999, DEVELOPMENT, V126, P4827; Machold R, 2005, NEURON, V48, P17, DOI 10.1016/j.neuron.2005.08.028; Maricich SM, 1999, J NEUROBIOL, V41, P281, DOI 10.1002/(SICI)1097-4695(19991105)41:2<281::AID-NEU10>3.0.CO;2-5; Martinez S, 1999, DEVELOPMENT, V126, P1189; Matsuda K, 2010, SCIENCE, V328, P363, DOI 10.1126/science.1185152; MCMAHON AP, 1992, CELL, V69, P581, DOI 10.1016/0092-8674(92)90222-X; Meyers EN, 1998, NAT GENET, V18, P136, DOI 10.1038/ng0298-136; Minaki Y, 2008, GENE EXPR PATTERNS, V8, P418, DOI 10.1016/j.gep.2008.04.004; Miyazaki T, 2003, EUR J NEUROSCI, V17, P2563, DOI 10.1046/j.1460-9568.2003.02698.x; Mizuhara E, 2010, DEV BIOL, V338, P202, DOI 10.1016/j.ydbio.2009.11.032; Park C, 2002, NAT GENET, V31, P279, DOI 10.1038/ng908; Raman IM, 1999, J NEUROSCI, V19, P1663; Salero E, 2007, P NATL ACAD SCI USA, V104, P2997, DOI 10.1073/pnas.0610879104; Sato T, 2001, DEVELOPMENT, V128, P2461; Simeone A, 2000, TRENDS GENET, V16, P237, DOI 10.1016/S0168-9525(00)02000-X; Su HL, 2006, DEV BIOL, V290, P287, DOI 10.1016/j.ydbio.2005.11.010; Tao O, 2010, J NEUROSCI RES, V88, P234, DOI 10.1002/jnr.22208; THOMAS KR, 1990, NATURE, V346, P847, DOI 10.1038/346847a0; Uemura T, 2010, CELL, V141, P1068, DOI 10.1016/j.cell.2010.04.035; Watanabe K, 2005, NAT NEUROSCI, V8, P288, DOI 10.1038/nn1402; Wataya T, 2008, P NATL ACAD SCI USA, V105, P11796, DOI 10.1073/pnas.0803078105; Wilson L, 2005, DEV BIOL, V282, P1, DOI 10.1016/j.ydbio.2005.02.027; Wingate RJT, 1999, DEVELOPMENT, V126, P4395; Ye WL, 1998, CELL, V93, P755, DOI 10.1016/S0092-8674(00)81437-3; Zervas M, 2004, NEURON, V43, P345, DOI 10.1016/j.neuron.2004.07.010	42	103	109	1	8	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2010	13	10					1171	1180		10.1038/nn.2638	http://dx.doi.org/10.1038/nn.2638			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	654MB	20835252				2022-12-28	WOS:000282171300008
J	Glauser, DA; Goodman, MB				Glauser, Dominique A.; Goodman, Miriam B.			Neuropeptides strike back	NATURE NEUROSCIENCE			English	Editorial Material							CAENORHABDITIS-ELEGANS; CIRCUIT; NEURONS; MODULATION; FMRFAMIDE; BEHAVIOR		[Glauser, Dominique A.; Goodman, Miriam B.] Stanford Univ, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA	Stanford University	Glauser, DA (corresponding author), Stanford Univ, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA.	mbgoodman@stanford.edu	Goodman, Miriam B./H-3036-2019; Glauser, Dominique/B-3918-2012	Goodman, Miriam B./0000-0002-5810-1272; Glauser, Dominique/0000-0002-3228-7304	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047715, R21NS061147] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS047715, R21 NS061147] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bacaj T, 2008, SCIENCE, V322, P744, DOI [10.1126/science.1163074, 10.1126/science.1161473]; Bargmann C. I., 2006, WORMBOOK; Biron D, 2008, P NATL ACAD SCI USA, V105, P11002, DOI 10.1073/pnas.0805004105; Brown TM, 2007, J NEUROPHYSIOL, V97, P2553, DOI 10.1152/jn.01206.2006; Chalasani SH, 2007, NATURE, V450, P63, DOI 10.1038/nature06292; Chalasani SH, 2010, NAT NEUROSCI, V13, P615, DOI 10.1038/nn.2526; Gray JM, 2005, P NATL ACAD SCI USA, V102, P3184, DOI 10.1073/pnas.0409009101; Ignell R, 2009, P NATL ACAD SCI USA, V106, P13070, DOI 10.1073/pnas.0813004106; Li C, 2008, WORMBOOK; Lockery SR, 2009, NAT NEUROSCI, V12, P377, DOI 10.1038/nn0409-377; Marder E, 2007, ANNU REV PHYSIOL, V69, P291, DOI 10.1146/annurev.physiol.69.031905.161516; Nathoo AN, 2001, P NATL ACAD SCI USA, V98, P14000, DOI 10.1073/pnas.241231298; Ni MM, 2008, CLIN EXP PHARMACOL P, V35, P563, DOI 10.1111/j.1440-1681.2007.04840.x; Park D, 2003, CHEM SENSES, V28, P339, DOI 10.1093/chemse/28.4.339; Putney JW, 2008, J PHYSIOL-LONDON, V586, P3055, DOI 10.1113/jphysiol.2008.153221	15	1	1	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2010	13	5					528	529		10.1038/nn0510-528	http://dx.doi.org/10.1038/nn0510-528			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	588JM	20421897				2022-12-28	WOS:000277065700005
J	Gonzalez-Maeso, J				Gonzalez-Maeso, Javier			Anxious interactions	NATURE NEUROSCIENCE			English	Editorial Material							PROTEIN-COUPLED RECEPTORS; ANXIETY; DEPRESSION; ENDOCYTOSIS; MOUSE		[Gonzalez-Maeso, Javier] Mt Sinai Sch Med, Dept Psychiat, New York, NY 10029 USA; [Gonzalez-Maeso, Javier] Mt Sinai Sch Med, Dept Neurol, New York, NY USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Gonzalez-Maeso, J (corresponding author), Mt Sinai Sch Med, Dept Psychiat, New York, NY 10029 USA.	javier.maeso@mssm.edu			NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH084894] Funding Source: NIH RePORTER; NIMH NIH HHS [R01 MH084894] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Arzt E, 2006, TRENDS PHARMACOL SCI, V27, P531, DOI 10.1016/j.tips.2006.08.007; Croon KF, 2009, CNS DRUGS, V23, P427, DOI 10.2165/00023210-200923050-00006; Cryan JF, 2005, NAT REV DRUG DISCOV, V4, P775, DOI 10.1038/nrd1825; Gavarini S, 2004, BIOL CELL, V96, P373, DOI 10.1016/j.biolcel.2004.03.001; Gross C, 2004, NAT REV NEUROSCI, V5, P545, DOI 10.1038/nrn1429; Kalueff AV, 2007, BEHAV BRAIN RES, V179, P1, DOI 10.1016/j.bbr.2007.01.023; Koenig JA, 1997, TRENDS PHARMACOL SCI, V18, P276, DOI 10.1016/S0165-6147(97)01091-2; Lopez-Gimenez JF, 2008, MOL PHARMACOL, V74, P1278, DOI 10.1124/mol.108.048272; Magalhaes AC, 2010, NAT NEUROSCI, V13, P622, DOI 10.1038/nn.2529; Milligan G, 2009, BRIT J PHARMACOL, V158, P5, DOI 10.1111/j.1476-5381.2009.00169.x; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; Sorkin A, 2009, NAT REV MOL CELL BIO, V10, P609, DOI 10.1038/nrm2748; Valdez GR, 2006, CNS DRUGS, V20, P887, DOI 10.2165/00023210-200620110-00002; VALE W, 1981, SCIENCE, V213, P1394, DOI 10.1126/science.6267699; Weisstaub NV, 2006, SCIENCE, V313, P536, DOI 10.1126/science.1123432	15	9	9	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2010	13	5					524	526		10.1038/nn0510-524	http://dx.doi.org/10.1038/nn0510-524			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	588JM	20421895	Green Accepted			2022-12-28	WOS:000277065700003
J	Goldberg, JH; Fee, MS				Goldberg, Jesse H.; Fee, Michale S.			A cortical motor nucleus drives the basal ganglia-recipient thalamus in singing birds	NATURE NEUROSCIENCE			English	Article							FOREBRAIN CIRCUIT; GLOBUS-PALLIDUS; BASIC PROCESS; SONG SYSTEM; NEURONS; MOVEMENT; DISINHIBITION; INHIBITION; DISCHARGE; RELAY	The pallido-recipient thalamus transmits information from the basal ganglia to the cortex and is critical for motor initiation and learning. Thalamic activity is strongly inhibited by pallidal inputs from the basal ganglia, but the role of nonpallidal inputs, such as excitatory inputs from cortex, remains unclear. We simultaneously recorded from presynaptic pallidal axon terminals and postsynaptic thalamocortical neurons in a basal ganglia-recipient thalamic nucleus that is necessary for vocal variability and learning in zebra finches. We found that song-locked rate modulations in the thalamus could not be explained by pallidal inputs alone and persisted following pallidal lesion. Instead, thalamic activity was likely driven by inputs from a motor cortical nucleus that is also necessary for singing. These findings suggest a role for cortical inputs to the pallido-recipient thalamus in driving premotor signals that are important for exploratory behavior and learning.	[Goldberg, Jesse H.; Fee, Michale S.] MIT, McGovern Inst Brain Res, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Fee, MS (corresponding author), MIT, McGovern Inst Brain Res, Dept Brain & Cognit Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	fee@mit.edu		Fee, Michale/0000-0001-7539-1745	US National Institutes of Health [R01DC009183, K99NS067062]; Charles King Trust; Damon Runyon Research Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K99NS067062] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC009183] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Charles King Trust; Damon Runyon Research Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank A. Graybiel and M. Farries for comments on the manuscript. This work was supported by grants from the US National Institutes of Health (R01DC009183 to M.S.F. and K99NS067062 to J.H.G.), and post-doctoral fellowships from the Charles King Trust and Damon Runyon Research Foundation.	ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; Andalman AS, 2009, P NATL ACAD SCI USA, V106, P12518, DOI 10.1073/pnas.0903214106; ANDERSON ME, 1985, J NEUROPHYSIOL, V54, P433, DOI 10.1152/jn.1985.54.2.433; ANDERSON ME, 1991, EXP BRAIN RES, V86, P623; ANDERSON ME, 1991, J NEUROPHYSIOL, V66, P879, DOI 10.1152/jn.1991.66.3.879; Aronov D, 2008, SCIENCE, V320, P630, DOI 10.1126/science.1155140; Aronov D, 2011, J NEUROSCI, V31, P16353, DOI 10.1523/JNEUROSCI.3009-11.2011; BOTTJER SW, 1984, SCIENCE, V224, P901, DOI 10.1126/science.6719123; Butler AB, 2011, ANN NY ACAD SCI, V1225, P14, DOI 10.1111/j.1749-6632.2011.06006.x; CHEVALIER G, 1990, TRENDS NEUROSCI, V13, P277, DOI 10.1016/0166-2236(90)90109-N; COULTER DA, 1989, J PHYSIOL-LONDON, V414, P587, DOI 10.1113/jphysiol.1989.sp017705; DELONG MR, 1990, TRENDS NEUROSCI, V13, P281, DOI 10.1016/0166-2236(90)90110-V; DENIAU JM, 1985, BRAIN RES, V334, P227, DOI 10.1016/0006-8993(85)90214-8; DENIAU JM, 1978, BRAIN RES, V145, P27, DOI 10.1016/0006-8993(78)90793-X; Doupe AJ, 2005, TRENDS NEUROSCI, V28, P353, DOI 10.1016/j.tins.2005.05.005; Fee MS, 2011, NEUROSCIENCE, V198, P152, DOI 10.1016/j.neuroscience.2011.09.069; GEORGOPOULOS AP, 1983, J NEUROSCI, V3, P1586; Goldberg JH, 2011, J NEUROPHYSIOL, V105, P2729, DOI 10.1152/jn.00823.2010; Goldberg JH, 2010, J NEUROSCI, V30, P7088, DOI 10.1523/JNEUROSCI.0168-10.2010; Graybiel AM, 2005, CURR OPIN NEUROBIOL, V15, P638, DOI 10.1016/j.conb.2005.10.006; Hikosaka O, 2007, PROG BRAIN RES, V160, P209, DOI 10.1016/S0079-6123(06)60012-5; Inase M, 1996, J NEUROPHYSIOL, V75, P1087, DOI 10.1152/jn.1996.75.3.1087; Jarvis ED, 2004, ANN NY ACAD SCI, V1016, P749, DOI 10.1196/annals.1298.038; Jeanmonod D, 1996, BRAIN, V119, P363, DOI 10.1093/brain/119.2.363; Kojima S, 2009, J NEUROSCI, V29, P4782, DOI 10.1523/JNEUROSCI.4903-08.2009; Kultas-Ilinsky K, 2003, J COMP NEUROL, V457, P133, DOI 10.1002/cne.10539; Kunimatsu J, 2010, J NEUROSCI, V30, P5108, DOI 10.1523/JNEUROSCI.0406-10.2010; Leblois A, 2009, J NEUROSCI, V29, P15420, DOI 10.1523/JNEUROSCI.3060-09.2009; Llinas RR, 2006, J NEUROPHYSIOL, V95, P3297, DOI 10.1152/jn.00166.2006; Luo MM, 1999, J NEUROSCI, V19, P6700; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; McFarland NR, 2002, J NEUROSCI, V22, P8117; Mink JW, 1996, PROG NEUROBIOL, V50, P381, DOI 10.1016/S0301-0082(96)00042-1; Okun M, 2008, NAT NEUROSCI, V11, P535, DOI 10.1038/nn.2105; PARE D, 1990, NEUROSCIENCE, V35, P217, DOI 10.1016/0306-4522(90)90077-H; Pasupathy A, 2005, NATURE, V433, P873, DOI 10.1038/nature03287; Person AL, 2007, J NEUROSCI, V27, P8687, DOI 10.1523/JNEUROSCI.2045-07.2007; Person AL, 2005, NEURON, V46, P129, DOI 10.1016/j.neuron.2004.12.057; Reiner A, 2009, ADV BEHAV BIOL, V58, P3, DOI 10.1007/978-1-4419-0340-2_1; SCHARFF C, 1991, J NEUROSCI, V11, P2896; Sherman, 2006, EXPLORING THALAMUS I, P357; Sheth SA, 2011, J NEUROSCI, V31, P4878, DOI 10.1523/JNEUROSCI.3658-10.2011; STRICK PL, 1976, J NEUROPHYSIOL, V39, P1032, DOI 10.1152/jn.1976.39.5.1032; Vates GE, 1997, J COMP NEUROL, V380, P275; Veit L, 2011, J NEUROPHYSIOL, V106, P1747, DOI 10.1152/jn.00247.2011; Vogels TP, 2009, NAT NEUROSCI, V12, P483, DOI 10.1038/nn.2276; Warren TL, 2011, J NEUROPHYSIOL, V106, P1806, DOI 10.1152/jn.00311.2011; WILD JM, 1993, J COMP NEUROL, V338, P225, DOI 10.1002/cne.903380207; Yoshida A, 2009, CEREB CORTEX, V19, P206, DOI 10.1093/cercor/bhn069	49	62	63	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2012	15	4					620	627		10.1038/nn.3047	http://dx.doi.org/10.1038/nn.3047			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	916PA	22327474	Green Accepted, Green Submitted			2022-12-28	WOS:000302114500023
J	English, DF; Ibanez-Sandoval, O; Stark, E; Tecuapetla, F; Buzsaki, G; Deisseroth, K; Tepper, JM; Koos, T				English, Daniel F.; Ibanez-Sandoval, Osvaldo; Stark, Eran; Tecuapetla, Fatuel; Buzsaki, Gyoergy; Deisseroth, Karl; Tepper, James M.; Koos, Tibor			GABAergic circuits mediate the reinforcement-related signals of striatal cholinergic interneurons	NATURE NEUROSCIENCE			English	Article							TONICALLY ACTIVE NEURONS; FAST-SPIKING INTERNEURONS; NICOTINIC ACH RECEPTORS; MIDBRAIN DOPAMINE; PRIMATES STRIATUM; GABA(A) RECEPTORS; TOURETTE-SYNDROME; RESPONSES; REWARD; DESENSITIZATION	Neostriatal cholinergic interneurons are believed to be important for reinforcement-mediated learning and response selection by signaling the occurrence and motivational value of behaviorally relevant stimuli through precisely timed multiphasic population responses. An important problem is to understand how these signals regulate the functioning of the neostriatum. Here we describe the synaptic organization of a previously unknown circuit that involves direct nicotinic excitation of several classes of GABAergic interneurons, including neuroptide Y-expressing neurogilaform neurons, and enables cholinergic interneurons to exert rapid inhibitory control of the activity of projection neurons. We also found that, in vivo, the dominant effect of an optogenetically reproduced pause-excitation population response of cholinergic interneurons was powerful and rapid inhibition of the firing of projection neurons that is coincident with synchronous cholinergic activation. These results reveal a previously unknown circuit mechanism that transmits reinforcement-related information of ChAT interneurons in the mouse neostriatal network.	[English, Daniel F.; Ibanez-Sandoval, Osvaldo; Stark, Eran; Tecuapetla, Fatuel; Buzsaki, Gyoergy; Tepper, James M.; Koos, Tibor] Rutgers State Univ, Ctr Mol & Behav Neurosci, Newark, NJ 07102 USA; [Deisseroth, Karl] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA	Rutgers State University Newark; Rutgers State University New Brunswick; Stanford University	Koos, T (corresponding author), Rutgers State Univ, Ctr Mol & Behav Neurosci, Newark, NJ 07102 USA.	tibkoos@yahoo.com	Tepper, James/AAA-3828-2019	Tepper, James/0000-0002-8643-4082; Tecuapetla, Fatuel/0000-0002-9191-6553; Buzsaki, Gyorgy/0000-0002-3100-4800; English, Daniel/0000-0003-2284-870X; Stark, Eran/0000-0002-2446-9140	US National Institutes of Health [NS072950, NS034865]; Rutgers University; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS034865, R01NS072950, R01NS034865] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rutgers University; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank J. Berlin for confocal microscopy, L. Zaborszky for providing ChAT-EGFP mice, R. Yanez-Munoz for providing integration deficient pCMV-dR8.74-D64V plasmid DNA and for advice regarding virus production, N. Altan-Bonnet, W. Friedman and Haesun Kim for generously providing access to an ultracentrifuge facility and other equipment in their laboratories, C. T. Unal and A. Kreitzer for valuable discussion, A. Berenyi, S. Fujisawa and M. Vandecasteele for advice regarding in vivo recording methods, H. Xenias for help with confocal imaging, F. Shah for help with immunocytochemical procedures and other technical assistance, and I. Tadros for virus injections. The research was supported by US National Institutes of Health grant NS072950 and a Busch Biomedical Research Grant of Rutgers University to T. K., US National Institutes of Health grant NS034865 to J. M. T. and Rutgers University funds.	AOSAKI T, 1995, J NEUROPHYSIOL, V73, P1234, DOI 10.1152/jn.1995.73.3.1234; AOSAKI T, 1994, J NEUROSCI, V14, P3969; Apicella P, 1998, J NEUROPHYSIOL, V80, P3341, DOI 10.1152/jn.1998.80.6.3341; Apicella P, 2007, TRENDS NEUROSCI, V30, P299, DOI 10.1016/j.tins.2007.03.011; Banks MI, 2000, NEURON, V25, P449, DOI 10.1016/S0896-6273(00)80907-1; Banks MI, 1998, J NEUROSCI, V18, P1305; Banks MI, 2000, J NEUROSCI, V20, P937, DOI 10.1523/JNEUROSCI.20-03-00937.2000; Berke JD, 2009, EUR J NEUROSCI, V30, P848, DOI 10.1111/j.1460-9568.2009.06843.x; Berke JD, 2008, J NEUROSCI, V28, P10075, DOI 10.1523/JNEUROSCI.2192-08.2008; Capogna M, 2011, TRENDS NEUROSCI, V34, P101, DOI 10.1016/j.tins.2010.10.005; CHANG HT, 1992, BRAIN RES, V574, P307, DOI 10.1016/0006-8993(92)90830-3; De Rover M, 2005, SYNAPSE, V55, P17, DOI 10.1002/syn.20087; Ding JB, 2010, NEURON, V67, P294, DOI 10.1016/j.neuron.2010.06.017; Giniatullin R, 2005, TRENDS NEUROSCI, V28, P371, DOI 10.1016/j.tins.2005.04.009; Gittis AH, 2010, J NEUROSCI, V30, P2223, DOI 10.1523/JNEUROSCI.4870-09.2010; Gradinaru V, 2010, CELL, V141, P154, DOI 10.1016/j.cell.2010.02.037; Gradinaru V, 2008, BRAIN CELL BIOL, V36, P129, DOI 10.1007/s11068-008-9027-6; Graybiel AM, 1998, NEUROBIOL LEARN MEM, V70, P119, DOI 10.1006/nlme.1998.3843; Han X, 2009, NEURON, V62, P191, DOI 10.1016/j.neuron.2009.03.011; HIKOSAKA O, 1989, J NEUROPHYSIOL, V61, P814, DOI 10.1152/jn.1989.61.4.814; HILL JA, 1993, J NEUROSCI, V13, P1551; Hyland BI, 2002, NEUROSCIENCE, V114, P475, DOI 10.1016/S0306-4522(02)00267-1; Ibanez-Sandoval O, 2011, J NEUROSCI, V31, P16757, DOI 10.1523/JNEUROSCI.2628-11.2011; Ibanez-Sandoval O, 2010, J NEUROSCI, V30, P6999, DOI 10.1523/JNEUROSCI.5996-09.2010; Jog MS, 2002, J NEUROSCI METH, V117, P141, DOI 10.1016/S0165-0270(02)00092-4; Joshua M, 2008, J NEUROSCI, V28, P11673, DOI 10.1523/JNEUROSCI.3839-08.2008; Karayannis T, 2010, J NEUROSCI, V30, P9898, DOI 10.1523/JNEUROSCI.5883-09.2010; Kataoka Y, 2010, J COMP NEUROL, V518, P277, DOI 10.1002/cne.22206; KIMURA M, 1984, P NATL ACAD SCI-BIOL, V81, P4998, DOI 10.1073/pnas.81.15.4998; Koos T, 1999, NAT NEUROSCI, V2, P467, DOI 10.1038/8138; Koos T, 2002, J NEUROSCI, V22, P529, DOI 10.1523/JNEUROSCI.22-02-00529.2002; KUBOTA Y, 1993, NEUROREPORT, V5, P205, DOI 10.1097/00001756-199312000-00004; Leckman JF, 2006, J CHILD PSYCHOL PSYC, V47, P537, DOI 10.1111/j.1469-7610.2006.01620.x; Matsumoto N, 2001, J NEUROPHYSIOL, V85, P960, DOI 10.1152/jn.2001.85.2.960; MCGEHEE DS, 1995, SCIENCE, V269, P1692, DOI 10.1126/science.7569895; Morris G, 2004, NEURON, V43, P133, DOI 10.1016/j.neuron.2004.06.012; Olah S, 2009, NATURE, V461, P1278, DOI 10.1038/nature08503; Overstreet LS, 2000, J NEUROSCI, V20, P7914; PEARCE RA, 1993, NEURON, V10, P189, DOI 10.1016/0896-6273(93)90310-N; Rice ME, 2004, NAT NEUROSCI, V7, P583, DOI 10.1038/nn1244; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; Sullivan MA, 2008, J NEUROSCI, V28, P8682, DOI 10.1523/JNEUROSCI.2411-08.2008; Szabadics J, 2007, P NATL ACAD SCI USA, V104, P14831, DOI 10.1073/pnas.0707204104; Tamas G, 2003, SCIENCE, V299, P1902, DOI 10.1126/science.1082053; Tecuapetla F, 2009, J NEUROSCI, V29, P8977, DOI 10.1523/JNEUROSCI.6145-08.2009; Wilson CJ, 2005, NEURON, V45, P575, DOI 10.1016/j.neuron.2004.12.053; Witten IB, 2010, SCIENCE, V330, P1677, DOI 10.1126/science.1193771; Wonnacott S, 1997, TRENDS NEUROSCI, V20, P92, DOI 10.1016/S0166-2236(96)10073-4; Yanez-Munoz RJ, 2006, NAT MED, V12, P348, DOI 10.1038/nm1365; Zhou FM, 2001, NAT NEUROSCI, V4, P1224, DOI 10.1038/nn769	50	203	205	0	41	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2012	15	1					123	U155		10.1038/nn.2984	http://dx.doi.org/10.1038/nn.2984			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	866VO	22158514	Green Accepted			2022-12-28	WOS:000298414400022
J	Bhogal, B; Jepson, JE; Savva, YA; Pepper, ASR; Reenan, RA; Jongens, TA				Bhogal, Balpreet; Jepson, James E.; Savva, Yiannis A.; Pepper, Anita S-R; Reenan, Robert A.; Jongens, Thomas A.			Modulation of dADAR-dependent RNA editing by the Drosophila fragile X mental retardation protein	NATURE NEUROSCIENCE			English	Article							TANDEM AFFINITY PURIFICATION; MESSENGER-RNA; SYNAPTIC STRUCTURE; FMRP; POLYRIBOSOMES; EXPRESSION; NEURONS; DFMR1; ADAR; LOCALIZATION	Loss of FMR1 gene function results in fragile X syndrome, the most common heritable form of intellectual disability. The protein encoded by this locus (FMRP) is an RNA-binding protein that is thought to primarily act as a translational regulator; however, recent studies have implicated FMRP in other mechanisms of gene regulation. We found that the Drosophila fragile X homolog (dFMR1) biochemically interacted with the adenosine-to-inosine RNA-editing enzyme dADAR. Adar and Fmr1 mutant larvae exhibited distinct morphological neuromuscular junction (NMJ) defects. Epistasis experiments based on these phenotypic differences revealed that Adar acts downstream of Fmr1 and that dFMR1 modulates dADAR activity. Furthermore, sequence analyses revealed that a loss or overexpression of dFMR1 affects editing efficiency on certain dADAR targets with defined roles in synaptic transmission. These results link dFMR1 with the RNA-editing pathway and suggest that proper NMJ synaptic architecture requires modulation of dADAR activity by dFMR1.	[Bhogal, Balpreet; Pepper, Anita S-R; Jongens, Thomas A.] Univ Penn, Perelman Sch Med, Dept Genet, Philadelphia, PA 19104 USA; [Jepson, James E.; Savva, Yiannis A.; Reenan, Robert A.] Brown Univ, Dept Mol Biol Cell Biol & Biochem, Providence, RI 02912 USA	University of Pennsylvania; Pennsylvania Medicine; Brown University	Jongens, TA (corresponding author), Univ Penn, Perelman Sch Med, Dept Genet, Philadelphia, PA 19104 USA.	jongens@mail.med.upenn.edu	Pepper, Anita/GWC-7680-2022	Bhogal, Balpreet/0000-0002-3997-7316; jepson, james/0000-0002-3357-2801	National Institute of Mental Health [MH086705]; National Institute of General Medical Science [GM086902]; Ellison Medical Foundation;  [5T32GM008216]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008216, R01GM086902] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH086705] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of General Medical Science(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Ellison Medical Foundation(Lawrence Ellison Foundation); ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank current and former members of the Jongens laboratory for helpful discussions and technical support, especially R. Beerman for preliminary studies with the LMB experiments, and S. Cruz and C. Dubowy. We also thank M. Sundaram and D. Hancks for critical reading of the manuscript. We are grateful to R. Carstens, G. Bashaw, T. Dockendorff, C. Hughes, K. Kaestner, S. Artavanis-Tsakonas, the Bloomington Stock Center and the Developmental Studies Hybridoma Bank for fly strains and reagents. We also thank C.-X. Yuan and The Perelman School of Medicine at the University of Pennsylvania Proteomics Facility for help with the mass spectrometry results. This work was supported by a Predoctoral Training grant in Genetics (5T32GM008216 to B.B.), a National Institute of Mental Health grant (MH086705 to T.A.J.), a National Institute of General Medical Science grant (GM086902 to T.A.J.) and an Ellison Medical Foundation Senior Scholar award to R.A.R.	Antar LN, 2005, GENES BRAIN BEHAV, V4, P350, DOI 10.1111/j.1601-183X.2005.00128.x; Aravamudan B, 1999, NAT NEUROSCI, V2, P965, DOI 10.1038/14764; Banerjee P, 2007, GENETICS, V175, P1241, DOI 10.1534/genetics.106.068908; Bass BL, 2002, ANNU REV BIOCHEM, V71, P817, DOI 10.1146/annurev.biochem.71.110601.135501; Bechara EG, 2009, PLOS BIOL, V7, P133, DOI 10.1371/journal.pbio.1000016; Caudy AA, 2002, GENE DEV, V16, P2491, DOI 10.1101/gad.1025202; Corbin F, 1997, HUM MOL GENET, V6, P1465, DOI 10.1093/hmg/6.9.1465; Darnell JC, 2005, GENE DEV, V19, P903, DOI 10.1101/gad.1276805; Darnell JC, 2001, CELL, V107, P489, DOI 10.1016/S0092-8674(01)00566-9; DEVYS D, 1993, NAT GENET, V4, P335, DOI 10.1038/ng0893-335; Dickman DK, 2006, CURR BIOL, V16, P591, DOI 10.1016/j.cub.2006.02.058; Dictenberg JB, 2008, DEV CELL, V14, P926, DOI 10.1016/j.devcel.2008.04.003; Dockendorff TC, 2002, NEURON, V34, P973, DOI 10.1016/S0896-6273(02)00724-9; Eberhart DE, 1996, HUM MOL GENET, V5, P1083, DOI 10.1093/hmg/5.8.1083; Edbauer D, 2010, NEURON, V65, P373, DOI 10.1016/j.neuron.2010.01.005; Estes PS, 2008, MOL CELL NEUROSCI, V39, P170, DOI 10.1016/j.mcn.2008.06.012; Feng Y, 1997, J NEUROSCI, V17, P1539; Feng Y, 1997, MOL CELL, V1, P109, DOI 10.1016/S1097-2765(00)80012-X; Gallo A, 2003, EMBO J, V22, P3421, DOI 10.1093/emboj/cdg327; Gatto CL, 2008, DEVELOPMENT, V135, P2637, DOI 10.1242/dev.022244; Higuchi M, 2000, NATURE, V406, P78, DOI 10.1038/35017558; Hoopengardner B, 2003, SCIENCE, V301, P832, DOI 10.1126/science.1086763; Ishizuka A, 2002, GENE DEV, V16, P2497, DOI 10.1101/gad.1022002; Jepson JEC, 2011, J BIOL CHEM, V286, P8325, DOI 10.1074/jbc.M110.186817; Jin P, 2004, NAT NEUROSCI, V7, P113, DOI 10.1038/nn1174; Keegan LP, 2005, EMBO J, V24, P2183, DOI 10.1038/sj.emboj.7600691; Khandjian EW, 1996, NAT GENET, V12, P91, DOI 10.1038/ng0196-91; Koh YH, 2000, MICROSC RES TECHNIQ, V49, P14, DOI 10.1002/(SICI)1097-0029(20000401)49:1<14::AID-JEMT3>3.3.CO;2-7; Laggerbauer B, 2001, HUM MOL GENET, V10, P329, DOI 10.1093/hmg/10.4.329; Li ZZ, 2001, NUCLEIC ACIDS RES, V29, P2276, DOI 10.1093/nar/29.11.2276; Monzo K, 2006, P NATL ACAD SCI USA, V103, P18160, DOI 10.1073/pnas.0606508103; Nishikura K, 2010, ANNU REV BIOCHEM, V79, P321, DOI 10.1146/annurev-biochem-060208-105251; O'Donnell WT, 2002, ANNU REV NEUROSCI, V25, P315, DOI 10.1146/annurev.neuro.25.112701.142909; Palladino MJ, 2000, CELL, V102, P437, DOI 10.1016/S0092-8674(00)00049-0; Palladino MJ, 2000, RNA, V6, P1004, DOI 10.1017/S1355838200000248; Pepper ASR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007618; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Tamanini F, 1997, HUM MOL GENET, V6, P1315, DOI 10.1093/hmg/6.8.1315; Tonkin LA, 2002, EMBO J, V21, P6025, DOI 10.1093/emboj/cdf607; Tsai A, 2006, NAT PROTOC, V1, P2820, DOI 10.1038/nprot.2006.371; Veraksa A, 2005, DEV DYNAM, V232, P827, DOI 10.1002/dvdy.20272; Wan LL, 2000, MOL CELL BIOL, V20, P8536, DOI 10.1128/MCB.20.22.8536-8547.2000; Weiler IJ, 1997, P NATL ACAD SCI USA, V94, P5395, DOI 10.1073/pnas.94.10.5395; Xu XL, 2008, J NEUROSCI, V28, P11883, DOI 10.1523/JNEUROSCI.4114-08.2008; Zalfa F, 2007, NAT NEUROSCI, V10, P578, DOI 10.1038/nn1893; Zang JB, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000758; Zeng F, 2006, NAT PROTOC, V1, P920, DOI 10.1038/nprot.2006.81; Zhang B, 1998, NEURON, V21, P1465, DOI 10.1016/S0896-6273(00)80664-9; Zhang YQ, 2001, CELL, V107, P591, DOI 10.1016/S0092-8674(01)00589-X	50	63	63	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	2011	14	12					1517	U40		10.1038/nn.2950	http://dx.doi.org/10.1038/nn.2950			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	855EJ	22037499	Green Accepted			2022-12-28	WOS:000297546300010
J	Farovik, A; Place, RJ; Miller, DR; Eichenbaum, H				Farovik, Anja; Place, Ryan James; Miller, Danielle Renee; Eichenbaum, Howard			Amygdala lesions selectively impair familiarity in recognition memory	NATURE NEUROSCIENCE			English	Article							MEDIAL TEMPORAL-LOBE; EMOTIONAL MEMORY; RECOLLECTION; HIPPOCAMPAL; STIMULI; RATS	A major controversy in the study of memory concerns whether there are distinct medial temporal lobe (MTL) substrates of recollection and familiarity. Studies using receiver operating characteristics analyses of recognition memory indicate that the hippocampus is essential for recollection, but not for familiarity. We found the converse pattern in the amygdala, wherein damage impaired familiarity while sparing recollection. Combined with previous findings, these results dissociate recollection and familiarity by selective MTL damage.	[Farovik, Anja; Place, Ryan James; Miller, Danielle Renee; Eichenbaum, Howard] Boston Univ, Ctr Memory & Brain, Boston, MA 02215 USA	Boston University	Eichenbaum, H (corresponding author), Boston Univ, Ctr Memory & Brain, Boston, MA 02215 USA.	hbe@bu.edu		Sullivan, Danielle R./0000-0002-0141-5887	National Institute of Mental Health [MH52090]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH052090] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank A. Yonelinas and M. Sauvage for their thoughtful comments on data analysis, and National Institute on Drug Abuse (NIDA) for valuable inspiration. This work was supported by National Institute of Mental Health Project Grant MH52090.	Adolphs R, 2005, NAT NEUROSCI, V8, P512, DOI 10.1038/nn1413; AGGLETON JP, 1989, BEHAV NEUROSCI, V103, P962, DOI 10.1037/0735-7044.103.5.962; Babiloni C, 2009, HUM BRAIN MAPP, V30, P2077, DOI 10.1002/hbm.20648; Bowles B, 2007, P NATL ACAD SCI USA, V104, P16382, DOI 10.1073/pnas.0705273104; Bowles B, 2010, NEUROPSYCHOLOGIA, V48, P2640, DOI 10.1016/j.neuropsychologia.2010.05.010; Eichenbaum H, 2007, ANNU REV NEUROSCI, V30, P123, DOI 10.1146/annurev.neuro.30.051606.094328; Fortin NJ, 2004, NATURE, V431, P188, DOI 10.1038/nature02853; Kensinger EA, 2006, J NEUROSCI, V26, P2564, DOI 10.1523/JNEUROSCI.5241-05.2006; LaBar KS, 2006, NAT REV NEUROSCI, V7, P54, DOI 10.1038/nrn1825; McGaugh JL, 2004, ANNU REV NEUROSCI, V27, P1, DOI 10.1146/annurev.neuro.27.070203.144157; Packard MG, 1998, NEUROBIOL LEARN MEM, V69, P163, DOI 10.1006/nlme.1997.3815; Pitkanen A, 2000, ANN NY ACAD SCI, V911, P369; Sharot T, 2004, NAT NEUROSCI, V7, P1376, DOI 10.1038/nn1353; Squire LR, 2007, NAT REV NEUROSCI, V8, P872, DOI 10.1038/nrn2154; ZAJONC RB, 1968, J PERS SOC PSYCHOL, V9, P1, DOI 10.1037/h0025848	15	30	31	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2011	14	11					1416	1417		10.1038/nn.2919	http://dx.doi.org/10.1038/nn.2919			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	841NI	21946327	Green Accepted			2022-12-28	WOS:000296518600016
J	Hjelmeland, AB; Lathia, JD; Sathornsumetee, S; Rich, JN				Hjelmeland, Anita B.; Lathia, Justin D.; Sathornsumetee, Sith; Rich, Jeremy N.			Twisted tango: brain tumor neurovascular interactions	NATURE NEUROSCIENCE			English	Review							CANCER STEM-CELLS; NEWLY-DIAGNOSED GLIOBLASTOMA; ENDOTHELIAL GROWTH-FACTOR; GLIOMA-INITIATING CELLS; HIGH-GRADE GLIOMA; PHASE-II; RECURRENT GLIOBLASTOMA; MALIGNANT GLIOMA; SELF-RENEWAL; PERIVASCULAR NICHE	The brain is a complicated organ with complexity derived from cellular and microenvironmental interactions. Similarly, brain tumor cells actively modify and are regulated by their microenvironment. Brain tumors are highly heterogeneous and frequently show a cellular hierarchy with self-renewing tumorigenic brain tumor stem cells (BTSCs) at the apex. Although BTSCs are distinct from neural stem cells, they share characteristics, including bidirectional interplay with supportive vasculature critical for maintenance of undifferentiated states and survival. BTSCs stimulate angiogenesis through growth factor secretion and are enriched in perivascular niches. Microenvironmental conditions, including hypoxia, drive expression of stem cell genes and proangiogenic factors, further linking cellular hierarchy regulation and instructive stromal elements. BTSCs may also directly contribute to tumor vasculature through plasticity toward an endothelial lineage. Interrogating the codependence of BTSCs and the perivascular niche may directly inform clinical approaches for brain tumor therapy through targeting of highly angiogenic and tumorigenic cellular subsets.	[Hjelmeland, Anita B.; Lathia, Justin D.; Rich, Jeremy N.] Cleveland Clin, Dept Stem Cell Biol & Regenerat Med, Lerner Res Inst, Cleveland, OH 44106 USA; [Sathornsumetee, Sith] Mahidol Univ, Siriraj Hosp, Fac Med, Dept Med, Bangkok 10700, Thailand; [Rich, Jeremy N.] Case Western Reserve Univ, Sch Med, Lerner Coll Med, Dept Mol Med,Cleveland Clin, Cleveland, OH 44106 USA; [Rich, Jeremy N.] Univ Hosp, Cleveland, OH USA	Cleveland Clinic Foundation; Mahidol University; Case Western Reserve University; Cleveland Clinic Foundation; University Hospitals of Cleveland	Hjelmeland, AB (corresponding author), Cleveland Clin, Dept Stem Cell Biol & Regenerat Med, Lerner Res Inst, Cleveland, OH 44106 USA.	hjelmea@ccf.org; richj@ccf.org	Rich, Jeremy/AAM-1445-2021; Lathia, Justin/AHB-8296-2022	Sathornsumetee, Sith/0000-0003-1350-0672; Hjelmeland, Anita/0000-0003-2200-3248	US National Institutes of Health [CA151522, CA142159, CA129958, CA116659, CA154130]; American Brain Tumor Association; James S. McDonnell Foundation; NATIONAL CANCER INSTITUTE [R01CA151522, R01CA129958, R01CA116659, F32CA142159, R01CA154130] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024989] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Brain Tumor Association; James S. McDonnell Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	We thank the sources of our funding, including the US National Institutes of Health (CA151522 for A. B. H.; CA142159 for J.D.L.; CA129958, CA116659 and CA154130 for J.N.R.), the American Brain Tumor Association (J.D.L.) and the James S. McDonnell Foundation (J.N.R.).	Anido J, 2010, CANCER CELL, V18, P655, DOI 10.1016/j.ccr.2010.10.023; Bao SD, 2008, CANCER RES, V68, P6043, DOI 10.1158/0008-5472.CAN-08-1079; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Bao SD, 2006, CANCER RES, V66, P7843, DOI 10.1158/0008-5472.CAN-06-1010; Bar EE, 2007, STEM CELLS, V25, P2524, DOI 10.1634/stemcells.2007-0166; Bar EE, 2010, AM J PATHOL, V177, P1491, DOI 10.2353/ajpath.2010.091021; Batchelor TT, 2007, CANCER CELL, V11, P83, DOI 10.1016/j.ccr.2006.11.021; Batchelor TT, 2010, J CLIN ONCOL, V28, P2817, DOI 10.1200/JCO.2009.26.3988; Becher OJ, 2008, CANCER RES, V68, P2241, DOI 10.1158/0008-5472.CAN-07-6350; Butler JM, 2010, CELL STEM CELL, V6, P251, DOI 10.1016/j.stem.2010.02.001; Calabrese C, 2007, CANCER CELL, V11, P69, DOI 10.1016/j.ccr.2006.11.020; Charles NA, 2010, CELL STEM CELL, V6, P6, DOI 10.1016/j.stem.2009.12.005; Cheng L, 2011, BIOCHEM BIOPH RES CO, V406, P643, DOI 10.1016/j.bbrc.2011.02.123; Chiao MT, 2011, CURR NEUROVASC RES, V8, P210, DOI 10.2174/156720211796558023; Clement V, 2007, CURR BIOL, V17, P165, DOI 10.1016/j.cub.2006.11.033; de Groot JF, 2011, J CLIN ONCOL, V29, P2689, DOI 10.1200/JCO.2010.34.1636; Deleyrolle LP, 2011, BRAIN, V134, P1331, DOI 10.1093/brain/awr081; Eyler CE, 2011, CELL, V146, P53, DOI 10.1016/j.cell.2011.06.006; Fan X, 2006, CANCER RES, V66, P7445, DOI 10.1158/0008-5472.CAN-06-0858; Fan X, 2010, STEM CELLS, V28, P5, DOI 10.1002/stem.254; Folkins C, 2007, CANCER RES, V67, P3560, DOI 10.1158/0008-5472.CAN-06-4238; Folkins C, 2009, CANCER RES, V69, P7243, DOI 10.1158/0008-5472.CAN-09-0167; Friedman HS, 2009, J CLIN ONCOL, V27, P4733, DOI 10.1200/JCO.2008.19.8721; Galan-Moya EM, 2011, EMBO REP, V12, P470, DOI 10.1038/embor.2011.39; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Gibson P, 2010, NATURE, V468, P1095, DOI 10.1038/nature09587; Gilbertson RJ, 2007, NAT REV CANCER, V7, P733, DOI 10.1038/nrc2246; Hambardzumyan D, 2008, GENE DEV, V22, P436, DOI 10.1101/gad.1627008; Hattermann K, 2010, CANCER RES, V70, P3299, DOI 10.1158/0008-5472.CAN-09-3642; Heddleston JM, 2009, CELL CYCLE, V8, P3274, DOI 10.4161/cc.8.20.9701; Hemmati HD, 2003, P NATL ACAD SCI USA, V100, P15178, DOI 10.1073/pnas.2036535100; Hovinga KE, 2010, STEM CELLS, V28, P1019, DOI 10.1002/stem.429; Hsieh A, 2011, J CELL PHYSIOL, V226, P1118, DOI 10.1002/jcp.22433; Ikushima H, 2009, CELL STEM CELL, V5, P504, DOI 10.1016/j.stem.2009.08.018; Johnson RA, 2010, NATURE, V466, P632, DOI 10.1038/nature09173; Kawataki T, 2007, EXP CELL RES, V313, P3819, DOI 10.1016/j.yexcr.2007.07.038; Keunen O, 2011, P NATL ACAD SCI USA, V108, P3749, DOI 10.1073/pnas.1014480108; Kioi M, 2010, J CLIN INVEST, V120, P694, DOI 10.1172/JCI40283; Knizetova P, 2008, CELL CYCLE, V7, P2553, DOI 10.4161/cc.7.16.6442; Komatani H, 2009, INT J ONCOL, V34, P665, DOI 10.3892/ijo_00000192; Kreisl TN, 2009, J CLIN ONCOL, V27, P740, DOI 10.1200/JCO.2008.16.3055; Lai A, 2011, J CLIN ONCOL, V29, P142, DOI 10.1200/JCO.2010.30.2729; Laks DR, 2009, STEM CELLS, V27, P980, DOI 10.1002/stem.15; Lamborn KR, 2008, NEURO-ONCOLOGY, V10, P162, DOI 10.1215/15228517-2007-062; Lathia JD, 2007, DEV DYNAM, V236, P3267, DOI 10.1002/dvdy.21319; Lathia JD, 2010, CELL STEM CELL, V6, P421, DOI 10.1016/j.stem.2010.02.018; Li Z, 2009, CANCER CELL, V15, P501, DOI 10.1016/j.ccr.2009.03.018; Liu GT, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-67; Ljubimova JY, 2004, CANCER-AM CANCER SOC, V101, P604, DOI 10.1002/cncr.20397; Maderna E, 2007, CANCER BIOL THER, V6, P1018, DOI 10.4161/cbt.6.7.4362; Mazzoleni S, 2010, CANCER RES, V70, P7500, DOI 10.1158/0008-5472.CAN-10-2353; Michael LE, 2008, NEOPLASIA, V10, P1343, DOI 10.1593/neo.81078; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Mokry J, 2004, STEM CELLS DEV, V13, P658, DOI 10.1089/scd.2004.13.658; Norden AD, 2009, NAT REV NEUROL, V5, P610, DOI 10.1038/nrneurol.2009.159; Ogden AT, 2008, NEUROSURGERY, V62, P505, DOI 10.1227/01.neu.0000316019.28421.95; Paez-Ribes M, 2009, CANCER CELL, V15, P220, DOI 10.1016/j.ccr.2009.01.027; Pastrana E, 2011, CELL STEM CELL, V8, P486, DOI 10.1016/j.stem.2011.04.007; Pen A, 2008, ONCOGENE, V27, P6834, DOI 10.1038/onc.2008.287; Penuelas S, 2009, CANCER CELL, V15, P315, DOI 10.1016/j.ccr.2009.02.011; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Ping YF, 2011, J PATHOL, V224, P344, DOI 10.1002/path.2908; Pollard SM, 2009, CELL STEM CELL, V4, P568, DOI 10.1016/j.stem.2009.03.014; Qiu B, 2011, MOL BIOL REP, V38, P3585, DOI 10.1007/s11033-010-0469-4; Read TA, 2009, CANCER CELL, V15, P135, DOI 10.1016/j.ccr.2008.12.016; Reardon DA, 2008, J CLIN ONCOL, V26, P5610, DOI 10.1200/JCO.2008.16.7510; Ricci-Vitiani L, 2010, NATURE, V468, P824, DOI 10.1038/nature09557; Rubenstein JL, 2000, NEOPLASIA, V2, P306, DOI 10.1038/sj.neo.7900102; Sakariassen PO, 2006, P NATL ACAD SCI USA, V103, P16466, DOI 10.1073/pnas.0607668103; Salmaggi A, 2006, GLIA, V54, P850, DOI 10.1002/glia.20414; Seidel S, 2010, BRAIN, V133, P983, DOI 10.1093/brain/awq042; Shih AH, 2006, NEOPLASIA, V8, P1072, DOI 10.1593/neo.06526; Singec I, 2006, NAT METHODS, V3, P801, DOI 10.1038/nmeth926; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Soda Y, 2011, P NATL ACAD SCI USA, V108, P4274, DOI 10.1073/pnas.1016030108; Soeda A, 2009, ONCOGENE, V28, P3949, DOI 10.1038/onc.2009.252; Son MJ, 2009, CELL STEM CELL, V4, P440, DOI 10.1016/j.stem.2009.03.003; Stupp R, 2010, J CLIN ONCOL, V28, P2712, DOI 10.1200/JCO.2009.26.6650; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Takezaki T, 2011, CANCER SCI, V102, P1306, DOI 10.1111/j.1349-7006.2011.01943.x; Taylor MD, 2005, CANCER CELL, V8, P323, DOI 10.1016/j.ccr.2005.09.001; Tchoghandjian A, 2010, BRAIN PATHOL, V20, P211, DOI 10.1111/j.1750-3639.2009.00269.x; Ulasov IV, 2011, MOL MED, V17, P103, DOI 10.2119/molmed.2010.00062; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Vredenburgh JJ, 2011, CLIN CANCER RES, V17, P4119, DOI 10.1158/1078-0432.CCR-11-0120; Wang JL, 2010, STEM CELLS, V28, P17, DOI 10.1002/stem.261; Wang R, 2010, NATURE, V468, P829, DOI 10.1038/nature09624; WANG X, 2011, ONCOGENE        0620, DOI DOI 10.1038/ONC.2011.232; Ward RJ, 2009, CANCER RES, V69, P4682, DOI 10.1158/0008-5472.CAN-09-0342; Wefel JS, 2011, NEURO-ONCOLOGY, V13, P660, DOI 10.1093/neuonc/nor024; Wong ET, 1999, J CLIN ONCOL, V17, P2572, DOI 10.1200/JCO.1999.17.8.2572; Wu A, 2010, NEURO-ONCOLOGY, V12, P1113, DOI 10.1093/neuonc/noq082; Wurmser AE, 2004, NATURE, V430, P350, DOI 10.1038/nature02604; Xu QJ, 2008, STEM CELLS, V26, P3018, DOI 10.1634/stemcells.2008-0459; Yang SX, 2005, BIOCHEM BIOPH RES CO, V335, P523, DOI 10.1016/j.bbrc.2005.07.113; Zhang XP, 2008, MOL CELL BIOCHEM, V307, P101, DOI 10.1007/s11010-007-9589-0; Zhao YD, 2010, BRAIN RES BULL, V82, P308, DOI 10.1016/j.brainresbull.2010.06.006; Zheng PP, 2007, ANN NEUROL, V62, P40, DOI 10.1002/ana.21151	98	50	52	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2011	14	11					1375	1381		10.1038/nn.2955	http://dx.doi.org/10.1038/nn.2955			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	841NI	22030548	Green Accepted			2022-12-28	WOS:000296518600009
J	Sanders, LH; Greenamyre, JT				Sanders, Laurie H.; Greenamyre, J. Timothy			Regulation of complex I by Engrailed is complex too	NATURE NEUROSCIENCE			English	Editorial Material							DOPAMINERGIC-NEURONS; PARKINSONS-DISEASE; MIDBRAIN; CELLS		[Sanders, Laurie H.; Greenamyre, J. Timothy] Univ Pittsburgh, Sch Med, Pittsburgh Inst Neurodegenerat Dis, Pittsburgh, PA 15260 USA; [Sanders, Laurie H.; Greenamyre, J. Timothy] Univ Pittsburgh, Sch Med, Dept Neurol, Pittsburgh, PA 15261 USA; [Sanders, Laurie H.; Greenamyre, J. Timothy] Pittsburgh Vet Adm Healthcare Syst, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Sanders, LH (corresponding author), Univ Pittsburgh, Sch Med, Pittsburgh Inst Neurodegenerat Dis, Pittsburgh, PA 15260 USA.	jgreena@pitt.edu		Greenamyre, J. Timothy/0000-0003-3468-7878				Alvarez-Fischer D, 2011, NAT NEUROSCI, V14, P1260, DOI 10.1038/nn.2916; Brunet I, 2005, NATURE, V438, P94, DOI 10.1038/nature04110; Chinta SJ, 2010, NEUROSCI LETT, V486, P235, DOI 10.1016/j.neulet.2010.09.061; Fuchs J, 2009, NEUROBIOL AGING, V30, P731, DOI 10.1016/j.neurobiolaging.2007.08.014; Greenamyre JT, 2001, IUBMB LIFE, V52, P135, DOI 10.1080/15216540152845939; Haubenberger D, 2011, NEUROBIOL AGING, V32, P302, DOI 10.1016/j.neurobiolaging.2009.02.015; Horowitz MP, 2010, CLIN PHARMACOL THER, V88, P467, DOI 10.1038/clpt.2010.138; Muftuoglu M, 2004, MOVEMENT DISORD, V19, P544, DOI 10.1002/mds.10695; Richter JD, 2009, GENE DEV, V23, P1, DOI 10.1101/gad.1735809; She H, 2011, J CLIN INVEST, V121, P930, DOI 10.1172/JCI43871; Shim JH, 2011, MITOCHONDRION, V11, P707, DOI 10.1016/j.mito.2011.05.013; Simon HH, 2001, J NEUROSCI, V21, P3126, DOI 10.1523/JNEUROSCI.21-09-03126.2001; Sonnier L, 2007, J NEUROSCI, V27, P1063, DOI 10.1523/JNEUROSCI.4583-06.2007; Wang J, 2009, J BIOL CHEM, V284, P14011, DOI 10.1074/jbc.M901310200; Wegrzyn J, 2009, SCIENCE, V323, P793, DOI 10.1126/science.1164551	15	3	3	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2011	14	10					1221	1222		10.1038/nn.2939	http://dx.doi.org/10.1038/nn.2939			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	825EQ	21952262				2022-12-28	WOS:000295254200002
J	Kuhlman, SJ; Tring, E; Trachtenberg, JT				Kuhlman, Sandra J.; Tring, Elaine; Trachtenberg, Joshua T.			Fast-spiking interneurons have an initial orientation bias that is lost with vision	NATURE NEUROSCIENCE			English	Article							CRITICAL PERIOD PLASTICITY; VISUAL-CORTEX; NEURONS; SELECTIVITY; EXPERIENCE; DIVERSITY; RESPONSES; CIRCUITS; MOUSE	We found that in mice, following eye opening, fast-spiking, parvalbumin-positive GABAergic interneurons had well-defined orientation tuning preferences and that subsequent visual experience broadened this tuning. Broad inhibitory tuning was not required for the developmental sharpening of excitatory tuning but did precede binocular matching of excitatory orientation tuning. We propose that experience-dependent broadening of inhibition is a candidate for initiating the critical period of excitatory binocular plasticity in developing visual cortex.	[Kuhlman, Sandra J.; Tring, Elaine; Trachtenberg, Joshua T.] Univ Calif Los Angeles, Dept Neurobiol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Trachtenberg, JT (corresponding author), Univ Calif Los Angeles, Dept Neurobiol, Los Angeles, CA 90095 USA.	jtrachtenberg@mednet.ucla.edu	Kuhlman, Sandra/Q-1211-2015	Kuhlman, Sandra/0000-0003-0450-7282	US National Eye Institute [EY016052, EY016052S2]; NATIONAL EYE INSTITUTE [R01EY016052] Funding Source: NIH RePORTER	US National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank A. Silva for use of equipment and space, P. Golshani and D. Chow for technical training and discussion, D. Ringach and R. Gruver for help with data analysis, and T. Otis, S. Smith, M. Stryker and D. Ringach for comments on earlier versions of the manuscript. This work was supported by the US National Eye Institute (grants EY016052 and EY016052S2).	Alonso JM, 2005, J NEUROPHYSIOL, V94, P26, DOI 10.1152/jn.01281.2004; Bock DD, 2011, NATURE, V471, P177, DOI 10.1038/nature09802; Gogolla N, 2009, J NEURODEV DISORD, V1, P172, DOI 10.1007/s11689-009-9023-x; Gonzalez-Burgos G, 2010, CURR PSYCHIAT REP, V12, P335, DOI 10.1007/s11920-010-0124-8; Gordon JA, 1996, J NEUROSCI, V16, P3274; Hensch TK, 2005, NAT REV NEUROSCI, V6, P877, DOI 10.1038/nrn1787; Hull C, 2007, NAT NEUROSCI, V10, P400, DOI 10.1038/nn0407-400; Kerlin AM, 2010, NEURON, V67, P858, DOI 10.1016/j.neuron.2010.08.002; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; Liu BH, 2009, J NEUROSCI, V29, P10520, DOI 10.1523/JNEUROSCI.1915-09.2009; Ma WP, 2010, J NEUROSCI, V30, P14371, DOI 10.1523/JNEUROSCI.3248-10.2010; Ringach DL, 2002, J NEUROSCI, V22, P5639; Wang BS, 2010, NEURON, V65, P246, DOI 10.1016/j.neuron.2010.01.002; White LE, 2001, NATURE, V411, P1049, DOI 10.1038/35082568; Zariwala HA, 2011, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00162	15	75	75	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2011	14	9					1121	1123		10.1038/nn.2890	http://dx.doi.org/10.1038/nn.2890			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	812ID	21750548	Green Accepted			2022-12-28	WOS:000294284900011
J	Dreosti, E; Esposti, F; Baden, T; Lagnado, L				Dreosti, Elena; Esposti, Federico; Baden, Tom; Lagnado, Leon			In vivo evidence that retinal bipolar cells generate spikes modulated by light	NATURE NEUROSCIENCE			English	Article							EXOCYTOSIS; CHANNELS; CURRENTS; INFLUX	Retinal bipolar cells have been assumed to generate purely graded responses to light. To test this idea we imaged the presynaptic calcium transient in live zebrafish. We found that ON, OFF, transient and sustained bipolar cells are all capable of generating fast 'all-or-none' calcium transients modulated by visual stimulation.	[Dreosti, Elena; Esposti, Federico; Baden, Tom; Lagnado, Leon] MRC, Mol Biol Lab, Cambridge CB2 2QH, England	MRC Laboratory Molecular Biology	Lagnado, L (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.	ll1@mrc-lmb.cam.ac.uk		Esposti, Federico/0000-0002-0033-3118; Dreosti, Elena/0000-0002-6738-7057; Baden, Tom/0000-0003-2808-4210	Wellcome Trust [083220]; MRC [MC_U105178794] Funding Source: UKRI; Medical Research Council [MC_U105178794] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We would like to thank all of the members of the Lagnado laboratory for discussions that contributed to this work. We also thank the Wellcome Trust for funding (grant 083220).	Burrone J, 1997, J PHYSIOL-LONDON, V505, P571, DOI 10.1111/j.1469-7793.1997.571ba.x; Burrone J, 2002, NEURON, V33, P101, DOI 10.1016/S0896-6273(01)00565-7; Cui JJ, 2008, VISUAL NEUROSCI, V25, P635, DOI 10.1017/S0952523808080851; Dreosti E, 2009, NAT METHODS, V6, P883, DOI 10.1038/nmeth.1399; Masland RH, 2001, NAT NEUROSCI, V4, P877, DOI 10.1038/nn0901-877; Neves G, 2001, P NATL ACAD SCI USA, V98, P15282, DOI 10.1073/pnas.261311698; Palmer MJ, 2006, J PHYSIOL-LONDON, V572, P747, DOI 10.1113/jphysiol.2006.105205; Pan ZH, 2000, J NEUROPHYSIOL, V84, P2564, DOI 10.1152/jn.2000.84.5.2564; Protti DA, 2000, NEURON, V25, P215, DOI 10.1016/S0896-6273(00)80884-3; Zenisek D, 2001, J NEUROSCI, V21, P4543, DOI 10.1523/JNEUROSCI.21-13-04543.2001	11	47	49	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2011	14	8					951	952		10.1038/nn.2841	http://dx.doi.org/10.1038/nn.2841			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	797KC	21706020	Green Accepted			2022-12-28	WOS:000293123700006
J	Fischer, BJ; Pena, JL				Fischer, Brian J.; Pena, Jose Luis			Owl's behavior and neural representation predicted by Bayesian inference	NATURE NEUROSCIENCE			English	Article							BARN-OWL; SOUND LOCALIZATION; INTERAURAL TIME; AUDITORY SPACE; OPTIC TECTUM; TYTO-ALBA; RESPONSES; MAPS	The owl captures prey using sound localization. In the classical model, the owl infers sound direction from the position of greatest activity in a brain map of auditory space. However, this model fails to describe the actual behavior. Although owls accurately localize sources near the center of gaze, they systematically underestimate peripheral source directions. We found that this behavior is predicted by statistical inference, formulated as a Bayesian model that emphasizes central directions. We propose that there is a bias in the neural coding of auditory space, which, at the expense of inducing errors in the periphery, achieves high behavioral accuracy at the ethologically relevant range. We found that the owl's map of auditory space decoded by a population vector is consistent with the behavioral model. Thus, a probabilistic model describes both how the map of auditory space supports behavior and why this representation is optimal.	[Fischer, Brian J.] Ecole Normale Super, Group Neural Theory, Dept Etud Cognit, F-75231 Paris, France; [Fischer, Brian J.] INSERM, Lab Neurosci Cognit, U960, Paris, France; [Pena, Jose Luis] Albert Einstein Coll Med, Dominick P Purpura Dept Neurosci, Bronx, NY 10467 USA	UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Institut National de la Sante et de la Recherche Medicale (Inserm); Yeshiva University; Albert Einstein College of Medicine	Fischer, BJ (corresponding author), Ecole Normale Super, Group Neural Theory, Dept Etud Cognit, 24 Rue Lhomond, F-75231 Paris, France.	bfischer.su@gmail.com		Pena, Jose/0000-0001-6773-5640	US National Institutes of Health [DC007690]; Marie Curie Team of Excellence [BIND MECT-CT-20095-02481]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC007690] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Marie Curie Team of Excellence(European Commission); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank L. Hausmann and H. Wagner for providing the behavioral data and C. Keller and T. Takahashi for providing the head-related transfer functions. We thank S. Edut, D. Eilam, E. Knudsen, M. Konishi and K. Saberi, whose work substantially contributed to testing our hypothesis. We thank S. Deneve, M. Konishi, A. Margolis, A. Oster, O. Schwartz and A. Wohrer for advice and comments on the manuscript. This study was supported by US National Institutes of Health grant DC007690 (J.L.P.) and the Marie Curie Team of Excellence grant BIND MECT-CT-20095-02481 (B.J.F.).	Bergan JF, 2005, J NEUROSCI, V25, P9816, DOI 10.1523/JNEUROSCI.2533-05.2005; Blauert J., 1983, SPATIAL HEARING PSYC; CARR CE, 1990, J NEUROSCI, V10, P3227; Christianson GB, 2006, J NEUROSCI, V26, P5948, DOI 10.1523/JNEUROSCI.0220-06.2006; Edut S, 2004, BEHAV BRAIN RES, V155, P207, DOI 10.1016/j.bbr.2004.04.018; Fischer BJ, 2008, J NEUROSCI, V28, P8107, DOI 10.1523/JNEUROSCI.1969-08.2008; Ganguli D., 2010, ADV NEURAL INFORM PR, V23; Georgopoulos A. P., 1984, DYNAMIC ASPECTS NEOC, P501; Girshick AR, 2011, NAT NEUROSCI, V14, P926, DOI 10.1038/nn.2831; Harper NS, 2004, NATURE, V430, P682, DOI 10.1038/nature02768; Hausmann L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007721; JAY MF, 1990, COMP PERCEPTION, P351; JEFFRESS LA, 1948, J COMP PHYSIOL PSYCH, V41, P35, DOI 10.1037/h0061495; Keller CH, 1998, HEARING RES, V118, P13, DOI 10.1016/S0378-5955(98)00014-8; KNUDSEN EI, 1978, SCIENCE, V200, P795, DOI 10.1126/science.644324; KNUDSEN EI, 1982, J NEUROSCI, V2, P1177; KNUDSEN EI, 1979, J COMP PHYSIOL, V133, P1, DOI 10.1007/BF00663105; Kover H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010497; Konishi M, 2003, ANNU REV NEUROSCI, V26, P31, DOI 10.1146/annurev.neuro.26.041002.131123; Li BW, 2003, J NEUROPHYSIOL, V90, P204, DOI 10.1152/jn.00954.2002; MASINO T, 1990, NATURE, V345, P434, DOI 10.1038/345434a0; Nix J, 2006, J ACOUST SOC AM, V119, P463, DOI 10.1121/1.2139619; Nodal FR, 2008, NEUROSCIENCE, V154, P397, DOI 10.1016/j.neuroscience.2007.12.022; OLSEN JF, 1989, J NEUROSCI, V9, P2591; Pecka M, 2010, J NEUROPHYSIOL, V103, P38, DOI 10.1152/jn.00628.2009; Perez ML, 2009, J NEUROPHYSIOL, V102, P1472, DOI 10.1152/jn.00400.2009; Populin LC, 1998, J NEUROSCI, V18, P2147; Saberi K, 1998, NEURON, V21, P789, DOI 10.1016/S0896-6273(00)80595-4; Salinas E, 1994, J Comput Neurosci, V1, P89, DOI 10.1007/BF00962720; SEUNG HS, 1993, P NATL ACAD SCI USA, V93, P339; SHI L, 2009, ADV NEURAL INFORM PR, V22; Smith EC, 2006, NATURE, V439, P978, DOI 10.1038/nature04485; Stern R. M., 1996, BINAURAL SPATIAL HEA, P499; Stocker AA, 2006, NAT NEUROSCI, V9, P578, DOI 10.1038/nn1669; van Hemmen JL, 2008, BIOL CYBERN, V98, P509, DOI 10.1007/s00422-008-0215-3; Weiss Y, 2002, NAT NEUROSCI, V5, P598, DOI 10.1038/nn858; ZAHN JR, 1978, SENS PROCESS, V2, P32	38	79	79	2	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2011	14	8					1061	U163		10.1038/nn.2872	http://dx.doi.org/10.1038/nn.2872			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	797KC	21725311	Green Accepted			2022-12-28	WOS:000293123700021
J	Mayer, C; Boehm, U				Mayer, Christian; Boehm, Ulrich			Female reproductive maturation in the absence of kisspeptin/GPR54 signaling	NATURE NEUROSCIENCE			English	Article							ESTROGEN-RECEPTOR-ALPHA; HORMONE-SECRETION; DIPHTHERIA-TOXIN; ARCUATE NUCLEUS; NEUROBIOLOGICAL MECHANISMS; KISS-1 PEPTIDE; PREOPTIC AREA; NEURONS; PUBERTY; GPR54	Puberty onset is initiated in the brain by activation of gonadotropin-releasing hormone (GnRH) neurosecretion. Different permissive signals must be integrated for the initiation of reproductive maturation; however, the neural circuits controlling timely awakening of the reproductive axis are not understood. The identification of the neuropeptide kisspeptin as a potent activator of GnRH neuronal activity suggests that kisspeptin-releasing neurons might coordinate puberty onset. To test this hypothesis, we generated mice that specifically lack kisspeptin cells. Puberty onset in females was unaffected by kisspeptin neuron ablation. Furthermore, the animals were fertile, albeit with smaller ovaries. Consistent with this, female mice lacking neurons that express the kisspeptin receptor GPR54 were also fertile. Acute ablation of kisspeptin neurons in adult mice inhibited fertility, suggesting that there is compensation for the loss of kisspeptin neurons early in development. Our data indicate that the initiation and completion of reproductive maturation can occur in the absence of kisspeptin/GPR54 signaling.	[Mayer, Christian; Boehm, Ulrich] Univ Hamburg, Ctr Mol Neurobiol, Inst Neural Signal Transduct, D-2000 Hamburg, Germany	University of Hamburg	Boehm, U (corresponding author), Univ Hamburg, Ctr Mol Neurobiol, Inst Neural Signal Transduct, D-2000 Hamburg, Germany.	ulrich.boehm@zmnh.uni-hamburg.de		Mayer, Christian/0000-0003-3152-5574	Deutsche Forschungsgemeinschaft [BO1743/2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We are indebted to O. Pongs for continuous support. A. Marquardt and D. Drexler provided expert technical assistance. We thank R. Kuhn for providing the IGD3.2 embryonic stem cells and A. Waisman for providing the R26-iDTR mice, I. Hermans-Borgmeyer for help with embryonic stem cell work and blastocyst injections, A. Derin and U. Wolters for animal caretaking, B. Mann for performing the hormone assays and M. Roberson and K. Duncan for helpful discussions. This project was supported by Deutsche Forschungsgemeinschaft grant BO1743/2 to U.B.	Bewick GA, 2005, FASEB J, V19, P1680, DOI 10.1096/fj.04-3434fje; Boehm U, 2005, CELL, V123, P683, DOI 10.1016/j.cell.2005.09.027; Brockschniedier D, 2006, GENESIS, V44, P322, DOI 10.1002/dvg.20218; Buch T, 2005, NAT METHODS, V2, P419, DOI 10.1038/NMETH762; Castellano JM, 2006, ENDOCRINOLOGY, V147, P4852, DOI 10.1210/en.2006-0117; Chan YM, 2009, J NEUROENDOCRINOL, V21, P1015, DOI 10.1111/j.1365-2826.2009.01926.x; Clarkson J, 2009, J NEUROENDOCRINOL, V21, P673, DOI 10.1111/j.1365-2826.2009.01892.x; Clarkson J, 2006, ENDOCRINOLOGY, V147, P5817, DOI 10.1210/en.2006-0787; Clarkson J, 2010, MOL CELL ENDOCRINOL, V324, P45, DOI 10.1016/j.mce.2010.01.026; Collier RJ, 2001, TOXICON, V39, P1793, DOI 10.1016/S0041-0101(01)00165-9; Cravo RM, 2011, NEUROSCIENCE, V173, P37, DOI 10.1016/j.neuroscience.2010.11.022; d'Anglemont de Tassigny X, 2007, P NATL ACAD SCI USA, V104, P10714, DOI 10.1073/pnas.0704114104; de Roux N, 2003, P NATL ACAD SCI USA, V100, P10972, DOI 10.1073/pnas.1834399100; Eggan E, 2004, NATURE, V428, P44, DOI 10.1038/nature02375; Franceschini I, 2006, NEUROSCI LETT, V401, P225, DOI 10.1016/j.neulet.2006.03.039; Funes S, 2003, BIOCHEM BIOPH RES CO, V312, P1357, DOI 10.1016/j.bbrc.2003.11.066; GIBSON MJ, 1984, SCIENCE, V225, P949, DOI 10.1126/science.6382608; Gottsch ML, 2004, ENDOCRINOLOGY, V145, P4073, DOI 10.1210/en.2004-0431; Gropp E, 2005, NAT NEUROSCI, V8, P1289, DOI 10.1038/nn1548; Gutierrez-Pascual E, 2007, J NEUROENDOCRINOL, V19, P521, DOI 10.1111/j.1365-2826.2007.01558.x; Harris GC, 2003, ENDOCRINOLOGY, V144, P163, DOI 10.1210/en.2002-220767; Herbison AE, 2008, ENDOCRINOLOGY, V149, P597, DOI 10.1210/en.2007-1139; Herbison AE, 2010, ENDOCRINOLOGY, V151, P312, DOI 10.1210/en.2009-0552; Irwig MS, 2004, NEUROENDOCRINOLOGY, V80, P264, DOI 10.1159/000083140; Kauffman AS, 2007, TRENDS NEUROSCI, V30, P504, DOI 10.1016/j.tins.2007.08.001; Lapatto R, 2007, ENDOCRINOLOGY, V148, P4927, DOI 10.1210/en.2007-0078; Li XF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008334; Luquet S, 2005, SCIENCE, V310, P683, DOI 10.1126/science.1115524; Matsui H, 2004, BIOCHEM BIOPH RES CO, V320, P383, DOI 10.1016/j.bbrc.2004.05.185; Mayer C, 2010, P NATL ACAD SCI USA, V107, P22693, DOI 10.1073/pnas.1012406108; Messager S, 2005, P NATL ACAD SCI USA, V102, P1761, DOI 10.1073/pnas.0409330102; Navarro VM, 2009, J NEUROSCI, V29, P11859, DOI 10.1523/JNEUROSCI.1569-09.2009; Navarro VM, 2005, ENDOCRINOLOGY, V146, P1689, DOI 10.1210/en.2004-1353; Navarro VM, 2004, J PHYSIOL-LONDON, V561, P379, DOI 10.1113/jphysiol.2004.072298; Oakley AE, 2009, ENDOCR REV, V30, P713, DOI 10.1210/er.2009-0005; Ojeda SR, 2006, KNOBIL AND NEILL'S PHYSIOLOGY OF REPRODUCTION, VOLS 1 AND 2, 3RD EDITON, P2061; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Pineda R, 2010, ENDOCRINOLOGY, V151, P722, DOI 10.1210/en.2009-0803; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; Seminara SB, 2008, J NEUROENDOCRINOL, V20, P727, DOI 10.1111/j.1365-2826.2008.01731.x; Seminara SB, 2003, NEW ENGL J MED, V349, P1614, DOI 10.1056/NEJMoa035322; Sisk CL, 2004, NAT NEUROSCI, V7, P1040, DOI 10.1038/nn1326; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Tena-Sempere M, 2010, ENDOCRIN DEV, V17, P52, DOI 10.1159/000262528; Terasawa E, 2001, ENDOCR REV, V22, P111, DOI 10.1210/er.22.1.111; Wen SP, 2011, ENDOCRINOLOGY, V152, P1515, DOI 10.1210/en.2010-1208	46	150	155	1	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2011	14	6					704	U297		10.1038/nn.2818	http://dx.doi.org/10.1038/nn.2818			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	768SH	21516099				2022-12-28	WOS:000290958000012
J	Polymenidou, M; Lagier-Tourenne, C; Hutt, KR; Huelga, SC; Moran, J; Liang, TY; Ling, SC; Sun, E; Wancewicz, E; Mazur, C; Kordasiewicz, H; Sedaghat, Y; Donohue, JP; Shiue, L; Bennett, CF; Yeo, GW; Cleveland, DW				Polymenidou, Magdalini; Lagier-Tourenne, Clotilde; Hutt, Kasey R.; Huelga, Stephanie C.; Moran, Jacqueline; Liang, Tiffany Y.; Ling, Shuo-Chien; Sun, Eveline; Wancewicz, Edward; Mazur, Curt; Kordasiewicz, Holly; Sedaghat, Yalda; Donohue, John Paul; Shiue, Lily; Bennett, C. Frank; Yeo, Gene W.; Cleveland, Don W.			Long pre-mRNA depletion and RNA missplicing contribute to neuronal vulnerability from loss of TDP-43	NATURE NEUROSCIENCE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; FRONTOTEMPORAL LOBAR DEGENERATION; NUCLEAR FACTOR TDP-43; BINDING-PROTEIN; TARDBP MUTATIONS; GENE; EXPRESSION; REGULATOR; TAU; ASSOCIATION	We used cross-linking and immunoprecipitation coupled with high-throughput sequencing to identify binding sites in 6,304 genes as the brain RNA targets for TDP-43, an RNA binding protein that, when mutated, causes amyotrophic lateral sclerosis. Massively parallel sequencing and splicing-sensitive junction arrays revealed that levels of 601 mRNAs were changed (including Fus (Tls), progranulin and other transcripts encoding neurodegenerative disease-associated proteins) and 965 altered splicing events were detected (including in sortilin, the receptor for progranulin) following depletion of TDP-43 from mouse adult brain with antisense oligonucleotides. RNAs whose levels were most depleted by reduction in TDP-43 were derived from genes with very long introns and that encode proteins involved in synaptic activity. Lastly, we found that TDP-43 autoregulates its synthesis, in part by directly binding and enhancing splicing of an intron in the 3' untranslated region of its own transcript, thereby triggering nonsense-mediated RNA degradation.	[Polymenidou, Magdalini; Lagier-Tourenne, Clotilde; Moran, Jacqueline; Ling, Shuo-Chien; Sun, Eveline; Kordasiewicz, Holly; Cleveland, Don W.] Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA; [Polymenidou, Magdalini; Lagier-Tourenne, Clotilde; Hutt, Kasey R.; Huelga, Stephanie C.; Moran, Jacqueline; Liang, Tiffany Y.; Ling, Shuo-Chien; Sun, Eveline; Kordasiewicz, Holly; Yeo, Gene W.; Cleveland, Don W.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Hutt, Kasey R.; Huelga, Stephanie C.; Liang, Tiffany Y.; Yeo, Gene W.] Univ Calif San Diego, Inst Genom Med, La Jolla, CA 92093 USA; [Hutt, Kasey R.; Huelga, Stephanie C.; Liang, Tiffany Y.; Yeo, Gene W.] Univ Calif San Diego, Stem Cell Program, La Jolla, CA 92093 USA; [Wancewicz, Edward; Mazur, Curt; Sedaghat, Yalda; Bennett, C. Frank] ISIS Pharmaceut, Carlsbad, CA 92008 USA; [Donohue, John Paul; Shiue, Lily] Univ Calif Santa Cruz, Sinsheimer Labs, Dept Mol Cell & Dev Biol, RNA Ctr, Santa Cruz, CA 95064 USA	Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Isis Pharmaceuticals Inc; University of California System; University of California Santa Cruz	Cleveland, DW (corresponding author), Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA.	geneyeo@ucsd.edu; dcleveland@ucsd.edu	Yeo, Gene/AAE-7676-2019; lagier-Tourenne, Clotilde/ABE-6303-2020; Cleveland, Don/AAN-9783-2021; Polymenidou, Magdalini/D-2254-2014	Yeo, Gene/0000-0002-0799-6037; lagier-Tourenne, Clotilde/0000-0002-3058-8322; Cleveland, Don/0000-0002-1934-3682; LING, Shuo-Chien/0000-0002-0300-8812; Liang, Tiffany/0000-0002-1986-5966	Human Frontier Science Program; Amyotrophic Lateral Sclerosis Association; Ludwig Institute for Cancer Research; National Science Foundation; US National Institutes of Health [R37 NS27036, HG004659, GM084317]; University of California, San Diego; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004659] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084317] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS027036] Funding Source: NIH RePORTER	Human Frontier Science Program(Human Frontier Science Program); Amyotrophic Lateral Sclerosis Association; Ludwig Institute for Cancer Research; National Science Foundation(National Science Foundation (NSF)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California, San Diego(University of California System); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors would like to thank members of B. Ren's laboratory, especially Z. Ye, S. Kuan and L. Edsall for technical help with the Illumina sequencing and U. Wagner for helpful discussions, K. Clutario and J. Boubaker for technical help, as well as all of the members of the Yeo and Cleveland laboratories, M. Ares Jr for generous support, and the neuro-team of ISIS Pharmaceuticals for critical comments and suggestions on this project. M. P. is the recipient of a Human Frontier Science Program Long Term Fellowship. C. L.-T. is the recipient of the Milton-Safenowitz post-doctoral fellowship from the Amyotrophic Lateral Sclerosis Association. D. W. C. receives salary support from the Ludwig Institute for Cancer Research. S. C. H. is funded by a National Science Foundation Graduate Research Fellowship. This work was supported by grants from the US National Institutes of Health (R37 NS27036 and an American Recovery and Reinvestment Act Challenge grant) to D. W. C and partially by grants from the US National Institutes of Health (HG004659 and GM084317) and the Stem Cell Program at the University of California, San Diego to G.W.Y.	Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; Ayala YM, 2011, EMBO J, V30, P277, DOI 10.1038/emboj.2010.310; Baker M, 2006, NATURE, V442, P916, DOI 10.1038/nature05016; BERGERON C, 1994, J NEUROPATH EXP NEUR, V53, P221, DOI 10.1097/00005072-199405000-00002; Birve A, 2010, HUM MOL GENET, V19, P4201, DOI 10.1093/hmg/ddq338; Buratti E, 2001, EMBO J, V20, P1774, DOI 10.1093/emboj/20.7.1774; Buratti E, 2010, FEBS J, V277, P2268, DOI 10.1111/j.1742-4658.2010.07643.x; Carrasquillo MM, 2010, AM J HUM GENET, V87, P890, DOI 10.1016/j.ajhg.2010.11.002; Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170; Cooper TA, 2009, CELL, V136, P777, DOI 10.1016/j.cell.2009.02.011; Cruts M, 2006, NATURE, V442, P920, DOI 10.1038/nature05017; Dreumont N, 2010, NUCLEIC ACIDS RES, V38, P1353, DOI 10.1093/nar/gkp1086; Du HQ, 2010, NAT STRUCT MOL BIOL, V17, P187, DOI 10.1038/nsmb.1720; Fiesel FC, 2010, EMBO J, V29, P209, DOI 10.1038/emboj.2009.324; Gitcho MA, 2008, ANN NEUROL, V63, P535, DOI 10.1002/ana.21344; Hu FH, 2010, NEURON, V68, P654, DOI 10.1016/j.neuron.2010.09.034; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Igaz LM, 2011, J CLIN INVEST, V121, P726, DOI 10.1172/JCI44867; Kabashi E, 2008, NAT GENET, V40, P572, DOI 10.1038/ng.132; Kwiatkowski TJ, 2009, SCIENCE, V323, P1205, DOI 10.1126/science.1166066; Lagier-Tourenne C, 2010, HUM MOL GENET, V19, pR46, DOI 10.1093/hmg/ddq137; Le Hir H, 2000, GENE DEV, V14, P1098; Licatalosi DD, 2008, NATURE, V456, P464, DOI 10.1038/nature07488; Lin SR, 2008, NAT STRUCT MOL BIOL, V15, P819, DOI 10.1038/nsmb.1461; Ling SC, 2010, P NATL ACAD SCI USA, V107, P13318, DOI 10.1073/pnas.1008227107; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Mercado PA, 2005, NUCLEIC ACIDS RES, V33, P6000, DOI 10.1093/nar/gki897; Mili S, 2004, RNA, V10, P1692, DOI 10.1261/rna.7151404; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Pang KC, 2005, NUCLEIC ACIDS RES, V33, pD125, DOI 10.1093/nar/gri089; Parkhomchuk D, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp596; Perlick HA, 1996, P NATL ACAD SCI USA, V93, P10928, DOI 10.1073/pnas.93.20.10928; Schwab C, 2008, J NEUROPATH EXP NEUR, V67, P1159, DOI 10.1097/NEN.0b013e31818e8951; Sephton CF, 2011, J BIOL CHEM, V286, P1204, DOI 10.1074/jbc.M110.190884; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Strong MJ, 2007, MOL CELL NEUROSCI, V35, P320, DOI 10.1016/j.mcn.2007.03.007; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Sureau A, 2001, EMBO J, V20, P1785, DOI 10.1093/emboj/20.7.1785; Tollervey JR, 2011, NAT NEUROSCI, V14, P452, DOI 10.1038/nn.2778; Ule J, 2003, SCIENCE, V302, P1212, DOI 10.1126/science.1090095; Valdmanis PN, 2009, ANN HUM GENET, V73, P652, DOI 10.1111/j.1469-1809.2009.00546.x; Van Deerlin VM, 2008, LANCET NEUROL, V7, P409, DOI 10.1016/S1474-4422(08)70071-1; Vance C, 2009, SCIENCE, V323, P1208, DOI 10.1126/science.1165942; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wollerton MC, 2004, MOL CELL, V13, P91, DOI 10.1016/S1097-2765(03)00502-1; Xu YF, 2010, J NEUROSCI, V30, P10851, DOI 10.1523/JNEUROSCI.1630-10.2010; Yeo GW, 2007, PLOS GENET, V3, P814, DOI 10.1371/journal.pgen.0030085; Yeo GW, 2009, NAT STRUCT MOL BIOL, V16, P130, DOI 10.1038/nsmb.1545; Zisoulis DG, 2010, NAT STRUCT MOL BIOL, V17, P173, DOI 10.1038/nsmb.1745	50	804	817	6	87	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2011	14	4					459	U92		10.1038/nn.2779	http://dx.doi.org/10.1038/nn.2779			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	741FQ	21358643	Green Accepted			2022-12-28	WOS:000288849400017
J	Diester, I; Kaufman, MT; Mogri, M; Pashaie, R; Goo, W; Yizhar, O; Ramakrishnan, C; Deisseroth, K; Shenoy, KV				Diester, Ilka; Kaufman, Matthew T.; Mogri, Murtaza; Pashaie, Ramin; Goo, Werapong; Yizhar, Ofer; Ramakrishnan, Charu; Deisseroth, Karl; Shenoy, Krishna V.			An optogenetic toolbox designed for primates	NATURE NEUROSCIENCE			English	Article							SENSORY-MOTOR CORTEX; IN-VIVO CONTROL; OPTICAL CONTROL; MILLISECOND-TIMESCALE; ADENOASSOCIATED VIRUS; CORTICAL-NEURONS; NEURAL CIRCUITRY; NONHUMAN PRIMATE; GENE-THERAPY; MONKEY	Optogenetics is a technique for controlling subpopulations of neurons in the intact brain using light. This technique has the potential to enhance basic systems neuroscience research and to inform the mechanisms and treatment of brain injury and disease. Before launching large-scale primate studies, the method needs to be further characterized and adapted for use in the primate brain. We assessed the safety and efficiency of two viral vector systems (lentivirus and adeno-associated virus), two human promoters (human synapsin (hSyn) and human thymocyte-1 (hThy-1)) and three excitatory and inhibitory mammalian codon-optimized opsins (channelrhodopsin-2, enhanced Natronomonas pharaonis halorhodopsin and the step-function opsin), which we characterized electrophysiologically, histologically and behaviorally in rhesus monkeys (Macaca mulatta). We also introduced a new device for measuring in vivo fluorescence over time, allowing minimally invasive assessment of construct expression in the intact brain. We present a set of optogenetic tools designed for optogenetic experiments in the non-human primate brain.	[Diester, Ilka; Mogri, Murtaza; Pashaie, Ramin; Goo, Werapong; Yizhar, Ofer; Ramakrishnan, Charu; Deisseroth, Karl; Shenoy, Krishna V.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Kaufman, Matthew T.; Deisseroth, Karl; Shenoy, Krishna V.] Stanford Univ, Neurosci Program, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Shenoy, Krishna V.] Stanford Univ, Dept Elect Engn, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University	Deisseroth, K (corresponding author), Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.	deissero@stanford.edu; shenoy@stanford.edu	Kaufman, Matthew T/B-6273-2014; YIZHAR, OFER/AAV-8497-2021; Kaufman, Matthew/AAK-2860-2020; Diester, Ilka/D-4473-2011; Core, Vector/CAF-4832-2022	Kaufman, Matthew T/0000-0002-8072-023X; Kaufman, Matthew/0000-0002-8072-023X; Yizhar, Ofer/0000-0003-4228-1448; Ramakrishnan, Charu/0000-0002-3474-6332	Human Frontier Science Program; German Academic Exchange Service Award; National Science Foundation; Bio-X; Stanford Graduate Fellowship; Stanford University; William M. Keck Foundation; Snyder Foundation; Albert Yu and Mary Bechmann Foundation; Wallace Coulter Foundation; California Institute for Regenerative Medicine; McKnight Foundation; Esther A. and Joseph Klingenstein Fund; National Institute of Mental Health; National Institute on Drug Abuse; US National Institutes of Health [1DP1OD006409]; Burroughs Wellcome Fund; US National Institutes of Health-National Institute of Neurological Disorders and Stroke [CRCNS R01-NS054283]; Defense Advanced Research Projects Agency [N66001-10-C-2010]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054283] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD006409] Funding Source: NIH RePORTER	Human Frontier Science Program(Human Frontier Science Program); German Academic Exchange Service Award(Deutscher Akademischer Austausch Dienst (DAAD)); National Science Foundation(National Science Foundation (NSF)); Bio-X; Stanford Graduate Fellowship(Stanford University); Stanford University(Stanford University); William M. Keck Foundation(W.M. Keck Foundation); Snyder Foundation; Albert Yu and Mary Bechmann Foundation; Wallace Coulter Foundation; California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); McKnight Foundation; Esther A. and Joseph Klingenstein Fund; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); US National Institutes of Health-National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank M. Vessal and A. Lilak for technical assistance during perfusions, M. Churchland for technical support during surgeries and technical discussions, S. Ryu for surgical assistance, M. Risch for veterinary care, D. Haven for technical support, S. Eisensee for administrative assistance, I. Witten for advice and members of the Deisseroth and Shenoy laboratories for discussions. I. D. is supported by a Human Frontier Science Program fellowship and a German Academic Exchange Service Award, M. T. K. by a National Science Foundation graduate fellowship, M.M. by Bio-X and a Stanford Graduate Fellowship and R. P. by a Stanford University Dean's Postdoctoral Fellowship Award. W. G. is supported by a Stanford Graduate Fellowship. O.Y. is supported by a Human Frontier Science Program fellowship. K. D. is supported by the William M. Keck Foundation, the Snyder Foundation, the Albert Yu and Mary Bechmann Foundation, the Wallace Coulter Foundation, the California Institute for Regenerative Medicine, the McKnight Foundation, the Esther A. and Joseph Klingenstein Fund, the National Science Foundation, the National Institute of Mental Health, the National Institute on Drug Abuse and a US National Institutes of Health Director's Pioneer Award. K. V. S. is supported by a Burroughs Wellcome Fund Career Award in the Biomedical Sciences, US National Institutes of Health-National Institute of Neurological Disorders and Stroke grant CRCNS R01-NS054283 and a US National Institutes of Health Director's Pioneer Award (1DP1OD006409). K. D. and K. V. S. are supported by Defense Advanced Research Projects Agency Reorganization and Plasticity to Accelerate Injury Recovery (N66001-10-C-2010).	Adamantidis AR, 2007, NATURE, V450, P420, DOI 10.1038/nature06310; Adelsberger H, 2005, NAT NEUROSCI, V8, P988, DOI 10.1038/nn1502; Airan RD, 2009, NATURE, V458, P1025, DOI 10.1038/nature07926; Aravanis AM, 2007, J NEURAL ENG, V4, pS143, DOI 10.1088/1741-2560/4/3/S02; Berndt A, 2009, NAT NEUROSCI, V12, P229, DOI 10.1038/nn.2247; Bogen IL, 2009, NEUROCHEM INT, V55, P13, DOI 10.1016/j.neuint.2009.02.006; Boutin S, 2010, HUM GENE THER, V21, P704, DOI 10.1089/hum.2009.182; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Burger C, 2004, MOL THER, V10, P302, DOI 10.1016/j.ymthe.2004.05.024; CALVIN WH, 1976, J NEUROPHYSIOL, V39, P420, DOI 10.1152/jn.1976.39.2.420; Cardin JA, 2010, NAT PROTOC, V5, P247, DOI 10.1038/nprot.2009.228; Caroni P, 1997, J NEUROSCI METH, V71, P3, DOI 10.1016/S0165-0270(96)00121-5; Chen CH, 2007, J CELL BIOCHEM, V101, P566, DOI 10.1002/jcb.21217; Christine CW, 2009, NEUROLOGY, V73, P1662, DOI 10.1212/WNL.0b013e3181c29356; Churchland MM, 2007, J NEUROPHYSIOL, V97, P348, DOI 10.1152/jn.00808.2006; Colle MA, 2010, HUM MOL GENET, V19, P147, DOI 10.1093/hmg/ddp475; Diester I, 2008, J NEUROSCI, V28, P7737, DOI 10.1523/JNEUROSCI.1347-08.2008; Disbrow E, 2003, J COMP NEUROL, V462, P382, DOI 10.1002/cne.10731; Dodiya HB, 2010, MOL THER, V18, P579, DOI 10.1038/mt.2009.216; Frigault MM, 2009, J CELL SCI, V122, P753, DOI 10.1242/jcs.033837; GILJA V, IEEE T BIOM IN PRESS; Gordon T, 2009, NEUROSURGERY, V65, pA132, DOI 10.1227/01.NEU.0000335650.09473.D3; Gradinaru V, 2007, J NEUROSCI, V27, P14231, DOI 10.1523/JNEUROSCI.3578-07.2007; Gradinaru V, 2010, CELL, V141, P154, DOI 10.1016/j.cell.2010.02.037; Gradinaru V, 2009, SCIENCE, V324, P354, DOI 10.1126/science.1167093; Gradinaru V, 2008, BRAIN CELL BIOL, V36, P129, DOI 10.1007/s11068-008-9027-6; Grimm D, 2008, J VIROL, V82, P5887, DOI 10.1128/JVI.00254-08; Gunaydin LA, 2010, NAT NEUROSCI, V13, P387, DOI 10.1038/nn.2495; Han X, 2009, NEURON, V62, P191, DOI 10.1016/j.neuron.2009.03.011; HIKOSAKA O, 1983, BRAIN RES, V272, P368, DOI 10.1016/0006-8993(83)90586-3; Histed MH, 2009, NEURON, V63, P508, DOI 10.1016/j.neuron.2009.07.016; HOUSER CR, 1983, J NEUROCYTOL, V12, P617, DOI 10.1007/BF01181527; JONES EG, 1994, J NEUROSCI, V14, P611; Kaplitt MG, 2007, LANCET, V369, P2097, DOI 10.1016/S0140-6736(07)60982-9; Kaufman MT, 2010, J NEUROPHYSIOL, V104, P799, DOI 10.1152/jn.00231.2009; Kim S, 2007, IEEE T NEUR SYS REH, V15, P493, DOI 10.1109/TNSRE.2007.908429; Lee JH, 2010, NATURE, V465, P788, DOI 10.1038/nature09108; LEICHNETZ GR, 1986, J COMP NEUROL, V254, P460, DOI 10.1002/cne.902540403; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; McFarland NR, 2009, J NEUROCHEM, V109, P838, DOI 10.1111/j.1471-4159.2009.06010.x; MCLENDON RE, 1994, BRAIN PATHOL, V4, P221, DOI 10.1111/j.1750-3639.1994.tb00837.x; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; Nathanson JL, 2009, NEUROSCIENCE, V161, P441, DOI 10.1016/j.neuroscience.2009.03.032; Taylor DM, 2002, SCIENCE, V296, P1829, DOI 10.1126/science.1070291; Tsai HC, 2009, SCIENCE, V324, P1080, DOI 10.1126/science.1168878; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744; Zhang F, 2006, NAT METHODS, V3, P785, DOI 10.1038/nmeth936; Zhang F, 2010, NAT PROTOC, V5, P439, DOI 10.1038/nprot.2009.226; Zhang JY, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/5/055007	49	318	345	1	104	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2011	14	3					387	397		10.1038/nn.2749	http://dx.doi.org/10.1038/nn.2749			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	725MW	21278729	Green Accepted			2022-12-28	WOS:000287650100021
J	[Anonymous]				[Anonymous]			Focus on computational and systems neuroscience	NATURE NEUROSCIENCE			English	Editorial Material								We present a special focus on computational and systems neuroscience, highlighting recent advances in combining empirical and theoretical approaches, including work presented at the Cosyne meeting in past years.											0	0	0	3	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2011	14	2					121	121		10.1038/nn0211-121	http://dx.doi.org/10.1038/nn0211-121			1	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	711MJ	21270774	Bronze			2022-12-28	WOS:000286595400001
J	Gabriel, JP; Ausborn, J; Ampatzis, K; Mahmood, R; Eklof-Ljunggren, E; El Manira, A				Gabriel, Jens Peter; Ausborn, Jessica; Ampatzis, Konstantinos; Mahmood, Riyadh; Eklof-Ljunggren, Emma; El Manira, Abdeljabbar			Principles governing recruitment of motoneurons during swimming in zebrafish	NATURE NEUROSCIENCE			English	Article							TELEOST BRACHYDANIO-RERIO; MOTOR-NEURON DIVERSITY; MUSCLE-FIBER TYPES; SPINAL-CORD; SIZE PRINCIPLE; POSTHATCHING DEVELOPMENT; LARVAL ZEBRAFISH; NKX6 PROTEINS; CELL-SIZE; SPECIFICATION	Locomotor movements are coordinated by a network of neurons that produces sequential muscle activation. Different motoneurons need to be recruited in an orderly manner to generate movement with appropriate speed and force. However, the mechanisms governing recruitment order have not been fully clarified. Using an in vitro juvenile/adult zebrafish brainstem-spinal cord preparation, we found that motoneurons were organized into four pools with specific topographic locations and were incrementally recruited to produce swimming at different frequencies. The threshold of recruitment was not dictated by the input resistance of motoneurons, but was instead set by a combination of specific biophysical properties and the strength of the synaptic currents. Our results provide insights into the cellular and synaptic computations governing recruitment of motoneurons during locomotion.	[Gabriel, Jens Peter; Ausborn, Jessica; Ampatzis, Konstantinos; Mahmood, Riyadh; Eklof-Ljunggren, Emma; El Manira, Abdeljabbar] Karolinska Inst, Dept Neurosci, Stockholm, Sweden	Karolinska Institutet	El Manira, A (corresponding author), Karolinska Inst, Dept Neurosci, Stockholm, Sweden.	abdel.elmanira@ki.se	Ausborn, Jessica/J-7418-2012	Ausborn, Jessica/0000-0003-4500-5131; El Manira, Abdel/0000-0001-5920-9384; Ampatzis, Konstantinos/0000-0001-7998-6463	Swedish Research Council; European Commission; Soderberg Foundation; Karolinska Institutet; German Science Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); European Commission(European CommissionEuropean Commission Joint Research Centre); Soderberg Foundation; Karolinska Institutet(Karolinska Institutet); German Science Foundation(German Research Foundation (DFG))	We thank K. Dougherty, R. Hill, S. Grillner and D. McLean for comments and critical discussion of this manuscript. This work was funded by a grant from the Swedish Research Council, European Commission (FP7, Spinal Cord Repair), Soderberg Foundation and Karolinska Institutet. J.P.G. and J.A. received postdoctoral fellowships from the German Science Foundation.	Bhatt DH, 2007, NEURON, V53, P91, DOI 10.1016/j.neuron.2006.11.011; Binder MD, 2002, ADV EXP MED BIOL, V508, P207; BONE Q, 1978, FISH B-NOAA, V76, P691; Briscoe J, 2001, CURR OPIN NEUROBIOL, V11, P43, DOI 10.1016/S0959-4388(00)00172-0; Buss RR, 2000, J NEUROPHYSIOL, V84, P1545, DOI 10.1152/jn.2000.84.3.1545; Cheesman SE, 2004, DEVELOPMENT, V131, P5221, DOI 10.1242/dev.01397; Cope TC, 1995, NEWS PHYSIOL SCI, V10, P280, DOI 10.1152/physiologyonline.1995.10.6.280; Dasen JS, 2008, CELL, V134, P304, DOI 10.1016/j.cell.2008.06.019; Dasen JS, 2009, CURR TOP DEV BIOL, V88, P169, DOI 10.1016/S0070-2153(09)88006-X; Dasen JS, 2005, CELL, V123, P477, DOI 10.1016/j.cell.2005.09.009; El Manira A, 2010, PHYSIOLOGY, V25, P230, DOI 10.1152/physiol.00007.2010; El Manira A, 2008, NAT NEUROSCI, V11, P1367, DOI 10.1038/nn1208-1367; ENOKA RM, 1984, TRENDS NEUROSCI, V7, P226, DOI 10.1016/S0166-2236(84)80210-6; Fetcho JR, 2010, ANN NY ACAD SCI, V1198, P94, DOI 10.1111/j.1749-6632.2010.05539.x; Gabriel JP, 2008, J NEUROPHYSIOL, V99, P37, DOI 10.1152/jn.00785.2007; Gabriel JP, 2009, J NEUROSCI, V29, P10387, DOI 10.1523/JNEUROSCI.1978-09.2009; Goulding M, 2009, NAT REV NEUROSCI, V10, P507, DOI 10.1038/nrn2608; GUSTAFSSON B, 1984, J PHYSIOL-LONDON, V357, P453, DOI 10.1113/jphysiol.1984.sp015511; Heckman CJ, 2008, J PHYSIOL-LONDON, V586, P1225, DOI 10.1113/jphysiol.2007.145078; Heckman CJ, 2003, TRENDS NEUROSCI, V26, P688, DOI 10.1016/j.tins.2003.10.002; HECKMAN CJ, 1988, J NEUROPHYSIOL, V60, P1946, DOI 10.1152/jn.1988.60.6.1946; HENNEMAN E, 1965, J NEUROPHYSIOL, V28, P560, DOI 10.1152/jn.1965.28.3.560; HENNEMAN E, 1957, SCIENCE, V126, P1345, DOI 10.1126/science.126.3287.1345; Henneman E, 2010, HDB PHYSL NERVOUS 1, DOI 10.1002/cphy.cp010211; Hutchinson SA, 2007, DEVELOPMENT, V134, P1671, DOI 10.1242/dev.02826; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Johnston D, 2008, TRENDS NEUROSCI, V31, P309, DOI 10.1016/j.tins.2008.03.004; JOHNSTON IA, 1983, MAR BEHAV PHYSIOL, V9, P83, DOI 10.1080/10236248309378586; KERNELL D, 1981, BRAIN RES, V204, P311, DOI 10.1016/0006-8993(81)90591-6; Lewis KE, 2003, PROG NEUROBIOL, V69, P419, DOI 10.1016/S0301-0082(03)00052-2; LIU DW, 1988, J PHYSIOL-LONDON, V403, P73, DOI 10.1113/jphysiol.1988.sp017239; McLean DL, 2007, NATURE, V446, P71, DOI 10.1038/nature05588; McLean DL, 2009, J NEUROSCI, V29, P13566, DOI 10.1523/JNEUROSCI.3277-09.2009; McLean DL, 2008, NAT NEUROSCI, V11, P1419, DOI 10.1038/nn.2225; McLean DL, 2000, BRAIN RES BULL, V53, P595, DOI 10.1016/S0361-9230(00)00393-2; Mendell LM, 2005, J NEUROPHYSIOL, V93, P3024, DOI 10.1152/classicessays.00025.2005; MYERS PZ, 1985, J COMP NEUROL, V236, P555, DOI 10.1002/cne.902360411; Nanou E, 2008, P NATL ACAD SCI USA, V105, P20941, DOI 10.1073/pnas.0806403106; Sillar KT, 1998, ANN NY ACAD SCI, V860, P318, DOI 10.1111/j.1749-6632.1998.tb09059.x; Vallstedt A, 2001, NEURON, V31, P743, DOI 10.1016/S0896-6273(01)00412-3; VANRAAMSDONK W, 1982, ANAT EMBRYOL, V164, P51; VANRAAMSDONK W, 1978, ANAT EMBRYOL, V153, P137; VANRAAMSDONK W, 1983, ANAT EMBRYOL, V167, P125; WESTERFIELD M, 1986, J NEUROSCI, V6, P2267; Westerfield M., 1993, ZEBRAFISH BOOK GUIDE	45	74	75	1	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2011	14	1					93	U125		10.1038/nn.2704	http://dx.doi.org/10.1038/nn.2704			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	699TE	21113162				2022-12-28	WOS:000285684900019
J	LaPlant, Q; Vialou, V; Covington, HE; Dumitriu, D; Feng, JA; Warren, BL; Maze, I; Dietz, DM; Watts, EL; Iniguez, SD; Koo, JW; Mouzon, E; Renthal, W; Hollis, F; Wang, H; Noonan, MA; Ren, YH; Eisch, AJ; Bolanos, CA; Kabbaj, M; Xiao, GH; Neve, RL; Hurd, YL; Oosting, RS; Fan, GP; Morrison, JH; Nestler, EJ				LaPlant, Quincey; Vialou, Vincent; Covington, Herbert E., III; Dumitriu, Dani; Feng, Jian; Warren, Brandon L.; Maze, Ian; Dietz, David M.; Watts, Emily L.; Iniguez, Sergio D.; Koo, Ja Wook; Mouzon, Ezekiell; Renthal, William; Hollis, Fiona; Wang, Hui; Noonan, Michele A.; Ren, Yanhua; Eisch, Amelia J.; Bolanos, Carlos A.; Kabbaj, Mohamed; Xiao, Guanghua; Neve, Rachael L.; Hurd, Yasmin L.; Oosting, Ronald S.; Fan, Gouping; Morrison, John H.; Nestler, Eric J.			Dnmt3a regulates emotional behavior and spine plasticity in the nucleus accumbens	NATURE NEUROSCIENCE			English	Article							COCAINE-INDUCED PLASTICITY; DENDRITIC SPINES; DNA METHYLATION; CHROMATIN REGULATION; SYNAPTIC PLASTICITY; PREFRONTAL CORTEX; IN-VIVO; NEURONS; INCREASES; REWARD	Despite abundant expression of DNA methyltransferases (Dnmts) in brain, the regulation and behavioral role of DNA methylation remain poorly understood. We found that Dnmt3a expression was regulated in mouse nucleus accumbens (NAc) by chronic cocaine use and chronic social defeat stress. Moreover, NAc-specific manipulations that block DNA methylation potentiated cocaine reward and exerted antidepressant-like effects, whereas NAc-specific Dnmt3a overexpression attenuated cocaine reward and was pro-depressant. On a cellular level, we found that chronic cocaine use selectively increased thin dendritic spines on NAc neurons and that DNA methylation was both necessary and sufficient to mediate these effects. These data establish the importance of Dnmt3a in the NAc in regulating cellular and behavioral plasticity to emotional stimuli.	[LaPlant, Quincey; Vialou, Vincent; Covington, Herbert E., III; Dumitriu, Dani; Feng, Jian; Warren, Brandon L.; Maze, Ian; Dietz, David M.; Watts, Emily L.; Iniguez, Sergio D.; Koo, Ja Wook; Mouzon, Ezekiell; Ren, Yanhua; Hurd, Yasmin L.; Oosting, Ronald S.; Morrison, John H.; Nestler, Eric J.] Mt Sinai Sch Med, Fishberg Dept Neurosci, New York, NY USA; [LaPlant, Quincey; Renthal, William; Noonan, Michele A.; Eisch, Amelia J.] Univ Texas SW Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA; [Warren, Brandon L.; Iniguez, Sergio D.; Bolanos, Carlos A.] Florida State Univ, Dept Psychol, Tallahassee, FL 32306 USA; [Hollis, Fiona; Wang, Hui; Kabbaj, Mohamed] Florida State Univ, Dept Biomed Sci, Tallahassee, FL 32306 USA; [Xiao, Guanghua] Univ Texas SW Med Ctr Dallas, Dept Clin Sci, Dallas, TX 75390 USA; [Neve, Rachael L.] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Oosting, Ronald S.] Univ Utrecht, Dept Pharmacol, Utrecht Inst Pharmaceut Sci, Utrecht, Netherlands; [Fan, Gouping] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA	Icahn School of Medicine at Mount Sinai; University of Texas System; University of Texas Southwestern Medical Center Dallas; State University System of Florida; Florida State University; State University System of Florida; Florida State University; University of Texas System; University of Texas Southwestern Medical Center Dallas; Massachusetts Institute of Technology (MIT); Utrecht University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Nestler, EJ (corresponding author), Mt Sinai Sch Med, Fishberg Dept Neurosci, New York, NY USA.	eric.nestler@mssm.edu	Morrison, John/F-9229-2012; vialou, vincent/F-2968-2013; Maze, Ian/P-8077-2018; Kabbaj, Mohamed/M-9240-2016; Dietz, David/AAW-4574-2021; feng, jian/G-9313-2011; Iniguez, Sergio D/J-2410-2015; Dietz, David/J-9458-2015; Yan, Shuo/B-8381-2009	vialou, vincent/0000-0002-8212-751X; Dietz, David/0000-0002-6927-9236; Iniguez, Sergio D/0000-0001-5748-4219; Dietz, David/0000-0002-6927-9236; Hollis, Fiona/0000-0001-6559-5736; Renthal, William/0000-0003-0206-2101; Eisch, Amelia/0000-0001-6476-5385; Dumitriu, Dani/0000-0002-7873-5192; Maze, Ian/0000-0003-1490-7781	National Institute on Drug Abuse; National Institute of Mental Health; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH066172] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R33DA027592, P01DA008227, R01DA014133, R21DA027592] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank R. Jaenisch for the generous gift of the Dnmt3a plasmid and W. G. Janssen for animal perfusions. We also thank A.J. Robison for helpful discussions and comments on the manuscript. This work was supported by grants from the National Institute on Drug Abuse and National Institute of Mental Health.	Azdad K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006908; Barrot M, 2002, P NATL ACAD SCI USA, V99, P11435, DOI 10.1073/pnas.172091899; Brueckner B, 2005, CANCER RES, V65, P6305, DOI 10.1158/0008-5472.CAN-04-2957; CHRISTOFFELL D, SOC NEUR AB IN PRESS; Clark MS, 2002, J NEUROSCI, V22, P4550, DOI 10.1523/JNEUROSCI.22-11-04550.2002; Covington HE, 2009, J NEUROSCI, V29, P11451, DOI 10.1523/JNEUROSCI.1758-09.2009; Dong E, 2008, P NATL ACAD SCI USA, V105, P13614, DOI 10.1073/pnas.0805493105; Feng J, 2005, J NEUROSCI RES, V79, P734, DOI 10.1002/jnr.20404; Feng J, 2010, NAT NEUROSCI, V13, P423, DOI 10.1038/nn.2514; Frick KM, 2003, BEHAV NEUROSCI, V117, P1283, DOI 10.1037/0735-7044.117.6.1283; Graham DL, 2007, NAT NEUROSCI, V10, P1029, DOI 10.1038/nn1929; Grimm JW, 2003, J NEUROSCI, V23, P742; Heiman M, 2008, CELL, V135, P738, DOI 10.1016/j.cell.2008.10.028; Huang YHH, 2009, NEURON, V63, P40, DOI 10.1016/j.neuron.2009.06.007; JUTTERMANN R, 1994, P NATL ACAD SCI USA, V91, P11797, DOI 10.1073/pnas.91.25.11797; Kasai H, 2010, TRENDS NEUROSCI, V33, P121, DOI 10.1016/j.tins.2010.01.001; Kourrich S, 2007, J NEUROSCI, V27, P7921, DOI 10.1523/JNEUROSCI.1859-07.2007; Kourrich S, 2009, J NEUROSCI, V29, P12275, DOI 10.1523/JNEUROSCI.3028-09.2009; Krishnan V, 2008, BIOL PSYCHIAT, V64, P691, DOI 10.1016/j.biopsych.2008.06.003; Krishnan V, 2007, CELL, V131, P391, DOI 10.1016/j.cell.2007.09.018; Kumar A, 2005, NEURON, V48, P303, DOI 10.1016/j.neuron.2005.09.023; Lee KW, 2006, P NATL ACAD SCI USA, V103, P3399, DOI 10.1073/pnas.0511244103; Levenson JM, 2006, J BIOL CHEM, V281, P15763, DOI 10.1074/jbc.M511767200; Levine AA, 2005, P NATL ACAD SCI USA, V102, P19186, DOI 10.1073/pnas.0509735102; Li YL, 2004, EUR J NEUROSCI, V20, P1647, DOI 10.1111/j.1460-9568.2004.03612.x; Linhart HG, 2007, GENE DEV, V21, P3110, DOI 10.1101/gad.1594007; Malvaez M, 2010, BIOL PSYCHIAT, V67, P36, DOI 10.1016/j.biopsych.2009.07.032; Maze I, 2010, SCIENCE, V327, P213, DOI 10.1126/science.1179438; Metivier R, 2008, NATURE, V452, P45, DOI 10.1038/nature06544; Miller CA, 2007, NEURON, V53, P857, DOI 10.1016/j.neuron.2007.02.022; Nelson ED, 2008, J NEUROSCI, V28, P395, DOI 10.1523/JNEUROSCI.3796-07.2008; Noonan MA, 2008, J NEUROSCI, V28, P2516, DOI 10.1523/JNEUROSCI.4661-07.2008; Norrholm SD, 2003, NEUROSCIENCE, V116, P19, DOI 10.1016/S0306-4522(02)00560-2; Ooi SKT, 2008, CELL, V133, P1145, DOI 10.1016/j.cell.2008.06.009; PORSOLT RD, 1977, NATURE, V266, P730, DOI 10.1038/266730a0; Pulipparacharuvil S, 2008, NEURON, V59, P621, DOI 10.1016/j.neuron.2008.06.020; Radley JJ, 2006, CEREB CORTEX, V16, P313, DOI 10.1093/cercor/bhi104; Renthal W, 2007, NEURON, V56, P517, DOI 10.1016/j.neuron.2007.09.032; Renthal W, 2009, NEURON, V62, P335, DOI 10.1016/j.neuron.2009.03.026; Robinson TE, 1999, EUR J NEUROSCI, V11, P1598, DOI 10.1046/j.1460-9568.1999.00576.x; Rodriguez A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001997; Russo SJ, 2010, TRENDS NEUROSCI, V33, P267, DOI 10.1016/j.tins.2010.02.002; Russo SJ, 2009, J NEUROSCI, V29, P3529, DOI 10.1523/JNEUROSCI.6173-08.2009; Schroeder FA, 2008, NEUROPSYCHOPHARMACOL, V33, P2981, DOI 10.1038/npp.2008.15; Shen HW, 2009, J NEUROSCI, V29, P2876, DOI 10.1523/JNEUROSCI.5638-08.2009; Spano MS, 2007, BIOL PSYCHIAT, V61, P554, DOI 10.1016/j.biopsych.2006.03.073; Tsankova N, 2007, NAT REV NEUROSCI, V8, P355, DOI 10.1038/nrn2132; Vialou V, 2010, NAT NEUROSCI, V13, P745, DOI 10.1038/nn.2551; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Wilkinson MB, 2009, J NEUROSCI, V29, P7820, DOI 10.1523/JNEUROSCI.0932-09.2009	50	442	456	0	57	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2010	13	9					1137	U141		10.1038/nn.2619	http://dx.doi.org/10.1038/nn.2619			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	643XC	20729844	Green Accepted, Green Submitted			2022-12-28	WOS:000281332600020
J	Johnson, HA; Goel, A; Buonomano, DV				Johnson, Hope A.; Goel, Anubhuthi; Buonomano, Dean V.			Neural dynamics of in vitro cortical networks reflects experienced temporal patterns	NATURE NEUROSCIENCE			English	Article							DEPENDENT PLASTICITY; CULTURES	Learning ultimately relies on changes in the flow of activity in neural microcircuits. The plasticity of neural dynamics is particularly relevant for the processing of temporal information. Chronic stimulation of cultured rat cortical networks revealed experience-dependent plasticity in neural dynamics. We observed changes in the temporal structure of activity that reflected the intervals used during training, suggesting that cortical circuits are inherently capable of temporal processing on short timescales.	[Goel, Anubhuthi; Buonomano, Dean V.] Univ Calif Los Angeles, Brain Res Inst, Dept Neurobiol, Los Angeles, CA 90024 USA; [Goel, Anubhuthi; Buonomano, Dean V.] Univ Calif Los Angeles, Brain Res Inst, Dept Psychol, Los Angeles, CA 90024 USA; [Johnson, Hope A.] Inst Gulbenkian Ciencias, Champalimaud Neurosci Programme, Oeiras, Portugal	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Fundacao Champalimaud; Instituto Gulbenkian de Ciencia	Buonomano, DV (corresponding author), Univ Calif Los Angeles, Brain Res Inst, Dept Neurobiol, Los Angeles, CA 90024 USA.	dbuono@ucla.edu			National Institute of Mental Health [MH60163]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060163] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank T. Carvalho, J. Feldman, T. O'Dell and F. Schweizer for helpful discussion and comments on this manuscript. We thank K. Gurley, J. Lee and T. Lee for technical assistance. This work was supported by the National Institute of Mental Health (MH60163).	Bi GQ, 1999, NATURE, V401, P792, DOI 10.1038/44573; Buonomano DV, 2003, P NATL ACAD SCI USA, V100, P4897, DOI 10.1073/pnas.0736909100; Fiete IR, 2010, NEURON, V65, P563, DOI 10.1016/j.neuron.2010.02.003; Ivry RB, 2008, TRENDS COGN SCI, V12, P273, DOI 10.1016/j.tics.2008.04.002; Jimbo Y, 1999, BIOPHYS J, V76, P670, DOI 10.1016/S0006-3495(99)77234-6; Johnson HA, 2009, J NEUROSCI METH, V176, P136, DOI 10.1016/j.jneumeth.2008.08.037; Karmarkar UR, 2006, NEURON, V52, P577, DOI 10.1016/j.neuron.2006.11.001; Liu JK, 2009, J NEUROSCI, V29, P13172, DOI 10.1523/JNEUROSCI.2358-09.2009; MacLean JN, 2005, NEURON, V48, P811, DOI 10.1016/j.neuron.2005.09.035; MAUK MD, 2004, ANNU REV NEUROSCI, V307, P340; Pratt KG, 2008, NAT NEUROSCI, V11, P467, DOI 10.1038/nn2076; Ruaro ME, 2005, IEEE T BIO-MED ENG, V52, P371, DOI 10.1109/TBME.2004.842975; Shahaf G, 2001, J NEUROSCI, V21, P8782, DOI 10.1523/JNEUROSCI.21-22-08782.2001; Wagenaar DA, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-11; Wagenaar DA, 2006, J NEGAT RESULTS BIOM, V5, DOI 10.1186/1477-5751-5-16	15	56	56	1	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2010	13	8					917	919		10.1038/nn.2579	http://dx.doi.org/10.1038/nn.2579			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	632DK	20543842	Green Accepted			2022-12-28	WOS:000280400600007
J	Brown, MR; Kronengold, J; Gazula, VR; Chen, Y; Strumbos, JG; Sigworth, FJ; Navaratnam, D; Kaczmarek, LK				Brown, Maile R.; Kronengold, Jack; Gazula, Valeswara-Rao; Chen, Yi; Strumbos, John G.; Sigworth, Fred J.; Navaratnam, Dhasakumar; Kaczmarek, Leonard K.			Fragile X mental retardation protein controls gating of the sodium-activated potassium channel Slack	NATURE NEUROSCIENCE			English	Article							AUDITORY NEURONS; TRANSLATION; GENE; RNA	In humans, the absence of Fragile X mental retardation protein (FMRP), an RNA-binding protein, results in Fragile X syndrome, the most common inherited form of intellectual disability. Using biochemical and electrophysiological studies, we found that FMRP binds to the C terminus of the Slack sodium-activated potassium channel to activate the channel in mice. Our findings suggest that Slack activity provides a link between patterns of neuronal firing and changes in protein translation.	[Brown, Maile R.; Kronengold, Jack; Gazula, Valeswara-Rao; Strumbos, John G.; Kaczmarek, Leonard K.] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06510 USA; [Chen, Yi; Sigworth, Fred J.; Kaczmarek, Leonard K.] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06510 USA; [Navaratnam, Dhasakumar] Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06510 USA; [Navaratnam, Dhasakumar] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06510 USA	Yale University; Yale University; Yale University; Yale University	Kaczmarek, LK (corresponding author), Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06510 USA.	leonard.kaczmarek@yale.edu			US National Institutes of Health [NS61479, DC008449, DC01919]; FRAXA Research Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS018492, F32NS061479] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [F32DC008449, R01DC001919] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FRAXA Research Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This research was supported by US National Institutes of Health grants NS61479 (M.R.B.), DC008449 (J.K.), DC01919 and the FRAXA Research Foundation (L.K.K.).	Bhattacharjee A, 2003, J NEUROSCI, V23, P11681; DRYER SE, 1994, TRENDS NEUROSCI, V17, P155, DOI 10.1016/0166-2236(94)90093-0; Lu R, 2004, P NATL ACAD SCI USA, V101, P15201, DOI 10.1073/pnas.0404995101; Pfeiffer BE, 2009, NEUROSCIENTIST, V15, P549, DOI 10.1177/1073858409333075; Ramos A, 2006, STRUCTURE, V14, P21, DOI 10.1016/j.str.2005.09.018; SIOMI H, 1993, CELL, V74, P291, DOI 10.1016/0092-8674(93)90420-U; Sjekloca L, 2009, BIOCHEM J, V419, P347, DOI 10.1042/BJ20082197; Wang LG, 2009, NATURE, V461, P292, DOI 10.1038/nature08291; Wang LY, 1998, J PHYSIOL-LONDON, V509, P183, DOI 10.1111/j.1469-7793.1998.183bo.x; Yang B, 2007, J NEUROSCI, V27, P2617, DOI 10.1523/JNEUROSCI.5308-06.2007; Zalfa F, 2003, CELL, V112, P317, DOI 10.1016/S0092-8674(03)00079-5; Zhang YQ, 2001, CELL, V107, P591, DOI 10.1016/S0092-8674(01)00589-X; Zukin RS, 2009, FRONT NEURAL CIRCUIT, V3, DOI 10.3389/neuro.04.014.2009	13	169	179	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2010	13	7					819	821		10.1038/nn.2563	http://dx.doi.org/10.1038/nn.2563			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	615YF	20512134	Green Accepted			2022-12-28	WOS:000279173900012
J	Chatzigeorgiou, M; Yoo, S; Watson, JD; Lee, WH; Spencer, WC; Kindt, KS; Hwang, SW; Miller, DM; Treinin, M; Driscoll, M; Schafer, WR				Chatzigeorgiou, Marios; Yoo, Sungjae; Watson, Joseph D.; Lee, Wei-Hsiang; Spencer, W. Clay; Kindt, Katie S.; Hwang, Sun Wook; Miller, David M., III; Treinin, Millet; Driscoll, Monica; Schafer, William R.			Specific roles for DEG/ENaC and TRP channels in touch and thermosensation in C. elegans nociceptors	NATURE NEUROSCIENCE			English	Article							CAPSAICIN RECEPTOR; GENE-EXPRESSION; MOTOR-NEURONS; ION-CHANNEL; ASH NEURONS; PAIN; MECHANOSENSATION; IDENTIFICATION; ADAPTATION; BEHAVIOR	Polymodal nociceptors detect noxious stimuli, including harsh touch, toxic chemicals and extremes of heat and cold. The molecular mechanisms by which nociceptors are able to sense multiple qualitatively distinct stimuli are not well understood. We found that the C. elegans PVD neurons are mulitidendritic nociceptors that respond to harsh touch and cold temperatures. The harsh touch modality specifically required the DEG/ENaC proteins MEC-10 and DEGT-1, which represent putative components of a harsh touch mechanotransduction complex. In contrast, responses to cold required the TRPA-1 channel and were MEC-10 and DEGT-1 independent. Heterologous expression of C. elegans TRPA-1 conferred cold responsiveness to other C. elegans neurons and to mammalian cells, indicating that TRPA-1 is a cold sensor. Our results suggest that C. elegans nociceptors respond to thermal and mechanical stimuli using distinct sets of molecules and identify DEG/ENaC channels as potential receptors for mechanical pain.	[Chatzigeorgiou, Marios; Schafer, William R.] MRC Lab Mol Biol, Div Cell Biol, Cambridge, England; [Yoo, Sungjae; Hwang, Sun Wook] Korea Univ, Grad Sch Med, Seoul, South Korea; [Watson, Joseph D.; Spencer, W. Clay; Miller, David M., III] Vanderbilt Univ, Dept Cell & Dev Biol, Nashville, TN USA; [Lee, Wei-Hsiang; Driscoll, Monica] Rutgers State Univ, Dept Mol Biol & Biochem, Nelson Biol Labs, Piscataway, NJ 08855 USA; [Kindt, Katie S.; Schafer, William R.] Univ Calif San Diego, Div Biol, La Jolla, CA 92093 USA; [Treinin, Millet] Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Med Neurobiol, Inst Med Res Israel Canada, IL-91010 Jerusalem, Israel	MRC Laboratory Molecular Biology; Korea University; Korea University Medicine (KU Medicine); Vanderbilt University; Rutgers State University New Brunswick; University of California System; University of California San Diego; Hebrew University of Jerusalem	Schafer, WR (corresponding author), MRC Lab Mol Biol, Div Cell Biol, Cambridge, England.	wschafer@mrc-lmb.cam.ac.uk	Spencer, William/E-8529-2010; Kindt, Katie/AAS-3275-2020	Hwang, Sun Wook/0000-0001-8460-7480; Schafer, William/0000-0002-6676-8034	Medical Research Council; National Institute on Drug Abuse; National Institute of Neurological Disorders and Stroke; Ministry of Education, Science and Technology of Korea [M103KV010015-06K2201-01510]; National Research Foundation of Korea [KRF-2008-331-E00457, 2009-0076543]; US-Israel Binational Science Foundation [2005036]; MRC [MC_U105185857] Funding Source: UKRI; Medical Research Council [MC_U105185857] Funding Source: researchfish; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS026115, R01NS034435] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA016445] Funding Source: NIH RePORTER	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Ministry of Education, Science and Technology of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea); National Research Foundation of Korea(National Research Foundation of Korea); US-Israel Binational Science Foundation(US-Israel Binational Science Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank the Caenorhabditis Genetics Center, the National Bioresource Project and the Mitani laboratory for worm strains, N. Barry for help with microscopy, I. Rabinowitz for writing software to analyze averaged ratio traces, D. Cattermole and P. Heard in the LMB technical workshop for designing and building thermal controllers, the Vanderbilt Functional Genomics Shared Resource for help with microarray experiments and R. Branicky for comments on the manuscript. This research was supported by the Medical Research Council and grants from the National Institute on Drug Abuse (W.R.S.) and the National Institute of Neurological Disorders and Stroke (M.D. and D.M.M.), from the Brain Research Center of the 21st Century Frontier Research Program funded by the Ministry of Education, Science and Technology of Korea (code M103KV010015-06K2201-01510) and National Research Foundation of Korea (codes KRF-2008-331-E00457 and 2009-0076543) to S.W.H., and from the US-Israel Binational Science Foundation (grant 2005036 to M.T. and D.M.M.).	Bandell M, 2004, NEURON, V41, P849, DOI 10.1016/S0896-6273(04)00150-3; Bautista DM, 2006, CELL, V124, P1269, DOI 10.1016/j.cell.2006.02.023; Bianchi L, 2004, NAT NEUROSCI, V7, P1337, DOI 10.1038/nn1347; Bounoutas A, 2007, PFLUG ARCH EUR J PHY, V454, P691, DOI 10.1007/s00424-006-0187-x; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Chelur DS, 2002, NATURE, V420, P669, DOI 10.1038/nature01205; Christensen AP, 2007, NAT REV NEUROSCI, V8, P510, DOI 10.1038/nrn2149; Colbert HA, 1997, J NEUROSCI, V17, P8259; CROLL NA, 1975, J ZOOL, V176, P159, DOI 10.1111/j.1469-7998.1975.tb03191.x; DRISCOLL M, 1991, NATURE, V349, P588, DOI 10.1038/349588a0; Esposito G, 2007, GENE, V395, P170, DOI 10.1016/j.gene.2007.03.002; Fox RM, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-42; GarciaAnoveros J, 1997, ANNU REV NEUROSCI, V20, P567, DOI 10.1146/annurev.neuro.20.1.567; Goodman MB, 2002, NATURE, V415, P1039, DOI 10.1038/4151039a; Goodman Miriam B, 2006, WormBook, P1; Gray JM, 2005, P NATL ACAD SCI USA, V102, P3184, DOI 10.1073/pnas.0409009101; Hall DH., 2008, C ELEGANS ATLAS; Hilliard MA, 2005, EMBO J, V24, P63, DOI 10.1038/sj.emboj.7600493; Hilliard MA, 2004, EMBO J, V23, P1101, DOI 10.1038/sj.emboj.7600107; HUANG MX, 1994, NATURE, V367, P467, DOI 10.1038/367467a0; Kahn-Kirby AH, 2006, ANNU REV PHYSIOL, V68, P719, DOI 10.1146/annurev.physiol.68.040204.100715; Kamath RS, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2000-2-1-research0002; Kang K, 2010, NATURE, V464, P597, DOI 10.1038/nature08848; KAPLAN JM, 1993, P NATL ACAD SCI USA, V90, P2227, DOI 10.1073/pnas.90.6.2227; Kerr R, 2000, NEURON, V26, P583, DOI 10.1016/S0896-6273(00)81196-4; Kerr Rex A, 2006, WormBook, P1; Kindt KS, 2007, NAT NEUROSCI, V10, P568, DOI 10.1038/nn1886; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; O'Hagan R, 2005, NAT NEUROSCI, V8, P43, DOI 10.1038/nn1362; Patapoutian A, 2009, NAT REV DRUG DISCOV, V8, P55, DOI 10.1038/nrd2757; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; Price MP, 2001, NEURON, V32, P1071, DOI 10.1016/S0896-6273(01)00547-5; SMITH CJ, DEV BIOL IN PRESS; Sonnichsen B, 2005, NATURE, V434, P462, DOI 10.1038/nature03353; Srivastava N, 2009, J NEUROPHYSIOL, V102, P1172, DOI 10.1152/jn.90952.2008; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; Suzuki H, 2003, NEURON, V39, P1005, DOI 10.1016/j.neuron.2003.08.015; Tobin DM, 2002, NEURON, V35, P307, DOI 10.1016/S0896-6273(02)00757-2; Tominaga M, 1998, NEURON, V21, P531, DOI 10.1016/S0896-6273(00)80564-4; Tsalik EL, 2003, DEV BIOL, V263, P81, DOI 10.1016/S0012-1606(03)00447-0; Von Stetina SE, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r135; Von Stetina SE, 2007, GENE DEV, V21, P332, DOI 10.1101/gad.1502107; Watson JD, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-84; WAY JC, 1989, GENE DEV, V3, P1823, DOI 10.1101/gad.3.12a.1823; Wemmie JA, 2006, TRENDS NEUROSCI, V29, P578, DOI 10.1016/j.tins.2006.06.014; Yassin L, 2002, BIOCHEMISTRY-US, V41, P12329, DOI 10.1021/bi020193y; Zhang SF, 2004, CURR BIOL, V14, P1888, DOI 10.1016/j.cub.2004.10.030; Zhong LX, 2010, CURR BIOL, V20, P429, DOI 10.1016/j.cub.2009.12.057	48	158	164	1	45	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2010	13	7					861	U106		10.1038/nn.2581	http://dx.doi.org/10.1038/nn.2581			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	615YF	20512132	Green Accepted			2022-12-28	WOS:000279173900019
J	Liebe, S; Hoerzer, GM; Logothetis, NK; Rainer, G				Liebe, Stefanie; Hoerzer, Gregor M.; Logothetis, Nikos K.; Rainer, Gregor			Theta coupling between V4 and prefrontal cortex predicts visual short-term memory performance	NATURE NEUROSCIENCE			English	Article							WORKING-MEMORY; PHASE-LOCKING; NEURONAL SYNCHRONIZATION; PARIETAL CORTEX; SPATIAL MEMORY; NEURAL BASIS; OSCILLATIONS; TASK; BRAIN; REPRESENTATION	Short-term memory requires communication between multiple brain regions that collectively mediate the encoding and maintenance of sensory information. It has been suggested that oscillatory synchronization underlies intercortical communication. Yet, whether and how distant cortical areas cooperate during visual memory remains elusive. We examined neural interactions between visual area V4 and the lateral prefrontal cortex using simultaneous local field potential (LFP) recordings and single-unit activity (SUA) in monkeys performing a visual short-term memory task. During the memory period, we observed enhanced between-area phase synchronization in theta frequencies (3-9 Hz) of LFPs together with elevated phase locking of SUA to theta oscillations across regions. In addition, we found that the strength of intercortical locking was predictive of the animals' behavioral performance. This suggests that theta-band synchronization coordinates action potential communication between V4 and prefrontal cortex that may contribute to the maintenance of visual short-term memories.	[Liebe, Stefanie; Logothetis, Nikos K.; Rainer, Gregor] Max Planck Inst Biol Cybernet, Dept Physiol Cognit Proc, Tubingen, Germany; [Hoerzer, Gregor M.] Graz Univ Technol, Inst Theoret Comp Sci, A-8010 Graz, Austria; [Logothetis, Nikos K.] Univ Manchester, Fac Med & Human Sci, Manchester, Lancs, England; [Rainer, Gregor] Univ Fribourg, Dept Med, CH-1700 Fribourg, Switzerland	Max Planck Society; Graz University of Technology; University of Manchester; University of Fribourg	Liebe, S (corresponding author), UCL, Dept Physiol Pharmacol & Neurosci, London, England.	s.liebe@ucl.ac.uk; gregor.rainer@unifr.ch	Rainer, Gregor/B-5876-2012; Logothetis, Nikos/U-9282-2019	Rainer, Gregor/0000-0002-5805-2220	Deutsche Forschungsgemeinschaft [Sonderforschungsbereich 550]; Max Planck Society; European Union [FP7-231267, FP7-506778]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Max Planck Society(Max Planck SocietyFoundation CELLEX); European Union(European Commission)	We would like to thank J. Macke for discussions regarding analyses, and T. Mrsic-Flogel and J. Macke for useful comments on the manuscript. We also thank A.-L. Keller for help with histology. S. L. was supported by the Deutsche Forschungsgemeinschaft Sonderforschungsbereich 550 and a doctoral Fellowship of the Max Planck Society. G. M. H. was supported by projects FP7-231267 ("Self-Organized Recurrent Neural Learning for Language Processing", ORGANIC) and FP7-506778 (Pattern Analysis, Statistical Modeling and Computational Learning, PASCAL2) of the European Union. G.R. is a European Science Foundation European Young Investigator.	Akam T, 2010, NEURON, V67, P308, DOI 10.1016/j.neuron.2010.06.019; Azouz R, 2003, NEURON, V37, P513, DOI 10.1016/S0896-6273(02)01186-8; Buzsaki G, 1996, CEREB CORTEX, V6, P81, DOI 10.1093/cercor/6.2.81; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; Fell J, 2008, NEUROIMAGE, V43, P410, DOI 10.1016/j.neuroimage.2008.07.021; Fell J, 2011, NAT REV NEUROSCI, V12, P105, DOI 10.1038/nrn2979; Fries P, 2005, TRENDS COGN SCI, V9, P474, DOI 10.1016/j.tics.2005.08.011; Fries P, 2001, SCIENCE, V291, P1560, DOI 10.1126/science.1055465; Fuentemilla L, 2010, CURR BIOL, V20, P606, DOI 10.1016/j.cub.2010.01.057; FUSTER JM, 1971, SCIENCE, V173, P652, DOI 10.1126/science.173.3997.652; Graimann B, 2006, PROG BRAIN RES, V159, P79, DOI 10.1016/S0079-6123(06)59006-5; Guderian S, 2005, HIPPOCAMPUS, V15, P901, DOI 10.1002/hipo.20125; Hoerzer GM, 2010, FRONT COMPUT NEUROSC, V4, DOI 10.3389/fncom.2010.00014; HUERTA PT, 1995, NEURON, V15, P1053, DOI 10.1016/0896-6273(95)90094-2; Jensen O, 2005, TRENDS NEUROSCI, V28, P67, DOI 10.1016/j.tins.2004.12.001; Jones MW, 2005, PLOS BIOL, V3, P2187, DOI 10.1371/journal.pbio.0030402; Kahana MJ, 1999, NATURE, V399, P781, DOI 10.1038/21645; Klimesch W, 1996, INT J PSYCHOPHYSIOL, V24, P61, DOI 10.1016/S0167-8760(96)00057-8; Lachaux JP, 1999, HUM BRAIN MAPP, V8, P194, DOI 10.1002/(SICI)1097-0193(1999)8:4<194::AID-HBM4>3.0.CO;2-C; Lee H, 2005, NEURON, V45, P147, DOI 10.1016/j.neuron.2004.12.025; Liebe S, 2011, J NEUROSCI, V31, P10215, DOI 10.1523/JNEUROSCI.1791-10.2011; Liebe S, 2009, J VISION, V9, DOI 10.1167/9.5.14; Lynch MA, 2004, PHYSIOL REV, V84, P87, DOI 10.1152/physrev.00014.2003; Mehta MR, 2000, NEURON, V25, P707, DOI 10.1016/S0896-6273(00)81072-7; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Mongillo G, 2008, SCIENCE, V319, P1543, DOI 10.1126/science.1150769; O'Keefe J, 1993, Curr Opin Neurobiol, V3, P917, DOI 10.1016/0959-4388(93)90163-S; Orban GA, 2008, PHYSIOL REV, V88, P59, DOI 10.1152/physrev.00008.2007; Pasternak T, 2005, NAT REV NEUROSCI, V6, DOI 10.1038/nrn1637; Pasupathy A, 2006, PROG BRAIN RES, V154, P293, DOI 10.1016/S0079-6121(06)54016-6; PAVLIDES C, 1988, BRAIN RES, V439, P383, DOI 10.1016/0006-8993(88)91499-0; Pesaran B, 2002, NAT NEUROSCI, V5, P805, DOI 10.1038/nn890; Raghavachari S, 2001, J NEUROSCI, V21, P3175, DOI 10.1523/JNEUROSCI.21-09-03175.2001; Rainer G, 2002, EUR J NEUROSCI, V15, P1244, DOI 10.1046/j.1460-9568.2002.01958.x; Rutishauser U, 2010, NATURE, V464, P903, DOI 10.1038/nature08860; Sarnthein J, 1998, P NATL ACAD SCI USA, V95, P7092, DOI 10.1073/pnas.95.12.7092; Schack B, 2002, INT J PSYCHOPHYSIOL, V44, P143, DOI 10.1016/S0167-8760(01)00199-4; Shadlen MN, 2001, J NEUROPHYSIOL, V86, P1916, DOI 10.1152/jn.2001.86.4.1916; Siapas AG, 2005, NEURON, V46, P141, DOI 10.1016/j.neuron.2005.02.028; Siegel M, 2009, P NATL ACAD SCI USA, V106, P21341, DOI 10.1073/pnas.0908193106; Tallon-Baudry C, 1999, TRENDS COGN SCI, V3, P151, DOI 10.1016/S1364-6613(99)01299-1; Tesche CD, 2000, P NATL ACAD SCI USA, V97, P919, DOI 10.1073/pnas.97.2.919; Tiesinga P, 2008, NAT REV NEUROSCI, V9, P97, DOI 10.1038/nrn2315; TOWE AL, 1970, EXP NEUROL, V29, P366, DOI 10.1016/0014-4886(70)90065-8; Volgushev M, 1998, NEUROSCIENCE, V83, P15, DOI 10.1016/S0306-4522(97)00380-1; Weiss S, 2000, NEUROREPORT, V11, P2357, DOI 10.1097/00001756-200008030-00005; Womelsdorf T, 2007, SCIENCE, V316, P1609, DOI [10.1126/science.1139597, 10.1126/science.1139178]; ZEKI S, 1980, NATURE, V284, P412, DOI 10.1038/284412a0	49	199	202	1	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2012	15	3					456	U150		10.1038/nn.3038	http://dx.doi.org/10.1038/nn.3038			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	899CY	22286175	Green Submitted			2022-12-28	WOS:000300793100020
J	Endo, K; Karim, MR; Taniguchi, H; Krejci, A; Kinameri, E; Siebert, M; Ito, K; Bray, SJ; Moore, AW				Endo, Keita; Karim, M. Rezaul; Taniguchi, Hiroaki; Krejci, Alena; Kinameri, Emi; Siebert, Matthias; Ito, Kei; Bray, Sarah J.; Moore, Adrian W.			Chromatin modification of Notch targets in olfactory receptor neuron diversification	NATURE NEUROSCIENCE			English	Article							EXTERNAL SENSORY ORGANS; CELL FATE DECISIONS; TRANSCRIPTIONAL CONTROL; GENE CHOICE; STEM-CELLS; DROSOPHILA; EXPRESSION; METHYLATION; ENHANCER; COMPLEX	Neuronal-class diversification is central during neurogenesis. This requirement is exemplified in the olfactory system, which utilizes a large array of olfactory receptor neuron (ORN) classes. We discovered an epigenetic mechanism in which neuron diversity is maximized via locus-specific chromatin modifications that generate context-dependent responses from a single, generally used intracellular signal. Each ORN in Drosophila acquires one of three basic identities defined by the compound outcome of three iterated Notch signaling events during neurogenesis. Hamlet, the Drosophila Evil and Prdm16 proto-oncogene homolog, modifies cellular responses to these iteratively used Notch signals in a context-dependent manner, and controls odorant receptor gene choice and ORN axon targeting specificity. In nascent ORNs, Hamlet erases the Notch state inherited from the parental cell, enabling a modified response in a subsequent round of Notch signaling. Hamlet directs locus-specific modifications of histone methylation and histone density and controls accessibility of the DNA-binding protein Suppressor of Hairless at the Notch target promoter.	[Karim, M. Rezaul; Taniguchi, Hiroaki; Kinameri, Emi; Siebert, Matthias; Moore, Adrian W.] RIKEN Brain Sci Inst, Wako, Saitama, Japan; [Endo, Keita; Ito, Kei] Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo, Japan; [Krejci, Alena; Bray, Sarah J.] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, England; [Krejci, Alena] Univ S Bohemia, Fac Sci, Ceske Budejovice, Czech Republic; [Krejci, Alena] Acad Sci Czech Republic, Inst Entomol, Ctr Biol, CR-37005 Ceske Budejovice, Czech Republic	RIKEN; University of Tokyo; University of Cambridge; University of South Bohemia Ceske Budejovice; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences	Moore, AW (corresponding author), RIKEN Brain Sci Inst, Wako, Saitama, Japan.	adrianm@brain.riken.jp	Taniguchi, Hiroaki/H-6329-2016; Siebert, Matthias/K-8494-2014; Moore, Adrian W/A-3339-2013; Moore, Adrian Walton/AAN-5656-2021; Krejci, Alena/H-2623-2014	Siebert, Matthias/0000-0002-1739-5825; Moore, Adrian W/0000-0002-8242-301X; Moore, Adrian Walton/0000-0002-8242-301X; Krejci, Alena/0000-0001-7589-4035; Karim, M. Rezaul/0000-0001-5440-0315; Bray, Sarah/0000-0002-1642-599X; Taniguchi, Hiroaki/0000-0001-7270-390X	Japan Society for the Promotion of Science; RIKEN; Medical Research Council; RIKEN Brain Science Institute; MRC [G0800034] Funding Source: UKRI; Medical Research Council [G0800034] Funding Source: researchfish	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); RIKEN; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); RIKEN Brain Science Institute; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank L. Luo, T. Hummel, Y. Hiromi, Y.N. Jan, F. Matsuzaki, S. Parkhurst, the Bloomington Drosophila Stock Center, Bloomington Drosophila Genomics Resource Center, the Iowa Developmental Studies Hybridoma Bank and Flybase for Drosophila stocks, DNA clones, antibodies and indispensable database information, and C. Yokoyama and members of the Moore laboratory for advice on the manuscript. Funding was provided by Japan Society for the Promotion of Science Grants-in-Aid Young Scientists (B) to H.T. and Scientific Research (C) to K.E., a RIKEN-Deutscher Akademischer Austauschdienst Research Internship Scholarship to M.S., a Medical Research Council program grant to S.J.B., and a RIKEN Brain Science Institute core award to A.W.M.	Abdelilah-Seyfried S, 2000, GENETICS, V155, P733; Andrews HK, 2009, EMBO REP, V10, P636, DOI 10.1038/embor.2009.66; Bai L, 2009, J NEUROSCI, V29, P12940, DOI 10.1523/JNEUROSCI.3525-09.2009; Bernstein BE, 2002, P NATL ACAD SCI USA, V99, P8695, DOI 10.1073/pnas.082249499; Bray S, 2001, CURR BIOL, V11, pR217, DOI 10.1016/S0960-9822(01)00109-9; Bray S, 2010, CURR TOP DEV BIOL, V92, P253, DOI 10.1016/S0070-2153(10)92008-5; Chinnadurai G, 2007, INT J BIOCHEM CELL B, V39, P1593, DOI 10.1016/j.biocel.2007.01.025; Chou YH, 2010, CELL, V142, P954, DOI 10.1016/j.cell.2010.08.015; Cooper MTD, 2000, DEV BIOL, V221, P390, DOI 10.1006/dbio.2000.9691; Couto A, 2005, CURR BIOL, V15, P1535, DOI 10.1016/j.cub.2005.07.034; Endo K, 2007, NAT NEUROSCI, V10, P153, DOI 10.1038/nn1832; Fishilevich E, 2005, CURR BIOL, V15, P1548, DOI 10.1016/j.cub.2005.07.066; Gupta BP, 1997, GENES CELLS, V2, P225, DOI 10.1046/j.1365-2443.1997.d01-312.x; Hayashi S, 2002, GENESIS, V34, P58, DOI 10.1002/gene.10137; He SH, 2009, ANNU REV CELL DEV BI, V25, P377, DOI 10.1146/annurev.cellbio.042308.113248; Izutsu K, 2001, BLOOD, V97, P2815, DOI 10.1182/blood.V97.9.2815; Kajimura S, 2008, GENE DEV, V22, P1397, DOI 10.1101/gad.1666108; Kinameri E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003859; Komiyama T, 2004, NAT NEUROSCI, V7, P819, DOI 10.1038/nn1284; KRAMATSCHEK B, 1994, DEVELOPMENT, V120, P815; Krejci A, 2007, GENE DEV, V21, P1322, DOI 10.1101/gad.424607; Kurtovic A, 2007, NATURE, V446, P542, DOI 10.1038/nature05672; Lim DA, 2009, NATURE, V458, P529, DOI 10.1038/nature07726; Louvi A, 2006, NAT REV NEUROSCI, V7, P93, DOI 10.1038/nrn1847; Lu BW, 1998, CELL, V95, P225, DOI 10.1016/S0092-8674(00)81753-5; Magklara A, 2011, CELL, V145, P555, DOI 10.1016/j.cell.2011.03.040; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Moore AW, 2002, SCIENCE, V297, P1355, DOI 10.1126/science.1072387; Moore AW, 2004, GENE DEV, V18, P623, DOI 10.1101/gad.1170904; Mori K, 2011, ANNU REV NEUROSCI, V34, P467, DOI 10.1146/annurev-neuro-112210-112917; Mukherjee A, 2005, NAT CELL BIOL, V7, P1191, DOI 10.1038/ncb1327; Palmer S, 2001, J BIOL CHEM, V276, P25834, DOI 10.1074/jbc.M102343200; Pierfelice TJ, 2008, COLD SH Q B, V73, P367, DOI 10.1101/sqb.2008.73.013; Pires-daSilva A, 2003, NAT REV GENET, V4, P39, DOI 10.1038/nrg977; Rand MD, 2000, MOL CELL BIOL, V20, P1825, DOI 10.1128/MCB.20.5.1825-1835.2000; Ray A, 2007, NEURON, V53, P353, DOI 10.1016/j.neuron.2006.12.010; Schneider R, 2004, NAT CELL BIOL, V6, P73, DOI 10.1038/ncb1076; Seale P, 2007, CELL METAB, V6, P38, DOI 10.1016/j.cmet.2007.06.001; Shi YJ, 2003, NATURE, V422, P735, DOI 10.1038/nature01550; Stevens CF, 1998, CURR BIOL, V8, pR708, DOI 10.1016/S0960-9822(98)70454-3; Suh GSB, 2004, NATURE, V431, P854, DOI 10.1038/nature02980; Swanson CI, 2010, DEV CELL, V18, P359, DOI 10.1016/j.devcel.2009.12.026; Tichy AL, 2008, J NEUROSCI, V28, P7121, DOI 10.1523/JNEUROSCI.2063-08.2008; Volkel P, 2007, BIOCHIMIE, V89, P1, DOI 10.1016/j.biochi.2006.07.009; Vosshall LB, 1999, CELL, V96, P725, DOI 10.1016/S0092-8674(00)80582-6; Wang SW, 1997, DEVELOPMENT, V124, P4435	46	60	60	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2012	15	2					224	233		10.1038/nn.2998	http://dx.doi.org/10.1038/nn.2998			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	882ZX	22197833				2022-12-28	WOS:000299603500013
J	Lee, H; Choi, MK; Lee, D; Kim, HS; Hwang, H; Kim, H; Park, S; Paik, YK; Lee, J				Lee, Harksun; Choi, Myung-kyu; Lee, Daehan; Kim, Hye-sung; Hwang, Hyejin; Kim, Heekyeong; Park, Sungsu; Paik, Young-ki; Lee, Junho			Nictation, a dispersal behavior of the nematode Caenorhabditis elegans, is regulated by IL2 neurons	NATURE NEUROSCIENCE			English	Article							DAUER-INDUCING PHEROMONE; C-ELEGANS; DEFICIENT MUTANTS; GENETIC-ANALYSIS; EXCITABLE CELLS; CHANNELRHODOPSIN-2; NEUROTRANSMISSION; TRANSMISSION; LOCOMOTION; RESPONSES	Many nematodes show a stage-specific behavior called nictation in which a worm stands on its tail and waves its head in three dimensions. Here we show that nictation is a dispersal behavior regulated by a specific set of neurons, the IL2 cells, in C. elegans. We established assays for nictation and showed that cholinergic transmission was required for nictation. Cell type-specific rescue experiments and genetic ablation experiments revealed that the IL2 ciliated head neurons were essential for nictation. Intact cilia in IL2 neurons, but not in other ciliated head neurons, were essential, as the restoration of the corresponding wild-type gene activity in IL2 neurons alone in cilia-defective mutants was sufficient to restore nictation. Optogenetic activation of IL2 neurons induced nictation, suggesting that signals from IL2 neurons are sufficient for nictation. Finally, we demonstrated that nictation is required for transmission of C. elegans to a new niche using flies as artificial carriers, suggesting a role of nictation as a dispersal and survival strategy under harsh conditions.	[Lee, Harksun; Choi, Myung-kyu; Lee, Daehan; Kim, Hye-sung; Lee, Junho] Seoul Natl Univ, Sch Biol Sci, Inst Mol Biol & Genet, Res Ctr Funct Cellul, Seoul, South Korea; [Hwang, Hyejin; Park, Sungsu] Ewha Womans Univ, Dept Chem & Nano Sci, Seoul, South Korea; [Kim, Heekyeong; Paik, Young-ki] Yonsei Univ, Dept Biochem, Coll Life Sci & Biotechnol, Yonsei Proteome Res Ctr, Seoul 120749, South Korea; [Lee, Junho] Seoul Natl Univ, World Class Univ, Dept Biophys & Chem Biol, Seoul, South Korea	Seoul National University (SNU); Ewha Womans University; Yonsei University; Seoul National University (SNU)	Lee, J (corresponding author), Seoul Natl Univ, Sch Biol Sci, Inst Mol Biol & Genet, Res Ctr Funct Cellul, Seoul, South Korea.	elegans@snu.ac.kr	Lee, Junho/AAO-4706-2021; Park, Sungsu/L-1920-2013; Park, Sungsu/AAF-4792-2020; Lee, Daehan/AAZ-6469-2021	Park, Sungsu/0000-0003-3062-1302; Lee, Daehan/0000-0002-0546-8484	Brain Research Center; World Class University program; Research Center for Functional Cellulomics; Seoul Scholarship Foundation	Brain Research Center; World Class University program; Research Center for Functional Cellulomics; Seoul Scholarship Foundation	This work was initiated when J.L. was at his sabbatical leave in M. Han's laboratory (University of Colorado at Boulder). The authors thank Y. Kohara (National Institute of Genetics, Japan) for cDNA clones, A. Fire (Stanford University) for vectors, the J. Yim laboratory and the C. K. Chung laboratory (Seoul National University) for providing flies for our experiment, A. Gottschalk (Goethe University) for the ChR2 plasmid, P. Sengupta (Brandeis University) for the daf-10 cDNA plasmid and the Caenorhabditis Genetics Center for C. elegans strains. This work was supported by Brain Research Center of the 21st Century Frontier Research Program, the World Class University program and Research Center for Functional Cellulomics. M. C. was supported by Hi Seoul Science Fellowship from the Seoul Scholarship Foundation.	ALBERT PS, 1983, J COMP NEUROL, V219, P461, DOI 10.1002/cne.902190407; Barriere A, 2005, CURR BIOL, V15, P1176, DOI 10.1016/j.cub.2005.06.022; Barriere Antoine, 2005, P1; BRENNER S, 1974, GENETICS, V77, P71; Butcher RA, 2007, NAT CHEM BIOL, V3, P420, DOI 10.1038/nchembio.2007.3; CAMPBELL JF, 1993, BEHAVIOUR, V126, P155, DOI 10.1163/156853993X00092; CASSADA RC, 1975, DEV BIOL, V46, P326, DOI 10.1016/0012-1606(75)90109-8; Chang AJ, 2006, PLOS BIOL, V4, P1588, DOI 10.1371/journal.pbio.0040274; Chen J, 2006, EXP GERONTOL, V41, P1059, DOI 10.1016/j.exger.2006.07.005; Conradt B, 1998, CELL, V93, P519, DOI 10.1016/S0092-8674(00)81182-4; Croll NA., 1977, BIOL NEMATODES, P152; Darwin C., 1877, ORIGIN SPECIES; Evans A. A. F., 1976, The organization of nematodes., P383; Fayyazuddin A, 2006, PLOS BIOL, V4, P420, DOI 10.1371/journal.pbio.0040063; Gittenberger E, 2006, NATURE, V439, P409, DOI 10.1038/439409a; GOLDEN JW, 1984, J CHEM ECOL, V10, P1265, DOI 10.1007/BF00988553; Hobert O, 2002, BIOTECHNIQUES, V32, P728, DOI 10.2144/02324bm01; Jeong PY, 2005, NATURE, V433, P541, DOI 10.1038/nature03201; Kass J, 2001, J NEUROSCI, V21, P9265, DOI 10.1523/JNEUROSCI.21-23-09265.2001; Lee RYN, 1999, J NEUROSCI, V19, P159, DOI 10.1523/JNEUROSCI.19-01-00159.1999; LOER CM, 1993, J NEUROSCI, V13, P5407, DOI 10.1523/JNEUROSCI.13-12-05407.1993; MacQueen AJ, 2005, MOL BIOL CELL, V16, P3247, DOI 10.1091/mbc.E04-12-1061; Mahoney TR, 2006, NAT PROTOC, V1, P1772, DOI 10.1038/nprot.2006.281; MCINTIRE SL, 1993, NATURE, V364, P334, DOI 10.1038/364334a0; MILLER MW, 1992, J NEUROPHYSIOL, V68, P2174, DOI 10.1152/jn.1992.68.6.2174; Nagel G, 2005, CURR BIOL, V15, P2279, DOI 10.1016/j.cub.2005.11.032; Nonet ML, 1997, J NEUROSCI, V17, P8061; Ouellet J, 2008, DEVELOPMENT, V135, P2583, DOI 10.1242/dev.012435; Palikhova TA, 2006, B EXP BIOL MED+, V142, P275, DOI 10.1007/s10517-006-0345-3; Park S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002550; Peden EM, 2005, CURR BIOL, V15, P394, DOI 10.1016/j.cub.2004.12.073; Praitis V, 2001, GENETICS, V157, P1217; Ramot D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002208; RAND JB, 1984, GENETICS, V106, P227; RAND JB, 1989, GENETICS, V122, P73; REED EM, 1965, NATURE, V206, P210, DOI 10.1038/206210a0; Sivasundar A, 2003, GENETICS, V163, P147; SUDHAUS W, 1989, NEMATOLOGICA, V35, P305, DOI 10.1163/002825989X00412; Sze JY, 2000, NATURE, V403, P560, DOI 10.1038/35000609; VOWELS JJ, 1992, GENETICS, V130, P105; WARD S, 1975, J COMP NEUROL, V160, P313, DOI 10.1002/cne.901600305; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Xia YN, 1998, ANGEW CHEM INT EDIT, V37, P550, DOI 10.1002/(SICI)1521-3773(19980316)37:5<550::AID-ANIE550>3.0.CO;2-G; Yono O, 2008, ZOOL SCI, V25, P517, DOI 10.2108/zsj.25.517; Zhang F, 2006, NAT METHODS, V3, P785, DOI 10.1038/nmeth936	45	96	96	1	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2012	15	1					107	U134		10.1038/nn.2975	http://dx.doi.org/10.1038/nn.2975			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	866VO	22081161				2022-12-28	WOS:000298414400020
J	Simons, SB; Caruana, DA; Zhao, ML; Dudek, SM				Simons, Stephen B.; Caruana, Douglas A.; Zhao, Meilan; Dudek, Serena M.			Caffeine-induced synaptic potentiation in hippocampal CA2 neurons	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; ADENOSINE; RECEPTOR; PLASTICITY; TRANSMISSION; ANTAGONISTS; MEMORY; RATS	Caffeine enhances cognition, but even high non-physiological doses have modest effects on synapses. A(1) adenosine receptors (A(1)Rs) are antagonized by caffeine and are most highly enriched in hippocampal CA2, which has not been studied in this context. We found that physiological doses of caffeine in vivo or A(1)R antagonists in vitro induced robust, long-lasting potentiation of synaptic transmission in rat CA2 without affecting other regions of the hippocampus.	[Simons, Stephen B.; Caruana, Douglas A.; Zhao, Meilan; Dudek, Serena M.] Natl Inst Environm Hlth Sci, US Natl Inst Hlth, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Dudek, SM (corresponding author), Natl Inst Environm Hlth Sci, US Natl Inst Hlth, Res Triangle Pk, NC 27709 USA.	dudek@niehs.nih.gov	Dudek, Serena/C-6561-2009	Dudek, Serena/0000-0003-4094-8368; Caruana, Douglas/0000-0002-8687-0263	US National Institutes of Health, National Institute of Environmental Health Sciences [Z01 ES 100221]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES100221, ZIAES100221] Funding Source: NIH RePORTER	US National Institutes of Health, National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank D. Armstrong and members of the Dudek laboratory for their input on the manuscript. This research was supported by the Intramural Research Program of the US National Institutes of Health, National Institute of Environmental Health Sciences (Z01 ES 100221).	ARAI A, 1992, BRAIN RES, V598, P173, DOI 10.1016/0006-8993(92)90181-8; Benes FM, 1998, BIOL PSYCHIAT, V44, P88, DOI 10.1016/S0006-3223(98)00138-3; CHOI OH, 1988, LIFE SCI, V43, P387, DOI 10.1016/0024-3205(88)90517-6; Dunwiddie TV, 2001, ANNU REV NEUROSCI, V24, P31, DOI 10.1146/annurev.neuro.24.1.31; FORGHANI R, 1995, HIPPOCAMPUS, V5, P71, DOI 10.1002/hipo.450050109; GARASCHUK O, 1992, NEUROSCI LETT, V135, P10, DOI 10.1016/0304-3940(92)90124-P; Lee SE, 2010, P NATL ACAD SCI USA, V107, P16994, DOI 10.1073/pnas.1005362107; LUCAS PB, 1990, BIOL PSYCHIAT, V28, P35, DOI 10.1016/0006-3223(90)90429-6; MCPHERSON PS, 1991, NEURON, V7, P17, DOI 10.1016/0896-6273(91)90070-G; Ochiishi T, 1999, NEUROSCIENCE, V93, P955, DOI 10.1016/S0306-4522(99)00179-7; Prediger RDS, 2005, NEUROSCI LETT, V376, P160, DOI 10.1016/j.neulet.2004.11.049; Simons SB, 2009, P NATL ACAD SCI USA, V106, P14080, DOI 10.1073/pnas.0904775106; Wersinger SR, 2002, MOL PSYCHIATR, V7, P975, DOI 10.1038/sj.mp.4001195; WU LG, 1994, NEURON, V12, P1139, DOI 10.1016/0896-6273(94)90321-2; Zhao M, 2007, J NEUROSCI, V27, P12025, DOI 10.1523/JNEUROSCI.4094-07.2007	15	55	56	0	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2012	15	1					23	25		10.1038/nn.2962	http://dx.doi.org/10.1038/nn.2962			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	866VO	22101644	Green Accepted			2022-12-28	WOS:000298414400009
J	Viventi, J; Kim, DH; Vigeland, L; Frechette, ES; Blanco, JA; Kim, YS; Avrin, AE; Tiruvadi, VR; Hwang, SW; Vanleer, AC; Wulsin, DF; Davis, K; Gelber, CE; Palmer, L; Van der Spiegel, J; Wu, J; Xiao, JL; Huang, YG; Contreras, D; Rogers, JA; Litt, B				Viventi, Jonathan; Kim, Dae-Hyeong; Vigeland, Leif; Frechette, Eric S.; Blanco, Justin A.; Kim, Yun-Soung; Avrin, Andrew E.; Tiruvadi, Vineet R.; Hwang, Suk-Won; Vanleer, Ann C.; Wulsin, Drausin F.; Davis, Kathryn; Gelber, Casey E.; Palmer, Larry; Van der Spiegel, Jan; Wu, Jian; Xiao, Jianliang; Huang, Yonggang; Contreras, Diego; Rogers, John A.; Litt, Brian			Flexible, foldable, actively multiplexed, high-density electrode array for mapping brain activity in vivo	NATURE NEUROSCIENCE			English	Article							PRIMARY VISUAL-CORTEX; ELECTRICAL-ACTIVITY; MOTOR CORTEX; NEOCORTEX; EPILEPSY; SILICON; WAVES; ELECTROCORTICOGRAMS; ARRANGEMENTS; VARIABILITY	Arrays of electrodes for recording and stimulating the brain are used throughout clinical medicine and basic neuroscience research, yet are unable to sample large areas of the brain while maintaining high spatial resolution because of the need to individually wire each passive sensor at the electrode-tissue interface. To overcome this constraint, we developed new devices that integrate ultrathin and flexible silicon nanomembrane transistors into the electrode array, enabling new dense arrays of thousands of amplified and multiplexed sensors that are connected using fewer wires. We used this system to record spatial properties of cat brain activity in vivo, including sleep spindles, single-trial visual evoked responses and electrographic seizures. We found that seizures may manifest as recurrent spiral waves that propagate in the neocortex. The developments reported here herald a new generation of diagnostic and therapeutic brain-machine interface devices.	[Frechette, Eric S.; Davis, Kathryn; Litt, Brian] Hosp Univ Penn, Dept Neurol, Penn Epilepsy Ctr, Philadelphia, PA 19104 USA; [Viventi, Jonathan] NYU, Polytech Inst, Dept Elect & Comp Engn, Brooklyn, NY USA; [Viventi, Jonathan] NYU, Ctr Neural Sci, New York, NY 10003 USA; [Kim, Dae-Hyeong] Seoul Natl Univ, Sch Chem & Biol Engn, Seoul, South Korea; [Vigeland, Leif; Palmer, Larry; Contreras, Diego] Univ Penn, Sch Med, Dept Neurosci, Philadelphia, PA 19104 USA; [Blanco, Justin A.] USN Acad, Dept Elect & Comp Engn, Annapolis, MD 21402 USA; [Kim, Yun-Soung; Hwang, Suk-Won; Rogers, John A.] Univ Illinois, Beckman Inst Adv Sci & Technol, Dept Mat Sci & Engn, Urbana, IL USA; [Kim, Yun-Soung; Hwang, Suk-Won; Rogers, John A.] Univ Illinois, Frederick Seitz Mat Res Lab, Urbana, IL USA; [Avrin, Andrew E.; Van der Spiegel, Jan] Univ Penn, Dept Elect & Syst Engn, Philadelphia, PA 19104 USA; [Tiruvadi, Vineet R.; Vanleer, Ann C.; Wulsin, Drausin F.; Gelber, Casey E.; Litt, Brian] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA; [Wu, Jian] Tsinghua Univ, Dept Engn Mech, Beijing 100084, Peoples R China; [Xiao, Jianliang] Univ Colorado, Dept Mech Engn, Boulder, CO 80309 USA; [Huang, Yonggang] Northwestern Univ, Dept Civil & Environm Engn, Evanston, IL USA; [Huang, Yonggang] Northwestern Univ, Dept Mech Engn, Evanston, IL 60208 USA	University of Pennsylvania; Pennsylvania Medicine; New York University; New York University Tandon School of Engineering; New York University; Seoul National University (SNU); University of Pennsylvania; United States Department of Defense; United States Navy; United States Naval Academy; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Pennsylvania; University of Pennsylvania; Tsinghua University; University of Colorado System; University of Colorado Boulder; Northwestern University; Northwestern University	Litt, B (corresponding author), Hosp Univ Penn, Dept Neurol, Penn Epilepsy Ctr, 3400 Spruce St, Philadelphia, PA 19104 USA.	jrogers@uiuc.edu; littb@mail.med.upenn.edu	Wu, Jian/I-3466-2012; Rogers, John/L-2798-2016; huang, yonggang/O-6236-2019; Huang, Yonggang/B-6998-2009; Xiao, Jianliang/B-4535-2008; HWANG, SUKWON/Q-8329-2018	Wu, Jian/0000-0003-2295-6815; HWANG, SUKWON/0000-0002-6883-201X; Kim, Dae-Hyeong/0000-0002-4722-1893	National Science Foundation [DMI0328162]; US Department of Energy, Division of Materials Sciences through the Materials Research Laboratory and Center for Microanalysis of Materials at the University of Illinois at Urbana-Champaign [DE-FG02-07ER46471, DE-FG02-07ER46453]; US National Institutes of Health (National Institute of Neurological Disorders and Stroke) [RO1-NS041811, RO1-NS48598]; Citizens United for Research in Epilepsy; Dr. Michel and Mrs. Anna Mirowski Discovery Fund for Epilepsy Research; Ruth L. Kirschstein National Research Service from the US National Institutes of Health, National Heart, Lung and Blood Institute [2T32HL007954]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR031724] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY020765, T32EY007035] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007954] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041811, R01NS048598] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); US Department of Energy, Division of Materials Sciences through the Materials Research Laboratory and Center for Microanalysis of Materials at the University of Illinois at Urbana-Champaign(United States Department of Energy (DOE)); US National Institutes of Health (National Institute of Neurological Disorders and Stroke)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Citizens United for Research in Epilepsy; Dr. Michel and Mrs. Anna Mirowski Discovery Fund for Epilepsy Research; Ruth L. Kirschstein National Research Service from the US National Institutes of Health, National Heart, Lung and Blood Institute; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Science Foundation (grant DMI0328162) and the US Department of Energy, Division of Materials Sciences (Award No. DE-FG02-07ER46471), through the Materials Research Laboratory and Center for Microanalysis of Materials (DE-FG02-07ER46453) at the University of Illinois at Urbana-Champaign. J.A.R. acknowledges a National Security Science and Engineering Faculty Fellowship. Work at the University of Pennsylvania was supported by grants from the US National Institutes of Health (National Institute of Neurological Disorders and Stroke RO1-NS041811 and RO1-NS48598), the Julie's Hope Award from the Citizens United for Research in Epilepsy, and the Dr. Michel and Mrs. Anna Mirowski Discovery Fund for Epilepsy Research. J.V. received a Ruth L. Kirschstein National Research Service Award (2T32HL007954) from the US National Institutes of Health, National Heart, Lung and Blood Institute.	Amunts K, 2000, NEUROIMAGE, V11, P66, DOI 10.1006/nimg.1999.0516; Andersen RA, 2004, CURR OPIN NEUROBIOL, V14, P720, DOI 10.1016/j.conb.2004.10.005; Anderson WS, 2007, BIOL CYBERN, V97, P173, DOI 10.1007/s00422-007-0166-0; Besson P, 2008, BRAIN, V131, P3246, DOI 10.1093/brain/awn224; Blanco JA, 2010, J NEUROPHYSIOL, V104, P2900, DOI 10.1152/jn.01082.2009; Branco DM, 2003, J CLIN NEUROPHYSIOL, V20, P17, DOI 10.1097/00004691-200302000-00002; Brunner P, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00005; CAMPBELL PK, 1991, IEEE T BIO-MED ENG, V38, P758, DOI 10.1109/10.83588; Cardin JA, 2008, NEURON, V59, P150, DOI 10.1016/j.neuron.2008.05.002; Cardin JA, 2007, J NEUROSCI, V27, P10333, DOI 10.1523/JNEUROSCI.1692-07.2007; Chao Zenas C, 2010, Front Neuroeng, V3, P3, DOI 10.3389/fneng.2010.00003; Fox PT, 2001, NEUROIMAGE, V13, P196, DOI 10.1006/nimg.2000.0659; Freeman WJ, 2000, J NEUROSCI METH, V95, P111, DOI 10.1016/S0165-0270(99)00160-0; Gais S, 2002, J NEUROSCI, V22, P6830; Griffith RW, 2006, NEUROSCI LETT, V406, P81, DOI 10.1016/j.neulet.2006.07.018; Hastie T., 2009, ELEMENTS STAT LEARNI, DOI 10.1007/978-0-387-84858-7_7; Hinton GE, 2006, SCIENCE, V313, P504, DOI 10.1126/science.1127647; Hochberg LR, 2006, NATURE, V442, P164, DOI 10.1038/nature04970; Huang XY, 2010, NEURON, V68, P978, DOI 10.1016/j.neuron.2010.11.007; Huang XY, 2004, J NEUROSCI, V24, P9897, DOI 10.1523/JNEUROSCI.2705-04.2004; Kellis S, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/5/056007; Kellis SS, 2009, NEUROSURG FOCUS, V27, DOI 10.3171/2009.4.FOCUS0974; Kim DH, 2010, NAT MATER, V9, P511, DOI [10.1038/NMAT2745, 10.1038/nmat2745]; Kitzmiller JP, 2007, J NEUROSCI METH, V162, P155, DOI 10.1016/j.jneumeth.2007.01.004; Larochelle H., 2007, P 24 INT C MACH LEAR, P473, DOI DOI 10.1145/1273496.1273556; Llinas RR, 1999, P NATL ACAD SCI USA, V96, P15222, DOI 10.1073/pnas.96.26.15222; Margalit E, 2003, J NEUROSCI METH, V123, P129, DOI 10.1016/S0165-0270(02)00345-X; Mehring C, 2003, NAT NEUROSCI, V6, P1253, DOI 10.1038/nn1158; Padnick LB, 1999, VISION RES, V39, P2833, DOI 10.1016/S0042-6989(99)00016-4; PAULLET JE, 1994, SIAM J APPL MATH, V54, P1720, DOI 10.1137/S0036139993250683; Polikov VS, 2005, J NEUROSCI METH, V148, P1, DOI 10.1016/j.jneumeth.2005.08.015; Prechtl JC, 1997, P NATL ACAD SCI USA, V94, P7621, DOI 10.1073/pnas.94.14.7621; Ryu SI, 2009, NEUROSURG FOCUS, V27, DOI 10.3171/2009.4.FOCUS0987; Schevon CA, 2008, J CLIN NEUROPHYSIOL, V25, P321, DOI 10.1097/WNP.0b013e31818e8010; SCHMIDT S, 1993, J BIOMED MATER RES, V27, P1393, DOI 10.1002/jbm.820271106; Sekitani T, 2007, NAT MATER, V6, P413, DOI 10.1038/nmat1903; Stead M, 2010, BRAIN, V133, P2789, DOI 10.1093/brain/awq190; Stieglitz T, 2002, SENSOR ACTUAT B-CHEM, V83, P8, DOI 10.1016/S0925-4005(01)01021-8; Stieglitz T, 2001, SENSOR ACTUAT A-PHYS, V90, P203, DOI 10.1016/S0924-4247(01)00520-9; Streetman B. G., 1981, SOLID STATE ELECT DE; Tamminen J, 2010, J NEUROSCI, V30, P14356, DOI 10.1523/JNEUROSCI.3028-10.2010; Taylor Z, 2004, J BIOMECH, V37, P1263, DOI 10.1016/j.jbiomech.2003.11.027; Thompson SE, 2004, IEEE T ELECTRON DEV, V51, P1790, DOI 10.1109/TED.2004.836648; Tibshirani R, 2001, J ROY STAT SOC B, V63, P411, DOI 10.1111/1467-9868.00293; TUSA RJ, 1979, J COMP NEUROL, V185, P657, DOI 10.1002/cne.901850405; VANESSEN DC, 1984, VISION RES, V24, P429, DOI 10.1016/0042-6989(84)90041-5; Viventi J, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000738; Witkowski FX, 1998, NATURE, V392, P78, DOI 10.1038/32170; Yanagisawa T, 2009, NEUROIMAGE, V45, P1099, DOI 10.1016/j.neuroimage.2008.12.069; Yeager JD, 2008, J NEUROSCI METH, V173, P279, DOI 10.1016/j.jneumeth.2008.06.024	50	757	794	32	523	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	2011	14	12					1599	U138		10.1038/nn.2973	http://dx.doi.org/10.1038/nn.2973			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	855EJ	22081157	Green Accepted, Green Submitted			2022-12-28	WOS:000297546300021
J	Alvarez-Fischer, D; Fuchs, J; Castagner, F; Stettler, O; Massiani-Beaudoin, O; Moya, KL; Bouillot, C; Oertel, WH; Lombes, A; Faigle, W; Joshi, RL; Hartmann, A; Prochiantz, A				Alvarez-Fischer, Daniel; Fuchs, Julia; Castagner, Francois; Stettler, Olivier; Massiani-Beaudoin, Olivia; Moya, Kenneth L.; Bouillot, Colette; Oertel, Wolfgang H.; Lombes, Anne; Faigle, Wolfgang; Joshi, Rajiv L.; Hartmann, Andreas; Prochiantz, Alain			Engrailed protects mouse midbrain dopaminergic neurons against mitochondrial complex I insults	NATURE NEUROSCIENCE			English	Article							FACTOR 4E EIF4E; PARKINSONS-DISEASE; TRANSCRIPTION FACTOR; RETINAL AXONS; MICE; TRANSLATION; MECHANISMS; SURVIVAL; MODEL; VULNERABILITY	Mice heterozygous for the homeobox gene Engrailed-1 (En1) display progressive loss of mesencephalic dopaminergic (mDA) neurons. We report that exogenous Engrailed-1 and Engrailed-2 (collectively Engrailed) protect mDA neurons from 1-methyl-4- phenyl-1,2,3,6-tetrahydropyridine (MPTP), a mitochondrial complex I toxin used to model Parkinson's disease in animals. Engrailed enhances the translation of nuclearly encoded mRNAs for two key complex I subunits, Ndufs1 and Ndufs3, and increases complex I activity. Accordingly, in vivo protection against MPTP by Engrailed is antagonized by Ndufs1 small interfering RNA. An association between Engrailed and complex I is further confirmed by the reduced expression of Ndufs1 and Ndufs3 in the substantia nigra pars compacta of En1 heterozygous mice. Engrailed also confers in vivo protection against 6-hydroxydopamine and alpha-synuclein-A30P. Finally, the unilateral infusion of Engrailed into the midbrain increases striatal dopamine content, resulting in contralateral amphetamine-induced turning. Therefore, Engrailed is both a survival factor for adult mDA neurons and a regulator of their physiological activity.	[Alvarez-Fischer, Daniel; Fuchs, Julia; Castagner, Francois; Stettler, Olivier; Massiani-Beaudoin, Olivia; Moya, Kenneth L.; Bouillot, Colette; Joshi, Rajiv L.; Prochiantz, Alain] Coll France, INSERM, Ctr Interdisciplinary Res Biol, CNRS,Unite Mixte Rech 7241,U1050, F-75231 Paris, France; [Alvarez-Fischer, Daniel; Hartmann, Andreas] Univ Paris 06, INSERM, Ctr Rech, Inst Cerveau & Moelle Epiniere,INSERM,Unite Mixte, Paris, France; [Alvarez-Fischer, Daniel; Hartmann, Andreas] Grp Hosp Pitie Salpetriere, F-75634 Paris, France; [Alvarez-Fischer, Daniel; Oertel, Wolfgang H.] Univ Marburg, Dept Neurol, Marburg, Germany; [Fuchs, Julia; Castagner, Francois; Stettler, Olivier; Massiani-Beaudoin, Olivia; Moya, Kenneth L.; Bouillot, Colette; Joshi, Rajiv L.; Prochiantz, Alain] Paris Sci Lettres Res Univ, Paris, France; [Fuchs, Julia; Castagner, Francois; Massiani-Beaudoin, Olivia; Moya, Kenneth L.; Bouillot, Colette; Joshi, Rajiv L.; Prochiantz, Alain] Univ Paris 06, Ecole Doctorale 158, Paris, France; [Stettler, Olivier] Univ Paris 05, Paris, France; [Lombes, Anne] Hop La Pitie Salpetriere, INSERM, U975, Paris, France; [Faigle, Wolfgang] Inst Curie, Lab Spectrometrie Masse, Paris, France	UDICE-French Research Universities; PSL Research University Paris; College de France; Ecole Normale Superieure (ENS); Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Philipps University Marburg; UDICE-French Research Universities; PSL Research University Paris; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie	Prochiantz, A (corresponding author), Coll France, INSERM, Ctr Interdisciplinary Res Biol, CNRS,Unite Mixte Rech 7241,U1050, U114, F-75231 Paris, France.	rajiv.joshi@college-de-france.fr; andreas.hartmann@psl.aphp.fr; alain.prochiantz@college-de-france.fr	Alvarez-Fischer, Daniel/AAJ-7572-2021; Lombes, Anne/G-4684-2014; Fuchs, Julia/M-7529-2017	Alvarez-Fischer, Daniel/0000-0001-7655-9589; Lombes, Anne/0000-0002-9064-0399; Fuchs, Julia/0000-0002-3045-0470; Castagner, Francois/0000-0002-9830-0057; Faigle, Wolfgang/0000-0002-7664-8722	Agence Nationale pour la Recherche [ANR-06-013-01]; Michael. J. Fox Foundation (MJFF); Fondation de France; European Community [222999]; University Medical Center Giessen and Marburg (UKGM); German Academic Exchange Service (DAAD); German Research Foundation (DFG); FRM; NERF (Neuropole de Recherche Francilien)	Agence Nationale pour la Recherche(French National Research Agency (ANR)); Michael. J. Fox Foundation (MJFF); Fondation de France(Fondation de France); European Community(European Commission); University Medical Center Giessen and Marburg (UKGM); German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); German Research Foundation (DFG)(German Research Foundation (DFG)); FRM(Fondation pour la Recherche Medicale); NERF (Neuropole de Recherche Francilien)	This work was supported by Agence Nationale pour la Recherche (ANR-06-013-01), the Michael. J. Fox Foundation (MJFF), Fondation de France (Physiopathology of Parkinson disease) and the European Community (FP7 222999, mdDANeurodev project). D.A.-F. was funded by the MJFF, the University Medical Center Giessen and Marburg (UKGM) and the German Academic Exchange Service (DAAD). The CIRB group is part of a Global Research Laboratory (KAIST, South Korea) and a Foundation for Medical Research (FRM) team. J. F. was funded by the German Research Foundation (DFG), the MJFF, FRM and NERF (Neuropole de Recherche Francilien). A. H. was temporarily supported by INSERM. We thank E. Ipendey for technical help. Confocal imaging and quantification were performed by V. Mignon and B. Saubamea. We thank the Laboratory of Mass Spectrometry and Proteomics, Institut Curie for assistance. We are indebted to A. Prigent, E. Hirsch, P. Michel and M. Volovitch for intellectual input.	Abou-Sleiman PM, 2006, NAT REV NEUROSCI, V7, P207, DOI 10.1038/nrn1868; Alberi L, 2004, DEVELOPMENT, V131, P3229, DOI 10.1242/dev.01128; Alvarez-Fischer D, 2008, EXP NEUROL, V210, P182, DOI 10.1016/j.expneurol.2007.10.012; Ang SL, 2006, DEVELOPMENT, V133, P3499, DOI 10.1242/dev.02501; Benit P, 2004, J MED GENET, V41, P14, DOI 10.1136/jmg.2003.014316; Boldogh IR, 2007, TRENDS CELL BIOL, V17, P502, DOI 10.1016/j.tcb.2007.07.008; Brundin P, 2008, NAT REV NEUROSCI, V9, P741, DOI 10.1038/nrn2477; Brunet I, 2005, NATURE, V438, P94, DOI 10.1038/nature04110; Chung CY, 2010, BRAIN, V133, P2022, DOI 10.1093/brain/awq142; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Dawson TM, 2003, SCIENCE, V302, P819, DOI 10.1126/science.1087753; De Toni A, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-13; De Vos KJ, 2008, ANNU REV NEUROSCI, V31, P151, DOI 10.1146/annurev.neuro.31.061307.090711; Di Nardo AA, 2007, MOL CELL NEUROSCI, V35, P230, DOI 10.1016/j.mcn.2007.02.015; Di Salvio M, 2010, NAT NEUROSCI, V13, P1481, DOI 10.1038/nn.2661; Dieteren CEJ, 2008, J BIOL CHEM, V283, P34753, DOI 10.1074/jbc.M807323200; Douhou A, 2001, J NEUROCHEM, V78, P163, DOI 10.1046/j.1471-4159.2001.00401.x; Ekstrand MI, 2007, P NATL ACAD SCI USA, V104, P1325, DOI 10.1073/pnas.0605208103; Flanagan JG, 2006, CURR OPIN NEUROBIOL, V16, P59, DOI 10.1016/j.conb.2006.01.010; Franklin K. B. J., 2008, PAXINOS FRANKLINS MO; Fuchs J, 2009, NEUROBIOL AGING, V30, P731, DOI 10.1016/j.neurobiolaging.2007.08.014; HANKS M, 1995, SCIENCE, V269, P679, DOI 10.1126/science.7624797; Haubenberger D, 2011, NEUROBIOL AGING, V32, P302, DOI 10.1016/j.neurobiolaging.2009.02.015; HIRSCH E, 1988, NATURE, V334, P345, DOI 10.1038/334345a0; Hoglinger GU, 2003, J NEUROCHEM, V84, P491, DOI 10.1046/j.1471-4159.2003.01533.x; HOLLINGSWORTH EB, 1985, J NEUROSCI, V5, P2240; Iaccarino C, 2007, HUM MOL GENET, V16, P1319, DOI 10.1093/hmg/ddm080; Iancu R, 2005, BEHAV BRAIN RES, V162, P1, DOI 10.1016/j.bbr.2005.02.023; Ibad RT, 2011, J NEUROSCI, V31, P5495, DOI 10.1523/JNEUROSCI.0187-11.2011; Iuso A, 2006, J BIOL CHEM, V281, P10374, DOI 10.1074/jbc.M513387200; Joliot A, 2004, NAT CELL BIOL, V6, P189, DOI 10.1038/ncb0304-189; Joshi RL, 2011, FEBS LETT, V585, P1573, DOI 10.1016/j.febslet.2011.05.006; Kadkhodaei B, 2009, J NEUROSCI, V29, P15923, DOI 10.1523/JNEUROSCI.3910-09.2009; KAWAMOTO JC, 1986, BRAIN RES, V384, P84, DOI 10.1016/0006-8993(86)91222-9; Marc P, 2002, EMBO REP, V3, P159, DOI 10.1093/embo-reports/kvf025; Nedelec S, 2004, P NATL ACAD SCI USA, V101, P10815, DOI 10.1073/pnas.0403824101; Prochiantz A, 2003, NAT REV MOL CELL BIO, V4, P814, DOI 10.1038/nrm1227; Recchia A, 2008, NEUROBIOL DIS, V30, P8, DOI 10.1016/j.nbd.2007.11.002; Ricci JE, 2004, CELL, V117, P773, DOI 10.1016/j.cell.2004.05.008; Richter JD, 2009, GENE DEV, V23, P1, DOI 10.1101/gad.1735809; Salthun-Lassalle B, 2004, J NEUROSCI, V24, P5922, DOI 10.1523/JNEUROSCI.5668-03.2004; Schapira AHV, 2008, LANCET NEUROL, V7, P97, DOI 10.1016/S1474-4422(07)70327-7; She H, 2011, J CLIN INVEST, V121, P930, DOI 10.1172/JCI43871; Sonnier L, 2007, J NEUROSCI, V27, P1063, DOI 10.1523/JNEUROSCI.4583-06.2007; Tatton NA, 1997, NEUROSCIENCE, V77, P1037, DOI 10.1016/S0306-4522(96)00545-3; Topisirovic I, 2005, HISTOL HISTOPATHOL, V20, P1275, DOI 10.14670/HH-20.1275; Topisirovic I, 2005, MOL CELL BIOL, V25, P1100, DOI 10.1128/MCB.25.3.1100-1112.2005; Villasana LE, 2006, J NEUROSCI METH, V158, P30, DOI 10.1016/j.jneumeth.2006.05.008; Wegrzyn J, 2009, SCIENCE, V323, P793, DOI 10.1126/science.1164551; Wizenmann A, 2009, NEURON, V64, P355, DOI 10.1016/j.neuron.2009.09.018	50	98	100	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2011	14	10					1260	U182		10.1038/nn.2916	http://dx.doi.org/10.1038/nn.2916			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	825EQ	21892157	Green Submitted			2022-12-28	WOS:000295254200014
J	Straub, C; Hunt, DL; Yamasaki, M; Kim, KS; Watanabe, M; Castillo, PE; Tomita, S				Straub, Christoph; Hunt, David L.; Yamasaki, Miwako; Kim, Kwang S.; Watanabe, Masahiko; Castillo, Pablo E.; Tomita, Susumu			Distinct functions of kainate receptors in the brain are determined by the auxiliary subunit Neto1	NATURE NEUROSCIENCE			English	Article							MOSSY-FIBER SYNAPSES; MEDIATED SYNAPTIC-TRANSMISSION; THALAMOCORTICAL SYNAPSES; HIPPOCAMPAL INTERNEURONS; GLUTAMATE RECEPTORS; ACTIVATION; DESENSITIZATION; GLUR6; EXPRESSION; AMPA	Ionotropic glutamate receptors principally mediate fast excitatory transmission in the brain. Among the three classes of ionotropic glutamate receptors, kainate receptors (KARs) have a unique brain distribution, which has been historically defined by H-3-radiolabeled kainate binding. Compared with recombinant KARs expressed in heterologous cells, synaptic KARs exhibit characteristically slow rise-time and decay kinetics. However, the mechanisms responsible for these distinct KAR properties remain unclear. We found that both the high-affinity binding pattern in the mouse brain and the channel properties of native KARs are determined by the KAR auxiliary subunit Neto1. Through modulation of agonist binding affinity and off-kinetics of KARs, but not trafficking of KARs, Neto1 determined both the KAR high-affinity binding pattern and the distinctively slow kinetics of postsynaptic KARs. By regulating KAR excitatory postsynaptic current kinetics, Neto1 can control synaptic temporal summation, spike generation and fidelity.	[Straub, Christoph; Kim, Kwang S.; Tomita, Susumu] Yale Univ, Sch Med, Program Cellular Neurosci Neurodegenerat & Repair, New Haven, CT 06520 USA; [Straub, Christoph; Kim, Kwang S.; Tomita, Susumu] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06510 USA; [Hunt, David L.; Castillo, Pablo E.] Albert Einstein Coll Med, Dominick P Purpura Dept Neurosci, Bronx, NY 10467 USA; [Straub, Christoph; Hunt, David L.] Hokkaido Univ, Grad Sch Med, Dept Anat, Sapporo, Hokkaido, Japan	Yale University; Yale University; Yeshiva University; Albert Einstein College of Medicine; Hokkaido University	Tomita, S (corresponding author), Yale Univ, Sch Med, Program Cellular Neurosci Neurodegenerat & Repair, New Haven, CT 06520 USA.	pablo.castillo@einstein.yu.edu; susumu.tomita@yale.edu	Watanabe, Masahiko/S-3614-2019; Yamasaki, Miwako/I-8053-2014; WATANABE, Masahiko/A-4055-2012	Watanabe, Masahiko/0000-0001-5037-7138; Yamasaki, Miwako/0000-0003-4974-9349; WATANABE, Masahiko/0000-0001-5037-7138; Hunt, David/0000-0002-7567-5649; Castillo, Pablo/0000-0002-9834-1801	US National Institutes of Health/National Institute of Mental Health [R01 MH085080, R01 MH081935]; Boehringer-Ingelheim PhD fellowship; Ministry of Education, Culture, Sports, Science and Technology of Japan [19100005]; Grants-in-Aid for Scientific Research [19100005] Funding Source: KAKEN; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH081935, R01MH085080] Funding Source: NIH RePORTER	US National Institutes of Health/National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Boehringer-Ingelheim PhD fellowship; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank members of the Tomita and Castillo laboratories for helpful discussions. We thank M. T. W. Ho for technical advice on slice preparation, G. Somers for maintaining mouse colonies, S. F. Heinemann (Salk Institute) for generating GluK2 knockout mice and the KOMP for creating Neto1 KO mice. S. T. and P. E. C. are supported by grants from the US National Institutes of Health/National Institute of Mental Health (R01 MH085080 and R01 MH081935, respectively). C. S. is supported by a Boehringer-Ingelheim PhD fellowship. M. W. is supported by Grants-in-Aid for Scientific Research (19100005) provided by the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Barberis A, 2008, J NEUROSCI, V28, P6402, DOI 10.1523/JNEUROSCI.1204-08.2008; BERGER M, 1983, NEUROSCI LETT, V39, P237, DOI 10.1016/0304-3940(83)90306-3; Bowie D, 2003, J PHYSIOL-LONDON, V547, P373, DOI 10.1113/jphysiol.2002.033076; Bureau I, 2000, P NATL ACAD SCI USA, V97, P6838, DOI 10.1073/pnas.97.12.6838; Castillo PE, 1997, NATURE, V388, P182, DOI 10.1038/40645; Contractor A, 2003, J NEUROSCI, V23, P422, DOI 10.1523/JNEUROSCI.23-02-00422.2003; Contractor A, 2011, TRENDS NEUROSCI, V34, P154, DOI 10.1016/j.tins.2010.12.002; Coussen F, 2002, J NEUROSCI, V22, P6426, DOI 10.1523/jneurosci.22-15-06426.2002; Cui CH, 1999, J NEUROSCI, V19, P8281; Cunningham MO, 2006, P NATL ACAD SCI USA, V103, P5597, DOI 10.1073/pnas.0600604103; Erreger Kevin, 2004, Critical Reviews in Neurobiology, V16, P187; Fernandes HB, 2009, NEURON, V63, P818, DOI 10.1016/j.neuron.2009.08.010; FOSTER AC, 1981, NATURE, V289, P73, DOI 10.1038/289073a0; Frerking M, 2002, J NEUROSCI, V22, P7434; Frerking M, 1998, NAT NEUROSCI, V1, P479, DOI 10.1038/2194; Garcia EP, 1998, NEURON, V21, P727, DOI 10.1016/S0896-6273(00)80590-5; Heckmann M, 1996, BIOPHYS J, V71, P1743, DOI 10.1016/S0006-3495(96)79375-X; HERB A, 1992, NEURON, V8, P775, DOI 10.1016/0896-6273(92)90098-X; Hirbec H, 2003, NEURON, V37, P625, DOI 10.1016/S0896-6273(02)01191-1; Jane DE, 2009, NEUROPHARMACOLOGY, V56, P90, DOI 10.1016/j.neuropharm.2008.08.023; Kidd FL, 1999, NATURE, V400, P569, DOI 10.1038/23040; Kidd FL, 2001, J NEUROPHYSIOL, V86, P1139, DOI 10.1152/jn.2001.86.3.1139; Kwon HB, 2008, NEURON, V60, P1082, DOI 10.1016/j.neuron.2008.10.045; Laezza F, 2007, MOL CELL NEUROSCI, V34, P539, DOI 10.1016/j.mcn.2006.12.003; Lerma J, 2003, NAT REV NEUROSCI, V4, P481, DOI 10.1038/nrn1118; Lerma J, 2006, CURR OPIN PHARMACOL, V6, P89, DOI 10.1016/j.coph.2005.08.004; Li H, 1998, NEUROPHARMACOLOGY, V37, P1279, DOI 10.1016/S0028-3908(98)00109-9; Li P, 1999, NATURE, V397, P161, DOI 10.1038/16469; Michishita M, 2004, DEV BRAIN RES, V153, P135, DOI 10.1016/j.devbrainres.2004.06.012; Michishita M, 2003, BIOCHEM BIOPH RES CO, V306, P680, DOI 10.1016/S0006-291X(03)01035-0; Mott DD, 2010, J PHYSIOL-LONDON, V588, P683, DOI 10.1113/jphysiol.2009.185207; Mulle C, 1998, NATURE, V392, P601, DOI 10.1038/33408; Ng D, 2009, PLOS BIOL, V7, P278, DOI 10.1371/journal.pbio.1000041; Paternain AV, 1998, NEUROPHARMACOLOGY, V37, P1249, DOI 10.1016/S0028-3908(98)00098-7; Pinheiro P, 2006, CELL TISSUE RES, V326, P457, DOI 10.1007/s00441-006-0265-6; Pinheiro PS, 2008, NAT REV NEUROSCI, V9, P423, DOI 10.1038/nrn2379; Sachidhanandam S, 2009, J NEUROSCI, V29, P5000, DOI 10.1523/JNEUROSCI.5807-08.2009; Salinas GD, 2006, J BIOL CHEM, V281, P40164, DOI 10.1074/jbc.M608194200; Schiffer HH, 1997, NEURON, V19, P1141, DOI 10.1016/S0896-6273(00)80404-3; Swanson GT, 2002, NEURON, V34, P589, DOI 10.1016/S0896-6273(02)00676-1; Swanson GT, 1998, J PHYSIOL-LONDON, V513, P639, DOI 10.1111/j.1469-7793.1998.639ba.x; Tomita S, 2005, NATURE, V435, P1052, DOI 10.1038/nature03624; Tomita S, 2004, SCIENCE, V303, P1508, DOI 10.1126/science.1090262; Traynelis SF, 1997, J PHYSIOL-LONDON, V503, P513, DOI 10.1111/j.1469-7793.1997.513bg.x; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Vignes M, 1997, NATURE, V388, P179, DOI 10.1038/40639; Wondolowski J, 2009, J NEUROSCI, V29, P563, DOI 10.1523/JNEUROSCI.4788-08.2009; Wu LJ, 2005, J NEUROPHYSIOL, V94, P1805, DOI 10.1152/jn.00091.2005; Zhang W, 2009, NEURON, V61, P385, DOI 10.1016/j.neuron.2008.12.014	49	93	95	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2011	14	7					866	U83		10.1038/nn.2837	http://dx.doi.org/10.1038/nn.2837			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	783KR	21623363	Green Accepted			2022-12-28	WOS:000292081700014
J	Allen, D; Bond, CT; Lujan, R; Ballesteros-Merino, C; Lin, MT; Wang, K; Klett, N; Watanabe, M; Shigemoto, R; Stackman, RW; Maylie, J; Adelman, JP				Allen, Duane; Bond, Chris T.; Lujan, Rafael; Ballesteros-Merino, Carmen; Lin, Mike T.; Wang, Kang; Klett, Nathan; Watanabe, Masahiko; Shigemoto, Ryuichi; Stackman, Robert W., Jr.; Maylie, James; Adelman, John P.			The SK2-long isoform directs synaptic localization and function of SK2-containing channels	NATURE NEUROSCIENCE			English	Article							SMALL-CONDUCTANCE; AMPA RECEPTORS; GLUTAMATE RECEPTORS; SK2 CHANNELS; TRAFFICKING; MEMORY; PLASTICITY; SYNAPSES; SUBUNITS; LOOP	SK2-containing channels are expressed in the postsynaptic density (PSD) of dendritic spines on mouse hippocampal area CA1 pyramidal neurons and influence synaptic responses, plasticity and learning. The Sk2 gene (also known as Kcnn2) encodes two isoforms that differ only in the length of their N-terminal domains. SK2-long (SK2-L) and SK2-short (SK2-S) are coexpressed in CA1 pyramidal neurons and likely form heteromeric channels. In mice lacking SK2-L (SK2-S only mice), SK2-S-containing channels were expressed in the extrasynaptic membrane, but were excluded from the PSD. The SK channel contribution to excitatory postsynaptic potentials was absent in SK2-S only mice and was restored by SK2-L re-expression. Blocking SK channels increased the amount of long-term potentiation induced in area CA1 in slices from wild-type mice but had no effect in slices from SK2-S only mice. Furthermore, SK2-S only mice outperformed wild-type mice in the novel object recognition task. These results indicate that SK2-L directs synaptic SK2-containing channel expression and is important for normal synaptic signaling, plasticity and learning.	[Maylie, James] Oregon Hlth & Sci Univ, Dept Obstet & Gynecol, Portland, OR 97201 USA; [Allen, Duane; Bond, Chris T.; Lin, Mike T.; Wang, Kang; Klett, Nathan; Adelman, John P.] Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97201 USA; [Lujan, Rafael; Ballesteros-Merino, Carmen] Univ Castilla La Mancha, Fac Med, Inst Invest Discapacidades Neurol, Dept Ciencias Med, Albacete, Spain; [Watanabe, Masahiko] Hokkaido Univ, Sch Med, Dept Anat, Sapporo, Hokkaido 060, Japan; [Shigemoto, Ryuichi] Natl Inst Physiol Sci, Div Cerebral Struct, Okazaki, Aichi 444, Japan; [Stackman, Robert W., Jr.] Florida Atlantic Univ, Dept Psychol, Ctr Complex Syst & Brain Sci, Boca Raton, FL 33431 USA; [Stackman, Robert W., Jr.] Florida Atlantic Univ, FAU Max Planck Florida Inst Integrat Biol, Boca Raton, FL 33431 USA; [Stackman, Robert W., Jr.] Florida Atlantic Univ, Neurosci Program, Boca Raton, FL 33431 USA	Oregon Health & Science University; Oregon Health & Science University; Universidad de Castilla-La Mancha; Hokkaido University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); State University System of Florida; Florida Atlantic University; State University System of Florida; Florida Atlantic University; State University System of Florida; Florida Atlantic University	Maylie, J (corresponding author), Oregon Hlth & Sci Univ, Dept Obstet & Gynecol, Portland, OR 97201 USA.	mayliej@ohsu.edu; adelman@ohsu.edu	Shigemoto, Ryuichi/E-3628-2013; Wang, Kang/AAE-1168-2019; WATANABE, Masahiko/A-4055-2012; Watanabe, Masahiko/S-3614-2019; Stackman, Robert W./E-8685-2019; Lujan, Rafael/G-2555-2015	Shigemoto, Ryuichi/0000-0001-8761-9444; Wang, Kang/0000-0002-4563-7385; WATANABE, Masahiko/0000-0001-5037-7138; Watanabe, Masahiko/0000-0001-5037-7138; Lujan Miras, Rafael/0000-0003-2001-9545; Stackman Jr, Robert/0000-0002-5950-046X	US National Institutes of Health [NS038880, MH081860-01, F32MH080480, MH0876591-01]; National Science Foundation [IBN 0630522]; Spanish Ministry of Education and Science [CSD2008-00005, BFU-2009-08404/BFI]; Consejeria de Educacion y Ciencia, Junta de Comunidades de Castilla-La Mancha [PPII11-0284-9301]; Grants-in-Aid for Scientific Research [19100005] Funding Source: KAKEN; NATIONAL INSTITUTE OF MENTAL HEALTH [F32MH080480, R01MH081860, R01MH076752, R01MH086591] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038880] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Spanish Ministry of Education and Science(Spanish Government); Consejeria de Educacion y Ciencia, Junta de Comunidades de Castilla-La Mancha(Junta de Comunidades de Castilla-La Mancha); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank K. Vick, C. Christakis and K. Smith (all from FAU) for their expert assistance with the behavioral testing. This work was supported by US National Institutes of Health grants NS038880 (J.P.A.), MH081860-01 (J.M.), F32MH080480 (M.T.L.) and MH0876591-01 (R.W.S.), National Science Foundation grant IBN 0630522 (R.W.S.), and grants from the Spanish Ministry of Education and Science (CONSOLIDER CSD2008-00005) and Consejeria de Educacion y Ciencia, Junta de Comunidades de Castilla-La Mancha (PPII11-0284-9301) and Spanish Ministry of Education and Science (BFU-2009-08404/BFI) to R.L.	Adesnik H, 2005, NEURON, V48, P977, DOI 10.1016/j.neuron.2005.11.030; Bellone C, 2007, NEURON, V55, P779, DOI 10.1016/j.neuron.2007.07.035; Bloodgood BL, 2007, NEURON, V53, P249, DOI 10.1016/j.neuron.2006.12.017; Bond CT, 2000, SCIENCE, V289, P1942, DOI 10.1126/science.289.5486.1942; Bond CT, 2004, J NEUROSCI, V24, P5301, DOI 10.1523/JNEUROSCI.0182-04.2004; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Carroll RC, 2002, TRENDS NEUROSCI, V25, P571, DOI 10.1016/S0166-2236(02)02272-5; Davuluri RV, 2008, TRENDS GENET, V24, P167, DOI 10.1016/j.tig.2008.01.008; Derkach VA, 2007, NAT REV NEUROSCI, V8, P101, DOI 10.1038/nrn2055; FUJIMOTO K, 1995, J CELL SCI, V108, P3443; Hammond RS, 2006, J NEUROSCI, V26, P1844, DOI 10.1523/JNEUROSCI.4106-05.2006; Harris AZ, 2008, J NEUROPHYSIOL, V99, P524, DOI 10.1152/jn.01169.2007; Kohler M, 1996, SCIENCE, V273, P1709, DOI 10.1126/science.273.5282.1709; Kye MJ, 2007, MOL CELL BIOCHEM, V300, P9, DOI 10.1007/s11010-006-9320-6; Lin MT, 2008, NAT NEUROSCI, V11, P170, DOI 10.1038/nn2041; Lin MT, 2010, J NEUROSCI, V30, P11726, DOI 10.1523/JNEUROSCI.1411-10.2010; Lu W, 2010, P NATL ACAD SCI USA, V107, P22266, DOI 10.1073/pnas.1016289107; Lujan R, 1996, EUR J NEUROSCI, V8, P1488, DOI 10.1111/j.1460-9568.1996.tb01611.x; Makino H, 2009, NEURON, V64, P381, DOI 10.1016/j.neuron.2009.08.035; Ngo-Anh TJ, 2005, NAT NEUROSCI, V8, P642, DOI 10.1038/nn1449; PETRALIA RS, 1992, J COMP NEUROL, V318, P329, DOI 10.1002/cne.903180309; Stackman RW, 2008, LEARN MEMORY, V15, P208, DOI 10.1101/lm.906808; Stackman RW, 2002, J NEUROSCI, V22, P10163; Stocker M, 1999, P NATL ACAD SCI USA, V96, P4662, DOI 10.1073/pnas.96.8.4662; Stocker M, 2000, MOL CELL NEUROSCI, V15, P476, DOI 10.1006/mcne.2000.0842; Strassmaier T, 2005, J BIOL CHEM, V280, P21231, DOI 10.1074/jbc.M413125200; van Zundert B, 2004, TRENDS NEUROSCI, V27, P428, DOI 10.1016/j.tins.2004.05.010; Vick KA, 2010, NEUROPHARMACOLOGY, V58, P650, DOI 10.1016/j.neuropharm.2009.11.008	28	48	50	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2011	14	6					744	U344		10.1038/nn.2832	http://dx.doi.org/10.1038/nn.2832			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	768SH	21602822	Green Accepted			2022-12-28	WOS:000290958000017
J	Lee, HHC; Deeb, TZ; Walker, JA; Davies, PA; Moss, SJ				Lee, Henry H. C.; Deeb, Tarek Z.; Walker, Joshua A.; Davies, Paul A.; Moss, Stephen J.			NMDA receptor activity downregulates KCC2 resulting in depolarizing GABA(A) receptor-mediated currents	NATURE NEUROSCIENCE			English	Article							TEMPORAL-LOBE EPILEPSY; K-CL COTRANSPORTER; CATION-CHLORIDE COTRANSPORTERS; NEURONAL-SPECIFIC ISOFORM; POSTNATAL RAT BRAINS; SPINAL-CORD-INJURY; HIPPOCAMPAL SLICE; NEUROPATHIC PAIN; GLUTAMATE; PHOSPHORYLATION	KCC2 is a neuron-specific K+-Cl- co-transporter that maintains a low intracellular Cl-concentration that is essential for hyperpolarizing inhibition mediated by GABA(A) receptors. Deficits in KCC2 activity occur in disease states associated with pathophysiological glutamate release. However, the mechanisms by which elevated glutamate alters KCC2 function are unknown. The phosphorylation of KCC2 residue Ser940 is known to regulate its surface activity. We found that NMDA receptor activity and Ca2+ influx caused the dephosphorylation of Ser940 in dissociated rat neurons, leading to a loss of KCC2 function that lasted longer than 20 min. Protein phosphatase 1 mediated the dephosphorylation events of Ser940 that coincided with a deficit in hyperpolarizing GABAergic inhibition resulting from the loss of KCC2 activity. Blocking dephosphorylation of Ser940 reduced the glutamate-induced downregulation of KCC2 and substantially improved the maintenance of hyperpolarizing GABAergic inhibition. Reducing the downregulation of KCC2 therefore has therapeutic potential in the treatment of neurological disorders.	[Lee, Henry H. C.; Deeb, Tarek Z.; Walker, Joshua A.; Davies, Paul A.; Moss, Stephen J.] Tufts Univ, Dept Neurosci, Boston, MA 02111 USA; [Moss, Stephen J.] UCL, Dept Neurosci Physiol & Pharmacol, London, England	Tufts University; University of London; University College London	Moss, SJ (corresponding author), Tufts Univ, Dept Neurosci, Boston, MA 02111 USA.	stephen.moss@tufts.edu	Davies, Paul A/P-4595-2017	Davies, Paul A/0000-0002-3973-3143; Lee, Henry/0000-0003-4975-7330	US National Institutes of Health/National Institute of Neurological Disorders and Stroke [NS036296, NS047478, NS048045, NS054900]; American Heart Association; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R29NS036296, R01NS047478, R01NS036296, R01NS081986, R21NS080064, P01NS054900, R01NS048045, R01NS051195] Funding Source: NIH RePORTER	US National Institutes of Health/National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Y. Haydon and L.K. Chau for critical comments on the manuscript and H. Tang and L. Silayeva for providing technical assistance. The work was supported in part by US National Institutes of Health/National Institute of Neurological Disorders and Stroke grants NS036296, NS047478, NS048045 and NS054900. H.H.C.L. is supported by a Postdoctoral Fellowship from the American Heart Association.	Banke TG, 2008, J PHYSIOL-LONDON, V586, P4925, DOI 10.1113/jphysiol.2008.157024; Banke TG, 2006, J NEUROSCI, V26, P11720, DOI 10.1523/JNEUROSCI.2887-06.2006; Ben-Ari Y, 2002, NAT REV NEUROSCI, V3, P728, DOI 10.1038/nrn920; Bladin CF, 2000, ARCH NEUROL-CHICAGO, V57, P1617, DOI 10.1001/archneur.57.11.1617; Blaesse P, 2009, NEURON, V61, P820, DOI 10.1016/j.neuron.2009.03.003; Cavus I, 2008, EPILEPSIA, V49, P1358, DOI 10.1111/j.1528-1167.2008.01603.x; Clarkson AN, 2010, NATURE, V468, P305, DOI 10.1038/nature09511; Cohen I, 2002, SCIENCE, V298, P1418, DOI 10.1126/science.1076510; COHEN P, 1989, ANNU REV BIOCHEM, V58, P453, DOI 10.1146/annurev.bi.58.070189.002321; Coull JAM, 2003, NATURE, V424, P938, DOI 10.1038/nature01868; Cramer SW, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-36; DURING MJ, 1993, LANCET, V341, P1607; Foldy C, 2010, NAT NEUROSCI, V13, P1047, DOI 10.1038/nn.2609; Galeffi F, 2004, J NEUROSCI, V24, P4478, DOI 10.1523/JNEUROSCI.0755-04.2004; Garrett MC, 2009, J CRIT CARE, V24, P335, DOI 10.1016/j.jcrc.2008.10.015; Ginsberg MD, 2008, NEUROPHARMACOLOGY, V55, P363, DOI 10.1016/j.neuropharm.2007.12.007; Hewitt SA, 2009, NAT NEUROSCI, V12, P438, DOI 10.1038/nn.2274; Huberfeld G, 2007, J NEUROSCI, V27, P9866, DOI 10.1523/JNEUROSCI.2761-07.2007; Hubner CA, 2001, NEURON, V30, P515, DOI 10.1016/S0896-6273(01)00297-5; Jaenisch N, 2010, STROKE, V41, pE151, DOI 10.1161/STROKEAHA.109.570424; Jin XM, 2005, J NEUROPHYSIOL, V93, P2117, DOI 10.1152/jn.00728.2004; Kahle KT, 2008, NAT CLIN PRACT NEURO, V4, P490, DOI 10.1038/ncpneuro0883; Kahle KT, 2005, P NATL ACAD SCI USA, V102, P16783, DOI 10.1073/pnas.0508307102; Kitamura A, 2008, NEUROSCI RES, V62, P270, DOI 10.1016/j.neures.2008.09.002; Kristensen BW, 2003, BRAIN RES, V973, P303, DOI 10.1016/S0006-8993(03)02550-2; Lee HHC, 2007, J BIOL CHEM, V282, P29777, DOI 10.1074/jbc.M705053200; Lee HHC, 2010, MOL CELL NEUROSCI, V45, P173, DOI 10.1016/j.mcn.2010.06.008; Lu J, 1999, J NEUROBIOL, V39, P558, DOI 10.1002/(SICI)1097-4695(19990615)39:4<558::AID-NEU9>3.0.CO;2-5; Lu Y, 2008, J PHYSIOL-LONDON, V586, P5701, DOI 10.1113/jphysiol.2008.152348; Nabekura J, 2002, J NEUROSCI, V22, P4412, DOI 10.1523/JNEUROSCI.22-11-04412.2002; Palma E, 2006, P NATL ACAD SCI USA, V103, P8465, DOI 10.1073/pnas.0602979103; Papp E, 2008, NEUROSCIENCE, V154, P677, DOI 10.1016/j.neuroscience.2008.03.072; Pathak HR, 2007, J NEUROSCI, V27, P14012, DOI 10.1523/JNEUROSCI.4390-07.2007; Payne JA, 1996, J BIOL CHEM, V271, P16245, DOI 10.1074/jbc.271.27.16245; Plotkin MD, 1997, J NEUROBIOL, V33, P781, DOI 10.1002/(SICI)1097-4695(19971120)33:6<781::AID-NEU6>3.0.CO;2-5; Price TJ, 2009, BRAIN RES REV, V60, P149, DOI 10.1016/j.brainresrev.2008.12.015; Rinehart J, 2009, CELL, V138, P525, DOI 10.1016/j.cell.2009.05.031; Rivera C, 2004, J NEUROSCI, V24, P4683, DOI 10.1523/JNEUROSCI.5265-03.2004; Rivera C, 1999, NATURE, V397, P251, DOI 10.1038/16697; Rivera C, 2002, J CELL BIOL, V159, P747, DOI 10.1083/jcb.200209011; Semah F, 1998, NEUROLOGY, V51, P1256, DOI 10.1212/WNL.51.5.1256; Staley K, 1996, NEURON, V17, P543, DOI 10.1016/S0896-6273(00)80186-5; Stephen LJ, 2001, EPILEPSIA, V42, P357, DOI 10.1046/j.1528-1157.2001.29000.x; THOMPSON SM, 1989, J NEUROPHYSIOL, V61, P512, DOI 10.1152/jn.1989.61.3.512; Toyoda H, 2003, J NEUROPHYSIOL, V89, P1353, DOI 10.1152/jn.00721.2002; Vargova L, 2001, J CEREBR BLOOD F MET, V21, P1077, DOI 10.1097/00004647-200109000-00005; Wake H, 2007, J NEUROSCI, V27, P1642, DOI 10.1523/JNEUROSCI.3104-06.2007; Watanabe M, 2009, J BIOL CHEM, V284, P27980, DOI 10.1074/jbc.M109.043620; Wu LA, 2009, NEUROSCI LETT, V457, P36, DOI 10.1016/j.neulet.2009.03.107	49	188	192	0	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2011	14	6					736	U390		10.1038/nn.2806	http://dx.doi.org/10.1038/nn.2806			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	768SH	21532577	Green Accepted			2022-12-28	WOS:000290958000016
J	Jo, J; Whitcomb, DJ; Olsen, KM; Kerrigan, TL; Lo, SC; Bru-Mercier, G; Dickinson, B; Scullion, S; Sheng, MG; Collingridge, G; Cho, K				Jo, Jihoon; Whitcomb, Daniel J.; Olsen, Kimberly Moore; Kerrigan, Talitha L.; Lo, Shih-Ching; Bru-Mercier, Gilles; Dickinson, Bryony; Scullion, Sarah; Sheng, Morgan; Collingridge, Graham; Cho, Kwangwook			A beta(1-42) inhibition of LTP is mediated by a signaling pathway involving caspase-3, Akt1 and GSK-3 beta	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; ALZHEIMERS-DISEASE; SYNAPTIC PLASTICITY; PROTEIN-KINASE; BETA; ACTIVATION; DEPRESSION; OLIGOMERS; MEMORY	Amyloid-beta(1-42) (A beta) is thought to be a major mediator of the cognitive deficits in Alzheimer's disease. The ability of A. to inhibit hippocampal long-term potentiation provides a cellular correlate of this action, but the underlying molecular mechanism is only partially understood. We found that a signaling pathway involving caspase-3, Akt1 and glycogen synthase kinase-3b is an important mediator of this effect in rats and mice.	[Jo, Jihoon; Whitcomb, Daniel J.; Kerrigan, Talitha L.; Bru-Mercier, Gilles; Dickinson, Bryony; Scullion, Sarah; Cho, Kwangwook] Univ Bristol, Sch Clin Sci, Fac Med & Dent, Henry Wellcome Labs Integrat Neurosci & Endocrino, Bristol, Avon, England; [Olsen, Kimberly Moore; Lo, Shih-Ching; Sheng, Morgan] Genentech Inc, Dept Neurosci, San Francisco, CA 94080 USA; [Scullion, Sarah; Collingridge, Graham; Cho, Kwangwook] Univ Bristol, MRC Ctr Synapt Plast, Bristol, Avon, England; [Collingridge, Graham] Univ Bristol, Sch Physiol & Pharmacol, Bristol, Avon, England	University of Bristol; Roche Holding; Genentech; University of Bristol; University of Bristol	Cho, K (corresponding author), Univ Bristol, Sch Clin Sci, Fac Med & Dent, Henry Wellcome Labs Integrat Neurosci & Endocrino, Bristol, Avon, England.	kei.cho@bristol.ac.uk	Kerrigan, Talitha/C-3759-2016; Collingridge, Graham L/C-4605-2015; collingridge, graham/AAI-8362-2020	Collingridge, Graham L/0000-0002-9572-5359; Kerrigan, Talitha/0000-0003-2158-567X; Whitcomb, Daniel/0000-0003-2703-1643; Cho, Kwangwook/0000-0001-6724-7073; Lo, Shih-Ching/0000-0002-5187-0730	UK Alzheimer's Research Trust; Biotechnology and Biological Sciences Research Council; Medical Research Council; Royal Society; BBSRC [BB/G003963/1] Funding Source: UKRI; MRC [MC_G1000734] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G003963/1] Funding Source: researchfish; Medical Research Council [MC_G1000734, G0601841B] Funding Source: researchfish	UK Alzheimer's Research Trust; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Royal Society(Royal Society of London); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by the UK Alzheimer's Research Trust (K. C.), Biotechnology and Biological Sciences Research Council (K. C.), Medical Research Council (G. L. C.) and The Royal Society (J.J.). G. L. C. is a World Class University International Scholar and D.J.W. is an UK Alzheimer's Research Trust-funded Ph.D. student.	Allen JW, 2001, J NEUROSCI RES, V65, P45, DOI 10.1002/jnr.1126; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Cho JH, 2004, J BIOL CHEM, V279, P54716, DOI 10.1074/jbc.M403364200; Chong YH, 2006, J BIOL CHEM, V281, P20315, DOI 10.1074/jbc.M601016200; Hsieh H, 2006, NEURON, V52, P831, DOI 10.1016/j.neuron.2006.10.035; Kotilinek LA, 2008, BRAIN, V131, P651, DOI 10.1093/brain/awn008; Li SM, 2009, NEURON, V62, P788, DOI 10.1016/j.neuron.2009.05.012; Li Z, 2010, CELL, V141, P859, DOI 10.1016/j.cell.2010.03.053; Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621; Palop JJ, 2010, NAT NEUROSCI, V13, P812, DOI 10.1038/nn.2583; Peineau S, 2007, NEURON, V53, P703, DOI 10.1016/j.neuron.2007.01.029; Phiel CJ, 2003, NATURE, V423, P435, DOI 10.1038/nature01640; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Wang QW, 2004, J NEUROSCI, V24, P3370, DOI 10.1523/JNEUROSCI.1633-03.2004	15	244	253	1	56	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2011	14	5					545	547		10.1038/nn.2785	http://dx.doi.org/10.1038/nn.2785			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	754VU	21441921				2022-12-28	WOS:000289886600007
J	Chen, Y; Wang, HB; Yoon, SO; Xu, XM; Hottiger, MO; Svaren, J; Nave, KA; Kim, HA; Olson, EN; Lu, QR				Chen, Ying; Wang, Haibo; Yoon, Sung Ok; Xu, Xiaomei; Hottiger, Michael O.; Svaren, John; Nave, Klaus A.; Kim, Haesun A.; Olson, Eric N.; Lu, Q. Richard			HDAC-mediated deacetylation of NF-kappa B is critical for Schwann cell myelination	NATURE NEUROSCIENCE			English	Article							PERIPHERAL-NERVE; DIFFERENTIATION; REMYELINATION; TRANSCRIPTION; RECEPTOR; GENES; MICE	Schwann cell myelination is tightly regulated by timely expression of key transcriptional regulators that respond to specific environmental cues, but the molecular mechanisms underlying such a process are poorly understood. We found that the acetylation state of NF-kappa B, which is regulated by histone deacetylases (HDACs) 1 and 2, is critical for orchestrating the myelination program. Mice lacking both HDACs 1 and 2 (HDAC1/2) exhibited severe myelin deficiency with Schwann cell development arrested at the immature stage. NF-kappa B p65 became heavily acetylated in HDAC1/2 mutants, inhibiting the expression of positive regulators of myelination and inducing the expression of differentiation inhibitors. We observed that the NF-.B protein complex switched from associating with p300 to associating with HDAC1/2 as Schwann cells differentiated. NF-kappa B and HDAC1/2 acted in a coordinated fashion to regulate the transcriptionally linked chromatin state for Schwann cell myelination. Thus, our results reveal an HDAC-mediated developmental switch for controlling myelination in the peripheral nervous system.	[Chen, Ying; Wang, Haibo; Xu, Xiaomei; Lu, Q. Richard] Univ Texas SW Med Ctr Dallas, Dept Dev Biol, Dallas, TX 75390 USA; [Chen, Ying; Wang, Haibo; Xu, Xiaomei; Lu, Q. Richard] Univ Texas SW Med Ctr Dallas, Kent Waldrep Fdn Ctr Basic Neurosci Res Nerve Gro, Dallas, TX 75390 USA; [Yoon, Sung Ok] Ohio State Univ, Dept Mol & Cellular Biochem, Ctr Mol Neurobiol, Columbus, OH 43210 USA; [Hottiger, Michael O.] Univ Zurich, Inst Vet Biochem & Mol Biol, CH-8001 Zurich, Switzerland; [Svaren, John] Univ Wisconsin, Dept Comparat Biosci, Madison, WI 53706 USA; [Svaren, John] Univ Wisconsin, Waisman Ctr, Madison, WI 53705 USA; [Nave, Klaus A.] Max Planck Inst Expt Med, Dept Neurogenet, D-37075 Gottingen, Germany; [Kim, Haesun A.] Rutgers State Univ, Dept Biol Sci, Newark, NJ 07102 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University System of Ohio; Ohio State University; University of Zurich; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Max Planck Society; Rutgers State University Newark; Rutgers State University New Brunswick	Lu, QR (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Dev Biol, Dallas, TX 75390 USA.	qrichard.lu@utsouthwestern.edu	Nave, Klaus-Armin/C-8883-2011; Yoon, Sung Ok/C-5992-2012; Svaren, John/A-1605-2010; Hottiger, Michael O./J-7747-2013	Svaren, John/0000-0003-2963-7921; Hottiger, Michael O./0000-0002-7323-2270	US National Institutes of Health [NS072427]; National Multiple Sclerosis Society [RG3978]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD003352] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS072427] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Multiple Sclerosis Society(National Multiple Sclerosis Society); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We would like to thank D. Meijer for Dhh-cre mice, B. Carter and J. Chan for critical comments, and P. Casaccia for initial discussions. We thank Q. Weng and Z. Ma for technical support, O. Nakagawa and J. Chen for the p300/CBP and p65/RelA expression vectors, and R. Kageyama for the Hes5 luciferase reporter. This study was funded in part by grants from the US National Institutes of Health (NS072427) and the National Multiple Sclerosis Society (RG3978) to Q.R.L.	Antonellis A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000174; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; BROCKES JP, 1979, BRAIN RES, V165, P105, DOI 10.1016/0006-8993(79)90048-9; Calao M, 2008, TRENDS BIOCHEM SCI, V33, P339, DOI 10.1016/j.tibs.2008.04.015; Chen LF, 2002, EMBO J, V21, P6539, DOI 10.1093/emboj/cdf660; Chen Y, 2009, NAT NEUROSCI, V12, P1398, DOI 10.1038/nn.2410; Fancy SPJ, 2009, GENE DEV, V23, P1571, DOI 10.1101/gad.1806309; Harada N, 1999, EMBO J, V18, P5931, DOI 10.1093/emboj/18.21.5931; He Y, 2010, NAT NEUROSCI, V13, P1472, DOI 10.1038/nn.2686; Jacob C, 2011, NAT NEUROSCI, V14, P429, DOI 10.1038/nn.2762; Jaegle M, 2003, GENE DEV, V17, P1380, DOI 10.1101/gad.258203; Jang SW, 2006, J NEUROCHEM, V98, P1678, DOI 10.1111/j.1471-4159.2006.04069.x; Jessen KR, 2005, NAT REV NEUROSCI, V6, P671, DOI 10.1038/nrn1746; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Nickols JC, 2003, NAT NEUROSCI, V6, P161, DOI 10.1038/nn995; Rothgiesser KM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-22; Shahbazian MD, 2007, ANNU REV BIOCHEM, V76, P75, DOI 10.1146/annurev.biochem.76.052705.162114; Shen SM, 2008, NAT NEUROSCI, V11, P1024, DOI 10.1038/nn.2172; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Suter U, 2003, NAT REV NEUROSCI, V4, P714, DOI 10.1038/nrn1196; Svaren J, 2008, GLIA, V56, P1541, DOI 10.1002/glia.20767; Ye F, 2009, NAT NEUROSCI, V12, P829, DOI 10.1038/nn.2333; Yeiser EC, 2004, J NEUROSCI, V24, P10521, DOI 10.1523/JNEUROSCI.1390-04.2004	23	142	146	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2011	14	4					437	U59		10.1038/nn.2780	http://dx.doi.org/10.1038/nn.2780			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	741FQ	21423191	Green Accepted			2022-12-28	WOS:000288849400014
J	Rancz, EA; Franks, KM; Schwarz, MK; Pichler, B; Schaefer, AT; Margrie, TW				Rancz, Ede A.; Franks, Kevin M.; Schwarz, Martin K.; Pichler, Bruno; Schaefer, Andreas T.; Margrie, Troy W.			Transfection via whole-cell recording in vivo: bridging single-cell physiology, genetics and connectomics	NATURE NEUROSCIENCE			English	Article							ENCODED CALCIUM INDICATOR; RABIES VIRUS; NEURONAL-ACTIVITY; CORTEX; NETWORKS; MICROSTIMULATION; TECHNOLOGIES; STIMULATION; INHIBITION; EXPRESSION	Single-cell genetic manipulation is expected to substantially advance the field of systems neuroscience. However, existing gene delivery techniques do not allow researchers to electrophysiologically characterize cells and to thereby establish an experimental link between physiology and genetics for understanding neuronal function. In the mouse brain in vivo, we found that neurons remained intact after 'blind' whole-cell recording, that DNA vectors could be delivered through the patch-pipette during such recordings and that these vectors drove protein expression in recorded cells for at least 7 d. To illustrate the utility of this approach, we recorded visually evoked synaptic responses in primary visual cortical cells while delivering DNA plasmids that allowed retrograde, monosynaptic tracing of each neuron's presynaptic inputs. By providing a biophysical profile of a cell before its specific genetic perturbation, this combinatorial method captures the synaptic and anatomical receptive field of a neuron.	[Rancz, Ede A.; Franks, Kevin M.; Schaefer, Andreas T.; Margrie, Troy W.] UCL, Dept Neurosci Physiol & Pharmacol, London, England; [Rancz, Ede A.; Pichler, Bruno; Margrie, Troy W.] Natl Inst Med Res, Div Neurophysiol, Mill Hill, England; [Franks, Kevin M.] Columbia Univ, Dept Neurosci, New York, NY USA; [Schwarz, Martin K.] Max Planck Inst Med Res, Dept Mol Neurobiol, Heidelberg, Germany; [Schaefer, Andreas T.] Max Planck Inst Med Res, SNWG Behav Neurophysiol, Heidelberg, Germany	University of London; University College London; MRC National Institute for Medical Research; Columbia University; Max Planck Society; Max Planck Society	Margrie, TW (corresponding author), UCL, Dept Neurosci Physiol & Pharmacol, London, England.	troy.margrie@nimr.mrc.ac.uk	Rancz, Ede Attila/AAS-6867-2020	Rancz, Ede Attila/0000-0002-7951-1385; Schaefer, Andreas/0000-0002-4677-8788	The Robert Leet and Clara Guthrie Patterson Trust; National Institute on Deafness and Other Communication Disorders (NIDCD) [K99]; The Max-Planck Gesellschaft; Medical Research Council (MRC); The Alexander Von Humboldt Foundation; Medical Research Council [MC_U117597156] Funding Source: researchfish; MRC [MC_U117597156] Funding Source: UKRI	The Robert Leet and Clara Guthrie Patterson Trust; National Institute on Deafness and Other Communication Disorders (NIDCD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); The Max-Planck Gesellschaft; Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); The Alexander Von Humboldt Foundation(Alexander von Humboldt Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	K. M. F. thanks S. Siegelbaum and R. Axel for support and encouragement and A. Mulligan for technical assistance. We also thank P. H. Seeburg for support; D. Castro, B. Matynoga and D. Drechsel for advice; K.-K. Conzelmann for rabies virus SAD-Delta G-mCherry; and P. Boross, E. Callaway, H. Wildner and F. Guillemot for discussions and reagents. E.A.R. is a Sir Henry Wellcome Postdoctoral Fellow. This work was supported by The Robert Leet and Clara Guthrie Patterson Trust and a National Institute on Deafness and Other Communication Disorders (NIDCD) K99 grant (K.M.F.), The Max-Planck Gesellschaft (A.T.S., M.K.S.), the Medical Research Council (MRC) and The Alexander Von Humboldt Foundation (T.W.M.).	Arenkiel BR, 2009, NATURE, V461, P900, DOI 10.1038/nature08536; Arenz A, 2008, SCIENCE, V321, P977, DOI 10.1126/science.1158391; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Brecht M, 2004, J COMP NEUROL, V479, P360, DOI 10.1002/cne.20306; Brecht M, 2004, NATURE, V427, P704, DOI 10.1038/nature02266; Cetin A, 2006, NAT PROTOC, V1, P3166, DOI 10.1038/nprot.2006.450; Conchello JA, 2005, NAT METHODS, V2, P920, DOI 10.1038/NMETH815; de Kock CPJ, 2009, P NATL ACAD SCI USA, V106, P16446, DOI 10.1073/pnas.0904143106; Douglas RJ, 2007, NEURON, V56, P226, DOI 10.1016/j.neuron.2007.10.017; EILERS J, 2005, IMAGING NEUROSCIENCE, P277; Epsztein J, 2010, SCIENCE, V327, P474, DOI 10.1126/science.1182773; FERSTER D, 1987, J NEUROSCI, V7, P1780; Geschwind DH, 2009, NATURE, V461, P908, DOI 10.1038/nature08537; Gradinaru V, 2010, CELL, V141, P154, DOI 10.1016/j.cell.2010.02.037; Harvey CD, 2009, NATURE, V461, P941, DOI 10.1038/nature08499; Helmchen F, 2005, NAT METHODS, V2, P932, DOI 10.1038/NMETH818; Hromadka T, 2008, PLOS BIOL, V6, P124, DOI 10.1371/journal.pbio.0060016; Huber D, 2008, NATURE, V451, P61, DOI 10.1038/nature06445; Kitamura K, 2008, NAT METHODS, V5, P61, DOI 10.1038/NMETH1150; Kleinfeld D, 2005, PLOS BIOL, V3, P1685, DOI 10.1371/journal.pbio.0030355; Komai S, 2006, NAT NEUROSCI, V9, P1125, DOI 10.1038/nn1752; Kugler S, 2003, GENE THER, V10, P337, DOI 10.1038/sj.gt.3301905; Le Be JV, 2006, P NATL ACAD SCI USA, V103, P13214, DOI 10.1073/pnas.0604691103; Lee AK, 2009, NAT PROTOC, V4, P385, DOI 10.1038/nprot.2009.5; Lichtman JW, 2008, NAT REV NEUROSCI, V9, P417, DOI 10.1038/nrn2391; Loewenstein Y, 2005, NAT NEUROSCI, V8, P202, DOI 10.1038/nn1393; Lutcke H, 2010, FRONT NEURAL CIRCUIT, V4, DOI 10.3389/fncir.2010.00009; Luo L, 2008, NEURON, V57, P634, DOI 10.1016/j.neuron.2008.01.002; Mank M, 2008, NAT METHODS, V5, P805, DOI 10.1038/NMETH.1243; Margrie TW, 2003, NEURON, V39, P911, DOI 10.1016/j.neuron.2003.08.012; Margrie TW, 2002, PFLUG ARCH EUR J PHY, V444, P491, DOI 10.1007/s00424-002-0831-z; Margrie TW, 2001, P NATL ACAD SCI USA, V98, P319, DOI 10.1073/pnas.011523098; Marino J, 2005, NAT NEUROSCI, V8, P194, DOI 10.1038/nn1391; Marshel JH, 2010, NEURON, V67, P562, DOI 10.1016/j.neuron.2010.08.001; Mebatsion T, 1996, CELL, V84, P941, DOI 10.1016/S0092-8674(00)81072-7; Mebatsion T, 2001, J VIROL, V75, P11496, DOI 10.1128/JVI.75.23.11496-11502.2001; Nevian T, 2007, PFLUG ARCH EUR J PHY, V454, P675, DOI 10.1007/s00424-007-0234-2; O'Connor DH, 2009, NATURE, V461, P923, DOI 10.1038/nature08539; Ohki K, 2005, NATURE, V433, P597, DOI 10.1038/nature03274; Rochefort NL, 2009, P NATL ACAD SCI USA, V106, P15049, DOI 10.1073/pnas.0907660106; Scanziani M, 2009, NATURE, V461, P930, DOI 10.1038/nature08540; Stosiek C, 2003, P NATL ACAD SCI USA, V100, P7319, DOI 10.1073/pnas.1232232100; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; UGOLINI G, 1995, J COMP NEUROL, V356, P457, DOI 10.1002/cne.903560312; Ugolini G, 2010, J NEUROSCI METH, V194, P2, DOI 10.1016/j.jneumeth.2009.12.001; Waters J, 2003, J NEUROSCI, V23, P8558; Wehr M, 2003, NATURE, V426, P442, DOI 10.1038/nature02116; Wickersham IR, 2007, NEURON, V53, P639, DOI 10.1016/j.neuron.2007.01.033; Zhang F, 2007, NAT REV NEUROSCI, V8, P577, DOI 10.1038/nrn2192; Zhang F, 2006, NAT METHODS, V3, P785, DOI 10.1038/nmeth936	50	95	96	0	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2011	14	4					527	U169		10.1038/nn.2765	http://dx.doi.org/10.1038/nn.2765			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	741FQ	21336272	Green Accepted			2022-12-28	WOS:000288849400025
J	Hakeda-Suzuki, S; Berger-Muller, S; Tomasi, T; Usui, T; Horiuchi, S; Uemura, T; Suzuki, T				Hakeda-Suzuki, Satoko; Berger-Mueller, Sandra; Tomasi, Tatiana; Usui, Tadao; Horiuchi, Shin-ya; Uemura, Tadashi; Suzuki, Takashi			Golden Goal collaborates with Flamingo in conferring synaptic-layer specificity in the visual system	NATURE NEUROSCIENCE			English	Article							7-PASS TRANSMEMBRANE CADHERIN; AXON-TARGET INTERACTIONS; DROSOPHILA; PROTEIN; RECEPTOR; SELECTION; POLARITY; NEURONS; CONNECTIONS; MOLECULES	Neuronal connections are often organized in layers that contain synapses between neurons that have similar functions. In Drosophila, R7 and R8 photoreceptors, which detect different wavelengths, form synapses in distinct medulla layers. The mechanisms underlying the specificity of synaptic-layer selection remain unclear. We found that Golden Goal (Gogo) and Flamingo (Fmi), two cell-surface proteins involved in photoreceptor targeting, functionally interact in R8 photoreceptor axons. Our results indicate that Gogo promotes R8 photoreceptor axon adhesion to the temporary layer M1, whereas Gogo and Fmi collaborate to mediate axon targeting to the final layer M3. Structure-function analysis suggested that Gogo and Fmi interact with intracellular components through the Gogo cytoplasmic domain. Moreover, Fmi was also required in target cells for R8 photoreceptor axon targeting. We propose that Gogo acts as a functional partner of Fmi for R8 photoreceptor axon targeting and that the dynamic regulation of their interaction specifies synaptic-layer selection of photoreceptors.	[Hakeda-Suzuki, Satoko; Berger-Mueller, Sandra; Tomasi, Tatiana; Suzuki, Takashi] Max Planck Inst Neurobiol, Martinsried, Germany; [Usui, Tadao; Horiuchi, Shin-ya; Uemura, Tadashi] Kyoto Univ, Grad Sch Biostudies, Kyoto, Japan; [Uemura, Tadashi] Japan Sci & Technol Agcy, CREST, Kyoto, Japan	Max Planck Society; Kyoto University; Japan Science & Technology Agency (JST)	Suzuki, T (corresponding author), Max Planck Inst Neurobiol, Martinsried, Germany.	suzukit@neuro.mpg.de	Suzuki, Takashi/D-3651-2019; Hakeda-suzuki, Satoko/AAU-5348-2020	Suzuki, Takashi/0000-0001-9093-2562; Hakeda-suzuki, Satoko/0000-0001-8749-1479; UEMURA, Tadashi/0000-0001-7204-3606; Usui, Tadao/0000-0002-0507-1495	Max Planck Society; Deutsche Forschungsgemeinschaft	Max Planck Society(Max Planck Society); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank N. Hengrung for helping with BiFC experiments, I. Siwanowicz for helping with agarose sections and M. Braun for electron microscopy sections. We thank I. Salecker, T. Clandinin, J. Axelrod, D. Strutt, B. Dickson, K. Keleman, H. Oda, H. Bellen, J. Morante, J. Smith, Developmental Studies Hybridoma Bank (University of Iowa), Drosophila Genetic Resource Center (Kyoto), Exelixis Collection at Harvard and Bloomington Stock Center for reagents, and FlyBase for information resources. We thank R. Klein, F. Schnorrer, J. Egea for suggestions and comments, and members of the Suzuki laboratory for critical discussions. This work was supported by the Max Planck Society and an individual grant from the Deutsche Forschungsgemeinschaft (T.S.).	Astigarraga S, 2010, CURR OPIN GENET DEV, V20, P400, DOI 10.1016/j.gde.2010.04.001; Bazigou E, 2007, CELL, V128, P961, DOI 10.1016/j.cell.2007.02.024; Berger J, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000085; Chen PL, 2008, NEURON, V58, P26, DOI 10.1016/j.neuron.2008.01.007; Chen WS, 2008, CELL, V133, P1093, DOI 10.1016/j.cell.2008.04.048; Clandinin TR, 2001, NEURON, V32, P237, DOI 10.1016/S0896-6273(01)00474-3; Gajadhar A, 2010, BIOTECHNIQUES, V48, P145, DOI 10.2144/000113354; Gao FB, 2000, NEURON, V28, P91, DOI 10.1016/S0896-6273(00)00088-X; Garrity PA, 1999, NEURON, V22, P707, DOI 10.1016/S0896-6273(00)80730-8; Grueber WB, 2002, DEVELOPMENT, V129, P2867; Huberman AD, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001743; Keleman K, 2001, NEURON, V32, P605, DOI 10.1016/S0896-6273(01)00505-0; Kimura H, 2006, J CELL SCI, V119, P1118, DOI 10.1242/jcs.02832; Lee CH, 2001, NEURON, V30, P437, DOI 10.1016/S0896-6273(01)00291-4; Lee RC, 2003, NAT NEUROSCI, V6, P557, DOI 10.1038/nn1063; Luo LQ, 2007, NEURON, V56, P284, DOI 10.1016/j.neuron.2007.10.014; Mast JD, 2006, SEMIN CELL DEV BIOL, V17, P42, DOI 10.1016/j.semcdb.2005.11.004; Maurel-Zaffran C, 2001, NEURON, V32, P225, DOI 10.1016/S0896-6273(01)00471-8; MCGUIRE SE, 2004, SCI STKE, pPL6; Nern A, 2008, NEURON, V58, P34, DOI 10.1016/j.neuron.2008.03.022; Newsome TP, 2000, DEVELOPMENT, V127, P851; Saka Y, 2008, METHODS, V45, P192, DOI 10.1016/j.ymeth.2008.06.005; Sanes JR, 2010, NEURON, V66, P15, DOI 10.1016/j.neuron.2010.01.018; Sanes JR, 2009, ANNU REV CELL DEV BI, V25, P161, DOI 10.1146/annurev.cellbio.24.110707.175402; Senti KA, 2003, CURR BIOL, V13, P828, DOI 10.1016/S0960-9822(03)00291-4; Shima Y, 2004, DEV CELL, V7, P205, DOI 10.1016/j.devcel.2004.07.007; Shima Y, 2007, NAT NEUROSCI, V10, P963, DOI 10.1038/nn1933; Shinza-Kameda M, 2006, NEURON, V49, P205, DOI 10.1016/j.neuron.2005.11.013; Shishido E, 1998, SCIENCE, V280, P2118, DOI 10.1126/science.280.5372.2118; STRUHL G, 1993, CELL, V72, P527, DOI 10.1016/0092-8674(93)90072-X; Strutt H, 2008, CURR BIOL, V18, P1555, DOI 10.1016/j.cub.2008.08.063; Takemura SY, 2008, J COMP NEUROL, V509, P493, DOI 10.1002/cne.21757; Ting CY, 2007, CURR OPIN NEUROBIOL, V17, P65, DOI 10.1016/j.conb.2006.12.004; Ting CY, 2005, DEVELOPMENT, V132, P953, DOI 10.1242/dev.01661; Tomasi T, 2008, NEURON, V57, P691, DOI 10.1016/j.neuron.2008.01.012; Usui T, 1999, CELL, V98, P585, DOI 10.1016/S0092-8674(00)80046-X; Vladar EK, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002964; Yamagata M, 2002, CELL, V110, P649, DOI 10.1016/S0092-8674(02)00910-8; Yamagata M, 2008, NATURE, V451, P465, DOI 10.1038/nature06469	39	47	47	1	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2011	14	3					314	323		10.1038/nn.2756	http://dx.doi.org/10.1038/nn.2756			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	725MW	21317905				2022-12-28	WOS:000287650100011
J	Freedman, DJ; Assad, JA				Freedman, David J.; Assad, John A.			A proposed common neural mechanism for categorization and perceptual decisions	NATURE NEUROSCIENCE			English	Article							LATERAL INTRAPARIETAL AREA; POSTERIOR PARIETAL CORTEX; EYE FIELD; REPRESENTATION; NEURONS; MACAQUE; MONKEY; CONNECTIONS; ATTENTION; INTENTION	One of the most fascinating issues in neuroscience is how the brain makes decisions. Recent evidence points to the parietal cortex as an important locus for certain kinds of decisions. Because parietal neurons are also involved in movements, it has been proposed that decisions are encoded in an intentional, action-based framework based on the movements used to report decisions. An alternative or complementary view is that decisions represent more abstract information not linked to movements per se. Parallel experiments on categorization suggest that parietal neurons can indeed represent abstract categorical outcomes that are not linked to movements. This could provide a unified or complementary view of how the brain decides and categorizes.	[Freedman, David J.] Univ Chicago, Dept Neurobiol, Chicago, IL 60637 USA; [Assad, John A.] Italian Inst Technol, Ctr Neurosci & Cognit Syst, Rovereto, Italy; [Assad, John A.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	University of Chicago; Istituto Italiano di Tecnologia - IIT; Harvard University; Harvard Medical School	Freedman, DJ (corresponding author), Univ Chicago, Dept Neurobiol, Chicago, IL 60637 USA.	dfreedman@uchicago.edu; jassad@hms.harvard.edu						Andersen R A, 1992, Curr Opin Neurobiol, V2, P840, DOI 10.1016/0959-4388(92)90143-9; BENNUR S, J NEUROSCI IN PRESS; Bisley JW, 2010, ANNU REV NEUROSCI, V33, P1, DOI 10.1146/annurev-neuro-060909-152823; BLATT GJ, 1990, J COMP NEUROL, V299, P421, DOI 10.1002/cne.902990404; Ferrera VP, 2009, NAT NEUROSCI, V12, P1458, DOI 10.1038/nn.2434; Freedman DJ, 2006, NATURE, V443, P85, DOI 10.1038/nature05078; Freedman DJ, 2009, J NEUROSCI, V29, P5671, DOI 10.1523/JNEUROSCI.2878-08.2009; Freedman DJ, 2001, SCIENCE, V291, P312, DOI 10.1126/science.291.5502.312; Freedman DJ, 2003, J NEUROSCI, V23, P5235; Glimcher PW, 2004, SCIENCE, V306, P447, DOI 10.1126/science.1102566; Glimcher PW, 2003, BRADFORD BOOKS, P1; Gold JI, 2003, J NEUROSCI, V23, P632, DOI 10.1523/JNEUROSCI.23-02-00632.2003; Gold JI, 2007, ANNU REV NEUROSCI, V30, P535, DOI 10.1146/annurev.neuro.29.051605.113038; Goldberg ME, 2006, PROG BRAIN RES, V155, P157, DOI 10.1016/S0079-6123(06)55010-1; Gottlieb J, 2007, NEURON, V53, P9, DOI 10.1016/j.neuron.2006.12.009; Huk AC, 2005, J NEUROSCI, V25, P10420, DOI 10.1523/JNEUROSCI.4684-04.2005; Kable JW, 2009, NEURON, V63, P733, DOI 10.1016/j.neuron.2009.09.003; Lewis JW, 2000, J COMP NEUROL, V428, P112, DOI 10.1002/1096-9861(20001204)428:1<112::AID-CNE8>3.0.CO;2-9; MAUNSELL JHR, 1987, ANNU REV NEUROSCI, V10, P363, DOI 10.1146/annurev.ne.10.030187.002051; Miller EK, 2003, CURR OPIN NEUROBIOL, V13, P198, DOI 10.1016/S0959-4388(03)00037-0; NEWSOME WT, 1989, NATURE, V341, P52, DOI 10.1038/341052a0; PADOASCHIOPPA C, ANN REV NEU IN PRESS; Roitman JD, 2002, J NEUROSCI, V22, P9475; Shadlen MN, 2001, J NEUROPHYSIOL, V86, P1916, DOI 10.1152/jn.2001.86.4.1916; Shadlen MN, 2008, BETTER CONSCIOUS DEC, P71, DOI 10.7551/mitpress/9780262195805.003.0004; Snyder LH, 2000, VISION RES, V40, P1433, DOI 10.1016/S0042-6989(00)00052-3; Stoet G, 2004, NEURON, V42, P1003, DOI 10.1016/j.neuron.2004.06.003; Toth LJ, 2002, NATURE, V415, P165, DOI 10.1038/415165a; Williams ZM, 2003, NAT NEUROSCI, V6, P616, DOI 10.1038/nn1055; Wunderlich K, 2009, P NATL ACAD SCI USA, V106, P17199, DOI 10.1073/pnas.0901077106	31	91	92	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2011	14	2					143	146		10.1038/nn.2740	http://dx.doi.org/10.1038/nn.2740			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	711MJ	21270782				2022-12-28	WOS:000286595400009
J	Jeanneteau, F; Deinhardt, K; Miyoshi, G; Bennett, AM; Chao, MV				Jeanneteau, Freddy; Deinhardt, Katrin; Miyoshi, Goichi; Bennett, Anton M.; Chao, Moses V.			The MAP kinase phosphatase MKP-1 regulates BDNF-induced axon branching	NATURE NEUROSCIENCE			English	Article							IN-VIVO; NEUROTROPHIC FACTOR; CATALYTIC ACTIVATION; TYROSINE-PHOSPHATASE; HIPPOCAMPAL-NEURONS; NERVOUS-SYSTEM; ARBOR GROWTH; PROTEIN; GENE; EXPRESSION	The refinement of neural circuits during development depends on a dynamic process of branching of axons and dendrites that leads to synapse formation and connectivity. The neurotrophin brain-derived neurotrophic factor (BDNF) is essential for the outgrowth and activity-dependent remodeling of axonal arbors in vivo. However, the mechanisms that translate extracellular signals into the formation of axonal branches are incompletely understood. We found that MAP kinase phosphatase-1 (MKP-1) controls axon branching. MKP-1 expression induced by BDNF signaling caused spatiotemporal deactivation of c-jun N-terminal kinase (JNK), which reduced the phosphorylation of JNK substrates that destabilize microtubules. Indeed, neurons from mkp-1 null mice could not produce axon branches in response to BDNF. Our results identify a signaling mechanism that regulates axonal branching and provide a framework for studying the molecular mechanisms of innervation and axonal remodeling under normal and pathological conditions.	[Jeanneteau, Freddy; Deinhardt, Katrin; Chao, Moses V.] Skirball Inst Biomol Med, Mol Neurobiol Program, New York, NY USA; [Miyoshi, Goichi] New York Univ Langone Sch Med, Smilow Neurosci Program, New York, NY USA; [Bennett, Anton M.] Yale Univ Sch Med, Dept Pharmacol, New Haven, CT USA	New York University; Yale University	Jeanneteau, F (corresponding author), Skirball Inst Biomol Med, Mol Neurobiol Program, New York, NY USA.	freddy.jeanneteau@med.nyu.edu; katrin.deinhardt@med.nyu.edu	Jeanneteau, Freddy/AAC-7052-2021; Miyoshi, Goichi/H-4759-2012; Miyoshi, Goichi/O-2029-2019	Jeanneteau, freddy/0000-0002-9606-2892; Deinhardt, Katrin/0000-0002-6473-5298; Chao, Moses/0000-0002-6969-3744; Bennett, Anton/0000-0001-5187-7599	National Alliance for Research on Schizophrenia and Depression; Human Frontier Science Program Organization; US National Institutes of Health [NS21072, HD23315, R01 AR46504]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD023315] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR046504] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK075776] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH086651] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS021072] Funding Source: NIH RePORTER	National Alliance for Research on Schizophrenia and Depression(NARSAD); Human Frontier Science Program Organization(Human Frontier Science Program); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by the National Alliance for Research on Schizophrenia and Depression (F.J. and G. M.), the Human Frontier Science Program Organization (K. D.) and grants from the US National Institutes of Health to M. V. C. (NS21072 and HD23315) and A. M. B. (R01 AR46504).	Alsina B, 2001, NAT NEUROSCI, V4, P1093, DOI 10.1038/nn735; Balkowiec A, 2000, J NEUROSCI, V20, P7417, DOI 10.1523/jneurosci.20-19-07417.2000; Baquet ZC, 2004, J NEUROSCI, V24, P4250, DOI 10.1523/JNEUROSCI.3920-03.2004; Bartkowska K, 2007, DEVELOPMENT, V134, P4369, DOI 10.1242/dev.008227; Bogoyevitch MA, 2006, MICROBIOL MOL BIOL R, V70, P1061, DOI 10.1128/MMBR.00025-06; Boutros T, 2008, PHARMACOL REV, V60, P261, DOI 10.1124/pr.107.00106; Brondello JM, 1999, SCIENCE, V286, P2514, DOI 10.1126/science.286.5449.2514; Camps M, 1998, SCIENCE, V280, P1262, DOI 10.1126/science.280.5367.1262; CARRASCO D, 1993, CELL GROWTH DIFFER, V4, P849; Chang LF, 2003, DEV CELL, V4, P521, DOI 10.1016/S1534-5807(03)00094-7; CHAO MV, 1992, CELL, V68, P995, DOI 10.1016/0092-8674(92)90068-N; COHENCORY S, 1995, NATURE, V378, P192, DOI 10.1038/378192a0; Conde C, 2009, NAT REV NEUROSCI, V10, P319, DOI 10.1038/nrn2631; Cox LJ, 2008, NAT CELL BIOL, V10, P149, DOI 10.1038/ncb1677; Curmi PA, 1999, CELL STRUCT FUNCT, V24, P345; Danzer SC, 2002, J NEUROSCI, V22, P9754; Davis S, 2000, J NEUROSCI, V20, P4563, DOI 10.1523/JNEUROSCI.20-12-04563.2000; DISTEFANO PS, 1992, NEURON, V8, P983, DOI 10.1016/0896-6273(92)90213-W; Doi M, 2007, J BIOL RHYTHM, V22, P127, DOI 10.1177/0748730406298332; Dorfman K, 1996, ONCOGENE, V13, P925; Gerecke KM, 2004, MOL CELL NEUROSCI, V27, P379, DOI 10.1016/j.mcn.2004.08.001; Glorioso C, 2006, MOL PSYCHIATR, V11, P633, DOI 10.1038/sj.mp.4001835; Huang JK, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-59; Hutchins BI, 2008, J NEUROSCI, V28, P143, DOI 10.1523/JNEUROSCI.4548-07.2008; Ibanez CF, 2007, TRENDS CELL BIOL, V17, P519, DOI 10.1016/j.tcb.2007.09.003; Jeanneteau F, 2008, P NATL ACAD SCI USA, V105, P4862, DOI 10.1073/pnas.0709102105; KEYSE SM, 1992, NATURE, V359, P644, DOI 10.1038/359644a0; Langevin LM, 2007, DEV DYNAM, V236, P1273, DOI 10.1002/dvdy.21126; Levin-Salomon V, 2008, J BIOL CHEM, V283, P34500, DOI 10.1074/jbc.M806443200; Li Z, 2000, NAT NEUROSCI, V3, P217, DOI 10.1038/72920; Lin YW, 2006, J BIOL CHEM, V281, P915, DOI 10.1074/jbc.M508720200; MAISONPIERRE PC, 1990, NEURON, V5, P501, DOI 10.1016/0896-6273(90)90089-X; Markus A, 2002, CURR OPIN NEUROBIOL, V12, P523, DOI 10.1016/S0959-4388(02)00372-0; Marshak S, 2007, J NEUROSCI, V27, P2444, DOI 10.1523/JNEUROSCI.4434-06.2007; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Martinez A, 1998, J NEUROSCI, V18, P7336; McAllister AK, 1999, ANNU REV NEUROSCI, V22, P295, DOI 10.1146/annurev.neuro.22.1.295; Meijering E, 2004, CYTOM PART A, V58A, P167, DOI 10.1002/cyto.a.20022; Miyoshi G, 2010, J NEUROSCI, V30, P1582, DOI 10.1523/JNEUROSCI.4515-09.2010; Oliva AA, 2006, J NEUROSCI, V26, P9462, DOI 10.1523/JNEUROSCI.2625-06.2006; Owens DM, 2007, ONCOGENE, V26, P3203, DOI 10.1038/sj.onc.1210412; Poulain FE, 2007, MOL CELL NEUROSCI, V34, P137, DOI 10.1016/j.mcn.2006.10.012; Rico B, 2002, NAT NEUROSCI, V5, P225, DOI 10.1038/nn808; Saito T, 2001, DEV BIOL, V240, P237, DOI 10.1006/dbio.2001.0439; Slack DN, 2001, J BIOL CHEM, V276, P16491, DOI 10.1074/jbc.M010966200; Suh LH, 2004, J NEUROSCI, V24, P1976, DOI 10.1523/JNEUROSCI.1670-03.2004; Tararuk T, 2006, J CELL BIOL, V173, P265, DOI 10.1083/jcb.200511055; Waetzig V, 2005, TRENDS PHARMACOL SCI, V26, P455, DOI 10.1016/j.tips.2005.07.006; WISE SP, 1976, J COMP NEUROL, V168, P313, DOI 10.1002/cne.901680302; Wu JJ, 2006, CELL METAB, V4, P61, DOI 10.1016/j.cmet.2006.05.010	50	115	118	0	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2010	13	11					1373	U103		10.1038/nn.2655	http://dx.doi.org/10.1038/nn.2655			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	673KI	20935641	Green Accepted			2022-12-28	WOS:000283658200018
J	Padmanabhan, K; Urban, NN				Padmanabhan, Krishnan; Urban, Nathaniel N.			Intrinsic biophysical diversity decorrelates neuronal firing while increasing information content	NATURE NEUROSCIENCE			English	Article							RAT OLFACTORY-BULB; PYRAMIDAL NEURONS; NEOCORTICAL NEURONS; MITRAL/TUFTED CELLS; ODOR DISCRIMINATION; LATERAL INHIBITION; ANTENNAL LOBE; SENSORY INPUT; RELIABILITY; CIRCUIT	Although examples of variation and diversity exist throughout the nervous system, their importance remains a source of debate. Even neurons of the same molecular type have notable intrinsic differences. Largely unknown, however, is the degree to which these differences impair or assist neural coding. We examined the outputs from a single type of neuron, the mitral cells of the mouse olfactory bulb, to identical stimuli and found that each cell's spiking response was dictated by its unique biophysical fingerprint. Using this intrinsic heterogeneity, diverse populations were able to code for twofold more information than their homogeneous counterparts. In addition, biophysical variability alone reduced pair-wise output spike correlations to low levels. Our results indicate that intrinsic neuronal diversity is important for neural coding and is not simply the result of biological imprecision.	[Padmanabhan, Krishnan; Urban, Nathaniel N.] Carnegie Mellon Univ, Dept Biol Sci, Pittsburgh, PA 15213 USA; [Padmanabhan, Krishnan; Urban, Nathaniel N.] Ctr Neural Basis Cognit, Pittsburgh, PA USA; [Urban, Nathaniel N.] Univ Pittsburgh, Dept Neurosci, Pittsburgh, PA USA	Carnegie Mellon University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Urban, NN (corresponding author), Carnegie Mellon Univ, Dept Biol Sci, 4400 5th Ave, Pittsburgh, PA 15213 USA.	nurban@cmu.edu	Urban, Nathaniel/A-4974-2008	Urban, Nathaniel/0000-0002-0365-9068	National Institute on Deafness and Other Communication Disorders [R01DC0005798]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005798, R01DC011184] Funding Source: NIH RePORTER	National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We wish to thank G.M. LaRocca for assistance with the immunohistochemistry and B. Benedetti, A. Barth, J. Castro and members of the Urban laboratory for helpful comments on this manuscript. Funding was provided by the National Institute on Deafness and Other Communication Disorders (R01DC0005798).	Arevian AC, 2008, NAT NEUROSCI, V11, P80, DOI 10.1038/nn2030; Bazhenov M, 2001, NEURON, V30, P553, DOI 10.1016/S0896-6273(01)00284-7; Brody CD, 2003, NEURON, V37, P843, DOI 10.1016/S0896-6273(03)00120-X; BRYANT HL, 1976, J PHYSIOL-LONDON, V260, P279, DOI 10.1113/jphysiol.1976.sp011516; Chen TW, 2009, P NATL ACAD SCI USA, V106, P2401, DOI 10.1073/pnas.0810151106; Chen WR, 1997, BRAIN RES, V745, P189, DOI 10.1016/S0006-8993(96)01150-X; Chou YH, 2010, NAT NEUROSCI, V13, P439, DOI 10.1038/nn.2489; Day M, 2005, J NEUROSCI, V25, P8776, DOI 10.1523/JNEUROSCI.2650-05.2005; Desai NS, 1999, NAT NEUROSCI, V2, P515, DOI 10.1038/9165; Ecker AS, 2010, SCIENCE, V327, P584, DOI 10.1126/science.1179867; Ermentrout GB, 2008, TRENDS NEUROSCI, V31, P428, DOI 10.1016/j.tins.2008.06.002; Ermentrout GB, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.248103; Friedrich RW, 2001, SCIENCE, V291, P889, DOI 10.1126/science.291.5505.889; Galan RF, 2006, J NEUROSCI, V26, P3646, DOI 10.1523/JNEUROSCI.4605-05.2006; Galan RF, 2008, J NEUROPHYSIOL, V99, P277, DOI 10.1152/jn.00563.2007; Geffen MN, 2009, NEURON, V61, P570, DOI 10.1016/j.neuron.2009.01.021; Goaillard JM, 2009, NAT NEUROSCI, V12, P1424, DOI 10.1038/nn.2404; Gupta A, 2000, SCIENCE, V287, P273, DOI 10.1126/science.287.5451.273; Kashiwadani H, 1999, J NEUROPHYSIOL, V82, P1786, DOI 10.1152/jn.1999.82.4.1786; Kazama H, 2009, NAT NEUROSCI, V12, P1136, DOI 10.1038/nn.2376; Laurent G, 2001, ANNU REV NEUROSCI, V24, P263, DOI 10.1146/annurev.neuro.24.1.263; MAINEN ZF, 1995, SCIENCE, V268, P1503, DOI 10.1126/science.7770778; Mainen ZF, 1996, NATURE, V382, P363, DOI 10.1038/382363a0; Marder E, 2006, NAT REV NEUROSCI, V7, P563, DOI 10.1038/nrn1949; Margrie TW, 2001, P NATL ACAD SCI USA, V98, P319, DOI 10.1073/pnas.011523098; MEISTER M, 1994, J NEUROSCI METH, V51, P95, DOI 10.1016/0165-0270(94)90030-2; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Osborne LC, 2008, J NEUROSCI, V28, P13522, DOI 10.1523/JNEUROSCI.4390-08.2008; Ramon y Cajal S, 1952, B LOS ANGEL NEURO SO, V17, P5; Renart A, 2010, SCIENCE, V327, P587, DOI 10.1126/science.1179850; Salinas E, 2001, NAT REV NEUROSCI, V2, P539, DOI 10.1038/35086012; Schaefer AT, 2006, PLOS BIOL, V4, P1010, DOI 10.1371/journal.pbio.0040163; Schaefer AT, 2003, J NEUROPHYSIOL, V89, P3143, DOI 10.1152/jn.00046.2003; Schoppa NE, 1999, NAT NEUROSCI, V2, P1106, DOI 10.1038/16033; Schulz DJ, 2006, NAT NEUROSCI, V9, P356, DOI 10.1038/nn1639; Schwartz O, 2006, J VISION, V6, P484, DOI 10.1167/6.4.13; Stocks NG, 2000, PHYS REV LETT, V84, P2310, DOI 10.1103/PhysRevLett.84.2310; Stopfer M, 1997, NATURE, V390, P70, DOI 10.1038/36335; Sugino K, 2006, NAT NEUROSCI, V9, P99, DOI 10.1038/nn1618; Taylor AL, 2009, J NEUROSCI, V29, P5573, DOI 10.1523/JNEUROSCI.4438-08.2009; vanSteveninck RRD, 1997, SCIENCE, V275, P1805, DOI 10.1126/science.275.5307.1805; Verhagen JV, 2007, NAT NEUROSCI, V10, P631, DOI 10.1038/nn1892; Wachowiak M, 2004, P NATL ACAD SCI USA, V101, P9097, DOI 10.1073/pnas.0400438101; Wang Y, 2002, CEREB CORTEX, V12, P395, DOI 10.1093/cercor/12.4.395; Wang Y, 2006, NAT NEUROSCI, V9, P534, DOI 10.1038/nn1670; WELLIS DP, 1989, J NEUROPHYSIOL, V61, P1161, DOI 10.1152/jn.1989.61.6.1161; Wesson DW, 2009, J NEUROPHYSIOL, V101, P1089, DOI 10.1152/jn.90981.2008	47	199	200	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2010	13	10					1276	1282		10.1038/nn.2630	http://dx.doi.org/10.1038/nn.2630			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	654MB	20802489	Green Accepted			2022-12-28	WOS:000282171300021
J	Onishi, A; Peng, GH; Chen, SM; Blackshaw, S				Onishi, Akishi; Peng, Guang-Hua; Chen, Shiming; Blackshaw, Seth			Pias3-dependent SUMOylation controls mammalian cone photoreceptor differentiation	NATURE NEUROSCIENCE			English	Article							THYROID-HORMONE RECEPTOR; RETINOIC ACID; CHROMATIN IMMUNOPRECIPITATION; OPSIN EXPRESSION; HOMEOBOX GENE; IN-VIVO; EVOLUTION; TRANSCRIPTION; CRX; ROD	Selective expression of retinal cone opsin genes is essential for color vision, but the mechanism mediating this process is poorly understood. Both vertebrate rod and medium wavelength-sensitive (M) cone photoreceptors differentiate by repression of a short wavelength-sensitive (S) cone differentiation program. We found that Pias3 acts in mouse cone photoreceptors to activate expression of M opsin and repress expression of S opsin, with the transcription factors Tr beta 2 and Rxr gamma mediating preferential expression of Pias3 in M cones. Finally, we observed that Pias3 directly regulated M and S cone opsin expression by modulating the cone-enriched transcription factors Rxr gamma, Ror alpha and Tr beta 1. Our results indicate that Pias3-dependent SUMOylation of photoreceptor-specific transcription factors is a common mechanism that controls both rod and cone photoreceptor subtype specification, regulating distinct molecular targets in the two cell types.	[Onishi, Akishi; Blackshaw, Seth] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; [Peng, Guang-Hua; Chen, Shiming] Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, St Louis, MO 63110 USA; [Chen, Shiming] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO USA; [Blackshaw, Seth] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Blackshaw, Seth] Johns Hopkins Univ, Sch Med, Dept Ophthalmol, Baltimore, MD 21205 USA; [Blackshaw, Seth] Johns Hopkins Univ, Sch Med, Ctr High Throughput Biol, Baltimore, MD 21205 USA; [Blackshaw, Seth] Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD 21205 USA	Johns Hopkins University; Washington University (WUSTL); Washington University (WUSTL); Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Blackshaw, S (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA.	sblack@jhmi.edu	Huang, Yifei/ABE-7566-2020		US National Institutes of Health [R01EY017015, RO1EY012543]; NATIONAL EYE INSTITUTE [R01EY017015, R01EY012543] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank D. Forrest for providing antibodies to Tr beta 2 and for supplying Tr beta 2<SUP>-/-</SUP> and Tr beta 1<SUP>-/-</SUP>; Tr beta 2<SUP>-/-</SUP> mice. We also thank J. Nathans, T. Shimogori, W. Yap and members of the Blackshaw laboratory for their comments on the manuscript. This work was supported by grants from the US National Institutes of Health (R01EY017015 to S. B. and RO1EY012543 to S. C.). S. B. is a W. M. Keck Distinguished Young Investigator in Medical Science.	Akhmedov NB, 2000, P NATL ACAD SCI USA, V97, P5551, DOI 10.1073/pnas.97.10.5551; Alvarez-Delfin K, 2009, P NATL ACAD SCI USA, V106, P2023, DOI 10.1073/pnas.0809439106; Applebury ML, 2007, DEV DYNAM, V236, P1203, DOI 10.1002/dvdy.21155; Applebury ML, 2000, NEURON, V27, P513, DOI 10.1016/S0896-6273(00)00062-3; Barroso-Chinea P, 2007, J NEUROSCI METH, V162, P119, DOI 10.1016/j.jneumeth.2006.12.017; Blackshaw S, 2004, PLOS BIOL, V2, P1411, DOI 10.1371/journal.pbio.0020247; Boggio R, 2004, MOL CELL, V16, P549, DOI 10.1016/j.molcel.2004.11.007; Bowmaker JK, 2008, VISION RES, V48, P2022, DOI 10.1016/j.visres.2008.03.025; Collin Shaun P, 2004, Clin Exp Optom, V87, P217; ELAKAWI Z, 1994, BIOCHEMISTRY-US, V33, P1938, DOI 10.1021/bi00173a042; Fujieda H, 2009, J NEUROCHEM, V108, P91, DOI 10.1111/j.1471-4159.2008.05739.x; Furukawa T, 1997, CELL, V91, P531, DOI 10.1016/S0092-8674(00)80439-0; Geisberg JV, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh148; Haider NB, 2000, NAT GENET, V24, P127, DOI 10.1038/72777; Hennig AK, 2008, BRAIN RES, V1192, P114, DOI 10.1016/j.brainres.2007.06.036; Hwang EJ, 2009, BIOCHEM BIOPH RES CO, V378, P513, DOI 10.1016/j.bbrc.2008.11.072; KLIEWER SA, 1992, NATURE, V355, P446, DOI 10.1038/355446a0; Lamb TD, 2007, NAT REV NEUROSCI, V8, P960, DOI 10.1038/nrn2283; Lamb TD, 2009, PHILOS T R SOC B, V364, P2911, DOI 10.1098/rstb.2009.0102; Li DS, 2002, MOL CELL BIOL, V22, P5782, DOI 10.1128/MCB.22.16.5782-5792.2002; Li HX, 2000, MECH DEVELOP, V95, P283, DOI 10.1016/S0925-4773(00)00352-X; Lin M, 2003, J BIOL CHEM, V278, P9856, DOI 10.1074/jbc.M211417200; Long JY, 2004, P NATL ACAD SCI USA, V101, P99, DOI 10.1073/pnas.0307598100; Lukats A, 2005, HISTOL HISTOPATHOL, V20, P551, DOI 10.14670/HH-20.551; Matsuda T, 2004, P NATL ACAD SCI USA, V101, P16, DOI 10.1073/pnas.2235688100; McCaffery P, 1999, MECH DEVELOP, V82, P119, DOI 10.1016/S0925-4773(99)00022-2; MCCAFFERY P, 1993, DEV BIOL, V158, P390, DOI 10.1006/dbio.1993.1197; Mears AJ, 2001, NAT GENET, V29, P447, DOI 10.1038/ng774; Ng L, 2001, NAT GENET, V27, P94, DOI 10.1038/83829; Ng L, 2009, NEUROREPORT, V20, P627, DOI 10.1097/WNR.0b013e32832a2c63; Nishida A, 2003, NAT NEUROSCI, V6, P1255, DOI 10.1038/nn1155; Onishi A, 2009, NEURON, V61, P234, DOI 10.1016/j.neuron.2008.12.006; Osorio D, 2008, VISION RES, V48, P2042, DOI 10.1016/j.visres.2008.06.018; Pearson BJ, 2004, ANNU REV CELL DEV BI, V20, P619, DOI 10.1146/annurev.cellbio.19.111301.115142; Peichl L, 2005, ANAT REC PART A, V287A, P1001, DOI 10.1002/ar.a.20262; Peng GH, 2005, VISUAL NEUROSCI, V22, P575, DOI 10.1017/S0952523805225063; Peng GH, 2005, HUM MOL GENET, V14, P747, DOI 10.1093/hmg/ddi070; Pessoa CN, 2008, INVEST OPHTH VIS SCI, V49, P2039, DOI 10.1167/iovs.07-0908; Pichaud F, 1999, CURR OPIN NEUROBIOL, V9, P622, DOI 10.1016/S0959-4388(99)00014-8; Roberts MR, 2006, P NATL ACAD SCI USA, V103, P6218, DOI 10.1073/pnas.0509981103; Roberts MR, 2005, INVEST OPHTH VIS SCI, V46, P2897, DOI 10.1167/iovs.05-0093; ROHLICH P, 1994, NEURON, V13, P1159, DOI 10.1016/0896-6273(94)90053-1; Shichida Y, 2009, PHILOS T R SOC B, V364, P2881, DOI 10.1098/rstb.2009.0051; Solomon SG, 2007, NAT REV NEUROSCI, V8, P276, DOI 10.1038/nrn2094; SZEL A, 1993, J COMP NEUROL, V331, P564, DOI 10.1002/cne.903310411; Terakita A, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-213	46	36	36	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2010	13	9					1059	U44		10.1038/nn.2618	http://dx.doi.org/10.1038/nn.2618			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	643XC	20729845	Green Accepted			2022-12-28	WOS:000281332600010
J	Cho, M				Cho, Min			Focus on neurodegeneration	NATURE NEUROSCIENCE			English	Editorial Material														Cho, Min/0000-0003-4696-0173					0	6	6	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2010	13	7					787	787		10.1038/nn0710-787	http://dx.doi.org/10.1038/nn0710-787			1	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	615YF	20581813	Bronze			2022-12-28	WOS:000279173900006
J	Alexandre, P; Reugels, AM; Barker, D; Blanc, E; Clarke, JDW				Alexandre, Paula; Reugels, Alexander M.; Barker, David; Blanc, Eric; Clarke, Jonathan D. W.			Neurons derive from the more apical daughter in asymmetric divisions in the zebrafish neural tube	NATURE NEUROSCIENCE			English	Article							INTERKINETIC NUCLEAR MIGRATION; NEUROEPITHELIAL CELLS; SPINDLE ORIENTATION; PROGENITOR CELLS; VERTEBRATE RETINOGENESIS; MAMMALIAN NEUROGENESIS; CORTICAL NEUROGENESIS; PLANAR DIVISIONS; CEREBRAL-CORTEX; STEM-CELLS	In the developing CNS, asymmetric cell division is critical for maintaining the balanced production of differentiating neurons while renewing the population of neural progenitors. In invertebrates, this process depends on asymmetric inheritance of fate determinants during progenitor divisions. A similar mechanism is widely believed to underlie asymmetrically fated divisions in vertebrates, but compelling evidence for this is missing. We used live imaging of individual progenitors in the intact zebrafish embryo CNS to test this hypothesis. We found that asymmetric inheritance of a subcellular domain is strongly correlated with asymmetric daughter fates and our results reveal an unexpected feature of this process. The daughter cell destined to become a neuron was derived from the more apical of the two daughters, whereas the more basal daughter inherited the basal process and replenished the apical progenitor pool.	[Alexandre, Paula; Barker, David; Blanc, Eric; Clarke, Jonathan D. W.] Kings Coll London, MRC Ctr Dev Neurobiol, London WC2R 2LS, England; [Reugels, Alexander M.] Univ Cologne, Inst Entwicklungsphysiol, D-5000 Cologne, Germany	University of London; King's College London; University of Cologne	Clarke, JDW (corresponding author), Kings Coll London, MRC Ctr Dev Neurobiol, London WC2R 2LS, England.	jon.clarke@kcl.ac.uk	Alexandre, Paula/ABE-7203-2020; Zebrafish, UCL/A-3125-2009; Alexandre, Paula/D-8187-2012; Barker, David JP/A-5671-2013	Alexandre, Paula/0000-0002-6333-6199; 	European Molecular Biology Organization [ALTF-764-2005]; EU [IEF 039695]; Medical Research Council [G0901899B, G0900650] Funding Source: researchfish; MRC [G0900650] Funding Source: UKRI	European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); EU(European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank C. Araya, C. Buckley, K. Cerveny, G. Girdler, A. Lumsden, X. Ren, M. Tada, M. Tawk and M. Wassef for discussions and comments on the manuscript and the University College London and King's College London fish facilities for providing and taking care of the fish. We thank F. Mahmood for the aPKC immunostaining. P.A. was supported by an European Molecular Biology Organization fellowship (ALTF-764-2005) and an EU Marie Curie fellowship (IEF 039695).	Afonso C, 2006, J CELL SCI, V119, P4293, DOI 10.1242/jcs.03170; Attardo A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002388; Baye LM, 2007, J NEUROSCI, V27, P10143, DOI 10.1523/JNEUROSCI.2754-07.2007; Bultje RS, 2009, NEURON, V63, P189, DOI 10.1016/j.neuron.2009.07.004; Calegari F, 2005, J NEUROSCI, V25, P6533, DOI 10.1523/JNEUROSCI.0778-05.2005; Cayouette M, 2003, NEURON, V40, P897, DOI 10.1016/S0896-6273(03)00756-6; Cayouette M, 2003, DEVELOPMENT, V130, P2329, DOI 10.1242/dev.00446; CHENN A, 1995, CELL, V82, P631, DOI 10.1016/0092-8674(95)90035-7; Costa MR, 2008, DEVELOPMENT, V135, P11, DOI 10.1242/dev.009951; Coumailleau F, 2009, NATURE, V458, P1051, DOI 10.1038/nature07854; Cui S, 2007, MOL CELL NEUROSCI, V34, P431, DOI 10.1016/j.mcn.2006.11.016; Del Bene F, 2008, CELL, V134, P1055, DOI 10.1016/j.cell.2008.07.017; Georgiou M, 2008, CURR BIOL, V18, P1631, DOI 10.1016/j.cub.2008.09.029; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Henrique D, 1997, CURR BIOL, V7, P661, DOI 10.1016/S0960-9822(06)00293-4; Hodge RD, 2004, J NEUROSCI, V24, P10201, DOI 10.1523/JNEUROSCI.3246-04.2004; Huttner WB, 1997, CURR OPIN NEUROBIOL, V7, P29, DOI 10.1016/S0959-4388(97)80117-1; Iacopetti P, 1999, P NATL ACAD SCI USA, V96, P4639, DOI 10.1073/pnas.96.8.4639; Konno D, 2008, NAT CELL BIOL, V10, P93, DOI 10.1038/ncb1673; Kosodo Y, 2004, EMBO J, V23, P2314, DOI 10.1038/sj.emboj.7600223; Kosodo Y, 2008, EMBO J, V27, P3151, DOI 10.1038/emboj.2008.227; Langevin J, 2005, CURR BIOL, V15, P955, DOI 10.1016/j.cub.2005.04.054; Le Borgne R, 2006, CURR OPIN CELL BIOL, V18, P213, DOI 10.1016/j.ceb.2006.02.011; Leibfried A, 2008, CURR BIOL, V18, P1639, DOI 10.1016/j.cub.2008.09.063; Manabe N, 2002, DEV DYNAM, V225, P61, DOI 10.1002/dvdy.10139; Marthiens V, 2009, EMBO REP, V10, P515, DOI 10.1038/embor.2009.36; McCaffrey LM, 2009, GENE DEV, V23, P1450, DOI 10.1101/gad.1795909; Miyata T, 2001, NEURON, V31, P727, DOI 10.1016/S0896-6273(01)00420-2; Morin X, 2007, NAT NEUROSCI, V10, P1440, DOI 10.1038/nn1984; Nakayama Y, 2009, DEV CELL, V16, P889, DOI 10.1016/j.devcel.2009.04.009; Noctor SC, 2001, NATURE, V409, P714, DOI 10.1038/35055553; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; Park HC, 2000, DEV BIOL, V227, P279, DOI 10.1006/dbio.2000.9898; Petersen PH, 2004, NAT NEUROSCI, V7, P803, DOI 10.1038/nn1289; Rasin MR, 2007, NAT NEUROSCI, V10, P819, DOI 10.1038/nn1924; Reugels AM, 2006, DEV DYNAM, V235, P934, DOI 10.1002/dvdy.20699; Sanada K, 2005, CELL, V122, P119, DOI 10.1016/j.cell.2005.05.009; Schwamborn JC, 2009, CELL, V136, P913, DOI 10.1016/j.cell.2008.12.024; Shen Q, 2002, DEVELOPMENT, V129, P4843; Tawk M, 2007, NATURE, V446, P797, DOI 10.1038/nature05722; von Trotha JW, 2006, DEV DYNAM, V235, P967, DOI 10.1002/dvdy.20715; Wei XY, 2004, DEV BIOL, V269, P286, DOI 10.1016/j.ydbio.2004.01.017; Wilcock AC, 2007, DEVELOPMENT, V134, P1943, DOI 10.1242/dev.002519; Xie ZG, 2007, NEURON, V56, P79, DOI 10.1016/j.neuron.2007.08.026; Zigman M, 2005, NEURON, V48, P539, DOI 10.1016/j.neuron.2005.09.030	45	103	103	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2010	13	6					673	U38		10.1038/nn.2547	http://dx.doi.org/10.1038/nn.2547			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	600QY	20453852	Green Submitted			2022-12-28	WOS:000278003300011
J	Tissir, F; Qu, YB; Montcouquiol, M; Zhou, LB; Komatsu, K; Shi, DB; Fujimori, T; Labeau, J; Tyteca, D; Courtoy, P; Poumay, Y; Uemura, T; Goffinet, AM				Tissir, Fadel; Qu, Yibo; Montcouquiol, Mireille; Zhou, Libing; Komatsu, Kouji; Shi, Dongbo; Fujimori, Toshihiko; Labeau, Jason; Tyteca, Donatienne; Courtoy, Pierre; Poumay, Yves; Uemura, Tadashi; Goffinet, Andre M.			Lack of cadherins Celsr2 and Celsr3 impairs ependymal ciliogenesis, leading to fatal hydrocephalus	NATURE NEUROSCIENCE			English	Article							PLANAR CELL POLARITY; NEURAL STEM-CELLS; TISSUE POLARITY; GENES; EXPRESSION; CILIA; POLARIZATION; MUTATION; DEFECTS; MORPHOGENESIS	Ependymal cells form the epithelial lining of cerebral ventricles. Their apical surface is covered by cilia that beat in a coordinated fashion to facilitate circulation of the cerebrospinal fluid (CSF). The genetic factors that govern the development and function of ependymal cilia remain poorly understood. We found that the planar cell polarity cadherins Celsr2 and Celsr3 control these processes. In Celsr2-deficient mice, the development and planar organization of ependymal cilia are compromised, leading to defective CSF dynamics and hydrocephalus. In Celsr2 and Celsr3 double mutant ependyma, ciliogenesis is markedly impaired, resulting in lethal hydrocephalus. The membrane distribution of Vangl2 and Fzd3, two key planar cell polarity proteins, was disturbed in Celsr2 mutants, and even more so in Celsr2 and Celsr3 double mutants. Our findings suggest that planar cell polarity signaling is involved in ependymal cilia development and in the pathophysiology of hydrocephalus, with possible implications in other ciliopathies.	[Tissir, Fadel; Qu, Yibo; Zhou, Libing; Labeau, Jason; Goffinet, Andre M.] Catholic Univ Louvain, Inst Neurosci, B-1200 Brussels, Belgium; [Montcouquiol, Mireille] Neuroctr Magendie, INSERM, U862, Mol Basis Planar Polar Grp, Bordeaux, France; [Komatsu, Kouji; Fujimori, Toshihiko] Natl Inst Basic Biol, Div Embryol, Okazaki, Japan; [Komatsu, Kouji; Shi, Dongbo; Fujimori, Toshihiko; Uemura, Tadashi] Japan Sci & Technol Agcy, CREST, Tokyo, Japan; [Shi, Dongbo; Uemura, Tadashi] Kyoto Univ, Grad Sch Biostudies, Kyoto, Japan; [Tyteca, Donatienne; Courtoy, Pierre] Catholic Univ Louvain, de Duve Inst, B-1200 Brussels, Belgium; [Poumay, Yves] Fac Univ Notre Dame Paix, B-5000 Namur, Belgium	Universite Catholique Louvain; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Japan Science & Technology Agency (JST); Kyoto University; Universite Catholique Louvain; University of Namur	Tissir, F (corresponding author), Catholic Univ Louvain, Inst Neurosci, B-1200 Brussels, Belgium.	fadel.tissir@uclouvain.be; andre.goffinet@uclouvain.be	Fujimori, Toshihiko/L-7711-2016; Poumay, Yves/G-4525-2016; Shi, Dongbo/AAB-9994-2020; Komatsu, Kouji/R-6087-2019; montcouquiol, mireille/L-6199-2017	Fujimori, Toshihiko/0000-0001-5200-4634; Poumay, Yves/0000-0001-5200-3367; Shi, Dongbo/0000-0002-4408-3042; montcouquiol, mireille/0000-0001-8739-6519; Zhou, Libing/0000-0002-8975-5228; Komatsu, Kouji/0000-0003-3137-4569; Tissir, Fadel/0000-0002-9292-6622; UEMURA, Tadashi/0000-0001-7204-3606	Actions de Recherches Concertees [ARC-186]; FRFC [2.1501.01]; FRSM [3.4501.07]; Fondation medicale Reine Elisabeth; Wallonne and Bruxelloise regions; Japan Science and Technology Corporation; Interuniversity Poles of Attraction (SSTC) [PAI p6/20]	Actions de Recherches Concertees; FRFC(Fonds de la Recherche Scientifique - FNRS); FRSM(Fonds de la Recherche Scientifique - FNRS); Fondation medicale Reine Elisabeth; Wallonne and Bruxelloise regions; Japan Science and Technology Corporation(Japan Science & Technology Agency (JST)); Interuniversity Poles of Attraction (SSTC)	We thank K. Jones for Emx1-Cre mice, G. Meyer for the antibody to SCO-spondin, and K.-A. Nave for NEX-Cre mice. We also thank V. Bonte, I. Lambermont and E. Paitre for technical assistance and M. F. Boulanger, Y. Houbion, M.- J. Vertez and R. Vigneron for help with electron microscopy. This work was supported by grants from the Actions de Recherches Concertees (ARC-186), FRFC 2.1501.01, FRSM 3.4501.07, Interuniversity Poles of Attraction (SSTC, PAI p6/20), the Fondation medicale Reine Elisabeth, the Wallonne and Bruxelloise regions from Belgium and from the Japan Science and Technology Corporation. F.T. is a research associate at the Belgian Fonds National de la Recherche Scientifique.	Banizs B, 2005, DEVELOPMENT, V132, P5329, DOI 10.1242/dev.02153; BOISVIEUXULRICH E, 1987, CELL MOTIL CYTOSKEL, V8, P333, DOI 10.1002/cm.970080406; BOISVIEUXULRICH E, 1990, CELL TISSUE RES, V259, P443, DOI 10.1007/BF01740770; BOISVIEUXULRICH E, 1991, BIOL CELL, V72, P3, DOI 10.1016/0248-4900(91)90072-U; Brody SL, 2000, AM J RESP CELL MOL, V23, P45, DOI 10.1165/ajrcmb.23.1.4070; Chen JC, 1998, J CLIN INVEST, V102, P1077, DOI 10.1172/JCI4786; Curtin JA, 2003, CURR BIOL, V13, P1129, DOI 10.1016/S0960-9822(03)00374-9; Danilov AI, 2009, GLIA, V57, P136, DOI 10.1002/glia.20741; Davenport JR, 2005, AM J PHYSIOL-RENAL, V289, pF1159, DOI 10.1152/ajprenal.00118.2005; Davy BE, 2003, HUM MOL GENET, V12, P1163, DOI 10.1093/hmg/ddg122; Dawe HR, 2007, J CELL SCI, V120, P7, DOI 10.1242/jcs.03305; Devenport D, 2008, NAT CELL BIOL, V10, P1257, DOI 10.1038/ncb1784; Formstone CJ, 2001, MECH DEVELOP, V109, P91, DOI 10.1016/S0925-4773(01)00515-9; Goebbels S, 2006, GENESIS, V44, P611, DOI 10.1002/dvg.20256; Gomperts BN, 2004, J CELL SCI, V117, P1329, DOI 10.1242/jcs.00978; Guo N, 2004, P NATL ACAD SCI USA, V101, P9277, DOI 10.1073/pnas.0402802101; Ibanez-Tallon I, 2004, HUM MOL GENET, V13, P2133, DOI 10.1093/hmg/ddh219; Jones C, 2008, NAT GENET, V40, P69, DOI 10.1038/ng.2007.54; Kibar Z, 2001, NAT GENET, V28, P251, DOI 10.1038/90081; Lechtreck KF, 2008, J CELL BIOL, V180, P633, DOI 10.1083/jcb.200710162; Marshall WF, 2008, CURR OPIN CELL BIOL, V20, P48, DOI 10.1016/j.ceb.2007.11.009; Marshall WF, 2008, J CELL BIOL, V180, P17, DOI 10.1083/jcb.200710085; Mirzadeh Z, 2008, CELL STEM CELL, V3, P265, DOI 10.1016/j.stem.2008.07.004; Mirzadeh Z, 2010, J NEUROSCI, V30, P2600, DOI 10.1523/JNEUROSCI.3744-09.2010; Mitchell B, 2007, NATURE, V447, P97, DOI 10.1038/nature05771; Montcouquiol M, 2006, J NEUROSCI, V26, P5265, DOI 10.1523/JNEUROSCI.4680-05.2006; Pan JH, 2007, J CELL SCI, V120, P1868, DOI 10.1242/jcs.005306; Park TJ, 2008, NAT GENET, V40, P871, DOI 10.1038/ng.104; Park TJ, 2006, NAT GENET, V38, P303, DOI 10.1038/ng1753; Ravni A, 2009, J INVEST DERMATOL, V129, P2507, DOI 10.1038/jid.2009.84; Ropper A.H. a.B., 2005, ADAMS VICTORS PRINCI; Ross AJ, 2005, NAT GENET, V37, P1135, DOI 10.1038/ng1644; Salathe M, 2007, ANNU REV PHYSIOL, V69, P401, DOI 10.1146/annurev.physiol.69.040705.141253; Sawamoto K, 2006, SCIENCE, V311, P629, DOI 10.1126/science.1119133; Sharma N, 2008, CURR TOP DEV BIOL, V85, P371, DOI 10.1016/S0070-2153(08)00813-2; Shima Y, 2002, DEV DYNAM, V223, P321, DOI 10.1002/dvdy.10054; Shima Y, 2007, NAT NEUROSCI, V10, P963, DOI 10.1038/nn1933; Simons M, 2008, ANNU REV GENET, V42, P517, DOI 10.1146/annurev.genet.42.110807.091432; Spassky N, 2005, J NEUROSCI, V25, P10, DOI 10.1523/JNEUROSCI.1108-04.2005; Strutt DI, 1997, NATURE, V387, P292, DOI 10.1038/387292a0; Tissir F, 2006, EUR J NEUROSCI, V23, P597, DOI 10.1111/j.1460-9568.2006.04596.x; Tissir F, 2005, NAT NEUROSCI, V8, P451, DOI 10.1038/nn1428; Tissir F, 2002, MECH DEVELOP, V112, P157, DOI 10.1016/S0925-4773(01)00623-2; Town T, 2008, P NATL ACAD SCI USA, V105, P2853, DOI 10.1073/pnas.0712385105; Voronina VA, 2009, J CELL BIOL, V185, P225, DOI 10.1083/jcb.200809144; Wang YS, 2007, DEVELOPMENT, V134, P647, DOI 10.1242/dev.02772; Wang YH, 2006, J NEUROSCI, V26, P2147, DOI 10.1523/JNEUROSCI.4698-05.2005; Wang YS, 2002, J NEUROSCI, V22, P8563; WONG LL, 1993, J CELL BIOL, V123, P209, DOI 10.1083/jcb.123.1.209; Zhou LB, 2008, SCIENCE, V320, P946, DOI 10.1126/science.1155244	50	228	233	2	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2010	13	6					700	U71		10.1038/nn.2555	http://dx.doi.org/10.1038/nn.2555			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	600QY	20473291				2022-12-28	WOS:000278003300014
J	Chia, PH; Patel, MR; Shen, K				Chia, Poh Hui; Patel, Maulik R.; Shen, Kang			NAB-1 instructs synapse assembly by linking adhesion molecules and F-actin to active zone proteins	NATURE NEUROSCIENCE			English	Article							FILAMENT-BINDING PROTEIN; LIPRIN-ALPHA; VESICLE EXOCYTOSIS; CELL-ADHESION; C. ELEGANS; DROSOPHILA; NEURABIN; MORPHOGENESIS; CYTOSKELETON; MATURATION	During synaptogenesis, macromolecular protein complexes assemble at the pre- and postsynaptic membrane. Extensive literature identifies many transmembrane molecules sufficient to induce synapse formation and several intracellular scaffolding molecules responsible for assembling active zones and recruiting synaptic vesicles. However, little is known about the molecular mechanisms coupling membrane receptors to active zone molecules during development. Using Caenorhabditis elegans, we identify an F-actin network present at nascent presynaptic terminals and required for presynaptic assembly. We unravel a sequence of events whereby specificity-determining adhesion molecules define the location of developing synapses and locally assemble F-actin. Next, the adaptor protein NAB-1 (neurabin) binds to F-actin and recruits active zone proteins SYD-1 and SYD-2 (liprin-alpha) by forming a tripartite complex. NAB-1 localizes transiently to synapses during development and is required for presynaptic assembly. Altogether, we identify a role for the actin cytoskeleton during presynaptic development and characterize a molecular pathway whereby NAB-1 links synaptic partner recognition to active zone assembly.	[Chia, Poh Hui; Shen, Kang] Stanford Univ, Howard Hughes Med Inst, Dept Biol, Stanford, CA 94305 USA; [Chia, Poh Hui] Stanford Univ, Sch Med, Neurosci Program, Stanford, CA 94305 USA	Howard Hughes Medical Institute; Stanford University; Stanford University	Shen, K (corresponding author), Stanford Univ, Howard Hughes Med Inst, Dept Biol, Stanford, CA 94305 USA.	kangshen@stanford.edu			Howard Hughes Medical Institute; US National Institutes of Health [R01 NS048392]; Agency for Science, Technology, and Research (Singapore); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048392] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Agency for Science, Technology, and Research (Singapore)(Agency for Science Technology & Research (A*STAR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the Caenorhabditis Genetics Center and Japanese National Bioresource Project for strains. We also thank C. Gao and Y. Fu for technical assistance and T. Clandinin, K. Zito, K. Mizumoto, C.Y. Ou and Shen laboratory members for manuscript comments. This work was funded by the Howard Hughes Medical Institute and US National Institutes of Health grant R01 NS048392. P.H.C. is supported by the Agency for Science, Technology, and Research (Singapore).	Allen PB, 1997, P NATL ACAD SCI USA, V94, P9956, DOI 10.1073/pnas.94.18.9956; Ball RW, 2010, NEURON, V66, P536, DOI 10.1016/j.neuron.2010.04.011; Burkel BM, 2007, CELL MOTIL CYTOSKEL, V64, P822, DOI 10.1002/cm.20226; Butz S, 1998, CELL, V94, P773, DOI 10.1016/S0092-8674(00)81736-5; Chen EH, 2004, TRENDS CELL BIOL, V14, P452, DOI 10.1016/j.tcb.2004.07.008; Cingolani LA, 2008, NAT REV NEUROSCI, V9, P344, DOI 10.1038/nrn2373; Dai Y, 2006, NAT NEUROSCI, V9, P1479, DOI 10.1038/nn1808; Dai ZS, 1996, MOL CELL NEUROSCI, V7, P443, DOI 10.1006/mcne.1996.0032; Dean C, 2003, NAT NEUROSCI, V6, P708, DOI 10.1038/nn1074; Dieck ST, 1998, J CELL BIOL, V142, P499, DOI 10.1083/jcb.142.2.499; Edwards KA, 1997, DEV BIOL, V191, P103, DOI 10.1006/dbio.1997.8707; Hung W, 2007, DEVELOPMENT, V134, P237, DOI 10.1242/dev.02725; Kaufmann N, 2002, NEURON, V34, P27, DOI 10.1016/S0896-6273(02)00643-8; Keep NH, 2000, NEUROL SCI, V21, pS929, DOI 10.1007/s100720070006; Kittel RJ, 2006, SCIENCE, V312, P1051, DOI 10.1126/science.1126308; Li J, 2007, NEURON, V55, P741, DOI 10.1016/j.neuron.2007.08.002; Lucido AL, 2009, J NEUROSCI, V29, P12449, DOI 10.1523/JNEUROSCI.1381-09.2009; Morales M, 2000, NEURON, V27, P539, DOI 10.1016/S0896-6273(00)00064-7; Mukherjee K, 2010, P NATL ACAD SCI USA, V107, P6504, DOI 10.1073/pnas.1002307107; Nakanishi H, 1997, J CELL BIOL, V139, P951, DOI 10.1083/jcb.139.4.951; Norwood FLM, 2000, STRUCTURE, V8, P481, DOI 10.1016/S0969-2126(00)00132-5; Owald D, 2010, J CELL BIOL, V188, P565, DOI 10.1083/jcb.200908055; Patel MR, 2006, NAT NEUROSCI, V9, P1488, DOI 10.1038/nn1806; Patel MR, 2009, SCIENCE, V323, P1500, DOI 10.1126/science.1169025; Poulopoulos A, 2009, NEURON, V63, P628, DOI 10.1016/j.neuron.2009.08.023; Ryan XZP, 2005, NEURON, V47, P85, DOI 10.1016/j.neuron.2005.05.013; Sankaranarayanan S, 2003, NAT NEUROSCI, V6, P127, DOI 10.1038/nn1002; Satoh A, 1998, J BIOL CHEM, V273, P3470, DOI 10.1074/jbc.273.6.3470; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Shen K, 2003, CELL, V112, P619, DOI 10.1016/S0092-8674(03)00113-2; Shen K, 2004, CELL, V116, P869, DOI 10.1016/S0092-8674(04)00251-X; Shen K, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001842; Sieburth D, 2005, NATURE, V436, P510, DOI 10.1038/nature03809; Spangler SA, 2007, BIOCHEM SOC T, V35, P1278, DOI 10.1042/BST0351278; Tallafuss A, 2010, EUR J NEUROSCI, V32, P198, DOI 10.1111/j.1460-9568.2010.07340.x; Terry-Lorenzo RT, 2005, MOL BIOL CELL, V16, P2349, DOI 10.1091/mbc.E04-12-1054; Uemura T, 2010, CELL, V141, P1068, DOI 10.1016/j.cell.2010.04.035; Wagh DA, 2006, NEURON, V49, P833, DOI 10.1016/j.neuron.2006.02.008; Williams ME, 2010, NEURON, V68, P9, DOI 10.1016/j.neuron.2010.09.007; Yamagata M, 2003, CURR OPIN CELL BIOL, V15, P621, DOI 10.1016/S0955-0674(03)00107-8; Zhang WD, 2002, J NEUROSCI RES, V69, P427, DOI 10.1002/jnr.10313; Zhang WD, 2001, J NEUROSCI, V21, P5169, DOI 10.1523/JNEUROSCI.21-14-05169.2001; Zhen M, 1999, NATURE, V401, P371, DOI 10.1038/43886; Zito K, 2004, NEURON, V44, P321, DOI 10.1016/j.neuron.2004.09.022	44	57	60	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2012	15	2					234	242		10.1038/nn.2991	http://dx.doi.org/10.1038/nn.2991			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	882ZX	22231427	Green Accepted			2022-12-28	WOS:000299603500014
J	Kauer, TM; Figueiredo, JL; Hingtgen, S; Shah, K				Kauer, Timo M.; Figueiredo, Jose-Luiz; Hingtgen, Shawn; Shah, Khalid			Encapsulated therapeutic stem cells implanted in the tumor resection cavity induce cell death in gliomas	NATURE NEUROSCIENCE			English	Article							GLIOBLASTOMA-MULTIFORME CELLS; RADIOTHERAPY PLUS CONCOMITANT; IN-VIVO; S-TRAIL; ADJUVANT TEMOZOLOMIDE; MALIGNANT GLIOMA; BRAIN-TUMORS; APOPTOSIS; DELIVERY; CANCER	Therapeutically engineered stem cells have shown promise for glioblastoma multiforme (GBM) therapy; however, key preclinical studies are urgently needed for their clinical translation. In this study, we investigated a new approach to GBM treatment using therapeutic stem cells encapsulated in biodegradable, synthetic extracellular matrix (sECM) in mouse models of human GBM resection. Using multimodal imaging, we first showed quantitative surgical debulking of human GBM tumors in mice, which resulted in increased survival. Next, sECM encapsulation of engineered stem cells increased their retention in the tumor resection cavity, permitted tumor-selective migration and release of diagnostic and therapeutic proteins in vivo. Simulating the clinical scenario of GBM treatment, the release of tumor-selective S-TRAIL (secretable tumor necrosis factor apoptosis inducing ligand) from sECM-encapsulated stem cells in the resection cavity eradicated residual tumor cells by inducing caspase-mediated apoptosis, delayed tumor regrowth and significantly increased survival of mice. This study demonstrates the efficacy of encapsulated therapeutic stem cells in mouse models of GBM resection and may have implications for developing effective therapies for GBM.	[Kauer, Timo M.; Figueiredo, Jose-Luiz; Hingtgen, Shawn; Shah, Khalid] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Mol Neurotherapy & Imaging Lab, Boston, MA 02114 USA; [Kauer, Timo M.; Figueiredo, Jose-Luiz; Hingtgen, Shawn; Shah, Khalid] Harvard Univ, Sch Med, Dept Radiol, Massachusetts Gen Hosp, Boston, MA 02115 USA; [Shah, Khalid] Harvard Univ, Sch Med, Dept Neurol, Massachusetts Gen Hosp, Boston, MA 02115 USA; [Shah, Khalid] Harvard Univ, Harvard Stem Cell Inst, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University	Shah, K (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Mol Neurotherapy & Imaging Lab, Boston, MA 02114 USA.	kshah@helix.mgh.harvard.edu			Alliance for Cancer Cell and Gene Therapy; American Cancer Society; James McDonald Foundation; NATIONAL CANCER INSTITUTE [R01CA138922] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS071197] Funding Source: NIH RePORTER	Alliance for Cancer Cell and Gene Therapy; American Cancer Society(American Cancer Society); James McDonald Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank G. Prestwich (University of Utah) and T. Zarembinski (Biotime Inc.) for providing us with sECMs, H. Wakimoto (Massachusetts General Hospital) for providing the primary GBM lines and D. Bhere for critical reading of the manuscript. This work was supported by the Alliance for Cancer Cell and Gene Therapy (K.S.), American Cancer Society (K.S.) and James McDonald Foundation (K.S.).	Adamson C, 2009, EXPERT OPIN INV DRUG, V18, P1061, DOI 10.1517/13543780903052764; Affronti ML, 2009, CANCER, V115, P3501, DOI 10.1002/cncr.24398; Akbar U, 2009, J NEURO-ONCOL, V94, P203, DOI 10.1007/s11060-009-9857-9; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Asthagiri AR, 2007, NEUROL CLIN, V25, P975, DOI 10.1016/j.ncl.2007.07.006; Bagci-Onder T, 2011, CANCER RES, V71, P154, DOI 10.1158/0008-5472.CAN-10-1601; Balyasnikova IV, 2011, CANCER LETT, V310, P148, DOI 10.1016/j.canlet.2011.06.029; Chen JA, 2010, TUMOR BIOL, V31, P613, DOI 10.1007/s13277-010-0077-x; Choi SA, 2012, EUR J CANCER, V48, P129, DOI 10.1016/j.ejca.2011.04.033; Corsten MF, 2008, LANCET ONCOL, V9, P376, DOI 10.1016/S1470-2045(08)70099-8; de Oliveira MS, 2009, J NEURO-ONCOL, V93, P191, DOI 10.1007/s11060-008-9775-2; Ehtesham M, 2002, CANCER RES, V62, P7170; Erpolat OP, 2009, TUMORI J, V95, P191; Germano IM, 2006, J NEUROSURG, V105, P88, DOI 10.3171/jns.2006.105.1.88; Grigoriadis N, 2011, EXP NEUROL, V230, P78, DOI 10.1016/j.expneurol.2011.02.021; Hall B, 2007, INT J HEMATOL, V86, P8, DOI 10.1532/IJH97.06230; Hingtgen S, 2008, MOL CANCER THER, V7, P3575, DOI 10.1158/1535-7163.MCT-08-0640; Hingtgen SD, 2010, STEM CELLS, V28, P832, DOI 10.1002/stem.313; Jain RK, 2007, CANCER RES, V67, P2729, DOI 10.1158/0008-5472.CAN-06-4102; Kahana S, 2011, CELL SIGNAL, V23, P1348, DOI 10.1016/j.cellsig.2011.03.017; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Kim SM, 2010, STEM CELLS, V28, P2217, DOI 10.1002/stem.543; Kock N, 2007, NEOPLASIA, V9, P435, DOI 10.1593/neo.07223; Ma W, 2004, EXP NEUROL, V190, P276, DOI 10.1016/j.expneurol.2003.10.016; Mattis VB, 2011, LANCET NEUROL, V10, P383, DOI 10.1016/S1474-4422(11)70022-9; Menon LG, 2009, STEM CELLS, V27, P2320, DOI 10.1002/stem.136; Minniti G, 2008, J NEURO-ONCOL, V88, P97, DOI 10.1007/s11060-008-9538-0; Mooney DJ, 2008, CELL STEM CELL, V2, P205, DOI 10.1016/j.stem.2008.02.005; Muldoon LL, 2007, J CLIN ONCOL, V25, P2295, DOI 10.1200/JCO.2006.09.9861; Orive G, 2009, NAT REV NEUROSCI, V10, P682, DOI 10.1038/nrn2685; Pan LJ, 2009, J NEUROSCI RES, V87, P3207, DOI 10.1002/jnr.22142; Pandita A, 2004, GENE CHROMOSOME CANC, V39, P29, DOI 10.1002/gcc.10300; Panner A, 2005, MOL CELL BIOL, V25, P8809, DOI 10.1128/MCB.25.20.8809-8823.2005; Park KI, 2002, NAT BIOTECHNOL, V20, P1111, DOI 10.1038/nbt751; Potter W, 2008, FRONT BIOSCI-LANDMRK, V13, P806, DOI 10.2741/2721; Ren B, 2009, CANCER RES, V69, P3856, DOI 10.1158/0008-5472.CAN-08-2940; Rieger J, 1998, FEBS LETT, V427, P124, DOI 10.1016/S0014-5793(98)00409-8; Sarin H, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-77; Sasportas LS, 2009, P NATL ACAD SCI USA, V106, P4822, DOI 10.1073/pnas.0806647106; Shah K, 2008, J NEUROSCI, V28, P4406, DOI 10.1523/JNEUROSCI.0296-08.2008; Shah K, 2012, ADV DRUG DELIVER REV, V64, P739, DOI 10.1016/j.addr.2011.06.010; Siegelin MD, 2009, NEUROSCI LETT, V454, P223, DOI 10.1016/j.neulet.2009.03.031; Snyder EY, 2011, EXP NEUROL, V230, P75, DOI 10.1016/j.expneurol.2011.03.012; Teng YD, 2002, P NATL ACAD SCI USA, V99, P3024, DOI 10.1073/pnas.052678899; Terrovitis J, 2008, J AM COLL CARDIOL, V52, P1652, DOI 10.1016/j.jacc.2008.06.051; Tian XB, 2011, J BIOL CHEM, V286, P29408, DOI 10.1074/jbc.M110.197665; van Eekelen M, 2010, ONCOGENE, V29, P3185, DOI 10.1038/onc.2010.75; Wakimoto H, 2009, CANCER RES, V69, P3472, DOI 10.1158/0008-5472.CAN-08-3886; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Xu XY, 2009, PROSTAG OTH LIPID M, V89, P140, DOI 10.1016/j.prostaglandins.2009.07.006	50	156	162	1	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2012	15	2					197	204		10.1038/nn.3019	http://dx.doi.org/10.1038/nn.3019			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	882ZX	22197831	Green Accepted			2022-12-28	WOS:000299603500010
J	Wallis, JD				Wallis, Jonathan D.			Cross-species studies of orbitofrontal cortex and value-based decision-making	NATURE NEUROSCIENCE			English	Review							MEDIAL PREFRONTAL CORTEX; NEURONAL-ACTIVITY; WORKING-MEMORY; REWARD VALUE; NEURAL BASIS; ARCHITECTONIC SUBDIVISION; ENCODES RESPONSE; SUBJECTIVE VALUE; HUMAN AMYGDALA; GOAL VALUES	Recent work has emphasized the role that orbitofrontal cortex (OFC) has in value-based decision-making. However, it is also clear that a number of discrepancies have arisen when comparing the findings from animal models to those from humans. Here, we examine several possibilities that might explain these discrepancies, including anatomical difference between species, the behavioral tasks used to probe decision-making and the methodologies used to assess neural function. Understanding how these differences affect the interpretation of experimental results will help us to better integrate future results from animal models. This will enable us to fully realize the benefits of using multiple approaches to understand OFC function.	[Wallis, Jonathan D.] Univ Calif Berkeley, Dept Psychol, Berkeley, CA 94720 USA; [Wallis, Jonathan D.] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Wallis, JD (corresponding author), Univ Calif Berkeley, Dept Psychol, 3210 Tolman Hall, Berkeley, CA 94720 USA.	wallis@berkeley.edu		Wallis, Joni/0000-0001-7262-7417	National Institute on Drug Abuse [R01DA19028]; National Institute of Neurological Disorders and Stroke [P01NS04081]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS040813] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA019028] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	I would like to thank R. Cools, E. Murray, C. Padoa-Schioppa, E. Rich, G. Schoenbaum and S. Wise for their valuable comments on an earlier draft of this manuscript. The preparation of this manuscript was supported by grants from the National Institute on Drug Abuse (R01DA19028) and the National Institute of Neurological Disorders and Stroke (P01NS04081).	Abe H, 2011, NEURON, V70, P731, DOI 10.1016/j.neuron.2011.03.026; Arana FS, 2003, J NEUROSCI, V23, P9632; Ballard K, 2009, NEUROIMAGE, V45, P143, DOI 10.1016/j.neuroimage.2008.11.004; Bartels A, 2004, NEUROIMAGE, V21, P1155, DOI 10.1016/j.neuroimage.2003.11.003; Basten U, 2010, P NATL ACAD SCI USA, V107, P21767, DOI 10.1073/pnas.0908104107; Baxter MG, 2000, J NEUROSCI, V20, P4311; Bechara A, 1998, J NEUROSCI, V18, P428; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; Blake R, 2002, NAT REV NEUROSCI, V3, P13, DOI 10.1038/nrn701; Bouret S, 2010, J NEUROSCI, V30, P8591, DOI 10.1523/JNEUROSCI.0049-10.2010; Burke KA, 2008, NATURE, V454, P340, DOI 10.1038/nature06993; Buzsaki G, 2007, NEURON, V56, P771, DOI 10.1016/j.neuron.2007.11.008; Canolty RT, 2010, P NATL ACAD SCI USA, V107, P17356, DOI 10.1073/pnas.1008306107; Carmichael ST, 1996, J COMP NEUROL, V371, P179, DOI 10.1002/(SICI)1096-9861(19960722)371:2<179::AID-CNE1>3.0.CO;2-#; Carmichael ST, 1995, J COMP NEUROL, V363, P642, DOI 10.1002/cne.903630409; Carmichael ST, 1995, J COMP NEUROL, V363, P615, DOI 10.1002/cne.903630408; Cavada C, 2000, CEREB CORTEX, V10, P220, DOI 10.1093/cercor/10.3.220; Cavada C, 2000, CEREB CORTEX, V10, P205, DOI 10.1093/cercor/10.3.205; Chaudhry AM, 2009, EUR J NEUROSCI, V29, P1047, DOI 10.1111/j.1460-9568.2009.06646.x; Croxson PL, 2009, J NEUROSCI, V29, P4531, DOI 10.1523/JNEUROSCI.4515-08.2009; Croxson PL, 2005, J NEUROSCI, V25, P8854, DOI 10.1523/JNEUROSCI.1311-05.2005; Damasio A.R., 2005, DESCARTES ERROR EMOT; Elston G.N., 2007, EVOLUTION NERVOUS SY, P191, DOI DOI 10.1016/B0-12-370878-8/00164-6; Feierstein CE, 2006, NEURON, V51, P495, DOI 10.1016/j.neuron.2006.06.032; Fellows LK, 2007, CEREB CORTEX, V17, P2669, DOI 10.1093/cercor/bhl176; FitzGerald THB, 2009, J NEUROSCI, V29, P8388, DOI 10.1523/JNEUROSCI.0717-09.2009; Furuyashiki T, 2008, J NEUROSCI, V28, P5127, DOI 10.1523/JNEUROSCI.0319-08.2008; Gallagher M, 1999, J NEUROSCI, V19, P6610; Glover GH, 2001, MAGNET RESON MED, V46, P515, DOI 10.1002/mrm.1222; Gold JI, 2007, ANNU REV NEUROSCI, V30, P535, DOI 10.1146/annurev.neuro.29.051605.113038; Gottfried JA, 2003, SCIENCE, V301, P1104, DOI 10.1126/science.1087919; HABER SN, 1995, J NEUROSCI, V15, P4851; Hare TA, 2008, J NEUROSCI, V28, P5623, DOI 10.1523/JNEUROSCI.1309-08.2008; Haynes JD, 2006, NAT REV NEUROSCI, V7, P523, DOI 10.1038/nrn1931; Kable JW, 2007, NAT NEUROSCI, V10, P1625, DOI 10.1038/nn2007; Kahnt T, 2010, P NATL ACAD SCI USA, V107, P6010, DOI 10.1073/pnas.0912838107; Kennerley SW, 2009, J NEUROPHYSIOL, V102, P3352, DOI 10.1152/jn.00273.2009; Kennerley SW, 2009, EUR J NEUROSCI, V29, P2061, DOI 10.1111/j.1460-9568.2009.06743.x; Kennerley SW, 2009, J COGNITIVE NEUROSCI, V21, P1162, DOI 10.1162/jocn.2009.21100; Kepecs A, 2008, NATURE, V455, P227, DOI 10.1038/nature07200; King-Casas B, 2005, SCIENCE, V308, P78, DOI 10.1126/science.1108062; Lara AH, 2009, J NEUROSCI, V29, P765, DOI 10.1523/JNEUROSCI.4637-08.2009; Logothetis NK, 2008, NATURE, V453, P869, DOI 10.1038/nature06976; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Mackey S, 2009, NEUROSCIENCE, V159, P1089, DOI 10.1016/j.neuroscience.2009.01.036; Mackey S, 2010, EUR J NEUROSCI, V32, P1940, DOI 10.1111/j.1460-9568.2010.07465.x; Manes F, 2002, BRAIN, V125, P624, DOI 10.1093/brain/awf049; Morrison SE, 2009, J NEUROSCI, V29, P11471, DOI 10.1523/JNEUROSCI.1815-09.2009; Murray EA, 2007, J NEUROSCI, V27, P8166, DOI 10.1523/JNEUROSCI.1556-07.2007; Noonan MP, 2010, P NATL ACAD SCI USA, V107, P20547, DOI 10.1073/pnas.1012246107; Noonan MP, 2010, EUR J NEUROSCI, V31, P2341, DOI 10.1111/j.1460-9568.2010.07271.x; Norman KA, 2006, TRENDS COGN SCI, V10, P424, DOI 10.1016/j.tics.2006.07.005; O'Doherty J, 2001, NAT NEUROSCI, V4, P95, DOI 10.1038/82959; Ongur D, 1998, J COMP NEUROL, V401, P480; Ongur D, 2003, J COMP NEUROL, V460, P425, DOI 10.1002/cne.10609; Padoa-Schioppa C, 2006, NATURE, V441, P223, DOI 10.1038/nature04676; Padoa-Schioppa C, 2011, ANNU REV NEUROSCI, V34, P333, DOI 10.1146/annurev-neuro-061010-113648; Padoa-Schioppa C, 2009, J NEUROSCI, V29, P14004, DOI 10.1523/JNEUROSCI.3751-09.2009; Palomero-Gallagher N, 2004, RAT NERVOUS SYSTEM, P729; Peters J, 2009, J NEUROSCI, V29, P15727, DOI 10.1523/JNEUROSCI.3489-09.2009; Petrides M., 1994, HDB NEUROPSYCHOLOGY, V9, P17; Plassmann H, 2007, J NEUROSCI, V27, P9984, DOI 10.1523/JNEUROSCI.2131-07.2007; Plassmann H, 2010, J NEUROSCI, V30, P10799, DOI 10.1523/JNEUROSCI.0788-10.2010; Price JL, 2007, ANN NY ACAD SCI, V1121, P54, DOI 10.1196/annals.1401.008; Rangel A, 2008, NAT REV NEUROSCI, V9, P545, DOI 10.1038/nrn2357; Rilling JK, 2002, NEURON, V35, P395, DOI 10.1016/S0896-6273(02)00755-9; Roesch MR, 2006, NEURON, V51, P509, DOI 10.1016/j.neuron.2006.06.027; Roesch MR, 2005, J NEUROPHYSIOL, V94, P2457, DOI 10.1152/jn.00373.2005; Roesch MR, 2004, SCIENCE, V304, P307, DOI 10.1126/science.1093223; Romanski LM, 1999, J COMP NEUROL, V403, P141, DOI 10.1002/(SICI)1096-9861(19990111)403:2<141::AID-CNE1>3.0.CO;2-V; Rudebeck PH, 2006, SCIENCE, V313, P1310, DOI 10.1126/science.1128197; Rudebeck PH, 2006, NAT NEUROSCI, V9, P1161, DOI 10.1038/nn1756; Rudebeck PH, 2011, J NEUROSCI, V31, P10569, DOI 10.1523/JNEUROSCI.0091-11.2011; Schoenbaum G, 1998, NAT NEUROSCI, V1, P155, DOI 10.1038/407; Sescousse G, 2010, J NEUROSCI, V30, P13095, DOI 10.1523/JNEUROSCI.3501-10.2010; Sirotin YB, 2009, NATURE, V457, P475, DOI 10.1038/nature07664; Smith DV, 2010, J NEUROSCI, V30, P2490, DOI 10.1523/JNEUROSCI.3319-09.2010; Talmi D, 2009, J NEUROSCI, V29, P14617, DOI 10.1523/JNEUROSCI.2026-09.2009; Tom SM, 2007, SCIENCE, V315, P515, DOI 10.1126/science.1134239; Tremblay L, 1999, NATURE, V398, P704, DOI 10.1038/19525; Tsuchida A, 2010, J NEUROSCI, V30, P16868, DOI 10.1523/JNEUROSCI.1958-10.2010; Tsujimoto S, 2009, J NEUROSCI, V29, P2569, DOI 10.1523/JNEUROSCI.5777-08.2009; Valentin VV, 2007, J NEUROSCI, V27, P4019, DOI 10.1523/JNEUROSCI.0564-07.2007; van Duuren E, 2007, LEARN MEMORY, V14, P446, DOI 10.1101/lm.546207; van Duuren E, 2009, J NEUROSCI, V29, P8965, DOI 10.1523/JNEUROSCI.0005-09.2009; van Wingerden M, 2010, J NEUROSCI, V30, P10025, DOI 10.1523/JNEUROSCI.0222-10.2010; Wallis JD, 2003, EUR J NEUROSCI, V18, P2069, DOI 10.1046/j.1460-9568.2003.02922.x; Wallis JD, 2007, ANN NY ACAD SCI, V1121, P447, DOI 10.1196/annals.1401.009; Wallis JD, 2007, ANNU REV NEUROSCI, V30, P31, DOI 10.1146/annurev.neuro.30.051606.094334; Walton ME, 2010, NEURON, V65, P927, DOI 10.1016/j.neuron.2010.02.027; Wise SP, 2008, TRENDS NEUROSCI, V31, P599, DOI 10.1016/j.tins.2008.08.008	92	234	236	0	46	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2012	15	1					13	19		10.1038/nn.2956	http://dx.doi.org/10.1038/nn.2956			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	866VO	22101646	Green Accepted			2022-12-28	WOS:000298414400007
J	Saha, RN; Wissink, EM; Bailey, ER; Zhao, ML; Fargo, DC; Hwang, JY; Daigle, KR; Fenn, JD; Adelman, K; Dudek, SM				Saha, Ramendra N.; Wissink, Erin M.; Bailey, Emma R.; Zhao, Meilan; Fargo, David C.; Hwang, Ji-Yeon; Daigle, Kelly R.; Fenn, J. Daniel; Adelman, Karen; Dudek, Serena M.			Rapid activity-induced transcription of Arc and other IEGs relies on poised RNA polymerase II	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; IMMEDIATE-EARLY GENE; BREAST-CANCER CELLS; LATE-PHASE; HIPPOCAMPAL-NEURONS; DROSOPHILA-MELANOGASTER; PROTEIN EXPRESSION; HSP70 GENE; IN-VIVO; P-TEFB	Transcription of immediate early genes (IEGs) in neurons is highly sensitive to neuronal activity, but the mechanism underlying these early transcription events is largely unknown. We found that several IEGs, such as Arc (also known as Arg3.1), are poised for near-instantaneous transcription by the stalling of RNA polymerase II (Pol II) just downstream of the transcription start site in rat neurons. Depletion through RNA interference of negative elongation factor, a mediator of Pol II stalling, reduced the Pol II occupancy of the Arc promoter and compromised the rapid induction of Arc and other IEGs. In contrast, reduction of Pol II stalling did not prevent transcription of IEGs that were expressed later and largely lacked promoter-proximal Pol II stalling. Together, our data strongly indicate that the rapid induction of neuronal IEGs requires poised Pol II and suggest a role for this mechanism in a wide variety of transcription-dependent processes, including learning and memory.	[Saha, Ramendra N.; Wissink, Erin M.; Bailey, Emma R.; Zhao, Meilan; Hwang, Ji-Yeon; Daigle, Kelly R.; Fenn, J. Daniel; Dudek, Serena M.] Natl Inst Environm Hlth Sci, Neurobiol Lab, US Natl Inst Hlth, Res Triangle Pk, NC 27709 USA; [Fargo, David C.] Natl Inst Environm Hlth Sci, Lib & Informat Serv, US Natl Inst Hlth, Res Triangle Pk, NC USA; [Adelman, Karen] Natl Inst Environm Hlth Sci, Mol Carcinogenesis Lab, US Natl Inst Hlth, Res Triangle Pk, NC USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Dudek, SM (corresponding author), Natl Inst Environm Hlth Sci, Neurobiol Lab, US Natl Inst Hlth, Res Triangle Pk, NC 27709 USA.	dudek@niehs.nih.gov	Saha, Ramendra/C-7000-2014; Dudek, Serena/C-6561-2009	Saha, Ramendra/0000-0002-5494-2584; Dudek, Serena/0000-0003-4094-8368; Wissink, Erin/0000-0003-1054-4899; Adelman, Karen/0000-0001-5364-334X	US National Institutes of Health, NIEHS [Z01 ES100221, Z01 ES101987]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZICES102445, ZICES102506, Z01ES100221, ZIAES100221, ZIAES101987, Z01ES101987] Funding Source: NIH RePORTER	US National Institutes of Health, NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank D. Armstrong, P. Wade and members of the Dudek laboratory for critical review of the manuscript, the National Institute of Environmental Health Sciences (NIEHS) Viral Vector Core for lentivirus preparations, the NIEHS Microarray Core for generating, processing and analyzing microarray data, the US National Institutes of Health Intramural Sequencing Center for ChIP-seq sample preparations and sequencing, and the NIEHS Imaging Center for assistance with confocal imaging. This research was supported by the Intramural Research Program of the US National Institutes of Health, NIEHS (Z01 ES100221 to S. M. D. and Z01 ES101987 to K.A.).	Adams JP, 2005, NAT REV NEUROSCI, V6, P737, DOI 10.1038/nrn1749; Adelman K, 2009, P NATL ACAD SCI USA, V106, P18207, DOI 10.1073/pnas.0910177106; Aida M, 2006, MOL CELL BIOL, V26, P6094, DOI 10.1128/MCB.02366-05; Aiyar SE, 2007, ONCOGENE, V26, P2543, DOI 10.1038/sj.onc.1210047; Boettiger AN, 2009, SCIENCE, V325, P471, DOI 10.1126/science.1173976; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Chao SH, 2000, J BIOL CHEM, V275, P28345, DOI 10.1074/jbc.C000446200; Chen YC, 2008, J NEUROSCI METH, V171, P239, DOI 10.1016/j.jneumeth.2008.03.013; Coulon V, 1999, J BIOL CHEM, V274, P30439, DOI 10.1074/jbc.274.43.30439; Egloff S, 2008, TRENDS GENET, V24, P280, DOI 10.1016/j.tig.2008.03.008; FREY U, 1989, NEUROSCI LETT, V97, P135, DOI 10.1016/0304-3940(89)90152-3; Frey U, 1996, J PHYSIOL-LONDON, V490, P703, DOI 10.1113/jphysiol.1996.sp021179; Frey U, 1997, NATURE, V385, P533, DOI 10.1038/385533a0; Gilchrist DA, 2008, GENE DEV, V22, P1921, DOI 10.1101/gad.1643208; GILMOUR DS, 1986, MOL CELL BIOL, V6, P3984, DOI 10.1128/MCB.6.11.3984; Giorgi C, 2007, CELL, V130, P179, DOI 10.1016/j.cell.2007.05.028; Guzowski JF, 2001, J NEUROSCI, V21, P5089, DOI 10.1523/JNEUROSCI.21-14-05089.2001; Guzowski JF, 1999, NAT NEUROSCI, V2, P1120, DOI 10.1038/16046; Hardingham GE, 1997, NATURE, V385, P260, DOI 10.1038/385260a0; Kauderer BS, 2000, P NATL ACAD SCI USA, V97, P13342, DOI 10.1073/pnas.97.24.13342; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; LINK W, 1995, P NATL ACAD SCI USA, V92, P5734, DOI 10.1073/pnas.92.12.5734; LYFORD GL, 1995, NEURON, V14, P433, DOI 10.1016/0896-6273(95)90299-6; Margaritis T, 2008, CELL, V133, P581, DOI 10.1016/j.cell.2008.04.027; Messaoudi E, 2002, J NEUROSCI, V22, P7453; Miyashita T, 2009, J NEUROSCI, V29, P898, DOI 10.1523/JNEUROSCI.4588-08.2009; Muse GW, 2007, NAT GENET, V39, P1507, DOI 10.1038/ng.2007.21; Narita T, 2003, MOL CELL BIOL, V23, P1863, DOI 10.1128/MCB.23.6.1863-1873.2003; Nechaev S, 2008, CELL CYCLE, V7, P1539, DOI 10.4161/cc.7.11.6006; NGUYEN PV, 1994, SCIENCE, V265, P1104, DOI 10.1126/science.8066450; Peterlin BM, 2006, MOL CELL, V23, P297, DOI 10.1016/j.molcel.2006.06.014; Phatnani HP, 2006, GENE DEV, V20, P2922, DOI 10.1101/gad.1477006; Ptashne M, 1997, NATURE, V386, P569, DOI 10.1038/386569a0; Ramirez-Amaya V, 2005, J NEUROSCI, V25, P1761, DOI 10.1523/JNEUROSCI.4342-04.2005; Rao VR, 2006, NAT NEUROSCI, V9, P887, DOI 10.1038/nn1708; ROUGVIE AE, 1988, CELL, V54, P795, DOI 10.1016/S0092-8674(88)91087-2; Saha RN, 2008, EXP BIOL MED, V233, P385, DOI 10.3181/0709-MR-241; Saunders A, 2006, NAT REV MOL CELL BIO, V7, P557, DOI 10.1038/nrm1981; Sun JL, 2008, J CELL BIOCHEM, V103, P1798, DOI 10.1002/jcb.21568; Thompson KR, 2004, NEURON, V44, P997, DOI 10.1016/j.neuron.2004.11.025; West AE, 2002, NAT REV NEUROSCI, V3, P921, DOI 10.1038/nrn987; Wu CH, 2003, GENE DEV, V17, P1402, DOI 10.1101/gad.1091403; Yamaguchi Y, 2002, MOL CELL BIOL, V22, P2918, DOI 10.1128/MCB.22.9.2918-2927.2002; Zeitlinger J, 2007, NAT GENET, V39, P1512, DOI 10.1038/ng.2007.26; Zou ZH, 2006, SCIENCE, V311, P1477, DOI 10.1126/science.1124755	46	114	115	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2011	14	7					848	U62		10.1038/nn.2839	http://dx.doi.org/10.1038/nn.2839			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	783KR	21623364	Green Accepted			2022-12-28	WOS:000292081700012
J	Calderon, DP; Fremont, R; Kraenzlin, F; Khodakhah, K				Calderon, D. Paola; Fremont, Rachel; Kraenzlin, Franca; Khodakhah, Kamran			The neural substrates of rapid-onset Dystonia-Parkinsonism	NATURE NEUROSCIENCE			English	Article							BASAL GANGLIA; DENTATE STIMULATION; NEURONAL ACTIVITY; NA+/K+-ATPASE; MOTOR SYSTEM; OUABAIN; RAT; CEREBELLUM; MICE; NA,K-ATPASE	Although dystonias are a common group of movement disorders, the mechanisms by which brain dysfunction results in dystonia are not understood. Rapid-onset Dystonia-Parkinsonism (RDP) is a hereditary dystonia caused by mutations in the ATP1A3 gene. Affected individuals can be free of symptoms for years, but rapidly develop persistent dystonia and Parkinsonism-like symptoms after a stressful experience. Using a mouse model, we found that an adverse interaction between the cerebellum and basal ganglia can account for the symptoms of these individuals. The primary instigator of dystonia was the cerebellum, whose aberrant activity altered basal ganglia function, which in turn caused dystonia. This adverse interaction between the cerebellum and basal ganglia was mediated through a di-synaptic thalamic pathway that, when severed, alleviated dystonia. Our results provide a unifying hypothesis for the involvement of cerebellum and basal ganglia in the generation of dystonia and suggest therapeutic strategies for the treatment of RDP.	[Calderon, D. Paola; Fremont, Rachel; Kraenzlin, Franca; Khodakhah, Kamran] Albert Einstein Coll Med, Dominick P Purpura Dept Neurosci, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine	Khodakhah, K (corresponding author), Albert Einstein Coll Med, Dominick P Purpura Dept Neurosci, Bronx, NY 10467 USA.	k.khodakhah@einstein.yu.edu	Calderon, Diany/D-4683-2011	Fremont, Rachel/0000-0001-5285-7899	US National Institutes of Health [NS063227, NS054251, NS058949]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027888] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007288] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050808, R01NS058949, R01NS063227, R21NS054251] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the members of the Khodakhah laboratory for invaluable discussions and comments on the manuscript, and for evaluating and scoring motor dysfunction. We also thank D. Purpura, R. Sillitoe and S. Reeber for help and advice. This work was supported by US National Institutes of Health grants NS063227 and NS054251 to K. K. Additional support was provided by an administrative supplement to US National Institutes of Health grant NS058949 (A. Brashear).	Aguiar PD, 2004, NEURON, V43, P169, DOI 10.1016/j.neuron.2004.06.028; ALLEN JC, 1970, ARCH BIOCHEM BIOPHYS, V141, P322, DOI 10.1016/0003-9861(70)90138-4; ANDREW J, 1983, BRAIN, V106, P981, DOI 10.1093/brain/106.4.981; Bagrov AY, 2008, NAT CLIN PRACT NEPHR, V4, P378, DOI 10.1038/ncpneph0848; Bauer N, 2005, HYPERTENSION, V45, P1024, DOI 10.1161/01.HYP.0000165024.47728.f7; Brashear A, 2007, BRAIN, V130, P828, DOI 10.1093/brain/awl340; Breakefield XO, 2008, NAT REV NEUROSCI, V9, P222, DOI 10.1038/nrn2337; BROWN LL, 1989, J NEUROSCI, V9, P4033; Campbell DB, 1999, EXP NEUROL, V160, P268, DOI 10.1006/exnr.1999.7171; Clapcote SJ, 2009, P NATL ACAD SCI USA, V106, P14085, DOI 10.1073/pnas.0904817106; DeAndrade MP, 2011, BEHAV BRAIN RES, V216, P659, DOI 10.1016/j.bbr.2010.09.009; DONALDSON J, 1972, CAN J BIOCHEM CELL B, V50, P888, DOI 10.1139/o72-124; Fahn S, 1987, RECENT DEV PARKINSON; FRAIOLI B, 1975, APPL NEUROPHYSIOL, V38, P81; HEIMBURGER RF, 1967, CONFIN NEUROL, V29, P101; Hoshi E, 2005, NAT NEUROSCI, V8, P1491, DOI 10.1038/nn1544; Ichinohe N, 2000, BRAIN RES, V880, P191, DOI 10.1016/S0006-8993(00)02744-X; Jankovic J, 2008, J NEUROL NEUROSUR PS, V79, P368, DOI 10.1136/jnnp.2007.131045; Jinnah HA, 2006, NEUROLOGY, V67, P1740, DOI 10.1212/01.wnl.0000246112.19504.61; Jinnah HA, 2005, MOVEMENT DISORD, V20, P283, DOI 10.1002/mds.20364; Kim JH, 2007, NAT NEUROSCI, V10, P196, DOI 10.1038/nn1839; Le Ber I, 2006, NEUROLOGY, V67, P1769, DOI 10.1212/01.wnl.0000244484.60489.50; LeDoux M S, 1998, Adv Neurol, V78, P63; LEDOUX MS, 1993, EXP NEUROL, V120, P302, DOI 10.1006/exnr.1993.1064; Lepoutre AC, 2006, J NEUROL NEUROSUR PS, V77, P1229, DOI 10.1136/jnnp.2005.083998; LI CL, 1969, EXP NEUROL, V24, P298, DOI 10.1016/0014-4886(69)90023-5; LORDEN JF, 1992, EXP NEUROL, V118, P95, DOI 10.1016/0014-4886(92)90026-M; Manto MU, 2005, CEREBELLUM, V4, P2, DOI 10.1080/14734220510007914; MCGRAIL KM, 1991, J NEUROSCI, V11, P381, DOI 10.1523/jneurosci.11-02-00381.1991; Moseley AE, 2007, J NEUROSCI, V27, P616, DOI 10.1523/JNEUROSCI.4464-06.2007; Muller U, 2009, BRAIN, V132, P2005, DOI 10.1093/brain/awp172; Neychev VK, 2008, BRAIN, V131, P2499, DOI 10.1093/brain/awn168; NIEOULLON A, 1978, BRAIN RES, V148, P143, DOI 10.1016/0006-8993(78)90384-0; Pizoli CE, 2002, J NEUROSCI, V22, P7825; RATCHESON RA, 1969, EXP NEUROL, V25, P268, DOI 10.1016/0014-4886(69)90050-8; Richter A, 1998, MOVEMENT DISORD, V13, P718, DOI 10.1002/mds.870130419; Rousseaux M, 1996, REV NEUROL, V152, P732; Ruktanonchai DJ, 1998, PHYSIOL BEHAV, V63, P403, DOI 10.1016/S0031-9384(97)00457-5; RUMBACH L, 1995, MOVEMENT DISORD, V10, P522, DOI 10.1002/mds.870100424; Sotnikova TD, 2005, PLOS BIOL, V3, P1488, DOI 10.1371/journal.pbio.0030271; Stacy MA, 2006, HDB DYSTONIA; Tanabe LM, 2009, NAT REV NEUROL, V5, P598, DOI 10.1038/nrneurol.2009.160; URAYAMA O, 1988, BIOCHEM BIOPH RES CO, V156, P796, DOI 10.1016/S0006-291X(88)80914-8; Weidemann H, 2004, J NEUROENDOCRINOL, V16, P458, DOI 10.1111/j.1365-2826.2004.01181.x; Yoon JH, 2007, ARCH NEUROL-CHICAGO, V64, P1652, DOI 10.1001/archneur.64.11.1652; Zadro I, 2008, MOVEMENT DISORD, V23, P919, DOI 10.1002/mds.21981; ZERVAS NT, 1967, CONFIN NEUROL, V29, P93; Zhang YR, 2010, CLIN EXP PHARMACOL P, V37, P613, DOI 10.1111/j.1440-1681.2010.05364.x; Zhang YR, 2010, J COMP PHYSIOL B, V180, P117, DOI 10.1007/s00360-009-0391-z	49	164	165	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2011	14	3					357	365		10.1038/nn.2753	http://dx.doi.org/10.1038/nn.2753			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	725MW	21297628	Green Accepted			2022-12-28	WOS:000287650100017
J	Shepherd, JD; Bear, MF				Shepherd, Jason D.; Bear, Mark F.			New views of Arc, a master regulator of synaptic plasticity	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; IMMEDIATE-EARLY GENE; OCULAR DOMINANCE PLASTICITY; MOUSE VISUAL-CORTEX; AMPA RECEPTOR TRAFFICKING; MESSENGER-RNA; PROTEIN EXPRESSION; MEMORY CONSOLIDATION; ANGELMAN SYNDROME; DENDRITIC SPINE	Many proteins have been implicated in synaptic and experience-dependent plasticity. However, few demonstrate the exquisite regulation of expression and breadth of functional importance as the immediate early gene product Arc. Here we review and attempt to synthesize the disparate views of Arc in neuronal function. The main conclusion garnered from this body of work is that Arc is a critical effector molecule downstream of many molecular signaling pathways and that dysregulation of Arc expression can have dire consequences for normal brain function.	[Shepherd, Jason D.] MIT, Dept Brain & Cognit Sci, Picower Inst Learning & Memory, Cambridge, MA 02139 USA; MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Northwell Health; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Shepherd, JD (corresponding author), MIT, Dept Brain & Cognit Sci, Picower Inst Learning & Memory, E25-618, Cambridge, MA 02139 USA.	jshephe@mit.edu; mbear@mit.edu	Shepherd, Jason/N-8555-2018	Shepherd, Jason/0000-0001-7384-8289; Bear, Mark/0000-0002-9903-2541	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K99NS076364] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NINDS NIH HHS [K99 NS076364] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adams JP, 2009, NEUROREPORT, V20, P1429, DOI 10.1097/WNR.0b013e3283311db6; BIENENSTOCK EL, 1982, J NEUROSCI, V2, P32, DOI 10.1523/jneurosci.02-01-00032.1982; Bramham CR, 2008, J NEUROSCI, V28, P11760, DOI 10.1523/JNEUROSCI.3864-08.2008; Chen TJ, 2009, J NEUROSCI RES, V87, P2297, DOI 10.1002/jnr.22057; Cho KKA, 2009, P NATL ACAD SCI USA, V106, P5377, DOI 10.1073/pnas.0808104106; Chowdhury S, 2006, NEURON, V52, P445, DOI 10.1016/j.neuron.2006.08.033; DAVIS HP, 1984, PSYCHOL BULL, V96, P518, DOI 10.1037/0033-2909.96.3.518; Dickey CA, 2004, J NEUROCHEM, V88, P434, DOI 10.1046/j.1471-4159.2003.02185.x; Frenkel MY, 2006, NEURON, V51, P339, DOI 10.1016/j.neuron.2006.06.026; Frey U, 1997, NATURE, V385, P533, DOI 10.1038/385533a0; Fukazawa' Y, 2003, NEURON, V38, P447, DOI 10.1016/S0896-6273(03)00206-X; Gao M, 2010, J NEUROSCI, V30, P7168, DOI 10.1523/JNEUROSCI.1067-10.2010; Giorgi C, 2007, CELL, V130, P179, DOI 10.1016/j.cell.2007.05.028; Goel A, 2007, J NEUROSCI, V27, P6692, DOI 10.1523/JNEUROSCI.5038-06.2007; Greer PL, 2010, CELL, V140, P704, DOI 10.1016/j.cell.2010.01.026; Guzowski JF, 2005, CURR OPIN NEUROBIOL, V15, P599, DOI 10.1016/j.conb.2005.08.018; Guzowski JF, 2000, J NEUROSCI, V20, P3993; Hsieh H, 2006, NEURON, V52, P831, DOI 10.1016/j.neuron.2006.10.035; Husi H, 2000, NAT NEUROSCI, V3, P661, DOI 10.1038/76615; Kaneko M, 2008, NEURON, V58, P673, DOI 10.1016/j.neuron.2008.04.023; Kishino T, 1997, NAT GENET, V15, P70, DOI 10.1038/ng0197-70; Lacor PN, 2004, J NEUROSCI, V24, P10191, DOI 10.1523/JNEUROSCI.3432-04.2004; LINK W, 1995, P NATL ACAD SCI USA, V92, P5734, DOI 10.1073/pnas.92.12.5734; LYFORD GL, 1995, NEURON, V14, P433, DOI 10.1016/0896-6273(95)90299-6; McCurry CL, 2010, NAT NEUROSCI, V13, P450, DOI 10.1038/nn.2508; Messaoudi E, 2007, J NEUROSCI, V27, P10445, DOI 10.1523/JNEUROSCI.2883-07.2007; Palop JJ, 2005, J NEUROSCI, V25, P9686, DOI 10.1523/JNEUROSCI.2829-05.2005; Palop JJ, 2007, NEURON, V55, P697, DOI 10.1016/j.neuron.2007.07.025; Panja D, 2009, J BIOL CHEM, V284, P31498, DOI 10.1074/jbc.M109.056077; Park S, 2008, NEURON, V59, P70, DOI 10.1016/j.neuron.2008.05.023; Plath N, 2006, NEURON, V52, P437, DOI 10.1016/j.neuron.2006.08.024; Ploski JE, 2008, J NEUROSCI, V28, P12383, DOI 10.1523/JNEUROSCI.1662-08.2008; Ramirez-Amaya V, 2005, J NEUROSCI, V25, P1761, DOI 10.1523/JNEUROSCI.4342-04.2005; Sharma N, 2010, NEURON, V67, P422, DOI 10.1016/j.neuron.2010.07.018; Shepherd JD, 2007, ANNU REV CELL DEV BI, V23, P613, DOI 10.1146/annurev.cellbio.23.090506.123516; Shepherd JD, 2006, NEURON, V52, P475, DOI 10.1016/j.neuron.2006.08.034; Smith GB, 2009, PHILOS T R SOC B, V364, P357, DOI 10.1098/rstb.2008.0198; Smith-Hicks C, 2010, NAT NEUROSCI, V13, P1082, DOI 10.1038/nn.2611; Steward O, 2001, NEURON, V30, P227, DOI 10.1016/S0896-6273(01)00275-6; Steward O, 1998, NEURON, V21, P741, DOI 10.1016/S0896-6273(00)80591-7; Sutton MA, 2006, CELL, V127, P49, DOI 10.1016/j.cell.2006.09.014; Tagawa Y, 2005, NAT NEUROSCI, V8, P380, DOI 10.1038/nn1410; Turrigiano GG, 2008, CELL, V135, P422, DOI 10.1016/j.cell.2008.10.008; Tzingounis AV, 2006, NEURON, V52, P403, DOI 10.1016/j.neuron.2006.10.016; Vazdarjanova A, 2006, J COMP NEUROL, V498, P317, DOI 10.1002/cne.21003; Venkitaramani DV, 2007, J NEUROSCI, V27, P11832, DOI 10.1523/JNEUROSCI.3478-07.2007; Waltereit R, 2001, J NEUROSCI, V21, P5484, DOI 10.1523/JNEUROSCI.21-15-05484.2001; Waung MW, 2008, NEURON, V59, P84, DOI 10.1016/j.neuron.2008.05.014; Whitlock JR, 2006, SCIENCE, V313, P1093, DOI 10.1126/science.1128134; Yashiro K, 2009, NAT NEUROSCI, V12, P777, DOI 10.1038/nn.2327	50	331	345	0	51	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2011	14	3					279	284		10.1038/nn.2708	http://dx.doi.org/10.1038/nn.2708			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	725MW	21278731	Green Accepted			2022-12-28	WOS:000287650100005
J	Nagel, KI; Wilson, RI				Nagel, Katherine I.; Wilson, Rachel I.			Biophysical mechanisms underlying olfactory receptor neuron dynamics	NATURE NEUROSCIENCE			English	Article							DROSOPHILA ODORANT RECEPTORS; ANTENNAL LOBE; ADAPTATION; SYSTEM; MELANOGASTER; RESPONSES; CHANNELS; INPUT; BULB; REPRESENTATIONS	The responses of olfactory receptor neurons (ORNs) to odors have complex dynamics. Using genetics and pharmacology, we found that these dynamics in Drosophila ORNs could be separated into sequential steps, corresponding to transduction and spike generation. Each of these steps contributed distinct dynamics. Transduction dynamics could be largely explained by a simple kinetic model of ligand-receptor interactions, together with an adaptive feedback mechanism that slows transduction onset. Spiking dynamics were well described by a differentiating linear filter that was stereotyped across odors and cells. Genetic knock-down of sodium channels reshaped this filter, implying that it arises from the regulated balance of intrinsic conductances in ORNs. Complex responses can be understood as a consequence of how the stereotyped spike filter interacts with odor- and receptor-specific transduction dynamics. However, in the presence of rapidly fluctuating natural stimuli, spiking simply increases the speed and sensitivity of encoding.	[Nagel, Katherine I.; Wilson, Rachel I.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Wilson, Rachel I.] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Wilson, RI (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA.	rachel_wilson@hms.harvard.edu	Wilson, Rachel/E-2227-2012	Wilson, Rachel/0000-0001-8573-9266	Helen Hay Whitney Foundation; US National Institutes of Health [R01DC008174]; McKnight Scholar Award; Beckman Young Investigator Award; Howard Hughes Medical Institute; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC008174] Funding Source: NIH RePORTER	Helen Hay Whitney Foundation; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); McKnight Scholar Award; Beckman Young Investigator Award; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank J.R. Carlson for Or33c-Gal4, Or46a-Gal4, UAS-Or47a and UAS-Or47b, B.J. Dickson for Or59c-Gal4 and Or42a-Gal4, L. Luo for pebbled-Gal, L. Stevens for UAS-DTl, J.S. Bell, J.B. Cohen, A. L. Fairhall, M. Wachowiak and G. Yellen for conversations, and A. W. Liu, M. Meister, D. Schoppik and members of the Wilson laboratory for feedback on the manuscript. This work was funded by a Helen Hay Whitney Foundation Fellowship (to K.I.N.), a grant from the US National Institutes of Health (R01DC008174), a McKnight Scholar Award and a Beckman Young Investigator Award (to R. I. W.), and a Howard Hughes Medical Institute Early Career Scientist award (to R. I. W.).	ALMAAS TJ, 1991, J COMP PHYSIOL A, V169, P249; Benton R, 2006, PLOS BIOL, V4, P240, DOI 10.1371/journal.pbio.0040020; Bhandawat V, 2005, SCIENCE, V308, P1931, DOI 10.1126/science.1109886; Bhandawat V, 2007, NAT NEUROSCI, V10, P1474, DOI 10.1038/nn1976; Budick SA, 2006, J EXP BIOL, V209, P3001, DOI 10.1242/jeb.02305; Carey RM, 2009, J NEUROPHYSIOL, V101, P1073, DOI 10.1152/jn.90902.2008; Couto A, 2005, CURR BIOL, V15, P1535, DOI 10.1016/j.cub.2005.07.034; Daly KC, 2004, J NEUROPHYSIOL, V92, P236, DOI 10.1152/jn.01132.2003; de Bruyne M, 1999, J NEUROSCI, V19, P4520; de Bruyne M, 2001, NEURON, V30, P537, DOI 10.1016/S0896-6273(01)00289-6; Deshpande M, 2000, J NEUROBIOL, V43, P282, DOI 10.1002/(SICI)1097-4695(20000605)43:3<282::AID-NEU6>3.0.CO;2-T; Dobritsa AA, 2003, NEURON, V37, P827, DOI 10.1016/S0896-6273(03)00094-1; Famulare M, 2010, NEURAL COMPUT, V22, P581, DOI 10.1162/neco.2009.02-09-956; Field GD, 2005, ANNU REV PHYSIOL, V67, P491, DOI 10.1146/annurev.physiol.67.031103.151256; Flecke C, 2009, J COMP PHYSIOL A, V195, P529, DOI 10.1007/s00359-009-0429-4; Geffen MN, 2009, NEURON, V61, P570, DOI 10.1016/j.neuron.2009.01.021; Goldman AL, 2005, NEURON, V45, P661, DOI 10.1016/j.neuron.2005.01.025; Gu YQ, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000321; Hallem EA, 2006, CELL, V125, P143, DOI 10.1016/j.cell.2006.01.050; Hallem EA, 2004, CELL, V117, P965, DOI 10.1016/j.cell.2004.05.012; Johnston D., 1995, FDN CELLULAR NEUROPH; KAISSLING KE, 1987, ANN NY ACAD SCI, V510, P104; Kaissling KE, 1998, CHEM SENSES, V23, P99, DOI 10.1093/chemse/23.1.99; KAISSLING KE, 1986, ANNU REV NEUROSCI, V9, P121, DOI 10.1146/annurev.ne.09.030186.001005; KANG JS, 1995, J NEUROPHYSIOL, V74, P1435, DOI 10.1152/jn.1995.74.4.1435; Kim AJ, 2011, J COMPUT NEUROSCI, V30, P143, DOI 10.1007/s10827-010-0265-0; Laurent G, 1996, J NEUROSCI, V16, P3837; LIU MY, 1994, SCIENCE, V266, P1348, DOI 10.1126/science.266.5189.1348; Lundstrom BN, 2008, NEURAL COMPUT, V20, P1239, DOI 10.1162/neco.2007.05-07-536; MURLIS J, 1992, ANNU REV ENTOMOL, V37, P505, DOI 10.1146/annurev.en.37.010192.002445; Nagel KI, 2006, NEURON, V51, P845, DOI 10.1016/j.neuron.2006.08.030; Neuhaus EM, 2005, NAT NEUROSCI, V8, P15, DOI 10.1038/nn1371; Olsen SR, 2007, NEURON, V54, P89, DOI 10.1016/j.neuron.2007.03.010; Raman B, 2010, J NEUROSCI, V30, P1994, DOI 10.1523/JNEUROSCI.5639-09.2010; Rauch A, 2003, J NEUROPHYSIOL, V90, P1598, DOI 10.1152/jn.00293.2003; Reisert J, 1999, J PHYSIOL-LONDON, V519, P801, DOI 10.1111/j.1469-7793.1999.0801n.x; REYES AD, 1994, J NEUROSCI, V14, P5352; RUSHTON WAH, 1972, J PHYSIOL-LONDON, V220, pP1; Sato K, 2008, NATURE, V452, P1002, DOI 10.1038/nature06850; SCHNEIDER D, 1969, SCIENCE, V163, P1031, DOI 10.1126/science.163.3871.1031; Schuckel J, 2009, J NEUROPHYSIOL, V102, P214, DOI 10.1152/jn.00162.2009; Soo FS, 2008, J NEUROSCI, V28, P1331, DOI 10.1523/JNEUROSCI.4121-07.2008; Spors H, 2006, J NEUROSCI, V26, P1247, DOI 10.1523/JNEUROSCI.3100-05.2006; Stopfer M, 2003, NEURON, V39, P991, DOI 10.1016/j.neuron.2003.08.011; Stortkuhl KF, 1999, J NEUROSCI, V19, P4839; Sweeney LB, 2007, NEURON, V53, P185, DOI 10.1016/j.neuron.2006.12.022; Vickers NJ, 2001, NATURE, V410, P466, DOI 10.1038/35068559; Wicher D, 2008, NATURE, V452, P1007, DOI 10.1038/nature06861; Yao CA, 2010, J NEUROSCI, V30, P4562, DOI 10.1523/JNEUROSCI.6357-09.2010	50	117	118	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2011	14	2					208	U296		10.1038/nn.2725	http://dx.doi.org/10.1038/nn.2725			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	711MJ	21217763	Green Accepted			2022-12-28	WOS:000286595400018
J	Rolfs, M; Jonikaitis, D; Deubel, H; Cavanagh, P				Rolfs, Martin; Jonikaitis, Donatas; Deubel, Heiner; Cavanagh, Patrick			Predictive remapping of attention across eye movements	NATURE NEUROSCIENCE			English	Article							PRIMARY VISUAL-CORTEX; SPATIAL ATTENTION; PSYCHOPHYSICS TOOLBOX; PARIETAL CORTEX; SELECTION; SACCADES; SYSTEM; REPRESENTATION; PERCEPTION	Many cells in retinotopic brain areas increase their activity when saccades (rapid eye movements) are about to bring stimuli into their receptive fields. Although previous work has attempted to look at the functional correlates of such predictive remapping, no study has explicitly tested for better attentional performance at the future retinal locations of attended targets. We found that, briefly before the eyes start moving, attention drawn to the targets of upcoming saccades also shifted to those retinal locations that the targets would cover once the eyes had moved, facilitating future movements. This suggests that presaccadic visual attention shifts serve to both improve presaccadic perceptual processing at the target locations and speed subsequent eye movements to their new postsaccadic locations. Predictive remapping of attention provides a sparse, efficient mechanism for keeping track of relevant parts of the scene when frequent rapid eye movements provoke retinal smear and temporal masking.	[Rolfs, Martin; Cavanagh, Patrick] Univ Paris 05, Lab Psychol Percept, Paris, France; [Rolfs, Martin] NYU, Dept Psychol, New York, NY 10003 USA; [Jonikaitis, Donatas; Deubel, Heiner] Univ Munich, Dept Psychol, Munich, Germany	UDICE-French Research Universities; Universite Paris Cite; New York University; University of Munich	Rolfs, M (corresponding author), Univ Paris 05, Lab Psychol Percept, Paris, France.	martin.rolfs@gmail.com; patrick.cavanagh@parisdescartes.fr	Jonikaitis, Donatas/K-6782-2019; Rolfs, Martin/A-7214-2008	Rolfs, Martin/0000-0002-8214-8556; Jonikaitis, Donatas/0000-0001-9851-0903	European Commission [235625]; Deutsche Forschungsgemeinschaft [GRK 1091]; Chaire d'Excellence grant	European Commission(European CommissionEuropean Commission Joint Research Centre); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Chaire d'Excellence grant	We thank C. Buss for help with data acquisition. This work was supported by the 7th Framework Program of the European Commission (Marie Curie International Outgoing Fellowship 235625 awarded to M. R.), by Deutsche Forschungsgemeinschaft (GRK 1091, as a fellowship to D.J.) and by a Chaire d'Excellence grant to P. C.	Awh E, 2006, TRENDS COGN SCI, V10, P124, DOI 10.1016/j.tics.2006.01.001; Baldauf D, 2008, EXP BRAIN RES, V184, P411, DOI 10.1007/s00221-007-1114-x; BECKER W, 1979, VISION RES, V19, P967, DOI 10.1016/0042-6989(79)90222-0; Berman R, 2009, VISION RES, V49, P1233, DOI 10.1016/j.visres.2008.06.017; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Castet E, 2002, P NATL ACAD SCI USA, V99, P15159, DOI 10.1073/pnas.232377199; Cavanagh P, 2010, TRENDS COGN SCI, V14, P147, DOI 10.1016/j.tics.2010.01.007; Chen Y, 2008, NAT NEUROSCI, V11, P974, DOI 10.1038/nn.2147; Collins T, 2009, J VISION, V9, DOI 10.1167/9.5.29; Cornelissen FW, 2002, BEHAV RES METH INS C, V34, P613, DOI 10.3758/BF03195489; Deubel H, 1996, VISION RES, V36, P1827, DOI 10.1016/0042-6989(95)00294-4; Deubel H, 2008, PSYCHOL RES-PSYCH FO, V72, P630, DOI 10.1007/s00426-008-0165-3; DUHAMEL JR, 1992, SCIENCE, V255, P90, DOI 10.1126/science.1553535; Engbert R, 2006, P NATL ACAD SCI USA, V103, P7192, DOI 10.1073/pnas.0509557103; Gersch TM, 2006, VIS COGN, V14, P104; Godijn R, 2003, J EXP PSYCHOL HUMAN, V29, P882, DOI 10.1037/0096-1523.29.5.882; Golomb JD, 2008, J NEUROSCI, V28, P10654, DOI 10.1523/JNEUROSCI.2525-08.2008; Gottlieb JP, 1998, NATURE, V391, P481, DOI 10.1038/35135; GUTHRIE BL, 1983, SCIENCE, V221, P1193, DOI 10.1126/science.6612334; HALLETT PE, 1976, VISION RES, V16, P107, DOI 10.1016/0042-6989(76)90084-5; KARNI A, 1991, P NATL ACAD SCI USA, V88, P4966, DOI 10.1073/pnas.88.11.4966; Knapen T, 2010, J VISION, V10, DOI 10.1167/10.1.8; KOWLER E, 1995, VISION RES, V35, P1897, DOI 10.1016/0042-6989(94)00279-U; Mack A., 1998, INATTENTIONAL BLINDN; Macknik S. L., 2009, COGNITIVE NEUROSCIEN; Mathot S, 2010, EXP BRAIN RES, V200, P117, DOI 10.1007/s00221-009-2055-3; Melcher D, 2007, NAT NEUROSCI, V10, P903, DOI 10.1038/nn1917; Melcher D, 2008, TRENDS COGN SCI, V12, P466, DOI 10.1016/j.tics.2008.09.003; Montagnini A, 2007, J VISION, V7, DOI 10.1167/7.14.8; O'Regan JK, 1999, NATURE, V398, P34, DOI 10.1038/17953; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; POLAT U, 1993, VISION RES, V33, P993, DOI 10.1016/0042-6989(93)90081-7; Rolfs M, 2005, EXP BRAIN RES, V166, P427, DOI 10.1007/s00221-005-2382-y; Solomon JA, 2004, VISION RES, V44, P1209, DOI 10.1016/j.visres.2003.12.003; Sommer MA, 2002, SCIENCE, V296, P1480, DOI 10.1126/science.1069590; Sommer MA, 2006, NATURE, V444, P374, DOI 10.1038/nature05279; WATSON AB, 1983, PERCEPT PSYCHOPHYS, V33, P113, DOI 10.3758/BF03202828; Wurtz RH, 2008, VISION RES, V48, P2070, DOI 10.1016/j.visres.2008.03.021	38	225	227	3	47	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2011	14	2					252	U347		10.1038/nn.2711	http://dx.doi.org/10.1038/nn.2711			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	711MJ	21186360				2022-12-28	WOS:000286595400024
J	Lee, CC; Middlebrooks, JC				Lee, Chen-Chung; Middlebrooks, John C.			Auditory cortex spatial sensitivity sharpens during task performance	NATURE NEUROSCIENCE			English	Article							CORTICAL MAP REORGANIZATION; LEARNING-INDUCED PLASTICITY; THALAMIC RETICULAR NUCLEUS; SOUND-LOCALIZATION; RECEPTIVE-FIELDS; DORSAL ZONE; NEURONS; REPRESENTATION; CAT; ATTENTION	Activity in the primary auditory cortex (A1) is essential for normal sound localization behavior, but previous studies of the spatial sensitivity of neurons in A1 have found broad spatial tuning. We tested the hypothesis that spatial tuning sharpens when an animal engages in an auditory task. Cats performed a task that required evaluation of the locations of sounds and one that required active listening, but in which sound location was irrelevant. Some 26-44% of the units recorded in A1 showed substantially sharpened spatial tuning during the behavioral tasks as compared with idle conditions, with the greatest sharpening occurring during the location-relevant task. Spatial sharpening occurred on a scale of tens of seconds and could be replicated multiple times in similar to 1.5-h test sessions. Sharpening resulted primarily from increased suppression of responses to sounds at least-preferred locations. That and an observed increase in latencies suggest an important role of inhibitory mechanisms.	[Lee, Chen-Chung; Middlebrooks, John C.] Univ Calif Irvine, Dept Otolaryngol Head & Neck Surg, Irvine, CA 92717 USA; [Lee, Chen-Chung; Middlebrooks, John C.] Univ Calif Irvine, Ctr Hearing Res, Irvine, CA USA; [Lee, Chen-Chung] Univ Michigan, Dept Otolaryngol Head & Neck Surg, Kresge Hearing Res Inst, Ann Arbor, MI 48109 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of Michigan System; University of Michigan	Middlebrooks, JC (corresponding author), Univ Calif Irvine, Dept Otolaryngol Head & Neck Surg, Irvine, CA 92717 USA.	j.midd@uci.edu			National Institute on Deafness and Other Communication Disorders [R01 DC-000420, P30 DC-05188]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [P30DC005188, R01DC000420] Funding Source: NIH RePORTER	National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank I. Harrington, E. Macpherson, J. Wiler, E. Hand, G. Rising, D. Vailliencourt, C. Ellinger and Z. Onsan for technical support. We thank A. Kirby and R. Adrian for helpful comments on the manuscript. This work was supported by National Institute on Deafness and Other Communication Disorders grants R01 DC-000420, and P30 DC-05188 (to J. Schacht).	Allen K, 2009, ATTEN PERCEPT PSYCHO, V71, P164, DOI 10.3758/APP.71.1.164; Atiani S, 2009, NEURON, V61, P467, DOI 10.1016/j.neuron.2008.12.027; Bao SW, 2001, NATURE, V412, P79, DOI 10.1038/35083586; BENSON DA, 1981, BRAIN RES, V219, P249, DOI 10.1016/0006-8993(81)90290-0; Best V, 2008, P NATL ACAD SCI USA, V105, P13174, DOI 10.1073/pnas.0803718105; Brechmann A, 2005, CEREB CORTEX, V15, P578, DOI 10.1093/cercor/bhh159; Cansino S, 1997, BRAIN RES, V764, P53, DOI 10.1016/S0006-8993(97)00321-1; Cotillon-Williams N, 2008, J NEUROPHYSIOL, V99, P1137, DOI 10.1152/jn.01159.2007; DIAMOND DM, 1989, BEHAV NEUROSCI, V103, P471, DOI 10.1037/0735-7044.103.3.471; Efron B., 1994, MONOGRAPHS STAT APPL; Fritz J, 2003, NAT NEUROSCI, V6, P1216, DOI 10.1038/nn1141; Furukawa S, 2002, J NEUROPHYSIOL, V87, P1749, DOI 10.1152/jn.00491.2001; Ghose GM, 2004, CURR OPIN NEUROBIOL, V14, P513, DOI 10.1016/j.conb.2004.07.003; Golmayo L, 2003, NEUROSCIENCE, V119, P597, DOI 10.1016/S0306-4522(03)00031-9; Green DM, 1966, SIGNAL DETECTION THE; IMIG TJ, 1990, J NEUROPHYSIOL, V63, P1448, DOI 10.1152/jn.1990.63.6.1448; JENKINS WM, 1984, J NEUROPHYSIOL, V52, P819, DOI 10.1152/jn.1984.52.5.819; Kidd G, 2005, J ACOUST SOC AM, V118, P3804, DOI 10.1121/1.2109187; Kilgard MP, 1998, SCIENCE, V279, P1714, DOI 10.1126/science.279.5357.1714; Kimura A, 2007, EUR J NEUROSCI, V26, P3524, DOI 10.1111/j.1460-9568.2007.05925.x; Kopco N, 2007, J ACOUST SOC AM, V121, P420, DOI 10.1121/1.2390677; Lee CC, 2008, J COMP NEUROL, V507, P1920, DOI 10.1002/cne.21613; Ma XF, 2009, J NEUROSCI, V29, P4888, DOI 10.1523/JNEUROSCI.0167-09.2009; Malhotra S, 2004, J NEUROPHYSIOL, V92, P1625, DOI 10.1152/jn.01205.2003; Malhotra S, 2008, J NEUROPHYSIOL, V99, P1628, DOI 10.1152/jn.01228.2007; McAlonan K, 2006, J NEUROSCI, V26, P4444, DOI 10.1523/JNEUROSCI.5602-05.2006; McDonald JJ, 1999, J EXP PSYCHOL HUMAN, V25, P1234, DOI 10.1037/0096-1523.25.5.1234; Mickey BJ, 2003, J NEUROSCI, V23, P8649; MIDDLEBROOKS JC, 1981, J NEUROSCI, V1, P107, DOI 10.1523/JNEUROSCI.01-01-00107.1981; MIDDLEBROOKS JC, 1994, SCIENCE, V264, P842, DOI 10.1126/science.8171339; MONDOR TA, 1995, J EXP PSYCHOL HUMAN, V21, P387, DOI 10.1037/0096-1523.21.2.387; MOORE BCJ, 1983, J ACOUST SOC AM, V74, P750, DOI 10.1121/1.389861; Nunamaker EA, 2007, J BIOMED MATER RES A, V83A, P1128, DOI 10.1002/jbm.a.31275; Ohl FW, 2005, CURR OPIN NEUROBIOL, V15, P470, DOI 10.1016/j.conb.2005.07.002; Otazu GH, 2009, NAT NEUROSCI, V12, P646, DOI 10.1038/nn.2306; Polley DB, 2006, J NEUROSCI, V26, P4970, DOI 10.1523/JNEUROSCI.3771-05.2006; Rasmusson DD, 2007, NEUROSCIENCE, V149, P232, DOI 10.1016/j.neuroscience.2007.06.057; RECANZONE GH, 1993, J NEUROSCI, V13, P87; RHODES G, 1987, PERCEPT PSYCHOPHYS, V42, P1, DOI 10.3758/BF03211508; Roberts KL, 2009, J EXP PSYCHOL HUMAN, V35, P1178, DOI 10.1037/a0014249; Scott BH, 2007, J NEUROSCI, V27, P6489, DOI 10.1523/JNEUROSCI.0016-07.2007; SPENCE CJ, 1994, J EXP PSYCHOL HUMAN, V20, P555, DOI 10.1037/0096-1523.20.3.555; Stecker GC, 2005, J NEUROPHYSIOL, V94, P1267, DOI 10.1152/jn.00104.2005; Ter-Mikaelian M, 2007, J NEUROSCI, V27, P6091, DOI 10.1523/JNEUROSCI.4848-06.2007; Verbny YI, 2006, J NEUROPHYSIOL, V96, P3194, DOI 10.1152/jn.00484.2006; Wang XQ, 2005, NATURE, V435, P341, DOI 10.1038/nature03565; Witte RS, 2005, COGNITIVE BRAIN RES, V23, P171, DOI 10.1016/j.cogbrainres.2004.10.018; Zhang YF, 2008, CEREB CORTEX, V18, P1521, DOI 10.1093/cercor/bhm188; ZHOU B, 1992, J ACOUST SOC AM, V92, P1169, DOI 10.1121/1.404045; Zikopoulos B, 2006, J NEUROSCI, V26, P7348, DOI 10.1523/JNEUROSCI.5511-05.2006	50	122	122	2	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2011	14	1					108	U144		10.1038/nn.2713	http://dx.doi.org/10.1038/nn.2713			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	699TE	21151120	Green Submitted, Green Accepted			2022-12-28	WOS:000285684900021
J	Kuzmiski, JB; Marty, V; Baimoukhametova, DV; Bains, JS				Kuzmiski, J. Brent; Marty, Vincent; Baimoukhametova, Dinara V.; Bains, Jaideep S.			Stress-induced priming of glutamate synapses unmasks associative short-term plasticity	NATURE NEUROSCIENCE			English	Article							CORTICOTROPIN-RELEASING-FACTOR; PITUITARY-ADRENAL AXIS; MESSENGER-RNA LEVELS; METHYL-D-ASPARTATE; PARAVENTRICULAR NUCLEUS; RAT HYPOTHALAMUS; SYNAPTIC-TRANSMISSION; INDUCED SENSITIZATION; GENE-EXPRESSION; AMPA RECEPTORS	Exposure to a stressor sensitizes or 'primes' the hypothalamic-pituitary-adrenal axis to a subsequent novel stressor. The synaptic mechanisms underlying this priming, however, are not known. We found that exposing a rat to a single stressor primed glutamate synapses in the paraventricular nucleus of the hypothalamus and allowed them to undergo a short-term potentiation (STP) following a burst of high-frequency afferent activity. This transient potentiation requires a corticotrophin-releasing hormone-dependent depression of postsynaptic NMDA receptors (NMDARs). The long-term depression of NMDAR function after stress prevented the vesicular release of an inhibitory retrograde messenger that, in control conditions, arrests STP. Following stress, STP manifested as an increase in the release probability of glutamate that was sufficient to induce multivesicular release. Our findings indicate that the priming of synapses to express STP is a synaptic correlate to stress-induced behavioral and neuroendocrine sensitization.	[Kuzmiski, J. Brent; Marty, Vincent; Baimoukhametova, Dinara V.; Bains, Jaideep S.] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada; [Kuzmiski, J. Brent; Marty, Vincent; Baimoukhametova, Dinara V.; Bains, Jaideep S.] Univ Calgary, Dept Physiol & Pharmacol, Calgary, AB, Canada	University of Calgary; University of Calgary	Bains, JS (corresponding author), Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada.	jsbains@ucalgary.ca		Kuzmiski, Brent/0000-0002-9240-4867; Bains, Jaideep/0000-0002-3634-6463	Hotchkiss Brain Institute; Canadian Institutes for Health Research	Hotchkiss Brain Institute; Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR))	We thank members of the Bains laboratory and Q.J. Pittman for comments and thoughtful discussion regarding the manuscript. V.M. was supported by a fellowship from the Hotchkiss Brain Institute. J.S.B. is an Alberta Heritage Foundation for Medical Research Senior Scholar. This work was funded by an operating grant from the Canadian Institutes for Health Research.	Armario A, 2008, NEUROSCI BIOBEHAV R, V32, P1121, DOI 10.1016/j.neubiorev.2008.04.003; BARTANUSZ V, 1995, NEUROSCIENCE, V66, P247, DOI 10.1016/0306-4522(95)00084-V; Blank T, 2002, J NEUROSCI, V22, P3788; Borgdorff AJ, 2002, NATURE, V417, P649, DOI 10.1038/nature00780; Branco T, 2008, NEURON, V59, P475, DOI 10.1016/j.neuron.2008.07.006; Brenowitz SD, 2005, NEURON, V45, P419, DOI 10.1016/j.neuron.2004.12.045; Bruijnzeel AW, 2001, BRAIN RES, V908, P187, DOI 10.1016/S0006-8993(01)02646-4; Burrone J, 2002, NATURE, V420, P414, DOI 10.1038/nature01242; Champagne D, 1998, J NEUROENDOCRINOL, V10, P119, DOI 10.1046/j.1365-2826.1998.00179.x; Chen Y, 2004, NEUROSCIENCE, V126, P533, DOI 10.1016/j.neuroscience.2004.03.036; Chen YC, 2008, J NEUROSCI, V28, P2903, DOI 10.1523/JNEUROSCI.0225-08.2008; Cook CJ, 2004, PHYSIOL BEHAV, V82, P751, DOI 10.1016/j.physbeh.2004.06.013; Frank CA, 2006, NEURON, V52, P663, DOI 10.1016/j.neuron.2006.09.029; Givalois L, 2000, MOL BRAIN RES, V75, P166, DOI 10.1016/S0169-328X(99)00290-9; Heine M, 2008, SCIENCE, V320, P201, DOI 10.1126/science.1152089; Hewitt SA, 2009, NAT NEUROSCI, V12, P438, DOI 10.1038/nn.2274; Iremonger KJ, 2009, J NEUROSCI, V29, P7349, DOI 10.1523/JNEUROSCI.0381-09.2009; Justice NJ, 2008, J COMP NEUROL, V511, P479, DOI 10.1002/cne.21848; Keller C, 2002, DRUG METAB DISPOS, V30, P173, DOI 10.1124/dmd.30.2.173; Lau CG, 2010, J NEUROSCI, V30, P242, DOI 10.1523/JNEUROSCI.4933-08.2010; LEE S, 1994, MOL BRAIN RES, V24, P192, DOI 10.1016/0169-328X(94)90132-5; Li Y, 2008, J NEUROSCI, V28, P2814, DOI 10.1523/JNEUROSCI.5447-07.2008; LIPOSITS Z, 1985, HISTOCHEMISTRY, V83, P5, DOI 10.1007/BF00495294; Lledo PM, 1998, SCIENCE, V279, P399, DOI 10.1126/science.279.5349.399; MAKARA GB, 1975, NEUROENDOCRINOLOGY, V18, P213, DOI 10.1159/000122400; Mansi JA, 1996, ENDOCRINOLOGY, V137, P4619, DOI 10.1210/en.137.11.4619; MANZONI OJ, 1994, SCIENCE, V265, P2098, DOI 10.1126/science.7916485; Morishita W, 2005, NAT NEUROSCI, V8, P1043, DOI 10.1038/nn1506; Murthy VN, 2001, NEURON, V32, P673, DOI 10.1016/S0896-6273(01)00500-1; Nemeroff CB, 2006, J PSYCHIATR RES, V40, P1, DOI 10.1016/j.jpsychires.2005.07.005; O'Connor KA, 2004, NEUROENDOCRINOLOGY, V80, P252, DOI 10.1159/000082876; ONO N, 1985, P NATL ACAD SCI USA, V82, P3528, DOI 10.1073/pnas.82.10.3528; Panatier A, 2006, CELL, V125, P775, DOI 10.1016/j.cell.2006.02.051; PARKES D, 1993, MOL ENDOCRINOL, V7, P1357, DOI 10.1210/me.7.10.1357; PECHNICK RN, 1989, EUR J PHARMACOL, V164, P257, DOI 10.1016/0014-2999(89)90466-4; Petrini EM, 2009, NEURON, V63, P92, DOI 10.1016/j.neuron.2009.05.025; PRETEL S, 1990, J COMP NEUROL, V294, P192, DOI 10.1002/cne.902940204; Regehr WG, 2009, NEURON, V63, P154, DOI 10.1016/j.neuron.2009.06.021; Risbrough VB, 2006, HORM BEHAV, V50, P550, DOI 10.1016/j.yhbeh.2006.06.019; Sheng H, 2008, ENDOCRINOLOGY, V149, P1389, DOI 10.1210/en.2007-1378; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; Smith GB, 2009, PHILOS T R SOC B, V364, P357, DOI 10.1098/rstb.2008.0198; Timpl P, 1998, NAT GENET, V19, P162, DOI 10.1038/520; VANDENPOL AN, 1990, SCIENCE, V250, P1276, DOI 10.1126/science.1978759; VYKLICKY L, 1991, NEURON, V7, P971, DOI 10.1016/0896-6273(91)90342-W; Wong YN, 2000, NEUROENDOCRINOLOGY, V71, P354, DOI 10.1159/000054556; Zhou Y, 1998, EUR J PHARMACOL, V352, P65, DOI 10.1016/S0014-2999(98)00332-X; Ziegler DR, 2000, ENDOCRINOLOGY, V141, P4801, DOI 10.1210/en.141.12.4801; Zorrilla EP, 2010, DRUG DISCOV TODAY, V15, P371, DOI 10.1016/j.drudis.2010.02.011	49	51	51	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2010	13	10					1257	1264		10.1038/nn.2629	http://dx.doi.org/10.1038/nn.2629			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	654MB	20818385				2022-12-28	WOS:000282171300018
J	Deng, JV; Rodriguiz, RM; Hutchinson, AN; Kim, IH; Wetsel, WC; West, AE				Deng, Jie V.; Rodriguiz, Ramona M.; Hutchinson, Ashley N.; Kim, Il-Hwan; Wetsel, William C.; West, Anne E.			MeCP2 in the nucleus accumbens contributes to neural and behavioral responses to psychostimulants	NATURE NEUROSCIENCE			English	Article							MOUSE MODEL; RETT-SYNDROME; DOPAMINERGIC MODULATION; SYNAPTIC PLASTICITY; BDNF TRANSCRIPTION; SPINY NEURONS; MUTANT MICE; DELTA-FOSB; COCAINE; EXPRESSION	MeCP2 is a methyl DNA-binding transcriptional regulator that contributes to the development and function of CNS synapses; however, the requirement for MeCP2 in stimulus-regulated behavioral plasticity is not fully understood. Here we show that acute viral manipulation of MeCP2 expression in the nucleus accumbens (NAc) bidirectionally modulates amphetamine (AMPH)-induced conditioned place preference. Mecp2 hypomorphic mutant mice have more NAc GABAergic synapses and show deficient AMPH-induced structural plasticity of NAc dendritic spines. Furthermore, these mice show deficient plasticity of striatal immediate early gene inducibility after repeated AMPH administration. Notably, psychostimulants induce phosphorylation of MeCP2 at Ser421, a site that regulates MeCP2's function as a repressor. Phosphorylation is selectively induced in GABAergic interneurons of the NAc, and its extent strongly predicts the degree of behavioral sensitization. These data reveal new roles for MeCP2 both in mesolimbocortical circuit development and in the regulation of psychostimulant-induced behaviors.	[Deng, Jie V.; Hutchinson, Ashley N.; Wetsel, William C.; West, Anne E.] Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; [Rodriguiz, Ramona M.; Kim, Il-Hwan; Wetsel, William C.] Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Durham, NC 27710 USA; [Rodriguiz, Ramona M.; Wetsel, William C.] Duke Univ, Med Ctr, Mouse Behav & Neuroendocrine Anal Core Facil, Durham, NC 27710 USA; [Wetsel, William C.] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA	Duke University; Duke University; Duke University; Duke University	West, AE (corresponding author), Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA.	west@neuro.duke.edu			National Institute of Drug Abuse [R01-DA022202, F32-DA025447]; March of Dimes Foundation [1-FY07-482]; Duke University; NATIONAL INSTITUTE ON DRUG ABUSE [F32DA025447, R01DA022202] Funding Source: NIH RePORTER	National Institute of Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); March of Dimes Foundation(March of Dimes); Duke University; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We are deeply grateful to M. E. Greenberg (Harvard Medical School), Z. Zhou and S. Cohen for sharing unpublished data and reagents. We thank N. Calakos (Duke University Medical Center) and F. Polleux (University of North Carolina, Chapel Hill) for providing transgenic mice; K. Vaishnav, J. Zhou, L. Du, M. Fukui, M. Cools, N. Negbenebor, P. Pattabiraman, W.-H. Qian, R. Chereau and M. Presby for technical assistance; and D. Fitzpatrick, G. Feng, J.O. McNamara, A. Brunet and M. Caron for critical reading of the manuscript. Support for this work was provided by National Institute of Drug Abuse grants R01-DA022202 (A.E.W.) and F32-DA025447 (J.V.D.); grant 1-FY07-482 from the March of Dimes Foundation (A.E.W.); along with the Duke University postdoctoral training program in Fundamental and Translational Neuroscience and the predoctoral Pharmacological Sciences Training Program.	Bibb JA, 2001, NATURE, V410, P376, DOI 10.1038/35066591; Bracci E, 2002, J NEUROPHYSIOL, V87, P2190, DOI 10.1152/jn.00754.2001; Carlezon WA, 1998, SCIENCE, V282, P2272, DOI 10.1126/science.282.5397.2272; Cassel S, 2006, MOL PHARMACOL, V70, P487, DOI 10.1124/mol.106.022301; Chahrour M, 2007, NEURON, V56, P422, DOI 10.1016/j.neuron.2007.10.001; Chao HT, 2007, NEURON, V56, P58, DOI 10.1016/j.neuron.2007.08.018; Chen WG, 2003, SCIENCE, V302, P885, DOI 10.1126/science.1086446; Cobos I, 2006, CEREB CORTEX, V16, pI82, DOI 10.1093/cercor/bhk003; Dani VS, 2005, P NATL ACAD SCI USA, V102, P12560, DOI 10.1073/pnas.0506071102; Giacometti E, 2007, P NATL ACAD SCI USA, V104, P1931, DOI 10.1073/pnas.0610593104; Gruber AJ, 2009, J NEUROPHYSIOL, V101, P1876, DOI 10.1152/jn.91002.2008; Guzman JN, 2003, J NEUROSCI, V23, P8931; Heiman M, 2008, CELL, V135, P738, DOI 10.1016/j.cell.2008.10.028; Hiroi N, 1997, P NATL ACAD SCI USA, V94, P10397, DOI 10.1073/pnas.94.19.10397; HOPE B, 1992, P NATL ACAD SCI USA, V89, P5764, DOI 10.1073/pnas.89.13.5764; Huang YHH, 2009, NEURON, V63, P40, DOI 10.1016/j.neuron.2009.06.007; Hyman SE, 2006, ANNU REV NEUROSCI, V29, P565, DOI 10.1146/annurev.neuro.29.051605.113009; Kauer JA, 2007, NAT REV NEUROSCI, V8, P844, DOI 10.1038/nrn2234; KAWAGUCHI Y, 1995, TRENDS NEUROSCI, V18, P527, DOI 10.1016/0166-2236(95)98374-8; Kelz MB, 1999, NATURE, V401, P272, DOI 10.1038/45790; Koos T, 1999, NAT NEUROSCI, V2, P467, DOI 10.1038/8138; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Maze I, 2010, SCIENCE, V327, P213, DOI 10.1126/science.1179438; McGill BE, 2006, P NATL ACAD SCI USA, V103, P18267, DOI 10.1073/pnas.0608702103; Moratalla R, 1996, NEURON, V17, P147, DOI 10.1016/S0896-6273(00)80288-3; Moretti P, 2006, J NEUROSCI, V26, P319, DOI 10.1523/JNEUROSCI.2623-05.2006; Moretti P, 2005, HUM MOL GENET, V14, P205, DOI 10.1093/hmg/ddi016; Nelson ED, 2006, CURR BIOL, V16, P710, DOI 10.1016/j.cub.2006.02.062; Nestler EJ, 2001, NAT REV NEUROSCI, V2, P119, DOI 10.1038/35053570; Nicola SM, 2000, ANNU REV NEUROSCI, V23, P185, DOI 10.1146/annurev.neuro.23.1.185; Norrholm SD, 2003, NEUROSCIENCE, V116, P19, DOI 10.1016/S0306-4522(02)00560-2; Poo MM, 2001, NAT REV NEUROSCI, V2, P24, DOI 10.1038/35049004; Pulipparacharuvil S, 2008, NEURON, V59, P621, DOI 10.1016/j.neuron.2008.06.020; Renthal W, 2008, J NEUROSCI, V28, P7344, DOI 10.1523/JNEUROSCI.1043-08.2008; Robinson TE, 1997, J NEUROSCI, V17, P8491; Russo SJ, 2009, J NEUROSCI, V29, P3529, DOI 10.1523/JNEUROSCI.6173-08.2009; Samaco RC, 2008, HUM MOL GENET, V17, P1718, DOI 10.1093/hmg/ddn062; Shahbazian MD, 2002, NEURON, V35, P243, DOI 10.1016/S0896-6273(02)00768-7; Shuen JA, 2008, J NEUROSCI, V28, P2681, DOI 10.1523/JNEUROSCI.5492-07.2008; Stearns NA, 2007, NEUROSCIENCE, V146, P907, DOI 10.1016/j.neuroscience.2007.02.009; Thomas MJ, 2001, NAT NEUROSCI, V4, P1217, DOI 10.1038/nn757; Tropea D, 2009, P NATL ACAD SCI USA, V106, P2029, DOI 10.1073/pnas.0812394106; Tzschentke TM, 2003, MOL PSYCHIATR, V8, P373, DOI 10.1038/sj.mp.4001269; Wiltschko AB, 2010, NEUROPSYCHOPHARMACOL, V35, P1261, DOI 10.1038/npp.2009.226; Zhang DS, 2002, J NEUROCHEM, V82, P1453, DOI 10.1046/j.1471-4159.2002.01089.x; Zhang JH, 2006, J NEUROSCI, V26, P13287, DOI 10.1523/JNEUROSCI.3795-06.2006; Zhang ZW, 2010, J NEUROPHYSIOL, V103, P2470, DOI 10.1152/jn.00601.2009; Zhou ZL, 2006, NEURON, V52, P255, DOI 10.1016/j.neuron.2006.09.037	48	145	154	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2010	13	9					1128	U132		10.1038/nn.2614	http://dx.doi.org/10.1038/nn.2614			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	643XC	20711186	Green Accepted			2022-12-28	WOS:000281332600019
J	Pangrsic, T; Lasarow, L; Reuter, K; Takago, H; Schwander, M; Riedel, D; Frank, T; Tarantino, LM; Bailey, JS; Strenzke, N; Brose, N; Muller, U; Reisinger, E; Moser, T				Pangrsic, Tina; Lasarow, Livia; Reuter, Kirsten; Takago, Hideki; Schwander, Martin; Riedel, Dietmar; Frank, Thomas; Tarantino, Lisa M.; Bailey, Janice S.; Strenzke, Nicola; Brose, Nils; Mueller, Ulrich; Reisinger, Ellen; Moser, Tobias			Hearing requires otoferlin-dependent efficient replenishment of synaptic vesicles in hair cells	NATURE NEUROSCIENCE			English	Article							TRANSMITTER RELEASE; CALCIUM-DEPENDENCE; DETERMINES FAST; MYOSIN VI; RIBBON; EXOCYTOSIS; DEAFNESS; TRANSMISSION; ENDOCYTOSIS; POOL	Inner hair cell ribbon synapses indefatigably transmit acoustic information. The proteins mediating their fast vesicle replenishment (hundreds of vesicles per s) are unknown. We found that an aspartate to glycine substitution in the C2F domain of the synaptic vesicle protein otoferlin impaired hearing by reducing vesicle replenishment in the pachanga mouse model of human deafness DFNB9. In vitro estimates of vesicle docking, the readily releasable vesicle pool (RRP), Ca2+ signaling and vesicle fusion were normal. Moreover, we observed postsynaptic excitatory currents of variable size and spike generation. However, mutant active zones replenished vesicles at lower rates than wild-type ones and sound-evoked spiking in auditory neurons was sparse and only partially improved during longer interstimulus intervals. We conclude that replenishment does not match the release of vesicles at mutant active zones in vivo and a sufficient standing RRP therefore cannot be maintained. We propose that otoferlin is involved in replenishing synaptic vesicles.	[Pangrsic, Tina; Takago, Hideki; Frank, Thomas; Moser, Tobias] Univ Med Ctr Gottingen, Dept Otolaryngol, InnerEarLab, Gottingen, Germany; [Pangrsic, Tina; Takago, Hideki; Frank, Thomas; Moser, Tobias] Univ Med Ctr Gottingen, Ctr Mol Physiol Brain, Gottingen, Germany; [Lasarow, Livia; Strenzke, Nicola] Univ Med Ctr Gottingen, Dept Otolaryngol, Auditory Syst Physiol Grp, Gottingen, Germany; [Reuter, Kirsten; Reisinger, Ellen] Univ Med Ctr Gottingen, Dept Otolaryngol, Mol Biol Cochlear Neurotransmiss Grp, Gottingen, Germany; [Schwander, Martin; Mueller, Ulrich] Scripps Res Inst, Dept Cell Biol, Inst Childhood & Neglected Dis, La Jolla, CA 92037 USA; [Riedel, Dietmar] Max Planck Inst Biophys Chem, Electron Microscopy Lab, D-37077 Gottingen, Germany; [Tarantino, Lisa M.; Bailey, Janice S.] Univ N Carolina, Dept Psychiat, Chapel Hill, NC USA; [Brose, Nils] Max Planck Inst Expt Med, Dept Mol Neurobiol, Gottingen, Germany; [Brose, Nils] Ctr Mol Physiol Brain, Gottingen, Germany; [Moser, Tobias] Univ Gottingen, Bernstein Ctr Computat Neurosci, Gottingen, Germany	University of Gottingen; University of Gottingen; University of Gottingen; University of Gottingen; Scripps Research Institute; Max Planck Society; University of North Carolina; University of North Carolina Chapel Hill; Max Planck Society; University of Gottingen	Moser, T (corresponding author), Univ Med Ctr Gottingen, Dept Otolaryngol, InnerEarLab, Gottingen, Germany.	ereisin@gwdg.de; tmoser@gwdg.de	Strenzke, Nicola/AAP-5349-2021; Moser, Tobias/L-5068-2014; Frank, Thomas/F-5273-2012	Strenzke, Nicola/0000-0003-1673-1046; Moser, Tobias/0000-0001-7145-0533; Frank, Thomas/0000-0002-5113-176X; Takago, Hideki/0000-0003-2875-4667; Reisinger, Ellen/0000-0003-3739-7569	German Research Foundation (Center for Molecular Physiology of the Brain); European Commission; Max-Planck-Society; German Ministry for Education and Science via the Bernstein Focus Neurotechnology Goettingen [01GQ0810]; State of Lower Saxony; US National Institutes of Health [DC007704]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC007704] Funding Source: NIH RePORTER	German Research Foundation (Center for Molecular Physiology of the Brain)(German Research Foundation (DFG)); European Commission(European CommissionEuropean Commission Joint Research Centre); Max-Planck-Society(Max Planck SocietyFoundation CELLEX); German Ministry for Education and Science via the Bernstein Focus Neurotechnology Goettingen; State of Lower Saxony(European Commission); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We would like to thank E. Glowatzki and D. Khimich for teaching us the postsynaptic patch clamp, K. Tittman, D. Fasshauer and R. Jahn for advice and support for protein biochemistry, C.P. Richter and M.A. Cheatham for advice on the electrocochleography, A. Leonov and C. Griesinger for the DM-nitrophen, P. Jonas for the parvalbumin taqman probe, members of the InnerEarLab for discussion, M. Rutherford, J. Singer, E. Neher, J. Siegel, P. Heil, T. Sakaba, R. Nouvian, A. Lysakowski and A. Lee for comments on the manuscript and C. Rudiger, S. Blume, N. Dankenbrink-Werder and M. Koppler for expert technical assistance. This work was supported by a fellowship of the Alexander von Humboldt Foundation to T.P., a fellowship of the Boehringer Ingelheim Fonds to K.R., a fellowship of MED-EL company to H.T., grants from the German Research Foundation (Center for Molecular Physiology of the Brain, T.M. and N.B.; Fellowship to N.S.), the European Commission (Eurohear, T.M.), the Max-Planck-Society (Tandemproject, T.M. and N.B.), the German Ministry for Education and Science via the Bernstein Focus Neurotechnology Goettingen (grant no. 01GQ0810 to T.M.), the State of Lower Saxony ('VW-Vorab' to T.M. and Christoph Matthias), and the US National Institutes of Health (DC007704, U.M.).	Beutner D, 2001, NEURON, V29, P681, DOI 10.1016/S0896-6273(01)00243-4; Brandt A, 2005, J NEUROSCI, V25, P11577, DOI 10.1523/JNEUROSCI.3411-05.2005; de Wit H, 2009, CELL, V138, P935, DOI 10.1016/j.cell.2009.07.027; Dulon D, 2009, J NEUROSCI, V29, P10474, DOI 10.1523/JNEUROSCI.1009-09.2009; Eisen MD, 2004, J NEUROPHYSIOL, V91, P2422, DOI 10.1152/jn.01130.2003; Frank T, 2009, P NATL ACAD SCI USA, V106, P4483, DOI 10.1073/pnas.0813213106; Geisler C. D., 1998, SOUND SYNAPSE; Glowatzki E, 2002, NAT NEUROSCI, V5, P147, DOI 10.1038/nn796; Gomis A, 1999, J NEUROSCI, V19, P6309; Goodman MB, 2000, J NEUROSCI METH, V100, P13, DOI 10.1016/S0165-0270(00)00224-7; Goutman JD, 2007, P NATL ACAD SCI USA, V104, P16341, DOI 10.1073/pnas.0705756104; Grant L, 2010, J NEUROSCI, V30, P4210, DOI 10.1523/JNEUROSCI.4439-09.2010; Griesinger CB, 2005, NATURE, V435, P212, DOI 10.1038/nature03567; Heidrych P, 2009, HUM MOL GENET, V18, P2779, DOI 10.1093/hmg/ddp213; Hosoi N, 2007, J NEUROSCI, V27, P14286, DOI 10.1523/JNEUROSCI.4122-07.2007; Hosoi N, 2009, NEURON, V63, P216, DOI 10.1016/j.neuron.2009.06.010; Jackman SL, 2009, NAT NEUROSCI, V12, P303, DOI 10.1038/nn.2267; Johnson SL, 2005, J PHYSIOL-LONDON, V563, P177, DOI 10.1113/jphysiol.2004.074740; Keen EC, 2006, P NATL ACAD SCI USA, V103, P5537, DOI 10.1073/pnas.0601103103; Khimich D, 2005, NATURE, V434, P889, DOI 10.1038/nature03418; KIANG NYS, 1965, DISCHARGE PATTERN SI; Li GL, 2009, J NEUROSCI, V29, P7558, DOI 10.1523/JNEUROSCI.0514-09.2009; MCCUE MP, 1994, J NEUROSCI, V14, P6058; Meyer AC, 2009, NAT NEUROSCI, V12, P444, DOI 10.1038/nn.2293; Moser T, 2000, P NATL ACAD SCI USA, V97, P883, DOI 10.1073/pnas.97.2.883; Moser T, 2006, J PHYSIOL-LONDON, V576, P55, DOI 10.1113/jphysiol.2006.114835; Neef A, 2007, J NEUROSCI, V27, P12933, DOI 10.1523/JNEUROSCI.1996-07.2007; Neef J, 2009, J NEUROSCI, V29, P10730, DOI 10.1523/JNEUROSCI.1577-09.2009; Obholzer N, 2008, J NEUROSCI, V28, P2110, DOI 10.1523/JNEUROSCI.5230-07.2008; PARSONS TD, 1994, NEURON, V13, P875, DOI 10.1016/0896-6273(94)90253-4; Rabl K, 2005, J NEUROSCI, V25, P4633, DOI 10.1523/JNEUROSCI.4298-04.2005; Roux I, 2006, CELL, V127, P277, DOI 10.1016/j.cell.2006.08.040; Roux I, 2009, HUM MOL GENET, V18, P4615, DOI 10.1093/hmg/ddp429; Ruel J, 2008, AM J HUM GENET, V83, P278, DOI 10.1016/j.ajhg.2008.07.008; Saviane C, 2006, NATURE, V439, P983, DOI 10.1038/nature04509; Schnee ME, 2005, NEURON, V47, P243, DOI 10.1016/j.neuron.2005.06.004; Schwander M, 2007, J NEUROSCI, V27, P2163, DOI 10.1523/JNEUROSCI.4975-06.2007; Seal RP, 2008, NEURON, V57, P263, DOI 10.1016/j.neuron.2007.11.032; Singer JH, 2006, J NEUROPHYSIOL, V95, P3191, DOI 10.1152/jn.01309.2005; Spassova MA, 2004, JARO-J ASSOC RES OTO, V5, P376, DOI 10.1007/s10162-004-5003-8; Starr A., 2008, SENSES COMPREHENSIVE, P397; Sterling P, 2005, TRENDS NEUROSCI, V28, P20, DOI 10.1016/j.tins.2004.11.009; Strenzke N, 2009, J NEUROSCI, V29, P7991, DOI 10.1523/JNEUROSCI.0632-09.2009; Taberner AM, 2005, J NEUROPHYSIOL, V93, P557, DOI 10.1152/jn.00574.2004; Thoreson WB, 2004, NEURON, V42, P595, DOI 10.1016/S0896-6273(04)00254-5; vonGersdorff H, 1997, J NEUROSCI, V17, P1919; Wadel K, 2007, NEURON, V53, P563, DOI 10.1016/j.neuron.2007.01.021; Wittig JH, 2008, J NEUROPHYSIOL, V100, P1724, DOI 10.1152/jn.90322.2008; Wolfel M, 2007, J NEUROSCI, V27, P3198, DOI 10.1523/JNEUROSCI.4471-06.2007; Zenisek D, 2000, NATURE, V406, P849, DOI 10.1038/35022500	50	143	151	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2010	13	7					869	U116		10.1038/nn.2578	http://dx.doi.org/10.1038/nn.2578			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	615YF	20562868	Green Published			2022-12-28	WOS:000279173900020
J	Fietz, SA; Kelava, I; Vogt, J; Wilsch-Brauninger, M; Stenzel, D; Fish, JL; Corbeil, D; Riehn, A; Distler, W; Nitsch, R; Huttner, WB				Fietz, Simone A.; Kelava, Iva; Vogt, Johannes; Wilsch-Braeuninger, Michaela; Stenzel, Denise; Fish, Jennifer L.; Corbeil, Denis; Riehn, Axel; Distler, Wolfgang; Nitsch, Robert; Huttner, Wieland B.			OSVZ progenitors of human and ferret neocortex are epithelial-like and expand by integrin signaling	NATURE NEUROSCIENCE			English	Article							MAMMALIAN NEUROEPITHELIAL CELLS; MOUSE CEREBRAL-CORTEX; RADIAL GLIA; NEURAL STEM; CORTICAL NEUROGENESIS; SUBVENTRICULAR ZONE; DIVISIONS; DIFFERENTIATION; EVOLUTION; BRAIN	A major cause of the cerebral cortex expansion that occurred during evolution is the increase in subventricular zone (SVZ) progenitors. We found that progenitors in the outer SVZ (OSVZ) of developing human neocortex retain features of radial glia, in contrast to rodent SVZ progenitors, which have limited proliferation potential. Although delaminating from apical adherens junctions, OSVZ progenitors maintained a basal process contacting the basal lamina, a canonical epithelial property. OSVZ progenitor divisions resulted in asymmetric inheritance of their basal process. Notably, OSVZ progenitors are also found in the ferret, a gyrencephalic nonprimate. Functional disruption of integrins, expressed on the basal process of ferret OSVZ progenitors, markedly decreased the OSVZ progenitor population size, but not that of other, process-lacking SVZ progenitors, in slice cultures of ferret neocortex. Our findings suggest that maintenance of this epithelial property allows integrin-mediated, repeated asymmetric divisions of OSVZ progenitors, providing a basis for neocortical expansion.	[Fietz, Simone A.; Kelava, Iva; Wilsch-Braeuninger, Michaela; Stenzel, Denise; Fish, Jennifer L.; Huttner, Wieland B.] Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany; [Vogt, Johannes; Nitsch, Robert] Charite, Ctr Anat, Inst Cell Biol & Neurobiol, Berlin, Germany; [Corbeil, Denis] Tech Univ Dresden, BIOTEC, Dresden, Germany; [Riehn, Axel; Distler, Wolfgang] Tech Univ Dresden, Univ Klinikum Carl Gustav Carus, Klin & Poliklin Frauenheilkunde & Geburtshilfe, Dresden, Germany	Max Planck Society; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Technische Universitat Dresden; Technische Universitat Dresden; Carl Gustav Carus University Hospital; University of Hamburg; University Medical Center Hamburg-Eppendorf	Huttner, WB (corresponding author), Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany.	huttner@mpi-cbg.de	Corbeil, Denis/AFL-1008-2022; Huttner, Wieland B./P-4080-2018; Vogt, Johannes/O-4289-2019; Corbeil, Denis/A-6519-2010; Nitsch, Robert/AAI-9129-2021; Corbeil, Denis/L-2340-2019; Vogt, Johannes/K-2278-2015	Corbeil, Denis/0000-0003-1181-3659; Fish, Jennifer/0000-0002-2654-2583; Vogt, Johannes/0000-0003-2439-8247	Deutsche Forschungsgemeinschaft (DFG) [SFB 655, A2]; Fonds der Chemischen Industrie	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission)	We thank J. Helppi and other members of the animal facility, and the light microscopy facility, of the Max Planck Institute of Molecular Cell Biology and Genetics for excellent support, A.-M. Marzesco and E. Taverna for experimental advice, C. Haffner for excellent technical assistance, S. Preibisch for developing the Fiji plug-in, and J. Pulvers for his helpful comments on the manuscript. We are grateful to the Bundesinstitut fur Risikobewertung and Biotie Therapies for ferret housing. S.A.F., I.K. and J.L.F. were members of the International Max Planck Research School for Molecular Cell Biology and Bioengineering. W.B.H. was supported by a grant from the Deutsche Forschungsgemeinschaft (DFG) (SFB 655, A2) and by the DFG-funded Center for Regenerative Therapies Dresden and by the Fonds der Chemischen Industrie.	AakuSaraste E, 1996, DEV BIOL, V180, P664, DOI 10.1006/dbio.1996.0336; Abdel-Mannan O, 2008, BRAIN RES BULL, V75, P398, DOI 10.1016/j.brainresbull.2007.10.047; Attardo A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002388; Bayatti N, 2008, CEREB CORTEX, V18, P1536, DOI 10.1093/cercor/bhm184; Calvete JJ, 2005, TOXICON, V45, P1063, DOI 10.1016/j.toxicon.2005.02.024; Carney RSE, 2007, BRAIN STRUCT FUNCT, V212, P37, DOI 10.1007/s00429-007-0142-4; Chenn A, 1998, MOL CELL NEUROSCI, V11, P183, DOI 10.1006/mcne.1998.0680; Costa MR, 2008, DEVELOPMENT, V135, P11, DOI 10.1242/dev.009951; Englund C, 2005, J NEUROSCI, V25, P247, DOI 10.1523/JNEUROSCI.2899-04.2005; Fish JL, 2008, J CELL SCI, V121, P2783, DOI 10.1242/jcs.023465; Fish JL, 2006, P NATL ACAD SCI USA, V103, P10438, DOI 10.1073/pnas.0604066103; Flanagan LA, 2006, J NEUROSCI RES, V83, P845, DOI 10.1002/jnr.20778; Fuchs E, 2009, CELL STEM CELL, V4, P499, DOI 10.1016/j.stem.2009.05.001; Giebel B, 2004, BLOOD, V104, P2332, DOI 10.1182/blood-2004-02-0511; Gotz M, 1998, NEURON, V21, P1031, DOI 10.1016/S0896-6273(00)80621-2; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Hansen DV, 2010, NATURE, V464, P554, DOI 10.1038/nature08845; Haubst N, 2006, DEVELOPMENT, V133, P3245, DOI 10.1242/dev.02486; HIRSCH E, 1994, DEV DYNAM, V201, P108, DOI 10.1002/aja.1002010203; Kamei Y, 1998, GLIA, V23, P191, DOI 10.1002/(SICI)1098-1136(199807)23:3<191::AID-GLIA2>3.0.CO;2-8; Karbanova J, 2008, J HISTOCHEM CYTOCHEM, V56, P977, DOI 10.1369/jhc.2008.951897; Konno D, 2008, NAT CELL BIOL, V10, P93, DOI 10.1038/ncb1673; Kosodo Y, 2004, EMBO J, V23, P2314, DOI 10.1038/sj.emboj.7600223; Kosodo Y, 2008, EMBO J, V27, P3151, DOI 10.1038/emboj.2008.227; Kowalczyk T, 2009, CEREB CORTEX, V19, P2439, DOI 10.1093/cercor/bhn260; Kriegstein AR, 2003, GLIA, V43, P37, DOI 10.1002/glia.10250; Kriegstein A, 2006, NAT REV NEUROSCI, V7, P883, DOI 10.1038/nrn2008; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Lathia JD, 2007, DEV DYNAM, V236, P3267, DOI 10.1002/dvdy.21319; Lechler T, 2005, NATURE, V437, P275, DOI 10.1038/nature03922; LEVITT P, 1980, J COMP NEUROL, V193, P815, DOI 10.1002/cne.901930316; Lukaszewicz A, 2005, NEURON, V47, P353, DOI 10.1016/j.neuron.2005.06.032; Manabe N, 2002, DEV DYNAM, V225, P61, DOI 10.1002/dvdy.10139; Middeldorp J, 2010, DEVELOPMENT, V137, P313, DOI 10.1242/dev.041632; Miyata T, 2001, NEURON, V31, P727, DOI 10.1016/S0896-6273(01)00420-2; Mo ZC, 2008, CEREB CORTEX, V18, P1455, DOI 10.1093/cercor/bhm181; Molnar Z, 2006, EUR J NEUROSCI, V23, P921, DOI 10.1111/j.1460-9568.2006.04611.x; Murphy WJ, 2007, GENOME RES, V17, P413, DOI 10.1101/gr.5918807; Neal J, 2007, J ANAT, V210, P66, DOI 10.1111/j.1469-7580.2006.00674.x; Noctor SC, 2008, J COMP NEUROL, V508, P28, DOI 10.1002/cne.21669; Preibisch S, 2009, BIOINFORMATICS, V25, P1463, DOI 10.1093/bioinformatics/btp184; Radakovits R, 2009, J NEUROSCI, V29, P7694, DOI 10.1523/JNEUROSCI.5537-08.2009; Rakic P, 2009, NAT REV NEUROSCI, V10, P724, DOI 10.1038/nrn2719; Schmid RS, 2003, CEREB CORTEX, V13, P219, DOI 10.1093/cercor/13.3.219; SMART IHM, 1986, J ANAT, V146, P141; Smart IHM, 2002, CEREB CORTEX, V12, P37, DOI 10.1093/cercor/12.1.37; Weigmann A, 1997, P NATL ACAD SCI USA, V94, P12425, DOI 10.1073/pnas.94.23.12425; Wierzbicka-Patynowski I, 1999, J BIOL CHEM, V274, P37809, DOI 10.1074/jbc.274.53.37809; WOODHAMS PL, 1981, ANAT EMBRYOL, V163, P331, DOI 10.1007/BF00315709; Yoshida N, 2003, EXP CELL RES, V287, P262, DOI 10.1016/S0014-4827(03)00158-7	50	527	534	4	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2010	13	6					690	U62		10.1038/nn.2553	http://dx.doi.org/10.1038/nn.2553			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	600QY	20436478				2022-12-28	WOS:000278003300013
J	Vialou, V; Robison, AJ; LaPlant, QC; Covington, HE; Dietz, DM; Ohnishi, YN; Mouzon, E; Rush, AJ; Watts, EL; Wallace, DL; Iniguez, SD; Ohnishi, YH; Steiner, MA; Warren, BL; Krishnan, V; Bolanos, CA; Neve, RL; Ghose, S; Berton, O; Tamminga, CA; Nestler, EJ				Vialou, Vincent; Robison, Alfred J.; LaPlant, Quincey C.; Covington, Herbert E., III; Dietz, David M.; Ohnishi, Yoshinori N.; Mouzon, Ezekiell; Rush, Augustus J., III; Watts, Emily L.; Wallace, Deanna L.; Iniguez, Sergio D.; Ohnishi, Yoko H.; Steiner, Michel A.; Warren, Brandon L.; Krishnan, Vaishnav; Bolanos, Carlos A.; Neve, Rachael L.; Ghose, Subroto; Berton, Olivier; Tamminga, Carol A.; Nestler, Eric J.			Delta FosB in brain reward circuits mediates resilience to stress and antidepressant responses	NATURE NEUROSCIENCE			English	Article							SOCIAL DEFEAT STRESS; NUCLEUS-ACCUMBENS NEURONS; VENTRAL TEGMENTAL AREA; CHROMATIN REGULATION; EXCITATORY SYNAPSES; SYNAPTIC PLASTICITY; BEHAVIORAL DEFICITS; GENE-EXPRESSION; AMPA RECEPTORS; MESSENGER-RNA	In contrast with the many studies of stress effects on the brain, relatively little is known about the molecular mechanisms of resilience, the ability of some individuals to escape the deleterious effects of stress. We found that the transcription factor Delta FosB mediates an essential mechanism of resilience in mice. Induction of Delta FosB in the nucleus accumbens, an important brain reward-associated region, in response to chronic social defeat stress was both necessary and sufficient for resilience. Delta FosB induction was also required for the standard antidepressant fluoxetine to reverse behavioral pathology induced by social defeat. Delta FosB produced these effects through induction of the GluR2 AMPA glutamate receptor subunit, which decreased the responsiveness of nucleus accumbens neurons to glutamate, and through other synaptic proteins. Together, these findings establish a previously unknown molecular pathway underlying both resilience and antidepressant action.	[Vialou, Vincent; Robison, Alfred J.; LaPlant, Quincey C.; Covington, Herbert E., III; Dietz, David M.; Ohnishi, Yoshinori N.; Mouzon, Ezekiell; Watts, Emily L.; Ohnishi, Yoko H.; Nestler, Eric J.] Mt Sinai Sch Med, Fishberg Dept Neurosci, New York, NY 10029 USA; [Rush, Augustus J., III; Wallace, Deanna L.; Krishnan, Vaishnav; Ghose, Subroto; Berton, Olivier; Tamminga, Carol A.] Univ Texas SW Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA; [Rush, Augustus J., III; Wallace, Deanna L.; Krishnan, Vaishnav; Ghose, Subroto; Berton, Olivier; Tamminga, Carol A.] Univ Texas SW Med Ctr Dallas, Ctr Basic Neurosci, Dallas, TX 75390 USA; [Iniguez, Sergio D.; Warren, Brandon L.; Bolanos, Carlos A.] Florida State Univ, Dept Psychol, Tallahassee, FL 32306 USA; [Steiner, Michel A.] Max Planck Inst Psychiat, D-80804 Munich, Germany; [Neve, Rachael L.] MIT, Cambridge, MA 02139 USA	Icahn School of Medicine at Mount Sinai; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; State University System of Florida; Florida State University; Max Planck Society; Massachusetts Institute of Technology (MIT)	Nestler, EJ (corresponding author), Mt Sinai Sch Med, Fishberg Dept Neurosci, New York, NY 10029 USA.	eric.nestler@mssm.edu	Yan, Shuo/B-8381-2009; Ghose, Subroto/J-6732-2016; Robison, Alfred J/P-8521-2018; Dietz, David/AAW-4574-2021; Dietz, David/J-9458-2015; vialou, vincent/F-2968-2013; Iniguez, Sergio D/J-2410-2015	Robison, Alfred J/0000-0002-4150-9570; Dietz, David/0000-0002-6927-9236; Dietz, David/0000-0002-6927-9236; vialou, vincent/0000-0002-8212-751X; Iniguez, Sergio D/0000-0001-5748-4219; Krishnan, Vaishnav/0000-0002-2847-0069	National Institute of Mental Health; AstraZeneca; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH051399, P50MH066172] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); AstraZeneca(AstraZeneca); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by grants from the National Institute of Mental Health and by a research alliance with AstraZeneca. We thank P. McKinnon and H. Russell for the SC1 cDNA; and I. Maze, R. Oosting, S. Gautron and D. Vialou for discussion and comments on the manuscript.	Anderson SM, 2008, NAT NEUROSCI, V11, P344, DOI 10.1038/nn2054; Becker C, 2001, J NEUROSCI, V21, P262, DOI 10.1523/JNEUROSCI.21-01-00262.2001; Berton O, 2006, SCIENCE, V311, P864, DOI 10.1126/science.1120972; Boudreau AC, 2007, J NEUROSCI, V27, P10621, DOI 10.1523/JNEUROSCI.2163-07.2007; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Campioni MR, 2009, J NEUROPHYSIOL, V101, P3192, DOI 10.1152/jn.91111.2008; Chen JS, 1998, MOL PHARMACOL, V54, P495, DOI 10.1124/mol.54.3.495; Churchill L, 1999, J NEUROCHEM, V72, P2397, DOI 10.1046/j.1471-4159.1999.0722397.x; Conrad KL, 2008, NATURE, V454, P118, DOI 10.1038/nature06995; Covington HE, 2009, J NEUROSCI, V29, P11451, DOI 10.1523/JNEUROSCI.1758-09.2009; De Kloet ER, 2004, ANN NY ACAD SCI, V1018, P1, DOI 10.1196/annals.1296.001; DETKE MJ, 1995, PSYCHOPHARMACOLOGY, V121, P66, DOI 10.1007/BF02245592; Feder A, 2009, NAT REV NEUROSCI, V10, P446, DOI 10.1038/nrn2649; Frischknecht R, 2009, NAT NEUROSCI, V12, P897, DOI 10.1038/nn.2338; Grace AA, 2007, TRENDS NEUROSCI, V30, P220, DOI 10.1016/j.tins.2007.03.003; HANEY M, 1995, BRAIN RES, V698, P46, DOI 10.1016/0006-8993(95)00788-R; Kalivas PW, 2005, NEURON, V45, P647, DOI 10.1016/j.neuron.2005.02.005; Kelz MB, 1999, NATURE, V401, P272, DOI 10.1038/45790; Kollack-Walker S, 1999, J NEUROENDOCRINOL, V11, P547; Koob GF, 2008, NEURON, V59, P11, DOI 10.1016/j.neuron.2008.06.012; Koolhaas JM, 1997, NEUROSCI BIOBEHAV R, V21, P775, DOI 10.1016/S0149-7634(96)00057-7; Krishnan V, 2008, NATURE, V455, P894, DOI 10.1038/nature07455; Krishnan V, 2007, CELL, V131, P391, DOI 10.1016/j.cell.2007.09.018; Lively S, 2008, J NEUROSCI RES, V86, P2895, DOI 10.1002/jnr.21735; Martinez M, 2002, STRESS, V5, P3, DOI 10.1080/102538902900012369; McClung CA, 2003, NAT NEUROSCI, V6, P1208, DOI 10.1038/nn1143; McEwen BS, 2007, PHYSIOL REV, V87, P873, DOI 10.1152/physrev.00041.2006; Nestler EJ, 2008, PHILOS T R SOC B, V363, P3245, DOI 10.1098/rstb.2008.0067; Nikulina EM, 2008, EUR J NEUROSCI, V27, P2272, DOI 10.1111/j.1460-9568.2008.06176.x; Nikulina EM, 2004, NEUROSCIENCE, V123, P857, DOI 10.1016/j.neuroscience.2003.10.029; Peakman MC, 2003, BRAIN RES, V970, P73, DOI 10.1016/S0006-8993(03)02230-3; Perrotti LI, 2004, J NEUROSCI, V24, P10594, DOI 10.1523/JNEUROSCI.2542-04.2004; Rada P, 2003, NEUROSCIENCE, V119, P557, DOI 10.1016/S0306-4522(03)00162-3; Renthal W, 2009, NEURON, V62, P335, DOI 10.1016/j.neuron.2009.03.026; Ressler KJ, 2007, NAT NEUROSCI, V10, P1116, DOI 10.1038/nn1944; Reynolds SM, 2003, EUR J NEUROSCI, V17, P2187, DOI 10.1046/j.1460-9568.2003.02642.x; Roitman MF, 2005, NEURON, V45, P587, DOI 10.1016/j.neuron.2004.12.055; Rygula R, 2005, BEHAV BRAIN RES, V162, P127, DOI 10.1016/j.bbr.2005.03.009; Rygula R, 2006, BEHAV BRAIN RES, V174, P188, DOI 10.1016/j.bbr.2006.07.017; Schlaepfer TE, 2008, NEUROPSYCHOPHARMACOL, V33, P368, DOI 10.1038/sj.npp.1301408; Sesack SR, 2010, NEUROPSYCHOPHARMACOL, V35, P27, DOI 10.1038/npp.2009.93; Taha SA, 2006, J NEUROSCI, V26, P217, DOI 10.1523/JNEUROSCI.3227-05.2006; Tidey JW, 1997, PSYCHOPHARMACOLOGY, V130, P203, DOI 10.1007/s002130050230; Todtenkopf MS, 2006, J NEUROSCI, V26, P11665, DOI 10.1523/JNEUROSCI.3070-06.2006; TORNATZKY W, 1993, PHYSIOL BEHAV, V53, P983, DOI 10.1016/0031-9384(93)90278-N; Tremblay LK, 2005, ARCH GEN PSYCHIAT, V62, P1228, DOI 10.1001/archpsyc.62.11.1228; Vythilingam M, 2009, PSYCHIAT RES-NEUROIM, V172, P75, DOI 10.1016/j.pscychresns.2008.06.008; Wallace DL, 2009, NAT NEUROSCI, V12, P200, DOI 10.1038/nn.2257; Wilkinson MB, 2009, J NEUROSCI, V29, P7820, DOI 10.1523/JNEUROSCI.0932-09.2009; Yehuda R, 2006, ANN NY ACAD SCI, V1071, P379, DOI 10.1196/annals.1364.028	50	341	346	3	42	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2010	13	6					745	U126		10.1038/nn.2551	http://dx.doi.org/10.1038/nn.2551			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	600QY	20473292	Green Accepted			2022-12-28	WOS:000278003300020
J	Deneris, ES; Wyler, SC				Deneris, Evan S.; Wyler, Steven C.			Serotonergic transcriptional networks and potential importance to mental health	NATURE NEUROSCIENCE			English	Review							MICE LACKING; TRANSPORTER GENE; MOTOR-NEURON; MOLECULAR-GENETICS; CELL-BODIES; LMX1B; PET-1; SYSTEM; EXPRESSION; RAT	Transcription regulatory networks governing the genesis, maturation and maintenance of vertebrate brain serotonin (5-HT) neurons determine the level of serotonergic gene expression and signaling throughout an animal's lifespan. Recent studies suggest that alterations in these networks can cause behavioral and physiological pathogenesis in mice. Here, we synthesize findings from vertebrate loss-of-function and gain-of-function studies to build a new model of the transcriptional regulatory networks that specify 5-HT neurons during fetal life, integrate them into CNS circuitry in early postnatal life and maintain them in adulthood. We then describe findings from animal and human genetic studies that support possible alterations in the activity of serotonergic regulatory networks in the etiology of mental illness. We conclude with a discussion of the potential utility of our model, as an experimentally well-defined molecular pathway, to predict and interpret the biological effect of genetic variation that may be discovered in the orthologous human network.	[Deneris, Evan S.; Wyler, Steven C.] Case Western Reserve Univ, Sch Med, Dept Neurosci, Cleveland, OH 44106 USA	Case Western Reserve University	Deneris, ES (corresponding author), Case Western Reserve Univ, Sch Med, Dept Neurosci, Cleveland, OH 44106 USA.	esd@case.edu			Vanderbilt/NIMH Silvio O Conte Center for Neuroscience Research, from the US National Institutes of Health [P50 MH078028];  [RO1 MH062723]; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH078028, R01MH062723] Funding Source: NIH RePORTER	Vanderbilt/NIMH Silvio O Conte Center for Neuroscience Research, from the US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank R. Blakely (Vanderbilt University) and E. Gilmore (Case Western Reserve University) for valuable discussions and critical comments on the manuscript. Research in the Deneris Lab is supported by grants RO1 MH062723 and the Vanderbilt/NIMH Silvio O Conte Center for Neuroscience Research, P50 MH078028 from the US National Institutes of Health.	Akil H, 2010, SCIENCE, V327, P1580, DOI 10.1126/science.1188654; Albert PR, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-21; Alenina N, 2009, P NATL ACAD SCI USA, V106, P10332, DOI 10.1073/pnas.0810793106; Arber S, 2000, CELL, V101, P485, DOI 10.1016/S0092-8674(00)80859-4; Azmitia E C, 1986, Adv Neurol, V43, P407; BAKER KG, 1991, SYNAPSE, V7, P301, DOI 10.1002/syn.890070407; Beaulieu JM, 2008, P NATL ACAD SCI USA, V105, P1333, DOI 10.1073/pnas.0711496105; Bennett AJ, 2002, MOL PSYCHIATR, V7, P118, DOI 10.1038/sj/mp/4000949; Bethea CL, 2011, J CHEM NEUROANAT, V41, P200, DOI 10.1016/j.jchemneu.2011.05.010; Blakely RD, 2005, NEURON, V48, P701, DOI 10.1016/j.neuron.2005.11.029; Bonnin A, 2006, NEUROSCIENCE, V141, P781, DOI 10.1016/j.neuroscience.2006.04.036; Briscoe J, 1999, NATURE, V398, P622, DOI 10.1038/19315; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; Chen H, 1998, NAT GENET, V19, P51, DOI 10.1038/ng0598-51; Cheng LP, 2003, J NEUROSCI, V23, P9961; Cirulli ET, 2010, NAT REV GENET, V11, P415, DOI 10.1038/nrg2779; Cordes SP, 2005, CLIN GENET, V68, P487, DOI 10.1111/j.1399-0004.2005.00534.x; Craven SE, 2004, DEVELOPMENT, V131, P1165, DOI 10.1242/dev.01024; Cummings KJ, 2011, J APPL PHYSIOL, V111, P825, DOI 10.1152/japplphysiol.00336.2011; Cummings KJ, 2011, J PHYSIOL-LONDON, V589, P2055, DOI 10.1113/jphysiol.2010.203679; Cummings KJ, 2010, AM J PHYSIOL-REG I, V298, pR1333, DOI 10.1152/ajpregu.00110.2010; Dai JX, 2008, P NATL ACAD SCI USA, V105, P11981, DOI 10.1073/pnas.0801329105; Dai JX, 2009, DEV GROWTH DIFFER, V51, P241, DOI 10.1111/j.1440-169X.2008.01083.x; De-Leon SBT, 2007, ANNU REV BIOPH BIOM, V36, P191, DOI 10.1146/annurev.biophys.35.040405.102002; Demarque M, 2010, NEURON, V67, P321, DOI 10.1016/j.neuron.2010.06.006; Deneris ES, 2011, NEUROSCIENCE, V197, P17, DOI 10.1016/j.neuroscience.2011.08.061; Ding YQ, 2003, NAT NEUROSCI, V6, P933, DOI 10.1038/nn1104; Dolmazon V, 2011, STEM CELLS DEV, V20, P301, DOI 10.1089/scd.2010.0224; Dreyer SD, 1998, NAT GENET, V19, P47, DOI 10.1038/ng0598-47; Dunston JA, 2004, GENOMICS, V84, P565, DOI 10.1016/j.ygeno.2004.06.002; Erickson JT, 2007, RESP PHYSIOL NEUROBI, V159, P85, DOI 10.1016/j.resp.2007.06.002; Erickson JT, 2009, J APPL PHYSIOL, V106, P1785, DOI 10.1152/japplphysiol.90729.2008; Fernandez SP, 2012, NEUROPHARMACOLOGY, V62, P144, DOI 10.1016/j.neuropharm.2011.08.049; Flames N, 2011, ANNU REV NEUROSCI, V34, P153, DOI 10.1146/annurev-neuro-061010-113824; Gaddum John H., 1954, CIBA F S HYPERTENSIO, P75; Gaspar P, 2003, NAT REV NEUROSCI, V4, P1002, DOI 10.1038/nrn1256; Goridis C, 2002, NAT REV NEUROSCI, V3, P531, DOI 10.1038/nrn871; Hariri AR, 2006, TRENDS COGN SCI, V10, P182, DOI 10.1016/j.tics.2006.02.011; Hendricks T, 1999, J NEUROSCI, V19, P10348; Hendricks TJ, 2003, NEURON, V37, P233, DOI 10.1016/S0896-6273(02)01167-4; Hirsch MR, 1998, DEVELOPMENT, V125, P599; Hobert O, 2010, TRENDS NEUROSCI, V33, P435, DOI 10.1016/j.tins.2010.05.006; Hodges MR, 2008, J NEUROSCI, V28, P2495, DOI 10.1523/JNEUROSCI.4729-07.2008; Hodges MR, 2011, RESP PHYSIOL NEUROBI, V177, P133, DOI 10.1016/j.resp.2011.03.020; Hodges MR, 2009, J NEUROSCI, V29, P10341, DOI 10.1523/JNEUROSCI.1963-09.2009; Holmes A, 2008, NEUROSCI BIOBEHAV R, V32, P1293, DOI 10.1016/j.neubiorev.2008.03.006; Hornung JP, 2003, J CHEM NEUROANAT, V26, P331, DOI 10.1016/j.jchemneu.2003.10.002; ISHIMURA K, 1988, NEUROSCI LETT, V91, P265, DOI 10.1016/0304-3940(88)90691-X; Iyo AH, 2005, SYNAPSE, V57, P223, DOI 10.1002/syn.20178; Jacob J, 2007, NAT NEUROSCI, V10, P1433, DOI 10.1038/nn1985; Jacob J, 2009, DEVELOPMENT, V136, P2477, DOI 10.1242/dev.034546; Jacobsen JPR, 2012, MOL PSYCHIATR, V17, P694, DOI 10.1038/mp.2011.50; Jacobsen KX, 2011, J NEUROCHEM, V116, P1066, DOI 10.1111/j.1471-4159.2010.07161.x; Jensen P, 2008, NAT NEUROSCI, V11, P417, DOI 10.1038/nn2050; Kaestner KH, 2010, CURR OPIN GENET DEV, V20, P527, DOI 10.1016/j.gde.2010.06.005; Kim H, 2010, NAT MED, V16, P804, DOI 10.1038/nm.2173; Kiyasova V, 2011, J NEUROSCI, V31, P2756, DOI 10.1523/JNEUROSCI.4080-10.2011; Krueger KC, 2008, J NEUROSCI, V28, P12748, DOI 10.1523/JNEUROSCI.4349-08.2008; Lerch-Haner JK, 2008, NAT NEUROSCI, V11, P1001, DOI 10.1038/nn.2176; Lesch KP, 1996, SCIENCE, V274, P1527, DOI 10.1126/science.274.5292.1527; LIDOV HGW, 1982, BRAIN RES BULL, V8, P389, DOI 10.1016/0361-9230(82)90077-6; LIDOV HGW, 1982, BRAIN RES BULL, V9, P559, DOI 10.1016/0361-9230(82)90164-2; Lillesaar C, 2007, DEV DYNAM, V236, P1072, DOI 10.1002/dvdy.21095; Lima FB, 2009, NEUROSCIENCE, V164, P676, DOI 10.1016/j.neuroscience.2009.08.010; Liu C, 2010, NAT NEUROSCI, V13, P1190, DOI 10.1038/nn.2623; Livet J, 2002, NEURON, V35, P877, DOI 10.1016/S0896-6273(02)00863-2; Lopez-Arvizu C, 2011, AM J MED GENET B, V156B, P59, DOI 10.1002/ajmg.b.31138; Maurer P, 2004, NEUROSCI LETT, V357, P215, DOI 10.1016/j.neulet.2003.12.086; McClellan J, 2010, CELL, V141, P210, DOI 10.1016/j.cell.2010.03.032; Muller CP., 2010, HDB BEHAV NEUROBIOLO; Murphy DL, 2008, NEUROPHARMACOLOGY, V55, P932, DOI 10.1016/j.neuropharm.2008.08.034; Osterberg N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019239; Pattyn A, 2004, NAT NEUROSCI, V7, P589, DOI 10.1038/nn1247; Pattyn A, 2000, DEVELOPMENT, V127, P1349; Pattyn A, 2003, GENE DEV, V17, P729, DOI 10.1101/gad.255803; Paulus EV, 2012, PHYSIOL BEHAV, V105, P257, DOI 10.1016/j.physbeh.2011.08.032; Pfaar H, 2002, DEV GENES EVOL, V212, P43, DOI 10.1007/s00427-001-0208-x; Phillips PC, 2008, NAT REV GENET, V9, P855, DOI 10.1038/nrg2452; Prasad HC, 2005, P NATL ACAD SCI USA, V102, P11545, DOI 10.1073/pnas.0501432102; Richardson-Jones JW, 2011, J NEUROSCI, V31, P6008, DOI 10.1523/JNEUROSCI.5836-10.2011; Schmid C, 2006, DEV BIOL, V293, P403, DOI 10.1016/j.ydbio.2006.02.042; Scott MM, 2005, P NATL ACAD SCI USA, V102, P16472, DOI 10.1073/pnas.0504510102; Scott MM, 2005, INT J DEV NEUROSCI, V23, P277, DOI 10.1016/j.ijdevneu.2004.05.012; Song NN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015998; State MW, 2011, NAT NEUROSCI, V14, P1499, DOI 10.1038/nn.2924; STEINBUSCH HWM, 1981, NEUROSCIENCE, V6, P557, DOI 10.1016/0306-4522(81)90146-9; Sutcliffe JS, 2005, AM J HUM GENET, V77, P265, DOI 10.1086/432648; Tokuyama Y, 2010, EXP BIOL MED, V235, P649, DOI 10.1258/ebm.2010.009307; TSAI FY, 1994, NATURE, V371, P221, DOI 10.1038/371221a0; van Doorninck J H, 1999, J Neurosci, V19, pRC12; Vollrath D, 1998, HUM MOL GENET, V7, P1091, DOI 10.1093/hmg/7.7.1091; Waider J, 2011, PSYCHONEUROENDOCRINO, V36, P393, DOI 10.1016/j.psyneuen.2010.12.012; WALLACE JA, 1983, BRAIN RES BULL, V10, P459, DOI 10.1016/0361-9230(83)90144-2; Wendland JR, 2008, HUM MOL GENET, V17, P717, DOI 10.1093/hmg/ddm343; WOOLLEY DW, 1954, P NATL ACAD SCI USA, V40, P228, DOI 10.1073/pnas.40.4.228; Wylie CJ, 2010, J NEUROSCI, V30, P670, DOI 10.1523/JNEUROSCI.4656-09.2010; Zhang XD, 2005, NEURON, V45, P11, DOI 10.1016/j.neuron.2004.12.014; Zhao ZQ, 2006, J NEUROSCI, V26, P12781, DOI 10.1523/JNEUROSCI.4143-06.2006; Zhao ZQ, 2007, J NEUROSCI, V27, P6045, DOI 10.1523/JNEUROSCI.1623-07.2007	99	80	84	0	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2012	15	4					519	527		10.1038/nn.3039	http://dx.doi.org/10.1038/nn.3039			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	916PA	22366757	Green Accepted			2022-12-28	WOS:000302114500009
J	Kratsios, P; Stolfi, A; Levine, M; Hobert, O				Kratsios, Paschalis; Stolfi, Alberto; Levine, Michael; Hobert, Oliver			Coordinated regulation of cholinergic motor neuron traits through a conserved terminal selector gene	NATURE NEUROSCIENCE			English	Article							CAENORHABDITIS-ELEGANS; HOMEOBOX GENES; IDENTIFICATION; EXPRESSION; FAMILY; SPECIFICATION; REPRESSION; DIFFERENTIATION; DIVERSITY; CHORDATE	Cholinergic motor neurons are defined by the coexpression of a battery of genes encoding proteins that act sequentially to synthesize, package and degrade acetylcholine and reuptake its breakdown product, choline. How expression of these critical motor neuron identity determinants is controlled and coordinated is not understood. We show here that, in the nematode Caenorhabditis elegans, all members of the cholinergic gene battery, as well as many other markers of terminal motor neuron fate, are co-regulated by a shared cis-regulatory signature and a common trans-acting factor, the phylogenetically conserved COE (Collier, Olf, EBF)-type transcription factor UNC-3. UNC-3 initiated and maintained expression of cholinergic fate markers and was sufficient to induce cholinergic fate in other neuron types. UNC-3 furthermore operated in negative feedforward loops to induce the expression of transcription factors that repress individual UNC-3-induced terminal fate markers, resulting in diversification of motor neuron differentiation programs in specific motor neuron subtypes. A chordate ortholog of UNC-3, Ciona intestinalis COE, was also both required and sufficient for inducing a cholinergic fate. Thus, UNC-3 is a terminal selector for cholinergic motor neuron differentiation whose function is conserved across phylogeny.	[Kratsios, Paschalis; Hobert, Oliver] Columbia Univ, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, Med Ctr, New York, NY 10032 USA; [Stolfi, Alberto; Levine, Michael] Univ Calif Berkeley, Dept Mol & Cell Biol, Ctr Integrat Genom, Div Genet Genom & Dev, Berkeley, CA 94720 USA	Columbia University; Howard Hughes Medical Institute; University of California System; University of California Berkeley	Kratsios, P (corresponding author), Columbia Univ, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, Med Ctr, New York, NY 10032 USA.	pk2357@columbia.edu; or38@columbia.edu	Stolfi, Alberto/AAS-8031-2021	Hobert, Oliver/0000-0002-7634-2854; Kratsios, Paschalis/0000-0002-1363-9271; Levine, Michael/0000-0001-7629-0081	Muscle Dystrophy Association; US National Institutes of Health [R01NS039996, R01NS050266]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039996, R01NS050266] Funding Source: NIH RePORTER	Muscle Dystrophy Association; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Q. Chen for expert assistance in generating transgenic strains; P. Sengupta (Brandeis University) for providing plasmids; many colleagues in the C. elegans community, particularly D. Miller (Vanderbilt University), for providing reporter strains; D. Wu and G. Minevich for bioinformatic analysis; and I. Rand and members of the Hobert laboratory for comments on the manuscript. We are grateful to Caenorhabditis Genetics Center (University of Minnesota) for providing strains. This work was funded by the Muscle Dystrophy Association and the US National Institutes of Health (R01NS039996; R01NS050266). O.H. is an Investigator of the Howard Hughes Medical Institute.	ALFONSO A, 1993, SCIENCE, V261, P617, DOI 10.1126/science.8342028; Alon U., 2006, INTRO SYSTEMS BIOL D; Altun-Gultekin Z, 2001, DEVELOPMENT, V128, P1951; Bigelow HR, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-27; Combes D, 2003, EUR J NEUROSCI, V18, P497, DOI 10.1046/j.1460-9568.2003.02749.x; Corradi A, 2003, DEVELOPMENT, V130, P401, DOI 10.1242/dev.00215; Daburon V, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-131; Davidson B, 2006, GENE DEV, V20, P2728, DOI 10.1101/gad.1467706; di Sanguinetto SADT, 2008, CURR OPIN NEUROBIOL, V18, P36, DOI 10.1016/j.conb.2008.04.002; Esmaeili B, 2002, DEVELOPMENT, V129, P853; FIRE A, 1990, GENE, V93, P189, DOI 10.1016/0378-1119(90)90224-F; Fox RM, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-42; Garel S, 1997, DEV DYNAM, V210, P191, DOI 10.1002/(SICI)1097-0177(199711)210:3<191::AID-AJA1>3.0.CO;2-B; Hallam S, 2000, DEVELOPMENT, V127, P4239; Hobert O, 2010, TRENDS NEUROSCI, V33, P435, DOI 10.1016/j.tins.2010.05.006; Hobert O, 2008, P NATL ACAD SCI USA, V105, P20067, DOI 10.1073/pnas.0806070105; Horie T, 2010, ZOOL SCI, V27, P181, DOI 10.2108/zsj.27.181; JIN YS, 1994, NATURE, V372, P780, DOI 10.1038/372780a0; Kim K, 2005, DEV BIOL, V286, P136, DOI 10.1016/j.ydbio.2005.07.024; Kurima K, 2003, GENOMICS, V82, P300, DOI 10.1016/S0888-7543(03)00154-X; Langer SZ, 1997, TRENDS PHARMACOL SCI, V18, P95, DOI 10.1016/S0165-6147(96)01034-6; Lanjuin A, 2003, DEV CELL, V5, P621, DOI 10.1016/S1534-5807(03)00293-4; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; Lickteig KM, 2001, J NEUROSCI, V21, P2001, DOI 10.1523/JNEUROSCI.21-06-02001.2001; Naciff JM, 1999, J NEUROCHEM, V72, P17, DOI 10.1046/j.1471-4159.1999.0720017.x; O'Meara MM, 2009, GENETICS, V181, P1679, DOI 10.1534/genetics.108.097832; Okuda T, 2000, NAT NEUROSCI, V3, P120, DOI 10.1038/72059; Prasad BC, 1998, DEVELOPMENT, V125, P1561; Prasad B, 2008, DEV BIOL, V323, P207, DOI 10.1016/j.ydbio.2008.08.029; Rand James B, 2007, WormBook, P1; Russo MT, 2004, DEV BIOL, V267, P517, DOI 10.1016/j.ydbio.2003.11.005; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; Stolfi A, 2011, DEVELOPMENT, V138, P995, DOI 10.1242/dev.061507; Stolfi A, 2010, SCIENCE, V329, P565, DOI 10.1126/science.1190181; Treiber T, 2010, IMMUNITY, V32, P714, DOI 10.1016/j.immuni.2010.04.013; Von Stetina SE, 2005, INT REV NEUROBIOL, V69, P125, DOI 10.1016/S0074-7742(05)69005-8; Von Stetina SE, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r135; Von Stetina SE, 2007, GENE DEV, V21, P332, DOI 10.1101/gad.1502107; WANG MM, 1993, NATURE, V364, P121, DOI 10.1038/364121a0; Wang SS, 1997, J NEUROSCI, V17, P4149; Wenick AS, 2004, DEV CELL, V6, P757, DOI 10.1016/j.devcel.2004.05.004; WHITE JG, 1976, PHILOS T R SOC B, V275, P327, DOI 10.1098/rstb.1976.0086; Winnier AR, 1999, GENE DEV, V13, P2774, DOI 10.1101/gad.13.21.2774; Yoshida R, 2004, GENESIS, V39, P130, DOI 10.1002/gene.20032	44	102	103	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2012	15	2					205	214		10.1038/nn.2989	http://dx.doi.org/10.1038/nn.2989			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	882ZX	22119902	Green Accepted			2022-12-28	WOS:000299603500011
J	Eggermann, E; Jonas, P				Eggermann, Emmanuel; Jonas, Peter			How the 'slow' Ca2+ buffer parvalbumin affects transmitter release in nanodomain-coupling regimes	NATURE NEUROSCIENCE			English	Article							TERM SYNAPTIC PLASTICITY; FACILITATION; CELL; NEURONS	Parvalbumin is thought to act in a manner similar to EGTA, but how a slow Ca2+ buffer affects nanodomain-coupling regimes at GABAergic synapses is unclear. Direct measurements of parvalbumin concentration and paired recordings in rodent hippocampus and cerebellum revealed that parvalbumin affects synaptic dynamics only when expressed at high levels. Modeling suggests that, in high concentrations, parvalbumin may exert BAPTA-like effects, modulating nanodomain coupling via competition with local saturation of endogenous fixed buffers.	[Jonas, Peter] IST Austria, Klosterneuburg, Austria; [Eggermann, Emmanuel; Jonas, Peter] Univ Freiburg, Inst Physiol 1, D-79106 Freiburg, Germany	Institute of Science & Technology - Austria; University of Freiburg	Jonas, P (corresponding author), IST Austria, Klosterneuburg, Austria.	peter.jonas@ist.ac.at		Jonas, Peter/0000-0001-5001-4804	European Research Council [268548] Funding Source: Medline	European Research Council(European Research Council (ERC)European Commission)		Atluri PP, 1996, J NEUROSCI, V16, P5661; Bucurenciu I, 2008, NEURON, V57, P536, DOI 10.1016/j.neuron.2007.12.026; Caillard O, 2000, P NATL ACAD SCI USA, V97, P13372, DOI 10.1073/pnas.230362997; Christie JM, 2011, NAT NEUROSCI, V14, P62, DOI 10.1038/nn.2718; Collin T, 2005, J NEUROSCI, V25, P96, DOI 10.1523/JNEUROSCI.3748-04.2005; Faas GC, 2011, NAT NEUROSCI, V14, P301, DOI 10.1038/nn.2746; Felmy F, 2003, NEURON, V37, P801, DOI 10.1016/S0896-6273(03)00085-0; Matveev V, 2004, BIOPHYS J, V86, P2691, DOI 10.1016/S0006-3495(04)74324-6; Muller A, 2005, J NEUROSCI, V25, P558, DOI 10.1523/JNEUROSCI.3799-04.2005; Rozov A, 2001, J PHYSIOL-LONDON, V531, P807, DOI 10.1111/j.1469-7793.2001.0807h.x; Sakaba T, 2008, NEURON, V57, P406, DOI 10.1016/j.neuron.2007.11.029; Schmidt H, 2003, BIOPHYS J, V84, P2599, DOI 10.1016/S0006-3495(03)75065-6; Schwaller Beat, 2002, Cerebellum, V1, P241, DOI 10.1080/147342202320883551; Vreugdenhil M, 2003, J NEUROPHYSIOL, V89, P1414, DOI 10.1152/jn.00576.2002; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	15	90	94	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2012	15	1					20	22		10.1038/nn.3002	http://dx.doi.org/10.1038/nn.3002			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	866VO	22138646	Green Accepted			2022-12-28	WOS:000298414400008
J	Ip, JPK; Shi, L; Chen, Y; Itoh, Y; Fu, WY; Betz, A; Yung, WH; Gotoh, Y; Fu, AKY; Ip, NY				Ip, Jacque P. K.; Shi, Lei; Chen, Yu; Itoh, Yasuhiro; Fu, Wing-Yu; Betz, Andrea; Yung, Wing-Ho; Gotoh, Yukiko; Fu, Amy K. Y.; Ip, Nancy Y.			alpha 2-chimaerin controls neuronal migration and functioning of the cerebral cortex through CRMP-2	NATURE NEUROSCIENCE			English	Article							RADIAL MIGRATION; CORTICAL-NEURONS; REGULATOR; MODEL; EPHA4; BRAIN; CDK5; RETRACTION; DIVISION; EPILEPSY	Disrupted cortical neuronal migration is associated with epileptic seizures and developmental delay. However, the molecular mechanism by which disruptions of early cortical development result in neurological symptoms is poorly understood. Here we report alpha 2-chimaerin as a key regulator of cortical neuronal migration and function. In utero suppression of alpha 2-chimaerin arrested neuronal migration at the multipolar stage, leading to accumulation of ectopic neurons in the subcortical region. Mice with such migration defects showed an imbalance between excitation and inhibition in local cortical circuitry and greater susceptibility to convulsant-induced seizures. We further show that alpha 2-chimaerin regulates bipolar transition and neuronal migration through modulating the activity of CRMP-2, a microtubule-associated protein. These findings establish a new alpha 2-chimaerin-dependent mechanism underlying neuronal migration and proper functioning of the cerebral cortex and provide insights into the pathogenesis of seizure-related neurodevelopmental disorders.	[Ip, Jacque P. K.; Shi, Lei; Chen, Yu; Fu, Wing-Yu; Fu, Amy K. Y.; Ip, Nancy Y.] Hong Kong Univ Sci & Technol, Div Life Sci, Hong Kong, Hong Kong, Peoples R China; [Ip, Jacque P. K.; Shi, Lei; Chen, Yu; Fu, Wing-Yu; Fu, Amy K. Y.; Ip, Nancy Y.] Hong Kong Univ Sci & Technol, Mol Neurosci Ctr, Hong Kong, Hong Kong, Peoples R China; [Ip, Jacque P. K.; Shi, Lei; Chen, Yu; Fu, Wing-Yu; Fu, Amy K. Y.; Ip, Nancy Y.] Hong Kong Univ Sci & Technol, State Key Lab Mol Neurosci, Hong Kong, Hong Kong, Peoples R China; [Itoh, Yasuhiro; Gotoh, Yukiko] Univ Tokyo, Inst Mol & Cellular Biosci, Tokyo, Japan; [Betz, Andrea] Univ Otago, Dept Pathol, Christchurch, New Zealand; [Yung, Wing-Ho] Chinese Univ Hong Kong, Sch Biomed Sci, Hong Kong, Hong Kong, Peoples R China	Hong Kong University of Science & Technology; Hong Kong University of Science & Technology; Hong Kong University of Science & Technology; University of Tokyo; University of Otago; Chinese University of Hong Kong	Ip, NY (corresponding author), Hong Kong Univ Sci & Technol, Div Life Sci, Hong Kong, Hong Kong, Peoples R China.	boip@ust.hk	Ip, Jacque Pak Kan/AAH-1744-2020; Yung, Ho/R-6161-2018	Ip, Jacque Pak Kan/0000-0003-4545-8261; Yung, Ho/0000-0002-5542-8173; Shi, Lei/0000-0001-8695-3432; Ito, Yasuhiro/0000-0001-8590-9122; Ip, Nancy Yuk-Yu/0000-0002-2763-8907; Fu, Kit Yu/0000-0003-4085-6201	Research Grants Council of Hong Kong [HKUST 661007, 660808, 660610, 660110]; University Grants Committee [AoE/B-15/01]; Hong Kong Jockey Club; Croucher Foundation	Research Grants Council of Hong Kong(Hong Kong Research Grants Council); University Grants Committee; Hong Kong Jockey Club; Croucher Foundation	We are grateful to C. Hall (University College London) for alpha 2-chimaerin constructs, antibody and CRMP-2 constructs; K. Kaibuchi (Nagoya University Graduate School of Medicine) for pCRMP-2 (Thr514) antibody; and T. Matsuda and C. L. Cepko (Harvard Medical School) for pCAG vectors. We thank N. Brose and T. Marquardt (Max Planck Institute) for providing Chn1<SUP>-/-</SUP> mice. We thank K.-O. Lai and Z. Cheung for critical reading of the manuscript and members of the Ip laboratory for discussions. We also thank C. Kwong, H. W. Tsang, Y. Dai, B. Butt, T. Ye and K. Ho for technical assistance. This study was supported in part by the Research Grants Council of Hong Kong (HKUST 661007, 660808, 660610 and 660110), the Area of Excellence Scheme of the University Grants Committee (AoE/B-15/01) and the Hong Kong Jockey Club. J.P.K.I. and N. Y. I. are recipients of a Croucher Foundation Research Studentship and Croucher Foundation Senior Research Fellowship, respectively.	Ackman JB, 2009, J NEUROSCI, V29, P313, DOI 10.1523/JNEUROSCI.4093-08.2009; Arimura N, 2004, J NEUROBIOL, V58, P34, DOI 10.1002/neu.10269; Ayala R, 2007, CELL, V128, P29, DOI 10.1016/j.cell.2006.12.021; Bacchelli E, 2003, MOL PSYCHIATR, V8, P916, DOI 10.1038/sj.mp.4001340; Bai JL, 2003, NAT NEUROSCI, V6, P1277, DOI 10.1038/nn1153; Bar I, 2000, EUR J MORPHOL, V38, P321, DOI 10.1076/ejom.38.5.321.7361; Beg AA, 2007, NEURON, V55, P768, DOI 10.1016/j.neuron.2007.07.036; Brown M, 2004, J NEUROSCI, V24, P8994, DOI 10.1523/JNEUROSCI.3184-04.2004; CHANG BS, 2006, PRINCIPLES MOL MED, V13, P1073; Chen G, 2008, NAT NEUROSCI, V11, P36, DOI 10.1038/nn2018; Davidsson J, 2008, EPILEPSY RES, V81, P69, DOI 10.1016/j.eplepsyres.2008.04.018; Deutsch SI, 2010, EUR NEUROPSYCHOPHARM, V20, P281, DOI 10.1016/j.euroneuro.2010.02.005; Fu WY, 2007, NAT NEUROSCI, V10, P67, DOI 10.1038/nn1811; Fukata Y, 2002, NAT CELL BIOL, V4, P583, DOI 10.1038/ncb825; Fukumitsu H, 2006, J NEUROSCI, V26, P13218, DOI 10.1523/JNEUROSCI.4251-06.2006; Gleeson JG, 2000, TRENDS NEUROSCI, V23, P352, DOI 10.1016/S0166-2236(00)01607-6; Guerrini R, 2003, EPILEPTIC DISORD, V5, pS9; Hall C, 2005, TRENDS BIOCHEM SCI, V30, P169, DOI 10.1016/j.tibs.2005.02.003; Hall C, 2001, J NEUROSCI, V21, P5191, DOI 10.1523/JNEUROSCI.21-14-05191.2001; Itoh Y, 2007, J BIOL CHEM, V282, P390, DOI 10.1074/jbc.M609944200; Iwasato T, 2007, CELL, V130, P742, DOI 10.1016/j.cell.2007.07.022; Jacobs KM, 1999, EPILEPSY RES, V36, P165, DOI 10.1016/S0920-1211(99)00050-9; Kawauchi T, 2008, DEV NEUROSCI-BASEL, V30, P36, DOI 10.1159/000109850; Lapray D, 2010, CEREB CORTEX, V20, P2694, DOI 10.1093/cercor/bhq014; Lencz T, 2007, P NATL ACAD SCI USA, V104, P19942, DOI 10.1073/pnas.0710021104; Lo KY, 2005, J BIOL CHEM, V280, P41744, DOI 10.1074/jbc.M506554200; LoTurco JJ, 2006, TRENDS NEUROSCI, V29, P407, DOI 10.1016/j.tins.2006.05.006; Manent JB, 2009, NAT MED, V15, P84, DOI 10.1038/nm.1897; Marin O, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001834; Medina DL, 2004, EMBO J, V23, P3803, DOI 10.1038/sj.emboj.7600399; Miyake N, 2008, SCIENCE, V321, P839, DOI 10.1126/science.1156121; Nadarajah B, 2003, CEREB CORTEX, V13, P607, DOI 10.1093/cercor/13.6.607; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; North HA, 2009, DEVELOPMENT, V136, P2467, DOI 10.1242/dev.034405; Ohmiya M, 2002, NEUROSCI LETT, V317, P21, DOI 10.1016/S0304-3940(01)02412-0; Ohshima T, 2007, DEVELOPMENT, V134, P2273, DOI 10.1242/dev.02854; Pawson T, 2004, CELL, V116, P191, DOI 10.1016/S0092-8674(03)01077-8; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Shi L, 2007, P NATL ACAD SCI USA, V104, P16347, DOI 10.1073/pnas.0706626104; Singh KK, 2010, NEURON, V67, P33, DOI 10.1016/j.neuron.2010.06.002; Tabata H, 2003, J NEUROSCI, V23, P9996; Thomas EA, 2003, MOL PSYCHIATR, V8, P983, DOI 10.1038/sj.mp.4001425; Torii M, 2009, NATURE, V461, P524, DOI 10.1038/nature08362; Tsai JW, 2005, J CELL BIOL, V170, P935, DOI 10.1083/jcb.200505166; Valiente M, 2010, CURR OPIN NEUROBIOL, V20, P68, DOI 10.1016/j.conb.2009.12.003; Wegiel J, 2010, ACTA NEUROPATHOL, V119, P755, DOI 10.1007/s00401-010-0655-4; Wegmeyer H, 2007, NEURON, V55, P756, DOI 10.1016/j.neuron.2007.07.038; Yoshimura T, 2005, CELL, V120, P137, DOI 10.1016/j.cell.2004.11.012; Young-Pearse TL, 2007, J NEUROSCI, V27, P14459, DOI 10.1523/JNEUROSCI.4701-07.2007; Zhao CT, 2009, P NATL ACAD SCI USA, V106, P21353, DOI 10.1073/pnas.0812872106	50	68	69	1	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2012	15	1					39	U55		10.1038/nn.2972	http://dx.doi.org/10.1038/nn.2972			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	866VO	22138645				2022-12-28	WOS:000298414400012
J	Benilova, I; De Strooper, B				Benilova, Iryna; De Strooper, Bart			An overlooked neurotoxic species in Alzheimer's disease	NATURE NEUROSCIENCE			English	Editorial Material							AMYLOID-BETA-PROTEIN; GAMMA-SECRETASE; PRESENILIN MUTATIONS; HYPOTHESIS; A-BETA-40	A study now finds early memory impairment in a mouse model of amyloid beta 43 (A beta 43)-overproducing familial Alzheimer's disease and suggests that this overlooked amyloidogenic A beta species contributes to pathology.	[Benilova, Iryna; De Strooper, Bart] Univ Leuven, Ctr Human Genet, Louvain, Belgium; [Benilova, Iryna; De Strooper, Bart] Flanders Inst Biotechnol, Dept Mol & Dev Genet, Louvain, Belgium	KU Leuven; Flanders Institute for Biotechnology (VIB)	Benilova, I (corresponding author), Univ Leuven, Ctr Human Genet, Louvain, Belgium.	bart.destrooper@cme.vib-kuleuven.be	De Strooper, Bart/F-6507-2012; de+Strooper, Bart/Z-1638-2019; Benilova, Iryna/H-6533-2019	De Strooper, Bart/0000-0001-5455-5819; 				Bentahir M, 2006, J NEUROCHEM, V96, P732, DOI 10.1111/j.1471-4159.2005.03578.x; De Strooper B, 2007, EMBO REP, V8, P141, DOI 10.1038/sj.embor.7400897; De Strooper B, 2010, NAT REV NEUROL, V6, P99, DOI 10.1038/nrneurol.2009.218; DESTROOPER B, 1995, EMBO J, V14, P4932, DOI 10.1002/j.1460-2075.1995.tb00176.x; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hardy J, 2009, J NEUROCHEM, V110, P1129, DOI 10.1111/j.1471-4159.2009.06181.x; JARRETT JT, 1993, BIOCHEMISTRY-US, V32, P4693, DOI 10.1021/bi00069a001; Jin M, 2011, P NATL ACAD SCI USA, V108, P5819, DOI 10.1073/pnas.1017033108; Kumar-Singh S, 2006, HUM MUTAT, V27, P686, DOI 10.1002/humu.20336; Martins IC, 2008, EMBO J, V27, P224, DOI 10.1038/sj.emboj.7601953; Noguchi A, 2009, J BIOL CHEM, V284, P32895, DOI 10.1074/jbc.M109.000208; Qi-Takahara Y, 2005, J NEUROSCI, V25, P436, DOI 10.1523/JNEUROSCI.1575-04.2005; Saito T, 2011, NAT NEUROSCI, V14, P1023, DOI 10.1038/nn.2858; Takami M, 2009, J NEUROSCI, V29, P13042, DOI 10.1523/JNEUROSCI.2362-09.2009; Welander H, 2009, J NEUROCHEM, V110, P697, DOI 10.1111/j.1471-4159.2009.06170.x	15	13	13	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2011	14	8					949	950		10.1038/nn.2871	http://dx.doi.org/10.1038/nn.2871			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	797KC	21792191				2022-12-28	WOS:000293123700005
J	Kaun, KR; Azanchi, R; Maung, Z; Hirsh, J; Heberlein, U				Kaun, Karla R.; Azanchi, Reza; Maung, Zaw; Hirsh, Jay; Heberlein, Ulrike			A Drosophila model for alcohol reward	NATURE NEUROSCIENCE			English	Article							LONG-TERM-MEMORY; CONDITIONED PLACE PREFERENCE; MUSHROOM BODY; ETHANOL SENSITIVITY; NEURAL MECHANISMS; DOPAMINE; NOTCH; EXPRESSION; NEURONS; PROTEIN	The rewarding properties of drugs contribute to the development of abuse and addiction. We developed a new assay for investigating the motivational properties of ethanol in the genetically tractable model Drosophila melanogaster. Flies learned to associate cues with ethanol intoxication and, although transiently aversive, the experience led to a long-lasting attraction for the ethanol-paired cue, implying that intoxication is rewarding. Temporally blocking transmission in dopaminergic neurons revealed that flies require activation of these neurons to express, but not develop, conditioned preference for ethanol-associated cues. Moreover, flies acquired, consolidated and retrieved these rewarding memories using distinct sets of neurons in the mushroom body. Finally, mutations in scabrous, encoding a fibrinogen-related peptide that regulates Notch signaling, disrupted the formation of memories for ethanol reward. Our results thus establish that Drosophila can be useful for understanding the molecular, genetic and neural mechanisms underling the rewarding properties of ethanol.	[Kaun, Karla R.; Azanchi, Reza; Maung, Zaw; Heberlein, Ulrike] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; [Hirsh, Jay] Univ Virginia, Dept Biol, Charlottesville, VA USA	University of California System; University of California San Francisco; University of Virginia	Kaun, KR (corresponding author), Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA.	karla.kaun@ucsf.edu; ulrike.heberlein@ucsf.edu		Kaun, Karla/0000-0002-8756-9528	Heart and Stroke Foundation of Canada; US National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084128] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA010035] Funding Source: NIH RePORTER	Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	We thank S. Waddell, J. Levine, M. Sokolowski, A. Barron and members of the Heberlein laboratory for reagents, input and advice, and S. Birman (Developmental Biology Institute of Marseilles-Luminy), F. Wolf (Gallo Institute), S. Sweeney (University of York), K. Kaiser (Glasgow University), N. Baker (Albert Einstein College of Medicine) and the Bloomington Stock Center for flies. Funding was provided by a Heart and Stroke Foundation of Canada Research Fellowship to K. R. K. and the US National Institutes of Health to U.H.	Akalal DBG, 2010, J NEUROSCI, V30, P16699, DOI 10.1523/JNEUROSCI.1882-10.2010; Aso Y, 2009, J NEUROGENET, V23, P156, DOI 10.1080/01677060802471718; Bainton RJ, 2000, CURR BIOL, V10, P187, DOI 10.1016/S0960-9822(00)00336-5; BAKER NE, 1990, SCIENCE, V250, P1370, DOI 10.1126/science.2175046; Berger KH, 2008, ALCOHOL CLIN EXP RES, V32, P895, DOI 10.1111/j.1530-0277.2008.00659.x; BRAND AH, 1994, METHOD CELL BIOL, V44, P635, DOI 10.1016/S0091-679X(08)60936-X; Claridge-Chang A, 2009, CELL, V139, P405, DOI 10.1016/j.cell.2009.08.034; Costa RM, 2003, CURR BIOL, V13, P1348, DOI 10.1016/S0960-9822(03)00492-5; Cunningham CL, 2000, PHARMACOL BIOCHEM BE, V67, P693, DOI 10.1016/S0091-3057(00)00414-7; Deadwyler SA, 2010, ANN NY ACAD SCI, V1187, P140, DOI 10.1111/j.1749-6632.2009.05155.x; Devineni AV, 2009, CURR BIOL, V19, P2126, DOI 10.1016/j.cub.2009.10.070; Dhonnchadha BAN, 2008, BEHAV BRAIN RES, V195, P39, DOI 10.1016/j.bbr.2008.06.026; Dubnau J, 2001, NATURE, V411, P476, DOI 10.1038/35078077; Friggi-Grelin F, 2003, J NEUROBIOL, V54, P618, DOI 10.1002/neu.10185; Ge XC, 2004, P NATL ACAD SCI USA, V101, P10172, DOI 10.1073/pnas.0403497101; Gremel CM, 2009, NEUROPSYCHOPHARMACOL, V34, P1443, DOI 10.1038/npp.2008.179; Hardie SL, 2006, J NEUROSCI METH, V153, P243, DOI 10.1016/j.jneumeth.2005.11.001; HU XX, 1995, GENETICS, V141, P607; Hyman SE, 2006, ANNU REV NEUROSCI, V29, P565, DOI 10.1146/annurev.neuro.29.051605.113009; Isabel G, 2004, SCIENCE, V304, P1024, DOI 10.1126/science.1094932; Kim YC, 2007, J NEUROSCI, V27, P7640, DOI 10.1523/JNEUROSCI.1167-07.2007; King I, 2011, J NEUROSCI, V31, P1139, DOI 10.1523/JNEUROSCI.4416-10.2011; Kitamoto T, 2002, J NEUROGENET, V16, P205, DOI 10.1080/01677060216295; Kong EC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009954; Krashes MJ, 2007, NEURON, V53, P103, DOI 10.1016/j.neuron.2006.11.021; Krashes MJ, 2009, CELL, V139, P416, DOI 10.1016/j.cell.2009.08.035; LaFerriere H, 2008, GENETICS, V178, P1895, DOI 10.1534/genetics.107.084582; Laviolette SR, 2004, NAT REV NEUROSCI, V5, P55, DOI 10.1038/nrn1298; Li H, 2000, CURR BIOL, V10, P211, DOI 10.1016/S0960-9822(00)00340-7; Louvi A, 2006, NAT REV NEUROSCI, V7, P93, DOI 10.1038/nrn1847; McGuire SE, 2001, SCIENCE, V293, P1330, DOI 10.1126/science.1062622; Miyamoto A, 2006, J BIOL CHEM, V281, P10089, DOI 10.1074/jbc.M600298200; Nehring LC, 2005, J BIOL CHEM, V280, P20349, DOI 10.1074/jbc.M500273200; Pautassi RM, 2008, PHARMACOL BIOCHEM BE, V88, P393, DOI 10.1016/j.pbb.2007.09.012; Phillips TJ, 1996, INT REV NEUROBIOL, V39, P243, DOI 10.1016/S0074-7742(08)60669-8; Powell PA, 2001, NATURE, V409, P626, DOI 10.1038/35054566; Presente A, 2004, P NATL ACAD SCI USA, V101, P1764, DOI 10.1073/pnas.0308259100; Risinger FO, 2001, J NEUROSCI, V21, P340, DOI 10.1523/JNEUROSCI.21-01-00340.2001; Rodan AR, 2010, INT REV NEUROBIOL, V91, P25, DOI 10.1016/S0074-7742(10)91002-7; Schultz W, 2002, NEURON, V36, P241, DOI 10.1016/S0896-6273(02)00967-4; Schwaerzel M, 2003, J NEUROSCI, V23, P10495, DOI 10.1523/jneurosci.23-33-10495.2003; Tzschentke TM, 2007, ADDICT BIOL, V12, P227, DOI 10.1111/j.1369-1600.2007.00070.x; Walker BM, 2007, BEHAV NEUROSCI, V121, P401, DOI 10.1037/0735-7044.121.2.401; Wang Y, 2004, P NATL ACAD SCI USA, V101, P9458, DOI 10.1073/pnas.0308126101; Zars T, 2000, SCIENCE, V288, P672, DOI 10.1126/science.288.5466.672	45	151	154	0	49	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2011	14	5					612	U103		10.1038/nn.2805	http://dx.doi.org/10.1038/nn.2805			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	754VU	21499254	Green Accepted			2022-12-28	WOS:000289886600017
J	Riazanski, V; Deriy, LV; Shevchenko, PD; Le, B; Gomez, EA; Nelson, DJ				Riazanski, Vladimir; Deriy, Ludmila V.; Shevchenko, Pavel D.; Le, Brandy; Gomez, Erwin A.; Nelson, Deborah J.			Presynaptic CLC-3 determines quantal size of inhibitory transmission in the hippocampus	NATURE NEUROSCIENCE			English	Article							SYNAPTIC VESICLES; FUNCTIONAL RECONSTITUTION; ENERGY-DEPENDENCE; TRANSPORT; SYNAPSES; CHANNELS; RELEASE; CYCLE; LEADS	The absence of the chloride channel CLC-3 in Clcn3(-/-) mice results in hippocampal degeneration with a distinct temporal-spatial sequence that resembles neuronal loss in temporal lobe epilepsy. We examined how the loss of CLC-3 might affect GABAergic synaptic transmission in the hippocampus. An electrophysiological study of synaptic function in hippocampal slices taken from Clcn3(-/-) mice before the onset of neurodegeneration revealed a substantial decrease in the amplitude and frequency of miniature inhibitory postsynaptic currents compared with those in wild-type slices. We found that CLC-3 colocalized with the vesicular GABA transporter VGAT in the CA1 region of the hippocampus. Acidification of inhibitory synaptic vesicles induced by Cl- showed a marked dependence on CLC-3 expression. The decrease in inhibitory transmission in Clcn3(-/-) mice suggests that the neurotransmitter loading of synaptic vesicles was reduced, which we attribute to defective vesicular acidification. Our observations extend the role of Cl- in inhibitory transmission from that of a postsynaptic permeant species to a presynaptic regulatory element.	[Riazanski, Vladimir; Deriy, Ludmila V.; Shevchenko, Pavel D.; Le, Brandy; Gomez, Erwin A.; Nelson, Deborah J.] Univ Chicago, Dept Neurobiol Pharmacol & Physiol, Chicago, IL 60637 USA	University of Chicago	Nelson, DJ (corresponding author), Univ Chicago, Dept Neurobiol Pharmacol & Physiol, Chicago, IL 60637 USA.	nelson@uchicago.edu			NIH [R01 GM36823, R01 DK 080364]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080364] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM036823] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Fox, S. Takamori, R. Edwards, L. Farmer and R. Sarac for conversations, V. Bindokas and P. Toth for technical help with microscopy, Y. Chen for help with immuno-electron microscopy, and F. Lamb (Univ. Iowa) for the Clcn3<SUP>-/-</SUP> strain. The study was supported by NIH R01 GM36823 and NIH R01 DK 080364 to D.J.N.	Atluri PP, 2006, J NEUROSCI, V26, P2313, DOI 10.1523/JNEUROSCI.4425-05.2006; Bartos M, 2001, J NEUROSCI, V21, P2687, DOI 10.1523/JNEUROSCI.21-08-02687.2001; Cuddapah VA, 2010, J BIOL CHEM, V285, P11188, DOI 10.1074/jbc.M109.097675; Deriy LV, 2009, J BIOL CHEM, V284, P35926, DOI 10.1074/jbc.M109.057372; Deriy LV, 2009, CELL METAB, V10, P316, DOI 10.1016/j.cmet.2009.08.012; Dickerson LW, 2002, BRAIN RES, V958, P227, DOI 10.1016/S0006-8993(02)03519-9; Edwards RH, 2007, NEURON, V55, P835, DOI 10.1016/j.neuron.2007.09.001; Gandhi SP, 2003, NATURE, V423, P607, DOI 10.1038/nature01677; Gronborg M, 2010, J NEUROSCI, V30, P2, DOI 10.1523/JNEUROSCI.4074-09.2010; Gulyas AI, 1999, J NEUROSCI, V19, P10082; Habela CW, 2008, J NEUROSCI, V28, P9205, DOI 10.1523/JNEUROSCI.1897-08.2008; Hell J. W, 1994, CELL BIOL LAB HDB, P567; HELL JW, 1990, J BIOL CHEM, V265, P2111; Hnasko TS, 2010, NEURON, V65, P643, DOI 10.1016/j.neuron.2010.02.012; Huang P, 2001, J BIOL CHEM, V276, P20093, DOI 10.1074/jbc.M009376200; Juge N, 2009, J BIOL CHEM, V284, P35073, DOI 10.1074/jbc.M109.062414; Kerr AM, 2008, P NATL ACAD SCI USA, V105, P15581, DOI 10.1073/pnas.0800621105; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; Kraushaar U, 2000, J NEUROSCI, V20, P5594, DOI 10.1523/JNEUROSCI.20-15-05594.2000; Maritzen T, 2008, J NEUROSCI, V28, P10587, DOI 10.1523/JNEUROSCI.3750-08.2008; MAYCOX PR, 1988, J BIOL CHEM, V263, P15423; Schenck S, 2009, NAT NEUROSCI, V12, P156, DOI 10.1038/nn.2248; Stobrawa SM, 2001, NEURON, V29, P185, DOI 10.1016/S0896-6273(01)00189-1; Takamori S, 2000, J NEUROSCI, V20, P4904; Wang XQ, 2006, NEURON, V52, P321, DOI 10.1016/j.neuron.2006.08.035; Yoshikawa M, 2002, GENES CELLS, V7, P597, DOI 10.1046/j.1365-2443.2002.00539.x; Zhang Q, 2007, P NATL ACAD SCI USA, V104, P17843, DOI 10.1073/pnas.0706906104; Zhou Q, 2000, J PHYSIOL-LONDON, V525, P195, DOI 10.1111/j.1469-7793.2000.t01-1-00195.x	28	50	52	1	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2011	14	4					487	U124		10.1038/nn.2775	http://dx.doi.org/10.1038/nn.2775			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	741FQ	21378974	Green Accepted			2022-12-28	WOS:000288849400020
J	He, Y; Kim, JY; Dupree, J; Tewari, A; Melendez-Vasquez, C; Svaren, J; Casaccia, P				He, Ye; Kim, Jin Young; Dupree, Jeffrey; Tewari, Ambika; Melendez-Vasquez, Carmen; Svaren, John; Casaccia, Patrizia			Yy1 as a molecular link between neuregulin and transcriptional modulation of peripheral myelination	NATURE NEUROSCIENCE			English	Article							SCHWANN-CELL DIFFERENTIATION; AXONAL REGULATION; CYCLE EXIT; GENE; EXPRESSION; PROTEINS; OCT-6; PROLIFERATION; YIN-YANG-1; SURVIVAL	Fast axonal conduction depends on myelin, which is formed by Schwann cells in the PNS. We found that the transcription factor Yin Yang 1 (YY1) is crucial for peripheral myelination. Conditional ablation of Yy1 in the Schwann cell lineage resulted in severe hypomyelination, which occurred independently of altered Schwann cell proliferation or apoptosis. In Yy1 mutant mice, Schwann cells established a 1:1 relationship with axons but were unable to myelinate them. The Schwann cells expressed low levels of myelin proteins and of Egr2 (also called Krox20), which is an important regulator of peripheral myelination. In vitro, Schwann cells that lacked Yy1 did not upregulate Egr2 in response to neuregulin1 and did not express myelin protein zero. This phenotype was rescued by overexpression of Egr2. In addition, neuregulin-induced phosphorylation of YY1 was required for transcriptional activation of Egr2. Thus, YY1 emerges as an important activator of peripheral myelination that links neuregulin signaling with Egr2 expression.	[He, Ye; Kim, Jin Young; Casaccia, Patrizia] Mt Sinai Sch Med, Dept Neurosci & Genet & Genom, New York, NY USA; [Dupree, Jeffrey] Virginia Commonwealth Univ, Dept Anat & Neurobiol, Richmond, VA USA; [Tewari, Ambika; Melendez-Vasquez, Carmen] CUNY Hunter Coll, Dept Cell Biol, New York, NY 10021 USA; [Svaren, John] Univ Wisconsin, Dept Comparat Biosci, Madison, WI 53706 USA; [Svaren, John] Univ Wisconsin, Waisman Ctr, Madison, WI 53706 USA	Icahn School of Medicine at Mount Sinai; Virginia Commonwealth University; City University of New York (CUNY) System; Hunter College (CUNY); University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Casaccia, P (corresponding author), Mt Sinai Sch Med, Dept Neurosci & Genet & Genom, New York, NY USA.	patrizia.casaccia@mssm.edu	He, Ye/G-7500-2011; Svaren, John/A-1605-2010	Svaren, John/0000-0003-2963-7921; Melendez-Vasquez, Carmen/0000-0001-8752-8956; TEWARI, AMBIKA/0000-0002-8740-5080; He, Ye/0000-0002-3936-4958; KIM, Jin Young/0000-0003-4438-1872	NJ Commission on Spinal Cord Research [08B-010-SCR3]; US National Institutes of Health Natinal Institute of Neurological Disorders and Stroke Center [5P30NS047463-02];  [5R01NS042925-08];  [R01NS052738-04];  [NS04295-08S ARRA];  [NMSS RG-4134]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD041590] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042925, R01NS052738, P30NS047463] Funding Source: NIH RePORTER	NJ Commission on Spinal Cord Research; US National Institutes of Health Natinal Institute of Neurological Disorders and Stroke Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); ; ; ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Y. Shi, K.A. Nave and B. Popko for mouse lines; G. Crabtree, D. Meijer and M. Grumet for plasmids and antibodies; H. Kim and P. Maurel for advice on Schwann cell and myelination cultures; C. Krier for assistance with microarrays; J. Salzer, K. Jessen, P. Brophy and C. Taveggia for discussions; and N. Kuo, J. Li and R. Srinivasan for technical assistance. This work was supported by grant numbers 5R01NS042925-08, R01NS052738-04 and NS04295-08S ARRA supplement and NMSS RG-4134 to P.C. and in part by the NJ Commission on Spinal Cord Research (08B-010-SCR3 to Y.H.). Electron microscopy was performed at the VCU Department of Anatomy and Neurobiology Microscopy Facility and supported, in part, by funding from a US National Institutes of Health Natinal Institute of Neurological Disorders and Stroke Center core grant (5P30NS047463-02).	Affar E, 2006, MOL CELL BIOL, V26, P3565, DOI 10.1128/MCB.26.9.3565-3581.2006; Beausoleil SA, 2004, P NATL ACAD SCI USA, V101, P12130, DOI 10.1073/pnas.0404720101; BECKER KG, 1994, GENE, V150, P259, DOI 10.1016/0378-1119(94)90435-9; Britsch S, 2001, GENE DEV, V15, P66, DOI 10.1101/gad.186601; Chan R, 2004, DEVELOPMENT, V131, P5551, DOI 10.1242/dev.01425; Chen S, 2006, J NEUROSCI, V26, P3079, DOI 10.1523/JNEUROSCI.3785-05.2006; Doerflinger NH, 2003, GENESIS, V35, P63, DOI 10.1002/gene.10154; Dupree JL, 1998, J NEUROSCI, V18, P1642; Fragoso G, 2003, EXP NEUROL, V183, P34, DOI 10.1016/S0014-4886(03)00101-8; Friedrich RP, 2005, MOL CELL BIOL, V25, P1821, DOI 10.1128/MCB.25.5.1821-1829.2005; Garratt AN, 2000, J CELL BIOL, V148, P1035, DOI 10.1083/jcb.148.5.1035; Haines JD, 2008, J MOL NEUROSCI, V35, P23, DOI 10.1007/s12031-007-9011-0; Harrisingh MC, 2004, EMBO J, V23, P3061, DOI 10.1038/sj.emboj.7600309; He Y, 2007, NEURON GLIA BIOL, V3, P221, DOI 10.1017/S1740925X08000057; He Y, 2007, NEURON, V55, P217, DOI 10.1016/j.neuron.2007.06.029; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jaegle M, 2003, GENE DEV, V17, P1380, DOI 10.1101/gad.258203; Jaegle M, 1996, SCIENCE, V273, P507, DOI 10.1126/science.273.5274.507; Jessen KR, 2005, NAT REV NEUROSCI, V6, P671, DOI 10.1038/nrn1746; Kao SC, 2009, SCIENCE, V323, P651, DOI 10.1126/science.1166562; Kim HA, 1997, J NEUROSCI RES, V49, P236; Kim JY, 2010, NAT NEUROSCI, V13, P180, DOI 10.1038/nn.2471; Kwon HJ, 2003, BIOCHEM BIOPH RES CO, V306, P1008, DOI 10.1016/S0006-291X(03)01071-4; Lappe-Siefke C, 2003, NAT GENET, V33, P366, DOI 10.1038/ng1095; Le N, 2005, NAT NEUROSCI, V8, P932, DOI 10.1038/nn1490; Le N, 2005, P NATL ACAD SCI USA, V102, P2596, DOI 10.1073/pnas.0407836102; Liu AX, 2007, J NEUROSCI, V27, P7339, DOI 10.1523/JNEUROSCI.1226-07.2007; Mager GM, 2008, J BIOL CHEM, V283, P18187, DOI 10.1074/jbc.M803330200; Marcus J, 2006, GLIA, V53, P372, DOI 10.1002/glia.20292; Maurel P, 2000, J NEUROSCI, V20, P4635, DOI 10.1523/JNEUROSCI.20-12-04635.2000; Meintanis S, 2001, GLIA, V34, P39, DOI 10.1002/glia.1038; Michailov GV, 2004, SCIENCE, V304, P700, DOI 10.1126/science.1095862; Morgan MJ, 2004, J BIOL CHEM, V279, P46826, DOI 10.1074/jbc.M406140200; Murphy P, 1996, DEVELOPMENT, V122, P2847; Navel KA, 2006, CURR OPIN NEUROBIOL, V16, P492, DOI 10.1016/j.conb.2006.08.008; Nousiainen M, 2006, P NATL ACAD SCI USA, V103, P5391, DOI 10.1073/pnas.0507066103; Paivalainen S, 2008, MOL CELL NEUROSCI, V37, P568, DOI 10.1016/j.mcn.2007.12.005; Parkinson DB, 2001, J NEUROSCI, V21, P8572, DOI 10.1523/JNEUROSCI.21-21-08572.2001; Parkinson DB, 2004, J CELL BIOL, V164, P385, DOI 10.1083/jcb.200307132; Ryu EJ, 2007, J NEUROSCI, V27, P11552, DOI 10.1523/JNEUROSCI.5497-06.2007; Stewart HJS, 1997, J NEUROSCI RES, V50, P684; Svaren J, 2008, GLIA, V56, P1541, DOI 10.1002/glia.20767; Taveggia C, 2005, NEURON, V47, P681, DOI 10.1016/j.neuron.2005.08.017; TOPILKO P, 1994, NATURE, V371, P796, DOI 10.1038/371796a0; Warner LE, 1998, NAT GENET, V18, P382, DOI 10.1038/ng0498-382; Woodhoo A, 2009, NAT NEUROSCI, V12, P839, DOI 10.1038/nn.2323; Zanazzi G, 2001, J CELL BIOL, V152, P1289, DOI 10.1083/jcb.152.6.1289; Zhou FF, 2004, BIOCHEM BIOPH RES CO, V325, P1443, DOI 10.1016/j.bbrc.2004.11.001; Zorick TS, 1999, DEVELOPMENT, V126, P1397; Zorick TS, 1996, MOL CELL NEUROSCI, V8, P129, DOI 10.1006/mcne.1996.0052	50	84	86	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2010	13	12					1472	U54		10.1038/nn.2686	http://dx.doi.org/10.1038/nn.2686			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	684CW	21057508	Green Accepted			2022-12-28	WOS:000284525800011
J	Tsai, JW; Lian, WN; Kemal, S; Kriegstein, AR; Vallee, RB				Tsai, Jin-Wu; Lian, Wei-Nan; Kemal, Shahrnaz; Kriegstein, Arnold R.; Vallee, Richard B.			Kinesin 3 and cytoplasmic dynein mediate interkinetic nuclear migration in neural stem cells	NATURE NEUROSCIENCE			English	Article							NEURONAL MIGRATION; ENVELOPE BREAKDOWN; AXONAL-TRANSPORT; BINDING PROTEIN; MYOSIN-II; MOTOR; CENTROSOME; DYNACTIN; LIS1; SUPERFAMILY	Radial glial progenitor cells exhibit bidirectional cell cycle-dependent nuclear oscillations. The purpose and underlying mechanism of this unusual 'interkinetic nuclear migration' are poorly understood. We investigated the basis for this behavior by live imaging of nuclei, centrosomes and microtubules in embryonic rat brain slices, coupled with the use of RNA interference (RNAi) and the myosin inhibitor blebbistatin. We found that nuclei migrated independent of centrosomes and unidirectionally away from or toward the ventricular surface along microtubules, which were uniformly oriented from the ventricular surface to the pial surface of the brain. RNAi directed against cytoplasmic dynein specifically inhibited nuclear movement toward the apical surface. An RNAi screen of kinesin genes identified Kif1a, a member of the kinesin-3 family, as the motor for basally directed nuclear movement. These observations provide direct evidence that kinesins are involved in nuclear migration and neurogenesis and suggest that a cell cycle-dependent switch between distinct microtubule motors drives interkinetic nuclear migration.	[Tsai, Jin-Wu; Lian, Wei-Nan; Kemal, Shahrnaz; Vallee, Richard B.] Columbia Univ, Coll Phys & Surg, Dept Pathol & Cell Biol, New York, NY 10027 USA; [Kriegstein, Arnold R.] Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA	Columbia University; University of California System; University of California San Francisco	Vallee, RB (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Pathol & Cell Biol, New York, NY 10027 USA.	rv2025@columbia.edu		Tsai, Jin-Wu/0000-0003-0135-759X	US National Institutes of Health [HD40182]; New York State Spinal Cord Injury Research Board; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD040182] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New York State Spinal Cord Injury Research Board; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We thank K.H. Bremner for assistance in surgical procedures, X. Wang for help in molecular cloning, G. Kreitzer for reagents and X. Wang, G. Kreitzer, W. Gruber, J. Canman and S. Cappello for helpful comments and suggestions. This work was supported by US National Institutes of Health grant HD40182 to R.B.V. and a New York State Spinal Cord Injury Research Board fellowship to J.- W.T.	Beaudouin J, 2002, CELL, V108, P83, DOI 10.1016/S0092-8674(01)00627-4; Bellion A, 2005, J NEUROSCI, V25, P5691, DOI 10.1523/JNEUROSCI.1030-05.2005; Chenn A, 1998, MOL CELL NEUROSCI, V11, P183, DOI 10.1006/mcne.1998.0680; Contreras A, 2003, MOL CELL BIOL, V23, P8626, DOI 10.1128/MCB.23.23.8626-8636.2003; Deacon SW, 2003, J CELL BIOL, V160, P297, DOI 10.1083/jcb.200210066; Del Bene F, 2008, CELL, V134, P1055, DOI 10.1016/j.cell.2008.07.017; Echeverri CJ, 1996, J CELL BIOL, V132, P617, DOI 10.1083/jcb.132.4.617; Faulkner NE, 2000, NAT CELL BIOL, V2, P784, DOI 10.1038/35041020; HALL DH, 1991, CELL, V65, P837, DOI 10.1016/0092-8674(91)90391-B; Hammond JW, 2009, PLOS BIOL, V7, P650, DOI 10.1371/journal.pbio.1000072; Hebbar S, 2008, J CELL BIOL, V182, P1063, DOI 10.1083/jcb.200803071; Klopfenstein DR, 2004, MOL BIOL CELL, V15, P3729, DOI 10.1091/mbc.E04-04-0326; Kolega J, 2004, BIOCHEM BIOPH RES CO, V320, P1020, DOI 10.1016/j.bbrc.2004.06.045; Ligon LA, 2004, J BIOL CHEM, V279, P19201, DOI 10.1074/jbc.M313472200; Medeiros NA, 2006, NAT CELL BIOL, V8, P215, DOI 10.1038/ncb1367; MESSIER PE, 1973, J EMBRYOL EXP MORPH, V30, P661; Miki H, 2005, TRENDS CELL BIOL, V15, P467, DOI 10.1016/j.tcb.2005.07.006; Mimori-Kiyosue Y, 2000, CURR BIOL, V10, P865, DOI 10.1016/S0960-9822(00)00600-X; Niwa S, 2008, NAT CELL BIOL, V10, P1269, DOI 10.1038/ncb1785; Noctor SC, 2001, NATURE, V409, P714, DOI 10.1038/35055553; Norden C, 2009, CELL, V138, P1195, DOI 10.1016/j.cell.2009.06.032; OKADA Y, 1995, CELL, V81, P769, DOI 10.1016/0092-8674(95)90538-3; Okada Y, 1999, SCIENCE, V283, P1152, DOI 10.1126/science.283.5405.1152; PASCHAL BM, 1987, J CELL BIOL, V105, P1273, DOI 10.1083/jcb.105.3.1273; Quintyne NJ, 1999, J CELL BIOL, V147, P321, DOI 10.1083/jcb.147.2.321; Ryu JB, 2006, NEURON, V49, P175, DOI 10.1016/j.neuron.2005.12.017; Salina D, 2002, CELL, V108, P97, DOI 10.1016/S0092-8674(01)00628-6; Sauer FC, 1935, J COMP NEUROL, V62, P377, DOI 10.1002/cne.900620207; Schaar BT, 2005, P NATL ACAD SCI USA, V102, P13652, DOI 10.1073/pnas.0506008102; Schenk J, 2009, P NATL ACAD SCI USA, V106, P16487, DOI 10.1073/pnas.0908928106; Siller KH, 2005, MOL BIOL CELL, V16, P5127, DOI 10.1091/mbc.E05-04-0338; Solecki DJ, 2009, NEURON, V63, P63, DOI 10.1016/j.neuron.2009.05.028; Solecki DJ, 2004, NAT NEUROSCI, V7, P1195, DOI 10.1038/nn1332; Spassky N, 2008, DEV BIOL, V317, P246, DOI 10.1016/j.ydbio.2008.02.026; Splinter D, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000350; Stepanova T, 2003, J NEUROSCI, V23, P2655; TAKAHASHI T, 1993, J NEUROSCI, V13, P820; Tomishige M, 2002, SCIENCE, V297, P2263, DOI 10.1126/science.1073386; Tsai JW, 2007, NAT NEUROSCI, V10, P970, DOI 10.1038/nn1934; Tsai JW, 2005, J CELL BIOL, V170, P935, DOI 10.1083/jcb.200505166; Vallee RB, 2009, TRENDS CELL BIOL, V19, P347, DOI 10.1016/j.tcb.2009.03.009; Visel A, 2004, NUCLEIC ACIDS RES, V32, pD552, DOI 10.1093/nar/gkh029; Wang XQ, 2009, NATURE, V461, P947, DOI 10.1038/nature08435; WATTERSON RL, 1956, ANAT REC, V124, P379; WEBSTER W, 1978, AM J ANAT, V152, P209, DOI 10.1002/aja.1001520204; Whited JL, 2004, DEVELOPMENT, V131, P4677, DOI 10.1242/dev.01366; Wozniak MJ, 2004, TRAFFIC, V5, P400, DOI 10.1111/j.1600-0854.2004.00191.x; Xie ZG, 2007, NEURON, V56, P79, DOI 10.1016/j.neuron.2007.08.026; Yonekawa Y, 1998, J CELL BIOL, V141, P431, DOI 10.1083/jcb.141.2.431; Zhang XC, 2009, NEURON, V64, P173, DOI 10.1016/j.neuron.2009.08.018	50	167	168	3	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2010	13	12					1463	U43		10.1038/nn.2665	http://dx.doi.org/10.1038/nn.2665			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	684CW	21037580	Green Submitted, Green Accepted			2022-12-28	WOS:000284525800010
J	Im, HI; Hollander, JA; Bali, P; Kenny, PJ				Im, Heh-In; Hollander, Jonathan A.; Bali, Purva; Kenny, Paul J.			MeCP2 controls BDNF expression and cocaine intake through homeostatic interactions with microRNA-212	NATURE NEUROSCIENCE			English	Article							ELEMENT-BINDING PROTEIN; MESOLIMBIC DOPAMINE SYSTEM; NUCLEUS-ACCUMBENS; RETT-SYNDROME; NEUROTROPHIC FACTOR; BRAIN; INCREASES; NEURONS; SEEKING; REWARD	The X-linked transcriptional repressor methyl CpG binding protein 2 (MeCP2), known for its role in the neurodevelopmental disorder Rett syndrome, is emerging as an important regulator of neuroplasticity in postmitotic neurons. Cocaine addiction is commonly viewed as a disorder of neuroplasticity, but the potential involvement of MeCP2 has not been explored. Here we identify a key role for MeCP2 in the dorsal striatum in the escalating cocaine intake seen in rats with extended access to the drug, a process that mimics the increasingly uncontrolled cocaine use seen in addicted humans. MeCP2 regulates cocaine intake through homeostatic interactions with microRNA-212 (miR-212) to control the effects of cocaine on striatal brain-derived neurotrophic factor (BDNF) levels. These data suggest that homeostatic interactions between MeCP2 and miR-212 in dorsal striatum may be important in regulating vulnerability to cocaine addiction.	[Im, Heh-In; Hollander, Jonathan A.; Bali, Purva; Kenny, Paul J.] Scripps Res Inst Scripps Florida, Dept Mol Therapeut, Lab Behav & Mol Neurosci, Jupiter, FL USA	Scripps Research Institute; State University System of Florida; University of Florida	Kenny, PJ (corresponding author), Scripps Res Inst Scripps Florida, Dept Mol Therapeut, Lab Behav & Mol Neurosci, Jupiter, FL USA.	pjkenny@scripps.edu			US National Institute on Drug Abuse [DA025983]; Ruth L. Kirschstein National Research Service; National Alliance for Research on Schizophrenia and Depression (NARSAD); NATIONAL INSTITUTE ON DRUG ABUSE [F32DA024932, R01DA025983] Funding Source: NIH RePORTER	US National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Ruth L. Kirschstein National Research Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Alliance for Research on Schizophrenia and Depression (NARSAD)(French National Research Agency (ANR)NARSAD); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank B. Xu from Georgetown University for the BDNF 3'-UTR reporter construct. This work was supported by a grant from the US National Institute on Drug Abuse to P.J.K. (DA025983); Ruth L. Kirschstein National Research Service Awards to H.-I. I. and J.A.H.; and a National Alliance for Research on Schizophrenia and Depression (NARSAD) Young Investigator Award to H.-I. I. This is manuscript number 20438 from The Scripps Research Institute.	Abuhatzira L, 2007, EPIGENETICS-US, V2, P214, DOI 10.4161/epi.2.4.5212; Ahmed SH, 1998, SCIENCE, V282, P298, DOI 10.1126/science.282.5387.298; Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; An JJ, 2008, CELL, V134, P175, DOI 10.1016/j.cell.2008.05.045; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Belin D, 2008, NEURON, V57, P432, DOI 10.1016/j.neuron.2007.12.019; Berglind WJ, 2007, EUR J NEUROSCI, V26, P757, DOI 10.1111/j.1460-9568.2007.05692.x; Carlezon WA, 1998, SCIENCE, V282, P2272, DOI 10.1126/science.282.5397.2272; Cassel S, 2006, MOL PHARMACOL, V70, P487, DOI 10.1124/mol.106.022301; Chahrour M, 2008, SCIENCE, V320, P1224, DOI 10.1126/science.1153252; Chang QA, 2006, NEURON, V49, P341, DOI 10.1016/j.neuron.2005.12.027; CHAO HT, 2008, SOC NEUR M WASH DC, P310; Choi KH, 2006, NEUROSCIENCE, V137, P373, DOI 10.1016/j.neuroscience.2005.10.049; DiNieri JA, 2009, J NEUROSCI, V29, P1855, DOI 10.1523/JNEUROSCI.5104-08.2009; Dong Y, 2006, NAT NEUROSCI, V9, P475, DOI 10.1038/nn1661; Dunn HG, 2001, BRAIN DEV-JPN, V23, pS99, DOI 10.1016/S0387-7604(01)00354-0; Everitt BJ, 2005, NAT NEUROSCI, V8, P1481, DOI 10.1038/nn1579; Fasano S, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.029.2009; Gemelli T, 2006, BIOL PSYCHIAT, V59, P468, DOI 10.1016/j.biopsych.2005.07.025; Graham DL, 2007, NAT NEUROSCI, V10, P1029, DOI 10.1038/nn1929; Graham DL, 2009, BIOL PSYCHIAT, V65, P696, DOI 10.1016/j.biopsych.2008.09.032; Grimm JW, 2003, J NEUROSCI, V23, P742; Hall FS, 2003, NEUROPSYCHOPHARMACOL, V28, P1485, DOI 10.1038/sj.npp.1300192; Hasbi A, 2009, P NATL ACAD SCI USA, V106, P21377, DOI 10.1073/pnas.0903676106; Hollander JA, 2010, NATURE, V466, P197, DOI 10.1038/nature09202; Horger BA, 1999, J NEUROSCI, V19, P4110; Huang YH, 2008, J BIOL CHEM, V283, P2751, DOI 10.1074/jbc.M706578200; Jeanblanc J, 2009, J NEUROSCI, V29, P13494, DOI 10.1523/JNEUROSCI.2243-09.2009; Jin J, 2008, INT J DEV NEUROSCI, V26, P457, DOI 10.1016/j.ijdevneu.2008.02.009; Klein ME, 2007, NAT NEUROSCI, V10, P1513, DOI 10.1038/nn2010; Kondo M, 2008, EUR J NEUROSCI, V27, P3342, DOI 10.1111/j.1460-9568.2008.06305.x; Larimore JL, 2009, NEUROBIOL DIS, V34, P199, DOI 10.1016/j.nbd.2008.12.011; Logrip ML, 2008, FASEB J, V22, P2393, DOI 10.1096/fj.07-099135; Lu L, 2004, J NEUROSCI, V24, P1604, DOI 10.1523/JNEUROSCI.5124-03.2004; Lu L, 2005, NAT NEUROSCI, V8, P212, DOI 10.1038/nn1383; MEEHAN RR, 1992, NUCLEIC ACIDS RES, V20, P5085, DOI 10.1093/nar/20.19.5085; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Nelson ED, 2006, CURR BIOL, V16, P710, DOI 10.1016/j.cub.2006.02.062; Oo TF, 2009, MOL CELL NEUROSCI, V41, P440, DOI 10.1016/j.mcn.2009.04.009; Pelka GJ, 2005, GENOMICS, V85, P441, DOI 10.1016/j.ygeno.2004.12.002; Piazza PV, 2000, J NEUROSCI, V20, P4226; Russo SJ, 2009, NEUROPHARMACOLOGY, V56, P73, DOI 10.1016/j.neuropharm.2008.06.059; Schoenbaum G, 2007, NAT NEUROSCI, V10, P935, DOI 10.1038/nn0807-935; Temudo T, 2008, MOVEMENT DISORD, V23, P1384, DOI 10.1002/mds.22115; Van Esch H, 2005, AM J HUM GENET, V77, P442, DOI 10.1086/444549; Vo N, 2005, P NATL ACAD SCI USA, V102, P16426, DOI 10.1073/pnas.0508448102; Wada R, 2010, INT J CANCER, V127, P1106, DOI 10.1002/ijc.25126; Wallace DL, 2009, NAT NEUROSCI, V12, P200, DOI 10.1038/nn.2257; Walters CL, 2001, J NEUROSCI, V21, P9438, DOI 10.1523/JNEUROSCI.21-23-09438.2001; Yasui DH, 2007, P NATL ACAD SCI USA, V104, P19416, DOI 10.1073/pnas.0707442104	50	322	346	0	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2010	13	9					1120	U121		10.1038/nn.2615	http://dx.doi.org/10.1038/nn.2615			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	643XC	20711185	Green Accepted			2022-12-28	WOS:000281332600018
J	Goldman, N; Chen, M; Fujita, T; Xu, QW; Peng, WG; Liu, W; Jensen, TK; Pei, Y; Wang, FS; Han, XN; Chen, JF; Schnermann, J; Takano, T; Bekar, L; Tieu, K; Nedergaard, M				Goldman, Nanna; Chen, Michael; Fujita, Takumi; Xu, Qiwu; Peng, Weiguo; Liu, Wei; Jensen, Tina K.; Pei, Yong; Wang, Fushun; Han, Xiaoning; Chen, Jiang-Fan; Schnermann, Jurgen; Takano, Takahiro; Bekar, Lane; Tieu, Kim; Nedergaard, Maiken			Adenosine A1 receptors mediate local anti-nociceptive effects of acupuncture	NATURE NEUROSCIENCE			English	Article							PROSTATIC ACID-PHOSPHATASE; ADENOSINE A(1) RECEPTOR; TUBULOGLOMERULAR FEEDBACK; INFLAMMATORY PAIN; CINGULATE CORTEX; DORSAL-HORN; SPINAL-CORD; MICE; RAT; ELECTROACUPUNCTURE	Acupuncture is an invasive procedure commonly used to relieve pain. Acupuncture is practiced worldwide, despite difficulties in reconciling its principles with evidence-based medicine. We found that adenosine, a neuromodulator with anti-nociceptive properties, was released during acupuncture in mice and that its anti-nociceptive actions required adenosine A1 receptor expression. Direct injection of an adenosine A1 receptor agonist replicated the analgesic effect of acupuncture. Inhibition of enzymes involved in adenosine degradation potentiated the acupuncture-elicited increase in adenosine, as well as its anti-nociceptive effect. These observations indicate that adenosine mediates the effects of acupuncture and that interfering with adenosine metabolism may prolong the clinical benefit of acupuncture.	[Goldman, Nanna; Chen, Michael; Fujita, Takumi; Xu, Qiwu; Peng, Weiguo; Liu, Wei; Jensen, Tina K.; Pei, Yong; Wang, Fushun; Han, Xiaoning; Takano, Takahiro; Bekar, Lane; Tieu, Kim; Nedergaard, Maiken] Univ Rochester, Med Ctr, Ctr Translat Neuromed, Rochester, NY 14642 USA; [Chen, Jiang-Fan] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Schnermann, Jurgen] NIDDKD, US Natl Inst Hlth, Bethesda, MD USA	University of Rochester; Boston University; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Nedergaard, M (corresponding author), Univ Rochester, Med Ctr, Ctr Translat Neuromed, Rochester, NY 14642 USA.	nedergaard@urmc.rochester.edu	Tieu, Kim/F-5426-2012; Bekar, Lane K./AAI-2645-2021; Tieu, Kim/AAG-7336-2019	Tieu, Kim/0000-0001-6606-4371; Tieu, Kim/0000-0001-6606-4371; Chen, Jiang-Fan/0000-0002-0446-3956; Bekar, Lane/0000-0001-5083-0967; Takano, Takahiro/0000-0002-6235-6673	US National Institutes of Health; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES017470, R01ES014899] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS075177] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by a grant from the US National Institutes of Health to M.N. and K.T.	Abbracchio MP, 2009, TRENDS NEUROSCI, V32, P19, DOI 10.1016/j.tins.2008.10.001; Bekar L, 2008, NAT MED, V14, P75, DOI 10.1038/nm1693; Bonafede M, 2008, MED CARE, V46, P41, DOI 10.1097/MLR.0b013e3181589b7d; Burnstock G, 2007, PHYSIOL REV, V87, P659, DOI 10.1152/physrev.00043.2006; Burnstock G, 2009, MED HYPOTHESES, V73, P470, DOI 10.1016/j.mehy.2009.05.031; Castrop H, 2004, J CLIN INVEST, V114, P634, DOI 10.1172/JCI200421851; Chen JF, 1999, J NEUROSCI, V19, P9192, DOI 10.1523/jneurosci.19-21-09192.1999; Cui M, 2010, J BIOL CHEM, V285, P11740, DOI 10.1074/jbc.M109.066662; CULLITON BJ, 1972, SCIENCE, V177, P592, DOI 10.1126/science.177.4049.592; CUNHA RA, 1991, EUR J PHARMACOL, V197, P83, DOI 10.1016/0014-2999(91)90368-Z; Davis KD, 1997, J NEUROPHYSIOL, V77, P3370, DOI 10.1152/jn.1997.77.6.3370; Eisenach JC, 2004, J PAIN, V5, P64, DOI 10.1016/j.jpain.2003.10.001; Fredholm BB, 2007, CELL DEATH DIFFER, V14, P1315, DOI 10.1038/sj.cdd.4402132; Fredholm BB, 2001, PHARMACOL REV, V53, P527; GOLEMBIOWSKA K, 1995, BRAIN RES, V699, P315, DOI 10.1016/0006-8993(95)00926-H; Han JS, 2004, NEUROSCI LETT, V361, P258, DOI 10.1016/j.neulet.2003.12.019; Huang C, 2002, BRAIN RES, V945, P20, DOI 10.1016/S0006-8993(02)02503-9; KARLSTEN R, 1992, Pharmacology and Toxicology, V70, P434; Kelly RB, 2009, AM FAM PHYSICIAN, V80, P481; Lamanna Nicole, 2009, Clin Adv Hematol Oncol, V7, P386; Lao LX, 2004, BRAIN RES, V1020, P18, DOI 10.1016/j.brainres.2004.01.092; Li JH, 2005, CIRCULATION, V111, P2748, DOI 10.1161/CIRCULATIONAHA.104.510669; Li JH, 2003, J APPL PHYSIOL, V95, P577, DOI 10.1152/japplphysiol.00185.2003; Li WM, 2005, JPN J PHYSIOL, V55, P339, DOI 10.2170/jjphysiol.RP001505; LOHSE MJ, 1988, N-S ARCH PHARMACOL, V337, P687; Maione S, 2007, PAIN, V131, P281, DOI 10.1016/j.pain.2007.01.013; Martucci C, 2008, PAIN, V137, P81, DOI 10.1016/j.pain.2007.08.017; POORTMANS JR, 2003, PRINCIPLES EXERCISE; Quintero IB, 2007, CANCER RES, V67, P6549, DOI 10.1158/0008-5472.CAN-07-1651; Raghavendra V, 2004, EUR J NEUROSCI, V20, P467, DOI 10.1111/j.1460-9568.2004.03514.x; Ramsay DJ, 1998, JAMA-J AM MED ASSOC, V280, P1518; REEVE AJ, 1995, NEUROSCI LETT, V194, P81, DOI 10.1016/0304-3940(95)11732-C; SALTER MW, 1987, NEUROSCIENCE, V22, P631, DOI 10.1016/0306-4522(87)90359-9; Sawynok J, 1998, EUR J PHARMACOL, V347, P1, DOI 10.1016/S0014-2999(97)01605-1; Sawynok J, 1998, PAIN, V74, P75, DOI 10.1016/S0304-3959(97)00153-X; Sichardt K, 2007, PURINERG SIGNAL, V3, P285, DOI 10.1007/s11302-007-9065-z; Sjolund KF, 1999, ANESTH ANALG, V88, P605, DOI 10.1097/00000539-199903000-00027; Sun DQ, 2001, P NATL ACAD SCI USA, V98, P9983, DOI 10.1073/pnas.171317998; Takakura Nobuari, 2009, Open Med, V3, pe54; Volonte MG, 2004, J PHARMACEUT BIOMED, V35, P647, DOI 10.1016/j.jpba.2004.02.002; Wei F, 2001, J PHYSIOL-LONDON, V532, P823, DOI 10.1111/j.1469-7793.2001.0823e.x; Weidenhammer W, 2007, CLIN J PAIN, V23, P128, DOI 10.1097/01.ajp.0000210952.09127.df; Zhao ZQ, 2008, PROG NEUROBIOL, V85, P355, DOI 10.1016/j.pneurobio.2008.05.004; Zijlstra FJ, 2003, MEDIAT INFLAMM, V12, P59, DOI 10.1080/0962935031000114943; Zylka MJ, 2008, NEURON, V60, P111, DOI 10.1016/j.neuron.2008.08.024	45	503	578	10	193	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2010	13	7					883	U130		10.1038/nn.2562	http://dx.doi.org/10.1038/nn.2562			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	615YF	20512135	Green Accepted			2022-12-28	WOS:000279173900022
J	Hines, JH; Abu-Rub, M; Henley, JR				Hines, Jacob H.; Abu-Rub, Mohammad; Henley, John R.			Asymmetric endocytosis and remodeling of beta(1)-integrin adhesions during growth cone chemorepulsion by MAG	NATURE NEUROSCIENCE			English	Article							MYELIN-ASSOCIATED GLYCOPROTEIN; NERVE GROWTH; INTEGRIN ENDOCYTOSIS; CELL-MIGRATION; RECEPTOR; MECHANISMS; INHIBITORS; EXPRESSION; TRANSPORT; GUIDANCE	Gradients of chemorepellent factors released from myelin may impair axon pathfinding and neuroregeneration after injury. We found that, analogously to the process of chemotaxis in invasive tumor cells, axonal growth cones of Xenopus spinal neurons modulate the functional distribution of integrin receptors during chemorepulsion induced by myelin-associated glycoprotein (MAG). A focal MAG gradient induced polarized endocytosis and concomitant asymmetric loss of beta(1)-integrin and vinculin-containing adhesions on the repellent side during repulsive turning. Loss of symmetrical beta(1)-integrin function was both necessary and sufficient for chemorepulsion, which required internalization by clathrin-mediated endocytosis. Induction of repulsive Ca2+ signals was necessary and sufficient for the stimulated rapid endocytosis of beta(1)-integrin. Altogether, these findings identify beta(1)-integrin as an important functional cargo during Ca2+-dependent rapid endocytosis stimulated by a diffusible guidance cue. Such dynamic redistribution allows the growth cone to rapidly adjust adhesiveness across its axis, an essential feature for initiating chemotactic turning.	[Abu-Rub, Mohammad; Henley, John R.] Mayo Clin, Dept Neurol Surg, Rochester, MN 55905 USA; [Hines, Jacob H.] Mayo Clin, Mayo Grad Sch, Rochester, MN USA; [Henley, John R.] Mayo Clin, Dept Physiol & Biomed Engn, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Mayo Clinic	Henley, JR (corresponding author), Mayo Clin, Dept Neurol Surg, Rochester, MN 55905 USA.	henley.john@mayo.edu	Henley, John/D-7171-2011; Abu Rub, Mohammad/AAI-2255-2020	Hines, Jacob/0000-0003-1557-3795; Henley, John/0000-0003-1846-5941	Mayo Clinic; Craig Neilsen Foundation; Robert D. and Patricia E. Kern Predoctoral Fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS067311] Funding Source: NIH RePORTER	Mayo Clinic; Craig Neilsen Foundation; Robert D. and Patricia E. Kern Predoctoral Fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank K. Yamada (US National Institutes of Health), D. DeSimone (University of Virginia) and M. McNiven (Mayo Clinic) for generous gifts of antibodies to beta<INF>1</INF>-integrin, alpha<INF>5</INF>-integrin and dynamin (MC64 control rabbit IgG), respectively. The pFLAG-CMV2-AP180-C plasmid was from M. McNiven (Mayo Clinic) and the pCS2+RFP plasmid (Addgene) was from R. Moon (University of Washington). We also thank R. Muthu for assistance with beta<INF>1</INF> Fab purification; T. Gomez, B. Horazdovsky, C. Howe, M. McNiven, R. Pagano and members of the Henley group for critical comments; A. Windebank for sharing laboratory space at the beginning of these studies; and J. Tarara, S. Henle, E. Liang, J. Nesbitt, Z. Chen, B.-Y. Lin, V. Petrov and D. Triner for technical assistance. This work was supported by a John M. Nasseff, Sr., Career Development Award in Neurologic Surgery Research from the Mayo Clinic (J.R.H.) and career development funds from the Craig Neilsen Foundation (J.R.H.). A Robert D. and Patricia E. Kern Predoctoral Fellowship award supported J.H.H.	Akiyama H, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000196; Atwal JK, 2008, SCIENCE, V322, P967, DOI 10.1126/science.1161151; Bechara A, 2008, EMBO J, V27, P1549, DOI 10.1038/emboj.2008.86; Bonanomi D, 2008, J CELL SCI, V121, P3757, DOI 10.1242/jcs.033803; Caswell P, 2008, TRENDS CELL BIOL, V18, P257, DOI 10.1016/j.tcb.2008.03.004; CHENG TPO, 1985, J CELL BIOL, V101, P1473, DOI 10.1083/jcb.101.4.1473; Condic ML, 2001, J NEUROSCI, V21, P4782, DOI 10.1523/JNEUROSCI.21-13-04782.2001; Condic ML, 1997, NATURE, V389, P852, DOI 10.1038/39878; Conklin MW, 2005, DEV BIOL, V287, P201, DOI 10.1016/j.ydbio.2005.09.006; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; Diefenbach TJ, 1999, J NEUROSCI, V19, P9436; Domeniconi M, 2002, NEURON, V35, P283, DOI 10.1016/S0896-6273(02)00770-5; Ezratty EJ, 2009, J CELL BIOL, V187, P733, DOI 10.1083/jcb.200904054; Filbin MT, 2008, NEURON, V60, P740, DOI 10.1016/j.neuron.2008.12.001; Fournier AE, 2000, J CELL BIOL, V149, P411, DOI 10.1083/jcb.149.2.411; GAILIT J, 1988, J BIOL CHEM, V263, P12927; Goh ELK, 2008, MOL BRAIN, V1, DOI 10.1186/1756-6606-1-10; Hanley JG, 2005, EMBO J, V24, P3266, DOI 10.1038/sj.emboj.7600801; Henley JR, 2004, NEURON, V44, P909, DOI 10.1016/j.neuron.2004.11.030; Hong K, 2000, NATURE, V403, P93, DOI 10.1038/47507; Jin M, 2005, J NEUROSCI, V25, P2338, DOI 10.1523/JNEUROSCI.4889-04.2005; Kamiguchi H, 2001, J NEUROSCI, V21, P9194, DOI 10.1523/JNEUROSCI.21-23-09194.2001; Leung KM, 2006, NAT NEUROSCI, V9, P1247, DOI 10.1038/nn1775; Liu BP, 2002, SCIENCE, V297, P1190, DOI 10.1126/science.1073031; LIU JP, 1994, SCIENCE, V265, P970, DOI 10.1126/science.8052858; Ming GI, 1999, NEURON, V23, P139, DOI 10.1016/S0896-6273(00)80760-6; Niederost B, 2002, J NEUROSCI, V22, P10368; Nishimura T, 2007, DEV CELL, V13, P15, DOI 10.1016/j.devcel.2007.05.003; Piper M, 2005, NAT NEUROSCI, V8, P179, DOI 10.1038/nn1380; Piper M, 2006, NEURON, V49, P215, DOI 10.1016/j.neuron.2005.12.008; Poinat P, 2002, CURR BIOL, V12, P622, DOI 10.1016/S0960-9822(02)00764-9; Robles E, 2006, NAT NEUROSCI, V9, P1274, DOI 10.1038/nn1762; Serini G, 2003, NATURE, V424, P391, DOI 10.1038/nature01784; Song HJ, 1998, SCIENCE, V281, P1515, DOI 10.1126/science.281.5382.1515; Stevens A, 2002, J NEUROSCI, V22, P4448, DOI 10.1523/JNEUROSCI.22-11-04448.2002; Sydor AM, 1996, J CELL BIOL, V134, P1197, DOI 10.1083/jcb.134.5.1197; Tang S, 1997, MOL CELL NEUROSCI, V9, P333, DOI 10.1006/mcne.1997.0633; Tojima T, 2007, NAT NEUROSCI, V10, P58, DOI 10.1038/nn1814; Tysseling-Mattiace VM, 2008, J NEUROSCI, V28, P3814, DOI 10.1523/JNEUROSCI.0143-08.2008; Wen ZX, 2007, J CELL BIOL, V178, P107, DOI 10.1083/jcb.200703055; Wong ST, 2002, NAT NEUROSCI, V5, P1302, DOI 10.1038/nn975; Woo S, 2006, J NEUROSCI, V26, P1418, DOI 10.1523/JNEUROSCI.4209-05.2006; Wu XS, 2009, NAT NEUROSCI, V12, P1003, DOI 10.1038/nn.2355; Yamashita T, 2002, J CELL BIOL, V157, P565, DOI 10.1083/jcb.200202010; Zhao XH, 2001, J CELL SCI, V114, P353; Zheng JQ, 2007, ANNU REV CELL DEV BI, V23, P375, DOI 10.1146/annurev.cellbio.23.090506.123221; Zheng JQ, 2000, NATURE, V403, P89, DOI 10.1038/47501; ZHENG JQ, 1994, NATURE, V368, P140, DOI 10.1038/368140a0	48	61	63	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2010	13	7					829	U68		10.1038/nn.2554	http://dx.doi.org/10.1038/nn.2554			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	615YF	20512137	Green Accepted			2022-12-28	WOS:000279173900015
J	Sendtner, M				Sendtner, Michael			Therapy development in spinal muscular atrophy	NATURE NEUROSCIENCE			English	Article							MOTOR-NEURON GENE; MOUSE MODEL; SMN EXPRESSION; EXTENDS SURVIVAL; VALPROIC ACID; RNA; DELIVERY; PRODUCT; PROTEIN; RESCUE	Proximal spinal muscular atrophy (SMA) is the predominant form of motor neuron disease in children and young adults. In contrast to other neurodegenerative disorders, SMA is a genetically homozygous autosomal recessive disease that is caused by deficiency of the survival motor neuron (SMN) protein. This homogeneity should in principle facilitate therapy development. Previous therapy approaches have focused on upregulation of SMN expression from a second SMN (SMN2) gene that gives rise to low amounts of functional SMN protein. Drug development to target disease-specific mechanisms at cellular and physiological levels is in its early stages, as the pathophysiological processes that underlie the main disease symptoms are still not fully understood. Mouse models have helped to make conceptual progress in the disease mechanism, but their suitability in the search for therapeutic agents remains to be validated-an issue that is ubiquitous to the translational therapeutic research of other neurodegenerative diseases. Human induced pluripotent stem cell technology for generation of large numbers of human motor neurons could help to fill this gap and advance the power of drug screening. In parallel, advances in oligonucleotide technologies for engineering SMN2 pre-mRNA splicing are approaching their first clinical trials, whose success depends on improved technologies for drug delivery to motor neurons. If this obstacle can be overcome, this could boost therapy development, not only for SMA but also for other neurodegenerative disorders.	Univ Wurzburg, Inst Clin Neurobiol, Wurzburg, Germany	University of Wurzburg	Sendtner, M (corresponding author), Univ Wurzburg, Inst Clin Neurobiol, Wurzburg, Germany.	sendtner_m@klinik.uni-wuerzburg.de	Sendtner, Michael/J-1542-2012; Sendtner, Michael/M-8137-2014	Sendtner, Michael/0000-0002-4737-2974; Sendtner, Michael/0000-0002-4737-2974	SMA Foundation; Hermann und Lilly Schilling Stiftung im Stifterverband der Deutschen Industrie; Deutsche Forschungsgemeinschaft [SFB 581, B1]	SMA Foundation; Hermann und Lilly Schilling Stiftung im Stifterverband der Deutschen Industrie; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	I thank R. Blum and R. Gotz for critical reading and many helpful comments. Work in my laboratory on spinal muscular atrophy was supported by the SMA Foundation, the Hermann und Lilly Schilling Stiftung im Stifterverband der Deutschen Industrie and the Deutsche Forschungsgemeinschaft, grant SFB 581, B1.	Aartsma-Rus A, 2010, EUR J HUM GENET, V18, P146, DOI 10.1038/ejhg.2009.160; Avila AM, 2007, J CLIN INVEST, V117, P659, DOI 10.1172/JCI29562; Azzouz M, 2004, J CLIN INVEST, V114, P1726, DOI 10.1172/JCI200422922; Burghes AHM, 2009, NAT REV NEUROSCI, V10, P597, DOI 10.1038/nrn2670; Butchbach MER, 2010, HUM MOL GENET, V19, P454, DOI 10.1093/hmg/ddp510; Cartegni L, 2002, NAT GENET, V30, P377, DOI 10.1038/ng854; Chang JG, 2001, P NATL ACAD SCI USA, V98, P9808, DOI 10.1073/pnas.171105098; Cho SC, 2010, GENE DEV, V24, P438, DOI 10.1101/gad.1884910; Crawford TO, 1996, NEUROBIOL DIS, V3, P97, DOI 10.1006/nbdi.1996.0010; Ebert AD, 2009, NATURE, V457, P277, DOI 10.1038/nature07677; Foust KD, 2010, NAT BIOTECHNOL, V28, P271, DOI 10.1038/nbt.1610; Foust KD, 2009, NAT BIOTECHNOL, V27, P59, DOI 10.1038/nbt.1515; Garbes L, 2009, HUM MOL GENET, V18, P3645, DOI 10.1093/hmg/ddp313; Goyenvalle A, 2004, SCIENCE, V306, P1796, DOI 10.1126/science.1104297; Hua YM, 2008, AM J HUM GENET, V82, P834, DOI 10.1016/j.ajhg.2008.01.014; Hua YM, 2007, PLOS BIOL, V5, P729, DOI 10.1371/journal.pbio.0050073; Jablonka S, 2000, HUM MOL GENET, V9, P341, DOI 10.1093/hmg/9.3.341; Jarecki J, 2005, HUM MOL GENET, V14, P2003, DOI 10.1093/hmg/ddi205; Jedrzejowska M, 2008, EUR J HUM GENET, V16, P930, DOI 10.1038/ejhg.2008.41; Kashima T, 2003, NAT GENET, V34, P460, DOI 10.1038/ng1207; Khoo B, 2009, CURR OPIN MOL THER, V11, P108; Kong LL, 2009, J NEUROSCI, V29, P842, DOI 10.1523/JNEUROSCI.4434-08.2009; Le TT, 2005, HUM MOL GENET, V14, P845, DOI 10.1093/hmg/ddi078; Marks PA, 2004, ADV CANCER RES, V91, P137, DOI 10.1016/S0065-230X(04)91004-4; Mattis VB, 2006, HUM GENET, V120, P589, DOI 10.1007/s00439-006-0245-7; McWhorter ML, 2003, J CELL BIOL, V162, P919, DOI 10.1083/jcb.200303168; Meyer K, 2009, HUM MOL GENET, V18, P546, DOI 10.1093/hmg/ddn382; Monani UR, 2000, HUM MOL GENET, V9, P333, DOI 10.1093/hmg/9.3.333; Pan WH, 2006, J CELL BIOCHEM, V98, P14, DOI 10.1002/jcb.20790; Passini MA, 2010, J CLIN INVEST, V120, P1253, DOI 10.1172/JCI41615; Rak K, 2009, NEUROBIOL DIS, V36, P477, DOI 10.1016/j.nbd.2009.08.014; Ralph GS, 2005, NAT MED, V11, P429, DOI 10.1038/nm1205; Rossoll W, 2002, HUM MOL GENET, V11, P93, DOI 10.1093/hmg/11.1.93; Rossoll W, 2003, J CELL BIOL, V163, P801, DOI 10.1083/jcb.200304128; Schrank B, 1997, P NATL ACAD SCI USA, V94, P9920, DOI 10.1073/pnas.94.18.9920; Simpson CL, 2006, BBA-MOL BASIS DIS, V1762, P973, DOI 10.1016/j.bbadis.2006.08.001; Singh NN, 2007, NUCLEIC ACIDS RES, V35, P371, DOI 10.1093/nar/gkl1050; Storkebaum E, 2004, BIOESSAYS, V26, P943, DOI 10.1002/bies.20092; Sumner CJ, 2003, ANN NEUROL, V54, P647, DOI 10.1002/ana.10743; Swoboda KJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005268; Thoenen H, 2002, NAT NEUROSCI, V5, P1046, DOI 10.1038/nn938; Towne C, 2010, GENE THER, V17, P141, DOI 10.1038/gt.2009.119; Towne C, 2008, MOL THER, V16, P1018, DOI 10.1038/mt.2008.73; Tsai LK, 2006, NEUROBIOL DIS, V24, P286, DOI 10.1016/j.nbd.2006.07.004; Valdmanis PN, 2009, CURR NEUROL NEUROSCI, V9, P198, DOI 10.1007/s11910-009-0030-9; van Deutekom JC, 2007, NEW ENGL J MED, V357, P2677, DOI 10.1056/NEJMoa073108; Wirth B, 2000, HUM MUTAT, V15, P228, DOI 10.1002/(SICI)1098-1004(200003)15:3<228::AID-HUMU3>3.0.CO;2-9; Zaiss AK, 2008, GENE THER, V15, P808, DOI 10.1038/gt.2008.54	48	24	24	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2010	13	7					795	799		10.1038/nn.2565	http://dx.doi.org/10.1038/nn.2565			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	615YF	20581815				2022-12-28	WOS:000279173900008
J	Henny, P; Brown, MTC; Northrop, A; Faunes, M; Ungless, MA; Magill, PJ; Bolam, JP				Henny, Pablo; Brown, Matthew T. C.; Northrop, Augustus; Faunes, Macarena; Ungless, Mark A.; Magill, Peter J.; Bolam, J. Paul			Structural correlates of heterogeneous in vivo activity of midbrain dopaminergic neurons	NATURE NEUROSCIENCE			English	Article							VENTRAL TEGMENTAL AREA; PARS RETICULATA NEURONS; SUBSTANTIA-NIGRA; SQUIRREL-MONKEY; TOTAL NUMBER; RAT; INHIBITION; PROJECTION; SYNAPSES; NUCLEUS	Dopaminergic neurons of the substantia nigra pars compacta (SNc) exhibit functional heterogeneity that likely underpins their diverse roles in behavior. We examined how the functional diversity of identified dopaminergic neurons in vivo correlates with differences in somato-dendritic architecture and afferent synaptic organization. Stereological analysis of individually recorded and labeled dopaminergic neurons of rat SNc revealed that they received approximately 8,000 synaptic inputs, at least 30% of which were glutamatergic and 40-70% were GABAergic. The latter synapses were proportionally greater in number and denser on dendrites located in the substantia nigra pars reticulata (SNr) than on those located in SNc, revealing the existence of two synaptically distinct and region-specific subcellular domains. We also found that the relative extension of SNc neuron dendrites into the SNr dictated overall GABAergic innervation and predicted inhibition responses to aversive stimuli. We conclude that diverse wiring patterns determine the heterogeneous activities of midbrain dopaminergic neurons in vivo.	[Henny, Pablo; Brown, Matthew T. C.; Northrop, Augustus; Ungless, Mark A.; Magill, Peter J.; Bolam, J. Paul] Univ Oxford, Dept Pharmacol, MRC, Anat Neuropharmacol Unit, Oxford OX1 3QT, England; [Henny, Pablo; Faunes, Macarena] Pontificia Univ Catolica Chile, Dept Anat Normal, Escuela Med, Santiago, Chile; [Henny, Pablo; Faunes, Macarena] Pontificia Univ Catolica Chile, Ctr Interdisciplinario Neurocien, NeuroUC, Santiago, Chile; [Magill, Peter J.; Bolam, J. Paul] Univ Oxford, Oxford Parkinsons Dis Ctr, Oxford, England	University of Oxford; Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile; University of Oxford	Henny, P (corresponding author), Univ Oxford, Dept Pharmacol, MRC, Anat Neuropharmacol Unit, S Parks Rd, Oxford OX1 3QT, England.	pablohenny@gmail.com		Brown, Matthew/0000-0001-6983-962X; Ungless, Mark/0000-0002-1730-3353; Magill, Peter/0000-0001-7141-7071; Bolam, J Paul/0000-0002-5008-8405	Medical Research Council (UK); Parkinson's UK [G-0601]; Comision Nacional de Investigacion Cientifica y Tecnologica (Fondecyt) [11100433]; Medical Research Council [MC_U138197109, MC_U138164490, MC_U120085816] Funding Source: researchfish; Parkinson&quot;s UK [G-0601] Funding Source: researchfish; MRC [MC_U138164490, MC_U138197109, MC_U120085816] Funding Source: UKRI	Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Parkinson's UK(Parkinson's UK); Comision Nacional de Investigacion Cientifica y Tecnologica (Fondecyt)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Parkinson&quot;s UK(Parkinson&apos;s UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We are grateful to M. West for providing critical comments during the development of the single-cell stereological protocol. We also thank E. Norman, C. Francis, K. Whitworth, B. Micklem, S. Fernandez, J. Mpodozis and G. Marin for expert technical assistance, and C. Morales and M. Quispe for statistical analysis. This work was supported by the Medical Research Council (UK), Parkinson's UK (grant G-0601, to J.P.B., P.J.M. and M.A.U.), and the Comision Nacional de Investigacion Cientifica y Tecnologica (Fondecyt grant 11100433, Conicyt, Chile to P.H.).	Ascoli GA, 2006, NAT REV NEUROSCI, V7, P318, DOI 10.1038/nrn1885; BAYER VE, 1991, BRAIN RES, V559, P44, DOI 10.1016/0006-8993(91)90285-4; Blythe SN, 2009, J NEUROSCI, V29, P15531, DOI 10.1523/JNEUROSCI.2961-09.2009; BOLAM JP, 1990, BRAIN RES, V529, P57, DOI 10.1016/0006-8993(90)90811-O; BOLAM JP, 1991, NEUROSCIENCE, V41, P483, DOI 10.1016/0306-4522(91)90343-M; Borgius L, 2010, MOL CELL NEUROSCI, V45, P245, DOI 10.1016/j.mcn.2010.06.016; Brischoux F, 2009, P NATL ACAD SCI USA, V106, P4894, DOI 10.1073/pnas.0811507106; Bromberg-Martin ES, 2010, NEURON, V68, P815, DOI 10.1016/j.neuron.2010.11.022; Brown MTC, 2009, J NEUROSCI, V29, P2915, DOI 10.1523/JNEUROSCI.4423-08.2009; Coizet V, 2010, NEUROSCIENCE, V168, P263, DOI 10.1016/j.neuroscience.2010.03.049; Comoli E, 2003, NAT NEUROSCI, V6, P974, DOI 10.1038/nn1113; CORVAJA N, 1993, NEUROSCIENCE, V55, P417, DOI 10.1016/0306-4522(93)90510-M; Fallon James H., 1995, P215; Fiala JC., 1999, DENDRITES, P1, DOI DOI 10.1093/ACPROF:OSO/9780198566564.003.0001; GERFEN CR, 1987, J NEUROSCI, V7, P3935; GRACE AA, 1979, EUR J PHARMACOL, V59, P211, DOI 10.1016/0014-2999(79)90283-8; Gulacsi A, 2003, J NEUROSCI, V23, P8237; GUNDERSEN HJG, 1986, J MICROSC-OXFORD, V143, P3, DOI 10.1111/j.1365-2818.1986.tb02764.x; HAJOS M, 1994, BRAIN RES, V660, P216, DOI 10.1016/0006-8993(94)91292-0; Iribe Y, 1999, J NEUROPHYSIOL, V82, P925, DOI 10.1152/jn.1999.82.2.925; Jhou TC, 2009, NEURON, V61, P786, DOI 10.1016/j.neuron.2009.02.001; Joshua M, 2008, J NEUROSCI, V28, P11673, DOI 10.1523/JNEUROSCI.3839-08.2008; Kitai ST, 1999, CURR OPIN NEUROBIOL, V9, P690, DOI 10.1016/S0959-4388(99)00040-9; LAVOIE B, 1994, J COMP NEUROL, V344, P232, DOI 10.1002/cne.903440205; Lodge DJ, 2011, NEUROPSYCHOPHARMACOL, V36, P1227, DOI 10.1038/npp.2011.7; MAEDA H, 1982, BRAIN RES BULL, V8, P7, DOI 10.1016/0361-9230(82)90021-1; Magee JC, 2000, NAT REV NEUROSCI, V1, P181, DOI 10.1038/35044552; Mailly P, 2003, J NEUROSCI, V23, P5247; Mann EO, 2007, TRENDS NEUROSCI, V30, P343, DOI 10.1016/j.tins.2007.05.003; Matsumoto M, 2009, NATURE, V459, P837, DOI 10.1038/nature08028; Megias M, 2001, NEUROSCIENCE, V102, P527, DOI 10.1016/S0306-4522(00)00496-6; NAITO A, 1994, BRAIN RES, V637, P317, DOI 10.1016/0006-8993(94)91252-1; Omelchenko N, 2007, NEUROSCIENCE, V146, P1259, DOI 10.1016/j.neuroscience.2007.02.016; Paladini CA, 1999, NEUROSCIENCE, V89, P799, DOI 10.1016/S0306-4522(98)00355-8; Pinault D, 1996, J NEUROSCI METH, V65, P113, DOI 10.1016/0165-0270(95)00144-1; PRESTON RJ, 1981, NEUROSCIENCE, V6, P331, DOI 10.1016/0306-4522(81)90127-5; Schultz W, 2007, TRENDS NEUROSCI, V30, P203, DOI 10.1016/j.tins.2007.03.007; Smith Y, 1996, J COMP NEUROL, V364, P231, DOI 10.1002/(SICI)1096-9861(19960108)364:2<231::AID-CNE4>3.0.CO;2-6; SMITH Y, 1990, J COMP NEUROL, V294, P306, DOI 10.1002/cne.902940213; Smith Y, 1998, NEUROSCIENCE, V86, P353; Spruston N, 2008, NAT REV NEUROSCI, V9, P206, DOI 10.1038/nrn2286; Tepper JM, 2007, PROG BRAIN RES, V160, P189, DOI 10.1016/S0079-6123(06)60011-3; Tsai HC, 2009, SCIENCE, V324, P1080, DOI 10.1126/science.1168878; Wang HL, 2009, EUR J NEUROSCI, V29, P340, DOI 10.1111/j.1460-9568.2008.06576.x; West MJ, 1999, TRENDS NEUROSCI, V22, P51, DOI 10.1016/S0166-2236(98)01362-9; Wise RA, 2009, TRENDS NEUROSCI, V32, P517, DOI 10.1016/j.tins.2009.06.004	46	91	93	2	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2012	15	4					613	619		10.1038/nn.3048	http://dx.doi.org/10.1038/nn.3048			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	916PA	22327472	Green Accepted			2022-12-28	WOS:000302114500022
J	Zheng, S; Gray, EE; Chawla, G; Porse, BT; O'Dell, TJ; Black, DL				Zheng, Sika; Gray, Erin E.; Chawla, Geetanjali; Porse, Bo Torben; O'Dell, Thomas J.; Black, Douglas L.			PSD-95 is post-transcriptionally repressed during early neural development by PTBP1 and PTBP2	NATURE NEUROSCIENCE			English	Article							TRACT BINDING-PROTEIN; NONSENSE-MEDIATED DECAY; LONG-TERM POTENTIATION; AMPA RECEPTOR FUNCTION; MESSENGER-RNA DECAY; EXCITATORY SYNAPSES; EXPRESSION; SWITCH; CELLS; MOUSE	Postsynaptic density protein 95 (PSD-95) is essential for synaptic maturation and plasticity. Although its synaptic regulation has been widely studied, the control of PSD-95 cellular expression is not understood. We found that Psd-95 was controlled post-transcriptionally during neural development. Psd-95 was transcribed early in mouse embryonic brain, but most of its product transcripts were degraded. The polypyrimidine tract binding proteins PTBP1 and PTBP2 repressed Psd-95 (also known as Dlg4) exon 18 splicing, leading to premature translation termination and nonsense-mediated mRNA decay. The loss of first PTBP1 and then of PTBP2 during embryonic development allowed splicing of exon 18 and expression of PSD-95 late in neuronal maturation. Re-expression of PTBP1 or PTBP2 in differentiated neurons inhibited PSD-95 expression and impaired the development of glutamatergic synapses. Thus, expression of PSD-95 during early neural development is controlled at the RNA level by two PTB proteins whose sequential downregulation is necessary for synapse maturation.	[Zheng, Sika; Chawla, Geetanjali; Black, Douglas L.] Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90024 USA; [Gray, Erin E.] Univ Calif Los Angeles, Interdept PhD Program Neurosci, Los Angeles, CA 90024 USA; [Porse, Bo Torben] Univ Copenhagen, Rigshosp, Finsen Lab, DK-2100 Copenhagen, Denmark; [Porse, Bo Torben] Univ Copenhagen, Fac Hlth Sci, Copenhagen, Denmark; [Porse, Bo Torben] Univ Copenhagen, Biotech Res & Innovat Ctr, Copenhagen, Denmark; [O'Dell, Thomas J.] Univ Calif Los Angeles, Dept Physiol, Los Angeles, CA 90024 USA; [Black, Douglas L.] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90024 USA	Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Rigshospitalet; University of Copenhagen; University of Copenhagen; University of Copenhagen; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Black, DL (corresponding author), Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90024 USA.	dougb@microbio.ucla.edu	Chawla, Geetanjali/AAH-9493-2021; Zheng, Sika/ABB-9203-2020	Chawla, Geetanjali/0000-0003-0354-3716; Zheng, Sika/0000-0002-0573-4981; Porse, Bo/0000-0001-6043-0844	US National Institutes of Health [RO1 GM 49662, R01 MH60919, NIH F32 MH84562]; Lundbeck Foundation [R5-2006-99] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049662] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060919, F31MH085462] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lundbeck Foundation(Lundbeckfonden); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank J. Baraban and E. Anderson for thoughtful suggestions on the manuscript, and K. Martin, L. Zipursky, W. Yang and members of the Black laboratory for helpful discussion. We thank S. Sharma for the His-tagged PTBP1 recombinant proteins, and A. Han and S. Sharma for help with the EMSA experiments. We thank Q. Lin for help with Imaris software. This work was supported in part by grants from the US National Institutes of Health (RO1 GM 49662 to D.L.B., R01 MH60919 to T.J.O. and NIH F32 MH84562 to E.E.G.). D.L.B. is an Investigator of the Howard Hughes Medical Institute.	Amir-Ahmady B, 2005, RNA, V11, P699, DOI 10.1261/rna.2250405; Ashiya M, 1997, RNA, V3, P996; Beique JC, 2006, P NATL ACAD SCI USA, V103, P19535, DOI 10.1073/pnas.0608492103; Besse F, 2008, NAT REV MOL CELL BIO, V9, P971, DOI 10.1038/nrm2548; Black DL, 2008, NEURON, V58, P297, DOI 10.1016/j.neuron.2008.04.019; Boutz PL, 2007, GENE DEV, V21, P1636, DOI 10.1101/gad.1558107; Bruno IG, 2011, MOL CELL, V42, P500, DOI 10.1016/j.molcel.2011.04.018; Calarco JA, 2009, CELL, V138, P898, DOI 10.1016/j.cell.2009.06.012; Carlisle HJ, 2008, J PHYSIOL-LONDON, V586, P5885, DOI 10.1113/jphysiol.2008.163469; CARTER MS, 1995, J BIOL CHEM, V270, P28995, DOI 10.1074/jbc.270.48.28995; Chang YF, 2007, ANNU REV BIOCHEM, V76, P51, DOI 10.1146/annurev.biochem.76.050106.093909; Chen L, 2000, NATURE, V408, P936, DOI 10.1038/35050030; Chen L, 2010, NUCLEIC ACIDS RES, V38, P1086, DOI 10.1093/nar/gkp1136; Chen L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002806; Chen Z, 2008, NEURON, V58, P325, DOI 10.1016/j.neuron.2008.02.016; Ehrlich I, 2007, P NATL ACAD SCI USA, V104, P4176, DOI 10.1073/pnas.0609307104; El-Hussein AE, 2000, SCIENCE, V290, P1364; Elias GM, 2006, NEURON, V52, P307, DOI 10.1016/j.neuron.2006.09.012; Firestein BL, 2001, MOL BIOL CELL, V12, P3465, DOI 10.1091/mbc.12.11.3465; Funke L, 2005, ANNU REV BIOCHEM, V74, P219, DOI 10.1146/annurev.biochem.74.082803.133339; Gardner LB, 2008, MOL CELL BIOL, V28, P3729, DOI 10.1128/MCB.02284-07; Giorgi C, 2007, CELL, V130, P179, DOI 10.1016/j.cell.2007.05.028; Giorgi C, 2007, SEMIN CELL DEV BIOL, V18, P186, DOI 10.1016/j.semcdb.2007.01.002; Guo L, 2007, NEUROSCIENCE, V145, P100, DOI 10.1016/j.neuroscience.2006.11.042; Hyvonen MT, 2006, RNA, V12, P1569, DOI 10.1261/rna.39806; Iwasato T, 2004, GENESIS, V38, P130, DOI 10.1002/gene.20009; Lareau LF, 2007, NATURE, V446, P926, DOI 10.1038/nature05676; Lejeune F, 2005, CURR OPIN CELL BIOL, V17, P309, DOI 10.1016/j.ceb.2005.03.002; Liu HY, 2002, RNA, V8, P137, DOI 10.1017/S1355838202015029; Makeyev EV, 2007, MOL CELL, V27, P435, DOI 10.1016/j.molcel.2007.07.015; Medghalchi SM, 2001, HUM MOL GENET, V10, P99, DOI 10.1093/hmg/10.2.99; Mendell JT, 2004, NAT GENET, V36, P1073, DOI 10.1038/ng1429; Migaud M, 1998, NATURE, V396, P433, DOI 10.1038/24790; Muddashetty RS, 2007, J NEUROSCI, V27, P5338, DOI 10.1523/JNEUROSCI.0937-07.2007; Ni JZ, 2007, GENE DEV, V21, P708, DOI 10.1101/gad.1525507; Qin XF, 2003, P NATL ACAD SCI USA, V100, P183, DOI 10.1073/pnas.232688199; Sans N, 2000, J NEUROSCI, V20, P1260, DOI 10.1523/JNEUROSCI.20-03-01260.2000; Schluter OM, 2006, NEURON, V51, P99, DOI 10.1016/j.neuron.2006.05.016; Sheng M, 2007, ANNU REV BIOCHEM, V76, P823, DOI 10.1146/annurev.biochem.76.060805.160029; Sorek R, 2003, GENOME RES, V13, P1631, DOI 10.1101/gr.1208803; Spellman R, 2005, BIOCHEM SOC T, V33, P457, DOI 10.1042/BST0330457; Spellman R, 2007, MOL CELL, V27, P420, DOI 10.1016/j.molcel.2007.06.016; Sugnet CW, 2006, PLOS COMPUT BIOL, V2, P22, DOI 10.1371/journal.pcbi.0020004; Weischenfeldt J, 2008, GENE DEV, V22, P1381, DOI 10.1101/gad.468808; WOODS DF, 1991, CELL, V66, P451, DOI 10.1016/0092-8674(81)90009-X; Wyneken U, 2001, NEUROSCIENCE, V102, P65, DOI 10.1016/S0306-4522(00)00469-3; Xue YC, 2009, MOL CELL, V36, P996, DOI 10.1016/j.molcel.2009.12.003; Yeo GW, 2005, P NATL ACAD SCI USA, V102, P2850, DOI 10.1073/pnas.0409742102; Zalfa F, 2007, NAT NEUROSCI, V10, P578, DOI 10.1038/nn1893; Zheng S, 2010, J CLIN INVEST, V120, P2446, DOI 10.1172/JCI33144	50	147	152	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2012	15	3					381	U202		10.1038/nn.3026	http://dx.doi.org/10.1038/nn.3026			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	899CY	22246437	Green Accepted, Green Submitted			2022-12-28	WOS:000300793100011
J	Saygin, ZM; Osher, DE; Koldewyn, K; Reynolds, G; Gabrieli, JDE; Saxe, RR				Saygin, Zeynep M.; Osher, David E.; Koldewyn, Kami; Reynolds, Gretchen; Gabrieli, John D. E.; Saxe, Rebecca R.			Anatomical connectivity patterns predict face selectivity in the fusiform gyrus	NATURE NEUROSCIENCE			English	Article							RHESUS-MONKEY; FUNCTIONAL LOCALIZATION; CORTICAL REGION; CORTEX; AREA; PERCEPTION; PROSOPAGNOSIA; MACAQUE; BRAIN; PROJECTIONS	A fundamental assumption in neuroscience is that brain structure determines function. Accordingly, functionally distinct regions of cortex should be structurally distinct in their connections to other areas. We tested this hypothesis in relation to face selectivity in the fusiform gyrus. By using only structural connectivity, as measured through diffusion-weighted imaging, we were able to predict functional activation to faces in the fusiform gyrus. These predictions outperformed two control models and a standard group-average benchmark. The structure function relationship discovered from the initial participants was highly robust in predicting activation in a second group of participants, despite differences in acquisition parameters and stimuli. This approach can thus reliably estimate activation in participants who cannot perform functional imaging tasks and is an alternative to group-activation maps. Additionally, we identified cortical regions whose connectivity was highly influential in predicting face selectivity within the fusiform, suggesting a possible mechanistic architecture underlying face processing in humans.	[Saygin, Zeynep M.; Osher, David E.; Koldewyn, Kami; Reynolds, Gretchen; Gabrieli, John D. E.; Saxe, Rebecca R.] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Saygin, Zeynep M.; Osher, David E.; Koldewyn, Kami; Gabrieli, John D. E.] MIT, McGovern Inst Brain Res, Cambridge, MA 02139 USA; [Gabrieli, John D. E.] MIT, Harvard MIT Hlth Sci & Technol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT)	Saygin, ZM (corresponding author), MIT, Dept Brain & Cognit Sci, E25-618, Cambridge, MA 02139 USA.	zsaygin@mit.edu; dosher@mit.edu	Gabrieli, John/AAJ-2869-2020; Koldewyn, Kami/Q-6108-2019; Saygin, Zeynep M./AAV-4951-2020; Koldewyn, Kami/B-6434-2013	Koldewyn, Kami/0000-0003-3588-6449; /0000-0003-2377-1791	US Public Health Service [DA023427]; US National Institute of Mental Health [F32 MH084488]; US National Eye Institute [T32 EY013935]; Poitras Center for Affective Disorders Research; Simons Foundation; Ellison Medical Foundation; NATIONAL EYE INSTITUTE [T32EY013935] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [F32MH084488] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R90DA023427] Funding Source: NIH RePORTER	US Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); US National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); US National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Poitras Center for Affective Disorders Research; Simons Foundation; Ellison Medical Foundation(Lawrence Ellison Foundation); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank N. Kanwisher, S. Ghosh, F. Polli and the Athinoula A. Martinos Imaging Center at McGovern Institute for Brain Research, Massachusetts Institute of Technology. This work was supported by US Public Health Service DA023427, US National Institute of Mental Health F32 MH084488, US National Eye Institute T32 EY013935, the Poitras Center for Affective Disorders Research, the Simons Foundation and the Ellison Medical Foundation.	Annese J, 2005, CEREB CORTEX, V15, P1044, DOI 10.1093/cercor/bhh205; Barton JJS, 2002, NEUROLOGY, V58, P71, DOI 10.1212/WNL.58.1.71; Behrens TEJ, 2003, NAT NEUROSCI, V6, P750, DOI 10.1038/nn1075; Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609; Catani M, 2003, BRAIN, V126, P2093, DOI 10.1093/brain/awg203; Dauguet J, 2007, NEUROIMAGE, V37, P530, DOI 10.1016/j.neuroimage.2007.04.067; Dickerson BC, 2008, NEUROIMAGE, V39, P10, DOI 10.1016/j.neuroimage.2007.08.042; Epstein R, 1998, NATURE, V392, P598, DOI 10.1038/33402; Epstein RA, 2008, TRENDS COGN SCI, V12, P388, DOI 10.1016/j.tics.2008.07.004; Gholipour A, 2007, IEEE T MED IMAGING, V26, P427, DOI 10.1109/TMI.2007.892508; GLICKSTEIN M, 1994, J COMP NEUROL, V349, P51, DOI 10.1002/cne.903490105; Gloor P., 1997, TEMPORAL LOBE LIMBIC; Golland P, 2003, LECT NOTES COMPUT SC, V2732, P330; Hastie T., 2009, UNSUPERVISED LEARNIN; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; Haxby JV, 1999, NEURON, V22, P189, DOI 10.1016/S0896-6273(00)80690-X; Hilgetag CC, 2004, NEUROINFORMATICS, V2, P353, DOI 10.1385/NI:2:3:353; Hinds OP, 2008, NEUROIMAGE, V39, P1585, DOI 10.1016/j.neuroimage.2007.10.033; Ishai A, 2008, NEUROIMAGE, V40, P415, DOI 10.1016/j.neuroimage.2007.10.040; Johansen-Berg H, 2004, P NATL ACAD SCI USA, V101, P13335, DOI 10.1073/pnas.0403743101; Kanwisher N, 1999, NEUROREPORT, V10, P183, DOI 10.1097/00001756-199901180-00035; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kanwisher N, 2006, PHILOS T R SOC B, V361, P2109, DOI 10.1098/rstb.2006.1934; LANDIS T, 1986, CORTEX, V22, P243, DOI 10.1016/S0010-9452(86)80048-X; McCarthy G, 1997, J COGNITIVE NEUROSCI, V9, P605, DOI 10.1162/jocn.1997.9.5.605; MCNEIL JE, 1993, Q J EXP PSYCHOL-A, V46, P1, DOI 10.1080/14640749308401064; Moeller S, 2008, SCIENCE, V320, P1355, DOI 10.1126/science.1157436; O'Reilly JX, 2010, CEREB CORTEX, V20, P953, DOI 10.1093/cercor/bhp157; Passingham RE, 2002, NAT REV NEUROSCI, V3, P606, DOI 10.1038/nrn893; Peled S., 2005, P I SOC MAGN RESON M, V13, P1323; PERRETT DI, 1992, PHILOS T ROY SOC B, V335, P23, DOI 10.1098/rstb.1992.0003; Pitcher D, 2007, CURR BIOL, V17, P1568, DOI 10.1016/j.cub.2007.07.063; Saxe R, 2006, SOC COGN AFFECT NEUR, V1, P229, DOI 10.1093/scan/nsl034; SCHMAHMANN JD, 1993, J COMP NEUROL, V337, P94, DOI 10.1002/cne.903370107; SCHMAHMANN JD, 1992, J COMP NEUROL, V326, P159, DOI 10.1002/cne.903260202; SELTZER B, 1994, J COMP NEUROL, V343, P445, DOI 10.1002/cne.903430308; Sewards TV, 2011, NEUROPSYCHOLOGIA, V49, P277, DOI 10.1016/j.neuropsychologia.2010.11.018; Sporns O, 2004, NEUROINFORMATICS, V2, P145, DOI 10.1385/NI:2:2:145; Thomas C, 2009, NAT NEUROSCI, V12, P29, DOI 10.1038/nn.2224; Tsao DY, 2008, NAT NEUROSCI, V11, P877, DOI 10.1038/nn.2158; Tsao DY, 2006, SCIENCE, V311, P670, DOI 10.1126/science.1119983	41	194	199	1	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2012	15	2					321	327		10.1038/nn.3001	http://dx.doi.org/10.1038/nn.3001			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	882ZX	22197830	Green Accepted, Green Submitted			2022-12-28	WOS:000299603500025
J	Pollarolo, G; Schulz, JG; Munck, S; Dotti, CG				Pollarolo, Giulia; Schulz, Joachim G.; Munck, Sebastian; Dotti, Carlos G.			Cytokinesis remnants define first neuronal asymmetry in vivo	NATURE NEUROSCIENCE			English	Article							CELL-CELL ADHESION; ADHERENS JUNCTIONS; CLEAVAGE FURROW; DROSOPHILA; POLARITY; LOCALIZATION; RHO; MODULATION; MIGRATION; CADHERINS	Giulia Pollarolo(1,2,4), Joachim G Schulz(1,2,4), Sebastian Munck(1,2) & Carlos G Dotti(1-3) Polarization of a neuron begins with the appearance of the first neurite, thus defining the ultimate growth axis. Unlike late occurring polarity events (such as axonal growth), very little is known about this fundamental process. We show here that, in Drosophila melanogaster neurons in vivo, the first membrane deformation occurred 3.6 min after precursor division. Clustering of adhesion complex components (Bazooka (Par-3), cadherin-catenin) marked this place by 2.8 min after division; the upstream phosphatidylinositol 4,5-bisphosphate, by 0.7 min after division; and the furrow components RhoA and Aurora kinase, from the time of cytokinesis. Local DE-cadherin inactivation prevented sprout formation, whereas perturbation of division orientation did not alter polarization from the cytokinesis pole. This is, to our knowledge, the first molecular study of initial neuronal polarization in vivo. The mechanisms of polarization seem to be defined at the precursor stage.	[Pollarolo, Giulia; Schulz, Joachim G.; Munck, Sebastian; Dotti, Carlos G.] Vlaams Inst Biotechnol, Dept Mol & Dev Genet, Louvain, Belgium; [Pollarolo, Giulia; Schulz, Joachim G.; Munck, Sebastian; Dotti, Carlos G.] Katholieke Univ Leuven, Ctr Human Genet, Louvain, Belgium; [Dotti, Carlos G.] Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa, Madrid, Spain	Flanders Institute for Biotechnology (VIB); KU Leuven; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM)	Schulz, JG (corresponding author), Vlaams Inst Biotechnol, Dept Mol & Dev Genet, Campus Gasthuisberg, Louvain, Belgium.	joachim.schulz@med.kuleuven.be; carlos.dotti@cme.vib-kuleuven.be	Dotti, Carlos G/I-5533-2015	Dotti, Carlos G/0000-0003-4052-1719; Munck, Sebastian/0000-0002-5182-5358; Pollarolo, Giulia/0000-0002-7140-8981	Boehringer Ingelheim Foundation; Katholieke Universiteit Leuven; Fonds Wetenschappelijk Onderzook-Vlaanderen	Boehringer Ingelheim Foundation(Boehringer Ingelheim); Katholieke Universiteit Leuven(KU Leuven); Fonds Wetenschappelijk Onderzook-Vlaanderen	We would like to thank C. Gonzalez, F. Calderon de Anda, A. Gartner and F. Feiguin for discussions; M. Morgan for technical help and discussions; T. Lecuit and R. Levayer for sharing their adapted CALI protocol; and Y. Bellaiche (Curie Institute), H. Bellen (Baylor College of Medicine), C. Gonzalez (Institut de Recerca Biomedica, Barcelona), T.J.C. Harris (University of Toronto), S. Hayashi (RIKEN Center for Developmental Biology), Y. Hong (University of Pittsburgh), J. Knoblich (Institute of Molecular Biotechnology, Wien), H. Oda (JT Biohistory Research Hall, Takatsuki), M. Rolls (Pennsylvania State University), the Bloomington Drosophila Stock Center and the Developmental Studies Hybridoma Bank for providing us with stocks and reagents. G.P. was supported by a Boehringer Ingelheim Foundation scholarship. This work was supported by Katholieke Universiteit Leuven and Fonds Wetenschappelijk Onderzook-Vlaanderen.	Barnes AP, 2009, ANNU REV NEUROSCI, V32, P347, DOI 10.1146/annurev.neuro.31.060407.125536; Basto R, 2006, CELL, V125, P1375, DOI 10.1016/j.cell.2006.05.025; Berdnik D, 2002, CURR BIOL, V12, P640, DOI 10.1016/S0960-9822(02)00766-2; Carmena M, 2003, NAT REV MOL CELL BIO, V4, P842, DOI 10.1038/nrm1245; CHONG LD, 1994, CELL, V79, P507, DOI 10.1016/0092-8674(94)90259-3; de Anda FC, 2005, NATURE, V436, P704, DOI 10.1038/nature03811; de Anda FC, 2008, J CELL SCI, V121, P178, DOI 10.1242/jcs.023143; Dupin I, 2009, J CELL BIOL, V185, P779, DOI 10.1083/jcb.200812034; Emery G, 2005, CELL, V122, P763, DOI 10.1016/j.cell.2005.08.017; Emoto K, 2005, J BIOL CHEM, V280, P37901, DOI 10.1074/jbc.M504282200; Field SJ, 2005, CURR BIOL, V15, P1407, DOI 10.1016/j.cub.2005.06.059; Gao L, 2009, MOL BIOL CELL, V20, P2540, DOI 10.1091/mbc.E09-03-0194; Gervais L, 2008, DEVELOPMENT, V135, P3829, DOI 10.1242/dev.029009; Gho M, 1998, NATURE, V393, P178, DOI 10.1038/30265; Gho M, 1996, DEVELOPMENT, V122, P1673; Gho M, 1999, DEVELOPMENT, V126, P3573; HARTENSTEIN V, 1989, DEVELOPMENT, V107, P389; Hu CK, 2008, J CELL BIOL, V181, P195, DOI 10.1083/jcb.200711105; Huang J, 2009, P NATL ACAD SCI USA, V106, P8284, DOI 10.1073/pnas.0900641106; Kakihara K, 2008, MECH DEVELOP, V125, P325, DOI 10.1016/j.mod.2007.10.012; Keil TA, 1997, MICROSC RES TECHNIQ, V39, P506, DOI 10.1002/(SICI)1097-0029(19971215)39:6<506::AID-JEMT5>3.0.CO;2-B; Khazaei MR, 2009, J BIOL CHEM, V284, P33571, DOI 10.1074/jbc.M109.055897; Kondylis V, 2005, MOL BIOL CELL, V16, P4061, DOI 10.1091/mbc.E04-10-0938; Krahn MP, 2010, CURR BIOL, V20, P636, DOI 10.1016/j.cub.2010.01.065; Krummel MF, 2006, NAT IMMUNOL, V7, P1143, DOI 10.1038/ni1404; Lecuit T, 2007, NAT REV MOL CELL BIO, V8, P633, DOI 10.1038/nrm2222; Ling K, 2006, TRENDS CELL BIOL, V16, P276, DOI 10.1016/j.tcb.2006.03.007; Lu BW, 1998, CELL, V95, P225, DOI 10.1016/S0092-8674(00)81753-5; McGill MA, 2009, J CELL BIOL, V185, P787, DOI 10.1083/jcb.200812146; Menchon SA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024190; Monier B, 2010, NAT CELL BIOL, V12, P60, DOI 10.1038/ncb2005; Mori D, 2009, NAT CELL BIOL, V11, P1057, DOI 10.1038/ncb1919; Nelson WJ, 2003, NATURE, V422, P766, DOI 10.1038/nature01602; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; Oda H, 1999, DEV BIOL, V216, P406, DOI 10.1006/dbio.1999.9494; ODA H, 1994, DEV BIOL, V165, P716, DOI 10.1006/dbio.1994.1287; Peel N, 2007, CURR BIOL, V17, P834, DOI 10.1016/j.cub.2007.04.036; Piekny A, 2005, TRENDS CELL BIOL, V15, P651, DOI 10.1016/j.tcb.2005.10.006; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Rieger S, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000240; Rolls MM, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-7; Sahai E, 2002, NAT CELL BIOL, V4, P408, DOI 10.1038/ncb796; St Johnston D, 2010, CELL, V141, P757, DOI 10.1016/j.cell.2010.05.011; Stauffer TP, 1998, CURR BIOL, V8, P343, DOI 10.1016/S0960-9822(98)70135-6; Tahirovic S, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001644; Varmark H, 2007, CURR BIOL, V17, P1735, DOI 10.1016/j.cub.2007.09.031; Wong R, 2005, CURR BIOL, V15, P1401, DOI 10.1016/j.cub.2005.06.060; Wu H, 2007, MOL CELL, V28, P886, DOI 10.1016/j.molcel.2007.10.028; Yamada S, 2007, J CELL BIOL, V178, P517, DOI 10.1083/jcb.200701058; Yonemura S, 2010, NAT CELL BIOL, V12, P533, DOI 10.1038/ncb2055	50	59	60	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	2011	14	12					1525	U50		10.1038/nn.2976	http://dx.doi.org/10.1038/nn.2976			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	855EJ	22081156				2022-12-28	WOS:000297546300011
J	Wisotsky, Z; Medina, A; Freeman, E; Dahanukar, A				Wisotsky, Zev; Medina, Adriana; Freeman, Erica; Dahanukar, Anupama			Evolutionary differences in food preference rely on Gr64e, a receptor for glycerol	NATURE NEUROSCIENCE			English	Article							LABELLAR SUGAR RECEPTOR; DROSOPHILA-MELANOGASTER; CHEMOSENSORY RECEPTORS; GUSTATORY RECEPTORS; CELLULAR BASIS; BITTER TASTE; SWEET; PERCEPTION; RESPONSES; NEURONS	Very little is known about how stimuli that are typically not rich in sugars, such as beer, trigger attractive gustatory responses in Drosophila. We identified a member of the gustatory receptor family, Gr64e, as a receptor that is required for feeding preference for beer and other sources that have fermenting yeast. We found that Gr64e is required for neuronal and behavioral responses to glycerol, an abundant component of growing yeast and fermentation products. Ectopic expression of Gr64e in an olfactory neuron conferred responsiveness to glycerol. We also found that Drosophila species that are predicted to carry pseudogenes of Gr64e had reduced glycerol sensitivity. Our results provide insight into the molecular mechanisms of feeding acceptance of yeast products and raise the possibility that Gr64e contributes to specific evolutionary variations in appetitive selectivity across Drosophila species.	[Wisotsky, Zev; Dahanukar, Anupama] Univ Calif Riverside, Interdept Neurosci Program, Riverside, CA 92521 USA; [Medina, Adriana; Dahanukar, Anupama] Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA; [Freeman, Erica; Dahanukar, Anupama] Univ Calif Riverside, Bioengn Interdept Grad Program, Riverside, CA 92521 USA	University of California System; University of California Riverside; University of California System; University of California Riverside; University of California System; University of California Riverside	Dahanukar, A (corresponding author), Univ Calif Riverside, Interdept Neurosci Program, Riverside, CA 92521 USA.	anupama.dahanukar@ucr.edu		Dahanukar, Anupama/0000-0003-0534-7700	Whitehall Foundation [2010-12-42]; National Science Foundation Integrated Graduate Education Research and Training Program in Video Bioinformatics [DGE0903667]	Whitehall Foundation; National Science Foundation Integrated Graduate Education Research and Training Program in Video Bioinformatics	We thank W. Tom and A. Ray for help with olfactory single-sensillum recordings, K. Risser for initial behavioral analysis, members of the Dahanukar and Ray laboratories for helpful discussions, and A. Ray, S. Charlu and S. Siemens for comments on the manuscript. This research was supported in part by a Whitehall Foundation Research grant (2010-12-42, to A.D.) and a fellowship from the National Science Foundation Integrated Graduate Education Research and Training Program in Video Bioinformatics (DGE0903667 to E.F.)	Abuin L, 2011, NEURON, V69, P44, DOI 10.1016/j.neuron.2010.11.042; Amrein H, 2005, CURR BIOL, V15, pR673, DOI 10.1016/j.cub.2005.08.021; ANDRE L, 1991, FEBS LETT, V286, P13, DOI 10.1016/0014-5793(91)80930-2; Bamforth CW, 2005, J I BREWING, V111, P259, DOI 10.1002/j.2050-0416.2005.tb00681.x; Benton R, 2006, PLOS BIOL, V4, P240, DOI 10.1371/journal.pbio.0040020; Benton R, 2009, CELL, V136, P149, DOI 10.1016/j.cell.2008.12.001; Brandolini V, 2002, WORLD J MICROB BIOT, V18, P481, DOI 10.1023/A:1015574117335; COOPER DM, 1960, EVOLUTION, V14, P41, DOI 10.2307/2405921; DACUNHA AB, 1951, EVOLUTION, V5, P97, DOI 10.1111/j.1558-5646.1951.tb02766.x; DACUNHA AB, 1957, ECOLOGY, V38, P98, DOI 10.2307/1932131; Dahanukar A, 2001, NAT NEUROSCI, V4, P1182, DOI 10.1038/nn765; Dahanukar A, 2007, NEURON, V56, P503, DOI 10.1016/j.neuron.2007.10.024; de Bruyne M, 2001, NEURON, V30, P537, DOI 10.1016/S0896-6273(01)00289-6; DETHIER VG, 1955, Q REV BIOL, V30, P348, DOI 10.1086/401030; Dobritsa AA, 2003, NEURON, V37, P827, DOI 10.1016/S0896-6273(03)00094-1; DOBZHANSKY T, 1956, ECOLOGY, V37, P544, DOI 10.2307/1930178; FALK R, 1976, J MORPHOL, V150, P327, DOI 10.1002/jmor.1051500206; Fischler W, 2007, NATURE, V448, P1054, DOI 10.1038/nature06101; Gordesky-Gold B, 2008, CHEM SENSES, V33, P301, DOI 10.1093/chemse/bjm088; Hiroi M, 2004, J NEUROBIOL, V61, P333, DOI 10.1002/neu.20063; Hiroi M, 2002, ZOOL SCI, V19, P1009, DOI 10.2108/zsj.19.1009; Intelmann D, 2009, CHEMOSENS PERCEPT, V2, P118, DOI 10.1007/s12078-009-9049-1; Jiao Y, 2007, P NATL ACAD SCI USA, V104, P14110, DOI 10.1073/pnas.0702421104; Jiao YC, 2008, CURR BIOL, V18, P1797, DOI 10.1016/j.cub.2008.10.009; Jones WD, 2007, NATURE, V445, P86, DOI 10.1038/nature05466; Keller A, 2007, CURR BIOL, V17, pR77, DOI 10.1016/j.cub.2006.12.031; Kent LB, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-41; KLOPPER WJ, 1986, J I BREWING, V92, P225, DOI 10.1002/j.2050-0416.1986.tb04405.x; Koseki T, 2005, CHEM SENSES, V30, pI277, DOI 10.1093/chemse/bjh222; Koseki T, 2004, CHEM SENSES, V29, P703, DOI 10.1093/chemse/bjh075; Kwon JY, 2007, P NATL ACAD SCI USA, V104, P3574, DOI 10.1073/pnas.0700079104; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Lee Y, 2010, NEURON, V67, P555, DOI 10.1016/j.neuron.2010.07.006; Lee Y, 2009, P NATL ACAD SCI USA, V106, P4495, DOI 10.1073/pnas.0811744106; Li X, 2005, PLOS GENET, V1, P27, DOI 10.1371/journal.pgen.0010003; Marella S, 2006, NEURON, V49, P285, DOI 10.1016/j.neuron.2005.11.037; MATTICK LR, 1970, AM J ENOL VITICULT, V21, P213; Montell C, 2009, CURR OPIN NEUROBIOL, V19, P345, DOI 10.1016/j.conb.2009.07.001; Robertson HM, 2003, P NATL ACAD SCI USA, V100, P14537, DOI 10.1073/pnas.2335847100; Robertson Hugh M., 2009, Journal of Insect Science (Tucson), V9, P1; Romano P, 1997, J APPL MICROBIOL, V82, P615, DOI 10.1111/j.1365-2672.1997.tb03592.x; ROSINI G, 1982, MICROBIAL ECOL, V8, P83, DOI 10.1007/BF02011464; Scanes K. T., 1998, South African Journal for Enology and Viticulture, V19, P17; Slone J, 2007, CURR BIOL, V17, P1809, DOI 10.1016/j.cub.2007.09.027; STOCKER RF, 1994, CELL TISSUE RES, V275, P3, DOI 10.1007/BF00305372; Thorne N, 2004, CURR BIOL, V14, P1065, DOI 10.1016/j.cub.2004.05.019; Wang ZR, 2004, CELL, V117, P981, DOI 10.1016/j.cell.2004.06.011; Weiss LA, 2011, NEURON, V69, P258, DOI 10.1016/j.neuron.2011.01.001; WIECZOREK H, 1989, J COMP PHYSIOL A, V164, P825, DOI 10.1007/BF00616754; Yarmolinsky DA, 2009, CELL, V139, P234, DOI 10.1016/j.cell.2009.10.001	50	58	60	2	51	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2011	14	12					1534	U161		10.1038/nn.2944	http://dx.doi.org/10.1038/nn.2944			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	855EJ	22057190				2022-12-28	WOS:000297546300012
J	Kim, JI; Lee, HR; Sim, SE; Baek, J; Yu, NK; Choi, JH; Ko, HG; Lee, YS; Park, SW; Kwak, C; Ahn, SJ; Choi, SY; Kim, H; Kim, KH; Backx, PH; Bradley, CA; Kim, E; Jang, DJ; Lee, K; Kim, SJ; Zhuo, M; Collingridge, GL; Kaang, BK				Kim, Jae-Ick; Lee, Hye-Ryeon; Sim, Su-eon; Baek, Jinhee; Yu, Nam-Kyung; Choi, Jun-Hyeok; Ko, Hyoung-Gon; Lee, Yong-Seok; Park, Soo-Won; Kwak, Chuljung; Ahn, Sung-Ji; Choi, So Yoen; Kim, Hyun; Kim, Kyoung-Han; Backx, Peter H.; Bradley, Clarrisa A.; Kim, Eunjoon; Jang, Deok-Jin; Lee, Kyungmin; Kim, Sang Jeong; Zhuo, Min; Collingridge, Graham L.; Kaang, Bong-Kiun			PI3K gamma is required for NMDA receptor-dependent long-term depression and behavioral flexibility	NATURE NEUROSCIENCE			English	Article							D-ASPARTATE RECEPTOR; SYNAPTIC PLASTICITY; PHOSPHATIDYLINOSITOL 3-KINASE; PHOSPHOINOSITIDE 3-KINASE; NOVELTY ACQUISITION; SIGNALING PATHWAY; IN-VITRO; KINASE; MEMORY; POTENTIATION	Phosphatidylinositol 3-kinase (PI3K) has been implicated in synaptic plasticity and other neural functions in the brain. However, the role of individual PI3K isoforms in the brain is unclear. We investigated the role of PI3K gamma in hippocampal-dependent synaptic plasticity and cognitive functions. We found that PI3K gamma has a crucial and specific role in NMDA receptor (NMDAR)-mediated synaptic plasticity at mouse Schaffer collateral-commissural synapses. Both genetic deletion and pharmacological inhibition of PI3K gamma disrupted NMDAR long-term depression (LTD) while leaving other forms of synaptic plasticity intact. Accompanying this physiological deficit, the impairment of NMDAR LTD by PI3K gamma blockade was specifically correlated with deficits in behavioral flexibility. These findings suggest that a specific PI3K isoform, PI3K gamma, is critical for NMDAR LTD and some forms of cognitive function. Thus, individual isoforms of PI3Ks may have distinct roles in different types of synaptic plasticity and may therefore influence various kinds of behavior.	[Kim, Jae-Ick; Lee, Hye-Ryeon; Sim, Su-eon; Baek, Jinhee; Yu, Nam-Kyung; Choi, Jun-Hyeok; Ko, Hyoung-Gon; Lee, Yong-Seok; Park, Soo-Won; Kwak, Chuljung; Kaang, Bong-Kiun] Seoul Natl Univ, Coll Nat Sci, Natl Creat Res Initiat Ctr Memory, Dept Biol Sci, Seoul 151742, South Korea; [Sim, Su-eon; Bradley, Clarrisa A.; Kim, Sang Jeong; Zhuo, Min; Collingridge, Graham L.; Kaang, Bong-Kiun] Seoul Natl Univ, Coll Nat Sci, Dept Brain & Cognit Sci, Seoul 151742, South Korea; [Ahn, Sung-Ji; Kim, Sang Jeong] Seoul Natl Univ, Coll Med, Dept Physiol, Seoul, South Korea; [Choi, So Yoen; Kim, Hyun] Korea Univ, Coll Med, Dept Anat, Seoul 136705, South Korea; [Kim, Kyoung-Han; Backx, Peter H.; Zhuo, Min] Univ Toronto, Fac Med, Dept Physiol, Toronto, ON M5S 1A8, Canada; [Kim, Eunjoon] Korea Adv Inst Sci & Technol, Dept Biol Sci, Natl Creat Res Initiat Ctr Synaptogenesis, Taejon 305701, South Korea; [Jang, Deok-Jin] Kyungpook Natl Univ, Coll Ecol & Environm, Dept Appl Biol, Sangju Si, Kyeongbuk, South Korea; [Lee, Kyungmin] Kyungpook Natl Univ, Sch Med, Dept Anat, Taegu, South Korea; [Collingridge, Graham L.] Sch Physiol & Pharmacol, MRC Ctr Synapt Plast, Bristol, Avon, England	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Korea University; Korea University Medicine (KU Medicine); University of Toronto; Korea Advanced Institute of Science & Technology (KAIST); Kyungpook National University; Kyungpook National University; University of Bristol	Kaang, BK (corresponding author), Seoul Natl Univ, Coll Nat Sci, Natl Creat Res Initiat Ctr Memory, Dept Biol Sci, Seoul 151742, South Korea.	kaang@snu.ac.kr	collingridge, graham/AAI-8362-2020; Kim, Eunjoon/C-1566-2011; Kim, Sang Jeong/J-2740-2012; Kim, Jae-Ick/AAY-6005-2020; Kim, Jae-Ick/R-4007-2017; Zhuo, Min/A-2072-2008; Lee, Yong Seok/J-5587-2012; Collingridge, Graham L/C-4605-2015; Lee, Kyungmin/ABC-5624-2020; Lee, Kyungmin/AAH-9165-2020; Choi, So Yoen/AAV-1947-2020; Kim, Kyoung-Han/AAZ-4908-2021	Kim, Jae-Ick/0000-0001-9705-0394; Zhuo, Min/0000-0001-9062-3241; Collingridge, Graham L/0000-0002-9572-5359; Lee, Kyungmin/0000-0002-5425-4212; Ahn, Sung Ji/0000-0001-8836-8069; Baek, Jinhee/0000-0002-0998-0047; Kim, Kyoung-Han/0000-0002-0433-656X; Kim, Sang Jeong/0000-0001-8931-3713; Kim, Hyun/0000-0002-7210-5798; Ko, Hyoung-Gon/0000-0002-7730-6986; Park, Soowon/0000-0002-3348-940X	Korean Ministry of Science and Technology; World Class University; BK21 fellowship; Seoul Science fellowship; Canadian Institutes of Health Research [62954]; MRC [G0601813] Funding Source: UKRI; Medical Research Council [G0601813] Funding Source: researchfish	Korean Ministry of Science and Technology(Ministry of Science & Technology (MOST), Republic of Korea); World Class University; BK21 fellowship(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea); Seoul Science fellowship; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Creative Research Initiatives Program of the Korean Ministry of Science and Technology and World Class University project. J.-I.K. and H.-R.L. are supported by a BK21 fellowship and Seoul Science fellowship. S.-E. S. and J.B. are supported by a BK21 fellowship. P. H. B. is a Career Investigator of the Heart and Stroke Foundation of Ontario and has support from a Canadian Institutes of Health Research grant (62954). B.-K.K. is a Yonam Foundation Scholar. G. L. C. and M.Z. are WCU International Scholars.	Barros DM, 2001, BEHAV PHARMACOL, V12, P629, DOI 10.1097/00008877-200112000-00007; Bartlett SE, 1999, J NEUROSCI RES, V56, P44, DOI 10.1002/(SICI)1097-4547(19990401)56:1<44::AID-JNR6>3.0.CO;2-6; Bernstein HG, 1998, CELL MOL BIOL, V44, P973; Bondev A, 1999, BIOL CHEM, V380, P1337, DOI 10.1515/BC.1999.171; Bos JL, 2001, NAT REV MOL CELL BIO, V2, P369, DOI 10.1038/35073073; Camps M, 2005, NAT MED, V11, P936, DOI 10.1038/nm1284; Carpenter CL, 1996, CURR OPIN CELL BIOL, V8, P153, DOI 10.1016/S0955-0674(96)80060-3; Chen X, 2005, NAT NEUROSCI, V8, P925, DOI 10.1038/nn1482; Collingridge GL, 2010, NAT REV NEUROSCI, V11, P459, DOI 10.1038/nrn2867; Daw MI, 2002, NAT NEUROSCI, V5, P835, DOI 10.1038/nn903; DHAND R, 1994, EMBO J, V13, P522, DOI 10.1002/j.1460-2075.1994.tb06290.x; Etkin A, 2006, NEURON, V50, P127, DOI 10.1016/j.neuron.2006.03.013; Hansel C, 2001, NAT NEUROSCI, V4, P467, DOI 10.1038/87419; Hawkins PT, 2006, BIOCHEM SOC T, V34, P647, DOI 10.1042/BST0340647; Hayakawa M, 2006, BIOORGAN MED CHEM, V14, P6847, DOI 10.1016/j.bmc.2006.06.046; Hayer S, 2009, FASEB J, V23, P4288, DOI 10.1096/fj.09-135160; Hisatsune C, 1999, GENES CELLS, V4, P657, DOI 10.1046/j.1365-2443.1999.00287.x; Horwood JM, 2006, EUR J NEUROSCI, V23, P3375, DOI 10.1111/j.1460-9568.2006.04859.x; Hou LF, 2004, J NEUROSCI, V24, P6352, DOI 10.1523/JNEUROSCI.0995-04.2004; Husi H, 2000, NAT NEUROSCI, V3, P661, DOI 10.1038/76615; Jin YJ, 2007, NEURON, V55, P277, DOI 10.1016/j.neuron.2007.06.035; Kang H, 2010, P NATL ACAD SCI USA, V107, P12901, DOI 10.1073/pnas.1001499107; Kelly A, 2000, NEUROPHARMACOLOGY, V39, P643, DOI 10.1016/S0028-3908(99)00169-0; Kemp A, 2004, P NATL ACAD SCI USA, V101, P8192, DOI 10.1073/pnas.0402650101; Kerfant EG, 2006, TRENDS CARDIOVAS MED, V16, P250, DOI 10.1016/j.tcm.2006.04.006; Lin CH, 2001, NEURON, V31, P841, DOI 10.1016/S0896-6273(01)00433-0; Liu LD, 2004, SCIENCE, V304, P1021, DOI 10.1126/science.1096615; Manahan-Vaughan D, 1999, P NATL ACAD SCI USA, V96, P8739, DOI 10.1073/pnas.96.15.8739; Mizuno M, 2003, MOL PSYCHIATR, V8, P217, DOI 10.1038/sj.mp.4001215; Morishita W, 1997, J NEUROSCI, V17, P941; Nicholls RE, 2008, NEURON, V58, P104, DOI 10.1016/j.neuron.2008.01.039; Opazo P, 2003, J NEUROSCI, V23, P3679; Oudit GY, 2004, J MOL CELL CARDIOL, V37, P449, DOI 10.1016/j.yjmcc.2004.05.015; Peineau S, 2007, NEURON, V53, P703, DOI 10.1016/j.neuron.2007.01.029; Peineau S, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-22; Ran I, 2009, J NEUROSCI, V29, P5605, DOI 10.1523/JNEUROSCI.5355-08.2009; Sanna PP, 2002, J NEUROSCI, V22, P3359; Sasaki T, 2000, SCIENCE, V287, P1040, DOI 10.1126/science.287.5455.1040; SELBACH O, 2009, ACTA PHYSL OXF, V198, P277; Toker A, 1997, NATURE, V387, P673, DOI 10.1038/42648; van der Heide LP, 2005, J NEUROCHEM, V94, P1158, DOI 10.1111/j.1471-4159.2005.03269.x; Vanhaesebroeck B, 2010, NAT REV MOL CELL BIO, V11, P329, DOI 10.1038/nrm2882; Wong TP, 2007, P NATL ACAD SCI USA, V104, P11471, DOI 10.1073/pnas.0702308104; Wymann MP, 1998, BBA-MOL CELL BIOL L, V1436, P127, DOI 10.1016/S0005-2760(98)00139-8; Yamboliev IA, 2000, AM J PHYSIOL-CELL PH, V279, pC352, DOI 10.1152/ajpcell.2000.279.2.C352; Zeng HK, 2001, CELL, V107, P617, DOI 10.1016/S0092-8674(01)00585-2; Zhu JJ, 2002, CELL, V110, P443, DOI 10.1016/S0092-8674(02)00897-8; Zhu YH, 2005, NEURON, V46, P905, DOI 10.1016/j.neuron.2005.04.037; Zhuo M, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-4	50	108	109	0	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2011	14	11					1447	U123		10.1038/nn.2937	http://dx.doi.org/10.1038/nn.2937			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	841NI	22019731				2022-12-28	WOS:000296518600021
J	Bromberg-Martin, ES; Hikosaka, O				Bromberg-Martin, Ethan S.; Hikosaka, Okihide			Lateral habenula neurons signal errors in the prediction of reward information	NATURE NEUROSCIENCE			English	Article							MIDBRAIN DOPAMINE NEURONS; OBSERVING RESPONSES; STIMULATION; UNCERTAINTY; ACQUISITION; ENCODE; DECISIONS; CORTEX	Humans and animals have the ability to predict future events, which they cultivate by continuously searching their environment for sources of predictive information. However, little is known about the neural systems that motivate this behavior. We hypothesized that information-seeking is assigned value by the same circuits that support reward-seeking, such that neural signals encoding reward prediction errors (RPEs) include analogous information prediction errors (IPEs). To test this, we recorded from neurons in the lateral habenula, a nucleus that encodes RPEs, while monkeys chose between cues that provided different chances to view information about upcoming rewards. We found that a subpopulation of lateral habenula neurons transmitted signals resembling IPEs, responding when reward information was unexpectedly cued, delivered or denied. These signals evaluated information sources reliably, even when the monkey's decisions did not. These neurons could provide a common instructive signal for reward-seeking and information-seeking behavior.	[Bromberg-Martin, Ethan S.; Hikosaka, Okihide] NEI, Sensorimotor Res Lab, US Natl Inst Hlth, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Bromberg-Martin, ES (corresponding author), NEI, Sensorimotor Res Lab, US Natl Inst Hlth, Bldg 10, Bethesda, MD 20892 USA.	bromberge@mail.nih.gov			National Eye Institute; NATIONAL EYE INSTITUTE [ZIAEY000415] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank M. Matsumoto, S. Hong, I. Monosov, M. Yasuda, S. Yamamoto, Y. Tachibana, H. Kim and D. Lee for valuable discussions. This work was supported by the intramural research program at the National Eye Institute.	Bayer HM, 2005, NEURON, V47, P129, DOI 10.1016/j.neuron.2005.05.020; Beierholm U.R., 2010, PLOS COMPUT BIOL, V6, P9; Bromberg-Martin ES, 2010, NEURON, V68, P815, DOI 10.1016/j.neuron.2010.11.022; Bromberg-Martin ES, 2010, NEURON, V67, P499, DOI 10.1016/j.neuron.2010.06.031; Bromberg-Martin ES, 2009, NEURON, V63, P119, DOI 10.1016/j.neuron.2009.06.009; Butko NJ, 2010, IEEE T AUTON MENT DE, V2, P91, DOI 10.1109/TAMD.2010.2051029; Caplin A, 2001, Q J ECON, V116, P55, DOI 10.1162/003355301556347; CHEW SH, 1994, J RISK UNCERTAINTY, V8, P267, DOI 10.1007/BF01064045; CHRISTOPH GR, 1986, J NEUROSCI, V6, P613; DALY HB, 1992, LEARNING AND MEMORY : THE BEHAVIORAL AND BIOLOGICAL SUBSTRATES, P81; Daw ND, 2006, NATURE, V441, P876, DOI 10.1038/nature04766; DINSMOOR JA, 1983, BEHAV BRAIN SCI, V6, P693, DOI 10.1017/S0140525X00017969; Doya K, 2002, NEURAL NETWORKS, V15, P495, DOI 10.1016/S0893-6080(02)00044-8; Eliaz K, 2007, AM ECON REV, V97, P166, DOI 10.1257/aer.97.2.166; Fantino E., 1977, HDB OPERANT BEHAV; Friedman A, 2011, NEUROPHARMACOLOGY, V60, P381, DOI 10.1016/j.neuropharm.2010.10.006; Hayden BY, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00166; Hikosaka O, 2010, NAT REV NEUROSCI, V11, P503, DOI 10.1038/nrn2866; Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI 10.1037/0033-295X.109.4.679; Hong S, 2008, NEURON, V60, P720, DOI 10.1016/j.neuron.2008.09.035; Houk JC, 1995, MODELS INFORMATION P, P249; Ikemoto S, 2010, NEUROSCI BIOBEHAV R, V35, P129, DOI 10.1016/j.neubiorev.2010.02.001; Ji HF, 2007, J NEUROSCI, V27, P6923, DOI 10.1523/JNEUROSCI.0958-07.2007; Joshua M, 2009, CURR OPIN NEUROBIOL, V19, P615, DOI 10.1016/j.conb.2009.10.001; Kim H, 2009, J NEUROSCI, V29, P14701, DOI 10.1523/JNEUROSCI.2728-09.2009; KREPS DM, 1978, ECONOMETRICA, V46, P185, DOI 10.2307/1913656; Lecourtier L, 2008, EUR J NEUROSCI, V27, P1755, DOI 10.1111/j.1460-9568.2008.06130.x; Luhmann CC, 2008, J NEUROSCI, V28, P14459, DOI 10.1523/JNEUROSCI.5058-08.2008; Matsumoto M, 2007, NAT NEUROSCI, V10, P647, DOI 10.1038/nn1890; Matsumoto M, 2007, NATURE, V447, P1111, DOI 10.1038/nature05860; Matsumoto M, 2009, NATURE, V459, P837, DOI 10.1038/nature08028; Matsumoto M, 2009, NAT NEUROSCI, V12, P77, DOI 10.1038/nn.2233; McClure SM, 2003, NEURON, V38, P339, DOI 10.1016/S0896-6273(03)00154-5; Morris G, 2006, NAT NEUROSCI, V9, P1057, DOI 10.1038/nn1743; Nakamura K, 2008, J NEUROSCI, V28, P5331, DOI 10.1523/JNEUROSCI.0021-08.2008; O'Doherty JP, 2003, NEURON, V38, P329, DOI 10.1016/S0896-6273(03)00169-7; Oyama K, 2010, J NEUROSCI, V30, P11447, DOI 10.1523/JNEUROSCI.1719-10.2010; PROKASY WF, 1956, J COMP PHYSIOL PSYCH, V49, P131, DOI 10.1037/h0046740; Ranade SP, 2009, J NEUROPHYSIOL, V102, P3026, DOI 10.1152/jn.00507.2009; Redgrave P, 2006, NAT REV NEUROSCI, V7, P967, DOI 10.1038/nrn2022; Rescorla R.A., 1972, CLASSICAL CONDITION, P64, DOI DOI 10.1101/GR.110528.110; Roesch MR, 2007, NAT NEUROSCI, V10, P1615, DOI 10.1038/nn2013; Salas R, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00036; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Seo H, 2007, J NEUROSCI, V27, P8366, DOI 10.1523/JNEUROSCI.2369-07.2007; Shumake J, 2010, J NEUROSCI, V30, P5876, DOI 10.1523/JNEUROSCI.3604-09.2010; SUTHERLAND RJ, 1981, J COMP PHYSIOL PSYCH, V95, P781, DOI 10.1037/h0077833; WARD EF, 1971, PSYCHON SCI, V24, P139, DOI 10.3758/BF03331790; WYCKOFF LB, 1952, PSYCHOL REV, V59, P431, DOI 10.1037/h0053932; WYCKOFF LB, 1959, PSYCHOL REV, V66, P68, DOI 10.1037/h0046882	50	159	159	0	20	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2011	14	9					1209	U149		10.1038/nn.2902	http://dx.doi.org/10.1038/nn.2902			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	812ID	21857659	Green Accepted			2022-12-28	WOS:000294284900023
J	Chakrabarty, P; Ceballos-Diaz, C; Lin, WL; Beccard, A; Jansen-West, K; McFarland, NR; Janus, C; Dickson, D; Das, P; Golde, TE				Chakrabarty, Paramita; Ceballos-Diaz, Carolina; Lin, Wen-Lang; Beccard, Amanda; Jansen-West, Karen; McFarland, Nikolaus R.; Janus, Christopher; Dickson, Dennis; Das, Pritam; Golde, Todd E.			Interferon-gamma induces progressive nigrostriatal degeneration and basal ganglia calcification	NATURE NEUROSCIENCE			English	Article							TRANSGENIC MICE; CALCINOSIS; EXPRESSION	We found that CNS-directed expression of interferon-gamma (IFN-gamma) resulted in basal ganglia calcification, reminiscent of human idiopathic basal ganglia calcification (IBGC), and nigrostriatal degeneration. Our results indicate that IFN-gamma mediates age-progressive nigrostriatal degeneration in the absence of exogenous stressors. Further study of this model may provide insight into selective nigrostriatal degeneration in human IBGC and other Parkinson syndromes.	[Chakrabarty, Paramita; Ceballos-Diaz, Carolina; Beccard, Amanda; Janus, Christopher; Golde, Todd E.] Univ Florida, Dept Neurosci, Ctr Translat Res Neurodegenerat Dis, Gainesville, FL 32610 USA; [Lin, Wen-Lang; Jansen-West, Karen; Dickson, Dennis; Das, Pritam] Mayo Clin, Coll Med, Dept Neurosci, Jacksonville, FL 32224 USA; [McFarland, Nikolaus R.] Univ Florida, Dept Neurol, Gainesville, FL 32610 USA	State University System of Florida; University of Florida; Mayo Clinic; State University System of Florida; University of Florida	Golde, TE (corresponding author), Univ Florida, Dept Neurosci, Ctr Translat Res Neurodegenerat Dis, Gainesville, FL 32610 USA.	tgolde@mbi.ufl.edu	McFarland, Nikolaus R/I-4209-2017	McFarland, Nikolaus R/0000-0002-8699-8857; Dickson, Dennis W/0000-0001-7189-7917	US National Institutes of Health/National Institute on Aging; Ellison Medical Foundation; American Health Assistance Foundation; NATIONAL INSTITUTE ON AGING [R01AG029886, R01AG018454, P01AG025531] Funding Source: NIH RePORTER	US National Institutes of Health/National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Ellison Medical Foundation(Lawrence Ellison Foundation); American Health Assistance Foundation(BrightFocus Foundation); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the US National Institutes of Health/National Institute on Aging (T.E.G.), the Ellison Medical Foundation (T.E.G.) and American Health Assistance Foundation (P.D.).	Baba Y, 2005, MAYO CLIN PROC, V80, P641, DOI 10.4065/80.5.641; Chakrabarty P, 2010, J IMMUNOL, V184, P5333, DOI 10.4049/jimmunol.0903382; Chakrabarty P, 2010, FASEB J, V24, P548, DOI 10.1096/fj.09-141754; Corbin JG, 1996, MOL CELL NEUROSCI, V7, P354, DOI 10.1006/mcne.1996.0026; Devos D, 2010, FUND CLIN PHARMACOL, V24, P407, DOI 10.1111/j.1472-8206.2009.00798.x; Frank-Cannon TC, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-47; Horwitz MS, 1997, NAT MED, V3, P1037, DOI 10.1038/nm0997-1037; Jang H, 2009, BBA-MOL BASIS DIS, V1792, P714, DOI 10.1016/j.bbadis.2008.08.001; Manyam BV, 2001, MOVEMENT DISORD, V16, P258, DOI 10.1002/mds.1049; Morishima T, 2002, EUR J NEUROL, V9, P521, DOI 10.1046/j.1468-1331.2002.00449.x; Mount MP, 2007, J NEUROSCI, V27, P3328, DOI 10.1523/JNEUROSCI.5321-06.2007; Paschali A, 2009, CLIN NUCL MED, V34, P421, DOI 10.1097/RLU.0b013e3181a7d195; Savoldi F, 1980, Acta Neurol (Napoli), V2, P231; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Shelton GD, 1999, MUSCLE NERVE, V22, P156, DOI 10.1002/(SICI)1097-4598(199902)22:2<156::AID-MUS3>3.0.CO;2-U	15	53	55	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2011	14	6					694	696		10.1038/nn.2829	http://dx.doi.org/10.1038/nn.2829			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	768SH	21572432	Green Accepted			2022-12-28	WOS:000290958000010
J	Wang, GJ; Kang, LJ; Kim, JE; Maro, GS; Xu, XZS; Shen, K				Wang, George J.; Kang, Lijun; Kim, Julie E.; Maro, Geraldine S.; Xu, X. Z. Shawn; Shen, Kang			GRLD-1 regulates cell-wide abundance of glutamate receptor through post-transcriptional regulation	NATURE NEUROSCIENCE			English	Article							CAENORHABDITIS-ELEGANS; NERVOUS-SYSTEM; EXPRESSION; SHARP; EXPORT; LOCALIZATION; TRANSLATION; COMPONENT; PROTEINS; CURRENTS	AMPA receptors mediate most of the fast postsynaptic response at glutamatergic synapses. The abundance of AMPA receptors in neurons and at postsynaptic membranes is tightly regulated. It has been suggested that changes in synaptic AMPA receptor levels are an important regulatory event in synaptic plasticity and learning and memory. Although the local, synapse-specific regulation of AMPA receptors has been intensely studied, global, cell-wide control is less well understood. Using a forward genetic approach, we identified glutamate receptor level decreased-1 (GRLD-1), a putative RNA-binding protein that was required for efficient production of GLR-1 in the AVE interneurons in the nematode Caenorhabditis elegans. In grld-1 mutants, GLR-1 levels were markedly reduced. Consistently, glutamate-induced currents in AVE were diminished and glr-1-dependent nose-touch avoidance behavior was defective in grld-1 mutants. We propose that this evolutionarily conserved family of proteins controls the abundance of GLR-1 by regulating glr-1 transcript splicing.	[Wang, George J.; Kim, Julie E.; Maro, Geraldine S.; Shen, Kang] Stanford Univ, Dept Biol, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Kang, Lijun; Xu, X. Z. Shawn] Univ Michigan, Life Sci Inst, Ann Arbor, MI 48109 USA; [Kang, Lijun; Xu, X. Z. Shawn] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA	Howard Hughes Medical Institute; Stanford University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Shen, K (corresponding author), Stanford Univ, Dept Biol, Howard Hughes Med Inst, Stanford, CA 94305 USA.	kangshen@stanford.edu		KANG, Lijun/0000-0001-9939-5134	Human Frontier Science Foundation; W.M. Keck Foundation; Howard Hughes Medical Institute; Pew Scholar Award; US National Institutes of Health; National Science Foundation; Burt and Deedee McMurtry Stanford Graduate Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078276, R01GM083241] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048392] Funding Source: NIH RePORTER	Human Frontier Science Foundation(Human Frontier Science Program); W.M. Keck Foundation(W.M. Keck Foundation); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Pew Scholar Award; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Burt and Deedee McMurtry Stanford Graduate Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the International Caenorhabditis Genetic Center for worm strains and the Antebi, Bargmann, Kaplan and Sengupta laboratories for strains and constructs. We also thank Q. Hu, C. Gao, F. Chen and Y. Fu for assistance and members of the Shen laboratory for comments on the manuscript. This work was supported by grants from the Human Frontier Science Foundation, the W.M. Keck Foundation and the Howard Hughes Medical Institute to K.S., the Pew Scholar Award and the US National Institutes of Health to X.Z.S.X. and the National Science Foundation Graduate Research Fellowship Program and the Burt and Deedee McMurtry Stanford Graduate Fellowship to G.J.W.	Bolognani F, 2008, J NEUROSCI RES, V86, P481, DOI 10.1002/jnr.21473; Brockie PJ, 2001, NEURON, V31, P617, DOI 10.1016/S0896-6273(01)00394-4; Brockie PJ, 2001, J NEUROSCI, V21, P1510, DOI 10.1523/JNEUROSCI.21-05-01510.2001; BROCKIE PJ, 2006, WORMBOOK, DOI DOI 10.1895/WORMB00K.1.61.1; Burbea M, 2002, NEURON, V35, P107, DOI 10.1016/S0896-6273(02)00749-3; Chang JL, 2008, DEV BIOL, V314, P100, DOI 10.1016/j.ydbio.2007.11.023; Fei YJ, 2000, J BIOL CHEM, V275, P9563, DOI 10.1074/jbc.275.13.9563; Feng Y, 2007, CANCER RES, V67, P482, DOI 10.1158/0008-5472.CAN-06-2314; Girard LR, 2007, NUCLEIC ACIDS RES, V35, pD472, DOI 10.1093/nar/gkl894; Goodman MB, 1998, NEURON, V20, P763, DOI 10.1016/S0896-6273(00)81014-4; Grunwald ME, 2004, P NATL ACAD SCI USA, V101, P3190, DOI 10.1073/pnas.0306156101; HART AC, 1995, NATURE, V378, P82, DOI 10.1038/378082a0; Hiriart E, 2005, J BIOL CHEM, V280, P36935, DOI 10.1074/jbc.M501725200; Jemc J, 2006, GENETICS, V173, P279, DOI 10.1534/genetics.106.055558; Johns L, 2007, MOL CELL BIOL, V27, P5630, DOI 10.1128/MCB.00410-07; Juo P, 2004, CURR BIOL, V14, P2057, DOI 10.1016/j.cub.2004.11.010; KOLODZIEJ PA, 1995, NEURON, V15, P273, DOI 10.1016/0896-6273(95)90033-0; Kuang B, 2000, DEVELOPMENT, V127, P1517; Kuroda K, 2003, IMMUNITY, V18, P301, DOI 10.1016/S1074-7613(03)00029-3; Le Hir H, 2003, TRENDS BIOCHEM SCI, V28, P215, DOI 10.1016/S0968-0004(03)00052-5; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Lindtner S, 2006, J BIOL CHEM, V281, P36915, DOI 10.1074/jbc.M608745200; Ludewig AH, 2004, GENE DEV, V18, P2120, DOI 10.1101/gad.312604; Ma XY, 2007, MOL CELL BIOL, V27, P3056, DOI 10.1128/MCB.01339-06; Maghsoodi B, 2008, P NATL ACAD SCI USA, V105, P16015, DOI 10.1073/pnas.0804801105; MARICQ AV, 1995, NATURE, V378, P78, DOI 10.1038/378078a0; Maris C, 2005, FEBS J, V272, P2118, DOI 10.1111/j.1742-4658.2005.04653.x; Mello C, 1995, METHOD CELL BIOL, V48, P451; Merritt C, 2008, CURR BIOL, V18, P1476, DOI 10.1016/j.cub.2008.08.013; Moore MJ, 2009, CELL, V136, P688, DOI 10.1016/j.cell.2009.02.001; Mu YY, 2003, NEURON, V40, P581, DOI 10.1016/S0896-6273(03)00676-7; Oswald F, 2002, EMBO J, V21, P5417, DOI 10.1093/emboj/cdf549; Paganoni S, 2003, J NEUROSCI RES, V73, P429, DOI 10.1002/jnr.10674; Poon VY, 2008, NATURE, V455, P669, DOI 10.1038/nature07291; Richmond JE, 1999, NAT NEUROSCI, V2, P791, DOI 10.1038/12160; Riddle DL, 1997, C ELEGANS; Rongo C, 1999, NATURE, V402, P195, DOI 10.1038/46065; Rongo C, 1998, CELL, V94, P751, DOI 10.1016/S0092-8674(00)81734-1; Shepherd JD, 2007, ANNU REV CELL DEV BI, V23, P613, DOI 10.1146/annurev.cellbio.23.090506.123516; Shi YH, 2001, GENE DEV, V15, P1140, DOI 10.1101/gad.871201; Sieburth D, 2005, NATURE, V436, P510, DOI 10.1038/nature03809; STRINGHAM EG, 1992, MOL BIOL CELL, V3, P221, DOI 10.1091/mbc.3.2.221; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; Tursun B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004625; Wang D, 2005, NATURE, V436, P593, DOI 10.1038/nature04010; Ward A, 2008, NAT NEUROSCI, V11, P916, DOI 10.1038/nn.2155; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Yabe D, 2007, GENESIS, V45, P300, DOI 10.1002/dvg.20296; Zheng Y, 2004, NATURE, V427, P451, DOI 10.1038/nature02244; Zhou ZL, 2002, NATURE, V419, P182, DOI 10.1038/nature01031	50	6	9	0	3	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2010	13	12					1489	U71		10.1038/nn.2667	http://dx.doi.org/10.1038/nn.2667			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	684CW	21037582	Green Accepted			2022-12-28	WOS:000284525800013
J	Silies, M; Klambt, C				Silies, Marion; Klaembt, Christian			APC/C-Fzr/Cdh1-dependent regulation of cell adhesion controls glial migration in the Drosophila PNS	NATURE NEUROSCIENCE			English	Article							ANAPHASE-PROMOTING COMPLEX; FASCICLIN-II; PERIPHERAL GLIA; NEURONAL MIGRATION; DIFFERENT ISOFORMS; POLYSIALIC ACID; MITOTIC CYCLINS; NERVOUS-SYSTEM; EMBRYONIC CNS; MOLECULE	Interactions between neurons and glia are a key feature during the assembly of the nervous system. During development, glial cells often follow extending axons, implying that axonal outgrowth and glial migration are precisely coordinated. We found that the anaphase-promoting complex/cyclosome (APC/C) co-activator fizzy-related/Cdh1 (Fzr/Cdh1) is involved in the non-autonomous control of peripheral glial migration in postmitotic Drosophila neurons. APC/C-Fzr/Cdh1 is a cell-cycle regulator that targets proteins that are required for G1 arrest for ubiquitination and subsequent degradation. We found that Fzr/Cdh1 function is mediated by the immunoglobulin superfamily cell adhesion molecule Fasciclin2 (Fas2). In motor neurons Fzr/Cdh1 is crucial for the establishment of a graded axonal distribution of Fas2. Axonal Fas2 interacts homophilically with a glial isoform of Fas2. Glial migration is initiated along axonal segments that have low levels of Fas2 but stalls in axonal domains with high levels of Fas2 on their surfaces. This represents a simple mechanism by which a subcellular gradient of adhesiveness can coordinate glial migration with axonal growth.	[Silies, Marion; Klaembt, Christian] Univ Munster, Inst Neurobiol, Munster, Germany	University of Munster	Klambt, C (corresponding author), Univ Munster, Inst Neurobiol, Munster, Germany.	klaembt@uni-muenster.de			Klambt lab; Boehringer Ingelheim Fonds; Deutsche Forschungsgemeinschaft	Klambt lab; Boehringer Ingelheim Fonds(Boehringer Ingelheim); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank C. Lehner, J. Raff, B. Altenhein, T. Orr-Weaver, G. Tear, K. Basler, M. Landgraf and A. Nose for flies and antibodies; T. Hummel, E. Raz, A. Puschel and T. R. Clandinin for comments on the manuscript; G. Edenfeld, K. Krukkert, N. Otto, A. Weinbrecht and H. Neuert for help with initial experiments; J. Lipp for help with statistical analysis; and members of the Klambt lab for support and discussions. This work was supported by a PhD fellowship of the Boehringer Ingelheim Fonds to M. S. and grants of the Deutsche Forschungsgemeinschaft to C.K.	Ango F, 2004, CELL, V119, P257, DOI 10.1016/j.cell.2004.10.004; BASTIANI MJ, 1987, CELL, V48, P745, DOI 10.1016/0092-8674(87)90072-9; Berger C, 2007, DEV DYNAM, V236, P3562, DOI 10.1002/dvdy.21372; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; Buszczak M, 2007, GENETICS, V175, P1505, DOI 10.1534/genetics.106.065961; Cavallaro U, 2001, NAT CELL BIOL, V3, P650, DOI 10.1038/35083041; CREMER H, 1994, NATURE, V367, P455, DOI 10.1038/367455a0; Diestel S, 2007, J CELL SCI, V120, P4035, DOI 10.1242/jcs.019729; DODD J, 1988, NEURON, V1, P105, DOI 10.1016/0896-6273(88)90194-8; Edenfeld G, 2007, DEV BIOL, V301, P27, DOI 10.1016/j.ydbio.2006.11.013; Edenfeld G, 2006, NEURON, V52, P969, DOI 10.1016/j.neuron.2006.10.029; Franzdottir SR, 2009, NATURE, V460, P758, DOI 10.1038/nature08167; Freeman MR, 2003, NEURON, V38, P567, DOI 10.1016/S0896-6273(03)00289-7; Freeman MR, 2006, TRENDS NEUROSCI, V29, P82, DOI 10.1016/j.tins.2005.12.002; Gieffers C, 1999, P NATL ACAD SCI USA, V96, P11317, DOI 10.1073/pnas.96.20.11317; Gilmour DT, 2002, NEURON, V34, P577, DOI 10.1016/S0896-6273(02)00683-9; GRENNINGLOH G, 1991, CELL, V67, P45, DOI 10.1016/0092-8674(91)90571-F; Halassa MM, 2010, ANNU REV PHYSIOL, V72, P335, DOI 10.1146/annurev-physiol-021909-135843; Higgins MR, 2002, DEV BIOL, V244, P134, DOI 10.1006/dbio.2002.0583; Hummel T, 1999, DEV BIOL, V209, P381, DOI 10.1006/dbio.1999.9235; Juo P, 2004, CURR BIOL, V14, P2057, DOI 10.1016/j.cub.2004.11.010; Katsuki T, 2009, NEURON, V64, P188, DOI 10.1016/j.neuron.2009.08.019; Kirby BB, 2006, NAT NEUROSCI, V9, P1506, DOI 10.1038/nn1803; Klambt C, 2009, NAT REV NEUROSCI, V10, P769, DOI 10.1038/nrn2720; Kohsaka H, 2007, J CELL BIOL, V179, P1289, DOI 10.1083/jcb.200705154; Konishi Y, 2004, SCIENCE, V303, P1026, DOI 10.1126/science.1093712; Kucenas S, 2008, NAT NEUROSCI, V11, P143, DOI 10.1038/nn2025; Lehembre F, 2008, EMBO J, V27, P2603, DOI 10.1038/emboj.2008.178; Lyons DA, 2005, CURR BIOL, V15, P513, DOI 10.1016/j.cub.2005.02.030; Maness PF, 2007, NAT NEUROSCI, V10, P19, DOI 10.1038/nn1827; Mao YL, 2009, DEVELOPMENT, V136, P473, DOI 10.1242/dev.026054; Mathew D, 2003, J NEUROSCI, V23, P10710; Nave KA, 2008, ANNU REV NEUROSCI, V31, P535, DOI 10.1146/annurev.neuro.30.051606.094309; Paratcha G, 2003, CELL, V113, P867, DOI 10.1016/S0092-8674(03)00435-5; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Prag S, 2002, J CELL SCI, V115, P283; Reber A, 2006, DEVELOPMENT, V133, P3201, DOI 10.1242/dev.02488; Rutishauser U, 2008, NAT REV NEUROSCI, V9, P26, DOI 10.1038/nrn2285; Sepp KJ, 2000, GLIA, V30, P122, DOI 10.1002/(SICI)1098-1136(200004)30:2<122::AID-GLIA2>3.0.CO;2-B; Sepp KJ, 2003, DEVELOPMENT, V130, P1825, DOI 10.1242/dev.00413; Sigrist SJ, 1997, CELL, V90, P671, DOI 10.1016/S0092-8674(00)80528-0; Silies M, 2007, J NEUROSCI, V27, P13130, DOI 10.1523/JNEUROSCI.3583-07.2007; Stegmuller J, 2006, NEURON, V50, P389, DOI 10.1016/j.neuron.2006.03.034; van Roessel P, 2004, CELL, V119, P707, DOI 10.1016/j.cell.2004.11.028; von Hilchen CM, 2008, MECH DEVELOP, V125, P337, DOI 10.1016/j.mod.2007.10.010; von Hilchen CM, 2010, DEVELOPMENT, V137, P1251, DOI 10.1242/dev.042853; Weinhold B, 2005, J BIOL CHEM, V280, P42971, DOI 10.1074/jbc.M511097200; Wright JW, 2001, DEV BIOL, V234, P24, DOI 10.1006/dbio.2001.0247; Wright JW, 2000, DEV BIOL, V225, P59, DOI 10.1006/dbio.2000.9777; Yang Y, 2009, SCIENCE, V326, P575, DOI 10.1126/science.1177087	50	47	47	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2010	13	11					1357	U25		10.1038/nn.2656	http://dx.doi.org/10.1038/nn.2656			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	673KI	20890296				2022-12-28	WOS:000283658200016
J	[Anonymous]				[Anonymous]			Focus on epigenetics	NATURE NEUROSCIENCE			English	Editorial Material																			0	0	0	1	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2010	13	11					1299	1299		10.1038/nn1110-1299	http://dx.doi.org/10.1038/nn1110-1299			1	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	673KI	20975746	Bronze			2022-12-28	WOS:000283658200001
J	Evers, DM; Matta, JA; Hoe, HS; Zarkowsky, D; Lee, SH; Isaac, JT; Pak, DTS				Evers, Danielle M.; Matta, Jose A.; Hoe, Hyang-Sook; Zarkowsky, Devin; Lee, Sang Hyoung; Isaac, John T.; Pak, Daniel T. S.			Plk2 attachment to NSF induces homeostatic removal of GluA2 during chronic overexcitation	NATURE NEUROSCIENCE			English	Article							AMPA RECEPTOR TRAFFICKING; ETHYLMALEIMIDE-SENSITIVE FACTOR; DOMAIN-CONTAINING PROTEINS; LONG-TERM POTENTIATION; POLO-LIKE KINASE; HIPPOCAMPAL-NEURONS; SYNAPTIC-TRANSMISSION; SURFACE EXPRESSION; SUBUNIT COMPOSITION; BINDING PROTEIN	Trafficking of AMPA receptors (AMPARs) is important for many forms of synaptic plasticity. However, the link between activity and resulting synaptic alterations is not fully understood. We identified a direct interaction between N-ethylmaleimide-sensitive fusion protein (NSF), an ATPase involved in membrane fusion events and stabilization of surface AMPARs, and Polo-like kinase-2 (Plk2), an activity-inducible kinase that homeostatically decreases excitatory synapse number and strength. Plk2 disrupted the interaction of NSF with the GluA2 subunit of AMPARs, promoting extensive loss of surface GluA2 in rat hippocampal neurons, greater association of GluA2 with adaptor proteins PICK1 and GRIP1, and decreased synaptic AMPAR current. Plk2 engagement of NSF, but not Plk2 kinase activity, was required for this mechanism and occurred through a motif in the Plk2 protein that was independent of the canonical polo box interaction sites. These data reveal that heightened synaptic activity, acting through Plk2, leads to homeostatic decreases in surface AMPAR expression via the direct dissociation of NSF from GluA2.	[Evers, Danielle M.; Matta, Jose A.; Zarkowsky, Devin; Pak, Daniel T. S.] Georgetown Univ, Med Ctr, Dept Pharmacol, Washington, DC 20007 USA; [Matta, Jose A.; Isaac, John T.] NIGMS, NIH, Bethesda, MD USA; [Hoe, Hyang-Sook] Georgetown Univ, Dept Neurosci, Washington, DC 20007 USA; [Lee, Sang Hyoung] Med Coll Wisconsin, Dept Pharmacol, Milwaukee, WI 53226 USA	Georgetown University; National Institutes of Health (NIH) - USA; NIH National Institute of General Medical Sciences (NIGMS); Georgetown University; Medical College of Wisconsin	Pak, DTS (corresponding author), Georgetown Univ, Med Ctr, Dept Pharmacol, Washington, DC 20007 USA.	dtp6@georgetown.edu	Lee, Sang/R-7518-2019	Lee, Sang H./0000-0001-5467-0331	US National Institutes of Health; National Institute of Neurological Disorders and Stroke (Biacore Molecular Interactions Shared Resource of Lombardi Comprehensive Cancer Center) [NS048085, F31NS061467, P30CA051008]; NATIONAL CANCER INSTITUTE [P30CA051008] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003011, F31NS061467, R01NS048085] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Neurological Disorders and Stroke (Biacore Molecular Interactions Shared Resource of Lombardi Comprehensive Cancer Center)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank L. Bilello for technical assistance. This work was supported by US National Institutes of Health and National Institute of Neurological Disorders and Stroke grants NS048085 (D.T.S.P.), F31NS061467 (D.M.E.) and P30CA051008 (Biacore Molecular Interactions Shared Resource of Lombardi Comprehensive Cancer Center).	Ang XL, 2008, J BIOL CHEM, V283, P29424, DOI 10.1074/jbc.M802475200; Beretta F, 2005, MOL CELL NEUROSCI, V28, P650, DOI 10.1016/j.mcn.2004.11.008; Biou V, 2008, P NATL ACAD SCI USA, V105, P1038, DOI 10.1073/pnas.0711412105; Braithwaite SP, 2002, P NATL ACAD SCI USA, V99, P7096, DOI 10.1073/pnas.102156099; Chung HJ, 2000, J NEUROSCI, V20, P7258; Daw MI, 2000, NEURON, V28, P873, DOI 10.1016/S0896-6273(00)00160-4; DeSouza S, 2002, J NEUROSCI, V22, P3493; Dong HL, 1999, ANN NY ACAD SCI, V868, P535, DOI 10.1111/j.1749-6632.1999.tb11323.x; Elia AEH, 2003, CELL, V115, P83, DOI 10.1016/S0092-8674(03)00725-6; Feng Y, 1999, BIOCHEM J, V339, P435, DOI 10.1042/0264-6021:3390435; Fukata Y, 2005, J CELL BIOL, V169, P399, DOI 10.1083/jcb.200501121; Gainey MA, 2009, J NEUROSCI, V29, P6479, DOI 10.1523/JNEUROSCI.3753-08.2009; Gardner SM, 2005, NEURON, V45, P903, DOI 10.1016/j.neuron.2005.02.026; Hanley JG, 2002, NEURON, V34, P53, DOI 10.1016/S0896-6273(02)00638-4; Huang Y, 2005, NEURON, V46, P533, DOI 10.1016/j.neuron.2005.03.028; Jia ZP, 1996, NEURON, V17, P945, DOI 10.1016/S0896-6273(00)80225-1; Kauselmann G, 1999, EMBO J, V18, P5528, DOI 10.1093/emboj/18.20.5528; Kim CH, 2001, P NATL ACAD SCI USA, V98, P11725, DOI 10.1073/pnas.211132798; Lee KS, 1998, P NATL ACAD SCI USA, V95, P9301, DOI 10.1073/pnas.95.16.9301; Lee SH, 2002, NEURON, V36, P661, DOI 10.1016/S0896-6273(02)01024-3; Lin DT, 2007, J NEUROSCI, V27, P13903, DOI 10.1523/JNEUROSCI.1750-07.2007; Liu BS, 2006, J NEUROSCI, V26, P5309, DOI 10.1523/JNEUROSCI.0567-06.2006; Lu W, 2009, NEURON, V62, P254, DOI 10.1016/j.neuron.2009.02.027; Luscher C, 1999, NEURON, V24, P649, DOI 10.1016/S0896-6273(00)81119-8; Luthi A, 1999, NEURON, V24, P389, DOI 10.1016/S0896-6273(00)80852-1; Meng YH, 2003, NEURON, V39, P163, DOI 10.1016/S0896-6273(03)00368-4; Narisawa-Saito M, 2002, J BIOL CHEM, V277, P40901, DOI 10.1074/jbc.M202158200; Nishimune A, 1998, NEURON, V21, P87, DOI 10.1016/S0896-6273(00)80517-6; Noel J, 1999, NEURON, V23, P365, DOI 10.1016/S0896-6273(00)80786-2; Osten P, 2000, NEURON, V27, P313, DOI 10.1016/S0896-6273(00)00039-8; Osten P, 1998, NEURON, V21, P99, DOI 10.1016/S0896-6273(00)80518-8; Pak DTS, 2001, NEURON, V31, P289, DOI 10.1016/S0896-6273(01)00355-5; Pak DTS, 2003, SCIENCE, V302, P1368, DOI 10.1126/science.1082475; Perez JL, 2001, J NEUROSCI, V21, P5417, DOI 10.1523/JNEUROSCI.21-15-05417.2001; Plant K, 2006, NAT NEUROSCI, V9, P602, DOI 10.1038/nn1678; Seeburg DP, 2008, J NEUROSCI, V28, P6583, DOI 10.1523/JNEUROSCI.1853-08.2008; Seeburg DP, 2008, NEURON, V58, P571, DOI 10.1016/j.neuron.2008.03.021; Sheng M, 2001, CELL, V105, P825, DOI 10.1016/S0092-8674(01)00406-8; Shepherd JD, 2006, NEURON, V52, P475, DOI 10.1016/j.neuron.2006.08.034; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; SIMMONS DL, 1992, MOL CELL BIOL, V12, P4164, DOI 10.1128/MCB.12.9.4164; Song I, 1998, NEURON, V21, P393, DOI 10.1016/S0896-6273(00)80548-6; States BA, 2008, MOL CELL NEUROSCI, V38, P189, DOI 10.1016/j.mcn.2008.02.003; Terashima A, 2004, J NEUROSCI, V24, P5381, DOI 10.1523/JNEUROSCI.4378-03.2004; Thiagarajan TC, 2007, NEUROPHARMACOLOGY, V52, P156, DOI 10.1016/j.neuropharm.2006.07.030; Turrigiano G, 2007, CURR OPIN NEUROBIOL, V17, P318, DOI 10.1016/j.conb.2007.04.004; Wenthold RJ, 1996, J NEUROSCI, V16, P1982; Xia J, 2000, NEURON, V28, P499, DOI 10.1016/S0896-6273(00)00128-8; Yao YD, 2008, J NEUROSCI, V28, P7820, DOI 10.1523/JNEUROSCI.0223-08.2008; Zhao CX, 2007, FEBS LETT, V581, P2140, DOI 10.1016/j.febslet.2007.03.032	50	51	54	1	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2010	13	10					1199	1207		10.1038/nn.2624	http://dx.doi.org/10.1038/nn.2624			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	654MB	20802490	Green Accepted			2022-12-28	WOS:000282171300011
J	Miller, CA; Gavin, CF; White, JA; Parrish, RR; Honasoge, A; Yancey, CR; Rivera, IM; Rubio, MD; Rumbaugh, G; Sweatt, JD				Miller, Courtney A.; Gavin, Cristin F.; White, Jason A.; Parrish, R. Ryley; Honasoge, Avinash; Yancey, Christopher R.; Rivera, Ivonne M.; Rubio, Maria D.; Rumbaugh, Gavin; Sweatt, J. David			Cortical DNA methylation maintains remote memory	NATURE NEUROSCIENCE			English	Article							LONG-TERM-MEMORY; NEUROBIOLOGY; INVOLVEMENT; PLASTICITY	A behavioral memory's lifetime represents multiple molecular lifetimes, suggesting the necessity for a self-perpetuating signal. One candidate is DNA methylation, a transcriptional repression mechanism that maintains cellular memory throughout development. We found that persistent, gene-specific cortical hypermethylation was induced in rats by a single, hippocampus-dependent associative learning experience and pharmacologic inhibition of methylation 1 month after learning disrupted remote memory. We propose that the adult brain utilizes DNA methylation to preserve long-lasting memories.	[Miller, Courtney A.; Gavin, Cristin F.; White, Jason A.; Parrish, R. Ryley; Honasoge, Avinash; Yancey, Christopher R.; Rivera, Ivonne M.; Rubio, Maria D.; Rumbaugh, Gavin; Sweatt, J. David] Univ Alabama, Sch Med, Evelyn F McKnight Brain Inst, Birmingham, AL USA; [Miller, Courtney A.; Gavin, Cristin F.; White, Jason A.; Parrish, R. Ryley; Honasoge, Avinash; Yancey, Christopher R.; Rivera, Ivonne M.; Rubio, Maria D.; Rumbaugh, Gavin; Sweatt, J. David] Univ Alabama, Sch Med, Dept Neurobiol, Birmingham, AL USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Miller, CA (corresponding author), Scripps Inst, Dept Metab & Aging, Jupiter, FL USA.	cmiller@scripps.edu; dsweatt@nrc.uab.edu	Miller, Courtney A/E-8651-2010	Miller, Courtney A/0000-0001-8628-4902; Sweatt, J. David/0000-0003-3567-485X; Gavin, Cristin/0000-0001-7113-5015; Parrish, R Ryley/0000-0001-6798-6140	National Institute of Mental Health; National Institute of Neurological Disorders and Stroke; National Institute on Aging; National Institute on Drug Abuse; American Health Assistance Foundation; Evelyn F. McKnight Brain Research Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS061788, R01NS064079, F32NS057953] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K99DA024761, R00DA024761] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); American Health Assistance Foundation; Evelyn F. McKnight Brain Research Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The authors would like to thank O.S. Ahmed for technical assistance and M. Han of the UAB Genomics Core Facility. This work was supported by the National Institute of Mental Health, the National Institute of Neurological Disorders and Stroke, the National Institute on Aging, the National Institute on Drug Abuse, the American Health Assistance Foundation, the Evelyn F. McKnight Brain Research Foundation and Philip Morris.	BENVENGA MJ, 1988, PHARMACOL BIOCHEM BE, V30, P205, DOI 10.1016/0091-3057(88)90445-5; BIRD AP, 1986, NATURE, V321, P209, DOI 10.1038/321209a0; CRICK F, 1984, NATURE, V312, P101, DOI 10.1038/312101a0; Dudai Y, 2004, ANNU REV PSYCHOL, V55, P51, DOI 10.1146/annurev.psych.55.090902.142050; Frankland PW, 2004, SCIENCE, V304, P881, DOI 10.1126/science.1094804; Holliday R, 1999, J THEOR BIOL, V200, P339, DOI 10.1006/jtbi.1999.0995; Kasai H, 2010, TRENDS NEUROSCI, V33, P121, DOI 10.1016/j.tins.2010.01.001; Kessels HW, 2009, NEURON, V61, P340, DOI 10.1016/j.neuron.2009.01.015; Malleret G, 2001, CELL, V104, P675, DOI 10.1016/S0092-8674(01)00264-1; Miller CA, 2007, NEURON, V53, P857, DOI 10.1016/j.neuron.2007.02.022; MULKEY RM, 1994, NATURE, V369, P486, DOI 10.1038/369486a0; Roberson ED, 1999, LEARN MEMORY, V6, P381; Sacktor TC, 2008, PROG BRAIN RES, V169, P27, DOI 10.1016/S0079-6123(07)00002-7; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598; Weeber EJ, 2002, J BIOL CHEM, V277, P39944, DOI 10.1074/jbc.M205147200	15	374	385	0	64	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2010	13	6					664	666		10.1038/nn.2560	http://dx.doi.org/10.1038/nn.2560			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	600QY	20495557	Green Accepted			2022-12-28	WOS:000278003300008
J	Benilova, I; Karran, E; De Strooper, B				Benilova, Iryna; Karran, Eric; De Strooper, Bart			The toxic A beta oligomer and Alzheimer's disease: an emperor in need of clothes	NATURE NEUROSCIENCE			English	Review							LONG-TERM POTENTIATION; SOLUBLE AMYLOID OLIGOMERS; SYNAPTIC PLASTICITY; PROTEIN OLIGOMERS; IN-VITRO; TAU-HYPERPHOSPHORYLATION; ANTIBODIES RECOGNIZE; MONOCLONAL-ANTIBODY; SECRETED OLIGOMERS; DIFFUSIBLE LIGANDS	The 'toxic A beta oligomer' hypothesis has attracted considerable attention among Alzheimer's disease researchers as a way of resolving the lack of correlation between deposited amyloid-beta (A beta) in amyloid plaques-in terms of both amount and location- and cognitive impairment or neurodegeneration. However, the lack of a common, agreed-upon experimental description of the toxic A beta oligomer makes interpretation and direct comparison of data between different research groups impossible. Here we critically review the evidence supporting toxic A beta oligomers as drivers of neurodegeneration and make some suggestions that might facilitate progress in this complex field.	[Benilova, Iryna; Karran, Eric; De Strooper, Bart] Katholieke Univ Leuven, Ctr Human Genet, Leuven Inst Neurodegenerat Dis LIND, Louvain, Belgium; [Benilova, Iryna; De Strooper, Bart] VIB Ctr Biol Dis, Louvain, Belgium	KU Leuven; Flanders Institute for Biotechnology (VIB)	De Strooper, B (corresponding author), Katholieke Univ Leuven, Ctr Human Genet, Leuven Inst Neurodegenerat Dis LIND, Louvain, Belgium.	bart.destrooper@cme.vib-kuleuven.be	de+Strooper, Bart/Z-1638-2019; De Strooper, Bart/F-6507-2012; Benilova, Iryna/H-6533-2019	De Strooper, Bart/0000-0001-5455-5819; 	European Research Council (ERC); Fund for Scientific Research, Flanders; University of Leuven; VIB; Flemish government; Foundation for Alzheimer Research (SAO/FRMA); Interuniversity Attraction Poles Program	European Research Council (ERC)(European Research Council (ERC)European Commission); Fund for Scientific Research, Flanders(FWO); University of Leuven(KU Leuven); VIB; Flemish government(European Commission); Foundation for Alzheimer Research (SAO/FRMA); Interuniversity Attraction Poles Program(Belgian Federal Science Policy Office)	The authors acknowledge funding from the European Research Council (ERC); the Fund for Scientific Research, Flanders; the University of Leuven; the VIB; the Methusalem grant from the University of Leuven and the Flemish government; the Foundation for Alzheimer Research (SAO/FRMA); and the Interuniversity Attraction Poles Program. B. D. S. is the Arthur Bax and Anna Vanluffelen Chair for Alzheimer's Disease at the University of Leuven. The authors acknowledge T. Golde, D. Teplow, T. Hard and D. Walsh for fruitful discussions and/or sharing their amyloid-beta preparations.	Aguzzi A, 2009, PHYSIOL REV, V89, P1105, DOI 10.1152/physrev.00006.2009; [Anonymous], 2011, NAT NEUROSCI, V14, P399; BAKER HF, 1994, MOL NEUROBIOL, V8, P25, DOI 10.1007/BF02778005; Barghorn S, 2005, J NEUROCHEM, V95, P834, DOI 10.1111/j.1471-4159.2005.03407.x; Baumketner A, 2006, PROTEIN SCI, V15, P420, DOI 10.1110/ps.051762406; Bezprozvanny I, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.263pe16; Bitan G, 2005, AMYLOID, V12, P88, DOI 10.1080/13506120500106958; Bleiholder C, 2011, NAT CHEM, V3, P172, DOI 10.1038/NCHEM.945; Campioni S, 2010, NAT CHEM BIOL, V6, P140, DOI [10.1038/NCHEMBIO.283, 10.1038/nchembio.283]; Castellano JM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002156; Caughey B, 2003, ANNU REV NEUROSCI, V26, P267, DOI 10.1146/annurev.neuro.26.010302.081142; Cerf E, 2011, FASEB J, V25, P1585, DOI 10.1096/fj.10-175976; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; Collinge J, 2007, SCIENCE, V318, P930, DOI 10.1126/science.1138718; De Felice FG, 2008, NEUROBIOL AGING, V29, P1334, DOI 10.1016/j.neurobiolaging.2007.02.029; De Strooper B, 2010, PHYSIOL REV, V90, P465, DOI 10.1152/physrev.00023.2009; Demuro A, 2005, J BIOL CHEM, V280, P17294, DOI 10.1074/jbc.M500997200; Deshpande A, 2006, J NEUROSCI, V26, P6011, DOI 10.1523/JNEUROSCI.1189-06.2006; Dineley KT, 2001, J NEUROSCI, V21, P4125, DOI 10.1523/JNEUROSCI.21-12-04125.2001; Eisele YS, 2010, SCIENCE, V330, P980, DOI 10.1126/science.1194516; Englund H, 2007, J NEUROCHEM, V103, P334, DOI 10.1111/j.1471-4159.2007.04759.x; Galeazzi L, 1999, AMYLOID, V6, P7, DOI 10.3109/13506129908993282; Gardberg AS, 2007, P NATL ACAD SCI USA, V104, P15659, DOI 10.1073/pnas.0705888104; Giuffrida ML, 2010, REV NEUROSCIENCE, V21, P83; Habicht G, 2007, P NATL ACAD SCI USA, V104, P19232, DOI 10.1073/pnas.0703793104; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hardy J, 2009, J NEUROCHEM, V110, P1129, DOI 10.1111/j.1471-4159.2009.06181.x; Harper JD, 1997, CHEM BIOL, V4, P119, DOI 10.1016/S1074-5521(97)90255-6; Hartley DM, 2008, J BIOL CHEM, V283, P16790, DOI 10.1074/jbc.M802215200; Hepler RW, 2006, BIOCHEMISTRY-US, V45, P15157, DOI 10.1021/bi061850f; Hillen H, 2010, J NEUROSCI, V30, P10369, DOI 10.1523/JNEUROSCI.5721-09.2010; Hoshi M, 2003, P NATL ACAD SCI USA, V100, P6370, DOI 10.1073/pnas.1237107100; Hu XY, 2009, P NATL ACAD SCI USA, V106, P20324, DOI 10.1073/pnas.0911281106; Ittner LM, 2010, CELL, V142, P387, DOI 10.1016/j.cell.2010.06.036; JARRETT JT, 1993, BIOCHEMISTRY-US, V32, P4693, DOI 10.1021/bi00069a001; Jin M, 2011, P NATL ACAD SCI USA, V108, P5819, DOI 10.1073/pnas.1017033108; Jo J, 2011, NAT NEUROSCI, V14, P545, DOI 10.1038/nn.2785; Karran E, 2011, NAT REV DRUG DISCOV, V10, P698, DOI 10.1038/nrd3505; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kayed R, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-18; Kumar S, 2011, EMBO J, V30, P2255, DOI 10.1038/emboj.2011.138; Kuperstein I, 2010, EMBO J, V29, P3408, DOI 10.1038/emboj.2010.211; Lafaye P, 2009, MOL IMMUNOL, V46, P695, DOI 10.1016/j.molimm.2008.09.008; Lambert MP, 2007, J NEUROCHEM, V100, P23, DOI 10.1111/j.1471-4159.2006.04157.x; Lambert MP, 2001, J NEUROCHEM, V79, P595, DOI 10.1046/j.1471-4159.2001.00592.x; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lasagna-Reeves C.A., 2011, J BIOL CHEM; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Lee EB, 2006, J BIOL CHEM, V281, P4292, DOI 10.1074/jbc.M511018200; Lee J, 2011, NAT CHEM BIOL, V7, P602, DOI [10.1038/nchembio.624, 10.1038/NCHEMBIO.624]; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Li SM, 2009, NEURON, V62, P788, DOI 10.1016/j.neuron.2009.05.012; Liu C, 2011, J AM CHEM SOC, V133, P6736, DOI 10.1021/ja200222n; Lord A, 2009, NEUROBIOL DIS, V36, P425, DOI 10.1016/j.nbd.2009.08.007; Matsumura S, 2011, J BIOL CHEM; Mc Donald JM, 2010, BRAIN, V133, P1328, DOI 10.1093/brain/awq065; Meli G, 2009, J MOL BIOL, V387, P584, DOI 10.1016/j.jmb.2009.01.061; Meyer-Luehmann M, 2006, SCIENCE, V313, P1781, DOI 10.1126/science.1131864; Morales R, 2011, MOL PSYCHIAT; Moretto N, 2007, J BIOL CHEM, V282, P11436, DOI 10.1074/jbc.M609690200; Nilsberth C, 2001, NAT NEUROSCI, V4, P887, DOI 10.1038/nn0901-887; Noguchi A, 2009, J BIOL CHEM, V284, P32895, DOI 10.1074/jbc.M109.000208; O'Nuallain B, 2002, P NATL ACAD SCI USA, V99, P1485, DOI 10.1073/pnas.022662599; O'Nuallain B, 2011, J NEUROCHEM, V119, P189, DOI 10.1111/j.1471-4159.2011.07389.x; O'Nuallain B, 2010, J NEUROSCI, V30, P14411, DOI 10.1523/JNEUROSCI.3537-10.2010; ODA T, 1995, EXP NEUROL, V136, P22, DOI 10.1006/exnr.1995.1080; Ono K, 2009, P NATL ACAD SCI USA, V106, P14745, DOI 10.1073/pnas.0905127106; Perrin RJ, 2009, NATURE, V461, P916, DOI 10.1038/nature08538; Petkova AT, 2005, SCIENCE, V307, P262, DOI 10.1126/science.1105850; PIKE CJ, 1991, BRAIN RES, V563, P311, DOI 10.1016/0006-8993(91)91553-D; PODLISNY MB, 1995, J BIOL CHEM, V270, P9564, DOI 10.1074/jbc.270.16.9564; Portelius E, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-2; Reed MN, 2011, NEUROBIOL AGING, V32, P1784, DOI 10.1016/j.neurobiolaging.2009.11.007; Roher AE, 1996, J BIOL CHEM, V271, P20631, DOI 10.1074/jbc.271.34.20631; Ross CA, 2005, NAT REV MOL CELL BIO, V6, P891, DOI 10.1038/nrm1742; Sandberg A, 2010, P NATL ACAD SCI USA, V107, P15595, DOI 10.1073/pnas.1001740107; Schlenzig D, 2009, BIOCHEMISTRY-US, V48, P7072, DOI 10.1021/bi900818a; Schupf N, 2008, P NATL ACAD SCI USA, V105, P14052, DOI 10.1073/pnas.0805902105; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Shankar GM, 2009, NEUROBIOL DIS, V36, P293, DOI 10.1016/j.nbd.2009.07.021; Shen J, 2007, P NATL ACAD SCI USA, V104, P403, DOI 10.1073/pnas.0608332104; Shipton OA, 2011, J NEUROSCI, V31, P1688, DOI 10.1523/JNEUROSCI.2610-10.2011; Shughrue PJ, 2010, NEUROBIOL AGING, V31, P189, DOI 10.1016/j.neurobiolaging.2008.04.003; Smith DP, 2006, J BIOL CHEM, V281, P15145, DOI 10.1074/jbc.M600417200; Soucek T, 2003, NEURON, V39, P43, DOI 10.1016/S0896-6273(03)00367-2; Thathiah A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.293re8; Tomiyama T, 2008, ANN NEUROL, V63, P377, DOI 10.1002/ana.21321; Townsend M, 2006, J PHYSIOL-LONDON, V572, P477, DOI 10.1113/jphysiol.2005.103754; van Helmond Z, 2009, J NEUROSCI METH, V176, P206, DOI 10.1016/j.jneumeth.2008.09.002; Villemagne VL, 2010, J NEUROSCI, V30, P6315, DOI 10.1523/JNEUROSCI.5180-09.2010; Walsh DM, 1997, J BIOL CHEM, V272, P22364, DOI 10.1074/jbc.272.35.22364; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Wang XL, 2010, NEURODEGENER DIS, V7, P56, DOI 10.1159/000283484; Wogulis M, 2005, J NEUROSCI, V25, P1071, DOI 10.1523/JNEUROSCI.2381-04.2005; Wu HY, 2010, J NEUROSCI, V30, P2636, DOI 10.1523/JNEUROSCI.4456-09.2010; Xia WM, 1997, J BIOL CHEM, V272, P7977, DOI 10.1074/jbc.272.12.7977; Yamin G, 2009, J NEUROSCI RES, V87, P1729, DOI 10.1002/jnr.21998; Zameer A, 2008, J MOL BIOL, V384, P917, DOI 10.1016/j.jmb.2008.09.068; Zempel H, 2010, J NEUROSCI, V30, P11938, DOI 10.1523/JNEUROSCI.2357-10.2010	100	1407	1461	10	516	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2012	15	3					349	357		10.1038/nn.3028	http://dx.doi.org/10.1038/nn.3028			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	899CY	22286176				2022-12-28	WOS:000300793100006
J	Ping, Y; Tsunoda, S				Ping, Yong; Tsunoda, Susan			Inactivity-induced increase in nAChRs upregulates Shal K+ channels to stabilize synaptic potentials	NATURE NEUROSCIENCE			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTORS; HIPPOCAMPAL PYRAMIDAL NEURONS; CENTRAL-NERVOUS-SYSTEM; DROSOPHILA-MELANOGASTER; POTASSIUM CURRENTS; DELAYED RECTIFIER; CO-ASSEMBLE; EXCITABILITY; PLASTICITY; KV4.2	Long-term synaptic changes, which are essential for learning and memory, are dependent on homeostatic mechanisms that stabilize neural activity. Homeostatic responses have also been implicated in pathological conditions, including nicotine addiction. Although multiple homeostatic pathways have been described, little is known about how compensatory responses are tuned to prevent them from overshooting their optimal range of activity. We found that prolonged inhibition of nicotinic acetylcholine receptors (nAChRs), the major excitatory receptors in the Drosophila CNS, resulted in a homeostatic increase in the Drosophila alpha 7 (D alpha 7)-nAChR. This response then induced an increase in the transient A-type K+ current carried by Shaker cognate L (Shal; also known as voltage-gated K+ channel 4, Kv4) channels. Although increasing D alpha 7-nAChRs boosted miniature excitatory postsynaptic currents, the ensuing increase in Shal channels served to stabilize postsynaptic potentials. These data identify a previously unknown mechanism for fine tuning the homeostatic response.	[Ping, Yong; Tsunoda, Susan] Colorado State Univ, Dept Biomed Sci, Ft Collins, CO 80523 USA	Colorado State University	Tsunoda, S (corresponding author), Colorado State Univ, Dept Biomed Sci, Ft Collins, CO 80523 USA.	susan.tsunoda@colostate.edu		Ping, Yong/0000-0003-1066-5471	US National Institutes of Health [R01 GM083335]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083335] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank G. Waro for genetic crosses and technical assistance. We thank H. Bellen (Baylor College of Medicine) for the antibody to D alpha 7 and the D alpha 7-deficient mutant line, S. Sigrist (Institute for Biology/Genetics) for the UAS-nAcR alpha-18C-EGFP fly line, M. Fujioka (Thomas Jefferson University) for the RRa-GAL4, RN2-GAL4 and EL-GAL4 fly lines, S. Singh (State University of New York, Buffalo) for the Shab[3] line, and E. Gundelfinger and U. Thomas (Leibniz Institute for Neurobiology) for the antibodies to Drosophila nAChRs. We also thank C. Yeung for carrying out genetic mapping and crosses for the transgenic HA-Shal line. S. T. is supported by a grant from the US National Institutes of Health (R01 GM083335).	Albuquerque EX, 2009, PHYSIOL REV, V89, P73, DOI 10.1152/physrev.00015.2008; Aracava Y, 2005, J PHARMACOL EXP THER, V312, P1195, DOI 10.1124/jpet.104.077172; Baines RA, 2001, J NEUROSCI, V21, P1523, DOI 10.1523/JNEUROSCI.21-05-01523.2001; Brickley SG, 2001, NATURE, V409, P88, DOI 10.1038/35051086; Bushey D, 2011, SCIENCE, V332, P1576, DOI 10.1126/science.1202839; Cai X, 2004, NEURON, V44, P351, DOI 10.1016/j.neuron.2004.09.026; Chamaon K, 2000, FEBS LETT, V482, P189, DOI 10.1016/S0014-5793(00)02057-3; Chamaon K, 2002, J NEUROCHEM, V80, P149, DOI 10.1046/j.0022-3042.2001.00685.x; Chen XX, 2006, J NEUROSCI, V26, P12143, DOI 10.1523/JNEUROSCI.2667-06.2006; Chou YH, 2010, NAT NEUROSCI, V13, P439, DOI 10.1038/nn.2489; Davis GW, 2006, ANNU REV NEUROSCI, V29, P307, DOI 10.1146/annurev.neuro.28.061604.135751; De Biasi M, 2011, ANNU REV NEUROSCI, V34, P105, DOI 10.1146/annurev-neuro-061010-113734; Desai NS, 1999, NAT NEUROSCI, V2, P515, DOI 10.1038/9165; Diao FQ, 2009, MOL CELL NEUROSCI, V42, P33, DOI 10.1016/j.mcn.2009.05.003; Fayyazuddin A, 2006, PLOS BIOL, V4, P420, DOI 10.1371/journal.pbio.0040063; Fenster CP, 1999, J NEUROSCI, V19, P4804; Fujioka M, 2003, DEVELOPMENT, V130, P5385, DOI 10.1242/dev.00770; Gotti C, 2009, BIOCHEM PHARMACOL, V78, P703, DOI 10.1016/j.bcp.2009.05.024; Grauso M, 2002, GENETICS, V160, P1519; GRIFFITH LC, 1993, NEURON, V10, P501, DOI 10.1016/0896-6273(93)90337-Q; Groth RD, 2011, P NATL ACAD SCI USA, V108, P828, DOI 10.1073/pnas.1018022108; Hegde P, 1999, J BIOL CHEM, V274, P22109, DOI 10.1074/jbc.274.31.22109; Hoffman DA, 1997, NATURE, V387, P869, DOI 10.1038/43119; Jerng HH, 2004, MOL CELL NEUROSCI, V27, P343, DOI 10.1016/j.mcn.2004.06.011; JONAS PE, 1994, J NEUROBIOL, V25, P1494, DOI 10.1002/neu.480251203; Kazama H, 2008, NEURON, V58, P401, DOI 10.1016/j.neuron.2008.02.030; Kim JY, 2007, NEURON, V54, P933, DOI 10.1016/j.neuron.2007.05.026; Kremer MC, 2010, CURR BIOL, V20, P1938, DOI 10.1016/j.cub.2010.09.060; Kuba H, 2010, NATURE, V465, P1075, DOI 10.1038/nature09087; Lee D, 1999, J NEUROSCI, V19, P5311; LEUNG HT, 1989, NEURON, V3, P767, DOI 10.1016/0896-6273(89)90245-6; Lichtman JW, 2000, NEURON, V25, P269, DOI 10.1016/S0896-6273(00)80893-4; Magee JC, 2000, NAT NEUROSCI, V3, P895, DOI 10.1038/78800; Misonou H, 2010, NEUROSCIENTIST, V16, P51, DOI 10.1177/1073858409341085; Nataraj K, 2010, NEURON, V68, P750, DOI 10.1016/j.neuron.2010.09.033; Picciotto MR, 2008, PROG NEUROBIOL, V84, P329, DOI 10.1016/j.pneurobio.2007.12.005; Ping Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016043; Pozo K, 2010, NEURON, V66, P337, DOI 10.1016/j.neuron.2010.04.028; Pulver SR, 2010, NAT NEUROSCI, V13, P53, DOI 10.1038/nn.2444; Schmidt H, 1997, DEV BIOL, V189, P186, DOI 10.1006/dbio.1997.8660; Schulz R, 2000, J NEUROCHEM, V74, P2537, DOI 10.1046/j.1471-4159.2000.0742537.x; Small DH, 2008, TRENDS MOL MED, V14, P103, DOI 10.1016/j.molmed.2007.12.006; Su HL, 2003, J NEUROSCI, V23, P9246; Thiagarajan TC, 2002, NEURON, V36, P1103, DOI 10.1016/S0896-6273(02)01049-8; Tripodi M, 2008, PLOS BIOL, V6, P2172, DOI 10.1371/journal.pbio.0060260; TSUNODA S, 1995, J NEUROSCI, V15, P1741, DOI 10.1523/JNEUROSCI.15-03-01741.1995; TSUNODA S, 1995, J NEUROSCI, V15, P5209; Turrigiano G, 2011, ANNU REV NEUROSCI, V34, P89, DOI 10.1146/annurev-neuro-060909-153238; Varga AW, 2004, J NEUROSCI, V24, P3643, DOI 10.1523/JNEUROSCI.0154-04.2004; Watson GB, 2010, INSECT BIOCHEM MOLEC, V40, P376, DOI 10.1016/j.ibmb.2009.11.004	50	28	28	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2012	15	1					90	U115		10.1038/nn.2969	http://dx.doi.org/10.1038/nn.2969			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	866VO	22081160	Green Accepted			2022-12-28	WOS:000298414400018
J	Stephan, AB; Tobochnik, S; Dibattista, M; Wall, CM; Reisert, J; Zhao, HQ				Stephan, Aaron B.; Tobochnik, Steven; Dibattista, Michele; Wall, Crystal M.; Reisert, Johannes; Zhao, Haiqing			The Na+/Ca2+ exchanger NCKX4 governs termination and adaptation of the mammalian olfactory response	NATURE NEUROSCIENCE			English	Article							SODIUM-CALCIUM EXCHANGE; ROD OUTER SEGMENTS; SENSORY NEURONS; RECEPTOR-CELLS; SODIUM/CALCIUM EXCHANGER; MOLECULAR-CLONING; ADENYLYL-CYCLASE; ODOR ADAPTATION; CHANNEL; MOUSE	Sensory perception requires accurate encoding of stimulus information by sensory receptor cells. We identified NCKX4, a potassium-dependent Na+/Ca2+ exchanger, as being necessary for rapid response termination and proper adaptation of vertebrate olfactory sensory neurons (OSNs). Nckx4(-/-) (also known as Slc24a4) mouse OSNs displayed substantially prolonged responses and stronger adaptation. Single-cell electrophysiological analyses revealed that the majority of Na+-dependent Ca2+ exchange in OSNs relevant to sensory transduction is a result of NCKX4 and that Nckx4(-/-) mouse OSNs are deficient in encoding action potentials on repeated stimulation. Olfactory-specific Nckx4(-/-) mice had lower body weights and a reduced ability to locate an odorous source. These results establish the role of NCKX4 in shaping olfactory responses and suggest that rapid response termination and proper adaptation of peripheral sensory receptor cells tune the sensory system for optimal perception.	[Stephan, Aaron B.; Tobochnik, Steven; Wall, Crystal M.; Zhao, Haiqing] Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA; [Dibattista, Michele; Reisert, Johannes] Monell Chem Senses Ctr, Philadelphia, PA 19104 USA	Johns Hopkins University; Monell Chemical Senses Center	Zhao, HQ (corresponding author), Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA.	hzhao@jhu.edu	DIBATTISTA, Michele/AAC-7621-2022	DIBATTISTA, Michele/0000-0002-3955-4663; Wall, Crystal/0000-0002-2169-7156; Tobochnik, Steven/0000-0001-9071-8398	US National Institutes of Health [DC007395]; Morley Kare Fellowship; Monell Chemical Senses Center; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC007395] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Morley Kare Fellowship; Monell Chemical Senses Center; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank T. Bozza for providing the OMP-Cre mouse line. We thank K. Cunningham, K. Cygnar, D. Fambrough, S. Hattar, R. Kuruvilla, D. Luo and F. Margolis for suggestions and discussions. We also thank members of the Hattar-Kuruvilla-Zhao mouse tri-laboratory of the Johns Hopkins Department of Biology for discussions. This research was supported by US National Institutes of Health grant DC007395, a Morley Kare Fellowship (to J.R.) and the Monell Chemical Senses Center. A. B. S. is currently a Department of Energy Biosciences Fellow of the Life Sciences Research Foundation.	Altimimi HF, 2007, CHANNELS, V1, P62, DOI 10.4161/chan.4366; Antolin S, 2007, J PHYSIOL-LONDON, V581, P495, DOI 10.1113/jphysiol.2007.131094; BAKALYAR HA, 1990, SCIENCE, V250, P1403, DOI 10.1126/science.2255909; Belluscio L, 1998, NEURON, V20, P69, DOI 10.1016/S0896-6273(00)80435-3; Billig GM, 2011, NAT NEUROSCI, V14, P763, DOI 10.1038/nn.2821; Blaustein MP, 1999, PHYSIOL REV, V79, P763, DOI 10.1152/physrev.1999.79.3.763; BRADLEY J, 1994, P NATL ACAD SCI USA, V91, P8890, DOI 10.1073/pnas.91.19.8890; Brunet LJ, 1996, NEURON, V17, P681, DOI 10.1016/S0896-6273(00)80200-7; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Buiakova OI, 1996, P NATL ACAD SCI USA, V93, P9858, DOI 10.1073/pnas.93.18.9858; Cygnar KD, 2009, NAT NEUROSCI, V12, P454, DOI 10.1038/nn.2289; Cygnar KD, 2010, JOVE-J VIS EXP, V37, pe1850; Danaceau JP, 2000, J GEN PHYSIOL, V115, P759, DOI 10.1085/jgp.115.6.759; DHALLAN RS, 1990, NATURE, V347, P184, DOI 10.1038/347184a0; Fain GL, 2001, PHYSIOL REV, V81, P117, DOI 10.1152/physrev.2001.81.1.117; JONES DT, 1989, SCIENCE, V244, P790, DOI 10.1126/science.2499043; JUNG A, 1994, NEUROREPORT, V5, P1741, DOI 10.1097/00001756-199409080-00013; Kaupp UB, 2010, NAT REV NEUROSCI, V11, P188, DOI 10.1038/nrn2789; Kleene SJ, 1997, BIOPHYS J, V73, P1110, DOI 10.1016/S0006-3495(97)78143-8; Kleene SJ, 2008, CHEM SENSES, V33, P839, DOI 10.1093/chemse/bjn048; Li JS, 2004, NATURE, V428, P393, DOI 10.1038/nature02433; Li XF, 2002, J BIOL CHEM, V277, P48410, DOI 10.1074/jbc.M210011200; LIMAN ER, 1994, NEURON, V13, P611, DOI 10.1016/0896-6273(94)90029-9; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; LOWE G, 1993, NATURE, V366, P283, DOI 10.1038/366283a0; Lytton J, 2007, BIOCHEM J, V406, P365, DOI 10.1042/BJ20070619; MENCO BPM, 1984, CELL TISSUE RES, V235, P225; Michalakis S, 2006, J BIOL CHEM, V281, P35156, DOI 10.1074/jbc.M606409200; Munger SD, 2001, SCIENCE, V294, P2172, DOI 10.1126/science.1063224; Noe J, 1997, NEUROCHEM INT, V30, P523, DOI 10.1016/S0197-0186(96)00090-3; Pyrski M, 2007, J COMP NEUROL, V501, P944, DOI 10.1002/cne.21290; Reisert J, 2005, NEURON, V45, P553, DOI 10.1016/j.neuron.2005.01.012; Reisert J, 1998, J GEN PHYSIOL, V112, P529, DOI 10.1085/jgp.112.5.529; Reisert J, 2001, J PHYSIOL-LONDON, V535, P637, DOI 10.1111/j.1469-7793.2001.00637.x; Reisert J, 2001, J PHYSIOL-LONDON, V530, P113, DOI 10.1111/j.1469-7793.2001.0113m.x; Reisert J, 2007, J PHYSIOL-LONDON, V585, P731, DOI 10.1113/jphysiol.2007.142471; Sammeta N, 2007, J COMP NEUROL, V502, P1138, DOI 10.1002/cne.21365; Sautter A, 1998, P NATL ACAD SCI USA, V95, P4696, DOI 10.1073/pnas.95.8.4696; SCHNETKAMP PPM, 1995, CELL CALCIUM, V18, P322, DOI 10.1016/0143-4160(95)90028-4; SCHNETKAMP PPM, 1991, ANN NY ACAD SCI, V639, P10, DOI 10.1111/j.1749-6632.1991.tb17285.x; Scott JW, 2002, MICROSC RES TECHNIQ, V58, P152, DOI 10.1002/jemt.10133; Song Y, 2008, NEURON, V58, P374, DOI 10.1016/j.neuron.2008.02.029; Stephan AB, 2009, P NATL ACAD SCI USA, V106, P11776, DOI 10.1073/pnas.0903304106; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Visser F, 2007, J BIOL CHEM, V282, P4453, DOI 10.1074/jbc.M610582200; Wang T, 2005, NEURON, V45, P367, DOI 10.1016/j.neuron.2004.12.046; Wong ST, 2000, NEURON, V27, P487, DOI 10.1016/S0896-6273(00)00060-X; YAN C, 1995, P NATL ACAD SCI USA, V92, P9677, DOI 10.1073/pnas.92.21.9677; Zhao HQ, 2001, CELL, V104, P651, DOI 10.1016/S0092-8674(02)01107-8; Zufall F, 2000, CHEM SENSES, V25, P473, DOI 10.1093/chemse/25.4.473	50	84	87	2	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2012	15	1					131	U164		10.1038/nn.2943	http://dx.doi.org/10.1038/nn.2943			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	866VO	22057188	Green Submitted, Green Accepted			2022-12-28	WOS:000298414400023
J	Sreenivasan, S; Fiete, I				Sreenivasan, Sameet; Fiete, Ila			Grid cells generate an analog error-correcting code for singularly precise neural computation	NATURE NEUROSCIENCE			English	Article							SYNAPTIC PLASTICITY; FISHER INFORMATION; UNIT-ACTIVITY; SPATIAL MAP; DIRECTION; CA1; HIPPOCAMPUS; INTEGRATION; MODEL; REPRESENTATION	Entorhinal grid cells in mammals fire as a function of animal location, with spatially periodic response patterns. This nonlocal periodic representation of location, a local variable, is unlike other neural codes. There is no theoretical explanation for why such a code should exist. We examined how accurately the grid code with noisy neurons allows an ideal observer to estimate location and found this code to be a previously unknown type of population code with unprecedented robustness to noise. In particular, the representational accuracy attained by grid cells over the coding range was in a qualitatively different class from what is possible with observed sensory and motor population codes. We found that a simple neural network can effectively correct the grid code. To the best of our knowledge, these results are the first demonstration that the brain contains, and may exploit, powerful error-correcting codes for analog variables.	[Sreenivasan, Sameet; Fiete, Ila] Univ Texas Austin, Ctr Learning & Memory, Austin, TX 78712 USA; [Sreenivasan, Sameet] Rensselaer Polytech Inst, Dept Comp Sci, Troy, NY 12180 USA	University of Texas System; University of Texas Austin; Rensselaer Polytechnic Institute	Fiete, I (corresponding author), Univ Texas Austin, Ctr Learning & Memory, Austin, TX 78712 USA.	ilafiete@mail.clm.utexas.edu		Fiete, Ila/0000-0003-4738-2539	Office of Naval Research through the Multidisciplinary University Research Initiative	Office of Naval Research through the Multidisciplinary University Research Initiative	We are grateful to Y. Burak, S. Seung, A. Kepecs, P. Latham, A. Pouget and P. Dayan for thought-provoking questions and comments, S. H. Lee for helpful conversations, T. Lam for advice on a volume computation, D. Johnston, A. Huk, N. Priebe, A. Tan and members of our laboratory for comments on the manuscript, and A. Preston for useful pointers to the literature. I. F. is a Sloan Foundation Fellow, a Searle Scholar and a McKnight Scholar, and receives funding from the Office of Naval Research through the Multidisciplinary University Research Initiative.	Abbott LF, 1999, NEURAL COMPUT, V11, P91, DOI 10.1162/089976699300016827; Ahmed OJ, 2009, TRENDS NEUROSCI, V32, P329, DOI 10.1016/j.tins.2009.01.009; AMARAL DG, 1989, NEUROSCIENCE, V31, P571, DOI 10.1016/0306-4522(89)90424-7; Ang CW, 2005, J NEUROSCI, V25, P9567, DOI 10.1523/JNEUROSCI.2992-05.2005; [Anonymous], 1988, EYE BRAIN VISION; Bethge M, 2002, NEURAL COMPUT, V14, P2317, DOI 10.1162/08997660260293247; Brun VH, 2008, NEURON, V57, P290, DOI 10.1016/j.neuron.2007.11.034; Brunel N, 1998, NEURAL COMPUT, V10, P1731, DOI 10.1162/089976698300017115; Burak Y, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000291; Burgess N, 2007, HIPPOCAMPUS, V17, P801, DOI 10.1002/hipo.20327; Burgess N, 2008, HIPPOCAMPUS, V18, P1157, DOI 10.1002/hipo.20518; Carr MF, 2011, NAT NEUROSCI, V14, P147, DOI 10.1038/nn.2732; Deneve S, 1999, NAT NEUROSCI, V2, P740, DOI 10.1038/11205; Fiete IR, 2008, J NEUROSCI, V28, P6858, DOI 10.1523/JNEUROSCI.5684-07.2008; Fiete IR, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.048104; Fuhs MC, 2006, J NEUROSCI, V26, P4266, DOI 10.1523/JNEUROSCI.4353-05.2006; GOBLICK TJ, 1965, IEEE T INFORM THEORY, V11, P558, DOI 10.1109/TIT.1965.1053821; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Hafting T, 2008, NATURE, V453, P1248, DOI 10.1038/nature06957; HANZO L, 2002, TURBO CODING TURBO E; Jarsky T, 2005, NAT NEUROSCI, V8, P1667, DOI 10.1038/nn1599; Jin DHZ, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.051922; Kao MH, 2005, NATURE, V433, P638, DOI 10.1038/nature03127; Knierim JJ, 1998, J NEUROPHYSIOL, V80, P425, DOI 10.1152/jn.1998.80.1.425; Latham PE, 2003, J PHYSIOL-PARIS, V97, P683, DOI 10.1016/j.jphysparis.2004.01.022; Lever C, 2009, J NEUROSCI, V29, P9771, DOI 10.1523/JNEUROSCI.1319-09.2009; Ma WJ, 2006, NAT NEUROSCI, V9, P1432, DOI 10.1038/nn1790; McDonald D., 2004, PRACTICAL HAZOPS TRI; MCNAUGHTON BL, 1983, EXP BRAIN RES, V52, P41; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; PARADISO MA, 1988, BIOL CYBERN, V58, P35, DOI 10.1007/BF00363954; Remondes M, 2003, LEARN MEMORY, V10, P247, DOI 10.1101/lm.59103; Ristic B., 2003, KALMAN FILTER PARTIC; Schreiner CE, 2000, ANNU REV NEUROSCI, V23, P501, DOI 10.1146/annurev.neuro.23.1.501; Seung HS, 2003, NEURON, V40, P1063, DOI 10.1016/S0896-6273(03)00761-X; SEUNG HS, 1993, P NATL ACAD SCI USA, V90, P10749, DOI 10.1073/pnas.90.22.10749; Shamir M, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000286; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; SOFTKY WR, 1993, J NEUROSCI, V13, P334; Sompolinsky H, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.051904; STEVENS CF, 1994, NATURE, V371, P704, DOI 10.1038/371704a0; Sudan M, 2001, ANN IEEE SYMP FOUND, P36; Takahashi H, 2009, NEURON, V62, P102, DOI 10.1016/j.neuron.2009.03.007; TAUBE JS, 1990, J NEUROSCI, V10, P420; Tsodyks M, 1999, HIPPOCAMPUS, V9, P481, DOI 10.1002/(SICI)1098-1063(1999)9:4<481::AID-HIPO14>3.0.CO;2-S; van Strien NM, 2009, NAT REV NEUROSCI, V10, P272, DOI 10.1038/nrn2614; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520; Xie XH, 2002, PHYS REV E, V66, DOI 10.1003/PhysRevE.66.041902; Zhang K, 1996, J NEUROSCI, V16, P2112; Zhang KC, 1999, NEURAL COMPUT, V11, P75, DOI 10.1162/089976699300016809	51	111	111	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2011	14	10					1330	U154		10.1038/nn.2901	http://dx.doi.org/10.1038/nn.2901			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	825EQ	21909090				2022-12-28	WOS:000295254200023
J	Halassa, MM; Siegle, JH; Ritt, JT; Ting, JT; Feng, GP; Moore, CI				Halassa, Michael M.; Siegle, Joshua H.; Ritt, Jason T.; Ting, Jonathan T.; Feng, Guoping; Moore, Christopher I.			Selective optical drive of thalamic reticular nucleus generates thalamic bursts and cortical spindles	NATURE NEUROSCIENCE			English	Article							SLEEP; OSCILLATIONS; PATTERNS; CORTEX; SLOW	The thalamic reticular nucleus (TRN) is hypothesized to regulate neocortical rhythms and behavioral states. Using optogenetics and multi-electrode recording in behaving mice, we found that brief selective drive of TRN switched the thalamocortical firing mode from tonic to bursting and generated state-dependent neocortical spindles. These findings provide causal support for the involvement of the TRN in state regulation in vivo and introduce a new model for addressing the role of this structure in behavior.	[Halassa, Michael M.; Siegle, Joshua H.; Ting, Jonathan T.; Feng, Guoping] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Halassa, Michael M.] Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA; [Ritt, Jason T.] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA; [Moore, Christopher I.] Brown Univ, Dept Neurosci, Providence, RI 02912 USA	Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts General Hospital; Boston University; Brown University	Feng, GP (corresponding author), MIT, Dept Brain & Cognit Sci, E25-618, Cambridge, MA 02139 USA.	fengg@mit.edu; cim@mit.edu	Feng, Guoping/Y-2827-2019	Ting, Jonathan/0000-0001-8266-0392; Moore, Christopher/0000-0003-4534-1602	US National Institutes of Health [R01 NS045130-05]; NATIONAL INSTITUTE OF MENTAL HEALTH [R25MH094612] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045130] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was partially supported by a US National Institutes of Health award (R01 NS045130-05) to C.I.M.	Bezdudnaya T, 2006, NEURON, V49, P421, DOI 10.1016/j.neuron.2006.01.010; Contreras D, 1997, J NEUROSCI, V17, P1179; Dang-Vu TT, 2010, CURR BIOL, V20, pR626, DOI 10.1016/j.cub.2010.06.032; Espinosa F, 2008, J NEUROSCI, V28, P5570, DOI 10.1523/JNEUROSCI.0747-08.2008; Ferrarelli F, 2010, AM J PSYCHIAT, V167, P1339, DOI 10.1176/appi.ajp.2010.09121731; Lesica NA, 2006, PLOS BIOL, V4, P1201, DOI 10.1371/journal.pbio.0040209; Li B, 1999, J PHYSIOL-LONDON, V514, P857, DOI 10.1111/j.1469-7793.1999.857ad.x; McAlonan K, 2008, NATURE, V456, P391, DOI 10.1038/nature07382; McCormick DA, 1997, ANNU REV NEUROSCI, V20, P185, DOI 10.1146/annurev.neuro.20.1.185; Nir Y, 2011, NEURON, V70, P153, DOI 10.1016/j.neuron.2011.02.043; Sherman SM, 2001, NAT NEUROSCI, V4, P344, DOI 10.1038/85973; Sirota A, 2003, P NATL ACAD SCI USA, V100, P2065, DOI 10.1073/pnas.0437938100; Sohal VS, 2006, J NEUROSCI, V26, P4247, DOI 10.1523/JNEUROSCI.3812-05.2006; STERIADE M, 1987, J NEUROPHYSIOL, V57, P260, DOI 10.1152/jn.1987.57.1.260; Steriade M, 2001, NAT NEUROSCI, V4, P671, DOI 10.1038/89434	15	188	194	1	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2011	14	9					1118	1120		10.1038/nn.2880	http://dx.doi.org/10.1038/nn.2880			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	812ID	21785436	Green Accepted			2022-12-28	WOS:000294284900010
J	Puram, SV; Kim, AH; Ikeuchi, Y; Wilson-Grady, JT; Merdes, A; Gygi, SP; Bonni, A				Puram, Sidharth V.; Kim, Albert H.; Ikeuchi, Yoshiho; Wilson-Grady, Joshua T.; Merdes, Andreas; Gygi, Steven P.; Bonni, Azad			A CaMKII beta signaling pathway at the centrosome regulates dendrite patterning in the brain	NATURE NEUROSCIENCE			English	Article							DEPENDENT PROTEIN-KINASE; DEVELOPING CEREBELLUM; NEURONAL DEVELOPMENT; ASSOCIATION DOMAIN; MENTAL-RETARDATION; RAT-BRAIN; MORPHOGENESIS; MECHANISMS; NEUROBIOLOGY; SEPARATION	The protein kinase calcium/calmodulin-dependent kinase II (CaMKII) predominantly consists of the alpha and beta isoforms in the brain. Although CaMKII alpha functions have been elucidated, the isoform-specific catalytic functions of CaMKII beta have remained unknown. Using knockdown analyses in primary rat neurons and in the rat cerebellar cortex in vivo, we report that CaMKII beta operates at the centrosome in a CaMKII alpha-independent manner to drive dendrite retraction and pruning. We also find that the targeting protein PCM1 (pericentriolar material 1) localizes CaMKII beta to the centrosome. Finally, we uncover the E3 ubiquitin ligase Cdc20-APC (cell division cycle 20-anaphase promoting complex) as a centrosomal substrate of CaMKII beta. CaMKII beta phosphorylates Cdc20 at Ser51, which induces Cdc20 dispersion from the centrosome, thereby inhibiting centrosomal Cdc20-APC activity and triggering the transition from growth to retraction of dendrites. Our findings define a new, isoform-specific function for CaMKII beta that regulates ubiquitin signaling at the centrosome and thereby orchestrates dendrite patterning, with important implications for neuronal connectivity in the brain.	[Puram, Sidharth V.; Kim, Albert H.; Ikeuchi, Yoshiho; Bonni, Azad] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Puram, Sidharth V.; Wilson-Grady, Joshua T.; Bonni, Azad] Harvard Univ, Sch Med, Program Biol & Biomed Sci, Boston, MA USA; [Puram, Sidharth V.] Harvard Univ, Sch Med, MD PhD Program, Boston, MA USA; [Kim, Albert H.] Childrens Hosp, Dept Neurosurg, Brigham & Womens Hosp, Boston, MA 02115 USA; [Wilson-Grady, Joshua T.; Gygi, Steven P.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA USA; [Merdes, Andreas] Ctr Natl Rech Sci Pierre Fabre, Ctr Rech Pharmacol Sante, Unite Mixte Rech 2587, Toulouse, France	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Bonni, A (corresponding author), Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA.	azad_bonni@hms.harvard.edu	ikeuchi, yoshiho/C-1713-2014; Ikeuchi, Yoshiho/N-1057-2019; Kim, Albert H./HGF-0057-2022	ikeuchi, yoshiho/0000-0002-2829-3840; Puram, Sidharth/0000-0003-3543-889X	US National Institutes of Health [NS051255]; Ruth L. Kirschstein National Research Service (National Cancer Institute); Brain Science Foundation; Human Frontier Science Program Long-term Fellowship; NATIONAL CANCER INSTITUTE [F32CA124028] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051255] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ruth L. Kirschstein National Research Service (National Cancer Institute)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Brain Science Foundation; Human Frontier Science Program Long-term Fellowship(Human Frontier Science Program); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank M. Ericsson for assistance with electron microscopy experiments and J. Blenis, G. Corfas and members of the Bonni laboratory for discussions and critical reading of the manuscript. This work was supported by US National Institutes of Health grant NS051255 (A.B.), a Ruth L. Kirschstein National Research Service Award (National Cancer Institute), a Brain Science Foundation grant (A.H.K.) and a Human Frontier Science Program Long-term Fellowship (Y.I.).	Altman J, 1997, DEV CEREBELLAR SYSTE; Badano JL, 2005, NAT REV GENET, V6, P194, DOI 10.1038/nrg1557; BORNENS M, 1987, CELL MOTIL CYTOSKEL, V8, P238, DOI 10.1002/cm.970080305; BROCKE L, 1995, J NEUROSCI, V15, P6797; CAJAL SRY, 1995, HISTOLOGY NERVOUS SY, V2, P3; Colbran RJ, 2004, BIOCHEM J, V378, P1, DOI 10.1042/BJ20031547; Corty MM, 2009, DEVELOPMENT, V136, P1049, DOI 10.1242/dev.014423; Dammermann A, 2002, J CELL BIOL, V159, P255, DOI 10.1083/jcb.200204023; de la Torre-Ubieta L, 2010, GENE DEV, V24, P799, DOI 10.1101/gad.1880510; Dierssen M, 2006, GENES BRAIN BEHAV, V5, P48, DOI 10.1111/j.1601-183X.2006.00224.x; ERONDU NE, 1985, J NEUROSCI, V5, P3270; Fink CC, 2003, NEURON, V39, P283, DOI 10.1016/S0896-6273(03)00428-8; Gaudilliere B, 2004, NEURON, V41, P229, DOI 10.1016/S0896-6273(03)00841-9; Gaudilliere B, 2002, J BIOL CHEM, V277, P46442, DOI 10.1074/jbc.M206653200; Gillingham AK, 2000, EMBO REP, V1, P524; GOSLIN K, 1998, RAT HIPPOCAMPAL NEUR; Griffith LC, 2004, J NEUROSCI, V24, P8391, DOI 10.1523/JNEUROSCI.2888-04.2004; HATTEN ME, 1995, ANNU REV NEUROSCI, V18, P385, DOI 10.1146/annurev.ne.18.030195.002125; Higginbotham HR, 2007, TRENDS NEUROSCI, V30, P276, DOI 10.1016/j.tins.2007.04.001; Hoelz A, 2003, MOL CELL, V11, P1241, DOI 10.1016/S1097-2765(03)00171-0; Hudmon A, 2002, BIOCHEM J, V364, P593, DOI 10.1042/BJ20020228; Jan YN, 2003, NEURON, V40, P229, DOI 10.1016/S0896-6273(03)00631-7; KANASEKI T, 1991, J CELL BIOL, V115, P1049, DOI 10.1083/jcb.115.4.1049; Kaufmann WE, 2000, CEREB CORTEX, V10, P981, DOI 10.1093/cercor/10.10.981; Kim AH, 2009, CELL, V136, P322, DOI 10.1016/j.cell.2008.11.050; Kolb SJ, 1998, J BIOL CHEM, V273, P31555, DOI 10.1074/jbc.273.47.31555; Konishi Y, 2004, SCIENCE, V303, P1026, DOI 10.1126/science.1093712; Konur S, 2005, NEURON, V46, P401, DOI 10.1016/j.neuron.2005.04.022; Lee A, 2003, DEVELOPMENT, V130, P5543, DOI 10.1242/dev.00792; Mason CA, 1997, PERSPECT DEV NEUROBI, V5, P69; Miller FD, 2003, CURR OPIN NEUROBIOL, V13, P391, DOI 10.1016/s0959-4388(03)00072-2; MILLER SG, 1985, J BIOL CHEM, V260, P9039; NICOLL RA, 1995, NATURE, V377, P115, DOI 10.1038/377115a0; O'Leary H, 2006, MOL BIOL CELL, V17, P4656, DOI 10.1091/mbc.E06-03-0252; Okamoto KI, 2007, P NATL ACAD SCI USA, V104, P6418, DOI 10.1073/pnas.0701656104; Palay S. L., 1974, CEREBELLAR CORTEX CY; Pardo CA, 2007, BRAIN PATHOL, V17, P434, DOI 10.1111/j.1750-3639.2007.00102.x; Powell SK, 1997, J NEUROBIOL, V32, P223, DOI 10.1002/(SICI)1097-4695(199702)32:2<223::AID-NEU7>3.0.CO;2-A; Rosenberg OS, 2006, FEBS J, V273, P682, DOI 10.1111/j.1742-4658.2005.05088.x; Shalizi A, 2006, SCIENCE, V311, P1012, DOI 10.1126/science.1122513; Shalizi A, 2007, J NEUROSCI, V27, P10037, DOI 10.1523/JNEUROSCI.0361-07.2007; SILVA AJ, 1992, SCIENCE, V257, P206, DOI 10.1126/science.1321493; Songyang Z, 1996, MOL CELL BIOL, V16, P6486; Stegmuller J, 2006, NEURON, V50, P389, DOI 10.1016/j.neuron.2006.03.034; Vaillant AR, 2002, NEURON, V34, P985, DOI 10.1016/S0896-6273(02)00717-1; VALLANO ML, 1989, J NEUROSCI METH, V30, P1, DOI 10.1016/0165-0270(89)90067-8; Wayman GA, 2008, NEURON, V59, P914, DOI 10.1016/j.neuron.2008.08.021; Zou DJ, 1999, J NEUROSCI, V19, P8909, DOI 10.1523/JNEUROSCI.19-20-08909.1999; Zur A, 2001, EMBO J, V20, P792, DOI 10.1093/emboj/20.4.792	49	64	65	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2011	14	8					973	U58		10.1038/nn.2857	http://dx.doi.org/10.1038/nn.2857			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	797KC	21725312	Green Accepted			2022-12-28	WOS:000293123700010
J	Shang, YH; Haynes, P; Pirez, N; Harrington, KI; Guo, F; Pollack, J; Hong, PY; Griffith, LC; Rosbash, M				Shang, Yuhua; Haynes, Paula; Pirez, Nicolas; Harrington, Kyle I.; Guo, Fang; Pollack, Jordan; Hong, Pengyu; Griffith, Leslie C.; Rosbash, Michael			Imaging analysis of clock neurons reveals light buffers the wake-promoting effect of dopamine	NATURE NEUROSCIENCE			English	Article							DROSOPHILA-MELANOGASTER; CIRCADIAN CLOCK; ADENYLYL-CYCLASE; LATERAL NEURONS; REGULATES SLEEP; PDF CELLS; RECEPTOR; OCTOPAMINE; CIRCUIT; AROUSAL	How animals maintain proper amounts of sleep yet remain flexible to changes in environmental conditions remains unknown. We found that environmental light suppressed the wake-promoting effects of dopamine in fly brains. The ten large lateral-ventral neurons (l-LNvs), a subset of clock neurons, are wake-promoting and respond to dopamine, octopamine and light. Behavioral and imaging analyses suggested that dopamine is a stronger arousal signal than octopamine. Notably, light exposure not only suppressed l-LNv responses, but also synchronized responses of neighboring l-LNvs. This regulation occurred by distinct mechanisms: light-mediated suppression of octopamine responses was regulated by the circadian clock, whereas light regulation of dopamine responses occurred by upregulation of inhibitory dopamine receptors. Plasticity therefore alters the relative importance of diverse cues on the basis of the environmental mix of stimuli. The regulatory mechanisms described here may contribute to the control of sleep stability while still allowing behavioral flexibility.	[Shang, Yuhua; Guo, Fang; Rosbash, Michael] Brandeis Univ, Howard Hughes Med Inst, Natl Ctr Behav Genom, Waltham, MA 02254 USA; [Shang, Yuhua; Haynes, Paula; Pirez, Nicolas; Guo, Fang; Griffith, Leslie C.; Rosbash, Michael] Brandeis Univ, Dept Biol, Waltham, MA 02254 USA; [Harrington, Kyle I.; Pollack, Jordan; Hong, Pengyu] Brandeis Univ, Dept Comp Sci, Waltham, MA USA	Brandeis University; Howard Hughes Medical Institute; Brandeis University; Brandeis University	Rosbash, M (corresponding author), Brandeis Univ, Howard Hughes Med Inst, Natl Ctr Behav Genom, Waltham, MA 02254 USA.	rosbash@brandeis.edu	Guo, Fang/H-4067-2014; Hong, Pengyu/AAE-6736-2020	Guo, Fang/0000-0003-2219-2886; Harrington, Kyle/0000-0002-7237-1973; Griffith, Leslie/0000-0003-3164-9876; Hong, Pengyu/0000-0002-3177-2754; Pirez, Nicolas/0000-0002-0463-0080	US National Institutes of Health [PO1 NS044232-06, R01 MH067284, NIH R01 EB007042]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB007042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM033205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH067284] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS045713, P01NS044232] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank P. Taghert for kindly providing pdfGal4 (X) and UAS-EPAC flies. We obtained UAS-D2R-RNAi lines from the Vienna Drosophila RNAi center. We are grateful to O. Shafer for technical help with cAMP imaging. We also thank E. Dougherty for assistance in confocal microscopy, K. Palm and S. Pescatore for administrative assistance and C. Vecsey for comments on the manuscript. The work was supported in part by grants from the US National Institutes of Health (PO1 NS044232-06 to M. R., R01 MH067284 to L. C. G. and NIH R01 EB007042 to P. Hong).	Andretic R, 2005, CURR BIOL, V15, P1165, DOI 10.1016/j.cub.2005.05.025; Bonci A, 2005, NEURON, V47, P335, DOI 10.1016/j.neuron.2005.07.015; Cayre M, 1999, J NEUROPHYSIOL, V81, P1, DOI 10.1152/jn.1999.81.1.1; Chiang AS, 2011, CURR BIOL, V21, P1, DOI 10.1016/j.cub.2010.11.056; Crocker A, 2008, J NEUROSCI, V28, P9377, DOI 10.1523/JNEUROSCI.3072-08a.2008; Crocker A, 2010, GENE DEV, V24, P1220, DOI 10.1101/gad.1913110; Crocker A, 2010, NEURON, V65, P670, DOI 10.1016/j.neuron.2010.01.032; Donlea JM, 2009, SCIENCE, V324, P105, DOI 10.1126/science.1166657; Feinberg EH, 2008, NEURON, V57, P353, DOI 10.1016/j.neuron.2007.11.030; Ganguly-Fitzgerald I, 2006, SCIENCE, V313, P1775, DOI 10.1126/science.1130408; Gervasi N, 2010, NEURON, V65, P516, DOI 10.1016/j.neuron.2010.01.014; Gordon MD, 2009, NEURON, V61, P373, DOI 10.1016/j.neuron.2008.12.033; Hall JC, 2005, METHOD ENZYMOL, V393, P61, DOI 10.1016/S0076-6879(05)93004-8; Hamada FN, 2008, NATURE, V454, P217, DOI 10.1038/nature07001; Han KA, 1996, NEURON, V16, P1127, DOI 10.1016/S0896-6273(00)80139-7; Hearn MG, 2002, P NATL ACAD SCI USA, V99, P14554, DOI 10.1073/pnas.202498299; Helfrich-Forster C, 2007, J COMP NEUROL, V500, P47, DOI 10.1002/cne.21146; Hendricks JC, 2000, NEURON, V25, P129, DOI 10.1016/S0896-6273(00)80877-6; Ho KS, 2005, METHOD ENZYMOL, V393, P772, DOI 10.1016/S0076-6879(05)93041-3; Keene AC, 2010, CURR BIOL, V20, P1209, DOI 10.1016/j.cub.2010.05.029; Kula-Eversole E, 2010, P NATL ACAD SCI USA, V107, P13497, DOI 10.1073/pnas.1002081107; Mao ZM, 2009, FRONT NEURAL CIRCUIT, V3, DOI 10.3389/neuro.04.005.2009; MEYER F, 1994, SIGNAL PROCESS, V38, P113, DOI 10.1016/0165-1684(94)90060-4; Nitabach MN, 2005, J NEUROBIOL, V62, P1, DOI 10.1002/neu.20053; Parisky KM, 2008, NEURON, V60, P672, DOI 10.1016/j.neuron.2008.10.042; Renn SCP, 1999, CELL, V99, P791, DOI 10.1016/S0092-8674(00)81676-1; Shafer OT, 2008, NEURON, V58, P223, DOI 10.1016/j.neuron.2008.02.018; Shakiryanova D, 2008, P NATL ACAD SCI USA, V105, P13610, DOI 10.1073/pnas.0802131105; Shang YH, 2008, P NATL ACAD SCI USA, V105, P19587, DOI 10.1073/pnas.0809577105; Shaw PJ, 2000, SCIENCE, V287, P1834, DOI 10.1126/science.287.5459.1834; Sheeba V, 2008, CURR BIOL, V18, P1537, DOI 10.1016/j.cub.2008.08.033; Sheeba V, 2008, J NEUROPHYSIOL, V99, P976, DOI 10.1152/jn.00930.2007; Soille P., 2004, MORPHOLOGICAL IMAGE, DOI [10.1007/978-3-662-05088-0, DOI 10.1007/978-3-662-05088-0]; SUGAMORI KS, 1995, FEBS LETT, V362, P131, DOI 10.1016/0014-5793(95)00224-W; Wang JW, 2003, CELL, V112, P271, DOI 10.1016/S0092-8674(03)00004-7; Wijnen H, 2006, PLOS GENET, V2, P326, DOI 10.1371/journal.pgen.0020039	36	77	79	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2011	14	7					889	U110		10.1038/nn.2860	http://dx.doi.org/10.1038/nn.2860			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	783KR	21685918	Green Accepted			2022-12-28	WOS:000292081700017
J	McCarthy, MM; Arnold, AP				McCarthy, Margaret M.; Arnold, Arthur P.			Reframing sexual differentiation of the brain	NATURE NEUROSCIENCE			English	Review							ESTROGEN-RECEPTOR-ALPHA; COMPLEMENT AFFECTS NOCICEPTION; CHROMOSOME COMPLEMENT; GENE-EXPRESSION; EPIGENETIC REGULATION; CELL-DEATH; ESTRADIOL; BEHAVIOR; ADULT; MASCULINIZATION	In the twentieth century, the dominant model of sexual differentiation stated that genetic sex (XX versus XY) causes differentiation of the gonads, which then secrete gonadal hormones that act directly on tissues to induce sex differences in function. This serial model of sexual differentiation was simple, unifying and seductive. Recent evidence, however, indicates that the linear model is incorrect and that sex differences arise in response to diverse sex-specific signals originating from inherent differences in the genome and involve cellular mechanisms that are specific to individual tissues or brain regions. Moreover, sex-specific effects of the environment reciprocally affect biology, sometimes profoundly, and must therefore be integrated into a realistic model of sexual differentiation. A more appropriate model is a parallel-interactive model that encompasses the roles of multiple molecular signals and pathways that differentiate males and females, including synergistic and compensatory interactions among pathways and an important role for the environment.	[McCarthy, Margaret M.] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA; [McCarthy, Margaret M.] Univ Maryland, Sch Med, Dept Psychiat, Baltimore, MD 21201 USA; [McCarthy, Margaret M.] Univ Maryland, Sch Med, Program Neurosci, Baltimore, MD 21201 USA; [Arnold, Arthur P.] Univ Calif Los Angeles, Dept Integrat Biol & Physiol, Los Angeles, CA USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University of California System; University of California Los Angeles	McCarthy, MM (corresponding author), Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA.	mmccarth@umaryland.edu	McCarthy, Margaret/O-2059-2017	McCarthy, Margaret/0000-0003-2243-4726; Arnold, Arthur/0000-0002-9908-9767	 [MH52716];  [NS050525];  [NS043196];  [DC000217]; NATIONAL INSTITUTE OF MENTAL HEALTH [R29MH052716, R01MH052716] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS050525, R01NS050525, R01NS043196] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC000217] Funding Source: NIH RePORTER	; ; ; ; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	Work on this manuscript was supported by grants MH52716 and NS050525 to M.M.M. and grants NS043196 and DC000217 to A.P.A.	ABEL JM, 2011, NEUROENDOCRINOL 0216, DOI DOI 10.1159/000324402; Amateau SK, 2004, NAT NEUROSCI, V7, P643, DOI 10.1038/nn1254; Arnold AP, 2004, NAT REV NEUROSCI, V5, P701, DOI 10.1038/nrn1494; Arnold AP, 2004, ENDOCRINOLOGY, V145, P1057, DOI 10.1210/en.2003-1491; Arnold AP, 2009, HORM BEHAV, V55, P570, DOI 10.1016/j.yhbeh.2009.03.011; Arnold AP, 2009, J NEUROENDOCRINOL, V21, P377, DOI 10.1111/j.1365-2826.2009.01831.x; Arnold AP, 2009, FRONT NEUROENDOCRIN, V30, P1, DOI 10.1016/j.yfrne.2008.11.001; Bakker J, 2003, ANN NY ACAD SCI, V1007, P251, DOI 10.1196/annals.1286.024; Bakker J, 2010, J NEUROENDOCRINOL, V22, P728, DOI 10.1111/j.1365-2826.2010.02016.x; Balthazart J, 2006, TRENDS NEUROSCI, V29, P241, DOI 10.1016/j.tins.2006.03.004; Barker JM, 2010, J NEUROSCI, V30, P9140, DOI 10.1523/JNEUROSCI.0548-10.2010; Beato M, 2000, HUM REPROD UPDATE, V6, P225, DOI 10.1093/humupd/6.3.225; BEATO M, 1989, CELL, V56, P335, DOI 10.1016/0092-8674(89)90237-7; Becker JB, 2001, ANN NY ACAD SCI, V937, P172, DOI 10.1111/j.1749-6632.2001.tb03564.x; Beery AK, 2011, NEUROSCI BIOBEHAV R, V35, P565, DOI 10.1016/j.neubiorev.2010.07.002; Bowers J Michael, 2010, Biol Sex Differ, V1, P8, DOI 10.1186/2042-6410-1-8; Cahill L, 2006, NAT REV NEUROSCI, V7, P477, DOI 10.1038/nrn1909; Champagne FA, 2008, FRONT NEUROENDOCRIN, V29, P386, DOI 10.1016/j.yfrne.2008.03.003; Chang SC, 2006, FRONT BIOSCI-LANDMRK, V11, P852, DOI 10.2741/1842; Chen XQ, 2008, DEV NEUROBIOL, V68, P265, DOI 10.1002/dneu.20581; Chen XQ, 2009, EUR J NEUROSCI, V29, P768, DOI 10.1111/j.1460-9568.2009.06610.x; Cox KH, 2011, GENES BRAIN BEHAV, V10, P465, DOI 10.1111/j.1601-183X.2011.00688.x; Davies W, 2006, BIOESSAYS, V28, P35, DOI 10.1002/bies.20341; de Vries GJ, 2008, ENDOCRINOLOGY, V149, P4632, DOI 10.1210/en.2008-0448; De Vries GJ, 2004, ENDOCRINOLOGY, V145, P1063, DOI 10.1210/en.2003-1504; De Vries GJ, 2002, J NEUROSCI, V22, P9005; Dewing P, 2006, CURR BIOL, V16, P415, DOI 10.1016/j.cub.2006.01.017; Fausto-Sterling A, 2000, SEXING BODY GENDER P; Forger NG, 2004, P NATL ACAD SCI USA, V101, P13666, DOI 10.1073/pnas.0404644101; Frome PM, 1998, J PERS SOC PSYCHOL, V74, P435, DOI 10.1037/0022-3514.74.2.435; Garcia-Segura LM, 2008, REPRODUCTION, V135, P419, DOI 10.1530/REP-07-0540; Gatewood JD, 2006, J NEUROSCI, V26, P2335, DOI 10.1523/JNEUROSCI.3743-05.2006; Gioiosa L, 2008, J PAIN, V9, P962, DOI 10.1016/j.jpain.2008.06.001; Gioiosa L, 2008, HORM BEHAV, V53, P124, DOI 10.1016/j.yhbeh.2007.09.003; GOODFELLOW PN, 1993, ANNU REV GENET, V27, P71, DOI 10.1146/annurev.ge.27.120193.000443; Gregg C, 2010, SCIENCE, V329, P682, DOI 10.1126/science.1190831; GRISHAM W, 1994, J NEUROBIOL, V25, P185, DOI 10.1002/neu.480250209; HERRMANN K, 1991, J NEUROBIOL, V22, P29, DOI 10.1002/neu.480220104; Hill MN, 2010, J NEUROSCI, V30, P14980, DOI 10.1523/JNEUROSCI.4283-10.2010; Honda S, 1998, BIOCHEM BIOPH RES CO, V252, P445, DOI 10.1006/bbrc.1998.9672; Isgor C, 1998, HORM BEHAV, V34, P183, DOI 10.1006/hbeh.1998.1477; Jazin E, 2010, NAT REV NEUROSCI, V11, P9, DOI 10.1038/nrn2754; Juntti SA, 2008, HORM BEHAV, V53, P627, DOI 10.1016/j.yhbeh.2007.12.012; Juntti SA, 2010, NEURON, V66, P260, DOI 10.1016/j.neuron.2010.03.024; Krebs-Kraft DL, 2010, P NATL ACAD SCI USA, V107, P20535, DOI 10.1073/pnas.1005003107; Krishnan S, 2009, P NATL ACAD SCI USA, V106, P16692, DOI 10.1073/pnas.0906293106; Kudwa AE, 2005, P NATL ACAD SCI USA, V102, P4608, DOI 10.1073/pnas.0500752102; Kurian JR, 2010, ENDOCRINOLOGY, V151, P2297, DOI 10.1210/en.2009-0649; Lenz KM, 2006, BRAIN RES, V1092, P87, DOI 10.1016/j.brainres.2006.03.070; Lippa RA, 2010, ARCH SEX BEHAV, V39, P619, DOI 10.1007/s10508-008-9380-7; London SE, 2009, FRONT NEUROENDOCRIN, V30, P302, DOI 10.1016/j.yfrne.2009.05.001; Majdic G, 2011, FRONT NEUROENDOCRIN, V32, P137, DOI 10.1016/j.yfrne.2011.02.009; Matsumoto A, 2000, SEXUAL DIFFERENTIATION OF THE BRAIN, P203; McCarthy MM, 2009, HORMONES, BRAIN AND BEHAVIOR, VOLS 1-5, 2ND EDITION, P1707; Mccarthy MM, 2008, PHYSIOL REV, V88, P91, DOI 10.1152/physrev.00010.2007; McCarthy MM, 2009, J NEUROSCI, V29, P12815, DOI 10.1523/JNEUROSCI.3331-09.2009; McCarthy MM, 2005, FRONT NEUROENDOCRIN, V26, P85, DOI 10.1016/j.yfrne.2005.06.001; McPhie-Lalmansingh AA, 2008, HORM BEHAV, V54, P565, DOI 10.1016/j.yhbeh.2008.05.016; Micevych P, 2009, J NEUROENDOCRINOL, V21, P249, DOI 10.1111/j.1365-2826.2009.01833.x; MIGEON BR, 2007, FEMALES MOSAIC X INA; Mogil JS, 2005, PAIN, V117, P1, DOI 10.1016/j.pain.2005.06.020; Mong JA, 1999, J NEUROSCI, V19, P1464; Mong JA, 2002, J NEUROENDOCRINOL, V14, P45, DOI 10.1046/j.1365-2826.2002.00737.x; MOORE CL, 1984, DEV PSYCHOBIOL, V17, P347, DOI 10.1002/dev.420170403; Morris JA, 2004, NAT NEUROSCI, V7, P1034, DOI 10.1038/nn1325; Murray EK, 2009, ENDOCRINOLOGY, V150, P4241, DOI 10.1210/en.2009-0458; Ogawa S, 1998, ENDOCRINOLOGY, V139, P5070, DOI 10.1210/en.139.12.5070; Ogawa S, 2000, P NATL ACAD SCI USA, V97, P14737, DOI 10.1073/pnas.250473597; Park JH, 2010, J NEUROSCI, V30, P9967, DOI 10.1523/JNEUROSCI.1988-10.2010; Petrosino S, 2010, CURR OPIN INVEST DR, V11, P51; PHOENIX CH, 1959, ENDOCRINOLOGY, V65, P369, DOI 10.1210/endo-65-3-369; Quinn JJ, 2007, NAT NEUROSCI, V10, P1398, DOI 10.1038/nn1994; Remage-Healey L, 2008, NAT NEUROSCI, V11, P1327, DOI 10.1038/nn.2200; Schwarz JM, 2008, HORM BEHAV, V54, P662, DOI 10.1016/j.yhbeh.2008.07.004; Schwarz JM, 2008, NEURON, V58, P584, DOI 10.1016/j.neuron.2008.03.008; Schwarz JM, 2010, ENDOCRINOLOGY, V151, P4871, DOI 10.1210/en.2010-0142; Simerly RB, 2002, ANNU REV NEUROSCI, V25, P507, DOI 10.1146/annurev.neuro.25.112701.142745; Sisk CL, 2005, FRONT NEUROENDOCRIN, V26, P163, DOI 10.1016/j.yfrne.2005.10.003; Smith-Bouvier DL, 2008, J EXP MED, V205, P1099, DOI 10.1084/jem.20070850; SWAAB DF, 1995, TRENDS NEUROSCI, V18, P264, DOI 10.1016/0166-2236(95)93913-I; Szyf M, 2008, ENVIRON MOL MUTAGEN, V49, P46, DOI 10.1002/em.20357; Todd BJ, 2007, DEV NEUROBIOL, V67, P304, DOI 10.1002/dneu.20337; Tsai HW, 2009, EPIGENETICS-US, V4, P47, DOI 10.4161/epi.4.1.7288; van Nas A, 2009, ENDOCRINOLOGY, V150, P1235, DOI 10.1210/en.2008-0563; Voskuhl Rhonda, 2011, Biol Sex Differ, V2, P1, DOI 10.1186/2042-6410-2-1; Waters EM, 2009, J NEUROSCI, V29, P9714, DOI 10.1523/JNEUROSCI.0135-09.2009; Westberry JM, 2010, ENDOCRINOLOGY, V151, P731, DOI 10.1210/en.2009-0955; Woolley CS, 2007, ANNU REV PHARMACOL, V47, P657, DOI 10.1146/annurev.pharmtox.47.120505.105219; Wright CL, 2008, DEV NEUROBIOL, V68, P1406, DOI 10.1002/dneu.20665; Wright CL, 2009, J NEUROSCI, V29, P13274, DOI 10.1523/JNEUROSCI.3603-09.2009; Zhang JM, 2008, EUR J NEUROSCI, V27, P791, DOI 10.1111/j.1460-9568.2008.06073.x; Zhao D, 2010, NATURE, V464, P237, DOI 10.1038/nature08852	92	451	462	1	105	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2011	14	6					677	683		10.1038/nn.2834	http://dx.doi.org/10.1038/nn.2834			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	768SH	21613996	Green Accepted			2022-12-28	WOS:000290958000006
J	Deeg, KE; Aizenman, CD				Deeg, Katherine E.; Aizenman, Carlos D.			Sensory modality-specific homeostatic plasticity in the developing optic tectum	NATURE NEUROSCIENCE			English	Article							SYNAPTIC-TRANSMISSION; QUANTAL AMPLITUDE; EXPERIENCE; CONVERGENCE; SYNAPSES; NEURONS	We found a previously unknown form of homeostatic synaptic plasticity in multisensory neurons in the optic tectum of Xenopus laevis tadpoles. Individual tectal neurons are known to receive converging inputs from multiple sensory modalities. We observed that long-term alterations in either visual or mechanosensory activity in vivo resulted in homeostatic changes specific to each sensory modality. In contrast with typical forms of homeostatic synaptic plasticity, such as synaptic scaling, we found that this type of plasticity occurred in a pathway-specific manner that is more reminiscent of Hebbian-type plasticity.	[Deeg, Katherine E.; Aizenman, Carlos D.] Brown Univ, Dept Neurosci, Providence, RI 02912 USA	Brown University	Aizenman, CD (corresponding author), Brown Univ, Dept Neurosci, Providence, RI 02912 USA.	carlos_aizenman@brown.edu			National Science Foundation Division of Integrative Organismal Systems; National Eye Institute of the US National Institutes of Health; Whitehall Foundation; NATIONAL EYE INSTITUTE [R01EY019578] Funding Source: NIH RePORTER	National Science Foundation Division of Integrative Organismal Systems(National Science Foundation (NSF)); National Eye Institute of the US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Whitehall Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We would like to thank B. Connors for helpful comments on the manuscript and members of the Aizenman laboratory for their support. Funding was provided by the National Science Foundation Division of Integrative Organismal Systems, the National Eye Institute of the US National Institutes of Health and the Whitehall Foundation.	Deeg KE, 2009, J NEUROPHYSIOL, V102, P3392, DOI 10.1152/jn.00632.2009; Desai NS, 2002, NAT NEUROSCI, V5, P783, DOI 10.1038/nn878; Goel A, 2006, NAT NEUROSCI, V9, P1001, DOI 10.1038/nn1725; Hiramoto M, 2009, DEV NEUROBIOL, V69, P959, DOI 10.1002/dneu.20754; Kim J, 2008, NEURON, V58, P925, DOI 10.1016/j.neuron.2008.05.009; Kuczewski N, 2009, MOL NEUROBIOL, V39, P37, DOI 10.1007/s12035-009-8050-7; Pratt KG, 2008, NAT NEUROSCI, V11, P467, DOI 10.1038/nn2076; Pratt KG, 2007, J NEUROSCI, V27, P8268, DOI 10.1523/JNEUROSCI.1738-07.2007; Rutherford LC, 1998, NEURON, V21, P521, DOI 10.1016/S0896-6273(00)80563-2; Steward O, 2003, NEURON, V40, P347, DOI 10.1016/S0896-6273(03)00635-4; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; Turrigiano GG, 2000, CURR OPIN NEUROBIOL, V10, P358, DOI 10.1016/S0959-4388(00)00091-X; Tyler WJ, 2007, J NEUROSCI, V27, P9427, DOI 10.1523/JNEUROSCI.0664-07.2007; Xu-Friedman MA, 2000, J NEUROSCI, V20, P4414, DOI 10.1523/JNEUROSCI.20-12-04414.2000	14	30	30	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2011	14	5					548	550		10.1038/nn.2772	http://dx.doi.org/10.1038/nn.2772			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	754VU	21441922	Green Accepted			2022-12-28	WOS:000289886600008
J	Westerlund, N; Zdrojewska, J; Padzik, A; Komulainen, E; Bjorkblom, B; Rannikko, E; Tararuk, T; Garcia-Frigola, C; Sandholm, J; Nguyen, L; Kallunki, T; Courtney, MJ; Coffey, ET				Westerlund, Nina; Zdrojewska, Justyna; Padzik, Artur; Komulainen, Emilia; Bjorkblom, Benny; Rannikko, Emmy; Tararuk, Tanya; Garcia-Frigola, Cristina; Sandholm, Jouko; Nguyen, Laurent; Kallunki, Tuula; Courtney, Michael J.; Coffey, Eleanor T.			Phosphorylation of SCG10/stathmin-2 determines multipolar stage exit and neuronal migration rate	NATURE NEUROSCIENCE			English	Article							N-TERMINAL KINASE-1; C-JUN; MICROTUBULE DYNAMICS; CELL-MIGRATION; PROTEIN SCG10; GROWTH CONES; IN-VITRO; JNK1; STATHMIN; BRAIN	Cell migration is the consequence of the sum of positive and negative regulatory mechanisms. Although appropriate migration of neurons is a principal feature of brain development, the negative regulatory mechanisms remain obscure. We found that JNK1 was highly active in developing cortex and that selective inhibition of JNK in the cytoplasm markedly increased both the frequency of exit from the multipolar stage and radial migration rate and ultimately led to an ill-defined cellular organization. Moreover, regulation of multipolar-stage exit and radial migration in Jnk1(-/-) (also known as Mapk8) mice, resulted from consequential changes in phosphorylation of the microtubule regulator SCG10 (also called stathmin-2). Expression of an SCG10 mutant that mimics the JNK1-phosphorylated form restored normal migration in the brains of Jnk1(-/-) mouse embryos. These findings indicate that the phosphorylation of SCG10 by JNK1 is a fundamental mechanism that governs the transition from the multipolar stage and the rate of neuronal cell movement during cortical development.	[Westerlund, Nina; Zdrojewska, Justyna; Padzik, Artur; Komulainen, Emilia; Bjorkblom, Benny; Rannikko, Emmy; Tararuk, Tanya; Sandholm, Jouko; Coffey, Eleanor T.] Abo Akad Univ, Turku Ctr Biotechnol, Turku, Finland; [Westerlund, Nina; Zdrojewska, Justyna; Padzik, Artur; Komulainen, Emilia; Bjorkblom, Benny; Rannikko, Emmy; Tararuk, Tanya; Sandholm, Jouko; Coffey, Eleanor T.] Univ Turku, Turku, Finland; [Bjorkblom, Benny] Univ Hosp, Norwegian Ctr Movement Disorders, Stavanger, Norway; [Garcia-Frigola, Cristina] Univ Miguel Hernandez, CSIC, Inst Neurociencias, Alicante, Spain; [Nguyen, Laurent] Univ Liege, Grp Interdisciplinaire Genoproteom Appl Neurosci, B-4000 Liege, Belgium; [Kallunki, Tuula] Danish Canc Soc, Copenhagen, Denmark; [Courtney, Michael J.] Univ Eastern Finland, Kuopio, Finland	Abo Akademi University; University of Turku; University of Turku; Stavanger University Hospital; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Miguel Hernandez de Elche; CSIC-UMH - Instituto de Neurociencias de Alicante (IN); University of Liege; Danish Cancer Society; University of Eastern Finland	Coffey, ET (corresponding author), Abo Akad Univ, Turku Ctr Biotechnol, Turku, Finland.	ecoffey@btk.fi	Courtney, Michael J/D-6648-2016; Komulainen, Emilia/AAR-5657-2021	Courtney, Michael J/0000-0001-8693-3933; Coffey, Eleanor/0000-0002-9717-5610; Komulainen, Emilia/0000-0002-2804-1678; Garcia-Frigola, Cristina/0000-0003-2434-3879; Sandholm, Jouko/0000-0003-0638-2444; Kallunki, Tuula/0000-0002-8571-383X; Rannikko, Emmy/0000-0001-6517-275X; Nguyen, Laurent/0000-0002-8560-3008	Academy of Finland [218125, 125860, 206497, 111870, 203520, 110445]; Turku Graduate School of Biomedical Sciences; Finnish Graduate School of Neuroscience; Magnus Ehrnrooth's Foundation; FP6 STRESSPROTECT; Abo Akademi University; Danish Cancer Society; Walloon Excellence in Lifesciences and Biotechnology	Academy of Finland(Academy of Finland); Turku Graduate School of Biomedical Sciences; Finnish Graduate School of Neuroscience; Magnus Ehrnrooth's Foundation; FP6 STRESSPROTECT(European Commission); Abo Akademi University; Danish Cancer Society(Danish Cancer Society); Walloon Excellence in Lifesciences and Biotechnology	We thank T. Herdegen for mice for pilot experiments. This work was supported by grants from the Academy of Finland (218125, 125860, 206497, 111870, 203520 and 110445), Turku Graduate School of Biomedical Sciences, the Finnish Graduate School of Neuroscience, Magnus Ehrnrooth's Foundation, FP6 STRESSPROTECT and Abo Akademi University. T.K. was supported by the Danish Cancer Society. L.N. is funded by Walloon Excellence in Lifesciences and Biotechnology.	Antonsson B, 1998, J BIOL CHEM, V273, P8439, DOI 10.1074/jbc.273.14.8439; Ayala R, 2007, CELL, V128, P29, DOI 10.1016/j.cell.2006.12.021; Baas PW, 2001, TRENDS CELL BIOL, V11, P244, DOI 10.1016/S0962-8924(01)02005-0; Baldassarre G, 2005, CANCER CELL, V7, P51, DOI 10.1016/j.ccr.2004.11.025; Bjorkblom B, 2005, J NEUROSCI, V25, P6350, DOI 10.1523/JNEUROSCI.1517-05.2005; Bjorkblom B, 2008, J BIOL CHEM, V283, P19704, DOI 10.1074/jbc.M707744200; Bogoyevitch MA, 2006, MICROBIOL MOL BIOL R, V70, P1061, DOI 10.1128/MMBR.00025-06; Chang LF, 2003, DEV CELL, V4, P521, DOI 10.1016/S1534-5807(03)00094-7; Charbaut E, 2001, J BIOL CHEM, V276, P16146, DOI 10.1074/jbc.M010637200; Coffey ET, 2002, J NEUROSCI, V22, P4335, DOI 10.1523/JNEUROSCI.22-11-04335.2002; Coffey ET, 2000, J NEUROSCI, V20, P7602; Dehmelt L, 2006, BRAIN CELL BIOL, V35, P39, DOI 10.1007/s11068-006-9001-0; Etienne-Manneville S, 2004, TRAFFIC, V5, P470, DOI 10.1111/j.1600-0854.2004.00196.x; Gavet O, 2002, J NEUROSCI RES, V68, P535, DOI 10.1002/jnr.10234; Gigant B, 2000, CELL, V102, P809, DOI 10.1016/S0092-8674(00)00069-6; Guerrini R, 2006, EXP BRAIN RES, V173, P322, DOI 10.1007/s00221-006-0501-z; HATTEN ME, 1990, TRENDS NEUROSCI, V13, P179, DOI 10.1016/0166-2236(90)90044-B; Hatten ME, 1999, ANNU REV NEUROSCI, V22, P511, DOI 10.1146/annurev.neuro.22.1.511; Heng JIT, 2008, NATURE, V455, P114, DOI 10.1038/nature07198; Hevner RF, 2001, NEURON, V29, P353, DOI 10.1016/S0896-6273(01)00211-2; Hirai S, 2002, DEVELOPMENT, V129, P4483; Huang SC, 2005, BIOCHEM PHARMACOL, V69, P221, DOI 10.1016/j.bcp.2004.09.019; Javelaud D, 2003, J BIOL CHEM, V278, P24624, DOI 10.1074/jbc.M301942200; KALLUNKI T, 1994, GENE DEV, V8, P2996, DOI 10.1101/gad.8.24.2996; Kawauchi T, 2003, EMBO J, V22, P4190, DOI 10.1093/emboj/cdg413; Kuan CY, 1999, NEURON, V22, P667, DOI 10.1016/S0896-6273(00)80727-8; LIM SS, 1990, J CELL BIOL, V111, P123, DOI 10.1083/jcb.111.1.123; LoTurco JJ, 2006, TRENDS NEUROSCI, V29, P407, DOI 10.1016/j.tins.2006.05.006; Manna T, 2007, BIOCHEMISTRY-US, V46, P3543, DOI 10.1021/bi061819d; Marin O, 2003, ANNU REV NEUROSCI, V26, P441, DOI 10.1146/annurev.neuro.26.041002.131058; Ozon S, 2002, MOL BIOL CELL, V13, P698, DOI 10.1091/mbc.01-07-0362; Palazzo Alexander F, 2002, Sci STKE, V2002, ppe31, DOI 10.1126/stke.2002.139.pe31; Rana S, 2008, EXPERT REV ANTICANC, V8, P1461, DOI 10.1586/14737140.8.9.1461; Sabapathy K, 1999, MECH DEVELOP, V89, P115, DOI 10.1016/S0925-4773(99)00213-0; Schaefer AW, 2002, J CELL BIOL, V158, P139, DOI 10.1083/jcb.200203038; SIDMAN RL, 1973, BRAIN RES, V62, P1, DOI 10.1016/0006-8993(73)90617-3; Sluss HK, 1997, J CELL BIOCHEM, V67, P1; STEIN R, 1988, NEURON, V1, P463, DOI 10.1016/0896-6273(88)90177-8; Takatori A, 2008, DEVELOPMENT, V135, P23, DOI 10.1242/dev.007120; TANAKA E, 1995, J CELL BIOL, V128, P139, DOI 10.1083/jcb.128.1.139; Tararuk T, 2006, J CELL BIOL, V173, P265, DOI 10.1083/jcb.200511055; Wang X, 2007, MOL CELL BIOL, V27, P7935, DOI 10.1128/MCB.00226-07; Westerlund N, 2008, EXPERT OPIN THER TAR, V12, P31, DOI 10.1517/14728222.12.1.31; Xia Y, 2004, TRENDS CELL BIOL, V14, P94, DOI 10.1016/j.tcb.2003.12.005	44	84	91	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2011	14	3					305	313		10.1038/nn.2755	http://dx.doi.org/10.1038/nn.2755			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	725MW	21297631	Green Submitted			2022-12-28	WOS:000287650100010
J	Marder, E; Taylor, AL				Marder, Eve; Taylor, Adam L.			Multiple models to capture the variability in biological neurons and networks	NATURE NEUROSCIENCE			English	Article							ACTIVITY-DEPENDENT REGULATION; RHYTHMICALLY ACTIVE NEURONS; CENTRAL PATTERN GENERATOR; CIRCUIT PARAMETERS; CONDUCTANCES; EXPRESSION; SINGLE; CURRENTS; DYNAMICS; CONSTRUCTION	How tightly tuned are the synaptic and intrinsic properties that give rise to neuron and circuit function? Experimental work shows that these properties vary considerably across identified neurons in different animals. Given this variability in experimental data, this review describes some of the complications of building computational models to aid in understanding how system dynamics arise from the interaction of system components. We argue that instead of trying to build a single model that captures the generic behavior of a neuron or circuit, it is beneficial to construct a population of models that captures the behavior of the population that provided the experimental data. Studying a population of models with different underlying structure and similar behaviors provides opportunities to discover unsuspected compensatory mechanisms that contribute to neuron and network function.	[Marder, Eve; Taylor, Adam L.] Brandeis Univ, Dept Biol, Waltham, MA 02254 USA; [Marder, Eve; Taylor, Adam L.] Brandeis Univ, Volen Ctr, Waltham, MA 02254 USA	Brandeis University; Brandeis University	Marder, E (corresponding author), Brandeis Univ, Dept Biol, Waltham, MA 02254 USA.	marder@brandeis.edu	Marder, Eve/A-5713-2012		US National Institutes of Health [NS17813, MH46742]; James D. McDonnell Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH046742, R37MH046742] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS017813, R01NS017813] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); James D. McDonnell Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by US National Institutes of Health grants NS17813 and MH46742, and by the James D. McDonnell Foundation.	Beer RD, 1999, J COMPUT NEUROSCI, V7, P119, DOI 10.1023/A:1008920021246; BHALLA US, 1993, J NEUROPHYSIOL, V69, P1948, DOI 10.1152/jn.1993.69.6.1948; Bucher D, 2005, J NEUROSCI, V25, P1611, DOI 10.1523/JNEUROSCI.3679-04.2005; Butera RJ, 1999, J NEUROPHYSIOL, V82, P398, DOI 10.1152/jn.1999.82.1.398; CONNOR JA, 1977, BIOPHYS J, V18, P81, DOI 10.1016/S0006-3495(77)85598-7; Davis GW, 2006, ANNU REV NEUROSCI, V29, P307, DOI 10.1146/annurev.neuro.28.061604.135751; Demarque M, 2010, NEURON, V67, P321, DOI 10.1016/j.neuron.2010.06.006; Desai NS, 1999, NEUROCOMPUTING, V26-7, P101, DOI 10.1016/S0925-2312(99)00004-1; Edelman GM, 2001, P NATL ACAD SCI USA, V98, P13763, DOI 10.1073/pnas.231499798; Goaillard JM, 2009, NAT NEUROSCI, V12, P1424, DOI 10.1038/nn.2404; Goldman MS, 2001, J NEUROSCI, V21, P5229, DOI 10.1523/JNEUROSCI.21-14-05229.2001; Golowasch J, 2002, J NEUROPHYSIOL, V87, P1129, DOI 10.1152/jn.00412.2001; Grashow R, 2010, J NEUROSCI, V30, P9145, DOI 10.1523/JNEUROSCI.0980-10.2010; Grashow R, 2009, P NATL ACAD SCI USA, V106, P11742, DOI 10.1073/pnas.0905614106; GUCKENHEIMER J, 1993, PHILOS T ROY SOC B, V341, P345, DOI 10.1098/rstb.1993.0121; Gunay C, 2008, J NEUROSCI, V28, P7476, DOI 10.1523/JNEUROSCI.4198-07.2008; HAGIWARA SUSUMU, 1958, JAPANESE JOUR PHYSIOL, V8, P234; Hobbs KH, 2008, J NEUROPHYSIOL, V99, P1871, DOI 10.1152/jn.00032.2008; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Hudson AE, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000838; Jaeger D, 1997, J NEUROSCI, V17, P91, DOI 10.1523/JNEUROSCI.17-01-00091.1997; Jezzini SH, 2004, J NEUROPHYSIOL, V91, P958, DOI 10.1152/jn.00656.2003; Khorkova O, 2007, J NEUROSCI, V27, P8709, DOI 10.1523/JNEUROSCI.1274-07.2007; Korobkova E, 2004, NATURE, V428, P574, DOI 10.1038/nature02404; LEMASSON G, 1993, SCIENCE, V259, P1915, DOI 10.1126/science.8456317; Liu Z, 1998, J NEUROSCI, V18, P2309; MacLean JN, 2005, J NEUROPHYSIOL, V94, P3601, DOI 10.1152/jn.00281.2005; MacLean JN, 2003, NEURON, V37, P109, DOI 10.1016/S0896-6273(02)01104-2; Maffei A, 2009, CURR OPIN NEUROBIOL, V19, P168, DOI 10.1016/j.conb.2009.05.012; Marder E, 1996, PHYSIOL REV, V76, P687, DOI 10.1152/physrev.1996.76.3.687; Marder E, 2006, NAT REV NEUROSCI, V7, P563, DOI 10.1038/nrn1949; Nerbonne JM, 2008, J PHYSIOL-LONDON, V586, P1565, DOI 10.1113/jphysiol.2007.146597; Norris BJ, 2007, J NEUROPHYSIOL, V98, P2992, DOI 10.1152/jn.00877.2007; Olypher AV, 2007, J NEUROPHYSIOL, V98, P3749, DOI 10.1152/jn.00842.2007; Olypher AV, 2010, J COMPUT NEUROSCI, V28, P361, DOI 10.1007/s10827-010-0213-z; Padmanabhan K, 2010, NAT NEUROSCI, V13, P1276, DOI 10.1038/nn.2630; Prinz AA, 2004, NAT NEUROSCI, V7, P1345, DOI 10.1038/nn1352; Prinz AA, 2003, J NEUROPHYSIOL, V90, P3998, DOI 10.1152/jn.00641.2003; Robert C.P., 2000, TECHNOMETRICS, V42, P430, DOI [10.2307/1270959, DOI 10.2307/1270959]; Schulz DJ, 2007, P NATL ACAD SCI USA, V104, P13187, DOI 10.1073/pnas.0705827104; Schulz DJ, 2006, NAT NEUROSCI, V9, P356, DOI 10.1038/nn1639; Sobie EA, 2009, BIOPHYS J, V96, P1264, DOI 10.1016/j.bpj.2008.10.056; Swensen AM, 2005, J NEUROSCI, V25, P3509, DOI 10.1523/JNEUROSCI.3929-04.2005; Tang LS, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000469; Taylor AL, 2006, J NEUROPHYSIOL, V96, P891, DOI 10.1152/jn.00367.2006; Taylor AL, 2009, J NEUROSCI, V29, P5573, DOI 10.1523/JNEUROSCI.4438-08.2009; Tobin AE, 2006, J NEUROPHYSIOL, V96, P2089, DOI 10.1152/jn.00025.2006; TRAUB RD, 1991, J NEUROPHYSIOL, V66, P635, DOI 10.1152/jn.1991.66.2.635; Turrigiano GG, 2008, CELL, V135, P422, DOI 10.1016/j.cell.2008.10.008; Vanier MC, 1999, J COMPUT NEUROSCI, V7, P149, DOI 10.1023/A:1008972005316	50	255	256	0	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2011	14	2					133	138		10.1038/nn.2735	http://dx.doi.org/10.1038/nn.2735			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	711MJ	21270780	Green Accepted			2022-12-28	WOS:000286595400007
J	Li, SL; Overman, JJ; Katsman, D; Kozlov, SV; Donnelly, CJ; Twiss, JL; Giger, RJ; Coppola, G; Geschwind, DH; Carmichael, ST				Li, Songlin; Overman, Justine J.; Katsman, Diana; Kozlov, Serguei V.; Donnelly, Christopher J.; Twiss, Jeffery L.; Giger, Roman J.; Coppola, Giovanni; Geschwind, Daniel H.; Carmichael, S. Thomas			An age-related sprouting transcriptome provides molecular control of axonal sprouting after stroke	NATURE NEUROSCIENCE			English	Article							GROWTH-ASSOCIATED GENE; NEURITE OUTGROWTH; DNA METHYLATION; NOGO RECEPTOR; FACTOR-I; EXPRESSION; REGENERATION; NEURONS; BRAIN; REVEALS	Stroke is an age-related disease. Recovery after stroke is associated with axonal sprouting in cortex adjacent to the infarct. The molecular program that induces a mature cortical neuron to sprout a new connection after stroke is not known. We selectively isolated neurons that sprout a new connection in cortex after stroke and compared their whole-genome expression profile to that of adjacent, non-sprouting neurons. This 'sprouting transcriptome' identified a neuronal growth program that consists of growth factor, cell adhesion, axonal guidance and cytoskeletal modifying molecules that differed by age and time point. Gain and loss of function in three distinct functional classes showed new roles for these proteins in epigenetic regulation of axonal sprouting, growth factor-dependent survival of neurons and, in the aged mouse, paradoxical upregulation of myelin and ephrin receptors in sprouting neurons. This neuronal growth program may provide new therapeutic targets and suggest mechanisms for age-related differences in functional recovery.	[Li, Songlin; Overman, Justine J.; Katsman, Diana; Coppola, Giovanni; Geschwind, Daniel H.; Carmichael, S. Thomas] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA; [Kozlov, Serguei V.] NCI, Canc & Dev Biol Lab, Frederick, MD 21701 USA; [Donnelly, Christopher J.; Twiss, Jeffery L.] Drexel Univ, Dept Biol, Philadelphia, PA 19104 USA; [Giger, Roman J.] Univ Michigan, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA; [Giger, Roman J.] Univ Michigan, Dept Neurol, Ann Arbor, MI 48109 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Drexel University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Carmichael, ST (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA.	scarmichael@mednet.ucla.edu	Donnelly, Christopher/AGI-7461-2022; LI, Songlin/O-8512-2016; Li, Songlin/D-7768-2011	Donnelly, Christopher/0000-0002-2383-9015; Carmichael, S Thomas/0000-0002-1169-9203; Li, Songlin/0000-0002-1073-9779	US National Institutes of Health [NS045729, NS04733, NS049041, AHA 09SDG2310180, 0525144Y]; US Department of Veterans Affairs; Larry L Hillblom Foundation; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; American Federation of Aging Research; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS049041, R01NS041596, R01NS045729] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Veterans Affairs(US Department of Veterans Affairs); Larry L Hillblom Foundation; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; American Federation of Aging Research; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank S. Raike (University of Michigan) for help with obtaining NgR2 mutant mice. This research was funded by US National Institutes of Health NS045729, NS04733, NS049041, AHA 09SDG2310180 and 0525144Y; the US Department of Veterans Affairs; the Larry L Hillblom Foundation; the Dr. Miriam and Sheldon G. Adelson Medical Research Foundation and the American Federation of Aging Research.	Atwal JK, 2008, SCIENCE, V322, P967, DOI 10.1126/science.1161151; Berube NG, 2005, J CLIN INVEST, V115, P258, DOI 10.1172/JCI200522329; Boulanger LM, 2009, NEURON, V64, P93, DOI 10.1016/j.neuron.2009.09.001; Brown CE, 2009, J NEUROSCI, V29, P1719, DOI 10.1523/JNEUROSCI.4249-08.2009; CALLAWAY EM, 1990, J NEUROSCI, V10, P1134; CALLAWAY EM, 1992, J NEUROSCI, V12, P570; Cao Y, 2003, J CEREBR BLOOD F MET, V23, P739, DOI 10.1097/01.WCB.0000067720.12805.6F; Carmichael ST, 2001, NEUROBIOL DIS, V8, P910, DOI 10.1006/nbdi.2001.0425; Carmichael ST, 2005, EXP NEUROL, V193, P291, DOI 10.1016/j.expneurol.2005.01.004; Carmichael ST, 2006, ANN NEUROL, V59, P735, DOI 10.1002/ana.20845; Case LC, 2005, CURR BIOL, V15, pR749, DOI 10.1016/j.cub.2005.09.008; Chklovskii DB, 2004, NATURE, V431, P782, DOI 10.1038/nature03012; Costigan M, 2002, BMC NEUROSCI, V3, DOI 10.1186/1471-2202-3-16; Dalva MB, 2007, NEURON, V55, P681, DOI 10.1016/j.neuron.2007.08.015; Dancause N, 2005, J NEUROSCI, V25, P10167, DOI 10.1523/JNEUROSCI.3256-05.2005; Du J, 2007, CURR PHARM DESIGN, V13, P2507; Fan GP, 2005, DEVELOPMENT, V132, P3345, DOI 10.1242/dev.01912; Fischer D, 2004, J NEUROSCI, V24, P8726, DOI 10.1523/JNEUROSCI.2774-04.2004; Fitch MT, 2008, EXP NEUROL, V209, P294, DOI 10.1016/j.expneurol.2007.05.014; Ikegami K, 2006, J BIOL CHEM, V281, P30707, DOI 10.1074/jbc.M603984200; Ji B, 2006, MOL CELL NEUROSCI, V33, P311, DOI 10.1016/j.mcn.2006.08.003; Kooijman R, 2009, STROKE, V40, pE83, DOI 10.1161/STROKEAHA.108.528356; Lee JK, 2004, J NEUROSCI, V24, P6209, DOI 10.1523/JNEUROSCI.1643-04.2004; Lemons ML, 2008, EXP NEUROL, V209, P343, DOI 10.1016/j.expneurol.2007.05.027; Li SL, 2006, NEUROBIOL DIS, V23, P362, DOI 10.1016/j.nbd.2006.03.011; Lipton P, 1999, PHYSIOL REV, V79, P1431, DOI 10.1152/physrev.1999.79.4.1431; Liu BP, 2006, PHILOS T R SOC B, V361, P1593, DOI 10.1098/rstb.2006.1891; MacDonald JL, 2009, PROG NEUROBIOL, V88, P170, DOI 10.1016/j.pneurobio.2009.04.002; Ohab JJ, 2006, J NEUROSCI, V26, P13007, DOI 10.1523/JNEUROSCI.4323-06.2006; Ozdinler PH, 2006, NAT NEUROSCI, V9, P1371, DOI 10.1038/nn1789; Paxinos G., 1998, RAT BRAIN STEROTAXIC; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Pertz OC, 2008, P NATL ACAD SCI USA, V105, P1931, DOI 10.1073/pnas.0706545105; Petreanu L, 2009, NATURE, V457, P1142, DOI 10.1038/nature07709; Rosenstein JM, 2003, J NEUROSCI, V23, P11036; Salie R, 2005, INT J DEV NEUROSCI, V23, P587, DOI 10.1016/j.ijdevneu.2005.07.003; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036; Stowe AM, 2007, J CEREBR BLOOD F MET, V27, P76, DOI 10.1038/sj.jcbfm.9600320; Tanabe K, 2003, J NEUROSCI, V23, P9675; Topalli I, 2004, BRAIN RES, V1030, P116, DOI 10.1016/j.brainres.2004.09.057; Venkatesh K, 2005, J NEUROSCI, V25, P808, DOI 10.1523/JNEUROSCI.4464-04.2005; Venkatesh K, 2007, J CELL BIOL, V177, P393, DOI 10.1083/jcb.200702102; Wang F, 2007, NEUROSCI LETT, V417, P255, DOI 10.1016/j.neulet.2007.02.080; Xiao HS, 2002, P NATL ACAD SCI USA, V99, P8360, DOI 10.1073/pnas.122231899; Zai LL, 2009, J NEUROSCI, V29, P8187, DOI 10.1523/JNEUROSCI.0414-09.2009; Zheng BH, 2005, P NATL ACAD SCI USA, V102, P1205, DOI 10.1073/pnas.0409026102; Zheng JQ, 2001, J NEUROSCI, V21, P9291, DOI 10.1523/JNEUROSCI.21-23-09291.2001; Zhu ML, 2008, ENDOCR-RELAT CANCER, V15, P841, DOI 10.1677/ERC-08-0084; Zujovic V, 2005, J NEUROSCI RES, V82, P581, DOI 10.1002/jnr.20676	50	232	237	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2010	13	12					1496	U82		10.1038/nn.2674	http://dx.doi.org/10.1038/nn.2674			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	684CW	21057507	Green Accepted, Green Submitted			2022-12-28	WOS:000284525800014
J	Tanigawa, H; Lu, HDD; Roe, AW				Tanigawa, Hisashi; Lu, Haidong D.; Roe, Anna W.			Functional organization for color and orientation in macaque V4	NATURE NEUROSCIENCE			English	Article							MONKEY VISUAL-CORTEX; INFERIOR TEMPORAL CORTEX; FEATURE-BASED ATTENTION; AREA V4; STRIATE CORTEX; RHESUS-MONKEY; VISUOTOPIC ORGANIZATION; PRESTRIATE CORTEX; SELECTIVE NEURONS; PRELUNATE GYRUS	Visual area V4 in the macaque monkey is a cortical area that is strongly involved in color and shape perception. However, fundamental questions about V4 are still debated. V4 was initially characterized as a color-processing area, but subsequent studies revealed that it contains a diverse complement of cells, including those with preference for color, orientation, disparity and higher-order feature preferences. This has led to disputes and uncertainty about the role of V4 in vision. Using intrinsic signal optical imaging methods in awake, behaving monkeys, we found that different feature preferences are functionally organized in V4. Optical images revealed that regions with preferential response to color were largely separate from orientation-selective regions. Our results help to resolve long-standing controversies regarding functional diversity and retinotopy in V4 and indicate the presence of spatially biased distribution of featural representation in V4 in the ventral visual pathway.	[Tanigawa, Hisashi; Lu, Haidong D.; Roe, Anna W.] Vanderbilt Univ, Dept Psychol, Nashville, TN 37240 USA	Vanderbilt University	Roe, AW (corresponding author), Vanderbilt Univ, Dept Psychol, Nashville, TN 37240 USA.	anna.w.roe@vanderbilt.edu	Tanigawa, Hisashi/H-4792-2014	Tanigawa, Hisashi/0000-0002-7736-0683; Roe, Anna Wang/0000-0003-4146-9705	US National Institutes of Health; Vanderbilt Vision Research Center; Vanderbilt University Center for Integrative & Cognitive Neuroscience; NATIONAL EYE INSTITUTE [R01EY011744] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA023002] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanderbilt Vision Research Center; Vanderbilt University Center for Integrative & Cognitive Neuroscience; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank J.H. Kaas and G. Chen for comments on the manuscript and Y. Chu for technical assistance. This work was supported by grants from the US National Institutes of Health, Vanderbilt Vision Research Center and Vanderbilt University Center for Integrative & Cognitive Neuroscience to A.W.R.	BONHOEFFER T, 1991, NATURE, V353, P429, DOI 10.1038/353429a0; Bonhoeffer Tobias, 1996, P55; Chen LM, 2002, J NEUROSCI METH, V113, P41, DOI 10.1016/S0165-0270(01)00475-7; Conway BR, 2007, NEURON, V56, P560, DOI 10.1016/j.neuron.2007.10.008; DESIMONE R, 1987, J NEUROPHYSIOL, V57, P835, DOI 10.1152/jn.1987.57.3.835; Dobkins KR, 2000, J OPT SOC AM A, V17, P545, DOI 10.1364/JOSAA.17.000545; Fize D, 2003, J NEUROSCI, V23, P7395; GALLANT JL, 1993, SCIENCE, V259, P100, DOI 10.1126/science.8418487; GATTASS R, 1988, J NEUROSCI, V8, P1831; Ghose GM, 1997, J NEUROPHYSIOL, V77, P2191, DOI 10.1152/jn.1997.77.4.2191; Harada T, 2009, EUR J NEUROSCI, V30, P1960, DOI 10.1111/j.1460-9568.2009.06995.x; Hayden BY, 2005, NEURON, V47, P637, DOI 10.1016/j.neuron.2005.07.020; HUBEL DH, 1987, J NEUROSCI, V7, P3378; HUBEL DH, 1977, PROC R SOC SER B-BIO, V198, P1, DOI 10.1098/rspb.1977.0085; HUBEL DH, 1974, J COMP NEUROL, V158, P267, DOI 10.1002/cne.901580304; Huettel S. A., 2004, FUNCTIONAL MAGNETIC; KOBATAKE E, 1994, J NEUROPHYSIOL, V71, P856, DOI 10.1152/jn.1994.71.3.856; Koida K, 2007, NAT NEUROSCI, V10, P108, DOI 10.1038/nn1823; Kotake Y, 2009, J NEUROPHYSIOL, V102, P15, DOI 10.1152/jn.90624.2008; KRUGER J, 1980, J NEUROPHYSIOL, V43, P1055, DOI 10.1152/jn.1980.43.4.1055; LEVENTHAL AG, 1995, J NEUROSCI, V15, P1808, DOI 10.1523/JNEUROSCI.15-03-01808.1995; LEVITT JB, 1994, J NEUROPHYSIOL, V71, P2517, DOI 10.1152/jn.1994.71.6.2517; LIVINGSTONE M, 1988, SCIENCE, V240, P740, DOI 10.1126/science.3283936; LIVINGSTONE MS, 1984, J NEUROSCI, V4, P309; Lu HD, 2008, CEREB CORTEX, V18, P516, DOI 10.1093/cercor/bhm081; MAGUIRE WM, 1984, J NEUROSCI, V4, P1690; Maunsell JHR, 2006, TRENDS NEUROSCI, V29, P317, DOI 10.1016/j.tins.2006.04.001; Moore T, 2003, NATURE, V421, P370, DOI 10.1038/nature01341; Pasupathy A, 1999, J NEUROPHYSIOL, V82, P2490, DOI 10.1152/jn.1999.82.5.2490; ROE AW, 1995, J NEUROSCI, V15, P3689; SCHEIN SJ, 1982, J NEUROPHYSIOL, V47, P193, DOI 10.1152/jn.1982.47.2.193; Sincich LC, 2005, ANNU REV NEUROSCI, V28, P303, DOI 10.1146/annurev.neuro.28.061604.135731; Stepniewska I, 2005, CEREB CORTEX, V15, P809, DOI 10.1093/cercor/bhh182; TANAKA M, 1986, EXP BRAIN RES, V65, P11; Tootell RBH, 2004, CEREB CORTEX, V14, P353, DOI 10.1093/cercor/bhh001; Vanduffel W, 2002, CEREB CORTEX, V12, P647, DOI 10.1093/cercor/12.6.647; VANESSEN DC, 1978, J PHYSIOL-LONDON, V277, P193; Vanzetta I, 2004, NEURON, V42, P843, DOI 10.1016/j.neuron.2004.04.004; Wang Y, 2007, CEREB CORTEX, V17, P116, DOI 10.1093/cercor/bhj131; Xiao YP, 2007, NEUROIMAGE, V35, P771, DOI 10.1016/j.neuroimage.2006.11.059; Xiao YP, 1999, CEREB CORTEX, V9, P792, DOI 10.1093/cercor/9.8.792; Xiao YP, 2003, NATURE, V421, P535, DOI 10.1038/nature01372; Xu XM, 2004, J NEUROSCI, V24, P6237, DOI 10.1523/JNEUROSCI.1144-04.2004; ZEKI S, 1983, PROC R SOC SER B-BIO, V217, P449, DOI 10.1098/rspb.1983.0020; ZEKI SM, 1973, BRAIN RES, V53, P422, DOI 10.1016/0006-8993(73)90227-8; ZEKI SM, 1971, BRAIN RES, V34, P19, DOI 10.1016/0006-8993(71)90348-9; Zhan CA, 2006, CEREB CORTEX, V16, P896, DOI 10.1093/cercor/bhj033	47	119	119	0	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2010	13	12					1542	U135		10.1038/nn.2676	http://dx.doi.org/10.1038/nn.2676			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	684CW	21076422	Green Accepted			2022-12-28	WOS:000284525800020
J	Jo, J; Son, GH; Winters, BL; Kim, MJ; Whitcomb, DJ; Dickinson, BA; Lee, YB; Futai, K; Amici, M; Sheng, M; Collingridge, GL; Cho, K				Jo, Jihoon; Son, Gi Hoon; Winters, Bryony L.; Kim, Myung Jong; Whitcomb, Daniel J.; Dickinson, Bryony A.; Lee, Youn-Bok; Futai, Kensuke; Amici, Mascia; Sheng, Morgan; Collingridge, Graham L.; Cho, Kwangwook			Muscarinic receptors induce LTD of NMDAR EPSCs via a mechanism involving hippocalcin, AP2 and PSD-95	NATURE NEUROSCIENCE			English	Article							LONG-TERM DEPRESSION; METHYL-D-ASPARTATE; MEDIATED SYNAPTIC-TRANSMISSION; RAT HIPPOCAMPUS; GLUTAMATE RECEPTORS; CALCIUM SENSOR; AREA CA1; POTENTIATION; PLASTICITY; PROTEIN	Although muscarinic acetylcholine receptors (mAChRs) and NMDA receptors (NMDARs) are important for synaptic plasticity, learning and memory, the manner in which they interact is poorly understood. We found that stimulation of muscarinic receptors, either by an agonist or by the synaptic release of acetylcholine, led to long-term depression (LTD) of NMDAR-mediated synaptic transmission. This form of LTD involved the release of Ca2+ from IP3-sensitive intracellular stores and was expressed via the internalization of NMDARs. Our results suggest that the molecular mechanism involves a dynamic interaction between the neuronal calcium sensor protein hippocalcin, the clathrin adaptor molecule AP2, the postsynaptic density enriched protein PSD-95 and NMDARs. We propose that hippocalcin binds to the SH3 region of PSD-95 under basal conditions, but it translocates to the plasma membrane on sensing Ca2+; in doing so, it causes PSD-95 to dissociate from NMDARs, permitting AP2 to bind and initiate their dynamin-dependent endocytosis.	[Jo, Jihoon; Son, Gi Hoon; Winters, Bryony L.; Whitcomb, Daniel J.; Dickinson, Bryony A.; Lee, Youn-Bok; Cho, Kwangwook] Univ Bristol, Fac Med & Dent, Henry Wellcome Labs Integrat Neurosci & Endocrino, Bristol, Avon, England; [Winters, Bryony L.; Amici, Mascia; Collingridge, Graham L.; Cho, Kwangwook] Univ Bristol, MRC Ctr Synapt Plast, Bristol, Avon, England; [Kim, Myung Jong; Futai, Kensuke; Sheng, Morgan] MIT, Picower Inst Learning & Memory, Cambridge, MA 02139 USA	University of Bristol; University of Bristol; Massachusetts Institute of Technology (MIT); Northwell Health	Cho, K (corresponding author), Univ Bristol, Fac Med & Dent, Henry Wellcome Labs Integrat Neurosci & Endocrino, Bristol, Avon, England.	kei.cho@bristol.ac.uk	collingridge, graham/AAI-8362-2020; Collingridge, Graham L/C-4605-2015; Amici, Mascia/L-3842-2019	Collingridge, Graham L/0000-0002-9572-5359; Amici, Mascia/0000-0001-8548-4179; Sheng, Morgan/0000-0002-8703-5366; Winters, Bryony/0000-0002-4973-0771; Whitcomb, Daniel/0000-0003-2703-1643; Lee, Younbok/0000-0002-0479-9361; Cho, Kwangwook/0000-0001-6724-7073	Biotechnology and Biological Sciences Research Council; Medical Research Council; UK Alzheimer's Research Trust; Royal Society; Brain Research Centre; Korean Ministry of Education and Science and Technology; BBSRC [BB/G003963/1] Funding Source: UKRI; MRC [G0601813] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G003963/1] Funding Source: researchfish; Medical Research Council [G0601813, G0601841B] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Alzheimer's Research Trust; Royal Society(Royal Society of London); Brain Research Centre; Korean Ministry of Education and Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by the Biotechnology and Biological Sciences Research Council (K.C.), the Medical Research Council (G.L.C.), UK Alzheimer's Research Trust (K.C. and D.W.), The Royal Society (J.J.) and Brain Research Centre of the 21st Century Frontier Research Programme, funded by the Korean Ministry of Education and Science and Technology (K.C. and G.L.C.).	Abraham WC, 1996, TRENDS NEUROSCI, V19, P126, DOI 10.1016/S0166-2236(96)80018-X; Aramakis VB, 1999, SYNAPSE, V32, P262, DOI 10.1002/(SICI)1098-2396(19990615)32:4<262::AID-SYN3>3.3.CO;2-A; BASHIR ZI, 1991, NATURE, V349, P156, DOI 10.1038/349156a0; Bhattacharyya S, 2009, NAT NEUROSCI, V12, P172, DOI 10.1038/nn.2249; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Burgoyne RD, 2007, NAT REV NEUROSCI, V8, P182, DOI 10.1038/nrn2093; Carroll RC, 1999, P NATL ACAD SCI USA, V96, P14112, DOI 10.1073/pnas.96.24.14112; COLLINGRIDGE GL, 1983, J PHYSIOL-LONDON, V334, P33, DOI 10.1113/jphysiol.1983.sp014478; Collingridge GL, 2004, NAT REV NEUROSCI, V5, P952, DOI 10.1038/nrn1556; Collingridge GL, 2010, NAT REV NEUROSCI, V11, P459, DOI 10.1038/nrn2867; Dickinson BA, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-18; DUDEK SM, 1992, P NATL ACAD SCI USA, V89, P4363, DOI 10.1073/pnas.89.10.4363; Ehrlich I, 2007, P NATL ACAD SCI USA, V104, P4176, DOI 10.1073/pnas.0609307104; Elias GM, 2008, P NATL ACAD SCI USA, V105, P20953, DOI 10.1073/pnas.0811025106; FUJII S, 1991, BRAIN RES, V555, P112, DOI 10.1016/0006-8993(91)90867-U; Futai K, 2007, NAT NEUROSCI, V10, P186, DOI 10.1038/nn1837; Harney SC, 2006, J NEUROSCI, V26, P1128, DOI 10.1523/JNEUROSCI.2753-05.2006; HARVEY J, 1993, NEUROSCI LETT, V162, P165, DOI 10.1016/0304-3940(93)90586-A; Holbro N, 2009, P NATL ACAD SCI USA, V106, P15055, DOI 10.1073/pnas.0905110106; Hummer A, 2003, J BIOL CHEM, V278, P49386, DOI 10.1074/jbc.M306645200; Ireland DR, 2009, J NEUROPHYSIOL, V101, P1375, DOI 10.1152/jn.90643.2008; Jo J, 2006, NAT NEUROSCI, V9, P170, DOI 10.1038/nn1637; Jo J, 2008, NEURON, V60, P1095, DOI 10.1016/j.neuron.2008.10.050; Kim MJ, 2007, NEURON, V56, P488, DOI 10.1016/j.neuron.2007.09.007; Kirkwood A, 1999, J NEUROSCI, V19, P1599; Lau CG, 2007, NAT REV NEUROSCI, V8, P413, DOI 10.1038/nrn2153; Lin Y, 2004, J NEUROSCI, V24, P10138, DOI 10.1523/JNEUROSCI.3159-04.2004; MARKRAM H, 1990, NEUROSCI LETT, V113, P62, DOI 10.1016/0304-3940(90)90495-U; Migaud M, 1998, NATURE, V396, P433, DOI 10.1038/24790; MORRIS RGM, 1986, NATURE, V319, P774, DOI 10.1038/319774a0; MULKEY RM, 1992, NEURON, V9, P967, DOI 10.1016/0896-6273(92)90248-C; MULKEY RM, 1993, SCIENCE, V261, P1051, DOI 10.1126/science.8394601; MULKEY RM, 1994, NATURE, V369, P486, DOI 10.1038/369486a0; Nakagawa T, 2004, NEURON, V44, P453, DOI 10.1016/j.neuron.2004.10.012; Palmer CL, 2005, NEURON, V47, P487, DOI 10.1016/j.neuron.2005.06.014; Peineau S, 2007, NEURON, V53, P703, DOI 10.1016/j.neuron.2007.01.029; Peineau S, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-22; Roche KW, 2001, NAT NEUROSCI, V4, P794, DOI 10.1038/90498; Shinoe T, 2005, J NEUROSCI, V25, P11194, DOI 10.1523/JNEUROSCI.2338-05.2005; Tzingounis AV, 2007, NEURON, V53, P487, DOI 10.1016/j.neuron.2007.01.011; Volk LJ, 2007, J NEUROSCI, V27, P11624, DOI 10.1523/JNEUROSCI.2266-07.2007; Xu W, 2008, NEURON, V57, P248, DOI 10.1016/j.neuron.2007.11.027	42	78	82	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2010	13	10					1216	1224		10.1038/nn.2636	http://dx.doi.org/10.1038/nn.2636			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	654MB	20852624				2022-12-28	WOS:000282171300013
J	Tritsch, NX; Rodriguez-Contreras, A; Crins, TTH; Wang, HC; Borst, JGG; Bergles, DE				Tritsch, Nicolas X.; Rodriguez-Contreras, Adrian; Crins, Tom T. H.; Wang, Han Chin; Borst, J. Gerard G.; Bergles, Dwight E.			Calcium action potentials in hair cells pattern auditory neuron activity before hearing onset	NATURE NEUROSCIENCE			English	Article							TRAPEZOID BODY; MEDIAL NUCLEUS; STIMULATION; MATURATION	We found rat central auditory neurons to fire action potentials in a precise sequence of mini-bursts before the age of hearing onset. This stereotyped pattern was initiated by hair cells in the cochlea, which trigger brief bursts of action potentials in auditory neurons each time they fire a Ca(2+) spike. By generating theta-like activity, hair cells may limit the influence of synaptic depression in developing auditory circuits and promote consolidation of synapses.	[Tritsch, Nicolas X.; Wang, Han Chin; Bergles, Dwight E.] Johns Hopkins Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD USA; [Rodriguez-Contreras, Adrian; Crins, Tom T. H.; Borst, J. Gerard G.] Univ Med Ctr Rotterdam, Erasmus MC, Dept Neurosci, Rotterdam, Netherlands; [Crins, Tom T. H.] Univ Med Ctr Rotterdam, Dept Otorhinolaryngol Head & Neck Surg, Rotterdam, Netherlands; [Bergles, Dwight E.] Johns Hopkins Sch Med, Dept Otolaryngol Head & Neck Surg, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Medicine; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Johns Hopkins University; Johns Hopkins Medicine	Bergles, DE (corresponding author), Johns Hopkins Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD USA.	g.borst@erasmusmc.nl; dbergles@jhmi.edu	Tritsch, Nicolas/U-5266-2019; Rodriguez-Contreras, Adrian/ABC-8325-2020; Bergles, Dwight/U-8343-2019	Bergles, Dwight/0000-0002-7133-7378; Tritsch, Nicolas/0000-0003-3181-7681; Wang, Han Chin/0000-0001-8270-6645	US National Center for Research Resources [G12-RR03060]; European Union [LSHM-CT-2005-019055]; Heinsius Houbolt fund and SenterNovem (The Netherlands) [BSIK 03053]; US National Institutes of Health [DC008860, DC009464]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [SC1HD068129] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003060] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC008860, R21DC009464] Funding Source: NIH RePORTER	US National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); European Union(European Commission); Heinsius Houbolt fund and SenterNovem (The Netherlands)(Netherlands Government); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by grants from the US National Center for Research Resources (G12-RR03060) to A. R.-C., the European Union (EUSynapse, LSHM-CT-2005-019055), Heinsius Houbolt fund and SenterNovem (The Netherlands, Neuro-Bsik, BSIK 03053) to J.G.G.B., and the US National Institutes of Health (DC008860 and DC009464) to D.E.B.	Ben-Ari Y, 2001, TRENDS NEUROSCI, V24, P353, DOI 10.1016/S0166-2236(00)01813-0; Blankenship AG, 2010, NAT REV NEUROSCI, V11, P18, DOI 10.1038/nrn2759; Brenowitz S, 2001, J NEUROSCI, V21, P9487, DOI 10.1523/JNEUROSCI.21-23-09487.2001; CARLIER E, 1975, J PHYSIOL-PARIS, V70, P129; GUINAN JJ, 1990, HEARING RES, V49, P321, DOI 10.1016/0378-5955(90)90111-2; Johnson SL, 2005, J PHYSIOL-LONDON, V563, P177, DOI 10.1113/jphysiol.2004.074740; Jones TA, 2007, J NEUROPHYSIOL, V98, P1898, DOI 10.1152/jn.00472.2007; LARSON J, 1986, BRAIN RES, V368, P347, DOI 10.1016/0006-8993(86)90579-2; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Sonntag M, 2009, J NEUROSCI, V29, P9510, DOI 10.1523/JNEUROSCI.1377-09.2009; Tritsch NX, 2007, NATURE, V450, P50, DOI 10.1038/nature06233; Tritsch NX, 2010, J NEUROSCI, V30, P1539, DOI 10.1523/JNEUROSCI.3875-09.2010; von Gersdorff H, 2002, NAT REV NEUROSCI, V3, P53, DOI 10.1038/nrn705; Walsh Edward J., 1992, P161; Zhang W, 2003, NAT REV NEUROSCI, V4, P885, DOI 10.1038/nrn1248	15	147	147	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2010	13	9					1050	1052		10.1038/nn.2604	http://dx.doi.org/10.1038/nn.2604			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	643XC	20676105	Green Accepted			2022-12-28	WOS:000281332600007
J	Marek, KW; Kurtz, LM; Spitzer, NC				Marek, Kurt W.; Kurtz, Lisa M.; Spitzer, Nicholas C.			cJun integrates calcium activity and tlx3 expression to regulate neurotransmitter specification	NATURE NEUROSCIENCE			English	Article							ACTIVITY-DEPENDENT REGULATION; GENE-EXPRESSION; SPINAL-CORD; TRANSCRIPTION FACTORS; HOMEODOMAIN PROTEIN; ELECTRICAL-ACTIVITY; CELL-DEATH; C-JUN; NEURONS; PHENOTYPE	Neuronal differentiation is accomplished through cascades of intrinsic genetic factors initiated in neuronal progenitors by external gradients of morphogens. Activity has been thought to be important only late in development, but recent evidence suggests that activity also regulates early neuronal differentiation. Activity in post-mitotic neurons before synapse formation can regulate phenotypic specification, including neurotransmitter choice, but the mechanisms are not clear. We identified a mechanism that links endogenous calcium spike activity with an intrinsic genetic pathway to specify neurotransmitter choice in neurons in the dorsal embryonic spinal cord of Xenopus tropicalis. Early activity modulated transcription of the GABAergic/glutamatergic selection gene tlx3 through a variant cAMP response element (CRE) in its promoter. The cJun transcription factor bound to this CRE site, modulated transcription and regulated neurotransmitter phenotype via its transactivation domain. Calcium signaled through cJun N-terminal phosphorylation, which integrated activity-dependent and intrinsic neurotransmitter specification. This mechanism provides a basis for early activity to regulate genetic pathways at critical decision points, switching the phenotype of developing neurons.	[Marek, Kurt W.; Kurtz, Lisa M.; Spitzer, Nicholas C.] Univ Calif San Diego, Neurobiol Sect, Div Biol Sci, La Jolla, CA 92093 USA; [Marek, Kurt W.; Kurtz, Lisa M.; Spitzer, Nicholas C.] Univ Calif San Diego, Ctr Neural Circuits, Kavli Inst Brain & Mind, La Jolla, CA 92093 USA; [Marek, Kurt W.; Kurtz, Lisa M.] Univ Calif San Diego, Grad Program Neurosci, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Marek, KW (corresponding author), Univ Calif San Diego, Neurobiol Sect, Div Biol Sci, La Jolla, CA 92093 USA.	kmarek@ucsd.edu		Spitzer, Nicholas/0000-0002-3523-1103	Damon Runyon Cancer Research Foundation; US National Institutes of Health [T32 AG00216, MH 074702]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH074702, R56MH074702] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS015918, R01NS057690] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG000216] Funding Source: NIH RePORTER	Damon Runyon Cancer Research Foundation; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank S. Chung, G. Monsalve and A. de la Torre for technical assistance. We thank D. Berg, A. Ghosh and J. Gleeson for critical comments on the manuscript and I. Hsieh for technical support. This work was supported by a Damon Runyon Cancer Research Foundation Postdoctoral Fellowship to K. W. M., a US National Institutes of Health Predoctoral Fellowship (T32 AG00216) to L. M. K. and by a US National Institutes of Health grant (MH 074702) to N.C.S.	Baumgardt M, 2007, PLOS BIOL, V5, P295, DOI 10.1371/journal.pbio.0050037; Borghini S, 2006, MOL CANCER RES, V4, P635, DOI 10.1158/1541-7786.MCR-05-0250; Borodinsky LN, 2004, NATURE, V429, P523, DOI 10.1038/nature02518; Brosenitsch TA, 2002, MOL CELL NEUROSCI, V20, P447, DOI 10.1006/mcne.2002.1135; Buffelli M, 2003, NATURE, V424, P430, DOI 10.1038/nature01844; Chang LW, 2009, J NEUROSCI, V29, P7877, DOI 10.1523/JNEUROSCI.4264-08.2009; Cheng LP, 2004, NAT NEUROSCI, V7, P510, DOI 10.1038/nn1221; Cheng LP, 2005, NAT NEUROSCI, V8, P1510, DOI 10.1038/nn1569; DE KP, 1998, SCIENCE, V279, P227; Dolmetsch RE, 1998, NATURE, V392, P933, DOI 10.1038/31960; Dulcis D, 2008, NATURE, V456, P195, DOI 10.1038/nature07569; Flavell SW, 2008, ANNU REV NEUROSCI, V31, P563, DOI 10.1146/annurev.neuro.31.060407.125631; Flavell SW, 2006, SCIENCE, V311, P1008, DOI 10.1126/science.1122511; Ghosh S, 2005, ONCOGENE, V24, P2236, DOI 10.1038/sj.onc.1208415; Gomez-Lira G, 2005, J NEUROSCI, V25, P6939, DOI 10.1523/JNEUROSCI.1674-05.2005; GOODMAN CS, 1993, CELL, V72, P77, DOI 10.1016/S0092-8674(05)80030-3; Gorbunova YV, 2002, NATURE, V418, P93, DOI 10.1038/nature00835; GU XN, 1995, NATURE, V375, P784, DOI 10.1038/375784a0; Hanson MG, 2006, J NEUROSCI, V26, P12769, DOI 10.1523/JNEUROSCI.4170-06.2006; Hanson MG, 2004, NEURON, V43, P687, DOI 10.1016/j.neuron.2004.08.018; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; Heckert LL, 1996, J BIOL CHEM, V271, P31650, DOI 10.1074/jbc.271.49.31650; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Komuro H, 1996, NEURON, V17, P275, DOI 10.1016/S0896-6273(00)80159-2; Li WH, 1998, NATURE, V392, P936, DOI 10.1038/31965; LIEM KF, 1995, CELL, V82, P969, DOI 10.1016/0092-8674(95)90276-7; Lin YX, 2008, NATURE, V455, P1198, DOI 10.1038/nature07319; Liu XH, 2008, J NEUROPHYSIOL, V99, P2443, DOI 10.1152/jn.00762.2007; Ma QF, 2006, J PHYSIOL-LONDON, V575, P379, DOI 10.1113/jphysiol.2006.113449; Mizuguchi R, 2006, NAT NEUROSCI, V9, P770, DOI 10.1038/nn1706; Mo ZQ, 2004, DEVELOPMENT, V131, P1607, DOI 10.1242/dev.01071; Nakano T, 2005, DEV BIOL, V283, P474, DOI 10.1016/j.ydbio.2005.04.017; Ovcharenko I, 2004, GENOMICS, V84, P890, DOI 10.1016/j.ygeno.2004.07.011; Patterson KD, 1999, DEV DYNAM, V214, P34, DOI 10.1002/(SICI)1097-0177(199901)214:1<34::AID-DVDY4>3.0.CO;2-R; Peng Y, 2002, NEUROSCIENCE, V109, P657, DOI 10.1016/S0306-4522(01)00526-7; Picard D, 2000, METHOD ENZYMOL, V327, P385, DOI 10.1016/S0076-6879(00)27291-1; Pierani A, 2001, NEURON, V29, P367, DOI 10.1016/S0896-6273(01)00212-4; Pillai A, 2007, DEVELOPMENT, V134, P357, DOI 10.1242/dev.02717; Raivich G, 2008, J NEUROCHEM, V107, P898, DOI 10.1111/j.1471-4159.2008.05684.x; Root CM, 2008, J NEUROSCI, V28, P4777, DOI 10.1523/JNEUROSCI.4873-07.2008; Spitzer NC, 2006, NATURE, V444, P707, DOI 10.1038/nature05300; Sugiyama C, 2007, NEUROCHEM INT, V51, P467, DOI 10.1016/j.neuint.2007.04.025; Tanabe Y, 1998, CELL, V95, P67, DOI 10.1016/S0092-8674(00)81783-3; Thor S, 1999, NATURE, V397, P76, DOI 10.1038/16275; Weissman TA, 2004, NEURON, V43, P647, DOI 10.1016/j.neuron.2004.08.015; YAMADA T, 1993, CELL, V73, P673, DOI 10.1016/0092-8674(93)90248-O; Yano S, 1998, NATURE, V396, P584, DOI 10.1038/25147	47	60	61	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2010	13	8					944	U58		10.1038/nn.2582	http://dx.doi.org/10.1038/nn.2582			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	632DK	20581840	Green Accepted			2022-12-28	WOS:000280400600012
J	Shigetomi, E; Kracun, S; Sofroniew, MV; Khakh, BS				Shigetomi, Eiji; Kracun, Sebastian; Sofroniew, Michael V.; Khakh, Baljit S.			A genetically targeted optical sensor to monitor calcium signals in astrocyte processes	NATURE NEUROSCIENCE			English	Article							IN-SITU; HIPPOCAMPAL ASTROCYTES; NEURAL ACTIVITY; CA2+ INDICATOR; GLUTAMATE; GLIA; ACTIVATION; OSCILLATIONS; NEURONS; MICE	Calcium signaling is studied as a potential form of astrocyte excitability that may control astrocyte involvement in synaptic and cerebrovascular regulation. Fundamental questions remain unanswered about astrocyte calcium signaling, as current methods can not resolve calcium in small volume compartments, such as near the cell membrane and in distal cell processes. We modified the genetically encoded calcium sensor GCaMP2 with a membrane-tethering domain, Lck, increasing the level of Lck-GCaMP2 near the plasma membrane tenfold as compared with conventional GCaMP2. Using Lck-GCaMP2 in rat hippocampal astrocyte-neuron cocultures, we measured near-membrane calcium signals that were evoked pharmacologically or by single action potential-mediated neurotransmitter release. Moreover, we identified highly localized and frequent spontaneous calcium signals in astrocyte somata and processes that conventional GCaMP2 failed to detect. Lck-GCaMP2 acts as a genetically targeted calcium sensor for monitoring calcium signals in previously inaccessible parts of astrocytes, including fine processes.	[Shigetomi, Eiji; Kracun, Sebastian; Khakh, Baljit S.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Physiol, Los Angeles, CA 90095 USA; [Sofroniew, Michael V.; Khakh, Baljit S.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Khakh, BS (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Physiol, Los Angeles, CA 90095 USA.	bkhakh@mednet.ucla.edu	SHIGETOMI, EIJI/I-2372-2012; Sofroniew, Michael/ABE-8857-2020	Shigetomi, Eiji/0000-0002-5267-6155	National Institutes of Health [NS060677, NS057624]; Whitehall Foundation; S&R Foundation Ryuji Ueno Award; Stein-Oppenheimer Foundation Endowment Award; Uehara Memorial Foundation Fellowship of Japan; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS060677, R01NS057624, R21NS071292] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Whitehall Foundation; S&R Foundation Ryuji Ueno Award; Stein-Oppenheimer Foundation Endowment Award; Uehara Memorial Foundation Fellowship of Japan(Uehara Memorial Foundation); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank L. Looger for a preprint of a manuscript on GCaMP3, A. Sagasti for the GCaMP2 plasmid, D.E. Bergles for insightful discussions and for the Lck domain plasmid, and M. Simon for MrgA1-EGFP. Our work was supported by the National Institutes of Health (NS060677 and NS057624), the Whitehall Foundation, a S&R Foundation Ryuji Ueno Award for Ion Channels or Barrier Function Research and a Stein-Oppenheimer Foundation Endowment Award (B.S.K.). E.S. was partly supported by the Uehara Memorial Foundation Fellowship of Japan.	Agulhon C, 2008, NEURON, V59, P932, DOI 10.1016/j.neuron.2008.09.004; Araque A, 1999, TRENDS NEUROSCI, V22, P208, DOI 10.1016/S0166-2236(98)01349-6; Atkin SD, 2009, J NEUROSCI METH, V181, P212, DOI 10.1016/j.jneumeth.2009.05.006; Barres BA, 2008, NEURON, V60, P430, DOI 10.1016/j.neuron.2008.10.013; Bekar LK, 2008, CEREB CORTEX, V18, P2789, DOI 10.1093/cercor/bhn040; Benediktsson AM, 2005, J NEUROSCI METH, V141, P41, DOI 10.1016/j.jneumeth.2004.05.013; Bush TG, 1998, CELL, V93, P189, DOI 10.1016/S0092-8674(00)81571-8; Bushong EA, 2002, J NEUROSCI, V22, P183, DOI 10.1523/JNEUROSCI.22-01-00183.2002; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; CORNELLBELL AH, 1990, SCIENCE, V247, P470, DOI 10.1126/science.1967852; Dombeck DA, 2007, NEURON, V56, P43, DOI 10.1016/j.neuron.2007.08.003; Fellin T, 2004, NEURON, V43, P729, DOI 10.1016/j.neuron.2004.08.011; Fiacco TA, 2007, NEURON, V54, P611, DOI 10.1016/j.neuron.2007.04.032; Fiacco TA, 2009, ANNU REV PHARMACOL, V49, P151, DOI 10.1146/annurev.pharmtox.011008.145602; GOBEL W, 2001, NAT METHODS, V4, P13; GOLDMAN JE, 1990, BRAIN RES, V528, P189, DOI 10.1016/0006-8993(90)91657-3; Gordon GRJ, 2007, GLIA, V55, P1214, DOI 10.1002/glia.20543; Gordon GRJ, 2009, NEURON, V64, P391, DOI 10.1016/j.neuron.2009.10.021; Grosche J, 1999, NAT NEUROSCI, V2, P139, DOI 10.1038/5692; Halassa MM, 2007, J NEUROSCI, V27, P6473, DOI 10.1523/JNEUROSCI.1419-07.2007; Hirase H, 2004, PLOS BIOL, V2, P494, DOI 10.1371/journal.pbio.0020096; Iadecola C, 2007, NAT NEUROSCI, V10, P1369, DOI 10.1038/nn2003; Jaiswal JK, 2007, NAT CHEM BIOL, V3, P92, DOI 10.1038/nchembio855; Kofuji P, 2004, NEUROSCIENCE, V129, P1045, DOI 10.1016/j.neurscience.2004.06.008; Lee CJ, 2007, J PHYSIOL-LONDON, V581, P1057, DOI 10.1113/jphysiol.2007.130377; Lee SY, 2007, J PHYSIOL-LONDON, V581, P887, DOI 10.1113/jphysiol.2007.134676; Magistretti PJ, 2006, J EXP BIOL, V209, P2304, DOI 10.1242/jeb.02208; Mao T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001796; Nakai J, 2001, NAT BIOTECHNOL, V19, P137, DOI 10.1038/84397; Nett WJ, 2002, J NEUROPHYSIOL, V87, P528, DOI 10.1152/jn.00268.2001; Oberheim NA, 2008, J NEUROSCI, V28, P3264, DOI 10.1523/JNEUROSCI.4980-07.2008; Oberheim NA, 2009, J NEUROSCI, V29, P3276, DOI 10.1523/JNEUROSCI.4707-08.2009; Parpura V, 2000, P NATL ACAD SCI USA, V97, P8629, DOI 10.1073/pnas.97.15.8629; PARPURA V, 1994, NATURE, V369, P744, DOI 10.1038/369744a0; Pascual O, 2005, SCIENCE, V310, P113, DOI 10.1126/science.1116916; Pasti L, 1997, J NEUROSCI, V17, P7817; Perea G, 2009, TRENDS NEUROSCI, V32, P421, DOI 10.1016/j.tins.2009.05.001; Petravicz J, 2008, J NEUROSCI, V28, P4967, DOI 10.1523/JNEUROSCI.5572-07.2008; Porter JT, 1996, J NEUROSCI, V16, P5073; Reyes RC, 2009, NEUROCHEM INT, V55, P2, DOI 10.1016/j.neuint.2008.12.018; Richler E, 2008, NAT METHODS, V5, P87, DOI 10.1038/NMETH1144; Schummers J, 2008, SCIENCE, V320, P1638, DOI 10.1126/science.1156120; Shigetomi E, 2008, J NEUROSCI, V28, P6659, DOI 10.1523/JNEUROSCI.1717-08.2008; Shigetomi Eiji, 2009, J Vis Exp, DOI 10.3791/1142; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Tallini YN, 2006, P NATL ACAD SCI USA, V103, P4753, DOI 10.1073/pnas.0509378103; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Tritsch NX, 2007, NEURON, V54, P497, DOI 10.1016/j.neuron.2007.05.008; Wang P, 2006, J COASTAL RES, P816; Zlatkine P, 1997, J CELL SCI, V110, P673	50	173	178	1	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2010	13	6					759	U143		10.1038/nn.2557	http://dx.doi.org/10.1038/nn.2557			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	600QY	20495558	Green Accepted			2022-12-28	WOS:000278003300022
J	Epstein, DH; Shaham, Y				Epstein, David H.; Shaham, Yavin			Cheesecake-eating rats and the question of food addiction	NATURE NEUROSCIENCE			English	Editorial Material							WITHDRAWAL; REWARD; DECREASES		[Epstein, David H.; Shaham, Yavin] Natl Inst Drug Abuse, Intramural Res Program, US Natl Inst Hlth, Dept Hlth & Human Serv, Baltimore, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA)	Epstein, DH (corresponding author), Natl Inst Drug Abuse, Intramural Res Program, US Natl Inst Hlth, Dept Hlth & Human Serv, Baltimore, MD USA.	yshaham@intra.nida.nih.gov	shaham, yavin/G-1306-2014		NATIONAL INSTITUTE ON DRUG ABUSE [ZIADA000434] Funding Source: NIH RePORTER; Intramural NIH HHS [ZIA DA000434-11] Funding Source: Medline	NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Ahmed SH, 2002, NAT NEUROSCI, V5, P625, DOI 10.1038/nn872; Avena NM, 2008, NEUROSCI BIOBEHAV R, V32, P20, DOI 10.1016/j.neubiorev.2007.04.019; Cottone P, 2009, P NATL ACAD SCI USA, V106, P20016, DOI 10.1073/pnas.0908789106; Dalley JW, 2007, SCIENCE, V315, P1267, DOI 10.1126/science.1137073; Epping-Jordan MP, 1998, NATURE, V393, P76, DOI 10.1038/30001; Heindel JJ, 2009, MOL CELL ENDOCRINOL, V304, P90, DOI 10.1016/j.mce.2009.02.025; Johnson PM, 2010, NAT NEUROSCI, V13, P635, DOI 10.1038/nn.2519; Kenny PJ, 2006, J NEUROSCI, V26, P5894, DOI 10.1523/JNEUROSCI.0740-06.2006; Lenoir M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000698; Major GC, 2007, INT J OBESITY, V31, P204, DOI 10.1038/sj.ijo.0803523; MARKOU A, 1991, NEUROPSYCHOPHARMACOL, V4, P17; Nair SG, 2009, PROG NEUROBIOL, V89, P18, DOI 10.1016/j.pneurobio.2009.05.003; SCHULTEIS G, 1995, P NATL ACAD SCI USA, V92, P5880, DOI 10.1073/pnas.92.13.5880; Volkow ND, 2005, NAT NEUROSCI, V8, P555, DOI 10.1038/nn1452; Wonderlich SA, 2009, INT J EAT DISORDER, V42, P687, DOI 10.1002/eat.20719	15	27	27	1	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2010	13	5					529	531		10.1038/nn0510-529	http://dx.doi.org/10.1038/nn0510-529			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	588JM	20421898	Green Accepted			2022-12-28	WOS:000277065700006
J	Radulovic, J; Tronson, NC				Radulovic, Jelena; Tronson, Natalie C.			Receptors in (e)motion	NATURE NEUROSCIENCE			English	Editorial Material							FEAR MEMORIES; RECONSOLIDATION; EXTINCTION; CONSOLIDATION; ENDOCYTOSIS; MECHANISMS; GLUR2		[Radulovic, Jelena; Tronson, Natalie C.] Northwestern Univ, Dept Psychiat & Behav Sci, Asher Ctr Study & Treatment Depress Disorders, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Radulovic, J (corresponding author), Northwestern Univ, Dept Psychiat & Behav Sci, Asher Ctr Study & Treatment Depress Disorders, Feinberg Sch Med, Chicago, IL 60611 USA.	j-radulovic@northwestern.edu		Radulovic, Jelena/0000-0002-0268-2426; Tronson, Natalie/0000-0001-5676-1579	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH078064] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Ahmadian G, 2004, EMBO J, V23, P1040, DOI 10.1038/sj.emboj.7600126; Alberini CM, 2005, TRENDS NEUROSCI, V28, P51, DOI 10.1016/j.tins.2004.11.001; Dalton GL, 2008, NEUROPSYCHOPHARMACOL, V33, P2416, DOI 10.1038/sj.npp.1301642; Duprat F, 2003, PHILOS T ROY SOC B, V358, P715, DOI 10.1098/rstb.2002.1215; Kindt M, 2009, NAT NEUROSCI, V12, P256, DOI 10.1038/nn.2271; McKenzie S, 2011, NEURON, V71, P224, DOI 10.1016/j.neuron.2011.06.037; MISANIN JR, 1968, SCIENCE, V160, P554, DOI 10.1126/science.160.3827.554; Monfils MH, 2009, SCIENCE, V324, P951, DOI 10.1126/science.1167975; Nader K, 2000, NATURE, V406, P722, DOI 10.1038/35021052; O'Reilly RC, 2001, PSYCHOL REV, V108, P311, DOI 10.1037//0033-295X.108.2.311; Radulovic J, 2010, REV NEUROSCIENCE, V21, P1; Rao-Ruiz P, 2011, NAT NEUROSCI, V14, P1302, DOI 10.1038/nn.2907; Reuther ET, 2010, J TRAUMA STRESS, V23, P519, DOI 10.1002/jts.20549; Tronson NC, 2007, NAT REV NEUROSCI, V8, P262, DOI 10.1038/nrn2090; Walker MP, 2003, NATURE, V425, P616, DOI 10.1038/nature01930	15	1	1	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2011	14	10					1222	1224		10.1038/nn.2938	http://dx.doi.org/10.1038/nn.2938			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	825EQ	21952263				2022-12-28	WOS:000295254200003
J	Billig, GM; Pal, B; Fidzinski, P; Jentsch, TJ				Billig, Gwendolyn M.; Pal, Balazs; Fidzinski, Pawel; Jentsch, Thomas J.			Ca2+-activated Cl- currents are dispensable for olfaction	NATURE NEUROSCIENCE			English	Article							ACTIVATED CHLORIDE CHANNEL; NUCLEOTIDE-GATED CHANNEL; SENSORY NEURONS; MICE DEFICIENT; TMEM16A; ACCUMULATION; CONDUCTANCE; PROTEIN; DISCRIMINATION; AMPLIFICATION	Canonical olfactory signal transduction involves the activation of cyclic AMP-activated cation channels that depolarize the cilia of receptor neurons and raise intracellular calcium. Calcium then activates Cl- currents that may be up to tenfold larger than cation currents and are believed to powerfully amplify the response. We identified Anoctamin2 (Ano2, also known as TMEM16B) as the ciliary Ca2+-activated Cl- channel of olfactory receptor neurons. Ano2 is expressed in the main olfactory epithelium (MOE) and in the vomeronasal organ (VNO), which also expresses the related Ano1 channel. Disruption of Ano2 in mice virtually abolished Ca2+-activated Cl- currents in the MOE and VNO. Ano2 disruption reduced fluid-phase electro-olfactogram responses by only similar to 40%, did not change air-phase electro-olfactograms and did not reduce performance in olfactory behavioral tasks. In contrast with the current view, cyclic nucleotide-gated cation channels do not need a boost by Cl- channels to achieve near-physiological levels of olfaction.	[Billig, Gwendolyn M.; Pal, Balazs; Fidzinski, Pawel; Jentsch, Thomas J.] Max Delbruck Ctr Mol Med MDC, Leibniz Inst Mol Pharmakol FMP, Berlin, Germany; [Billig, Gwendolyn M.] Free Univ Berlin, Grad Program, D-1000 Berlin, Germany; [Jentsch, Thomas J.] Charite, Berlin, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP); Free University of Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Jentsch, TJ (corresponding author), Max Delbruck Ctr Mol Med MDC, Leibniz Inst Mol Pharmakol FMP, Berlin, Germany.	jentsch@fmp-berlin.de	Fidzinski, Pawel/AAM-8884-2020; Billig, Gwendolyn M/A-1297-2012	Fidzinski, Pawel/0000-0001-6373-4763; Jentsch, Thomas/0000-0002-3509-2553	Prix Louis-Jeantet de Medecine	Prix Louis-Jeantet de Medecine	We thank P. Mombaerts (Max Planck Institute for Biophysics) for providing Cnga2<SUP>-</SUP>, P2-IRES-tauLacZ and M72-IRES-tauLacZ mice, V. Hagen (FMP) for caged 8-Br-cAMP, I. Zarour and U. Heinemann (Charite) for help with ion-selective microelectrodes, S. Jabs and L. Leisle for help with flash photolysis, P. Mombaerts and B. Schroeder (MDC) for helpful discussions and N. Kronke and F. Binder for technical assistance. This work was supported, in part, by the Prix Louis-Jeantet de Medecine to T.J.J.	Boccaccio A, 2007, J NEUROPHYSIOL, V98, P153, DOI 10.1152/jn.00270.2007; Bodyak N, 1999, CHEM SENSES, V24, P637, DOI 10.1093/chemse/24.6.637; Bonigk W, 1999, J NEUROSCI, V19, P5332; Brunet LJ, 1996, NEURON, V17, P681, DOI 10.1016/S0896-6273(00)80200-7; Caputo A, 2008, SCIENCE, V322, P590, DOI 10.1126/science.1163518; CHIU D, 1988, CHEM SENSES, V13, P677; Cygnar K. D., 2010, J VIS EXP; Frings S, 2000, PROG NEUROBIOL, V60, P247, DOI 10.1016/S0301-0082(99)00027-1; Gomez-Pinilla PJ, 2009, AM J PHYSIOL-GASTR L, V296, pG1370, DOI 10.1152/ajpgi.00074.2009; Gribkoff VK, 1996, MOL PHARMACOL, V50, P206; Hengl T, 2010, P NATL ACAD SCI USA, V107, P6052, DOI 10.1073/pnas.0909032107; Kaneko H, 2004, J NEUROSCI, V24, P7931, DOI 10.1523/JNEUROSCI.2115-04.2004; KELLER A, 1975, J NEUROCHEM, V24, P1101, DOI 10.1111/j.1471-4159.1975.tb03883.x; Kelliher KR, 2003, P NATL ACAD SCI USA, V100, P4299, DOI 10.1073/pnas.0736071100; KLEENE SJ, 1993, NEURON, V11, P123, DOI 10.1016/0896-6273(93)90276-W; Kleene SJ, 1996, J NEUROPHYSIOL, V75, P1386, DOI 10.1152/jn.1996.75.4.1386; KLEENE SJ, 1991, J NEUROSCI, V11, P3624; Kleene SJ, 2008, CHEM SENSES, V33, P839, DOI 10.1093/chemse/bjn048; KURAHASHI T, 1993, NATURE, V363, P71, DOI 10.1038/363071a0; Lin WH, 2004, J NEUROSCI, V24, P3703, DOI 10.1523/JNEUROSCI.0188-04.2004; Lindemann B, 2001, BIOPHYS J, V80, P1712, DOI 10.1016/S0006-3495(01)76142-5; LOWE G, 1993, NATURE, V366, P283, DOI 10.1038/366283a0; Munger SD, 2009, ANNU REV PHYSIOL, V71, P115, DOI 10.1146/annurev.physiol.70.113006.100608; NAKAMURA T, 1987, NATURE, V325, P442, DOI 10.1038/325442a0; Nickell WT, 2007, J PHYSIOL-LONDON, V583, P1005, DOI 10.1113/jphysiol.2007.129601; Nickell WT, 2006, J NEUROPHYSIOL, V95, P2003, DOI 10.1152/jn.00962.2005; Pifferi S, 2006, P NATL ACAD SCI USA, V103, P12929, DOI 10.1073/pnas.0604505103; Pifferi S, 2009, PFLUG ARCH EUR J PHY, V458, P1023, DOI 10.1007/s00424-009-0684-9; Pifferi S, 2009, J PHYSIOL-LONDON, V587, P4265, DOI 10.1113/jphysiol.2009.176131; Pinato G, 2008, CHEM SENSES, V33, P397, DOI 10.1093/chemse/bjn007; Rasche S, 2010, CHEM SENSES, V35, P239, DOI 10.1093/chemse/bjq007; Reisert J, 2005, NEURON, V45, P553, DOI 10.1016/j.neuron.2005.01.012; Reisert J, 2003, J GEN PHYSIOL, V122, P349, DOI 10.1085/jgp.200308888; Reuter D, 1998, J NEUROSCI, V18, P6623; Rock JR, 2009, J BIOL CHEM, V284, P14875, DOI 10.1074/jbc.C109.000869; Romanenko VG, 2010, J BIOL CHEM, V285, P12990, DOI 10.1074/jbc.M109.068544; Sagheddu C, 2010, J PHYSIOL-LONDON, V588, P4189, DOI 10.1113/jphysiol.2010.194407; Schneppenheim R, 2007, J THROMB HAEMOST, V5, P722, DOI 10.1111/j.1538-7836.2007.02460.x; Schroeder BC, 2008, CELL, V134, P1019, DOI 10.1016/j.cell.2008.09.003; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Shimazaki R, 2006, CHEM SENSES, V31, P425, DOI 10.1093/chemse/bjj047; Slotnick B, 2005, CURR PROTOC NEUROSCI; Smith DW, 2008, PHYSIOL BEHAV, V93, P44, DOI 10.1016/j.physbeh.2007.07.011; Stephan AB, 2009, P NATL ACAD SCI USA, V106, P11776, DOI 10.1073/pnas.0903304106; Stohr H, 2009, J NEUROSCI, V29, P6809, DOI 10.1523/JNEUROSCI.5546-08.2009; Vogalis F, 2005, J PHYSIOL-LONDON, V562, P785, DOI 10.1113/jphysiol.2004.079228; Windmuller O, 2005, BRAIN, V128, P2042, DOI 10.1093/brain/awh545; Yang YD, 2008, NATURE, V455, P1210, DOI 10.1038/nature07313; Zheng C, 2000, NEURON, V26, P81, DOI 10.1016/S0896-6273(00)81140-X; Zou DJ, 2007, J NEUROSCI, V27, P6675, DOI 10.1523/JNEUROSCI.0699-07.2007	50	154	157	2	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2011	14	6					763	U370		10.1038/nn.2821	http://dx.doi.org/10.1038/nn.2821			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	768SH	21516098	Green Accepted			2022-12-28	WOS:000290958000020
J	Kay, L; Humphreys, L; Eickholt, BJ; Burrone, J				Kay, Louise; Humphreys, Lawrence; Eickholt, Britta J.; Burrone, Juan			Neuronal activity drives matching of pre- and postsynaptic function during synapse maturation	NATURE NEUROSCIENCE			English	Article							HIPPOCAMPAL SYNAPSES; RELEASE PROBABILITY; AMPA; EXPRESSION	The structure and function of presynaptic and postsynaptic compartments varies markedly in neurons, but little is known about how they are functionally arranged with respect to each other. In rat hippocampal neurons, we found that, although they are structurally correlated from the early moments of formation, synapses only gradually become functionally matched and that this process is dependent on ongoing electrical activity.	[Kay, Louise; Humphreys, Lawrence; Eickholt, Britta J.; Burrone, Juan] Kings Coll London, MRC Ctr Dev Neurobiol, London WC2R 2LS, England	University of London; King's College London	Burrone, J (corresponding author), Kings Coll London, MRC Ctr Dev Neurobiol, London WC2R 2LS, England.	juan.burrone@kcl.ac.uk	Eickholt, Britta/C-5337-2009	Burrone, Juan/0000-0003-1233-668X; Eickholt, Britta/0000-0001-7873-8687	MRC; Wellcome Trust; Lister prize fellowship; MRC [G0802289, G0901307, G0901899] Funding Source: UKRI; Medical Research Council [G0802289, G0901899, G0901307] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Lister prize fellowship; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We would like to thank the members of the Burrone and Eickholt laboratories for help and suggestions with experiments and M. Grubb for critical reading of the manuscript. This work was supported by MRC and Wellcome Trust project grants, as well as a Lister prize fellowship to J.B. and MRC studentships to L.K. and L.H.	Arellano JI, 2007, FRONT NEUROSCI-SWITZ, V1, P131, DOI 10.3389/neuro.01.1.1.010.2007; Dobrunz LE, 1997, NEURON, V18, P995, DOI 10.1016/S0896-6273(00)80338-4; HARRIS KM, 1989, J NEUROSCI, V9, P2982; Matsuzaki M, 2001, NAT NEUROSCI, V4, P1086, DOI 10.1038/nn736; Murthy VN, 1997, NEURON, V18, P599, DOI 10.1016/S0896-6273(00)80301-3; Nusser Z, 1998, NEURON, V21, P545, DOI 10.1016/S0896-6273(00)80565-6; Renger JJ, 2001, NEURON, V29, P469, DOI 10.1016/S0896-6273(01)00219-7; Schikorski T, 1999, P NATL ACAD SCI USA, V96, P4107, DOI 10.1073/pnas.96.7.4107; Takumi Y, 1999, NAT NEUROSCI, V2, P618, DOI 10.1038/10172; Tokuoka H, 2008, P NATL ACAD SCI USA, V105, P14656, DOI 10.1073/pnas.0805705105	10	33	33	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2011	14	6					688	690		10.1038/nn.2826	http://dx.doi.org/10.1038/nn.2826			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	768SH	21532580				2022-12-28	WOS:000290958000008
J	Ma, WJ; Navalpakkam, V; Beck, JM; van den Berg, R; Pouget, A				Ma, Wei Ji; Navalpakkam, Vidhya; Beck, Jeffrey M.; van den Berg, Ronald; Pouget, Alexandre			Behavior and neural basis of near-optimal visual search	NATURE NEUROSCIENCE			English	Article							PROBABILISTIC POPULATION CODES; BAYESIAN-INFERENCE; TARGET SELECTION; PARIETAL CORTEX; AREA V4; ATTENTION; MODELS; DECISION; NEURONS; COMPUTATION	The ability to search efficiently for a target in a cluttered environment is one of the most remarkable functions of the nervous system. This task is difficult under natural circumstances, as the reliability of sensory information can vary greatly across space and time and is typically a priori unknown to the observer. In contrast, visual-search experiments commonly use stimuli of equal and known reliability. In a target detection task, we randomly assigned high or low reliability to each item on a trial-by-trial basis. An optimal observer would weight the observations by their trial-to-trial reliability and combine them using a specific nonlinear integration rule. We found that humans were near-optimal, regardless of whether distractors were homogeneous or heterogeneous and whether reliability was manipulated through contrast or shape. We present a neural-network implementation of near-optimal visual search based on probabilistic population coding. The network matched human performance.	[Ma, Wei Ji; van den Berg, Ronald] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; [Navalpakkam, Vidhya] CALTECH, Dept Biol, Pasadena, CA 91125 USA; [Beck, Jeffrey M.] UCL, Gatsby Computat Neurosci Unit, London, England; [Pouget, Alexandre] Univ Rochester, Dept Brain & Cognit Sci, Rochester, NY USA	Baylor College of Medicine; California Institute of Technology; University of London; University College London; University of Rochester	Ma, WJ (corresponding author), Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA.	wjma@bcm.edu		Pouget, Alexandre/0000-0003-3054-6365; Ma, Wei Ji/0000-0002-9835-9083; van den Berg, Ronald/0000-0001-7353-5960	National Eye Institute [R01EY020958, P30EY001319]; National Science Foundation [0820582]; Gatsby Charitable Foundation; Netherlands Organization for Scientific Research (NWO); Multidisciplinary University Research Initiative [N00014-07-1-0937]; National Institute on Drug Abuse [BCS0346785]; James S. McDonnell Foundation; NATIONAL EYE INSTITUTE [P30EY001319, R01EY020958] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Science Foundation(National Science Foundation (NSF)); Gatsby Charitable Foundation; Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Multidisciplinary University Research Initiative(MURI); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); James S. McDonnell Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	W.J.M. is supported by award R01EY020958 from the National Eye Institute. V.N. is supported by National Science Foundation grant #0820582. J.M.B. is supported by the Gatsby Charitable Foundation and R.v.d.B. by the Netherlands Organization for Scientific Research (NWO). A.P. is supported by Multidisciplinary University Research Initiative grant N00014-07-1-0937, National Institute on Drug Abuse grant #BCS0346785, a research grant from the James S. McDonnell Foundation and award P30EY001319 from the National Eye Institute.	ANDERSEN RA, 1985, SCIENCE, V230, P456, DOI 10.1126/science.4048942; BECK J, 2009, FRONT SYST NEUR C CO, DOI DOI 10.3389/CONF.NEURO.06.2009.03.109; Beck JM, 2008, NEURON, V60, P1142, DOI 10.1016/j.neuron.2008.09.021; Bichot NP, 2005, SCIENCE, V308, P529, DOI 10.1126/science.1109676; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Bremmer F, 1997, J NEUROPHYSIOL, V77, P944, DOI 10.1152/jn.1997.77.2.944; Cover TM, 1991, ELEMENTS INFORM THEO; Deneve S, 1999, NAT NEUROSCI, V2, P740, DOI 10.1038/11205; DUNCAN J, 1989, PSYCHOL REV, V96, P433, DOI 10.1037/0033-295X.96.3.433; Eckstein MP, 2009, VISION RES, V49, P1097, DOI 10.1016/j.visres.2008.12.008; Eckstein MP, 1998, PSYCHOL SCI, V9, P111, DOI 10.1111/1467-9280.00020; Eckstein MP, 2000, PERCEPT PSYCHOPHYS, V62, P425, DOI 10.3758/BF03212096; ERIKSEN CW, 1953, J EXP PSYCHOL, V45, P126, DOI 10.1037/h0058018; ESTES WK, 1964, P NATL ACAD SCI USA, V52, P446, DOI 10.1073/pnas.52.2.446; FARMER EW, 1980, PERCEPT PSYCHOPHYS, V27, P267, DOI 10.3758/BF03204265; Gottlieb JP, 1998, NATURE, V391, P481, DOI 10.1038/35135; GRAHAM N, 1987, J MATH PSYCHOL, V31, P366, DOI 10.1016/0022-2496(87)90021-6; Green DM, 1966, SIGNAL DETECTION THE; HEEGER DJ, 1992, VISUAL NEUROSCI, V9, P181, DOI 10.1017/S0952523800009640; Itti L, 2001, NAT REV NEUROSCI, V2, P194, DOI 10.1038/35058500; Kepecs A, 2008, NATURE, V455, P227, DOI 10.1038/nature07200; Kersten D, 2004, ANNU REV PSYCHOL, V55, P271, DOI 10.1146/annurev.psych.55.090902.142005; Kiani R, 2009, SCIENCE, V324, P759, DOI 10.1126/science.1169405; Kim B, 2008, J NEUROSCI, V28, P2991, DOI 10.1523/JNEUROSCI.5424-07.2008; Knill DC, 2003, VISION RES, V43, P831, DOI 10.1016/S0042-6989(03)00003-8; Knill DC, 2004, TRENDS NEUROSCI, V27, P712, DOI 10.1016/j.tins.2004.10.007; Knill DC, 1996, PERCEPTION BAYESIAN; Ma WJ, 2006, NAT NEUROSCI, V9, P1432, DOI 10.1038/nn1790; MacKay D. J. C., 2003, INFORM THEORY INFERE; Morgan ML, 2008, NEURON, V59, P662, DOI 10.1016/j.neuron.2008.06.024; Najemnik J, 2005, NATURE, V434, P387, DOI 10.1038/nature03390; Navalpakkam V, 2007, NEURON, V53, P605, DOI 10.1016/j.neuron.2007.01.018; NOLTE LW, 1967, J ACOUST SOC AM, V41, P497, DOI 10.1121/1.1910360; Ogawa T, 2004, J NEUROSCI, V24, P6371, DOI 10.1523/JNEUROSCI.0569-04.2004; PALMER J, 1993, J EXP PSYCHOL HUMAN, V19, P108, DOI 10.1037/0096-1523.19.1.108; Palmer J, 2000, VISION RES, V40, P1227, DOI 10.1016/S0042-6989(99)00244-8; PETERSON WW, 1954, IRE T INFORM THEOR, P171, DOI 10.1109/TIT.1954.1057460; Pouget A, 2003, ANNU REV NEUROSCI, V26, P381, DOI 10.1146/annurev.neuro.26.041002.131112; QUICK RF, 1974, KYBERNETIK, V16, P65, DOI 10.1007/BF00271628; REGAN D, 1983, J OPT SOC AM, V73, P1684, DOI 10.1364/JOSA.73.001684; Reynolds JH, 2009, NEURON, V61, P168, DOI 10.1016/j.neuron.2009.01.002; Rosenholtz R, 2001, J EXP PSYCHOL HUMAN, V27, P985, DOI 10.1037//0096-1523.27.4.985; Schoups A, 2001, NATURE, V412, P549, DOI 10.1038/35087601; SEUNG HS, 1993, P NATL ACAD SCI USA, V90, P10749, DOI 10.1073/pnas.90.22.10749; Shaw M., 1980, ATTENTION PERFORM, VVIII, P277, DOI DOI 10.1017/CBO9781107415324.004; TEICHNER WH, 1974, PSYCHOL BULL, V81, P15, DOI 10.1037/h0035449; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; Verghese P, 2001, NEURON, V31, P523, DOI 10.1016/S0896-6273(01)00392-0; Vincent BT, 2009, J VISION, V9, DOI 10.1167/9.5.15; Zhang LY, 2008, J VISION, V8, DOI 10.1167/8.7.32	50	77	77	4	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2011	14	6					783	U150		10.1038/nn.2814	http://dx.doi.org/10.1038/nn.2814			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	768SH	21552276	Green Accepted			2022-12-28	WOS:000290958000023
J	Matsumoto, I; Ohmoto, M; Narukawa, M; Yoshihara, Y; Abe, K				Matsumoto, Ichiro; Ohmoto, Makoto; Narukawa, Masataka; Yoshihara, Yoshihiro; Abe, Keiko			Skn-1a (Pou2f3) specifies taste receptor cell lineage	NATURE NEUROSCIENCE			English	Article							CODES; SPECIFICATION	Functional diversification of taste cells is crucial for proper discrimination of taste qualities. We found the homeodomain protein Skn-1a (Pou2f3) to be expressed in sweet, umami and bitter taste cells. Skn-1a-deficient mice lacked electrophysiological and behavioral responses to sweet, umami and bitter tastes, as a result of a complete absence of sweet, umami and bitter cells and the concomitant expansion of sour cells. Skn-1a is critical for generating and balancing the diverse composition of taste cells.	[Matsumoto, Ichiro; Ohmoto, Makoto; Narukawa, Masataka; Abe, Keiko] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Tokyo, Japan; [Yoshihara, Yoshihiro] RIKEN Brain Sci Inst, Lab Neurobiol Synapse, Saitama, Japan	University of Tokyo; RIKEN	Matsumoto, I (corresponding author), Monell Chem Senses Ctr, 3500 Market St, Philadelphia, PA 19104 USA.	imatsumoto@monell.org; aka7308@mail.ecc.u-tokyo.ac.jp	Yoshihara, Yoshihiro/N-6481-2015	Yoshihara, Yoshihiro/0000-0002-0319-7166	Ministry of Education, Culture, Sports, Science and Technology of Japan [16688006, 18688020, 21780121, 16108004, 20380183]; Research and Development Program for New Bioindustry Initiatives; Ajinomoto Amino Acid Research Program; US National Institute on Deafness and Other Communication Disorders [R03 DC011143]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R03DC011143] Funding Source: NIH RePORTER	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Research and Development Program for New Bioindustry Initiatives; Ajinomoto Amino Acid Research Program; US National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank Y. Sato for assistance with the BAC library screening, the staff of the Research Resource Center, RIKEN, for assistance with generating chimeric and transgenic mice, and T. Kondo for useful comments on the manuscript. This work was supported in part by a Grant-in-Aid for Scientific Research (16688006 and 18688020 to I.M., 21780121 to M.O., and 16108004 and 20380183 to K.A.) and Innovative Areas (Systems Molecular Ethology, Y.Y.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan, a grant from the Research and Development Program for New Bioindustry Initiatives (K.A.), an Ajinomoto Amino Acid Research Program research grant (I.M.), and US National Institute on Deafness and Other Communication Disorders research grant R03 DC011143 (I.M.).	ANDERSEN B, 1993, SCIENCE, V260, P78, DOI 10.1126/science.7682011; Andersen B, 1997, GENE DEV, V11, P1873, DOI 10.1101/gad.11.14.1873; BEIDLER LM, 1965, J CELL BIOL, V27, P263, DOI 10.1083/jcb.27.2.263; Chandrashekar J, 2006, NATURE, V444, P288, DOI 10.1038/nature05401; Chandrashekar J, 2010, NATURE, V464, P297, DOI 10.1038/nature08783; Guillemot F, 2007, DEVELOPMENT, V134, P3771, DOI 10.1242/dev.006379; Huang AL, 2006, NATURE, V442, P934, DOI [10.1038/nature05084, 10.1038/nature050084]; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Ohmoto M, 2006, CHEM SENSES, V31, P739, DOI 10.1093/chemse/bjl016; Ryan AK, 1997, GENE DEV, V11, P1207, DOI 10.1101/gad.11.10.1207; STONE LM, 1995, P NATL ACAD SCI USA, V92, P1916, DOI 10.1073/pnas.92.6.1916	11	110	112	3	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2011	14	6					685	687		10.1038/nn.2820	http://dx.doi.org/10.1038/nn.2820			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	768SH	21572433	Green Accepted			2022-12-28	WOS:000290958000007
J	Ganguly, K; Dimitrov, DF; Wallis, JD; Carmena, JM				Ganguly, Karunesh; Dimitrov, Dragan F.; Wallis, Jonathan D.; Carmena, Jose M.			Reversible large-scale modification of cortical networks during neuroprosthetic control	NATURE NEUROSCIENCE			English	Article							BRAIN-COMPUTER INTERFACE; MOTOR CORTEX; REACHING MOVEMENTS; ARM MOVEMENTS; PERFORMANCE; ADAPTATION; STABILITY; PATTERNS; NEURONS; SIGNALS	Brain-machine interfaces (BMIs) provide a framework for studying cortical dynamics and the neural correlates of learning. Neuroprosthetic control has been associated with tuning changes in specific neurons directly projecting to the BMI (hereafter referred to as direct neurons). However, little is known about the larger network dynamics. By monitoring ensembles of neurons that were either causally linked to BMI control or indirectly involved, we found that proficient neuroprosthetic control is associated with large-scale modifications to the cortical network in macaque monkeys. Specifically, there were changes in the preferred direction of both direct and indirect neurons. Notably, with learning, there was a relative decrease in the net modulation of indirect neural activity in comparison with direct activity. These widespread differential changes in the direct and indirect population activity were markedly stable from one day to the next and readily coexisted with the long-standing cortical network for upper limb control. Thus, the process of learning BMI control is associated with differential modification of neural populations based on their specific relation to movement control.	[Ganguly, Karunesh; Wallis, Jonathan D.; Carmena, Jose M.] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; [Ganguly, Karunesh] San Francisco VA Med Ctr, Dept Neurol & Rehabil, San Francisco, CA USA; [Ganguly, Karunesh; Carmena, Jose M.] Univ Calif Berkeley, Dept Elect Engn & Comp Sci, Berkeley, CA 94720 USA; [Ganguly, Karunesh] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Dimitrov, Dragan F.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA; [Wallis, Jonathan D.] Univ Calif Berkeley, Dept Psychol, Berkeley, CA 94720 USA; [Carmena, Jose M.] Univ Calif Berkeley, Program Cognit Sci, Berkeley, CA 94720 USA; [Carmena, Jose M.] Univ Calif San Francisco, Joint Grad Grp Bioengn, San Francisco, CA 94143 USA	University of California System; University of California Berkeley; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; University of California System; University of California Berkeley; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California San Francisco	Carmena, JM (corresponding author), Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA.	carmena@eecs.berkeley.edu		Wallis, Joni/0000-0001-7262-7417	Department of Veterans Affairs, Veterans Health Administration, Rehabilitation Research and Development; American Heart Association/American Stroke Association; National Institute of Neurological Disorders and Stroke [NS21135]; Alfred P. Sloan Foundation; Christopher and Dana Reeve Foundation; National Science Foundation [0954243]; Defense Advanced Research Projects Agency [N66001-10-C-2008]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS040813, R01NS021135, R56NS021135, R37NS021135] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA019028] Funding Source: NIH RePORTER	Department of Veterans Affairs, Veterans Health Administration, Rehabilitation Research and Development(US Department of Veterans Affairs); American Heart Association/American Stroke Association(American Heart Association); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); Christopher and Dana Reeve Foundation; National Science Foundation(National Science Foundation (NSF)); Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the Department of Veterans Affairs, Veterans Health Administration, Rehabilitation Research and Development, and the American Heart Association/American Stroke Association (to K. G.), the National Institute of Neurological Disorders and Stroke grant number NS21135 (to J.D.W.), the Alfred P. Sloan Foundation, the Christopher and Dana Reeve Foundation, the National Science Foundation CAREER Award #0954243 and the Defense Advanced Research Projects Agency contract N66001-10-C-2008 (to J.M.C.).	Ajemian R, 2008, NEURON, V58, P414, DOI 10.1016/j.neuron.2008.02.033; Arce F, 2010, J NEUROSCI, V30, P9189, DOI 10.1523/JNEUROSCI.1603-10.2010; Birbaumer N, 1999, NATURE, V398, P297, DOI 10.1038/18581; Briggman KL, 2005, SCIENCE, V307, P896, DOI 10.1126/science.1103736; CAMINITI R, 1990, J NEUROSCI, V10, P2039; Carmena JM, 2005, J NEUROSCI, V25, P10712, DOI 10.1523/JNEUROSCI.2772-05.2005; Carmena JM, 2003, PLOS BIOL, V1, P193, DOI 10.1371/journal.pbio.0000042; Chapin JK, 1999, NAT NEUROSCI, V2, P664, DOI 10.1038/10223; Chestek CA, 2007, J NEUROSCI, V27, P10742, DOI 10.1523/JNEUROSCI.0959-07.2007; Churchland MM, 2007, CURR OPIN NEUROBIOL, V17, P609, DOI 10.1016/j.conb.2007.11.001; Davidson AG, 2007, SCIENCE, V318, P1934, DOI 10.1126/science.1149774; Fetz EE, 2007, J PHYSIOL-LONDON, V579, P571, DOI 10.1113/jphysiol.2006.127142; FETZ EE, 1973, J NEUROPHYSIOL, V36, P179, DOI 10.1152/jn.1973.36.2.179; FETZ EE, 1969, SCIENCE, V163, P955, DOI 10.1126/science.163.3870.955; Galan F, 2008, CLIN NEUROPHYSIOL, V119, P2159, DOI 10.1016/j.clinph.2008.06.001; Gandolfo F, 2000, P NATL ACAD SCI USA, V97, P2259, DOI 10.1073/pnas.040567097; Ganguly K, 2010, J MOTOR BEHAV, V42, P355, DOI 10.1080/00222895.2010.526457; Ganguly K, 2009, J NEUROSCI, V29, P12948, DOI 10.1523/JNEUROSCI.2471-09.2009; Ganguly K, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000153; GEORGOPOULOS AP, 1986, SCIENCE, V233, P1416, DOI 10.1126/science.3749885; Green AM, 2011, TRENDS NEUROSCI, V34, P61, DOI 10.1016/j.tins.2010.11.003; Greenberg PA, 2004, J NEUROPHYSIOL, V92, P1042, DOI 10.1152/jn.00062.2004; Grossman SE, 2008, J NEUROSCI, V28, P2864, DOI 10.1523/JNEUROSCI.4063-07.2008; Hochberg LR, 2006, NATURE, V442, P164, DOI 10.1038/nature04970; HUMPHREY DR, 1970, SCIENCE, V170, P758, DOI 10.1126/science.170.3959.758; Jarosiewicz B, 2008, P NATL ACAD SCI USA, V105, P19486, DOI 10.1073/pnas.0808113105; Lebedev MA, 2005, J NEUROSCI, V25, P4681, DOI 10.1523/JNEUROSCI.4088-04.2005; Legenstein R, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000180; Leuthardt EC, 2004, J NEURAL ENG, V1, P63, DOI 10.1088/1741-2560/1/2/001; Li CSR, 2001, NEURON, V30, P593, DOI 10.1016/S0896-6273(01)00301-4; Moritz CT, 2008, NATURE, V456, P639, DOI 10.1038/nature07418; Musallam S, 2004, SCIENCE, V305, P258, DOI 10.1126/science.1097938; Nicolelis MAL, 2003, P NATL ACAD SCI USA, V100, P11041, DOI 10.1073/pnas.1934665100; Nicolelis MAL, 2009, NAT REV NEUROSCI, V10, P530, DOI 10.1038/nrn2653; Padoa-Schioppa C, 2002, NEURON, V36, P751, DOI 10.1016/S0896-6273(02)01028-0; Paz R, 2004, PLOS BIOL, V2, P264, DOI 10.1371/journal.pbio.0020045; Paz R, 2003, NAT NEUROSCI, V6, P882, DOI 10.1038/nn1097; Rokni U, 2007, NEURON, V54, P653, DOI 10.1016/j.neuron.2007.04.030; Santhanam G, 2006, NATURE, V442, P195, DOI 10.1038/nature04968; Scott SH, 1997, J NEUROPHYSIOL, V77, P826, DOI 10.1152/jn.1997.77.2.826; Serruya MD, 2002, NATURE, V416, P141, DOI 10.1038/416141a; Taylor DM, 2002, SCIENCE, V296, P1829, DOI 10.1126/science.1070291; Velliste M, 2008, NATURE, V453, P1098, DOI 10.1038/nature06996; Wise SP, 1998, EXP BRAIN RES, V121, P285, DOI 10.1007/s002210050462; Wolpaw JR, 2004, P NATL ACAD SCI USA, V101, P17849, DOI 10.1073/pnas.0403504101	45	170	171	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2011	14	5					662	U164		10.1038/nn.2797	http://dx.doi.org/10.1038/nn.2797			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	754VU	21499255	Green Accepted			2022-12-28	WOS:000289886600024
J	Deguchi, Y; Donato, F; Galimberti, I; Cabuy, E; Caroni, P				Deguchi, Yuichi; Donato, Flavio; Galimberti, Ivan; Cabuy, Erik; Caroni, Pico			Temporally matched subpopulations of selectively interconnected principal neurons in the hippocampus	NATURE NEUROSCIENCE			English	Article							IN-SITU HYBRIDIZATION; TRANSGENIC MICE; DENTATE GYRUS; GRANULE CELLS; NEUROGENESIS; DROSOPHILA; NETWORKS; CIRCUITS; ORGANIZATION; SPECIFICITY	The extent to which individual neurons are interconnected selectively within brain circuits is an unresolved problem in neuroscience. Neurons can be organized into preferentially interconnected microcircuits, but whether this reflects genetically defined subpopulations is unclear. We found that the principal neurons in the main subdivisions of the hippocampus consist of distinct subpopulations that are generated during distinct time windows and that interconnect selectively across subdivisions. In two mouse lines in which transgene expression was driven by the neuron-specific Thy1 promoter, transgene expression allowed us to visualize distinct populations of principal neurons with unique and matched patterns of gene expression, shared distinct neurogenesis and synaptogenesis time windows, and selective connectivity at dentate gyrus-CA3 and CA3-CA1 synapses. Matched subpopulation marker genes and neuronal subtype markers mapped near clusters of olfactory receptor genes. The nonoverlapping matched timings of synaptogenesis accounted for the selective connectivities of these neurons in CA3. Therefore, the hippocampus contains parallel connectivity channels assembled from distinct principal neuron subpopulations through matched schedules of synaptogenesis.	[Deguchi, Yuichi; Donato, Flavio; Galimberti, Ivan; Cabuy, Erik; Caroni, Pico] Friedrich Miescher Inst, Basel, Switzerland	Friedrich Miescher Institute for Biomedical Research	Caroni, P (corresponding author), Friedrich Miescher Inst, Basel, Switzerland.	caroni@fmi.ch		Donato, Flavio/0000-0002-0732-1654				ALTMAN J, 1990, J COMP NEUROL, V301, P365, DOI 10.1002/cne.903010304; ALTMAN J, 1990, J COMP NEUROL, V301, P325, DOI 10.1002/cne.903010302; Amaral DaL P, 2007, HIPPOCAMPUS BOOK, P37; Baek M, 2009, J NEUROSCI, V29, P6904, DOI 10.1523/JNEUROSCI.1585-09.2009; Baumgardt M, 2009, CELL, V139, P969, DOI 10.1016/j.cell.2009.10.032; Brown SP, 2009, CURR OPIN NEUROBIOL, V19, P415, DOI 10.1016/j.conb.2009.07.011; Brown SP, 2009, NATURE, V457, P1133, DOI 10.1038/nature07658; Caroni P, 1997, J NEUROSCI METH, V71, P3, DOI 10.1016/S0165-0270(96)00121-5; Chehrehasa F, 2009, J NEUROSCI METH, V177, P122, DOI 10.1016/j.jneumeth.2008.10.006; Colgin LL, 2008, TRENDS NEUROSCI, V31, P469, DOI 10.1016/j.tins.2008.06.008; De Paola V, 2003, NAT NEUROSCI, V6, P491, DOI 10.1038/nn1046; Dijk F, 2004, BRAIN RES, V1026, P194, DOI 10.1016/j.brainres.2004.08.034; Elliott J, 2008, NEURON, V60, P26, DOI 10.1016/j.neuron.2008.08.008; Espinosa JS, 2008, J NEUROSCI, V28, P2301, DOI 10.1523/JNEUROSCI.5157-07.2008; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Frotscher M, 2007, PROG BRAIN RES, V163, P133, DOI 10.1016/S0079-6123(07)63007-6; Galimberti I, 2010, NEURON, V65, P627, DOI 10.1016/j.neuron.2010.02.016; Gaspard N, 2008, NATURE, V455, P351, DOI 10.1038/nature07287; Gelman DM, 2010, EUR J NEUROSCI, V31, P2136, DOI 10.1111/j.1460-9568.2010.07267.x; Godfrey PA, 2004, P NATL ACAD SCI USA, V101, P2156, DOI 10.1073/pnas.0308051100; Gogolla N, 2006, NAT PROTOC, V1, P1223, DOI 10.1038/nprot.2006.169; Gogolla N, 2009, NEURON, V62, P510, DOI 10.1016/j.neuron.2009.04.022; Haverkamp S, 2005, J NEUROSCI, V25, P5438, DOI 10.1523/JNEUROSCI.1117-05.2005; Hodge RD, 2008, J NEUROSCI, V28, P3707, DOI 10.1523/JNEUROSCI.4280-07.2008; Isshiki T, 2001, CELL, V106, P511, DOI 10.1016/S0092-8674(01)00465-2; Jefferis GSXE, 2001, NATURE, V414, P204, DOI 10.1038/35102574; Jones SP, 2003, HIPPOCAMPUS, V13, P413, DOI 10.1002/hipo.10121; Kamme F, 2003, J NEUROSCI, V23, P3607; Kampa BM, 2006, NAT NEUROSCI, V9, P1472, DOI 10.1038/nn1798; Knott GW, 2009, NAT PROTOC, V4, P1145, DOI 10.1038/nprot.2009.114; Lein ES, 2004, J NEUROSCI, V24, P3879, DOI 10.1523/JNEUROSCI.4710-03.2004; Li G, 2008, DEV NEUROSCI-BASEL, V30, P255, DOI 10.1159/000110347; McLean DL, 2009, J NEUROSCI, V29, P13566, DOI 10.1523/JNEUROSCI.3277-09.2009; Miyoshi G, 2007, J NEUROSCI, V27, P7786, DOI 10.1523/JNEUROSCI.1807-07.2007; Noctor SC, 2001, NATURE, V409, P714, DOI 10.1038/35055553; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; Petreanu L, 2009, NATURE, V457, P1142, DOI 10.1038/nature07709; Petrovic M, 2008, NATURE, V456, P800, DOI 10.1038/nature07407; Pinaud R, 2008, NAT PROTOC, V3, P1370, DOI 10.1038/nprot.2008.115; Saxena S, 2009, NAT NEUROSCI, V12, P627, DOI 10.1038/nn.2297; Song S, 2005, PLOS BIOL, V3, P507, DOI 10.1371/journal.pbio.0030068; Thompson CL, 2008, NEURON, V60, P1010, DOI 10.1016/j.neuron.2008.12.008; Tole S, 2001, J NEUROSCI, V21, P1580, DOI 10.1523/JNEUROSCI.21-05-01580.2001; Toni N, 2008, NAT NEUROSCI, V11, P901, DOI 10.1038/nn.2156; Tremblay ME, 2009, J COMP NEUROL, V512, P798, DOI 10.1002/cne.21922; Wojtowicz JM, 2006, NAT PROTOC, V1, P1399, DOI 10.1038/nprot.2006.224; Yoshimura Y, 2005, NAT NEUROSCI, V8, P1552, DOI 10.1038/nn1565; Yu YC, 2009, NATURE, V458, P501, DOI 10.1038/nature07722; Zylka MJ, 2005, NEURON, V45, P17, DOI 10.1016/j.neuron.2004.12.015	49	103	104	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2011	14	4					495	U135		10.1038/nn.2768	http://dx.doi.org/10.1038/nn.2768			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	741FQ	21358645				2022-12-28	WOS:000288849400021
J	Nouvian, R; Neef, J; Bulankina, AV; Reisinger, E; Pangrsic, T; Frank, T; Sikorra, S; Brose, N; Binz, T; Moser, T				Nouvian, Regis; Neef, Jakob; Bulankina, Anna V.; Reisinger, Ellen; Pangrsic, Tina; Frank, Thomas; Sikorra, Stefan; Brose, Nils; Binz, Thomas; Moser, Tobias			Exocytosis at the hair cell ribbon synapse apparently operates without neuronal SNARE proteins	NATURE NEUROSCIENCE			English	Article							SUBSTRATE RECOGNITION; AFFERENT SYNAPSE; NEUROEXOCYTOSIS; TRANSMISSION; ENDOCYTOSIS; NEUROTOXINS; MOUSE	SNARE proteins mediate membrane fusion. Neurosecretion depends on neuronal soluble NSF attachment protein receptors ( SNAREs; SNAP-25, syntaxin-1, and synaptobrevin-1 or synaptobrevin-2) and is blocked by neurotoxin-mediated cleavage or genetic ablation. We found that exocytosis in mouse inner hair cells (IHCs) was insensitive to neurotoxins and genetic ablation of neuronal SNAREs. mRNA, but no synaptically localized protein, of neuronal SNAREs was present in IHCs. Thus, IHC exocytosis is unconventional and may operate independently of neuronal SNAREs.	[Nouvian, Regis; Neef, Jakob; Bulankina, Anna V.; Pangrsic, Tina; Frank, Thomas; Moser, Tobias] Univ Gottingen, Dept Otolaryngol, Med Ctr, InnerEarLab, Gottingen, Germany; [Nouvian, Regis; Neef, Jakob; Bulankina, Anna V.; Pangrsic, Tina; Frank, Thomas; Moser, Tobias] Univ Gottingen, Ctr Mol Physiol Brain, Med Ctr, Gottingen, Germany; [Reisinger, Ellen] Univ Gottingen, Med Ctr, Dept Otolaryngol, Mol Biol Cochlear Neurotransmiss Grp, Gottingen, Germany; [Reisinger, Ellen; Brose, Nils] Max Planck Inst Expt Med, Dept Mol Neurobiol, D-37075 Gottingen, Germany; [Pangrsic, Tina] Univ Ljubljana, Fac Med, Inst Pathophysiol, Lab Neuroendocrinol Mol Cell Physiol, Ljubljana, Slovenia; [Sikorra, Stefan; Binz, Thomas] Hannover Med Sch, Dept Biochem, D-30623 Hannover, Germany	University of Gottingen; University of Gottingen; University of Gottingen; Max Planck Society; University of Ljubljana; Hannover Medical School	Moser, T (corresponding author), Univ Gottingen, Dept Otolaryngol, Med Ctr, InnerEarLab, Gottingen, Germany.	tmoser@gwdg.de	Frank, Thomas/F-5273-2012; Neef, Jakob/K-2553-2012; Moser, Tobias/L-5068-2014; Nouvian, Regis/AAW-4207-2021; Nouvian, Regis/AFQ-8065-2022	Frank, Thomas/0000-0002-5113-176X; Neef, Jakob/0000-0002-4757-9385; Moser, Tobias/0000-0001-7145-0533; Nouvian, Regis/0000-0002-0901-4666; Nouvian, Regis/0000-0002-0901-4666; Reisinger, Ellen/0000-0003-3739-7569	Deutsche Forschungsgemeinschaft [800/1-1, MO896 2-1]; Max Planck Society; Alexander von Humboldt Foundation	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Max Planck Society(Max Planck Society); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation)	We thank M. C. Wilson for providing SNAP-25 knockout mice, A. Nystuen for providing lethal-wasting mice, D. Bruns and T. C. Sudhof for providing synaptobrevin-2/3 double knockout mice, J. Sorensen for discussion, and A. Leonov and C. Griesinger for DM-Nitrophen. We would like to thank R. Jahn and E. Neher for comments on the manuscript and S. Blume, N. Dankenbrink-Werder and M. Koppler for technical assistance. This work was supported by grants of the Deutsche Forschungsgemeinschaft (800/1-1 to R. N. and MO896 2-1 to T. M.), the Max Planck Society (Tandem-Project to N. B. and T. M.) and by a fellowship of the Alexander von Humboldt Foundation (T. P.).	Beutner D, 2001, NEURON, V29, P681, DOI 10.1016/S0896-6273(01)00243-4; Borisovska M, 2005, EMBO J, V24, P2114, DOI 10.1038/sj.emboj.7600696; Chen S, 2006, J BIOL CHEM, V281, P10906, DOI 10.1074/jbc.M513032200; Khimich D, 2005, NATURE, V434, P889, DOI 10.1038/nature03418; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Moser T, 2000, P NATL ACAD SCI USA, V97, P883, DOI 10.1073/pnas.97.2.883; Nystuen AM, 2007, NEUROGENETICS, V8, P1, DOI 10.1007/s10048-006-0068-7; Roux I, 2006, CELL, V127, P277, DOI 10.1016/j.cell.2006.08.040; Safieddine S, 1999, EUR J NEUROSCI, V11, P803, DOI 10.1046/j.1460-9568.1999.00487.x; Sakaba T, 2005, SCIENCE, V309, P491, DOI 10.1126/science.1112645; Schiavo G, 2000, PHYSIOL REV, V80, P717, DOI 10.1152/physrev.2000.80.2.717; Sikorra S, 2008, J BIOL CHEM, V283, P21145, DOI 10.1074/jbc.M800610200; Strenzke N, 2009, J NEUROSCI, V29, P7991, DOI 10.1523/JNEUROSCI.0632-09.2009; Uthaiah RC, 2010, J NEUROSCI, V30, P12387, DOI 10.1523/JNEUROSCI.1014-10.2010; Washbourne P, 2002, NAT NEUROSCI, V5, P19, DOI 10.1038/nn783	15	80	81	1	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2011	14	4					411	413		10.1038/nn.2774	http://dx.doi.org/10.1038/nn.2774			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	741FQ	21378973				2022-12-28	WOS:000288849400007
J	Salimpoor, VN; Benovoy, M; Larcher, K; Dagher, A; Zatorre, RJ				Salimpoor, Valorie N.; Benovoy, Mitchel; Larcher, Kevin; Dagher, Alain; Zatorre, Robert J.			Anatomically distinct dopamine release during anticipation and experience of peak emotion to music	NATURE NEUROSCIENCE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; NUCLEUS-ACCUMBENS; DORSAL STRIATUM; HEALTHY-MEN; REWARD; PET; REGISTRATION; VALIDATION; PREDICTION; SUBSTRATE	Music, an abstract stimulus, can arouse feelings of euphoria and craving, similar to tangible rewards that involve the striatal dopaminergic system. Using the neurochemical specificity of [C-11]raclopride positron emission tomography scanning, combined with psychophysiological measures of autonomic nervous system activity, we found endogenous dopamine release in the striatum at peak emotional arousal during music listening. To examine the time course of dopamine release, we used functional magnetic resonance imaging with the same stimuli and listeners, and found a functional dissociation: the caudate was more involved during the anticipation and the nucleus accumbens was more involved during the experience of peak emotional responses to music. These results indicate that intense pleasure in response to music can lead to dopamine release in the striatal system. Notably, the anticipation of an abstract reward can result in dopamine release in an anatomical pathway distinct from that associated with the peak pleasure itself. Our results help to explain why music is of such high value across all human societies.	[Salimpoor, Valorie N.; Larcher, Kevin; Dagher, Alain; Zatorre, Robert J.] McGill Univ, Montreal Neurol Inst, Montreal, PQ, Canada; [Salimpoor, Valorie N.; Zatorre, Robert J.] Int Lab Brain Mus & Sound Res, Montreal, PQ, Canada; [Salimpoor, Valorie N.; Benovoy, Mitchel; Zatorre, Robert J.] Ctr Interdisciplinary Res Mus Media & Technol, Montreal, PQ, Canada; [Benovoy, Mitchel] McGill Univ, Ctr Intelligent Machines, Montreal, PQ, Canada	McGill University; Universite de Montreal; McGill University	Salimpoor, VN (corresponding author), McGill Univ, Montreal Neurol Inst, Montreal, PQ, Canada.	valorie.salimpoor@mail.mcgill.ca; robert.zatorre@mcgill.ca			Canadian Institutes of Health Research; Natural Science and Engineering Research Council; Jeanne Timmins Costello award; Centre for Interdisciplinary Research in Music Media and Technology	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Science and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Jeanne Timmins Costello award; Centre for Interdisciplinary Research in Music Media and Technology	We thank the staff of the Montreal Neurological Institute PET and MR Units and the staff of the Centre for Interdisciplinary Research in Music Media and Technology for help with data acquisition, M. Ferreira and M. Bouffard for their assistance with data analysis, and G. Longo for assistance with stimulus preparation. This research was supported by funding from the Canadian Institutes of Health Research to R.J.Z., a Natural Science and Engineering Research Council stipend to V.N.S., a Jeanne Timmins Costello award to V.N.S. and Centre for Interdisciplinary Research in Music Media and Technology awards to V.N.S. and M.B.	Aston JAD, 2000, NEUROIMAGE, V12, P245, DOI 10.1006/nimg.2000.0620; Barrett SP, 2004, SYNAPSE, V54, P65, DOI 10.1002/syn.20066; Blood AJ, 2001, P NATL ACAD SCI USA, V98, P11818, DOI 10.1073/pnas.191355898; Boileau I, 2003, SYNAPSE, V49, P226, DOI 10.1002/syn.10226; Boileau I, 2006, ARCH GEN PSYCHIAT, V63, P1386, DOI 10.1001/archpsyc.63.12.1386; COLLINS DL, 1994, J COMPUT ASSIST TOMO, V18, P192, DOI 10.1097/00004728-199403000-00005; Collins DL, 1997, INT J PATTERN RECOGN, V11, P1271, DOI 10.1142/S0218001497000597; Costes N, 2009, NEUROIMAGE, V47, P1496, DOI 10.1016/j.neuroimage.2009.05.052; Dube L, 2003, COGNITION EMOTION, V17, P263, DOI 10.1080/02699930302295; Egerton A, 2009, NEUROSCI BIOBEHAV R, V33, P1109, DOI 10.1016/j.neubiorev.2009.05.005; Endres CJ, 1997, J CEREBR BLOOD F MET, V17, P932, DOI 10.1097/00004647-199709000-00002; Everitt BJ, 2005, NAT NEUROSCI, V8, P1481, DOI 10.1038/nn1579; Grewe O, 2007, EMOTION, V7, P774, DOI 10.1037/1528-3542.7.4.774; Grewe O, 2009, ANN NY ACAD SCI, V1169, P351, DOI 10.1111/j.1749-6632.2009.04783.x; Gunn RN, 1997, NEUROIMAGE, V6, P279, DOI 10.1006/nimg.1997.0303; Haber SN, 2006, J NEUROSCI, V26, P8368, DOI 10.1523/JNEUROSCI.0271-06.2006; Haber SN, 2010, NEUROPSYCHOPHARMACOL, V35, P4, DOI 10.1038/npp.2009.129; Huron D, 2009, MUSIC EMOTION; Huron D.B., 2006, SWEET ANTICIPATION M; Knutson B, 2007, PSYCHOPHARMACOLOGY, V191, P813, DOI 10.1007/s00213-006-0686-7; Koelsch S, 2006, HUM BRAIN MAPP, V27, P239, DOI 10.1002/hbm.20180; Koepp MJ, 1998, NATURE, V393, P266, DOI 10.1038/30498; Kriegeskorte N, 2009, NAT NEUROSCI, V12, P535, DOI 10.1038/nn.2303; Krumhansl CL, 1997, CAN J EXP PSYCHOL, V51, P336, DOI 10.1037/1196-1961.51.4.336; Lammertsma AA, 1996, NEUROIMAGE, V4, P153, DOI 10.1006/nimg.1996.0066; Laruelle M, 2000, J CEREBR BLOOD F MET, V20, P423, DOI 10.1097/00004647-200003000-00001; Leyton M, 2002, NEUROPSYCHOPHARMACOL, V27, P1027, DOI 10.1016/S0893-133X(02)00366-4; LITTON JE, 1994, J CEREBR BLOOD F MET, V14, P358, DOI 10.1038/jcbfm.1994.45; Menon V, 2005, NEUROIMAGE, V28, P175, DOI 10.1016/j.neuroimage.2005.05.053; Meyer L., 1956, EMOTION MEANING MUSI; Mitterschiffthaler MT, 2007, HUM BRAIN MAPP, V28, P1150, DOI 10.1002/hbm.20337; O'Doherty JP, 2002, NEURON, V33, P815, DOI 10.1016/S0896-6273(02)00603-7; Panksepp J, 1995, MUSIC PERCEPT, V13, P171; Rickard N.S., 2004, PSYCHOL MUSIC, V32, P371, DOI [DOI 10.1177/0305735604046096, 10.1177%2F0305735604046096]; Salimpoor VN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007487; Schott BH, 2008, J NEUROSCI, V28, P14311, DOI 10.1523/JNEUROSCI.2058-08.2008; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Slifstein M, 2010, SYNAPSE, V64, P350, DOI 10.1002/syn.20734; Sloboda JA., 2001, MUSIC EMOTION THEORY; Sloboda JohnA., 1991, PSYCHOL MUSIC, V19, P110, DOI [10.1177/0305735691192002, DOI 10.1177/0305735691192002]; Small DM, 2003, NEUROIMAGE, V19, P1709, DOI 10.1016/S1053-8119(03)00253-2; Valentin VV, 2009, J NEUROPHYSIOL, V102, P3384, DOI 10.1152/jn.91195.2008; Volkow ND, 1997, NATURE, V386, P827, DOI 10.1038/386827a0; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406; Worsley KJ, 2002, NEUROIMAGE, V15, P1, DOI 10.1006/nimg.2001.0933; Worsley KJ, 1996, HUM BRAIN MAPP, V4, P58, DOI 10.1002/(SICI)1097-0193(1996)4:1<58::AID-HBM4>3.0.CO;2-O; Zald D. H., 2011, NEUROBIOLOGY SENSATI; Zald DH, 2004, J NEUROSCI, V24, P4105, DOI 10.1523/JNEUROSCI.4643-03.2004; Zijdenbos A, 1998, LECT NOTES COMPUT SC, V1496, P439, DOI 10.1007/BFb0056229	49	811	841	10	293	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2011	14	2					257	U355		10.1038/nn.2726	http://dx.doi.org/10.1038/nn.2726			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	711MJ	21217764				2022-12-28	WOS:000286595400025
J	D'Amelio, M; Cavallucci, V; Middei, S; Marchetti, C; Pacioni, S; Ferri, A; Diamantini, A; De Zio, D; Carrara, P; Battistini, L; Moreno, S; Bacci, A; Ammassari-Teule, M; Marie, H; Cecconi, F				D'Amelio, Marcello; Cavallucci, Virve; Middei, Silvia; Marchetti, Cristina; Pacioni, Simone; Ferri, Alberto; Diamantini, Adamo; De Zio, Daniela; Carrara, Paolo; Battistini, Luca; Moreno, Sandra; Bacci, Alberto; Ammassari-Teule, Martine; Marie, Helene; Cecconi, Francesco			Caspase-3 triggers early synaptic dysfunction in a mouse model of Alzheimer's disease	NATURE NEUROSCIENCE			English	Article							MILD COGNITIVE IMPAIRMENT; AMYLOID-BETA PROTEIN; LONG-TERM DEPRESSION; DENDRITIC SPINE LOSS; A-BETA; TRANSGENIC MICE; CELL-DEATH; PRECURSOR PROTEIN; IN-VIVO; ACTIVATION	Synaptic loss is the best pathological correlate of the cognitive decline in Alzheimer's disease; however, the molecular mechanisms underlying synaptic failure are unknown. We found a non-apoptotic baseline caspase-3 activity in hippocampal dendritic spines and an enhancement of this activity at the onset of memory decline in the Tg2576-APPswe mouse model of Alzheimer's disease. In spines, caspase-3 activated calcineurin, which in turn triggered dephosphorylation and removal of the GluR1 subunit of AMPA-type receptor from postsynaptic sites. These molecular modifications led to alterations of glutamatergic synaptic transmission and plasticity and correlated with spine degeneration and a deficit in hippocampal-dependent memory. Notably, pharmacological inhibition of caspase-3 activity in Tg2576 mice rescued the observed Alzheimer-like phenotypes. Our results identify a previously unknown caspase-3-dependent mechanism that drives synaptic failure and contributes to cognitive dysfunction in Alzheimer's disease. These findings indicate that caspase-3 is a potential target for pharmacological therapy during early disease stages.	[D'Amelio, Marcello; Cavallucci, Virve; Cecconi, Francesco] Fdn Santa Lucia, IRCCS, Dulbecco Telethon Inst, Lab Mol Neuroembryol, Rome, Italy; [D'Amelio, Marcello] Univ Campus Biomed, Lab Mol Neurosci, Rome, Italy; [Middei, Silvia; Ammassari-Teule, Martine] Fdn Santa Lucia, IRCCS, CNR, Inst Neurosci, Rome, Italy; [Marchetti, Cristina; Marie, Helene] European Brain Res Inst, Lab Mol Mech Synapt Plast, Rome, Italy; [Pacioni, Simone; Bacci, Alberto] European Brain Res Inst, Lab Cellular Physiol Cort Microcircuits, Rome, Italy; [Ferri, Alberto] CNR, Inst Neurosci, Dept Psychobiol & Psychopharmacol, Rome, Italy; [Diamantini, Adamo; Battistini, Luca] Fdn Santa Lucia, IRCCS, Lab Neuroimmunol, Rome, Italy; [De Zio, Daniela; Cecconi, Francesco] Univ Roma Tor Vergata, Dept Biol, Rome, Italy; [Carrara, Paolo; Moreno, Sandra] Univ Roma Tre, Dept Biol Interdept, Lab Electron Microscopy LIME, Rome, Italy	Fondazione Telethon; Dulbecco Telethon Institute (DTI); IRCCS Santa Lucia; University Campus Bio-Medico - Rome Italy; Consiglio Nazionale delle Ricerche (CNR); IRCCS Santa Lucia; Consiglio Nazionale delle Ricerche (CNR); IRCCS Santa Lucia; University of Rome Tor Vergata; Roma Tre University	Cecconi, F (corresponding author), Fdn Santa Lucia, IRCCS, Dulbecco Telethon Inst, Lab Mol Neuroembryol, Rome, Italy.	francesco.cecconi@uniroma2.it	Battistini, luca/ABE-1882-2021; Marchetti, Cristina/G-7220-2012; Marie, Hélène/F-1404-2011; Battistini, Luca/D-6920-2014; FERRI, ALBERTO/B-7660-2015; Moreno, Sandra/D-4254-2014; Cecconi, Francesco/K-3969-2016	Marie, Hélène/0000-0003-2310-6097; Battistini, Luca/0000-0002-6488-4891; FERRI, ALBERTO/0000-0002-4097-0605; Cecconi, Francesco/0000-0002-5614-4359; moreno, sandra/0000-0002-1079-3222; Cavallucci, Virve/0000-0003-3082-6359; D'Amelio, Marcello/0000-0001-6526-1832; De Zio, Daniela/0000-0002-9454-402X; Ammassari-Teule, Martine/0000-0003-1987-5723; middei, silvia/0000-0002-0488-323X; Bacci, Alberto/0000-0002-3355-5892	Telethon Foundation; Italian Ministry of Health; Italian Ministry of University; Research and Compagnia di San Paolo	Telethon Foundation(Fondazione Telethon); Italian Ministry of Health(Ministry of Health, Italy); Italian Ministry of University(Ministry of Education, Universities and Research (MIUR)); Research and Compagnia di San Paolo(Compagnia di San Paolo)	We thank the Animal Facility of the IRCCS Fondazione Santa Lucia/EBRI/CNR for the mouse work, Taconic for the Tg2576 mice, M. Acuna-Villa and M.W. Bennett for editorial and secretarial work, R. Nardacci, F. Fanelli and M. Nencini for research assistance and help with image processing, and A. Roberto and A. Pignataro for help with Neurolucida measurements. We are grateful to E. Perez-Paya for providing us with the apoptosome inhibitor QM56. This work was supported in part by grants from the Telethon Foundation, Ricerca Corrente and Ricerca Finalizzata from the Italian Ministry of Health, the Italian Ministry of University and Research and Compagnia di San Paolo.	Almeida CG, 2005, NEUROBIOL DIS, V20, P187, DOI 10.1016/j.nbd.2005.02.008; Arendt T, 2009, ACTA NEUROPATHOL, V118, P167, DOI 10.1007/s00401-009-0536-x; Bookheimer SY, 2000, NEW ENGL J MED, V343, P450, DOI 10.1056/NEJM200008173430701; Bourne JN, 2008, ANNU REV NEUROSCI, V31, P47, DOI 10.1146/annurev.neuro.31.060407.125646; Bravarenko NI, 2006, EUR J NEUROSCI, V23, P129, DOI 10.1111/j.1460-9568.2005.04549.x; Cecconi F, 1998, CELL, V94, P727, DOI 10.1016/S0092-8674(00)81732-8; Chapman PF, 1999, NAT NEUROSCI, V2, P271, DOI 10.1038/6374; Chen GQ, 2000, NATURE, V408, P975, DOI 10.1038/35050103; Cho DH, 2009, SCIENCE, V324, P102, DOI 10.1126/science.1171091; Elias MF, 2000, ARCH NEUROL-CHICAGO, V57, P808, DOI 10.1001/archneur.57.6.808; FERRER I, 1990, NEUROSCI LETT, V114, P11, DOI 10.1016/0304-3940(90)90420-E; Ferri A, 2000, J NEUROCHEM, V75, P606, DOI 10.1046/j.1471-4159.2000.0750606.x; Gervais FG, 1999, CELL, V97, P395, DOI 10.1016/S0092-8674(00)80748-5; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Gylys KH, 2004, NEUROCHEM INT, V44, P125, DOI 10.1016/S0197-0186(03)00146-3; Hakem R, 1998, CELL, V94, P339, DOI 10.1016/S0092-8674(00)81477-4; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Hsieh H, 2006, NEURON, V52, P831, DOI 10.1016/j.neuron.2006.10.035; Huesmann GR, 2006, NEURON, V52, P1061, DOI 10.1016/j.neuron.2006.10.033; Irizarry MC, 1997, J NEUROPATH EXP NEUR, V56, P965, DOI 10.1097/00005072-199709000-00002; Jacobsen JS, 2006, P NATL ACAD SCI USA, V103, P5161, DOI 10.1073/pnas.0600948103; Janus C, 2000, NATURE, V408, P979, DOI 10.1038/35050110; Kawarabayashi T, 2001, J NEUROSCI, V21, P372, DOI 10.1523/JNEUROSCI.21-02-00372.2001; Kuida K, 1998, CELL, V94, P325, DOI 10.1016/S0092-8674(00)81476-2; Kuida K, 1996, NATURE, V384, P368, DOI 10.1038/384368a0; Lajtha A, 2008, HDB NEUROCHEMISTRY M; Lanz TA, 2003, NEUROBIOL DIS, V13, P246, DOI 10.1016/S0969-9961(03)00079-2; Lee HK, 1998, NEURON, V21, P1151, DOI 10.1016/S0896-6273(00)80632-7; Lee I, 2004, HIPPOCAMPUS, V14, P301, DOI 10.1002/hipo.10177; Li SM, 2009, NEURON, V62, P788, DOI 10.1016/j.neuron.2009.05.012; Li Z, 2010, CELL, V141, P859, DOI 10.1016/j.cell.2010.03.053; Louneva N, 2008, AM J PATHOL, V173, P1488, DOI 10.2353/ajpath.2008.080434; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Manczak M, 2006, HUM MOL GENET, V15, P1437, DOI 10.1093/hmg/ddl066; Marie H, 2005, NEURON, V45, P741, DOI 10.1016/j.neuron.2005.01.039; Marin N, 2000, MECH AGEING DEV, V119, P63, DOI 10.1016/S0047-6374(00)00172-X; Mattson MP, 1998, EXP NEUROL, V153, P35, DOI 10.1006/exnr.1998.6863; Morrison JH, 1997, SCIENCE, V278, P412, DOI 10.1126/science.278.5337.412; Mukerjee N, 2000, ARCH BIOCHEM BIOPHYS, V379, P337, DOI 10.1006/abbi.2000.1889; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; Salvesen GS, 1997, CELL, V91, P443, DOI 10.1016/S0092-8674(00)80430-4; Santamaria B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006634; Scheff SW, 2007, NEUROLOGY, V68, P1501, DOI 10.1212/01.wnl.0000260698.46517.8f; Schulze-Osthoff K, 1998, EUR J BIOCHEM, V254, P439, DOI 10.1046/j.1432-1327.1998.2540439.x; Stadelmann C, 1999, AM J PATHOL, V155, P1459, DOI 10.1016/S0002-9440(10)65460-0; Takahashi RH, 2004, J NEUROSCI, V24, P3592, DOI 10.1523/JNEUROSCI.5167-03.2004; van Engeland M, 1998, CYTOMETRY, V31, P1, DOI 10.1002/(SICI)1097-0320(19980101)31:1<1::AID-CYTO1>3.0.CO;2-R; Vicent MJ, 2006, J MED CHEM, V49, P3763, DOI 10.1021/jm060458x; Westerman MA, 2002, J NEUROSCI, V22, P1858, DOI 10.1523/JNEUROSCI.22-05-01858.2002; Zhou YX, 2008, ALZHEIMERS DEMENT, V4, P265, DOI 10.1016/j.jalz.2008.04.006	50	408	417	0	81	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2011	14	1					69	U97		10.1038/nn.2709	http://dx.doi.org/10.1038/nn.2709			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	699TE	21151119	Green Submitted			2022-12-28	WOS:000285684900016
J	Wang, Q; Webber, RM; Stanley, GB				Wang, Qi; Webber, Roxanna M.; Stanley, Garrett B.			Thalamic synchrony and the adaptive gating of information flow to cortex	NATURE NEUROSCIENCE			English	Article							PERIODIC WHISKER DEFLECTIONS; RAT BARREL CORTEX; SOMATOSENSORY CORTEX; PSYCHOPHYSICAL PERFORMANCE; PERCEPTUAL DISCRIMINATION; THALAMOCORTICAL SYNAPSES; VIBROTACTILE STIMULI; SENSORY ADAPTATION; FIRING SYNCHRONY; VISUAL-CORTEX	Although it has long been posited that sensory adaptation serves to enhance information flow in sensory pathways, the neural basis remains elusive. Simultaneous single-unit recordings in the thalamus and cortex in anesthetized rats showed that adaptation differentially influenced thalamus and cortex in a manner that fundamentally changed the nature of information conveyed about vibrissa motion. Using an ideal observer of cortical activity, we found that performance in detecting vibrissal deflections degraded with adaptation while performance in discriminating among vibrissal deflections of different velocities was enhanced, a trend not observed in thalamus. Analysis of simultaneously recorded thalamic neurons did reveal, however, an analogous adaptive change in thalamic synchrony that mirrored the cortical response. An integrate-and-fire model using experimentally measured thalamic input reproduced the observed transformations. The results here suggest a shift in coding strategy with adaptation that directly controls information relayed to cortex, which could have implications for encoding velocity signatures of textures.	[Wang, Qi; Stanley, Garrett B.] Georgia Inst Technol, Coulter Dept Biomed Engn, Atlanta, GA 30332 USA; [Wang, Qi; Stanley, Garrett B.] Emory Univ, Atlanta, GA 30322 USA; [Wang, Qi] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Webber, Roxanna M.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	University System of Georgia; Georgia Institute of Technology; Emory University; Harvard University; Harvard University; Harvard Medical School	Stanley, GB (corresponding author), Georgia Inst Technol, Coulter Dept Biomed Engn, Atlanta, GA 30332 USA.	garrett.stanley@bme.gatech.edu		Stanley, Garrett/0000-0003-2039-7706	US National Institutes of Health [R01NS48285]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048285] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We would like to thank Jose-Manuel Alonso for comments at various points of this work and Daniel Millard for assistance in calibration and testing of the piezoelectric stimulator. This work was supported by the US National Institutes of Health (R01NS48285).	Ahissar E, 2000, NATURE, V406, P302, DOI 10.1038/35018568; Barlow H. B., 1961, SENS COMMUN, P217, DOI DOI 10.7551/MITPRESS/9780262518420.003.0013; Berg RW, 2003, J NEUROPHYSIOL, V89, P104, DOI 10.1152/jn.00600.2002; BRITTEN KH, 1992, J NEUROSCI, V12, P4745; Bruno RM, 2006, SCIENCE, V312, P1622, DOI 10.1126/science.1124593; Bruno RM, 2002, J NEUROSCI, V22, P10966; Butts DA, 2007, NATURE, V449, P92, DOI [10.1038/nature06105, 10.1038/natureO6105]; CARVELL GE, 1990, J NEUROSCI, V10, P2638; Castro-Alamancos MA, 2002, J NEUROSCI, V22, P9651; Chung S, 2002, NEURON, V34, P437, DOI 10.1016/S0896-6273(02)00659-1; CRICK F, 1984, P NATL ACAD SCI-BIOL, V81, P4586, DOI 10.1073/pnas.81.14.4586; Fairhall AL, 2001, NATURE, V412, P787, DOI 10.1038/35090500; Gabernet L, 2005, NEURON, V48, P315, DOI 10.1016/j.neuron.2005.09.022; Ganmor E, 2010, NEURON, V66, P273, DOI 10.1016/j.neuron.2010.03.032; Gerdjikov TV, 2010, NEURON, V65, P530, DOI 10.1016/j.neuron.2010.02.007; Goard M, 2009, NAT NEUROSCI, V12, P1444, DOI 10.1038/nn.2402; GOBLE AK, 1993, J ACOUST SOC AM, V93, P418, DOI 10.1121/1.405621; GOBLE AK, 1994, J ACOUST SOC AM, V96, P771, DOI 10.1121/1.410314; Hartings JA, 2003, J NEUROPHYSIOL, V90, P3087, DOI 10.1152/jn.00469.2003; Heiss JE, 2008, J NEUROSCI, V28, P13320, DOI 10.1523/JNEUROSCI.2646-08.2008; Higley MJ, 2006, J NEUROSCI, V26, P448, DOI 10.1523/JNEUROSCI.3506-05.2006; Jadhav SP, 2009, NAT NEUROSCI, V12, P792, DOI 10.1038/nn.2328; Jenks RA, 2010, J NEUROPHYSIOL, V103, P2195, DOI 10.1152/jn.00106.2009; Khatri V, 2004, J NEUROPHYSIOL, V92, P3244, DOI 10.1152/jn.00257.2004; Khatri V, 2007, CEREB CORTEX, V17, P599, DOI 10.1093/cercor/bhk006; Khatri V, 2009, J NEUROPHYSIOL, V101, P2328, DOI 10.1152/jn.91151.2008; Konig P, 1996, TRENDS NEUROSCI, V19, P130, DOI 10.1016/S0166-2236(96)80019-1; Krupa DJ, 2001, J NEUROSCI, V21, P5752, DOI 10.1523/JNEUROSCI.21-15-05752.2001; Lesica NA, 2004, J NEUROSCI, V24, P10731, DOI 10.1523/JNEUROSCI.3059-04.2004; Luna R, 2005, NAT NEUROSCI, V8, P1210, DOI 10.1038/nn1513; Maravall M, 2007, PLOS BIOL, V5, P323, DOI 10.1371/journal.pbio.0050019; Mehta SB, 2007, PLOS BIOL, V5, P309, DOI 10.1371/journal.pbio.0050015; Moore CI, 1999, TRENDS NEUROSCI, V22, P513, DOI 10.1016/S0166-2236(99)01452-6; Pinto DJ, 2000, J NEUROPHYSIOL, V83, P1158, DOI 10.1152/jn.2000.83.3.1158; Ritt JT, 2008, NEURON, V57, P599, DOI 10.1016/j.neuron.2007.12.024; Romo R, 2003, NEURON, V38, P649, DOI 10.1016/S0896-6273(03)00287-3; Roy SA, 2001, J NEUROSCI, V21, P2462, DOI 10.1523/JNEUROSCI.21-07-02462.2001; Schneidman E, 2006, NATURE, V440, P1007, DOI 10.1038/nature04701; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588; Stoelzel CR, 2009, J NEUROSCI, V29, P6851, DOI 10.1523/JNEUROSCI.5983-08.2009; Stuttgen MC, 2008, NAT NEUROSCI, V11, P1091, DOI 10.1038/nn.2162; Swadlow HA, 2001, NAT NEUROSCI, V4, P402, DOI 10.1038/86054; Tannan V, 2007, BRAIN RES, V1186, P164, DOI 10.1016/j.brainres.2007.10.024; Temereanca S, 2008, J NEUROSCI, V28, P11153, DOI 10.1523/JNEUROSCI.1586-08.2008; Usrey WM, 2000, J NEUROSCI, V20, P5461, DOI 10.1523/JNEUROSCI.20-14-05461.2000; Von Heimendahl M, 2007, PLOS BIOL, V5, P2696, DOI 10.1371/journal.pbio.0050305; Wang HP, 2010, SCIENCE, V328, P106, DOI 10.1126/science.1183108; Wolfe J, 2008, PLOS BIOL, V6, P1661, DOI 10.1371/journal.pbio.0060215; Womelsdorf T, 2006, NATURE, V439, P733, DOI 10.1038/nature04258; ZOHARY E, 1994, NATURE, V370, P140, DOI 10.1038/370140a0	50	117	118	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2010	13	12					1534	U127		10.1038/nn.2670	http://dx.doi.org/10.1038/nn.2670			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	684CW	21102447	Green Accepted			2022-12-28	WOS:000284525800019
J	Dombeck, DA; Harvey, CD; Tian, L; Looger, LL; Tank, DW				Dombeck, Daniel A.; Harvey, Christopher D.; Tian, Lin; Looger, Loren L.; Tank, David W.			Functional imaging of hippocampal place cells at cellular resolution during virtual navigation	NATURE NEUROSCIENCE			English	Article							FREELY MOVING ANIMALS; IN-VIVO; NEURAL ACTIVITY; PYRAMIDAL CELLS; UNIT-ACTIVITY; NEURONS; MEMORY; RATS; CA1; INTERNEURONS	Spatial navigation is often used as a behavioral task in studies of the neuronal circuits that underlie cognition, learning and memory in rodents. The combination of in vivo microscopy with genetically encoded indicators has provided an important new tool for studying neuronal circuits, but has been technically difficult to apply during navigation. Here we describe methods for imaging the activity of neurons in the CA1 region of the hippocampus with subcellular resolution in behaving mice. Neurons that expressed the genetically encoded calcium indicator GCaMP3 were imaged through a chronic hippocampal window. Head-restrained mice performed spatial behaviors in a setup combining a virtual reality system and a custom-built two-photon microscope. We optically identified populations of place cells and determined the correlation between the location of their place fields in the virtual environment and their anatomical location in the local circuit. The combination of virtual reality and high-resolution functional imaging should allow a new generation of studies to investigate neuronal circuit dynamics during behavior.	[Dombeck, Daniel A.; Harvey, Christopher D.; Tank, David W.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Dombeck, Daniel A.; Harvey, Christopher D.; Tank, David W.] Princeton Univ, Princeton Neurosci Inst, Princeton, NJ 08544 USA; [Tian, Lin; Looger, Loren L.] Howard Hughes Med Inst, Ashburn, VA USA	Princeton University; Princeton University; Howard Hughes Medical Institute	Tank, DW (corresponding author), Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.	ddombeck@princeton.edu; dwtank@princeton.edu		Dombeck, Daniel/0000-0003-2576-5918; Tian, Lin/0000-0001-7012-6926	Princeton University; National Institutes of Health [5R01MH083686-03]; Howard Hughes Medical Institute; Helen Hay Whitney Foundation; Patterson Trust; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH083686] Funding Source: NIH RePORTER	Princeton University(Princeton University); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Helen Hay Whitney Foundation; Patterson Trust; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by Princeton University, the National Institutes of Health (grant 5R01MH083686-03), The Howard Hughes Medical Institute, The Helen Hay Whitney Foundation and The Patterson Trust. We thank F. Collman for the brain motion correction algorithm.	Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Burger C, 2004, MOL THER, V10, P302, DOI 10.1016/j.ymthe.2004.05.024; Buzsaki G, 2004, NAT NEUROSCI, V7, P446, DOI 10.1038/nn1233; Denk W, 2004, PLOS BIOL, V2, P1900, DOI 10.1371/journal.pbio.0020329; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Denk W, 1997, NEURON, V18, P351, DOI 10.1016/S0896-6273(00)81237-4; Dombeck DA, 2007, NEURON, V56, P43, DOI 10.1016/j.neuron.2007.08.003; Dombeck DA, 2009, J NEUROSCI, V29, P13751, DOI 10.1523/JNEUROSCI.2985-09.2009; Ego-Stengel V, 2007, HIPPOCAMPUS, V17, P161, DOI 10.1002/hipo.20253; EICHENBAUM H, 1989, J NEUROSCI, V9, P2764; Ergorul C, 2004, LEARN MEMORY, V11, P397, DOI 10.1101/lm.73304; Fenton AA, 1998, P NATL ACAD SCI USA, V95, P3182, DOI 10.1073/pnas.95.6.3182; Frank LM, 2000, NEURON, V27, P169, DOI 10.1016/S0896-6273(00)00018-0; Greenberg DS, 2008, NAT NEUROSCI, V11, P749, DOI 10.1038/nn.2140; Griffin AL, 2007, J NEUROSCI, V27, P2416, DOI 10.1523/JNEUROSCI.4083-06.2007; Gupta AS, 2010, NEURON, V65, P695, DOI 10.1016/j.neuron.2010.01.034; Hampson RE, 1999, NATURE, V402, P610, DOI 10.1038/45154; Harvey CD, 2009, NATURE, V461, P941, DOI 10.1038/nature08499; Helmchen F, 2001, NEURON, V31, P903, DOI 10.1016/S0896-6273(01)00421-4; Henze DA, 2000, J NEUROPHYSIOL, V84, P390, DOI 10.1152/jn.2000.84.1.390; Holscher C, 2005, J EXP BIOL, V208, P561, DOI 10.1242/jeb.01371; Holtmaat A, 2009, NAT REV NEUROSCI, V10, P647, DOI 10.1038/nrn2699; Ji N, 2010, NAT METHODS, V7, P141, DOI 10.1038/NMETH.1411; KANDEL ER, 1961, J NEUROPHYSIOL, V24, P225, DOI 10.1152/jn.1961.24.3.225; Kerr JND, 2005, P NATL ACAD SCI USA, V102, P14063, DOI 10.1073/pnas.0506029102; Klausberger T, 2003, NATURE, V421, P844, DOI 10.1038/nature01374; Leutgeb S, 2005, CURR OPIN NEUROBIOL, V15, P738, DOI 10.1016/j.conb.2005.10.002; Luo L, 2008, NEURON, V57, P634, DOI 10.1016/j.neuron.2008.01.002; MCNAUGHTON BL, 1983, EXP BRAIN RES, V52, P41; Miyawaki A, 2003, DEV CELL, V4, P295, DOI 10.1016/S1534-5807(03)00060-1; Mizrahi A, 2004, J NEUROSCI, V24, P3147, DOI 10.1523/JNEUROSCI.5218-03.2004; Mukamel EA, 2009, NEURON, V63, P747, DOI 10.1016/j.neuron.2009.08.009; Nakamura NH, 2010, NEUROSCIENCE, V166, P994, DOI 10.1016/j.neuroscience.2009.12.069; Nakazawa K, 2003, NEURON, V38, P305, DOI 10.1016/S0896-6273(03)00165-X; O'Keefe J, 2007, HIPPOCAMPUS BOOK, P475, DOI DOI 10.1093/ACPROF:OSO/9780195100273.003.0011; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; Pologruto TA, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-13; Redish AD, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-05-j0004.2001; REGEHR WG, 1989, NATURE, V341, P533, DOI 10.1038/341533a0; Reidl J, 2007, NEUROIMAGE, V34, P94, DOI 10.1016/j.neuroimage.2006.08.031; Sato TR, 2007, PLOS BIOL, V5, P1440, DOI 10.1371/journal.pbio.0050189; Sawinski J, 2009, P NATL ACAD SCI USA, V106, P19557, DOI 10.1073/pnas.0903680106; SCHNEE A, 2008, RATS VIRTUAL REALITY; SPRUSTON N, 1995, SCIENCE, V268, P297, DOI 10.1126/science.7716524; Stosiek C, 2003, P NATL ACAD SCI USA, V100, P7319, DOI 10.1073/pnas.1232232100; Takahashi S, 2009, FRONT NEURAL CIRCUIT, V3, DOI 10.3389/neuro.04.009.2009; THIEL G, 1991, P NATL ACAD SCI USA, V88, P3431, DOI 10.1073/pnas.88.8.3431; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Wilent WB, 2007, J NEUROPHYSIOL, V97, P4152, DOI 10.1152/jn.01200.2006; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520	50	475	483	4	100	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2010	13	11					1433	U180		10.1038/nn.2648	http://dx.doi.org/10.1038/nn.2648			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	673KI	20890294	Green Accepted			2022-12-28	WOS:000283658200026
J	Higley, MJ; Sabatini, BL				Higley, Michael J.; Sabatini, Bernardo L.			Competitive regulation of synaptic Ca2+ influx by D2 dopamine and A2A adenosine receptors	NATURE NEUROSCIENCE			English	Article							MEDIUM SPINY NEURONS; DENDRITIC SPINES; NMDA RECEPTOR; BASAL GANGLIA; CALCIUM PERMEABILITY; ANTIPSYCHOTIC-DRUGS; CORTICAL AFFERENTS; DORSAL STRIATUM; DISEASE MODELS; MODULATION	Striatal D2-type dopamine receptors (D2Rs) have been implicated in the pathophysiology of neuropsychiatric disorders, including Parkinson's disease and schizophrenia. Although these receptors regulate striatal synaptic plasticity, the mechanisms underlying dopaminergic modulation of glutamatergic synapses are unclear. We combined optogenetics, two-photon microscopy and glutamate uncaging to examine D2R-dependent modulation of glutamatergic synaptic transmission in mouse striatopallidal neurons. We found that D2R activation reduces corticostriatal glutamate release and attenuates both synaptic-and action potential-evoked Ca2+ influx into dendritic spines by approximately 50%. Modulation of Ca2+ signaling was mediated by a protein kinase A (PKA)-dependent regulation of Ca2+ entry through NMDA-type glutamate receptors that was inhibited by D2Rs and enhanced by activation of 2A-type adenosine receptors (A2ARs). D2Rs also produced a PKA- and A2AR-independent reduction in Ca2+ influx through R-type voltage-gated Ca2+ channels. These findings reveal that dopamine regulates spine Ca2+ by multiple pathways and that competitive modulation of PKA controls NMDAR-mediated Ca2+ signaling in the striatum.	[Higley, Michael J.; Sabatini, Bernardo L.] Harvard Univ, Sch Med, Dept Neurobiol, Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Sabatini, BL (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, Howard Hughes Med Inst, Boston, MA 02115 USA.	bsabatini@hms.harvard.edu			Parkinson's Disease Foundation; National Institute of Neurological Disorders and Stroke [NS063663, NS046579]; National Alliance for Research on Schizophrenia and Depression; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046579, F32NS063663] Funding Source: NIH RePORTER	Parkinson's Disease Foundation; National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Alliance for Research on Schizophrenia and Depression(NARSAD); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors thank members of the Sabatini laboratory and J.A. Cardin for helpful comments during the preparation of this manuscript. We thank K. Deisseroth and V. Gradinaru for assistance with the ChR2 experiments. The work was funded by grants from the Parkinson's Disease Foundation (Postdoctoral Fellowship) and the National Institute of Neurological Disorders and Stroke (NS063663) to M.J.H. and grants from the National Institute of Neurological Disorders and Stroke (NS046579) and the National Alliance for Research on Schizophrenia and Depression (Independent Investigator Award) to B. L. S.	Bamford NS, 2004, J NEUROSCI, V24, P9541, DOI 10.1523/JNEUROSCI.2891-04.2004; Bloodgood BL, 2007, NEURON, V53, P249, DOI 10.1016/j.neuron.2006.12.017; Bonci A, 2005, NEURON, V47, P335, DOI 10.1016/j.neuron.2005.07.015; BURNASHEV N, 1992, SCIENCE, V257, P1415, DOI 10.1126/science.1382314; Busetto G, 2008, J PHYSIOL-LONDON, V586, P1519, DOI 10.1113/jphysiol.2007.149336; Calabresi P, 1997, J NEUROSCI, V17, P4536; Calabresi P, 2007, TRENDS NEUROSCI, V30, P211, DOI 10.1016/j.tins.2007.03.001; Carter AG, 2007, J NEUROSCI, V27, P8967, DOI 10.1523/JNEUROSCI.2798-07.2007; Carter AG, 2004, NEURON, V44, P483, DOI 10.1016/j.neuron.2004.10.013; CEPEDA C, 1993, P NATL ACAD SCI USA, V90, P9576, DOI 10.1073/pnas.90.20.9576; Day M, 2006, NAT NEUROSCI, V9, P251, DOI 10.1038/nn1632; Day M, 2008, J NEUROSCI, V28, P11603, DOI 10.1523/JNEUROSCI.1840-08.2008; Drew MR, 2007, J NEUROSCI, V27, P7731, DOI 10.1523/JNEUROSCI.1736-07.2007; Faber ESL, 2005, NAT NEUROSCI, V8, P635, DOI 10.1038/nn1450; Furukawa T, 2009, EUR J PHARMACOL, V613, P100, DOI 10.1016/j.ejphar.2009.04.036; Giuffrida A, 1999, NAT NEUROSCI, V2, P358, DOI 10.1038/7268; Gorski JA, 2002, J NEUROSCI, V22, P6309; Gradinaru V, 2009, SCIENCE, V324, P354, DOI 10.1126/science.1167093; Graybiel AM, 2000, CURR BIOL, V10, pR509, DOI 10.1016/S0960-9822(00)00593-5; Hakansson K, 2006, J NEUROCHEM, V96, P482, DOI 10.1111/j.1471-4159.2005.03558.x; Heintz N, 2001, NAT REV NEUROSCI, V2, P861, DOI 10.1038/35104049; HERSCH SM, 1995, J NEUROSCI, V15, P5222; Higley MJ, 2008, NEURON, V59, P902, DOI 10.1016/j.neuron.2008.08.020; Higley MJ, 2009, NAT NEUROSCI, V12, P1121, DOI 10.1038/nn.2368; Hoffmann H, 2000, J NEUROCHEM, V75, P1590, DOI 10.1046/j.1471-4159.2000.0751590.x; Kreitzer AC, 2005, J NEUROSCI, V25, P10537, DOI 10.1523/JNEUROSCI.2959-05.2005; Kreitzer AC, 2007, NATURE, V445, P643, DOI 10.1038/nature05506; Kreitzer AC, 2008, NEURON, V60, P543, DOI 10.1016/j.neuron.2008.11.005; Lipscombe D, 2004, J NEUROPHYSIOL, V92, P2633, DOI 10.1152/jn.00486.2004; LOPEZ SH, 2000, J NEUROSCI, V20, P8987; Mahon S, 2001, CEREB CORTEX, V11, P360, DOI 10.1093/cercor/11.4.360; Meltzer HY, 2004, CURR OPIN PHARMACOL, V4, P53, DOI 10.1016/j.coph.2003.09.010; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; Olson PA, 2005, J NEUROSCI, V25, P1050, DOI 10.1523/JNEUROSCI.3327-04.2005; Pawlak V, 2008, J NEUROSCI, V28, P2435, DOI 10.1523/JNEUROSCI.4402-07.2008; Pologruto TA, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-13; Ronesi J, 2005, J PHYSIOL-LONDON, V562, P245, DOI 10.1113/jphysiol.2004.068460; Salgado H, 2005, J NEUROPHYSIOL, V94, P3771, DOI 10.1152/jn.00455.2005; Schiffmann SN, 2007, PROG NEUROBIOL, V83, P277, DOI 10.1016/j.pneurobio.2007.05.001; SEEMAN P, 1975, SCIENCE, V188, P1217, DOI 10.1126/science.1145194; Shen WX, 2008, SCIENCE, V321, P848, DOI 10.1126/science.1160575; Skeberdis VA, 2006, NAT NEUROSCI, V9, P501, DOI 10.1038/nn1664; Sobczyk A, 2005, J NEUROSCI, V25, P6037, DOI 10.1523/JNEUROSCI.1221-05.2005; Surmeier DJ, 2007, TRENDS NEUROSCI, V30, P228, DOI 10.1016/j.tins.2007.03.008; Wang H, 2002, J COMP NEUROL, V442, P392, DOI 10.1002/cne.10086; Wang ZF, 2006, NEURON, V50, P443, DOI 10.1016/j.neuron.2006.04.010; Westphal RS, 1999, SCIENCE, V285, P93, DOI 10.1126/science.285.5424.93; WONG DF, 1986, SCIENCE, V234, P1558, DOI 10.1126/science.2878495; Yin HH, 2006, P NATL ACAD SCI USA, V103, P8251, DOI 10.1073/pnas.0510797103	49	183	185	0	36	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2010	13	8					958	U77		10.1038/nn.2592	http://dx.doi.org/10.1038/nn.2592			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	632DK	20601948	Green Accepted			2022-12-28	WOS:000280400600014
J	Janovjak, H; Szobota, S; Wyart, C; Trauner, D; Isacoff, EY				Janovjak, Harald; Szobota, Stephanie; Wyart, Claire; Trauner, Dirk; Isacoff, Ehud Y.			A light-gated, potassium-selective glutamate receptor for the optical inhibition of neuronal firing	NATURE NEUROSCIENCE			English	Article							LIGAND-BINDING DOMAIN; ION CHANNELS; CAENORHABDITIS-ELEGANS; NEURAL CIRCUITRY; REMOTE-CONTROL; K+ CHANNELS; ACTIVATION; ZEBRAFISH; TRANSPLANTATION; DROSOPHILA	Genetically targeted light-activated ion channels and pumps make it possible to determine the role of specific neurons in neuronal circuits, information processing and behavior. We developed a K+-selective ionotropic glutamate receptor that reversibly inhibits neuronal activity in response to light in dissociated neurons and brain slice and also reversibly suppresses behavior in zebrafish. The receptor is a chimera of the pore region of a K+-selective bacterial glutamate receptor and the ligand-binding domain of a light-gated mammalian kainate receptor. This hyperpolarizing light-gated channel, HyLighter, is turned on by a brief light pulse at one wavelength and turned off by a pulse at a second wavelength. The control is obtained at moderate intensity. After optical activation, the photocurrent and optical silencing of activity persists in the dark for extended periods. The low light requirement and bi-stability of HyLighter represent advantages for the dissection of neural circuitry.	[Janovjak, Harald; Szobota, Stephanie; Wyart, Claire; Isacoff, Ehud Y.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Janovjak, Harald; Szobota, Stephanie; Wyart, Claire; Isacoff, Ehud Y.] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; [Trauner, Dirk] Univ Munich, Dept Chem, Munich, Germany; [Isacoff, Ehud Y.] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Mat Sci, Berkeley, CA 94720 USA; [Isacoff, Ehud Y.] Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of Munich; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Isacoff, EY (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	ehud@berkeley.edu	Wyart, Claire/AAB-4603-2020; isacoff, ehud/AAP-1459-2020; Wyart, Claire/H-3783-2016; Janovjak, Harald/O-9070-2016	Wyart, Claire/0000-0002-1668-4975; Wyart, Claire/0000-0002-1668-4975; Janovjak, Harald/0000-0002-8023-9315; Isacoff, Ehud Y./0000-0003-4775-9359	US National Institutes of Health Nanomedicine Development Center for the Optical Control of Biological Function [5PN2EY018241]; Human Frontier Science Program [RPG23-2005]; National Science Foundation [FIBR 43C-1081892]; European Molecular Biology Organization; Marie-Curie fellowship; NATIONAL EYE INSTITUTE [PN2EY018241] Funding Source: NIH RePORTER	US National Institutes of Health Nanomedicine Development Center for the Optical Control of Biological Function(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontier Science Program(Human Frontier Science Program); National Science Foundation(National Science Foundation (NSF)); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Marie-Curie fellowship(European Commission); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank K. Partin, K. Kainanen, E. Gouaux and M. Hollmann for constructs, G. Sandoz, P. Koprowski and F. Tombola for discussions, D. Fortin, T. Tracey, K. Greenberg, A. Pham, M. Soden, H. Lu, E. Warp, K. McDaniel, R. Arant and Z. Fu for technical assistance, and M. Volgraf and V. Franckevicius for MAG compounds. This work was supported by the US National Institutes of Health Nanomedicine Development Center for the Optical Control of Biological Function (5PN2EY018241), the Human Frontier Science Program (RPG23-2005), the National Science Foundation (FIBR 43C-1081892), a fellowship of the European Molecular Biology Organization (to H.J.) and a Marie-Curie fellowship (to C. W.; the fellowship was obtained with the laboratory CNRS-UMR5020 'Neurosciences Sensorielles, Comportement Cognition').	Airan RD, 2009, NATURE, V458, P1025, DOI 10.1038/nature07926; Arrenberg AB, 2009, P NATL ACAD SCI USA, V106, P17968, DOI 10.1073/pnas.0906252106; Ayling OGS, 2009, NAT METHODS, V6, P219, DOI [10.1038/NMETH.1303, 10.1038/nmeth.1303]; Banghart M, 2004, NAT NEUROSCI, V7, P1381, DOI 10.1038/nn1356; Borisenko V, 2005, J PHOTOCH PHOTOBIO A, V173, P21, DOI 10.1016/j.jphotochem.2004.12.026; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; BUNCE NJ, 1987, J ORG CHEM, V52, P394, DOI 10.1021/jo00379a015; Chen GQ, 1999, NATURE, V402, P817, DOI 10.1038/45568; Chow BY, 2010, NATURE, V463, P98, DOI 10.1038/nature08652; Douglass AD, 2008, CURR BIOL, V18, P1133, DOI 10.1016/j.cub.2008.06.077; Ellis-Davies GCR, 2007, NAT METHODS, V4, P619, DOI 10.1038/NMETH1072; Fortin DL, 2008, NAT METHODS, V5, P331, DOI [10.1038/NMETH.1187, 10.1038/nmeth.1187]; Franks CJ, 2009, INVERTEBR NEUROSCI, V9, P43, DOI 10.1007/s10158-009-0088-8; GEREAU RW, 2008, GLUTAMATE RECEPTORS, V1; Gorostiza P, 2007, P NATL ACAD SCI USA, V104, P10865, DOI 10.1073/pnas.0701274104; Gradinaru V, 2009, SCIENCE, V324, P354, DOI 10.1126/science.1167093; Han X, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000299; Hansen KB, 2007, CURR OPIN NEUROBIOL, V17, P281, DOI 10.1016/j.conb.2007.03.014; Herlitze S, 2007, CURR OPIN NEUROBIOL, V17, P87, DOI 10.1016/j.conb.2006.12.002; Hoffmann J, 2006, MOL CELL NEUROSCI, V33, P335, DOI 10.1016/j.mcn.2006.08.006; Hoffmann J, 2006, MOL CELL NEUROSCI, V33, P358, DOI 10.1016/j.mcn.2006.08.004; Kotani T, 2006, METHODS, V39, P199, DOI 10.1016/j.ymeth.2005.12.006; Kuner T, 2003, TRENDS NEUROSCI, V26, P27, DOI 10.1016/S0166-2236(02)00010-3; Lagali PS, 2008, NAT NEUROSCI, V11, P667, DOI 10.1038/nn.2117; Lee JH, 2008, J MOL BIOL, V376, P308, DOI 10.1016/j.jmb.2007.10.081; Li X, 2005, P NATL ACAD SCI USA, V102, P17816, DOI 10.1073/pnas.0509030102; Liewald JF, 2008, NAT METHODS, V5, P895, DOI 10.1038/NMETH.1252; Liu Q, 2009, P NATL ACAD SCI USA, V106, P10823, DOI 10.1073/pnas.0903570106; Ma DK, 2001, SCIENCE, V291, P316, DOI 10.1126/science.291.5502.316; Mayer ML, 2005, CURR OPIN NEUROBIOL, V15, P282, DOI 10.1016/j.conb.2005.05.004; Mayer ML, 2001, J MOL BIOL, V311, P815, DOI 10.1006/jmbi.2001.4884; Nagel G, 2005, CURR BIOL, V15, P2279, DOI 10.1016/j.cub.2005.11.032; Numano R, 2009, P NATL ACAD SCI USA, V106, P6814, DOI 10.1073/pnas.0811899106; Pasternack A, 2002, J BIOL CHEM, V277, P49662, DOI 10.1074/jbc.M208349200; Schmid SM, 2009, P NATL ACAD SCI USA, V106, P10320, DOI 10.1073/pnas.0900329106; Schroll C, 2006, CURR BIOL, V16, P1741, DOI 10.1016/j.cub.2006.07.023; Scott EK, 2007, NAT METHODS, V4, P323, DOI 10.1038/NMETH1033; Suh GSB, 2007, CURR BIOL, V17, P905, DOI 10.1016/j.cub.2007.04.046; Szobota S, 2007, NEURON, V54, P535, DOI 10.1016/j.neuron.2007.05.010; Villmann C, 1999, EUR J NEUROSCI, V11, P1765, DOI 10.1046/j.1460-9568.1999.00594.x; Volgraf M, 2006, NAT CHEM BIOL, V2, P47, DOI 10.1038/nchembio756; WO ZG, 1995, TRENDS NEUROSCI, V18, P161; WOOD MW, 1995, P NATL ACAD SCI USA, V92, P4882, DOI 10.1073/pnas.92.11.4882; Wyart C, 2009, NATURE, V461, P407, DOI 10.1038/nature08323; Yelshansky MV, 2004, J NEUROSCI, V24, P4728, DOI 10.1523/JNEUROSCI.0757-04.2004; Zemelman BV, 2002, NEURON, V33, P15, DOI 10.1016/S0896-6273(01)00574-8; Zhang F, 2007, NAT REV NEUROSCI, V8, P577, DOI 10.1038/nrn2192; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744; Zhang W, 2007, EUR J NEUROSCI, V26, P2405, DOI 10.1111/j.1460-9568.2007.05862.x; Zhao SL, 2008, BRAIN CELL BIOL, V36, P141, DOI 10.1007/s11068-008-9034-7	50	99	103	0	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2010	13	8					1027	U160		10.1038/nn.2589	http://dx.doi.org/10.1038/nn.2589			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	632DK	20581843	Green Accepted			2022-12-28	WOS:000280400600023
J	Ban, H; Preston, TJ; Meeson, A; Welchman, AE				Ban, Hiroshi; Preston, Tim J.; Meeson, Alan; Welchman, Andrew E.			The integration of motion and disparity cues to depth in dorsal visual cortex	NATURE NEUROSCIENCE			English	Article							STRUCTURE-FROM-MOTION; MULTISENSORY INTEGRATION; HUMAN BRAIN; SUPERIOR COLLICULUS; 3D STRUCTURE; PERCEPTION; SHAPE; INFORMATION; TEXTURE; PARALLAX	Humans exploit a range of visual depth cues to estimate three-dimensional structure. For example, the slant of a nearby tabletop can be judged by combining information from binocular disparity, texture and perspective. Behavioral tests show humans combine cues near-optimally, a feat that could depend on discriminating the outputs from cue-specific mechanisms or on fusing signals into a common representation. Although fusion is computationally attractive, it poses a substantial challenge, requiring the integration of quantitatively different signals. We used functional magnetic resonance imaging (fMRI) to provide evidence that dorsal visual area V3B/KO meets this challenge. Specifically, we found that fMRI responses are more discriminable when two cues (binocular disparity and relative motion) concurrently signal depth, and that information provided by one cue is diagnostic of depth indicated by the other. This suggests a cortical node important when perceiving depth, and highlights computations based on fusion in the dorsal stream.	[Ban, Hiroshi; Preston, Tim J.; Meeson, Alan; Welchman, Andrew E.] Univ Birmingham, Sch Psychol, Birmingham B15 2TT, W Midlands, England; [Ban, Hiroshi] Japan Soc Promot Sci, Tokyo, Japan; [Preston, Tim J.] Univ Calif Santa Barbara, Dept Psychol, Santa Barbara, CA 93106 USA	University of Birmingham; Japan Society for the Promotion of Science; University of California System; University of California Santa Barbara	Welchman, AE (corresponding author), Univ Birmingham, Sch Psychol, Birmingham B15 2TT, W Midlands, England.	a.e.welchman@bham.ac.uk	Welchman, Andrew/B-7542-2013	Welchman, Andrew/0000-0002-7559-3299	Wellcome Trust [095183/Z/10/Z]; Biotechnology and Biological Sciences Research Council [C520620]; Japan Society for the Promotion of Science [H22,290]; Biotechnology and Biological Sciences Research Council [BB/C520620/1] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank B. Tjan, R. Fleming and A. Glennerster for discussions on the project. The work was supported by fellowships to A.E.W. from the Wellcome Trust (095183/Z/10/Z) and Biotechnology and Biological Sciences Research Council (C520620) and to H.B. from the Japan Society for the Promotion of Science (H22,290).	Avillac M, 2007, J NEUROSCI, V27, P1922, DOI 10.1523/JNEUROSCI.2646-06.2007; Backus BT, 2001, J NEUROPHYSIOL, V86, P2054, DOI 10.1152/jn.2001.86.4.2054; Bradshaw MF, 1996, VISION RES, V36, P3457, DOI 10.1016/0042-6989(96)00072-7; BULTHOFF HH, 1988, J OPT SOC AM A, V5, P1749, DOI 10.1364/JOSAA.5.001749; Chandrasekaran C, 2007, J NEUROPHYSIOL, V97, P1553, DOI 10.1152/jn.01074.2006; Clark J.J., 1990, DATA FUSION SENSORY; DeAngelis GC, 1999, J NEUROSCI, V19, P1398; Domini F, 2006, VISION RES, V46, P1707, DOI 10.1016/j.visres.2005.11.018; DOSHER BA, 1986, VISION RES, V26, P973, DOI 10.1016/0042-6989(86)90154-9; Durand JB, 2007, NEURON, V55, P493, DOI 10.1016/j.neuron.2007.06.040; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; Freeman J, 2011, J NEUROSCI, V31, P4792, DOI 10.1523/JNEUROSCI.5160-10.2011; Gu Y, 2008, NAT NEUROSCI, V11, P1201, DOI 10.1038/nn.2191; Hillis JM, 2002, SCIENCE, V298, P1627, DOI 10.1126/science.1075396; Knill DC, 2003, VISION RES, V43, P2539, DOI 10.1016/S0042-6989(03)00458-9; Kording KP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000943; Kriegeskorte N, 2010, NEUROIMAGE, V49, P1965, DOI 10.1016/j.neuroimage.2009.09.059; LANDY MS, 1995, VISION RES, V35, P389, DOI 10.1016/0042-6989(94)00176-M; Liu Y, 2004, J NEUROSCI, V24, P3795, DOI 10.1523/JNEUROSCI.0150-04.2004; Ma WJ, 2006, NAT NEUROSCI, V9, P1432, DOI 10.1038/nn1790; MEREDITH MA, 1983, SCIENCE, V221, P389, DOI 10.1126/science.6867718; Morgan ML, 2008, NEURON, V59, P662, DOI 10.1016/j.neuron.2008.06.024; Murray SO, 2003, CEREB CORTEX, V13, P508, DOI 10.1093/cercor/13.5.508; Nadler JW, 2008, NATURE, V452, P642, DOI 10.1038/nature06814; Nandy AS, 2008, J VISION, V8, DOI 10.1167/8.13.3; NAWROT M, 1989, SCIENCE, V244, P716, DOI 10.1126/science.2717948; Op de Beeck HP, 2010, NEUROIMAGE, V49, P1943, DOI 10.1016/j.neuroimage.2009.02.047; Orban GA, 2003, NEUROPSYCHOLOGIA, V41, P1757, DOI 10.1016/S0028-3932(03)00177-5; Orban GA, 1999, NEURON, V24, P929, DOI 10.1016/S0896-6273(00)81040-5; Orban GA, 2006, TRENDS NEUROSCI, V29, P466, DOI 10.1016/j.tins.2006.06.012; Paradis AL, 2000, CEREB CORTEX, V10, P772, DOI 10.1093/cercor/10.8.772; Parker AJ, 2007, NAT REV NEUROSCI, V8, P379, DOI 10.1038/nrn2131; Peuskens H, 2004, J COGNITIVE NEUROSCI, V16, P665, DOI 10.1162/089892904323057371; Poom L, 1999, J EXP PSYCHOL HUMAN, V25, P504, DOI 10.1037/0096-1523.25.2.504; Popple AV, 1998, VISION RES, V38, P319, DOI 10.1016/S0042-6989(97)00166-1; Preston TJ, 2008, J NEUROSCI, V28, P11315, DOI 10.1523/JNEUROSCI.2728-08.2008; Preston TJ, 2009, J NEUROSCI, V29, P1688, DOI 10.1523/JNEUROSCI.5021-08.2009; ROGERS B, 1979, PERCEPTION, V8, P125, DOI 10.1068/p080125; Sereno ME, 2002, NEURON, V33, P635, DOI 10.1016/S0896-6273(02)00598-6; Shmuel A, 2010, NEUROIMAGE, V49, P1957, DOI 10.1016/j.neuroimage.2009.08.040; Stanford TR, 2005, J NEUROSCI, V25, P6499, DOI 10.1523/JNEUROSCI.5095-04.2005; Tjan BS, 2006, J NEUROPHYSIOL, V96, P1556, DOI 10.1152/jn.01367.2005; Tsutsui KI, 2002, SCIENCE, V298, P409, DOI 10.1126/science.1074128; Tyler CW, 2006, NEUROIMAGE, V30, P228, DOI 10.1016/j.neuroimage.2005.09.067; Welchman AE, 2005, NAT NEUROSCI, V8, P820, DOI 10.1038/nn1461	45	74	75	4	58	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2012	15	4					636	643		10.1038/nn.3046	http://dx.doi.org/10.1038/nn.3046			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	916PA	22327475	Green Accepted			2022-12-28	WOS:000302114500025
J	Ding, JB; Oh, WJ; Sabatini, BL; Gu, CH				Ding, Jun B.; Oh, Won-Jong; Sabatini, Bernardo L.; Gu, Chenghua			Semaphorin 3E-Plexin-D1 signaling controls pathway-specific synapse formation in the striatum	NATURE NEUROSCIENCE			English	Article							MEDIUM SPINY NEURONS; CM-PF COMPLEX; BASAL GANGLIA; NEURAL CIRCUITS; RECOGNITION; CONNECTIONS; MECHANISMS; EXPRESSION; MOLECULES; PROTEINS	The proper formation of synaptic connectivity in the mammalian brain is critical for complex behavior. In the striatum, balanced excitatory synaptic transmission from multiple sources onto two classes of principal neurons is required for coordinated and voluntary motor control. Here we show that the interaction between the secreted semaphorin 3E (Sema3E) and its receptor Plexin-D1 is a critical determinant of synaptic specificity in cortico-thalamo-striatal circuits in mice. We find that Sema3e (encoding Sema3E) is highly expressed in thalamostriatal projection neurons, whereas in the striatum Plxnd1 (encoding Plexin-D1) is selectively expressed in direct-pathway medium spiny neurons (MSNs). Despite physical intermingling of the MSNs, genetic ablation of Plxnd1 or Sema3e results in functional and anatomical rearrangement of thalamostriatal synapses specifically in direct-pathway MSNs without effects on corticostriatal synapses. Thus, our results demonstrate that Sema3E and Plexin-D1 specify the degree of glutamatergic connectivity between a specific source and target in the complex circuitry of the basal ganglia.	[Ding, Jun B.; Oh, Won-Jong; Sabatini, Bernardo L.; Gu, Chenghua] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Ding, Jun B.; Sabatini, Bernardo L.] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Sabatini, BL (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA.	bernardo_sabatini@hms.harvard.edu; chenghua_gu@hms.harvard.edu	Ding, Jun/B-2513-2009	Ding, Jun/0000-0003-0690-1312	Lefler postdoctoral fellowship; Whitehall and Klingenstein foundations; Parkinson's Disease Foundation [PDF-FBS-1106]; US National Institute of Neurological Disorders and Stroke [K99-NS075136, NS046579, NS064583]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K99NS075136, T32NS007484, R37NS046579, R01NS046579, R00NS075136, R01NS064583] Funding Source: NIH RePORTER	Lefler postdoctoral fellowship; Whitehall and Klingenstein foundations(Klingenstein Philanthropies); Parkinson's Disease Foundation; US National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors thank L. Ding (Harvard NeuroDiscovery Center) for assistance in image analysis, T. lessen (Columbia University) and Y. Yoshida (Cincinnati Children's Hospital Medical Center) for providing Plexin-D1 conditional mice, C. Henderson (Columbia University) and F. Mann (Universite de la Mediterranee) for Sema3E mice, A. Kautzman, B. Stevens and E. Benecchi for assistance with array tomography and J. Hjorth for assistance with Scholl analysis. We thank members of Sabatini and Gu laboratories for discussions. This work was funded by a Lefler postdoctoral fellowship (W.-J.O.), the Whitehall and Klingenstein foundations (C.G.), the Parkinson's Disease Foundation (PDF-FBS-1106, J.B.D.) and the US National Institute of Neurological Disorders and Stroke (K99-NS075136, J.B.D.; NS046579, B.L.S.; NS064583, C.G.).	ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; Alvarez VA, 2007, ANNU REV NEUROSCI, V30, P79, DOI 10.1146/annurev.neuro.30.051606.094222; Chauvet S, 2007, NEURON, V56, P807, DOI 10.1016/j.neuron.2007.10.019; Ding J, 2008, J NEUROSCI, V28, P6483, DOI 10.1523/JNEUROSCI.0435-08.2008; Ding JB, 2010, NEURON, V67, P294, DOI 10.1016/j.neuron.2010.06.017; Doig NM, 2010, J NEUROSCI, V30, P14610, DOI 10.1523/JNEUROSCI.1623-10.2010; Fiala JC, 1998, J NEUROSCI, V18, P8900; Fox MA, 2007, CELL, V129, P179, DOI 10.1016/j.cell.2007.02.035; GRAYBIEL AM, 1994, SCIENCE, V265, P1826, DOI 10.1126/science.8091209; Gu CH, 2005, SCIENCE, V307, P265, DOI 10.1126/science.1105416; Heintz N, 2001, NAT REV NEUROSCI, V2, P861, DOI 10.1038/35104049; Jacobs EC, 2007, EUR J NEUROSCI, V25, P17, DOI 10.1111/j.1460-9568.2006.05258.x; Johnson-Venkatesh EM, 2010, EUR J NEUROSCI, V32, P181, DOI 10.1111/j.1460-9568.2010.07338.x; KAWAGUCHI Y, 1989, J NEUROPHYSIOL, V62, P1052, DOI 10.1152/jn.1989.62.5.1052; Luo LQ, 2000, NAT REV NEUROSCI, V1, P173, DOI 10.1038/35044547; Matsumoto N, 2001, J NEUROPHYSIOL, V85, P960, DOI 10.1152/jn.2001.85.2.960; Matsuoka RL, 2011, NATURE, V470, P259, DOI 10.1038/nature09675; Micheva KD, 2007, NEURON, V55, P25, DOI 10.1016/j.neuron.2007.06.014; Minamimoto T, 2002, J NEUROPHYSIOL, V87, P3090, DOI 10.1152/jn.2002.87.6.3090; Pecho-Vrieseling E, 2009, NATURE, V459, P842, DOI 10.1038/nature08000; Raju DV, 2006, J COMP NEUROL, V499, P231, DOI 10.1002/cne.21099; RAKIC P, 1986, SCIENCE, V232, P232, DOI 10.1126/science.3952506; Sanes JR, 2009, ANNU REV CELL DEV BI, V25, P161, DOI 10.1146/annurev.cellbio.24.110707.175402; Schultz W, 2006, ANNU REV PSYCHOL, V57, P87, DOI 10.1146/annurev.psych.56.091103.070229; Shen K, 2004, CELL, V116, P869, DOI 10.1016/S0092-8674(04)00251-X; Smith Y, 2004, TRENDS NEUROSCI, V27, P520, DOI 10.1016/j.tins.2004.07.004; Surmeier DJ, 2007, TRENDS NEUROSCI, V30, P228, DOI 10.1016/j.tins.2007.03.008; Surmeier DJ, 1996, J NEUROSCI, V16, P6579, DOI 10.1523/jneurosci.16-20-06579.1996; Suto F, 2007, NEURON, V53, P535, DOI 10.1016/j.neuron.2007.01.028; Terauchi A, 2010, NATURE, V465, P783, DOI 10.1038/nature09041; Tran TS, 2009, NATURE, V462, P1065, DOI 10.1038/nature08628; Vikis HG, 2002, GENE DEV, V16, P836, DOI 10.1101/gad.966402; Watakabe A, 2006, J COMP NEUROL, V499, P258, DOI 10.1002/cne.21106; Wichmann T, 1996, CURR OPIN NEUROBIOL, V6, P751, DOI 10.1016/S0959-4388(96)80024-9; Wickens JR, 2003, CURR OPIN NEUROBIOL, V13, P685, DOI 10.1016/j.conb.2003.10.013; Williams ME, 2010, NEURON, V68, P9, DOI 10.1016/j.neuron.2010.09.007; WILSON CJ, 2004, SYNAPTIC ORG BRAIN, P361, DOI DOI 10.1093/ACPROF:0S0/9780195159561.003.0009; Yamagata M, 2002, CELL, V110, P649, DOI 10.1016/S0092-8674(02)00910-8; Yamagata M, 2008, NATURE, V451, P465, DOI 10.1038/nature06469; Yamagata M, 2010, J NEUROSCI, V30, P3579, DOI 10.1523/JNEUROSCI.6319-09.2010	40	72	77	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2012	15	2					215	223		10.1038/nn.3003	http://dx.doi.org/10.1038/nn.3003			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	882ZX	22179111	Green Accepted			2022-12-28	WOS:000299603500012
J	Bagley, EE; Hacker, J; Chefer, VI; Mallet, C; McNally, GP; Chieng, BCH; Perroud, J; Shippenberg, TS; Christie, MJ				Bagley, Elena E.; Hacker, Jennifer; Chefer, Vladimir I.; Mallet, Christophe; McNally, Gavan P.; Chieng, Billy C. H.; Perroud, Julie; Shippenberg, Toni S.; Christie, MacDonald J.			Drug-induced GABA transporter currents enhance GABA release to induce opioid withdrawal behaviors	NATURE NEUROSCIENCE			English	Article							PERIAQUEDUCTAL GRAY; MORPHINE-WITHDRAWAL; MIDBRAIN NEURONS; RECEPTORS; TIAGABINE; OPIATE; INHIBITION; MODULATION; ACTIVATION; EXPRESSION	directly via transporter currents. A physiological or pathophysiological role for transporter currents has not been described. We found that GABA transporter 1 (GAT-1) cation currents directly increased GABAergic neuronal excitability and synaptic GABA release in the periaqueductal gray (PAG) during opioid withdrawal in rodents. In contrast, GAT-1 did not indirectly alter GABA receptor responses via modulation of extracellular GABA concentrations. Notably, we found that GAT-1-induced increases in GABAergic activity contributed to many PAG-mediated signs of opioid withdrawal. Together, these data support the hypothesis that GAT-1 activity directly produces opioid withdrawal signs through direct hyperexcitation of GABAergic PAG neurons and nerve terminals, which presumably enhances GABAergic inhibition of PAG output neurons. These data provide, to the best of our knowledge, the first evidence that dysregulation of a neurotransmitter transporter current is important for the maladaptive plasticity that underlies opiate withdrawal.	[Bagley, Elena E.; Christie, MacDonald J.] Univ Sydney, Discipline Pharmacol, Sydney, NSW 2006, Australia; [Bagley, Elena E.; Hacker, Jennifer; Mallet, Christophe; Chieng, Billy C. H.; Perroud, Julie; Christie, MacDonald J.] Univ Sydney, Brain & Mind Res Inst, Sydney, NSW 2006, Australia; [Chefer, Vladimir I.; Shippenberg, Toni S.] NIDA, Integrat Neurosci Sect, Baltimore, MD USA; [McNally, Gavan P.] Univ New S Wales, Sch Psychol, Sydney, NSW, Australia	University of Sydney; University of Sydney; National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA); University of New South Wales Sydney	Christie, MJ (corresponding author), Univ Sydney, Discipline Pharmacol, Sydney, NSW 2006, Australia.	mac.christie@sydney.edu.au	Christie, MacDonald J/F-4724-2013; Mallet, Christophe/K-2918-2015	Christie, MacDonald J/0000-0002-0622-609X; Chieng, Billy/0000-0003-0222-8001; McNally, Gavan/0000-0001-9061-6463; Bagley, Elena/0000-0002-3167-0707; Mallet, Christophe/0000-0002-0873-6763	National Health and Medical Research Council of Australia; National Institute on Drug Abuse of the US National Institutes of Health	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); National Institute on Drug Abuse of the US National Institutes of Health	We thank Y. Azriel for preparing the image shown in Figure 1a, and T. Kaneko (Kyoto University) for donating Gad67-GFP mice. This work was supported by the National Health and Medical Research Council of Australia and the National Institute on Drug Abuse Intramural Research Program of the US National Institutes of Health.	Bagley EE, 2005, NEURON, V45, P433, DOI 10.1016/j.neuron.2004.12.049; Barbaresi P, 2001, J COMP NEUROL, V429, P337, DOI 10.1002/1096-9861(20000108)429:2<337::AID-CNE12>3.0.CO;2-Z; Belelli D, 2009, J NEUROSCI, V29, P12757, DOI 10.1523/JNEUROSCI.3340-09.2009; Bonci A, 1997, J NEUROSCI, V17, P796; BOZARTH MA, 1984, SCIENCE, V224, P516, DOI 10.1126/science.6324347; Chefer VI, 2009, EUR J NEUROSCI, V30, P272, DOI 10.1111/j.1460-9568.2009.06827.x; Cherubini E, 2001, TRENDS NEUROSCI, V24, P155, DOI 10.1016/S0166-2236(00)01724-0; Chieng B, 1998, J NEUROSCI, V18, P7033; Chieng B, 1996, J NEUROSCI, V16, P7128; Chieng BCH, 2005, NEUROREPORT, V16, P1279, DOI 10.1097/01.wnr.0000175246.35837.5c; Chiu CS, 2005, J NEUROSCI, V25, P3234, DOI 10.1523/JNEUROSCI.3364-04.2005; CUSHMAN P, 1973, JAMA-J AM MED ASSOC, V226, P747, DOI 10.1001/jama.226.7.747; DISTEFANO PS, 1985, J PHARMACOL EXP THER, V233, P339; Gonzalez G, 2007, DRUG ALCOHOL DEPEN, V87, P1, DOI 10.1016/j.drugalcdep.2006.07.003; Hack SP, 2003, NEUROPHARMACOLOGY, V45, P575, DOI 10.1016/S0028-3908(03)00205-3; Hacker J, 2006, NEUROSCIENCE, V137, P1389, DOI 10.1016/j.neuroscience.2005.10.052; Hanoune J, 2001, ANNU REV PHARMACOL, V41, P145, DOI 10.1146/annurev.pharmtox.41.1.145; Ingram SL, 2002, NAT NEUROSCI, V5, P971, DOI 10.1038/nn920; Ingram SL, 1998, J NEUROSCI, V18, P10269; Itouji A, 1996, MOL BRAIN RES, V37, P309; Jensen K, 2003, J NEUROPHYSIOL, V90, P2690, DOI 10.1152/jn.00240.2003; KOOB GF, 1992, TRENDS NEUROSCI, V15, P186, DOI 10.1016/0166-2236(92)90171-4; Kullmann DM, 2005, PROG BIOPHYS MOL BIO, V87, P33, DOI 10.1016/j.pbiomolbio.2004.06.003; LASCHKA E, 1976, PSYCHOPHARMACOLOGIA, V46, P141, DOI 10.1007/BF00421383; Luer MS, 1998, ANN PHARMACOTHER, V32, P1173, DOI 10.1345/aph.18053; Mann JJ, 2005, NEW ENGL J MED, V353, P1819, DOI 10.1056/NEJMra050730; McNally GP, 2004, J NEUROSCI, V24, P6912, DOI 10.1523/JNEUROSCI.1828-04.2004; Minozzi S., 2008, COCHRANE DB SYST REV, V16; Myrick H, 2005, J PSYCHOACTIVE DRUGS, V37, P409, DOI 10.1080/02791072.2005.10399814; Nestler EJ, 2004, TRENDS PHARMACOL SCI, V25, P210, DOI 10.1016/j.tips.2004.02.005; Overstreet LS, 2003, J NEUROSCI, V23, P2618; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Sofuoglu M, 2005, PSYCHOPHARMACOLOGY, V181, P504, DOI 10.1007/s00213-005-0010-y; Tamamaki N, 2003, J COMP NEUROL, V467, P60, DOI 10.1002/cne.10905; Tzavara ET, 2002, EUR J NEUROSCI, V16, P149, DOI 10.1046/j.1460-9568.2002.02061.x; Vaughan CW, 1997, NATURE, V390, P611, DOI 10.1038/37610; Veruki ML, 2006, NAT NEUROSCI, V9, P1388, DOI 10.1038/nn1793; Williams JT, 2001, PHYSIOL REV, V81, P299, DOI 10.1152/physrev.2001.81.1.299; Yang K, 2003, BIOCHEM BIOPH RES CO, V302, P233, DOI 10.1016/S0006-291X(03)00156-6	40	41	43	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2011	14	12					1548	U76		10.1038/nn.2940	http://dx.doi.org/10.1038/nn.2940			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	855EJ	22037500				2022-12-28	WOS:000297546300014
J	Cavanagh, JF; Wiecki, TV; Cohen, MX; Figueroa, CM; Samanta, J; Sherman, SJ; Frank, MJ				Cavanagh, James F.; Wiecki, Thomas V.; Cohen, Michael X.; Figueroa, Christina M.; Samanta, Johan; Sherman, Scott J.; Frank, Michael J.			Subthalamic nucleus stimulation reverses mediofrontal influence over decision threshold	NATURE NEUROSCIENCE			English	Article							DEEP BRAIN-STIMULATION; BASAL GANGLIA; PREFRONTAL CORTEX; DYNAMICS; MODEL; SELECTION; HORSES; MONKEY; HOLD	It takes effort and time to tame one's impulses. Although medial prefrontal cortex (mPFC) is broadly implicated in effortful control over behavior, the subthalamic nucleus (STN) is specifically thought to contribute by acting as a brake on cortico-striatal function during decision conflict, buying time until the right decision can be made. Using the drift diffusion model of decision making, we found that trial-to-trial increases in mPFC activity (EEG theta power, 4-8 Hz) were related to an increased threshold for evidence accumulation (decision threshold) as a function of conflict. Deep brain stimulation of the STN in individuals with Parkinson's disease reversed this relationship, resulting in impulsive choice. In addition, intracranial recordings of the STN area revealed increased activity (2.5-5 Hz) during these same high-conflict decisions. Activity in these slow frequency bands may reflect a neural substrate for cortico-basal ganglia communication regulating decision processes.	[Cavanagh, James F.; Wiecki, Thomas V.; Figueroa, Christina M.; Frank, Michael J.] Brown Univ, Dept Cognit Linguist & Psychol Sci, Providence, RI 02912 USA; [Cohen, Michael X.] Univ Amsterdam, Dept Psychol, Amsterdam, Netherlands; [Cohen, Michael X.] Univ Arizona, Dept Physiol, Tucson, AZ USA; [Samanta, Johan; Sherman, Scott J.] Univ Arizona, Dept Neurol, Tucson, AZ USA; [Samanta, Johan] Banner Good Samaritan Med Ctr, Phoenix, AZ USA; [Frank, Michael J.] Brown Univ, Dept Psychiat, Providence, RI 02912 USA; [Frank, Michael J.] Brown Inst Brain Sci, Providence, RI USA	Brown University; University of Amsterdam; University of Arizona; University of Arizona; Banner Research; Banner Health; Brown University; Brown University	Cavanagh, JF (corresponding author), Brown Univ, Dept Cognit Linguist & Psychol Sci, Providence, RI 02912 USA.	jim.f.cav@gmail.com; michael_frank@brown.edu	Cohen, Michael X/H-8748-2019; Cavanagh, James F/I-5222-2015; Cohen, Michael/A-3092-2016	Cohen, Michael X/0000-0002-1879-3593; Cohen, Michael/0000-0002-1879-3593; Cavanagh, James/0000-0003-2428-3562	Michael J. Fox Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH019118] Funding Source: NIH RePORTER	Michael J. Fox Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The authors express their gratitude to T. Norton and his surgical staff for their support during the intraoperative recording sessions, L. Trujillo for a review of permutation methods, E.J. Wagenmakers for consultation on Bayesian data analysis, J.J.B. Allen and E. F. Martino for laboratory resources that facilitated some data acquisition and analyses, and K. Carlisle for help with subject recruitment. This project was funded by a grant from the Michael J. Fox Foundation to M. J. F.	[Anonymous], 2006, ADV NEURAL INFORM PR; Aron AR, 2007, J NEUROSCI, V27, P3743, DOI 10.1523/JNEUROSCI.0519-07.2007; Bogacz R, 2007, NEURAL COMPUT, V19, P442, DOI 10.1162/neco.2007.19.2.442; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Cavanagh JF, 2010, NEUROIMAGE, V49, P3198, DOI 10.1016/j.neuroimage.2009.11.080; Cavanagh JF, 2009, J NEUROSCI, V29, P98, DOI 10.1523/JNEUROSCI.4137-08.2009; Cohen MX, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00030; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Fleming SM, 2010, P NATL ACAD SCI USA, V107, P6005, DOI 10.1073/pnas.0910380107; Forstmann BU, 2008, P NATL ACAD SCI USA, V105, P17538, DOI 10.1073/pnas.0805903105; Forstmann BU, 2010, P NATL ACAD SCI USA, V107, P15916, DOI 10.1073/pnas.1004932107; Frank MJ, 2007, SCIENCE, V318, P1309, DOI 10.1126/science.1146157; Frank MJ, 2006, NEURAL NETWORKS, V19, P1120, DOI 10.1016/j.neunet.2006.03.006; Frank MJ, 2006, PSYCHOL REV, V113, P300, DOI 10.1037/0033-295X.113.2.300; Gelman A., 2004, BAYESIAN DATA ANAL; Halbig TD, 2009, EUR J NEUROL, V16, P493, DOI 10.1111/j.1468-1331.2008.02509.x; Hanslmayr S, 2008, J COGNITIVE NEUROSCI, V20, P215, DOI 10.1162/jocn.2008.20020; Humphries MD, 2006, J NEUROSCI, V26, P12921, DOI 10.1523/JNEUROSCI.3486-06.2006; Hutchison WD, 1998, ANN NEUROL, V44, P622, DOI 10.1002/ana.410440407; Inase M, 1999, BRAIN RES, V833, P191, DOI 10.1016/S0006-8993(99)01531-0; Isoda M, 2008, J NEUROSCI, V28, P7209, DOI 10.1523/JNEUROSCI.0487-08.2008; Isoda M, 2007, NAT NEUROSCI, V10, P240, DOI 10.1038/nn1830; Kayser J, 2006, CLIN NEUROPHYSIOL, V117, P348, DOI 10.1016/j.clinph.2005.08.034; Krajbich I, 2010, NAT NEUROSCI, V13, P1292, DOI 10.1038/nn.2635; Lo CC, 2006, NAT NEUROSCI, V9, P956, DOI 10.1038/nn1722; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Miller EK, 2000, NAT REV NEUROSCI, V1, P59, DOI 10.1038/35036228; Nambu A, 2002, NEUROSCI RES, V43, P111, DOI 10.1016/S0168-0102(02)00027-5; Neubert FX, 2010, P NATL ACAD SCI USA, V107, P13240, DOI 10.1073/pnas.1000674107; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Ratcliff R, 2008, NEURAL COMPUT, V20, P873, DOI 10.1162/neco.2008.12-06-420; Takada M, 2001, EUR J NEUROSCI, V14, P1633, DOI 10.1046/j.0953-816x.2001.01789.x; Tass P, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/1/016009; Thobois S, 2007, J CEREBR BLOOD F MET, V27, P1173, DOI 10.1038/sj.jcbfm.9600425; Vandekerckhove J, 2011, PSYCHOL METHODS, V16, P44, DOI 10.1037/a0021765; Voss A, 2008, J MATH PSYCHOL, V52, P1, DOI 10.1016/j.jmp.2007.09.005; Yeung N, 2004, PSYCHOL REV, V111, P931, DOI [10.1037/0033-295X.111.4.931, 10.1037/0033-295x.111.4.931]	37	389	393	14	114	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2011	14	11					1462	U140		10.1038/nn.2925	http://dx.doi.org/10.1038/nn.2925			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	841NI	21946325	Green Accepted			2022-12-28	WOS:000296518600023
J	Goldman, SA; Chen, ZX				Goldman, Steven A.; Chen, Zhuoxun			Perivascular instruction of cell genesis and fate in the adult brain	NATURE NEUROSCIENCE			English	Review							NEURAL STEM-CELLS; NITRIC-OXIDE SYNTHASE; ENDOTHELIAL GROWTH-FACTOR; EPITHELIUM-DERIVED FACTOR; FOCAL CEREBRAL-ISCHEMIA; INHIBITS TUMOR-GROWTH; BLOOD-VESSELS FORM; SUBVENTRICULAR ZONE; VASCULAR NICHE; PROGENITOR CELLS	The perivascular niche for neurogenesis was first reported as the co-association of newly generated neurons and their progenitors with both dividing and mitotically quiescent endothelial cells in restricted regions of the brain in adult birds and mammals alike. This review attempts to summarize our present understanding of the interaction of blood vessels with neural stem and progenitor cells, addressing both glial and neuronal progenitor cell interactions in the perivascular niche. We review the molecular interactions that are most critical to the endothelial control of stem and progenitor cell mobilization and differentiation. The focus throughout will be on defining those perivascular ligand-receptor interactions shared among these systems, as well as those that clearly differ as a function of cell type and setting, by which specificity may be achieved in the development of targeted therapeutics.	[Goldman, Steven A.] Univ Rochester, Sch Med, Dept Neurol, Rochester, NY 14627 USA; Univ Rochester, Sch Med, Ctr Translat Neuromed, Rochester, NY USA	University of Rochester; University of Rochester	Goldman, SA (corresponding author), Univ Rochester, Sch Med, Dept Neurol, Rochester, NY 14627 USA.	steven_goldman@urmc.rochester.edu		Goldman, Steven/0000-0002-5498-4303	National Institute of Neurological Disorders and Stroke [R37NS29813, R01NS75345, R01NS39559]; National Multiple Sclerosis Society; G. Harold and Leila Y. Mathers Charitable Foundation; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; CHDI Foundation; New York State Stem Cell Research Program; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS029813, R01NS075345, R01NS039559] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Multiple Sclerosis Society(National Multiple Sclerosis Society); G. Harold and Leila Y. Mathers Charitable Foundation; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; CHDI Foundation; New York State Stem Cell Research Program; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank M. Nedergaard for her comments on the manuscript and A. Benraiss and C. McClain for designing the schematics. Work discussed in the Goldman laboratory was supported by the National Institute of Neurological Disorders and Stroke (grants R37NS29813, R01NS75345 and R01NS39559) and by grants from the National Multiple Sclerosis Society, the G. Harold and Leila Y. Mathers Charitable Foundation, the Dr. Miriam and Sheldon G. Adelson Medical Research Foundation, the CHDI Foundation, and the New York State Stem Cell Research Program.	Ables JL, 2011, NAT REV NEUROSCI, V12, P269, DOI 10.1038/nrn3024; Aerts I, 2011, CLIN NEUROL NEUROSUR, V113, P224, DOI 10.1016/j.clineuro.2010.11.018; Agresti C, 2005, GLIA, V50, P132, DOI 10.1002/glia.20160; AHMED S, 1995, J NEUROSCI, V15, P5765; Alvarez-Buylla A, 2001, NAT REV NEUROSCI, V2, P287, DOI 10.1038/35067582; Andreu-Agullo C, 2009, NAT NEUROSCI, V12, P1514, DOI 10.1038/nn.2437; Arai K, 2009, J NEUROSCI, V29, P4351, DOI 10.1523/JNEUROSCI.0035-09.2009; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Bao SD, 2006, CANCER RES, V66, P7843, DOI 10.1158/0008-5472.CAN-06-1010; Bergers G, 2000, NAT CELL BIOL, V2, P737, DOI 10.1038/35036374; Bovetti S, 2007, J NEUROSCI, V27, P5976, DOI 10.1523/JNEUROSCI.0678-07.2007; Braun N, 2003, EUR J NEUROSCI, V17, P1355, DOI 10.1046/j.1460-9568.2003.02567.x; Burnstock G, 2006, TRENDS PHARMACOL SCI, V27, P166, DOI 10.1016/j.tips.2006.01.005; Calabrese C, 2007, CANCER CELL, V11, P69, DOI 10.1016/j.ccr.2006.11.020; Cao L, 2004, NAT GENET, V36, P827, DOI 10.1038/ng1395; Carreira BP, 2010, STEM CELLS, V28, P1219, DOI 10.1002/stem.444; Chang YC, 2007, P NATL ACAD SCI USA, V104, P10888, DOI 10.1073/pnas.0704366104; Charles NA, 2010, CELL STEM CELL, V6, P6, DOI 10.1016/j.stem.2009.12.005; Chen JL, 2005, J NEUROSCI, V25, P2366, DOI 10.1523/JNEUROSCI.5071-04.2005; Cheng AW, 2003, DEV BIOL, V258, P319, DOI 10.1016/S0012-1606(03)00120-9; Chiaramello S, 2007, EUR J NEUROSCI, V26, P1780, DOI 10.1111/j.1460-9568.2007.05818.x; Chmielnicki E, 2004, J NEUROSCI, V24, P2133, DOI 10.1523/JNEUROSCI.1554-03.2004; Cho SR, 2007, J CLIN INVEST, V117, P2889, DOI 10.1172/JCI31778; Cleaver O, 2003, NAT MED, V9, P661, DOI 10.1038/nm0603-661; Dawson DW, 1999, SCIENCE, V285, P245, DOI 10.1126/science.285.5425.245; Doetsch F, 2002, NEURON, V36, P1021, DOI 10.1016/S0896-6273(02)01133-9; Doetsch F, 1997, J NEUROSCI, V17, P5046; Donovan MH, 2008, HIPPOCAMPUS, V18, P435, DOI 10.1002/hipo.20410; Emsley JG, 2003, EXP NEUROL, V183, P273, DOI 10.1016/S0014-4886(03)00209-7; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Eyler CE, 2011, CELL, V146, P53, DOI 10.1016/j.cell.2011.06.006; Gadea A, 2009, J NEUROSCI, V29, P10047, DOI 10.1523/JNEUROSCI.0822-09.2009; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Galvao RP, 2008, J NEUROSCI, V28, P13368, DOI 10.1523/JNEUROSCI.2918-08.2008; Gilbertson RJ, 2007, NAT REV CANCER, V7, P733, DOI 10.1038/nrc2246; Goldman S, 2005, NAT BIOTECHNOL, V23, P862, DOI 10.1038/nbt1119; GOLDMAN SA, 1983, P NATL ACAD SCI-BIOL, V80, P2390, DOI 10.1073/pnas.80.8.2390; Goldman SA, 1998, J NEUROBIOL, V36, P267, DOI 10.1002/(SICI)1097-4695(199808)36:2<267::AID-NEU12>3.3.CO;2-N; Greenberg DA, 2005, NATURE, V438, P954, DOI 10.1038/nature04481; Han YG, 2008, NAT NEUROSCI, V11, P277, DOI 10.1038/nn2059; Hartog TE, 2009, J NEUROSCI, V29, P15511, DOI 10.1523/JNEUROSCI.2564-09.2009; Ihrie RA, 2011, NEURON, V70, P674, DOI 10.1016/j.neuron.2011.05.004; Im SH, 2010, NEUROSCIENCE, V169, P259, DOI 10.1016/j.neuroscience.2010.04.038; Jin KL, 2001, P NATL ACAD SCI USA, V98, P4710, DOI 10.1073/pnas.081011098; Kim DH, 2008, J NEUROSCI, V28, P208, DOI 10.1523/JNEUROSCI.3674-07.2008; KIRSCHENBAUM B, 1994, CEREB CORTEX, V4, P576, DOI 10.1093/cercor/4.6.576; KIRSCHENBAUM B, 1995, P NATL ACAD SCI USA, V92, P210, DOI 10.1073/pnas.92.1.210; KLEIN R, 1990, CELL, V61, P647, DOI 10.1016/0092-8674(90)90476-U; Kokovay E, 2010, CELL STEM CELL, V7, P163, DOI 10.1016/j.stem.2010.05.019; Kronenberg G, 2003, J COMP NEUROL, V467, P455, DOI 10.1002/cne.10945; Lehtinen MK, 2011, NEURON, V69, P893, DOI 10.1016/j.neuron.2011.01.023; Leventhal C, 1999, MOL CELL NEUROSCI, V13, P450, DOI 10.1006/mcne.1999.0762; Li Q, 2006, J NEUROSCI RES, V84, P1656, DOI 10.1002/jnr.21087; Licht T, 2011, P NATL ACAD SCI USA, V108, P5081, DOI 10.1073/pnas.1007640108; Lim DA, 2000, NEURON, V28, P713, DOI 10.1016/S0896-6273(00)00148-3; Lin JHC, 2007, DEV BIOL, V302, P356, DOI 10.1016/j.ydbio.2006.09.017; LOIS C, 1993, P NATL ACAD SCI USA, V90, P2074, DOI 10.1073/pnas.90.5.2074; Louissaint A, 2002, NEURON, V34, P945, DOI 10.1016/S0896-6273(02)00722-5; Luo CX, 2010, STEM CELLS, V28, P2041, DOI 10.1002/stem.522; LUSKIN MB, 1993, NEURON, V11, P173, DOI 10.1016/0896-6273(93)90281-U; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Mirzadeh Z, 2008, CELL STEM CELL, V3, P265, DOI 10.1016/j.stem.2008.07.004; Monje ML, 2003, CURR OPIN NEUROL, V16, P129, DOI 10.1097/00019052-200304000-00002; Monje ML, 2003, SCIENCE, V302, P1760, DOI 10.1126/science.1088417; Moreno-Lopez B, 2004, J NEUROSCI, V24, P85, DOI 10.1523/JNEUROSCI.1574-03.2004; MORSHEAD CM, 1994, NEURON, V13, P1071, DOI 10.1016/0896-6273(94)90046-9; Murillo-Carretero M, 2009, FREE RADICAL BIO MED, V46, P471, DOI 10.1016/j.freeradbiomed.2008.10.048; Nishiyama A, 2009, NAT REV NEUROSCI, V10, P9, DOI 10.1038/nrn2495; Noguera-Troise I, 2006, NATURE, V444, P1032, DOI 10.1038/nature05355; Nunes MC, 2003, NAT MED, V9, P439, DOI 10.1038/nm837; Ohab JJ, 2006, J NEUROSCI, V26, P13007, DOI 10.1523/JNEUROSCI.4323-06.2006; Packer MA, 2003, P NATL ACAD SCI USA, V100, P9566, DOI 10.1073/pnas.1633579100; Palmer TD, 2000, J COMP NEUROL, V425, P479, DOI 10.1002/1096-9861(20001002)425:4<479::AID-CNE2>3.0.CO;2-3; Parent JM, 2002, ANN NEUROL, V52, P802, DOI 10.1002/ana.10393; Park C, 2001, NEUROSCI LETT, V309, P9, DOI 10.1016/S0304-3940(01)02003-1; Pincus DW, 1998, ANN NEUROL, V43, P576, DOI 10.1002/ana.410430505; Poimenidi E, 2009, ANTICANCER RES, V29, P349; POTTEN CS, 1990, DEVELOPMENT, V110, P1001; Quinones-Hinojosa A, 2006, J COMP NEUROL, V494, P415, DOI 10.1002/cne.20798; Ramirez-Castillejo C, 2006, NAT NEUROSCI, V9, P331, DOI 10.1038/nn1657; Rasika S, 1999, NEURON, V22, P53, DOI 10.1016/S0896-6273(00)80678-9; Reif A, 2004, EUR J NEUROSCI, V20, P885, DOI 10.1111/j.1460-9568.2004.03559.x; Ridgway J, 2006, NATURE, V444, P1083, DOI 10.1038/nature05313; Roy NS, 2000, NAT MED, V6, P271; Sanai N, 2004, NATURE, V427, P740, DOI 10.1038/nature02301; Schanzer A, 2004, BRAIN PATHOL, V14, P237; Shen Q, 2004, SCIENCE, V304, P1338, DOI 10.1126/science.1095505; Shen Q, 2008, CELL STEM CELL, V3, P289, DOI 10.1016/j.stem.2008.07.026; Sirn FJ, 2006, ANN NEUROL, V59, P763, DOI 10.1002/ana.20812; Snapyan M, 2009, J NEUROSCI, V29, P4172, DOI 10.1523/JNEUROSCI.4956-08.2009; Tavazoie M, 2008, CELL STEM CELL, V3, P279, DOI 10.1016/j.stem.2008.07.025; Torroglosa A, 2007, STEM CELLS, V25, P88, DOI 10.1634/stemcells.2006-0131; Wang L, 2006, J NEUROSCI, V26, P5996, DOI 10.1523/JNEUROSCI.5380-05.2006; Wang R, 2010, NATURE, V468, P829, DOI 10.1038/nature09624; Wang XH, 2004, NAT MED, V10, P821, DOI 10.1038/nm1082; Whitman MC, 2009, J COMP NEUROL, V516, P94, DOI 10.1002/cne.22093; Wurmser AE, 2004, NATURE, V430, P350, DOI 10.1038/nature02604; Yamashita T, 2006, J NEUROSCI, V26, P6627, DOI 10.1523/JNEUROSCI.0149-06.2006; Young KM, 2007, J NEUROSCI, V27, P5146, DOI 10.1523/JNEUROSCI.0654-07.2007; Zhu DY, 2003, J NEUROSCI, V23, P223	100	105	110	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2011	14	11					1382	1389		10.1038/nn.2963	http://dx.doi.org/10.1038/nn.2963			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	841NI	22030549	Green Accepted			2022-12-28	WOS:000296518600010
J	Lapid, H; Shushan, S; Plotkin, A; Voet, H; Roth, Y; Hummel, T; Schneidman, E; Sobel, N				Lapid, Hadas; Shushan, Sagit; Plotkin, Anton; Voet, Hillary; Roth, Yehudah; Hummel, Thomas; Schneidman, Elad; Sobel, Noam			Neural activity at the human olfactory epithelium reflects olfactory perception	NATURE NEUROSCIENCE			English	Article							ODORANT STRUCTURE; NASAL CAVITY; RAT; RESPONSES; PATTERNS; MUCOSA; BULB; PLEASANTNESS; STIMULATION; DYNAMICS	Organization of receptive surfaces reflects primary axes of perception. In vision, retinal coordinates reflect spatial coordinates. In audition, cochlear coordinates reflect tonal coordinates. However, the rules underlying the organization of the olfactory receptive surface are unknown. To test the hypothesis that organization of the olfactory epithelium reflects olfactory perception, we inserted an electrode into the human olfactory epithelium to directly measure odorant-induced evoked responses. We found that pairwise differences in odorant pleasantness predicted pairwise differences in response magnitude; that is, a location that responded maximally to a pleasant odorant was likely to respond strongly to other pleasant odorants, and a location that responded maximally to an unpleasant odorant was likely to respond strongly to other unpleasant odorants. Moreover, the extent of an individual's perceptual span predicted their span in evoked response. This suggests that, similarly to receptor surfaces for vision and audition, organization of the olfactory receptor surface reflects key axes of perception.	[Lapid, Hadas; Shushan, Sagit; Plotkin, Anton; Schneidman, Elad; Sobel, Noam] Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel; [Lapid, Hadas] Weizmann Inst Sci, Dept Comp Sci & Appl Math, IL-76100 Rehovot, Israel; [Shushan, Sagit; Roth, Yehudah] Tel Aviv Univ, Sackler Sch Med, Edith Wolfson Med Ctr, Dept Otolaryngol Head & Neck Surg, Holon, Israel; [Voet, Hillary] Hebrew Univ Jerusalem, Robert H Smith Fac Agr Food & Environm, IL-76100 Rehovot, Israel; [Hummel, Thomas] Univ Dresden, Sch Med, Smell & Taste Clin, Dresden, Germany	Weizmann Institute of Science; Weizmann Institute of Science; Tel Aviv University; Sackler Faculty of Medicine; Hebrew University of Jerusalem; Technische Universitat Dresden	Lapid, H (corresponding author), Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel.	hadas.lapid@gmail.com; noam.sobel@weizmann.ac.il		Sobel, Noam/0000-0002-3232-9391; schneidman, elad/0000-0001-8653-9848	ERC [200850]; James S. McDonnell Foundation	ERC(European Research Council (ERC)European Commission); James S. McDonnell Foundation	This work was supported by ERC-FP7 Ideas grant #200850 and by the James S. McDonnell Foundation.	Ayci F, 2005, FLAVOUR FRAG J, V20, P481, DOI 10.1002/ffj.1487; DOTY RL, 1978, PHYSIOL BEHAV, V20, P175, DOI 10.1016/0031-9384(78)90070-7; EDWARDS DA, 1988, EXPERIENTIA, V44, P208, DOI 10.1007/BF01941707; EZEH PI, 1995, J NEUROPHYSIOL, V73, P2207, DOI 10.1152/jn.1995.73.6.2207; Fleischer J, 2009, FRONT CELL NEUROSCI, V3, DOI 10.3389/neuro.03.009.2009; Garcia GJM, 2009, J AEROSOL MED PULM D, V22, P139, DOI 10.1089/jamp.2008.0713; Gilad Y, 2003, AM J HUM GENET, V73, P489, DOI 10.1086/378132; Gottfried JA, 2006, NEURON, V49, P467, DOI 10.1016/j.neuron.2006.01.007; Gottfried JA, 2003, NEURON, V39, P375, DOI 10.1016/S0896-6273(03)00392-1; Haddad R, 2008, NAT METHODS, V5, P425, DOI [10.1038/nmeth.1197, 10.1038/NMETH.1197]; Haddad R, 2010, J NEUROSCI, V30, P9017, DOI 10.1523/JNEUROSCI.0398-10.2010; Hasin-Brumshtein Y, 2009, TRENDS GENET, V25, P178, DOI 10.1016/j.tig.2009.02.002; HORNUNG DE, 1977, BRAIN RES, V128, P158, DOI 10.1016/0006-8993(77)90244-X; Howe CQ, 2005, P NATL ACAD SCI USA, V102, P1234, DOI 10.1073/pnas.0409314102; Hummel T, 2003, TOXICOL LETT, V140, P273, DOI 10.1016/S0378-4274(03)00078-X; Iwema CL, 2004, J NEUROSCI, V24, P356, DOI 10.1523/JNEUROSCI.1219-03.2004; KAUER JS, 1974, J PHYSIOL-LONDON, V243, P717, DOI 10.1113/jphysiol.1974.sp010773; Keller A, 2007, NATURE, V449, P468, DOI 10.1038/nature06162; Keller A, 2007, P NATL ACAD SCI USA, V104, P5614, DOI 10.1073/pnas.0605321104; Kent PF, 2003, BRAIN RES, V981, P1, DOI 10.1016/S0006-8993(03)02512-5; Kepecs A, 2006, CHEM SENSES, V31, P167, DOI 10.1093/chemsce/bjj016; Khan RM, 2007, J NEUROSCI, V27, P10015, DOI 10.1523/JNEUROSCI.1158-07.2007; Knecht A, 2004, PHYSIOL BEHAV, V83, P13, DOI 10.1016/j.physbeh.2004.07.024; Kobal G, 1981, ELEKTROPHYSIOLOGISCH; Lapid H, 2009, J NEUROPHYSIOL, V102, P2121, DOI 10.1152/jn.91321.2008; Leopold DA, 2000, LARYNGOSCOPE, V110, P417, DOI 10.1097/00005537-200003000-00016; Li W, 2010, PSYCHOL SCI, V21, P1454, DOI 10.1177/0956797610382121; MACKAYSIM A, 1994, J NEUROPHYSIOL, V71, P150, DOI 10.1152/jn.1994.71.1.150; MACKAYSIM A, 1991, J NEUROSCI, V11, P979; Mainland J, 2006, CHEM SENSES, V31, P181, DOI 10.1093/chemse/bjj012; Maresh A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002640; MENCO BPM, 1980, CELL TISSUE RES, V207, P183; Miyamichi K, 2005, J NEUROSCI, V25, P3586, DOI 10.1523/JNEUROSCI.0324-05.2005; MORAN DT, 1982, J NEUROCYTOL, V11, P721, DOI 10.1007/BF01153516; MOZELL MM, 1973, SCIENCE, V181, P1247, DOI 10.1126/science.181.4106.1247; Purves D, 2001, PHILOS T ROY SOC B, V356, P285, DOI 10.1098/rstb.2000.0772; RICHARDSON JTE, 1989, PSYCHOL BULL, V105, P352, DOI 10.1037/0033-2909.105.3.352; Saito H, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000016; Sakano H, 2010, NEURON, V67, P530, DOI 10.1016/j.neuron.2010.07.003; SCHIFFMAN SS, 1974, SCIENCE, V185, P112, DOI 10.1126/science.185.4146.112; Scott JW, 2007, J NEUROPHYSIOL, V97, P1941, DOI 10.1152/jn.01305.2006; Scott JW, 1997, J NEUROPHYSIOL, V77, P1950, DOI 10.1152/jn.1997.77.4.1950; Vater M, 2011, HEARING RES, V273, P89, DOI 10.1016/j.heares.2010.05.018; Wesson DW, 2011, NEUROSCI BIOBEHAV R, V35, P655, DOI 10.1016/j.neubiorev.2010.08.004; Wise PM, 2009, ANN NY ACAD SCI, V1170, P206, DOI 10.1111/j.1749-6632.2009.03912.x; Yang GC, 2007, CHEM SENSES, V32, P215, DOI 10.1093/chemse/bjl047; Yeshurun Y, 2010, ANNU REV PSYCHOL, V61, P219, DOI 10.1146/annurev.psych.60.110707.163639; Zarzo M, 2008, J SENS STUD, V23, P354, DOI 10.1111/j.1745-459X.2008.00160.x; [No title captured]	50	67	67	2	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2011	14	11					1455	U132		10.1038/nn.2926	http://dx.doi.org/10.1038/nn.2926			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	841NI	21946326				2022-12-28	WOS:000296518600022
J	Jossin, Y; Cooper, JA				Jossin, Yves; Cooper, Jonathan A.			Reelin, Rap1 and N-cadherin orient the migration of multipolar neurons in the developing neocortex	NATURE NEUROSCIENCE			English	Article							CELL-CELL ADHESION; CEREBRAL-CORTEX; CORTICAL-NEURONS; RADIAL MIGRATION; INTERCELLULAR-JUNCTIONS; LAMINAR ORGANIZATION; SMALL GTPASES; MOUSE-BRAIN; ACTIVATION; POLARITY	Projection neurons migrate from the ventricular zone to the neocortical plate during the development of the mouse brain. Their overall movement is radial, but they become multipolar and move nonradially in the intermediate zone. Here we show that Reelin, the Rap1 GTPase and N-cadherin (NCad) are important for multipolar neurons to polarize their migration toward the cortical plate. Inhibition and rescue experiments indicated that Reelin regulates migration through Rap1 and Akt, and that the Rap1-regulated GTPases RalA, RalB, Rac1 and Cdc42 are also involved. We found that Rap1 regulated the plasma membrane localization of NCad and NCad rescued radial polarization when Rap1 was inhibited. However, inhibition of Rap1 or NCad had little effect on glia-dependent locomotion. We propose a multistep mechanism in which Reelin activates Rap1, Rap1 upregulates NCad, and NCad is needed to orient cell migration.	[Jossin, Yves; Cooper, Jonathan A.] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98104 USA	Fred Hutchinson Cancer Center	Jossin, Y (corresponding author), Fred Hutchinson Canc Res Ctr, Div Basic Sci, 1124 Columbia St, Seattle, WA 98104 USA.	yves.jossin@uclouvain.be; jcooper@fhcrc.org	cagnie, barbara/D-9830-2017; Roussel, Nathalie A/A-1267-2012; Kregel, Jeroen/J-7849-2015	cagnie, barbara/0000-0003-4342-4519; Roussel, Nathalie A/0000-0002-7409-878X; Kregel, Jeroen/0000-0002-5692-1461; Jossin, Yves/0000-0001-8466-7432	Fonds National de la Recherche Scientifique, Belgium; European Commission through the Universite Catholique de Louvain; National Institutes of Health [CA41072]; NATIONAL CANCER INSTITUTE [R01CA041072, R37CA041072] Funding Source: NIH RePORTER	Fonds National de la Recherche Scientifique, Belgium(Fonds de la Recherche Scientifique - FNRS); European Commission through the Universite Catholique de Louvain; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank L. Buck for the use of her confocal microscope, W. Arthur, R. Hevner, F. Polleux, K. Sanada, L.-H. Tsai, V. Vasioukhin, A. Puschel, Y. Gotoh, P. Phelps and M. White for reagents, J. Wang and E. Jhingan for technical assistance, A. Goffinet and F. Polleux for helpful discussions, and V. Vasioukhin, S. Parkhurst, B. Edgar and S. Simo for comments on the manuscript. This work was supported by the Fonds National de la Recherche Scientifique, Belgium (Y.J.), the European Commission under the Marie Curie International Outgoing Fellowship Program through the Universite Catholique de Louvain (Y.J.) and National Institutes of Health grant CA41072 (J.A.C.).	Arnaud L, 2003, MOL CELL BIOL, V23, P9293, DOI 10.1128/MCB.23.24.9293-9302.2003; Arthur WT, 2004, J CELL BIOL, V167, P111, DOI 10.1083/jcb.200404068; Ballif BA, 2004, CURR BIOL, V14, P606, DOI 10.1016/j.cub.2004.03.038; Beffert U, 2002, J BIOL CHEM, V277, P49958, DOI 10.1074/jbc.M209205200; Belvindrah R, 2007, J NEUROSCI, V27, P13854, DOI 10.1523/JNEUROSCI.4494-07.2007; Bielas S, 2004, ANNU REV CELL DEV BI, V20, P593, DOI 10.1146/annurev.cellbio.20.082503.103047; Bivona TG, 2004, J CELL BIOL, V164, P461, DOI 10.1083/jcb.200311093; Boettner B, 2009, CURR OPIN CELL BIOL, V21, P684, DOI 10.1016/j.ceb.2009.06.004; Chen G, 2008, NAT NEUROSCI, V11, P36, DOI 10.1038/nn2018; Chen XY, 2003, J CELL BIOL, V163, P547, DOI 10.1083/jcb.200305137; Davis MA, 2003, J CELL BIOL, V163, P525, DOI 10.1083/jcb.200307111; de Anda FC, 2010, J NEUROSCI, V30, P10391, DOI 10.1523/JNEUROSCI.0381-10.2010; Elias LAB, 2007, NATURE, V448, P901, DOI 10.1038/nature06063; Franco SJ, 2011, NEURON, V69, P482, DOI 10.1016/j.neuron.2011.01.003; Fulga TA, 2002, NAT CELL BIOL, V4, P715, DOI 10.1038/ncb848; GOFFINET AM, 1979, ANAT EMBRYOL, V157, P205, DOI 10.1007/BF00305160; Grindstaff KK, 1998, CELL, V93, P731, DOI 10.1016/S0092-8674(00)81435-X; Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9; Jossin Y, 2003, J NEUROSCI, V23, P9953; Jossin Y, 2004, MOL NEUROBIOL, V30, P225, DOI 10.1385/MN:30:3:225; Jossin Y, 2007, MOL CELL BIOL, V27, P7113, DOI 10.1128/MCB.00928-07; Jossin Y, 2007, J NEUROSCI, V27, P4243, DOI 10.1523/JNEUROSCI.0023-07.2007; Kadowaki M, 2007, DEV BIOL, V304, P22, DOI 10.1016/j.ydbio.2006.12.014; Kawauchi T, 2010, NEURON, V67, P588, DOI 10.1016/j.neuron.2010.07.007; Kooistra MRH, 2007, J CELL SCI, V120, P17, DOI 10.1242/jcs.03306; Kuroda S, 1998, SCIENCE, V281, P832, DOI 10.1126/science.281.5378.832; Liu C, 2008, MOL CELL BIOL, V28, P7109, DOI 10.1128/MCB.01060-08; Morimura T, 2009, BRAIN RES, V1304, P26, DOI 10.1016/j.brainres.2009.09.087; Moskalenko S, 2002, NAT CELL BIOL, V4, P66, DOI 10.1038/ncb728; Nadarajah B, 2001, NAT NEUROSCI, V4, P143, DOI 10.1038/83967; Nelson WJ, 2008, BIOCHEM SOC T, V36, P149, DOI 10.1042/BST0360149; Nichols AJ, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-50; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; OGAWA M, 1995, NEURON, V14, P899, DOI 10.1016/0896-6273(95)90329-1; Park HO, 2007, MICROBIOL MOL BIOL R, V71, P48, DOI 10.1128/MMBR.00028-06; Qin Y, 2005, J CELL BIOL, V171, P1061, DOI 10.1083/jcb.200506094; Rice DS, 1998, DEVELOPMENT, V125, P3719; Rieger S, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000240; RUBINFELD B, 1991, CELL, V65, P1033, DOI 10.1016/0092-8674(91)90555-D; Schwamborn JC, 2004, NAT NEUROSCI, V7, P923, DOI 10.1038/nn1295; Simo S, 2010, J NEUROSCI, V30, P5668, DOI 10.1523/JNEUROSCI.0035-10.2010; Tabata H, 2003, J NEUROSCI, V23, P9996; Tabata H, 2001, NEUROSCIENCE, V103, P865, DOI 10.1016/S0306-4522(01)00016-1; Takai Y, 2003, J CELL SCI, V116, P17, DOI 10.1242/jcs.00167; TAKEICHI M, 1991, SCIENCE, V251, P1451, DOI 10.1126/science.2006419; Taniguchi H, 2006, DEVELOPMENT, V133, P1923, DOI 10.1242/dev.02354; Tsai JW, 2005, J CELL BIOL, V170, P935, DOI 10.1083/jcb.200505166; Uchida T, 2009, J NEUROSCI, V29, P10653, DOI 10.1523/JNEUROSCI.0345-09.2009; Yang XS, 2008, DEVELOPMENT, V135, P3521, DOI 10.1242/dev.023416; Zhang JN, 2010, DEV CELL, V18, P472, DOI 10.1016/j.devcel.2009.12.025	50	233	241	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2011	14	6					697	U289		10.1038/nn.2816	http://dx.doi.org/10.1038/nn.2816			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	768SH	21516100	Green Accepted			2022-12-28	WOS:000290958000011
J	Held, R; Ostrovsky, Y; deGelder, B; Gandhi, T; Ganesh, S; Mathur, U; Sinha, P				Held, Richard; Ostrovsky, Yuri; deGelder, Beatrice; Gandhi, Tapan; Ganesh, Suma; Mathur, Umang; Sinha, Pawan			The newly sighted fail to match seen with felt	NATURE NEUROSCIENCE			English	Article							CORTEX	Would a blind subject, on regaining sight, be able to immediately visually recognize an object previously known only by touch? We addressed this question, first formulated by Molyneux three centuries ago, by working with treatable, congenitally blind individuals. We tested their ability to visually match an object to a haptically sensed sample after sight restoration. We found a lack of immediate transfer, but such cross-modal mappings developed rapidly.	[Held, Richard; Ostrovsky, Yuri; Sinha, Pawan] MIT, Cambridge, MA 02139 USA; [deGelder, Beatrice] Tilburg Univ, NL-5000 LE Tilburg, Netherlands; [Gandhi, Tapan] Indian Inst Technol, New Delhi, India; [Ganesh, Suma; Mathur, Umang] Dr Shroffs Char Eye Hosp, New Delhi, India	Massachusetts Institute of Technology (MIT); Tilburg University; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Delhi	Held, R (corresponding author), MIT, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	heldd@neco.edu; psinha@mit.edu		Gandhi, Tapan/0000-0002-3532-9389	James McDonnell Foundation; National Eye Institute [R21-EY015521]; NATIONAL EYE INSTITUTE [R21EY015521] Funding Source: NIH RePORTER	James McDonnell Foundation; National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The authors wish to thank all members of the Project Prakash team and especially the children who participated in this study. Funding for this work was provided by the James McDonnell Foundation's Scholar Award to P. S. and the National Eye Institute (grant R21-EY015521 to P.S.).	CHESELDEN W, 1728, PHILOS T, V402, P447; Dandona R, 2003, BRIT J OPHTHALMOL, V87, P263, DOI 10.1136/bjo.87.3.263; DEGENAAR MJL, 2010, CONTINUUM COMPANION, P179; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; Falchier A, 2002, J NEUROSCI, V22, P5749; Held R, 2009, OPTOMETRY VISION SCI, V86, P595, DOI 10.1097/OPX.0b013e3181a72999; LEWKOWICZ CJ, 1994, DEV INTERSENSORY PER; Locke John, 1959, ESSAY HUMAN UNDERSTA; Mandavilli A, 2006, NATURE, V441, P271, DOI 10.1038/441271a; Maurer D, 1999, CHILD DEV, V70, P1047, DOI 10.1111/1467-8624.00077; MELTZOFF AN, 1979, NATURE, V282, P403, DOI 10.1038/282403a0; MORGAN MJ, 1977, MOLYNEUXS QUESTION; Ostrovsky Y, 2009, PSYCHOL SCI, V20, P1484, DOI 10.1111/j.1467-9280.2009.02471.x; Pascual-Leone A, 2005, ANNU REV NEUROSCI, V28, P377, DOI 10.1146/annurev.neuro.27.070203.144216; von Senden M., 1960, SPACE SIGHT PERCEPTI	15	108	109	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2011	14	5					551	553		10.1038/nn.2795	http://dx.doi.org/10.1038/nn.2795			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	754VU	21478887				2022-12-28	WOS:000289886600009
J	Truccolo, W; Donoghue, JA; Hochberg, LR; Eskandar, EN; Madsen, JR; Anderson, WS; Brown, EN; Halgren, E; Cash, SS				Truccolo, Wilson; Donoghue, Jacob A.; Hochberg, Leigh R.; Eskandar, Emad N.; Madsen, Joseph R.; Anderson, William S.; Brown, Emery N.; Halgren, Eric; Cash, Sydney S.			Single-neuron dynamics in human focal epilepsy	NATURE NEUROSCIENCE			English	Article							HUMAN LIMBIC NEURONS; EPILEPTIFORM ACTIVITY; ENTORHINAL CORTEX; SPIKING ACTIVITY; FIRING PATTERNS; SEIZURES; BRAIN; TERMINATION; INITIATION; ENSEMBLE	Epileptic seizures are traditionally characterized as the ultimate expression of monolithic, hypersynchronous neuronal activity arising from unbalanced runaway excitation. Here we report the first examination of spike train patterns in large ensembles of single neurons during seizures in persons with epilepsy. Contrary to the traditional view, neuronal spiking activity during seizure initiation and spread was highly heterogeneous, not hypersynchronous, suggesting complex interactions among different neuronal groups even at the spatial scale of small cortical patches. In contrast to earlier stages, seizure termination is a nearly homogenous phenomenon followed by an almost complete cessation of spiking across recorded neuronal ensembles. Notably, even neurons outside the region of seizure onset showed significant changes in activity minutes before the seizure. These findings suggest a revision of current thinking about seizure mechanisms and point to the possibility of seizure prevention based on spiking activity in neocortical neurons.	[Truccolo, Wilson; Donoghue, Jacob A.; Hochberg, Leigh R.; Cash, Sydney S.] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Truccolo, Wilson; Donoghue, Jacob A.; Hochberg, Leigh R.; Eskandar, Emad N.; Madsen, Joseph R.; Anderson, William S.; Brown, Emery N.; Cash, Sydney S.] Harvard Univ, Sch Med, Boston, MA USA; [Truccolo, Wilson] Brown Univ, Dept Neurosci, Providence, RI 02912 USA; [Truccolo, Wilson; Hochberg, Leigh R.] Brown Univ, Inst Brain Sci, Providence, RI 02912 USA; [Truccolo, Wilson; Hochberg, Leigh R.] Rehabil Res & Dev Serv, Dept Vet Affairs, Providence, RI USA; [Hochberg, Leigh R.] Brown Univ, Sch Engn, Providence, RI 02912 USA; [Eskandar, Emad N.] Massachusetts Gen Hosp, Dept Neurosurg, Boston, MA 02114 USA; [Eskandar, Emad N.] Massachusetts Gen Hosp, Nayef Al Rodhan Labs Cellular Neurosurg & Neurosu, Boston, MA 02114 USA; [Madsen, Joseph R.] Childrens Hosp, Dept Neurosurg, Boston, MA 02115 USA; [Madsen, Joseph R.; Anderson, William S.] Brigham & Womens Hosp, Dept Neurosurg, Boston, MA 02115 USA; [Brown, Emery N.] Massachusetts Gen Hosp, Dept Anesthesia Crit Care & Pain Med, Boston, MA 02114 USA; [Brown, Emery N.] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Brown, Emery N.] MIT, Div Hlth Sci & Technol, Harvard Massachusetts Inst Technol, Cambridge, MA 02139 USA; [Halgren, Eric] Univ Calif San Diego, Dept Radiol, San Diego, CA 92103 USA; [Halgren, Eric] Univ Calif San Diego, Dept Neurosci, San Diego, CA 92103 USA; [Halgren, Eric] Univ Calif San Diego, Dept Psychiat, San Diego, CA 92103 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Brown University; Brown University; Brown University; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Boston Children's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Truccolo, W (corresponding author), Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA.	wilson_truccolo@brown.edu	Hochberg, Leigh/R-6872-2019	Hochberg, Leigh/0000-0003-0261-2273; Anderson, William/0000-0003-0958-050X	CIMIT; US National Institutes of Health (NIH) National Institute of Neurological Disorders and Stroke (NINDS) [NS062092]; NIH-NINDS [5K01NS057389]; NIH [NS018741, DP1OD003646]; NINDS [K08NS066099-01A1]; US National Eye Institute [EY017658]; US National Institute on Drug Abuse [NS063249]; US National Science Foundation [IOB 0645886]; Howard Hughes Medical Institute; Klingenstein Foundation; US Department of Veterans Affairs; Doris Duke Charitable Foundation; Massachusetts General Hospital-Deane Institute for Integrated Research on Atrial Fibrillation and Stroke; NIH-NIDCD [R01DC009899]; NATIONAL EYE INSTITUTE [R01EY017658] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS066099, R01NS018741, R01NS062092, K01NS057389] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC009899] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003646] Funding Source: NIH RePORTER	CIMIT; US National Institutes of Health (NIH) National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH-NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); US National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); US National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); US National Science Foundation(National Science Foundation (NSF)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Klingenstein Foundation(Klingenstein Philanthropies); US Department of Veterans Affairs(US Department of Veterans Affairs); Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); Massachusetts General Hospital-Deane Institute for Integrated Research on Atrial Fibrillation and Stroke; NIH-NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors thank the patients who participated in this study, as well as the nursing and physician staff at each facility. We also thank A. M. Chan, C.J. Keller, A. Dykstra and J.E. Cormier for technical assistance, and J.P. Donoghue and K.J. Staley for critical reading of the manuscript. This research is funded by a CIMIT grant and US National Institutes of Health (NIH) National Institute of Neurological Disorders and Stroke (NINDS) NS062092 to S. S. C.; an NIH-NINDS Career Award (5K01NS057389) to W. T.; NIH NS018741 to E. H.; NINDS K08NS066099-01A1 to W. S. A.; US National Eye Institute EY017658, US National Institute on Drug Abuse NS063249, US National Science Foundation IOB 0645886, Howard Hughes Medical Institute and the Klingenstein Foundation to E.N.E.; NIH Director's Pioneer Award DP1OD003646 to E.N.B.; US Department of Veterans Affairs Career Development Transition Award, Doris Duke Charitable Foundation-Clinical Scientist Development Award, Massachusetts General Hospital-Deane Institute for Integrated Research on Atrial Fibrillation and Stroke, and NIH-NIDCD R01DC009899 to L. R. H. The contents do not represent the views of the Department of Veterans Affairs or the United States government.	Amritkar RE, 2009, INT J BIFURCAT CHAOS, V19, P4263, DOI 10.1142/S0218127409025353; Amritkar RE, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.258102; BABB TL, 1987, ELECTROEN CLIN NEURO, V66, P467, DOI 10.1016/0013-4694(87)90093-9; Bartho P, 2004, J NEUROPHYSIOL, V92, P600, DOI 10.1152/jn.01170.2003; Bikson M, 2003, J NEUROPHYSIOL, V90, P2402, DOI 10.1152/jn.00467.2003; Bower MR, 2008, J NEUROPHYSIOL, V99, P2431, DOI 10.1152/jn.01369.2007; Bragin A, 1999, EPILEPSIA, V40, P127, DOI 10.1111/j.1528-1157.1999.tb02065.x; Bragin A, 1997, J NEUROSCI, V17, P2567; Buckmaster PS, 2004, COMPARATIVE MED, V54, P473; CONNORS BW, 1984, NATURE, V310, P685, DOI 10.1038/310685a0; Cymerblit-Sabba A, 2010, J NEUROSCI, V30, P1619, DOI 10.1523/JNEUROSCI.5078-09.2010; da Silva FHL, 2003, IEEE T BIO-MED ENG, V50, P540, DOI 10.1109/TBME.2003.810703; DELGADOESCUETA AV, 1983, EPILEPSY, P295; Engel AK, 2005, NAT REV NEUROSCI, V6, P35, DOI 10.1038/nrn1585; Engel Jr J, 1983, CLIN NEUROSCIENCES, P1349; Fisher RS, 2005, EPILEPSIA, V46, P470, DOI 10.1111/j.0013-9580.2005.66104.x; HALGREN E, 1977, EPILEPSIA, V18, P89, DOI 10.1111/j.1528-1157.1977.tb05590.x; Hochberg LR, 2006, NATURE, V442, P164, DOI 10.1038/nature04970; Jacobs MP, 2009, EPILEPSY BEHAV, V14, P438, DOI 10.1016/j.yebeh.2009.02.036; Jefferys JGR, 2003, EPILEPSIA, V44, P44, DOI 10.1111/j.0013-9580.2003.12004.x; Jiruska P, 2010, J NEUROSCI, V30, P5690, DOI 10.1523/JNEUROSCI.0535-10.2010; Keller CJ, 2010, BRAIN, V133, P1668, DOI 10.1093/brain/awq112; Kim SP, 2008, J NEURAL ENG, V5, P455, DOI 10.1088/1741-2560/5/4/010; Lado FA, 2008, EPILEPSIA, V49, P1651, DOI 10.1111/j.1528-1167.2008.01669.x; Lewicki MS, 1998, NETWORK-COMP NEURAL, V9, pR53, DOI 10.1088/0954-898X/9/4/001; MATSUMOTO H, 1964, EXP NEUROL, V9, P305, DOI 10.1016/0014-4886(64)90026-3; Mormann F, 2007, BRAIN, V130, P314, DOI 10.1093/brain/awl241; Penfield W, 1954, EPILEPSY FUNCTIONAL; Pinto DJ, 2005, J NEUROSCI, V25, P8131, DOI 10.1523/JNEUROSCI.2278-05.2005; Santhanam G, 2007, IEEE T BIO-MED ENG, V54, P2037, DOI 10.1109/TBME.2007.895753; SAWA M, 1968, ELECTROEN CLIN NEURO, V24, P146, DOI 10.1016/0013-4694(68)90120-X; Schevon CA, 2008, J CLIN NEUROPHYSIOL, V25, P321, DOI 10.1097/WNP.0b013e31818e8010; Schwartzkroin Philip A., 1993, P83; Staba RJ, 2002, J NEUROSCI, V22, P5694; TREIMAN DM, 2001, TREATMENT EPILEPSY P, P681; Truccolo W, 2005, J NEUROPHYSIOL, V93, P1074, DOI 10.1152/jn.00697.2004; Truccolo W, 2008, J NEUROSCI, V28, P1163, DOI 10.1523/JNEUROSCI.4415-07.2008; Truccolo W, 2010, NAT NEUROSCI, V13, P105, DOI 10.1038/nn.2455; Ulbert T, 2004, EPILEPSIA, V45, P48, DOI 10.1111/j.0013-9580.2004.04011.x; WYLER AR, 1982, ANN NEUROL, V11, P301, DOI 10.1002/ana.410110311; Yaari Y, 2002, BRAIN PATHOL, V12, P234; Ziburkus J, 2006, J NEUROPHYSIOL, V95, P3948, DOI 10.1152/jn.01378.2005	42	335	339	2	51	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2011	14	5					635	U130		10.1038/nn.2782	http://dx.doi.org/10.1038/nn.2782			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	754VU	21441925	Green Accepted, Green Published			2022-12-28	WOS:000289886600020
J	Zweifel, LS; Fadok, JP; Argilli, E; Garelick, MG; Jones, GL; Dickerson, TMK; Allen, JM; Mizumori, SJY; Bonci, A; Palmiter, RD				Zweifel, Larry S.; Fadok, Jonathan P.; Argilli, Emmanuela; Garelick, Michael G.; Jones, Graham L.; Dickerson, Tavis M. K.; Allen, James M.; Mizumori, Sheri J. Y.; Bonci, Antonello; Palmiter, Richard D.			Activation of dopamine neurons is critical for aversive conditioning and prevention of generalized anxiety	NATURE NEUROSCIENCE			English	Article							VENTRAL TEGMENTAL AREA; ACOUSTIC STARTLE RESPONSE; PREPULSE INHIBITION; NMDA-RECEPTORS; DISCHARGE RATE; FEAR; POTENTIATION; STIMULI; MICE; AMPHETAMINE	Generalized anxiety is thought to result, in part, from impairments in contingency awareness during conditioning to cues that predict aversive or fearful outcomes. Dopamine neurons of the ventral midbrain exhibit heterogeneous responses to aversive stimuli that are thought to provide a critical modulatory signal to facilitate orientation to environmental changes and assignment of motivational value to unexpected events. Here we describe a mouse model in which activation of dopamine neurons in response to an aversive stimulus is attenuated by conditional genetic inactivation of functional NMDA receptors on dopamine neurons. We discovered that altering the magnitude of excitatory responses by dopamine neurons in response to an aversive stimulus was associated with impaired conditioning to a cue that predicts an aversive outcome. Impaired conditioning by these mice was associated with the development of a persistent, generalized anxiety-like phenotype. These data are consistent with a role for dopamine in facilitating contingency awareness that is critical for the prevention of generalized anxiety.	[Zweifel, Larry S.; Jones, Graham L.] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; [Zweifel, Larry S.; Jones, Graham L.] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [Zweifel, Larry S.; Fadok, Jonathan P.; Dickerson, Tavis M. K.; Palmiter, Richard D.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Zweifel, Larry S.; Fadok, Jonathan P.; Dickerson, Tavis M. K.; Palmiter, Richard D.] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; [Fadok, Jonathan P.; Garelick, Michael G.] Univ Washington, Grad Program Neurobiol & Behav, Seattle, WA 98195 USA; [Argilli, Emmanuela; Bonci, Antonello] Univ Calif San Francisco, Ernest Gallo Clin & Res Ctr, San Francisco, CA 94143 USA; [Argilli, Emmanuela; Bonci, Antonello] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Allen, James M.] Univ Washington, Dept Neurol, Seattle, WA 98195 USA; [Mizumori, Sheri J. Y.] Univ Washington, Dept Psychol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of California System; University of California San Francisco; Ernest Gallo Clinic & Research Center; University of California System; University of California San Francisco; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Zweifel, LS (corresponding author), Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA.	larryz@uw.edu; palmiter@uw.edu	Zweifel, Larry/O-3284-2017; Fadok, Jonathan/AAX-2999-2020	Zweifel, Larry/0000-0003-3465-5331; Fadok, Jonathan/0000-0002-0608-5151	US National Institutes of Health [2T32 GM007270, 4 R25 GM 058501-05, 1 R01 MH58755]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007270, R25GM058501] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH058755] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank A. D. Guler and members of the Palmiter laboratory for thoughtful discussion of this manuscript. We thank G. Froelich, V. Wall and M.J. Kim for technical support. This work was supported in part by US National Institutes of Health grants 2T32 GM007270 (to J.P.F.), 4 R25 GM 058501-05 (to T. M. K. D.) and 1 R01 MH58755 (to S.J.Y.M.).	Brischoux F, 2009, P NATL ACAD SCI USA, V106, P4894, DOI 10.1073/pnas.0811507106; Bromberg-Martin ES, 2010, NEURON, V68, P815, DOI 10.1016/j.neuron.2010.11.022; CHIODO LA, 1979, BRAIN RES, V176, P385, DOI 10.1016/0006-8993(79)90994-6; CHIODO LA, 1980, BRAIN RES, V189, P544, DOI 10.1016/0006-8993(80)90366-2; DAVIS M, 1993, BEHAV BRAIN RES, V58, P175, DOI 10.1016/0166-4328(93)90102-V; Fadok JP, 2009, J NEUROSCI, V29, P11089, DOI 10.1523/JNEUROSCI.1616-09.2009; Flood DG, 2010, PSYCHOPHARMACOLOGY, V211, P325, DOI 10.1007/s00213-010-1901-0; Grillon C, 2002, BIOL PSYCHIAT, V51, P851, DOI 10.1016/S0006-3223(01)01370-1; Grillon C, 2002, BIOL PSYCHIAT, V52, P958, DOI 10.1016/S0006-3223(02)01665-7; Grillon C, 2006, PSYCHOPHARMACOLOGY, V186, P434, DOI 10.1007/s00213-005-0124-2; Hunter AJ, 2000, HUM MOL GENET, V9, P893, DOI 10.1093/hmg/9.6.893; Joshua M, 2008, J NEUROSCI, V28, P11673, DOI 10.1523/JNEUROSCI.3839-08.2008; Jovanovic T, 2010, PSYCHONEUROENDOCRINO, V35, P846, DOI 10.1016/j.psyneuen.2009.11.009; Koch M, 1997, BEHAV BRAIN RES, V89, P35, DOI 10.1016/S0166-4328(97)02296-1; Komendantov AO, 2004, J NEUROPHYSIOL, V91, P346, DOI 10.1152/jn.00062.2003; Lammel S, 2008, NEURON, V57, P760, DOI 10.1016/j.neuron.2008.01.022; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Lovibond PF, 2002, J EXP PSYCHOL-ANIM B, V28, P3, DOI 10.1037//0097-7403.28.1.3; Luo AH, 2008, EUR J NEUROSCI, V27, P408, DOI 10.1111/j.1460-9568.2007.05985.x; MANTZ J, 1989, BRAIN RES, V476, P377, DOI 10.1016/0006-8993(89)91263-8; Margolis EB, 2006, J PHYSIOL-LONDON, V577, P907, DOI 10.1113/jphysiol.2006.117069; Matsumoto M, 2009, NATURE, V459, P837, DOI 10.1038/nature08028; OVERTON P, 1992, SYNAPSE, V10, P131, DOI 10.1002/syn.890100208; Overton PG, 1997, BRAIN RES REV, V25, P312, DOI 10.1016/S0165-0173(97)00039-8; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Pezze MA, 2004, PROG NEUROBIOL, V74, P301, DOI 10.1016/j.pneurobio.2004.09.004; Ralph RJ, 1999, J NEUROSCI, V19, P4627; Richardson R, 2000, BEHAV BRAIN RES, V110, P109, DOI 10.1016/S0166-4328(99)00189-8; Robinson S, 2004, P NATL ACAD SCI USA, V101, P13329, DOI 10.1073/pnas.0405084101; Sanchez MM, 2005, BIOL PSYCHIAT, V57, P373, DOI 10.1016/j.biopsych.2004.11.032; SCHULTZ W, 1987, J NEUROPHYSIOL, V57, P201, DOI 10.1152/jn.1987.57.1.201; Swerdlow NR, 2000, J NEUROSCI, V20, P4325; Ungless MA, 2004, SCIENCE, V303, P2040, DOI 10.1126/science.1093360; Ungless MA, 2001, NATURE, V411, P583, DOI 10.1038/35079077; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406; Zweifel LS, 2008, NEURON, V59, P486, DOI 10.1016/j.neuron.2008.05.028; Zweifel LS, 2009, P NATL ACAD SCI USA, V106, P7281, DOI 10.1073/pnas.0813415106	37	167	169	3	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2011	14	5					620	U112		10.1038/nn.2808	http://dx.doi.org/10.1038/nn.2808			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	754VU	21499253	Green Accepted			2022-12-28	WOS:000289886600018
J	Xu, Y; Berglund, ED; Sohn, JW; Holland, WL; Chuang, JC; Fukuda, M; Rossi, J; Williams, W; Jones, JE; Zigman, JM; Lowell, BB; Scherer, PE; Elmquist, JK				Xu, Yong; Berglund, Eric D.; Sohn, Jong-Woo; Holland, William L.; Chuang, Jen-Chieh; Fukuda, Makoto; Rossi, Jari; Williams, W.; Jones, Juli E.; Zigman, Jeffrey M.; Lowell, Bradford B.; Scherer, Philipp E.; Elmquist, Joel K.			5-HT(2C)Rs expressed by pro-opiomelanocortin neurons regulate insulin sensitivity in liver	NATURE NEUROSCIENCE			English	Article							MELANOCORTIN SYSTEM; RAT; HOMEOSTASIS; PATHWAYS; BRAIN	Mice lacking 5-HT 2C receptors (5-HT(2C)Rs) displayed hepatic insulin resistance, a phenotype normalized by re-expression of 5-HT(2C)Rs only in pro-opiomelanocortin (POMC) neurons. 5-HT2CR deficiency also abolished the anti-diabetic effects of meta-chlorophenylpiperazine (a 5-HT2CR agonist); these effects were restored when 5-HT(2C)Rs were re-expressed in POMC neurons. Our findings indicate that 5-HT(2C)Rs expressed by POMC neurons are physiologically relevant regulators of insulin sensitivity and glucose homeostasis in the liver.	[Xu, Yong; Berglund, Eric D.; Sohn, Jong-Woo; Chuang, Jen-Chieh; Fukuda, Makoto; Rossi, Jari; Williams, W.; Zigman, Jeffrey M.; Elmquist, Joel K.] Univ Texas SW Med Ctr Dallas, Div Hypothalam Res, Dallas, TX 75390 USA; [Holland, William L.; Scherer, Philipp E.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Touchstone Diabet Ctr, Dallas, TX 75390 USA; [Xu, Yong; Berglund, Eric D.; Sohn, Jong-Woo; Chuang, Jen-Chieh; Fukuda, Makoto; Rossi, Jari; Williams, W.; Zigman, Jeffrey M.; Elmquist, Joel K.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Xu, Yong] Baylor Coll Med, Childrens Nutr Res Ctr, Dept Pediat, Houston, TX 77030 USA; [Jones, Juli E.; Lowell, Bradford B.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Med, Boston, MA 02215 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Baylor College of Medicine; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Elmquist, JK (corresponding author), Univ Texas SW Med Ctr Dallas, Div Hypothalam Res, Dallas, TX 75390 USA.	joel.elmquist@utsouthwestern.edu	Fukuda, Makoto/S-9748-2019; Williams, Kevin W/AAA-4243-2020; Fukuda, Makoto/I-7915-2014; Williams, Kevin W/ABD-5818-2021; Sohn, Jong Woo/D-6700-2014; Fukuda, Makoto/C-9745-2009; Scherer, Philipp E/K-7819-2012	Fukuda, Makoto/0000-0003-0112-9925; Williams, Kevin W/0000-0002-8434-8658; Fukuda, Makoto/0000-0003-0112-9925; Williams, Kevin W/0000-0002-8434-8658; Fukuda, Makoto/0000-0003-0112-9925; Scherer, Philipp E/0000-0003-0680-3392; Zigman, Jeffrey/0000-0003-3477-1295; Xu, Yong/0000-0002-4908-1572; Rossi, Jari/0000-0002-3728-9800	University of Texas [PL1 DK081182, UL1RR024923]; Canadian Institute of Health Research [K99DK085330, TL1DK081181, F32 DK083866-01, K01 DK087780, K08DK068069, PO1 DK088761, RC1-DK086629, R01-DK55758, PO1 DK56116, R01DK088423, R01DK53301, R01MH61583, RL1DK081185]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024923] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [UL1DE019584] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK083866, R37DK053301, RC1DK086629, RL1DK081185, PL1DK081182, TL1DK081181, P01DK088761, K08DK068069, R01DK088423, R00DK085330, K99DK085330, K01DK087780, P01DK056116, R01DK055758, R01DK053301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH061583] Funding Source: NIH RePORTER	University of Texas; Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank the University of Texas Southwestern Mouse Metabolic Phenotyping Core (supported by PL1 DK081182 and UL1RR024923). This work was supported by grants to Y.X. (Canadian Institute of Health Research and K99DK085330), E.D.B. (TL1DK081181), J.-W.S. (American Diabetes Association), W.L.H. (F32 DK083866-01), M.F. (American Heart Association), J.R. (Sigrid Juselius Foundation), K.W.W. (K01 DK087780), J.M.Z. (K08DK068069), P.E.S. (PO1 DK088761, RC1-DK086629 and R01-DK55758), B.B.L. (PO1 DK56116) and J.K.E. (R01DK088423, R01DK53301, R01MH61583 and RL1DK081185).	Cone RD, 2005, NAT NEUROSCI, V8, P571, DOI 10.1038/nn1455; Fan W, 2004, NAT NEUROSCI, V7, P335, DOI 10.1038/nn1214; Heisler LK, 2002, SCIENCE, V297, P609, DOI 10.1126/science.1072327; HOFFMAN BJ, 1989, FEBS LETT, V247, P453, DOI 10.1016/0014-5793(89)81390-0; KISS J, 1984, NEUROSCI LETT, V44, P119, DOI 10.1016/0304-3940(84)90068-5; STEINBUSCH HWM, 1981, NEUROSCIENCE, V6, P557, DOI 10.1016/0306-4522(81)90146-9; Wade JM, 2008, ENDOCRINOLOGY, V149, P955, DOI 10.1210/en.2007-0927; Xu Y, 2008, NEURON, V60, P582, DOI 10.1016/j.neuron.2008.09.033; Zhou L, 2007, CELL METAB, V6, P398, DOI 10.1016/j.cmet.2007.10.008	9	70	73	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	2010	13	12					1457	1459		10.1038/nn.2664	http://dx.doi.org/10.1038/nn.2664			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	684CW	21037584	Green Accepted			2022-12-28	WOS:000284525800008
J	Hoeck, JD; Jandke, A; Blake, SM; Nye, E; Spencer-Dene, B; Brandner, S; Behrens, A				Hoeck, Joerg D.; Jandke, Anett; Blake, Sophia M.; Nye, Emma; Spencer-Dene, Bradley; Brandner, Sebastian; Behrens, Axel			Fbw7 controls neural stem cell differentiation and progenitor apoptosis via Notch and c-Jun	NATURE NEUROSCIENCE			English	Article							RADIAL GLIAL-CELLS; CENTRAL-NERVOUS-SYSTEM; UBIQUITIN LIGASE; TUMOR-SUPPRESSOR; CYCLIN-E; INTERMEDIATE PROGENITORS; FATE SPECIFICATION; PROTEIN; GENE; PHOSPHORYLATION	Neural stem and progenitor cells (NSCs/NPCs) give rise to neurons, astrocytes and oligodendrocytes. However, the mechanisms underlying the decision of a stem cell to either self-renew or differentiate are incompletely understood. We demonstrate here that Fbw7 (F-box and WD repeat domain containing-7), the substrate recognition component of an SCF (complex of SKP1, CUL1 and F-box protein)-type E3 ubiquitin ligase, is a key regulator of NSC/NPC viability and differentiation. The absence of Fbw7 in the mouse brain caused severely impaired stem cell differentiation and increased progenitor cell death. Fbw7 deficiency resulted in accumulation of two SCF(Fbw7) substrates, the transcription factors active Notch1 and N-terminally phosphorylated c-Jun. Genetic and pharmacological rescue experiments identified c-Jun as a key substrate of Fbw7 in controlling progenitor cell viability, whereas inhibition of Notch signaling alleviated the block in stem cell differentiation. Thus Fbw7 controls neurogenesis by antagonizing Notch and c-Jun N-terminal kinase (JNK)/c-Jun signaling.	[Hoeck, Joerg D.; Jandke, Anett; Blake, Sophia M.; Behrens, Axel] Canc Res UK London Res Inst, Mammalian Genet Lab, London, England; [Nye, Emma; Spencer-Dene, Bradley] Canc Res UK London Res Inst, Expt Pathol Lab, London, England; [Brandner, Sebastian] UCL, Inst Neurol, Dept Neurodegenerat Dis, Div Neuropathol, London, England	Cancer Research UK; Cancer Research UK; University of London; University College London	Behrens, A (corresponding author), Canc Res UK London Res Inst, Mammalian Genet Lab, London, England.	axel.behrens@cancer.org.uk	Jandke, Anett/AAK-4545-2021; Brandner, Sebastian/J-4562-2014	Brandner, Sebastian/0000-0002-9821-0342; Behrens, Axel/0000-0002-1557-1143; Jandke, Anett/0000-0002-7681-7952; Hoeck, Joerg/0000-0002-2142-1555	Federation of the Societies of Biochemistry and Molecular Biology (FEBS); MRC [85704]; Cancer Research UK; MRC [G0800020] Funding Source: UKRI; Medical Research Council [G0800020] Funding Source: researchfish	Federation of the Societies of Biochemistry and Molecular Biology (FEBS); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We are grateful to the Animal Unit, Equipment Park, FACS Lab and the Experimental Pathology Lab at the London Research Institute for technical help and advice on histology. We are grateful to F. Radtke (Swiss Institute for Experimental Cancer Research, Lausanne, Switzerland) for floxed Notch1 mice. We thank R. Sancho for the data on Fbxw7 isoform expression in various tissues. We thank C. R. Da Costa, S. Marino and A. Martin-Villalba for critical reading of the manuscript. S. M. B. is supported by a Federation of the Societies of Biochemistry and Molecular Biology (FEBS) Long Term Fellowship. Part of this work is supported by an MRC project grant (85704) to A. B. The London Research Institute is funded by Cancer Research UK.	ANGEL P, 1988, CELL, V55, P875, DOI 10.1016/0092-8674(88)90143-2; Anthony TE, 2004, NEURON, V41, P881, DOI 10.1016/S0896-6273(04)00140-0; Anthony TE, 2005, GENE DEV, V19, P1028, DOI 10.1101/gad.1302105; Behrens A, 2003, DEVELOPMENT, V130, P103, DOI 10.1242/dev.00186; Behrens A, 1999, NAT GENET, V21, P326, DOI 10.1038/6854; Besirli CG, 2005, J CELL BIOL, V170, P401, DOI 10.1083/jcb.200501138; BossyWetzel E, 1997, EMBO J, V16, P1695, DOI 10.1093/emboj/16.7.1695; Chang LF, 2003, DEV CELL, V4, P521, DOI 10.1016/S1534-5807(03)00094-7; Coffey ET, 2002, J NEUROSCI, V22, P4335, DOI 10.1523/JNEUROSCI.22-11-04335.2002; Corbin JG, 2008, J NEUROCHEM, V106, P2272, DOI 10.1111/j.1471-4159.2008.05522.x; delaPompa J, 1997, DEVELOPMENT, V124, P1139; Fuchs SY, 2005, CANCER BIOL THER, V4, P506, DOI 10.4161/cbt.4.5.1703; Gaiano N, 2000, NEURON, V26, P395, DOI 10.1016/S0896-6273(00)81172-1; Gotz M, 2005, NEURON, V46, P369, DOI 10.1016/j.neuron.2005.04.012; Hartfuss E, 2001, DEV BIOL, V229, P15, DOI 10.1006/dbio.2000.9962; Ho MS, 2006, J BIOMED SCI, V13, P181, DOI 10.1007/s11373-005-9058-2; Hojo M, 2000, DEVELOPMENT, V127, P2515; Kramer ER, 2006, NEURON, V50, P35, DOI 10.1016/j.neuron.2006.02.020; Ma C, 2007, J BIOL CHEM, V282, P30901, DOI 10.1074/jbc.M608694200; Mao JH, 2004, NATURE, V432, P775, DOI 10.1038/nature03155; Matsuoka S, 2008, GENE DEV, V22, P986, DOI 10.1101/gad.1621808; Merkle FT, 2006, CURR OPIN CELL BIOL, V18, P704, DOI 10.1016/j.ceb.2006.09.008; Mizutani K, 2007, NATURE, V449, P351, DOI 10.1038/nature06090; Nateri AS, 2005, NATURE, V437, P281, DOI 10.1038/nature03914; Nateri AS, 2004, SCIENCE, V303, P1374, DOI 10.1126/science.1092880; Nelson BR, 2007, DEV BIOL, V304, P479, DOI 10.1016/j.ydbio.2007.01.001; Ohtsuka T, 1999, EMBO J, V18, P2196, DOI 10.1093/emboj/18.8.2196; Patten BA, 2003, J NEUROSCI, V23, P6132, DOI 10.1523/JNEUROSCI.23-14-06132.2003; Pollard SM, 2006, CEREB CORTEX, V16, pI112, DOI 10.1093/cercor/bhj167; Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0; Raivich G, 2004, NEURON, V43, P57, DOI 10.1016/j.neuron.2004.06.005; Reynolds BA, 2005, NAT METHODS, V2, P333, DOI 10.1038/nmeth758; Sangfelt O, 2008, CELL CYCLE, V7, P1075, DOI 10.4161/cc.7.8.5648; Selkoe D, 2003, ANNU REV NEUROSCI, V26, P565, DOI 10.1146/annurev.neuro.26.041002.131334; Tan YM, 2008, CANCER LETT, V271, P1, DOI 10.1016/j.canlet.2008.04.036; Tetzlaff MT, 2004, P NATL ACAD SCI USA, V101, P3338, DOI 10.1073/pnas.0307875101; Thompson BJ, 2008, J EXP MED, V205, P1395, DOI 10.1084/jem.20080277; Tsunematsu R, 2004, J BIOL CHEM, V279, P9417, DOI 10.1074/jbc.M312337200; van Drogen F, 2006, MOL CELL, V23, P37, DOI 10.1016/j.molcel.2006.05.020; Wang X, 2007, MOL CELL BIOL, V27, P7935, DOI 10.1128/MCB.00226-07; Welcker M, 2004, CURR BIOL, V14, P1852, DOI 10.1016/j.cub.2004.09.083; Welcker M, 2008, NAT REV CANCER, V8, P83, DOI 10.1038/nrc2290; Whitfield J, 2001, NEURON, V29, P629, DOI 10.1016/S0896-6273(01)00239-2; Yoon K, 2005, NAT NEUROSCI, V8, P709, DOI 10.1038/nn1475; Yoon KJ, 2008, NEURON, V58, P519, DOI 10.1016/j.neuron.2008.03.018	45	132	133	0	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2010	13	11					1365	U95		10.1038/nn.2644	http://dx.doi.org/10.1038/nn.2644			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	673KI	20935640				2022-12-28	WOS:000283658200017
J	Riccio, A				Riccio, Antonella			Dynamic epigenetic regulation in neurons: enzymes, stimuli and signaling pathways	NATURE NEUROSCIENCE			English	Review							HISTONE DEACETYLASE INHIBITORS; RUBINSTEIN-TAYBI SYNDROME; GENE-EXPRESSION; NITRIC-OXIDE; NERVOUS-SYSTEM; TRANSCRIPTION FACTORS; ARGININE METHYLATION; CHROMATIN REGULATION; SYNAPTIC PLASTICITY; BDNF TRANSCRIPTION	The development and function of neurons require the regulated expression of large numbers of very specific gene sets. Epigenetic modifications of both DNA and histone proteins are now emerging as fundamental mechanisms by which neurons adapt their transcriptional response to developmental and environmental cues. In the nervous system, the mechanisms by which extracellular signals regulate the activity of chromatin-modifying enzymes have just begun to be characterized. In this Review, I discuss how extracellular cues, including synaptic activity and neurotrophic factors, influence epigenetic modifications and regulate the neuronal transcriptional response. I also summarize additional mechanisms that induce chromatin remodeling events by combinatorial assembly of multiprotein complexes on neuronal gene promoters.	[Riccio, Antonella] UCL, MRC, Lab Mol & Cell Biol, London, England; [Riccio, Antonella] UCL, Dept Neurosci Physiol & Pharmacol, London, England	University of London; University College London; University of London; University College London	Riccio, A (corresponding author), UCL, MRC, Lab Mol & Cell Biol, London, England.	a.riccio@ucl.ac.uk			MRC; MRC [G120/934, G0802010] Funding Source: UKRI; Medical Research Council [G0802010, G120/934] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The author is grateful to L. Crepaldi and A. Nott for reading the manuscript. A. R. is the recipient of an MRC Senior Non Clinical Fellowship.	Bai SM, 2005, MOL CELL BIOL, V25, P751, DOI 10.1128/MCB.25.2.751-766.2005; Ballas N, 2005, CELL, V121, P645, DOI 10.1016/j.cell.2005.03.013; Ballas N, 2005, CURR OPIN NEUROBIOL, V15, P500, DOI 10.1016/j.conb.2005.08.015; Battaglioli E, 2002, J BIOL CHEM, V277, P41038, DOI 10.1074/jbc.M205691200; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Berger SL, 2009, GENE DEV, V23, P781, DOI 10.1101/gad.1787609; Bernstein BE, 2002, P NATL ACAD SCI USA, V99, P8695, DOI 10.1073/pnas.082249499; Bienvenu T, 2006, NAT REV GENET, V7, P415, DOI 10.1038/nrg1878; Boeger H, 2003, MOL CELL, V11, P1587, DOI 10.1016/S1097-2765(03)00231-4; Borrelli E, 2008, NEURON, V60, P961, DOI 10.1016/j.neuron.2008.10.012; Bowman GD, 2010, CURR OPIN STRUC BIOL, V20, P73, DOI 10.1016/j.sbi.2009.12.002; Brandl A, 2009, BIOL CELL, V101, P193, DOI 10.1042/BC20080158; BREDT DS, 1994, NEURON, V13, P301, DOI 10.1016/0896-6273(94)90348-4; Broide RS, 2007, J MOL NEUROSCI, V31, P47, DOI 10.1007/BF02686117; Bultman S, 2000, MOL CELL, V6, P1287, DOI 10.1016/S1097-2765(00)00127-1; Chahrour M, 2008, SCIENCE, V320, P1224, DOI 10.1126/science.1153252; Chawla S, 2003, J NEUROCHEM, V85, P151, DOI 10.1046/j.1471-4159.2003.01648.x; Chen WG, 2003, SCIENCE, V302, P885, DOI 10.1126/science.1086446; Chen ZF, 1998, NAT GENET, V20, P136, DOI 10.1038/2431; CHONG JHA, 1995, CELL, V80, P949, DOI 10.1016/0092-8674(95)90298-8; Colussi C, 2008, P NATL ACAD SCI USA, V105, P19183, DOI 10.1073/pnas.0805514105; Contestabile A, 2008, PROG NEUROBIOL, V84, P317, DOI 10.1016/j.pneurobio.2008.01.002; Crosio C, 2000, NAT NEUROSCI, V3, P1241, DOI 10.1038/81767; Crosio C, 2003, J CELL SCI, V116, P4905, DOI 10.1242/jcs.00804; Cuthbert GL, 2004, CELL, V118, P545, DOI 10.1016/j.cell.2004.08.020; Dhakshinamoorthy S, 2007, NUCLEIC ACIDS RES, V35, P5439, DOI 10.1093/nar/gkm594; Doi M, 2006, CELL, V125, P497, DOI 10.1016/j.cell.2006.03.033; Dulac C, 2010, NATURE, V465, P728, DOI 10.1038/nature09231; Fraser P, 2007, NATURE, V447, P413, DOI 10.1038/nature05916; Garriga-Canut M, 2006, NAT NEUROSCI, V9, P1382, DOI 10.1038/nn1791; Goodman RH, 2000, GENE DEV, V14, P1553; Gregoretti IV, 2004, J MOL BIOL, V338, P17, DOI 10.1016/j.jmb.2004.02.006; Guan JS, 2009, NATURE, V459, P55, DOI 10.1038/nature07925; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; Hait NC, 2009, SCIENCE, V325, P1254, DOI 10.1126/science.1176709; Hardingham GE, 1999, NEURON, V22, P789, DOI 10.1016/S0896-6273(00)80737-0; Hassan AH, 2001, CELL, V104, P817, DOI 10.1016/S0092-8674(01)00279-3; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Herz J, 2006, NAT REV NEUROSCI, V7, P850, DOI 10.1038/nrn2009; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; Ho L, 2010, NATURE, V463, P474, DOI 10.1038/nature08911; Hu SC, 1999, NEURON, V22, P799, DOI 10.1016/S0896-6273(00)80738-2; Impey S, 2002, NEURON, V34, P235, DOI 10.1016/S0896-6273(02)00654-2; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; Kazantsev AG, 2008, NAT REV DRUG DISCOV, V7, P854, DOI 10.1038/nrd2681; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; Lagger G, 2002, EMBO J, V21, P2672, DOI 10.1093/emboj/21.11.2672; Lessard J, 2007, NEURON, V55, P201, DOI 10.1016/j.neuron.2007.06.019; Liu YZ, 1999, NEUROREPORT, V10, P1239, DOI 10.1097/00001756-199904260-00016; Liu YZ, 1998, J BIOL CHEM, V273, P32400, DOI 10.1074/jbc.273.49.32400; Lonze BE, 2002, NEURON, V35, P605, DOI 10.1016/S0896-6273(02)00828-0; Lunyak VV, 2002, SCIENCE, V298, P1747, DOI 10.1126/science.1076469; Ma DK, 2009, SCIENCE, V323, P1074, DOI 10.1126/science.1166859; MacDonald JL, 2008, DEV DYNAM, V237, P2256, DOI 10.1002/dvdy.21626; MANUELIDIS L, 1984, P NATL ACAD SCI-BIOL, V81, P3123, DOI 10.1073/pnas.81.10.3123; Martinowich K, 2003, SCIENCE, V302, P890, DOI 10.1126/science.1090842; Merienne K, 2001, MOL CELL BIOL, V21, P7089, DOI 10.1128/MCB.21.20.7089-7096.2001; Michan S, 2007, BIOCHEM J, V404, P1, DOI 10.1042/BJ20070140; Miller CA, 2007, NEURON, V53, P857, DOI 10.1016/j.neuron.2007.02.022; Morey L, 2010, TRENDS BIOCHEM SCI, V35, P323, DOI 10.1016/j.tibs.2010.02.009; Muchardt C, 1999, J MOL BIOL, V293, P187, DOI 10.1006/jmbi.1999.2999; Nakahata Y, 2007, CURR OPIN CELL BIOL, V19, P230, DOI 10.1016/j.ceb.2007.02.016; Nakajima T, 1996, CELL, V86, P465, DOI 10.1016/S0092-8674(00)80119-1; Nishihara E, 2003, J NEUROSCI, V23, P213; Nott A, 2008, NATURE, V455, P411, DOI 10.1038/nature07238; Ooi L, 2007, NAT REV GENET, V8, P544, DOI 10.1038/nrg2100; Partanen M, 1999, INT J DEV BIOL, V43, P487; PETRIJ F, 1995, NATURE, V376, P348, DOI 10.1038/376348a0; Qiu Z, 2008, NEURON, V60, P775, DOI 10.1016/j.neuron.2008.09.040; Reinke H, 2003, MOL CELL, V11, P1599, DOI 10.1016/S1097-2765(03)00186-2; Riccio A, 2006, MOL CELL, V21, P283, DOI 10.1016/j.molcel.2005.12.006; Sassone-Corsi P, 1999, SCIENCE, V285, P886, DOI 10.1126/science.285.5429.886; SCHOENHERR CJ, 1995, SCIENCE, V267, P1360, DOI 10.1126/science.7871435; Segal RA, 2003, ANNU REV NEUROSCI, V26, P299, DOI 10.1146/annurev.neuro.26.041002.131421; Shahani N, 2011, ANTIOXID REDOX SIGN, V14, P1493, DOI 10.1089/ars.2010.3580; Shahbazian MD, 2007, ANNU REV BIOCHEM, V76, P75, DOI 10.1146/annurev.biochem.76.052705.162114; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Shi YJ, 2003, NATURE, V422, P735, DOI 10.1038/nature01550; Skene PJ, 2010, MOL CELL, V37, P457, DOI 10.1016/j.molcel.2010.01.030; Sterner DE, 2000, MICROBIOL MOL BIOL R, V64, P435, DOI 10.1128/MMBR.64.2.435-459.2000; Tanaka Y, 1997, P NATL ACAD SCI USA, V94, P10215, DOI 10.1073/pnas.94.19.10215; Turner BM, 2007, NAT CELL BIOL, V9, P2, DOI 10.1038/ncb0107-2; Turner BM, 2009, PHILOS T R SOC B, V364, P3403, DOI 10.1098/rstb.2009.0125; Valinluck V, 2004, NUCLEIC ACIDS RES, V32, P4100, DOI 10.1093/nar/gkh739; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Vo N, 2001, J BIOL CHEM, V276, P13505, DOI 10.1074/jbc.R000025200; Wang Y, 2004, SCIENCE, V306, P279, DOI 10.1126/science.1101400; Wang ZB, 2009, CELL, V138, P1019, DOI 10.1016/j.cell.2009.06.049; Wittmann M, 2009, J NEUROSCI, V29, P14687, DOI 10.1523/JNEUROSCI.1160-09.2009; Wong DS, 2004, J BIOL CHEM, V279, P55667, DOI 10.1074/jbc.M408174200; Wu H, 2010, SCIENCE, V329, P444, DOI 10.1126/science.1190485; Wu JI, 2007, NEURON, V56, P94, DOI 10.1016/j.neuron.2007.08.021; Wu JI, 2009, CELL, V136, P200, DOI 10.1016/j.cell.2009.01.009; Yang XJ, 2008, NAT REV MOL CELL BIO, V9, P206, DOI 10.1038/nrm2346; Yasui DH, 2007, P NATL ACAD SCI USA, V104, P19416, DOI 10.1073/pnas.0707442104; Yeo M, 2005, SCIENCE, V307, P596, DOI 10.1126/science.1100801; Yoo AS, 2009, CURR OPIN NEUROBIOL, V19, P120, DOI 10.1016/j.conb.2009.04.006; Zhou ZL, 2006, NEURON, V52, P255, DOI 10.1016/j.neuron.2006.09.037	100	131	134	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2010	13	11					1330	1337		10.1038/nn.2671	http://dx.doi.org/10.1038/nn.2671			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	673KI	20975757				2022-12-28	WOS:000283658200010
J	Rouaux, C; Arlotta, P				Rouaux, Caroline; Arlotta, Paola			Fezf2 directs the differentiation of corticofugal neurons from striatal progenitors in vivo	NATURE NEUROSCIENCE			English	Article							SUBTYPE-SPECIFIC GENES; SPECIFICATION	In the developing cerebral cortex, cell-extrinsic and cell-intrinsic signals govern the establishment of neuron subtype-specific identity. Here we show that, within the niche of the striatum, the expression of a single transcription factor, Fezf2, is sufficient to generate corticofugal neurons from progenitors fated to become medium spiny neurons. This demonstrates that a specific population of cortical projection neurons can be directed to differentiate outside of the cortex by cell-autonomous signaling.	[Rouaux, Caroline; Arlotta, Paola] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Regenerat Med, Boston, MA 02115 USA; [Rouaux, Caroline; Arlotta, Paola] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Neurosurg, Boston, MA USA; [Arlotta, Paola] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Arlotta, Paola] Harvard Univ, Harvard Stem Cell Inst, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard University	Arlotta, P (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Regenerat Med, Boston, MA 02115 USA.	paola_arlotta@hms.harvard.edu	Rouaux, Caroline/O-1712-2017	Rouaux, Caroline/0000-0002-5724-2903	US National Institutes of Health [NS062849]; Spastic Paraplegia Foundation; Harvard Stem Cell Institute; Harvard NeuroDiscovery Center; ALS Association; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS062849] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Spastic Paraplegia Foundation; Harvard Stem Cell Institute; Harvard NeuroDiscovery Center; ALS Association; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank J. Macklis (Harvard University) for reagents and advice; E. Abdel-Azim, G. Srubek-Tomassy, F. Zhang and S. Lodato for their comments; R. Hevner, (University of Washington), C. Lois (M. I. T.), K. Campbell (University of Cincinnati) and Q. Ma (Harvard Medical School) for generous sharing of antibodies, probes and expression vectors; and A. Meleski, A. Merlino and Z. Trayes-Gibson for technical support. This work was partially supported by grants to P. A. from the US National Institutes of Health (NS062849), the Spastic Paraplegia Foundation, the Harvard Stem Cell Institute and the Harvard NeuroDiscovery Center to P. A.; C. R. was partially supported by a Milton-Safenowitz postdoctoral fellowship from the ALS Association.	Arlotta P, 2005, NEURON, V45, P207, DOI 10.1016/j.neuron.2004.12.036; Campbell K, 1995, NEURON, V15, P1259, DOI 10.1016/0896-6273(95)90006-3; Chen B, 2005, P NATL ACAD SCI USA, V102, P17184, DOI 10.1073/pnas.0508732102; Chen JG, 2005, P NATL ACAD SCI USA, V102, P17792, DOI 10.1073/pnas.0509032102; FISHELL G, 1995, DEVELOPMENT, V121, pU4; Magrassi L, 1998, DEVELOPMENT, V125, P2847; Mattar P, 2008, MOL CELL BIOL, V28, P1456, DOI 10.1128/MCB.01510-07; Molyneaux BJ, 2005, NEURON, V47, P817, DOI 10.1016/j.neuron.2005.08.030; Molyneaux BJ, 2007, NAT REV NEUROSCI, V8, P427, DOI 10.1038/nrn2151; Molyneaux BJ, 2009, J NEUROSCI, V29, P12343, DOI 10.1523/JNEUROSCI.6108-08.2009; Rallu M, 2002, NAT REV NEUROSCI, V3, P943, DOI 10.1038/nrn989; Schuurmans C, 2002, CURR OPIN NEUROBIOL, V12, P26, DOI 10.1016/S0959-4388(02)00286-6; Schuurmans C, 2004, EMBO J, V23, P2892, DOI 10.1038/sj.emboj.7600278; Wichterle H, 2001, DEVELOPMENT, V128, P3759	14	80	82	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2010	13	11					1345	1347		10.1038/nn.2658	http://dx.doi.org/10.1038/nn.2658			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	673KI	20953195	Green Accepted			2022-12-28	WOS:000283658200012
J	Lovinger, DM				Lovinger, David M.			Endocannabinoids rein in pain outside the brain	NATURE NEUROSCIENCE			English	Editorial Material							INITIATION; EFFICACY; BLOCKADE		NIAAA, Lab Integrat Neurosci, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)	Lovinger, DM (corresponding author), NIAAA, Lab Integrat Neurosci, Bethesda, MD USA.	lovindav@mail.nih.gov			NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000407] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		Agarwal N, 2007, NAT NEUROSCI, V10, P870, DOI 10.1038/nn1916; Calignano A, 1998, NATURE, V394, P277, DOI 10.1038/28393; Christensen R, 2007, LANCET, V370, P1706, DOI 10.1016/S0140-6736(07)61721-8; Clapper JR, 2010, NAT NEUROSCI, V13, P1265, DOI 10.1038/nn.2632; Di Marzo V, 2001, NATURE, V410, P822, DOI 10.1038/35071088; Engeli S, 2005, DIABETES, V54, P2838, DOI 10.2337/diabetes.54.10.2838; GROBLEWSKI T, 2010, INT CANN RES SOC ABS, V38; Kinsey SG, 2009, J PHARMACOL EXP THER, V330, P902, DOI 10.1124/jpet.109.155465; Kunos G, 2009, TRENDS PHARMACOL SCI, V30, P1, DOI 10.1016/j.tips.2008.10.001; Marrs WR, 2010, NAT NEUROSCI, V13, P951, DOI 10.1038/nn.2601; Tam J, 2010, J CLIN INVEST, V120, P2953, DOI 10.1172/JCI42551; Walker JM, 2005, HANDB EXP PHARMACOL, V168, P509	12	2	2	0	3	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2010	13	10					1155	1156		10.1038/nn1010-1155	http://dx.doi.org/10.1038/nn1010-1155			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	654MB	20877276	Green Accepted			2022-12-28	WOS:000282171300003
J	Losonczy, A; Zemelman, BV; Vaziri, A; Magee, JC				Losonczy, Attila; Zemelman, Boris V.; Vaziri, Alipasha; Magee, Jeffrey C.			Network mechanisms of theta related neuronal activity in hippocampal CA1 pyramidal neurons	NATURE NEUROSCIENCE			English	Article							PHASE-PRECESSION; UNIT-ACTIVITY; GABA RELEASE; PLACE CELLS; OSCILLATIONS; DYNAMICS; INFORMATION; COMPUTATION; INHIBITION; MODULATION	Although hippocampal theta oscillations represent a prime example of temporal coding in the mammalian brain, little is known about the specific biophysical mechanisms. Intracellular recordings support a particular abstract oscillatory interference model of hippocampal theta activity, the soma-dendrite interference model. To gain insight into the cellular and circuit level mechanisms of theta activity, we implemented a similar form of interference using the actual hippocampal network in mice in vitro. We found that pairing increasing levels of phasic dendritic excitation with phasic stimulation of perisomatic projecting inhibitory interneurons induced a somatic polarization and action potential timing profile that reproduced most common features. Alterations in the temporal profile of inhibition were required to fully capture all features. These data suggest that theta-related place cell activity is generated through an interaction between a phasic dendritic excitation and a phasic perisomatic shunting inhibition delivered by interneurons, a subset of which undergo activity-dependent presynaptic modulation.	[Zemelman, Boris V.; Vaziri, Alipasha; Magee, Jeffrey C.] Howard Hughes Med Inst, Ashburn, VA USA; [Losonczy, Attila] Columbia Univ, Dept Neurosci, New York, NY USA	Howard Hughes Medical Institute; Columbia University	Magee, JC (corresponding author), Howard Hughes Med Inst, Janelia Farm Res Campus, Ashburn, VA USA.	mageej@janelia.hhmi.org		Zemelman, Boris/0000-0003-2463-4887	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Ali AB, 2010, EUR J NEUROSCI, V31, P1196, DOI 10.1111/j.1460-9568.2010.07165.x; Andrasfalvy BK, 2010, P NATL ACAD SCI USA, V107, P11981, DOI 10.1073/pnas.1006620107; Atasoy D, 2008, J NEUROSCI, V28, P7025, DOI 10.1523/JNEUROSCI.1954-08.2008; BLAND BH, 1986, PROG NEUROBIOL, V26, P1, DOI 10.1016/0301-0082(86)90019-5; Bose A, 2000, J COMPUT NEUROSCI, V9, P5, DOI 10.1023/A:1008976210366; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; Chance FS, 2002, NEURON, V35, P773, DOI 10.1016/S0896-6273(02)00820-6; Dave AS, 2000, SCIENCE, V290, P812, DOI 10.1126/science.290.5492.812; Freund TF, 2007, NEURON, V56, P33, DOI 10.1016/j.neuron.2007.09.012; Grieger JC, 2006, NAT PROTOC, V1, P1412, DOI 10.1038/nprot.2006.207; Harris KD, 2002, NATURE, V417, P738, DOI 10.1038/nature00808; Harvey CD, 2009, NATURE, V461, P941, DOI 10.1038/nature08499; Hasselmo ME, 2005, NEURAL NETWORKS, V18, P1172, DOI 10.1016/j.neunet.2005.08.007; Hefft S, 2005, NAT NEUROSCI, V8, P1319, DOI 10.1038/nn1542; Hippenmeyer S, 2005, PLOS BIOL, V3, P878, DOI 10.1371/journal.pbio.0030159; HOPFIELD JJ, 1995, NATURE, V376, P33, DOI 10.1038/376033a0; Jensen O, 1996, LEARN MEMORY, V3, P279, DOI 10.1101/lm.3.2-3.279; Kamondi A, 1998, HIPPOCAMPUS, V8, P244, DOI 10.1002/(SICI)1098-1063(1998)8:3<244::AID-HIPO7>3.0.CO;2-J; Katona I, 1999, J NEUROSCI, V19, P4544; Klausberger T, 2005, J NEUROSCI, V25, P9782, DOI 10.1523/JNEUROSCI.3269-05.2005; Kleinfeld D, 1999, SOMATOSENS MOT RES, V16, P69, DOI 10.1080/08990229970528; LAURENT G, 1994, SCIENCE, V265, P1872, DOI 10.1126/science.265.5180.1872; Lengyel M, 2003, HIPPOCAMPUS, V13, P700, DOI 10.1002/hipo.10116; Lisman JE, 2005, NEURON, V46, P703, DOI 10.1016/j.neuron.2005.05.002; Losonczy A, 2006, NEURON, V50, P291, DOI 10.1016/j.neuron.2006.03.016; Losonczy A, 2004, P NATL ACAD SCI USA, V101, P1362, DOI 10.1073/pnas.0304752101; Magee JC, 2001, J NEUROPHYSIOL, V86, P528, DOI 10.1152/jn.2001.86.1.528; Margrie TW, 2003, J PHYSIOL-LONDON, V546, P363, DOI 10.1113/jphysiol.2002.031245; Maurer AP, 2007, TRENDS NEUROSCI, V30, P325, DOI 10.1016/j.tins.2007.05.002; MCNAUGHTON BL, 1983, EXP BRAIN RES, V52, P41; Mehta MR, 2002, NATURE, V417, P741, DOI 10.1038/nature00807; Mitchell SJ, 2003, NEURON, V38, P433, DOI 10.1016/S0896-6273(03)00200-9; Mizuseki K, 2009, NEURON, V64, P267, DOI 10.1016/j.neuron.2009.08.037; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; Redish AD, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-05-j0004.2001; Robbe D, 2006, NAT NEUROSCI, V9, P1526, DOI 10.1038/nn1801; Robbe D, 2009, J NEUROSCI, V29, P12597, DOI 10.1523/JNEUROSCI.2407-09.2009; Royer S, 2010, EUR J NEUROSCI, V31, P2279, DOI 10.1111/j.1460-9568.2010.07250.x; Salinas E, 2001, NAT REV NEUROSCI, V2, P539, DOI 10.1038/35086012; Schmidt R, 2009, J NEUROSCI, V29, P13232, DOI 10.1523/JNEUROSCI.2270-09.2009; Skaggs WE, 1996, HIPPOCAMPUS, V6, P149, DOI 10.1002/(SICI)1098-1063(1996)6:2<149::AID-HIPO6>3.0.CO;2-K; Somogyi P, 1998, BRAIN RES REV, V26, P113, DOI 10.1016/S0165-0173(97)00061-1; Takahashi H, 2009, NEURON, V62, P102, DOI 10.1016/j.neuron.2009.03.007; Tsodyks MV, 1996, HIPPOCAMPUS, V6, P271, DOI 10.1002/(SICI)1098-1063(1996)6:3<271::AID-HIPO5>3.3.CO;2-Q; Vaziri A, 2008, P NATL ACAD SCI USA, V105, P20221, DOI 10.1073/pnas.0810636105; Wallenstein GV, 1997, J NEUROPHYSIOL, V78, P393, DOI 10.1152/jn.1997.78.1.393; Wilson RI, 2001, NATURE, V410, P588, DOI 10.1038/35069076	48	71	71	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2010	13	8					967	U25		10.1038/nn.2597	http://dx.doi.org/10.1038/nn.2597			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	632DK	20639875	Green Accepted			2022-12-28	WOS:000280400600015
J	Varga, C; Lee, SY; Soltesz, I				Varga, Csaba; Lee, Soo Yeun; Soltesz, Ivan			Target-selective GABAergic control of entorhinal cortex output	NATURE NEUROSCIENCE			English	Article							RAT; HIPPOCAMPUS; CELLS	The medial entorhinal cortex (MEC) is a major center for spatial navigation and memory. We found that cannabinoid type 1 receptor-expressing GABAergic basket cells selectively innervated principal cells in layer II of the rat MEC that projected outside the hippocampus but avoided neighboring cells that give rise to the perforant pathway to the dentate gyrus. These results indicate that the organization of GABAergic microcircuits reflects the long-distance axonal targets of principal neurons.	[Varga, Csaba; Lee, Soo Yeun; Soltesz, Ivan] Univ Calif Irvine, Dept Anat & Neurobiol, Irvine, CA 92717 USA	University of California System; University of California Irvine	Varga, C (corresponding author), Univ Calif Irvine, Dept Anat & Neurobiol, Irvine, CA 92717 USA.	cvarga@uci.edu		Varga, Csaba/0000-0002-9188-1282	US National Institutes of Health [NS35915]; American Epilepsy Society; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R29NS035915, R01NS035915, R37NS035915] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Epilepsy Society; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank R. Zhu and M. Cid for technical assistance and I. Sears-Kraxberger and H.S. Keirstead for their generous support with electron microscopy. This work was supported by the US National Institutes of Health grant NS35915 (I.S.) and the American Epilepsy Society (S.Y.L.).	Adelmann G, 1996, ANAT EMBRYOL, V193, P481; Bodor AL, 2005, J NEUROSCI, V25, P6845, DOI 10.1523/JNEUROSCI.0442-05.2005; Brown SP, 2009, NATURE, V457, P1133, DOI 10.1038/nature07658; Chin J, 2007, J NEUROSCI, V27, P2727, DOI 10.1523/JNEUROSCI.3758-06.2007; Deng PY, 2009, NEURON, V63, P230, DOI 10.1016/j.neuron.2009.06.022; Freund TF, 2007, NEURON, V56, P33, DOI 10.1016/j.neuron.2007.09.012; Fujimaru Y, 1996, NEUROSCI RES, V24, P329, DOI 10.1016/0168-0102(95)01008-4; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Jinno S, 2007, J NEUROSCI, V27, P8790, DOI 10.1523/JNEUROSCI.1847-07.2007; Kano M, 2009, PHYSIOL REV, V89, P309, DOI 10.1152/physrev.00019.2008; Mizuseki K, 2009, NEURON, V64, P267, DOI 10.1016/j.neuron.2009.08.037; Solstad T, 2008, SCIENCE, V322, P1865, DOI 10.1126/science.1166466; Somogyi J, 2004, EUR J NEUROSCI, V19, P552, DOI 10.1111/j.0953-816X.2003.03091.x; STEWARD O, 1976, J COMP NEUROL, V169, P347, DOI 10.1002/cne.901690306; van Strien NM, 2009, NAT REV NEUROSCI, V10, P272, DOI 10.1038/nrn2614	15	143	144	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2010	13	7					822	824		10.1038/nn.2570	http://dx.doi.org/10.1038/nn.2570			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	615YF	20512133	Green Submitted, Green Accepted			2022-12-28	WOS:000279173900013
J	Grandl, J; Kim, SE; Uzzell, V; Bursulaya, B; Petrus, M; Bandell, M; Patapoutian, A				Grandl, Joerg; Kim, Sung Eun; Uzzell, Valerie; Bursulaya, Badry; Petrus, Matt; Bandell, Michael; Patapoutian, Ardem			Temperature-induced opening of TRPV1 ion channel is stabilized by the pore domain	NATURE NEUROSCIENCE			English	Article							CAPSAICIN RECEPTOR; HEAT ACTIVATION; COLD RECEPTOR; THERMOSENSATION; VOLTAGE; SENSITIVITY; SENSATION; STIMULI; THERMODYNAMICS; REVEALS	TRPV1 is the founding and best-studied member of the family of temperature-activated transient receptor potential ion channels (thermoTRPs). Voltage, chemicals and heat allosterically gate TRPV1. Molecular determinants of TRPV1 activation by capsaicin, allicin, acid, ammonia and voltage have been identified. However, the structures and mechanisms mediating TRPV1's pronounced temperature sensitivity remain unclear. Recent studies of the related channel TRPV3 identified residues in the pore region that are required for heat activation. We used both random and targeted mutagenesis screens of rat TRPV1 and identified point mutations in the outer pore region that specifically impair temperature activation. Single-channel analysis indicated that TRPV1 mutations disrupted heat sensitivity by ablating long channel openings, which are part of the temperature-gating pathway. We propose that sequential occupancy of short and long open states on activation provides a mechanism for enhancing temperature sensitivity. Our results suggest that the outer pore is important for the heat sensitivity of thermoTRPs.	[Grandl, Joerg; Kim, Sung Eun; Uzzell, Valerie; Patapoutian, Ardem] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; [Bursulaya, Badry; Petrus, Matt; Bandell, Michael; Patapoutian, Ardem] Novartis Res Fdn, Genom Inst, San Diego, CA USA	Scripps Research Institute; Novartis	Patapoutian, A (corresponding author), Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA.	apatapou@gnf.org	KIM, SUNG EUN/E-4918-2011	Grandl, Jorg/0000-0001-7179-7609	US National Institutes of Health; Novartis Research Foundation; American Heart Association; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046303] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Novartis Research Foundation; American Heart Association(American Heart Association); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank A. Marelli and T. Orth for preparing mini-prep DNA, M. Caterina for providing rat TRPV1 plasmid DNA, and B. Coste for critical reading of the manuscript. This research was supported by the US National Institutes of Health, the Novartis Research Foundation and a fellowship to J.G. from the American Heart Association.	Ahern GP, 2005, J NEUROSCI, V25, P5109, DOI 10.1523/JNEUROSCI.0237-05.2005; Brauchi S, 2006, J NEUROSCI, V26, P4835, DOI 10.1523/JNEUROSCI.5080-05.2006; Brauchi S, 2004, P NATL ACAD SCI USA, V101, P15494, DOI 10.1073/pnas.0406773101; Brauchi S, 2007, P NATL ACAD SCI USA, V104, P10246, DOI 10.1073/pnas.0703420104; Caterina MJ, 2007, AM J PHYSIOL-REG I, V292, pR64, DOI 10.1152/ajpregu.00446.2006; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Davis JB, 2000, NATURE, V405, P183, DOI 10.1038/35012076; Dhaka A, 2006, ANNU REV NEUROSCI, V29, P135, DOI 10.1146/annurev.neuro.29.051605.112958; Dhaka A, 2009, J NEUROSCI, V29, P153, DOI 10.1523/JNEUROSCI.4901-08.2009; Gavva NR, 2004, J BIOL CHEM, V279, P20283, DOI 10.1074/jbc.M312577200; Grandl J, 2008, NAT NEUROSCI, V11, P1007, DOI 10.1038/nn.2169; Guler AD, 2002, J NEUROSCI, V22, P6408; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Hui KK, 2003, BIOPHYS J, V84, P2957, DOI 10.1016/S0006-3495(03)70022-8; Jordt SE, 2000, P NATL ACAD SCI USA, V97, P8134, DOI 10.1073/pnas.100129497; Jordt SE, 2002, CELL, V108, P421, DOI 10.1016/S0092-8674(02)00637-2; Kern D, 2003, CURR OPIN STRUC BIOL, V13, P748, DOI 10.1016/j.sbi.2003.10.008; Latorre R, 2007, CELL CALCIUM, V42, P427, DOI 10.1016/j.ceca.2007.04.004; Liu BY, 2003, BIOPHYS J, V85, P2988, DOI 10.1016/S0006-3495(03)74719-5; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Matta JA, 2007, J PHYSIOL-LONDON, V585, P469, DOI 10.1113/jphysiol.2007.144287; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Myers BR, 2008, NEURON, V58, P362, DOI 10.1016/j.neuron.2008.04.012; Nilius B, 2005, J PHYSIOL-LONDON, V567, P35, DOI 10.1113/jphysiol.2005.088377; Peier AM, 2002, SCIENCE, V296, P2046, DOI 10.1126/science.1073140; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; Premkumar LS, 2002, J PHYSIOL-LONDON, V545, P107, DOI 10.1113/jphysiol.2002.016352; Ryu SJ, 2007, J NEUROSCI, V27, P12797, DOI 10.1523/JNEUROSCI.2324-07.2007; Salazar H, 2008, NAT NEUROSCI, V11, P255, DOI 10.1038/nn2056; Smith GD, 2002, NATURE, V418, P186, DOI 10.1038/nature00894; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; Talavera K, 2005, NATURE, V438, P1022, DOI 10.1038/nature04248; Talavera K, 2008, TRENDS NEUROSCI, V31, P287, DOI 10.1016/j.tins.2008.03.002; Togashi K, 2006, EMBO J, V25, P1804, DOI 10.1038/sj.emboj.7601083; Tominaga M, 1998, NEURON, V21, P531, DOI 10.1016/S0896-6273(00)80564-4; Voets T, 2004, NATURE, V430, P748, DOI 10.1038/nature02732; Voets T, 2007, NAT CHEM BIOL, V3, P174, DOI 10.1038/nchembio862; Xu HX, 2002, NATURE, V418, P181, DOI 10.1038/nature00882; Yang F, 2010, P NATL ACAD SCI USA, V107, P7083, DOI 10.1073/pnas.1000357107	40	148	149	3	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2010	13	6					708	714		10.1038/nn.2552	http://dx.doi.org/10.1038/nn.2552			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	600QY	20414199	Green Accepted			2022-12-28	WOS:000278003300015
J	Dave, KA				Dave, Kathleen A.			Regulating brain size	NATURE NEUROSCIENCE			English	Editorial Material																			0	0	0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2010	13	5					531	531		10.1038/nn0510-531	http://dx.doi.org/10.1038/nn0510-531			1	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	588JM	20421899	Bronze			2022-12-28	WOS:000277065700007
J	Xu, SJ; Jiang, WC; Poo, MM; Dan, Y				Xu, Shengjin; Jiang, Wanchen; Poo, Mu-ming; Dan, Yang			Activity recall in a visual cortical ensemble	NATURE NEUROSCIENCE			English	Article							BARREL CORTEX; SYNAPTIC MODIFICATION; CORRELATED ACTIVITY; PREFRONTAL CORTEX; HUMAN HIPPOCAMPUS; AUDITORY-CORTEX; SINGLE NEURONS; OWL MONKEYS; PLASTICITY; SEQUENCES	Cue-triggered recall of learned temporal sequences is an important cognitive function that has been attributed to higher brain areas. Here recordings in both anesthetized and awake rats demonstrate that after repeated stimulation with a moving spot that evoked sequential firing of an ensemble of primary visual cortex (V1) neurons, just a brief flash at the starting point of the motion path was sufficient to evoke a sequential firing pattern that reproduced the activation order evoked by the moving spot. The speed of recalled spike sequences may reflect the internal dynamics of the network rather than the motion speed. In awake rats, such recall was observed during a synchronized ('quiet wakeful') brain state having large-amplitude, low-frequency local field potential (LFP) but not in a desynchronized ('active') state having low-amplitude, high-frequency LFP. Such conditioning-enhanced, cue-evoked sequential spiking of a V1 ensemble may contribute to experience-based perceptual inference in a brain state-dependent manner.	[Xu, Shengjin; Jiang, Wanchen; Poo, Mu-ming] Chinese Acad Sci, Shanghai Inst Biol Sci, State Key Lab Neurosci, Inst Neurosci, Shanghai, Peoples R China; [Xu, Shengjin; Jiang, Wanchen] Chinese Acad Sci, Grad Sch, Shanghai, Peoples R China; [Poo, Mu-ming; Dan, Yang] Univ Calif Berkeley, Dept Mol & Cell Biol, Div Neurobiol, Helen Wills Inst Neurosci, Berkeley, CA 94720 USA; [Dan, Yang] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley	Poo, MM (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, State Key Lab Neurosci, Inst Neurosci, Shanghai, Peoples R China.	mpoo@berkeley.edu	Xu, Shengjin/G-2594-2016	Dan, Yang/0000-0002-3818-877X	973 Program [2011CBA00400]; SSSTC [GJHZ0902]; Chinese Academy of Sciences [KSCX2-YW-R-29]; Howard Hughes Medical Institute; US National Institutes of Health [NS036999]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036999] Funding Source: NIH RePORTER	973 Program(National Basic Research Program of China); SSSTC; Chinese Academy of Sciences(Chinese Academy of Sciences); Howard Hughes Medical Institute(Howard Hughes Medical Institute); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank G. Buzsaki, H. D. Lv and H. S. Yao for comments and suggestions. This work was supported by 973 Program (2011CBA00400), SSSTC Program GJHZ0902 and the Knowledge Innovation Program of the Chinese Academy of Sciences (KSCX2-YW-R-29). Y.D. was supported in part by the Howard Hughes Medical Institute and M.-m.P. by a grant from the US National Institutes of Health (NS036999).	Abbott LF, 1996, CEREB CORTEX, V6, P406, DOI 10.1093/cercor/6.3.406; AHISSAR E, 1992, SCIENCE, V257, P1412, DOI 10.1126/science.1529342; Bezdudnaya T, 2006, NEURON, V49, P421, DOI 10.1016/j.neuron.2006.01.010; Bi GQ, 2001, ANNU REV NEUROSCI, V24, P139, DOI 10.1146/annurev.neuro.24.1.139; Bringuier V, 1999, SCIENCE, V283, P695, DOI 10.1126/science.283.5402.695; Buckner RL, 2010, ANNU REV PSYCHOL, V61, P27, DOI 10.1146/annurev.psych.60.110707.163508; CHIBA AA, 1994, BEHAV NEURAL BIOL, V61, P123, DOI 10.1016/S0163-1047(05)80065-2; Crochet S, 2006, NAT NEUROSCI, V9, P608, DOI 10.1038/nn1690; Davidson TJ, 2009, NEURON, V63, P497, DOI 10.1016/j.neuron.2009.07.027; Diba K, 2007, NAT NEUROSCI, V10, P1241, DOI 10.1038/nn1961; Ego-Stengel V, 2001, J NEUROPHYSIOL, V86, P422, DOI 10.1152/jn.2001.86.1.422; Euston DR, 2007, SCIENCE, V318, P1147, DOI 10.1126/science.1148979; FIORENTINI A, 1980, NATURE, V287, P43, DOI 10.1038/287043a0; Fortin NJ, 2002, NAT NEUROSCI, V5, P458, DOI 10.1038/nn834; Friston KJ, 2005, PHILOS T R SOC B, V360, P815, DOI 10.1098/rstb.2005.1622; Froemke RC, 2006, J NEUROPHYSIOL, V95, P1620, DOI 10.1152/jn.00910.2005; Fu YX, 2002, SCIENCE, V296, P1999, DOI 10.1126/science.1070521; Furmanski CS, 2004, CURR BIOL, V14, P573, DOI 10.1016/j.cub.2004.03.032; Gelbard-Sagiv H, 2008, SCIENCE, V322, P96, DOI 10.1126/science.1164685; Gervasoni D, 2004, J NEUROSCI, V24, P11137, DOI 10.1523/JNEUROSCI.3524-04.2004; Grinvald A, 2004, NAT REV NEUROSCI, V5, P874, DOI 10.1038/nrn1536; Han F, 2008, NEURON, V60, P321, DOI 10.1016/j.neuron.2008.08.026; Hebb Donald O., 1949, ORG BEHAV; HUGHES A, 1979, VISION RES, V19, P569, DOI 10.1016/0042-6989(79)90143-3; Ji DY, 2007, NAT NEUROSCI, V10, P100, DOI 10.1038/nn1825; Karlsson MP, 2009, NAT NEUROSCI, V12, P913, DOI 10.1038/nn.2344; KARNI A, 1991, P NATL ACAD SCI USA, V88, P4966, DOI 10.1073/pnas.88.11.4966; Kersten D, 2004, ANNU REV PSYCHOL, V55, P271, DOI 10.1146/annurev.psych.55.090902.142005; Kesner RP, 2002, BEHAV NEUROSCI, V116, P286, DOI 10.1037//0735-7044.116.2.286; Kimura F, 1999, EUR J NEUROSCI, V11, P3597, DOI 10.1046/j.1460-9568.1999.00779.x; Lehn H, 2009, J NEUROSCI, V29, P3475, DOI 10.1523/JNEUROSCI.5370-08.2009; Li W, 2004, NAT NEUROSCI, V7, P651, DOI 10.1038/nn1255; Lisman J, 2009, PHILOS T R SOC B, V364, P1193, DOI 10.1098/rstb.2008.0316; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; METHERATE R, 1993, SYNAPSE, V14, P132, DOI 10.1002/syn.890140206; MILLER KD, 1989, P NATL ACAD SCI USA, V86, P5183, DOI 10.1073/pnas.86.13.5183; Nadasdy Z, 1999, J NEUROSCI, V19, P9497; Niell CM, 2010, NEURON, V65, P472, DOI 10.1016/j.neuron.2010.01.033; O'Neill J, 2008, NAT NEUROSCI, V11, P209, DOI 10.1038/nn2037; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Poulet JFA, 2008, NATURE, V454, P881, DOI 10.1038/nature07150; Rao RPN, 2000, ADV NEUR IN, V12, P164; RECANZONE GH, 1993, J NEUROSCI, V13, P87; RECANZONE GH, 1992, J NEUROPHYSIOL, V67, P1031, DOI 10.1152/jn.1992.67.5.1031; Ribeiro S, 2004, PLOS BIOL, V2, P126, DOI 10.1371/journal.pbio.0020024; Schoups A, 2001, NATURE, V412, P549, DOI 10.1038/35087601; Shulz DE, 2000, NATURE, V403, P549, DOI 10.1038/35000586; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517; Yao HS, 2001, NEURON, V32, P315, DOI 10.1016/S0896-6273(01)00460-3; Yu AJ, 2005, NEURON, V46, P681, DOI 10.1016/j.neuron.2005.04.026	50	98	98	1	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2012	15	3					449	U141		10.1038/nn.3036	http://dx.doi.org/10.1038/nn.3036			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	899CY	22267160	Green Accepted, Green Submitted			2022-12-28	WOS:000300793100019
J	Cho, JH; Bayazitov, IT; Meloni, EG; Myers, KM; Carlezon, WA; Zakharenko, SS; Bolshakov, VY				Cho, Jun-Hyeong; Bayazitov, Ildar T.; Meloni, Edward G.; Myers, Karyn M.; Carlezon, William A., Jr.; Zakharenko, Stanislav S.; Bolshakov, Vadim Y.			Coactivation of thalamic and cortical pathways induces input timing-dependent plasticity in amygdala	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; FEAR CONDITIONING PATHWAYS; MEDIAL GENICULATE-BODY; LATERAL AMYGDALA; AUDITORY-CORTEX; SYNAPTIC PLASTICITY; EXTRACELLULAR RECORDINGS; GLUTAMATE UPTAKE; MEMORY FORMATION; TEMPORAL CORTEX	Long-term synaptic enhancements in cortical and thalamic auditory inputs to the lateral nucleus of the amygdala (LAn) mediate encoding of conditioned fear memory. It is not known, however, whether the convergent auditory conditioned stimulus (CSa) pathways interact with each other to produce changes in their synaptic function. We found that continuous paired stimulation of thalamic and cortical auditory inputs to the LAn with the interstimulus delay approximately mimicking a temporal pattern of their activation in behaving animals during auditory fear conditioning resulted in persistent potentiation of synaptic transmission in the cortico-amygdala pathway in rat brain slices. This form of input timing-dependent plasticity (ITDP) in cortical input depends on inositol 1,4,5-trisphosphate (InsP(3))-sensitive Ca2+ release from internal stores and postsynaptic Ca2+ influx through calcium-permeable kainate receptors during its induction. ITDP in the auditory projections to the LAn, determined by characteristics of presynaptic activity patterns, may contribute to the encoding of the complex CSa.	[Cho, Jun-Hyeong; Meloni, Edward G.; Myers, Karyn M.; Carlezon, William A., Jr.; Bolshakov, Vadim Y.] Harvard Univ, McLean Hosp, Sch Med, Dept Psychiat, Belmont, MA USA; [Bayazitov, Ildar T.; Zakharenko, Stanislav S.] St Jude Childrens Res Hosp, Dept Dev Neurobiol, Memphis, TN 38105 USA	Harvard University; McLean Hospital; St Jude Children's Research Hospital	Bolshakov, VY (corresponding author), Harvard Univ, McLean Hosp, Sch Med, Dept Psychiat, Belmont, MA USA.	vadimb@mclean.harvard.edu	Zakharenko, Stanislav/D-3287-2013; Cho, Jun-Hyeong/GXM-7966-2022	Zakharenko, Stanislav/0000-0001-8115-202X; Cho, Jun-Hyeong/0000-0002-6844-3583; /0000-0002-4162-3947	US National Institutes of Health [MH083011, MH090464, MH079079]; National Alliance for Research on Schizophrenia and Depression; Whitehall Foundation; US Army [W81XWH-08-2-0126]; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH083011, R01MH090464, R01MH079079] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Alliance for Research on Schizophrenia and Depression(NARSAD); Whitehall Foundation; US Army(United States Department of DefenseUnited States Army); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank Y. Li and K. Tully for constructive discussions. This study was supported by US National Institutes of Health grants MH083011, MH090464 (V. Y. B.) and MH079079 (S.S.Z.), the National Alliance for Research on Schizophrenia and Depression (V. Y. B.), Whitehall Foundation (V. Y. B.), and US Army Medical Research Acquisition Activity grant #W81XWH-08-2-0126 (V. Y. B.).	Armony JL, 1997, CEREB CORTEX, V7, P157, DOI 10.1093/cercor/7.2.157; Asztely F, 1997, NEURON, V18, P281, DOI 10.1016/S0896-6273(00)80268-8; Bardo S, 2006, TRENDS PHARMACOL SCI, V27, P78, DOI 10.1016/j.tips.2005.12.008; Bauer EP, 2002, J NEUROSCI, V22, P5239, DOI 10.1523/JNEUROSCI.22-12-05239.2002; Bissiere S, 2003, NAT NEUROSCI, V6, P587, DOI 10.1038/nn1058; BORDI F, 1994, EXP BRAIN RES, V98, P275, DOI 10.1007/BF00228415; Bortolotto ZA, 1999, NATURE, V402, P297, DOI 10.1038/46290; BOWIE D, 1995, NEURON, V15, P453, DOI 10.1016/0896-6273(95)90049-7; Burnashev N, 1996, J PHYSIOL-LONDON, V496, P165, DOI 10.1113/jphysiol.1996.sp021674; CAMPEAU S, 1995, J NEUROSCI, V15, P2312, DOI 10.1523/JNEUROSCI.15-03-02312.1995; CLUGNET MC, 1990, J NEUROSCI, V10, P2818; Doyere V, 2003, EUR J NEUROSCI, V17, P2703, DOI 10.1046/j.1460-9568.2003.02707.x; Dudman JT, 2007, NEURON, V56, P866, DOI 10.1016/j.neuron.2007.10.020; Fi XF, 1996, SYNAPSE, V24, P115, DOI 10.1002/(SICI)1098-2396(199610)24:2<115::AID-SYN3>3.0.CO;2-I; Harvey CD, 2007, NATURE, V450, P1195, DOI 10.1038/nature06416; Huang YY, 1998, NEURON, V21, P169, DOI 10.1016/S0896-6273(00)80524-3; Humeau Y, 2005, NEURON, V45, P119, DOI 10.1016/j.neuron.2004.12.019; Humeau Y, 2003, NATURE, V426, P841, DOI 10.1038/nature02194; Johnson LR, 2008, FRONT NEURAL CIRCUIT, V2, DOI 10.3389/neuro.04.003.2008; Ko S, 2005, J NEUROSCI, V25, P977, DOI 10.1523/JNEUROSCI.4059-04.2005; Kodirov SA, 2006, P NATL ACAD SCI USA, V103, P15218, DOI 10.1073/pnas.0607131103; Koike M, 1997, NEUROSCI RES, V29, P27, DOI 10.1016/S0168-0102(97)00067-9; Lang EJ, 1997, J NEUROPHYSIOL, V77, P341, DOI 10.1152/jn.1997.77.1.341; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; LEDOUX JE, 1985, J COMP NEUROL, V242, P182, DOI 10.1002/cne.902420204; Li H, 2001, NAT NEUROSCI, V4, P612, DOI 10.1038/88432; Li P, 1999, NATURE, V397, P161, DOI 10.1038/16469; Li XF, 1996, LEARN MEMORY, V3, P229, DOI 10.1101/lm.3.2-3.229; Mahanty NK, 1998, NATURE, V394, P683, DOI 10.1038/29312; Maren S, 2004, NAT REV NEUROSCI, V5, P844, DOI 10.1038/nrn1535; MASCAGNI F, 1993, NEUROSCIENCE, V57, P697, DOI 10.1016/0306-4522(93)90016-9; McKernan MG, 1997, NATURE, V390, P607, DOI 10.1038/37605; Pare D, 2000, J NEUROSCI, V20, P2701; Quirk GJ, 1997, NEURON, V19, P613, DOI 10.1016/S0896-6273(00)80375-X; QUIRK GJ, 1995, NEURON, V15, P1029, DOI 10.1016/0896-6273(95)90092-6; Raymond CR, 2002, J NEUROPHYSIOL, V88, P249, DOI 10.1152/jn.2002.88.1.249; Richardson RJ, 2009, J NEUROSCI, V29, P6406, DOI 10.1523/JNEUROSCI.0258-09.2009; Rodrigues SM, 2002, J NEUROSCI, V22, P5219, DOI 10.1523/JNEUROSCI.22-12-05219.2002; Rogan MT, 1997, NATURE, V390, P604, DOI 10.1038/37601; ROMANSKI LM, 1993, CEREB CORTEX, V3, P515, DOI 10.1093/cercor/3.6.515; ROMANSKI LM, 1992, J NEUROSCI, V12, P4501; Rumpel S, 2005, SCIENCE, V308, P83, DOI 10.1126/science.1103944; Shin RM, 2006, NEURON, V52, P883, DOI 10.1016/j.neuron.2006.10.010; Shin RM, 2010, P NATL ACAD SCI USA, V107, P19073, DOI 10.1073/pnas.1009803107; Shumyatsky GP, 2005, CELL, V123, P697, DOI 10.1016/j.cell.2005.08.038; SUGITA S, 1993, J PHYSIOL-LONDON, V460, P705, DOI 10.1113/jphysiol.1993.sp019495; Tsvetkov E, 2004, NEURON, V41, P139, DOI 10.1016/S0896-6273(03)00800-6; Tsvetkov E, 2002, NEURON, V34, P289, DOI 10.1016/S0896-6273(02)00645-1; Tully K, 2007, P NATL ACAD SCI USA, V104, P14146, DOI 10.1073/pnas.0704621104; Wilding TJ, 2005, J NEUROSCI, V25, P9470, DOI 10.1523/JNEUROSCI.2826-05.2005	50	46	46	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2012	15	1					113	U145		10.1038/nn.2993	http://dx.doi.org/10.1038/nn.2993			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	866VO	22158512	Green Submitted, Green Accepted			2022-12-28	WOS:000298414400021
J	Bellone, C; Mameli, M; Luscher, C				Bellone, Camilla; Mameli, Manuel; Luescher, Christian			In utero exposure to cocaine delays postnatal synaptic maturation of glutamatergic transmission in the VTA	NATURE NEUROSCIENCE			English	Article							VENTRAL TEGMENTAL AREA; LONG-TERM DEPRESSION; TRANSPORTER KNOCKOUT MICE; PRENATAL COCAINE; NMDA RECEPTORS; DOPAMINE-TRANSPORTER; AMPA RECEPTORS; SUBUNIT COMPOSITION; MATERNAL TOXICITY; WORKING-MEMORY	Maternal exposure to cocaine may perturb fetal development and affect synaptic maturation in the offspring. However, the molecular mechanism underlying such changes remains elusive. We focused on the postnatal maturation of glutamatergic transmission onto ventral tegmental area dopamine neurons in the mouse. We found that, during the first postnatal week, transmission was dominated by calcium-permeable AMPA receptors and GluN2B-containing NMDA receptors. Subsequently, mGluR1 receptors drove synaptic insertion of calcium-impermeable AMPA receptors and GluN2A-containing NMDAR. When pregnant mice were exposed to cocaine, this glutamate receptor switch was delayed in offspring as a result of a direct effect of cocaine on the fetal dopamine transporter and impaired mGluR1 function. Finally, positive modulation of mGluR1 in vivo was sufficient to rescue maturation. These data identify the molecular target through which in utero cocaine delays postnatal synaptic maturation, reveal the underlying expression mechanism of this impairment and propose a potential rescue strategy.	[Bellone, Camilla; Mameli, Manuel; Luescher, Christian] Univ Geneva, Fac Med, Dept Basic Neurosci, Geneva, Switzerland; [Luescher, Christian] Univ Hosp Geneva, Dept Clin Neurosci, Neurol Clin, Geneva, Switzerland	University of Geneva; University of Geneva	Bellone, C (corresponding author), Univ Geneva, Fac Med, Dept Basic Neurosci, Geneva, Switzerland.	camilla.bellone@unige.ch; christian.luscher@unige.ch	Lüscher, Christian/A-2496-2011	Lüscher, Christian/0000-0001-7917-4596; Mameli, Manuel/0000-0002-0570-6964; bellone, camilla/0000-0002-6774-6275	Swiss National Science Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	We thank members of the Luscher laboratory M. Serafin and A. Holtmaat for critical reading of the manuscript. We thank H. H. Gu, who provided the DAT knock-in mouse line, and K. Huber, who provided the breeding pairs for the mGluR1 mutant mouse line. C. B. is an Ambizione fellow. This work was supported by the Swiss National Science Foundation.	Argilli E, 2008, J NEUROSCI, V28, P9092, DOI 10.1523/JNEUROSCI.1001-08.2008; Bellone C, 2006, NAT NEUROSCI, V9, P636, DOI 10.1038/nn1682; Bellone C, 2005, EUR J NEUROSCI, V21, P1280, DOI 10.1111/j.1460-9568.2005.03979.x; Bellone C, 2007, NEURON, V55, P779, DOI 10.1016/j.neuron.2007.07.035; Brill J, 2008, J NEUROSCI, V28, P13918, DOI 10.1523/JNEUROSCI.3229-08.2008; Brown MTC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015870; Cantrell AR, 2001, NAT REV NEUROSCI, V2, P397, DOI 10.1038/35077553; Chen R, 2006, P NATL ACAD SCI USA, V103, P9333, DOI 10.1073/pnas.0600905103; Clancy B, 2007, NEUROINFORMATICS, V5, P79, DOI 10.1385/NI:5:1:79; CONQUET F, 1994, NATURE, V372, P237, DOI 10.1038/372237a0; Crozatier C, 2003, DEV BRAIN RES, V147, P97, DOI 10.1016/j.devbrainres.2003.10.006; Fayyazuddin A, 2000, NEURON, V25, P683, DOI 10.1016/S0896-6273(00)81070-3; Frank DA, 2001, JAMA-J AM MED ASSOC, V285, P1613, DOI 10.1001/jama.285.12.1613; Friedman E, 1998, ANN NY ACAD SCI, V846, P238, DOI 10.1111/j.1749-6632.1998.tb09741.x; Gendle MH, 2004, NEUROTOXICOL TERATOL, V26, P319, DOI 10.1016/j.ntt.2003.12.001; GOLDEN GS, 1973, DEV BIOL, V33, P300, DOI 10.1016/0012-1606(73)90139-5; Guerriero RM, 2005, DEV NEUROSCI-BASEL, V27, P235, DOI 10.1159/000085997; Hall FS, 2009, NEUROSCIENCE, V162, P870, DOI 10.1016/j.neuroscience.2009.05.058; Hecht GS, 1998, BEHAV NEUROSCI, V112, P410, DOI 10.1037/0735-7044.112.2.410; Ho MTW, 2007, J NEUROSCI, V27, P11651, DOI 10.1523/JNEUROSCI.2671-07.2007; Hu ZL, 2004, J COMP NEUROL, V476, P301, DOI 10.1002/cne.20230; HUTCHINGS DE, 1989, NEUROTOXICOL TERATOL, V11, P65, DOI 10.1016/0892-0362(89)90087-1; Keller RW, 1996, NEUROSCI LETT, V205, P153, DOI 10.1016/0304-3940(96)12409-5; Kelly L, 2009, NAT NEUROSCI, V12, P593, DOI 10.1038/nn.2309; Khan ZU, 2000, NEUROSCIENCE, V100, P689, DOI 10.1016/S0306-4522(00)00274-8; Knoflach F, 2001, P NATL ACAD SCI USA, V98, P13402, DOI 10.1073/pnas.231358298; Linares TJ, 2006, J PEDIATR PSYCHOL, V31, P85, DOI 10.1093/jpepsy/jsj020; Mameli M, 2007, SCIENCE, V317, P530, DOI 10.1126/science.1142365; Mameli M, 2011, NAT NEUROSCI, V14, P414, DOI 10.1038/nn.2763; Mameli M, 2009, NAT NEUROSCI, V12, P1036, DOI 10.1038/nn.2367; Matta JA, 2011, NEURON, V70, P339, DOI 10.1016/j.neuron.2011.02.045; Mayes L, 2007, CHILD NEUROPSYCHOL, V13, P205, DOI 10.1080/09297040600888753; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; Paoletti P, 2007, CURR OPIN PHARMACOL, V7, P39, DOI 10.1016/j.coph.2006.08.011; Roberts AC, 2009, NEURON, V63, P342, DOI 10.1016/j.neuron.2009.06.016; Rocha BA, 2002, PSYCHOPHARMACOLOGY, V163, P221, DOI 10.1007/s00213-002-1140-0; Rocha BA, 1998, NAT NEUROSCI, V1, P132, DOI 10.1038/381; SCALZO FM, 1990, PHARMACOL BIOCHEM BE, V37, P371, DOI 10.1016/0091-3057(90)90350-Q; Schilstrom B, 2006, J NEUROSCI, V26, P8549, DOI 10.1523/JNEUROSCI.5179-05.2006; SHENG M, 1994, NATURE, V368, P144, DOI 10.1038/368144a0; SOBRIAN SK, 1995, MOL NEUROBIOL, V11, P121, DOI 10.1007/BF02740690; Stanwood GD, 2001, CEREB CORTEX, V11, P430, DOI 10.1093/cercor/11.5.430; Substance Abuse and Mental Health Services Administration, 2010, NSDUH SERIES; Substance Abuse and Mental Health Services Administration, 2010, HHS PUBL, VSMA 09- 4425; Thompson BL, 2009, NAT REV NEUROSCI, V10, P303, DOI 10.1038/nrn2598; Thompson BL, 2005, BEHAV BRAIN RES, V164, P107, DOI 10.1016/j.bbr.2005.06.010; Thomsen M, 2009, J PHARMACOL EXP THER, V331, P204, DOI 10.1124/jpet.109.156265; Tilley MR, 2009, NEUROREPORT, V20, P9, DOI 10.1097/WNR.0b013e32831b9ce4; Tozzi A, 2003, EUR J NEUROSCI, V18, P2133, DOI 10.1046/j.1460-9568.2003.02936.x; Trksak GH, 2007, NEUROTOXICOL TERATOL, V29, P570, DOI 10.1016/j.ntt.2007.06.003; ZHOU QY, 1995, NATURE, V374, P640, DOI 10.1038/374640a0	51	60	60	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2011	14	11					1439	U113		10.1038/nn.2930	http://dx.doi.org/10.1038/nn.2930			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	841NI	21964489				2022-12-28	WOS:000296518600020
J	Kohl, MM; Shipton, OA; Deacon, RM; Rawlins, JNP; Deisseroth, K; Paulsen, O				Kohl, Michael M.; Shipton, Olivia A.; Deacon, Robert M.; Rawlins, J. Nicholas P.; Deisseroth, Karl; Paulsen, Ole			Hemisphere-specific optogenetic stimulation reveals left-right asymmetry of hippocampal plasticity	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; RECEPTOR SUBUNIT EXPRESSION; SYNAPTIC PLASTICITY; SYNAPSES; ALLOCATION; NEURONS; CORTEX; RAT	Postsynaptic spines at CA3-CA1 synapses differ in glutamate receptor composition according to the hemispheric origin of CA3 afferents. To study the functional consequences of this asymmetry, we used optogenetic tools to selectively stimulate axons of CA3 pyramidal cells originating in either left or right mouse hippocampus. We found that left CA3 input produced more long-term potentiation at CA1 synapses than right CA3 input as a result of differential expression of GluN2B subunit-containing NMDA receptors.	[Kohl, Michael M.; Shipton, Olivia A.; Paulsen, Ole] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, England; [Kohl, Michael M.; Shipton, Olivia A.; Paulsen, Ole] Univ Oxford, Dept Physiol Anat & Genet, Oxford, England; [Deacon, Robert M.; Rawlins, J. Nicholas P.] Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England; [Deisseroth, Karl] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA	University of Cambridge; University of Oxford; University of Oxford; Stanford University	Paulsen, O (corresponding author), Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, England.	op210@cam.ac.uk	Paulsen, Ole/ABB-4843-2020; Kohl, Michael/AAE-4767-2021	Paulsen, Ole/0000-0002-2258-5455; Kohl, Michael/0000-0002-2566-5426	Biotechnology and Biological Sciences Research Council; Wellcome Trust (OXION Initiative); EPA Cephalosporin Fund; BBSRC [BB/H002383/2] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/H002383/2] Funding Source: researchfish; Medical Research Council [G0001354, G0001354B, G1000183B] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust (OXION Initiative)(Wellcome Trust); EPA Cephalosporin Fund; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The authors would like to thank D. Paterson for providing surgery facilities, and D. Katzel and L. Upton for help with immunohistochemistry. This research was supported by the Biotechnology and Biological Sciences Research Council and the Wellcome Trust (OXION Initiative). An equipment grant from the EPA Cephalosporin Fund is gratefully acknowledged.	Aravanis AM, 2007, J NEURAL ENG, V4, pS143, DOI 10.1088/1741-2560/4/3/S02; Barria A, 2005, NEURON, V48, P289, DOI 10.1016/j.neuron.2005.08.034; BLISS TVP, 1983, J PHYSIOL-LONDON, V341, P617, DOI 10.1113/jphysiol.1983.sp014828; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Hoffmann H, 2000, J NEUROCHEM, V75, P1590, DOI 10.1046/j.1471-4159.2000.0751590.x; Kawakami R, 2003, SCIENCE, V300, P990, DOI 10.1126/science.1082609; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Mierau SB, 2004, P NATL ACAD SCI USA, V101, P15518, DOI 10.1073/pnas.0402916101; Pike FG, 1999, J PHYSIOL-LONDON, V518, P571, DOI 10.1111/j.1469-7793.1999.0571p.x; Shinohara Y, 2008, P NATL ACAD SCI USA, V105, P19498, DOI 10.1073/pnas.0807461105; Sohal VS, 2009, NATURE, V459, P698, DOI 10.1038/nature07991; Toga AW, 2003, NAT REV NEUROSCI, V4, P37, DOI 10.1038/nrn1009; WHEAL HV, 1983, BRAIN RES, V272, P247, DOI 10.1016/0006-8993(83)90570-X; Wu Y, 2005, J NEUROSCI, V25, P9213, DOI 10.1523/JNEUROSCI.2134-05.2005; Yashiro K, 2008, NEUROPHARMACOLOGY, V55, P1081, DOI 10.1016/j.neuropharm.2008.07.046	15	85	86	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2011	14	11					1413	1415		10.1038/nn.2915	http://dx.doi.org/10.1038/nn.2915			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	841NI	21946328	Green Accepted			2022-12-28	WOS:000296518600015
J	[Anonymous]				[Anonymous]			Focus on neurovascular interactions	NATURE NEUROSCIENCE			English	Editorial Material																			0	1	1	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2011	14	11					1353	1353		10.1038/nn1111-1353	http://dx.doi.org/10.1038/nn1111-1353			1	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	841NI	22030540	Bronze			2022-12-28	WOS:000296518600001
J	Goh, GY; Huang, H; Ullman, J; Borre, L; Hnasko, TS; Trussell, LO; Edwards, RH				Goh, Germaine Y.; Huang, Hai; Ullman, Julie; Borre, Lars; Hnasko, Thomas S.; Trussell, Laurence O.; Edwards, Robert H.			Presynaptic regulation of quantal size: K+/H+ exchange stimulates vesicular glutamate transport	NATURE NEUROSCIENCE			English	Article							SYNAPTIC VESICLES; CHROMAFFIN GHOSTS; ACTIVE-TRANSPORT; CLC PROTEINS; CHLORIDE; TRANSMITTER; RELEASE; PROTON; PH; TRAFFICKING	The amount of neurotransmitter stored in a single synaptic vesicle can determine the size of the postsynaptic response, but the factors that regulate vesicle filling are poorly understood. A proton electrochemical gradient (Delta mu(H+)) generated by the vacuolar H+-ATPase drives the accumulation of classical transmitters into synaptic vesicles. The chemical component of Delta mu(H+) (Delta pH) has received particular attention for its role in the vesicular transport of cationic transmitters as well as in protein sorting and degradation. Thus, considerable work has addressed the factors that promote Delta pH. However, synaptic vesicle uptake of the principal excitatory transmitter glutamate depends on the electrical component of Delta mu(H+) (Delta psi). We found that rat brain synaptic vesicles express monovalent cation/H+ exchange activity that converts Delta pH into Delta psi, and that this promotes synaptic vesicle filling with glutamate. Manipulating presynaptic K+ at a glutamatergic synapse influenced quantal size, indicating that synaptic vesicle K+/H+ exchange regulates glutamate release and synaptic transmission.	[Goh, Germaine Y.; Ullman, Julie; Borre, Lars; Hnasko, Thomas S.; Edwards, Robert H.] Univ Calif San Francisco, Dept Physiol, Grad Program Neurosci, San Francisco, CA 94143 USA; [Goh, Germaine Y.; Ullman, Julie; Borre, Lars; Hnasko, Thomas S.; Edwards, Robert H.] Univ Calif San Francisco, Dept Physiol, Grad Program Cell Biol, San Francisco, CA USA; [Goh, Germaine Y.; Ullman, Julie; Borre, Lars; Hnasko, Thomas S.; Edwards, Robert H.] Univ Calif San Francisco, Dept Physiol, Grad Program Bioengn, San Francisco, CA USA; [Goh, Germaine Y.; Ullman, Julie; Borre, Lars; Hnasko, Thomas S.; Edwards, Robert H.] Univ Calif San Francisco, Dept Neurol, Grad Program Neurosci, San Francisco, CA USA; [Goh, Germaine Y.; Ullman, Julie; Borre, Lars; Hnasko, Thomas S.; Edwards, Robert H.] Univ Calif San Francisco, Dept Neurol, Grad Program Cell Biol, San Francisco, CA USA; [Goh, Germaine Y.; Ullman, Julie; Borre, Lars; Hnasko, Thomas S.; Edwards, Robert H.] Univ Calif San Francisco, Dept Neurol, Grad Program Bioengn, San Francisco, CA USA; [Huang, Hai; Trussell, Laurence O.] Oregon Hlth & Sci Univ, Oregon Hearing Res Ctr, Portland, OR 97201 USA; [Huang, Hai; Trussell, Laurence O.] Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97201 USA; [Ullman, Julie] Univ Calif Berkeley, Grad Program Mol & Cellular Biol, Berkeley, CA 94720 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Oregon Health & Science University; Oregon Health & Science University; University of California System; University of California Berkeley	Edwards, RH (corresponding author), Univ Calif San Francisco, Dept Physiol, Grad Program Neurosci, Box 0444, San Francisco, CA 94143 USA.	robert.edwards@ucsf.edu	Huang, Hai/N-2330-2017	Huang, Hai/0000-0002-6928-3198; Hnasko, Thomas/0000-0001-6176-8513; Ullman, Julie/0000-0003-1325-0650	A*STAR; American Heart Association; National Institute on Deafness and Other Communication Disorders; National Institute of Neurological Disorders and Stroke; National Institute of Mental Health; National Institute on Drug Abuse; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007232] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH050712] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS028901] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K01DA026504, P01DA010154] Funding Source: NIH RePORTER	A*STAR(Agency for Science Technology & Research (A*STAR)); American Heart Association(American Heart Association); National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank J. Orlowski, S. Schuldiner and members of the Edwards laboratory for many thoughtful discussions, S. Manandhar and F. Farrimond for technical assistance, and R. P. Seal for critical reading of the manuscript. This work was supported by fellowships from A*STAR (to G.Y.G.) and the American Heart Association (to L. B.), and by grants from the National Institute on Deafness and Other Communication Disorders and the National Institute of Neurological Disorders and Stroke (to L.O.T.), and from the National Institute of Mental Health and the National Institute on Drug Abuse (to R.H.E.).	Accardi A, 2004, NATURE, V427, P803, DOI 10.1038/nature02314; Ali R, 2004, J BIOL CHEM, V279, P4498, DOI 10.1074/jbc.M307446200; Beg AA, 2008, CELL, V132, P149, DOI 10.1016/j.cell.2007.10.058; Borst JGG, 1995, J PHYSIOL-LONDON, V489, P825, DOI 10.1113/jphysiol.1995.sp021095; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Brett CL, 2005, MOL BIOL CELL, V16, P1396, DOI 10.1091/mbc.E04-11-0999; Brett CL, 2005, AM J PHYSIOL-CELL PH, V288, pC223, DOI 10.1152/ajpcell.00360.2004; Brunk I, 2006, J BIOL CHEM, V281, P33373, DOI 10.1074/jbc.M603204200; Chaudhry Farrukh A., 2008, V184, P77; Conti R, 2003, P NATL ACAD SCI USA, V100, P4885, DOI 10.1073/pnas.0630290100; Daniels RW, 2006, NEURON, V49, P11, DOI 10.1016/j.neuron.2005.11.032; De Gois S, 2005, J NEUROSCI, V25, P7121, DOI 10.1523/JNEUROSCI.5221-04.2005; Franke B, 2009, HUM GENET, V126, P13, DOI 10.1007/s00439-009-0663-4; Fremeau RT, 2004, SCIENCE, V304, P1815, DOI 10.1126/science.1097468; Gilfillan GD, 2008, AM J HUM GENET, V82, P1003, DOI 10.1016/j.ajhg.2008.01.013; Graves AR, 2008, NATURE, V453, P788, DOI 10.1038/nature06907; Gronborg M, 2010, J NEUROSCI, V30, P2, DOI 10.1523/JNEUROSCI.4074-09.2010; HARTINGER J, 1993, J BIOL CHEM, V268, P23122; HELL JW, 1994, PREPARATION SYNAPTIC; Hill JK, 2006, J NEUROSCI, V26, P9944, DOI 10.1523/JNEUROSCI.2990-06.2006; Hnasko TS, 2010, NEURON, V65, P643, DOI 10.1016/j.neuron.2010.02.012; Huang H, 2008, NEURON, V60, P975, DOI 10.1016/j.neuron.2008.10.052; Ishikawa T, 2002, NEURON, V34, P613, DOI 10.1016/S0896-6273(02)00692-X; JOHNSON RG, 1981, J BIOL CHEM, V256, P5773; JOHNSON RG, 1979, J BIOL CHEM, V254, P963; Karunanithi S, 2002, J NEUROSCI, V22, P10267; KNOTH J, 1981, BIOCHEMISTRY-US, V20, P6625, DOI 10.1021/bi00526a016; Krapivinsky G, 2006, NEURON, V52, P485, DOI 10.1016/j.neuron.2006.09.033; MAYCOX PR, 1988, J BIOL CHEM, V263, P15423; Moechars D, 2006, J NEUROSCI, V26, P12055, DOI 10.1523/JNEUROSCI.2556-06.2006; Morrow EM, 2008, SCIENCE, V321, P218, DOI 10.1126/science.1157657; Nakamura N, 2005, J BIOL CHEM, V280, P1561, DOI 10.1074/jbc.M410041200; Numata M, 2001, J BIOL CHEM, V276, P17387, DOI 10.1074/jbc.M101319200; Orlowski J, 2004, PFLUG ARCH EUR J PHY, V447, P549, DOI 10.1007/s00424-003-1110-3; Parsons SM, 2000, FASEB J, V14, P2423, DOI 10.1096/fj.00-0203rev; Picollo A, 2005, NATURE, V436, P420, DOI 10.1038/nature03720; Price GD, 2006, J NEUROSCI, V26, P11432, DOI 10.1523/JNEUROSCI.1660-06.2006; Sargent PB, 2005, J NEUROSCI, V25, P8173, DOI 10.1523/JNEUROSCI.2051-05.2005; Saroussi S, 2009, PFLUG ARCH EUR J PHY, V457, P581, DOI 10.1007/s00424-008-0458-9; Scheel O, 2005, NATURE, V436, P424, DOI [10.1038/nature03860, 10.1038/nature0386O]; Schenck S, 2009, NAT NEUROSCI, V12, P156, DOI 10.1038/nn.2248; Seal RP, 2008, NEURON, V57, P263, DOI 10.1016/j.neuron.2007.11.032; Steinert JR, 2006, NEURON, V50, P723, DOI 10.1016/j.neuron.2006.04.025; TABB JS, 1992, J BIOL CHEM, V267, P15412; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; VANDYKE RW, 1988, J BIOL CHEM, V263, P2603; Wojcik SM, 2004, P NATL ACAD SCI USA, V101, P7158, DOI 10.1073/pnas.0401764101; Wolosker H, 1996, J BIOL CHEM, V271, P11726, DOI 10.1074/jbc.271.20.11726; Wu XS, 2007, J NEUROSCI, V27, P3046, DOI 10.1523/JNEUROSCI.4415-06.2007	49	52	54	1	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2011	14	10					1285	U97		10.1038/nn.2898	http://dx.doi.org/10.1038/nn.2898			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	825EQ	21874016	Green Accepted			2022-12-28	WOS:000295254200017
J	MacEvoy, SP; Epstein, RA				MacEvoy, Sean P.; Epstein, Russell A.			Constructing scenes from objects in human occipitotemporal cortex	NATURE NEUROSCIENCE			English	Article							TOPOGRAPHICAL DISORIENTATION; NEURAL MECHANISMS; NATURAL IMAGES; PARAHIPPOCAMPAL; REPRESENTATIONS; INFORMATION; CATEGORY; NORMALIZATION; COMPETITION; ATTENTION	We used functional magnetic resonance imaging (fMRI) to demonstrate the existence of a mechanism in the human lateral occipital (LO) cortex that supports recognition of real-world visual scenes through parallel analysis of within-scene objects. Neural activity was recorded while subjects viewed four categories of scenes and eight categories of 'signature' objects strongly associated with the scenes in three experiments. Multivoxel patterns evoked by scenes in the LO cortex were well predicted by the average of the patterns elicited by their signature objects. By contrast, there was no relationship between scene and object patterns in the parahippocampal place area (PPA), even though this region responds strongly to scenes and is believed to be crucial for scene identification. By combining information about multiple objects within a scene, the LO cortex may support an object-based channel for scene recognition that complements the processing of global scene properties in the PPA.	[MacEvoy, Sean P.] Boston Coll, Dept Psychol, Chestnut Hill, MA 02167 USA; [MacEvoy, Sean P.; Epstein, Russell A.] Univ Penn, Dept Psychol, Philadelphia, PA 19104 USA	Boston College; University of Pennsylvania	MacEvoy, SP (corresponding author), Boston Coll, Dept Psychol, Chestnut Hill, MA 02167 USA.	sean.macevoy.1@bc.edu	Epstein, Russell/G-4517-2013; MA, Lei/I-4597-2014		US National Eye Institute [EY-016464]; NATIONAL EYE INSTITUTE [R01EY016464] Funding Source: NIH RePORTER	US National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The authors wish to thank E. Ward, A. Stigliani and Z. Yang for assistance with data collection. This work was supported by US National Eye Institute grant EY-016464 to R.A.E.	Aguirre GK, 2007, NEUROIMAGE, V35, P1480, DOI 10.1016/j.neuroimage.2007.02.005; Aguirre GK, 1999, BRAIN, V122, P1613, DOI 10.1093/brain/122.9.1613; Aguirre GK, 1998, NEURON, V21, P373, DOI 10.1016/S0896-6273(00)80546-2; Andresen DR, 2009, NEUROIMAGE, V45, P522, DOI 10.1016/j.neuroimage.2008.11.009; Bar M, 2003, NEURON, V38, P347, DOI 10.1016/S0896-6273(03)00167-3; Beck DM, 2007, J VISION, V7, DOI 10.1167/7.2.19; Beck DM, 2005, NAT NEUROSCI, V8, P1110, DOI 10.1038/nn1501; BIEDERMAN I, 1974, J EXP PSYCHOL, V103, P597, DOI 10.1037/h0037158; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Diana RA, 2008, HIPPOCAMPUS, V18, P536, DOI 10.1002/hipo.20433; Drucker DM, 2009, CEREB CORTEX, V19, P2269, DOI 10.1093/cercor/bhn244; Eger E, 2008, J NEUROPHYSIOL, V100, P2038, DOI 10.1152/jn.90305.2008; Epstein R, 2003, NEURON, V37, P865, DOI 10.1016/S0896-6273(03)00117-X; Epstein R, 1998, NATURE, V392, P598, DOI 10.1038/33402; Epstein RA, 2008, TRENDS COGN SCI, V12, P388, DOI 10.1016/j.tics.2008.07.004; Epstein RA, 2007, CEREB CORTEX, V17, P1680, DOI 10.1093/cercor/bhl079; Epstein RA, 2007, J NEUROSCI, V27, P6141, DOI 10.1523/JNEUROSCI.0799-07.2007; Fei-Fei L, 2007, J VISION, V7, DOI 10.1167/7.1.10; Greene MR, 2009, COGNITIVE PSYCHOL, V58, P137, DOI 10.1016/j.cogpsych.2008.06.001; HABIB M, 1987, CORTEX, V23, P73, DOI 10.1016/S0010-9452(87)80020-5; Haushofer J, 2008, PLOS BIOL, V6, P1459, DOI 10.1371/journal.pbio.0060187; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; Kay KN, 2008, NATURE, V452, P352, DOI 10.1038/nature06713; Kravitz DJ, 2011, J NEUROSCI, V31, P7322, DOI 10.1523/JNEUROSCI.4588-10.2011; Kravitz DJ, 2010, CEREB CORTEX, V20, P2916, DOI 10.1093/cercor/bhq042; Kriegeskorte N, 2006, P NATL ACAD SCI USA, V103, P3863, DOI 10.1073/pnas.0600244103; MacEvoy SP, 2009, CURR BIOL, V19, P943, DOI 10.1016/j.cub.2009.04.020; MacEvoy SP, 2009, NAT NEUROSCI, V12, P637, DOI 10.1038/nn.2310; MALACH R, 1995, P NATL ACAD SCI USA, V92, P8135, DOI 10.1073/pnas.92.18.8135; MORAN J, 1985, SCIENCE, V229, P782, DOI 10.1126/science.4023713; Naselaris T, 2009, NEURON, V63, P902, DOI 10.1016/j.neuron.2009.09.006; Park S, 2011, J NEUROSCI, V31, P1333, DOI 10.1523/JNEUROSCI.3885-10.2011; Peelen MV, 2009, NATURE, V460, P94, DOI 10.1038/nature08103; POTTER MC, 1975, SCIENCE, V187, P965, DOI 10.1126/science.1145183; Potter MC, 2004, J EXP PSYCHOL HUMAN, V30, P478, DOI 10.1037/0096-1523.30.3.478; Reddy L, 2009, P NATL ACAD SCI USA, V106, P21447, DOI 10.1073/pnas.0907330106; Renninger LW, 2004, VISION RES, V44, P2301, DOI 10.1016/j.visres.2004.04.006; Reynolds JH, 2009, NEURON, V61, P168, DOI 10.1016/j.neuron.2009.01.002; ROGOSA D, 1980, PSYCHOL BULL, V88, P307, DOI 10.1037/0033-2909.88.2.307; Sayres R, 2008, J NEUROPHYSIOL, V100, P249, DOI 10.1152/jn.01383.2007; Schwarzlose RF, 2008, P NATL ACAD SCI USA, V105, P4447, DOI 10.1073/pnas.0800431105; SCHYNS PG, 1994, PSYCHOL SCI, V5, P195, DOI 10.1111/j.1467-9280.1994.tb00500.x; Spiridon M, 2002, NEURON, V35, P1157, DOI 10.1016/S0896-6273(02)00877-2; Walther DB, 2009, J NEUROSCI, V29, P10573, DOI 10.1523/JNEUROSCI.0559-09.2009; Zoccolan D, 2005, J NEUROSCI, V25, P8150, DOI 10.1523/JNEUROSCI.2058-05.2005	45	110	114	0	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2011	14	10					1323	U144		10.1038/nn.2903	http://dx.doi.org/10.1038/nn.2903			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	825EQ	21892156	Green Accepted			2022-12-28	WOS:000295254200022
J	Helmstaedter, M; Briggman, KL; Denk, W				Helmstaedter, Moritz; Briggman, Kevin L.; Denk, Winfried			High-accuracy neurite reconstruction for high-throughput neuroanatomy	NATURE NEUROSCIENCE			English	Article							ELECTRON-MICROSCOPY; VALIDATION	Neuroanatomic analysis depends on the reconstruction of complete cell shapes. High-throughput reconstruction of neural circuits, or connectomics, using volume electron microscopy requires dense staining of all cells, which leads even experts to make annotation errors. Currently, reconstruction speed rather than acquisition speed limits the determination of neural wiring diagrams. We developed a method for fast and reliable reconstruction of densely labeled data sets. Our approach, based on manually skeletonizing each neurite redundantly (multiple times) with a visualization-annotation software tool called KNOSSOS, is similar to 50-fold faster than volume labeling. Errors are detected and eliminated by a redundant-skeleton consensus procedure (RESCOP), which uses a statistical model of how true neurite connectivity is transformed into annotation decisions. RESCOP also estimates the reliability of consensus skeletons. Focused reannotation of difficult locations promises a rather steep increase of reliability as a function of the average skeleton redundancy and thus the nearly error-free analysis of large neuroanatomical datasets.	[Helmstaedter, Moritz; Briggman, Kevin L.; Denk, Winfried] Max Planck Inst Med Res, Heidelberg, Germany	Max Planck Society	Helmstaedter, M (corresponding author), Max Planck Inst Med Res, Heidelberg, Germany.	moritz.helmstaedter@mpimf-heidelberg.mpg.de	denk, winfried/I-6627-2012		Max Planck Society	Max Planck Society(Max Planck SocietyFoundation CELLEX)	We thank B. Andres, F. Hamprecht, U. Kothe, V. Jain, S. Seung and S. Turaga for many fruitful discussions and comments on the manuscript, J. Bollmann and A. Schaefer for helpful comments on the manuscript, C. Roome for information technology support, J. Kornfeld and F. Svara for programming KNOSSOS, and J. Hanne, H. Jakobi and H. Wissler for help with annotator training. We thank N. Abazova, E. Abs, A. Antunes, P. Bastians, J. Bauer, M. Beez, M. Beining, S. Bender, S. Best, L. Brosi, M. Bucher, E. Buckler, J. Buhmann, C. Burkhardt, F. Drawitsch, L. Ehm, S. Ehm, C. Fianke, R. Foltin, S. Freiss, M. Funk, A. Gebhardt, M. Gruen, K. Haase, J. Hammerich, J. Hanne, B. Hauber, M. Hensen, L. Hofmann, P. Hofmann, M. Hulser, F. Isensee, H. Jakobi, M. Jonczyk, A. Joschko, A. Juenger, S. Kaspar, K. Kessler, A. Khan, M. Kiapes, A. Klein, C. Klein, S. Laiouar, T. Lang, L. Lebelt, H. Lesch, C. Lieven, D. Luft, E. Moeller, A. Muellner, M. Mueller, D. Ollech, A. Oppold, T. Otolski, S. Oumohand, S. Pfarr, M. Pohrath, A. Poos, S. Putzke, J. Reinhardt, A. Rommerskirchen, M. Roth, J. Sambel, K. Schramm, C. Sellmann, J. Sieber, I. Sonntag, M. Stahlberg, T. Stratmann, J. Trendel, F. Trogisch, M. Uhrig, A. Vogel, J. Volz, C. Weber, P. Weber, K. Weiss, L. Weisshaar, E. Wiegand, T. Wiegand, M. Wiese, R. Wiggers, C. Willburger and A. Zegarra for neurite skeletonizations. This work was funded by the Max Planck Society.	Andres B, 2008, LECT NOTES COMPUT SC, V5096, P142, DOI 10.1007/978-3-540-69321-5_15; Briggman KL, 2006, CURR OPIN NEUROBIOL, V16, P562, DOI 10.1016/j.conb.2006.08.010; BRIGGMAN KL, 2011, NATURE IN PRESS; CAJAL SRY, 1999, TEXTURA SISTEMA NERV; Chen BL, 2006, P NATL ACAD SCI USA, V103, P4723, DOI 10.1073/pnas.0506806103; Chklovskii DB, 2010, CURR OPIN NEUROBIOL, V20, P667, DOI 10.1016/j.conb.2010.08.002; Crook S, 2007, NEUROINFORMATICS, V5, P96, DOI 10.1007/s12021-007-0003-6; Denk W, 2004, PLOS BIOL, V2, P1900, DOI 10.1371/journal.pbio.0020329; Fiala JC, 2005, J MICROSC-OXFORD, V218, P52, DOI 10.1111/j.1365-2818.2005.01466.x; Golgi, 1873, GAZ MED ITAL LOMBARD, V33, P244, DOI DOI 10.1056/NEJMOA1602253; HARRIS KM, 1989, J NEUROSCI, V9, P2982; Hayworth K., 2006, MICROSCOPY MICROA S2, V12, P86, DOI [10.1017/s1431927606066268, DOI 10.1017/S1431927606066268]; Helmstaedter M, 2008, CURR OPIN NEUROBIOL, V18, P633, DOI 10.1016/j.conb.2009.03.005; HORIKAWA K, 1988, J NEUROSCI METH, V25, P1, DOI 10.1016/0165-0270(88)90114-8; Jeong WK, 2010, IEEE COMPUT GRAPH, V30, P58, DOI 10.1109/MCG.2010.56; Knott G, 2008, J NEUROSCI, V28, P2959, DOI 10.1523/JNEUROSCI.3189-07.2008; Kording K, 2007, SCIENCE, V318, P606, DOI 10.1126/science.1142998; Lichtman JW, 2008, NAT REV NEUROSCI, V9, P417, DOI 10.1038/nrn2391; Livet J, 2007, NATURE, V450, P56, DOI 10.1038/nature06293; Martin D, 2001, EIGHTH IEEE INTERNATIONAL CONFERENCE ON COMPUTER VISION, VOL II, PROCEEDINGS, P416, DOI 10.1109/ICCV.2001.937655; Mishchenko Y, 2010, NEURON, V67, P1009, DOI 10.1016/j.neuron.2010.08.014; Sporns O, 2005, PLOS COMPUT BIOL, V1, P245, DOI 10.1371/journal.pcbi.0010042; STEVENS JK, 1980, SCIENCE, V207, P317, DOI 10.1126/science.7350663; STRETTON AO, 1968, SCIENCE, V162, P132, DOI 10.1126/science.162.3849.132; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Turaga SC, 2010, NEURAL COMPUT, V22, P511, DOI 10.1162/neco.2009.10-08-881; Wang S, 2007, 2007 IEEE INTERNATIONAL SYMPOSIUM ON NANOSCALE ARCHITECTURE, P1; WANG W, 2009, IEEE INT S BIOM IM N, P342; Warfield SK, 2008, PHILOS T R SOC A, V366, P2361, DOI 10.1098/rsta.2008.0040; Warfield SK, 2004, IEEE T MED IMAGING, V23, P903, DOI 10.1109/TMI.2004.828354; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Wickersham IR, 2007, NEURON, V53, P639, DOI 10.1016/j.neuron.2007.01.033	32	171	174	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2011	14	8					1081	U189		10.1038/nn.2868	http://dx.doi.org/10.1038/nn.2868			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	797KC	21743472				2022-12-28	WOS:000293123700024
J	Armbruster, M; Ryan, TA				Armbruster, Moritz; Ryan, Timothy A.			Synaptic vesicle retrieval time is a cell-wide rather than individual-synapse property	NATURE NEUROSCIENCE			English	Article							HIPPOCAMPAL SYNAPSES; ENDOCYTOSIS; RELEASE	Although individual nerve terminals from the same neuron often differ in neurotransmitter release characteristics, the extent to which endocytic retrieval of synaptic vesicle components differs is unknown. We used high-fidelity optical recordings to undertake a large-scale analysis of endocytosis kinetics of individual boutons in hippocampal rat neurons. Our data indicate that endocytosis kinetics do not differ substantially across boutons from the same cell but instead appear to be controlled at a cell-wide level.	[Armbruster, Moritz; Ryan, Timothy A.] Weill Cornell Med Coll, Dept Biochem, New York, NY USA; [Armbruster, Moritz] Rockefeller Univ, David Rockefeller Grad Program, New York, NY 10021 USA	Cornell University; Rockefeller University	Ryan, TA (corresponding author), Weill Cornell Med Coll, Dept Biochem, New York, NY USA.	taryan@med.cornell.edu	Ryan, Timothy/AAO-8286-2020	Armbruster, Moritz/0000-0003-2341-513X; Ryan, Timothy/0000-0003-2533-9548	US National Institutes of Health; David Rockefeller Graduate School of the Rockefeller University; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036942] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); David Rockefeller Graduate School of the Rockefeller University; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We would like to thank members of the Ryan laboratory and J. Dittman for useful discussions and R. Kwan for excellent technical assistance. vGlut-pHluorin was kindly provided by S. Voglmaier and R. Edwards (University of California, San Francisco) and the synaptophysin-pHluorin construct was kindly provided by Y. Zhu (Salk Institute). This work was supported by grants from the US National Institutes of Health (T. A. R.) and the David Rockefeller Graduate School of the Rockefeller University.	Balaji J, 2008, J NEUROSCI, V28, P6742, DOI 10.1523/JNEUROSCI.1082-08.2008; Balaji J, 2007, P NATL ACAD SCI USA, V104, P20576, DOI 10.1073/pnas.0707574105; Branco T, 2008, NEURON, V59, P475, DOI 10.1016/j.neuron.2008.07.006; Elston RC, 2008, BASIC BIOSTATISTICS; Ferguson SM, 2007, SCIENCE, V316, P570, DOI 10.1126/science.1140621; Granseth B, 2006, NEURON, V51, P773, DOI 10.1016/j.neuron.2006.08.029; HEUSER JE, 1973, J CELL BIOL, V57, P315, DOI 10.1083/jcb.57.2.315; Kim SH, 2010, NEURON, V67, P797, DOI 10.1016/j.neuron.2010.08.003; Kim SH, 2009, J NEUROSCI, V29, P3865, DOI 10.1523/JNEUROSCI.5639-08.2009; KOENIG JH, 1983, J NEUROBIOL, V14, P411, DOI 10.1002/neu.480140602; Murthy VN, 2001, NEURON, V32, P673, DOI 10.1016/S0896-6273(01)00500-1; Newton AJ, 2006, P NATL ACAD SCI USA, V103, P17955, DOI 10.1073/pnas.0606212103; Turrigiano GG, 2008, CELL, V135, P422, DOI 10.1016/j.cell.2008.10.008; Vangel MG, 1996, AM STAT, V50, P21, DOI 10.2307/2685039	14	20	20	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2011	14	7					824	826		10.1038/nn.2828	http://dx.doi.org/10.1038/nn.2828			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	783KR	21623361	Green Accepted			2022-12-28	WOS:000292081700007
J	Arnal, LH; Wyart, V; Giraud, AL				Arnal, Luc H.; Wyart, Valentin; Giraud, Anne-Lise			Transitions in neural oscillations reflect prediction errors generated in audiovisual speech	NATURE NEUROSCIENCE			English	Article							SUPERIOR TEMPORAL SULCUS; AUDITORY-CORTEX; TOP-DOWN; COMPUTATIONAL PRINCIPLES; NEURONAL OSCILLATIONS; GAMMA-OSCILLATIONS; VISUAL-CORTEX; INFORMATION; INTEGRATION; SYNCHRONIZATION	According to the predictive coding theory, top-down predictions are conveyed by backward connections and prediction errors are propagated forward across the cortical hierarchy. Using MEG in humans, we show that violating multisensory predictions causes a fundamental and qualitative change in both the frequency and spatial distribution of cortical activity. When visual speech input correctly predicted auditory speech signals, a slow delta regime (3-4 Hz) developed in higher-order speech areas. In contrast, when auditory signals invalidated predictions inferred from vision, a low-beta (14-15 Hz) / high-gamma (60-80 Hz) coupling regime appeared locally in a multisensory area (area STS). This frequency shift in oscillatory responses scaled with the degree of audio-visual congruence and was accompanied by increased gamma activity in lower sensory regions. These findings are consistent with the notion that bottom-up prediction errors are communicated in predominantly high (gamma) frequency ranges, whereas top-down predictions are mediated by slower (beta) frequencies.	[Arnal, Luc H.; Giraud, Anne-Lise] Ecole Normale Super, INSERM, U960, F-75231 Paris, France; [Wyart, Valentin] Univ Paris 06, Ctr Rech, Ctr Natl Rech Sci,Unite Mixte Rech 7225, Inst Cerveau & Moelle Epiniere,INSERM,U975, Paris, France; [Giraud, Anne-Lise] Hop La Pitie Salpetriere, Ctr Neuroimagerie Rech, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Giraud, AL (corresponding author), Ecole Normale Super, INSERM, U960, 24 Rue Lhomond, F-75231 Paris, France.	anne-lise.giraud@ens.fr	Arnal, Luc/AAE-2356-2022	Arnal, Luc/0000-0002-2226-6497; Wyart, Valentin/0000-0001-6522-7837	Centre National de la Recherche Scientifique; Fondation Fyssen	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Fondation Fyssen	We thank the staff of the Centre de Neuroimagerie de Recherche and the Magnetoencephalography Center (Hopital de la Pitie-Salpetriere), in particular J.-D. Lemarechal, A. Ducorps and D. Schwarz, and the colleagues who commented on this work: V. van Wassenhove, B. Morillon, A. Hyafil, S. Deneve, L. Melloni, F. Griffon, A. Kleinschmidt, E. Koechlin, B. Fischer, K. Friston and C. Tallon-Baudry. This work was supported by the Centre National de la Recherche Scientifique (A.-L.G.) and the Fondation Fyssen (V.W.).	Akam T, 2010, NEURON, V67, P308, DOI 10.1016/j.neuron.2010.06.019; Arnal LH, 2009, J NEUROSCI, V29, P13445, DOI 10.1523/JNEUROSCI.3194-09.2009; Beauchamp MS, 2004, NEURON, V41, P809, DOI 10.1016/S0896-6273(04)00070-4; Buschman TJ, 2007, SCIENCE, V315, P1860, DOI 10.1126/science.1138071; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Canolty RT, 2006, SCIENCE, V313, P1626, DOI 10.1126/science.1128115; Chandrasekaran C, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000436; Colgin LL, 2009, NATURE, V462, P353, DOI 10.1038/nature08573; Engel AK, 2001, NAT REV NEUROSCI, V2, P704, DOI 10.1038/35094565; Engel AK, 2010, CURR OPIN NEUROBIOL, V20, P156, DOI 10.1016/j.conb.2010.02.015; Fries P, 1997, P NATL ACAD SCI USA, V94, P12699, DOI 10.1073/pnas.94.23.12699; Friston KJ, 2005, PHILOS T R SOC B, V360, P815, DOI 10.1098/rstb.2005.1622; Garrido MI, 2007, NEUROIMAGE, V36, P571, DOI 10.1016/j.neuroimage.2007.03.014; George D, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000532; Ghazanfar AA, 2008, J NEUROSCI, V28, P4457, DOI 10.1523/JNEUROSCI.0541-08.2008; Grill-Spector K, 2006, TRENDS COGN SCI, V10, P14, DOI 10.1016/j.tics.2005.11.006; Hagoort P, 2004, SCIENCE, V304, P438, DOI 10.1126/science.1095455; Hald LA, 2006, BRAIN LANG, V96, P90, DOI 10.1016/j.bandl.2005.06.007; Hickok G, 2007, NAT REV NEUROSCI, V8, P393, DOI 10.1038/nrn2113; Kayser C, 2009, FRONT INTEGR NEUROSC, V3, DOI 10.3389/neuro.07.007.2009; Kayser C, 2009, NEURON, V61, P597, DOI 10.1016/j.neuron.2009.01.008; Koch SP, 2009, J NEUROSCI, V29, P13962, DOI 10.1523/JNEUROSCI.1402-09.2009; Kopell N, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00187; Kramer MA, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000169; Lakatos P, 2005, J NEUROPHYSIOL, V94, P1904, DOI 10.1152/jn.00263.2005; Maris E, 2007, J NEUROSCI METH, V164, P177, DOI 10.1016/j.jneumeth.2007.03.024; MCGURK H, 1976, NATURE, V264, P746, DOI 10.1038/264746a0; Mukamel R, 2005, SCIENCE, V309, P951, DOI 10.1126/science.1110913; MUMFORD D, 1992, BIOL CYBERN, V66, P241, DOI 10.1007/BF00198477; Neisser U., 1967, COGNITIVE PSYCHOL; Niessing J, 2005, SCIENCE, V309, P948, DOI 10.1126/science.1110948; Panzeri S, 2010, TRENDS NEUROSCI, V33, P111, DOI 10.1016/j.tins.2009.12.001; Poeppel D, 2008, PHILOS T R SOC B, V363, P1071, DOI 10.1098/rstb.2007.2160; Rao RPN, 1999, NAT NEUROSCI, V2, P79, DOI 10.1038/4580; ROCKLAND KS, 1979, BRAIN RES, V179, P3, DOI 10.1016/0006-8993(79)90485-2; Roopun AK, 2008, FRONT CELL NEUROSCI, V2, DOI 10.3389/neuro.03.001.2008; Schroeder CE, 2009, BRAIN TOPOGR, V22, P24, DOI 10.1007/s10548-009-0080-y; Schroeder CE, 2009, TRENDS NEUROSCI, V32, P9, DOI 10.1016/j.tins.2008.09.012; Sejnowski TJ, 2006, J NEUROSCI, V26, P1673, DOI 10.1523/JNEUROSCI.3737-05d.2006; Shah AS, 2004, CEREB CORTEX, V14, P476, DOI 10.1093/cercor/bhh009; Spratling MW, 2008, FRONT COMPUT NEUROSC, V2, P1, DOI 10.3389/neuro.10.004.2008; Stevens KN, 1967, MODELS PERCEPTION SP, P88; TallonBaudry C, 1996, J NEUROSCI, V16, P4240; van Wassenhove V, 2005, P NATL ACAD SCI USA, V102, P1181, DOI 10.1073/pnas.0408949102; von Stein A, 2000, P NATL ACAD SCI USA, V97, P14748, DOI 10.1073/pnas.97.26.14748; Wang XJ, 2010, PHYSIOL REV, V90, P1195, DOI 10.1152/physrev.00035.2008; WOLPERT DM, 1995, SCIENCE, V269, P1880, DOI 10.1126/science.7569931; Womelsdorf T, 2007, SCIENCE, V316, P1609, DOI [10.1126/science.1139597, 10.1126/science.1139178]; Wrobel A, 2000, ACTA NEUROBIOL EXP, V60, P247; Wyart V, 2008, J NEUROSCI, V28, P2667, DOI 10.1523/JNEUROSCI.4748-07.2008	50	211	212	2	44	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2011	14	6					797	U164		10.1038/nn.2810	http://dx.doi.org/10.1038/nn.2810			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	768SH	21552273	Green Published			2022-12-28	WOS:000290958000025
J	Bell, MR; Belarde, JA; Johnson, HF; Aizenman, CD				Bell, Mark R.; Belarde, James A.; Johnson, Hannah F.; Aizenman, Carlos D.			A neuroprotective role for polyamines in a Xenopus tadpole model of epilepsy	NATURE NEUROSCIENCE			English	Article							HIPPOCAMPAL PYRAMIDAL CELLS; RAT-BRAIN; ORNITHINE-DECARBOXYLASE; STATUS-EPILEPTICUS; NEURONAL EXCITABILITY; SYNAPTIC-TRANSMISSION; SEIZURE ACTIVITY; GENE-EXPRESSION; TRANSGENIC MICE; ION CHANNELS	Polyamines are endogenous molecules involved in cell damage following neurological insults, although it is unclear whether polyamines reduce or exacerbate this damage. We used a developmental seizure model in which we exposed Xenopus laevis tadpoles to pentylenetetrazole (PTZ), a known convulsant. We found that, after an initial PTZ exposure, seizure onset times were delayed in response to a second PTZ exposure 4 h later. This protective effect was a result of activity-dependent increases in synthesis of putrescine, the simplest polyamine. Unlike more complex polyamines that directly modulate ion channels, putrescine exerted its effect by altering the balance of excitation to inhibition. Tectal neuron recordings, 4 h after the initial seizure, revealed an elevated frequency of GABAergic spontaneous inhibitory postsynaptic currents. Our data suggest that this effect is mediated by an atypical pathway that converts putrescine into GABA, which then activates presynaptic GABA(B) receptors. Our data suggest that polyamines have a previously unknown neuroprotective role in the developing brain.	[Bell, Mark R.; Belarde, James A.; Johnson, Hannah F.; Aizenman, Carlos D.] Brown Univ, Dept Neurosci, Providence, RI 02912 USA	Brown University	Aizenman, CD (corresponding author), Brown Univ, Dept Neurosci, Providence, RI 02912 USA.	carlos_aizenman@brown.edu			American Heart Association; US National Institutes of Health; Klingenstein Fund; National Science Foundation; Brain Science Siravo Award for Epilepsy Research; Brown University	American Heart Association(American Heart Association); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Klingenstein Fund(Klingenstein Philanthropies); National Science Foundation(National Science Foundation (NSF)); Brain Science Siravo Award for Epilepsy Research; Brown University	We would like to thank B. Connors and J. Kauer with helpful discussion and suggestions to the manuscript. We also thank I. Sears, B. Clarkson and E. Stackpole for technical support and J. Lippman Bell for editorial support. This work was supported by the American Heart Association and the US National Institutes of Health. C.D.A. was also supported by the Klingenstein Fund, M.R.B. by a Graduate Research Fellowship Program award from the National Science Foundation, J.A.B. by a Brain Science Siravo Award for Epilepsy Research and H.F.J. by a Brown University Undergraduate Teaching and Research Award.	Aizenman CD, 2003, NEURON, V39, P831, DOI 10.1016/S0896-6273(03)00527-0; Aizenman CD, 2002, NEURON, V34, P623, DOI 10.1016/S0896-6273(02)00674-8; Akerman CJ, 2006, J NEUROSCI, V26, P5117, DOI 10.1523/JNEUROSCI.0319-06.2006; Baraban SC, 2005, NEUROSCIENCE, V131, P759, DOI 10.1016/j.neuroscience.2004.11.031; BOWIE D, 1995, NEURON, V15, P453, DOI 10.1016/0896-6273(95)90049-7; Camon L, 2001, J NEUROSCI RES, V66, P1101, DOI 10.1002/jnr.10024; Clements JD, 1997, BIOPHYS J, V73, P220, DOI 10.1016/S0006-3495(97)78062-7; Cowan LD, 2002, MENT RETARD DEV D R, V8, P171, DOI 10.1002/mrdd.10035; de Vera N, 2002, EUR NEUROPSYCHOPHARM, V12, P397, DOI 10.1016/S0924-977X(02)00050-0; de Vera N, 2008, J NEUROSCI RES, V86, P861, DOI 10.1002/jnr.21538; Fleidervish IA, 2008, P NATL ACAD SCI USA, V105, P18994, DOI 10.1073/pnas.0803464105; GILAD GM, 1983, BRAIN RES, V273, P191, DOI 10.1016/0006-8993(83)91113-7; Haas KZ, 2001, HIPPOCAMPUS, V11, P615, DOI 10.1002/hipo.1076; Haas KZ, 1996, J NEUROSCI, V16, P4250; HALONEN T, 1993, EUR J NEUROSCI, V5, P1233, DOI 10.1111/j.1460-9568.1993.tb00978.x; HAYASHI Y, 1993, NEUROSCI LETT, V149, P63, DOI 10.1016/0304-3940(93)90348-O; HAYASHI Y, 1992, J NEUROCHEM, V58, P562, DOI 10.1111/j.1471-4159.1992.tb09756.x; Hewapathirane D Sesath, 2008, J Vis Exp, DOI 10.3791/705; Kaasinen SK, 2003, EXP NEUROL, V183, P645, DOI 10.1016/S0014-4886(03)00186-9; KAMBOJ SK, 1995, J PHYSIOL-LONDON, V486, P297, DOI 10.1113/jphysiol.1995.sp020812; LASCHET J, 1992, NEUROSCIENCE, V48, P151, DOI 10.1016/0306-4522(92)90345-3; LERMA J, 1992, NEURON, V8, P343, DOI 10.1016/0896-6273(92)90300-3; Liu Z, 1999, NEUROSCIENCE, V92, P1443, DOI 10.1016/S0306-4522(99)00064-0; NAJM I, 1992, DEV BRAIN RES, V69, P11, DOI 10.1016/0165-3806(92)90117-F; Nieuwkoop PD., 1956, DEVELOPMENT, DOI [DOI 10.1242/DEV.200356, 10.1242/dev.200356]; NOTO T, 1986, J NEUROCHEM, V46, P1877; Osawa M, 2009, J BIOL CHEM, V284, P26117, DOI 10.1074/jbc.M109.029355; PASCHEN W, 1992, MOL CHEM NEUROPATHOL, V16, P241, DOI 10.1007/BF03159973; PEARCE RA, 1995, J PHYSIOL-LONDON, V484, P425, DOI 10.1113/jphysiol.1995.sp020675; Pegg AE, 2006, J BIOL CHEM, V281, P14529, DOI 10.1074/jbc.R500031200; PITLER TA, 1994, NEURON, V13, P1447; PITLER TA, 1994, J NEUROPHYSIOL, V72, P2317, DOI 10.1152/jn.1994.72.5.2317; Pratt KG, 2007, J NEUROSCI, V27, P8268, DOI 10.1523/JNEUROSCI.1738-07.2007; Sankar R, 1997, DEV BRAIN RES, V98, P60, DOI 10.1016/S0165-3806(96)00165-4; Scharfman HE, 2007, CURR NEUROL NEUROSCI, V7, P348, DOI 10.1007/s11910-007-0053-z; Schousboe A, 2000, NEUROCHEM RES, V25, P1241, DOI 10.1023/A:1007692012048; Seiler N, 2004, AMINO ACIDS, V26, P217, DOI 10.1007/s00726-004-0070-z; SEILER N, 1974, BIOCHEM J, V144, P29, DOI 10.1042/bj1440029; Sequerra EB, 2007, NEUROSCIENCE, V146, P489, DOI 10.1016/j.neuroscience.2007.01.062; SHIMOSATO K, 1995, BRAIN RES, V684, P243, DOI 10.1016/0006-8993(95)00468-6; Shin J, 2005, J NEUROPHYSIOL, V93, P2634, DOI 10.1152/jn.01054.2004; Shin J, 2007, J PHYSIOL-LONDON, V581, P679, DOI 10.1113/jphysiol.2007.130963; TABOR CW, 1984, ANNU REV BIOCHEM, V53, P749, DOI 10.1146/annurev.bi.53.070184.003533; Williams K, 1997, CELL SIGNAL, V9, P1, DOI 10.1016/S0898-6568(96)00089-7; Williams K, 1997, BIOCHEM J, V325, P289, DOI 10.1042/bj3250289; Wu GY, 1996, SCIENCE, V274, P972, DOI 10.1126/science.274.5289.972; Yamasaki EN, 1999, INT J DEV NEUROSCI, V17, P201, DOI 10.1016/S0736-5748(99)00002-7; ZAWIA NH, 1990, MOL BRAIN RES, V7, P243, DOI 10.1016/0169-328X(90)90034-B; ZAWIA NH, 1993, DEV BRAIN RES, V71, P53, DOI 10.1016/0165-3806(93)90104-I	49	46	48	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2011	14	4					505	U144		10.1038/nn.2777	http://dx.doi.org/10.1038/nn.2777			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	741FQ	21378970				2022-12-28	WOS:000288849400022
J	Counotte, DS; Goriounova, NA; Li, KW; Loos, M; van der Schors, RC; Schetters, D; Schoffelmeer, ANM; Smit, AB; Mansvelder, HD; Pattij, T; Spijker, S				Counotte, Danielle S.; Goriounova, Natalia A.; Li, Ka Wan; Loos, Maarten; van der Schors, Roel C.; Schetters, Dustin; Schoffelmeer, Anton N. M.; Smit, August B.; Mansvelder, Huibert D.; Pattij, Tommy; Spijker, Sabine			Lasting synaptic changes underlie attention deficits caused by nicotine exposure during adolescence	NATURE NEUROSCIENCE			English	Article							REACTION-TIME-TASK; TOBACCO-SMOKE; BRAIN; CORTEX	Tobacco smoking and nicotine exposure during adolescence interfere with prefrontal cortex (PFC) development and lead to cognitive impairments in later life. The molecular and cellular underpinnings of these consequences remain elusive. We found that adolescent nicotine exposure induced lasting attentional disturbances and reduced mGluR2 protein and function on presynaptic terminals of PFC glutamatergic synapses. Restoring mGluR2 activity in vivo by local infusion of a group II mGluR agonist in adult rats that received nicotine as adolescents rescued attentional disturbances.	[Counotte, Danielle S.; Goriounova, Natalia A.; Li, Ka Wan; Loos, Maarten; van der Schors, Roel C.; Smit, August B.; Mansvelder, Huibert D.; Spijker, Sabine] Vrije Univ Amsterdam, Ctr Neurogenom & Cognit Res, Amsterdam, Netherlands; [Schetters, Dustin; Schoffelmeer, Anton N. M.; Pattij, Tommy] Vrije Univ Amsterdam, Med Ctr, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	Spijker, S (corresponding author), Vrije Univ Amsterdam, Ctr Neurogenom & Cognit Res, Amsterdam, Netherlands.	sabine.spijker@cncr.vu.nl	Spijker, Sabine/F-2300-2011; Smit, August B/E-8410-2011; Mansvelder, Huibert/N-6138-2018; Loos, Maarten/A-2768-2012; Goriounova, Natalia/ABE-6759-2020	Mansvelder, Huibert/0000-0003-1365-5340; Loos, Maarten/0000-0003-1629-2928; li, ka wan/0000-0001-6983-5055; Goriounova, Natalia/0000-0002-5917-983X; Pattij, Tommy/0000-0002-0079-7385; Spijker, Sabine/0000-0002-6814-2019	Netherlands Organization for Scientific Research; Center for Medical Systems Biology; VU University (VU European Research Council)	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Center for Medical Systems Biology; VU University (VU European Research Council)	We thank Y. van Mourik, M. Stegeman, H. Lodder, B. Lodder, C. de Kock and R. Binnekade for excellent technical assistance. Funding was received from Netherlands Organization for Scientific Research ( D.S.C., N.A.G., S.S., H.D.M., T.P., A.N.M.S. and A.B.S.), Center for Medical Systems Biology (K.W.L. and R.C.v.d.S.) and VU University (H.D.M.; Starting Independent Research Grant, VU European Research Council).	Casey BJ, 2005, TRENDS COGN SCI, V9, P104, DOI 10.1016/j.tics.2005.01.011; Chassin L, 1996, HEALTH PSYCHOL, V15, P478, DOI 10.1037/0278-6133.15.6.478; Chudasama Y, 2003, BEHAV BRAIN RES, V146, P105, DOI 10.1016/j.bbr.2003.09.020; Council for Disabled Children, 2022, CHILDREN YOUNG PEOPL; Counotte DS, 2009, NEUROPSYCHOPHARMACOL, V34, P299, DOI 10.1038/npp.2008.96; Dalley JW, 2004, NEUROSCI BIOBEHAV R, V28, P771, DOI 10.1016/j.neubiorev.2004.09.006; Jacobsen LK, 2007, NEUROPSYCHOPHARMACOL, V32, P2453, DOI 10.1038/sj.npp.1301398; Jacobsen LK, 2005, BIOL PSYCHIAT, V57, P56, DOI 10.1016/j.biopsych.2004.10.022; Mateo Z, 2007, NEUROSCIENCE, V146, P1062, DOI 10.1016/j.neuroscience.2007.02.053; Mathers M, 2006, ADDICTION, V101, P948, DOI 10.1111/j.1360-0443.2006.01438.x; Pattij T, 2008, TRENDS PHARMACOL SCI, V29, P192, DOI 10.1016/j.tips.2008.01.002; Robbins TW, 2002, PSYCHOPHARMACOLOGY, V163, P362, DOI 10.1007/s00213-002-1154-7; Slotkin TA, 2004, TOXICOL APPL PHARM, V198, P132, DOI 10.1016/j.taap.2003.06.001; Spear LP, 2000, NEUROSCI BIOBEHAV R, V24, P417, DOI 10.1016/S0149-7634(00)00014-2; ZUCKER RS, 1989, ANNU REV NEUROSCI, V12, P13, DOI 10.1146/annurev.neuro.12.1.13	15	90	94	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2011	14	4					417	419		10.1038/nn.2770	http://dx.doi.org/10.1038/nn.2770			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	741FQ	21336271				2022-12-28	WOS:000288849400009
J	Chan, CS; Glajch, KE; Gertler, TS; Guzman, JN; Mercer, JN; Lewis, AS; Goldberg, AB; Tkatch, T; Shigemoto, R; Fleming, SM; Chetkovich, DM; Osten, P; Kita, H; Surmeier, DJ				Chan, C. Savio; Glajch, Kelly E.; Gertler, Tracy S.; Guzman, Jaime N.; Mercer, Jeff N.; Lewis, Alan S.; Goldberg, Alan B.; Tkatch, Tatiana; Shigemoto, Ryuichi; Fleming, Sheila M.; Chetkovich, Dane M.; Osten, Pavel; Kita, Hitoshi; Surmeier, D. James			HCN channelopathy in external globus pallidus neurons in models of Parkinson's disease	NATURE NEUROSCIENCE			English	Article							BASAL GANGLIA; IN-VITRO; ABSENCE EPILEPSY; DOPAMINE; PLASTICITY; OSCILLATIONS; DISORDERS; RECEPTORS; MICE; PATHOPHYSIOLOGY	Parkinson's disease is a common neurodegenerative disorder characterized by a profound motor disability that is traceable to the emergence of synchronous, rhythmic spiking in neurons of the external segment of the globus pallidus (GPe). The origins of this pathophysiology are poorly defined for the generation of pacemaking. After the induction of a parkinsonian state in mice, there was a progressive decline in autonomous GPe pacemaking, which normally serves to desynchronize activity. The loss was attributable to the downregulation of an ion channel that is essential in pacemaking, the hyperpolarization and cyclic nucleotide-gated (HCN) channel. Viral delivery of HCN2 subunits restored pacemaking and reduced burst spiking in GPe neurons. However, the motor disability induced by dopamine (DA) depletion was not reversed, suggesting that the loss of pacemaking was a consequence, rather than a cause, of key network pathophysiology, a conclusion that is consistent with the ability of L-type channel antagonists to attenuate silencing after DA depletion.	[Chan, C. Savio; Glajch, Kelly E.; Gertler, Tracy S.; Guzman, Jaime N.; Mercer, Jeff N.; Goldberg, Alan B.; Tkatch, Tatiana; Chetkovich, Dane M.; Osten, Pavel; Surmeier, D. James] Northwestern Univ, Feinberg Sch Med, Dept Physiol, Chicago, IL 60611 USA; [Lewis, Alan S.; Chetkovich, Dane M.] Northwestern Univ, Feinberg Sch Med, Dept Neurol & Clin Neurosci, Chicago, IL 60611 USA; [Shigemoto, Ryuichi] Natl Inst Physiol Sci, Div Cerebral Struct, Okazaki, Aichi 444, Japan; [Fleming, Sheila M.] Univ Cincinnati, Dept Psychol, Cincinnati, OH 45221 USA; [Osten, Pavel] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Kita, Hitoshi] Univ Tennessee, Coll Med, Dept Anat & Neurobiol, Memphis, TN USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); University System of Ohio; University of Cincinnati; Cold Spring Harbor Laboratory; University of Tennessee System; University of Tennessee Health Science Center	Surmeier, DJ (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Physiol, Chicago, IL 60611 USA.	j-surmeier@northwestern.edu	Shigemoto, Ryuichi/E-3628-2013; Lewis, Alan/AAV-9582-2021; Chetkovich, Dane/AAV-5457-2021	Shigemoto, Ryuichi/0000-0001-8761-9444; Lewis, Alan/0000-0002-7165-5376; Chan, C. Savio/0000-0002-3474-1718; Tkatch, Tatiana/0000-0001-6626-7435	Parkinson's Disease Foundation; American Parkinson Disease Association Research; Michael J. Fox Foundation; Hartmann Foundation; US National Institutes of Health [NS069777, MH082522, NS064757, NS05595, NS059934, NS042762, NS047085]; NATIONAL INSTITUTE OF MENTAL HEALTH [F30MH082522] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS065391, R01NS042762, R01NS069777, P50NS047085, F30NS064757, R01NS059934, K02NS055995] Funding Source: NIH RePORTER	Parkinson's Disease Foundation; American Parkinson Disease Association Research; Michael J. Fox Foundation; Hartmann Foundation; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Y. Chen, K. Saporito and S. Ulrich for technical assistance. This work was supported by grants from the Parkinson's Disease Foundation and American Parkinson Disease Association Research to C.S.C.; a grant from the Michael J. Fox Foundation to P.O.; a grant from the Hartmann Foundation to D.J.S. and US National Institutes of Health grants NS069777 to C.S.C., MH082522 to T.S.G., NS064757 to A.S.L., NS05595 and NS059934 to D.M.C., NS042762 to H.K. and NS047085 to D.J.S.	ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; Bevan MD, 2002, TRENDS NEUROSCI, V25, P525, DOI 10.1016/S0166-2236(02)02235-X; Biel M, 2009, PHYSIOL REV, V89, P847, DOI 10.1152/physrev.00029.2008; Blume SR, 2009, EXP NEUROL, V219, P208, DOI 10.1016/j.expneurol.2009.05.017; Chan CS, 2007, NATURE, V447, P1081, DOI 10.1038/nature05865; Chan CS, 2004, J NEUROSCI, V24, P9921, DOI 10.1523/JNEUROSCI.2162-04.2004; Chung WK, 2009, NEUROBIOL DIS, V33, P499, DOI 10.1016/j.nbd.2008.12.004; Cooper AJ, 2001, NEUROPHARMACOLOGY, V41, P62, DOI 10.1016/S0028-3908(01)00038-7; DeLong MR, 2007, ARCH NEUROL-CHICAGO, V64, P20, DOI 10.1001/archneur.64.1.20; DELONG MR, 1971, J NEUROPHYSIOL, V34, P414, DOI 10.1152/jn.1971.34.3.414; Fleming SM, 2004, J NEUROSCI, V24, P9434, DOI 10.1523/JNEUROSCI.3080-04.2004; Galati S, 2009, J PHYSIOL-LONDON, V587, P4405, DOI 10.1113/jphysiol.2009.172759; Gillies A, 2002, P ROY SOC B-BIOL SCI, V269, P545, DOI 10.1098/rspb.2001.1817; Graybiel AM, 2008, ANNU REV NEUROSCI, V31, P359, DOI 10.1146/annurev.neuro.29.051605.112851; Hammond C, 2007, TRENDS NEUROSCI, V30, P357, DOI 10.1016/j.tins.2007.05.004; Heimer G, 2002, J NEUROSCI, V22, P7850; Hernandez A, 2006, J NEUROPHYSIOL, V96, P2877, DOI 10.1152/jn.00664.2006; Higley MJ, 2010, NAT NEUROSCI, V13, P958, DOI 10.1038/nn.2592; Iancu R, 2005, BEHAV BRAIN RES, V162, P1, DOI 10.1016/j.bbr.2005.02.023; KITA H, 1991, BRAIN RES, V564, P296, DOI 10.1016/0006-8993(91)91466-E; Kole MHP, 2007, J PHYSIOL-LONDON, V578, P507, DOI 10.1113/jphysiol.2006.122028; Lewis AS, 2009, J NEUROSCI, V29, P6250, DOI 10.1523/JNEUROSCI.0856-09.2009; Mallet N, 2006, J NEUROSCI, V26, P3875, DOI 10.1523/JNEUROSCI.4439-05.2006; Mallet N, 2008, J NEUROSCI, V28, P14245, DOI 10.1523/JNEUROSCI.4199-08.2008; Mercer JN, 2007, J NEUROSCI, V27, P13552, DOI 10.1523/JNEUROSCI.3430-07.2007; NAMBU A, 1994, J NEUROPHYSIOL, V72, P1127, DOI 10.1152/jn.1994.72.3.1127; Nolan MF, 2003, CELL, V115, P551, DOI 10.1016/S0092-8674(03)00884-5; Notomi T, 2004, J COMP NEUROL, V471, P241, DOI 10.1002/cne.11039; Obeso JA, 2000, TRENDS NEUROSCI, V23, pS8, DOI 10.1016/S1471-1931(00)00028-8; Rivlin-Etzion M, 2006, CURR OPIN NEUROBIOL, V16, P629, DOI 10.1016/j.conb.2006.10.002; Robinson RB, 2003, ANNU REV PHYSIOL, V65, P453, DOI 10.1146/annurev.physiol.65.092101.142734; Santoro B, 2004, J NEUROSCI, V24, P10750, DOI 10.1523/JNEUROSCI.3300-04.2004; Schallert T, 2000, NEUROPHARMACOLOGY, V39, P777, DOI 10.1016/S0028-3908(00)00005-8; Shah MM, 2004, NEURON, V44, P495, DOI 10.1016/j.neuron.2004.10.011; Shin RM, 2003, J NEUROSCI, V23, P11662; Stanford IM, 2003, J NEUROPHYSIOL, V89, P1713, DOI 10.1152/jn.00864.2002; Strauss U, 2004, EUR J NEUROSCI, V19, P3048, DOI 10.1111/j.0953-816X.2004.03392.x; Surmeier DJ, 2005, CURR OPIN NEUROBIOL, V15, P312, DOI 10.1016/j.conb.2005.05.007; Terman D, 2002, J NEUROSCI, V22, P2963, DOI 10.1523/JNEUROSCI.22-07-02963.2002; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; Walters JR, 2007, NEUROSCIENCE, V144, P762, DOI 10.1016/j.neuroscience.2006.10.006; Walters JR, 2000, TRENDS NEUROSCI, V23, pS41, DOI 10.1016/S1471-1931(00)00024-0; Watanabe K, 2009, J NEUROPHYSIOL, V101, P665, DOI 10.1152/jn.90806.2008; Xu WF, 2001, J NEUROSCI, V21, P5944, DOI 10.1523/JNEUROSCI.21-16-05944.2001; Zhang W, 2003, NAT REV NEUROSCI, V4, P885, DOI 10.1038/nrn1248; Zucker RS, 1999, CURR OPIN NEUROBIOL, V9, P305, DOI 10.1016/S0959-4388(99)80045-2	47	126	127	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2011	14	1					85	U117		10.1038/nn.2692	http://dx.doi.org/10.1038/nn.2692			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	699TE	21076425	Green Accepted			2022-12-28	WOS:000285684900018
J	Ferguson, SM; Eskenazi, D; Ishikawa, M; Wanat, MJ; Phillips, PEM; Dong, Y; Roth, BL; Neumaier, JF				Ferguson, Susan M.; Eskenazi, Daniel; Ishikawa, Masago; Wanat, Matthew J.; Phillips, Paul E. M.; Dong, Yan; Roth, Bryan L.; Neumaier, John F.			Transient neuronal inhibition reveals opposing roles of indirect and direct pathways in sensitization	NATURE NEUROSCIENCE			English	Article							PROTEIN-COUPLED RECEPTORS; STRIATOPALLIDAL NEURONS; ADDICTION; DOPAMINE; PLASTICITY; EXPRESSION; D1	Dorsal striatum is important for the development of drug addiction; however, a precise understanding of the roles of striatopallidal (indirect) and striatonigral (direct) pathway neurons in regulating behaviors remains elusive. Using viral-mediated expression of an engineered G protein-coupled receptor (hM(4)D), we found that activation of hM(4)D receptors with clozapine-N-oxide (CNO) potently reduced striatal neuron excitability. When hM(4)D receptors were selectively expressed in either direct or indirect pathway neurons, CNO did not change acute locomotor responses to amphetamine, but did alter behavioral plasticity associated with repeated drug treatment. Specifically, transiently disrupting striatopallidal neuronal activity facilitated behavioral sensitization, whereas decreasing excitability of striatonigral neurons impaired its persistence. These findings suggest that acute drug effects can be parsed from the behavioral adaptations associated with repeated drug exposure and highlight the utility of this approach for deconstructing neuronal pathway contributions to behavior.	[Ferguson, Susan M.; Eskenazi, Daniel; Wanat, Matthew J.; Phillips, Paul E. M.; Neumaier, John F.] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [Ishikawa, Masago; Dong, Yan] Washington State Univ, Program Neurosci, Pullman, WA 99164 USA; [Wanat, Matthew J.; Phillips, Paul E. M.; Neumaier, John F.] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; [Roth, Bryan L.] Univ N Carolina, Sch Med, Dept Pharmacol, Chapel Hill, NC USA	University of Washington; University of Washington Seattle; Washington State University; University of Washington; University of Washington Seattle; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Neumaier, JF (corresponding author), Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA.	neumaier@uw.edu	Roth, Bryan/ABE-7032-2020; Dong, Yan/A-4154-2016; Roth, Bryan L/F-3928-2010; Phillips, Paul E. M./A-4463-2008; Ferguson, Susan/J-5427-2013; Phillips, Paul/E-7813-2013	Roth, Bryan/0000-0002-0561-6520; Dong, Yan/0000-0003-0016-9028; Phillips, Paul E. M./0000-0002-8749-7026; Ferguson, Susan/0000-0002-2840-757X; Phillips, Paul/0000-0002-8749-7026; Wanat, Matthew/0000-0003-1643-6557	US National Institutes of Health [K99 DA024762, T32 GM07266, T32 GM07108, T32 AA009455, F32 DA026273, R21 DA021793, R01 DA023206, U19MH82441]; National Institute of Mental Health; National Alliance for Research on Schizophrenia and Depression Distinguished Investigator Award; Achievement Rewards for College Scientists;  [R21 DA021273]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007266, T32GM007108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U19MH082441] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA017204, R01DA023206, R21DA021793, F32DA026273, K99DA024762, R21DA021273] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Alliance for Research on Schizophrenia and Depression Distinguished Investigator Award(NARSAD); Achievement Rewards for College Scientists; ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by US National Institutes of Health grants K99 DA024762 (S.M.F.), T32 GM07266 and T32 GM07108 (D.E.), T32 AA009455 and F32 DA026273 (M.J.W.), R21 DA021793 (P.E.M.P.), R01 DA023206 (Y.D.), U19MH82441 and the National Institute of Mental Health Psychoactive Drug Screening Program (B.L.R.), and R21 DA021273 (J.F.N.), an Achievement Rewards for College Scientists (D.E.), and a National Alliance for Research on Schizophrenia and Depression Distinguished Investigator Award (B.L.R.).	Alexander GM, 2009, NEURON, V63, P27, DOI 10.1016/j.neuron.2009.06.014; Armbruster BN, 2007, P NATL ACAD SCI USA, V104, P5163, DOI 10.1073/pnas.0700293104; Badiani A, 1999, BEHAV BRAIN RES, V103, P203, DOI 10.1016/S0166-4328(99)00041-8; Berke JD, 2000, NEURON, V25, P515, DOI 10.1016/S0896-6273(00)81056-9; Clark JJ, 2010, NAT METHODS, V7, P126, DOI [10.1038/NMETH.1412, 10.1038/nmeth.1412]; Conklin BR, 2008, NAT METHODS, V5, P673, DOI 10.1038/nmeth.1232; Durieux PF, 2009, NAT NEUROSCI, V12, P393, DOI 10.1038/nn.2286; GERFEN CR, 1990, SCIENCE, V250, P1429, DOI 10.1126/science.2147780; Harlan RE, 1998, MOL NEUROBIOL, V16, P221, DOI 10.1007/BF02741385; Hyman SE, 2001, NAT REV NEUROSCI, V2, P695, DOI 10.1038/35094560; Nestler EJ, 2001, NAT REV NEUROSCI, V2, P119, DOI 10.1038/35053570; Robinson TE, 2001, ADDICTION, V96, P103, DOI 10.1046/j.1360-0443.2001.9611038.x; Shen WX, 2008, SCIENCE, V321, P848, DOI 10.1126/science.1160575; Smith Y, 1998, NEUROSCIENCE, V86, P353	14	319	322	1	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2011	14	1					22	24		10.1038/nn.2703	http://dx.doi.org/10.1038/nn.2703			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	699TE	21131952	Green Submitted, Green Accepted			2022-12-28	WOS:000285684900008
J	Bosco, DA; Morfini, G; Karabacak, NM; Song, YY; Gros-Louis, F; Pasinelli, P; Goolsby, H; Fontaine, BA; Lemay, N; McKenna-Yasek, D; Frosch, MP; Agar, JN; Julien, JP; Brady, ST; Brown, RH				Bosco, Daryl A.; Morfini, Gerardo; Karabacak, N. Murat; Song, Yuyu; Gros-Louis, Francois; Pasinelli, Piera; Goolsby, Holly; Fontaine, Benjamin A.; Lemay, Nathan; McKenna-Yasek, Diane; Frosch, Matthew P.; Agar, Jeffrey N.; Julien, Jean-Pierre; Brady, Scott T.; Brown, Robert H., Jr.			Wild-type and mutant SOD1 share an aberrant conformation and a common pathogenic pathway in ALS	NATURE NEUROSCIENCE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; FAST AXONAL-TRANSPORT; HUMAN SUPEROXIDE-DISMUTASE; MOTOR-NEURON DISEASE; NEURODEGENERATIVE DISEASES; PROTEIN AGGREGATION; EXTRUDED AXOPLASM; SPINAL-CORDS; LINKED SOD1; MOUSE MODEL	Many mutations confer one or more toxic function(s) on copper/zinc superoxide dismutase 1 (SOD1) that impair motor neuron viability and cause familial amyotrophic lateral sclerosis (FALS). Using a conformation-specific antibody that detects misfolded SOD1 (C4F6), we found that oxidized wild-type SOD1 and mutant SOD1 share a conformational epitope that is not present in normal wild-type SOD1. In a subset of human sporadic ALS (SALS) cases, motor neurons in the lumbosacral spinal cord were markedly C4F6 immunoreactive, indicating that an aberrant wild-type SOD1 species was present. Recombinant, oxidized wildtype SOD1 and wild-type SOD1 immunopurified from SALS tissues inhibited kinesin-based fast axonal transport in a manner similar to that of FALS-linked mutant SOD1. Our findings suggest that wild-type SOD1 can be pathogenic in SALS and identify an SOD1-dependent pathogenic mechanism common to FALS and SALS.	[Bosco, Daryl A.; Fontaine, Benjamin A.; Lemay, Nathan; McKenna-Yasek, Diane; Brown, Robert H., Jr.] Univ Massachusetts Med Ctr, Dept Neurol, Worcester, MA USA; [Morfini, Gerardo; Song, Yuyu; Brady, Scott T.] Univ Illinois, Dept Anat & Cell Biol, Chicago, IL USA; [Karabacak, N. Murat; Agar, Jeffrey N.] Brandeis Univ, Dept Chem, Waltham, MA 02254 USA; [Gros-Louis, Francois; Julien, Jean-Pierre] Univ Laval, Dept Psychiat & Neurosci, Res Ctr CHUQ, Quebec City, PQ, Canada; [Pasinelli, Piera] Thomas Jefferson Univ, Farber Inst Neurosci, Weinberg Unit ALS Res, Philadelphia, PA 19107 USA; [Goolsby, Holly; Frosch, Matthew P.] Massachusetts Gen Hosp, CS Kubik Lab Neuropathol, Boston, MA 02114 USA; [Morfini, Gerardo; Song, Yuyu; Brady, Scott T.] Marine Biol Lab, Woods Hole, MA 02543 USA	University of Massachusetts System; University of Massachusetts Worcester; University Massachusetts Worcester Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Brandeis University; Laval University; Jefferson University; Harvard University; Massachusetts General Hospital; Marine Biological Laboratory - Woods Hole	Bosco, DA (corresponding author), Univ Massachusetts Med Ctr, Dept Neurol, Worcester, MA USA.	daryl.bosco@umassmed.edu; robert.brown@umassmed.edu	Karabacak, N Murat/D-7227-2013; Song, Yuyu/J-8939-2019; Karabacak, Murat/AAG-2891-2019; Frosch, Matthew P/ABD-7456-2021	Karabacak, N Murat/0000-0003-2761-5593; Song, Yuyu/0000-0002-9196-1610; Karabacak, Murat/0000-0003-2761-5593; Frosch, Matthew P/0000-0002-3940-9861; Agar, Jeffery/0000-0003-2645-1873; Pasinelli, Piera/0000-0002-3385-2707	ALS Therapy Alliance-CVS Pharmacy; Marine Biological Laboratory; ALS Association; US National Institutes of Health; National Institute on Neurological Disorders and Stroke [RO1NS067206-01, U01NS05225-03, R01NS050557-05, 1RC1NS068391-01, 1RC2NS070342-01]; Canadian Institutes of Health Research; Angel Fund; ALS; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS023868, RC2NS070342, RC1NS068391, R01NS050557, R01NS065263, R01NS067206] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG005134] Funding Source: NIH RePORTER	ALS Therapy Alliance-CVS Pharmacy; Marine Biological Laboratory; ALS Association; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Angel Fund; ALS; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We are grateful to J. Landers and P. Sapp for DNA sequencing analysis of the SALS cases employed in this study, L. Hayward, A. Tiwari and R.-J. Chain for help with expression of recombinant wild-type SOD1, S. Berth, A. Leitman and M. Saparauskaite for help with axoplasm vesicle transport assays, A. Kaminska and L. Molla for help with biochemical experiments in squid axoplasm, M. Prudencio and D. Borchelt for cell lysates containing SOD1 G93 mutants, C. Vanderburg, E. Tamrazian, A. Bialik and the Diabetes and Endocrinology Research Center (University of Massachusetts Medical Center) for assistance with immunohistochemistry, K. Fitch and the Massachusetts Alzheimer Disease Research Center (P50AG005134) for assistance with human tissue samples, J. Zitzewitz for C6A/C111S-SOD1 protein, A. Weiss for assistance with mice, K. Green at the University of Massachusetts Medical Center Proteomics and Mass Spectrometry Facility for analysis of C6A/C111S-SOD1, and G. Petsko for insightful dialogue and support. We acknowledge financial support from the ALS Therapy Alliance-CVS Pharmacy (D. A. B. and G. M.), 2007/2008 Marine Biological Laboratory research fellowships (G. M.), the ALS Association (D. A. B., R. H. B. Jr, G. M. and S. T. B.), the US National Institutes of Health (D. A. B. (National Institute on Neurological Disorders and Stroke, RO1NS067206-01), R. H. B. Jr (National Institute on Neurological Disorders and Stroke, U01NS05225-03, R01NS050557-05, 1RC1NS068391-01 and 1RC2NS070342-01), S. T. B. and J.N.A.), Canadian Institutes of Health Research (J.-P.J.), the Angel Fund (R. H. B. Jr) and Project ALS (R.H.B.Jr).	Abou Ezzi S, 2007, J NEUROCHEM, V102, P170, DOI 10.1111/j.1471-4159.2007.04531.x; Banci L, 2007, P NATL ACAD SCI USA, V104, P11263, DOI 10.1073/pnas.0704307104; Beckman JS, 2001, TRENDS NEUROSCI, V24, pS15, DOI 10.1016/S0166-2236(00)01981-0; BRADY ST, 1982, SCIENCE, V218, P1129, DOI 10.1126/science.6183745; BRADY ST, 1985, CELL MOTIL CYTOSKEL, V5, P81, DOI 10.1002/cm.970050203; Bredesen DE, 1997, ANN NEUROL, V42, P135, DOI 10.1002/ana.410420202; Bruijn LI, 1998, SCIENCE, V281, P1851, DOI 10.1126/science.281.5384.1851; Chattopadhyay M, 2009, ANTIOXID REDOX SIGN, V11, P1603, DOI [10.1089/ars.2009.2536, 10.1089/ARS.2009.2536]; COLLARD JF, 1995, NATURE, V375, P61, DOI 10.1038/375061a0; De Vos KJ, 2008, ANNU REV NEUROSCI, V31, P151, DOI 10.1146/annurev.neuro.31.061307.090711; DURAZO A, 2009, J BIOL CHEM, V277, P15923; Estevez AG, 1999, SCIENCE, V286, P2498, DOI 10.1126/science.286.5449.2498; Fabian MA, 2005, NAT BIOTECHNOL, V23, P329, DOI 10.1038/nbt1068; Fischer LR, 2007, NEURODEGENER DIS, V4, P431, DOI 10.1159/000107704; Fujiwara N, 2007, J BIOL CHEM, V282, P35933, DOI 10.1074/jbc.M702941200; Furukawa Y, 2006, P NATL ACAD SCI USA, V103, P7148, DOI 10.1073/pnas.0602048103; Gros-Louis F, 2010, J NEUROCHEM, V113, P1188, DOI 10.1111/j.1471-4159.2010.06683.x; Gruzman A, 2007, P NATL ACAD SCI USA, V104, P12524, DOI 10.1073/pnas.0705044104; Hayward LJ, 2002, J BIOL CHEM, V277, P15923, DOI 10.1074/jbc.M112087200; Kabashi E, 2007, ANN NEUROL, V62, P553, DOI 10.1002/ana.21319; Kerman A, 2010, ACTA NEUROPATHOL, V119, P335, DOI 10.1007/s00401-010-0646-5; Lindberg MJ, 2004, P NATL ACAD SCI USA, V101, P15893, DOI 10.1073/pnas.0403979101; Liu HN, 2009, ANN NEUROL, V66, P75, DOI 10.1002/ana.21704; Molnar KS, 2009, J BIOL CHEM, V284, P30965, DOI 10.1074/jbc.M109.023945; Morfini G, 2002, EMBO J, V21, P281, DOI 10.1093/emboj/21.3.281; Morfini G, 2006, NAT NEUROSCI, V9, P907, DOI 10.1038/nn1717; Morfini GA, 2009, J NEUROSCI, V29, P12776, DOI 10.1523/JNEUROSCI.3463-09.2009; Morfini GA, 2009, NAT NEUROSCI, V12, P864, DOI 10.1038/nn.2346; Munoz L, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-21; Pasinelli P, 2004, NEURON, V43, P19, DOI 10.1016/j.neuron.2004.06.021; Prudencio M, 2009, HUM MOL GENET, V18, P3217, DOI 10.1093/hmg/ddp260; Rakhit R, 2004, J BIOL CHEM, V279, P15499, DOI 10.1074/jbc.M313295200; Rakhit R, 2002, J BIOL CHEM, V277, P47551, DOI 10.1074/jbc.M207356200; Rakhit R, 2007, NAT MED, V13, P754, DOI 10.1038/nm1559; SHIBATA N, 1994, NEUROSCI LETT, V179, P149, DOI 10.1016/0304-3940(94)90956-3; Shibata N, 1996, DEV NEUROSCI-BASEL, V18, P492, DOI 10.1159/000111445; Strange RW, 2006, J MOL BIOL, V356, P1152, DOI 10.1016/j.jmb.2005.11.081; Strom AL, 2008, J NEUROCHEM, V106, P495, DOI 10.1111/j.1471-4159.2008.05393.x; Svensson AKE, 2006, J MOL BIOL, V364, P1084, DOI 10.1016/j.jmb.2006.09.005; TANDAN R, 1985, ANN NEUROL, V18, P271, DOI 10.1002/ana.410180302; Tiwari A, 2009, J BIOL CHEM, V284, P27746, DOI 10.1074/jbc.M109.043729; Urushitani M, 2006, NAT NEUROSCI, V9, P108, DOI 10.1038/nn1603; Urushitani M, 2007, P NATL ACAD SCI USA, V104, P2495, DOI 10.1073/pnas.0606201104; Valdmanis PN, 2009, CURR NEUROL NEUROSCI, V9, P198, DOI 10.1007/s11910-009-0030-9; Valentine JS, 2005, ANNU REV BIOCHEM, V74, P563, DOI 10.1146/annurev.biochem.72.121801.161647; Ve Velde C., 2008, P NATL ACAD SCI USA, V105, P4022, DOI [DOI 10.1073/PNAS.0712209105, 10.1073/pnas.0712209105]; Wang LJ, 2009, HUM MOL GENET, V18, P1642, DOI 10.1093/hmg/ddp085; Wang Q, 2008, PLOS BIOL, V6, P1508, DOI 10.1371/journal.pbio.0060170; Watanabe M, 2001, NEUROBIOL DIS, V8, P933, DOI 10.1006/nbdi.2001.0443; Williamson TL, 1999, NAT NEUROSCI, V2, P50, DOI 10.1038/4553	50	494	515	1	65	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2010	13	11					1396	U133		10.1038/nn.2660	http://dx.doi.org/10.1038/nn.2660			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	673KI	20953194	Green Accepted, Green Submitted			2022-12-28	WOS:000283658200021
J	Fassier, C; Hutt, JA; Scholpp, S; Lumsden, A; Giros, B; Nothias, F; Schneider-Maunoury, S; Houart, C; Hazan, J				Fassier, Coralie; Hutt, James A.; Scholpp, Steffen; Lumsden, Andrew; Giros, Bruno; Nothias, Fatiha; Schneider-Maunoury, Sylvie; Houart, Corinne; Hazan, Jamile			Zebrafish atlastin controls motility and spinal motor axon architecture via inhibition of the BMP pathway	NATURE NEUROSCIENCE			English	Article							HEREDITARY SPASTIC PARAPLEGIA; REGULATES SYNAPTIC GROWTH; II RECEPTOR; MUTATIONS; PROTEIN; TRAFFICKING; MORPHOGENS; EXPRESSION; GUIDANCE; REQUIRES	To better understand hereditary spastic paraplegia (HSP), we characterized the function of atlastin, a protein that is frequently involved in juvenile forms of HSP, by analyzing loss- and gain-of-function phenotypes in the developing zebrafish. We found that knockdown of the gene for atlastin (atl1) caused a severe decrease in larval mobility that was preceded by abnormal architecture of spinal motor axons and was associated with a substantial upregulation of the bone morphogenetic protein (BMP) signaling pathway. Overexpression analyses confirmed that atlastin inhibits BMP signaling. In primary cultures of zebrafish spinal neurons, Atlastin partially colocalized with type I BMP receptors in late endosomes distributed along neurites, which suggests that atlastin may regulate BMP receptor trafficking. Finally, genetic or pharmacological inhibition of BMP signaling was sufficient to rescue the loss of mobility and spinal motor axon defects of atl1 morphants, emphasizing the importance of fine-tuning the balance of BMP signaling for vertebrate motor axon architecture and stability.	[Fassier, Coralie; Giros, Bruno; Nothias, Fatiha; Hazan, Jamile] CNRS, UMR 7224, Paris, France; [Fassier, Coralie; Giros, Bruno; Nothias, Fatiha; Hazan, Jamile] INSERM, U952, Paris, France; [Fassier, Coralie; Giros, Bruno; Nothias, Fatiha; Schneider-Maunoury, Sylvie; Hazan, Jamile] Univ Paris 06, Paris, France; [Hutt, James A.; Scholpp, Steffen; Lumsden, Andrew; Houart, Corinne; Hazan, Jamile] Kings Coll London, MRC, Ctr Dev Neurobiol, London WC2R 2LS, England; [Scholpp, Steffen] Karlsruhe Inst Technol, Inst Toxicol & Genet, Karlsruhe, Germany; [Giros, Bruno] McGill Univ, Dept Psychiat, Douglas Hosp, Montreal, PQ, Canada; [Schneider-Maunoury, Sylvie] CNRS, UMR7622, Paris, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; University of London; King's College London; Helmholtz Association; Karlsruhe Institute of Technology; McGill University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB)	Hazan, J (corresponding author), CNRS, UMR 7224, Paris, France.	corinne.houart@kcl.ac.uk; jhazan@snv.jussieu.fr	Scholpp, Steffen/H-2060-2013; GIROS, Bruno/ABD-5790-2021; Houart, Corinne/B-5128-2009; Schneider-Maunoury, Sylvie/K-6795-2017; Scholpp, Steffen/E-4472-2018; Lumsden, Andrew/C-5146-2009	Scholpp, Steffen/0000-0002-4903-9657; GIROS, Bruno/0000-0001-5876-9822; Houart, Corinne/0000-0002-2062-3964; Schneider-Maunoury, Sylvie/0000-0002-0797-4735; Scholpp, Steffen/0000-0002-4903-9657; Hazan, Jamile/0000-0001-8119-0325; Nothias-Chahir, Fatiha/0000-0002-2497-2096; Fassier, Coralie/0000-0003-3015-4281	Houart laboratory; Schneider-Maunoury laboratory; Nothias laboratory; King's College Charitable Foundation; FRM; AFM; MRC; Association Strumpell-Lorrain (A-SL); MRC [G0601064] Funding Source: UKRI; Medical Research Council [G0601064, G0901899B] Funding Source: researchfish	Houart laboratory; Schneider-Maunoury laboratory; Nothias laboratory; King's College Charitable Foundation; FRM(Fondation pour la Recherche Medicale); AFM(Association Francaise contre les Myopathies); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Association Strumpell-Lorrain (A-SL); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank J. Clarke, M. Salanoubat, J. Weissenbach and the Houart, Schneider-Maunoury and Nothias laboratories for discussions and support, S. Llewellyn-Jones, S. Thomas and G. Rodrigues for fish care at King's College London and IFR83/UPMC, and R. Schwartzmann and V. Georget for the IFR83 imaging platform. We thank the patients' Association Strumpell-Lorrain (A-SL) for their constant support. J. H., a CNRS research fellow, received a senior research fellowship from King's College Charitable Foundation for 2 years in C.H.'s lab. C. F. was supported by fellowships from the FRM and the AFM. This work was supported by research grants to C. H. from the MRC and from AFM and A-SL to J.H.	Aberle H, 2002, NEURON, V33, P545, DOI 10.1016/S0896-6273(02)00589-5; Andersen Soren S. L., 2001, Methods in Cell Science, V23, P205, DOI 10.1023/A:1016349232389; Ball RW, 2010, NEURON, V66, P536, DOI 10.1016/j.neuron.2010.04.011; Chang HCH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003209; Charron F, 2005, DEVELOPMENT, V132, P2251, DOI 10.1242/dev.01830; Colavita A, 1998, SCIENCE, V281, P706, DOI 10.1126/science.281.5377.706; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; Durr A, 2004, ARCH NEUROL-CHICAGO, V61, P1867, DOI 10.1001/archneur.61.12.1867; Eaton BA, 2005, NEURON, V47, P695, DOI 10.1016/j.neuron.2005.08.010; Flanagan-Steet H, 2005, DEVELOPMENT, V132, P4471, DOI 10.1242/dev.02044; Fusco C, 2010, BRAIN DEV-JPN, V32, P592, DOI 10.1016/j.braindev.2009.08.003; Higashijima S, 2000, J NEUROSCI, V20, P206, DOI 10.1523/JNEUROSCI.20-01-00206.2000; Hu JJ, 2009, CELL, V138, P549, DOI 10.1016/j.cell.2009.05.025; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kobielak K, 2003, J CELL BIOL, V163, P609, DOI 10.1083/jcb.200309042; Liu Y, 2008, J BIOL CHEM, V283, P6561, DOI 10.1074/jbc.M708096200; MACDONALD R, 1994, NEURON, V13, P1039, DOI 10.1016/0896-6273(94)90044-2; Marques G, 2002, NEURON, V33, P529, DOI 10.1016/S0896-6273(02)00595-0; Matsuura I, 2008, J NEUROCHEM, V105, P1471, DOI 10.1111/j.1471-4159.2008.05251.x; McCabe BD, 2004, NEURON, V41, P891, DOI 10.1016/S0896-6273(04)00073-X; McCabe BD, 2003, NEURON, V39, P241, DOI 10.1016/S0896-6273(03)00426-4; Mintzer KA, 2001, DEVELOPMENT, V128, P859; Namekawa M, 2007, MOL CELL NEUROSCI, V35, P1, DOI 10.1016/j.mcn.2007.01.012; O'Connor-Giles KM, 2008, NEURON, V58, P507, DOI 10.1016/j.neuron.2008.03.007; Orso G, 2009, NATURE, V460, P978, DOI 10.1038/nature08280; Park HC, 2002, DEV BIOL, V248, P356, DOI 10.1006/dbio.2002.0738; Piddini E, 2003, CURR OPIN CELL BIOL, V15, P474, DOI 10.1016/S0955-0674(03)00072-3; Pyati UJ, 2005, DEVELOPMENT, V132, P2333, DOI 10.1242/dev.01806; Rainier S, 2006, ARCH NEUROL-CHICAGO, V63, P445, DOI 10.1001/archneur.63.3.445; Ratnaparkhi A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002334; Reid E, 2003, J MED GENET, V40, P81, DOI 10.1136/jmg.40.2.81; Rismanchi N, 2008, HUM MOL GENET, V17, P1591, DOI 10.1093/hmg/ddn046; Salinas S, 2008, LANCET NEUROL, V7, P1127, DOI 10.1016/S1474-4422(08)70258-8; Sanderson CM, 2006, HUM MOL GENET, V15, P307, DOI 10.1093/hmg/ddi447; Scarano V, 2005, J NEUROL, V252, P901, DOI 10.1007/s00415-005-0768-1; SchulteMerker S, 1997, NATURE, V387, P862, DOI 10.1038/43092; Shanmugalingam S, 2000, DEVELOPMENT, V127, P2549; Smith BN, 2009, CLIN GENET, V75, P485, DOI 10.1111/j.1399-0004.2009.01184.x; Tarrade A, 2006, HUM MOL GENET, V15, P3544, DOI 10.1093/hmg/ddl431; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Tsang HTH, 2009, HUM MOL GENET, V18, P3805, DOI 10.1093/hmg/ddp324; Wang XN, 2007, NAT NEUROSCI, V10, P177, DOI 10.1038/nn1841; Wen ZX, 2007, J CELL BIOL, V178, P107, DOI 10.1083/jcb.200703055; Yang YS, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-12-234; Yui PB, 2008, NAT CHEM BIOL, V4, P33, DOI 10.1038/nchembio.2007.54; Zhao XP, 2001, NAT GENET, V29, P326, DOI 10.1038/ng758; Zhu PP, 2003, J BIOL CHEM, V278, P49063, DOI 10.1074/jbc.M306702200; Zhu PP, 2006, HUM MOL GENET, V15, P1343, DOI 10.1093/hmg/ddl054; Zou YM, 2007, CURR OPIN NEUROBIOL, V17, P22, DOI 10.1016/j.conb.2007.01.006	49	87	90	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2010	13	11					1380	U112		10.1038/nn.2662	http://dx.doi.org/10.1038/nn.2662			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	673KI	20935645				2022-12-28	WOS:000283658200019
J	Masri, S; Sassone-Corsi, P				Masri, Selma; Sassone-Corsi, Paolo			Plasticity and specificity of the circadian epigenome	NATURE NEUROSCIENCE			English	Article							SUPRACHIASMATIC NUCLEUS; TRANSCRIPTIONAL ACTIVATION; CHROMATIN MODIFICATION; BIOLOGICAL CLOCK; RECEPTOR; RHYTHMS; PHOSPHORYLATION; ACETYLATION; NEURONS; PATHWAY	Circadian clocks control a variety of neuronal, behavioral and physiological responses, via transcriptional regulation of an appreciable portion of the genome. We describe the complex communication network between the brain-specific central clock and the tissue-specific peripheral clocks that serve to synchronize the organism to both external and internal demands. In addition, we discuss and speculate on how epigenetic processes are involved in creating transcriptional environments that are permissive to tissue-specific gene expression programs, which work in concert with the circadian machinery. Accumulating data show that chromatin remodeling events may be critical for providing specificity and plasticity in circadian regulation, and metabolic cues may be involved in directing such epigenetic events. A detailed understanding of the communication cues between the central and peripheral clocks is crucial for a more complete understanding of the circadian system and the several levels of control that are implicated in maintaining biological timekeeping.	[Masri, Selma; Sassone-Corsi, Paolo] Univ Calif Irvine, Dept Pharmacol, INSERM Epigenet & Neuronal Plast U904, Sch Med, Irvine, CA 92717 USA	University of California System; University of California Irvine	Sassone-Corsi, P (corresponding author), Univ Calif Irvine, Dept Pharmacol, INSERM Epigenet & Neuronal Plast U904, Sch Med, Irvine, CA 92717 USA.	psc@uci.edu	Sassone-Corsi, Paolo/H-6182-2011	Masri, Selma/0000-0002-8619-8331	US National Institute of Health; INSERM (Institut National de la Sante et la Recherche Medicale), France; NATIONAL CANCER INSTITUTE [T32CA113265] Funding Source: NIH RePORTER	US National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); INSERM (Institut National de la Sante et la Recherche Medicale), France(Institut National de la Sante et de la Recherche Medicale (Inserm)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank all members of our laboratory for discussions and support. Work in the laboratory is supported by the US National Institute of Health and the INSERM (Institut National de la Sante et la Recherche Medicale), France.	ABE K, 1979, NEUROENDOCRINOLOGY, V29, P119, DOI 10.1159/000122913; Akhtar RA, 2002, CURR BIOL, V12, P540, DOI 10.1016/S0960-9822(02)00759-5; Alenghat T, 2008, NATURE, V456, P997, DOI 10.1038/nature07541; Asher G, 2008, CELL, V134, P317, DOI 10.1016/j.cell.2008.06.050; Aton SJ, 2005, NAT NEUROSCI, V8, P476, DOI 10.1038/nn1419; Baggs JE, 2009, PLOS BIOL, V7, P563, DOI 10.1371/journal.pbio.1000052; Balsalobre A, 2000, SCIENCE, V289, P2344, DOI 10.1126/science.289.5488.2344; Bechtold DA, 2010, TRENDS PHARMACOL SCI, V31, P191, DOI 10.1016/j.tips.2010.01.002; Belden WJ, 2007, MOL CELL, V25, P587, DOI 10.1016/j.molcel.2007.01.010; Cheng MY, 2002, NATURE, V417, P405, DOI 10.1038/417405a; Cheung P, 2000, MOL CELL, V5, P905, DOI 10.1016/S1097-2765(00)80256-7; Chwang WB, 2007, J NEUROSCI, V27, P12732, DOI 10.1523/JNEUROSCI.2522-07.2007; Crosio C, 2000, NAT NEUROSCI, V3, P1241, DOI 10.1038/81767; DING JM, 1994, SCIENCE, V266, P1713, DOI 10.1126/science.7527589; Doi M, 2006, CELL, V125, P497, DOI 10.1016/j.cell.2006.03.033; Duffield GE, 2002, CURR BIOL, V12, P551, DOI 10.1016/S0960-9822(02)00765-0; Duffield GE, 2009, CURR BIOL, V19, P297, DOI 10.1016/j.cub.2008.12.052; Eckel-Mahan K, 2009, NAT STRUCT MOL BIOL, V16, P462, DOI 10.1038/nsmb.1595; Etchegaray JP, 2006, J BIOL CHEM, V281, P21209, DOI 10.1074/jbc.M603722200; Etchegaray JP, 2003, NATURE, V421, P177, DOI 10.1038/nature01314; Gallego M, 2007, NAT REV MOL CELL BIO, V8, P139, DOI 10.1038/nrm2106; Gao J, 2010, NATURE, V466, P1105, DOI 10.1038/nature09271; Hirayama J, 2007, NATURE, V450, P1086, DOI 10.1038/nature06394; Impey S, 2002, NEURON, V34, P235, DOI 10.1016/S0896-6273(02)00654-2; Kalsbeek A, 2010, J NEUROENDOCRINOL, V22, P362, DOI 10.1111/j.1365-2826.2010.01956.x; KATADA S, NAT STRUCT IN PRESS; Kornmann B, 2007, PLOS BIOL, V5, P179, DOI 10.1371/journal.pbio.0050034; Kramer A, 2001, SCIENCE, V294, P2511, DOI 10.1126/science.1067716; Lamia KA, 2009, SCIENCE, V326, P437, DOI 10.1126/science.1172156; Nader N, 2009, FASEB J, V23, P1572, DOI 10.1096/fj.08-117697; Nakahata Y, 2008, CELL, V134, P329, DOI 10.1016/j.cell.2008.07.002; Nakahata Y, 2009, SCIENCE, V324, P654, DOI 10.1126/science.1170803; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; RALPH MR, 1990, SCIENCE, V247, P975, DOI 10.1126/science.2305266; Ramsey KM, 2009, SCIENCE, V324, P651, DOI 10.1126/science.1171641; Reppert SM, 2001, ANNU REV PHYSIOL, V63, P647, DOI 10.1146/annurev.physiol.63.1.647; Ripperger JRA, 2006, NAT GENET, V38, P369, DOI 10.1038/ng1738; Roozendaal B, 2010, J NEUROSCI, V30, P5037, DOI 10.1523/JNEUROSCI.5717-09.2010; Sahar S, 2009, NAT REV CANCER, V9, P886, DOI 10.1038/nrc2747; Thresher RJ, 1998, SCIENCE, V282, P1490, DOI 10.1126/science.282.5393.1490; Tousson E, 2004, J NEUROSCI, V24, P2983, DOI 10.1523/JNEUROSCI.5044-03.2004; Travnickova-Bendova Z, 2002, P NATL ACAD SCI USA, V99, P7728, DOI 10.1073/pnas.102075599; Tu HJ, 2007, CELL SIGNAL, V19, P1996, DOI 10.1016/j.cellsig.2007.05.004; Ueda HR, 2005, NAT GENET, V37, P187, DOI 10.1038/ng1504; Welsh DK, 2010, ANNU REV PHYSIOL, V72, P551, DOI 10.1146/annurev-physiol-021909-135919; WELSH DK, 1995, NEURON, V14, P697, DOI 10.1016/0896-6273(95)90214-7; Womac AD, 2009, EUR J NEUROSCI, V30, P869, DOI 10.1111/j.1460-9568.2009.06874.x; Yamazaki S, 2000, SCIENCE, V288, P682, DOI 10.1126/science.288.5466.682; Yan J, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000193; Yujnovsky I, 2006, P NATL ACAD SCI USA, V103, P6386, DOI 10.1073/pnas.0510691103	50	96	97	1	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2010	13	11					1324	1329		10.1038/nn.2668	http://dx.doi.org/10.1038/nn.2668			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	673KI	20975756	Green Accepted			2022-12-28	WOS:000283658200009
J	Hantman, AW; Jessell, TM				Hantman, Adam W.; Jessell, Thomas M.			Clarke's column neurons as the focus of a corticospinal corollary circuit	NATURE NEUROSCIENCE			English	Article							DORSAL SPINOCEREBELLAR TRACT; SPINAL-CORD; ORIGIN; TRANSMISSION; MOVEMENT; INTERNEURONS; CEREBELLUM; AFFERENTS; PATHWAY; FIBERS	Proprioceptive sensory signals inform the CNS of the consequences of motor acts, but effective motor planning involves internal neural systems capable of anticipating actual sensory feedback. Just where and how predictive systems exert their influence remains poorly understood. We explored the possibility that spinocerebellar neurons that convey proprioceptive sensory information also integrate information from cortical command systems. Analysis of the circuitry and physiology of identified dorsal spinocerebellar tract neurons in mouse spinal cord revealed distinct populations of Clarke's column neurons that received direct excitatory and/or indirect inhibitory inputs from descending corticospinal axons. The convergence of these descending inhibitory and excitatory inputs to Clarke's column neurons established local spinal circuits with the capacity to mark or modulate incoming proprioceptive input. Together, our genetic, anatomical and physiological results indicate that Clarke's column spinocerebellar neurons nucleate local spinal corollary circuits that are relevant to motor planning and evaluation.	[Jessell, Thomas M.] Columbia Univ, Howard Hughes Med Inst, Kavli Inst Brain Sci, Dept Neurosci, New York, NY 10032 USA; Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA	Columbia University; Howard Hughes Medical Institute; Columbia University	Jessell, TM (corresponding author), Columbia Univ, Howard Hughes Med Inst, Kavli Inst Brain Sci, Dept Neurosci, New York, NY 10032 USA.	tmj1@columbia.edu			Howard Hughes Medical Institute; Robert Leet and Clara Guthrie Patterson Trust; National Institute of Neurological Disorders and Stroke; Wellcome Trust; G. Harold and Leila Y. Mathers Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033245, R37NS033245] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Robert Leet and Clara Guthrie Patterson Trust; National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Wellcome Trust(Wellcome TrustEuropean Commission); G. Harold and Leila Y. Mathers Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank B. Han and K. Miao for technical assistance, J. de Nooij and G. Surmeli for help in retrograde labeling of proprioceptive afferents, J. Kirkland and M. Mendelsohn for animal care, and K. MacArthur and I. Schieren for help in preparing the manuscript. We are grateful to S. Arber, N. Asai, C. Cebrian, Z.J. Huang, J. Milbrandt, J. Sanes, G. Szabo and MMRCC-GENSAT for mouse lines, and especially to F. Costantini for permission to use unpublished Gdnf::CreERT2 mice. We thank R. Axel, M. Churchland, K. Franks, S. Grillner, J. Krakauer, C. Miall, S. Poliak, K. Ritola, D. Stettler and D. Wolpert for discussion and/or comments on the manuscript. A.W.H. was supported by the Howard Hughes Medical Institute and the Robert Leet and Clara Guthrie Patterson Trust Fellowship. T.M.J. was supported by grants from the National Institute of Neurological Disorders and Stroke, the Wellcome Trust, the G. Harold and Leila Y. Mathers Foundation, Project A.L.S. and is an investigator of the Howard Hughes Medical Institute.	Alvarez FJ, 2004, J COMP NEUROL, V472, P257, DOI 10.1002/cne.20012; ARSHAVSKY YI, 1972, BRAIN RES, V43, P276, DOI 10.1016/0006-8993(72)90296-X; ARSHAVSKY YI, 1984, EXP BRAIN RES, V54, P426; Bareyre FM, 2005, NAT MED, V11, P1355, DOI 10.1038/nm1331; Betley JN, 2009, CELL, V139, P161, DOI 10.1016/j.cell.2009.08.027; Blakemore SJ, 2003, EXP BRAIN RES, V153, P239, DOI 10.1007/s00221-003-1597-z; Bosco G, 2001, PHYSIOL REV, V81, P539, DOI 10.1152/physrev.2001.81.2.539; D'Esposito M., 2006, MOTOR COGNITION WHAT, P1, DOI [10.1093/acprof:oso/9780198569657.001.0001, DOI 10.1093/ACPROF:OSO/978019856]; Dumitriu D, 2007, CEREB CORTEX, V17, P81, DOI 10.1093/cercor/bhj126; Ebner T, 2008, CEREBELLUM, V7, P583, DOI 10.1007/s12311-008-0059-3; ECCLES JC, 1961, J PHYSIOL-LONDON, V158, P517, DOI 10.1113/jphysiol.1961.sp006783; EDGLEY SA, 1988, J PHYSIOL-LONDON, V397, P81, DOI 10.1113/jphysiol.1988.sp016989; Finger JH, 2002, J NEUROSCI, V22, P10346; Gorski JA, 2002, J NEUROSCI, V22, P6309; Hippenmeyer S, 2005, PLOS BIOL, V3, P878, DOI 10.1371/journal.pbio.0030159; HONGO T, 1987, J COMP NEUROL, V262, P159, DOI 10.1002/cne.902620202; HONGO T, 1967, EXP BRAIN RES, V3, P135; HONGO T, 1967, EXP BRAIN RES, V3, P163; Lomeli J, 1998, NATURE, V395, P600, DOI 10.1038/26975; Lopez-Bendito G, 2004, CEREB CORTEX, V14, P1122, DOI 10.1093/cercor/bhh072; LUNDBERG A., 1964, PROGR BRAIN RES, V12, P135, DOI 10.1016/S0079-6123(08)60621-4; LUNDBERG A, 1971, EXP BRAIN RES, V12, P317; MANN MD, 1973, BRAIN BEHAV EVOLUT, V7, P34, DOI 10.1159/000124397; MATSUSHITA M, 1979, BRAIN RES, V173, P185, DOI 10.1016/0006-8993(79)90620-6; Matsushita M, 1997, J COMP NEUROL, V386, P409, DOI 10.1002/(SICI)1096-9861(19970929)386:3<409::AID-CNE6>3.0.CO;2-5; Miall RC, 1996, NEURAL NETWORKS, V9, P1265, DOI 10.1016/S0893-6080(96)00035-4; Moore MW, 1996, NATURE, V382, P76, DOI 10.1038/382076a0; Mott F, 1888, J Anat Physiol, V22, P479; Mulliken GH, 2008, P NATL ACAD SCI USA, V105, P8170, DOI 10.1073/pnas.0802602105; Nosrat CA, 1996, CELL TISSUE RES, V286, P191, DOI 10.1007/s004410050688; OSCARSSON O, 1965, PHYSIOL REV, V45, P495, DOI 10.1152/physrev.1965.45.3.495; Poulet JFA, 2006, SCIENCE, V311, P518, DOI 10.1126/science.1120847; Prochazka A, 1997, J NEUROPHYSIOL, V77, P3237, DOI 10.1152/jn.1997.77.6.3237; Roy JE, 2001, J NEUROSCI, V21, P2131, DOI 10.1523/JNEUROSCI.21-06-02131.2001; Seki K, 2003, NAT NEUROSCI, V6, P1309, DOI 10.1038/nn1154; Sommer MA, 2002, SCIENCE, V296, P1480, DOI 10.1126/science.1069590; WALMSLEY B, 1991, PROG NEUROBIOL, V36, P391, DOI 10.1016/0301-0082(91)90017-U; WOLPERT DM, 1995, SCIENCE, V269, P1880, DOI 10.1126/science.7569931; Yoshida Y, 2006, NEURON, V52, P775, DOI 10.1016/j.neuron.2006.10.032	39	103	105	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2010	13	10					1233	1239		10.1038/nn.2637	http://dx.doi.org/10.1038/nn.2637			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	654MB	20835249	Green Accepted			2022-12-28	WOS:000282171300015
J	Pfister, JP; Dayan, P; Lengyel, M				Pfister, Jean-Pascal; Dayan, Peter; Lengyel, Mate			Synapses with short-term plasticity are optimal estimators of presynaptic membrane potentials	NATURE NEUROSCIENCE			English	Article							NEURAL-NETWORKS; SYNAPTIC DEPRESSION; FACILITATION; NEURONS; TRANSMISSION; DYNAMICS	The trajectory of the somatic membrane potential of a cortical neuron exactly reflects the computations performed on its afferent inputs. However, the spikes of such a neuron are a very low-dimensional and discrete projection of this continually evolving signal. We explored the possibility that the neuron's efferent synapses perform the critical computational step of estimating the membrane potential trajectory from the spikes. We found that short-term changes in synaptic efficacy can be interpreted as implementing an optimal estimator of this trajectory. Short-term depression arose when presynaptic spiking was sufficiently intense as to reduce the uncertainty associated with the estimate; short-term facilitation reflected structural features of the statistics of the presynaptic neuron such as up and down states. Our analysis provides a unifying account of a powerful, but puzzling, form of plasticity.	[Pfister, Jean-Pascal; Lengyel, Mate] Univ Cambridge, Dept Engn, Computat & Biol Learning Lab, Cambridge CB2 1PZ, England; [Dayan, Peter] UCL, Gatsby Computat Neurosci Unit, London, England	University of Cambridge; University of London; University College London	Pfister, JP (corresponding author), Univ Cambridge, Dept Engn, Computat & Biol Learning Lab, Cambridge CB2 1PZ, England.	jean-pascal.pfister@eng.cam.ac.uk	Lengyel, Mate/A-6665-2013	Lengyel, Mate/0000-0001-7266-0049; Pfister, Jean-Pascal/0000-0002-1847-3389; Dayan, Peter/0000-0003-3476-1839	Wellcome Trust; Gatsby Charitable Foundation	Wellcome Trust(Wellcome TrustEuropean Commission); Gatsby Charitable Foundation	We thank M. Hausser and R. Brown for useful references and L. Abbott, Sz. Kali and members of the Budapest Computational Neuroscience Forum for valuable discussions. This work was supported by the Wellcome Trust (J.-P.P., M.L. and P.D.) and the Gatsby Charitable Foundation (P.D.).	Abbott LF, 2004, NATURE, V431, P796, DOI 10.1038/nature03010; Abbott LF, 1997, SCIENCE, V275, P220, DOI 10.1126/science.275.5297.221; Anderson B.D.O., 1979, OPTIMAL FILTERING; [Anonymous], 2009, ADV NEURAL INFORM PR; Bobrowski O, 2009, NEURAL COMPUT, V21, P1277, DOI 10.1162/neco.2008.01-08-692; Carpenter G. A., 1991, PATTERN RECOGNITION; Chorev E, 2007, J NEUROSCI, V27, P5043, DOI 10.1523/JNEUROSCI.5187-06.2007; Cook DL, 2003, NATURE, V421, P66, DOI 10.1038/nature01248; Cossart R, 2003, NATURE, V423, P283, DOI 10.1038/nature01614; Cunningham J, 2008, ADV NEURAL INFORM PR, V20, P329; Dayan P, 2001, COMPUTATIONAL NEUROS; de la Rocha J, 2002, NEUROCOMPUTING, V44, P85, DOI 10.1016/S0925-2312(02)00362-4; Deneve S, 2008, NEURAL COMPUT, V20, P91, DOI 10.1162/neco.2008.20.1.91; Dittman JS, 2000, J NEUROSCI, V20, P1374; Dobrunz LE, 1997, P NATL ACAD SCI USA, V94, P14843, DOI 10.1073/pnas.94.26.14843; Eden UT, 2004, NEURAL COMPUT, V16, P971, DOI 10.1162/089976604773135069; Gerstner W, 2002, SPIKING NEURON MODEL; Goldman MS, 2002, J NEUROSCI, V22, P584, DOI 10.1523/JNEUROSCI.22-02-00584.2002; Harvey CD, 2009, NATURE, V461, P941, DOI 10.1038/nature08499; HASSELMO ME, 1993, TRENDS NEUROSCI, V16, P218, DOI 10.1016/0166-2236(93)90159-J; HOPFIELD JJ, 1982, P NATL ACAD SCI-BIOL, V79, P2554, DOI 10.1073/pnas.79.8.2554; Huys QJM, 2007, NEURAL COMPUT, V19, P404, DOI 10.1162/neco.2007.19.2.404; Jolivet R, 2006, J COMPUT NEUROSCI, V21, P35, DOI 10.1007/s10827-006-7074-5; Koester HJ, 2005, SCIENCE, V308, P863, DOI 10.1126/science.1100815; Lansky P, 2008, BIOL CYBERN, V99, P253, DOI 10.1007/s00422-008-0237-x; Lengyel M, 2005, NAT NEUROSCI, V8, P1677, DOI 10.1038/nn1561; Loebel A, 2009, FRONT COMPUT NEUROSC, V3, DOI 10.3389/neuro.10.027.2009; MANABE T, 1993, J NEUROPHYSIOL, V70, P1451, DOI 10.1152/jn.1993.70.4.1451; Markram H, 1998, P NATL ACAD SCI USA, V95, P5323, DOI 10.1073/pnas.95.9.5323; Markram H, 1996, NATURE, V382, P807, DOI 10.1038/382807a0; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; Merkel M, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.041921; Mongillo G, 2008, SCIENCE, V319, P1543, DOI 10.1126/science.1150769; Paninski L, 2004, NEURAL COMPUT, V16, P2533, DOI 10.1162/0899766042321797; Paninski L, 2006, J COMPUT NEUROSCI, V21, P71, DOI 10.1007/s10827-006-7200-4; PFISTER JP, 2009, FRONT SYST NEUR C CO; Reyes A, 1998, NAT NEUROSCI, V1, P279, DOI 10.1038/1092; SEUNG HS, 1993, P NATL ACAD SCI USA, V90, P10749, DOI 10.1073/pnas.90.22.10749; Shinomoto S, 1999, NEURAL COMPUT, V11, P935, DOI 10.1162/089976699300016511; Stanford TR, 2010, NAT NEUROSCI, V13, P379, DOI 10.1038/nn.2485; STEIN RB, 1965, BIOPHYS J, V5, P173, DOI 10.1016/S0006-3495(65)86709-1; STERIADE M, 1993, J NEUROSCI, V13, P3252, DOI 10.1523/jneurosci.13-08-03252.1993; Thomson AM, 2000, TRENDS NEUROSCI, V23, P305, DOI 10.1016/S0166-2236(00)01580-0; Thorpe S, 1996, NATURE, V381, P520, DOI 10.1038/381520a0; Tsodyks M, 1998, NEURAL COMPUT, V10, P821, DOI 10.1162/089976698300017502; Wark B, 2009, NEURON, V61, P750, DOI 10.1016/j.neuron.2009.01.019; WILSON HR, 1972, BIOPHYS J, V12, P1, DOI 10.1016/S0006-3495(72)86068-5; Zador A, 1998, J NEUROPHYSIOL, V79, P1219, DOI 10.1152/jn.1998.79.3.1219; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	49	46	46	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2010	13	10					1271	1275		10.1038/nn.2640	http://dx.doi.org/10.1038/nn.2640			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	654MB	20852625	Green Accepted			2022-12-28	WOS:000282171300020
J	Kendler, KS; Chen, XN; Dick, D; Maes, H; Gillespie, N; Neale, MC; Riley, B				Kendler, Kenneth S.; Chen, Xiangning; Dick, Danielle; Maes, Hermine; Gillespie, Nathan; Neale, Michael C.; Riley, Brien			Recent advances in the genetic epidemiology and molecular genetics of substance use disorders	NATURE NEUROSCIENCE			English	Review							ENVIRONMENTAL RISK-FACTORS; GENOME-WIDE ASSOCIATION; STRESSFUL LIFE EVENTS; LUNG-CANCER; NICOTINE DEPENDENCE; ALCOHOL DEPENDENCE; CHROMOSOME 15Q25.1; SUSCEPTIBILITY LOCUS; CANNABIS INITIATION; DRUG-DEPENDENCE	This article reviews current advances in the genetics of substance use disorders (SUDs). Both genetic and environmental sources of risk are required to develop a complete picture of SUD etiology. Genetic sources of risk for SUDs are not highly substance specific in their effects. Genetic and environmental risks for SUDs typically do not only add together but also interact with each other over development. Risk gene identification for SUDs has been difficult, with one recent success in identifying nicotinic receptor variants that affect risk for nicotine dependence. The impact of genetic variants on SUD risk will individually be small. Although genetic epidemiologic methods are giving us an increasingly accurate map of broad causal pathways to SUDs, gene discovery will be needed to identify the specific biological systems. Identifying these risk genes and understanding their action will require large clinical samples, and interaction between these studies and work in model organisms.	[Kendler, Kenneth S.; Chen, Xiangning; Dick, Danielle; Maes, Hermine; Gillespie, Nathan; Neale, Michael C.; Riley, Brien] Virginia Commonwealth Univ, Med Coll Virginia, Virginia Inst Psychiat & Behav Genet, Richmond, VA 23298 USA; [Kendler, Kenneth S.; Chen, Xiangning; Dick, Danielle; Maes, Hermine; Gillespie, Nathan; Neale, Michael C.; Riley, Brien] Virginia Commonwealth Univ, Med Coll Virginia, Dept Psychiat, Richmond, VA 23298 USA; [Kendler, Kenneth S.; Chen, Xiangning; Maes, Hermine; Neale, Michael C.; Riley, Brien] Virginia Commonwealth Univ, Med Coll Virginia, Dept Human & Mol Genet, Richmond, VA 23298 USA	Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University	Kendler, KS (corresponding author), Virginia Commonwealth Univ, Med Coll Virginia, Virginia Inst Psychiat & Behav Genet, Richmond, VA 23298 USA.	kendler@vcu.edu	Kendler, Kenneth/AAF-2876-2019; Gillespie, Nathan/D-6029-2013; Neale, Michael/AAD-5056-2020		US National Institutes of Health [DA18673, AA011408, AA017828, DA030005, AA018755, AA15416, DA023549, DA025109, DA022989, DA024413, DA027070, MH084952, DA019498]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R37AA011408, R01AA011408, P20AA017828, K02AA018755, R01AA015416] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA018673, K99DA023549, U01DA024413, R37DA018673, R01DA030005, R00DA023549, K01DA019498, R01DA024413, R21DA027070, R01DA025109] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported in part by US National Institutes of Health grants DA18673 (M.C.N., H.M.), AA011408, AA017828, DA030005 (K.S.K., B.R.), AA018755, AA15416 (D.D.), DA023549 (N.G.), DA025109, DA022989, DA024413, DA027070, MH084952 (H.M.) and DA019498 (X.C.).	Agrawal A, 2005, ADDICT BEHAV, V30, P1043, DOI 10.1016/j.addbeh.2004.09.007; Agrawal A, 2006, BEHAV GENET, V36, P640, DOI 10.1007/s10519-006-9069-4; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Amos CI, 2008, NAT GENET, V40, P616, DOI 10.1038/ng.109; Berrettine W, 2008, MOL PSYCHIATR, V13, P368, DOI 10.1038/sj.mp.4002154; Bienvenu OJ, 2011, PSYCHOL MED, V41, P33, DOI 10.1017/S003329171000084X; Bierut LJ, 2010, P NATL ACAD SCI USA, V107, P5082, DOI 10.1073/pnas.0911109107; Bierut LJ, 2008, AM J PSYCHIAT, V165, P1163, DOI 10.1176/appi.ajp.2008.07111711; Blomeyer D, 2008, BIOL PSYCHIAT, V63, P146, DOI 10.1016/j.biopsych.2007.04.026; Boardman JD, 2008, BEHAV GENET, V38, P234, DOI 10.1007/s10519-008-9197-0; Boardman JD, 2010, J HEALTH SOC BEHAV, V51, P108, DOI 10.1177/0022146509361195; Changeux JP, 2010, NAT REV NEUROSCI, V11, P389, DOI 10.1038/nrn2849; Chen XN, 2009, AM J MED GENET B, V150B, P926, DOI 10.1002/ajmg.b.30919; Conway KP, 2010, DRUG ALCOHOL DEPEN, V111, P4, DOI 10.1016/j.drugalcdep.2010.03.011; Covault J, 2004, AM J MED GENET B, V129B, P104, DOI 10.1002/ajmg.b.30091; Covault J, 2007, BIOL PSYCHIAT, V61, P609, DOI 10.1016/j.biopsych.2006.05.018; Davies AG, 2003, CELL, V115, P655, DOI 10.1016/S0092-8674(03)00979-6; Demeo DL, 2009, AM J HUM GENET, V85, P493, DOI 10.1016/j.ajhg.2009.09.004; Dick DM, 2011, MOL PSYCHIATR, V16, P800, DOI 10.1038/mp.2010.73; Dick DM, 2007, J ABNORM PSYCHOL, V116, P213, DOI 10.1037/0021-843X.116.1.213; Dick DM, 2006, BEHAV GENET, V36, P577, DOI 10.1007/s10519-005-9041-8; Dick DM, 2009, ARCH GEN PSYCHIAT, V66, P649, DOI 10.1001/archgenpsychiatry.2009.48; Dick DM, 2006, J STUD ALCOHOL, V67, P185, DOI 10.15288/jsa.2006.67.185; Dick DM, 2001, J ABNORM PSYCHOL, V110, P625, DOI 10.1037//0021-843X.110.4.625; Dickson PA, 2006, ALCOHOL CLIN EXP RES, V30, P1093, DOI 10.1111/j.1530-0277.2006.00128.x; Dopico AM, 1999, J PHYSIOL-LONDON, V519, P101, DOI 10.1111/j.1469-7793.1999.0101o.x; Edenberg HJ, 2004, AM J HUM GENET, V74, P705, DOI 10.1086/383283; Enoch MA, 2006, AM J MED GENET B, V141B, P599, DOI 10.1002/ajmg.b.30336; Erlich PM, 2010, HUM GENET, V128, P491, DOI 10.1007/s00439-010-0876-6; Furberg H, 2010, NAT GENET, V42, P441, DOI 10.1038/ng.571; Gillespie NA, 2007, ADDICTION, V102, P920, DOI 10.1111/j.1360-0443.2007.01804.x; Gillespie NA, 2011, DRUG ALCOHOL DEPEN, V118, P166, DOI 10.1016/j.drugalcdep.2011.03.014; Gillespie NA, 2009, ADDICTION, V104, P430, DOI 10.1111/j.1360-0443.2008.02456.x; GOEDDE HW, 1992, HUM GENET, V88, P344; Goldman D, 2005, NAT REV GENET, V6, P521, DOI 10.1038/nrg1635; Grobin AC, 1998, PSYCHOPHARMACOLOGY, V139, P2, DOI 10.1007/s002130050685; Grucza RA, 2008, BIOL PSYCHIAT, V64, P922, DOI 10.1016/j.biopsych.2008.04.018; Gruss M, 2001, EUR J NEUROSCI, V14, P1246, DOI 10.1046/j.0953-816x.2001.01754.x; Hansen HM, 2010, HUM MOL GENET, V19, P3652, DOI 10.1093/hmg/ddq268; HEATHERTON TF, 1991, BRIT J ADDICT, V86, P1119; Hicks BM, 2004, ARCH GEN PSYCHIAT, V61, P922, DOI 10.1001/archpsyc.61.9.922; Hicks BM, 2009, ARCH GEN PSYCHIAT, V66, P640, DOI 10.1001/archgenpsychiatry.2008.554; Hong LE, 2010, P NATL ACAD SCI USA, V107, P13509, DOI 10.1073/pnas.1004745107; Hung RJ, 2008, NATURE, V452, P633, DOI 10.1038/nature06885; Joslyn G, 2008, P NATL ACAD SCI USA, V105, P20368, DOI 10.1073/pnas.0810970105; Kaufman J, 2007, BIOL PSYCHIAT, V61, P1228, DOI 10.1016/j.biopsych.2006.06.039; Kendler K.S., 2006, GENES ENV PSYCHOPATH, V1st ed.; Kendler KS, 2008, ARCH GEN PSYCHIAT, V65, P674, DOI 10.1001/archpsyc.65.6.674; Kendler KS, 2007, ARCH GEN PSYCHIAT, V64, P958, DOI 10.1001/archpsyc.64.8.958; Kendler KS, 2007, ARCH GEN PSYCHIAT, V64, P1313, DOI 10.1001/archpsyc.64.11.1313; Kendler KS, 2011, ALCOHOL CLIN EXP RES, V35, P963, DOI 10.1111/j.1530-0277.2010.01427.x; Kendler KS, 2011, AM J PSYCHIAT, V168, P29, DOI 10.1176/appi.ajp.2010.10030340; Kendler KS, 2000, ARCH GEN PSYCHIAT, V57, P886, DOI 10.1001/archpsyc.57.9.886; Kendler KS, 2003, AM J PSYCHIAT, V160, P687, DOI 10.1176/appi.ajp.160.4.687; Kendler KS, 1999, PSYCHOL MED, V29, P299, DOI 10.1017/S0033291798008022; KENDLER KS, 1986, AM J PSYCHIAT, V143, P279; Koob GF, 2008, NEURON, V59, P11, DOI 10.1016/j.neuron.2008.06.012; Koob GF, 2010, NEUROPSYCHOPHARMACOL, V35, P217, DOI 10.1038/npp.2009.110; Koopmans JR, 1999, BEHAV GENET, V29, P445, DOI 10.1023/A:1021679005623; Kuryatov A, 2011, MOL PHARMACOL, V79, P119, DOI 10.1124/mol.110.066357; Lappalainen J, 2005, ALCOHOL CLIN EXP RES, V29, P493, DOI 10.1097/01.ALC.0000158938.97464.90; Li MD, 2003, ADDICTION, V98, P23, DOI 10.1046/j.1360-0443.2003.00295.x; Lips EH, 2010, INT J EPIDEMIOL, V39, P563, DOI 10.1093/ije/dyp288; Liu JZ, 2010, NAT GENET, V42, P436, DOI 10.1038/ng.572; Long JC, 1998, AM J MED GENET, V81, P216, DOI 10.1002/(SICI)1096-8628(19980508)81:3<216::AID-AJMG2>3.0.CO;2-U; Lubke G, 2008, MULTIVAR BEHAV RES, V43, P592, DOI 10.1080/00273170802490673; Maes H.H., 2009, NCI TOBACCO CONTROL, V20; Maes HH, 2011, BEHAV GENET, V41, P680, DOI 10.1007/s10519-011-9476-z; Maes HH, 2004, PSYCHOL MED, V34, P1251, DOI 10.1017/S0033291704002405; Munafo M.R, J NATL CANC IN PRESS; Muthen B, 2000, ALCOHOL CLIN EXP RES, V24, P882, DOI 10.1111/j.1530-0277.2000.tb02070.x; Neale MC, 1999, BEHAV GENET, V29, P233, DOI 10.1023/A:1021638122693; Neale MC, 2006, ADDICT BEHAV, V31, P1010, DOI 10.1016/j.addbeh.2006.03.047; Osier M, 1999, AM J HUM GENET, V64, P1147, DOI 10.1086/302317; Reich T, 1998, AM J MED GENET, V81, P207, DOI 10.1002/(SICI)1096-8628(19980508)81:3<207::AID-AJMG1>3.3.CO;2-X; Saccone NL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001053; Saccone SF, 2007, HUM MOL GENET, V16, P36, DOI 10.1093/hmg/ddl438; Schuckit MA, 1997, ADDICTION, V92, P979, DOI 10.1046/j.1360-0443.1997.9289797.x; Shen YC, 1997, ALCOHOL CLIN EXP RES, V21, P1272, DOI 10.1111/j.1530-0277.1997.tb04448.x; Spitz Margaret R, 2008, J Natl Cancer Inst, V100, P1552, DOI 10.1093/jnci/djn363; THOMASSON HR, 1994, ALCOHOL CLIN EXP RES, V18, P640, DOI 10.1111/j.1530-0277.1994.tb00923.x; Thorgeirsson TE, 2008, NATURE, V452, P638, DOI 10.1038/nature06846; Thorgeirsson TE, 2010, NAT GENET, V42, P448, DOI 10.1038/ng.573; Timberlake DS, 2006, NICOTINE TOB RES, V8, P123, DOI 10.1080/14622200500432054; Treutlein J, 2009, ARCH GEN PSYCHIAT, V66, P773, DOI 10.1001/archgenpsychiatry.2009.83; Tsuang MT, 1998, ARCH GEN PSYCHIAT, V55, P967, DOI 10.1001/archpsyc.55.11.967; Vanyukov MM, 2009, BEHAV GENET, V39, P233, DOI 10.1007/s10519-009-9269-9; Wang JA, 2010, CANCER-AM CANCER SOC, V116, P3458, DOI 10.1002/cncr.25085; Wang ZW, 2001, NEURON, V32, P867, DOI 10.1016/S0896-6273(01)00522-0	89	110	112	0	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2012	15	2					181	189		10.1038/nn.3018	http://dx.doi.org/10.1038/nn.3018			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	882ZX	22281715	Green Accepted			2022-12-28	WOS:000299603500007
J	Chapuis, J; Wilson, DA				Chapuis, Julie; Wilson, Donald A.			Bidirectional plasticity of cortical pattern recognition and behavioral sensory acuity	NATURE NEUROSCIENCE			English	Article							PIRIFORM CORTEX; ALZHEIMERS-DISEASE; OLFACTORY CORTEX; ODOR; DISCRIMINATION; NETWORK; NEURONS; MEMORY; RATS; HIPPOCAMPUS	Learning to adapt to a complex and fluctuating environment requires the ability to adjust neural representations of sensory stimuli. Through pattern completion processes, cortical networks can reconstruct familiar patterns from degraded input patterns, whereas pattern separation processes allow discrimination of even highly overlapping inputs. Here we show that the balance between pattern separation and completion is experience dependent. Rats given extensive training with overlapping complex odorant mixtures showed improved behavioral discrimination ability and enhanced piriform cortical ensemble pattern separation. In contrast, behavioral training to disregard normally detectable differences between overlapping mixtures resulted in impaired piriform cortical ensemble pattern separation (enhanced pattern completion) and impaired discrimination. This bidirectional effect was not found in the olfactory bulb; it may be due to plasticity within olfactory cortex itself. Thus pattern recognition, and the balance between pattern separation and completion, is highly malleable on the basis of task demands and occurs in concert with changes in perceptual performance.	[Chapuis, Julie; Wilson, Donald A.] Nathan S Kline Inst Psychiat Res, Emot Brain Inst, Orangeburg, NY 10962 USA; [Chapuis, Julie; Wilson, Donald A.] NYU, Langone Sch Med, Dept Child & Adolescent Psychiat, New York, NY USA	Nathan Kline Institute for Psychiatric Research; New York University; NYU Langone Medical Center	Chapuis, J (corresponding author), Nathan S Kline Inst Psychiat Res, Emot Brain Inst, Orangeburg, NY 10962 USA.	jchapuis@nki.rfmh.org; donald.wilson@nyumc.org		Wilson, Donald/0000-0001-8918-2151	US National Institutes of Health [DC003906, DC008982]; Fyssen Foundation; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC003906, R01DC008982] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fyssen Foundation; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by US National Institutes of Health grants DC003906 and DC008982 to D.A.W. and a Fyssen Foundation post-doctoral grant to J.C.	BAKIN JS, 1992, BRAIN RES, V577, P226, DOI 10.1016/0006-8993(92)90278-H; Barnes CA, 1997, NATURE, V388, P272, DOI 10.1038/40859; Barnes DC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018130; Barnes DC, 2008, NAT NEUROSCI, V11, P1378, DOI 10.1038/nn.2217; Beshel J, 2007, J NEUROSCI, V27, P8358, DOI 10.1523/JNEUROSCI.1199-07.2007; Brosh I, 2009, LEARN MEMORY, V16, P413, DOI 10.1101/lm.1430809; Chapuis J, 2009, J NEUROSCI, V29, P10287, DOI 10.1523/JNEUROSCI.0505-09.2009; Chen CFF, 2011, J NEUROPHYSIOL, V106, P3136, DOI 10.1152/jn.00721.2011; Cohen-Matsliah SI, 2009, EUR J NEUROSCI, V30, P1339, DOI 10.1111/j.1460-9568.2009.06894.x; Doucette W, 2011, NEURON, V69, P1176, DOI 10.1016/j.neuron.2011.02.024; Doucette W, 2008, PLOS BIOL, V6, P2266, DOI 10.1371/journal.pbio.0060258; Fell J, 2011, NAT REV NEUROSCI, V12, P105, DOI 10.1038/nrn2979; Fletcher ML, 2010, LEARN MEMORY, V17, P561, DOI 10.1101/lm.941510; Fletcher ML, 2005, J NEUROSCI, V25, P792, DOI 10.1523/JNEUROSCI.4673-04.2005; Fletcher ML, 2003, J NEUROSCI, V23, P6946; FREEMAN WJ, 1982, PSYCHOPHYSIOLOGY, V19, P44, DOI 10.1111/j.1469-8986.1982.tb02598.x; Haberly LB, 2001, CHEM SENSES, V26, P551, DOI 10.1093/chemse/26.5.551; HASSELMO ME, 1992, J NEUROPHYSIOL, V67, P1230, DOI 10.1152/jn.1992.67.5.1230; Jones SV, 2008, J NEUROSCI, V28, P13106, DOI 10.1523/JNEUROSCI.4465-08.2008; Kadohisa M, 2006, P NATL ACAD SCI USA, V103, P15206, DOI 10.1073/pnas.0604313103; Kay LM, 2010, J NEUROPHYSIOL, V104, P829, DOI 10.1152/jn.00166.2010; Kay LM, 2009, TRENDS NEUROSCI, V32, P207, DOI 10.1016/j.tins.2008.11.008; Kilgard MP, 1998, SCIENCE, V279, P1714, DOI 10.1126/science.279.5357.1714; Lee I, 2004, NATURE, V430, P456, DOI 10.1038/nature02739; Leutgeb S, 2004, SCIENCE, V305, P1295, DOI 10.1126/science.1100265; Li F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015401; Li W, 2010, BRAIN, V133, P2714, DOI 10.1093/brain/awq209; Martin C, 2007, J NEUROPHYSIOL, V98, P2196, DOI 10.1152/jn.00524.2007; McClelland JL, 1996, HIPPOCAMPUS, V6, P654; Murphy C, 1999, PHYSIOL BEHAV, V66, P177, DOI 10.1016/S0031-9384(98)00262-5; Nakazawa K, 2002, SCIENCE, V297, P211, DOI 10.1126/science.1071795; Nusser Z, 2001, J NEUROPHYSIOL, V86, P2823, DOI 10.1152/jn.2001.86.6.2823; Preacher K. J., 2002, CALCULATION TEST DIF; Resnik J, 2011, NAT NEUROSCI, V14, P791, DOI 10.1038/nn.2802; Restrepo D, 2009, TRENDS NEUROSCI, V32, P525, DOI 10.1016/j.tins.2009.06.001; Rinberg D, 2006, J NEUROSCI, V26, P8857, DOI 10.1523/JNEUROSCI.0884-06.2006; Saar D, 2003, EUR J NEUROSCI, V17, P2727, DOI 10.1046/j.1460-9568.2003.02699.x; Saar D, 1999, J NEUROSCI, V19, P8616; Seckinger RA, 2004, SCHIZOPHR RES, V69, P55, DOI 10.1016/S0920-9964(03)00124-5; SMITH DV, 1979, CHEM SENS FLAV, V4, P215, DOI 10.1093/chemse/4.3.215; Stokes CCA, 2010, NEURON, V67, P452, DOI 10.1016/j.neuron.2010.06.029; Suzuki N, 2011, J NEUROSCI, V31, P2156, DOI 10.1523/JNEUROSCI.5430-10.2011; Suzuki N, 2010, J COMP NEUROL, V518, P1670, DOI 10.1002/cne.22295; Tanila H, 1997, J NEUROSCI, V17, P5167; Tanila H, 1997, J NEUROSCI, V17, P5155; Tristan C, 2009, EUR J NEUROSCI, V29, P921, DOI 10.1111/j.1460-9568.2009.06651.x; Wesson DW, 2008, CHEM SENSES, V33, P581, DOI 10.1093/chemse/bjn029; Wesson DW, 2010, J NEUROSCI, V30, P505, DOI 10.1523/JNEUROSCI.4622-09.2010; Wilson DA, 2003, TRENDS NEUROSCI, V26, P243, DOI 10.1016/S0166-2236(03)00076-6; Wilson DA, 2010, J NEUROSCI, V30, P1760, DOI 10.1523/JNEUROSCI.5636-09.2010	50	135	135	0	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2012	15	1					155	U194		10.1038/nn.2966	http://dx.doi.org/10.1038/nn.2966			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	866VO	22101640	Green Accepted			2022-12-28	WOS:000298414400026
J	Graybeal, C; Feyder, M; Schulman, E; Saksida, LM; Bussey, TJ; Brigman, JL; Holmes, A				Graybeal, Carolyn; Feyder, Michael; Schulman, Emily; Saksida, Lisa M.; Bussey, Timothy J.; Brigman, Jonathan L.; Holmes, Andrew			Paradoxical reversal learning enhancement by stress or prefrontal cortical damage: rescue with BDNF	NATURE NEUROSCIENCE			English	Article							FEAR EXTINCTION; MICE; REORGANIZATION; EXPOSURE; CORTEX	Stress affects various forms of cognition. We found that moderate stress enhanced late reversal learning in a mouse touchscreen-based choice task. Ventromedial prefrontal cortex (vmPFC) lesions mimicked the effect of stress, whereas orbitofrontal and dorsolateral striatal lesions impaired reversal. Stress facilitation of reversal was prevented by BDNF infusion into the vmPFC. These findings suggest a mechanism by which stress-induced vmPFC dysfunction disinhibits learning by alternate (for example, striatal) systems.	[Graybeal, Carolyn; Feyder, Michael; Schulman, Emily; Brigman, Jonathan L.; Holmes, Andrew] NIAAA, Lab Behav & Genom Neurosci, US Natl Inst Hlth, Bethesda, MD USA; [Saksida, Lisa M.; Bussey, Timothy J.] Univ Cambridge, Dept Expt Psychol, Med Res Council, Cambridge CB2 3EB, England; [Saksida, Lisa M.; Bussey, Timothy J.] Univ Cambridge, Wellcome Trust Behav & Clin Neurosci Inst, Cambridge, England	National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Cambridge; University of Cambridge	Holmes, A (corresponding author), NIAAA, Lab Behav & Genom Neurosci, US Natl Inst Hlth, Bethesda, MD USA.	andrew.holmes@mail.nih.gov	Saksida, Lisa M/M-2753-2016; Bussey, Timothy J/M-2758-2016	Saksida, Lisa M/0000-0002-8416-8171; Bussey, Timothy J/0000-0001-7518-4041	National Institute on Alcohol Abuse; Alcoholism Intramural Research Program [Z01-AA000411]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [Z01AA000411, ZIAAA000411, K22AA020303] Funding Source: NIH RePORTER	National Institute on Alcohol Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Alcoholism Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	We thank Y. Shaham, G. Quirk and G. Schoenbaum for valuable discussions. This work was supported by the National Institute on Alcohol Abuse and Alcoholism Intramural Research Program (Z01-AA000411).	Arnsten AFT, 2009, NAT REV NEUROSCI, V10, P410, DOI 10.1038/nrn2648; BALLEINE B, 1992, Q J EXP PSYCHOL-B, V45, P285; Brigman JL, 2010, CEREB CORTEX, V20, P1955, DOI 10.1093/cercor/bhp266; Chudasama Y, 2006, BIOL PSYCHOL, V73, P19, DOI 10.1016/j.biopsycho.2006.01.005; Dias-Ferreira E, 2009, SCIENCE, V325, P621, DOI 10.1126/science.1171203; Duman Ronald S, 2009, Dialogues Clin Neurosci, V11, P239; Gourley SL, 2009, NEUROPSYCHOPHARMACOL, V34, P707, DOI 10.1038/npp.2008.123; Holmes A, 2009, NEUROSCI BIOBEHAV R, V33, P773, DOI 10.1016/j.neubiorev.2008.11.005; Izquierdo A, 2006, J NEUROSCI, V26, P5733, DOI 10.1523/JNEUROSCI.0474-06.2006; JONES B, 1972, EXP NEUROL, V36, P362, DOI 10.1016/0014-4886(72)90030-1; Karlsson RM, 2009, NEUROPSYCHOPHARMACOL, V34, P1578, DOI 10.1038/npp.2008.215; McEwen Bruce S, 2006, Dialogues Clin Neurosci, V8, P367; Peters J, 2010, SCIENCE, V328, P1288, DOI 10.1126/science.1186909; Shors TJ, 2006, ANNU REV PSYCHOL, V57, P55, DOI 10.1146/annurev.psych.57.102904.190205; Stalnaker TA, 2009, NEUROPHARMACOLOGY, V56, P63, DOI 10.1016/j.neuropharm.2008.07.019	15	124	125	1	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	2011	14	12					1507	1509		10.1038/nn.2954	http://dx.doi.org/10.1038/nn.2954			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	855EJ	22057192	Green Accepted, Green Submitted			2022-12-28	WOS:000297546300007
J	Rahnev, D; Maniscalco, B; Graves, T; Huang, E; de Lange, FP; Lau, H				Rahnev, Dobromir; Maniscalco, Brian; Graves, Tashina; Huang, Elliott; de lange, Floris P.; Lau, Hakwan			Attention induces conservative subjective biases in visual perception	NATURE NEUROSCIENCE			English	Article							SPATIAL ATTENTION; REPRESENTATION; MECHANISMS	Although attention usually enhances perceptual sensitivity, we found that it can also lead to relatively conservative detection biases and lower visibility ratings in discrimination tasks. These results are explained by a model in which attention reduces the trial-by-trial variability of the perceptual signal, and we determined how this model led to the observed behavior. These findings may partially reflect our impression of 'seeing' the whole visual scene despite our limited processing capacity outside of the focus of attention.	[Rahnev, Dobromir; Maniscalco, Brian; Graves, Tashina; Huang, Elliott; Lau, Hakwan] Columbia Univ, Dept Psychol, New York, NY 10027 USA; [Rahnev, Dobromir; de lange, Floris P.; Lau, Hakwan] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands; [Graves, Tashina] Johns Hopkins Univ, Dept Psychol & Brain Sci, Baltimore, MD USA	Columbia University; Radboud University Nijmegen; Johns Hopkins University	Lau, H (corresponding author), Columbia Univ, Dept Psychol, New York, NY 10027 USA.	drahnev@gmail.com; hakwan@gmail.com	Rahnev, Dobromir/AAC-4506-2019; de Lange, Floris/D-2860-2009	Rahnev, Dobromir/0000-0002-5265-2559; de Lange, Floris/0000-0002-6730-1452; Maniscalco, Brian/0000-0003-3116-6188	Human Frontiers Science Project; Templeton Foundation [21569]	Human Frontiers Science Project; Templeton Foundation	H.L. received funding from the Human Frontiers Science Project (Short-Term Fellowship) and the Templeton Foundation (grant number 21569).	AZZOPARDI P, 1993, NATURE, V361, P719, DOI 10.1038/361719a0; Carrasco M, 2011, VISION RES, V51, P1484, DOI 10.1016/j.visres.2011.04.012; Cohen MR, 2009, NAT NEUROSCI, V12, P1594, DOI 10.1038/nn.2439; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Dosher BA, 2000, PSYCHOL SCI, V11, P139, DOI 10.1111/1467-9280.00229; GORDON J, 1977, J OPT SOC AM, V67, P202, DOI 10.1364/JOSA.67.000202; Gorea A, 2000, P NATL ACAD SCI USA, V97, P12380, DOI 10.1073/pnas.97.22.12380; Green DM, 1966, SIGNAL DETECTION THE; Kim CY, 2005, TRENDS COGN SCI, V9, P381, DOI 10.1016/j.tics.2005.06.012; Lau H, 2011, TRENDS COGN SCI, V15, P365, DOI 10.1016/j.tics.2011.05.009; Lu ZL, 1998, VISION RES, V38, P1183, DOI 10.1016/S0042-6989(97)00273-3; Maier A, 2008, NAT NEUROSCI, V11, P1193, DOI 10.1038/nn.2173; McDonnell MD, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000348; Mitchell JF, 2009, NEURON, V63, P879, DOI 10.1016/j.neuron.2009.09.013; Reynolds JH, 2009, NEURON, V61, P168, DOI 10.1016/j.neuron.2009.01.002	15	121	122	1	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	2011	14	12					1513	1515		10.1038/nn.2948	http://dx.doi.org/10.1038/nn.2948			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	855EJ	22019729	Green Published			2022-12-28	WOS:000297546300009
J	Zonouzi, M; Renzi, M; Farrant, M; Cull-Candy, SG				Zonouzi, Marzieh; Renzi, Massimiliano; Farrant, Mark; Cull-Candy, Stuart G.			Bidirectional plasticity of calcium-permeable AMPA receptors in oligodendrocyte lineage cells	NATURE NEUROSCIENCE			English	Article							METABOTROPIC GLUTAMATE RECEPTORS; LONG-TERM POTENTIATION; SYNAPTIC PLASTICITY; GENE-EXPRESSION; WHITE-MATTER; ACTIVATION; RELEASE; NEURONS; PHOSPHORYLATION; EXCITOTOXICITY	Oligodendrocyte precursor cells (OPCs), a major glial cell type that gives rise to myelinating oligodendrocytes in the CNS, express calcium-permeable AMPA receptors (CP-AMPARs). Although CP-AMPARs are important for OPC proliferation and neuron-glia signaling, they render OPCs susceptible to ischemic damage in early development. We identified factors controlling the dynamic regulation of AMPAR subtypes in OPCs from rat optic nerve and mouse cerebellar cortex. We found that activation of group 1 mGluRs drove an increase in the proportion of CP-AMPARs, reflected by an increase in single-channel conductance and inward rectification. This plasticity required the elevation of intracellular calcium and used PI3K, PICK-1 and the JNK pathway. In white matter, neurons and astrocytes release both ATP and glutamate. Unexpectedly, activation of purinergic receptors in OPCs decreased CP-AMPAR expression, suggesting a capacity for homeostatic regulation. Finally, we found that stargazin-related transmembrane AMPAR regulatory proteins, which are critical for AMPAR surface expression in neurons, regulate CP-AMPAR plasticity in OPCs.	[Zonouzi, Marzieh; Renzi, Massimiliano; Farrant, Mark; Cull-Candy, Stuart G.] UCL, Dept Neurosci Physiol & Pharmacol, London, England	University of London; University College London	Cull-Candy, SG (corresponding author), UCL, Dept Neurosci Physiol & Pharmacol, London, England.	m.farrant@ucl.ac.uk; s.cull-candy@ucl.ac.uk		Farrant, Mark/0000-0002-9918-0376; Cull-Candy, Stuart G/0000-0002-0831-8326; RENZI, MASSIMILIANO/0000-0001-6973-3569; Funk, Marzieh/0000-0001-7371-9823; Zonouzi, Marzieh/0000-0002-7087-1202	Wellcome Trust; Medical Research Council (Laboratory for Molecular Cell Biology, University College London)	Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council (Laboratory for Molecular Cell Biology, University College London)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank I. Coombs, C. Bats, C. Shelley, D. Soto and D. Studniarczyk for invaluable help and discussion. We are grateful to E. Molnar (Bristol University) for CG4-OPC cells, D. Attwell and C. Reynell (University College London) for providing NG2-DsRed mice, R. Nicoll (University of California, San Francisco) for TARP cDNA (rat, gamma-2), J. Wood (University College London) for GFP-PICK-1 inhibitor peptide, M. Watanabe (Hokkaido University) for antibody to TARP gamma-2, B. Clark (University College London) for antibody to calbindin, and D. Cutler and M. Marsh (Laboratory for Molecular Cell Biology, University College London) for generous help and access to equipment. This work was supported by a Wellcome Trust Programme grant (S. G. C.-C. and M. F.). M.Z. was in receipt of a Medical Research Council (Laboratory for Molecular Cell Biology, University College London) studentship.	Ahn SM, 2010, J NEUROSCI RES, V88, P992, DOI 10.1002/jnr.22275; BARRES BA, 1994, DEVELOPMENT, V120, P1097; Bats C, 2007, NEURON, V53, P719, DOI 10.1016/j.neuron.2007.01.030; Bergles DE, 2000, NATURE, V405, P187, DOI 10.1038/35012083; Borsello T, 2003, NAT MED, V9, P1180, DOI 10.1038/nm911; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Clem RL, 2010, J NEUROSCI, V30, P6360, DOI 10.1523/JNEUROSCI.6276-09.2010; De Biase LM, 2010, J NEUROSCI, V30, P3600, DOI 10.1523/JNEUROSCI.6000-09.2010; Deng WB, 2004, P NATL ACAD SCI USA, V101, P7751, DOI 10.1073/pnas.0307850101; Domercq M, 2010, GLIA, V58, P730, DOI 10.1002/glia.20958; Etxeberria A, 2010, NAT NEUROSCI, V13, P287, DOI 10.1038/nn.2500; Fern R, 2000, J NEUROSCI, V20, P34, DOI 10.1523/JNEUROSCI.20-01-00034.2000; Follett PL, 2000, J NEUROSCI, V20, P9235; Fukaya M, 2005, NEUROSCI RES, V53, P376, DOI 10.1016/j.neures.2005.08.009; Gallo V, 1996, J NEUROSCI, V16, P2659, DOI 10.1523/jneurosci.16-08-02659.1996; Ge WP, 2006, SCIENCE, V312, P1533, DOI 10.1126/science.1124669; GEIGER JRP, 1995, NEURON, V15, P193, DOI 10.1016/0896-6273(95)90076-4; Gudz TI, 2006, J NEUROSCI, V26, P2458, DOI 10.1523/JNEUROSCI.4054-05.2006; Haberlandt C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017575; Hamilton N, 2010, GLIA, V58, P66, DOI 10.1002/glia.20902; Ishibashi T, 2006, NEURON, V49, P823, DOI 10.1016/j.neuron.2006.02.006; James G, 2001, CELL CALCIUM, V30, P251, DOI 10.1054/ceca.2001.0232; Jo J, 2008, NEURON, V60, P1095, DOI 10.1016/j.neuron.2008.10.050; Kelly L, 2009, NAT NEUROSCI, V12, P593, DOI 10.1038/nn.2309; Kukley M, 2010, J NEUROSCI, V30, P8320, DOI 10.1523/JNEUROSCI.0854-10.2010; Li XM, 2007, EUR J NEUROSCI, V25, P391, DOI 10.1111/j.1460-9568.2006.05300.x; Lin SC, 2005, NEURON, V46, P773, DOI 10.1016/j.neuron.2005.04.025; Lino M, 2001, SCIENCE, V292, P926, DOI 10.1126/science.1058827; Liu SQJ, 2000, NATURE, V405, P454, DOI 10.1038/35013064; Luyt K, 2003, J NEUROCHEM, V84, P1452, DOI 10.1046/j.1471-4159.2003.01661.x; Mameli M, 2007, SCIENCE, V317, P530, DOI 10.1126/science.1142365; Man HY, 2003, NEURON, V38, P611, DOI 10.1016/S0896-6273(03)00228-9; Pankratov YV, 2002, J NEUROSCI, V22, P8363; PENDE M, 1994, P NATL ACAD SCI USA, V91, P3215, DOI 10.1073/pnas.91.8.3215; Rouach N, 2005, NAT NEUROSCI, V8, P1525, DOI 10.1038/nn1551; Santos AE, 2006, CELL DEATH DIFFER, V13, P652, DOI 10.1038/sj.cdd.4401785; Shi Y, 2009, NEURON, V62, P633, DOI 10.1016/j.neuron.2009.05.016; Soto D, 2007, NAT NEUROSCI, V10, P1260, DOI 10.1038/nn1966; Soto D, 2009, NAT NEUROSCI, V12, P277, DOI 10.1038/nn.2266; Stevens B, 2002, NEURON, V36, P855, DOI 10.1016/S0896-6273(02)01067-X; Swanson GT, 1997, J NEUROSCI, V17, P58, DOI 10.1523/JNEUROSCI.17-01-00058.1997; Thomas GM, 2008, EMBO J, V27, P361, DOI 10.1038/sj.emboj.7601969; Tomita S, 2003, J CELL BIOL, V161, P805, DOI 10.1083/jcb.200212116; Tomita S, 2005, NEURON, V45, P269, DOI 10.1016/j.neuron.2005.01.009; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Vieira M, 2010, NEUROBIOL DIS, V40, P645, DOI 10.1016/j.nbd.2010.08.008; Volpe JJ, 2009, J CHILD NEUROL, V24, P1085, DOI 10.1177/0883073809338067; WYLLIE DJA, 1991, J PHYSIOL-LONDON, V432, P235, DOI 10.1113/jphysiol.1991.sp018383; Yamazaki M, 2010, EUR J NEUROSCI, V31, P2204, DOI 10.1111/j.1460-9568.2010.07254.x; Ziskin JL, 2007, NAT NEUROSCI, V10, P321, DOI 10.1038/nn1854	50	81	84	0	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2011	14	11					1430	U103		10.1038/nn.2942	http://dx.doi.org/10.1038/nn.2942			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	841NI	21983683	Green Accepted			2022-12-28	WOS:000296518600019
J	Barkat, TR; Polley, DB; Hensch, TK				Barkat, Tania Rinaldi; Polley, Daniel B.; Hensch, Takao K.			A critical period for auditory thalamocortical connectivity	NATURE NEUROSCIENCE			English	Article							IN-VIVO; CORTEX; PLASTICITY; EXPERIENCE; REPRESENTATION; ORGANIZATION; INPUTS; MOUSE; SELECTIVITY; PERCEPTION	Neural circuits are shaped by experience during periods of heightened brain plasticity in early postnatal life. Exposure to acoustic features produces age-dependent changes through largely unresolved cellular mechanisms and sites of origin. We isolated the refinement of auditory thalamocortical connectivity by in vivo recordings and day-by-day voltage-sensitive dye imaging in an acute brain slice preparation. Passive tone-rearing modified response strength and topography in mouse primary auditory cortex (A1) during a brief, 3-d window, but did not alter tonotopic maps in the thalamus. Gene-targeted deletion of a forebrain-specific cell-adhesion molecule (Icam5) accelerated plasticity in this critical period. Consistent with its normal role of slowing spinogenesis, loss of Icam5 induced precocious stubby spine maturation on pyramidal cell dendrites in neocortical layer 4 (L4), identifying a primary locus of change for the tonotopic plasticity. The evolving postnatal connectivity between thalamus and cortex in the days following hearing onset may therefore determine a critical period for auditory processing.	[Barkat, Tania Rinaldi; Hensch, Takao K.] Harvard Univ, Ctr Brain Sci, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Polley, Daniel B.] Harvard Univ, Sch Med, Dept Otol & Laryngol, Eaton Peabody Lab,Massachusetts Eye & Ear Infirm, Boston, MA 02115 USA	Harvard University; Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary	Hensch, TK (corresponding author), Harvard Univ, Ctr Brain Sci, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.	hensch@mcb.harvard.edu	Hensch, Takao/L-4182-2019	Rinaldi Barkat, Tania/0000-0001-8650-0986; Polley, Daniel/0000-0002-5120-2409	Core Research for Evolutional Science and Technology, Japan Science and Technology Agency; Human Frontiers Science Program; National Institute on Deafness and Other Communication Disorders [009836]; Harvard Society of Fellows; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC009836] Funding Source: NIH RePORTER	Core Research for Evolutional Science and Technology, Japan Science and Technology Agency(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Human Frontiers Science Program(Human Frontier Science Program); National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Harvard Society of Fellows; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	Icam5<SUP>-/-</SUP> mice and antibody were kindly provided by M. Mishina (University of Tokyo) and Y. Yoshihara (RIKEN BSI), respectively. We thank M. Nakamura, A. Takesian, N. Gogolla, E.-J. Yang, K. Quast, M. Marcotrigiano, M. Kelly, R. Pavlyuk, B. Jones O'Brien and V. Khatri for technical assistance and comments. This work was supported by Core Research for Evolutional Science and Technology, Japan Science and Technology Agency (T. K. H.), the Human Frontiers Science Program (T. K. H.), the National Institute on Deafness and Other Communication Disorders (grant 009836, D. B. P.) and the Harvard Society of Fellows (T.R.B.).	ALFORD BR, 1963, ANN OTO RHINOL LARYN, V72, P237, DOI 10.1177/000348946307200119; ALLENDOERFER KL, 1994, ANNU REV NEUROSCI, V17, P185, DOI 10.1146/annurev.neuro.17.1.185; Bajo VM, 2010, NAT NEUROSCI, V13, P253, DOI 10.1038/nn.2466; Cruikshank SJ, 2002, J NEUROPHYSIOL, V87, P361, DOI 10.1152/jn.00549.2001; de Villers-Sidani E, 2008, NAT NEUROSCI, V11, P957, DOI 10.1038/nn.2144; de Villers-Sidani E, 2007, J NEUROSCI, V27, P180, DOI 10.1523/JNEUROSCI.3227-06.2007; Dorrn AL, 2010, NATURE, V465, P932, DOI 10.1038/nature09119; Ferezou I, 2006, NEURON, V50, P617, DOI 10.1016/j.neuron.2006.03.043; Gan WB, 2000, NEURON, V27, P219, DOI 10.1016/S0896-6273(00)00031-3; Geissler DB, 2004, EUR J NEUROSCI, V19, P1027, DOI 10.1111/j.1460-9568.2004.03205.x; Grinvald A, 2004, NAT REV NEUROSCI, V5, P874, DOI 10.1038/nrn1536; Hackett TA, 2011, J NEUROSCI, V31, P2983, DOI 10.1523/JNEUROSCI.5333-10.2011; Han YK, 2007, NAT NEUROSCI, V10, P1191, DOI 10.1038/nn1941; Harris JA, 2006, HEARING RES, V216, P127, DOI 10.1016/j.heares.2006.03.016; Hensch TK, 2005, NAT REV NEUROSCI, V6, P877, DOI 10.1038/nrn1787; Hensch TK, 2004, ANNU REV NEUROSCI, V27, P549, DOI 10.1146/annurev.neuro.27.070203.144327; Insanally MN, 2009, J NEUROSCI, V29, P5456, DOI 10.1523/JNEUROSCI.5311-08.2009; Kandler K, 2009, NAT NEUROSCI, V12, P711, DOI 10.1038/nn.2332; Kanold PO, 2010, ANNU REV NEUROSCI, V33, P23, DOI 10.1146/annurev-neuro-060909-153244; Kaur S, 2005, NEUROSCIENCE, V134, P1033, DOI 10.1016/j.neuroscience.2005.04.052; Keuroghlian AS, 2007, PROG NEUROBIOL, V82, P109, DOI 10.1016/j.pneurobio.2007.03.005; Kim H, 2009, J NEUROSCI, V29, P5163, DOI 10.1523/JNEUROSCI.0365-09.2009; King AJ, 2009, NAT NEUROSCI, V12, P698, DOI 10.1038/nn.2308; Kleinfeld D, 1996, J COMP NEUROL, V375, P89, DOI 10.1002/(SICI)1096-9861(19961104)375:1<89::AID-CNE6>3.0.CO;2-K; MASINO SA, 1993, P NATL ACAD SCI USA, V90, P9998, DOI 10.1073/pnas.90.21.9998; Mataga N, 2004, NEURON, V44, P1031, DOI 10.1016/j.neuron.2004.11.028; Matsuno H, 2006, J NEUROSCI, V26, P1776, DOI 10.1523/JNEUROSCI.2651-05.2006; MOGDANS J, 1994, J NEUROPHYSIOL, V72, P2875, DOI 10.1152/jn.1994.72.6.2875; Morishita H, 2008, CURR OPIN NEUROBIOL, V18, P101, DOI 10.1016/j.conb.2008.05.009; Nakamura K, 2001, EUR J NEUROSCI, V13, P179, DOI 10.1046/j.0953-816X.2000.01366.x; Oviedo HV, 2010, NAT NEUROSCI, V13, P1413, DOI 10.1038/nn.2659; Petersen CCH, 2003, J NEUROSCI, V23, P1298, DOI 10.1523/JNEUROSCI.23-04-01298.2003; Popescu MV, 2010, NEURON, V65, P718, DOI 10.1016/j.neuron.2010.02.019; Razak KA, 2008, P NATL ACAD SCI USA, V105, P4465, DOI 10.1073/pnas.0709504105; Richardson RJ, 2009, J NEUROSCI, V29, P6406, DOI 10.1523/JNEUROSCI.0258-09.2009; Sanes DH, 2009, CURR OPIN NEUROBIOL, V19, P188, DOI 10.1016/j.conb.2009.05.014; SANES DH, 1983, SCIENCE, V221, P1183, DOI 10.1126/science.6612332; Seidl AH, 2005, J NEUROPHYSIOL, V94, P1028, DOI 10.1152/jn.01143.2004; SIMONS DJ, 1978, J NEUROPHYSIOL, V41, P798, DOI 10.1152/jn.1978.41.3.798; SMITH ZDJ, 1983, J COMP NEUROL, V220, P199, DOI 10.1002/cne.902200207; Stiebler I, 1997, J COMP PHYSIOL A, V181, P559, DOI 10.1007/s003590050140; Sun YJ, 2010, NATURE, V465, P927, DOI 10.1038/nature09079; Werker JF, 2005, DEV PSYCHOBIOL, V46, P233, DOI 10.1002/dev.20060; WIESEL TN, 1965, J NEUROPHYSIOL, V28, P1029, DOI 10.1152/jn.1965.28.6.1029; Winer JA, 2005, TRENDS NEUROSCI, V28, P255, DOI 10.1016/j.tins.2005.03.009; Winer JA, 1999, HEARING RES, V130, P42, DOI 10.1016/S0378-5955(98)00217-2; Yan W, 1998, NAT NEUROSCI, V1, P54, DOI 10.1038/255; Zhang LI, 2002, P NATL ACAD SCI USA, V99, P2309, DOI 10.1073/pnas.261707398; Zhao CP, 2009, J NEUROSCI, V29, P15479, DOI 10.1523/JNEUROSCI.4471-09.2009; Zhou X, 2008, NEUROSCIENCE, V154, P390, DOI 10.1016/j.neuroscience.2008.01.026	50	160	163	1	46	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2011	14	9					1189	U252		10.1038/nn.2882	http://dx.doi.org/10.1038/nn.2882			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	812ID	21804538	Green Accepted			2022-12-28	WOS:000294284900020
J	Xi, ZX; Peng, XQ; Li, X; Song, R; Zhang, HY; Liu, QR; Yang, HJ; Bi, GH; Li, J; Gardner, EL				Xi, Zheng-Xiong; Peng, Xiao-Qing; Li, Xia; Song, Rui; Zhang, Hai-Ying; Liu, Qing-Rong; Yang, Hong-Ju; Bi, Guo-Hua; Li, Jie; Gardner, Eliot L.			Brain cannabinoid CB2 receptors modulate cocaine's actions in mice	NATURE NEUROSCIENCE			English	Article							DORSAL-HORN NEURONS; PHARMACOLOGICAL CHARACTERIZATION; MOLECULAR CHARACTERIZATION; CHRONIC PAIN; RAT; EXPRESSION; DOPAMINE; AGONISTS; RESPONSES; IDENTIFICATION	The presence and function of cannabinoid CB2 receptors in the brain have been the subjects of much debate. We found that systemic, intranasal or intra-accumbens local administration of JWH133, a selective CB2 receptor agonist, dose-dependently inhibited intravenous cocaine self-administration, cocaine-enhanced locomotion, and cocaine-enhanced accumbens extracellular dopamine in wild-type and CB1 receptor knockout (CB1-/-, also known as Cnr1(-/-)) mice, but not in CB2-/-(Cnr2(-/-)) mice. This inhibition was mimicked by GW405833, another CB2 receptor agonist with a different chemical structure, and was blocked by AM630, a selective CB2 receptor antagonist. Intra-accumbens administration of JWH133 alone dose-dependently decreased, whereas intra-accumbens administration of AM630 elevated, extracellular dopamine and locomotion in wild-type and CB1-/- mice, but not in CB2-/- mice. Intra-accumbens administration of AM630 also blocked the reduction in cocaine self-administration and extracellular dopamine produced by systemic administration of JWH133. These findings suggest that brain CB2 receptors modulate cocaine's rewarding and locomotor-stimulating effects, likely by a dopamine-dependent mechanism.	[Xi, Zheng-Xiong; Peng, Xiao-Qing; Li, Xia; Song, Rui; Zhang, Hai-Ying; Liu, Qing-Rong; Yang, Hong-Ju; Bi, Guo-Hua; Li, Jie; Gardner, Eliot L.] Natl Inst Drug Abuse, Intramural Res Program, Baltimore, MD USA; [Song, Rui] Beijing Inst Pharmacol & Toxicol, Beijing, Peoples R China	National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA); Academy of Military Medical Sciences - China	Xi, ZX (corresponding author), Natl Inst Drug Abuse, Intramural Res Program, Baltimore, MD USA.	zxi@intra.nida.nih.gov	Liu, Qing-Rong/A-3059-2012	Liu, Qing-Rong/0000-0001-8477-6452; PENG, XIAOQING/0000-0002-7272-5428; Zhang, Haiying/0000-0003-0593-5940	National Institute on Drug Abuse; NATIONAL INSTITUTE ON DRUG ABUSE [ZIADA000478, ZIADA000513] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank Y. Shaham and E.A. Stein of the Intramural Research Program of the National Institute on Drug Abuse, and K. Mackie of Indiana University for their helpful comments on this manuscript. This research was supported by the Intramural Research Program of the National Institute on Drug Abuse.	Anand U, 2008, PAIN, V138, P667, DOI 10.1016/j.pain.2008.06.007; Ashton JC, 2008, CURR MED CHEM, V15, P1428, DOI 10.2174/092986708784567716; Atwood BK, 2010, BRIT J PHARMACOL, V160, P467, DOI 10.1111/j.1476-5381.2010.00729.x; Baek J-H, 2008, ACTA OTO-LARYNGOL, V128, P1; Bardo MT, 1998, CRIT REV NEUROBIOL, V12, P37, DOI 10.1615/CritRevNeurobiol.v12.i1-2.30; BAYEWITCH M, 1995, FEBS LETT, V375, P143, DOI 10.1016/0014-5793(95)01207-U; Beltramo M, 2006, EUR J NEUROSCI, V23, P1530, DOI 10.1111/j.1460-9568.2006.04684.x; Bingham B, 2007, BRIT J PHARMACOL, V151, P1061, DOI 10.1038/sj.bjp.0707303; Brown SM, 2002, BBA-GENE STRUCT EXPR, V1576, P255, DOI 10.1016/S0167-4781(02)00341-X; Buckley  NE, 2000, EUR J PHARMACOL, V396, P141, DOI 10.1016/S0014-2999(00)00211-9; Chin CL, 2008, BRIT J PHARMACOL, V153, P367, DOI 10.1038/sj.bjp.0707506; Costantino HR, 2007, INT J PHARMACEUT, V337, P1, DOI 10.1016/j.ijpharm.2007.03.025; Elmes SJR, 2004, EUR J NEUROSCI, V20, P2311, DOI 10.1111/j.1460-9568.2004.03690.x; Glass M, 1997, NEUROSCIENCE, V77, P299, DOI 10.1016/S0306-4522(96)00428-9; Goncalves MB, 2008, MOL CELL NEUROSCI, V38, P526, DOI 10.1016/j.mcn.2008.05.001; Gong JP, 2006, BRAIN RES, V1071, P10, DOI 10.1016/j.brainres.2005.11.035; Griffin G, 2000, J PHARMACOL EXP THER, V292, P886; Guindon J, 2008, BRIT J PHARMACOL, V153, P319, DOI 10.1038/sj.bjp.0707531; Haydon PG, 2009, NEUROPHARMACOLOGY, V56, P83, DOI 10.1016/j.neuropharm.2008.06.050; Huffman JW, 2005, MINI-REV MED CHEM, V5, P641, DOI 10.2174/1389557054368844; Ibrahim MM, 2005, P NATL ACAD SCI USA, V102, P3093, DOI 10.1073/pnas.0409888102; Jhaveri MD, 2008, EUR J NEUROSCI, V27, P1722, DOI 10.1111/j.1460-9568.2008.06162.x; Lanciego JL, 2011, J PSYCHOPHARMACOL, V25, P97, DOI 10.1177/0269881110367732; Li X, 2009, PSYCHOPHARMACOLOGY, V204, P1, DOI 10.1007/s00213-008-1432-0; Liu QR, 2009, GENES BRAIN BEHAV, V8, P519, DOI 10.1111/j.1601-183X.2009.00498.x; Mackie K, 2008, J NEUROENDOCRINOL, V20, P10, DOI 10.1111/j.1365-2826.2008.01671.x; Malan TP, 2003, CURR OPIN PHARMACOL, V3, P62, DOI 10.1016/S1471-4892(02)00004-8; Malan TP, 2001, PAIN, V93, P239, DOI 10.1016/S0304-3959(01)00321-9; Morgan NH, 2009, NEUROPHARMACOLOGY, V57, P356, DOI 10.1016/j.neuropharm.2009.07.017; Mukherjee S, 2004, EUR J PHARMACOL, V505, P1, DOI 10.1016/j.ejphar.2004.09.058; MUNRO S, 1993, NATURE, V365, P61, DOI 10.1038/365061a0; Onaivi ES, 2006, ANN NY ACAD SCI, V1074, P514, DOI 10.1196/annals.1369.052; Parolaro D, 2008, DRUG NEWS PERSPECT, V21, P149, DOI 10.1358/dnp.2008.21.3.1203411; Richardson NR, 1996, J NEUROSCI METH, V66, P1, DOI 10.1016/0165-0270(95)00153-0; Ross RA, 2001, NEUROPHARMACOLOGY, V40, P221, DOI 10.1016/S0028-3908(00)00135-0; Sagar DR, 2005, EUR J NEUROSCI, V22, P371, DOI 10.1111/j.1460-9568.2005.04206.x; Sagredo O, 2009, GLIA, V57, P1154, DOI 10.1002/glia.20838; Schatz AR, 1997, TOXICOL APPL PHARM, V142, P278, DOI 10.1006/taap.1996.8034; Schwarting RKW, 1997, NEUROTOXICOLOGY, V18, P689; Soria G, 2005, NEUROPSYCHOPHARMACOL, V30, P1670, DOI 10.1038/sj.npp.1300707; Stella N, 2010, GLIA, V58, P1017, DOI 10.1002/glia.20983; Thakur GA, 2005, MINI-REV MED CHEM, V5, P631, DOI 10.2174/1389557054368772; Valenzano KJ, 2005, NEUROPHARMACOLOGY, V48, P658, DOI 10.1016/j.neuropharm.2004.12.008; Van Sickle MD, 2005, SCIENCE, V310, P329, DOI 10.1126/science.1115740; Viscomi MT, 2009, J NEUROSCI, V29, P4564, DOI 10.1523/JNEUROSCI.0786-09.2009; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406; Xi ZX, 2008, NEUROPSYCHOPHARMACOL, V33, P1735, DOI 10.1038/sj.npp.1301552; Yao BB, 2006, BRIT J PHARMACOL, V149, P145, DOI 10.1038/sj.bjp.0706838; Zhang J, 2003, EUR J NEUROSCI, V17, P2750, DOI 10.1046/j.1460-9568.2003.02704.x; Zimmer A, 1999, P NATL ACAD SCI USA, V96, P5780, DOI 10.1073/pnas.96.10.5780	50	281	287	1	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2011	14	9					1160	U216		10.1038/nn.2874	http://dx.doi.org/10.1038/nn.2874			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	812ID	21785434	Green Accepted			2022-12-28	WOS:000294284900016
J	Hitoshi, S; Ishino, Y; Kumar, A; Jasmine, S; Tanaka, KF; Kondo, T; Kato, S; Hosoya, T; Hotta, Y; Ikenaka, K				Hitoshi, Seiji; Ishino, Yugo; Kumar, Akhilesh; Jasmine, Salma; Tanaka, Kenji F.; Kondo, Takeshi; Kato, Shigeaki; Hosoya, Toshihiko; Hotta, Yoshiki; Ikenaka, Kazuhiro			Mammalian Gcm genes induce Hes5 expression by active DNA demethylation and induce neural stem cells	NATURE NEUROSCIENCE			English	Article							NERVOUS-SYSTEM; MICE LACKING; DROSOPHILA; NEUROGENESIS; BINDING; DIFFERENTIATION; EMBRYOGENESIS; TRANSCRIPTION; GLYCOSYLASE; GLIOGENESIS	Signaling mediated by Notch receptors is crucial for the development of many organs and the maintenance of various stem cell populations. The activation of Notch signaling is first detectable by the expression of an effector gene, Hes5, in the neuroepithelium of mouse embryos at embryonic day (E) 8.0-8.5, and this activation is indispensable for the generation of neural stem cells. However, the molecular mechanism by which Hes5 expression is initiated in stem-producing cells remains unknown. We found that mammalian Gcm1 and Gcm2 (glial cells missing 1 and 2) are involved in the epigenetic regulation of Hes5 transcription by DNA demethylation independently of DNA replication. Loss of both Gcm genes and subsequent lack of Hes5 upregulation in the neuroepithelium of E7.5-8.5 Gcm1(-/-); Gcm2(-/-) mice resulted in the impaired induction of neural stem cells. Our data suggest that Hes5 expression is serially activated first by Gcms and later by the canonical Notch pathway.	[Hitoshi, Seiji; Ishino, Yugo; Kumar, Akhilesh; Jasmine, Salma; Tanaka, Kenji F.; Ikenaka, Kazuhiro] Natl Inst Physiol Sci, Div Neurobiol & Bioinformat, Okazaki, Aichi 444, Japan; [Hitoshi, Seiji; Ishino, Yugo; Kumar, Akhilesh; Jasmine, Salma; Tanaka, Kenji F.; Ikenaka, Kazuhiro] Grad Univ Adv Studies, Dept Physiol Sci, Sch Life Sci, Okazaki, Aichi, Japan; [Kondo, Takeshi; Kato, Shigeaki] Univ Tokyo, Inst Mol & Cellular Biosci, Tokyo, Japan; [Hosoya, Toshihiko] RIKEN, Hosoya Res Unit, Brain Sci Inst, Wako, Saitama, Japan; [Hotta, Yoshiki] Res Org Informat & Syst, Tokyo, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Graduate University for Advanced Studies - Japan; University of Tokyo; RIKEN; Research Organization of Information & Systems (ROIS)	Hitoshi, S (corresponding author), Natl Inst Physiol Sci, Div Neurobiol & Bioinformat, Okazaki, Aichi 444, Japan.	shitoshi-tky@umin.ac.jp	Kumar, Akhilesh/G-9413-2013; Hosoya, Toshihiko/Q-2514-2018	Hosoya, Toshihiko/0000-0001-8559-8344; Tanaka, Kenji/0000-0003-2511-0057	Ministry of Education, Culture, Sports, Science and Technology of Japan [19650096]; Grants-in-Aid for Scientific Research [23680042, 22115004] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank R. Kageyama, J.S. Nye, T. Miyazaki and T. Honjo for plasmids, T.-e.U and Y. Imai for MBD4 mutant mice, and R. Kageyama, D. van der Kooy and K. Nakashima for comments. This work was supported by a Grant-in-Aid for Exploratory Research (19650096) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (K.I.S.H.).	Akiyama Y, 1996, P NATL ACAD SCI USA, V93, P14912, DOI 10.1073/pnas.93.25.14912; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; BETTENHAUSEN B, 1995, DEVELOPMENT, V121, P2407; Bruniquel D, 2003, NAT IMMUNOL, V4, P235, DOI 10.1038/ni887; Cau E, 2000, DEVELOPMENT, V127, P2323; delaPompa J, 1997, DEVELOPMENT, V124, P1139; Donoviel DB, 1999, GENE DEV, V13, P2801, DOI 10.1101/gad.13.21.2801; Egger B, 2002, DEVELOPMENT, V129, P3295; Gunther T, 2000, NATURE, V406, P199, DOI 10.1038/35018111; Hatakeyama J, 2004, DEVELOPMENT, V131, P5539, DOI 10.1242/dev.01436; Hatakeyama J, 2006, CEREB CORTEX, V16, pI132, DOI 10.1093/cercor/bhj166; Hirata H, 2002, SCIENCE, V298, P840, DOI 10.1126/science.1074560; Hitoshi S, 2004, GENE DEV, V18, P1806, DOI 10.1101/gad.1208404; Hitoshi S, 2002, GENE DEV, V16, P846, DOI 10.1101/gad.975202; HOSOYA T, 1995, CELL, V82, P1025, DOI 10.1016/0092-8674(95)90281-3; Iwasaki Y, 2003, DEVELOPMENT, V130, P6027, DOI 10.1242/dev.00822; Jones BW, 2005, DEV BIOL, V278, P265, DOI 10.1016/j.ydbio.2004.11.022; JONES BW, 1995, CELL, V82, P1013, DOI 10.1016/0092-8674(95)90280-5; Kageyama R, 2008, NAT NEUROSCI, V11, P1247, DOI 10.1038/nn.2208; Kageyama R, 2007, DEVELOPMENT, V134, P1243, DOI 10.1242/dev.000786; Kim JS, 1998, P NATL ACAD SCI USA, V95, P12364, DOI 10.1073/pnas.95.21.12364; Kim MS, 2009, NATURE, V461, P1007, DOI 10.1038/nature08456; Kimura C, 2000, DEV BIOL, V225, P304, DOI 10.1006/dbio.2000.9835; Ma DK, 2009, SCIENCE, V323, P1074, DOI 10.1126/science.1166859; Martens DJ, 2000, J NEUROSCI, V20, P1085, DOI 10.1523/JNEUROSCI.20-03-01085.2000; Nakahira E, 2006, DEV BIOL, V291, P123, DOI 10.1016/j.ydbio.2005.12.010; Nakamura Y, 2000, J NEUROSCI, V20, P283, DOI 10.1523/JNEUROSCI.20-01-00283.2000; Ohtsuka T, 2001, J BIOL CHEM, V276, P30467, DOI 10.1074/jbc.M102420200; OKA C, 1995, DEVELOPMENT, V121, P3291; Okada Y, 2010, NATURE, V463, P554, DOI 10.1038/nature08732; Rai K, 2008, CELL, V135, P1201, DOI 10.1016/j.cell.2008.11.042; Reik W, 2007, NATURE, V447, P425, DOI 10.1038/nature05918; REYNOLDS BA, 1992, J NEUROSCI, V12, P4565, DOI 10.1523/jneurosci.12-11-04565.1992; Schreiber J, 2000, MOL CELL BIOL, V20, P2466, DOI 10.1128/MCB.20.7.2466-2474.2000; Schreiber J, 1997, P NATL ACAD SCI USA, V94, P4739, DOI 10.1073/pnas.94.9.4739; Schreiber J, 1998, NUCLEIC ACIDS RES, V26, P2337, DOI 10.1093/nar/26.10.2337; Shimojo H, 2008, NEURON, V58, P52, DOI 10.1016/j.neuron.2008.02.014; Waga S, 1998, ANNU REV BIOCHEM, V67, P721, DOI 10.1146/annurev.biochem.67.1.721; Wolffe AP, 1999, P NATL ACAD SCI USA, V96, P5894, DOI 10.1073/pnas.96.11.5894; Zhu B, 2000, P NATL ACAD SCI USA, V97, P5135, DOI 10.1073/pnas.100107597; Zhu JK, 2009, ANNU REV GENET, V43, P143, DOI 10.1146/annurev-genet-102108-134205	41	48	50	4	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2011	14	8					957	U35		10.1038/nn.2875	http://dx.doi.org/10.1038/nn.2875			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	797KC	21765423				2022-12-28	WOS:000293123700008
J	Sejourne, J; Placais, PY; Aso, Y; Siwanowicz, I; Trannoy, S; Thoma, V; Tedjakumala, SR; Rubin, GM; Tchenio, P; Ito, K; Isabel, G; Tanimoto, H; Preat, T				Sejourne, Julien; Placais, Pierre-Yves; Aso, Yoshinori; Siwanowicz, Igor; Trannoy, Severine; Thoma, Vladimiros; Tedjakumala, Stevanus R.; Rubin, Gerald M.; Tchenio, Paul; Ito, Kei; Isabel, Guillaume; Tanimoto, Hiromu; Preat, Thomas			Mushroom body efferent neurons responsible for aversive olfactory memory retrieval in Drosophila	NATURE NEUROSCIENCE			English	Article							LONG-TERM-MEMORY; TIMING-DEPENDENT PLASTICITY; EXTRINSIC NEURONS; CONSOLIDATED MEMORY; PROTEIN; BODIES; INTEGRATION; DOPAMINE; DYNAMICS; BEHAVIOR	Aversive olfactory memory is formed in the mushroom bodies in Drosophila melanogaster. Memory retrieval requires mushroom body output, but the manner in which a memory trace in the mushroom body drives conditioned avoidance of a learned odor remains unknown. To identify neurons that are involved in olfactory memory retrieval, we performed an anatomical and functional screen of defined sets of mushroom body output neurons. We found that MB-V2 neurons were essential for retrieval of both short- and long-lasting memory, but not for memory formation or memory consolidation. MB-V2 neurons are cholinergic efferent neurons that project from the mushroom body vertical lobes to the middle superiormedial protocerebrum and the lateral horn. Notably, the odor response of MB-V2 neurons was modified after conditioning. As the lateral horn has been implicated in innate responses to repellent odorants, we propose that MB-V2 neurons recruit the olfactory pathway involved in innate odor avoidance during memory retrieval.	[Sejourne, Julien; Placais, Pierre-Yves; Trannoy, Severine; Tchenio, Paul; Isabel, Guillaume; Preat, Thomas] Ecole Super Phys & Chim Ind Ville Paris, CNRS, Neurobiol Unit, Paris, France; [Aso, Yoshinori; Siwanowicz, Igor; Thoma, Vladimiros; Tedjakumala, Stevanus R.; Tanimoto, Hiromu] Max Planck Inst Neurobiol, Martinsried, Germany; [Aso, Yoshinori; Rubin, Gerald M.] Howard Hughes Med Inst, Ashburn, VA USA; [Tchenio, Paul] Univ Paris 11, CNRS, UPR 3321, F-91405 Orsay, France; [Ito, Kei] Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo, Japan	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Superieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI); Max Planck Society; Howard Hughes Medical Institute; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; University of Tokyo	Preat, T (corresponding author), Ecole Super Phys & Chim Ind Ville Paris, CNRS, Neurobiol Unit, Paris, France.	hiromut@neuro.mpg.de; thomas.preat@espci.fr	Tanimoto, Hiromu/J-6810-2016; Aso, Yoshinori/ACJ-9439-2022; Trannoy, Severine/D-1530-2015	Trannoy, Severine/0000-0002-5059-9846; Thoma, Vladimiros/0000-0002-2688-4639; Rubin, Gerald/0000-0001-8762-8703; Preat, Thomas/0000-0001-9976-1763	Japan Society for the Promotion of Science; Agence Nationale pour la Recherche; Fondation Bettencourt-Schueler; Fondation pour la Recherche Medicale; Deutsche Forschungsgemeinschaft; Bundesministerium fur Bildung und Forschung; Max-Planck-Gesellschaft; Region Ile-de-France; Deutscher Akademischer Austausch Dienst	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Agence Nationale pour la Recherche(French National Research Agency (ANR)); Fondation Bettencourt-Schueler; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Max-Planck-Gesellschaft(Max Planck Society); Region Ile-de-France(Region Ile-de-France); Deutscher Akademischer Austausch Dienst(Deutscher Akademischer Austausch Dienst (DAAD))	We thank J. Urban and G. M. Technau for the MZ160 line, the members of the NP consortium for the NP2492 line, J.-M. Dura for the y<SUP>1</SUP>w<SUP>1118</SUP>; GAL80[y<SUP>+</SUP>], Sb line and for discussions, L. L. Looger for the UAS-GCaMP3 line, T. Kitamoto for the GAD1-GAL80 and Cha<SUP>3.3kb</SUP>-GAL80 lines, and V. Hakim, I. Rivals and members of our laboratories for discussions. This work was supported by grants from the Japan Society for the Promotion of Science (K. I.), the Agence Nationale pour la Recherche (T. P.), the Fondation Bettencourt-Schueler (T. P.), the Fondation pour la Recherche Medicale (T. P.), the Emmy-Noether Program from Deutsche Forschungsgemeinschaft (H. T.), the Bernstein Focus Learning from Bundesministerium fur Bildung und Forschung (H. T.) and the Max-Planck-Gesellschaft (H. T.). J. S. and G. I. were supported by the Fondation pour la Recherche Medicale, P.-Y.P. was supported by a grant from Region Ile-de-France and Y.A. was supported by Deutscher Akademischer Austausch Dienst.	Aso Y, 2010, CURR BIOL, V20, P1445, DOI 10.1016/j.cub.2010.06.048; Bashir ZI, 2003, NEUROSCI RES, V45, P363, DOI 10.1016/S0168-0102(03)00002-6; Bender VA, 2006, J NEUROSCI, V26, P4166, DOI 10.1523/JNEUROSCI.0176-06.2006; Caporale N, 2008, ANNU REV NEUROSCI, V31, P25, DOI 10.1146/annurev.neuro.31.060407.125639; Claridge-Chang A, 2009, CELL, V139, P405, DOI 10.1016/j.cell.2009.08.034; Colomb J, 2009, GENES BRAIN BEHAV, V8, P407, DOI 10.1111/j.1601-183X.2009.00482.x; Crittenden JR, 1998, LEARN MEMORY, V5, P38; Daniels RW, 2008, J COMP NEUROL, V508, P131, DOI 10.1002/cne.21670; DEBELLE JS, 1994, SCIENCE, V263, P692, DOI 10.1126/science.8303280; Featherstone DE, 2000, NEURON, V27, P71, DOI 10.1016/S0896-6273(00)00010-6; FIALA A, 2003, SCI STKE, pPL6; Gervasi N, 2010, NEURON, V65, P516, DOI 10.1016/j.neuron.2010.01.014; Gordon MD, 2009, NEURON, V61, P373, DOI 10.1016/j.neuron.2008.12.033; Hashimotodani Y, 2005, NEURON, V45, P257, DOI 10.1016/j.neuron.2005.01.004; Isabel G, 2004, SCIENCE, V304, P1024, DOI 10.1126/science.1094932; Ito K, 1998, LEARN MEMORY, V5, P52; Keene AC, 2007, NAT REV NEUROSCI, V8, P341, DOI 10.1038/nrn2098; Kitamoto T, 2002, P NATL ACAD SCI USA, V99, P13232, DOI 10.1073/pnas.202489099; Kitamoto T, 2001, J NEUROBIOL, V47, P81, DOI 10.1002/neu.1018; Klagges BRE, 1996, J NEUROSCI, V16, P3154; Krashes MJ, 2008, J NEUROSCI, V28, P3103, DOI 10.1523/JNEUROSCI.5333-07.2008; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Liu X, 2009, NAT NEUROSCI, V12, P53, DOI 10.1038/nn.2235; Masse NY, 2009, CURR BIOL, V19, pR700, DOI 10.1016/j.cub.2009.06.026; MAUELSHAGEN J, 1993, J NEUROPHYSIOL, V69, P609, DOI 10.1152/jn.1993.69.2.609; McGuire SE, 2005, PROG NEUROBIOL, V76, P328, DOI 10.1016/j.pneurobio.2005.09.003; McGuire SE, 2001, SCIENCE, V293, P1330, DOI 10.1126/science.1062622; Menzel R, 2005, J EXP BIOL, V208, P4317, DOI 10.1242/jeb.01908; Neckameyer WS, 2000, NEUROBIOL AGING, V21, P145, DOI 10.1016/S0197-4580(99)00109-8; Okada R, 2007, J NEUROSCI, V27, P11736, DOI 10.1523/JNEUROSCI.2216-07.2007; Otsuna H, 2006, J COMP NEUROL, V497, P928, DOI 10.1002/cne.21015; Pascual A, 2001, SCIENCE, V294, P1115, DOI 10.1126/science.1064200; Pfeiffer BD, 2008, P NATL ACAD SCI USA, V105, P9715, DOI 10.1073/pnas.0803697105; Robinson IM, 2002, NATURE, V418, P336, DOI 10.1038/nature00915; Sakai T, 2009, GENES BRAIN BEHAV, V8, P546, DOI 10.1111/j.1601-183X.2009.00503.x; Schwaerzel M, 2003, J NEUROSCI, V23, P10495, DOI 10.1523/jneurosci.23-33-10495.2003; Sepp KJ, 1999, GENETICS, V151, P1093; Takagawa K, 1996, NEUROSCI RES, V24, P237, DOI 10.1016/0168-0102(95)00999-X; Tanaka NK, 2004, CURR BIOL, V14, P449, DOI 10.1016/j.cub.2004.03.006; Tanaka NK, 2008, J COMP NEUROL, V508, P711, DOI 10.1002/cne.21692; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Tomchik SM, 2009, NEURON, V64, P510, DOI 10.1016/j.neuron.2009.09.029; TULLY T, 1994, CELL, V79, P35, DOI 10.1016/0092-8674(94)90398-0; TULLY T, 1985, J COMP PHYSIOL A, V157, P263, DOI 10.1007/BF01350033; Wang YL, 2008, J NEUROSCI, V28, P4368, DOI 10.1523/JNEUROSCI.2958-07.2008; Wang YL, 2003, CURR BIOL, V13, P1900, DOI 10.1016/j.cub.2003.10.003; Wong AM, 2002, CELL, V109, P229, DOI 10.1016/S0092-8674(02)00707-9; Yu DH, 2006, NEURON, V52, P845, DOI 10.1016/j.neuron.2006.10.030; Yusuyama K, 2002, J COMP NEUROL, V445, P211, DOI 10.1002/cne.10155; Zhang YQ, 2002, GENESIS, V34, P142, DOI 10.1002/gene.10144	50	150	151	0	40	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2011	14	7					903	U129		10.1038/nn.2846	http://dx.doi.org/10.1038/nn.2846			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	783KR	21685917	Green Submitted			2022-12-28	WOS:000292081700019
J	Mameli, M; Bellone, C; Brown, MTC; Luscher, C				Mameli, Manuel; Bellone, Camilla; Brown, Matthew T. C.; Luescher, Christian			Cocaine inverts rules for synaptic plasticity of glutamate transmission in the ventral tegmental area	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; DOPAMINE NEURONS; AMPA RECEPTORS; IN-VIVO; PERSISTENCE	The manner in which drug-evoked synaptic plasticity affects reward circuits remains largely elusive. We found that cocaine reduced NMDA receptor excitatory postsynaptic currents and inserted GluA2-lacking AMPA receptors in dopamine neurons of mice. Consequently, a stimulation protocol pairing glutamate release with hyperpolarizing current injections further strengthened synapses after cocaine treatment. Our data suggest that early cocaine-evoked plasticity in the ventral tegmental area inverts the rules for activity-dependent plasticity, eventually leading to addictive behavior.	[Mameli, Manuel; Bellone, Camilla; Brown, Matthew T. C.; Luescher, Christian] Univ Geneva, Fac Med, Dept Basic Neurosci, Geneva, Switzerland; [Mameli, Manuel] UPMC, INSERM, Inst Fer Moulin, UMR S 839, Paris, France; [Luescher, Christian] Univ Hosp Geneva, Neurol Clin, Dept Clin Neurosci, Geneva, Switzerland	University of Geneva; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; University of Geneva	Luscher, C (corresponding author), Univ Geneva, Fac Med, Dept Basic Neurosci, Geneva, Switzerland.	christian.luscher@unige.ch	Lüscher, Christian/A-2496-2011	Lüscher, Christian/0000-0001-7917-4596; bellone, camilla/0000-0002-6774-6275; Brown, Matthew/0000-0001-6983-962X; Mameli, Manuel/0000-0002-0570-6964	Swiss National Science Foundation; Systems X initiative of the Swiss Confederation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Systems X initiative of the Swiss Confederation	We thank the members of the Luscher laboratory as well as M. Frerking and A. Holtmaat for comments on the manuscript and B. Cerutti for help with the statistical analysis. This work is supported by the Swiss National Science Foundation (C.L.), the Systems X initiative of the Swiss Confederation (NeuroChoice, C.L.).	Bellone C, 2006, NAT NEUROSCI, V9, P636, DOI 10.1038/nn1682; Bowers MS, 2010, NEURON, V67, P11, DOI 10.1016/j.neuron.2010.06.004; Brown MTC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015870; Conrad KL, 2008, NATURE, V454, P118, DOI 10.1038/nature06995; Engblom D, 2008, NEURON, V59, P497, DOI 10.1016/j.neuron.2008.07.010; Good CH, 2010, J NEUROSCI, V30, P7900, DOI 10.1523/JNEUROSCI.1507-10.2010; Kullmann DM, 1999, PHILOS T ROY SOC B, V354, P395, DOI 10.1098/rstb.1999.0392; Lamsa KP, 2007, SCIENCE, V315, P1262, DOI 10.1126/science.1137450; Lane DA, 2010, NEUROSCIENCE, V169, P559, DOI 10.1016/j.neuroscience.2010.05.056; Luu P, 2008, J NEUROPHYSIOL, V100, P533, DOI 10.1152/jn.01384.2007; Mameli M, 2007, SCIENCE, V317, P530, DOI 10.1126/science.1142365; Mameli M, 2009, NAT NEUROSCI, V12, P1036, DOI 10.1038/nn.2367; Ungless MA, 2004, TRENDS NEUROSCI, V27, P702, DOI 10.1016/j.tins.2004.10.001; Ungless MA, 2001, NATURE, V411, P583, DOI 10.1038/35079077; Wang HX, 2010, J PHYSIOL-LONDON, V588, P2823, DOI 10.1113/jphysiol.2010.187591	15	127	130	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2011	14	4					414	416		10.1038/nn.2763	http://dx.doi.org/10.1038/nn.2763			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	741FQ	21336270				2022-12-28	WOS:000288849400008
J	Anastassiou, CA; Perin, R; Markram, H; Koch, C				Anastassiou, Costas A.; Perin, Rodrigo; Markram, Henry; Koch, Christof			Ephaptic coupling of cortical neurons	NATURE NEUROSCIENCE			English	Article							HIPPOCAMPAL PYRAMIDAL CELLS; APPLIED ELECTRIC-FIELDS; THETA OSCILLATIONS; IN-VIVO; SINGLE NEURONS; FREQUENCY; MODULATION; NETWORK; SYNCHRONIZATION; INFORMATION	The electrochemical processes that underlie neural function manifest themselves in ceaseless spatiotemporal field fluctuations. However, extracellular fields feed back onto the electric potential across the neuronal membrane via ephaptic coupling, independent of synapses. The extent to which such ephaptic coupling alters the functioning of neurons under physiological conditions remains unclear. To address this question, we stimulated and recorded from rat cortical pyramidal neurons in slices with a 12-electrode setup. We found that extracellular fields induced ephaptically mediated changes in the somatic membrane potential that were less than 0.5 mV under subthreshold conditions. Despite their small size, these fields could strongly entrain action potentials, particularly for slow (<8 Hz) fluctuations of the extracellular field. Finally, we simultaneously measured from up to four patched neurons located proximally to each other. Our findings indicate that endogenous brain activity can causally affect neural function through field effects under physiological conditions.	[Anastassiou, Costas A.; Koch, Christof] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Anastassiou, Costas A.] Univ London Imperial Coll Sci Technol & Med, Dept Bioengn, London, England; [Perin, Rodrigo; Markram, Henry] Ecole Polytech Fed Lausanne, Lab Neural Microcircuitry, CH-1015 Lausanne, Switzerland; [Koch, Christof] Korea Univ, Dept Brain & Cognit Engn, Seoul, South Korea	California Institute of Technology; Imperial College London; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Korea University	Anastassiou, CA (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	costas@caltech.edu	Perin, Rodrigo/G-7691-2015	Perin, Rodrigo/0000-0001-5756-3769; Koch, Christof/0000-0001-6482-8067	Engineering Physical Sciences Research Council; Sloan-Swartz Foundation; Swiss National Science Foundation; EU Synapse; National Science Foundation; Mathers Foundation; Ministry of Education, Science and Technology [R31-10008]	Engineering Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Sloan-Swartz Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); EU Synapse; National Science Foundation(National Science Foundation (NSF)); Mathers Foundation; Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	We thank G. Buzsaki, U. Rutishauser and E. Schomburg for comments and discussions and J. Bastiaansen for assistance. This work was funded by the Engineering Physical Sciences Research Council (C.A.A.), the Sloan-Swartz Foundation (C.A.A.), the Swiss National Science Foundation (C.A.A.), EU Synapse (R.P.), the National Science Foundation (C.K. and C.A.A.), the Mathers Foundation (C.K. and C.A.A.) and the World Class University program through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology (R31-10008, C.K.).	Anastassiou CA, 2010, J NEUROSCI, V30, P1925, DOI 10.1523/JNEUROSCI.3635-09.2010; Arvanitaki A, 1942, J NEUROPHYSIOL, V5, P89, DOI 10.1152/jn.1942.5.2.89; Berens P, 2009, J STAT SOFTW, V31, P1, DOI 10.18637/jss.v031.i10; BUZSAKI G, 1983, BRAIN RES REV, V6, P139, DOI 10.1016/0165-0173(83)90037-1; BUZSAKI G, 1992, SCIENCE, V256, P1025, DOI 10.1126/science.1589772; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; CHAN CY, 1986, J PHYSIOL-LONDON, V371, P89, DOI 10.1113/jphysiol.1986.sp015963; CHAN CY, 1988, J PHYSIOL-LONDON, V402, P751, DOI 10.1113/jphysiol.1988.sp017232; Colgin LL, 2009, NATURE, V462, P353, DOI 10.1038/nature08573; Deans JK, 2007, J PHYSIOL-LONDON, V583, P555, DOI 10.1113/jphysiol.2007.137711; Fries P, 2001, SCIENCE, V291, P1560, DOI 10.1126/science.1055465; Ghai RS, 2000, J NEUROPHYSIOL, V84, P274, DOI 10.1152/jn.2000.84.1.274; Gold C, 2006, J NEUROPHYSIOL, V95, P3113, DOI 10.1152/jn.00979.2005; Haider B, 2009, NEURON, V62, P171, DOI 10.1016/j.neuron.2009.04.008; Harvey CD, 2009, NATURE, V461, P941, DOI 10.1038/nature08499; Histed MH, 2009, NEURON, V63, P508, DOI 10.1016/j.neuron.2009.07.016; Holt GR, 1999, J COMPUT NEUROSCI, V6, P169, DOI 10.1023/A:1008832702585; Hutcheon B, 2000, TRENDS NEUROSCI, V23, P216, DOI 10.1016/S0166-2236(00)01547-2; Jacobson GA, 2005, J PHYSIOL-LONDON, V564, P145, DOI 10.1113/jphysiol.2004.080903; JEFFERYS JGR, 1995, PHYSIOL REV, V75, P689, DOI 10.1152/physrev.1995.75.4.689; JEFFERYS JGR, 1982, NATURE, V300, P448, DOI 10.1038/300448a0; Kamondi A, 1998, HIPPOCAMPUS, V8, P244, DOI 10.1002/(SICI)1098-1063(1998)8:3<244::AID-HIPO7>3.0.CO;2-J; Kayser C, 2009, NEURON, V61, P597, DOI 10.1016/j.neuron.2009.01.008; Koch Christof, 1999, P1; Kreiman G, 2000, NAT NEUROSCI, V3, P946, DOI 10.1038/78868; Kreiman G, 2006, NEURON, V49, P433, DOI 10.1016/j.neuron.2005.12.019; Logothetis NK, 2007, NEURON, V55, P809, DOI 10.1016/j.neuron.2007.07.027; Lubenov EV, 2009, NATURE, V459, P534, DOI 10.1038/nature08010; Mann EO, 2010, NEURON, V67, P3, DOI 10.1016/j.neuron.2010.06.036; Marshall L, 2006, NATURE, V444, P610, DOI 10.1038/nature05278; Milstein J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004338; Montoro RJ, 2004, BRAIN RES REV, V47, P216, DOI 10.1016/j.brainresrev.2004.06.009; NOEBELS JL, 1978, J NEUROPHYSIOL, V41, P1267, DOI 10.1152/jn.1978.41.5.1267; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; Ozen S, 2010, J NEUROSCI, V30, P11476, DOI 10.1523/JNEUROSCI.5252-09.2010; Pastalkova E, 2008, SCIENCE, V321, P1322, DOI 10.1126/science.1159775; Pettersen KH, 2008, BIOPHYS J, V94, P784, DOI 10.1529/biophysj.107.111179; Quiroga RQ, 2005, NATURE, V435, P1102, DOI 10.1038/nature03687; Radman T, 2007, J NEUROSCI, V27, P3030, DOI 10.1523/JNEUROSCI.0095-07.2007; Rutishauser U, 2010, NATURE, V464, P903, DOI 10.1038/nature08860; STERIADE M, 1993, J NEUROSCI, V13, P3266; STERIADE M, 1993, J NEUROSCI, V13, P3252, DOI 10.1523/jneurosci.13-08-03252.1993; Stuart G, 2008, DENDRITES; Tabareau N, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000637; TRAUB RD, 1985, NEUROSCIENCE, V14, P1033, DOI 10.1016/0306-4522(85)90274-X; VANDERWOLF CH, 1969, ELECTROEN CLIN NEURO, V26, P407, DOI 10.1016/0013-4694(69)90092-3; Weiss SA, 2010, FRONT NEURAL CIRCUIT, V4, DOI 10.3389/fncir.2010.00015; Womelsdorf T, 2006, NATURE, V439, P733, DOI 10.1038/nature04258; Womelsdorf T, 2007, SCIENCE, V316, P1609, DOI [10.1126/science.1139597, 10.1126/science.1139178]; YLINEN A, 1995, J NEUROSCI, V15, P30	50	306	311	2	47	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2011	14	2					217	U304		10.1038/nn.2727	http://dx.doi.org/10.1038/nn.2727			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	711MJ	21240273				2022-12-28	WOS:000286595400019
J	Liu, T; Xu, ZZ; Park, CK; Berta, T; Ji, RR				Liu, Tong; Xu, Zhen-Zhong; Park, Chul-Kyu; Berta, Temugin; Ji, Ru-Rong			Toll-like receptor 7 mediates pruritus	NATURE NEUROSCIENCE			English	Article							ITCH SENSATION; INFLAMMATION; ACTIVATION; PAIN	Toll-like receptors are typically expressed in immune cells to regulate innate immunity. We found that functional Toll-like receptor 7 (TLR7) was expressed in C-fiber primary sensory neurons and was important for inducing itch (pruritus), but was not necessary for eliciting mechanical, thermal, inflammatory and neuropathic pain in mice. Our results indicate that TLR7 mediates itching and is a potential therapeutic target for anti-itch treatment in skin disease conditions.	[Liu, Tong; Xu, Zhen-Zhong; Park, Chul-Kyu; Berta, Temugin; Ji, Ru-Rong] Brigham & Womens Hosp, Dept Anesthesiol Perioperat & Pain Med, Sensory Plast Lab, Boston, MA 02115 USA; [Liu, Tong; Xu, Zhen-Zhong; Park, Chul-Kyu; Berta, Temugin; Ji, Ru-Rong] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Ji, RR (corresponding author), Brigham & Womens Hosp, Dept Anesthesiol Perioperat & Pain Med, Sensory Plast Lab, 75 Francis St, Boston, MA 02115 USA.	rrji@zeus.bwh.harvard.edu	Liu, Tong/C-7810-2012; Liu, Tong/E-3648-2010; Berta, Temugin/AAK-6365-2020; Berta, Temugin/A-6908-2016; Ji, Ru-Rong/L-7070-2017	Berta, Temugin/0000-0002-4486-8288; Berta, Temugin/0000-0002-4486-8288; Ji, Ru-Rong/0000-0002-9355-3688; Xu, Zhen-Zhong/0000-0001-6578-211X	US National Institutes of Health [R01-DE17794, R01-NS54362, R01-NS67686]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE017794] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS067686, F30NS054362, R01NS054932] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The work was supported by US National Institutes of Health grants R01-DE17794, R01-NS54362 and R01-NS67686 to R.-R.J.	Hemmi H, 2002, NAT IMMUNOL, V3, P196, DOI 10.1038/ni758; Ikoma A, 2006, NAT REV NEUROSCI, V7, P535, DOI 10.1038/nrn1950; Imamachi N, 2009, P NATL ACAD SCI USA, V106, P11330, DOI 10.1073/pnas.0905605106; Lee J, 2003, P NATL ACAD SCI USA, V100, P6646, DOI 10.1073/pnas.0631696100; Liu Q, 2009, CELL, V139, P1353, DOI 10.1016/j.cell.2009.11.034; Madan V, 2010, LANCET, V375, P673, DOI 10.1016/S0140-6736(09)61196-X; Marchand F, 2005, NAT REV NEUROSCI, V6, P521, DOI 10.1038/nrn1700; Paus R, 2006, J CLIN INVEST, V116, P1174, DOI 10.1172/JCI28553; Shim WS, 2007, J NEUROSCI, V27, P2331, DOI 10.1523/JNEUROSCI.4643-06.2007; Shim WS, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-29; Shimada SG, 2008, PAIN, V139, P681, DOI 10.1016/j.pain.2008.08.002; Sun YG, 2007, NATURE, V448, P700, DOI 10.1038/nature06029; Sun YG, 2009, SCIENCE, V325, P1531, DOI 10.1126/science.1174868; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; van der Fits L, 2009, J IMMUNOL, V182, P5836, DOI 10.4049/jimmunol.0802999	15	172	178	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	2010	13	12					1460	1462		10.1038/nn.2683	http://dx.doi.org/10.1038/nn.2683			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	684CW	21037581	Green Accepted			2022-12-28	WOS:000284525800009
J	Kumamoto, N; Gu, Y; Wang, J; Janoschka, S; Takemaru, KI; Levine, J; Ge, SY				Kumamoto, Natsuko; Gu, Yan; Wang, Jia; Janoschka, Stephen; Takemaru, Ken-Ichi; Levine, Joel; Ge, Shaoyu			A role for primary cilia in glutamatergic synaptic integration of adult-born neurons	NATURE NEUROSCIENCE			English	Article							NEWLY GENERATED NEURONS; BETA-CATENIN; HIPPOCAMPAL NEUROGENESIS; DENTATE GYRUS; PROGENITOR POOL; BRAIN; MORPHOGENESIS; DISEASE; MALFORMATION; MECHANISMS	The sequential synaptic integration of adult-born neurons has been widely examined in rodents, but the mechanisms regulating the integration remain largely unknown. The primary cilium, a microtubule-based signaling center, is essential for vertebrate development, including the development of the CNS. We examined the assembly and function of the primary cilium in the synaptic integration of adult-born mouse hippocampal neurons. Primary cilia were absent in young adult-born neurons, but assembled precisely at the stage when newborn neurons approach their final destination, further extend dendrites and form synapses with entorhinal cortical projections. Conditional deletion of cilia from adult-born neurons induced severe defects in dendritic refinement and synapse formation. Deletion of primary cilia led to enhanced Wnt and beta-catenin signaling, which may account for these developmental defects. Taken together, our findings identify the assembly of primary cilia as a critical regulatory event in the dendritic refinement and synaptic integration of adult-born neurons.	[Kumamoto, Natsuko; Gu, Yan; Wang, Jia; Janoschka, Stephen; Levine, Joel; Ge, Shaoyu] SUNY Stony Brook, Dept Neurobiol & Behav, Stony Brook, NY 11794 USA; [Janoschka, Stephen] SUNY Stony Brook, Program Neurosci, Stony Brook, NY 11794 USA; [Takemaru, Ken-Ichi] SUNY Stony Brook, Dept Pharmacol Sci, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Ge, SY (corresponding author), SUNY Stony Brook, Dept Neurobiol & Behav, Stony Brook, NY 11794 USA.	sge@notes.cc.sunysb.edu	Core, Vector/CAF-4832-2022; Gu, Yan/K-4702-2017	Gu, Yan/0000-0001-5562-6279	US National Institutes of Health [NS065915, HL107493]; American Heart Association [0930067N]; State University of New York Research Excellence in Academic Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL107493, R56HL107493] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS065915] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); State University of New York Research Excellence in Academic Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We would like to thank S. Halegoua, M. Kernan, G. Matthews, L. Role and H. Song for critical comments, and F.-Q. Li, J. Rodriguez and Q. Xiong for technical support. This work was supported by grants from the US National Institutes of Health (NS065915 to S. G. and HL107493 to K.-I.T.), the American Heart Association (0930067N to S.G.) and the State University of New York Research Excellence in Academic Health (to S.G.).	ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; Amaral DG, 2007, PROG BRAIN RES, V163, P3, DOI 10.1016/S0079-6123(07)63001-5; Bisgrove BW, 2006, DEVELOPMENT, V133, P4131, DOI 10.1242/dev.02595; Bishop GA, 2007, J COMP NEUROL, V505, P562, DOI 10.1002/cne.21510; Brault V, 2001, DEVELOPMENT, V128, P1253; Breunig JJ, 2008, P NATL ACAD SCI USA, V105, P13127, DOI 10.1073/pnas.0804558105; Brown CL, 2005, TRAFFIC, V6, P1114, DOI 10.1111/j.1600-0854.2005.00347.x; Budnik V, 2011, CURR OPIN NEUROBIOL, V21, P151, DOI 10.1016/j.conb.2010.12.002; Chizhikov VV, 2007, J NEUROSCI, V27, P9780, DOI 10.1523/JNEUROSCI.5586-06.2007; Corbit KC, 2008, NAT CELL BIOL, V10, P70, DOI 10.1038/ncb1670; Delaval B, 2011, NAT CELL BIOL, V13, P461, DOI 10.1038/ncb2202; Duan X, 2007, CELL, V130, P1146, DOI 10.1016/j.cell.2007.07.010; Esposito MS, 2005, J NEUROSCI, V25, P10074, DOI 10.1523/JNEUROSCI.3114-05.2005; Gao X, 2007, J NEUROSCI, V27, P14317, DOI 10.1523/JNEUROSCI.3206-07.2007; Ge SY, 2007, NEURON, V54, P559, DOI 10.1016/j.neuron.2007.05.002; Ge SY, 2007, TRENDS NEUROSCI, V30, P1, DOI 10.1016/j.tins.2006.11.001; Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404; Gerdes JM, 2009, CELL, V137, P32, DOI 10.1016/j.cell.2009.03.023; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; Han YG, 2008, NAT NEUROSCI, V11, P277, DOI 10.1038/nn2059; Han YG, 2010, CURR OPIN NEUROBIOL, V20, P58, DOI 10.1016/j.conb.2009.12.002; Huang P, 2009, DEVELOPMENT, V136, P3089, DOI 10.1242/dev.041343; Kelsch W, 2010, ANNU REV NEUROSCI, V33, P131, DOI 10.1146/annurev-neuro-060909-153252; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Kempermann G, 2002, ANN NEUROL, V52, P135, DOI 10.1002/ana.10262; Lancaster MA, 2009, CURR OPIN GENET DEV, V19, P220, DOI 10.1016/j.gde.2009.04.008; Lee JE, 2011, CURR OPIN NEUROL, V24, P98, DOI 10.1097/WCO.0b013e3283444d05; Li FQ, 2010, MOL BIOL CELL, V21, P311, DOI 10.1091/mbc.E09-05-0437; Lie DC, 2005, NATURE, V437, P1370, DOI 10.1038/nature04108; Ma DKK, 2010, NAT NEUROSCI, V13, P1338, DOI 10.1038/nn.2672; Maretto S, 2003, P NATL ACAD SCI USA, V100, P3299, DOI 10.1073/pnas.0434590100; Masdeu C, 2007, NEUROREPORT, V18, P395, DOI 10.1097/WNR.0b013e32801421ce; McDermott KM, 2010, CURR BIOL, V20, P731, DOI 10.1016/j.cub.2010.02.048; Nishimura T, 2004, NAT CELL BIOL, V6, P328, DOI 10.1038/ncb1118; Ocbina PJR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006839; Pazour GJ, 2000, J CELL BIOL, V151, P709, DOI 10.1083/jcb.151.3.709; Robert A, 2007, J CELL SCI, V120, P628, DOI 10.1242/jcs.03366; Rohatgi R, 2009, P NATL ACAD SCI USA, V106, P3196, DOI 10.1073/pnas.0813373106; Rosso SB, 2005, NAT NEUROSCI, V8, P34, DOI 10.1038/nn1374; Schneider L, 2010, CELL PHYSIOL BIOCHEM, V25, P279, DOI 10.1159/000276562; Spassky N, 2008, DEV BIOL, V317, P246, DOI 10.1016/j.ydbio.2008.02.026; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; Tsai LH, 2005, NEURON, V46, P383, DOI 10.1016/j.neuron.2005.04.013; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Wadiche LO, 2005, J NEUROPHYSIOL, V94, P4528, DOI 10.1152/jn.00633.2005; Willaredt MA, 2008, J NEUROSCI, V28, P12887, DOI 10.1523/JNEUROSCI.2084-08.2008; Yam PT, 2009, NEURON, V62, P349, DOI 10.1016/j.neuron.2009.03.022; Yu X, 2003, NAT NEUROSCI, V6, P1169, DOI 10.1038/nn1132; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033	50	118	124	1	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2012	15	3					399	U79		10.1038/nn.3042	http://dx.doi.org/10.1038/nn.3042			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	899CY	22306608	Green Accepted, Green Published			2022-12-28	WOS:000300793100013
J	Zhang, JY; Ackman, JB; Xu, HP; Crair, MC				Zhang, Jiayi; Ackman, James B.; Xu, Hong-Ping; Crair, Michael C.			Visual map development depends on the temporal pattern of binocular activity in mice	NATURE NEUROSCIENCE			English	Article							EYE-SPECIFIC SEGREGATION; RETINAL GANGLION-CELLS; DEVELOPING RETINOTECTAL SYSTEM; OCULAR DOMINANCE COLUMNS; RECEPTIVE-FIELDS; INSTRUCTIVE ROLE; NEURONAL-ACTIVITY; WAVES; RETINOGENICULATE; CORTEX	Binocular competition is thought to drive eye-specific segregation in the developing visual system, potentially through Hebbian synaptic learning rules that are sensitive to correlations in afferent activity. Altering retinal activity can disrupt eye-specific segregation, but little is known about the temporal features of binocular activity that modulate visual map development. We used optogenetic techniques to directly manipulate retinal activity in vivo and identified a critical period before eye opening in mice when specific binocular features of retinal activity drive visual map development. Synchronous activation of both eyes disrupted segregation, whereas asynchronous stimulation enhanced segregation. The optogenetic stimulus applied was spatially homogenous; accordingly, retinotopy of ipsilateral projections was markedly perturbed, but contralateral retinotopy was unaffected or even improved. These results provide direct evidence that the synchrony and precise temporal pattern of binocular retinal activity during a critical period in development regulates eye-specific segregation and retinotopy in the developing visual system.	[Zhang, Jiayi; Ackman, James B.; Xu, Hong-Ping; Crair, Michael C.] Yale Univ, Dept Neurobiol, New Haven, CT 06520 USA; [Crair, Michael C.] Yale Univ, Dept Ophthalmol & Visual Sci, New Haven, CT USA	Yale University; Yale University	Crair, MC (corresponding author), Yale Univ, Dept Neurobiol, New Haven, CT 06520 USA.	michael.crair@yale.edu		Ackman, James/0000-0003-0802-6080; Zhang, Jiayi/0000-0002-1575-0723	US National Institutes of Health [P30 EY000785, R01 EY015788, R01 EY015788S]; Research to Prevent Blindness; Brown-Coxe Fellowship; NATIONAL EYE INSTITUTE [R01EY001578, R01EY015788, P30EY000785] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007224] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Brown-Coxe Fellowship; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We would like to thank members of the Crair laboratory for comments on the manuscript, J. Cardin and M. Higley for experimental guidance and Y. Zhang for technical help. This work was supported by US National Institutes of Health grants P30 EY000785, R01 EY015788 and R01 EY015788S to M.C.C. and by a Research to Prevent Blindness Challenge Grant to the Department of Ophthalmology & Visual Sciences. J.Z. was supported by a Brown-Coxe Fellowship. M.C.C. also thanks the family of W. Ziegler III for their support.	ALTMANN L, 1987, J NEUROPHYSIOL, V58, P965, DOI 10.1152/jn.1987.58.5.965; [Anonymous], [No title captured]; Badea TC, 2009, NEURON, V61, P852, DOI 10.1016/j.neuron.2009.01.020; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Butts DA, 2001, J NEUROSCI, V21, P961, DOI 10.1523/JNEUROSCI.21-03-00961.2001; Butts DA, 2007, PLOS BIOL, V5, P651, DOI 10.1371/journal.pbio.0050061; Butts Daniel A, 2010, Front Synaptic Neurosci, V2, P30, DOI 10.3389/fnsyn.2010.00030; Cardin JA, 2010, NAT PROTOC, V5, P247, DOI 10.1038/nprot.2009.228; Chandrasekaran AR, 2005, J NEUROSCI, V25, P6929, DOI 10.1523/JNEUROSCI.1470-05.2005; Chapman B, 2000, SCIENCE, V287, P2479, DOI 10.1126/science.287.5462.2479; Crair MC, 1998, SCIENCE, V279, P566, DOI 10.1126/science.279.5350.566; Crair MC, 2001, J COMP NEUROL, V430, P235, DOI 10.1002/1096-9861(20010205)430:2<235::AID-CNE1028>3.0.CO;2-P; Dan Y, 2006, PHYSIOL REV, V86, P1033, DOI 10.1152/physrev.00030.2005; Demas J, 2006, NEURON, V50, P247, DOI 10.1016/j.neuron.2006.03.033; Demas JA, 2012, DEV NEUROBIOL, V72, P537, DOI 10.1002/dneu.20880; Dhande OS, 2011, J NEUROSCI, V31, P3384, DOI 10.1523/JNEUROSCI.4899-10.2011; Ecker JL, 2010, NEURON, V67, P49, DOI 10.1016/j.neuron.2010.05.023; Faguet J, 2009, J NEUROPHYSIOL, V101, P855, DOI 10.1152/jn.90893.2008; Feldheim DA, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001768; Garaschuk O, 2000, NAT NEUROSCI, V3, P452, DOI 10.1038/74823; GODEMENT P, 1984, J COMP NEUROL, V230, P552, DOI 10.1002/cne.902300406; Hayakawa I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011001; Huberman AD, 2008, NEURON, V59, P425, DOI 10.1016/j.neuron.2008.07.018; Huberman AD, 2008, ANNU REV NEUROSCI, V31, P479, DOI 10.1146/annurev.neuro.31.060407.125533; Huberman AD, 2006, NEURON, V52, P247, DOI 10.1016/j.neuron.2006.07.028; Johnson J, 2010, P NATL ACAD SCI USA, V107, P17374, DOI 10.1073/pnas.1008533107; Kastanenka KV, 2010, J NEUROSCI, V30, P10575, DOI 10.1523/JNEUROSCI.2773-10.2010; Kerschensteiner D, 2008, NEURON, V58, P851, DOI 10.1016/j.neuron.2008.04.025; Koch SM, 2011, NEURON, V71, P235, DOI 10.1016/j.neuron.2011.05.045; MEISTER M, 1991, SCIENCE, V252, P939, DOI 10.1126/science.2035024; Moody WJ, 2005, PHYSIOL REV, V85, P883, DOI 10.1152/physrev.00017.2004; Mu Y, 2006, NEURON, V50, P115, DOI 10.1016/j.neuron.2006.03.009; Muir-Robinson G, 2002, J NEUROSCI, V22, P5259; Petros TJ, 2008, ANNU REV NEUROSCI, V31, P295, DOI 10.1146/annurev.neuro.31.060407.125609; Pfeiffenberger C, 2006, J NEUROSCI, V26, P12873, DOI 10.1523/JNEUROSCI.3595-06.2006; RAKIC P, 1976, NATURE, V261, P467, DOI 10.1038/261467a0; Shah RD, 2008, J NEUROSCI, V28, P292, DOI 10.1523/JNEUROSCI.4276-07.2008; SHATZ CJ, 1983, J NEUROSCI, V3, P482; Stellwagen D, 2002, NEURON, V33, P357, DOI 10.1016/S0896-6273(02)00577-9; Thyagarajan S, 2010, J NEUROSCI, V30, P8745, DOI 10.1523/JNEUROSCI.4417-09.2010; Torborg CL, 2005, NAT NEUROSCI, V8, P72, DOI 10.1038/nn1376; Tritsch NX, 2007, NATURE, V450, P50, DOI 10.1038/nature06233; Vislay-Meltzer R, 2006, NEURON, V50, P101, DOI 10.1016/j.neuron.2006.02.016; Wang H, 2007, P NATL ACAD SCI USA, V104, P8143, DOI 10.1073/pnas.0700384104; Watt AJ, 2009, NAT NEUROSCI, V12, P463, DOI 10.1038/nn.2285; Weliky M, 1997, NATURE, V386, P680, DOI 10.1038/386680a0; Xu HP, 2011, NEURON, V70, P1115, DOI 10.1016/j.neuron.2011.04.028; Xu HP, 2010, NEURON, V65, P503, DOI 10.1016/j.neuron.2010.01.035	49	95	96	0	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2012	15	2					298	307		10.1038/nn.3007	http://dx.doi.org/10.1038/nn.3007			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	882ZX	22179110	Green Accepted			2022-12-28	WOS:000299603500022
J	Zhang, YL; Liu, RY; Heberton, GA; Smolen, P; Baxter, DA; Cleary, LJ; Byrne, JH				Zhang, Yili; Liu, Rong-Yu; Heberton, George A.; Smolen, Paul; Baxter, Douglas A.; Cleary, Leonard J.; Byrne, John H.			Computational design of enhanced learning protocols	NATURE NEUROSCIENCE			English	Article							LONG-TERM FACILITATION; ACTIVATED PROTEIN-KINASE; SENSORY NEURON SYNAPSES; TAIL-WITHDRAWAL REFLEX; SYNAPTIC FACILITATION; DISTRIBUTED PRACTICE; DISTINCT PHASES; APLYSIA; MEMORY; SEROTONIN	Learning and memory are influenced by the temporal pattern of training stimuli. However, the mechanisms that determine the effectiveness of a particular training protocol are not well understood. We tested the hypothesis that the efficacy of a protocol is determined in part by interactions among biochemical cascades that underlie learning and memory. Previous findings suggest that the protein kinase A (PKA) and extracellular signal-regulated kinase (ERK) cascades are necessary to induce long-term synaptic facilitation (LIE) in Aplysia, a neuronal correlate of memory. We developed a computational model of the PKA and ERK cascades and used it to identify a training protocol that maximized PKA and ERK interactions. In vitro studies confirmed that the protocol enhanced LIE Moreover, the protocol enhanced the levels of phosphorylation of the transcription factor CREB1. Behavioral training confirmed that long-term memory also was enhanced by the protocol. These results illustrate the feasibility of using computational models to design training protocols that improve memory.	[Zhang, Yili; Liu, Rong-Yu; Heberton, George A.; Smolen, Paul; Baxter, Douglas A.; Cleary, Leonard J.; Byrne, John H.] Univ Texas Med Sch Houston, WM Keck Ctr Neurobiol Learning & Memory, Dept Neurobiol & Anat, Houston, TX USA	University of Texas System; University of Texas Health Science Center Houston	Byrne, JH (corresponding author), Univ Texas Med Sch Houston, WM Keck Ctr Neurobiol Learning & Memory, Dept Neurobiol & Anat, Houston, TX USA.	john.h.byrne@uth.tmc.edu			US National Institutes of Health [P01 NS038310, R01 NS019895, R01 NS073974]; Keck Center National Library of Medicine of the Gulf Coast Consortia [T15LM007093]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS019895, P01NS038310, R01NS073974] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [T15LM007093] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Keck Center National Library of Medicine of the Gulf Coast Consortia; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	We thank M.J. Byrne for his help with implementing the particle swarm optimization algorithm. This work was supported by US National Institutes of Health grants P01 NS038310, R01 NS019895 and R01 NS073974, and by a training fellowship from the Keck Center National Library of Medicine Training Program in Biomedical Informatics of the Gulf Coast Consortia (grant T15LM007093).	ALBERINI CM, 1994, CELL, V76, P1099, DOI 10.1016/0092-8674(94)90386-7; Alberini CM, 2009, PHYSIOL REV, V89, P121, DOI 10.1152/physrev.00017.2008; BARTSCH D, 1995, CELL, V83, P979, DOI 10.1016/0092-8674(95)90213-9; Bartsch D, 1998, CELL, V95, P211, DOI 10.1016/S0092-8674(00)81752-3; Byrne J.H, 2009, MOL NETWORKS INTRO C, P539; Cai DC, 2008, CURR BIOL, V18, P920, DOI 10.1016/j.cub.2008.05.038; Casadio A, 1999, CELL, V99, P221, DOI 10.1016/S0092-8674(00)81653-0; Cepeda NJ, 2006, PSYCHOL BULL, V132, P354, DOI 10.1037/0033-2909.132.3.354; Cepeda NJ, 2009, EXP PSYCHOL, V56, P236, DOI 10.1027/1618-3169.56.4.236; Chain DG, 1999, NEURON, V22, P147, DOI 10.1016/S0896-6273(00)80686-8; Cleary LJ, 1998, J NEUROSCI, V18, P5988; CLEARY LJ, 1993, J NEUROPHYSIOL, V70, P1767, DOI 10.1152/jn.1993.70.5.1767; Dash PK, 1996, MOL BRAIN RES, V39, P43, DOI 10.1016/0169-328X(95)00350-2; FROST WN, 1985, P NATL ACAD SCI USA, V82, P8266, DOI 10.1073/pnas.82.23.8266; GOLDSMITH BA, 1991, P NATL ACAD SCI USA, V88, P9021, DOI 10.1073/pnas.88.20.9021; Hintzman D. L., 1976, PSYCHOL LEARN MOTIV, V10, P47, DOI DOI 10.1016/S0079-7421(08)60464-8; Hu JY, 2007, J NEUROSCI, V27, P8927, DOI 10.1523/JNEUROSCI.2322-07.2007; Lee JA, 2003, NEUROSCI LETT, V337, P9, DOI 10.1016/S0304-3940(02)01285-5; Lee JA, 2006, J CELL BIOL, V174, P827, DOI 10.1083/jcb.200512066; Lee YS, 2008, MOL BRAIN, V1, DOI 10.1186/1756-6606-1-3; Liu RY, 2011, J NEUROSCI, V31, P6871, DOI 10.1523/JNEUROSCI.5071-10.2011; Liu RY, 2011, LEARN MEMORY, V18, P245, DOI 10.1101/lm.2112111; Marinesco S, 2002, J NEUROSCI, V22, P2299, DOI 10.1523/JNEUROSCI.22-06-02299.2002; Martin KC, 1997, NEURON, V18, P899, DOI 10.1016/S0896-6273(00)80330-X; Mauelshagen J, 1998, LEARN MEMORY, V5, P246; MONTAROLO PG, 1986, SCIENCE, V234, P1249, DOI 10.1126/science.3775383; Muller U, 1998, NEURON, V21, P1423, DOI 10.1016/S0896-6273(00)80660-1; OCORR KA, 1985, NEUROSCI LETT, V55, P113, DOI 10.1016/0304-3940(85)90004-7; Philips GT, 2007, J NEUROSCI, V27, P13701, DOI 10.1523/JNEUROSCI.4262-07.2007; Philips GT, 2011, LEARN MEMORY, V18, P272, DOI 10.1101/lm.2125311; Sharma SK, 2004, LEARN MEMORY, V11, P373, DOI 10.1101/lm.81104; Sharma SK, 2003, J NEUROSCI, V23, P3899; Smolen P, 1998, AM J PHYSIOL-CELL PH, V274, pC531, DOI 10.1152/ajpcell.1998.274.2.C531; Sutton MA, 2002, LEARN MEMORY, V9, P29, DOI 10.1101/lm.44802; Wainwright ML, 2002, J NEUROSCI, V22, P4132, DOI 10.1523/JNEUROSCI.22-10-04132.2002; Wang DO, 2009, SCIENCE, V324, P1536, DOI 10.1126/science.1173205; WHITE JA, 1993, J NEUROPHYSIOL, V70, P1777, DOI 10.1152/jn.1993.70.5.1777	37	53	54	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2012	15	2					294	297		10.1038/nn.2990	http://dx.doi.org/10.1038/nn.2990			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	882ZX	22197829	Green Accepted			2022-12-28	WOS:000299603500021
J	Snellman, J; Mehta, B; Babai, N; Bartoletti, TM; Akmentin, W; Francis, A; Matthews, G; Thoreson, W; Zenisek, D				Snellman, Josefin; Mehta, Bhupesh; Babai, Norbert; Bartoletti, Theodore M.; Akmentin, Wendy; Francis, Adam; Matthews, Gary; Thoreson, Wallace; Zenisek, David			Acute destruction of the synaptic ribbon reveals a role for the ribbon in vesicle priming	NATURE NEUROSCIENCE			English	Article							INNER PLEXIFORM LAYER; EXOCYTOSED PROTONS; ACTIVE ZONES; BASSOON; POOL; ORGANIZATION; DEPRESSION; RECEPTORS; TRANSIENT; TRANSPORT	In vision, balance and hearing, sensory receptor cells translate sensory stimuli into electrical signals whose amplitude is graded with stimulus intensity. The output synapses of these sensory neurons must provide fast signaling to follow rapidly changing stimuli while also transmitting graded information covering a wide range of stimulus intensity and must be able to sustain this signaling for long time periods. To meet these demands, specialized machinery for transmitter release, the synaptic ribbon, has evolved at the synaptic outputs of these neurons. We found that acute disruption of synaptic ribbons by photodamage to the ribbon markedly reduced both sustained and transient components of neurotransmitter release in mouse bipolar cells and salamander cones without affecting the ultrastructure of the ribbon or its ability to localize synaptic vesicles to the active zone. Our results indicate that ribbons mediate both slow and fast signaling at sensory synapses and support an additional role for the synaptic ribbon in priming vesicles for exocytosis at active zones.	[Snellman, Josefin; Mehta, Bhupesh; Francis, Adam; Zenisek, David] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06510 USA; [Babai, Norbert; Bartoletti, Theodore M.; Thoreson, Wallace] Univ Nebraska Med Ctr, Dept Ophthalmol & Visual Sci, Omaha, NE USA; [Akmentin, Wendy; Matthews, Gary] SUNY Stony Brook, Dept Neurobiol & Behav, Stony Brook, NY 11794 USA; [Zenisek, David] Yale Univ, Sch Med, Dept Ophthalmol & Visual Sci, New Haven, CT 06510 USA; [Zenisek, David] Yale Univ, Sch Med, Ctr Cellular Neurosci Neurodegenerat & Repair, New Haven, CT USA	Yale University; University of Nebraska System; University of Nebraska Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Yale University; Yale University	Zenisek, D (corresponding author), Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06510 USA.	david.zenisek@yale.edu	Thoreson, Wallace B./F-6172-2010; Babai, Norbert/T-2952-2019; Zenisek, David/C-6555-2011	Thoreson, Wallace B./0000-0001-7104-042X; 	US National Institutes of Health [R01 EY003821, EY018111, EY10542]; Yale University [EY000785]; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [R01EY003821, R29EY010542, R01EY010542, R21EY018111, P30EY000785, R55EY010542, R01EY014990] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Yale University; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The authors would like to thank S. Mentone for electron microscopy. This work was funded by US National Institutes of Health grants R01 EY003821 (G. M.), EY018111 (D.Z.) and EY10542 (W. T.), Yale University Vision Core grant EY000785 (M. Crair) and Research to Prevent Blindness (W.T.).	Bartoletti TM, 2010, J NEUROPHYSIOL, V103, P419, DOI 10.1152/jn.00718.2009; Bonazzi M, 2005, NAT CELL BIOL, V7, P570, DOI 10.1038/ncb1260; Chol SY, 2008, VISUAL NEUROSCI, V25, P693, DOI 10.1017/S0952523808080814; Coggins MR, 2007, J PHYSIOL-LONDON, V584, P853, DOI 10.1113/jphysiol.2007.140848; Cowan WM, 2001, SYNAPSES, P1; Davis GW, 2001, ANNU REV PHYSIOL, V63, P847, DOI 10.1146/annurev.physiol.63.1.847; DeVries SH, 2001, NEURON, V32, P1107, DOI 10.1016/S0896-6273(01)00535-9; Dick O, 2003, NEURON, V37, P775, DOI 10.1016/S0896-6273(03)00086-2; Dieck ST, 2005, J CELL BIOL, V168, P825, DOI 10.1083/jcb.200408157; Frank T, 2010, NEURON, V68, P724, DOI 10.1016/j.neuron.2010.10.027; Frank T, 2009, P NATL ACAD SCI USA, V106, P4483, DOI 10.1073/pnas.0813213106; Grunert U, 2002, J COMP NEUROL, V447, P138, DOI 10.1002/cne.10220; Heidelberger R, 1998, J GEN PHYSIOL, V111, P225, DOI 10.1085/jgp.111.2.225; HEIDELBERGER R, 1994, NATURE, V371, P513, DOI 10.1038/371513a0; Heidelberger R, 2002, J NEUROPHYSIOL, V88, P98, DOI 10.1152/jn.2002.88.1.98; Hoffman-Kim D, 2007, METHOD CELL BIOL, V82, P335, DOI 10.1016/S0091-679(06)82011-X; Hull C, 2006, J NEUROPHYSIOL, V96, P2025, DOI 10.1152/jn.00364.2006; Jarsky T, 2010, J NEUROSCI, V30, P11885, DOI 10.1523/JNEUROSCI.1415-10.2010; Johnson SL, 2002, PFLUG ARCH EUR J PHY, V443, P653, DOI 10.1007/s00424-001-0763-z; Khimich D, 2005, NATURE, V434, P889, DOI 10.1038/nature03418; Lenzi D, 2001, BIOESSAYS, V23, P831, DOI 10.1002/bies.1118; LoGiudice L, 2008, J NEUROSCI, V28, P3150, DOI 10.1523/JNEUROSCI.5753-07.2008; LoGiudice L, 2009, NEUROSCIENTIST, V15, P380, DOI 10.1177/1073858408331373; Midorikawa M, 2007, NAT NEUROSCI, V10, P1268, DOI 10.1038/nn1963; Miller R F, 2001, Prog Brain Res, V131, P241; Molloy DP, 1998, J BIOL CHEM, V273, P20867, DOI 10.1074/jbc.273.33.20867; Morkve SH, 2002, J PHYSIOL-LONDON, V542, P147, DOI 10.1113/jphysiol.2002.020305; Paillart C, 2003, J NEUROSCI, V23, P4092; Palmer MJ, 2003, J NEUROSCI, V23, P11332; Rabl K, 2005, J NEUROSCI, V25, P4633, DOI 10.1523/JNEUROSCI.4298-04.2005; Rizo J, 2008, NAT STRUCT MOL BIOL, V15, P665, DOI 10.1038/nsmb.1450; Schmitz F, 2000, NEURON, V28, P857, DOI 10.1016/S0896-6273(00)00159-8; Singer JH, 2006, J NEUROPHYSIOL, V95, P3191, DOI 10.1152/jn.01309.2005; Singer JH, 2004, NAT NEUROSCI, V7, P826, DOI 10.1038/nn1280; Singer JH, 2003, J NEUROSCI, V23, P10923; Snellman J, 2009, J PHYSIOL-LONDON, V587, P2443, DOI 10.1113/jphysiol.2008.165241; Surrey T, 1998, P NATL ACAD SCI USA, V95, P4293, DOI 10.1073/pnas.95.8.4293; Thoreson WB, 2004, NEURON, V42, P595, DOI 10.1016/S0896-6273(04)00254-5; Tsukamoto Y, 2001, J NEUROSCI, V21, P8616, DOI 10.1523/JNEUROSCI.21-21-08616.2001; Veruki ML, 2006, NAT NEUROSCI, V9, P1388, DOI 10.1038/nn1793; Veruki ML, 2003, J PHYSIOL-LONDON, V549, P759, DOI 10.1113/jphysiol.2003.039982; vonGersdorff H, 1996, NEURON, V16, P1221, DOI 10.1016/S0896-6273(00)80148-8; VONGERSDORFF H, 1994, NATURE, V367, P735, DOI 10.1038/367735a0; WONGRILE.MT, 1974, J NEUROCYTOL, V3, P1, DOI 10.1007/BF01111929; Zenisek D, 2000, NATURE, V406, P849, DOI 10.1038/35022500; Zenisek D, 2004, J NEUROSCI, V24, P9752, DOI 10.1523/JNEUROSCI.2886-04.2004; Zenisek D, 2008, P NATL ACAD SCI USA, V105, P4922, DOI 10.1073/pnas.0709067105	47	95	95	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2011	14	9					1135	U262		10.1038/nn.2870	http://dx.doi.org/10.1038/nn.2870			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	812ID	21785435	Green Accepted			2022-12-28	WOS:000294284900013
J	Nozaki, C; Vergnano, AM; Filliol, D; Ouagazzal, AM; Le Goff, A; Carvalho, S; Reiss, D; Gaveriaux-Ruff, C; Neyton, J; Paoletti, P; Kieffer, BL				Nozaki, Chihiro; Vergnano, Angela Maria; Filliol, Dominique; Ouagazzal, Abdel-Mouttalib; Le Goff, Anne; Carvalho, Stephanie; Reiss, David; Gaveriaux-Ruff, Claire; Neyton, Jacques; Paoletti, Pierre; Kieffer, Brigitte L.			Zinc alleviates pain through high-affinity binding to the NMDA receptor NR2A subunit	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; SYNAPTICALLY RELEASED ZINC; SPINAL-CORD; MOLECULAR-MECHANISMS; ZN2+; DOMAIN; MICE; LOCALIZATION; HYPERALGESIA; ANTAGONISTS	Zinc is abundant in the central nervous system and regulates pain, but the underlying mechanisms are unknown. In vitro studies have shown that extracellular zinc modulates a plethora of signaling membrane proteins, including NMDA receptors containing the NR2A subunit, which display exquisite zinc sensitivity. We created NR2A-H128S knock-in mice to investigate whether Zn2+-NR2A interaction influences pain control. In these mice, high-affinity (nanomolar) zinc inhibition of NMDA currents was lost in the hippocampus and spinal cord. Knock-in mice showed hypersensitivity to radiant heat and capsaicin, and developed enhanced allodynia in inflammatory and neuropathic pain models. Furthermore, zinc-induced analgesia was completely abolished under both acute and chronic pain conditions. Our data establish that zinc is an endogenous modulator of excitatory neurotransmission in vivo and identify a new mechanism in pain processing that relies on NR2A NMDA receptors. The study also potentially provides a molecular basis for the pain-relieving effects of dietary zinc supplementation.	[Vergnano, Angela Maria; Le Goff, Anne; Carvalho, Stephanie; Neyton, Jacques; Paoletti, Pierre] Ecole Normale Super, Inst Biol, F-75231 Paris, France; [Nozaki, Chihiro; Filliol, Dominique; Ouagazzal, Abdel-Mouttalib; Reiss, David; Gaveriaux-Ruff, Claire; Kieffer, Brigitte L.] Inst Genet & Biol Mol & Cellulaire, Illkirch Graffenstaden, France; [Nozaki, Chihiro; Filliol, Dominique; Ouagazzal, Abdel-Mouttalib; Reiss, David; Gaveriaux-Ruff, Claire; Kieffer, Brigitte L.] CNRS, UMR7104, Illkirch Graffenstaden, France; [Nozaki, Chihiro; Filliol, Dominique; Ouagazzal, Abdel-Mouttalib; Reiss, David; Gaveriaux-Ruff, Claire; Kieffer, Brigitte L.] INSERM, U964, Illkirch Graffenstaden, France; [Nozaki, Chihiro; Filliol, Dominique; Ouagazzal, Abdel-Mouttalib; Reiss, David; Gaveriaux-Ruff, Claire; Kieffer, Brigitte L.] Univ Strasbourg, Illkirch Graffenstaden, France; [Vergnano, Angela Maria; Le Goff, Anne; Carvalho, Stephanie; Neyton, Jacques; Paoletti, Pierre] CNRS, UMR8197, Paris, France; [Vergnano, Angela Maria; Le Goff, Anne; Carvalho, Stephanie; Neyton, Jacques; Paoletti, Pierre] INSERM, U1024, Paris, France	UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm)	Paoletti, P (corresponding author), Ecole Normale Super, Inst Biol, 24 Rue Lhomond, F-75231 Paris, France.	pierre.paoletti@ens.fr	GAVERIAUX-RUFF, Claire/A-9671-2017; Paoletti, Pierre/L-7358-2013	GAVERIAUX-RUFF, Claire/0000-0002-3523-8102; Paoletti, Pierre/0000-0002-3681-4845	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (INSERM); Universite de Strasbourg; Agence Nationale de la Recherche (France); US National Institutes of Health, National Institue on Drug Abuse [DA05010]; Equipe Fondation pour la Recherche Medicale (FRM); Region Ile-de-France; NATIONAL INSTITUTE ON DRUG ABUSE [P50DA005010] Funding Source: NIH RePORTER	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Universite de Strasbourg; Agence Nationale de la Recherche (France)(French National Research Agency (ANR)); US National Institutes of Health, National Institue on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Equipe Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); Region Ile-de-France(Region Ile-de-France); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank B. Puvion, A. Matifas and R. Weibel for technical assistance and E. Krejci for help with the targeting vector. We thank B. Barbour, J. Becker and E. Schwartz for comments on the manuscript. We also thank Victor Faundez (Emory University) for the gift of the ZnT3 antibody. This research was supported by the Centre National de la Recherche Scientifique (CNRS), Institut National de la Sante et de la Recherche Medicale (INSERM), the Universite de Strasbourg, the Agence Nationale de la Recherche (France) grant SynapticZinc (P.P. and B.K.), the US National Institutes of Health, National Institue on Drug Abuse grant DA05010 (B.K.) and an Equipe Fondation pour la Recherche Medicale (FRM) grant (P.P.). C.N. was supported by the FRM and A.M.V. by the Region Ile-de-France.	Al-Hallaq RA, 2007, J NEUROSCI, V27, P8334, DOI 10.1523/JNEUROSCI.2155-07.2007; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; Boyce S, 1999, NEUROPHARMACOLOGY, V38, P611, DOI 10.1016/S0028-3908(98)00218-4; Cole TB, 1999, P NATL ACAD SCI USA, V96, P1716, DOI 10.1073/pnas.96.4.1716; Danscher G, 2001, NEUROSCIENCE, V105, P941, DOI 10.1016/S0306-4522(01)00243-3; Drdla R, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-18; Fayyazuddin A, 2000, NEURON, V25, P683, DOI 10.1016/S0896-6273(00)81070-3; Frederickson CJ, 2005, NAT REV NEUROSCI, V6, P449, DOI 10.1038/nrn1671; Frederickson CJ, 2000, J NUTR, V130, p1471S, DOI 10.1093/jn/130.5.1471S; Gaveriaux-Ruff C, 2011, PAIN, V152, P1238, DOI 10.1016/j.pain.2010.12.031; Gielen M, 2009, NATURE, V459, P703, DOI 10.1038/nature07993; Hambidge KM, 2007, J NUTR, V137, P1101, DOI 10.1093/jn/137.4.1101; Hatton CJ, 2005, NEURON, V46, P261, DOI 10.1016/j.neuron.2005.03.005; Head KA, 2006, ALTERN MED REV, V11, P294; Hirzel K, 2006, NEURON, V52, P679, DOI 10.1016/j.neuron.2006.09.035; Hu HZ, 2009, NAT CHEM BIOL, V5, P183, DOI 10.1038/nchembio.146; Jo SM, 2008, BIOMETALS, V21, P151, DOI 10.1007/s10534-007-9103-x; Kodirov SA, 2006, P NATL ACAD SCI USA, V103, P15218, DOI 10.1073/pnas.0607131103; Larson AA, 1997, J PHARMACOL EXP THER, V282, P1319; Latremoliere A, 2009, J PAIN, V10, P895, DOI 10.1016/j.jpain.2009.06.012; Le Bars D, 2001, PHARMACOL REV, V53, P597; Liu T, 1999, NEUROREPORT, V10, P1619, DOI 10.1097/00001756-199905140-00042; Low CM, 2000, P NATL ACAD SCI USA, V97, P11062, DOI 10.1073/pnas.180307497; Ma JY, 2001, BRAIN RES BULL, V56, P575, DOI 10.1016/S0361-9230(01)00728-6; Ma QP, 2000, NEUROSCIENCE, V101, P699, DOI 10.1016/S0306-4522(00)00419-X; Matsumoto M, 2010, J NEUROCHEM, V112, P521, DOI 10.1111/j.1471-4159.2009.06473.x; Miledi R, 2002, P NATL ACAD SCI USA, V99, P13238, DOI 10.1073/pnas.192445299; Mony L, 2009, BRIT J PHARMACOL, V157, P1301, DOI 10.1111/j.1476-5381.2009.00304.x; Paoletti P, 2009, NEUROSCIENCE, V158, P126, DOI 10.1016/j.neuroscience.2008.01.061; Paoletti P, 2000, NEURON, V28, P911, DOI 10.1016/S0896-6273(00)00163-X; Paoletti P, 1997, J NEUROSCI, V17, P5711; Rauner C, 2011, J BIOL CHEM, V286, P7558, DOI 10.1074/jbc.M110.182600; SafiehGarabedian B, 1996, NEUROPHARMACOLOGY, V35, P599, DOI 10.1016/0028-3908(96)84630-2; SAKURADA T, 1992, NEUROPHARMACOLOGY, V31, P1279, DOI 10.1016/0028-3908(92)90057-V; Sandkuhler J, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-9; Scherrer G, 2006, P NATL ACAD SCI USA, V103, P9691, DOI 10.1073/pnas.0603359103; Sendur OF, 2008, RHEUMATOL INT, V28, P1117, DOI 10.1007/s00296-008-0593-9; Sensi SL, 2009, NAT REV NEUROSCI, V10, P780, DOI 10.1038/nrn2734; Smart TG, 2004, NEUROSCIENTIST, V10, P432, DOI 10.1177/1073858404263463; Svensson CI, 2003, NEUROREPORT, V14, P1153, DOI 10.1097/00001756-200306110-00010; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Ueno S, 2002, J CELL BIOL, V158, P215, DOI 10.1083/jcb.200204066; Vardeh D, 2009, J CLIN INVEST, V119, P287, DOI 10.1172/JCI37098; Velazquez RA, 1999, J NEUROSCI, V19, P2288; Vogt K, 2000, NEURON, V26, P187, DOI 10.1016/S0896-6273(00)81149-6; Woolf CJ, 2000, SCIENCE, V288, P1765, DOI 10.1126/science.288.5472.1765; Yaksh TL, 1999, P NATL ACAD SCI USA, V96, P7680, DOI 10.1073/pnas.96.14.7680; Yeomans DC, 1996, PAIN, V68, P133, DOI 10.1016/S0304-3959(96)03176-4; Yoshida H, 2010, BRIT J ORAL MAX SURG, V48, P469, DOI 10.1016/j.bjoms.2009.08.001	49	85	90	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2011	14	8					1017	U108		10.1038/nn.2844	http://dx.doi.org/10.1038/nn.2844			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	797KC	21725314	Green Accepted, Green Submitted			2022-12-28	WOS:000293123700015
J	Klockener, T; Hess, S; Belgardt, BF; Paeger, L; Verhagen, LAW; Husch, A; Sohn, JW; Hampel, B; Dhillon, H; Zigman, JM; Lowell, BB; Williams, KW; Elmquist, JK; Horvath, TL; Kloppenburg, P; Bruning, JC				Kloeckener, Tim; Hess, Simon; Belgardt, Bengt F.; Paeger, Lars; Verhagen, Linda A. W.; Husch, Andreas; Sohn, Jong-Woo; Hampel, Brigitte; Dhillon, Harveen; Zigman, Jeffrey M.; Lowell, Bradford B.; Williams, Kevin W.; Elmquist, Joel K.; Horvath, Tamas L.; Kloppenburg, Peter; Bruening, Jens C.			High-fat feeding promotes obesity via insulin receptor/PI3K-dependent inhibition of SF-1 VMH neurons	NATURE NEUROSCIENCE			English	Article							VENTROMEDIAL HYPOTHALAMIC NUCLEUS; STEROIDOGENIC FACTOR-I; PROOPIOMELANOCORTIN NEURONS; BODY-WEIGHT; EXPRESSING NEURONS; ARCUATE NUCLEUS; POMC NEURONS; FOOD-INTAKE; GLUCOSE; LEPTIN	Steroidogenic factor 1 (SF-1)-expressing neurons of the ventromedial hypothalamus (VMH) control energy homeostasis, but the role of insulin action in these cells remains undefined. We show that insulin activates phosphatidylinositol-3-OH kinase (PI3K) signaling in SF-1 neurons and reduces firing frequency in these cells through activation of K-ATP channels. These effects were abrogated in mice with insulin receptor deficiency restricted to SF-1 neurons (SF-1(Delta IR) mice). Whereas body weight and glucose homeostasis remained the same in SF-1(Delta IR) mice as in controls under a normal chow diet, they were protected from diet-induced leptin resistance, weight gain, adiposity and impaired glucose tolerance. High-fat feeding activated PI3K signaling in SF-1 neurons of control mice, and this response was attenuated in the VMH of SF-1(Delta IR) mice. Mimicking diet-induced overactivation of PI3K signaling by disruption of the phosphatidylinositol-3,4,5-trisphosphate phosphatase PTEN led to increased body weight and hyperphagia under a normal chow diet. Collectively, our experiments reveal that high-fat diet-induced, insulin-dependent PI3K activation in VMH neurons contributes to obesity development.	[Kloeckener, Tim; Belgardt, Bengt F.; Verhagen, Linda A. W.; Hampel, Brigitte; Bruening, Jens C.] Univ Cologne, Inst Genet, Dept Mouse Genet & Metab, D-5000 Cologne, Germany; [Kloeckener, Tim; Belgardt, Bengt F.; Verhagen, Linda A. W.; Hampel, Brigitte; Bruening, Jens C.] Univ Hosp Cologne, Ctr Endocrinol Diabet & Prevent Med CEDP, Cologne, Germany; [Kloeckener, Tim; Hess, Simon; Belgardt, Bengt F.; Paeger, Lars; Verhagen, Linda A. W.; Husch, Andreas; Hampel, Brigitte; Kloppenburg, Peter; Bruening, Jens C.] Univ Cologne, CMMC, Cologne, Germany; [Kloeckener, Tim; Hess, Simon; Belgardt, Bengt F.; Paeger, Lars; Verhagen, Linda A. W.; Husch, Andreas; Hampel, Brigitte; Kloppenburg, Peter; Bruening, Jens C.] Cologne Excellence Cluster Cellular Stress Respon, Cologne, Germany; [Kloeckener, Tim; Belgardt, Bengt F.; Verhagen, Linda A. W.; Hampel, Brigitte; Bruening, Jens C.] Max Planck Inst Neurol Res, Cologne, Germany; [Hess, Simon; Paeger, Lars; Husch, Andreas; Kloppenburg, Peter] Univ Cologne, Inst Zool, Bioctr, D-5000 Cologne, Germany; [Sohn, Jong-Woo; Zigman, Jeffrey M.; Williams, Kevin W.; Elmquist, Joel K.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Ctr Hypothalam Res, Dallas, TX 75390 USA; [Elmquist, Joel K.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Dhillon, Harveen; Lowell, Bradford B.] Beth Israel Deaconess Med Ctr, Ctr Life Sci, Boston, MA 02215 USA; [Horvath, Tamas L.] Yale Univ, Sch Med, Comparat Med Sect, New Haven, CT 06510 USA	University of Cologne; University of Cologne; University of Cologne; University of Cologne; Max Planck Society; University of Cologne; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Harvard University; Beth Israel Deaconess Medical Center; Yale University	Bruning, JC (corresponding author), Univ Cologne, Inst Genet, Dept Mouse Genet & Metab, Weyertal 121, D-5000 Cologne, Germany.	jens.bruening@uni-koeln.de	Sohn, Jong Woo/D-6700-2014; Williams, Kevin W/AAA-4243-2020; Williams, Kevin W/ABD-5818-2021	Williams, Kevin W/0000-0002-8434-8658; Williams, Kevin W/0000-0002-8434-8658; Belgardt, Bengt-Frederik/0000-0003-4537-9002; Paeger, Lars/0000-0001-8716-3483; Zigman, Jeffrey/0000-0003-3477-1295	Federal Ministry of Education and Research [KL 762/2-2, FP7-HEALTH-2009-241592, FP7-KBBE-2010-4-266408, FKZ 01GI0845]; Deutsche Forschungsgemeinschaft [Br. 1492/7-1]; US National Institute of Health [R01DK53301, RL1DK081185, K01DK087780, R01 DK071051, P30 DK046200, P30 DK057521, OD006850, DK080000, PL1 DK081182, UL1RR024923, K08 DK068069-01A2]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024923] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK053301, R01DK080000, RL1DK081185, K01DK087780, P30DK057521, P30DK046200, K08DK068069, R01DK071051, PL1DK081182] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD006850] Funding Source: NIH RePORTER	Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); US National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank G. Schmall and T. Rayle for secretarial assistance and S. Irlenbusch and H. Wratil for technical assistance. We thank M. Low (Oregon Health & Science University) for providing POMC<SUP>GFP</SUP> mice. Recombinant mouse leptin was obtained from A. F. Parlow, the National Hormone and Peptide Program (NHPP), National Institute of Diabetes and Digestive and Kidney Diseases. This work was supported by grants from the Deutsche Forschungsgemeinschaft (KL 762/2-2 to P. K.); Cologne Center for Molecular Medicine (CMMC); under FP7-HEALTH-2009-241592 (European Union) EurOCHIP; under FP7-KBBE-2010-4-266408 (European Union) Full4Health and through the Kompetenznetz Adipositas (Competence Network for Adipositas) funded by the Federal Ministry of Education and Research (FKZ 01GI0845) to J.C.B.; and also through funds from the Deutsche Forschungsgemeinschaft (Br. 1492/7-1 to J.C.B.). This work was supported by US National Institute of Health grants R01DK53301 and RL1DK081185 (to J.K.E.); K01DK087780 (to K. W. W.); R01 DK071051, P30 DK046200 and P30 DK057521 (to B. B. L.); OD006850 and DK080000 (to T. L. H.); and PL1 DK081182, UL1RR024923 and K08 DK068069-01A2 (to J.M.Z.).	AKAIKE N, 1994, JPN J PHYSIOL, V44, P433, DOI 10.2170/jjphysiol.44.433; Asnicar MA, 2001, ENDOCRINOLOGY, V142, P4394, DOI 10.1210/en.142.10.4394; Belgardt BF, 2008, CELL METAB, V7, P291, DOI 10.1016/j.cmet.2008.01.006; Belgardt BF, 2010, P NATL ACAD SCI USA, V107, P6028, DOI 10.1073/pnas.1001796107; Bingham NC, 2008, ENDOCRINOLOGY, V149, P2138, DOI 10.1210/en.2007-1200; Brown LM, 2006, PHYSIOL BEHAV, V89, P687, DOI 10.1016/j.physbeh.2006.08.008; Bruning JC, 2000, SCIENCE, V289, P2122, DOI 10.1126/science.289.5487.2122; Choudhury AI, 2005, J CLIN INVEST, V115, P940; CLARK JT, 1987, REGUL PEPTIDES, V17, P31, DOI 10.1016/0167-0115(87)90030-9; Cotero VE, 2009, AM J PHYSIOL-ENDOC M, V296, pE1101, DOI 10.1152/ajpendo.90932.2008; Cowley MA, 2001, NATURE, V411, P480, DOI 10.1038/35078085; Davidowa H, 2001, NEUROREPORT, V12, P3201, DOI 10.1097/00001756-200110290-00012; Dhillon H, 2006, NEURON, V49, P191, DOI 10.1016/j.neuron.2005.12.021; Fan W, 1997, NATURE, V385, P165, DOI 10.1038/385165a0; Gelling RW, 2006, CELL METAB, V3, P67, DOI 10.1016/j.cmet.2005.11.013; Gropp E, 2005, NAT NEUROSCI, V8, P1289, DOI 10.1038/nn1548; Hallschmid M, 2004, DIABETES, V53, P3024, DOI 10.2337/diabetes.53.11.3024; Hill JW, 2008, J CLIN INVEST, V118, P1796, DOI 10.1172/JCI32964; HORN R, 1988, J GEN PHYSIOL, V92, P145, DOI 10.1085/jgp.92.2.145; IKEDA Y, 1995, MOL ENDOCRINOL, V9, P478, DOI 10.1210/me.9.4.478; Janoschek R, 2006, P NATL ACAD SCI USA, V103, P10707, DOI 10.1073/pnas.0600425103; Kleinridders A, 2009, CELL METAB, V10, P249, DOI 10.1016/j.cmet.2009.08.013; Kloppenburg P, 2007, J NEUROPHYSIOL, V98, P2910, DOI 10.1152/jn.00660.2007; Koch L, 2008, J CLIN INVEST, V118, P2132, DOI 10.1172/JCI31073; Konner AC, 2007, CELL METAB, V5, P438, DOI 10.1016/j.cmet.2007.05.004; Li G, 2003, DIABETES, V52, P1951, DOI 10.2337/diabetes.52.8.1951; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Majdic G, 2002, ENDOCRINOLOGY, V143, P607, DOI 10.1210/en.143.2.607; Mayer CM, 2010, ENDOCRINOLOGY, V151, P576, DOI 10.1210/en.2009-1122; MAYER J, 1956, NATURE, V178, P1399, DOI 10.1038/1781399a0; McMinn JE, 2000, AM J PHYSIOL-REG I, V279, pR695, DOI 10.1152/ajpregu.2000.279.2.R695; Mullier A, 2010, J COMP NEUROL, V518, P943, DOI 10.1002/cne.22273; Niswender KD, 2003, DIABETES, V52, P227, DOI 10.2337/diabetes.52.2.227; Novak A, 2000, GENESIS, V28, P147, DOI 10.1002/1526-968X(200011/12)28:3/4<147::AID-GENE90>3.0.CO;2-G; Obici S, 2002, NAT NEUROSCI, V5, P566, DOI 10.1038/nn861; Obici S, 2002, NAT MED, V8, P1376, DOI 10.1038/nm798; Plum L, 2007, CELL METAB, V6, P431, DOI 10.1016/j.cmet.2007.10.012; Plum L, 2006, J CLIN INVEST, V116, P1886, DOI 10.1172/JCI27123; Plum L, 2009, NAT MED, V15, P1195, DOI 10.1038/nm.2026; Pocai A, 2005, NATURE, V434, P1026, DOI 10.1038/nature03439; SADOVSKY Y, 1995, P NATL ACAD SCI USA, V92, P10939, DOI 10.1073/pnas.92.24.10939; Schubert M, 2004, P NATL ACAD SCI USA, V101, P3100, DOI 10.1073/pnas.0308724101; SHINODA K, 1995, DEV DYNAM, V204, P22, DOI 10.1002/aja.1002040104; Spanswick D, 2000, NAT NEUROSCI, V3, P757, DOI 10.1038/77660; Sternson SM, 2005, NAT NEUROSCI, V8, P1356, DOI 10.1038/nn1550; Tong QC, 2007, CELL METAB, V5, P383, DOI 10.1016/j.cmet.2007.04.001; Unger TJ, 2007, J NEUROSCI, V27, P14265, DOI 10.1523/JNEUROSCI.3308-07.2007; Xu BJ, 2003, NAT NEUROSCI, V6, P736, DOI 10.1038/nn1073; Xu Y, 2010, CELL METAB, V12, P88, DOI 10.1016/j.cmet.2010.05.002; Ye JH, 2006, J NEUROSCI METH, V158, P251, DOI 10.1016/j.jneumeth.2006.06.006	50	173	176	1	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2011	14	7					911	U139		10.1038/nn.2847	http://dx.doi.org/10.1038/nn.2847			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	783KR	21642975	Green Accepted			2022-12-28	WOS:000292081700020
J	Baumann, S; Griffiths, TD; Sun, L; Petkov, CI; Thiele, A; Rees, A				Baumann, Simon; Griffiths, Timothy D.; Sun, Li; Petkov, Christopher I.; Thiele, Alexander; Rees, Adrian			Orthogonal representation of sound dimensions in the primate midbrain	NATURE NEUROSCIENCE			English	Article							INFERIOR COLLICULUS; CAT; ORGANIZATION; RESPONSES; AWAKE	Natural sounds are characterized by their spectral content and the modulation of energy over time. Using functional magnetic resonance imaging in awake macaques, we observed topographical representations of these spectral and temporal dimensions in a single structure, the inferior colliculus, the principal auditory nucleus in the midbrain. These representations are organized as a map with two approximately perpendicular axes: one representing increasing temporal rate and the other increasing spectral frequency.	[Baumann, Simon; Griffiths, Timothy D.; Sun, Li; Petkov, Christopher I.; Thiele, Alexander; Rees, Adrian] Newcastle Univ, Fac Med Sci, Inst Neurosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Newcastle University - UK	Baumann, S (corresponding author), Newcastle Univ, Fac Med Sci, Inst Neurosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	simon.baumann@ncl.ac.uk	Rees, Adrian/H-2200-2012; Petkov, Christopher/O-5318-2015	Rees, Adrian/0000-0003-3313-8375; Petkov, Christopher/0000-0002-4932-7907; Thiele, Alexander/0000-0003-4894-0213; Sun, Li/0000-0003-3022-9191; Griffiths, Timothy/0000-0001-8066-4381	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	We wish to thank D. Hunter for his assistance in animal handling and data recording. This research was funded by the Wellcome Trust.	Baumann S, 2010, NEUROIMAGE, V50, P1099, DOI 10.1016/j.neuroimage.2009.12.103; BREGMAN AS, 1990, AUDITOY SCENE ANAL P; Griffiths TD, 2001, NAT NEUROSCI, V4, P633, DOI 10.1038/88459; Guimaraes AR, 1998, HUM BRAIN MAPP, V6, P33, DOI 10.1002/(SICI)1097-0193(1998)6:1<33::AID-HBM3>3.0.CO;2-M; HALL JW, 1984, J ACOUST SOC AM, V76, P50, DOI 10.1121/1.391005; Heil P, 1995, AUDIT NEUROSCI, V1, P363; Joris PX, 2004, PHYSIOL REV, V84, P541, DOI 10.1152/physrev.00029.2003; Krishna BS, 2000, J NEUROPHYSIOL, V84, P255, DOI 10.1152/jn.2000.84.1.255; Langner G, 2002, HEARING RES, V168, P110, DOI 10.1016/S0378-5955(02)00367-2; MERZENICH MM, 1974, BRAIN RES, V77, P397, DOI 10.1016/0006-8993(74)90630-1; MULLERPREUSS P, 1994, HEARING RES, V80, P197, DOI 10.1016/0378-5955(94)90111-2; ROSE JE, 1963, J NEUROPHYSIOL, V26, P294, DOI 10.1152/jn.1963.26.2.294; RYAN A, 1978, EXP BRAIN RES, V32, P389; SCHREINER CE, 1988, J NEUROPHYSIOL, V60, P1823, DOI 10.1152/jn.1988.60.6.1823; SHANNON RV, 1995, SCIENCE, V270, P303, DOI 10.1126/science.270.5234.303	15	88	89	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2011	14	4					423	425		10.1038/nn.2771	http://dx.doi.org/10.1038/nn.2771			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	741FQ	21378972	Green Accepted			2022-12-28	WOS:000288849400011
J	Carter, ME; Yizhar, O; Chikahisa, S; Nguyen, H; Adamantidis, A; Nishino, S; Deisseroth, K; de Lecea, L				Carter, Matthew E.; Yizhar, Ofer; Chikahisa, Sachiko; Nguyen, Hieu; Adamantidis, Antoine; Nishino, Seiji; Deisseroth, Karl; de Lecea, Luis			Tuning arousal with optogenetic modulation of locus coeruleus neurons	NATURE NEUROSCIENCE			English	Article							IN-VIVO MICRODIALYSIS; SLEEP-WAKING CYCLE; PREFRONTAL CORTEX; NORADRENERGIC SYSTEM; NOREPINEPHRINE; RATS; WAKE; ACTIVATION; CATAPLEXY; CERULEUS	Neural activity in the noradrenergic locus coeruleus correlates with periods of wakefulness and arousal. However, it is unclear whether tonic or phasic activity in these neurons is necessary or sufficient to induce transitions between behavioral states and to promote long-term arousal. Using optogenetic tools in mice, we found that there is a frequency-dependent, causal relationship among locus coeruleus firing, cortical activity, sleep-to-wake transitions and general locomotor arousal. We also found that sustained, high-frequency stimulation of the locus coeruleus at frequencies of 5 Hz and above caused reversible behavioral arrests. These results suggest that the locus coeruleus is finely tuned to regulate organismal arousal and that bursts of noradrenergic overexcitation cause behavioral attacks that resemble those seen in people with neuropsychiatric disorders.	[Carter, Matthew E.; Deisseroth, Karl; de Lecea, Luis] Stanford Univ, Neurosci Program, Stanford, CA 94305 USA; [Carter, Matthew E.; Nguyen, Hieu; Adamantidis, Antoine; de Lecea, Luis] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [Yizhar, Ofer; Deisseroth, Karl] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Chikahisa, Sachiko; Nishino, Seiji] Stanford Univ, Sleep & Circadian Neurobiol Lab, Stanford, CA 94305 USA; [Chikahisa, Sachiko] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Integrat Physiol, Tokushima 770, Japan	Stanford University; Stanford University; Stanford University; Stanford University; Tokushima University	de Lecea, L (corresponding author), Stanford Univ, Neurosci Program, Stanford, CA 94305 USA.	llecea@stanford.edu	de Lecea, Luis/ABE-4005-2021; de Lecea, Luis/B-3171-2009; YIZHAR, OFER/AAV-8497-2021; Core, Vector/CAF-4832-2022	de Lecea, Luis/0000-0002-8921-5942; de Lecea, Luis/0000-0002-8921-5942; Carter, Matthew/0000-0003-1802-090X; Yizhar, Ofer/0000-0003-4228-1448; Adamantidis, Antoine/0000-0003-2531-5175	NSF; US National Institutes of Health (NIH) [F31MH83439]; European Molecular Biology Organization; Japan Society for the Promotion of Science [21-8162]; Fonds National de la Recherche Scientifique; NIH [K99, R01MH072525, MH83702, MH87592, DA21880]; NARSAD; National Institute of Mental Health; National Institute on Drug Abuse; McKnight Foundation; Coulter Foundation; Snyder Foundation; Albert Yu Foundation; Mary Bechmann and Keck Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH087592, F31MH083439, R01MH072525, R01MH083702] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA021880] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Fonds National de la Recherche Scientifique(Fonds de la Recherche Scientifique - FNRS); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NARSAD(NARSAD); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); McKnight Foundation; Coulter Foundation; Snyder Foundation; Albert Yu Foundation; Mary Bechmann and Keck Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank members of the de Lecea laboratory for helpful advice and feedback, J. Shieh for assistance with confocal images, A. Hilgendorff for assistance with mouse cardiovascular measurements and S. Xie for access to custom-built SmartCages. M.E.C. received financial support from an NSF Graduate Research Fellowship and the US National Institutes of Health (NIH) National Research Service Award (F31MH83439). O.Y. is supported by a European Molecular Biology Organization long-term postdoctoral fellowship. S.C. is supported by the Excellent Young Researcher Overseas Visit Program (21-8162) of the Japan Society for the Promotion of Science. A.A. is supported by fellowships from the Fonds National de la Recherche Scientifique ('Charge de Recherche'), NIH (K99) and NARSAD. S.N. is supported by NIH grant R01MH072525. K.D. is supported by the National Science Foundation, National Institute of Mental Health, National Institute on Drug Abuse, and the McKnight, Coulter, Snyder, Albert Yu and Mary Bechmann, and Keck Foundations. L.d.L. is supported by the NIH (MH83702, MH87592, DA21880) and NARSAD.	Adamantidis AR, 2007, NATURE, V450, P420, DOI 10.1038/nature06310; Arnsten AFT, 2009, NAT REV NEUROSCI, V10, P410, DOI 10.1038/nrn2648; Aston-Jones G, 2005, ANNU REV NEUROSCI, V28, P403, DOI 10.1146/annurev.neuro.28.061604.135709; ASTONJONES G, 1981, J NEUROSCI, V1, P887; ASTONJONES G, 1981, J NEUROSCI, V1, P876; Berridge CW, 2003, BRAIN RES REV, V42, P33, DOI 10.1016/S0165-0173(03)00143-7; BERRIDGE CW, 1991, J NEUROSCI, V11, P3135; Berridge CW, 2000, NEUROSCIENCE, V99, P495, DOI 10.1016/S0306-4522(00)00215-3; Blanco-Centurion C, 2007, J NEUROSCI, V27, P14041, DOI 10.1523/JNEUROSCI.3217-07.2007; Boucetta S, 2009, J NEUROSCI, V29, P4664, DOI 10.1523/JNEUROSCI.5502-08.2009; Bouret S, 2005, TRENDS NEUROSCI, V28, P574, DOI 10.1016/j.tins.2005.09.002; Bourgin P, 2000, J NEUROSCI, V20, P7760; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Carter ME, 2009, J NEUROSCI, V29, P10939, DOI 10.1523/JNEUROSCI.1205-09.2009; DESARRO GB, 1987, BRIT J PHARMACOL, V90, P675; FLICKER C, 1982, BEHAV NEURAL BIOL, V34, P421, DOI 10.1016/S0163-1047(82)91843-X; FOOTE SL, 1980, P NATL ACAD SCI-BIOL, V77, P3033, DOI 10.1073/pnas.77.5.3033; FOOTE SL, 1983, PHYSIOL REV, V63, P844, DOI 10.1152/physrev.1983.63.3.844; Gradinaru V, 2007, J NEUROSCI, V27, P14231, DOI 10.1523/JNEUROSCI.3578-07.2007; Gradinaru V, 2008, BRAIN CELL BIOL, V36, P129, DOI 10.1007/s11068-008-9027-6; Hassani OK, 2009, J NEUROSCI, V29, P11828, DOI 10.1523/JNEUROSCI.1259-09.2009; HOBSON JA, 1975, SCIENCE, V189, P55, DOI 10.1126/science.1094539; Hunsley MS, 2003, SLEEP, V26, pA174; Jodo E, 1998, NEUROSCIENCE, V83, P63, DOI 10.1016/S0306-4522(97)00372-2; JONES BE, 1977, BRAIN RES, V124, P473, DOI 10.1016/0006-8993(77)90948-9; Kodama T, 2003, J NEUROSCI, V23, P1548, DOI 10.1523/JNEUROSCI.23-04-01548.2003; Lai YY, 2001, J NEUROSCI, V21, P7384, DOI 10.1523/JNEUROSCI.21-18-07384.2001; LIDBRINK P, 1974, BRAIN RES, V74, P19, DOI 10.1016/0006-8993(74)90109-7; Lindeberg J, 2004, GENESIS, V40, P67, DOI 10.1002/gene.20065; Luquet S, 2005, SCIENCE, V310, P683, DOI 10.1126/science.1115524; MCGINTY DJ, 1976, BRAIN RES, V101, P569, DOI 10.1016/0006-8993(76)90480-7; Parmentier R, 2002, J NEUROSCI, V22, P7695; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Ramos BP, 2007, PHARMACOL THERAPEUT, V113, P523, DOI 10.1016/j.pharmthera.2006.11.006; Saper CB, 2005, NATURE, V437, P1257, DOI 10.1038/nature04284; Sara SJ, 2009, NAT REV NEUROSCI, V10, P211, DOI 10.1038/nrn2573; Scammell TE, 2009, SLEEP, V32, P111; SEGAL DS, 1970, P NATL ACAD SCI USA, V66, P289, DOI 10.1073/pnas.66.2.289; Shipley MT, 1996, J COMP NEUROL, V365, P56, DOI 10.1002/(SICI)1096-9861(19960129)365:1<56::AID-CNE5>3.0.CO;2-I; Sohal VS, 2009, NATURE, V459, P698, DOI 10.1038/nature07991; Steriade M, 2004, PROG BRAIN RES, V145, P179, DOI 10.1016/S0079-6123(03)45013-9; Szot P, 2010, NEUROSCIENCE, V166, P279, DOI 10.1016/j.neuroscience.2009.12.027; Tsai HC, 2009, SCIENCE, V324, P1080, DOI 10.1126/science.1168878; VALENTINO RJ, 1992, NEUROSCIENCE, V48, P689, DOI 10.1016/0306-4522(92)90412-U; Van Bockstaele EJ, 1999, BIOL PSYCHIAT, V46, P1352, DOI 10.1016/S0006-3223(99)00213-9; Wu MF, 1999, NEUROSCIENCE, V91, P1389, DOI 10.1016/S0306-4522(98)00600-9; Wu MF, 2004, J PHYSIOL-LONDON, V554, P202, DOI 10.1113/jphysiol.2003.052134; Wu Q, 2009, CELL, V137, P1225, DOI 10.1016/j.cell.2009.04.022; Zhang F, 2007, NAT REV NEUROSCI, V8, P577, DOI 10.1038/nrn2192; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744	50	518	544	8	96	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2010	13	12					1526	U117		10.1038/nn.2682	http://dx.doi.org/10.1038/nn.2682			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	684CW	21037585	Green Accepted			2022-12-28	WOS:000284525800018
J	Ko, HK; Poletti, M; Rucci, M				Ko, Hee-kyoung; Poletti, Martina; Rucci, Michele			Microsaccades precisely relocate gaze in a high visual acuity task	NATURE NEUROSCIENCE			English	Article							FIXATIONAL EYE-MOVEMENTS; MONOCULAR FIXATION; STIMULI; VISION; MEMORY; IMAGE	The image on the retina is never stationary. Microscopic relocations of gaze, known as microsaccades, occur even during steady fixation. It has long been thought that microsaccades enable exploration of small regions in the scene in the same way saccades are normally used to scan larger regions. This hypothesis, however, has remained controversial, as it is believed that microsaccades are suppressed during fine spatial judgments. We examined the eye movements of human observers in a high-acuity visuomotor task, the threading of a needle in a computer-simulated virtual environment. Using a method for gaze-contingent display that enables accurate localization of the line of sight, we found that microsaccades precisely move the eye to nearby regions of interest and are dynamically modulated by the ongoing demands of the task. These results indicate that microsaccades are part of the oculomotor strategy by which the visual system acquires fine spatial detail.	[Ko, Hee-kyoung; Poletti, Martina; Rucci, Michele] Boston Univ, Dept Psychol, Boston, MA 02215 USA; [Rucci, Michele] Boston Univ, Program Neurosci, Boston, MA 02215 USA	Boston University; Boston University	Rucci, M (corresponding author), Boston Univ, Dept Psychol, 64 Cummington St, Boston, MA 02215 USA.	mrucci@bu.edu		Poletti, Martina/0000-0002-4773-8745; Rucci, Michele/0000-0002-3066-1964	US National Institutes of Health [EY018363]; National Science Foundation [BCS-0719849, IOS-0843304]; NATIONAL EYE INSTITUTE [R01EY018363] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The authors thank A. Casile and D. Richters for helpful comments on the manuscript. This work was supported by a grant from the US National Institutes of Health (EY018363) and grants from the National Science Foundation (BCS-0719849 and IOS-0843304).	Ahissar E, 2001, NEURON, V32, P185, DOI 10.1016/S0896-6273(01)00466-4; BALLARD DH, 1995, J COGNITIVE NEUROSCI, V7, P66, DOI 10.1162/jocn.1995.7.1.66; BRIDGEMAN B, 1980, VISION RES, V20, P813, DOI 10.1016/0042-6989(80)90013-9; Collewijn H, 2008, J VISION, V8, DOI 10.1167/8.14.20; CORNSWEET TN, 1956, J OPT SOC AM, V46, P987, DOI 10.1364/JOSA.46.000987; CUNITZ RJ, 1969, VISION RES, V9, P683, DOI 10.1016/0042-6989(69)90125-4; DITCHBURN RW, 1953, J PHYSIOL-LONDON, V119, P1; DITCHBURN RW, 1959, J PHYSIOL-LONDON, V145, P98, DOI 10.1113/jphysiol.1959.sp006130; Engbert R, 2004, PSYCHOL SCI, V15, P431, DOI 10.1111/j.0956-7976.2004.00697.x; EPELBOIM J, 1995, VISION RES, V35, P3401, DOI 10.1016/0042-6989(95)00080-X; HADDAD GM, 1973, VISION RES, V13, P1075, DOI 10.1016/0042-6989(73)90145-4; Hafed ZM, 2009, SCIENCE, V323, P940, DOI 10.1126/science.1166112; Johansson RS, 2001, J NEUROSCI, V21, P6917, DOI 10.1523/JNEUROSCI.21-17-06917.2001; Kagan I, 2008, J VISION, V8, DOI 10.1167/8.14.19; Martinez-Conde S, 2006, NEURON, V49, P297, DOI 10.1016/j.neuron.2005.11.033; Poletti M, 2010, J VISION, V10, DOI 10.1167/10.3.6; Putnam NM, 2005, J VISION, V5, P632, DOI 10.1167/5.7.3; RATLIFF F, 1950, J EXP PSYCHOL, V40, P687, DOI 10.1037/h0057754; Rolfs M, 2009, VISION RES, V49, P2415, DOI 10.1016/j.visres.2009.08.010; Rucci M, 2003, J VISION, V3, P852, DOI 10.1167/3.11.18; Rucci M, 2007, NATURE, V447, P851, DOI 10.1038/nature05866; Santini F, 2007, BEHAV RES METHODS, V39, P350, DOI 10.3758/BF03193003; SNODDERLY DM, 1987, VISION RES, V27, P401, DOI 10.1016/0042-6989(87)90089-7; STEINMAN RM, 1967, SCIENCE, V155, P1577, DOI 10.1126/science.155.3769.1577; STEINMAN RM, 1965, J OPT SOC AM, V55, P1158, DOI 10.1364/JOSA.55.001158; TIMBERLAKE GT, 1972, VISION RES, V12, P1059, DOI 10.1016/0042-6989(72)90027-2; van Hateren JH, 1998, P ROY SOC B-BIOL SCI, V265, P2315, DOI 10.1098/rspb.1998.0577; WINTERSON BJ, 1976, VISION RES, V16, P1387, DOI 10.1016/0042-6989(76)90156-5	30	204	205	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	2010	13	12					1549	U142		10.1038/nn.2663	http://dx.doi.org/10.1038/nn.2663			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	684CW	21037583	Green Accepted			2022-12-28	WOS:000284525800021
J	Logothetis, NK; Augath, M; Murayama, Y; Rauch, A; Sultan, F; Goense, J; Oeltermann, A; Merkle, H				Logothetis, Nikos K.; Augath, Mark; Murayama, Yusuke; Rauch, Alexander; Sultan, Fahad; Goense, Jozien; Oeltermann, Axel; Merkle, Hellmut			The effects of electrical microstimulation on cortical signal propagation	NATURE NEUROSCIENCE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; CAT VISUAL-CORTEX; FRONTAL EYE FIELD; STRIATE CORTEX; INTRACORTICAL MICROSTIMULATION; FUNCTIONAL MRI; RAT NEOCORTEX; MOTOR CORTEX; FMRI SIGNAL; AREA MT	Electrical stimulation has been used in animals and humans to study potential causal links between neural activity and specific cognitive functions. Recently, it has found increasing use in electrotherapy and neural prostheses. However, the manner in which electrical stimulation-elicited signals propagate in brain tissues remains unclear. We used combined electrostimulation, neurophysiology, microinjection and functional magnetic resonance imaging (fMRI) to study the cortical activity patterns elicited during stimulation of cortical afferents in monkeys. We found that stimulation of a site in the lateral geniculate nucleus (LGN) increased the fMRI signal in the regions of primary visual cortex (V1) that received input from that site, but suppressed it in the retinotopically matched regions of extrastriate cortex. Consistent with previous observations, intracranial recordings indicated that a short excitatory response occurring immediately after a stimulation pulse was followed by a long-lasting inhibition. Following microinjections of GABA antagonists in V1, LGN stimulation induced positive fMRI signals in all of the cortical areas. Taken together, our findings suggest that electrical stimulation disrupts cortico-cortical signal propagation by silencing the output of any neocortical area whose afferents are electrically stimulated.	[Logothetis, Nikos K.; Augath, Mark; Murayama, Yusuke; Rauch, Alexander; Goense, Jozien; Oeltermann, Axel] Max Planck Inst Biol Cybernet, Tubingen, Germany; [Logothetis, Nikos K.] Univ Manchester, Manchester, Lancs, England; [Sultan, Fahad] Univ Tubingen, Hertie Inst Clin Brain Res, Dept Cognit Neurol, Tubingen, Germany; [Merkle, Hellmut] NINDS, Lab Funct & Mol Imaging, US NIH, Bethesda, MD 20892 USA	Max Planck Society; University of Manchester; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Logothetis, NK (corresponding author), Max Planck Inst Biol Cybernet, Tubingen, Germany.	nikos.logothetis@tuebingen.mpg.de	Logothetis, Nikos/U-9282-2019		Max Planck Society; German Research Foundation [DFG SFB-A9]; US National Institutes of Health (National Institute Neurological Disorders and Stroke)	Max Planck Society(Max Planck Society); German Research Foundation(German Research Foundation (DFG)); US National Institutes of Health (National Institute Neurological Disorders and Stroke)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank C. Kayser, O. Eschenko and M. Munk for reading the manuscript and for useful suggestions. Many thanks also go to D. Blaurock for editing, S. Weber for fine-mechanic work and T. Steudel and P. Douay for help with the alert monkey experiments. This research was supported by the Max Planck Society, the German Research Foundation (DFG SFB-A9) and by the intramural research program of the US National Institutes of Health (National Institute Neurological Disorders and Stroke, H.M.).	Allen EA, 2007, SCIENCE, V317, P1918, DOI 10.1126/science.1146426; Armstrong KM, 2006, NEURON, V50, P791, DOI 10.1016/j.neuron.2006.05.010; Berger TK, 2009, J PHYSIOL-LONDON, V587, P5411, DOI 10.1113/jphysiol.2009.176552; BERMAN NJ, 1991, J PHYSIOL-LONDON, V440, P697, DOI 10.1113/jphysiol.1991.sp018731; Brewer AA, 2002, J NEUROSCI, V22, P10416; BULLIER J, 1979, J NEUROPHYSIOL, V42, P1271, DOI 10.1152/jn.1979.42.5.1271; Butovas S, 2003, J NEUROPHYSIOL, V90, P3024, DOI 10.1152/jn.00245.2003; Butovas S, 2007, EUR J NEUROSCI, V25, P2161, DOI 10.1111/j.1460-9568.2007.05449.x; Butovas S, 2006, J NEUROPHYSIOL, V96, P1227, DOI 10.1152/jn.01170.2005; Chung S, 1998, NEURON, V20, P1177, DOI 10.1016/S0896-6273(00)80498-5; Cowey A, 2005, PHILOS T R SOC B, V360, P1185, DOI 10.1098/rstb.2005.1658; DEFELIPE J, 1986, J NEUROSCI, V6, P3749, DOI 10.1523/jneurosci.06-12-03749.1986; DOUGLAS RJ, 1991, J PHYSIOL-LONDON, V440, P735, DOI 10.1113/jphysiol.1991.sp018733; DOUGLAS RJ, 1991, J PHYSIOL-LONDON, V440, P659, DOI 10.1113/jphysiol.1991.sp018730; Douglas RJ, 2007, CURR BIOL, V17, pR496, DOI 10.1016/j.cub.2007.04.024; Driver J, 2009, TRENDS COGN SCI, V13, P319, DOI 10.1016/j.tics.2009.04.007; Ekstrom LB, 2008, SCIENCE, V321, P414, DOI 10.1126/science.1153276; Ekstrom LB, 2009, J NEUROSCI, V29, P10683, DOI 10.1523/JNEUROSCI.0673-09.2009; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; FRIES W, 1983, PROC R SOC SER B-BIO, V219, P53, DOI 10.1098/rspb.1983.0058; FRISTON KJ, 1995, NEUROIMAGE, V2, P45, DOI 10.1006/nimg.1995.1007; Goense JBM, 2008, CURR BIOL, V18, P631, DOI 10.1016/j.cub.2008.03.054; Gradinaru V, 2009, SCIENCE, V324, P354, DOI 10.1126/science.1167093; Guillery RW, 1995, J ANAT, V187, P583; Hallett M, 2007, NEURON, V55, P187, DOI 10.1016/j.neuron.2007.06.026; Kara P, 2002, P NATL ACAD SCI USA, V99, P16261, DOI 10.1073/pnas.242625499; KELLER A, 1993, CEREB CORTEX, V3, P430, DOI 10.1093/cercor/3.5.430; LEHKY SR, 1988, NATURE, V333, P452, DOI 10.1038/333452a0; LI C, 1963, J CELL COMPAR PHYSL, V61, P165, DOI 10.1002/jcp.1030610207; Logothetis NK, 2007, NEURON, V55, P809, DOI 10.1016/j.neuron.2007.07.027; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; Moeller S, 2008, SCIENCE, V320, P1355, DOI 10.1126/science.1157436; Moore T, 2003, NEURON, V40, P671, DOI 10.1016/S0896-6273(03)00716-5; Moore T, 2003, NATURE, V421, P370, DOI 10.1038/nature01341; Murphey DK, 2007, CURR BIOL, V17, P862, DOI 10.1016/j.cub.2007.03.066; Okun M, 2008, NAT NEUROSCI, V11, P535, DOI 10.1038/nn.2105; Pezaris JS, 2007, P NATL ACAD SCI USA, V104, P7670, DOI 10.1073/pnas.0608563104; Rauch A, 2008, P NATL ACAD SCI USA, V105, P6759, DOI 10.1073/pnas.0800312105; Ruff CC, 2006, CURR BIOL, V16, P1479, DOI 10.1016/j.cub.2006.06.057; SALZMAN CD, 1992, J NEUROSCI, V12, P2331; SCHALL JD, 1995, J NEUROSCI, V15, P4464; Sherman SM, 2007, CURR OPIN NEUROBIOL, V17, P417, DOI 10.1016/j.conb.2007.07.003; Shipp S, 2003, PHILOS T R SOC B, V358, P1605, DOI 10.1098/rstb.2002.1213; Shmuel A, 2006, NAT NEUROSCI, V9, P569, DOI 10.1038/nn1675; Sincich LC, 2004, NAT NEUROSCI, V7, P1123, DOI 10.1038/nn1318; STANTON GB, 1995, J COMP NEUROL, V353, P291, DOI 10.1002/cne.903530210; Sultan F, 2007, MAGN RESON IMAGING, V25, P754, DOI 10.1016/j.mri.2007.03.014; Tehovnik EJ, 2005, J NEUROPHYSIOL, V93, P1, DOI 10.1152/jn.00736.2004; Tolias AS, 2005, NEURON, V48, P901, DOI 10.1016/j.neuron.2005.11.034	50	226	231	1	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2010	13	10					1283	1291		10.1038/nn.2631	http://dx.doi.org/10.1038/nn.2631			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	654MB	20818384				2022-12-28	WOS:000282171300022
J	Marrs, WR; Blankman, JL; Horne, EA; Thomazeau, A; Lin, YH; Coy, J; Bodor, AL; Muccioli, GG; Hu, SSJ; Woodruff, G; Fung, S; Lafourcade, M; Alexander, JP; Long, JZ; Li, WW; Xu, C; Moller, T; Mackie, K; Manzoni, OJ; Cravatt, BF; Stella, N				Marrs, William R.; Blankman, Jacqueline L.; Horne, Eric A.; Thomazeau, Aurore; Lin, Yi Hsing; Coy, Jonathan; Bodor, Agnes L.; Muccioli, Giulio G.; Hu, Sherry Shu-Jung; Woodruff, Grace; Fung, Susan; Lafourcade, Mathieu; Alexander, Jessica P.; Long, Jonathan Z.; Li, Weiwei; Xu, Cong; Moeller, Thomas; Mackie, Ken; Manzoni, Olivier J.; Cravatt, Benjamin F.; Stella, Nephi			The serine hydrolase ABHD6 controls the accumulation and efficacy of 2-AG at cannabinoid receptors	NATURE NEUROSCIENCE			English	Article							2-ARACHIDONOYLGLYCEROL HYDROLYSIS; ENDOGENOUS CANNABINOIDS; ENDOCANNABINOID SYSTEM; ANANDAMIDE; BLOCKADE; BRAIN; MODULATION; ACID; INHIBITOR; ENZYMES	The endocannabinoid 2-arachidonoylglycerol (2-AG) regulates neurotransmission and neuroinflammation by activating CB1 cannabinoid receptors on neurons and CB2 cannabinoid receptors on microglia. Enzymes that hydrolyze 2-AG, such as monoacylglycerol lipase, regulate the accumulation and efficacy of 2-AG at cannabinoid receptors. We found that the recently described serine hydrolase alpha-beta-hydrolase domain 6 (ABHD6) also controls the accumulation and efficacy of 2-AG at cannabinoid receptors. In cells from the BV-2 microglia cell line, ABHD6 knockdown reduced hydrolysis of 2-AG and increased the efficacy with which 2-AG can stimulate CB2-mediated cell migration. ABHD6 was expressed by neurons in primary culture and its inhibition led to activity-dependent accumulation of 2-AG. In adult mouse cortex, ABHD6 was located postsynaptically and its selective inhibition allowed the induction of CB1-dependent long-term depression by otherwise subthreshold stimulation. Our results indicate that ABHD6 is a rate-limiting step of 2-AG signaling and is therefore a bona fide member of the endocannabinoid signaling system.	[Horne, Eric A.; Lin, Yi Hsing; Coy, Jonathan; Xu, Cong; Stella, Nephi] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; [Marrs, William R.; Fung, Susan] Univ Washington, Neurobiol & Behav Grad Program, Seattle, WA 98195 USA; [Blankman, Jacqueline L.; Alexander, Jessica P.; Long, Jonathan Z.; Li, Weiwei; Cravatt, Benjamin F.] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA; [Blankman, Jacqueline L.; Alexander, Jessica P.; Long, Jonathan Z.; Li, Weiwei; Cravatt, Benjamin F.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Thomazeau, Aurore; Lafourcade, Mathieu; Manzoni, Olivier J.] Equipe Physiopathol Plast Synapt, INSERM, U862, Bordeaux, France; [Bodor, Agnes L.] Univ Washington, Dept Otolaryngol, Seattle, WA 98195 USA; [Muccioli, Giulio G.] Catholic Univ Louvain, Louvain Drug Res Inst, CHAM7230, Bioanal & Pharmacol Bioact Lipids Lab, B-1200 Brussels, Belgium; [Hu, Sherry Shu-Jung; Mackie, Ken] Indiana Univ, Gill Ctr Biomol Sci, Dept Psychol & Brain Sci, Bloomington, IN USA; [Woodruff, Grace] Univ Washington, Neurobiol Undergraduate Program, Seattle, WA 98195 USA; [Moeller, Thomas] Univ Washington, Dept Neurol, Seattle, WA 98195 USA; [Stella, Nephi] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Scripps Research Institute; Scripps Research Institute; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; University of Washington; University of Washington Seattle; Universite Catholique Louvain; Indiana University System; Indiana University Bloomington; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Stella, N (corresponding author), Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA.	nstella@uw.edu	Lafourcade, Mathieu/GQZ-7267-2022; LI, WEWEI/F-8657-2010; Manzoni, Olivier/M-7899-2016; Mackie, Kenneth P/B-7358-2011; Mackie, Ken/E-3715-2013	Manzoni, Olivier/0000-0002-5579-6208; Mackie, Ken/0000-0001-8501-6199; Thomazeau, Aurore/0000-0002-7668-2867; Lafourcade, Mathieu/0000-0001-6117-1194; Long, Jonathan/0000-0003-2631-7463; Muccioli, Giulio/0000-0002-1600-9259	National Institute on Drug Abuse [DA14486, DA26430, DA017259, DA009789, DA025285, DA026161]; National Institute of General Medical Sciences (PHS NRSA) [2T32 GM007270]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007270] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA009789, R01DA014486, R01DA025285, R01DA026430, P01DA017259, K05DA021696] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institute of General Medical Sciences (PHS NRSA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by grants from the National Institute on Drug Abuse (DA14486 and DA26430 to N.S., DA017259, DA009789 and DA025285 to B. F. C. and DA026161 to J.L.B.) and from the National Institute of General Medical Sciences (PHS NRSA 2T32 GM007270 to W. R. M.).	Berghuis P, 2007, SCIENCE, V316, P1212, DOI 10.1126/science.1137406; BEROD A, 1981, J HISTOCHEM CYTOCHEM, V29, P844, DOI 10.1177/29.7.6167611; Bisogno T, 2009, BBA-MOL CELL BIOL L, V1791, P53, DOI 10.1016/j.bbalip.2008.10.007; Blankman JL, 2007, CHEM BIOL, V14, P1347, DOI 10.1016/j.chembiol.2007.11.006; Burston JJ, 2008, J PHARMACOL EXP THER, V327, P546, DOI 10.1124/jpet.108.141382; Cabral GA, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409000957; Di Marzo V, 2008, NAT REV DRUG DISCOV, V7, P438, DOI 10.1038/nrd2553; Dinh TP, 2002, P NATL ACAD SCI USA, V99, P10819, DOI 10.1073/pnas.152334899; Dinh TP, 2004, MOL PHARMACOL, V66, P1260, DOI 10.1124/mol.104.002071; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Fegley D, 2005, J PHARMACOL EXP THER, V313, P352, DOI 10.1124/jpet.104.078980; Gobbi G, 2005, P NATL ACAD SCI USA, V102, P18620, DOI 10.1073/pnas.0509591102; Goparaju SK, 1998, FEBS LETT, V422, P69, DOI 10.1016/S0014-5793(97)01603-7; Gulyas AI, 2004, EUR J NEUROSCI, V20, P441, DOI 10.1111/j.1460-9568.2004.03428.x; Horne EA, 2008, FUTURE LIPIDOL, V3, P435, DOI 10.2217/17460875.3.4.435; Jessani N, 2005, NAT METHODS, V2, P691, DOI 10.1038/NMETH778; KANO M, 2009, PHYSIOL REV, V309, P380; Kathuria S, 2003, NAT MED, V9, P76, DOI 10.1038/nm803; Katona I, 2008, NAT MED, V14, P923, DOI 10.1038/nm.f.1869; Lafourcade M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000709; Li WW, 2007, J AM CHEM SOC, V129, P9594, DOI 10.1021/ja073650c; Liu YS, 1999, P NATL ACAD SCI USA, V96, P14694, DOI 10.1073/pnas.96.26.14694; Long JZ, 2009, P NATL ACAD SCI USA, V106, P20270, DOI 10.1073/pnas.0909411106; Long JZ, 2009, NAT CHEM BIOL, V5, P37, DOI 10.1038/nchembio.129; Maier S, 2006, J VIROL, V80, P9761, DOI 10.1128/JVI.00665-06; Marrs W, 2007, CHEM BIOL, V14, P1309, DOI 10.1016/j.chembiol.2007.12.004; Marrs W, 2009, AAPS J, V11, P307, DOI 10.1208/s12248-009-9109-0; Miller AM, 2009, GLIA, V57, P875, DOI 10.1002/glia.20813; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; MUCCIOLI GG, 2007, ANAL BIOCHEM, V373, P220; Muccioli GG, 2007, J NEUROSCI, V27, P2883, DOI 10.1523/JNEUROSCI.4830-06.2007; Saario SM, 2005, CHEM BIOL, V12, P649, DOI 10.1016/j.chembiol.2005.04.013; Stella N, 2001, EUR J PHARMACOL, V425, P189, DOI 10.1016/S0014-2999(01)01182-7; Stella N, 1997, NATURE, V388, P773, DOI 10.1038/42015; STELLA N, 1995, J NEUROSCI, V15, P3307; Stella N, 2009, NEUROPHARMACOLOGY, V56, P244, DOI 10.1016/j.neuropharm.2008.07.037; Straiker A, 2006, AAPS J, V8, pE272; Walter L, 2004, J NEUROSCI, V24, P8068, DOI 10.1523/JNEUROSCI.2419-04.2004; Walter L, 2003, J NEUROSCI, V23, P1398, DOI 10.1523/JNEUROSCI.23-04-01398.2003; Wilson RI, 2001, NATURE, V410, P588, DOI 10.1038/35069076; Witting A, 2004, P NATL ACAD SCI USA, V101, P3214, DOI 10.1073/pnas.0306707101; Yates JR, 1996, ANAL CHEM, V68, pA534, DOI 10.1021/ac962050l	42	322	330	0	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2010	13	8					951	U67		10.1038/nn.2601	http://dx.doi.org/10.1038/nn.2601			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	632DK	20657592	Green Accepted			2022-12-28	WOS:000280400600013
J	Taverna, E; Haffner, C; Pepperkok, R; Huttner, WB				Taverna, Elena; Haffner, Christiane; Pepperkok, Rainer; Huttner, Wieland B.			A new approach to manipulate the fate of single neural stem cells in tissue	NATURE NEUROSCIENCE			English	Article							RADIAL GLIA; IN-VIVO; NEUROEPITHELIAL CELLS; DEVELOPING NEOCORTEX; BASAL PROGENITORS; CEREBRAL-CORTEX; SELF-RENEWAL; NEURONS; NEUROGENESIS; EXPANSION	A challenge in the field of neural stem cell biology is the mechanistic dissection of single stem cell behavior in tissue. Although such behavior can be tracked by sophisticated imaging techniques, current methods of genetic manipulation do not allow researchers to change the level of a defined gene product on a truly acute time scale and are limited to very few genes at a time. To overcome these limitations, we established microinjection of neuroepithelial/radial glial cells (apical progenitors) in organotypic slice culture of embryonic mouse brain. Microinjected apical progenitors showed cell cycle parameters that were indistinguishable to apical progenitors in utero, underwent self-renewing divisions and generated neurons. Microinjection of single genes, recombinant proteins or complex mixtures of RNA was found to elicit acute and defined changes in apical progenitor behavior and progeny fate. Thus, apical progenitor microinjection provides a new approach to acutely manipulating single neural stem and progenitor cells in tissue.	[Taverna, Elena; Haffner, Christiane; Huttner, Wieland B.] Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany; [Pepperkok, Rainer] European Mol Biol Lab, Cell Biol & Biophys Unit, Heidelberg, Germany	Max Planck Society; European Molecular Biology Laboratory (EMBL)	Huttner, WB (corresponding author), Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany.	huttner@mpi-cbg.de	Huttner, Wieland B./P-4080-2018; Taverna, Elena/AFW-4935-2022; taverna, elena/O-8180-2014	taverna, elena/0000-0002-2430-4725; Pepperkok, Rainer/0000-0002-9762-3583	Max Planck Institute of Molecular Cell Biology and Genetics; Deutsche Forschungsgemeinschaft (DFG) [SFB 655, TRR 83]; European Research Council [250197]; Fonds der Chemischen Industrie	Max Planck Institute of Molecular Cell Biology and Genetics; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); European Research Council(European Research Council (ERC)European Commission); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission)	We are grateful to R.F. Hevner for kindly providing the Tbr2-GFP mouse line, T. Miyata for pCS2-Ngn2, E. Tanaka for pCAGGS-Cherry and C. Eckmann for OAT and helpful discussion. We thank J. Helppi and other members of the animal facility, as well as H. Wolf of the workshop, of the Max Planck Institute of Molecular Cell Biology and Genetics for excellent support, A. Ettinger for advice with NS-5 cells, K. Saito for advice with retina slice culture, J.F. Fei and Y.J. Chang for experimental advice, Y. Arai and). Pulvers for discussion, and A.-M. Marzesco, F. Mora-Bermudez, E. Paluch and F.K. Wong for helpful comments on the manuscript. W.B.H. was supported by grants from the Deutsche Forschungsgemeinschaft (DFG) (SFB 655, A2; TRR 83, Tp6) and the European Research Council (250197), by the DFG-funded Center for Regenerative Therapies Dresden, and by the Fonds der Chemischen Industrie.	Alexandre P, 2010, NAT NEUROSCI, V13, P673, DOI 10.1038/nn.2547; Alfei L, 1999, EUR J HISTOCHEM, V43, P29; Arai Y, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1155; Beckervordersandforth R, 2010, CELL STEM CELL, V7, P744, DOI 10.1016/j.stem.2010.11.017; Cappello S, 2006, NAT NEUROSCI, V9, P1099, DOI 10.1038/nn1744; Conti L, 2005, PLOS BIOL, V3, P1594, DOI 10.1371/journal.pbio.0030283; Englund C, 2005, J NEUROSCI, V25, P247, DOI 10.1523/JNEUROSCI.2899-04.2005; Farkas LM, 2008, NEURON, V60, P40, DOI 10.1016/j.neuron.2008.09.020; Farkas LM, 2008, CURR OPIN CELL BIOL, V20, P707, DOI 10.1016/j.ceb.2008.09.008; Fietz SA, 2011, CURR OPIN NEUROBIOL, V21, P23, DOI 10.1016/j.conb.2010.10.002; Fietz SA, 2010, NAT NEUROSCI, V13, P690, DOI 10.1038/nn.2553; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Hansen DV, 2010, NATURE, V464, P554, DOI 10.1038/nature08845; Haubensak W, 2004, P NATL ACAD SCI USA, V101, P3196, DOI 10.1073/pnas.0308600100; Kawaguchi A, 2008, DEVELOPMENT, V135, P3113, DOI 10.1242/dev.022616; Kitamura K, 2008, NAT METHODS, V5, P61, DOI 10.1038/NMETH1150; Kosodo Y, 2004, EMBO J, V23, P2314, DOI 10.1038/sj.emboj.7600223; Kowalczyk T, 2009, CEREB CORTEX, V19, P2439, DOI 10.1093/cercor/bhn260; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Kwon GS, 2007, GENESIS, V45, P208, DOI 10.1002/dvg.20293; Liu Y, 2004, DEV BIOL, V276, P31, DOI 10.1016/j.ydbio.2004.08.018; Ludtke JJ, 2002, MOL THER, V5, P579, DOI 10.1006/mthe.2002.0581; Lui JH, 2011, CELL, V146, P18, DOI 10.1016/j.cell.2011.06.030; Lyons DA, 2003, DEVELOPMENT, V130, P3427, DOI 10.1242/dev.00569; Miyata T, 2001, NEURON, V31, P727, DOI 10.1016/S0896-6273(01)00420-2; Narumiya S, 2006, CURR OPIN CELL BIOL, V18, P199, DOI 10.1016/j.ceb.2006.02.002; Noctor SC, 2001, NATURE, V409, P714, DOI 10.1038/35055553; Ochiai W, 2009, MOL CELL NEUROSCI, V40, P225, DOI 10.1016/j.mcn.2008.10.007; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Osumi N, 2001, METHODS, V24, P35, DOI 10.1006/meth.2001.1154; Panhuysen M, 2004, MOL CELL NEUROSCI, V26, P101, DOI 10.1016/j.mcn.2004.01.011; PEPPERKOK R, 1988, P NATL ACAD SCI USA, V85, P6748, DOI 10.1073/pnas.85.18.6748; Pepperkok R., 1994, CELL BIOL LAB HDB, P22; Pinto L, 2008, MOL CELL NEUROSCI, V38, P15, DOI 10.1016/j.mcn.2008.01.012; Pollard SM, 2006, METHOD ENZYMOL, V418, P151, DOI 10.1016/S0076-6879(06)18010-6; Rancz EA, 2011, NAT NEUROSCI, V14, P527, DOI 10.1038/nn.2765; Reillo I, 2011, CEREB CORTEX, V21, P1674, DOI 10.1093/cercor/bhq238; ROSA P, 1989, J CELL BIOL, V109, P17, DOI 10.1083/jcb.109.1.17; Sessa A, 2008, NEURON, V60, P56, DOI 10.1016/j.neuron.2008.09.028; Sul JY, 2009, P NATL ACAD SCI USA, V106, P7624, DOI 10.1073/pnas.0902161106; TAKAHASHI T, 1995, J NEUROSCI, V15, P6046; Taverna E, 2010, NEURON, V67, P906, DOI 10.1016/j.neuron.2010.08.027; Wilsch-Brauninger M, 2012, DEVELOPMENT, V139, P95, DOI 10.1242/dev.069294	44	25	25	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2012	15	2					329	337		10.1038/nn.3008	http://dx.doi.org/10.1038/nn.3008			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	882ZX	22179113				2022-12-28	WOS:000299603500026
J	Mogil, JS; Sorge, RE; LaCroix-Fralish, ML; Smith, SB; Fortin, A; Sotocinal, SG; Ritchie, J; Austin, JS; Schorscher-Petcu, A; Melmed, K; Czerminski, J; Bittong, RA; Mokris, JB; Neubert, JK; Campbell, CM; Edwards, RR; Campbell, JN; Crawley, JN; Lariviere, WR; Wallace, MR; Sternberg, WF; Balaban, CD; Belfer, I; Fillingim, RB				Mogil, Jeffrey S.; Sorge, Robert E.; LaCroix-Fralish, Michael L.; Smith, Shad B.; Fortin, Anny; Sotocinal, Susana G.; Ritchie, Jennifer; Austin, Jean-Sebastien; Schorscher-Petcu, Ara; Melmed, Kara; Czerminski, Jan; Bittong, Rosalie A.; Mokris, J. Brad; Neubert, John K.; Campbell, Claudia M.; Edwards, Robert R.; Campbell, James N.; Crawley, Jacqueline N.; Lariviere, William R.; Wallace, Margaret R.; Sternberg, Wendy F.; Balaban, Carey D.; Belfer, Inna; Fillingim, Roger B.			Pain sensitivity and vasopressin analgesia are mediated by a gene-sex-environment interaction	NATURE NEUROSCIENCE			English	Article							INBRED MOUSE STRAINS; STRESS-INDUCED ANALGESIA; NOCICEPTION; RESPONSES; RECEPTOR; OXYTOCIN; MICE; HERITABILITY; MECHANISMS; CAPSAICIN	Quantitative trait locus mapping of chemical/inflammatory pain in the mouse identified the Avpr1a gene, which encodes the vasopressin-1A receptor (V1AR), as being responsible for strain-dependent pain sensitivity to formalin and capsaicin. A genetic association study in humans revealed the influence of a single nucleotide polymorphism (rs10877969) in AVPR1A on capsaicin pain levels, but only in male subjects reporting stress at the time of testing. The analgesic efficacy of the vasopressin analog desmopressin revealed a similar interaction between the drug and acute stress, as desmopressin inhibition of capsaicin pain was only observed in nonstressed subjects. Additional experiments in mice confirmed the male-specific interaction of V1AR and stress, leading to the conclusion that vasopressin activates endogenous analgesia mechanisms unless they have already been activated by stress. These findings represent, to the best of our knowledge, the first explicit demonstration of analgesic efficacy depending on the emotional state of the recipient, and illustrate the heuristic power of a bench-to-bedside-to-bench translational strategy.	[Mogil, Jeffrey S.; Sorge, Robert E.; LaCroix-Fralish, Michael L.; Smith, Shad B.; Sotocinal, Susana G.; Ritchie, Jennifer; Austin, Jean-Sebastien; Schorscher-Petcu, Ara; Melmed, Kara; Czerminski, Jan] McGill Univ, Dept Psychol, Montreal, PQ, Canada; [Mogil, Jeffrey S.; Sorge, Robert E.; LaCroix-Fralish, Michael L.; Smith, Shad B.; Sotocinal, Susana G.; Ritchie, Jennifer; Austin, Jean-Sebastien; Schorscher-Petcu, Ara; Melmed, Kara; Czerminski, Jan] McGill Univ, Ctr Res Pain, Montreal, PQ, Canada; [Fortin, Anny] Emerillon Therapeut, Montreal, PQ, Canada; [Bittong, Rosalie A.; Mokris, J. Brad; Neubert, John K.; Fillingim, Roger B.] Univ Florida, Coll Dent, Gainesville, FL USA; [Campbell, Claudia M.; Edwards, Robert R.] Johns Hopkins Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD USA; [Campbell, James N.] Johns Hopkins Sch Med, Dept Neurosurg, Baltimore, MD USA; [Crawley, Jacqueline N.] NIMH, Bethesda, MD 20892 USA; [Lariviere, William R.; Belfer, Inna] Univ Pittsburgh, Dept Anesthesiol, Pittsburgh, PA USA; [Wallace, Margaret R.] Univ Florida, Dept Mol Genet & Microbiol, Gainesville, FL USA; [Sternberg, Wendy F.] Haverford Coll, Dept Psychol, Haverford, PA 19041 USA; [Balaban, Carey D.] Univ Pittsburgh, Dept Otolaryngol, Pittsburgh, PA 15260 USA; [Balaban, Carey D.] Univ Pittsburgh, Dept Neurobiol, Pittsburgh, PA USA; [Balaban, Carey D.] Univ Pittsburgh, Dept Commun Sci & Disorders, Pittsburgh, PA USA; [Balaban, Carey D.] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA USA	McGill University; McGill University; State University System of Florida; University of Florida; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; State University System of Florida; University of Florida; Haverford College; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Mogil, JS (corresponding author), McGill Univ, Dept Psychol, Montreal, PQ, Canada.	jeffrey.mogil@mcgill.ca	Balaban, Carey/O-6586-2019; Smith, Shad/AAO-8760-2020; Mogil, Jeffrey/AAA-9611-2019; Balaban, Carey/I-3467-2017; Fillingim, Roger/K-3569-2019; Melmed, Kara/AAS-3287-2020	Balaban, Carey/0000-0002-3570-3844; Mogil, Jeffrey/0000-0003-1359-5720; Balaban, Carey/0000-0002-3570-3844; Melmed, Kara/0000-0003-4084-8586; Fillingim, Roger/0000-0002-7699-8183; Czerminski, Jan/0000-0002-2576-4192; LaCroix-Fralish, Michael/0000-0002-8850-5972; Ritchie, Jennifer/0000-0003-2092-1387; Schorscher-Petcu, Ara/0000-0001-5808-5172	US National Institutes of Health [NS41670]; CTSA [RR02980]; Louise and Alan Edwards Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR002980] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE012735] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002179] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041670] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG028740] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA021198, R01DA015191] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CTSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Louise and Alan Edwards Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was supported by US National Institutes of Health grant NS41670 (R.B.F. and J.S.M.), CTSA grant RR02980 and the Louise and Alan Edwards Foundation (J.S.M.). We thank Pfeiffer of America for providing metered spray pumps.	ABBOTT FV, 1986, EUR J PHARMACOL, V126, P141, DOI 10.1016/0014-2999(86)90750-8; Balaban CD, 2005, J PAIN, V6, P315, DOI 10.1016/j.jpain.2005.01.346; Caldwell HK, 2008, PROG NEUROBIOL, V84, P1, DOI 10.1016/j.pneurobio.2007.10.007; Campbell CM, 2009, PAIN, V141, P114, DOI 10.1016/j.pain.2008.10.023; Costigan M, 2010, BRAIN, V133, P2519, DOI 10.1093/brain/awq195; Donaldson ZR, 2008, SCIENCE, V322, P900, DOI 10.1126/science.1158668; FANSELOW MS, 1986, J EXP PSYCHOL ANIM B, V12, P301, DOI 10.1037/0097-7403.12.3.301; Fillingim RB, 2005, J PAIN, V6, P116, DOI 10.1016/j.jpain.2004.11.005; Fortin A, 2001, GENOMICS, V74, P21, DOI 10.1006/geno.2001.6528; Frazer KA, 2007, NATURE, V448, P1050, DOI 10.1038/nature06067; GAMBLE GD, 1989, NEUROSCI LETT, V96, P312, DOI 10.1016/0304-3940(89)90397-2; Honda K, 2009, J PHARMACOL SCI, V109, P38, DOI 10.1254/jphs.08R30FM; Hu SB, 2003, J NEUROIMMUNOL, V135, P72, DOI 10.1016/S0165-5728(02)00442-3; KEMPPAINEN P, 1987, PHARMACOL TOXICOL, V61, P16, DOI 10.1111/j.1600-0773.1987.tb01765.x; LaCroix-Fralish ML, 2009, ANNU REV PHARMACOL, V49, P97, DOI 10.1146/annurev-pharmtox-061008-103222; Lariviere WR, 2005, J PAIN, V6, P777, DOI 10.1016/j.jpain.2005.06.007; Lariviere WR, 2002, PAIN, V97, P75, DOI 10.1016/S0304-3959(01)00492-4; Mogil JS, 2010, PROG BRAIN RES, V186, P141, DOI 10.1016/B978-0-444-53630-3.00009-9; Mogil Jefrey S., 1996, Physiology and Behavior, V59, P123, DOI 10.1016/0031-9384(95)02073-X; Mogil JS, 1997, PHARMACOL BIOCHEM BE, V56, P61, DOI 10.1016/S0091-3057(96)00157-8; Mogil JS, 1998, PAIN, V76, P115, DOI 10.1016/S0304-3959(98)00032-3; Mogil JS, 1999, PAIN, V80, P67, DOI 10.1016/S0304-3959(98)00197-3; Mogil JS, 2003, P NATL ACAD SCI USA, V100, P4867, DOI 10.1073/pnas.0730053100; Nair HK, 2011, PAIN, V152, P599, DOI 10.1016/j.pain.2010.11.029; Nissenbaum J, 2010, GENOME RES, V20, P1180, DOI 10.1101/gr.104976.110; Pohl J, 1996, PEPTIDES, V17, P641, DOI 10.1016/0196-9781(96)00034-4; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Schmelz M, 2009, EXP BRAIN RES, V196, P173, DOI 10.1007/s00221-009-1809-2; Schorscher-Petcu A, 2010, J NEUROSCI, V30, P8274, DOI 10.1523/JNEUROSCI.1594-10.2010; Shi MM, 1999, J CLIN PATHOL-MOL PA, V52, P295, DOI 10.1136/mp.52.5.295; Stern R. A., 1997, VISUAL ANALOG MOOD S; Tegeder I, 2006, NAT MED, V12, P1269, DOI 10.1038/nm1490; Thompson RR, 2006, P NATL ACAD SCI USA, V103, P7889, DOI 10.1073/pnas.0600406103; Tribollet E, 1998, PROG BRAIN RES, V119, P45; Walum H, 2008, P NATL ACAD SCI USA, V105, P14153, DOI 10.1073/pnas.0803081105; Wilson SG, 2002, PAIN, V96, P385, DOI 10.1016/S0304-3959(01)00489-4; Wong GT, 2002, NEUROPEPTIDES, V36, P230, DOI 10.1054/npep.2002.0905; Yang J, 2006, BRAIN RES, V1069, P127, DOI 10.1016/j.brainres.2005.11.045; Yang J, 2006, REGUL PEPTIDES, V137, P156, DOI 10.1016/j.regpep.2006.07.004; Young LJ, 2004, NAT NEUROSCI, V7, P1048, DOI 10.1038/nn1327	40	79	86	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	2011	14	12					1569	U99		10.1038/nn.2941	http://dx.doi.org/10.1038/nn.2941			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	855EJ	22019732	Green Accepted			2022-12-28	WOS:000297546300017
J	Szulwach, KE; Li, XK; Li, YJ; Song, CX; Wu, H; Dai, Q; Irier, H; Upadhyay, AK; Gearing, M; Levey, AI; Vasanthakumar, A; Godley, LA; Chang, Q; Cheng, XD; He, C; Jin, P				Szulwach, Keith E.; Li, Xuekun; Li, Yujing; Song, Chun-Xiao; Wu, Hao; Dai, Qing; Irier, Hasan; Upadhyay, Anup K.; Gearing, Marla; Levey, Allan I.; Vasanthakumar, Aparna; Godley, Lucy A.; Chang, Qiang; Cheng, Xiaodong; He, Chuan; Jin, Peng			5-hmC-mediated epigenetic dynamics during postnatal neurodevelopment and aging	NATURE NEUROSCIENCE			English	Article							EMBRYONIC STEM-CELLS; CPG-BINDING PROTEIN-2; DNA METHYLATION; L1 RETROTRANSPOSITION; RETT-SYNDROME; ADULT NEUROGENESIS; BDNF TRANSCRIPTION; MEMORY FORMATION; MECP2; 5-HYDROXYMETHYLCYTOSINE	DNA methylation dynamics influence brain function and are altered in neurological disorders. 5-hydroxymethylcytosine (5-hmC), a DNA base that is derived from 5-methylcytosine, accounts for similar to 40% of modified cytosine in the brain and has been implicated in DNA methylation-related plasticity. We mapped 5-hmC genome-wide in mouse hippocampus and cerebellum at three different ages, which allowed us to assess its stability and dynamic regulation during postnatal neurodevelopment through adulthood. We found developmentally programmed acquisition of 5-hmC in neuronal cells. Epigenomic localization of 5-hmC-regulated regions revealed stable and dynamically modified loci during neurodevelopment and aging. By profiling 5-hmC in human cerebellum, we found conserved genomic features of 5-hmC. Finally, we found that 5-hmC levels were inversely correlated with methyl-CpG-binding protein 2 dosage, a protein encoded by a gene in which mutations cause Rett syndrome. These data suggest that 5-hmC-mediated epigenetic modification is critical in neurodevelopment and diseases.	[Szulwach, Keith E.; Li, Xuekun; Li, Yujing; Irier, Hasan; Jin, Peng] Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA; [Song, Chun-Xiao; Dai, Qing; He, Chuan] Univ Chicago, Dept Chem, Chicago, IL 60637 USA; [Song, Chun-Xiao; Dai, Qing; He, Chuan] Univ Chicago, Inst Biophys Dynam, Chicago, IL 60637 USA; [Wu, Hao] Emory Univ, Rollins Sch Publ Hlth, Dept Biostat & Bioinformat, Atlanta, GA 30322 USA; [Upadhyay, Anup K.; Cheng, Xiaodong] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA; [Gearing, Marla; Levey, Allan I.] Emory Univ, Sch Med, Ctr Neurodegenerat Dis, Atlanta, GA 30322 USA; [Vasanthakumar, Aparna; Godley, Lucy A.] Univ Chicago, Dept Med, Hematol Oncol Sect, Chicago, IL 60637 USA; [Chang, Qiang] Univ Wisconsin, Waisman Ctr, Dept Genet & Neurol, Madison, WI 53705 USA	Emory University; University of Chicago; University of Chicago; Emory University; Rollins School Public Health; Emory University; Emory University; University of Chicago; University of Wisconsin System; University of Wisconsin Madison	Jin, P (corresponding author), Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA.	peng.jin@emory.edu	Wu, Hao/H-3899-2017; Li, Yujing/AAJ-1411-2020; Levey, Allan/F-2104-2011; Jin, Peng/B-5977-2012; Dai, Qing/ABD-8444-2021; Li, yujing/GQA-4109-2022	Wu, Hao/0000-0003-1269-7354; Li, Yujing/0000-0002-4363-2484; Levey, Allan/0000-0002-3153-502X; Jin, Peng/0000-0001-6137-6659; Song, Chun-Xiao/0000-0002-7781-6521	US National Institutes of Health (NIH) [T32MH087977]; NIH [CA129831, CA129831-03S1, GM071440, GM049245, NS051630, MH076090, P50AG025688]; Emory Alzheimer's Disease Center [P50AG025688]; Simons Foundation Autism Research Initiative; Beckman Young Investigator Award; Basil O'Connor Scholar Research Award; Emory Genetics Discovery Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD064743, P30HD003352] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA129831] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049245, R01GM071440] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH087977, R56MH076090, R01MH076090] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051630, R21NS067461] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG025688] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Emory Alzheimer's Disease Center; Simons Foundation Autism Research Initiative; Beckman Young Investigator Award; Basil O'Connor Scholar Research Award(March of Dimes); Emory Genetics Discovery Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We would like to thank the members of the Jin laboratory for their assistance, and S.T. Warren and C. Strauss for critical reading of the manuscript. H.I. is supported by the Training Program in Human Disease Genetics funded by the US National Institutes of Health (NIH, T32MH087977). L.A.G. is supported by NIH grants CA129831 and CA129831-03S1. C.H. was partially supported by NIH grant GM071440. X.C. was supported by NIH grant GM049245 and is a Georgia Research Alliance Eminent Scholar. M.G. and A.I.L. are partially supported by Emory Alzheimer's Disease Center (P50AG025688). P.J. is supported by NIH grants (NS051630, MH076090 and P50AG025688) and Simons Foundation Autism Research Initiative. P.J. is also the recipient of a Beckman Young Investigator Award, Basil O'Connor Scholar Research Award and Alfred P. Sloan Research Fellow in Neuroscience. This work was supported, in part, by the Emory Genetics Discovery Fund.	Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Chahrour M, 2007, NEURON, V56, P422, DOI 10.1016/j.neuron.2007.10.001; Chen RZ, 2001, NAT GENET, V27, P327, DOI 10.1038/85906; Chen WG, 2003, SCIENCE, V302, P885, DOI 10.1126/science.1086446; Collins AL, 2004, HUM MOL GENET, V13, P2679, DOI 10.1093/hmg/ddh282; Coufal NG, 2009, NATURE, V460, P1127, DOI 10.1038/nature08248; Day JJ, 2010, NAT NEUROSCI, V13, P1319, DOI 10.1038/nn.2666; Deininger PL, 2003, CURR OPIN GENET DEV, V13, P651, DOI 10.1016/j.gde.2003.10.013; Emig D, 2010, NUCLEIC ACIDS RES, V38, pW755, DOI 10.1093/nar/gkq405; Feschotte C, 2008, NAT REV GENET, V9, P397, DOI 10.1038/nrg2337; Ficz G, 2011, NATURE, V473, P398, DOI 10.1038/nature10008; Figueroa ME, 2010, CANCER CELL, V18, P553, DOI 10.1016/j.ccr.2010.11.015; Globisch D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015367; Guy J, 2001, NAT GENET, V27, P322, DOI 10.1038/85899; Hellman A, 2007, SCIENCE, V315, P1141, DOI 10.1126/science.1136352; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hutnick LK, 2009, HUM MOL GENET, V18, P2875, DOI 10.1093/hmg/ddp222; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Ko M, 2010, NATURE, V468, P839, DOI 10.1038/nature09586; Koh KP, 2011, CELL STEM CELL, V8, P200, DOI 10.1016/j.stem.2011.01.008; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; Kuemerle B, 1997, J NEUROSCI, V17, P7881; Lengner CJ, 2010, CELL, V141, P872, DOI 10.1016/j.cell.2010.04.010; Lister R, 2011, NATURE, V471, P68, DOI 10.1038/nature09798; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Ma DK, 2009, SCIENCE, V323, P1074, DOI 10.1126/science.1166859; Martinowich K, 2003, SCIENCE, V302, P890, DOI 10.1126/science.1090842; McGraw CM, 2011, SCIENCE, V333, P186, DOI 10.1126/science.1206593; Miller CA, 2007, NEURON, V53, P857, DOI 10.1016/j.neuron.2007.02.022; Muotri AR, 2010, NATURE, V468, P443, DOI 10.1038/nature09544; Muotri AR, 2005, NATURE, V435, P903, DOI 10.1038/nature03663; Nelson ED, 2008, J NEUROSCI, V28, P395, DOI 10.1523/JNEUROSCI.3796-07.2008; Pastor WA, 2011, NATURE, V473, P394, DOI 10.1038/nature10102; Riccio A, 2010, NAT NEUROSCI, V13, P1330, DOI 10.1038/nn.2671; Skene PJ, 2010, MOL CELL, V37, P457, DOI 10.1016/j.molcel.2010.01.030; Song CX, 2011, NAT BIOTECHNOL, V29, P68, DOI 10.1038/nbt.1732; Song DL, 1996, DEVELOPMENT, V122, P627; Szulwach KE, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002154; Szulwach KE, 2010, J CELL BIOL, V189, P127, DOI 10.1083/jcb.200908151; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Valinluck V, 2004, NUCLEIC ACIDS RES, V32, P4100, DOI 10.1093/nar/gkh739; Williams K, 2011, NATURE, V473, P343, DOI 10.1038/nature10066; WILSON VL, 1987, J BIOL CHEM, V262, P9948; Wu H, 2011, NATURE, V473, P389, DOI 10.1038/nature09934; Wu H, 2011, GENE DEV, V25, P679, DOI 10.1101/gad.2036011; Xu W, 2011, CANCER CELL, V19, P17, DOI 10.1016/j.ccr.2010.12.014; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhou ZL, 2006, NEURON, V52, P255, DOI 10.1016/j.neuron.2006.09.037; Zoghbi HY, 2003, SCIENCE, V302, P826, DOI 10.1126/science.1089071	50	579	602	1	88	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2011	14	12					1607	U150		10.1038/nn.2959	http://dx.doi.org/10.1038/nn.2959			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	855EJ	22037496	Green Accepted			2022-12-28	WOS:000297546300022
J	Guo, JJU; Ma, DKK; Mo, H; Ball, MP; Jang, MH; Bonaguidi, MA; Balazer, JA; Eaves, HL; Xie, B; Ford, E; Zhang, K; Ming, GL; Gao, Y; Song, HJ				Guo, Junjie U.; Ma, Dengke K.; Mo, Huan; Ball, Madeleine P.; Jang, Mi-Hyeon; Bonaguidi, Michael A.; Balazer, Jacob A.; Eaves, Hugh L.; Xie, Bin; Ford, Eric; Zhang, Kun; Ming, Guo-li; Gao, Yuan; Song, Hongjun			Neuronal activity modifies the DNA methylation landscape in the adult brain	NATURE NEUROSCIENCE			English	Article							REGULATES MEMORY FORMATION; EPIGENETIC REGULATION; GENE-REGULATION; DEMETHYLATION; CELLS; TRANSCRIPTION; PLASTICITY; GENOME; NEUROGENESIS; CANCER	DNA methylation has been traditionally viewed as a highly stable epigenetic mark in postmitotic cells. However, postnatal brains appear to show stimulus-induced methylation changes, at least in a few identified CpG dinucleotides. How extensively the neuronal DNA methylome is regulated by neuronal activity is unknown. Using a next-generation sequencing-based method for genome-wide analysis at single-nucleotide resolution, we quantitatively compared the CpG methylation landscape of adult mouse dentate granule neurons in vivo before and after synchronous neuronal activation. About 1.4% of 219,991 CpGs measured showed rapid active demethylation or de novo methylation. Some modifications remained stable for at least 24 h. These activity-modified CpGs showed a broad genomic distribution with significant enrichment in low-CpG density regions, and were associated with brain-specific genes related to neuronal plasticity. Our study implicates modification of the neuronal DNA methylome as a previously underappreciated mechanism for activity-dependent epigenetic regulation in the adult nervous system.	[Guo, Junjie U.; Ma, Dengke K.; Jang, Mi-Hyeon; Bonaguidi, Michael A.; Ming, Guo-li; Gao, Yuan; Song, Hongjun] Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD 21218 USA; [Guo, Junjie U.; Ming, Guo-li; Song, Hongjun] Johns Hopkins Univ, Sch Med, Solomon Snyder Dept Neurosci, Baltimore, MD USA; [Ma, Dengke K.; Jang, Mi-Hyeon; Bonaguidi, Michael A.; Ming, Guo-li; Song, Hongjun] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Mo, Huan; Eaves, Hugh L.] Virginia Commonwealth Univ, Ctr Study Biol Complex, Richmond, VA USA; [Ball, Madeleine P.] Harvard Univ, Sch Med, Dept Genet, Cambridge, MA 02138 USA; [Balazer, Jacob A.] Proofpoint Inc, Sunnyvale, CA USA; [Xie, Bin; Gao, Yuan] Lieber Inst Brain Dev, Div Genom Epigenom & Bioinformat, Baltimore, MD USA; [Ford, Eric] Johns Hopkins Univ, Sch Med, Dept Radiat Oncol, Baltimore, MD USA; [Zhang, Kun] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Virginia Commonwealth University; Harvard University; Johns Hopkins University; University of California System; University of California San Diego	Song, HJ (corresponding author), Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD 21218 USA.	garygao@gmail.com; shongju1@jhmi.edu	Ming, Guo-li/J-7880-2013; Gao, Yuan/E-1706-2011; Zhang, Kun/ABE-6349-2020	Zhang, Kun/0000-0002-7596-5224; Mo, Huan/0000-0001-6029-458X; Ball, Mad/0000-0003-0544-5925	US National Institutes of Health (NIH) [AG024984, NS047344]; McKnight Scholar Award; NARSAD; NIH [HD069184, NS048271]; Johns Hopkins Brain Science Institute; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; Lieber Institute; US National Institute of Mental Health [MH090115]; Maryland Stem Cell Research Fund (MSCRF); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD069184] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K99MH090115, R00MH090115] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048271, R37NS047344, R01NS047344, R56NS047344] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG024984] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA025779] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); McKnight Scholar Award; NARSAD(NARSAD); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Johns Hopkins Brain Science Institute(Johns Hopkins University); Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; Lieber Institute; US National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Maryland Stem Cell Research Fund (MSCRF); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank G. Church, S. Baylin, D. Ginty and K. Christian for comments and suggestions; G. Sun for help with FACS; and W. Y. Kim (Johns Hopkins University) for breeding Gadd45b knockout mice. This work was supported by US National Institutes of Health (NIH; AG024984, NS047344), McKnight Scholar Award and NARSAD (Brain and Behavior Research Fund) to H. S.; by NIH (HD069184, NS048271), Johns Hopkins Brain Science Institute, Dr. Miriam and Sheldon G. Adelson Medical Research Foundation, and NARSAD grants to G.-l. M.; and Lieber Institute start-up funds to Y. G. J.U.G. was a FARMS (Foundation for Advanced Research in Medical Sciences) fellow. M.H.J. was supported by a US National Institute of Mental Health K99 award (MH090115). M. A. B. was partially supported by a fellowship from Maryland Stem Cell Research Fund (MSCRF); M. P. B. was supported by grants from the NIH to G. Church.	Ball MP, 2009, NAT BIOTECHNOL, V27, P361, DOI 10.1038/nbt.1533; Borrelli E, 2008, NEURON, V60, P961, DOI 10.1016/j.neuron.2008.10.012; Day JJ, 2010, NAT NEUROSCI, V13, P1319, DOI 10.1038/nn.2666; Doi M, 2006, CELL, V125, P497, DOI 10.1016/j.cell.2006.03.033; Dong E, 2008, P NATL ACAD SCI USA, V105, P13614, DOI 10.1073/pnas.0805493105; Eaves HL, 2009, BIOINFORMATICS, V25, P969, DOI 10.1093/bioinformatics/btp092; Elliott E, 2010, NAT NEUROSCI, V13, P1351, DOI 10.1038/nn.2642; Feng J, 2010, NAT NEUROSCI, V13, P423, DOI 10.1038/nn.2514; Ford EC, 2011, RADIAT RES, V175, P774, DOI 10.1667/RR2214.1; Guan JS, 2009, NATURE, V459, P55, DOI 10.1038/nature07925; Guo JU, 2011, CELL CYCLE, V10, P2662, DOI 10.4161/cc.10.16.17093; Guo JU, 2011, CELL, V145, P423, DOI 10.1016/j.cell.2011.03.022; Hellman A, 2007, SCIENCE, V315, P1141, DOI 10.1126/science.1136352; Herman JG, 2003, NEW ENGL J MED, V349, P2042, DOI 10.1056/NEJMra023075; Illingworth RS, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001134; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Klug M, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-6-r63; LaPlant Q, 2010, NAT NEUROSCI, V13, P1137, DOI 10.1038/nn.2619; Laurent L, 2010, GENOME RES, V20, P320, DOI 10.1101/gr.101907.109; Lisanby SH, 2007, NEW ENGL J MED, V357, P1939, DOI 10.1056/NEJMct075234; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Lubin FD, 2008, J NEUROSCI, V28, P10576, DOI 10.1523/JNEUROSCI.1786-08.2008; Ma DKK, 2010, NAT NEUROSCI, V13, P1338, DOI 10.1038/nn.2672; Ma DKK, 2009, CELL CYCLE, V8, P1526, DOI 10.4161/cc.8.10.8500; Ma DK, 2009, SCIENCE, V323, P1074, DOI 10.1126/science.1166859; Martinowich K, 2003, SCIENCE, V302, P890, DOI 10.1126/science.1090842; Maze I, 2010, SCIENCE, V327, P213, DOI 10.1126/science.1179438; McGowan PO, 2009, NAT NEUROSCI, V12, P342, DOI 10.1038/nn.2270; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Miller CA, 2007, NEURON, V53, P857, DOI 10.1016/j.neuron.2007.02.022; Miller CA, 2010, NAT NEUROSCI, V13, P664, DOI 10.1038/nn.2560; Muotri AR, 2005, NATURE, V435, P903, DOI 10.1038/nature03663; Murgatroyd C, 2009, NAT NEUROSCI, V12, P1559, DOI 10.1038/nn.2436; NASS MMK, 1973, J MOL BIOL, V80, P155, DOI 10.1016/0022-2836(73)90239-8; Nelson ED, 2008, J NEUROSCI, V28, P395, DOI 10.1523/JNEUROSCI.3796-07.2008; Pierfelice T, 2011, NEURON, V69, P840, DOI 10.1016/j.neuron.2011.02.031; Reik W, 2007, NATURE, V447, P425, DOI 10.1038/nature05918; Shock LS, 2011, P NATL ACAD SCI USA, V108, P3630, DOI 10.1073/pnas.1012311108; Simonsson S, 2004, NAT CELL BIOL, V6, P984, DOI 10.1038/ncb1176; Stresemann C, 2006, CANCER RES, V66, P2794, DOI 10.1158/0008-5472.CAN-05-2821; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Szyf M, 2008, ENVIRON MOL MUTAGEN, V49, P46, DOI 10.1002/em.20357; Thompson RF, 2010, AGING CELL, V9, P506, DOI 10.1111/j.1474-9726.2010.00577.x; Tsankova N, 2007, NAT REV NEUROSCI, V8, P355, DOI 10.1038/nrn2132; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Wu H, 2010, SCIENCE, V329, P444, DOI 10.1126/science.1190485; Wu SC, 2010, NAT REV MOL CELL BIO, V11, P607, DOI 10.1038/nrm2950; Zemach A, 2010, SCIENCE, V328, P916, DOI 10.1126/science.1186366	50	459	467	0	63	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2011	14	10					1345	U172		10.1038/nn.2900	http://dx.doi.org/10.1038/nn.2900			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	825EQ	21874013	Green Accepted			2022-12-28	WOS:000295254200025
J	Miri, A; Daie, K; Arrenberg, AB; Baier, H; Aksay, E; Tank, DW				Miri, Andrew; Daie, Kayvon; Arrenberg, Aristides B.; Baier, Herwig; Aksay, Emre; Tank, David W.			Spatial gradients and multidimensional dynamics in a neural integrator circuit	NATURE NEUROSCIENCE			English	Article							FRACTIONAL-ORDER DYNAMICS; EYE-POSITION; PERSISTENT ACTIVITY; VESTIBULOOCULAR REFLEX; OCULOMOTOR INTEGRATOR; PREPOSITUS-HYPOGLOSSI; TEMPORAL INTEGRATION; WORKING-MEMORY; MODEL NEURON; ALERT CAT	In a neural integrator, the variability and topographical organization of neuronal firing-rate persistence can provide information about the circuit's functional architecture. We used optical recording to measure the time constant of decay of persistent firing (persistence time) across a population of neurons comprising the larval zebrafish oculomotor velocity-to-position neural integrator. We found extensive persistence time variation (tenfold; coefficients of variation = 0.58-1.20) across cells in individual larvae. We also found that the similarity in firing between two neurons decreased as the distance between them increased and that a gradient in persistence time was mapped along the rostrocaudal and dorsoventral axes. This topography is consistent with the emergence of persistence time heterogeneity from a circuit architecture in which nearby neurons are more strongly interconnected than distant ones. Integrator circuit models characterized by multiple dimensions of slow firing-rate dynamics can account for our results.	[Miri, Andrew; Tank, David W.] Princeton Univ, Princeton Neurosci Inst, Princeton, NJ 08544 USA; [Miri, Andrew; Tank, David W.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Daie, Kayvon; Aksay, Emre] Weill Cornell Med Coll, Inst Computat Biomed, New York, NY USA; [Daie, Kayvon; Aksay, Emre] Weill Cornell Med Coll, Dept Physiol & Biophys, New York, NY USA; [Daie, Kayvon] Cornell Univ, Dept Phys, Ithaca, NY 14853 USA; [Arrenberg, Aristides B.; Baier, Herwig] Univ Calif San Francisco, Dept Physiol, Program Neurosci, San Francisco, CA USA; [Arrenberg, Aristides B.; Baier, Herwig] Univ Calif San Francisco, Dept Physiol, Genet Program, San Francisco, CA USA; [Arrenberg, Aristides B.; Baier, Herwig] Univ Calif San Francisco, Dept Physiol, Program Dev Biol, San Francisco, CA USA	Princeton University; Princeton University; Cornell University; Cornell University; Cornell University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Tank, DW (corresponding author), Princeton Univ, Princeton Neurosci Inst, Princeton, NJ 08544 USA.	ema2004@med.cornell.edu; dwtank@princeton.edu		Arrenberg, Aristides/0000-0001-8262-7381; Aksay, Emre/0000-0002-4561-4175	National Science Foundation; US National Institutes of Health [EY007138-16, R01 MH060651, R01 NS053358]; Krevans fellowship; Burroughs Wellcome Career Award at the Scientific Interface; Frueauff Foundation; Human Frontier Science Program; NATIONAL EYE INSTITUTE [T32EY007138] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060651] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS053358] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Krevans fellowship; Burroughs Wellcome Career Award at the Scientific Interface(Burroughs Wellcome Fund); Frueauff Foundation; Human Frontier Science Program(Human Frontier Science Program); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank D. Dombeck for technical advice, F. Collman for motion-correction software, and M. Goldman, A. Kinkhabwala and P. Bradley for helpful discussions. This work was supported by a National Science Foundation predoctoral fellowship (A. M.), a US National Institutes of Health Training grant (EY007138-16, K. D.), a Krevans fellowship (A. B. A.), a Burroughs Wellcome Career Award at the Scientific Interface, a Searle Scholar award, the Frueauff Foundation (E. A.), the Human Frontier Science Program (H. B.), and US National Institutes of Health grants (R01 MH060651 to D. W. T. and R01 NS053358 to H.B.).	Aksay E, 2000, J NEUROPHYSIOL, V84, P1035, DOI 10.1152/jn.2000.84.2.1035; Aksay E, 2003, J NEUROSCI, V23, P10852; Aksay E, 2003, CEREB CORTEX, V13, P1173, DOI 10.1093/cercor/bhg099; Aksay E, 2001, NAT NEUROSCI, V4, P184, DOI 10.1038/84023; Aksay E, 2007, NAT NEUROSCI, V10, P494, DOI 10.1038/nn1877; ANASTASIO TJ, 1994, BIOL CYBERN, V72, P69, DOI 10.1007/BF00206239; Anastasio TJ, 1998, BIOL CYBERN, V79, P377, DOI 10.1007/s004220050487; Arrenberg AB, 2009, P NATL ACAD SCI USA, V106, P17968, DOI 10.1073/pnas.0906252106; Beck JC, 2006, J NEUROPHYSIOL, V96, P1370, DOI 10.1152/jn.00335.2006; CANNON SC, 1983, BIOL CYBERN, V49, P127, DOI 10.1007/BF00320393; COHEN B, 1972, EXP NEUROL, V36, P101, DOI 10.1016/0014-4886(72)90139-2; Dasen JS, 2009, CURR TOP DEV BIOL, V88, P169, DOI 10.1016/S0070-2153(09)88006-X; Debowy O, 2011, J NEUROPHYSIOL, V105, P896, DOI 10.1152/jn.00313.2010; ESCUDERO M, 1992, J PHYSIOL-LONDON, V458, P539, DOI 10.1113/jphysiol.1992.sp019433; Fransen E, 2006, NEURON, V49, P735, DOI 10.1016/j.neuron.2006.01.036; GOLDBERG JM, 1971, J NEUROPHYSIOL, V34, P635, DOI 10.1152/jn.1971.34.4.635; Goldman MS, 2009, NEURON, V61, P621, DOI 10.1016/j.neuron.2008.12.012; Goldman MS, 2003, CEREB CORTEX, V13, P1185, DOI 10.1093/cercor/bhg095; Helmstaedter M, 2008, CURR OPIN NEUROBIOL, V18, P633, DOI 10.1016/j.conb.2009.03.005; Higashijima S, 2004, J COMP NEUROL, V480, P1, DOI 10.1002/cne.20278; HUANG Z, 2009, THESIS PRINCETON U; Huk AC, 2005, J NEUROSCI, V25, P10420, DOI 10.1523/JNEUROSCI.4684-04.2005; Kinkhabwala A, 2011, P NATL ACAD SCI USA, V108, P1164, DOI 10.1073/pnas.1012185108; Koulakov AA, 2002, NAT NEUROSCI, V5, P775, DOI 10.1038/nn893; Loewenstein Y, 2003, NAT NEUROSCI, V6, P961, DOI 10.1038/nn1109; LOPEZBARNEO J, 1982, J NEUROPHYSIOL, V47, P329, DOI 10.1152/jn.1982.47.2.329; Ma LH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005944; Maass W, 2007, PLOS COMPUT BIOL, V3, P15, DOI 10.1371/journal.pcbi.0020165; Machens CK, 2005, SCIENCE, V307, P1121, DOI 10.1126/science.1104171; Major G, 2004, CURR OPIN NEUROBIOL, V14, P675, DOI 10.1016/j.conb.2004.10.017; Major G, 2004, P NATL ACAD SCI USA, V101, P7745, DOI 10.1073/pnas.0401992101; MCFARLAND JL, 1992, J NEUROPHYSIOL, V68, P319, DOI 10.1152/jn.1992.68.1.319; McLean DL, 2007, NATURE, V446, P71, DOI 10.1038/nature05588; McLean DL, 2008, NAT NEUROSCI, V11, P1419, DOI 10.1038/nn.2225; MILES FA, 1980, J NEUROPHYSIOL, V43, P1426, DOI 10.1152/jn.1980.43.5.1426; Miri A, 2011, J NEUROPHYSIOL, V105, P964, DOI 10.1152/jn.00702.2010; Oestreich J, 2006, NEURON, V49, P577, DOI 10.1016/j.neuron.2006.01.027; PASTOR AM, 1994, P NATL ACAD SCI USA, V91, P807, DOI 10.1073/pnas.91.2.807; ROBINSON DA, 1989, ANNU REV NEUROSCI, V12, P33, DOI 10.1146/annurev.neuro.12.1.33; Schoonheim PJ, 2010, J NEUROSCI, V30, P7111, DOI 10.1523/JNEUROSCI.5193-09.2010; Seung HS, 1996, P NATL ACAD SCI USA, V93, P13339, DOI 10.1073/pnas.93.23.13339; Seung HS, 2000, NEURON, V26, P259, DOI 10.1016/S0896-6273(00)81155-1; SHINODA Y, 1974, J NEUROPHYSIOL, V37, P653, DOI 10.1152/jn.1974.37.4.653; Singh R, 2006, J NEUROSCI, V26, P3667, DOI 10.1523/JNEUROSCI.4864-05.2006; SKAVENSKI AA, 1973, J NEUROPHYSIOL, V36, P724, DOI 10.1152/jn.1973.36.4.724; Sklavos S, 2005, VISION RES, V45, P1525, DOI 10.1016/j.visres.2005.01.005; Sussillo D, 2009, NEURON, V63, P544, DOI 10.1016/j.neuron.2009.07.018; Taube JS, 2003, CEREB CORTEX, V13, P1162, DOI 10.1093/cercor/bhg102; Teramae JN, 2005, J COMPUT NEUROSCI, V18, P105, DOI 10.1007/s10827-005-5474-6; Weiler N, 2008, NAT NEUROSCI, V11, P360, DOI 10.1038/nn2049	50	82	83	1	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2011	14	9					1150	U207		10.1038/nn.2888	http://dx.doi.org/10.1038/nn.2888			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	812ID	21857656	Green Accepted			2022-12-28	WOS:000294284900015
J	Bello, EP; Mateo, Y; Gelman, DM; Noain, D; Shin, JH; Low, MJ; Alvarez, VA; Lovinger, DM; Rubinstein, M				Bello, Estefania P.; Mateo, Yolanda; Gelman, Diego M.; Noain, Daniela; Shin, Jung H.; Low, Malcolm J.; Alvarez, Veronica A.; Lovinger, David M.; Rubinstein, Marcelo			Cocaine supersensitivity and enhanced motivation for reward in mice lacking dopamine D-2 autoreceptors	NATURE NEUROSCIENCE			English	Article							RECEPTOR-DEFICIENT MICE; CONDITIONED PLACE PREFERENCE; D2 RECEPTORS; FEEDBACK MECHANISM; LOCOMOTOR-ACTIVITY; MUTANT MICE; RELEASE; MOUSE; TRANSPORTER; ABSENCE	Dopamine (DA) D-2 receptors expressed in DA neurons (D-2 autoreceptors) exert a negative feedback regulation that reduces DA neuron firing, DA synthesis and DA release. As D-2 receptors are mostly expressed in postsynaptic neurons, pharmacological and genetic approaches have been unable to definitively address the in vivo contribution of D-2 autoreceptors to DA-mediated behaviors. We found that midbrain DA neurons from mice deficient in D-2 autoreceptors (Drd2(loxP/loxP); Dat(+/IRES-cre), referred to as autoDrd2KO mice) lacked DA-mediated somatodendritic synaptic responses and inhibition of DA release. AutoDrd2KO mice displayed elevated DA synthesis and release, hyperlocomotion and supersensitivity to the psychomotor effects of cocaine. The mice also exhibited increased place preference for cocaine and enhanced motivation for food reward. Our results highlight the importance of D-2 autoreceptors in the regulation of DA neurotransmission and demonstrate that D-2 autoreceptors are important for normal motor function, food-seeking behavior, and sensitivity to the locomotor and rewarding properties of cocaine.	[Bello, Estefania P.; Gelman, Diego M.; Noain, Daniela; Rubinstein, Marcelo] Consejo Nacl Invest Cient & Tecn, Inst Invest Ingn Genet & Biol, Buenos Aires, DF, Argentina; [Mateo, Yolanda; Lovinger, David M.] NIAAA, Sect Synapt Pharmacol, Lab Integrat Neurosci, US Natl Inst Hlth, Bethesda, MD USA; [Shin, Jung H.; Alvarez, Veronica A.] NIAAA, Sect Neuronal Struct, Lab Integrat Neurosci, US Natl Inst Hlth, Bethesda, MD USA; [Low, Malcolm J.] Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Ann Arbor, MI USA; [Rubinstein, Marcelo] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); University of Michigan System; University of Michigan; University of Buenos Aires	Rubinstein, M (corresponding author), Consejo Nacl Invest Cient & Tecn, Inst Invest Ingn Genet & Biol, Buenos Aires, DF, Argentina.	mrubins@dna.uba.ar	Alvarez, Veronica A/E-9745-2015	Alvarez, Veronica A/0000-0003-2611-8675; Low, Malcolm/0000-0002-9900-3708; Noain, Daniela/0000-0001-5482-7933	Howard Hughes Medical Institute; Universidad de Buenos Aires; Agencia Nacional de Promocion Cientifica y Tecnologica; National Science Foundation [INT-9901278]; US National Institutes of Health [R01-MH61326]; Consejo Nacional de Investigaciones Cientificas y Tecnicas, Argentina; Division of Intramural Clinical and Biological Research of the National Institute on Alcohol Abuse and Alcoholism; National Institute of Neurological Disorders and Stroke; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH061326] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000421, ZIAAA000416] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Universidad de Buenos Aires(University of Buenos Aires); Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); National Science Foundation(National Science Foundation (NSF)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Consejo Nacional de Investigaciones Cientificas y Tecnicas, Argentina(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Division of Intramural Clinical and Biological Research of the National Institute on Alcohol Abuse and Alcoholism; National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	We thank J. Sztein, G. Levin, C. Backman, V. Rodriguez, R. Lorenzo, S. Nemirovsky, M. Peper, S. Merani, C. Carbone, F. Maschi and M. Baetscher for their scientific and technical assistance. This work was supported in part by an International Research Scholar Grant of the Howard Hughes Medical Institute (M.R.), Universidad de Buenos Aires (M.R.) and Agencia Nacional de Promocion Cientifica y Tecnologica (M.R.), National Science Foundation grant INT-9901278 (M.J.L. and M.R.) and US National Institutes of Health grant R01-MH61326 (M.J.L.). E.P.B., D.N. and D.M.G. received doctoral fellowships from the Consejo Nacional de Investigaciones Cientificas y Tecnicas, Argentina. Y.M., J.H.S., V.A.A. and D.M.L. were supported by the Division of Intramural Clinical and Biological Research of the National Institute on Alcohol Abuse and Alcoholism. J.H.S. and V.A.A. received support from the Intramural Program of the National Institute of Neurological Disorders and Stroke.	Avale ME, 2004, MOL PSYCHIATR, V9, P718, DOI 10.1038/sj.mp.4001474; Backman CM, 2006, GENESIS, V44, P383, DOI 10.1002/dvg.20228; BAIK JH, 1995, NATURE, V377, P424, DOI 10.1038/377424a0; Benoit-Marand M, 2001, J NEUROSCI, V21, P9134, DOI 10.1523/JNEUROSCI.21-23-09134.2001; Berridge KC, 2007, PSYCHOPHARMACOLOGY, V191, P391, DOI 10.1007/s00213-006-0578-x; Bevins RA, 2006, NAT PROTOC, V1, P1306, DOI 10.1038/nprot.2006.205; Buckholtz JW, 2010, SCIENCE, V329, P532, DOI 10.1126/science.1185778; BUNNEY BS, 1973, NATURE-NEW BIOL, V245, P123, DOI 10.1038/newbio245123a0; Chausmer AL, 2002, PSYCHOPHARMACOLOGY, V163, P54, DOI 10.1007/s00213-002-1142-y; CUBEDDU LX, 1982, J PHARMACOL EXP THER, V223, P497; Cunningham CL, 2006, NAT PROTOC, V1, P1662, DOI 10.1038/nprot.2006.279; Cunningham CL, 2000, PHARMACOL BIOCHEM BE, V67, P693, DOI 10.1016/S0091-3057(00)00414-7; Diaz-Torga G, 2002, ENDOCRINOLOGY, V143, P1270, DOI 10.1210/en.143.4.1270; Dickinson SD, 1999, J NEUROCHEM, V72, P148, DOI 10.1046/j.1471-4159.1999.0720148.x; Falzone TL, 2002, EUR J NEUROSCI, V15, P158, DOI 10.1046/j.0953-816x.2001.01842.x; Ford CP, 2010, J NEUROSCI, V30, P6975, DOI 10.1523/JNEUROSCI.1020-10.2010; Giros B, 1996, NATURE, V379, P606, DOI 10.1038/379606a0; Goto Y, 2007, NEUROPHARMACOLOGY, V53, P583, DOI 10.1016/j.neuropharm.2007.07.007; Pellizzari EH, 2008, LIFE SCI, V83, P413, DOI 10.1016/j.lfs.2008.07.004; Hidalgo-Sanchez M, 2005, J COMP NEUROL, V483, P17, DOI 10.1002/cne.20402; John CE, 2006, J NEUROCHEM, V96, P267, DOI 10.1111/j.1471-4159.2005.03557.x; Jones SR, 1999, NAT NEUROSCI, V2, P649, DOI 10.1038/10204; Joseph JD, 2002, NEUROSCIENCE, V112, P39, DOI 10.1016/S0306-4522(02)00067-2; KEHR W, 1972, J PHARM PHARMACOL, V24, P744, DOI 10.1111/j.2042-7158.1972.tb09104.x; Kelly MA, 1998, J NEUROSCI, V18, P3470; KENNEDY RT, 1992, J NEUROCHEM, V59, P449, DOI 10.1111/j.1471-4159.1992.tb09391.x; Kenny PJ, 2011, NEURON, V69, P664, DOI 10.1016/j.neuron.2011.02.016; Koeltzow TE, 1998, J NEUROSCI, V18, P2231; Maina FK, 2010, ACS CHEM NEUROSCI, V1, P450, DOI 10.1021/cn100003u; Maldonado R, 1997, NATURE, V388, P586, DOI 10.1038/41567; Mercuri NB, 1997, NEUROSCIENCE, V79, P323; Morgan D, 2002, NAT NEUROSCI, V5, P169, DOI 10.1038/nn798; Nemirovsky SI, 2009, SYNAPSE, V63, P991, DOI 10.1002/syn.20680; Paladini CA, 2003, P NATL ACAD SCI USA, V100, P2866, DOI 10.1073/pnas.0138018100; Phillips PEM, 2002, SYNAPSE, V44, P15, DOI 10.1002/syn.10049; Phillips TJ, 1998, NAT NEUROSCI, V1, P610, DOI 10.1038/2843; Salamone JD, 2002, BEHAV BRAIN RES, V137, P3, DOI 10.1016/S0166-4328(02)00282-6; Sano H, 2003, J NEUROSCI, V23, P9078; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Schmitz Y, 2003, J NEUROCHEM, V87, P273, DOI 10.1046/j.1471-4159.2003.02050.x; Schmitz Y, 2002, J NEUROSCI, V22, P8002; Schultz W, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-24; Sulzer D, 2011, NEURON, V69, P628, DOI 10.1016/j.neuron.2011.02.010; Thanos PK, 2001, J NEUROCHEM, V78, P1094, DOI 10.1046/j.1471-4159.2001.00492.x; Volkow ND, 2009, NEUROPHARMACOLOGY, V56, P3, DOI 10.1016/j.neuropharm.2008.05.022; Volkow ND, 1999, AM J PSYCHIAT, V156, P1440; Volkow ND, 2002, SYNAPSE, V46, P79, DOI 10.1002/syn.10137; Welter M, 2007, P NATL ACAD SCI USA, V104, P6840, DOI 10.1073/pnas.0610790104; WOLF ME, 1990, ANN NY ACAD SCI, V604, P323, DOI 10.1111/j.1749-6632.1990.tb32003.x; Zhuang XX, 2001, P NATL ACAD SCI USA, V98, P1982, DOI 10.1073/pnas.98.4.1982	50	254	258	0	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2011	14	8					1033	U128		10.1038/nn.2862	http://dx.doi.org/10.1038/nn.2862			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	797KC	21743470	Green Accepted, Green Published			2022-12-28	WOS:000293123700017
J	Zhang, HB; Constantine, R; Vorobiev, S; Chen, Y; Seetharaman, J; Huang, YJ; Xiao, R; Montelione, GT; Gerstner, CD; Davis, MW; Inana, G; Whitby, FG; Jorgensen, EM; Hill, CP; Tong, L; Baehr, W				Zhang, Houbin; Constantine, Ryan; Vorobiev, Sergey; Chen, Yang; Seetharaman, Jayaraman; Huang, Yuanpeng Janet; Xiao, Rong; Montelione, Gaetano T.; Gerstner, Cecilia D.; Davis, M. Wayne; Inana, George; Whitby, Frank G.; Jorgensen, Erik M.; Hill, Christopher P.; Tong, Liang; Baehr, Wolfgang			UNC119 is required for G protein trafficking in sensory neurons	NATURE NEUROSCIENCE			English	Article							LIGHT-DRIVEN TRANSLOCATION; CAENORHABDITIS-ELEGANS; PHOTORECEPTOR PROTEIN; RETINAL DEGENERATION; BINDING PROTEIN; PDE-DELTA; C-ELEGANS; TRANSDUCIN; UNC-119; COMPLEX	UNC119 is widely expressed among vertebrates and other phyla. We found that UNC119 recognized the acylated N terminus of the rod photoreceptor transducin alpha (T alpha) subunit and Caenorhabditis elegans G proteins ODR-3 and GPA-13. The crystal structure of human UNC119 at 1.95-angstrom resolution revealed an immunoglobulin-like beta-sandwich fold. Pulldowns and isothermal titration calorimetry revealed a tight interaction between UNC119 and acylated G alpha peptides. The structure of co-crystals of UNC119 with an acylated T alpha N-terminal peptide at 2.0 angstrom revealed that the lipid chain is buried deeply into UNC119's hydrophobic cavity. UNC119 bound T alpha-GTP, inhibiting its GTPase activity, thereby providing a stable UNC119-T alpha-GTP complex capable of diffusing from the inner segment back to the outer segment after light-induced translocation. UNC119 deletion in both mouse and C. elegans led to G protein mislocalization. Thus, UNC119 is a Ga subunit cofactor essential for G protein trafficking in sensory cilia.	[Zhang, Houbin; Constantine, Ryan; Gerstner, Cecilia D.; Baehr, Wolfgang] Univ Utah, Hlth Sci Ctr, Dept Ophthalmol, Salt Lake City, UT 84132 USA; [Constantine, Ryan] Univ Utah, Hlth Sci Ctr, Grad Program Neurosci, Salt Lake City, UT USA; [Vorobiev, Sergey; Chen, Yang; Seetharaman, Jayaraman; Tong, Liang] Columbia Univ, Dept Biol Sci, NE Struct Genom Consortium, New York, NY 10027 USA; [Huang, Yuanpeng Janet; Xiao, Rong; Montelione, Gaetano T.] Rutgers State Univ, Dept Mol Biol & Biochem, Ctr Adv Biotechnol & Med, NE Struct Genom Consortium, Piscataway, NJ 08855 USA; [Davis, M. Wayne; Jorgensen, Erik M.; Baehr, Wolfgang] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; [Inana, George] Univ Miami, Miller Sch Med, Bascom Palmer Eye Inst, Miami, FL 33136 USA; [Whitby, Frank G.; Hill, Christopher P.] Univ Utah, Sch Med, Dept Biochem, Salt Lake City, UT USA; [Jorgensen, Erik M.] Univ Utah, Howard Hughes Med Inst, Salt Lake City, UT USA; [Baehr, Wolfgang] Univ Utah, Hlth Sci Ctr, Dept Neurobiol & Anat, Salt Lake City, UT USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Columbia University; Rutgers State University New Brunswick; Utah System of Higher Education; University of Utah; Bascom Palmer Eye Institute; University of Miami; Utah System of Higher Education; University of Utah; Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Baehr, W (corresponding author), Univ Utah, Hlth Sci Ctr, Dept Ophthalmol, Salt Lake City, UT 84132 USA.	wbaehr@hsc.utah.edu	Zhang, Houbin/A-8887-2012	Davis, Mikel/0000-0003-1867-1593; Montelione, Gaetano/0000-0002-9440-3059; Zhang, Houbin/0000-0002-2968-7454; Tong, Liang/0000-0002-0563-6468	US National Institutes of Health [EY08123, EY019298, EY014800-039003, EY10848, NS034307]; Howard Hughes Medical Institute; Protein Structure Initiative of the US National Institutes of Health; University of Utah Macromolecule Crystallography Core Facility; Foundation Fighting Blindness; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [P30EY014800, R01EY010848, R01EY008123, R01EY019298] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM074958] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS034307, R01NS034307] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Protein Structure Initiative of the US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Utah Macromolecule Crystallography Core Facility; Foundation Fighting Blindness(European Commission); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank R. Abramowitz and J. Schwanof for access to the X4A beamline at the National Synchrotron Light Source and G. DeTitta of Hauptman Woodward Research Institute for crystallization screening. This work was supported by US National Institutes of Health grants EY08123 (W. B.), EY019298 (W. B.), EY014800-039003 (National Eye Institute core grant), EY10848 (G. I.) and NS034307 (E. M. J.), by the Howard Hughes Medical Institute (E. M. J.), by a grant from the Protein Structure Initiative of the US National Institutes of Health (U54 GM074958), by the University of Utah Macromolecule Crystallography Core Facility, by a Center Grant of the Foundation Fighting Blindness to the University of Utah, and unrestricted grants to the Departments of Ophthalmology at the University of Utah from Research to Prevent Blindness. W. B. is a recipient of a Research to Prevent Blindness Senior Investigator Award.	Acton TB, 2005, METHOD ENZYMOL, V394, P210, DOI 10.1016/S0076-6879(05)94008-1; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Alpadi K, 2008, J BIOL CHEM, V283, P26461, DOI 10.1074/jbc.M801625200; BAEHR W, 1982, J BIOL CHEM, V257, P6452; BORK P, 1994, J MOL BIOL, V242, P309, DOI 10.1006/jmbi.1994.1582; Calvert PD, 2006, TRENDS CELL BIOL, V16, P560, DOI 10.1016/j.tcb.2006.09.001; CHAYEN NE, 1990, J APPL CRYSTALLOGR, V23, P297, DOI 10.1107/S0021889890003260; Chung S, 2007, GENE, V389, P45, DOI 10.1016/j.gene.2006.09.032; Cowan CW, 2000, METHOD ENZYMOL, V315, P524; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Elias R, 2004, MOL VIS, V10, P672; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gillingham AK, 2007, ANNU REV CELL DEV BI, V23, P579, DOI 10.1146/annurev.cellbio.23.090506.123209; Goc A, 2008, BIOCHEMISTRY-US, V47, P12409, DOI 10.1021/bi8015444; Gorska MM, 2006, J BIOL CHEM, V281, P14429, DOI 10.1074/jbc.M512718200; Haeseleer F, 2008, INVEST OPHTH VIS SCI, V49, P2366, DOI 10.1167/iovs.07-1166; Hanzal-Bayer M, 2002, EMBO J, V21, P2095, DOI 10.1093/emboj/21.9.2095; Higashide T, 1996, J BIOL CHEM, V271, P1797, DOI 10.1074/jbc.271.3.1797; Higashide T, 1998, INVEST OPHTH VIS SCI, V39, P690; Hoffman GR, 2000, CELL, V100, P345, DOI 10.1016/S0092-8674(00)80670-4; Ishiba Y, 2007, EXP EYE RES, V84, P473, DOI 10.1016/j.exer.2006.10.016; Jin H, 2010, CELL, V141, P1208, DOI 10.1016/j.cell.2010.05.015; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Keller LC, 2009, MOL BIOL CELL, V20, P1150, DOI 10.1091/mbc.E08-06-0619; Kerov V, 2007, J NEUROSCI, V27, P10270, DOI 10.1523/JNEUROSCI.2494-07.2007; Kim J, 2008, HUM MOL GENET, V17, P3796, DOI 10.1093/hmg/ddn277; Knobel KM, 2001, DEVELOPMENT, V128, P4079; Kobayashi A, 2000, INVEST OPHTH VIS SCI, V41, P3268; Kobayashi A, 2003, FEBS LETT, V534, P26, DOI 10.1016/S0014-5793(02)03766-3; Lans H, 2004, GENETICS, V167, P1677, DOI 10.1534/genetics.103.024786; Liu Q, 2007, MOL CELL PROTEOMICS, V6, P1299, DOI 10.1074/mcp.M700054-MCP200; MADURO M, 1995, GENETICS, V141, P977; Marrari Y, 2007, BIOCHEMISTRY-US, V46, P7665, DOI 10.1021/bi700338m; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PERKINS LA, 1986, DEV BIOL, V117, P456, DOI 10.1016/0012-1606(86)90314-3; Roayaie K, 1998, NEURON, V20, P55, DOI 10.1016/S0896-6273(00)80434-1; Rosenbaum JL, 2002, NAT REV MOL CELL BIO, V3, P813, DOI 10.1038/nrm952; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Slepak VZ, 2008, IUBMB LIFE, V60, P2, DOI 10.1002/iub.7; Sokolov M, 2004, J BIOL CHEM, V279, P19149, DOI 10.1074/jbc.M311058200; Sokolov M, 2002, NEURON, V34, P95, DOI 10.1016/S0896-6273(02)00636-0; Swanson DA, 1998, INVEST OPHTH VIS SCI, V39, P2085; Terwilliger TC, 2003, METHOD ENZYMOL, V374, P22, DOI 10.1016/S0076-6879(03)74002-6; Troemel ER, 1997, CELL, V91, P161, DOI 10.1016/S0092-8674(00)80399-2; Veltel S, 2008, FEBS LETT, V582, P2501, DOI 10.1016/j.febslet.2008.05.053; Vepachedu R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005211; Zhang H, 2007, P NATL ACAD SCI USA, V104, P8857, DOI 10.1073/pnas.0701681104; Zhang HB, 2004, J BIOL CHEM, V279, P407, DOI 10.1074/jbc.M306559200	50	117	124	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2011	14	7					874	+		10.1038/nn.2835	http://dx.doi.org/10.1038/nn.2835			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	783KR	21642972	Green Accepted			2022-12-28	WOS:000292081700015
J	Glynn, MW; Elmer, BM; Garay, PA; Liu, XB; Needleman, LA; El-Sabeawy, F; McAllister, AK				Glynn, Marian W.; Elmer, Bradford M.; Garay, Paula A.; Liu, Xiao-Bo; Needleman, Leigh A.; El-Sabeawy, Faten; McAllister, A. Kimberley			MHCI negatively regulates synapse density during the establishment of cortical connections	NATURE NEUROSCIENCE			English	Article							CLASS-I MOLECULES; ACTIVITY-DEPENDENT REGULATION; RECEPTOR INTERNALIZATION; ACTIVITY BLOCKADE; GENE-EXPRESSION; HEAVY-CHAINS; CNS; PLASTICITY; ABSENCE; SURFACE	Major histocompatibility complex class I (MHCI) molecules modulate activity-dependent refinement and plasticity. We found that MHCI also negatively regulates the density and function of cortical synapses during their initial establishment both in vitro and in vivo. MHCI molecules are expressed on cortical neurons before and during synaptogenesis. In vitro, decreasing surface MHCI (sMHCI) on neurons increased glutamatergic and GABAergic synapse density, whereas overexpression decreased it. In vivo, synapse density was higher throughout development in beta 2m(-/-) mice. MHCI also negatively regulated the strength of excitatory, but not inhibitory, synapses and controlled the balance of excitation and inhibition onto cortical neurons. sMHCI levels were modulated by activity and were necessary for activity to negatively regulate glutamatergic synapse density. Finally, acute changes in sMHCI and activity altered synapse density exclusively during early postnatal development. These results identify a previously unknown function for immune proteins in the negative regulation of the initial establishment and function of cortical connections.	[Glynn, Marian W.; Elmer, Bradford M.; Garay, Paula A.; Liu, Xiao-Bo; Needleman, Leigh A.; El-Sabeawy, Faten; McAllister, A. Kimberley] Univ Calif Davis, Ctr Neurosci, Davis, CA 95616 USA	University of California System; University of California Davis	McAllister, AK (corresponding author), Univ Calif Davis, Ctr Neurosci, Davis, CA 95616 USA.	kmcallister@ucdavis.edu		McAllister, A. Kimberley/0000-0001-9177-9889	National Institute for Environmental Health Sciences; John Merck Fund; March of Dimes; Cure Autism Now; Autism Speaks; National Institute of Neurological Disorders and Stroke [R01NS060125]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS060125] Funding Source: NIH RePORTER	National Institute for Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); John Merck Fund; March of Dimes(March of Dimes); Cure Autism Now; Autism Speaks; National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are grateful to M. Edidin (Johns Hopkins University) for the H2-K<SUP>b</SUP>-CFP construct, J. Fritschy (University of Zurich) for antibodies to GABA receptor and J. Trimmer (University of California Davis) for the antibody to PSD-95. We also thank J. Trimmer and E. Diaz (University of California Davis) for advice and for supporting the project. This project was funded by a National Institute for Environmental Health Sciences Training grant (M. W. G.), the John Merck Fund (A. K. M.), the March of Dimes (A. K. M.), Cure Autism Now (A. K. M.), Autism Speaks (A. K. M.) and National Institute of Neurological Disorders and Stroke grant R01NS060125 (A. K. M.). We are especially grateful to the Higgins and Gassin Family Foundations for their invaluable support of basic science research and our work.	Abbas A., 2017, CELLULAR MOL IMMUNOL, P281; Bodnar A, 2003, INT IMMUNOL, V15, P331, DOI 10.1093/intimm/dxg042; Boulanger LM, 2004, NAT REV NEUROSCI, V5, P521, DOI 10.1038/nrn1428; Bouwman J, 2004, NEUROSCIENCE, V126, P115, DOI 10.1016/j.neuroscience.2004.03.027; Burrone J, 2003, CURR OPIN NEUROBIOL, V13, P560, DOI 10.1016/j.conb.2003.09.007; Burrone J, 2002, NATURE, V420, P414, DOI 10.1038/nature01242; CHAKRABARTI A, 1992, BIOCHEMISTRY-US, V31, P7182, DOI 10.1021/bi00146a022; Cochilla AJ, 1999, ANNU REV NEUROSCI, V22, P1, DOI 10.1146/annurev.neuro.22.1.1; Corriveau RA, 1998, NEURON, V21, P505, DOI 10.1016/S0896-6273(00)80562-0; CRAIG AM, 1994, P NATL ACAD SCI USA, V91, P12373, DOI 10.1073/pnas.91.26.12373; Datwani A, 2009, NEURON, V64, P463, DOI 10.1016/j.neuron.2009.10.015; DeFelipe J, 1999, CEREB CORTEX, V9, P722, DOI 10.1093/cercor/9.7.722; DEMARIA S, 1992, CELL IMMUNOL, V142, P103, DOI 10.1016/0008-8749(92)90272-Q; Fishman D, 2004, FOLIA BIOL-PRAGUE, V50, P35; Flavell SW, 2006, SCIENCE, V311, P1008, DOI 10.1126/science.1122511; Glynn MW, 2006, NAT PROTOC, V1, P1287, DOI 10.1038/nprot.2006.220; Goddard CA, 2007, P NATL ACAD SCI USA, V104, P6828, DOI 10.1073/pnas.0702023104; Harms KJ, 2005, J COMP NEUROL, V490, P72, DOI 10.1002/cne.20635; Hartman KN, 2006, NAT NEUROSCI, V9, P642, DOI 10.1038/nn1677; HOCHMAN JH, 1988, J IMMUNOL, V140, P2322; Huh GS, 2000, SCIENCE, V290, P2155, DOI 10.1126/science.290.5499.2155; Huupponen J, 2007, J PHYSIOL-LONDON, V581, P505, DOI 10.1113/jphysiol.2007.130062; Kirov SA, 2004, NEUROPHARMACOLOGY, V47, P640, DOI 10.1016/j.neuropharm.2004.07.039; Lauri SE, 2003, MOL CELL NEUROSCI, V22, P107, DOI 10.1016/S1044-7431(02)00012-X; MADRIGAL JA, 1991, J EXP MED, V174, P1085, DOI 10.1084/jem.174.5.1085; Margolis SS, 2010, CELL, V143, P442, DOI 10.1016/j.cell.2010.09.038; McAllister AM, 2007, ANNU REV NEUROSCI, V30, P425, DOI 10.1146/annurev.neuro.29.051605.112830; MCALLISTER AK, 2007, ANN REV NEU IN PRESS; Naranda T, 1997, P NATL ACAD SCI USA, V94, P11692, DOI 10.1073/pnas.94.21.11692; Nawa H, 2000, MOL PSYCHIATR, V5, P594, DOI 10.1038/sj.mp.4000730; Needleman LA, 2010, P NATL ACAD SCI USA, V107, P16999, DOI 10.1073/pnas.1006087107; Neumann H, 1997, J EXP MED, V185, P305, DOI 10.1084/jem.185.2.305; O'Connor TP, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-18; OLSSON L, 1994, P NATL ACAD SCI USA, V91, P9086, DOI 10.1073/pnas.91.19.9086; Patel MR, 2009, SCIENCE, V323, P1500, DOI 10.1126/science.1169025; Patterson PH, 2002, CURR OPIN NEUROBIOL, V12, P115, DOI 10.1016/S0959-4388(02)00299-4; Rao A, 1997, NEURON, V19, P801, DOI 10.1016/S0896-6273(00)80962-9; Sabo SL, 2003, NAT NEUROSCI, V6, P1264, DOI 10.1038/nn1149; Santos SG, 2004, J BIOL CHEM, V279, P53062, DOI 10.1074/jbc.M408794200; Sassoe-Pognetto M, 2000, J COMP NEUROL, V420, P481, DOI 10.1002/(SICI)1096-9861(20000515)420:4<481::AID-CNE6>3.0.CO;2-5; SCHNABL E, 1990, J EXP MED, V171, P1431, DOI 10.1084/jem.171.5.1431; Shi LM, 2003, J NEUROSCI, V23, P297, DOI 10.1523/jneurosci.23-01-00297.2003; Spiliotis ET, 2002, MOL BIOL CELL, V13, P1566, DOI 10.1091/mbc.01-07-0322; Stagsted J, 1998, APMIS Suppl, V85, P1; Varoqueaux F, 2002, P NATL ACAD SCI USA, V99, P9037, DOI 10.1073/pnas.122623799; Verhage M, 2000, SCIENCE, V287, P864, DOI 10.1126/science.287.5454.864; Waites CL, 2005, ANNU REV NEUROSCI, V28, P251, DOI 10.1146/annurev.neuro.27.070203.144336; Wierenga CJ, 2006, J NEUROPHYSIOL, V96, P2127, DOI 10.1152/jn.00107.2006; WILLIAMS DB, 1989, J IMMUNOL, V142, P2796	49	120	127	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2011	14	4					442	U71		10.1038/nn.2764	http://dx.doi.org/10.1038/nn.2764			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	741FQ	21358642	Green Accepted			2022-12-28	WOS:000288849400015
J	Yang, JF; Dominguez, B; de Winter, F; Gould, TW; Eriksson, JE; Lee, KF				Yang, Jiefei; Dominguez, Bertha; de Winter, Fred; Gould, Thomas W.; Eriksson, John E.; Lee, Kuo-Fen			Nestin negatively regulates postsynaptic differentiation of the neuromuscular synapse	NATURE NEUROSCIENCE			English	Article							FILAMENT PROTEIN NESTIN; INTERMEDIATE-FILAMENTS; JUNCTION; PHOSPHORYLATION; INNERVATION; P35; EXPRESSION; MUSCLE; MICE; CDK5	Positive and negative regulation of neurotransmitter receptor aggregation on the postsynaptic membrane is a critical event during synapse formation. Acetylcholine (ACh) and agrin are two opposing signals that regulate ACh receptor (AChR) clustering during neuromuscular junction (NMJ) development. ACh induces dispersion of AChR clusters that are not stabilized by agrin via a cyclin-dependent kinase 5 (Cdk5)-mediated mechanism, but regulation of Cdk5 activation is poorly understood. We found that the intermediate filament protein nestin physically interacts with Cdk5 and is required for ACh-induced association of p35, the co-activator of Cdk5, with the muscle membrane. Blockade of nestin-dependent signaling inhibited ACh-induced Cdk5 activation and the dispersion of AChR clusters in cultured myotubes. Similar to the effects of Cdk5 gene inactivation, knockdown of nestin in agrin-deficient mouse embryos substantially restored AChR clusters. These results suggest that nestin is required for ACh-induced, Cdk5-dependent dispersion of AChR clusters during NMJ development.	[Yang, Jiefei; Dominguez, Bertha; de Winter, Fred; Gould, Thomas W.; Lee, Kuo-Fen] Salk Inst Biol Studies, La Jolla, CA USA; [Eriksson, John E.] Abo Akad Univ, Dept Biosci, Turku, Finland	Salk Institute; Abo Akademi University	Lee, KF (corresponding author), Salk Inst Biol Studies, La Jolla, CA USA.	klee@salk.edu	De Winter, Fred/AAZ-8671-2020	De Winter, Fred/0000-0002-3042-2429	US National Institutes of Health [HD034534, NS047345, NS060833, NS044420]; Muscular Dystrophy Association [MDA4230]; Academy of Finland, the Research Institute of the Abo Akademi University Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD034534] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS044420, R01NS060833, R01NS047345] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muscular Dystrophy Association(Muscular Dystrophy Association); Academy of Finland, the Research Institute of the Abo Akademi University Foundation(Academy of Finland); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank L.-H. Tsai for the Cdk5 and p35 constructs and A. Nagy for communicating his unpublished results. This study is supported by US National Institutes of Health grants HD034534, NS047345, NS060833 and NS044420 (K.-F.L.), Muscular Dystrophy Association fellowship MDA4230 (J.Y.), and Academy of Finland, the Research Institute of the Abo Akademi University Foundation (J.E.E.).	An MC, 2010, P NATL ACAD SCI USA, V107, P10702, DOI 10.1073/pnas.1004956107; Asada A, 2008, J NEUROCHEM, V106, P1325, DOI 10.1111/j.1471-4159.2008.05500.x; BLOCH RJ, 1981, DEV BIOL, V81, P386, DOI 10.1016/0012-1606(81)90305-5; BLOCH RJ, 1983, J NEUROSCI, V3, P2670; Carlsson L, 1999, EXP CELL RES, V251, P213, DOI 10.1006/excr.1999.4569; Chen F, 2007, NEURON, V55, P247, DOI 10.1016/j.neuron.2007.06.031; Dong XP, 2006, NEUROSIGNALS, V15, P53, DOI 10.1159/000094484; Flanagan-Steet H, 2005, DEVELOPMENT, V132, P4471, DOI 10.1242/dev.02044; Fu AKY, 2005, P NATL ACAD SCI USA, V102, P15224, DOI 10.1073/pnas.0507678102; Gilyarov A V, 2008, Neurosci Behav Physiol, V38, P165, DOI 10.1007/s11055-008-0025-z; Hamann M, 1995, J PHYSIOL-LONDON, V489, P791, DOI 10.1113/jphysiol.1995.sp021092; Helfand BT, 2005, TRENDS CELL BIOL, V15, P568, DOI 10.1016/j.tcb.2005.09.009; Herrmann H, 2000, CURR OPIN CELL BIOL, V12, P79, DOI 10.1016/S0955-0674(99)00060-5; Hombach-Klonisch S, 2008, J MOL MED, V86, P1301, DOI 10.1007/s00109-008-0383-6; Hyder CL, 2008, FEBS LETT, V582, P2140, DOI 10.1016/j.febslet.2008.04.064; Izawa I, 2006, CANCER SCI, V97, P167, DOI 10.1111/j.1349-7006.2006.00161.x; Kang H, 2007, J NEUROSCI, V27, P5948, DOI 10.1523/JNEUROSCI.0621-07.2007; Kesavapany S, 2004, J NEUROSCI, V24, P4421, DOI 10.1523/JNEUROSCI.0690-04.2004; Kim S, 2007, GENE DEV, V21, P1581, DOI 10.1101/gad.1552107; Ku NO, 2004, J CELL BIOL, V166, P479, DOI 10.1083/jcb.200402051; Ku NO, 2002, P NATL ACAD SCI USA, V99, P4373, DOI 10.1073/pnas.072624299; Lee CW, 2009, NAT NEUROSCI, V12, P848, DOI 10.1038/nn.2322; Lin S, 2008, P NATL ACAD SCI USA, V105, P11406, DOI 10.1073/pnas.0801683105; Lin WC, 2005, NEURON, V46, P569, DOI 10.1016/j.neuron.2005.04.002; Linnoila J, 2008, NEURON, V60, P625, DOI 10.1016/j.neuron.2008.09.025; Luo Z, 2003, NEURON, V40, P703, DOI 10.1016/S0896-6273(03)00695-0; Luo ZG, 2002, NEURON, V35, P489, DOI 10.1016/S0896-6273(02)00783-3; Madhavan R, 2005, MOL CELL NEUROSCI, V28, P403, DOI 10.1016/j.mcn.2004.10.005; Michalczyk K, 2005, HISTOL HISTOPATHOL, V20, P665, DOI 10.14670/HH-20.665; Nazarian J, 2005, PHYSIOL GENOMICS, V21, P70, DOI 10.1152/physiolgenomics.00227.2004; Omary MB, 2006, TRENDS BIOCHEM SCI, V31, P383, DOI 10.1016/j.tibs.2006.05.008; PALLARI HM, 2006, SCI STKE, pPE53, DOI DOI 10.1126/STKE.3662006PE53; Patrick GN, 1999, NATURE, V402, P615, DOI 10.1038/45159; Patrick GN, 1998, J BIOL CHEM, V273, P24057, DOI 10.1074/jbc.273.37.24057; Perlson E, 2005, NEURON, V45, P715, DOI 10.1016/j.neuron.2005.01.023; Sahlgren CM, 2006, EMBO J, V25, P4808, DOI 10.1038/sj.emboj.7601366; Sahlgren CM, 2003, MOL CELL BIOL, V23, P5090, DOI 10.1128/MCB.23.14.5090-5106.2003; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; Shi L, 2010, NEURON, V65, P204, DOI 10.1016/j.neuron.2010.01.012; Sihag RK, 2007, EXP CELL RES, V313, P2098, DOI 10.1016/j.yexcr.2007.04.010; Vaittinen S, 1999, AM J PATHOL, V154, P591, DOI 10.1016/S0002-9440(10)65304-7; Weston C, 2000, J CELL BIOL, V150, P205, DOI 10.1083/jcb.150.1.205; Wu HT, 2010, DEVELOPMENT, V137, P1017, DOI 10.1242/dev.038711; Wu SY, 2002, J BIOL CHEM, V277, P18077, DOI 10.1074/jbc.M110164200; Yang X, 2001, NEURON, V30, P399, DOI 10.1016/S0896-6273(01)00287-2; Yang X, 2000, SCIENCE, V287, P131, DOI 10.1126/science.287.5450.131	46	36	37	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2011	14	3					324	330		10.1038/nn.2747	http://dx.doi.org/10.1038/nn.2747			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	725MW	21278733	Green Accepted			2022-12-28	WOS:000287650100012
J	Graf, ABA; Kohn, A; Jazayeri, M; Movshon, JA				Graf, Arnulf B. A.; Kohn, Adam; Jazayeri, Mehrdad; Movshon, J. Anthony			Decoding the activity of neuronal populations in macaque primary visual cortex	NATURE NEUROSCIENCE			English	Article							NEURAL POPULATIONS; CODING EFFICIENCY; SINGLE NEURONS; CODES; DISCRIMINATION; INFORMATION; ORIENTATION; CELLS; VARIABILITY; COMPUTATION	Visual function depends on the accuracy of signals carried by visual cortical neurons. Combining information across neurons should improve this accuracy because single neuron activity is variable. We examined the reliability of information inferred from populations of simultaneously recorded neurons in macaque primary visual cortex. We considered a decoding framework that computes the likelihood of visual stimuli from a pattern of population activity by linearly combining neuronal responses and tested this framework for orientation estimation and discrimination. We derived a simple parametric decoder assuming neuronal independence and a more sophisticated empirical decoder that learned the structure of the measured neuronal response distributions, including their correlated variability. The empirical decoder used the structure of these response distributions to perform better than its parametric variant, indicating that their structure contains critical information for sensory decoding. These results show how neuronal responses can best be used to inform perceptual decision-making.	[Graf, Arnulf B. A.; Kohn, Adam; Jazayeri, Mehrdad; Movshon, J. Anthony] NYU, Ctr Neural Sci, New York, NY 10003 USA	New York University	Graf, ABA (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	graf@vis.caltech.edu			US National Institutes of Health [EY2017, EY4440]; Swartz Foundation;  [EY7158]; NATIONAL EYE INSTITUTE [R37EY004440, R01EY004440, R01EY002017] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swartz Foundation; ; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We are grateful to M. Smith and R. Kelly for their help with recording and to E. Simoncelli and M. Yanike for helpful comments on the manuscript. This research was supported by US National Institutes of Health research grants EY2017 and EY4440, training grant EY7158 and the Swartz Foundation.	Abbott LF, 1999, NEURAL COMPUT, V11, P91, DOI 10.1162/089976699300016827; Averbeck BB, 2006, NAT REV NEUROSCI, V7, P358, DOI 10.1038/nrn1888; Averbeck BB, 2006, J NEUROPHYSIOL, V95, P3633, DOI 10.1152/jn.00919.2005; Bair W, 2002, J NEUROSCI, V22, P3189, DOI 10.1523/JNEUROSCI.22-08-03189.2002; Beck JM, 2008, NEURON, V60, P1142, DOI 10.1016/j.neuron.2008.09.021; Benucci A, 2009, NAT NEUROSCI, V12, P1317, DOI 10.1038/nn.2398; BEVERLEY KI, 1975, J PHYSIOL-LONDON, V249, P387, DOI 10.1113/jphysiol.1975.sp011021; BRADLEY A, 1987, J NEUROPHYSIOL, V57, P755, DOI 10.1152/jn.1987.57.3.755; Braitenberg V, 1998, CORTEX STAT GEOMETRY; Britten KH, 1996, VISUAL NEUROSCI, V13, P87, DOI 10.1017/S095252380000715X; Butts DA, 2006, PLOS BIOL, V4, P639, DOI 10.1371/journal.pbio.0040092; Carandini M, 1997, J NEUROSCI, V17, P8621; Dayan P, 2001, COMPUTATIONAL NEUROS; Deneve S, 1999, NAT NEUROSCI, V2, P740, DOI 10.1038/11205; Ecker AS, 2010, SCIENCE, V327, P584, DOI 10.1126/science.1179867; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; FOLDIAK P, 1993, COMPUTATION AND NEURAL SYSTEMS, P55; Geisler WS, 1997, VISUAL NEUROSCI, V14, P897, DOI 10.1017/S0952523800011627; GEORGOPOULOS AP, 1986, SCIENCE, V233, P1416, DOI 10.1126/science.3749885; Gutnisky DA, 2008, NATURE, V452, P220, DOI 10.1038/nature06563; Jaynes E.T., 2003, PROBABILITY THEORY L; Jazayeri M, 2006, NAT NEUROSCI, V9, P690, DOI 10.1038/nn1691; Jazayeri M, 2007, NATURE, V446, P912, DOI 10.1038/nature05739; Law CT, 2008, NAT NEUROSCI, V11, P505, DOI 10.1038/nn2070; Ma WJ, 2006, NAT NEUROSCI, V9, P1432, DOI 10.1038/nn1790; Montani F, 2007, J NEUROSCI, V27, P2338, DOI 10.1523/JNEUROSCI.3417-06.2007; NEWSOME WT, 1989, NATURE, V341, P52, DOI 10.1038/341052a0; Nirenberg S, 2001, NATURE, V411, P698, DOI 10.1038/35079612; Oram MW, 1998, TRENDS NEUROSCI, V21, P259, DOI 10.1016/S0166-2236(97)01216-2; Pillow JW, 2008, NATURE, V454, P995, DOI 10.1038/nature07140; Pouget A, 2003, ANNU REV NEUROSCI, V26, P381, DOI 10.1146/annurev.neuro.26.041002.131112; Romo R, 2003, NEURON, V38, P649, DOI 10.1016/S0896-6273(03)00287-3; Salinas E, 1994, J Comput Neurosci, V1, P89, DOI 10.1007/BF00962720; Sanger TD, 1996, J NEUROPHYSIOL, V76, P2790, DOI 10.1152/jn.1996.76.4.2790; Schmolesky MT, 1998, J NEUROPHYSIOL, V79, P3272, DOI 10.1152/jn.1998.79.6.3272; Scholkopf B., 2002, LEARNING KERNELS; Series P, 2004, NAT NEUROSCI, V7, P1129, DOI 10.1038/nn1321; SEUNG HS, 1993, P NATL ACAD SCI USA, V90, P10749, DOI 10.1073/pnas.90.22.10749; Shadlen MN, 1996, J NEUROSCI, V16, pU5; Shamir M, 2006, NEURAL COMPUT, V18, P1951, DOI 10.1162/neco.2006.18.8.1951; Simoncelli E. P., 2009, COGNITIVE NEUROSCIEN; Smith MA, 2008, J NEUROSCI, V28, P12591, DOI 10.1523/JNEUROSCI.2929-08.2008; Tassinari H, 2006, J NEUROSCI, V26, P10154, DOI 10.1523/JNEUROSCI.2779-06.2006; TOLHURST DJ, 1983, VISION RES, V23, P775, DOI 10.1016/0042-6989(83)90200-6; Vapnik V.N., 1995, NATURE STAT LEARNING; VOGELS R, 1990, J NEUROSCI, V10, P3543; Wu S, 2001, NEURAL COMPUT, V13, P775, DOI 10.1162/089976601300014349; Yang T, 2007, NATURE, V447, P1075, DOI 10.1038/nature05852; Zhang KC, 1998, J NEUROPHYSIOL, V79, P1017, DOI 10.1152/jn.1998.79.2.1017; ZOHARY E, 1994, NATURE, V370, P140, DOI 10.1038/370140a0	50	166	168	1	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2011	14	2					239	U332		10.1038/nn.2733	http://dx.doi.org/10.1038/nn.2733			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	711MJ	21217762	Green Accepted			2022-12-28	WOS:000286595400022
J	Boulanger, A; Clouet-Redt, C; Farge, M; Flandre, A; Guignard, T; Fernando, C; Juge, F; Dura, JM				Boulanger, Ana; Clouet-Redt, Christelle; Farge, Morgane; Flandre, Adrien; Guignard, Thomas; Fernando, Celine; Juge, Francois; Dura, Jean-Maurice			ftz-f1 and Hr39 opposing roles on EcR expression during Drosophila mushroom body neuron remodeling	NATURE NEUROSCIENCE			English	Article							NUCLEAR RECEPTORS; ECDYSONE RECEPTOR; BINDING PROTEIN; TIME-LAPSE; GENE; METAMORPHOSIS; ELEMENT; TRANSCRIPTION; DEGENERATION; REQUIREMENT	Developmental axon pruning is a general mechanism that is required for maturation of neural circuits. During Drosophila metamorphosis, the larval-specific dendrites and axons of early gamma neurons of the mushroom bodies are pruned and replaced by adult-specific processes. We found that the nuclear receptor ftz-f1 is required for this pruning, activates expression of the steroid hormone receptor EcR-B1, whose activity is essential for gamma remodeling, and represses expression of Hr39, an ftz-f1 homologous gene. If inappropriately expressed in the gamma neurons, HR39 inhibits normal pruning, probably by competing with endogenous FTZ-F1, which results in decreased EcR-B1 expression. EcR-B1 was previously identified as a target of the TGF beta signaling pathway. We found that the ftz-f1 and Hr39 pathway apparently acts independently of TGF beta signaling, suggesting that EcR-B1 is the target of two parallel molecular pathways that act during gamma neuron remodeling.	[Boulanger, Ana; Clouet-Redt, Christelle; Farge, Morgane; Flandre, Adrien; Guignard, Thomas; Dura, Jean-Maurice] Inst Human Genet, CNRS, UPR1142, Montpellier, France; [Fernando, Celine; Juge, Francois] Inst Genet Mol Montpellier, CNRS, UMR 5535, Montpellier, France; [Fernando, Celine; Juge, Francois] Univ Montpellier 2, Montpellier, France; [Fernando, Celine; Juge, Francois] Univ Montpellier I, Montpellier, France	Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Universite de Montpellier; Universite de Montpellier	Dura, JM (corresponding author), Inst Human Genet, CNRS, UPR1142, Montpellier, France.	jmdura@igh.cnrs.fr	Juge, François/P-2371-2017	Juge, Francois/0000-0001-5015-2019	CNRS; Fondation pour la Recherche Medicale; EEC; Association pour la Recherche sur le Cancer [3744]; Association Francaise contre les Myopathies [MNM1 2007]; Agence Nationale de la Recherche [ANR-07-NEURO-034-01]; Association Francaise contre les Myopathies Agence Nationale de la Recherche; Region Languedoc-Roussillon; Association pour la Recherche sur le Cancer	CNRS(Centre National de la Recherche Scientifique (CNRS)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); EEC; Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); Agence Nationale de la Recherche(French National Research Agency (ANR)); Association Francaise contre les Myopathies Agence Nationale de la Recherche(French National Research Agency (ANR)); Region Languedoc-Roussillon(Region OccitanieRegion Ile-de-France); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council)	We are particularly grateful to L. Fradkin for helpful discussions and comments on the manuscript. We thank L. Luo and T. Lee for babo, usp and several MARCM stocks; H. Ueda for the ftz-f1<SUP>ex7</SUP>FRT2A stock, the pUAST-beta ftz-f1 vector and the antibody to FTZ-F1; C. Woodard for the ftz-f1<SUP>19</SUP> stock; L. Pick for the UAS-alpha ftz-f1 stock and the GST-FTZ-F1 expression vector; C. Thummel for the antibody to ECR-B1 (ascite fluid); B. Dickson for the antibody to TRIO; M. O'Connor for the UAS-babo-act (1B3 strong) and the UAS-babo Delta I (2 transgenes 5A2-8A2) stocks and unpublished data pertaining to antibody to BABO and to babo transcripts and K. Matthews and K. Cook at the Bloomington Drosophila Stock Center. We also thank N. Lautredou at the Centre Regional d'Imagerie Cellulaire and J. Cau at the "Plateau d'Imagerie Cellulaire" for help with confocal imaging and P. Atger and C. Sarrauste de Menthiere at the "service iconographie IGH". Transgenic lines were generated by BestGene. This work was supported by the CNRS, grants from the Fondation pour la Recherche Medicale, the EEC Marie Curie 5th framework, the Association pour la Recherche sur le Cancer (n<SUP>o</SUP> 3744), the Association Francaise contre les Myopathies (MNM1 2007) and the Agence Nationale de la Recherche (ANR-07-NEURO-034-01). A.B. was supported by a postdoctoral fellowship from Fondation pour la Recherche Medicale, EEC Marie Curie 5th framework, from Association Francaise contre les Myopathies Agence Nationale de la Recherche. C.C.-R. was supported by a joint Ph.D. grant from the CNRS and Region Languedoc-Roussillon and then by a predoctoral Association pour la Recherche sur le Cancer fellowship.	Allen AK, 2008, DEVELOPMENT, V135, P311, DOI 10.1242/dev.015156; Awasaki T, 2006, NEURON, V50, P855, DOI 10.1016/j.neuron.2006.04.027; Awasaki T, 2000, NEURON, V26, P119, DOI 10.1016/S0896-6273(00)81143-5; AYER S, 1993, NUCLEIC ACIDS RES, V21, P1619, DOI 10.1093/nar/21.7.1619; Bellen HJ, 2004, GENETICS, V167, P761, DOI 10.1534/genetics.104.026427; Brown HLD, 2006, DEVELOPMENT, V133, P275, DOI 10.1242/dev.02191; Crispi S, 1998, J MOL BIOL, V275, P561, DOI 10.1006/jmbi.1997.1473; Davis RL, 2005, ANNU REV NEUROSCI, V28, P275, DOI 10.1146/annurev.neuro.28.061604.135651; ENGELS WR, 1990, CELL, V62, P515, DOI 10.1016/0092-8674(90)90016-8; GONZYTREBOUL G, 1995, GENE DEV, V9, P1137, DOI 10.1101/gad.9.9.1137; Guichet A, 1997, NATURE, V385, P548, DOI 10.1038/385548a0; Hoopfer ED, 2008, J NEUROSCI, V28, P6092, DOI 10.1523/JNEUROSCI.0677-08.2008; Horner M., 1997, DROS INF SERV, V80, P35; HORNER MA, 1995, DEV BIOL, V168, P490, DOI 10.1006/dbio.1995.1097; Ito K, 1997, DEVELOPMENT, V124, P761; King-Jones K, 2005, NAT REV GENET, V6, P311, DOI 10.1038/nrg1581; Lam G, 2000, CURR BIOL, V10, P957, DOI 10.1016/S0960-9822(00)00631-X; LAVORGNA G, 1993, P NATL ACAD SCI USA, V90, P3004, DOI 10.1073/pnas.90.7.3004; Lee T, 1999, DEVELOPMENT, V126, P4065; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Lee T, 2000, NEURON, V28, P807, DOI 10.1016/S0896-6273(00)00155-0; Luo LQ, 2005, ANNU REV NEUROSCI, V28, P127, DOI 10.1146/annurev.neuro.28.061604.135632; Mehren JE, 2004, CURR OPIN NEUROBIOL, V14, P745, DOI 10.1016/j.conb.2004.10.012; Murata T, 1996, MOL CELL BIOL, V16, P6509; Nicolai M, 2003, J NEUROBIOL, V57, P291, DOI 10.1002/neu.10277; OHNO CK, 1994, MOL CELL BIOL, V14, P3166, DOI 10.1128/MCB.14.5.3166; ROBERTSON HM, 1988, GENETICS, V118, P461; Schuldiner O, 2008, DEV CELL, V14, P227, DOI 10.1016/j.devcel.2007.11.001; Sullivan AA, 2003, MOL ENDOCRINOL, V17, P2125, DOI 10.1210/me.2002-0430; TALBOT WS, 1993, CELL, V73, P1323, DOI 10.1016/0092-8674(93)90359-X; Thummel CS, 2001, DEV CELL, V1, P453, DOI 10.1016/S1534-5807(01)00060-0; UEDA H, 1991, NUCLEIC ACIDS RES, V19, P3689, DOI 10.1093/nar/19.13.3689; UEDA H, 1990, GENE DEV, V4, P624, DOI 10.1101/gad.4.4.624; Wang J, 2002, NEURON, V33, P559, DOI 10.1016/S0896-6273(02)00570-6; Watts RJ, 2003, NEURON, V38, P871, DOI 10.1016/S0896-6273(03)00295-2; Watts RJ, 2004, CURR BIOL, V14, P678, DOI 10.1016/j.cub.2004.03.035; Williams DW, 2005, J NEUROBIOL, V64, P24, DOI 10.1002/neu.20151; Williams DW, 2005, DEVELOPMENT, V132, P3631, DOI 10.1242/dev.01928; Yamada M, 2000, DEVELOPMENT, V127, P5083; YANG MY, 1995, NEURON, V15, P45; Zheng XY, 2003, CELL, V112, P303, DOI 10.1016/S0092-8674(03)00072-2	41	53	55	1	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2011	14	1					37	U57		10.1038/nn.2700	http://dx.doi.org/10.1038/nn.2700			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	699TE	21131955				2022-12-28	WOS:000285684900012
J	Ciarleglio, CM; Axley, JC; Strauss, BR; Gamble, KL; McMahon, DG				Ciarleglio, Christopher M.; Axley, John C.; Strauss, Benjamin R.; Gamble, Karen L.; McMahon, Douglas G.			Perinatal photoperiod imprints the circadian clock	NATURE NEUROSCIENCE			English	Article							MOUSE SUPRACHIASMATIC NUCLEUS; LIGHT; PACEMAKER; RESPONSES; BEHAVIOR; PERIOD	Using real-time gene expression imaging and behavioral analysis, we found that the perinatal photoperiod has lasting effects on the circadian rhythms expressed by clock neurons as well as on mouse behavior, and sets the responsiveness of the biological clock to subsequent changes in photoperiod. These developmental gene x environment interactions tune circadian clock responses to subsequent seasonal photoperiods and may contribute to the influence of season on neurobehavioral disorders in humans.	[Ciarleglio, Christopher M.; McMahon, Douglas G.] Vanderbilt Univ, Neurosci Grad Program, Nashville, TN 37203 USA; [Ciarleglio, Christopher M.; Axley, John C.; Strauss, Benjamin R.; Gamble, Karen L.; McMahon, Douglas G.] Vanderbilt Univ, Dept Biol Sci, Nashville, TN USA	Vanderbilt University; Vanderbilt University	McMahon, DG (corresponding author), Vanderbilt Univ, Neurosci Grad Program, Nashville, TN 37203 USA.	douglas.g.mcmahon@vanderbilt.edu	Gamble, Karen/A-1753-2010; Ciarleglio, Christopher M/D-8463-2013	Ciarleglio, Christopher M/0000-0002-8490-8715; Gamble, Karen/0000-0003-3813-8577; Axley, John/0000-0002-4207-7984	US National Institutes of Health [P50 MH078028, T32 MH64913, F31 MH080547]; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH078028, T32MH065215, T32MH064913, F31MH080547] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The authors would like to thank J.Y. Cohen for kindly providing custom software programming. This work was supported by US National Institutes of Health grants P50 MH078028 (D.G.M.), T32 MH64913 and F31 MH080547 (C.M.C.).	BARRETT RK, 1989, J COMP PHYSIOL A, V165, P41, DOI 10.1007/BF00613798; Ciarleglio CM, 2009, J NEUROSCI, V29, P1670, DOI 10.1523/JNEUROSCI.3801-08.2009; Dulcis D, 2008, NATURE, V456, P195, DOI 10.1038/nature07569; Foster RG, 2008, CURR BIOL, V18, pR784, DOI 10.1016/j.cub.2008.07.003; Inagaki N, 2007, P NATL ACAD SCI USA, V104, P7664, DOI 10.1073/pnas.0607713104; Ishida Y, 2001, J NEUROSCI RES, V64, P612, DOI 10.1002/jnr.1114; LEVAY S, 1980, J COMP NEUROL, V191, P1, DOI 10.1002/cne.901910102; Meng QJ, 2008, NEURON, V58, P78, DOI 10.1016/j.neuron.2008.01.019; Naito E, 2008, J BIOL RHYTHM, V23, P140, DOI 10.1177/0748730408314572; Ohta H, 2006, PEDIATR RES, V60, P304, DOI 10.1203/01.pdr.0000233114.18403.66; Pyter LM, 2006, BEHAV NEUROSCI, V120, P125, DOI 10.1037/0735-7044.120.1.125; VanderLeest HT, 2007, CURR BIOL, V17, P468, DOI 10.1016/j.cub.2007.01.048; Wehr TA, 2001, ARCH GEN PSYCHIAT, V58, P1108, DOI 10.1001/archpsyc.58.12.1108; WIESEL TN, 1963, J NEUROPHYSIOL, V26, P1003, DOI 10.1152/jn.1963.26.6.1003; WIESEL TN, 1963, J NEUROPHYSIOL, V26, P978, DOI 10.1152/jn.1963.26.6.978	15	108	109	0	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2011	14	1					25	27		10.1038/nn.2699	http://dx.doi.org/10.1038/nn.2699			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	699TE	21131951	Green Accepted			2022-12-28	WOS:000285684900009
J	Chittajallu, R; Isaac, JTR				Chittajallu, Ramesh; Isaac, John T. R.			Emergence of cortical inhibition by coordinated sensory-driven plasticity at distinct synaptic loci	NATURE NEUROSCIENCE			English	Article							RAT BARREL CORTEX; THALAMOCORTICAL FEEDFORWARD INHIBITION; EXCITATORY NEURONAL NETWORK; FAST-SPIKING INTERNEURONS; RECEPTOR SUBUNIT NR3A; SPINY STELLATE CELLS; NMDA RECEPTORS; LAYER-IV; SOMATOSENSORY CORTEX; REGIONAL EXPRESSION	Feedforward GABAergic inhibition sets the dendritic integration window, thereby controlling timing and output in cortical circuits. However, the manner in which feedforward inhibitory circuits emerge is unclear, despite this being a critical step for neocortical development and function. We found that sensory experience drove plasticity of the feedforward inhibitory circuit in mouse layer 4 somatosensory barrel cortex in the second postnatal week via two distinct mechanisms. First, sensory experience selectively strengthened thalamocortical-to-feedforward interneuron inputs via a presynaptic mechanism but did not regulate other inhibitory circuit components. Second, experience drove a postsynaptic mechanism in which a downregulation of a prominent thalamocortical NMDA excitatory postsynaptic potential in stellate cells regulated the final expression of functional feedforward inhibitory input. Thus, experience is required for specific, coordinated changes at thalamocortical synapses onto both inhibitory and excitatory neurons, producing a circuit plasticity that results in maturation of functional feedforward inhibition in layer 4.	[Chittajallu, Ramesh; Isaac, John T. R.] NINDS, Dev Synapt Plast Sect, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Chittajallu, R (corresponding author), NINDS, Dev Synapt Plast Sect, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA.	chittajallur@ninds.nih.gov; isaacj@ninds.nih.gov	Chittajallu, Ramesh/AAX-3749-2020	Chittajallu, Ramesh/0000-0002-9794-0052	National Institute of Neurological Disorders and Stroke	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank C. McBain for discussions and Y. Yanagawa (Gunma University) for providing GAD67-GFP knockin mouse. This work was supported by the National Institute of Neurological Disorders and Stroke Intramural Program.	Al-Hallaq RA, 2002, MOL PHARMACOL, V62, P1119, DOI 10.1124/mol.62.5.1119; Allen CB, 2003, NAT NEUROSCI, V6, P291, DOI 10.1038/nn1012; Bellone C, 2007, NEURON, V55, P779, DOI 10.1016/j.neuron.2007.07.035; Binshtok AM, 2006, J NEUROSCI, V26, P708, DOI 10.1523/JNEUROSCI.4409-05.2006; Bruno RM, 2006, SCIENCE, V312, P1622, DOI 10.1126/science.1124593; Bureau I, 2006, PLOS BIOL, V4, P2361, DOI 10.1371/journal.pbio.0040382; Cruikshank SJ, 2007, NAT NEUROSCI, V10, P462, DOI 10.1038/nn1861; Das S, 1998, NATURE, V393, P377, DOI 10.1038/30748; Daw MI, 2007, NAT NEUROSCI, V10, P453, DOI 10.1038/nn1866; Espinosa F, 2009, J NEUROPHYSIOL, V101, P2290, DOI 10.1152/jn.90754.2008; Feldmeyer D, 1999, J PHYSIOL-LONDON, V521, P169, DOI 10.1111/j.1469-7793.1999.00169.x; Foeller E, 2004, CURR OPIN NEUROBIOL, V14, P89, DOI 10.1016/j.conb.2004.01.011; FOX K, 1992, J NEUROSCI, V12, P1826; Fox K, 2002, NEUROSCIENCE, V111, P799, DOI 10.1016/S0306-4522(02)00027-1; Franks KM, 2005, NEURON, V47, P101, DOI 10.1016/j.neuron.2005.05.024; Gabernet L, 2005, NEURON, V48, P315, DOI 10.1016/j.neuron.2005.09.022; Hardingham N, 2008, NEURON, V60, P861, DOI 10.1016/j.neuron.2008.10.018; Heynen AJ, 2003, NAT NEUROSCI, V6, P854, DOI 10.1038/nn1100; Hull C, 2009, J NEUROSCI, V29, P9127, DOI 10.1523/JNEUROSCI.5971-08.2009; Kremkow J, 2010, J COMPUT NEUROSCI, V28, P579, DOI 10.1007/s10827-010-0240-9; Kullmann DM, 2007, NAT REV NEUROSCI, V8, P687, DOI 10.1038/nrn2207; Lee SH, 2007, J NEUROPHYSIOL, V97, P4380, DOI 10.1152/jn.01217.2006; Lefort S, 2009, NEURON, V61, P301, DOI 10.1016/j.neuron.2008.12.020; Maffei A, 2006, NATURE, V443, P81, DOI 10.1038/nature05079; Mierau SB, 2004, P NATL ACAD SCI USA, V101, P15518, DOI 10.1073/pnas.0402916101; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; Morishita W, 2005, NAT NEUROSCI, V8, P1043, DOI 10.1038/nn1506; Oren I, 2009, J NEUROSCI, V29, P939, DOI 10.1523/JNEUROSCI.3251-08.2009; Petersen CCH, 2000, J NEUROSCI, V20, P7579; Petreanu L, 2009, NATURE, V457, P1142, DOI 10.1038/nature07709; Philpot BD, 2001, NEURON, V29, P157, DOI 10.1016/S0896-6273(01)00187-8; Porter JT, 2001, J NEUROSCI, V21, P2699, DOI 10.1523/JNEUROSCI.21-08-02699.2001; Shoykhet M, 2005, J NEUROPHYSIOL, V94, P3987, DOI 10.1152/jn.00569.2005; SIMONS DJ, 1987, NATURE, V326, P694, DOI 10.1038/326694a0; Stern EA, 2001, NEURON, V31, P305, DOI 10.1016/S0896-6273(01)00360-9; Sun QQ, 2009, J NEUROPHYSIOL, V102, P2955, DOI 10.1152/jn.00562.2009; Sun QQ, 2006, J NEUROSCI, V26, P1219, DOI 10.1523/JNEUROSCI.4727-04.2006; Swadlow HA, 2002, PHILOS T R SOC B, V357, P1717, DOI 10.1098/rstb.2002.1156; Wang HP, 2010, SCIENCE, V328, P106, DOI 10.1126/science.1183108; Wong HK, 2002, J COMP NEUROL, V450, P303, DOI 10.1002/cne.10314; WOOLSEY TA, 1970, BRAIN RES, V17, P205, DOI 10.1016/0006-8993(70)90079-X; Yoon BJ, 2009, P NATL ACAD SCI USA, V106, P9860, DOI 10.1073/pnas.0901305106	42	64	64	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2010	13	10					1240	1248		10.1038/nn.2639	http://dx.doi.org/10.1038/nn.2639			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	654MB	20871602	Green Accepted			2022-12-28	WOS:000282171300016
J	Liu, C; Maejima, T; Wyler, SC; Casadesus, G; Herlitze, S; Deneris, ES				Liu, Chen; Maejima, Takashi; Wyler, Steven C.; Casadesus, Gemma; Herlitze, Stefan; Deneris, Evan S.			Pet-1 is required across different stages of life to regulate serotonergic function	NATURE NEUROSCIENCE			English	Article							TRANSPORTER MESSENGER-RNA; NORMAL ANXIETY-LIKE; NEURON DEVELOPMENT; RAPHE NEURONS; BEHAVIOR; STRESS; RAT; VULNERABILITY; PROJECTIONS; ACTIVATION	Transcriptional cascades are required for the specification of serotonin (5-HT) neurons and behaviors modulated by 5-HT. Several cascade factors are expressed throughout the lifespan, which suggests that their control of behavior might not be temporally restricted to programming normal numbers of 5-HT neurons. We used new mouse conditional targeting approaches to investigate the ongoing requirements for Pet-1 (also called Fev), a cascade factor that is required for the initiation of 5-HT synthesis, but whose expression persists into adulthood. We found that Pet-1 was required after the generation of 5-HT neurons for multiple steps in 5-HT neuron maturation, including axonal innervation of the somatosensory cortex, expression of appropriate firing properties, and the expression of the Htr1a and Htr1b autoreceptors. Pet-1 was still required in adult 5-HT neurons to preserve normal anxiety-related behaviors through direct autoregulated control of serotonergic gene expression. These findings indicate that Pet-1 is required across the lifespan of the mouse and that behavioral pathogenesis can result from both developmental and adult-onset alterations in serotonergic transcription.	[Liu, Chen; Maejima, Takashi; Wyler, Steven C.; Casadesus, Gemma; Herlitze, Stefan; Deneris, Evan S.] Case Western Reserve Univ, Sch Med, Dept Neurosci, Cleveland, OH 44106 USA	Case Western Reserve University	Deneris, ES (corresponding author), Case Western Reserve Univ, Sch Med, Dept Neurosci, Cleveland, OH 44106 USA.	esd@case.edu		Casadesus, Gemma/0000-0002-5206-5637; Liu, Chen/0000-0002-5922-0951	US National Institutes of Health [MH062723, MH078028]; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH078028, R01MH062723] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank L. Landmesser for suggestions on retrograde tracing; S. Dymecki and P. Chambon for CreER<SUP>T2</SUP> plasmids; Q. Ma for the mycPet-1 vector; J. Zhu for the Gata3<SUP>loxP/loxP</SUP> mice; K. Lobur for assistance with genotyping of mice; J. Reeves for behavioral testing in the Case Rodent Behavior Core; and L. Landmesser, S. Maricich and J. Silver for comments on the manuscript. This work was supported by grants MH062723 and MH078028 to E.S.D. (US National Institutes of Health).	Ansorge MS, 2007, CURR OPIN PHARMACOL, V7, P8, DOI 10.1016/j.coph.2006.11.006; Ansorge MS, 2004, SCIENCE, V306, P879, DOI 10.1126/science.1101678; Bayliss DA, 1997, J NEUROPHYSIOL, V77, P1349, DOI 10.1152/jn.1997.77.3.1349; Bonnin A, 2006, NEUROSCIENCE, V141, P781, DOI 10.1016/j.neuroscience.2006.04.036; Bonnin A, 2007, NAT NEUROSCI, V10, P588, DOI 10.1038/nn1896; Cordes SP, 2005, CLIN GENET, V68, P487, DOI 10.1111/j.1399-0004.2005.00534.x; Craven SE, 2004, DEVELOPMENT, V131, P1165, DOI 10.1242/dev.01024; Dai JX, 2008, P NATL ACAD SCI USA, V105, P11981, DOI 10.1073/pnas.0801329105; Feil R, 1997, BIOCHEM BIOPH RES CO, V237, P752, DOI 10.1006/bbrc.1997.7124; Flames N, 2009, NATURE, V458, P885, DOI 10.1038/nature07929; FORNAL CA, 1994, J PHARMACOL EXP THER, V270, P1345; Gardner KL, 2009, BRAIN RES, V1305, P47, DOI 10.1016/j.brainres.2009.09.065; Gross C, 2002, NATURE, V416, P396, DOI 10.1038/416396a; Gutknecht L, 2008, J NEURAL TRANSM, V115, P1127, DOI 10.1007/s00702-008-0096-6; Heisler LK, 1998, P NATL ACAD SCI USA, V95, P15049, DOI 10.1073/pnas.95.25.15049; Hendricks T, 1999, J NEUROSCI, V19, P10348; Hendricks TJ, 2003, NEURON, V37, P233, DOI 10.1016/S0896-6273(02)01167-4; Hobert O, 2008, P NATL ACAD SCI USA, V105, P20067, DOI 10.1073/pnas.0806070105; Holmes A, 2008, NEUROSCI BIOBEHAV R, V32, P1293, DOI 10.1016/j.neubiorev.2008.03.006; Jacob J, 2007, NAT NEUROSCI, V10, P1433, DOI 10.1038/nn1985; Jans LAW, 2007, MOL PSYCHIATR, V12, P522, DOI 10.1038/sj.mp.4001920; Janusonis S, 2004, J NEUROSCI, V24, P1652, DOI 10.1523/JNEUROSCI.4651-03.2004; Krueger KC, 2008, J NEUROSCI, V28, P12748, DOI 10.1523/JNEUROSCI.4349-08.2008; Le Francois B, 2008, NEUROPHARMACOLOGY, V55, P977, DOI 10.1016/j.neuropharm.2008.06.046; Lerch-Haner JK, 2008, NAT NEUROSCI, V11, P1001, DOI 10.1038/nn.2176; LIDOV HGW, 1982, BRAIN RES BULL, V8, P389, DOI 10.1016/0361-9230(82)90077-6; Ludwig V, 2007, J NEUROSCI METH, V162, P108, DOI 10.1016/j.jneumeth.2006.12.011; Maciag D, 2006, NEUROPSYCHOPHARMACOL, V31, P47, DOI 10.1038/sj.npp.1300823; Pattyn A, 2003, GENE DEV, V17, P729, DOI 10.1101/gad.255803; Pum ME, 2009, BEHAV NEUROSCI, V123, P449, DOI 10.1037/a0014478; Ramboz S, 1998, P NATL ACAD SCI USA, V95, P14476, DOI 10.1073/pnas.95.24.14476; Richardson-Jones JW, 2010, NEURON, V65, P40, DOI 10.1016/j.neuron.2009.12.003; Rivera HM, 2009, BRAIN RES, V1259, P51, DOI 10.1016/j.brainres.2008.12.067; Salichon N, 2001, J NEUROSCI, V21, P884, DOI 10.1523/JNEUROSCI.21-03-00884.2001; Sari Y, 2004, NEUROSCI BIOBEHAV R, V28, P565, DOI 10.1016/j.neubiorev.2004.08.008; Scott MM, 2005, P NATL ACAD SCI USA, V102, P16472, DOI 10.1073/pnas.0504510102; Scott MM, 2005, INT J DEV NEUROSCI, V23, P277, DOI 10.1016/j.ijdevneu.2004.05.012; Scott MM, 2005, J NEUROSCI, V25, P2628, DOI 10.1523/JNEUROSCI.4979-04.2005; Shishkina GT, 2007, NEUROSCIENCE, V150, P404, DOI 10.1016/j.neuroscience.2007.09.017; Sommer W, 2001, NEUROPSYCHOPHARMACOL, V24, P430, DOI 10.1016/S0893-133X(00)00210-4; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Varga V, 2009, SCIENCE, V326, P449, DOI 10.1126/science.1178307; Vertes RP, 1999, J COMP NEUROL, V407, P555; Vitalis T, 2007, EUR J NEUROSCI, V26, P331, DOI 10.1111/j.1460-9568.2007.05661.x; Vogt MA, 2008, EXP NEUROL, V211, P25, DOI 10.1016/j.expneurol.2007.12.012; Zhao ZQ, 2006, J NEUROSCI, V26, P12781, DOI 10.1523/JNEUROSCI.4143-06.2006; Zhu JF, 2004, NAT IMMUNOL, V5, P1157, DOI 10.1038/ni1128	47	129	130	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2010	13	10					1190	1198		10.1038/nn.2623	http://dx.doi.org/10.1038/nn.2623			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	654MB	20818386	Green Accepted, Green Submitted			2022-12-28	WOS:000282171300010
J	Placais, PY; Trannoy, S; Isabel, G; Aso, Y; Siwanowicz, I; Belliart-Guerin, G; Vernier, P; Birman, S; Tanimoto, H; Preat, T				Placais, Pierre-Yves; Trannoy, Severine; Isabel, Guillaume; Aso, Yoshinori; Siwanowicz, Igor; Belliart-Guerin, Ghislain; Vernier, Philippe; Birman, Serge; Tanimoto, Hiromu; Preat, Thomas			Slow oscillations in two pairs of dopaminergic neurons gate long-term memory formation in Drosophila	NATURE NEUROSCIENCE			English	Article							ANESTHESIA-RESISTANT MEMORY; VENTRAL TEGMENTAL AREA; MUSHROOM BODY; CONSOLIDATED MEMORY; OLFACTORY MEMORY; EXPRESSION; PERSISTENCE; MODULATION; RETENTION; DYNAMICS	A fundamental duty of any efficient memory system is to prevent long-lasting storage of poorly relevant information. However, little is known about dedicated mechanisms that appropriately trigger production of long-term memory (LTM). We examined the role of Drosophila dopaminergic neurons in the control of LTM formation and found that they act as a switch between two exclusive consolidation pathways leading to LTM or anesthesia-resistant memory (ARM). Blockade, after aversive olfactory conditioning, of three pairs of dopaminergic neurons projecting on mushroom bodies, the olfactory memory center, enhanced ARM, whereas their overactivation conversely impaired ARM. Notably, blockade of these neurons during the intertrial intervals of a spaced training precluded LTM formation. Two pairs of these dopaminergic neurons displayed sustained calcium oscillations in naive flies. Oscillations were weakened by ARM-inducing massed training and were enhanced during LTM formation. Our results indicate that oscillations of two pairs of dopaminergic neurons control ARM levels and gate LTM.	[Placais, Pierre-Yves; Trannoy, Severine; Isabel, Guillaume; Belliart-Guerin, Ghislain; Preat, Thomas] ESPCI, CNRS, Genes & Dynam Memory Syst, Neurobiol Unit, F-75005 Paris, France; [Aso, Yoshinori; Siwanowicz, Igor; Tanimoto, Hiromu] Max Planck Inst Neurobiol, Martinsried, Germany; [Vernier, Philippe] CNRS, Inst Neurobiol Alfred Fessard, Plasticite Syst Nerveux, Gif Sur Yvette, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Superieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI); Max Planck Society; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Preat, T (corresponding author), ESPCI, CNRS, Genes & Dynam Memory Syst, Neurobiol Unit, F-75005 Paris, France.	thomas.preat@espci.fr	Trannoy, Severine/D-1530-2015; Aso, Yoshinori/ACJ-9439-2022; Tanimoto, Hiromu/J-6810-2016	Trannoy, Severine/0000-0002-5059-9846; Preat, Thomas/0000-0001-9976-1763	Agence Nationale pour la Recherche; Fondation pour la Recherche Medicale; Fondation Bettencourt-Schueller; Deutsche Forschungsgemeinschaft; Bundesministerium fur Bildung und Forschung; Max-Planck-Gesellschaft; Region Ile-de-France; Deutscher Akademischer Austausch Dienst	Agence Nationale pour la Recherche(French National Research Agency (ANR)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Fondation Bettencourt-Schueller; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Max-Planck-Gesellschaft(Max Planck Society); Region Ile-de-France(Region Ile-de-France); Deutscher Akademischer Austausch Dienst(Deutscher Akademischer Austausch Dienst (DAAD))	We thank A. Pascual (Instituto de Biomedicina de Sevilla) and members of the Genes and Dynamics of Memory Systems group for critical reading of the manuscript. This work was supported by grants from the Agence Nationale pour la Recherche (T.P.), the Fondation pour la Recherche Medicale (T.P.), the Fondation Bettencourt-Schueller (T.P.), the Emmy-Noether Program from Deutsche Forschungsgemeinschaft (H.T.), the Bernstein focus Learning from Bundesministerium fur Bildung und Forschung (H.T) and the Max-Planck-Gesellschaft (H.T.). P.-Y.P. was supported by a grant from Region Ile-de-France, G.I. and S.T. by the Fondation pour la Recherche Medicale, and Y.A. by Deutscher Akademischer Austausch Dienst.	Aso Y, 2010, CURR BIOL, V20, P1445, DOI 10.1016/j.cub.2010.06.048; Benchenane K, 2010, NEURON, V66, P921, DOI 10.1016/j.neuron.2010.05.013; Bethus I, 2010, J NEUROSCI, V30, P1610, DOI 10.1523/JNEUROSCI.2721-09.2010; Claridge-Chang A, 2009, CELL, V139, P405, DOI 10.1016/j.cell.2009.08.034; Comas D, 2004, NATURE, V430, P460, DOI 10.1038/nature02726; Didelot G, 2006, SCIENCE, V313, P851, DOI 10.1126/science.1127215; FOLKERS E, 1993, P NATL ACAD SCI USA, V90, P8123, DOI 10.1073/pnas.90.17.8123; Folkers E, 2006, P NATL ACAD SCI USA, V103, P17496, DOI 10.1073/pnas.0608377103; Friggi-Grelin F, 2003, J NEUROBIOL, V54, P618, DOI 10.1002/neu.10185; Gao M, 2007, J NEUROSCI, V27, P5414, DOI 10.1523/JNEUROSCI.5347-06.2007; Gervasi N, 2010, NEURON, V65, P516, DOI 10.1016/j.neuron.2010.01.014; Heisenberg M, 2003, NAT REV NEUROSCI, V4, P266, DOI 10.1038/nrn1074; Horiuchi J, 2008, P NATL ACAD SCI USA, V105, P20976, DOI 10.1073/pnas.0810119105; Isabel G, 2004, SCIENCE, V304, P1024, DOI 10.1126/science.1094932; Keene AC, 2007, NAT REV NEUROSCI, V8, P341, DOI 10.1038/nrn2098; Kitamoto T, 2001, J NEUROBIOL, V47, P81, DOI 10.1002/neu.1018; Krashes MJ, 2009, CELL, V139, P416, DOI 10.1016/j.cell.2009.08.035; Lee PT, 2011, P NATL ACAD SCI USA, V108, P13794, DOI 10.1073/pnas.1019483108; Lyons DJ, 2010, NEURON, V65, P217, DOI 10.1016/j.neuron.2009.12.024; Mao ZM, 2009, FRONT NEURAL CIRCUIT, V3, DOI 10.3389/neuro.04.005.2009; Margulies C, 2005, CURR BIOL, V15, pR700, DOI 10.1016/j.cub.2005.08.024; Mery F, 2005, SCIENCE, V308, P1148, DOI 10.1126/science.1111331; Neumann N, 2010, BEHAV BRAIN RES, V215, P114, DOI 10.1016/j.bbr.2010.07.008; O'Carroll CM, 2006, LEARN MEMORY, V13, P760, DOI 10.1101/lm.321006; Pagani MR, 2009, CELL, V139, P186, DOI 10.1016/j.cell.2009.08.033; Riemensperger T, 2011, P NATL ACAD SCI USA, V108, P834, DOI 10.1073/pnas.1010930108; Rossato JI, 2009, SCIENCE, V325, P1017, DOI 10.1126/science.1172545; Schwaerzel M, 2003, J NEUROSCI, V23, P10495, DOI 10.1523/jneurosci.23-33-10495.2003; Shi WX, 2005, J NEUROPHYSIOL, V94, P3516, DOI 10.1152/jn.00317.2005; Tanaka NK, 2008, J COMP NEUROL, V508, P711, DOI 10.1002/cne.21692; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Tomchik SM, 2009, NEURON, V64, P510, DOI 10.1016/j.neuron.2009.09.029; Treffert DA, 2009, PHILOS T R SOC B, V364, P1351, DOI 10.1098/rstb.2008.0326; TULLY T, 1994, CELL, V79, P35, DOI 10.1016/0092-8674(94)90398-0; TULLY T, 1985, J COMP PHYSIOL A, V157, P263, DOI 10.1007/BF01350033; Waddell S, 2010, TRENDS NEUROSCI, V33, P457, DOI 10.1016/j.tins.2010.07.001; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406; YIN JCP, 1995, CELL, V81, P107, DOI 10.1016/0092-8674(95)90375-5; Zhang S, 2008, BIOCHEM BIOPH RES CO, V370, P82, DOI 10.1016/j.bbrc.2008.03.015	39	104	104	0	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2012	15	4					592	599		10.1038/nn.3055	http://dx.doi.org/10.1038/nn.3055			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	916PA	22366756				2022-12-28	WOS:000302114500019
J	Siegert, S; Cabuy, E; Scherf, BG; Kohler, H; Panda, S; Le, YZ; Fehling, HJ; Gaidatzis, D; Stadler, MB; Roska, B				Siegert, Sandra; Cabuy, Erik; Scherf, Brigitte Gross; Kohler, Hubertus; Panda, Satchidananda; Le, Yun-Zheng; Fehling, Hans Joerg; Gaidatzis, Dimos; Stadler, Michael B.; Roska, Botond			Transcriptional code and disease map for adult retinal cell types	NATURE NEUROSCIENCE			English	Article							MACULAR DEGENERATION; GENE-EXPRESSION; IN-VIVO; DOPAMINERGIC-NEURONS; ALZHEIMERS-DISEASE; HUMAN FIBROBLASTS; COMMON VARIANTS; AMACRINE CELLS; MOUSE; PHOTOTRANSDUCTION	Brain circuits are assembled from a large variety of morphologically and functionally diverse cell types. It is not known how the intermingled cell types of an individual adult brain region differ in their expressed genomes. Here we describe an atlas of cell type transcriptomes in one brain region, the mouse retina. We found that each adult cell type expressed a specific set of genes, including a unique set of transcription factors, forming a 'barcode' for cell identity. Cell type transcriptomes carried enough information to categorize cells into morphological classes and types. Several genes that were specifically expressed in particular retinal circuit elements, such as inhibitory neuron types, are associated with eye diseases. The resource described here allows gene expression to be compared across adult retinal cell types, experimenting with specific transcription factors to differentiate stem or somatic cells to retinal cell types, and predicting cellular targets of newly discovered disease-associated genes.	[Siegert, Sandra; Cabuy, Erik; Scherf, Brigitte Gross; Kohler, Hubertus; Gaidatzis, Dimos; Stadler, Michael B.; Roska, Botond] Friedrich Miescher Inst Biomed Res, Neural Circuit Labs, Basel, Switzerland; [Panda, Satchidananda] Salk Inst Biol Studies, Regulatory Biol Lab, La Jolla, CA 92037 USA; [Le, Yun-Zheng] Univ Oklahoma, Hlth Sci Ctr, Dept Med, Oklahoma City, OK USA; [Le, Yun-Zheng] Univ Oklahoma, Hlth Sci Ctr, Harold Hamm Oklahoma Diabet Ctr, Oklahoma City, OK USA; [Fehling, Hans Joerg] Univ Clin Ulm, Inst Immunol, Ulm, Germany; [Gaidatzis, Dimos; Stadler, Michael B.] Swiss Inst Bioinformat, Basel, Switzerland	Friedrich Miescher Institute for Biomedical Research; Salk Institute; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; Ulm University; Swiss Institute of Bioinformatics	Roska, B (corresponding author), Friedrich Miescher Inst Biomed Res, Neural Circuit Labs, Basel, Switzerland.	botond.roska@fmi.ch	Panda, Satchidananda/J-6891-2012; Siegert, Sandra/GWC-4507-2022; Roska, Botond/AAD-7268-2021	Siegert, Sandra/0000-0001-8635-0877; 	Friedrich Miescher Institute; Alcon award; National Center of Competence in Research; European Research Council; Swiss-Hungarian grant; European Union; NATIONAL EYE INSTITUTE [R01EY020900] Funding Source: NIH RePORTER	Friedrich Miescher Institute; Alcon award; National Center of Competence in Research(Swiss National Science Foundation (SNSF)); European Research Council(European Research Council (ERC)European Commission); Swiss-Hungarian grant; European Union(European Commission); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank S. Djaffer, J. Juttner, J. Hall and Y. Shimada for technical assistance, E. Oakeley for comments on the experimental design, D. Balya for providing help with programming, and K. Farrow, S. Rompani, K. Yonehara, V. Busskamp, S. Oakeley, P. King, A. Matus, S. Arber and F. Rijli for comments on the manuscript. We thank Z. Raics for making the webpage, and L. Kus and S. Gong (Rockefeller University) for help and for BACs from the GENSAT project. We thank I. Provencio (University of Virginia) for providing the melanopsin antibody. The study was supported by Friedrich Miescher Institute funds, Alcon award, a National Center of Competence in Research Genetics grant, a European Research Council grant, a Swiss-Hungarian grant, and RETICIRC, TREATRUSH, SEEBETTER and OPTONEURO grants from the European Union to B.R.	Agathocleous M, 2009, ANNU REV CELL DEV BI, V25, P45, DOI 10.1146/annurev.cellbio.042308.113259; Arendt D, 2003, INT J DEV BIOL, V47, P563; Arlotta P, 2005, NEURON, V45, P207, DOI 10.1016/j.neuron.2004.12.036; Briggman KL, 2011, NATURE, V471, P183, DOI 10.1038/nature09818; Caiazzo M, 2011, NATURE, V476, P224, DOI 10.1038/nature10284; Caputto BL, 2000, NEUROCHEM RES, V25, P153, DOI 10.1023/A:1007508020173; Chen J, 2007, J CLIN INVEST, V117, P2758, DOI 10.1172/JCI33513; Cherry TJ, 2009, P NATL ACAD SCI USA, V106, P9495, DOI 10.1073/pnas.0903264106; Corbo JC, 2007, P NATL ACAD SCI USA, V104, P12069, DOI 10.1073/pnas.0705465104; Dasen JS, 2009, CURR TOP DEV BIOL, V88, P169, DOI 10.1016/S0070-2153(09)88006-X; Doyle JP, 2008, CELL, V135, P749, DOI 10.1016/j.cell.2008.10.029; Eiraku M, 2011, NATURE, V472, P51, DOI 10.1038/nature09941; Geng RS, 2009, HUM MOL GENET, V18, P2748, DOI 10.1093/hmg/ddp210; Gollisch T, 2010, NEURON, V65, P150, DOI 10.1016/j.neuron.2009.12.009; Hardie RC, 2001, J EXP BIOL, V204, P3403; Hollingworth P, 2011, NAT GENET, V43, P429, DOI 10.1038/ng.803; Isoldi MC, 2005, P NATL ACAD SCI USA, V102, P1217, DOI 10.1073/pnas.0409252102; Jeon CJ, 1998, J NEUROSCI, V18, P8936; Kay JN, 2011, NAT NEUROSCI, V14, P965, DOI 10.1038/nn.2859; Kim DS, 2008, J COMP NEUROL, V507, P1795, DOI 10.1002/cne.21639; Kim J, 2011, CELL STEM CELL, V9, P413, DOI 10.1016/j.stem.2011.09.011; Klaver CCW, 1998, AM J HUM GENET, V63, P200, DOI 10.1086/301901; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Koyanagi M, 2005, CURR BIOL, V15, P1065, DOI 10.1016/j.cub.2005.04.063; Lamba DA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008763; Lee EC, 2001, GENOMICS, V73, P56, DOI 10.1006/geno.2000.6451; LEE YJ, 1994, NEURON, V13, P1143, DOI 10.1016/0896-6273(94)90052-3; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Livesey FJ, 2001, NAT REV NEUROSCI, V2, P109, DOI 10.1038/35053522; MacLaren RE, 2006, NATURE, V444, P203, DOI 10.1038/nature05161; Masland RH, 2001, NAT NEUROSCI, V4, P877, DOI 10.1038/nn0901-877; Matsuda T, 2004, P NATL ACAD SCI USA, V101, P16, DOI 10.1073/pnas.2235688100; Morrow EM, 1998, J NEUROSCI, V18, P3738; Naj AC, 2011, NAT GENET, V43, P436, DOI 10.1038/ng.801; Nelson SB, 2006, TRENDS NEUROSCI, V29, P339, DOI 10.1016/j.tins.2006.05.004; Okaty BW, 2011, J NEUROSCI, V31, P6939, DOI 10.1523/JNEUROSCI.0626-11.2011; Okaty BW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016493; Roesch K, 2008, J COMP NEUROL, V509, P225, DOI 10.1002/cne.21730; Sanes JR, 2010, NEURON, V66, P15, DOI 10.1016/j.neuron.2010.01.018; Sekaran S, 2007, J NEUROSCI, V27, P3981, DOI 10.1523/JNEUROSCI.4716-06.2007; Shibuya E, 2008, INVEST OPHTH VIS SCI, V49, P4453, DOI 10.1167/iovs.07-1575; Siegert S, 2009, NAT NEUROSCI, V12, P1197, DOI 10.1038/nn.2370; Son EY, 2011, CELL STEM CELL, V9, P205, DOI 10.1016/j.stem.2011.07.014; Sugino K, 2006, NAT NEUROSCI, V9, P99, DOI 10.1038/nn1618; Tarpey P, 2006, NAT GENET, V38, P1242, DOI 10.1038/ng1893; TERAKITA A, 1993, FEBS LETT, V330, P197, DOI 10.1016/0014-5793(93)80272-V; Tezel G, 2008, PROG BRAIN RES, V173, P409, DOI 10.1016/S0079-6123(08)01128-X; Trimarchi JM, 2007, J COMP NEUROL, V502, P1047, DOI 10.1002/cne.21368; Wassle H, 2004, NAT REV NEUROSCI, V5, P747, DOI 10.1038/nrn1497; Yoshida K, 2001, NEURON, V30, P771, DOI 10.1016/S0896-6273(01)00316-6	50	194	204	0	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2012	15	3					487	U191		10.1038/nn.3032	http://dx.doi.org/10.1038/nn.3032			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	899CY	22267162				2022-12-28	WOS:000300793100024
J	Dann, A; Poeck, H; Croxford, AL; Gaupp, S; Kierdorf, K; Knust, M; Pfeifer, D; Maihoefer, C; Endres, S; Kalinke, U; Meuth, SG; Wiendl, H; Knobeloch, KP; Akira, S; Waisman, A; Hartmann, G; Prinz, M				Dann, Angela; Poeck, Hendrik; Croxford, Andrew L.; Gaupp, Stefanie; Kierdorf, Katrin; Knust, Markus; Pfeifer, Dietmar; Maihoefer, Cornelius; Endres, Stefan; Kalinke, Ulrich; Meuth, Sven G.; Wiendl, Heinz; Knobeloch, Klaus-Peter; Akira, Shizuo; Waisman, Ari; Hartmann, Gunther; Prinz, Marco			Cytosolic RIG-I-like helicases act as negative regulators of sterile inflammation in the CNS	NATURE NEUROSCIENCE			English	Article							CENTRAL-NERVOUS-SYSTEM; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; T-HELPER-CELLS; NF-KAPPA-B; MULTIPLE-SCLEROSIS; PATHOGEN RECOGNITION; ANTIVIRAL RESPONSES; ADAPTER PROTEIN; INTERFERON-BETA; INNATE IMMUNITY	The action of cytosolic RIG-I-like helicases (RLHs) in the CNS during autoimmunity is largely unknown. Using a mouse model of multiple sclerosis, we found that mice lacking the RLH adaptor IPS-1 developed exacerbated disease that was accompanied by markedly higher inflammation, increased axonal damage and elevated demyelination with increased encephalitogenic immune responses. Furthermore, activation of RLH ligands such as 5'-triphosphate RNA oligonucleotides decreased CNS inflammation and improved clinical signs of disease. RLH stimulation repressed the maintenance and expansion of committed T(H)1 and T(H)17 cells, whereas T-cell differentiation was not altered. Notably, T(H)1 and T(H)17 suppression required type I interferon receptor engagement on dendritic cells, but not on macrophages or microglia. These results identify RLHs as negative regulators of T(H)1 and T(H)17 responses in the CNS, demonstrate a protective role of the RLH pathway for brain inflammation, and establish oligonucleotide ligands of RLHs as potential therapeutics for the treatment of multiple sclerosis.	[Dann, Angela; Gaupp, Stefanie; Kierdorf, Katrin; Knust, Markus; Knobeloch, Klaus-Peter; Prinz, Marco] Univ Freiburg, Dept Neuropathol, D-79106 Freiburg, Germany; [Dann, Angela; Kierdorf, Katrin; Knust, Markus] Univ Freiburg, Fac Biol, D-79106 Freiburg, Germany; [Poeck, Hendrik; Endres, Stefan; Hartmann, Gunther] Univ Bonn, Univ Hosp, Inst Clin Chem & Clin Pharmacol, Bonn, Germany; [Poeck, Hendrik] Tech Univ Munich, Klinikum Rechts Isar, Med Klin 3, D-8000 Munich, Germany; [Croxford, Andrew L.; Waisman, Ari] Johannes Gutenberg Univ Mainz, Inst Mol Med, Univ Med Ctr, Mainz, Germany; [Pfeifer, Dietmar] Univ Med Ctr Freiburg, Dept Hematol & Oncol, Freiburg, Germany; [Maihoefer, Cornelius] Univ Munich, Dept Radiat Oncol, Munich, Germany; [Endres, Stefan] Univ Munich, Ctr Integrated Prot Sci Munich, Munich, Germany; [Endres, Stefan] Univ Munich, Div Clin Pharmacol, Dept Internal Med, Munich, Germany; [Kalinke, Ulrich] Helmholtz Ctr Infect Res, TWINCORE, Ctr Expt & Clin Infect Res, Inst Expt Infect Res, Braunschweig, Germany; [Kalinke, Ulrich] Hannover Med Sch, D-3000 Hannover, Germany; [Meuth, Sven G.; Wiendl, Heinz] Univ Munster, Dept Neurol, D-4400 Munster, Germany; [Akira, Shizuo] Osaka Univ, Microbial Dis Res Inst, Dept Host Def, Suita, Osaka 565, Japan; [Prinz, Marco] Univ Freiburg, BIOSS Ctr Biol Signaling Studies, D-79106 Freiburg, Germany	University of Freiburg; University of Freiburg; University of Bonn; Technical University of Munich; Johannes Gutenberg University of Mainz; University of Freiburg; University of Munich; University of Munich; University of Munich; Helmholtz Association; Helmholtz-Center for Infection Research; Hannover Medical School; University of Munster; Osaka University; University of Freiburg	Prinz, M (corresponding author), Univ Freiburg, Dept Neuropathol, Hugstetter Str 55, D-79106 Freiburg, Germany.	marco.prinz@uniklinik-freiburg.de	Kierdorf, Katrin/AAO-6288-2021; Hartmann, Gunther/P-7492-2017; Meuth, Sven G/HHM-8941-2022; Akira, Shizuo/C-3134-2009; Waisman, Ari/C-7383-2015; Wiendl, Heinz/AAX-6041-2021	Hartmann, Gunther/0000-0003-1021-2018; Meuth, Sven G/0000-0003-2571-3501; Waisman, Ari/0000-0003-4304-8234; Kierdorf, Katrin/0000-0002-9272-4780; Wiendl, Heinz/0000-0003-4310-3432; Kalinke, Ulrich/0000-0003-0503-9564; Maihofer, Cornelius/0000-0002-0506-4519	German Research Council (DFG) [KFO177, SFB670, SFB704]; Bundesministerium fur Bildung und Forschung (BMBF); DFG [Graduiertenkolleg 1202, SFB 620, FOR133, PR 577/8-1]; Center of Integrated Protein Science Munich; Competence Network of Neurodegenerative Disorders; Center of Chronic Immunodeficiency (CCI); Gemeinnutzige Hertie-Foundation	German Research Council (DFG)(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF)); DFG(German Research Foundation (DFG)); Center of Integrated Protein Science Munich; Competence Network of Neurodegenerative Disorders; Center of Chronic Immunodeficiency (CCI); Gemeinnutzige Hertie-Foundation	This work was supported by KFO177, SFB670 and SFB704 of the German Research Council (DFG), and a Biofuture and a Go-Bio grant of the Bundesministerium fur Bildung und Forschung (BMBF) to G. H., a DFG Graduiertenkolleg 1202 fellowship to C. M., the Center of Integrated Protein Science Munich, a research professorship and a "BayImmunet" grant to S. E. M. P. was supported by the BMBF-funded Competence Network of Multiple Sclerosis, the Competence Network of Neurodegenerative Disorders, the Center of Chronic Immunodeficiency (CCI), the DFG (SFB 620, FOR1336 and PR 577/8-1) and the Gemeinnutzige Hertie-Foundation.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Batten M, 2006, NAT IMMUNOL, V7, P929, DOI 10.1038/ni1375; Bettelli E, 2004, J EXP MED, V200, P79, DOI 10.1084/jem.20031819; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Cucak H, 2009, IMMUNITY, V31, P491, DOI 10.1016/j.immuni.2009.07.005; Durelli L, 2009, ANN NEUROL, V65, P499, DOI 10.1002/ana.21652; FIERZ W, 1985, J IMMUNOL, V134, P3785; Guo BC, 2008, J CLIN INVEST, V118, P1680, DOI 10.1172/JCI33342; Heil F, 2003, EUR J IMMUNOL, V33, P2987, DOI 10.1002/eji.200324238; Heppner FL, 2005, NAT MED, V11, P146, DOI 10.1038/nm1177; Hofstetter HH, 2005, CELL IMMUNOL, V237, P123, DOI 10.1016/j.cellimm.2005.11.002; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Kamphuis E, 2006, BLOOD, V108, P3253, DOI 10.1182/blood-2006-06-027599; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kawai T, 2009, INT IMMUNOL, V21, P317, DOI 10.1093/intimm/dxp017; Komiyama Y, 2006, J IMMUNOL, V177, P566, DOI 10.4049/jimmunol.177.1.566; Kroenke MA, 2008, J EXP MED, V205, P1535, DOI 10.1084/jem.20080159; Kumar H, 2006, J EXP MED, V203, P1795, DOI 10.1084/jem.20060792; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; MATZINGER P, 1994, ANNU REV IMMUNOL, V12, P991, DOI 10.1146/annurev.iy.12.040194.005015; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Mildner A, 2009, BRAIN, V132, P2487, DOI 10.1093/brain/awp144; Mitsdoerffer M, 2009, ANN NEUROL, V65, P487, DOI 10.1002/ana.21722; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Nejentsev S, 2009, SCIENCE, V324, P387, DOI 10.1126/science.1167728; Pichlmair A, 2007, IMMUNITY, V27, P370, DOI 10.1016/j.immuni.2007.08.012; Pichlmair A, 2009, J VIROL, V83, P10761, DOI 10.1128/JVI.00770-09; Pirhonen J, 2007, J LEUKOCYTE BIOL, V82, P1185, DOI 10.1189/jlb.0307157; Prinz M, 2006, J CLIN INVEST, V116, P456, DOI 10.1172/JCI26078; Prinz M, 2008, IMMUNITY, V28, P675, DOI 10.1016/j.immuni.2008.03.011; Prinz M, 2011, NAT NEUROSCI, V14, P1227, DOI 10.1038/nn.2923; Prinz M, 2010, TRENDS MOL MED, V16, P379, DOI 10.1016/j.molmed.2010.06.001; Prinz M, 2010, J NEUROIMMUNOL, V224, P80, DOI 10.1016/j.jneuroim.2010.05.015; Sabbah A, 2009, NAT IMMUNOL, V10, P1073, DOI 10.1038/ni.1782; Schlee M, 2009, IMMUNITY, V31, P25, DOI 10.1016/j.immuni.2009.05.008; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Shinohara ML, 2008, IMMUNITY, V29, P68, DOI 10.1016/j.immuni.2008.05.008; Smyth DJ, 2008, NEW ENGL J MED, V359, P2767, DOI 10.1056/NEJMoa0807917; Steinman L, 2002, ANNU REV NEUROSCI, V25, P491, DOI 10.1146/annurev.neuro.25.112701.142913; Steinman L, 2007, NAT MED, V13, P139, DOI 10.1038/nm1551; Stromnes IM, 2008, NAT MED, V14, P337, DOI 10.1038/nm1715; Stumhofer JS, 2006, NAT IMMUNOL, V7, P937, DOI 10.1038/ni1376; Sutton CE, 2009, IMMUNITY, V31, P331, DOI 10.1016/j.immuni.2009.08.001; Tzartos JS, 2008, AM J PATHOL, V172, P146, DOI 10.2353/ajpath.2008.070690; van Loo G, 2006, NAT IMMUNOL, V7, P954, DOI 10.1038/ni1372; Vilaysane A, 2009, SEMIN IMMUNOL, V21, P208, DOI 10.1016/j.smim.2009.05.006; Wang Y, 2007, CELL RES, V17, P858, DOI 10.1038/cr.2007.81; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014	50	54	56	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2012	15	1					98	U126		10.1038/nn.2964	http://dx.doi.org/10.1038/nn.2964			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	866VO	22138643				2022-12-28	WOS:000298414400019
J	Vitureira, N; Letellier, M; White, IJ; Goda, Y				Vitureira, Nathalia; Letellier, Mathieu; White, Ian J.; Goda, Yukiko			Differential control of presynaptic efficacy by postsynaptic N-cadherin and beta-catenin	NATURE NEUROSCIENCE			English	Article							AMPA RECEPTOR TRAFFICKING; CELL-ADHESION MOLECULES; LONG-TERM POTENTIATION; SYNAPTIC PLASTICITY; EXCITATORY SYNAPSES; HIPPOCAMPAL SYNAPSES; RELEASE PROBABILITY; HOMEOSTATIC PLASTICITY; DENDRITIC SPINES; GLUR2	N-cadherin is a homophilic adhesion protein that remains expressed at mature excitatory synapses beyond its developmental role in synapse formation. We investigated the trans-synaptic activity of N-cadherin in regulating synapse function in rodent cultured hippocampal neurons using optical methods and electrophysiology. Interfering with N-cadherin in postsynaptic neurons reduced basal release probability (p(r)) at inputs to the neuron, and this trans-synaptic impairment of release accompanied impaired vesicle endocytosis. Moreover, loss of the GluA2 AMPA-type glutamate receptor subunit, which decreased p(r) by itself, occluded the interference with postsynaptic N-cadherin. The loss of postsynaptic N-cadherin activity, however, did not affect the compensatory upregulation of p(r) induced by chronic activity silencing, whereas postsynaptic beta-catenin deletion blocked this presynaptic homeostatic adaptation. Our findings suggest that postsynaptic N-cadherin helps link basal pre- and postsynaptic strengths to control the p(r) offset, whereas the p(r) gain adjustment requires a distinct trans-synaptic pathway involving beta-catenin.	[Vitureira, Nathalia; Letellier, Mathieu; White, Ian J.; Goda, Yukiko] UCL, Mol Cell Biol Lab, MRC, London, England; [Vitureira, Nathalia; Letellier, Mathieu; White, Ian J.; Goda, Yukiko] UCL, Cell Biol Unit, London, England; [Goda, Yukiko] RIKEN, Brain Sci Inst, Wako, Saitama, Japan	University of London; University College London; University of London; University College London; RIKEN	Goda, Y (corresponding author), UCL, Mol Cell Biol Lab, MRC, London, England.	goda@brain.riken.jp	Mathieu, Letellier/R-9031-2019; Goda, Yukiko/AAR-5641-2020; Goda, Yukiko/A-6576-2016	Mathieu, Letellier/0000-0003-4008-298X; Goda, Yukiko/0000-0003-0352-9498; Goda, Yukiko/0000-0003-0352-9498; Vitureira, Nathalia/0000-0003-1196-4094	UK Medical Research Council; European Union; RIKEN Brain Science Institute; MRC [MC_U122669937] Funding Source: UKRI; Medical Research Council [MC_U122669937] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union(European Commission); RIKEN Brain Science Institute; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank R. Kemler (Max Planck Institute of Immunology) for beta-catenin floxed mice, T. Okuda (Keio University) and M. Passafaro (University of Milan) for sharing plasmids, D. Elliott for expert technical assistance and the members of the Goda laboratory for discussions. This work was supported by the UK Medical Research Council, the European Union 7th Framework Program EUROSPIN project and the RIKEN Brain Science Institute.	Abe K, 2004, NAT NEUROSCI, V7, P357, DOI 10.1038/nn1212; Arikkath J, 2008, TRENDS NEUROSCI, V31, P487, DOI 10.1016/j.tins.2008.07.001; Bamji SX, 2003, NEURON, V40, P719, DOI 10.1016/S0896-6273(03)00718-9; Bozdagi O, 2010, J NEUROSCI, V30, P9984, DOI 10.1523/JNEUROSCI.1223-10.2010; Branco T, 2008, NEURON, V59, P475, DOI 10.1016/j.neuron.2008.07.006; Brault V, 2001, DEVELOPMENT, V128, P1253; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Burrone J, 2003, CURR OPIN NEUROBIOL, V13, P560, DOI 10.1016/j.conb.2003.09.007; Burrone J, 2002, NATURE, V420, P414, DOI 10.1038/nature01242; Cathala L, 2005, NAT NEUROSCI, V8, P1310, DOI 10.1038/nn1534; Cingolani LA, 2008, NEURON, V58, P749, DOI 10.1016/j.neuron.2008.04.011; Frank CA, 2006, NEURON, V52, P663, DOI 10.1016/j.neuron.2006.09.029; Frank CA, 2009, NEURON, V61, P556, DOI 10.1016/j.neuron.2008.12.028; Futai K, 2007, NAT NEUROSCI, V10, P186, DOI 10.1038/nn1837; Gainey MA, 2009, J NEUROSCI, V29, P6479, DOI 10.1523/JNEUROSCI.3753-08.2009; Gottmann K, 2008, J NEUROSCI RES, V86, P223, DOI 10.1002/jnr.21484; Han EB, 2009, P NATL ACAD SCI USA, V106, P10817, DOI 10.1073/pnas.0903603106; HESSLER NA, 1993, NATURE, V366, P569, DOI 10.1038/366569a0; Jakawich SK, 2010, NEURON, V68, P1143, DOI 10.1016/j.neuron.2010.11.034; Jungling K, 2006, J NEUROSCI, V26, P6968, DOI 10.1523/JNEUROSCI.1013-06.2006; Lindskog M, 2010, P NATL ACAD SCI USA, V107, P21806, DOI 10.1073/pnas.1016399107; Mendez P, 2010, J CELL BIOL, V189, P589, DOI 10.1083/jcb.201003007; Murase S, 2002, NEURON, V35, P91, DOI 10.1016/S0896-6273(02)00764-X; Murthy VN, 1997, NEURON, V18, P599, DOI 10.1016/S0896-6273(00)80301-3; Nakayama K, 2005, J NEUROSCI, V25, P4040, DOI 10.1523/JNEUROSCI.4115-04.2005; Newpher TM, 2008, NEURON, V58, P472, DOI 10.1016/j.neuron.2008.04.030; Nuriya M, 2006, J NEUROCHEM, V97, P652, DOI 10.1111/j.1471-4159.2006.03740.x; Okuda T, 2007, P NATL ACAD SCI USA, V104, P13479, DOI 10.1073/pnas.0702334104; Pang ZPP, 2010, CURR OPIN CELL BIOL, V22, P496, DOI 10.1016/j.ceb.2010.05.001; Passafaro M, 2003, NATURE, V424, P677, DOI 10.1038/nature01781; Pozo K, 2010, NEURON, V66, P337, DOI 10.1016/j.neuron.2010.04.028; Ripley B, 2011, P NATL ACAD SCI USA, V108, P367, DOI 10.1073/pnas.1015163108; ROSENMUND C, 1993, SCIENCE, V262, P754, DOI 10.1126/science.7901909; Ryan TA, 1997, NATURE, V388, P478, DOI 10.1038/41335; RYAN TA, 1993, NEURON, V11, P713, DOI 10.1016/0896-6273(93)90081-2; Saglietti L, 2007, NEURON, V54, P461, DOI 10.1016/j.neuron.2007.04.012; Sheng M, 2007, ANNU REV BIOCHEM, V76, P823, DOI 10.1146/annurev.biochem.76.060805.160029; Song JY, 1999, P NATL ACAD SCI USA, V96, P1100, DOI 10.1073/pnas.96.3.1100; Stan A, 2010, P NATL ACAD SCI USA, V107, P11116, DOI 10.1073/pnas.0914233107; Sutton MA, 2006, CELL, V127, P49, DOI 10.1016/j.cell.2006.09.014; TAKEICHI M, 1990, ANNU REV BIOCHEM, V59, P237, DOI 10.1146/annurev.biochem.59.1.237; Tanaka H, 2000, NEURON, V25, P93, DOI 10.1016/S0896-6273(00)80874-0; Tang LX, 1998, NEURON, V20, P1165, DOI 10.1016/S0896-6273(00)80497-3; Thiagarajan TC, 2005, NEURON, V47, P725, DOI 10.1016/j.neuron.2005.06.037; Togashi H, 2006, J CELL BIOL, V174, P141, DOI 10.1083/jcb.200601089; Tokuoka H, 2008, P NATL ACAD SCI USA, V105, P14656, DOI 10.1073/pnas.0805705105; Turrigiano GG, 2008, CELL, V135, P422, DOI 10.1016/j.cell.2008.10.008; Wierenga CJ, 2005, J NEUROSCI, V25, P2895, DOI 10.1523/JNEUROSCI.5217-04.2005; Wierenga CJ, 2006, J NEUROPHYSIOL, V96, P2127, DOI 10.1152/jn.00107.2006; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	50	52	52	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2012	15	1					81	U106		10.1038/nn.2995	http://dx.doi.org/10.1038/nn.2995			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	866VO	22138644	Green Accepted			2022-12-28	WOS:000298414400017
J	Takahashi, YK; Roesch, MR; Wilson, RC; Toreson, K; O'Donnell, P; Niv, Y; Schoenbaum, G				Takahashi, Yuji K.; Roesch, Matthew R.; Wilson, Robert C.; Toreson, Kathy; O'Donnell, Patricio; Niv, Yael; Schoenbaum, Geoffrey			Expectancy-related changes in firing of dopamine neurons depend on orbitofrontal cortex	NATURE NEUROSCIENCE			English	Article							VENTRAL TEGMENTAL AREA; ORBITAL PREFRONTAL CORTEX; ENCODES RESPONSE; DECISION-MAKING; FRONTAL-CORTEX; REWARD VALUE; MODEL-FREE; RAT; PREDICTION; STRIATUM	The orbitofrontal cortex has been hypothesized to carry information regarding the value of expected rewards. Such information is essential for associative learning, which relies on comparisons between expected and obtained reward for generating instructive error signals. These error signals are thought to be conveyed by dopamine neurons. To test whether orbitofrontal cortex contributes to these error signals, we recorded from dopamine neurons in orbitofrontal-lesioned rats performing a reward learning task. Lesions caused marked changes in dopaminergic error signaling. However, the effect of lesions was not consistent with a simple loss of information regarding expected value. Instead, without orbitofrontal input, dopaminergic error signals failed to reflect internal information about the impending response that distinguished externally similar states leading to differently valued future rewards. These results are consistent with current conceptualizations of orbitofrontal cortex as supporting model-based behavior and suggest an unexpected role for this information in dopaminergic error signaling.	[Takahashi, Yuji K.; Toreson, Kathy; Schoenbaum, Geoffrey] Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA; [Roesch, Matthew R.] Univ Maryland, Dept Psychol, College Pk, MD 20742 USA; [Roesch, Matthew R.] Univ Maryland, Program Neurosci & Cognit Sci, College Pk, MD 20742 USA; [Wilson, Robert C.; Niv, Yael] Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA; [Wilson, Robert C.; Niv, Yael] Princeton Univ, Inst Neurosci, Princeton, NJ 08544 USA; [O'Donnell, Patricio; Schoenbaum, Geoffrey] Univ Maryland, Sch Med, Dept Psychiat, Baltimore, MD 21201 USA; [Schoenbaum, Geoffrey] NIDA, Intramural Res Program, Baltimore, MD USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; Princeton University; Princeton University; University System of Maryland; University of Maryland Baltimore; National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA)	Takahashi, YK (corresponding author), Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA.	ytaka001@umaryland.edu; schoenbg@schoenbaumlab.org		O'Donnell, Patricio/0000-0001-7788-624X	US National Institute on Drug Abuse; US National Institute on Mental Health; Binational United States-Israel Science Foundation; Sloan Research Fellowship; NATIONAL INSTITUTE OF MENTAL HEALTH [K99MH083940] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [ZIADA000587, K01DA021609, R01DA015718, R01DA031695] Funding Source: NIH RePORTER	US National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); US National Institute on Mental Health; Binational United States-Israel Science Foundation; Sloan Research Fellowship(Alfred P. Sloan Foundation); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by grants from the US National Institute on Drug Abuse to G.S. and M.R. and from the US National Institute on Mental Health to Y.K.T., a Sloan Research Fellowship to Y.N. and a Binational United States-Israel Science Foundation grant to Y.N. and R.C.W.	Abe H, 2011, NEURON, V70, P731, DOI 10.1016/j.neuron.2011.03.026; Bayer HM, 2005, NEURON, V47, P129, DOI 10.1016/j.neuron.2005.05.020; Bromberg-Martin ES, 2010, J NEUROPHYSIOL, V104, P1068, DOI 10.1152/jn.00158.2010; Burke KA, 2008, NATURE, V454, P340, DOI 10.1038/nature06993; Chudasama Y, 2003, J NEUROSCI, V23, P8771; Daw ND, 2005, NAT NEUROSCI, V8, P1704, DOI 10.1038/nn1560; DAW ND, NEURON IN PRESS; Feierstein CE, 2006, NEURON, V51, P495, DOI 10.1016/j.neuron.2006.06.032; Fellows LK, 2003, BRAIN, V126, P1830, DOI 10.1093/brain/awg180; Furuyashiki T, 2008, J NEUROSCI, V28, P5127, DOI 10.1523/JNEUROSCI.0319-08.2008; Gershman SJ, 2010, CURR OPIN NEUROBIOL, V20, P251, DOI 10.1016/j.conb.2010.02.008; Gershman SJ, 2010, PSYCHOL REV, V117, P197, DOI 10.1037/a0017808; Glascher J, 2010, NEURON, V66, P585, DOI 10.1016/j.neuron.2010.04.016; Gottfried JA, 2003, SCIENCE, V301, P1104, DOI 10.1126/science.1087919; GRACE AA, 1984, J NEUROSCI, V4, P2877; Hampton AN, 2006, J NEUROSCI, V26, P8360, DOI 10.1523/JNEUROSCI.1010-06.2006; Hollerman JR, 1998, NAT NEUROSCI, V1, P304, DOI 10.1038/1124; Izquierdo A, 2004, J NEUROSCI, V24, P7540, DOI 10.1523/JNEUROSCI.1921-04.2004; Jin X, 2010, NATURE, V466, P457, DOI 10.1038/nature09263; Lodge DJ, 2011, NEUROPSYCHOPHARMACOL, V36, P1227, DOI 10.1038/npp.2011.7; Margolis EB, 2006, J PHYSIOL-LONDON, V577, P907, DOI 10.1113/jphysiol.2006.117069; McDannald MA, 2011, J NEUROSCI, V31, P2700, DOI 10.1523/JNEUROSCI.5499-10.2011; Morris G, 2006, NAT NEUROSCI, V9, P1057, DOI 10.1038/nn1743; Niv Y, 2006, NAT NEUROSCI, V9, P987, DOI 10.1038/nn0806-987; O'Doherty J, 2004, SCIENCE, V304, P452, DOI 10.1126/science.1094285; O'Doherty JP, 2002, NEURON, V33, P815, DOI 10.1016/S0896-6273(02)00603-7; Ostlund SB, 2007, J NEUROSCI, V27, P4819, DOI 10.1523/JNEUROSCI.5443-06.2007; Padoa-Schioppa C, 2006, NATURE, V441, P223, DOI 10.1038/nature04676; Pan WX, 2005, J NEUROSCI, V25, P6235, DOI 10.1523/JNEUROSCI.1478-05.2005; PEARCE JM, 1980, PSYCHOL REV, V87, P532, DOI 10.1037/0033-295X.87.6.532; Pickens CL, 2003, J NEUROSCI, V23, P11078; Ramus SJ, 2000, J NEUROSCI, V20, P8199, DOI 10.1523/jneurosci.20-21-08199.2000; Redish AD, 2007, PSYCHOL REV, V114, P784, DOI 10.1037/0033-295X.114.3.784; Rescorla R.A., 1972, CLASSICAL CONDITION, P64, DOI DOI 10.1101/GR.110528.110; Roesch MR, 2007, NAT NEUROSCI, V10, P1615, DOI 10.1038/nn2013; Roesch MR, 2006, NEURON, V51, P509, DOI 10.1016/j.neuron.2006.06.027; Schoenbaum G, 2009, NAT REV NEUROSCI, V10, P885, DOI 10.1038/nrn2753; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; SIMON DA, J NEUROSCI IN PRESS; Sul JH, 2010, NEURON, V66, P449, DOI 10.1016/j.neuron.2010.03.033; Takahashi YK, 2009, NEURON, V62, P269, DOI 10.1016/j.neuron.2009.03.005; Tsuchida A, 2010, J NEUROSCI, V30, P16868, DOI 10.1523/JNEUROSCI.1958-10.2010; Tsujimoto S, 2009, J NEUROSCI, V29, P2569, DOI 10.1523/JNEUROSCI.5777-08.2009; van Duuren E, 2008, J NEUROSCI, V28, P8590, DOI 10.1523/JNEUROSCI.5549-07.2008; van Duuren E, 2009, J NEUROSCI, V29, P8965, DOI 10.1523/JNEUROSCI.0005-09.2009; Vazquez-Borsetti P, 2009, CEREB CORTEX, V19, P1678, DOI 10.1093/cercor/bhn204; Voorn P, 2004, TRENDS NEUROSCI, V27, P468, DOI 10.1016/j.tins.2004.06.006; Walton ME, 2010, NEURON, V65, P927, DOI 10.1016/j.neuron.2010.02.027; Young JJ, 2011, J NEUROSCI, V31, P5989, DOI 10.1523/JNEUROSCI.5436-10.2011	50	176	178	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	2011	14	12					1590	U129		10.1038/nn.2957	http://dx.doi.org/10.1038/nn.2957			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	855EJ	22037501	Green Accepted			2022-12-28	WOS:000297546300020
J	Sharot, T; Korn, CW; Dolan, RJ				Sharot, Tali; Korn, Christoph W.; Dolan, Raymond J.			How unrealistic optimism is maintained in the face of reality	NATURE NEUROSCIENCE			English	Article							FUTURE LIFE EVENTS; PREFRONTAL CORTEX; NEURAL MECHANISMS; DECISION-MAKING; REWARD; PERCEPTIONS; CHOICE; HEALTH	Unrealistic optimism is a pervasive human trait that influences domains ranging from personal relationships to politics and finance. How people maintain unrealistic optimism, despite frequently encountering information that challenges those biased beliefs, is unknown. We examined this question and found a marked asymmetry in belief updating. Participants updated their beliefs more in response to information that was better than expected than to information that was worse. This selectivity was mediated by a relative failure to code for errors that should reduce optimism. Distinct regions of the prefrontal cortex tracked estimation errors when those called for positive update, both in individuals who scored high and low on trait optimism. However, highly optimistic individuals exhibited reduced tracking of estimation errors that called for negative update in right inferior prefrontal gyrus. These findings indicate that optimism is tied to a selective update failure and diminished neural coding of undesirable information regarding the future.	[Sharot, Tali; Dolan, Raymond J.] UCL, Wellcome Trust Ctr Neuroimaging, London, England; [Korn, Christoph W.] Free Univ Berlin, Dept Educ & Psychol, D-1000 Berlin, Germany; [Korn, Christoph W.] Humboldt Univ, Sch Mind & Brain, Berlin, Germany	University of London; University College London; Free University of Berlin; Humboldt University of Berlin	Sharot, T (corresponding author), UCL, Wellcome Trust Ctr Neuroimaging, London, England.	t.sharot@ucl.ac.uk		Korn, Christoph/0000-0002-8228-2624; Dolan, Ray/0000-0001-9356-761X	Wellcome Trust; British Academy; German Academic Exchange Service (DAAD)	Wellcome Trust(Wellcome TrustEuropean Commission); British Academy; German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD))	We thank S. Fleming for assistance with analysis, P. Dayan for discussion, and T. Behrens, D. Schiller, Q. Huys, J. Winston, B. De Martino, S. Fleming, S. Bengtsson, K. Wunderlich, H. Heekeren, S. Kennerley and M. Guitart-Masip for comments on a previous version of this manuscript. This study was supported by a Wellcome Trust Program grant to R. J. D., a British Academy Postdoctoral Fellowship to T. S., and a German Academic Exchange Service (DAAD) scholarship to C. W. K.	Armor D.A., 2012, HEURISTICS BIASES PS, P334, DOI [DOI 10.1017/CBO9780511808098.021, 10.1017/cbo9780511808098.021]; BAKER LA, 1993, LAW HUMAN BEHAV, V17, P439, DOI 10.1007/BF01044377; Bengtsson SL, 2009, CEREB CORTEX, V19, P797, DOI 10.1093/cercor/bhn127; Calderon TG, 1993, MIDATLANTIC J BUS, V29, P41, DOI DOI 10.1016/0001-4575(89)90024-9; CHANG EC, 2000, OPTIMISM PESSIMISM I; Cools R, 2002, J NEUROSCI, V22, P4563, DOI 10.1523/JNEUROSCI.22-11-04563.2002; Ekman, 1983, QUESTIONS EMOTIONS, P39; Gerrard Meg, 1999, Journal of the National Cancer Institute Monographs, P94; Greening SG, 2011, NEUROIMAGE, V54, P1432, DOI 10.1016/j.neuroimage.2010.09.017; Mitchell DGV, 2009, J NEUROSCI, V29, P10827, DOI 10.1523/JNEUROSCI.0963-09.2009; PEARCE JM, 1980, PSYCHOL REV, V87, P532, DOI 10.1037/0033-295X.87.6.532; Puri M, 2007, J FINANC ECON, V86, P71, DOI 10.1016/j.jfineco.2006.09.003; SCHEIER MF, 1989, J PERS SOC PSYCHOL, V57, P1024, DOI 10.1037/0022-3514.57.6.1024; SCHEIER MF, 1994, J PERS SOC PSYCHOL, V67, P1063, DOI 10.1037/0022-3514.67.6.1063; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; Sharot T., 2011, OPTIMISM BIAS; Sharot T, 2007, NATURE, V450, P102, DOI 10.1038/nature06280; Shefrin H., 2010, ROUTLEDGE COMPANION; Strunk DR, 2006, BEHAV RES THER, V44, P861, DOI 10.1016/j.brat.2005.07.001; TAYLOR SE, 1988, PSYCHOL BULL, V103, P193, DOI 10.1037/0033-2909.103.2.193; Taylor SE, 2000, AM PSYCHOL, V55, P99, DOI 10.1037//0003-066X.55.1.99; Taylor SF, 2007, NEUROSCIENTIST, V13, P160, DOI 10.1177/1073858406298184; UBEL P, 2009, FORBES          0222; Varki A, 2009, NATURE, V460, P684, DOI 10.1038/460684c; WEINSTEIN ND, 1980, J PERS SOC PSYCHOL, V39, P806, DOI 10.1037/0022-3514.39.5.806; WEINSTEIN ND, 1995, HEALTH PSYCHOL, V14, P132, DOI 10.1037/0278-6133.14.2.132; Yeung N, 2005, CEREB CORTEX, V15, P535, DOI 10.1093/cercor/bhh153	29	316	321	5	123	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2011	14	11					1475	U156		10.1038/nn.2949	http://dx.doi.org/10.1038/nn.2949			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	841NI	21983684	Green Published, Green Accepted			2022-12-28	WOS:000296518600025
J	Tognini, P; Putignano, E; Coatti, A; Pizzorusso, T				Tognini, Paola; Putignano, Elena; Coatti, Alessandro; Pizzorusso, Tommaso			Experience-dependent expression of miR-132 regulates ocular dominance plasticity	NATURE NEUROSCIENCE			English	Article								miR-132 is a CREB-induced microRNA that is involved in dendritic spine plasticity. We found that visual experience regulated histone post-translational modifications at a CRE locus that is important for miR-212 and miR-132 cluster transcription, and regulated miR-132 expression in the visual cortex of juvenile mice. Monocular deprivation reduced miR-132 expression in the cortex contralateral to the deprived eye. Counteracting this miR-132 reduction with an infusion of chemically modified miR-132 mimic oligonucleotides completely blocked ocular dominance plasticity.	[Tognini, Paola; Putignano, Elena; Coatti, Alessandro; Pizzorusso, Tommaso] CNR, Ist Neurosci, I-56100 Pisa, Italy; [Tognini, Paola; Putignano, Elena; Coatti, Alessandro] Scuola Normale Super Pisa, Pisa, Italy; [Pizzorusso, Tommaso] Univ Florence, Dipartimento Psicol, Florence, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Neuroscienze (IN-CNR); Scuola Normale Superiore di Pisa; University of Florence	Pizzorusso, T (corresponding author), CNR, Ist Neurosci, I-56100 Pisa, Italy.	tommaso@in.cnr.it	Pizzorusso, Tommaso/D-1399-2013	Pizzorusso, Tommaso/0000-0001-5614-0668; Putignano, Elena/0000-0002-4313-408X	European Union [223326, 223524]; EXTRAPLAST IIT project; Telethon project [GGP09196]; MIUR	European Union(European Commission); EXTRAPLAST IIT project; Telethon project(Fondazione Telethon); MIUR(Ministry of Education, Universities and Research (MIUR))	We thank L. Dolfi and F. Cremisi for help with ISH. This work was supported by European Union 7th Framework Program (FP2007-2013) grant agreements 223326 and 223524, EXTRAPLAST IIT project, Telethon project GGP09196 and MIUR EpiGen.	Anand S, 2010, NAT MED, V16, P909, DOI 10.1038/nm.2186; Boggio Elena M, 2010, Front Synaptic Neurosci, V2, P28, DOI 10.3389/fnsyn.2010.00028; Day JJ, 2011, NEURON, V70, P813, DOI 10.1016/j.neuron.2011.05.019; Edbauer D, 2010, NEURON, V65, P373, DOI 10.1016/j.neuron.2010.01.005; Fagiolini M, 2009, CURR OPIN NEUROBIOL, V19, P207, DOI 10.1016/j.conb.2009.05.009; Hansen KF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015497; Hensch TK, 2005, NAT REV NEUROSCI, V6, P877, DOI 10.1038/nrn1787; Impey S, 2010, MOL CELL NEUROSCI, V43, P146, DOI 10.1016/j.mcn.2009.10.005; Kuhn DE, 2010, J BIOL CHEM, V285, P1529, DOI 10.1074/jbc.M109.033407; Putignano E, 2007, NEURON, V53, P747, DOI 10.1016/j.neuron.2007.02.007; Remenyi J, 2010, BIOCHEM J, V428, P281, DOI 10.1042/BJ20100024; Spolidoro M, 2012, CEREB CORTEX, V22, P725, DOI 10.1093/cercor/bhr158; Vo N, 2005, P NATL ACAD SCI USA, V102, P16426, DOI 10.1073/pnas.0508448102; Wayman GA, 2008, P NATL ACAD SCI USA, V105, P9093, DOI 10.1073/pnas.0803072105	14	102	102	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2011	14	10					1237	1239		10.1038/nn.2920	http://dx.doi.org/10.1038/nn.2920			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	825EQ	21892154	Green Accepted, Green Submitted			2022-12-28	WOS:000295254200007
J	Ajami, B; Bennett, JL; Krieger, C; McNagny, KM; Rossi, FMV				Ajami, Bahareh; Bennett, Jami L.; Krieger, Charles; McNagny, Kelly M.; Rossi, Fabio M. V.			Infiltrating monocytes trigger EAE progression, but do not contribute to the resident microglia pool	NATURE NEUROSCIENCE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; CENTRAL-NERVOUS-SYSTEM; BLOOD-BRAIN-BARRIER; MULTIPLE-SCLEROSIS; PERIVASCULAR CELLS; CNS; MACROPHAGES; MIGRATION; PATHOGENESIS	In multiple sclerosis and the experimental autoimmune encephalitis (EAE) mouse model, two pools of morphologically indistinguishable phagocytic cells, microglia and inflammatory macrophages, accrue from proliferating resident precursors and recruitment of blood-borne progenitors, respectively. Whether these cell types are functionally equivalent is hotly debated, but is challenging to address experimentally. Using a combination of parabiosis and myeloablation to replace circulating progenitors without affecting CNS-resident microglia, we found a strong correlation between monocyte infiltration and progression to the paralytic stage of EAE. Inhibition of chemokine receptor-dependent recruitment of monocytes to the CNS blocked EAE progression, suggesting that these infiltrating cells are essential for pathogenesis. Finally, we found that, although microglia can enter the cell cycle and return to quiescence following remission, recruited monocytes vanish, and therefore do not ultimately contribute to the resident microglial pool. In conclusion, we identified two distinct subsets of myelomonocytic cells with distinct roles in neuroinflammation and disease progression.	[Ajami, Bahareh; Bennett, Jami L.; Krieger, Charles; McNagny, Kelly M.; Rossi, Fabio M. V.] Univ British Columbia, Biomed Res Ctr, Vancouver, BC, Canada	University of British Columbia	Rossi, FMV (corresponding author), Univ British Columbia, Biomed Res Ctr, Vancouver, BC, Canada.	fabio@brc.ubc.ca	Rossi, Fabio MV/B-5587-2013; McNagny, Kelly/P-5239-2014; Ajami, Bahareh/AAA-7262-2019	Rossi, Fabio MV/0000-0002-0368-2620; McNagny, Kelly/0000-0003-4737-3499; 	Canadian Institute for Health Research (CIHR) [MOP 81382]; Multiple Sclerosis Society of Canada; Amyotrophic Lateral Sclerosis Society of Canada; Muscular Dystrophy Canada [JNM-69682]; Natural Science and Engineering Research Council of Canada [CHRP 299119]; Michael Smith Foundation for Health Research Senior Scholar; Michael Smith Foundation; Canadian Research Chairs program	Canadian Institute for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Multiple Sclerosis Society of Canada; Amyotrophic Lateral Sclerosis Society of Canada; Muscular Dystrophy Canada(Muscular Dystrophy Association); Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Michael Smith Foundation for Health Research Senior Scholar(Michael Smith Foundation for Health Research); Michael Smith Foundation(Michael Smith Foundation for Health Research); Canadian Research Chairs program(Canada Research Chairs)	We thank B. Chua, T. Godbey, K. Ranta, M. Cowan, L. Rollins and the Biomedical Research Center animal unit personnel for advice and help on animal welfare. We thank A. Johnson, C. K. Chang, J. Kang and D. Mahdaviani for their technical help. This work was supported by Canadian Institute for Health Research (CIHR, MOP 81382) grants and a grant from the Multiple Sclerosis Society of Canada to F.M. V.R., a Neuromuscular Research Partnership grant from the CIHR, a grant from the Amyotrophic Lateral Sclerosis Society of Canada and Muscular Dystrophy Canada to C.K. and F.M.V.R. (JNM-69682), a Collaborative Health Research grant from the CIHR and the Natural Science and Engineering Research Council of Canada to C.K. and F.M.V.R. (CHRP 299119), and a research grant from the Multiple Sclerosis Society of Canada to K.M.M. K.M.M. is a Michael Smith Foundation for Health Research Senior Scholar. B. A is supported by a Michael Smith Foundation Senior Graduate Studentship and a CIHR-Amyotrophic Lateral Sclerosis Doctoral Research Award. J.L.B. is supported by a Multiple Sclerosis Society of Canada Postdoctoral Research Fellowship. This research was undertaken, in part, thanks to funding from the Canadian Research Chairs program to F.M.V.R.	Ajami B, 2007, NAT NEUROSCI, V10, P1538, DOI 10.1038/nn2014; Bauer J, 1995, GLIA, V15, P437, DOI 10.1002/glia.440150407; BAUER J, 1994, J NEUROSCI RES, V38, P365, DOI 10.1002/jnr.490380402; Benveniste EN, 1997, J MOL MED-JMM, V75, P165, DOI 10.1007/s001090050101; BROSNAN CF, 1981, J IMMUNOL, V126, P614; BUKILICA M, 1991, INT J NEUROSCI, V59, P167, DOI 10.3109/00207459108985460; Carson MJ, 2006, CLIN NEUROSCI RES, V6, P237, DOI 10.1016/j.cnr.2006.09.004; Diserbo M, 2002, CAN J PHYSIOL PHARM, V80, P670, DOI 10.1139/Y02-070; Engelhardt B, 2006, J NEURAL TRANSM, V113, P477, DOI 10.1007/s00702-005-0409-y; Fife BT, 2000, J EXP MED, V192, P899, DOI 10.1084/jem.192.6.899; Getts DR, 2008, J EXP MED, V205, P2319, DOI 10.1084/jem.20080421; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Heppner FL, 2005, NAT MED, V11, P146, DOI 10.1038/nm1177; Hess DC, 2004, EXP NEUROL, V186, P134, DOI 10.1016/j.expneurol.2003.11.005; HICKEY WF, 1991, J NEUROSCI RES, V28, P254, DOI 10.1002/jnr.490280213; HICKEY WF, 1988, SCIENCE, V239, P290, DOI 10.1126/science.3276004; Hickey WF, 1991, BRAIN PATHOL, V1, P97, DOI 10.1111/j.1750-3639.1991.tb00646.x; HUITINGA I, 1990, J EXP MED, V172, P1025, DOI 10.1084/jem.172.4.1025; Izikson L, 2000, J EXP MED, V192, P1075, DOI 10.1084/jem.192.7.1075; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Kennedy DW, 1997, BLOOD, V90, P986, DOI 10.1182/blood.V90.3.986.986_986_993; Kim JV, 2009, NATURE, V457, P191, DOI 10.1038/nature07591; King IL, 2009, BLOOD, V113, P3190, DOI 10.1182/blood-2008-07-168575; KRALL WJ, 1994, BLOOD, V83, P2737; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Langer-Gould A, 2005, NEW ENGL J MED, V353, P375, DOI 10.1056/NEJMoa051847; LAWSON LJ, 1992, NEUROSCIENCE, V48, P405, DOI 10.1016/0306-4522(92)90500-2; Li YQ, 2004, RADIAT RES, V161, P143, DOI 10.1667/RR3117; Luster AD, 2005, NAT IMMUNOL, V6, P1182, DOI 10.1038/ni1275; MASON D, 1991, IMMUNOL TODAY, V12, P57, DOI 10.1016/0167-5699(91)90158-P; Mildner A, 2007, NAT NEUROSCI, V10, P1544, DOI 10.1038/nn2015; Mildner A, 2009, BRAIN, V132, P2487, DOI 10.1093/brain/awp144; Miller DH, 2003, NEW ENGL J MED, V348, P15, DOI 10.1056/NEJMoa020696; Nagai Y, 2006, IMMUNITY, V24, P801, DOI 10.1016/j.immuni.2006.04.008; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Ponomarev ED, 2005, J NEUROSCI RES, V81, P374, DOI 10.1002/jnr.20488; Priller J, 2001, NAT MED, V7, P1356, DOI 10.1038/nm1201-1356; Raivich G, 2005, TRENDS NEUROSCI, V28, P571, DOI 10.1016/j.tins.2005.09.001; Saederup N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013693; Santambrogio L, 2001, P NATL ACAD SCI USA, V98, P6295, DOI 10.1073/pnas.111152498; Steinman L, 2005, NAT REV DRUG DISCOV, V4, P510, DOI 10.1038/nrd1752; Steinman L, 2002, ANNU REV NEUROSCI, V25, P491, DOI 10.1146/annurev.neuro.25.112701.142913; Streit WJ, 2002, E SCHERING RES FDN W, V39, P11; Streit WJ, 1999, PROG NEUROBIOL, V57, P563, DOI 10.1016/S0301-0082(98)00069-0; SWANBORG RH, 1995, CLIN IMMUNOL IMMUNOP, V77, P4, DOI 10.1016/0090-1229(95)90130-2; ULVESTAD E, 1994, J LEUKOCYTE BIOL, V56, P732, DOI 10.1002/jlb.56.6.732; Wright DE, 2001, BLOOD, V97, P2278, DOI 10.1182/blood.V97.8.2278; Wujek JR, 2002, J NEUROPATH EXP NEUR, V61, P23, DOI 10.1093/jnen/61.1.23; YEDNOCK TA, 1992, NATURE, V356, P63, DOI 10.1038/356063a0	50	737	750	0	69	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2011	14	9					1142	U263		10.1038/nn.2887	http://dx.doi.org/10.1038/nn.2887			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	812ID	21804537				2022-12-28	WOS:000294284900014
J	Paik, SB; Ringach, DL				Paik, Se-Bum; Ringach, Dario L.			Retinal origin of orientation maps in visual cortex	NATURE NEUROSCIENCE			English	Article							CELL RECEPTIVE-FIELDS; FUNCTIONAL ARCHITECTURE; PREFERENCE MAPS; GANGLION-CELLS; ON-CENTER; SELECTIVITY; COLUMNS; ORGANIZATION; DOMAINS; SPECIFICITY	The orientation map is a hallmark of primary visual cortex in higher mammals. It is not yet known how orientation maps develop, what function they have in visual processing and why some species lack them. Here we advance the notion that quasi-periodic orientation maps are established by moire interference of regularly spaced ON- and OFF-center retinal ganglion cell mosaics. A key prediction of the theory is that the centers of iso-orientation domains must be arranged in a hexagonal lattice on the cortical surface. Here we show that such a pattern is observed in individuals of four different species: monkeys, cats, tree shrews and ferrets. The proposed mechanism explains how orientation maps can develop without requiring precise patterns of spontaneous activity or molecular guidance. Further, it offers a possible account for the emergence of orientation tuning in single neurons despite the absence of orderly orientation maps in rodents species.	[Paik, Se-Bum; Ringach, Dario L.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol, Los Angeles, CA 90095 USA; [Ringach, Dario L.] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles	Ringach, DL (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol, Los Angeles, CA 90095 USA.	dario@ucla.edu	Paik, Se-Bum/B-8277-2013	Paik, Se-Bum/0000-0002-4078-305X	 [EY017396];  [EY018322]; NATIONAL EYE INSTITUTE [R01EY018322] Funding Source: NIH RePORTER	; ; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We are grateful to A. Benucci and M. Carandini (University College London) for sharing their imaging data of cat primary visual cortex, supported by research grant EY017396 to M. Carandini. We also thank D. Fitzpatrick (Max Planck Florida Institute), L. White (Duke University), W. Bosking (University Texas at Austin) and Y. Li (UC Berkeley) for sharing existing ferret and tree shrew maps. We thank M. Carandini, D. Fitzpatrick, R. Shapley, J.-M. Alonso and E. Callaway for providing comments on earlier versions of this manuscript. This work was supported by research grant EY018322 (D.L.R.).	Adams DL, 2003, NAT NEUROSCI, V6, P113, DOI 10.1038/nn1004; ALBUS K, 1984, J PHYSIOL-LONDON, V348, P153, DOI 10.1113/jphysiol.1984.sp015104; AMIDROR I, 2000, THEORY MOIRE PHENOME; Anishchenko A, 2010, J NEUROPHYSIOL, V103, P1856, DOI 10.1152/jn.00896.2009; Benucci A, 2009, NAT NEUROSCI, V12, P1317, DOI 10.1038/nn.2398; Blair HT, 2007, J NEUROSCI, V27, P3211, DOI 10.1523/JNEUROSCI.4724-06.2007; BLASDEL GG, 1986, NATURE, V321, P579, DOI 10.1038/321579a0; BLASDEL GG, 1992, J NEUROSCI, V12, P3139, DOI 10.1523/JNEUROSCI.12-08-03139.1992; BONHOEFFER T, 1993, J NEUROSCI, V13, P4157; BONHOEFFER T, 1991, NATURE, V353, P429, DOI 10.1038/353429a0; BRAASTAD BO, 1985, J NEUROPHYSIOL, V53, P1158, DOI 10.1152/jn.1985.53.5.1158; Chapman B, 1996, J NEUROSCI, V16, P6443; Crair MC, 1998, SCIENCE, V279, P566, DOI 10.1126/science.279.5350.566; Das A, 1997, NATURE, V387, P594, DOI 10.1038/42461; Eglen SJ, 2005, VISUAL NEUROSCI, V22, P859, DOI 10.1017/S0952523805226147; Gauthier JL, 2009, J NEUROSCI, V29, P4675, DOI 10.1523/JNEUROSCI.5294-08.2009; Godecke I, 1997, EUR J NEUROSCI, V9, P1754; Horton JC, 2005, PHILOS T R SOC B, V360, P837, DOI 10.1098/rstb.2005.1623; HUBEL DH, 1963, J NEUROPHYSIOL, V26, P994, DOI 10.1152/jn.1963.26.6.994; HUBEL DH, 1977, PROC R SOC SER B-BIO, V198, P1, DOI 10.1098/rspb.1977.0085; Jin JZ, 2011, NAT NEUROSCI, V14, P232, DOI 10.1038/nn.2729; Jin JZ, 2008, NAT NEUROSCI, V11, P88, DOI 10.1038/nn2029; LIVINGSTONE MS, 1995, VISION RES, V35, P345, DOI 10.1016/0042-6989(94)00133-7; MILLER KD, 1992, NEUROREPORT, V3, P73, DOI 10.1097/00001756-199201000-00019; MILLER KD, 1994, J NEUROSCI, V14, P409; Miller KD, 1999, J NEUROBIOL, V41, P44, DOI 10.1002/(SICI)1097-4695(199910)41:1<44::AID-NEU7>3.0.CO;2-V; Muir DR, 2011, CEREB CORTEX, V21, P2244, DOI 10.1093/cercor/bhq290; Niell CM, 2008, J NEUROSCI, V28, P7520, DOI 10.1523/JNEUROSCI.0623-08.2008; OBERMAYER K, 1993, J NEUROSCI, V13, P4114; Ohki K, 2005, NATURE, V433, P597, DOI 10.1038/nature03274; Ohshiro T, 2006, NAT NEUROSCI, V9, P1541, DOI 10.1038/nn1799; POGGIO GF, 1975, BRAIN RES, V100, P25, DOI 10.1016/0006-8993(75)90240-1; PURVES D, 1992, TRENDS NEUROSCI, V15, P362, DOI 10.1016/0166-2236(92)90180-G; REID RC, 1995, NATURE, V378, P281, DOI 10.1038/378281a0; Ringach DL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000251; Ringach DL, 2002, J NEUROPHYSIOL, V88, P455, DOI 10.1152/jn.2002.88.1.455; Ringach DL, 2004, J NEUROPHYSIOL, V92, P468, DOI 10.1152/jn.01202.2003; Rockhill RL, 2000, P NATL ACAD SCI USA, V97, P2303, DOI 10.1073/pnas.030413497; SHERK H, 1976, J NEUROPHYSIOL, V39, P63, DOI 10.1152/jn.1976.39.1.63; Smith SL, 2010, NAT NEUROSCI, V13, P1144, DOI 10.1038/nn.2620; SOODAK RE, 1987, P NATL ACAD SCI USA, V84, P3936, DOI 10.1073/pnas.84.11.3936; Swindale NV, 1996, NETWORK-COMP NEURAL, V7, P161, DOI 10.1088/0954-898X/7/2/002; Tavazoie SF, 2000, NAT NEUROSCI, V3, P608, DOI 10.1038/75786; TSO DY, 1990, SCIENCE, V249, P417, DOI 10.1126/science.2165630; Usrey WM, 1999, J NEUROPHYSIOL, V82, P3527, DOI 10.1152/jn.1999.82.6.3527; Van Hooser SD, 2005, J NEUROSCI, V25, P19, DOI 10.1523/JNEUROSCI.4042-04.2005; Van Hooser SD, 2007, NEUROSCIENTIST, V13, P639, DOI 10.1177/1073858407306597; Vanduffel W, 2002, CEREB CORTEX, V12, P647, DOI 10.1093/cercor/12.6.647; WASSLE H, 1981, PROC R SOC SER B-BIO, V212, P177, DOI 10.1098/rspb.1981.0033; White LE, 2001, NATURE, V411, P1049, DOI 10.1038/35082568	50	88	88	1	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2011	14	7					919	U147		10.1038/nn.2824	http://dx.doi.org/10.1038/nn.2824			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	783KR	21623365	Green Accepted			2022-12-28	WOS:000292081700021
J	Ohshiro, T; Angelaki, DE; DeAngelis, GC				Ohshiro, Tomokazu; Angelaki, Dora E.; DeAngelis, Gregory C.			A normalization model of multisensory integration	NATURE NEUROSCIENCE			English	Article							SUPERIOR COLLICULUS NEURONS; NEURAL-NETWORK MODEL; CAT STRIATE CORTEX; VISUAL-CORTEX; UNISENSORY INTEGRATION; POPULATION ACTIVITY; HEADING PERCEPTION; RECEPTIVE-FIELDS; SIMPLE CELLS; MST NEURONS	Responses of neurons that integrate multiple sensory inputs are traditionally characterized in terms of a set of empirical principles. However, a simple computational framework that accounts for these empirical features of multisensory integration has not been established. We propose that divisive normalization, acting at the stage of multisensory integration, can account for many of the empirical principles of multisensory integration shown by single neurons, such as the principle of inverse effectiveness and the spatial principle. This model, which uses a simple functional operation (normalization) for which there is considerable experimental support, also accounts for the recent observation that the mathematical rule by which multisensory neurons combine their inputs changes with cue reliability. The normalization model, which makes a strong testable prediction regarding cross-modal suppression, may therefore provide a simple unifying computational account of the important features of multisensory integration by neurons.	[Ohshiro, Tomokazu; DeAngelis, Gregory C.] Univ Rochester, Ctr Visual Sci, Dept Brain & Cognit Sci, Rochester, NY 14627 USA; [Angelaki, Dora E.] Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA	University of Rochester; Washington University (WUSTL)	DeAngelis, GC (corresponding author), Univ Rochester, Ctr Visual Sci, Dept Brain & Cognit Sci, Rochester, NY 14627 USA.	gdeangelis@cvs.rochester.edu		DeAngelis, Gregory/0000-0002-1635-1273	US National Institutes of Health [EY016178, EY019087]; NATIONAL EYE INSTITUTE [R01EY019087, R01EY016178] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We would like to thank R. Jacobs, A. Pouget, J. Drugowitsch, D. Barany, A. Anzai, T. Sanada, R. Sasaki and H. Kim for helpful discussions and comments on the manuscript. This work was supported by US National Institutes of Health R01 grants EY016178 to G.C.D. and EY019087 to D.E.A.	Abbott LF, 1997, SCIENCE, V275, P220, DOI 10.1126/science.275.5297.221; Alais D, 2004, CURR BIOL, V14, P257, DOI 10.1016/j.cub.2004.01.029; ALBRECHT DG, 1982, J NEUROPHYSIOL, V48, P217, DOI 10.1152/jn.1982.48.1.217; Alvarado JC, 2007, J NEUROPHYSIOL, V97, P3193, DOI 10.1152/jn.00018.2007; Alvarado JC, 2008, BRAIN RES, V1242, P13, DOI 10.1016/j.brainres.2008.03.074; Avillac M, 2007, J NEUROSCI, V27, P1922, DOI 10.1523/JNEUROSCI.2646-06.2007; Britten KH, 1999, J NEUROSCI, V19, P5074; Britten KH, 1998, J NEUROPHYSIOL, V80, P762, DOI 10.1152/jn.1998.80.2.762; Busse L, 2009, NEURON, V64, P931, DOI 10.1016/j.neuron.2009.11.004; Carandini M, 1997, J NEUROSCI, V17, P8621; Alvarado JC, 2009, J NEUROSCI, V29, P6580, DOI 10.1523/JNEUROSCI.0525-09.2009; Cuppini C, 2010, FRONT INTEGR NEUROSC, V4, DOI 10.3389/fnint.2010.00006; DEANGELIS GC, 1992, J NEUROPHYSIOL, V68, P144, DOI 10.1152/jn.1992.68.1.144; Duffy CJ, 1998, J NEUROPHYSIOL, V80, P1816, DOI 10.1152/jn.1998.80.4.1816; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; Fetsch CR, 2009, J NEUROSCI, V29, P15601, DOI 10.1523/JNEUROSCI.2574-09.2009; Gu Y, 2006, J NEUROSCI, V26, P73, DOI 10.1523/JNEUROSCI.2356-05.2006; Gu Y, 2008, NAT NEUROSCI, V11, P1201, DOI 10.1038/nn.2191; Gu Y, 2007, NAT NEUROSCI, V10, P1038, DOI 10.1038/nn1935; Gu Y, 2010, NEURON, V66, P596, DOI 10.1016/j.neuron.2010.04.026; HEEGER DJ, 1992, VISUAL NEUROSCI, V9, P181, DOI 10.1017/S0952523800009640; HEEGER DJ, 1992, VISUAL NEUROSCI, V9, P427, DOI 10.1017/S095252380001124X; Heuer HW, 2007, J NEUROPHYSIOL, V98, P1115, DOI 10.1152/jn.00083.2007; Jiang W, 2001, J NEUROPHYSIOL, V85, P506, DOI 10.1152/jn.2001.85.2.506; Kadunce DC, 1997, J NEUROPHYSIOL, V78, P2834, DOI 10.1152/jn.1997.78.6.2834; Kouh M, 2008, NEURAL COMPUT, V20, P1427, DOI 10.1162/neco.2008.02-07-466; Ma WJ, 2006, NAT NEUROSCI, V9, P1432, DOI 10.1038/nn1790; Magosso E, 2008, NEURAL NETWORKS, V21, P817, DOI 10.1016/j.neunet.2008.06.003; MEREDITH MA, 1987, J NEUROSCI, V7, P3215; Meredith MA, 1996, J NEUROPHYSIOL, V75, P1843, DOI 10.1152/jn.1996.75.5.1843; MEREDITH MA, 1986, BRAIN RES, V365, P350; MEREDITH MA, 1986, J NEUROPHYSIOL, V56, P640, DOI 10.1152/jn.1986.56.3.640; Morgan ML, 2008, NEURON, V59, P662, DOI 10.1016/j.neuron.2008.06.024; MORRONE MC, 1982, PROC R SOC SER B-BIO, V216, P335, DOI 10.1098/rspb.1982.0078; Olsen SR, 2010, NEURON, V66, P287, DOI 10.1016/j.neuron.2010.04.009; Patton PE, 2003, NEURAL COMPUT, V15, P783, DOI 10.1162/08997660360581903; Perrault TJ, 2005, J NEUROPHYSIOL, V93, P2575, DOI 10.1152/jn.00926.2004; Perrault TJ, 2003, J NEUROPHYSIOL, V90, P4022, DOI 10.1152/jn.00494.2003; Priebe NJ, 2006, NAT NEUROSCI, V9, P552, DOI 10.1038/nn1660; Priebe NJ, 2004, NAT NEUROSCI, V7, P1113, DOI 10.1038/nn1310; Recanzone GH, 1997, J NEUROPHYSIOL, V78, P2904, DOI 10.1152/jn.1997.78.6.2904; Reynolds JH, 2009, NEURON, V61, P168, DOI 10.1016/j.neuron.2009.01.002; Rowland BA, 2007, PERCEPTION, V36, P1431, DOI 10.1068/p5842; Simoncelli EP, 1998, VISION RES, V38, P743, DOI 10.1016/S0042-6989(97)00183-1; Stanford TR, 2005, J NEUROSCI, V25, P6499, DOI 10.1523/JNEUROSCI.5095-04.2005; Stein BE, 2008, NAT REV NEUROSCI, V9, P255, DOI 10.1038/nrn2331; Sugihara T, 2006, J NEUROSCI, V26, P11138, DOI 10.1523/JNEUROSCI.3550-06.2006; Tolhurst DJ, 1997, VISUAL NEUROSCI, V14, P293, DOI 10.1017/S0952523800011433; Ursino M, 2009, J COMPUT NEUROSCI, V26, P55, DOI 10.1007/s10827-008-0096-4; WALLACE MT, 1994, J NEUROPHYSIOL, V71, P429, DOI 10.1152/jn.1994.71.1.429	50	180	180	3	64	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2011	14	6					775	U281		10.1038/nn.2815	http://dx.doi.org/10.1038/nn.2815			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	768SH	21552274	Green Accepted			2022-12-28	WOS:000290958000022
J	Wilson, SR; Gerhold, KA; Bifolck-Fisher, A; Liu, Q; Patel, KN; Dong, XZ; Bautista, DM				Wilson, Sarah R.; Gerhold, Kristin A.; Bifolck-Fisher, Amber; Liu, Qin; Patel, Kush N.; Dong, Xinzhong; Bautista, Diana M.			TRPA1 is required for histamine-independent, Mas-related G protein-coupled receptor-mediated itch	NATURE NEUROSCIENCE			English	Article							G-BETA-GAMMA; ION-CHANNEL TRPA1; SPINOTHALAMIC TRACT NEURONS; ALLERGIC RHINITIS; ACTIVATED RECEPTOR-2; SPINAL-CORD; PAIN; PRURITUS; MICE; PATHWAY	Itch, the unpleasant sensation that evokes a desire to scratch, accompanies numerous skin and nervous system disorders. In many cases, pathological itch is insensitive to antihistamine treatment. Recent studies have identified members of the Mas-related G protein-coupled receptor (Mrgpr) family that are activated by mast cell mediators and promote histamine-independent itch. MrgprA3 and MrgprC11 act as receptors for the pruritogens chloroquine and BAM8-22, respectively. However, the signaling pathways and transduction channels activated downstream of these pruritogens are largely unknown. We found that TRPA1 is the downstream target of both MrgprA3 and MrgprC11 in cultured sensory neurons and heterologous cells. TRPA1 is required for Mrgpr-mediated signaling, as sensory neurons from TRPA1-deficient mice exhibited markedly diminished responses to chloroquine and BAM8-22. Similarly, TRPA1-deficient mice displayed little to no scratching in response to these pruritogens. Our findings indicate that TRPA1 is an essential component of the signaling pathways that promote histamine-independent itch.	[Wilson, Sarah R.; Gerhold, Kristin A.; Bifolck-Fisher, Amber; Bautista, Diana M.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Liu, Qin; Patel, Kush N.; Dong, Xinzhong] Johns Hopkins Univ, Sch Med, Ctr Sensory Biol, Solomon H Snyder Dept Neurosci, Baltimore, MD USA; [Liu, Qin; Patel, Kush N.; Dong, Xinzhong] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA	University of California System; University of California Berkeley; Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University	Bautista, DM (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	dbautista@berkeley.edu			US National Institutes of Health [DOD007123A]; Pew Scholars Program; Rita Allen Foundation; McKnight Scholars Fund; National Science Foundation; US National Institutes of Health; NATIONAL EYE INSTITUTE [T32EY017203] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR059385] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD007123] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pew Scholars Program; Rita Allen Foundation; McKnight Scholars Fund; National Science Foundation(National Science Foundation (NSF)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank M. Kollarik for advice on PCR, R. Brem for use of equipment, T. Morita for technical support, and R. Brem, J. Ngai, J. Sack, M. Tsunozaki, P. Aryal and M. Pellegrino for helpful discussions and critical reading of the manuscript. This study was supported by a US National Institutes of Health Innovator Award (DOD007123A), the Pew Scholars Program, the Rita Allen Foundation, and the McKnight Scholars Fund (D. M. B.), the National Science Foundation (S. R. W.), and a US National Institutes of Health grant (X.D.).	Abila B, 1994, Afr J Med Med Sci, V23, P139; AJAYI AA, 1989, EUR J CLIN PHARMACOL, V37, P539, DOI 10.1007/BF00558141; Andriantsoanirina V, 2010, SCAND J INFECT DIS, V42, P22, DOI 10.3109/00365540903289670; Bandell M, 2004, NEURON, V41, P849, DOI 10.1016/S0896-6273(04)00150-3; Bautista DM, 2006, CELL, V124, P1269, DOI 10.1016/j.cell.2006.02.023; Bianchi E, 2009, J NEUROCHEM, V111, P171, DOI 10.1111/j.1471-4159.2009.06308.x; Dascal N, 2001, TRENDS ENDOCRIN MET, V12, P391, DOI 10.1016/S1043-2760(01)00475-1; Davidson S, 2007, J NEUROSCI, V27, P10007, DOI 10.1523/JNEUROSCI.2862-07.2007; Davidson S, 2009, NAT NEUROSCI, V12, P544, DOI 10.1038/nn.2292; Eid SR, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-48; Guan Y, 2010, P NATL ACAD SCI USA, V107, P15933, DOI 10.1073/pnas.1011221107; Han SK, 2006, NEURON, V52, P691, DOI 10.1016/j.neuron.2006.09.036; Han SK, 2002, P NATL ACAD SCI USA, V99, P14740, DOI 10.1073/pnas.192565799; Howarth PH, 2000, ALLERGY, V55, P7, DOI 10.1034/j.1398-9995.2000.00802.x; Ikoma A, 2006, NAT REV NEUROSCI, V7, P535, DOI 10.1038/nrn1950; Imamachi N, 2009, P NATL ACAD SCI USA, V106, P11330, DOI 10.1073/pnas.0905605106; Johanek LM, 2008, J NEUROSCI, V28, P7659, DOI 10.1523/JNEUROSCI.1760-08.2008; Jordt SE, 2004, NATURE, V427, P260, DOI 10.1038/nature02282; JULIUS D, 1988, SCIENCE, V241, P558, DOI 10.1126/science.3399891; Kerstein PC, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-19; Kim BM, 2004, NEUROSCI LETT, V361, P159, DOI 10.1016/j.neulet.2004.01.019; Kremeyer B, 2010, NEURON, V66, P671, DOI 10.1016/j.neuron.2010.04.030; Lee MG, 2008, J IMMUNOL, V180, P2251, DOI 10.4049/jimmunol.180.4.2251; Liu Q, 2009, CELL, V139, P1353, DOI 10.1016/j.cell.2009.11.034; Ma QF, 2010, J CLIN INVEST, V120, P3773, DOI 10.1172/JCI43426; Mathews JL, 2008, J NEUROSCI, V28, P12183, DOI 10.1523/JNEUROSCI.2326-08.2008; McNamara CR, 2007, P NATL ACAD SCI USA, V104, P13525, DOI 10.1073/pnas.0705924104; Montell C, 2008, NEURON, V58, P825, DOI 10.1016/j.neuron.2008.06.006; Namer B, 2008, J NEUROPHYSIOL, V100, P2062, DOI 10.1152/jn.90482.2008; Nathan RA, 2009, SOUTH MED J, V102, P935, DOI 10.1097/SMJ.0b013e3181b01c68; Parsons ME, 2006, BRIT J PHARMACOL, V147, pS127, DOI 10.1038/sj.bjp.0706440; Reddy VB, 2008, J NEUROSCI, V28, P4331, DOI 10.1523/JNEUROSCI.0716-08.2008; Rishal I, 2005, J BIOL CHEM, V280, P16685, DOI 10.1074/jbc.M412196200; Ross SE, 2010, NEURON, V65, P886, DOI 10.1016/j.neuron.2010.02.025; Rousset M, 2004, J BIOL CHEM, V279, P14619, DOI 10.1074/jbc.M313284200; Rukwied R, 2000, BRIT J DERMATOL, V142, P1114, DOI 10.1046/j.1365-2133.2000.03535.x; Sardana N, 2010, ALLERGY ASTHMA PROC, V31, P5, DOI 10.2500/aap.2010.31.3308; Schmelz M, 2003, J NEUROPHYSIOL, V89, P2441, DOI 10.1152/jn.01139.2002; Shim WS, 2007, J NEUROSCI, V27, P2331, DOI 10.1523/JNEUROSCI.4643-06.2007; Shimada SG, 2008, PAIN, V139, P681, DOI 10.1016/j.pain.2008.08.002; Steinhoff M, 2003, J NEUROSCI, V23, P6176; Sun YG, 2007, NATURE, V448, P700, DOI 10.1038/nature06029; Sun YG, 2009, SCIENCE, V325, P1531, DOI 10.1126/science.1174868; Tsujii K, 2009, J PHARMACOL SCI, V109, P388, DOI 10.1254/jphs.08332FP; Wang S, 2008, BRAIN, V131, P1241, DOI 10.1093/brain/awn060; Wang YY, 2008, J BIOL CHEM, V283, P32691, DOI 10.1074/jbc.M803568200; Yosipovitch G, 2003, AM J CLIN DERMATOL, V4, P617, DOI 10.2165/00128071-200304090-00004; Zhou YX, 2008, BIOCHEMISTRY-US, V47, P4410, DOI 10.1021/bi800044n; Zurborg S, 2007, NAT NEUROSCI, V10, P277, DOI 10.1038/nn1843; Zylka MJ, 2003, P NATL ACAD SCI USA, V100, P10043, DOI 10.1073/pnas.1732949100	50	394	414	4	82	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2011	14	5					595	U82		10.1038/nn.2789	http://dx.doi.org/10.1038/nn.2789			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	754VU	21460831	Green Submitted, Green Accepted			2022-12-28	WOS:000289886600015
J	Faas, GC; Raghavachari, S; Lisman, JE; Mody, I				Faas, Guido C.; Raghavachari, Sridhar; Lisman, John E.; Mody, Istvan			Calmodulin as a direct detector of Ca2+ signals	NATURE NEUROSCIENCE			English	Article							IQ-MOTIF PROTEINS; CALCIUM-BINDING; HIPPOCAMPAL-NEURONS; CALBINDIN-D-28K; DENDRITES; SPINES; BRAIN	Many forms of signal transduction occur when Ca2+ enters the cytoplasm of a cell. It has been generally thought that there is a fast buffer that rapidly reduces the free Ca2+ level and that it is this buffered level of Ca2+ that triggers downstream biochemical processes, notably the activation of calmodulin (CaM) and the resulting activation of CaM-dependent enzymes. Given the importance of these transduction processes, it is crucial to understand exactly how Ca2+ activates CaM. We have determined the rate at which Ca2+ binds to CaM and found that Ca2+ binds more rapidly to CaM than to other Ca2+-binding proteins. This property of CaM and its high concentration support a new view of signal transduction: CaM directly intercepts incoming Ca2+ and sets the free Ca2+ level (that is, it strongly contributes to fast Ca2+ buffering) rather than responding to the lower Ca2+ level set by other buffers. This property is crucial for making CaM an efficient transducer. Our results also suggest that other Ca2+ binding proteins have a previously undescribed role in regulating the lifetime of Ca2+ bound to CaM and thereby setting the gain of signal transduction.	[Faas, Guido C.; Mody, Istvan] Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90024 USA; [Raghavachari, Sridhar] Duke Univ, Dept Neurobiol, Durham, NC USA; [Lisman, John E.] Brandeis Univ, Dept Biol, Waltham, MA 02254 USA; [Mody, Istvan] Univ Calif Los Angeles, Dept Physiol, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; Duke University; Brandeis University; University of California System; University of California Los Angeles	Faas, GC (corresponding author), Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90024 USA.	gfaas@ucla.edu		Faas, Guido/0000-0002-1339-7698	US National Institutes of Health (NIH) [NS027528, NS030549]; Coelho Endowment; NIH [DA027807]; National Science Foundation [NSF0642000]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS027528, R37NS030549, R01NS030549] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA027807] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Coelho Endowment; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank J. Adelman (The Vollum Institute) for purified CaM and mutants of CaM (CaM<INF>EF12</INF> and CaM<INF>EF34</INF>), K. Baimbridge (University of Britsh Columbia) for purified calbindin and E. B. S. Faas (Syrinx Design) for help in designing the photodiode pre-amplifier. J. E. L. would like to thank W. Ross and I. Llano for conversations at the Marine Biological Laboratory Woods Hole that led to important insights into this problem. Supported by the US National Institutes of Health (NIH) grants NS027528, NS030549 and the Coelho Endowment to I. M., NIH grant DA027807 to J. E. L. and S. R., and the National Science Foundation grant NSF0642000 to S.R.	Arnold DB, 1997, P NATL ACAD SCI USA, V94, P8842, DOI 10.1073/pnas.94.16.8842; BANAYSCHWARTZ M, 1992, AGE, V15, P51, DOI 10.1007/BF02435024; Berggard T, 2002, J BIOL CHEM, V277, P16662, DOI 10.1074/jbc.M200415200; Bers DM, 2008, ANNU REV PHYSIOL, V70, P23, DOI 10.1146/annurev.physiol.70.113006.100455; BIBER A, 1984, EXP BRAIN RES, V56, P323; Bloodgood BL, 2005, SCIENCE, V310, P866, DOI 10.1126/science.1114816; BROWN BL, 1985, CLIN ENDOCRINOL, V23, P201, DOI 10.1111/j.1365-2265.1985.tb00216.x; Cornelisse LN, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001073; Faas GC, 2005, BIOPHYS J, V88, P4421, DOI 10.1529/biophysj.104.057745; Faas GC, 2007, PLOS BIOL, V5, P2646, DOI 10.1371/journal.pbio.0050311; Gaertner TR, 2004, J BIOL CHEM, V279, P39374, DOI 10.1074/jbc.M405352200; Helmchen F, 1996, BIOPHYS J, V70, P1069, DOI 10.1016/S0006-3495(96)79653-4; Kubota Y, 2008, J NEUROPHYSIOL, V99, P264, DOI 10.1152/jn.00876.2007; Kubota Y, 2007, BIOPHYS J, V93, P3848, DOI 10.1529/biophysj.107.106849; Lee SJR, 2009, NATURE, V458, P299, DOI 10.1038/nature07842; Lee SH, 2000, J PHYSIOL-LONDON, V525, P405, DOI 10.1111/j.1469-7793.2000.t01-3-00405.x; LINSE S, 1991, J BIOL CHEM, V266, P8050; Meinrenken CJ, 2002, J NEUROSCI, V22, P1648, DOI 10.1523/JNEUROSCI.22-05-01648.2002; Muller A, 2005, J NEUROSCI, V25, P558, DOI 10.1523/JNEUROSCI.3799-04.2005; Nagerl UV, 2000, BIOPHYS J, V79, P3009, DOI 10.1016/S0006-3495(00)76537-4; Nagerl UV, 2000, J NEUROSCI, V20, P1831; NEHER E, 1992, J PHYSIOL-LONDON, V450, P273, DOI 10.1113/jphysiol.1992.sp019127; Otmakhov N, 1997, J NEUROSCI, V17, P5357; PORUMB T, 1994, ANAL BIOCHEM, V220, P227, DOI 10.1006/abio.1994.1332; Putkey JA, 2003, J BIOL CHEM, V278, P49667, DOI 10.1074/jbc.C300372200; Sabatini BL, 2002, NEURON, V33, P439, DOI 10.1016/S0896-6273(02)00573-1; Scheuss V, 2006, J NEUROSCI, V26, P8183, DOI 10.1523/JNEUROSCI.1962-06.2006; Xia ZG, 2005, NAT REV NEUROSCI, V6, P267, DOI 10.1038/nrn1647	28	125	126	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2011	14	3					301	304		10.1038/nn.2746	http://dx.doi.org/10.1038/nn.2746			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	725MW	21258328	Green Accepted			2022-12-28	WOS:000287650100009
J	Schwarzkopf, DS; Song, C; Rees, G				Schwarzkopf, D. Samuel; Song, Chen; Rees, Geraint			The surface area of human V1 predicts the subjective experience of object size	NATURE NEUROSCIENCE			English	Article							PRIMARY VISUAL-CORTEX; EBBINGHAUS ILLUSION; REPRESENTATION; CONNECTIONS	The surface area of human primary visual cortex (V1) varies substantially between individuals for unknown reasons. We found that this variability was strongly and negatively correlated with the magnitude of two common visual illusions, where two physically identical objects appear different in size as a result of their context. Because such illusions dissociate conscious perception from physical stimulation, our findings indicate that the surface area of V1 predicts variability in conscious experience.	[Schwarzkopf, D. Samuel; Song, Chen; Rees, Geraint] UCL, Inst Cognit Neurosci, London, England; [Schwarzkopf, D. Samuel; Rees, Geraint] UCL, Wellcome Trust Ctr Neuroimaging, London, England	University of London; University College London; University of London; University College London	Schwarzkopf, DS (corresponding author), UCL, Inst Cognit Neurosci, London, England.	s.schwarzkopf@fil.ion.ucl.ac.uk	Schwarzkopf, D. Sam/F-5285-2012; Song, Chen/B-3269-2008; Song, Chen/ABC-2033-2021; Rees, Geraint/C-1493-2008	Schwarzkopf, D. Sam/0000-0003-3686-1622; Song, Chen/0000-0002-5418-5747; Rees, Geraint/0000-0002-9623-7007	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	We thank F. Sengpiel for comments on the manuscript. This work was supported by the Wellcome Trust.	Adams DL, 2007, J NEUROSCI, V27, P10391, DOI 10.1523/JNEUROSCI.2923-07.2007; Bosking WH, 1997, J NEUROSCI, V17, P2112; Dakin S, 2005, NEURON, V48, P497, DOI 10.1016/j.neuron.2005.10.018; de Fockert J, 2007, J EXP PSYCHOL HUMAN, V33, P738, DOI 10.1037/0096-1523.33.3.738; Dougherty RF, 2003, J VISION, V3, P586, DOI 10.1167/3.10.1; Duncan RO, 2003, NEURON, V38, P659, DOI 10.1016/S0896-6273(03)00265-4; Edden RAE, 2009, J NEUROSCI, V29, P15721, DOI 10.1523/JNEUROSCI.4426-09.2009; Fang F, 2008, CURR BIOL, V18, P1707, DOI 10.1016/j.cub.2008.09.025; FISHER GH, 1967, NATURE, V215, P553, DOI 10.1038/215553a0; Frith C, 1999, TRENDS COGN SCI, V3, P105, DOI 10.1016/S1364-6613(99)01281-4; GILBERT CD, 1989, J NEUROSCI, V9, P2432; MASSARO DW, 1971, J EXP PSYCHOL, V89, P147, DOI 10.1037/h0031158; Murray SO, 2006, NAT NEUROSCI, V9, P429, DOI 10.1038/nn1641; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376	14	188	189	0	47	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2011	14	1					28	30		10.1038/nn.2706	http://dx.doi.org/10.1038/nn.2706			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	699TE	21131954	Green Accepted			2022-12-28	WOS:000285684900010
J	Grueter, BA; Brasnjo, G; Malenka, RC				Grueter, Brad A.; Brasnjo, Gabor; Malenka, Robert C.			Postsynaptic TRPV1 triggers cell type-specific long-term depression in the nucleus accumbens	NATURE NEUROSCIENCE			English	Article							COCAINE-INDUCED REINSTATEMENT; CENTRAL-NERVOUS-SYSTEM; IN-VIVO EXPOSURE; SYNAPTIC PLASTICITY; BEHAVIORAL SENSITIZATION; RECEPTORS; CHANNELS; ANANDAMIDE; EXPRESSION; ADDICTION	Synaptic modifications in the nucleus accumbens (NAc) are important for adaptive and pathological reward-dependent learning. Medium spiny neurons (MSNs), the major cell type in the NAc, participate in two parallel circuits that subserve distinct behavioral functions, yet little is known about differences in their electrophysiological and synaptic properties. Using bacterial artificial chromosome transgenic mice, we found that synaptic activation of group I metabotropic glutamate receptors in NAc MSNs in the indirect, but not direct, pathway led to the production of endocannabinoids, which activated presynaptic CB1 receptors to trigger endocannabinoid-mediated long-term depression (eCB-LTD) as well as postsynaptic transient receptor potential vanilloid 1 (TRPV1) channels to trigger a form of LTD resulting from endocytosis of AMPA receptors. These results reveal a previously unknown action of TRPV1 channels and indicate that the postsynaptic generation of endocannabinoids can modulate synaptic strength in a cell type-specific fashion by activating distinct pre- and postsynaptic targets.	[Grueter, Brad A.; Brasnjo, Gabor; Malenka, Robert C.] Stanford Univ, Sch Med, Nancy Pritzker Lab, Dept Psychiat & Behav Sci, Palo Alto, CA 94304 USA	Stanford University	Malenka, RC (corresponding author), Stanford Univ, Sch Med, Nancy Pritzker Lab, Dept Psychiat & Behav Sci, Palo Alto, CA 94304 USA.	malenka@stanford.edu		Grueter, Brad/0000-0002-4224-3866	National Institute on Drug Abuse [DA009264, DA008227, 5F32DA023741-2]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA009264, P01DA008227, F32DA023741] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank members of the Malenka lab for their comments. This work was supported by grants from the National Institute on Drug Abuse (DA009264, DA008227 to R.C.M.; 5F32DA023741-2 to B.A.G.).	Brebner K, 2005, SCIENCE, V310, P1340, DOI 10.1126/science.1116894; Caterina MJ, 2001, ANNU REV NEUROSCI, V24, P487, DOI 10.1146/annurev.neuro.24.1.487; Chavez AE, 2010, NAT NEUROSCI, V13, P1511, DOI 10.1038/nn.2684; Conrad KL, 2008, NATURE, V454, P118, DOI 10.1038/nature06995; de Lago E, 2004, BRAIN RES, V1007, P152, DOI 10.1016/j.brainres.2004.02.016; Di Marzo V, 2001, EUR J PHARMACOL, V420, P123, DOI 10.1016/S0014-2999(01)01012-3; Durieux PF, 2009, NAT NEUROSCI, V12, P393, DOI 10.1038/nn.2286; Fourgeaud L, 2004, J NEUROSCI, V24, P6939, DOI 10.1523/JNEUROSCI.0671-04.2004; Gibson HE, 2008, NEURON, V57, P746, DOI 10.1016/j.neuron.2007.12.027; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Grueter BA, 2006, J NEUROSCI, V26, P3210, DOI 10.1523/JNEUROSCI.0170-06.2006; Heifets BD, 2009, ANNU REV PHYSIOL, V71, P283, DOI 10.1146/annurev.physiol.010908.163149; Hikida T, 2010, NEURON, V66, P896, DOI 10.1016/j.neuron.2010.05.011; Hoffman AF, 2003, J NEUROSCI, V23, P4815; Kalivas PW, 2009, NAT REV NEUROSCI, V10, P561, DOI 10.1038/nrn2515; Kasanetz F, 2010, SCIENCE, V328, P1709, DOI 10.1126/science.1187801; Kauer JA, 2007, NAT REV NEUROSCI, V8, P844, DOI 10.1038/nrn2234; Kauer JA, 2009, TRENDS NEUROSCI, V32, P215, DOI 10.1016/j.tins.2008.12.006; Kourrich S, 2007, J NEUROSCI, V27, P7921, DOI 10.1523/JNEUROSCI.1859-07.2007; Kravitz AV, 2010, NATURE, V466, P622, DOI 10.1038/nature09159; Kreitzer AC, 2007, NATURE, V445, P643, DOI 10.1038/nature05506; Kreitzer AC, 2008, NEURON, V60, P543, DOI 10.1016/j.neuron.2008.11.005; Lee J, 2006, NEUROPHARMACOLOGY, V51, P557, DOI 10.1016/j.neuropharm.2006.04.016; Luscher C, 1999, NEURON, V24, P649, DOI 10.1016/S0896-6273(00)81119-8; Maccarrone M, 2008, NAT NEUROSCI, V11, P152, DOI 10.1038/nn2042; Maione S, 2009, J PHYSIOL-LONDON, V587, P2521, DOI 10.1113/jphysiol.2009.171900; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Marsch R, 2007, J NEUROSCI, V27, P832, DOI 10.1523/JNEUROSCI.3303-06.2007; Mato S, 2004, NAT NEUROSCI, V7, P585, DOI 10.1038/nn1251; McFarland K, 2001, J NEUROSCI, V21, P8655; Micale V, 2009, NEUROPSYCHOPHARMACOL, V34, P593, DOI 10.1038/npp.2008.98; Ramsey IS, 2006, ANNU REV PHYSIOL, V68, P619, DOI 10.1146/annurev.physiol.68.040204.100431; Robbe D, 2002, P NATL ACAD SCI USA, V99, P8384, DOI 10.1073/pnas.122149199; Roberts JC, 2004, BRAIN RES, V995, P176, DOI 10.1016/j.brainres.2003.10.001; Schoch S, 2002, NATURE, V415, P321, DOI 10.1038/415321a; Sesack SR, 2010, NEUROPSYCHOPHARMACOL, V35, P27, DOI 10.1038/npp.2009.93; Starowicz K, 2008, CURR PHARM DESIGN, V14, P42; Szumlinski KK, 2006, CURR OPIN NEUROBIOL, V16, P251, DOI 10.1016/j.conb.2006.05.002; Tang XC, 2005, J NEUROSCI, V25, P4512, DOI 10.1523/JNEUROSCI.0685-05.2005; Thomas MJ, 2001, NAT NEUROSCI, V4, P1217, DOI 10.1038/nn757; Torregrossa MM, 2008, NEUROSCI LETT, V438, P142, DOI 10.1016/j.neulet.2008.04.016; Tzavara ET, 2006, BIOL PSYCHIAT, V59, P508, DOI 10.1016/j.biopsych.2005.08.019; van der Stelt M, 2005, EMBO J, V24, P3026, DOI 10.1038/sj.emboj.7600784; Vezina P, 2009, NEUROPHARMACOLOGY, V56, P160, DOI 10.1016/j.neuropharm.2008.06.070; Wettschureck N, 2006, MOL CELL BIOL, V26, P5888, DOI 10.1128/MCB.00397-06; Zygmunt PM, 1999, NATURE, V400, P452, DOI 10.1038/22761	46	254	257	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2010	13	12					1519	U107		10.1038/nn.2685	http://dx.doi.org/10.1038/nn.2685			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	684CW	21076424	Green Accepted			2022-12-28	WOS:000284525800017
J	Herrmann, K; Montaser-Kouhsari, L; Carrasco, M; Heeger, DJ				Herrmann, Katrin; Montaser-Kouhsari, Leila; Carrasco, Marisa; Heeger, David J.			When size matters: attention affects performance by contrast or response gain	NATURE NEUROSCIENCE			English	Article							HUMAN VISUAL-CORTEX; SPATIAL ATTENTION; COVERT ATTENTION; PHYSIOLOGICAL CORRELATE; SUSTAINED ATTENTION; ZOOM LENS; AREA V4; MECHANISMS; FMRI; SENSITIVITY	Covert attention, the selective processing of visual information in the absence of eye movements, improves behavioral performance. We found that attention, both exogenous (involuntary) and endogenous (voluntary), can affect performance by contrast or response gain changes, depending on the stimulus size and the relative size of the attention field. These two variables were manipulated in a cueing task while stimulus contrast was varied. We observed a change in behavioral performance consonant with a change in contrast gain for small stimuli paired with spatial uncertainty and a change in response gain for large stimuli presented at one location (no uncertainty) and surrounded by irrelevant flanking distracters. A complementary neuroimaging experiment revealed that observers' attention fields were wider with than without spatial uncertainty. Our results support important predictions of the normalization model of attention and reconcile previous, seemingly contradictory findings on the effects of visual attention.	[Herrmann, Katrin; Montaser-Kouhsari, Leila; Carrasco, Marisa; Heeger, David J.] NYU, Dept Psychol, New York, NY 10003 USA; [Carrasco, Marisa; Heeger, David J.] NYU, Ctr Neural Sci, New York, NY 10003 USA	New York University; New York University	Heeger, DJ (corresponding author), NYU, Dept Psychol, 6 Washington Pl, New York, NY 10003 USA.	david.heeger@nyu.edu			US National Institutes of Health [R01-EY019693, R01-MH06980, R01-EY016200]; NATIONAL EYE INSTITUTE [R01EY016200, R01EY019693] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH069880] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank Mike Landy and members of the Carrasco and Heeger laboratories for their helpful comments. The psychophysical experiments were presented at the Annual Meeting of the Vision Science Society (2009) and the European Conference on Visual Perception (2009). This work was supported by US National Institutes of Health grants R01-EY019693 (D.J.H. and M.C.), R01-MH06980 (D.J.H.) and R01-EY016200 (M.C.).	Bartels A, 2008, TRENDS NEUROSCI, V31, P444, DOI 10.1016/j.tins.2008.06.004; Belopolsky AV, 2007, PSYCHON B REV, V14, P934, DOI 10.3758/BF03194124; Boynton GM, 2009, VISION RES, V49, P1129, DOI 10.1016/j.visres.2008.11.001; Brefczynski JA, 1999, NAT NEUROSCI, V2, P370, DOI 10.1038/7280; Buracas GT, 2007, J NEUROSCI, V27, P93, DOI 10.1523/JNEUROSCI.3162-06.2007; Carandini M, 2004, PLOS BIOL, V2, P1483, DOI 10.1371/journal.pbio.0020264; Carrasco M, 2006, PROG BRAIN RES, V154, P33; CASTIELLO U, 1990, ACTA PSYCHOL, V73, P195, DOI 10.1016/0001-6918(90)90022-8; Datta R, 2009, VISION RES, V49, P1037, DOI 10.1016/j.visres.2009.01.014; DEAN AF, 1981, EXP BRAIN RES, V44, P437; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Donner TH, 2008, J NEUROSCI, V28, P10298, DOI 10.1523/JNEUROSCI.2371-08.2008; Gandhi SP, 1999, P NATL ACAD SCI USA, V96, P3314, DOI 10.1073/pnas.96.6.3314; Giordano AM, 2009, J VISION, V9, DOI 10.1167/9.3.30; Heeger DJ, 2002, NAT REV NEUROSCI, V3, P142, DOI 10.1038/nrn730; HERNANDEZ M, ATTEN PERCEPT PSYCHO, V72, P963; Huang LQ, 2005, VISION RES, V45, P1201, DOI 10.1016/j.visres.2004.10.024; Jazayeri M, 2006, NAT NEUROSCI, V9, P690, DOI 10.1038/nn1691; JONIDES J, 1981, COGNITION, V10, P145, DOI 10.1016/0010-0277(81)90038-X; Kastner S, 1999, NEURON, V22, P751, DOI 10.1016/S0896-6273(00)80734-5; Katkov M, 2007, VISION RES, V47, P2855, DOI 10.1016/j.visres.2007.06.024; Lee J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004651; Li X, 2008, P NATL ACAD SCI USA, V105, P6202, DOI 10.1073/pnas.0801390105; Ling S, 2006, VISION RES, V46, P1210, DOI 10.1016/j.visres.2005.05.008; Ling S, 2006, NAT NEUROSCI, V9, P1243, DOI 10.1038/nn1761; Liu TS, 2007, VISION RES, V47, P108, DOI 10.1016/j.visres.2006.09.017; Liu TS, 2005, NEURON, V45, P469, DOI 10.1016/j.neuron.2004.12.039; Logothetis NK, 2004, ANNU REV PHYSIOL, V66, P735, DOI 10.1146/annurev.physiol.66.082602.092845; Lu ZL, 2000, J EXP PSYCHOL HUMAN, V26, P1534, DOI 10.1037//0096-1523.26.5.1534; Martinez-Trujillo JC, 2002, NEURON, V35, P365, DOI 10.1016/S0896-6273(02)00778-X; McAdams CJ, 1999, J NEUROSCI, V19, P431, DOI 10.1523/JNEUROSCI.19-01-00431.1999; Morrone MC, 2004, VISION RES, V44, P1389, DOI 10.1016/j.visres.2003.10.014; Morrone MC, 2002, CURR BIOL, V12, P1134, DOI 10.1016/S0960-9822(02)00921-1; NAKAYAMA K, 1989, VISION RES, V29, P1631, DOI 10.1016/0042-6989(89)90144-2; Pestilli F, 2005, VISION RES, V45, P1867, DOI 10.1016/j.visres.2005.01.019; Pestilli F, 2007, J VISION, V7, DOI 10.1167/7.7.9; Pestilli F, 2009, VISION RES, V49, P1144, DOI 10.1016/j.visres.2008.09.018; Reynolds JH, 2004, ANNU REV NEUROSCI, V27, P611, DOI 10.1146/annurev.neuro.26.041002.131039; Reynolds JH, 1999, J NEUROSCI, V19, P1736; Reynolds JH, 2000, NEURON, V26, P703, DOI 10.1016/S0896-6273(00)81206-4; Reynolds JH, 2009, NEURON, V61, P168, DOI 10.1016/j.neuron.2009.01.002; SCLAR G, 1990, VISION RES, V30, P1, DOI 10.1016/0042-6989(90)90123-3; Somers DC, 1999, P NATL ACAD SCI USA, V96, P1663, DOI 10.1073/pnas.96.4.1663; Sperling G., 1986, HDB PERCEPTION PERFO, V1, P1; Tootell RBH, 1998, NEURON, V21, P1409, DOI 10.1016/S0896-6273(00)80659-5; Wandell BA, 2007, NEURON, V56, P366, DOI 10.1016/j.neuron.2007.10.012; Williford T, 2006, J NEUROPHYSIOL, V96, P40, DOI 10.1152/jn.01207.2005; Yeshurun Y, 2008, VISION RES, V48, P80, DOI 10.1016/j.visres.2007.10.015	50	193	194	2	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2010	13	12					1554	U149		10.1038/nn.2669	http://dx.doi.org/10.1038/nn.2669			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	684CW	21057509	Green Accepted			2022-12-28	WOS:000284525800022
J	Lomber, SG; Meredith, MA; Kral, A				Lomber, Stephen G.; Meredith, M. Alex; Kral, Andrej			Cross-modal plasticity in specific auditory cortices underlies visual compensations in the deaf	NATURE NEUROSCIENCE			English	Article							DORSAL ZONE; REVERSIBLE DEACTIVATION; COOLING DEACTIVATION; DISCRIMINATION TASK; DOUBLE DISSOCIATION; CONGENITALLY BLIND; SOUND LOCALIZATION; MOVEMENT DETECTION; PARIETAL CORTEX; WHITE CATS	When the brain is deprived of input from one sensory modality, it often compensates with supranormal performance in one or more of the intact sensory systems. In the absence of acoustic input, it has been proposed that cross-modal reorganization of deaf auditory cortex may provide the neural substrate mediating compensatory visual function. We tested this hypothesis using a battery of visual psychophysical tasks and found that congenitally deaf cats, compared with hearing cats, have superior localization in the peripheral field and lower visual movement detection thresholds. In the deaf cats, reversible deactivation of posterior auditory cortex selectively eliminated superior visual localization abilities, whereas deactivation of the dorsal auditory cortex eliminated superior visual motion detection. Our results indicate that enhanced visual performance in the deaf is caused by cross-modal reorganization of deaf auditory cortex and it is possible to localize individual visual functions in discrete portions of reorganized auditory cortex.	[Lomber, Stephen G.] Univ Western Ontario, Dept Psychol, Dept Physiol & Pharmacol, Ctr Brain & Mind, London, ON, Canada; [Meredith, M. Alex] Virginia Commonwealth Univ, Sch Med, Dept Anat & Neurobiol, Richmond, VA USA; [Kral, Andrej] Hannover Med Sch, Inst Audioneurotechnol, Dept Expt Otol, Hannover, Germany	Western University (University of Western Ontario); Virginia Commonwealth University; Hannover Medical School	Lomber, SG (corresponding author), Univ Western Ontario, Dept Psychol, Dept Physiol & Pharmacol, Ctr Brain & Mind, London, ON, Canada.	steve.lomber@uwo.ca	Lomber, Stephen/B-6820-2015	Lomber, Stephen/0000-0002-3001-7909; Kral, Andrej/0000-0002-7762-4642; Meredith, M Alex/0000-0002-8081-6901	Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council of Canada; Deutsche Forschungsgemeinschaft; US National Institutes of Health	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank B. D. Corneil, M. A. Goodale, W. A. Roberts, D. F. Sherry, B. Timney and J. Snow for helpful discussions and comments on the project and manuscript. We thank A. J. McMillan and A. Carrasco for preparing all of the figures and for help with the preparation of the manuscript. We also thank A. J. McMillan for assistance with the fabrication of the cooling loops, surgical implantations and care of the animals. J. G. Mellott graciously assisted with the histological processing of the brains. We gratefully acknowledge the support of the Canadian Institutes of Health Research, Natural Sciences and Engineering Research Council of Canada, Deutsche Forschungsgemeinschaft and the US National Institutes of Health.	Auer ET, 2007, NEUROREPORT, V18, P645, DOI 10.1097/WNR.0b013e3280d943b9; Bavelier D, 2002, NAT REV NEUROSCI, V3, P443, DOI 10.1038/nrn848; Bavelier D, 2000, J NEUROSCI, V20, DOI 10.1523/JNEUROSCI.20-17-j0001.2000; Bavelier D, 2006, TRENDS COGN SCI, V10, P512, DOI 10.1016/j.tics.2006.09.006; Berkley M.A., 1970, ANIMAL PSYCHOPHYSICS, P231; Bosworth RG, 2002, BRAIN COGNITION, V49, P152, DOI 10.1006/brcg.2001.1497; BROSS M, 1979, PERCEPT MOTOR SKILL, V48, P187, DOI 10.2466/pms.1979.48.1.187; Brozinsky CJ, 2004, COGNITIVE BRAIN RES, V21, P1, DOI 10.1016/j.cogbrainres.2004.05.002; Carrasco A, 2009, J NEUROSCI, V29, P14323, DOI 10.1523/JNEUROSCI.2905-09.2009; Collignon O, 2009, EXP BRAIN RES, V192, P343, DOI 10.1007/s00221-008-1553-z; Finney EM, 2001, NAT NEUROSCI, V4, P1171, DOI 10.1038/nn763; Finney EM, 2001, COGNITIVE BRAIN RES, V11, P171, DOI 10.1016/S0926-6410(00)00082-3; GUILLERY RW, 1981, INVEST OPHTH VIS SCI, V21, P27; HALL SE, 1991, BEHAV BRAIN RES, V44, P1, DOI 10.1016/S0166-4328(05)80233-5; He JF, 1997, J NEUROSCI, V17, P2615; Heid S, 1998, HEARING RES, V115, P101, DOI 10.1016/S0378-5955(97)00182-2; KNIGHT PL, 1977, BRAIN RES, V130, P447, DOI 10.1016/0006-8993(77)90108-1; Kral A, 2003, EXP BRAIN RES, V153, P605, DOI 10.1007/s00221-003-1609-z; Kral A, 2002, CEREB CORTEX, V12, P797, DOI 10.1093/cercor/12.8.797; Kral A, 2006, PROG BRAIN RES, V157, P283, DOI 10.1016/S0079-6123(06)57018-9; Lessard N, 1998, NATURE, V395, P278, DOI 10.1038/26228; LEVICK WR, 1980, VISION RES, V20, P1001, DOI 10.1016/0042-6989(80)90083-8; LEVITT H, 1971, J ACOUST SOC AM, V49, P467, DOI 10.1121/1.1912375; Lomber SG, 1999, J NEUROSCI METH, V86, P179, DOI 10.1016/S0165-0270(98)00165-4; Lomber SG, 2001, PROG BRAIN RES, V134, P265; Lomber SG, 2001, VISUAL NEUROSCI, V18, P487, DOI 10.1017/S0952523801183148; Lomber SG, 2008, NAT NEUROSCI, V11, P609, DOI 10.1038/nn.2108; Malhotra S, 2008, J NEUROPHYSIOL, V99, P1628, DOI 10.1152/jn.01228.2007; Malhotra S, 2007, J NEUROPHYSIOL, V97, P26, DOI 10.1152/jn.00720.2006; Mellott JG, 2010, HEARING RES, V267, P119, DOI 10.1016/j.heares.2010.04.003; Merabet LB, 2010, NAT REV NEUROSCI, V11, P44, DOI 10.1038/nrn2758; MIDDLEBROOKS JC, 1983, J NEUROSCI, V3, P203; NEVILLE HJ, 1987, BRAIN RES, V405, P268, DOI 10.1016/0006-8993(87)90296-4; Nishimura H, 1999, NATURE, V397, P116, DOI 10.1038/16376; PALMER LA, 1978, J COMP NEUROL, V177, P237, DOI 10.1002/cne.901770205; PASTERNAK T, 1980, J COMP PHYSIOL PSYCH, V94, P943, DOI 10.1037/h0077806; Petitto LA, 2000, P NATL ACAD SCI USA, V97, P13961, DOI 10.1073/pnas.97.25.13961; Ptito M, 2005, BRAIN, V128, P606, DOI 10.1093/brain/awh380; RAUSCHECKER JP, 1995, TRENDS NEUROSCI, V18, P36, DOI 10.1016/0166-2236(95)93948-W; REALE RA, 1980, J COMP NEUROL, V192, P265, DOI 10.1002/cne.901920207; REYNOLDS HN, 1993, AM J PSYCHOL, V106, P523, DOI 10.2307/1422967; Roder B, 1999, NATURE, V400, P162, DOI 10.1038/22106; Sadato N, 1996, NATURE, V380, P526, DOI 10.1038/380526a0; Stecker GC, 2005, J NEUROPHYSIOL, V94, P1267, DOI 10.1152/jn.00104.2005; STEWART DL, 1970, EXP NEUROL, V28, P525, DOI 10.1016/0014-4886(70)90190-1; SUR M, 1988, SCIENCE, V242, P1437, DOI 10.1126/science.2462279; Voss P, 2008, NEUROIMAGE, V40, P746, DOI 10.1016/j.neuroimage.2007.12.020; Weeks R, 2000, J NEUROSCI, V20, P2664; Winters BD, 2004, J NEUROSCI, V24, P5901, DOI 10.1523/JNEUROSCI.1346-04.2004; Yang XF, 2006, NEUROBIOL DIS, V23, P637, DOI 10.1016/j.nbd.2006.05.006	50	309	315	3	58	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2010	13	11					1421	U163		10.1038/nn.2653	http://dx.doi.org/10.1038/nn.2653			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	673KI	20935644				2022-12-28	WOS:000283658200024
J	Altimus, CM; Guler, AD; Alam, NM; Arman, AC; Prusky, GT; Sampath, AP; Hattar, S				Altimus, Cara M.; Gueler, Ali D.; Alam, Nazia M.; Arman, A. Cyrus; Prusky, Glen T.; Sampath, Alapakkam P.; Hattar, Samer			Rod photoreceptors drive circadian photoentrainment across a wide range of light intensities	NATURE NEUROSCIENCE			English	Article							RETINAL GANGLION-CELLS; SPECTRAL SENSITIVITY; VISUAL FUNCTIONS; NON-CONE; MELANOPSIN; MOUSE; RESPONSES; PHASE; MICE; RHYTHMS	In mammals, synchronization of the circadian pacemaker in the hypothalamus is achieved through direct input from the eyes conveyed by intrinsically photosensitive retinal ganglion cells (ipRGCs). Circadian photoentrainment can be maintained by rod and cone photoreceptors, but their functional contributions and their retinal circuits that impinge on ipRGCs are not well understood. Using mice that lack functional rods or in which rods are the only functional photoreceptors, we found that rods were solely responsible for photoentrainment at scotopic light intensities. Rods were also capable of driving circadian photoentrainment at photopic intensities at which they were incapable of supporting a visually guided behavior. Using mice in which cone photoreceptors were ablated, we found that rods signal through cones at high light intensities, but not at low light intensities. Thus, rods use two distinct retinal circuits to drive ipRGC function to support circadian photoentrainment across a wide range of light intensities.	[Altimus, Cara M.; Gueler, Ali D.; Hattar, Samer] Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA; [Alam, Nazia M.; Prusky, Glen T.] Cornell Univ, Weill Med Coll, Dept Physiol & Biophys, New York, NY 10021 USA; [Arman, A. Cyrus; Sampath, Alapakkam P.] Univ So Calif, Keck Sch Med, Dept Physiol & Biophys, Zilkha Neurogenet Inst, Los Angeles, CA 90033 USA; [Hattar, Samer] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21218 USA	Johns Hopkins University; Cornell University; University of Southern California; Johns Hopkins University	Hattar, S (corresponding author), Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA.	asampath@usc.edu; shattar@jhu.edu	Hattar, Samer/W-6927-2019	Guler, Ali Deniz/0000-0001-8218-850X	Johns Hopkins University Mouse Tri-Lab; US National Institutes of Health [GM076430, EY017606]; David and Lucile Packard Foundation; Alfred P. Sloan Foundation; McKnight Endowment Fund for Neurosciences; NATIONAL EYE INSTITUTE [R01EY017606] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076430] Funding Source: NIH RePORTER	Johns Hopkins University Mouse Tri-Lab; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); David and Lucile Packard Foundation(The David & Lucile Packard Foundation); Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); McKnight Endowment Fund for Neurosciences; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to thank J. Nathans for the h. red DTA mice. We also want to thank R. Kuruvilla, H. Zhao and M. Halpern for their careful reading of the manuscript and helpful suggestions and the Johns Hopkins University Mouse Tri-Lab for its support. This work was supported by US National Institutes of Health grants GM076430 (S.H.) and EY017606 (A.P.S.), the David and Lucile Packard Foundation (S.H.), the Alfred P. Sloan Foundation (S.H.) and the McKnight Endowment Fund for Neurosciences (A.P.S.).	Armstrong-Gold CE, 2003, J NEUROSCI, V23, P3796; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; Biel M, 1999, P NATL ACAD SCI USA, V96, P7553, DOI 10.1073/pnas.96.13.7553; Brainard GC, 2001, J NEUROSCI, V21, P6405; Calvert PD, 2000, P NATL ACAD SCI USA, V97, P13913, DOI 10.1073/pnas.250478897; Chang B, 2006, INVEST OPHTH VIS SCI, V47, P5017, DOI 10.1167/iovs.05-1468; CORNWALL MC, 1994, J PHYSIOL-LONDON, V480, P261, DOI 10.1113/jphysiol.1994.sp020358; CORNWALL MC, 1990, J GEN PHYSIOL, V96, P345, DOI 10.1085/jgp.96.2.345; Dacey DM, 2005, NATURE, V433, P749, DOI 10.1038/nature03387; DACHEUX RF, 1986, J NEUROSCI, V6, P331; Dkhissi-Benyahya O, 2007, NEURON, V53, P677, DOI 10.1016/j.neuron.2007.02.005; Do MTH, 2009, NATURE, V457, P281, DOI 10.1038/nature07682; Doyle SE, 2006, P NATL ACAD SCI USA, V103, P10432, DOI 10.1073/pnas.0600934103; EBIHARA S, 1980, PHYSIOL BEHAV, V24, P523, DOI 10.1016/0031-9384(80)90246-2; FOSTER RG, 1991, J COMP PHYSIOL A, V169, P39, DOI 10.1007/BF00198171; Freedman MS, 1999, SCIENCE, V284, P502, DOI 10.1126/science.284.5413.502; Goz D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003153; Gooley JJ, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000741; Guler AD, 2007, COLD SPRING HARB SYM, V72, P509, DOI 10.1101/sqb.2007.72.074; Guler AD, 2008, NATURE, V453, P102, DOI 10.1038/nature06829; Hack I, 1999, P NATL ACAD SCI USA, V96, P14130, DOI 10.1073/pnas.96.24.14130; Hatori M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002451; Hattar S, 2003, NATURE, V424, P76, DOI 10.1038/nature01761; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; IBUKA N, 1977, BRAIN RES, V122, P33, DOI 10.1016/0006-8993(77)90660-6; Lockley SW, 2003, J CLIN ENDOCR METAB, V88, P4502, DOI 10.1210/jc.2003-030570; Lucas RJ, 2003, SCIENCE, V299, P245, DOI 10.1126/science.1077293; Lucas RJ, 2001, BEHAV BRAIN RES, V125, P97, DOI 10.1016/S0166-4328(01)00274-1; Lucas RJ, 1999, SCIENCE, V284, P505, DOI 10.1126/science.284.5413.505; Lyubarsky AL, 1996, J NEUROSCI, V16, P563, DOI 10.1523/jneurosci.16-02-00563.1996; Mrosovsky N, 2005, J COMP PHYSIOL A, V191, P1011, DOI 10.1007/s00359-005-0017-1; Mrosovsky N, 2003, CHRONOBIOL INT, V20, P989, DOI 10.1081/CBI-120026043; Mrosovsky N, 2003, J COMP PHYSIOL A, V189, P69, DOI 10.1007/s00359-002-0378-7; Panda S, 2003, SCIENCE, V301, P525, DOI 10.1126/science.1086179; Panda S, 2002, SCIENCE, V298, P2213, DOI 10.1126/science.1076848; Protti DA, 2005, J NEUROPHYSIOL, V93, P3479, DOI 10.1152/jn.00839.2004; Provencio I, 2000, J NEUROSCI, V20, P600, DOI 10.1523/JNEUROSCI.20-02-00600.2000; PROVENCIO I, 1995, BRAIN RES, V694, P183, DOI 10.1016/0006-8993(95)00694-L; Prusky GT, 2004, INVEST OPHTH VIS SCI, V45, P4611, DOI 10.1167/iovs.04-0541; Sampath AP, 2005, NEURON, V46, P413, DOI 10.1016/j.neuron.2005.04.006; Sharpe LT, 1999, TRENDS NEUROSCI, V22, P497, DOI 10.1016/S0166-2236(99)01458-7; SMITH RG, 1986, J NEUROSCI, V6, P3505; Soucy E, 1998, NEURON, V21, P481, DOI 10.1016/S0896-6273(00)80560-7; TAKAHASHI JS, 1984, NATURE, V308, P186, DOI 10.1038/308186a0; Umino Y, 2008, J NEUROSCI, V28, P189, DOI 10.1523/JNEUROSCI.3551-07.2008; Wong KY, 2007, J PHYSIOL-LONDON, V582, P279, DOI 10.1113/jphysiol.2007.133751; Wright HR, 2004, J PINEAL RES, V36, P140, DOI 10.1046/j.1600-079X.2003.00108.x; Xin DY, 1999, VISUAL NEUROSCI, V16, P653, DOI 10.1017/S0952523899164058; Yoshimura T, 1996, J COMP PHYSIOL A, V178, P797	50	179	182	2	31	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2010	13	9					1107	U102		10.1038/nn.2617	http://dx.doi.org/10.1038/nn.2617			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	643XC	20711184	Green Submitted, Green Accepted			2022-12-28	WOS:000281332600016
J	Smith-Hicks, C; Xiao, B; Deng, RK; Ji, YF; Zhao, X; Shepherd, JD; Posern, G; Kuhl, D; Huganir, RL; Ginty, DD; Worley, PF; Linden, DJ				Smith-Hicks, Constance; Xiao, Bo; Deng, Rongkang; Ji, Yifei; Zhao, Xia; Shepherd, Jason D.; Posern, Guido; Kuhl, Dietmar; Huganir, Richard L.; Ginty, David D.; Worley, Paul F.; Linden, David J.			SRF binding to SRE 6.9 in the Arc promoter is essential for LTD in cultured Purkinje cells	NATURE NEUROSCIENCE			English	Article							LONG-TERM DEPRESSION; SERUM RESPONSE FACTOR; IMMEDIATE-EARLY GENE; PROTEIN-SYNTHESIS; SYNAPTIC PLASTICITY; SIGNAL-TRANSDUCTION; GROWTH-FACTOR; LATE-PHASE; ARC/ARG3.1; TRANSCRIPTION	It has been suggested that gene expression and protein synthesis are required for both long-term memory consolidation and late phases of long-term potentiation and long-term depression (LTD). The necessary genes and the specific transcription factor binding sites in their promoters remain unknown. We found that inhibition of the transcription factor SRF or its cofactor MAL blocked the late phase of LTD in mouse cultured cerebellar Purkinje cells, as did deletion of the immediate early gene Arc. Using neuronal bacterial artificial chromosome (BAC) transfection, we found that, in Arc(-/-) cells transfected with a wild-type Arc BAC, late-phase LTD was rescued. However, mutation of one SRF-binding site in the Arc promoter (SRE 6.9RF engineered to bind mutated SRE 6.9 restored late-phase LTD in Arc(-/-), S) blocked this rescue. Co-transfection of wild-type Arc and SRE 6.9 mutant BAC cells. Thus, SRF binding to SRE 6.9 in the Arc promoter is required for the late phase of cerebellar LTD.	[Smith-Hicks, Constance; Xiao, Bo; Shepherd, Jason D.; Huganir, Richard L.; Ginty, David D.; Worley, Paul F.; Linden, David J.] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21218 USA; [Smith-Hicks, Constance; Worley, Paul F.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Xiao, Bo; Deng, Rongkang; Ji, Yifei; Zhao, Xia] Sichuan Univ, W China Hosp, State Key Lab Biotherapy, Chengdu 610064, Peoples R China; [Shepherd, Jason D.; Huganir, Richard L.; Ginty, David D.] Howard Hughes Med Inst, Chevy Chase, MD USA; [Posern, Guido] Max Planck Inst Biochem, Dept Mol Biol, D-82152 Martinsried, Germany; [Kuhl, Dietmar] Univ Med Ctr Hamburg Eppendorf, Ctr Mol Neurobiol, Inst Mol & Cellular Cognit, Hamburg, Germany	Johns Hopkins University; Johns Hopkins University; Sichuan University; Howard Hughes Medical Institute; Max Planck Society; University of Hamburg; University Medical Center Hamburg-Eppendorf	Linden, DJ (corresponding author), Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21218 USA.	dlinden@jhmi.edu	Shepherd, Jason/N-8555-2018; Kuhl, Dietmar/A-4689-2009	Shepherd, Jason/0000-0001-7384-8289; Kuhl, Dietmar/0000-0002-4772-6701; Xiao, Bo/0000-0002-6161-9478	US Public Health Service (NIH) [R37 MH51106, P50 MH084020, 5K12 NS001696-07]; National Basic Research Program of China [2004CB518800]; Science Fund for Creative Research Group, China; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH084020, R01MH064856, R37MH051106] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K12NS001696] Funding Source: NIH RePORTER	US Public Health Service (NIH)(United States Department of Health & Human ServicesUnited States Public Health ServiceNational Institutes of Health (NIH) - USA); National Basic Research Program of China(National Basic Research Program of China); Science Fund for Creative Research Group, China(Science Fund for Creative Research Groups); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank D. VanNess for excellent technical assistance and to members of the Linden and Worley laboratories for helpful suggestions. M. Greenberg's laboratory (Harvard University) provided the Gal4-SRF fusion construct plasmid. The authors thank B. Knoll (University of Tubingen) for sharing beta-actin constructs and for helpful suggestions. The FLAG-tagged dominant-negative MAL was a generous gift from R. Prywes (Columbia University). This work supported by grants from the US Public Health Service (NIH R37 MH51106 to D.J.L., P50 MH084020 to D.J.L., D.D.G., P.F.W. and R.L.H., and NIH 5K12 NS001696-07 to C.S.-H.), the National Basic Research Program of China (2004CB518800 to B.X. and 2004CB518800 to X.Z.) and the Science Fund for Creative Research Group, China (B.X.).	Ahn S, 1999, NEURON, V23, P559, DOI 10.1016/S0896-6273(00)80808-9; Barski JJ, 2000, GENESIS, V28, P93, DOI 10.1002/1526-968X(200011/12)28:3/4<93::AID-GENE10>3.3.CO;2-N; Chowdhury S, 2006, NEURON, V52, P445, DOI 10.1016/j.neuron.2006.08.033; Chung HJ, 2003, SCIENCE, V300, P1751, DOI 10.1126/science.1082915; DAVIS HP, 1984, PSYCHOL BULL, V96, P518, DOI 10.1037/0033-2909.96.3.518; HILL CS, 1993, CELL, V73, P395, DOI 10.1016/0092-8674(93)90238-L; Hou LF, 2006, NEURON, V51, P441, DOI 10.1016/j.neuron.2006.07.005; Huber KM, 2000, SCIENCE, V288, P1254, DOI 10.1126/science.288.5469.1254; Ito M, 2001, PHYSIOL REV, V81, P1143, DOI 10.1152/physrev.2001.81.3.1143; Josselyn Sheena A., 2005, Current Drug Targets - CNS and Neurological Disorders, V4, P481, DOI 10.2174/156800705774322058; Karachot L, 2001, J NEUROPHYSIOL, V86, P280, DOI 10.1152/jn.2001.86.1.280; Kawashima T, 2009, P NATL ACAD SCI USA, V106, P316, DOI 10.1073/pnas.0806518106; Knoll B, 2009, TRENDS NEUROSCI, V32, P432, DOI 10.1016/j.tins.2009.05.004; Knoll B, 2006, NAT NEUROSCI, V9, P195, DOI 10.1038/nn1627; Leitges M, 2004, NEURON, V44, P585, DOI 10.1016/j.neuron.2004.10.024; LINDEN DJ, 1991, SCIENCE, V254, P1656, DOI 10.1126/science.1721243; Linden DJ, 1996, NEURON, V17, P483, DOI 10.1016/S0896-6273(00)80180-4; LINK W, 1995, P NATL ACAD SCI USA, V92, P5734, DOI 10.1073/pnas.92.12.5734; Lonze BE, 2002, NEURON, V34, P371, DOI 10.1016/S0896-6273(02)00686-4; LYFORD GL, 1995, NEURON, V14, P433, DOI 10.1016/0896-6273(95)90299-6; Mantamadiotis T, 2002, NAT GENET, V31, P47, DOI 10.1038/ng882; Miralles F, 2003, CELL, V113, P329, DOI 10.1016/S0092-8674(03)00278-2; MIRANTI CK, 1995, MOL CELL BIOL, V15, P3672; Murashima M, 1999, J NEUROSCI, V19, P7326, DOI 10.1523/JNEUROSCI.19-17-07326.1999; Park S, 2008, NEURON, V59, P70, DOI 10.1016/j.neuron.2008.05.023; Pintchovski SA, 2009, J NEUROSCI, V29, P1525, DOI 10.1523/JNEUROSCI.5575-08.2009; Plath N, 2006, NEURON, V52, P437, DOI 10.1016/j.neuron.2006.08.024; Posern G, 2004, EMBO J, V23, P3973, DOI 10.1038/sj.emboj.7600404; Posern G, 2006, TRENDS CELL BIOL, V16, P588, DOI 10.1016/j.tcb.2006.09.008; Ramanan N, 2005, NAT NEUROSCI, V8, P759, DOI 10.1038/nn1462; Selvaraj A, 2004, BMC MOL BIOL, V5, DOI 10.1186/1471-2199-5-13; Shepherd JD, 2006, NEURON, V52, P475, DOI 10.1016/j.neuron.2006.08.034; Stern S, 2009, J NEUROSCI, V29, P4512, DOI 10.1523/JNEUROSCI.0333-09.2009; Steward O, 2003, NEURON, V40, P347, DOI 10.1016/S0896-6273(03)00635-4; Steward O, 1998, NEURON, V21, P741, DOI 10.1016/S0896-6273(00)80591-7; Stritt C, 2010, MOL CELL BIOL, V30, P1828, DOI 10.1128/MCB.01434-09; Verde EMR, 2006, NEURON, V52, P461, DOI 10.1016/j.neuron.2006.09.031; Waung MW, 2008, NEURON, V59, P84, DOI 10.1016/j.neuron.2008.05.014	38	49	49	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2010	13	9					1082	U73		10.1038/nn.2611	http://dx.doi.org/10.1038/nn.2611			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	643XC	20694003	Green Accepted			2022-12-28	WOS:000281332600013
J	Clayton, EL; Sue, N; Smillie, KJ; O'Leary, T; Bache, N; Cheung, G; Cole, AR; Wyllie, DJ; Sutherland, C; Robinson, PJ; Cousin, MA				Clayton, Emma L.; Sue, Nancy; Smillie, Karen J.; O'Leary, Timothy; Bache, Nicolai; Cheung, Giselle; Cole, Adam R.; Wyllie, David J.; Sutherland, Calum; Robinson, Phillip J.; Cousin, Michael A.			Dynamin I phosphorylation by GSK3 controls activity-dependent bulk endocytosis of synaptic vesicles	NATURE NEUROSCIENCE			English	Article							GLYCOGEN-SYNTHASE KINASE-3; MEMBRANE RETRIEVAL; STIMULATION; INHIBITORS; DISCOVERY; CDK5; VIVO; WNT	Glycogen synthase kinase 3 (GSK3) is a critical enzyme in neuronal physiology; however, it is not yet known whether it has any specific role in presynaptic function. We found that GSK3 phosphorylates a residue on the large GTPase dynamin I (Ser-774) both in vitro and in primary rat neuronal cultures. This was dependent on prior phosphorylation of Ser-778 by cyclin-dependent kinase 5. Using both acute inhibition with pharmacological antagonists and silencing of expression with short hairpin RNA, we found that GSK3 was specifically required for activity-dependent bulk endocytosis (ADBE) but not clathrin-mediated endocytosis. Moreover we found that the specific phosphorylation of Ser-774 on dynamin I by GSK3 was both necessary and sufficient for ADBE. These results demonstrate a presynaptic role for GSK3 and they indicate that a protein kinase signaling cascade prepares synaptic vesicles for retrieval during elevated neuronal activity.	[Clayton, Emma L.; Smillie, Karen J.; O'Leary, Timothy; Cheung, Giselle; Wyllie, David J.; Cousin, Michael A.] Univ Edinburgh, Ctr Integrat Physiol, Edinburgh, Midlothian, Scotland; [Sue, Nancy; Bache, Nicolai; Robinson, Phillip J.] Univ Sydney, Childrens Med Res Inst, Sydney, NSW 2006, Australia; [Cole, Adam R.; Sutherland, Calum] Univ Dundee, Ninewells Hosp & Med Sch, Biomed Res Inst, Dundee DD1 9SY, Scotland	University of Edinburgh; Children's Medical Research Institute - Australia; University of Sydney; University of Dundee	Cousin, MA (corresponding author), Univ Edinburgh, Ctr Integrat Physiol, Edinburgh, Midlothian, Scotland.	m.cousin@ed.ac.uk	Wyllie, David J A/AAK-4678-2021; Robinson, Phillip J/G-4008-2011; Cole, Adam/B-9785-2011	Wyllie, David J A/0000-0002-4957-6049; Robinson, Phillip J/0000-0002-7878-0313; Cousin, Michael/0000-0002-1762-160X; Sutherland, Calum/0000-0003-4398-7434; O'Leary, Timothy/0000-0002-1029-0158; Cheung, Giselle/0000-0001-8457-2572; Smillie, Karen/0000-0003-4369-0470; Clayton, Emma/0000-0003-0937-2874	Wellcome Trust [070569, 084277]; Epilepsy Research UK [0503]; Cancer Institute NSW; Ramaciotti Foundation; Australian National Health and Medical Research Council; Alzheimer's Research Trust [ART/PG2007/4]; MRC [88158]; Danish Agency for Science, Technology and Innovation [274-08-0066]; Australian NHMRC [454886]; Alzheimers Research UK [ART-PG2005-1] Funding Source: researchfish; Biotechnology and Biological Sciences Research Council [C18727] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Epilepsy Research UK; Cancer Institute NSW; Ramaciotti Foundation; Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Alzheimer's Research Trust; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Danish Agency for Science, Technology and Innovation; Australian NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We wish to thank A. Prescott and J. James (both University of Dundee) for excellent technical assistance. This work was supported by grants from the Wellcome Trust (Ref: 070569 & 084277), Epilepsy Research UK (0503), Cancer Institute NSW, The Ramaciotti Foundation, and the Australian National Health and Medical Research Council. C.S. is supported by the Alzheimer's Research Trust (ART/PG2007/4) and the MRC (88158). N.B. is supported by the Danish Agency for Science, Technology and Innovation (grant 274-08-0066). A.R.C. is supported by an Australian NH&MRC Peter Doherty Fellowship (454886).	Ahmad-Annuar A, 2006, J CELL BIOL, V174, P127, DOI 10.1083/jcb.200511054; Andersson F, 2008, J NEUROSCI, V28, P3925, DOI 10.1523/JNEUROSCI.1754-07.2008; Anggono V, 2006, NAT NEUROSCI, V9, P752, DOI 10.1038/nn1695; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Bhat R, 2003, J BIOL CHEM, V278, P45937, DOI 10.1074/jbc.M306268200; Chen Y, 2003, CELL, V115, P37, DOI 10.1016/S0092-8674(03)00726-8; Clayton EL, 2008, J NEUROSCI, V28, P6627, DOI 10.1523/JNEUROSCI.1445-08.2008; Clayton EL, 2009, J NEUROSCI, V29, P7706, DOI 10.1523/JNEUROSCI.1976-09.2009; Cole AR, 2006, J BIOL CHEM, V281, P16591, DOI 10.1074/jbc.M513344200; Cousin MA, 2001, TRENDS NEUROSCI, V24, P659, DOI 10.1016/S0166-2236(00)01930-5; Dhavan R, 2001, NAT REV MOL CELL BIO, V2, P749, DOI 10.1038/35096019; Eldar-Finkelman H, 2002, TRENDS MOL MED, V8, P126, DOI 10.1016/S1471-4914(01)02266-3; Evans GJO, 2007, J NEUROSCI, V27, P401, DOI 10.1523/JNEUROSCI.3809-06.2007; Frame S, 2001, BIOCHEM J, V359, P1, DOI 10.1042/0264-6021:3590001; Graham ME, 2007, J BIOL CHEM, V282, P14695, DOI 10.1074/jbc.M609713200; Granseth B, 2006, NEURON, V51, P773, DOI 10.1016/j.neuron.2006.08.029; Holt M, 2003, J NEUROSCI, V23, P1329, DOI 10.1523/JNEUROSCI.23-04-01329.2003; Hongisto V, 2008, MOL CELL BIOL, V28, P1515, DOI 10.1128/MCB.02227-06; Hooper C, 2008, J NEUROCHEM, V104, P1433, DOI 10.1111/j.1471-4159.2007.05194.x; Koh TW, 2007, J CELL BIOL, V178, P309, DOI 10.1083/jcb.200701030; Larsen MR, 2005, MOL CELL PROTEOMICS, V4, P873, DOI 10.1074/mcp.T500007-MCP200; Ma YC, 2008, NEURON, V58, P65, DOI 10.1016/j.neuron.2008.01.037; Newton AJ, 2006, P NATL ACAD SCI USA, V103, P17955, DOI 10.1073/pnas.0606212103; Peineau S, 2007, NEURON, V53, P703, DOI 10.1016/j.neuron.2007.01.029; Richards DA, 2000, NEURON, V27, P551, DOI 10.1016/S0896-6273(00)00065-9; Shupliakov O, 1997, SCIENCE, V276, P259, DOI 10.1126/science.276.5310.259; Tan TC, 2003, NAT CELL BIOL, V5, P701, DOI 10.1038/ncb1020; Teng HB, 2007, J PHYSIOL-LONDON, V582, P243, DOI 10.1113/jphysiol.2007.130989; Wagman AS, 2004, CURR PHARM DESIGN, V10, P1105, DOI 10.2174/1381612043452668; WOODGETT JR, 1990, EMBO J, V9, P2431, DOI 10.1002/j.1460-2075.1990.tb07419.x; Zhu YL, 2009, NEURON, V61, P397, DOI 10.1016/j.neuron.2008.12.024	31	119	123	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2010	13	7					845	U85		10.1038/nn.2571	http://dx.doi.org/10.1038/nn.2571			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	615YF	20526333	Green Submitted, Green Accepted			2022-12-28	WOS:000279173900017
J	Perez-Tilve, D; Hofmann, SM; Basford, J; Nogueiras, R; Pfluger, PT; Patterson, JT; Grant, E; Wilson-Perez, HE; Granholm, NA; Arnold, M; Trevaskis, JL; Butler, AA; Davidson, WS; Woods, SC; Benoit, SC; Sleeman, MW; DiMarchi, RD; Hui, DY; Tschop, MH				Perez-Tilve, Diego; Hofmann, Susanna M.; Basford, Joshua; Nogueiras, Ruben; Pfluger, Paul T.; Patterson, James T.; Grant, Erin; Wilson-Perez, Hilary E.; Granholm, Norman A.; Arnold, Myrtha; Trevaskis, James L.; Butler, Andrew A.; Davidson, William S.; Woods, Stephen C.; Benoit, Stephen C.; Sleeman, Mark W.; DiMarchi, Richard D.; Hui, David Y.; Tschoep, Matthias H.			Melanocortin signaling in the CNS directly regulates circulating cholesterol	NATURE NEUROSCIENCE			English	Article							RECEPTOR CLASS-B; DENSITY-LIPOPROTEIN HDL; I SR-BI; MICE LACKING; TARGETED MUTATION; SELECTIVE UPTAKE; LEPTIN; OBESE; EXPRESSION; MECHANISM	Cholesterol circulates in the blood in association with triglycerides and other lipids, and elevated blood low-density lipoprotein cholesterol carries a risk for metabolic and cardiovascular disorders, whereas high-density lipoprotein (HDL) cholesterol in the blood is thought to be beneficial. Circulating cholesterol is the balance among dietary cholesterol absorption, hepatic synthesis and secretion, and the metabolism of lipoproteins by various tissues. We found that the CNS is also an important regulator of cholesterol in rodents. Inhibiting the brain's melanocortin system by pharmacological, genetic or endocrine mechanisms increased circulating HDL cholesterol by reducing its uptake by the liver independent of food intake or body weight. Our data suggest that a neural circuit in the brain is directly involved in the control of cholesterol metabolism by the liver.	[Perez-Tilve, Diego; Hofmann, Susanna M.; Nogueiras, Ruben; Pfluger, Paul T.; Grant, Erin; Wilson-Perez, Hilary E.; Woods, Stephen C.; Benoit, Stephen C.; Tschoep, Matthias H.] Univ Cincinnati, Coll Med, Dept Med, Div Endocrinol,Metab Dis Inst, Cincinnati, OH 45221 USA; [Perez-Tilve, Diego; Hofmann, Susanna M.; Nogueiras, Ruben; Pfluger, Paul T.; Grant, Erin; Wilson-Perez, Hilary E.; Woods, Stephen C.; Benoit, Stephen C.; Tschoep, Matthias H.] Univ Cincinnati, Coll Med, Dept Psychiat, Div Endocrinol,Metab Dis Inst, Cincinnati, OH USA; [Basford, Joshua; Granholm, Norman A.; Davidson, William S.; Hui, David Y.] Univ Cincinnati, Coll Med, Dept Pathol, Lipid Res Ctr, Cincinnati, OH USA; [Patterson, James T.; DiMarchi, Richard D.] Indiana Univ, Dept Chem, Bloomington, IN USA; [Arnold, Myrtha] Swiss Fed Inst Technol, Inst Anim Sci, Schwerzenbach, Switzerland; [Trevaskis, James L.; Butler, Andrew A.] Pennington Biomed Res Ctr, Neuropeptides Lab, Baton Rouge, LA USA; [Sleeman, Mark W.] Regeneron Pharmaceut Inc, Tarrytown, NY USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; Indiana University System; Indiana University Bloomington; Swiss Federal Institutes of Technology Domain; ETH Zurich; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Regeneron	Tschop, MH (corresponding author), Univ Cincinnati, Coll Med, Dept Med, Div Endocrinol,Metab Dis Inst, Cincinnati, OH 45221 USA.	matthias.tschoep@uc.edu	Hofmann, Susanna/F-2654-2014; Pfluger, Paul T/A-3770-2019; Tschoep, Matthias H/I-5443-2014; Nogueiras, Ruben/AAS-9427-2021	Hofmann, Susanna/0000-0001-7682-5840; Pfluger, Paul T/0000-0002-8118-7588; Nogueiras, Ruben/0000-0002-9976-9930; Perez-Tilve, Diego/0000-0002-0351-4133; Butler, Andrew/0000-0001-7196-0170; Patterson, James/0000-0001-6006-7184; Trevaskis, James/0000-0002-5356-6118; Tschoep, Matthias/0000-0002-4744-371X; Davidson, William/0000-0003-2756-2989	US National Institute of Health [NIDDK56863, 5R01DK077975, R01 DK076907, HL67093]; American Heart Association [0635079N]; American Diabetes Association [1-10-BS-72]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067093, R21HL104136] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK077975, R01DK073189, R01DK076907] Funding Source: NIH RePORTER	US National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); American Diabetes Association(American Diabetes Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by US National Institute of Health grants NIDDK56863 (S. C. W. and M. H. T.), 5R01DK077975 (M. H. T.), R01 DK076907 (D.Y.H.) and HL67093 (W. S. D.). S. M. H. is the recipient of a Scientist Development Award from the American Heart Association (#0635079N). S. M. H. is a recipient of a Basic Science Award (1-10-BS-72) from the American Diabetes Association.	Ahren B, 2000, DIABETOLOGIA, V43, P393, DOI 10.1007/s001250051322; ARAI T, 1994, ARTERIOSCLER THROMB, V14, P1129, DOI 10.1161/01.ATV.14.7.1129; Bluher S, 2004, DIABETES, V53, P82, DOI 10.2337/diabetes.53.1.82; Castaneda TR, 2005, J NUTR, V135, P1314, DOI 10.1093/jn/135.5.1314; Cettour-Rose P, 2002, ENDOCRINOLOGY, V143, P2277, DOI 10.1210/en.143.6.2277; Chen AS, 2000, NAT GENET, V26, P97, DOI 10.1038/79254; Coll AP, 2007, CELL, V129, P251, DOI 10.1016/j.cell.2007.04.001; Cone RD, 2006, ENDOCR REV, V27, P736, DOI 10.1210/er.2006-0034; Cowley MA, 2003, NEURON, V37, P649, DOI 10.1016/S0896-6273(03)00063-1; Cummings DE, 2007, J CLIN INVEST, V117, P13, DOI 10.1172/JCI30227; Cummings DE, 2006, PHYSIOL BEHAV, V89, P71, DOI 10.1016/j.physbeh.2006.05.022; Engelking LJ, 2005, J CLIN INVEST, V115, P2489, DOI 10.1172/JCI25614; Enriori PJ, 2007, CELL METAB, V5, P181, DOI 10.1016/j.cmet.2007.02.004; Ford ES, 2002, JAMA-J AM MED ASSOC, V287, P356, DOI 10.1001/jama.287.3.356; Ginsberg HN, 2000, J CLIN INVEST, V106, P453, DOI 10.1172/JCI10762; Gruen ML, 2005, J LIPID RES, V46, P2007, DOI 10.1194/jlr.M500181-JLR200; Grundy SM, 2007, J CLIN ENDOCR METAB, V92, P399, DOI 10.1210/jc.2006-0513; Hasty AH, 2001, J BIOL CHEM, V276, P37402, DOI 10.1074/jbc.M010176200; Horton JD, 2002, COLD SPRING HARB SYM, V67, P491, DOI 10.1101/sqb.2002.67.491; Huby T, 2006, J CLIN INVEST, V116, P2767, DOI 10.1172/JCI26893; Lam TKT, 2007, NAT MED, V13, P171, DOI 10.1038/nm1540; Lambert G, 2003, J BIOL CHEM, V278, P2563, DOI 10.1074/jbc.M209525200; Lowell BB, 2000, NATURE, V404, P652, DOI 10.1038/35007527; Lundasen T, 2003, J BIOL CHEM, V278, P43224, DOI 10.1074/jbc.M302645200; Ma XS, 2007, J NEUROSCI, V27, P7125, DOI 10.1523/JNEUROSCI.1025-07.2007; Morton GJ, 2006, NATURE, V443, P289, DOI 10.1038/nature05026; Nogueiras R, 2007, J CLIN INVEST, V117, P3475, DOI 10.1172/JCI31743; PITTMAN RC, 1987, J BIOL CHEM, V262, P2443; Pocai A, 2005, CELL METAB, V1, P53, DOI 10.1016/j.cmet.2004.11.001; Rader DJ, 2006, J CLIN INVEST, V116, P3090, DOI 10.1172/JCI30163; Rigotti A, 1997, P NATL ACAD SCI USA, V94, P12610, DOI 10.1073/pnas.94.23.12610; SCHNOLZER M, 1992, INT J PEPT PROT RES, V40, P180; Schoonjans K, 2002, EMBO REP, V3, P1181, DOI 10.1093/embo-reports/kvf238; Shetty S, 2006, ARTERIOSCL THROM VAS, V26, P2125, DOI 10.1161/01.ATV.0000233335.26362.37; Silver DL, 2000, J CLIN INVEST, V105, P151, DOI 10.1172/JCI8087; Silver DL, 1999, J BIOL CHEM, V274, P4140, DOI 10.1074/jbc.274.7.4140; Sutton GM, 2006, ENDOCRINOLOGY, V147, P2183, DOI 10.1210/en.2005-1209; Tondu AL, 2005, J BIOL CHEM, V280, P33536, DOI 10.1074/jbc.M502392200; Tschop M, 2000, NATURE, V407, P908, DOI 10.1038/35038090; Vaisse C, 2000, J CLIN INVEST, V106, P253, DOI 10.1172/JCI9238; Varban ML, 1998, P NATL ACAD SCI USA, V95, P4619, DOI 10.1073/pnas.95.8.4619; Zhang YZ, 2005, J CLIN INVEST, V115, P2870, DOI 10.1172/JCI25327	42	73	77	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2010	13	7					877	U123		10.1038/nn.2569	http://dx.doi.org/10.1038/nn.2569			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	615YF	20526334	Green Accepted			2022-12-28	WOS:000279173900021
J	Mak, GK; Weiss, S				Mak, Gloria K.; Weiss, Samuel			Paternal recognition of adult offspring mediated by newly generated CNS neurons	NATURE NEUROSCIENCE			English	Article							INBREEDING AVOIDANCE; OLFACTORY-BULB; STIMULATED NEUROGENESIS; KIN RECOGNITION; NEWBORN NEURONS; BEHAVIOR; MICE; DISCRIMINATION; PROLACTIN; EXPOSURE	In mammals, olfaction is often used to distinguish individuals on the basis of their unique odor types (genetically programmed body odors). Parental-offspring recognition behavior is mediated, in part, by learning and processing of different odor types and is crucial for reproductive success. Maternal recognition behavior and associated brain plasticity has been well characterized, but paternal recognition behavior and brain plasticity is poorly understood. We found that paternal-adult offspring recognition behavior in mice was dependent on postnatal offspring interaction and was associated with increased neurogenesis in the paternal olfactory bulb and hippocampus. Newly generated paternal olfactory interneurons were preferentially activated by adult offspring odors. Disrupting prolactin signaling abolished increased paternal neurogenesis and adult offspring recognition. Rescuing this neurogenesis restored recognition behavior. Thus, neurogenesis in the paternal brain may be involved in offspring recognition.	[Mak, Gloria K.; Weiss, Samuel] Univ Calgary, Fac Med, Dept Cell Biol & Anat, Hotchkiss Brain Inst, Calgary, AB, Canada	University of Calgary	Weiss, S (corresponding author), Univ Calgary, Fac Med, Dept Cell Biol & Anat, Hotchkiss Brain Inst, Calgary, AB, Canada.	weiss@ucalgary.ca			Canadian Institutes of Health Research; Alberta Heritage Foundation for Medical Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Heritage Foundation for Medical Research(Alberta Heritage Foundation for Medical ResearchGeneral Electric)	We are grateful to K. Markham for her helpful instruction and mentorship. We thank C. Gregg, B. Kolb, K. Lukowiak and D. van der Kooy for comments on earlier versions of this manuscript. This work was supported by the Canadian Institutes of Health Research and studentship (G.K.M.) and scientist (S.W.) awards from the Alberta Heritage Foundation for Medical Research.	Brennan PA, 2006, PHILOS T R SOC B, V361, P2061, DOI 10.1098/rstb.2006.1931; Buchan JC, 2003, NATURE, V425, P179, DOI 10.1038/nature01866; Curtis MA, 2007, SCIENCE, V315, P1243, DOI 10.1126/science.1136281; DEWSBURY DA, 1988, BEHAV GENET, V18, P525, DOI 10.1007/BF01065519; Dubas JS, 2009, HUM NATURE-INT BIOS, V20, P80, DOI 10.1007/s12110-009-9058-4; Enwere E, 2004, J NEUROSCI, V24, P8354, DOI 10.1523/JNEUROSCI.2751-04.2004; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Gregg C, 2007, J NEUROSCI, V27, P1812, DOI 10.1523/JNEUROSCI.4441-06.2007; Hurst JL, 2005, P ROY SOC B-BIOL SCI, V272, P715, DOI 10.1098/rspb.2004.3004; JIMENEZ JA, 1994, SCIENCE, V266, P271, DOI 10.1126/science.7939661; Kelly PA, 2001, FRONT NEUROENDOCRIN, V22, P140, DOI 10.1006/frne.2001.0212; Ling C, 2000, ENDOCRINOLOGY, V141, P3564, DOI 10.1210/en.141.10.3564; Lledo PM, 2005, PHYSIOL REV, V85, P281, DOI 10.1152/physrev.00008.2004; Lonstein JS, 2000, NEUROSCI BIOBEHAV R, V24, P669, DOI 10.1016/S0149-7634(00)00036-1; Lonstein JS, 2002, CURR PROTOC NEUROSCI, V8; Magavi SSP, 2005, J NEUROSCI, V25, P10729, DOI 10.1523/JNEUROSCI.2250-05.2005; Mak GK, 2007, NAT NEUROSCI, V10, P1003, DOI 10.1038/nn1928; MAKIN JW, 1984, BEHAV NEURAL BIOL, V41, P135, DOI 10.1016/S0163-1047(84)90513-2; MANNING CJ, 1992, NATURE, V360, P581, DOI 10.1038/360581a0; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; Ormandy CJ, 1997, J MAMMARY GLAND BIOL, V2, P355, DOI 10.1023/A:1026395229025; OSTERMEYER MC, 1983, DEV PSYCHOBIOL, V16, P75, DOI 10.1002/dev.420160202; Pillay N, 2002, MAMM BIOL, V67, P212, DOI 10.1078/1616-5047-00032; Porter RH, 1998, GENETICA, V104, P259, DOI 10.1023/A:1026404319384; Pusey A, 1996, TRENDS ECOL EVOL, V11, P201, DOI 10.1016/0169-5347(96)10028-8; PUSEY AE, 1987, TRENDS ECOL EVOL, V2, P295, DOI 10.1016/0169-5347(87)90081-4; Restrepo D, 2006, TRENDS NEUROSCI, V29, P604, DOI 10.1016/j.tins.2006.08.001; Rochefort C, 2005, EUR J NEUROSCI, V22, P2863, DOI 10.1111/j.1460-9568.2005.04486.x; Rochefort C, 2002, J NEUROSCI, V22, P2679, DOI 10.1523/JNEUROSCI.22-07-02679.2002; Ruscio MG, 2008, BEHAV BRAIN RES, V187, P9, DOI 10.1016/j.bbr.2007.08.028; Sanchez-Andrade G, 2005, J REPROD DEVELOP, V51, P547, DOI 10.1262/jrd.17031; Sherborne AL, 2007, CURR BIOL, V17, P2061, DOI 10.1016/j.cub.2007.10.041; Shingo T, 2003, SCIENCE, V299, P117, DOI 10.1126/science.1076647; Singh PB, 2001, REPRODUCTION, V121, P529, DOI 10.1530/reprod/121.4.529; Trinh K, 2003, NAT NEUROSCI, V6, P519, DOI 10.1038/nn1039; WOODROFFE R, 1994, TRENDS ECOL EVOL, V9, P294, DOI 10.1016/0169-5347(94)90033-7; Yamazaki K, 2000, P NATL ACAD SCI USA, V97, P10500, DOI 10.1073/pnas.180320997	37	148	152	0	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2010	13	6					753	U134		10.1038/nn.2550	http://dx.doi.org/10.1038/nn.2550			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	600QY	20453850				2022-12-28	WOS:000278003300021
J	Meeks, JP; Arnson, HA; Holy, TE				Meeks, Julian P.; Arnson, Hannah A.; Holy, Timothy E.			Representation and transformation of sensory information in the mouse accessory olfactory system	NATURE NEUROSCIENCE			English	Article							AXONAL PROJECTIONS; VOMERONASAL ORGAN; ODORANT RECEPTOR; MITRAL CELLS; BULB; NEURONS; RESPONSES; PATTERNS; SPARSE; INPUT	In mice, nonvolatile social cues are detected and analyzed by the accessory olfactory system (AOS). Here we provide a first view of information processing in the AOS with respect to individual chemical cues. 12 sulfated steroids, recently discovered mouse AOS ligands, caused widespread activity among vomeronasal sensory neurons (VSNs), yet VSN responses clustered into a small number of repeated functional patterns or processing streams. Downstream neurons in the accessory olfactory bulb (AOB) responded to these ligands with enhanced signal/noise compared to VSNs. Although the dendritic connectivity of AOB mitral cells suggests the capacity for broad integration, most sulfated steroid responses were well-modeled by linear excitatory drive from just one VSN processing stream. However, a substantial minority demonstrated multi-stream integration. Most VSN excitation patterns were also observed in the AOB, but excitation by estradiol sulfate processing streams was rare, suggesting AOB circuit organization is specific to the biological relevance of sensed cues.	[Meeks, Julian P.; Arnson, Hannah A.; Holy, Timothy E.] Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA; [Arnson, Hannah A.] Washington Univ, Grad Program Neurosci, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Holy, TE (corresponding author), Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA.	holy@wustl.edu	Meeks, Julian/ABE-4361-2020	Meeks, Julian/0000-0002-7537-4491	G. Harold and Leila Y. Mathers Foundation; US National Institute for Deafness and Other Communication Disorders [R01DC005964, R01DC010381, F32DC009352]; W.M. Keck Foundation; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005964, F32DC009352, R01DC010381] Funding Source: NIH RePORTER	G. Harold and Leila Y. Mathers Foundation; US National Institute for Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); W.M. Keck Foundation(W.M. Keck Foundation); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank D. Kerschensteiner for comments and suggestions and all members of the Holy laboratory for helpful feedback. We acknowledge the generous support of the G. Harold and Leila Y. Mathers Foundation (T.E.H.), the US National Institute for Deafness and Other Communication Disorders (R01DC005964 and R01DC010381 to T.E.H.; F32DC009352 to J.P.M.) and the W.M. Keck Foundation (J.P.M.).	Belluscio L, 1999, CELL, V97, P209, DOI 10.1016/S0092-8674(00)80731-X; Bhandawat V, 2007, NAT NEUROSCI, V10, P1474, DOI 10.1038/nn1976; Bozza T, 2004, NEURON, V42, P9, DOI 10.1016/S0896-6273(04)00144-8; Comaniciu D, 2002, IEEE T PATTERN ANAL, V24, P603, DOI 10.1109/34.1000236; Davison IG, 2007, J NEUROSCI, V27, P2091, DOI 10.1523/JNEUROSCI.3779-06.2007; Del Punta K, 2002, NEURON, V35, P1057, DOI 10.1016/S0896-6273(02)00904-2; Del Punta K, 2002, NATURE, V419, P70, DOI 10.1038/nature00955; DUCHAMPVIRET P, 1989, J NEUROPHYSIOL, V61, P1085, DOI 10.1152/jn.1989.61.5.1085; Dulac C, 2007, CURR OPIN NEUROBIOL, V17, P675, DOI 10.1016/j.conb.2008.01.009; Fantana AL, 2008, NEURON, V59, P802, DOI 10.1016/j.neuron.2008.07.039; Fletcher ML, 2003, J NEUROSCI, V23, P6946; Friedrich RW, 2004, J NEUROPHYSIOL, V91, P2658, DOI 10.1152/jn.01143.2003; Friedrich RW, 1997, NEURON, V18, P737, DOI 10.1016/S0896-6273(00)80314-1; Grosmaitre X, 2009, J NEUROSCI, V29, P14545, DOI 10.1523/JNEUROSCI.2752-09.2009; Hallem EA, 2006, CELL, V125, P143, DOI 10.1016/j.cell.2006.01.050; Hendrickson RC, 2008, J NEUROSCI, V28, P12523, DOI 10.1523/JNEUROSCI.2715-08.2008; Holekamp TF, 2008, NEURON, V57, P661, DOI 10.1016/j.neuron.2008.01.011; Holy TE, 2000, SCIENCE, V289, P1569, DOI 10.1126/science.289.5484.1569; Keller M, 2009, BEHAV BRAIN RES, V200, P268, DOI 10.1016/j.bbr.2009.01.020; Laariva-Sahd J, 2008, J COMP NEUROL, V510, P309, DOI 10.1002/cne.21790; Luo MM, 2003, SCIENCE, V299, P1196, DOI 10.1126/science.1082133; Martini S, 2001, J NEUROSCI, V21, P843, DOI 10.1523/JNEUROSCI.21-03-00843.2001; Meeks JP, 2009, J NEUROSCI METH, V177, P440, DOI 10.1016/j.jneumeth.2008.11.013; Nodari F, 2008, J NEUROSCI, V28, P6407, DOI 10.1523/JNEUROSCI.1425-08.2008; Ramon y Cajal S, 1995, HISTOLOGY NERVOUS SY; Rodriguez I, 2002, NAT NEUROSCI, V5, P134, DOI 10.1038/nn795; Rodriguez I, 1999, CELL, V97, P199, DOI 10.1016/S0092-8674(00)80730-8; Segev R, 2004, NAT NEUROSCI, V7, P1155, DOI 10.1038/nn1323; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; Soucy ER, 2009, NAT NEUROSCI, V12, P210, DOI 10.1038/nn.2262; Stopfer M, 2003, NEURON, V39, P991, DOI 10.1016/j.neuron.2003.08.011; Touhara K, 2009, ANNU REV PHYSIOL, V71, P307, DOI 10.1146/annurev.physiol.010908.163209; Tsuboi A, 1999, J NEUROSCI, V19, P8409; Wachowiak M, 2003, J NEUROPHYSIOL, V89, P1623, DOI 10.1152/jn.00747.2002; Wagner S, 2006, NEURON, V50, P697, DOI 10.1016/j.neuron.2006.04.033; Willmore B, 2001, NETWORK-COMP NEURAL, V12, P255, DOI 10.1088/0954-898X/12/3/302; Yonekura J, 2008, MOL CELL NEUROSCI, V37, P708, DOI 10.1016/j.mcn.2007.12.016; Zhang JJ, 2007, CHEM SENSES, V32, P355, DOI 10.1093/chemse/bjm005	39	61	62	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2010	13	6					723	U98		10.1038/nn.2546	http://dx.doi.org/10.1038/nn.2546			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	600QY	20453853	Green Accepted			2022-12-28	WOS:000278003300017
J	Takahashi, H; Katayama, K; Sohya, K; Miyamoto, H; Prasad, T; Matsumoto, Y; Ota, M; Yasuda, H; Tsumoto, T; Aruga, J; Craig, AM				Takahashi, Hideto; Katayama, Kei-ichi; Sohya, Kazuhiro; Miyamoto, Hiroyuki; Prasad, Tuhina; Matsumoto, Yoshifumi; Ota, Maya; Yasuda, Hiroki; Tsumoto, Tadaharu; Aruga, Jun; Craig, Ann Marie			Selective control of inhibitory synapse development by Slitrk3-PTP delta trans-synaptic interaction	NATURE NEUROSCIENCE			English	Article							PTP-DELTA; TYROSINE PHOSPHATASES; PROTEIN FAMILY; NEUREXINS; ADHESION; AUTISM; GABA; LAR; DIFFERENTIATION; NEUROLIGIN-2	Balanced development of excitatory and inhibitory synapses is required for normal brain function, and an imbalance in this development may underlie the pathogenesis of many neuropsychiatric disorders. Compared with the many identified trans-synaptic adhesion complexes that organize excitatory synapses, little is known about the organizers that are specific for inhibitory synapses. We found that Slit and NTRK-like family member 3 (Slitrk3) acts as a postsynaptic adhesion molecule that selectively regulates inhibitory synapse development via trans-interaction with axonal tyrosine phosphatase receptor PTP delta. When expressed in fibroblasts, Slitrk3 triggered only inhibitory presynaptic differentiation in contacting axons of co-cultured rat hippocampal neurons. Recombinant Slitrk3 preferentially localized to inhibitory postsynaptic sites. Slitrk3-deficient mice exhibited decreases in inhibitory, but not excitatory, synapse number and function in hippocampal CA1 neurons and exhibited increased seizure susceptibility and spontaneous epileptiform activity. Slitrk3 required trans-interaction with axonal PTP delta to induce inhibitory presynaptic differentiation. These results identify Slitrk3-PTP delta as an inhibitory-specific trans-synaptic organizing complex that is required for normal functional GABAergic synapse development.	[Katayama, Kei-ichi; Matsumoto, Yoshifumi; Ota, Maya; Aruga, Jun] RIKEN Brain Sci Inst BSI, Lab Behav & Dev Disorders, Wako, Saitama, Japan; [Takahashi, Hideto; Prasad, Tuhina; Craig, Ann Marie] Univ British Columbia, Brain Res Ctr, Vancouver, BC V5Z 1M9, Canada; [Takahashi, Hideto; Prasad, Tuhina; Craig, Ann Marie] Univ British Columbia, Dept Psychiat, Vancouver, BC, Canada; [Sohya, Kazuhiro; Tsumoto, Tadaharu] RIKEN BSI, Lab Cort Circuit Plast, Wako, Saitama, Japan; [Sohya, Kazuhiro; Miyamoto, Hiroyuki] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol, Saitama, Japan; [Miyamoto, Hiroyuki] RIKEN BSI, Lab Neurobiol Synapse, Wako, Saitama, Japan; [Yasuda, Hiroki] Gunma Univ, Grad Sch Med, Educat & Res Support Ctr, Maebashi, Gunma 371, Japan	RIKEN; University of British Columbia; University of British Columbia; RIKEN; Japan Science & Technology Agency (JST); RIKEN; Gunma University	Aruga, J (corresponding author), RIKEN Brain Sci Inst BSI, Lab Behav & Dev Disorders, Wako, Saitama, Japan.	jaruga@brain.riken.jp; acraig@mail.ubc.ca	Craig, Ann Marie/M-2054-2014; Aruga, Jun/H-5837-2011; Katayama, Kei-ichi/J-4699-2013; Takahashi, Hideto/T-2650-2018	Aruga, Jun/0000-0001-7936-1375; Katayama, Kei-ichi/0000-0003-0527-4644; Takahashi, Hideto/0000-0002-6473-5060; Yasuda, Hiroki/0000-0001-5911-609X	NeuroDevNet Canadian Network of Centre of Excellence; US National Institutes of Health [MH070860]; Canadian Institutes of Health Research [MOP-84241]; Canada Research Chair; Japan Society for the Promotion of Science; National Alliance for Research on Schizophrenia and Depression; RIKEN BSI; Ministry of Education, Culture, Sports, Science (Japan) [21240031]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH070860] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [23500461, 21200016] Funding Source: KAKEN	NeuroDevNet Canadian Network of Centre of Excellence; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); National Alliance for Research on Schizophrenia and Depression(NARSAD); RIKEN BSI; Ministry of Education, Culture, Sports, Science (Japan)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank X. Zhou (Brain Research Centre, University of British Columbia) for excellent preparation of neuron cultures, N. Takashima (Lab for Behavioral and Developmental Disorders, RIKEN BSI) for technical assistance with seizure experiments and C. Nishioka (Research Resource Center, RIKEN BSI) for help generating Slitrk3 knockout mice. This work was supported by a NeuroDevNet Canadian Network of Centre of Excellence Opportunities Initiative Award, US National Institutes of Health grant MH070860, Canadian Institutes of Health Research grant MOP-84241 and Canada Research Chair awards to A. M. C., a Japan Society for the Promotion of Science Postdoctoral Fellowship for Research Abroad and a National Alliance for Research on Schizophrenia and Depression (Brain and Behavior Research Fund) Young Investigator grant to H. T., and RIKEN BSI funds and a Ministry of Education, Culture, Sports, Science (Japan) Grant-in-Aid for Scientific Research (A) (21240031) to J.A.	Abelson JF, 2005, SCIENCE, V310, P317, DOI 10.1126/science.1116502; Akerman CJ, 2007, TRENDS NEUROSCI, V30, P382, DOI 10.1016/j.tins.2007.06.002; Aruga J, 2003, MOL CELL NEUROSCI, V24, P117, DOI 10.1016/S1044-7431(03)00129-5; Beaubien F, 2009, DEV DYNAM, V238, P3285, DOI 10.1002/dvdy.22160; BENSON DL, 1994, J NEUROCYTOL, V23, P279, DOI 10.1007/BF01188497; Betancur C, 2009, TRENDS NEUROSCI, V32, P402, DOI 10.1016/j.tins.2009.04.003; Blundell J, 2009, GENES BRAIN BEHAV, V8, P114, DOI 10.1111/j.1601-183X.2008.00455.x; Chih B, 2005, SCIENCE, V307, P1324, DOI 10.1126/science.1107470; Cline H, 2005, CURR BIOL, V15, pR203, DOI 10.1016/j.cub.2005.03.010; Dalva MB, 2007, NAT REV NEUROSCI, V8, P206, DOI 10.1038/nrn2075; de Wit J, 2009, NEURON, V64, P799, DOI 10.1016/j.neuron.2009.12.019; Dunah AW, 2005, NAT NEUROSCI, V8, P458, DOI 10.1038/nn1416; Elia J, 2010, MOL PSYCHIATR, V15, P637, DOI 10.1038/mp.2009.57; Gibson JR, 2009, J NEUROSCI, V29, P13883, DOI 10.1523/JNEUROSCI.2457-09.2009; Graf ER, 2004, CELL, V119, P1013, DOI 10.1016/j.cell.2004.11.035; Hensch TK, 2005, NAT REV NEUROSCI, V6, P877, DOI 10.1038/nrn1787; Huang ZJ, 2007, NAT REV NEUROSCI, V8, P673, DOI 10.1038/nrn2188; ICHTCHENKO K, 1995, CELL, V81, P435, DOI 10.1016/0092-8674(95)90396-8; Jedlicka P, 2011, CEREB CORTEX, V21, P357, DOI 10.1093/cercor/bhq100; Katayama K, 2010, MOL PSYCHIATR, V15, P177, DOI 10.1038/mp.2008.97; Ko J, 2009, NEURON, V64, P791, DOI 10.1016/j.neuron.2009.12.012; Kwon SK, 2010, J BIOL CHEM, V285, P13966, DOI 10.1074/jbc.M109.061127; Linhoff MW, 2009, NEURON, V61, P734, DOI 10.1016/j.neuron.2009.01.017; Maffei A, 2004, NAT NEUROSCI, V7, P1353, DOI 10.1038/nn1351; Mohler H, 2006, J RECEPT SIG TRANSD, V26, P731, DOI 10.1080/10799890600920035; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Piton A, 2011, MOL PSYCHIATR, V16, P867, DOI 10.1038/mp.2010.54; Poulopoulos A, 2009, NEURON, V63, P628, DOI 10.1016/j.neuron.2009.08.023; Rubenstein JLR, 2003, GENES BRAIN BEHAV, V2, P255, DOI 10.1034/j.1601-183X.2003.00037.x; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Schormair B, 2008, NAT GENET, V40, P946, DOI 10.1038/ng.190; Shen K, 2010, ANNU REV NEUROSCI, V33, P473, DOI 10.1146/annurev.neuro.051508.135302; Shmelkov SV, 2010, NAT MED, V16, P598, DOI 10.1038/nm.2125; Siddiqui TJ, 2011, CURR OPIN NEUROBIOL, V21, P132, DOI 10.1016/j.conb.2010.08.016; Siddiqui TJ, 2010, J NEUROSCI, V30, P7495, DOI 10.1523/JNEUROSCI.0470-10.2010; Singer HS, 2003, BRAIN DEV-JPN, V25, pS70, DOI 10.1016/S0387-7604(03)90012-X; Smith EN, 2009, MOL PSYCHIATR, V14, P755, DOI 10.1038/mp.2009.43; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Suzuki T, 2009, HUM MOL GENET, V18, P1099, DOI 10.1093/hmg/ddp006; Takahashi H, 2011, NEURON, V69, P287, DOI 10.1016/j.neuron.2010.12.024; Talebizadeh Z, 2008, AUTISM RES, V1, P240, DOI 10.1002/aur.33; Terauchi A, 2010, NATURE, V465, P783, DOI 10.1038/nature09041; Uetani N, 2000, EMBO J, V19, P2775, DOI 10.1093/emboj/19.12.2775; Valnegri P, 2011, HUM MOL GENET, V20, P4797, DOI 10.1093/hmg/ddr418; Varoqueaux F, 2004, EUR J CELL BIOL, V83, P449, DOI 10.1078/0171-9335-00410; Wassef A, 2003, J CLIN PSYCHOPHARM, V23, P601, DOI 10.1097/01.jcp.0000095349.32154.a5; Woo J, 2009, NAT NEUROSCI, V12, P428, DOI 10.1038/nn.2279; Yasuda H, 2003, NAT NEUROSCI, V6, P15, DOI 10.1038/nn985; Yoshida T, 2011, J NEUROSCI, V31, P13485, DOI 10.1523/JNEUROSCI.2136-11.2011; Zuchner S, 2006, MOL PSYCHIATR, V11, P888, DOI 10.1038/sj.mp.4001865	50	159	159	0	10	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2012	15	3					389	U214		10.1038/nn.3040	http://dx.doi.org/10.1038/nn.3040			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	899CY	22286174	Green Accepted			2022-12-28	WOS:000300793100012
J	Stoianov, I; Zorzi, M				Stoianov, Ivilin; Zorzi, Marco			Emergence of a 'visual number sense' in hierarchical generative models	NATURE NEUROSCIENCE			English	Article							REPRESENTATION; NUMEROSITY; CORTEX	Numerosity estimation is phylogenetically ancient and foundational to human mathematical learning, but its computational bases remain controversial. Here we show that visual numerosity emerges as a statistical property of images in 'deep networks' that learn a hierarchical generative model of the sensory input. Emergent numerosity detectors had response profiles resembling those of monkey parietal neurons and supported numerosity estimation with the same behavioral signature shown by humans and animals.	[Stoianov, Ivilin; Zorzi, Marco] Univ Padua, Dipartimento Psicol Gen, I-35100 Padua, Italy; [Zorzi, Marco] Univ Padua, Ctr Cognit Sci, I-35100 Padua, Italy	University of Padua; University of Padua	Zorzi, M (corresponding author), Univ Padua, Dipartimento Psicol Gen, I-35100 Padua, Italy.	marco.zorzi@unipd.it	Stoianov, Ivilin/G-5904-2011; Zorzi, Marco/B-7863-2008; Stoianov, Ivilin/AAX-8528-2020	Stoianov, Ivilin/0000-0003-0642-259X; Zorzi, Marco/0000-0002-4651-6390; 	European Research Council [210922]	European Research Council(European Research Council (ERC)European Commission)	This study was supported by the European Research Council (grant no. 210922 to M.Z.)	ALLIK J, 1991, PERCEPT PSYCHOPHYS, V49, P303, DOI 10.3758/BF03205986; Brannon EM, 1998, SCIENCE, V282, P746, DOI 10.1126/science.282.5389.746; Burr D, 2008, CURR BIOL, V18, P425, DOI 10.1016/j.cub.2008.02.052; DEHAENE S, 1993, J COGNITIVE NEUROSCI, V5, P390, DOI 10.1162/jocn.1993.5.4.390; Durgin FH, 2008, CURR BIOL, V18, pR855, DOI 10.1016/j.cub.2008.07.053; Halberda J, 2008, NATURE, V455, P665, DOI 10.1038/nature07246; Hinton GE, 2006, SCIENCE, V313, P504, DOI 10.1126/science.1127647; Hinton GE, 2007, TRENDS COGN SCI, V11, P428, DOI 10.1016/j.tics.2007.09.004; Nieder A, 2005, NAT REV NEUROSCI, V6, P177, DOI 10.1038/nrn1626; Nieder A, 2002, SCIENCE, V297, P1708, DOI 10.1126/science.1072493; Piazza M, 2004, NEURON, V44, P547, DOI 10.1016/j.neuron.2004.10.014; Piazza M, 2010, COGNITION, V116, P33, DOI 10.1016/j.cognition.2010.03.012; Roitman JD, 2007, PLOS BIOL, V5, P1672, DOI 10.1371/journal.pbio.0050208; Santens S, 2010, CEREB CORTEX, V20, P77, DOI 10.1093/cercor/bhp080; Verguts T, 2004, J COGNITIVE NEUROSCI, V16, P1493, DOI 10.1162/0898929042568497	15	183	185	1	36	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2012	15	2					194	196		10.1038/nn.2996	http://dx.doi.org/10.1038/nn.2996			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	882ZX	22231428				2022-12-28	WOS:000299603500009
J	Liu, OW; Shen, K				Liu, Oliver W.; Shen, Kang			The transmembrane LRR protein DMA-1 promotes dendrite branching and growth in C. elegans	NATURE NEUROSCIENCE			English	Article							STRUCTURAL INSIGHTS; SIGNALING PATHWAY; NERVOUS-SYSTEM; DROSOPHILA; EXPRESSION; GENE; MORPHOGENESIS; TRANSPORT; RECEPTOR; NEURONS	Dendrites often adopt complex branched structures. The development and organization of these arbors fundamentally determine the potential input and connectivity of a given neuron. The cell-surface receptors that control dendritic branching remain poorly understood. We found that, in Caenorhabditis elegans, a previously uncharacterized transmembrane protein containing extracellular leucine-rich repeat (LRR) domains, which we named DMA-1 (dendrite-morphogenesis-abnormal), promotes dendrite branching and growth. Sustained expression of dma-1 was found only in the elaborately branched sensory neurons PVD and FLP. Genetic analysis revealed that the loss of dma-1 resulted in much reduced dendritic arbors, whereas overexpression of dma-1 resulted in excessive branching. Forced expression of dma-1 in neurons with simple dendrites was sufficient to promote ectopic branching. Worms lacking dma-1 were defective in sensing harsh touch. DMA-1 is the first transmembrane LRR protein to be implicated in dendritic branching and expands the breadth of roles of LRR receptors in nervous system development.	[Liu, Oliver W.; Shen, Kang] Stanford Univ, Howard Hughes Med Inst, Dept Biol, Stanford, CA 94305 USA	Howard Hughes Medical Institute; Stanford University	Shen, K (corresponding author), Stanford Univ, Howard Hughes Med Inst, Dept Biol, Stanford, CA 94305 USA.	kangshen@stanford.edu			Howard Hughes Medical Institute; US National Institutes of Health; Jane Coffin Childs Memorial Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048392] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jane Coffin Childs Memorial Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank C. Gao and Y. Fu for technical assistance, C. Chen, K. Mizumoto, P. Chia and A. Hellman for critical reading of the manuscript, and the members of the Shen laboratory for helpful discussion. We would also like to thank the members of the Hobert and the Jorgensen laboratories for sharing plasmids and expertise regarding fosmid recombineering and MosDel. This work was supported by grants from the Howard Hughes Medical Institute and the US National Institutes of Health to K. S., and a postdoctoral fellowship from the Jane Coffin Childs Memorial Fund to O.W.L.	Aizawa H, 2004, SCIENCE, V303, P197, DOI 10.1126/science.1089845; Albeg A, 2011, MOL CELL NEUROSCI, V46, P308, DOI 10.1016/j.mcn.2010.10.001; Bella J, 2008, CELL MOL LIFE SCI, V65, P2307, DOI 10.1007/s00018-008-8019-0; Caldwell JC, 2007, FLY, V1, P146, DOI 10.4161/fly.4562; Chen YN, 2006, BRAIN RES REV, V51, P265, DOI 10.1016/j.brainresrev.2005.11.005; de Wit J, 2009, NEURON, V64, P799, DOI 10.1016/j.neuron.2009.12.019; Dimitrova S, 2008, DEV BIOL, V324, P18, DOI 10.1016/j.ydbio.2008.08.028; Dolan J, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-320; Emoto K, 2004, CELL, V119, P245, DOI 10.1016/j.cell.2004.09.036; Frokjaer-Jensen C, 2010, NAT METHODS, V7, P451, DOI [10.1038/NMETH.1454, 10.1038/nmeth.1454]; Gaudilliere B, 2004, NEURON, V41, P229, DOI 10.1016/S0896-6273(03)00841-9; Grueber WB, 2003, CELL, V112, P805, DOI 10.1016/S0092-8674(03)00160-0; Grueber WB, 2007, DEVELOPMENT, V134, P55, DOI 10.1242/dev.02666; Hattori D, 2008, ANNU REV CELL DEV BI, V24, P597, DOI 10.1146/annurev.cellbio.24.110707.175250; Hong WZ, 2009, NAT NEUROSCI, V12, P1542, DOI 10.1038/nn.2442; Hutter H, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-529; Jan YN, 2010, NAT REV NEUROSCI, V11, P316, DOI 10.1038/nrn2836; Jaworski J, 2005, J NEUROSCI, V25, P11300, DOI 10.1523/JNEUROSCI.2270-05.2005; Ko J, 2009, NEURON, V64, P791, DOI 10.1016/j.neuron.2009.12.012; Li W, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1308; Linhoff MW, 2009, NEURON, V61, P734, DOI 10.1016/j.neuron.2009.01.017; Long H, 2009, DEVELOPMENT, V136, P3475, DOI 10.1242/dev.040220; Masland RH, 2004, CURR BIOL, V14, pR497, DOI 10.1016/j.cub.2004.06.035; McAllister AK, 1997, NEURON, V18, P767, DOI 10.1016/S0896-6273(00)80316-5; Mello C, 1995, METHOD CELL BIOL, V48, P451; Morita A, 2006, J NEUROSCI, V26, P2971, DOI 10.1523/JNEUROSCI.5453-05.2006; Morlot C, 2007, P NATL ACAD SCI USA, V104, P14923, DOI 10.1073/pnas.0705310104; Oldenburg KR, 1997, NUCLEIC ACIDS RES, V25, P451, DOI 10.1093/nar/25.2.451; Oren-Suissa M, 2010, SCIENCE, V328, P1285, DOI 10.1126/science.1189095; Ramon y Cajal S, 1995, HISTOLOGY NERVOUS SY; Satoh D, 2008, NAT CELL BIOL, V10, P1164, DOI 10.1038/ncb1776; Schubert WD, 2002, CELL, V111, P825, DOI 10.1016/S0092-8674(02)01136-4; Shapiro L, 2007, ANNU REV NEUROSCI, V30, P451, DOI 10.1146/annurev.neuro.29.051605.113034; Shen K, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001842; Smith CJ, 2010, DEV BIOL, V345, P18, DOI 10.1016/j.ydbio.2010.05.502; Sugimura K, 2004, NEURON, V43, P809, DOI 10.1016/j.neuron.2004.08.016; Sweeney NT, 2006, CURR BIOL, V16, P1006, DOI 10.1016/j.cub.2006.03.067; Tsalik EL, 2003, DEV BIOL, V263, P81, DOI 10.1016/S0012-1606(03)00447-0; Tursun B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004625; Wang GJ, 2010, NAT NEUROSCI, V13, P1489, DOI 10.1038/nn.2667; WAY JC, 1989, GENE DEV, V3, P1823, DOI 10.1101/gad.3.12a.1823; Wen Q, 2009, P NATL ACAD SCI USA, V106, P12536, DOI 10.1073/pnas.0901530106; Ye B, 2004, CURR BIOL, V14, P314, DOI 10.1016/j.cub.2004.01.052; Ye B, 2007, CELL, V130, P717, DOI 10.1016/j.cell.2007.06.032; Zheng Y, 2008, NAT CELL BIOL, V10, P1172, DOI 10.1038/ncb1777	45	65	67	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2012	15	1					57	U74		10.1038/nn.2978	http://dx.doi.org/10.1038/nn.2978			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	866VO	22138642	Green Accepted			2022-12-28	WOS:000298414400014
J	Alexander, WH; Brown, JW				Alexander, William H.; Brown, Joshua W.			Medial prefrontal cortex as an action-outcome predictor	NATURE NEUROSCIENCE			English	Article							ANTERIOR CINGULATE CORTEX; SUPPLEMENTARY EYE FIELD; TIME-ESTIMATION TASK; ERROR LIKELIHOOD; NEURONAL-ACTIVITY; COGNITIVE CONTROL; DECISION-MAKING; CONFLICT; PERFORMANCE; REWARD	The medial prefrontal cortex (mPFC) and especially anterior cingulate cortex is central to higher cognitive function and many clinical disorders, yet its basic function remains in dispute. Various competing theories of mPFC have treated effects of errors, conflict, error likelihood, volatility and reward, using findings from neuroimaging and neurophysiology in humans and monkeys. No single theory has been able to reconcile and account for the variety of findings. Here we show that a simple model based on standard learning rules can simulate and unify an unprecedented range of known effects in mPFC. The model reinterprets many known effects and suggests a new view of mPFC, as a region concerned with learning and predicting the likely outcomes of actions, whether good or bad. Cognitive control at the neural level is then seen as a result of evaluating the probable and actual outcomes of one's actions.	[Alexander, William H.; Brown, Joshua W.] Indiana Univ, Dept Psychol & Brain Sci, Bloomington, IN 47405 USA	Indiana University System; Indiana University Bloomington	Brown, JW (corresponding author), Indiana Univ, Dept Psychol & Brain Sci, Bloomington, IN 47405 USA.	jwmbrown@indiana.edu	Brown, Joshua/G-2867-2011		Air Force Office of Scientific Research [FA9550-07-1-0454, R03 DA023462, R01 DA026457]; NARSAD; Sidney R. Baer Jr. Foundation; Department of the Interior (DOI) [D10PC20023]; NATIONAL INSTITUTE ON DRUG ABUSE [R03DA023462, R01DA026457] Funding Source: NIH RePORTER	Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); NARSAD(NARSAD); Sidney R. Baer Jr. Foundation; Department of the Interior (DOI); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank L. Pessoa, S. Padmala, T. Braver, V. Stuphorn, A. Krawitz, D. Nee and the J. Schall laboratory for critical feedback. Supported in part by Air Force Office of Scientific Research FA9550-07-1-0454 (J. W. B.), R03 DA023462 (J. W. B.), R01 DA026457 (J. W. B.), a NARSAD Young Investigator Award (J. W. B.) and the Sidney R. Baer Jr. Foundation (J. W. B.). Supported by the Intelligence Advanced Research Projects Activity (IARPA) through Department of the Interior (DOI) contract D10PC20023. The US Government is authorized to reproduce and distribute reprints for Governmental purposes notwithstanding any copyright annotation thereon. The views and conclusions contained herein are those of the authors and should not be interpreted as necessarily representing the official policies or endorsements, either expressed or implied, of IARPA, DOI or the US Government.	Aarts E, 2008, J NEUROSCI, V28, P4671, DOI 10.1523/JNEUROSCI.4400-07.2008; Amador N, 2000, J NEUROPHYSIOL, V84, P2166, DOI 10.1152/jn.2000.84.4.2166; Amiez C, 2005, EUR J NEUROSCI, V21, P3447, DOI 10.1111/j.1460-9568.2005.04170.x; Amiez C, 2006, CEREB CORTEX, V16, P1040, DOI 10.1093/cercor/bhj046; Behrens TEJ, 2007, NAT NEUROSCI, V10, P1214, DOI 10.1038/nn1954; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Braver T. S., 2007, VARIATION WORKING ME, P76, DOI DOI 10.1093/ACPROF:OSO/9780195168648.003.0004; Brown JW, 2007, COGN AFFECT BEHAV NE, V7, P266, DOI 10.3758/CABN.7.4.266; Brown JW, 2009, PSYCHOL RES-PSYCH FO, V73, P744, DOI 10.1007/s00426-008-0198-7; Brown JW, 2009, NEUROIMAGE, V47, P334, DOI 10.1016/j.neuroimage.2009.04.034; Brown JW, 2005, SCIENCE, V307, P1118, DOI 10.1126/science.1105783; Burle B, 2008, J COGNITIVE NEUROSCI, V20, P1637, DOI 10.1162/jocn.2008.20110; Bush G, 2002, P NATL ACAD SCI USA, V99, P523, DOI 10.1073/pnas.012470999; Carter CS, 1998, SCIENCE, V280, P747, DOI 10.1126/science.280.5364.747; Carter CS, 2001, AM J PSYCHIAT, V158, P1423, DOI 10.1176/appi.ajp.158.9.1423; Cole MW, 2009, TRENDS NEUROSCI, V32, P566, DOI 10.1016/j.tins.2009.07.001; Croxson PL, 2009, J NEUROSCI, V29, P4531, DOI 10.1523/JNEUROSCI.4515-08.2009; Doya K, 2002, NEURAL COMPUT, V14, P1347, DOI 10.1162/089976602753712972; FALKENSTEIN M, 1991, ELECTROEN CLIN NEURO, V78, P447, DOI 10.1016/0013-4694(91)90062-9; Ford KA, 2009, NEUROIMAGE, V45, P470, DOI 10.1016/j.neuroimage.2008.12.009; GEHRING WJ, 1990, PSYCHOPHYSIOLOGY, V27, P34; Glascher J, 2010, NEURON, V66, P585, DOI 10.1016/j.neuron.2010.04.016; Haggard P, 2008, NAT REV NEUROSCI, V9, P934, DOI 10.1038/nrn2497; Holroyd CB, 2005, J EXP PSYCHOL GEN, V134, P163, DOI 10.1037/0096-3445.134.2.163; Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI 10.1037/0033-295X.109.4.679; Holroyd CB, 2007, PSYCHOPHYSIOLOGY, V44, P913, DOI 10.1111/j.1469-8986.2007.00561.x; Ito S, 2003, SCIENCE, V302, P120, DOI 10.1126/science.1087847; Jessup RK, 2010, J NEUROSCI, V30, P3467, DOI 10.1523/JNEUROSCI.4130-09.2010; Kennerley SW, 2009, J COGNITIVE NEUROSCI, V21, P1162, DOI 10.1162/jocn.2009.21100; Matsumoto K, 2003, SCIENCE, V301, P229, DOI 10.1126/science.1084204; Matsumoto M, 2007, NAT NEUROSCI, V10, P647, DOI 10.1038/nn1890; Miltner WHR, 1997, J COGNITIVE NEUROSCI, V9, P788, DOI 10.1162/jocn.1997.9.6.788; Nakamura K, 2005, J NEUROPHYSIOL, V93, P884, DOI 10.1152/jn.00305.2004; Nee DE, 2011, NEUROIMAGE, V54, P528, DOI 10.1016/j.neuroimage.2010.08.027; Oliveira FTP, 2007, J COGNITIVE NEUROSCI, V19, P1994, DOI 10.1162/jocn.2007.19.12.1994; Olson CR, 2002, PHYSIOL BEHAV, V77, P663, DOI 10.1016/S0031-9384(02)00945-9; PEARCE JM, 1980, PSYCHOL REV, V87, P532, DOI 10.1037/0033-295X.87.6.532; Procyk E, 2000, NAT NEUROSCI, V3, P502, DOI 10.1038/74880; Quilodran R, 2008, NEURON, V57, P314, DOI 10.1016/j.neuron.2007.11.031; Rudebeck PH, 2008, J NEUROSCI, V28, P13775, DOI 10.1523/JNEUROSCI.3541-08.2008; Sallet J, 2007, COGN AFFECT BEHAV NE, V7, P327, DOI 10.3758/CABN.7.4.327; Scheffers MK, 2000, J EXP PSYCHOL HUMAN, V26, P141, DOI 10.1037/0096-1523.26.1.141; Schoenbaum G, 2003, NEURON, V39, P855, DOI 10.1016/S0896-6273(03)00474-4; Shidara M, 2002, SCIENCE, V296, P1709, DOI 10.1126/science.1069504; Shima K, 1998, SCIENCE, V282, P1335, DOI 10.1126/science.282.5392.1335; Singh SP, 1996, MACH LEARN, V22, P123, DOI 10.1007/BF00114726; Walton ME, 2004, NAT NEUROSCI, V7, P1259, DOI 10.1038/nn1339; WATKINS CJCH, 1992, MACH LEARN, V8, P279, DOI 10.1007/BF00992698; Yeung N, 2009, J NEUROSCI, V29, P14506, DOI 10.1523/JNEUROSCI.3615-09.2009; Yu AJ, 2005, NEURON, V46, P681, DOI 10.1016/j.neuron.2005.04.026	50	638	644	5	127	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2011	14	10					1338	U163		10.1038/nn.2921	http://dx.doi.org/10.1038/nn.2921			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	825EQ	21926982	Green Accepted			2022-12-28	WOS:000295254200024
J	Hofer, SB; Ko, H; Pichler, B; Vogelstein, J; Ros, H; Zeng, HK; Lein, E; Lesica, NA; Mrsic-Flogel, TD				Hofer, Sonja B.; Ko, Ho; Pichler, Bruno; Vogelstein, Joshua; Ros, Hana; Zeng, Hongkui; Lein, Ed; Lesica, Nicholas A.; Mrsic-Flogel, Thomas D.			Differential connectivity and response dynamics of excitatory and inhibitory neurons in visual cortex	NATURE NEUROSCIENCE			English	Article							IN-VIVO; CORTICAL-NEURONS; FUNCTIONAL CONNECTIVITY; GABAERGIC NEURONS; TRANSGENIC MICE; STRIATE CORTEX; BEHAVING MICE; BARREL CORTEX; SIMPLE CELLS; NETWORKS	Neuronal responses during sensory processing are influenced by both the organization of intracortical connections and the statistical features of sensory stimuli. How these intrinsic and extrinsic factors govern the activity of excitatory and inhibitory populations is unclear. Using two-photon calcium imaging in vivo and intracellular recordings in vitro, we investigated the dependencies between synaptic connectivity, feature selectivity and network activity in pyramidal cells and fast-spiking parvalbumin-expressing (PV) interneurons in mouse visual cortex. In pyramidal cell populations, patterns of neuronal correlations were largely stimulus-dependent, indicating that their responses were not strongly dominated by functionally biased recurrent connectivity. By contrast, visual stimulation only weakly modified co-activation patterns of fast-spiking PV cells, consistent with the observation that these broadly tuned interneurons received very dense and strong synaptic input from nearby pyramidal cells with diverse feature selectivities. Therefore, feedforward and recurrent network influences determine the activity of excitatory and inhibitory ensembles in fundamentally different ways.	[Hofer, Sonja B.; Ko, Ho; Pichler, Bruno; Ros, Hana; Mrsic-Flogel, Thomas D.] UCL, Dept Neurosci Physiol & Pharmacol, London, England; [Vogelstein, Joshua] Johns Hopkins Univ, Baltimore, MD USA; [Zeng, Hongkui; Lein, Ed] Allen Inst Brain Sci, Seattle, WA USA; [Lesica, Nicholas A.] UCL, Ear Inst, London, England	University of London; University College London; Johns Hopkins University; Allen Institute for Brain Science; University of London; University College London	Mrsic-Flogel, TD (corresponding author), UCL, Dept Neurosci Physiol & Pharmacol, London, England.	t.mrsic-flogel@ucl.ac.uk	Ko, Ho/I-7513-2016; Vogelstein, Joshua/AAG-5489-2019; Ko, Ho/AAH-2755-2020	Ko, Ho/0000-0002-0254-3274; Vogelstein, Joshua/0000-0003-2487-6237; Ko, Ho/0000-0002-0254-3274; Lesica, Nicholas/0000-0001-5238-4462; Mrsic-Flogel, Tom/0000-0002-8947-408X; Hofer, Sonja/0000-0003-4921-8521	Wellcome Trust; European Research Council; European Molecular Biology Organization; Humboldt Foundation; European Community [FP2007-2013, 223326]	Wellcome Trust(Wellcome TrustEuropean Commission); European Research Council(European Research Council (ERC)European Commission); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Humboldt Foundation(Alexander von Humboldt Foundation); European Community(European Commission)	We thank T. Margrie, A. Arenz and E. Rancz for help with in vivo electrophysiology, J. Sjostrom and K. Buchanan for help with in vitro electrophysiology, J. Rothman for NeuroMatic software, and M. Hubener and M. Sahani for comments on an earlier version of this manuscript. This work was supported by the Wellcome Trust (T.D.M.-F.), the European Research Council (T.D.M.-F.), the European Molecular Biology Organization (S.B.H.) and the Humboldt Foundation (S.B.H.). We also received funding from the European Community's Seventh Framework Programme (FP2007-2013) under grant agreement no. 223326 (T.D.M.-F.).	Alonso JM, 1998, NAT NEUROSCI, V1, P395, DOI 10.1038/1609; Alonso JM, 2001, J NEUROSCI, V21, P4002, DOI 10.1523/JNEUROSCI.21-11-04002.2001; Bock DD, 2011, NATURE, V471, P177, DOI 10.1038/nature09802; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Cardin JA, 2007, J NEUROSCI, V27, P10333, DOI 10.1523/JNEUROSCI.1692-07.2007; Ch'ng YH, 2010, FRONT INTEGR NEUROSC, V4, DOI 10.3389/fnint.2010.00020; Chelaru MI, 2008, P NATL ACAD SCI USA, V105, P16344, DOI 10.1073/pnas.0807744105; Ecker AS, 2010, SCIENCE, V327, P584, DOI 10.1126/science.1179867; Fiser J, 2004, NATURE, V431, P573, DOI 10.1038/nature02907; Galarreta M, 1999, NATURE, V402, P72, DOI 10.1038/47029; Gentet LJ, 2010, NEURON, V65, P422, DOI 10.1016/j.neuron.2010.01.006; Gibson JR, 1999, NATURE, V402, P75, DOI 10.1038/47035; GILBERT CD, 1989, J NEUROSCI, V9, P2432; Gonchar Yuri, 2007, Front Neuroanat, V1, P3, DOI 10.3389/neuro.05.003.2007; Hirsch JA, 2003, NAT NEUROSCI, V6, P1300, DOI 10.1038/nn1152; Holmgren C, 2003, J PHYSIOL-LONDON, V551, P139, DOI 10.1113/jphysiol.2003.044784; Jermakowicz WJ, 2009, J NEUROPHYSIOL, V101, P2279, DOI 10.1152/jn.91207.2008; Kerlin AM, 2010, NEURON, V67, P858, DOI 10.1016/j.neuron.2010.08.002; Ko H, 2011, NATURE, V473, P87, DOI 10.1038/nature09880; Kohn A, 2005, J NEUROSCI, V25, P3661, DOI 10.1523/JNEUROSCI.5106-04.2005; Liu BH, 2010, NAT NEUROSCI, V13, P89, DOI 10.1038/nn.2443; Luczak A, 2009, NEURON, V62, P413, DOI 10.1016/j.neuron.2009.03.014; Ma WP, 2010, J NEUROSCI, V30, P14371, DOI 10.1523/JNEUROSCI.3248-10.2010; MacLean JN, 2005, NEURON, V48, P811, DOI 10.1016/j.neuron.2005.09.035; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; Mrsic-Flogel TD, 2007, NEURON, V54, P961, DOI 10.1016/j.neuron.2007.05.028; Nauhaus I, 2009, NAT NEUROSCI, V12, P70, DOI 10.1038/nn.2232; Niell CM, 2008, J NEUROSCI, V28, P7520, DOI 10.1523/JNEUROSCI.0623-08.2008; Nimmerjahn A, 2004, NAT METHODS, V1, P31, DOI 10.1038/nmeth706; Nowak LG, 2008, CEREB CORTEX, V18, P1058, DOI 10.1093/cercor/bhm137; Ohiorhenuan IE, 2010, NATURE, V466, P617, DOI 10.1038/nature09178; Ohki K, 2005, NATURE, V433, P597, DOI 10.1038/nature03274; Oswald AMM, 2009, J NEUROSCI, V29, P10321, DOI 10.1523/JNEUROSCI.1703-09.2009; Ozeki H, 2009, NEURON, V62, P578, DOI 10.1016/j.neuron.2009.03.028; Poulet JFA, 2008, NATURE, V454, P881, DOI 10.1038/nature07150; Priebe NJ, 2008, NEURON, V57, P482, DOI 10.1016/j.neuron.2008.02.005; Renart A, 2010, SCIENCE, V327, P587, DOI 10.1126/science.1179850; Runyan CA, 2010, NEURON, V67, P847, DOI 10.1016/j.neuron.2010.08.006; SILLITO AM, 1975, J PHYSIOL-LONDON, V250, P305, DOI 10.1113/jphysiol.1975.sp011056; Smith MA, 2008, J NEUROSCI, V28, P12591, DOI 10.1523/JNEUROSCI.2929-08.2008; Sohya K, 2007, J NEUROSCI, V27, P2145, DOI 10.1523/JNEUROSCI.4641-06.2007; Stosiek C, 2003, P NATL ACAD SCI USA, V100, P7319, DOI 10.1073/pnas.1232232100; Tanahira C, 2009, NEUROSCI RES, V63, P213, DOI 10.1016/j.neures.2008.12.007; Thomson AM, 2007, FRONT NEUROSCI-SWITZ, V1, P19, DOI 10.3389/neuro.01.1.1.002.2007; Tsodyks M, 1999, SCIENCE, V286, P1943, DOI 10.1126/science.286.5446.1943; Vogelstein JT, 2010, J NEUROPHYSIOL, V104, P3691, DOI 10.1152/jn.01073.2009; Yoshimura Y, 2005, NATURE, V433, P868, DOI 10.1038/nature03252; Yoshimura Y, 2005, NAT NEUROSCI, V8, P1552, DOI 10.1038/nn1565; ZOHARY E, 1994, NATURE, V370, P140, DOI 10.1038/370140a0	50	298	298	1	54	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2011	14	8					1045	U146		10.1038/nn.2876	http://dx.doi.org/10.1038/nn.2876			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	797KC	21765421	Green Accepted			2022-12-28	WOS:000293123700019
J	Hayden, BY; Pearson, JM; Platt, ML				Hayden, Benjamin Y.; Pearson, John M.; Platt, Michael L.			Neuronal basis of sequential foraging decisions in a patchy environment	NATURE NEUROSCIENCE			English	Article							ANTERIOR CINGULATE CORTEX; REWARD SIGNALS; PREDICTION ERRORS; UNCERTAINTY; DOPAMINE; STRATEGY; CHOICE; BRAIN; DELAY; AREA	Deciding when to leave a depleting resource to exploit another is a fundamental problem for all decision makers. The neuronal mechanisms mediating patch-leaving decisions remain unknown. We found that neurons in primate (Macaca mulatta) dorsal anterior cingulate cortex, an area that is linked to reward monitoring and executive control, encode a decision variable signaling the relative value of leaving a depleting resource for a new one. Neurons fired during each sequential decision to stay in a patch and, for each travel time, these responses reached a fixed threshold for patch-leaving. Longer travel times reduced the gain of neural responses for choosing to stay in a patch and increased the firing rate threshold mandating patch-leaving. These modulations more closely matched behavioral decisions than any single task variable. These findings portend an understanding of the neural basis of foraging decisions and endorse the unification of theoretical and experimental work in ecology and neuroscience.	[Hayden, Benjamin Y.; Pearson, John M.; Platt, Michael L.] Duke Univ, Sch Med, Dept Neurobiol, Durham, NC 27710 USA; [Hayden, Benjamin Y.; Pearson, John M.; Platt, Michael L.] Duke Univ, Ctr Cognit Neurosci, Durham, NC USA; [Platt, Michael L.] Duke Univ, Dept Evolutionary Anthropol, Durham, NC USA	Duke University; Duke University; Duke University	Hayden, BY (corresponding author), Duke Univ, Sch Med, Dept Neurobiol, Durham, NC 27710 USA.	benhayden@gmail.com	Hayden, Benjamin/J-7994-2013	Hayden, Benjamin/0000-0002-7678-4281; Pearson, John/0000-0002-9876-7837	US National Institutes of Health [R01EY013496, K99 DA027718-01]; Tourette Syndrome Association; NATIONAL EYE INSTITUTE [R01EY013496] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K99DA027718] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tourette Syndrome Association; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank S. Heilbronner for comments on design, analysis and writing. This research was supported by US National Institutes of Health grant R01EY013496 (M. L. P.), a Fellowship from the Tourette Syndrome Association (B.Y.H.) and US National Institutes of Health grant K99 DA027718-01 (B.Y.H.).	Agetsuma N, 1998, J ETHOL, V16, P49, DOI 10.1007/BF02769282; Amiez C, 2006, CEREB CORTEX, V16, P1040, DOI 10.1093/cercor/bhj046; Baler RD, 2006, TRENDS MOL MED, V12, P559, DOI 10.1016/j.molmed.2006.10.005; Bendesky A, 2011, NATURE, V472, P313, DOI 10.1038/nature09821; Bonser R, 1998, ECOL ENTOMOL, V23, P15, DOI 10.1046/j.1365-2311.1998.00103.x; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Carpenter RHS, 1988, MOVEMENTS EYES; CHARNOV EL, 1976, THEOR POPUL BIOL, V9, P129, DOI 10.1016/0040-5809(76)90040-X; Cornelissen FW, 2002, BEHAV RES METH INS C, V34, P613, DOI 10.3758/BF03195489; DEVINSKY O, 1995, BRAIN, V118, P279, DOI 10.1093/brain/118.1.279; Evans TA, 2007, J GEN PSYCHOL, V134, P199, DOI 10.3200/GENP.134.2.199-216; Gold JI, 2002, NEURON, V36, P299, DOI 10.1016/S0896-6273(02)00971-6; Gold JI, 2007, ANNU REV NEUROSCI, V30, P535, DOI 10.1146/annurev.neuro.29.051605.113038; Hanes DP, 1996, SCIENCE, V274, P427, DOI 10.1126/science.274.5286.427; Hayden BY, 2011, J NEUROSCI, V31, P4178, DOI 10.1523/JNEUROSCI.4652-10.2011; Hayden BY, 2010, J NEUROSCI, V30, P3339, DOI 10.1523/JNEUROSCI.4874-09.2010; Hayden BY, 2009, SCIENCE, V324, P948, DOI 10.1126/science.1168488; Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI 10.1037/0033-295X.109.4.679; Horwitz GD, 2004, J NEUROPHYSIOL, V91, P2281, DOI 10.1152/jn.00872.2003; Ito S, 2003, SCIENCE, V302, P120, DOI 10.1126/science.1087847; KAHNEMAN D, 1991, J ECON PERSPECT, V5, P193, DOI 10.1257/jep.5.1.193; Kennerley SW, 2006, NAT NEUROSCI, V9, P940, DOI 10.1038/nn1724; Kennerley SW, 2009, J COGNITIVE NEUROSCI, V21, P1162, DOI 10.1162/jocn.2009.21100; Kim S, 2008, NEURON, V59, P161, DOI 10.1016/j.neuron.2008.05.010; Latty T, 2009, BEHAV ECOL, V20, P1160, DOI 10.1093/beheco/arp111; Louie K, 2010, J NEUROSCI, V30, P5498, DOI 10.1523/JNEUROSCI.5742-09.2010; Marr D., 1982, VISION COMPUTATIONAL, DOI [10.7551/mitpress/9780262514620.001.0001, DOI 10.7551/MITPRESS/9780262514620.001.0001]; Matsumoto M, 2007, NAT NEUROSCI, V10, P647, DOI 10.1038/nn1890; Mazur J.E., 1987, QUANTITATIVE ANAL BE, V5; McNickle GG, 2009, P NATL ACAD SCI USA, V106, P4747, DOI 10.1073/pnas.0807971106; Prins HHT, 1996, ECOLOGY BEHAV AFRICA; Quilodran R, 2008, NEURON, V57, P314, DOI 10.1016/j.neuron.2007.11.031; Roitman JD, 2002, J NEUROSCI, V22, P9475; Rushworth MFS, 2008, NAT NEUROSCI, V11, P389, DOI 10.1038/nn2066; Sallet J, 2007, COGN AFFECT BEHAV NE, V7, P327, DOI 10.3758/CABN.7.4.327; Schall JD, 2004, ANNU REV PSYCHOL, V55, P23, DOI 10.1146/annurev.psych.55.090902.141907; Seo H, 2007, J NEUROSCI, V27, P8366, DOI 10.1523/JNEUROSCI.2369-07.2007; Shidara M, 2002, SCIENCE, V296, P1709, DOI 10.1126/science.1069504; Shima K, 1998, SCIENCE, V282, P1335, DOI 10.1126/science.282.5392.1335; Smith E.A., 1992, EVOL ECOL; Stephens D., 2007, FORAGING BEHAV ECOLO; Stephens D.W., 1986, pi; Stephens DW, 2001, BEHAV ECOL, V12, P330, DOI 10.1093/beheco/12.3.330; Stern E, 2000, ARCH GEN PSYCHIAT, V57, P741, DOI 10.1001/archpsyc.57.8.741; Thompson D, 2001, ANIM BEHAV, V61, P287, DOI 10.1006/anbe.2000.1539; Tobler PN, 2005, SCIENCE, V307, P1642, DOI 10.1126/science.1105370; Wallis JD, 2010, CURR OPIN NEUROBIOL, V20, P191, DOI 10.1016/j.conb.2010.02.009; Williams ZM, 2004, NAT NEUROSCI, V7, P1370, DOI 10.1038/nn1354; Wilson E. O., 1998, CONSILIENCE UNITY KN; Yu AJ, 2005, NEURON, V46, P681, DOI 10.1016/j.neuron.2005.04.026	50	269	271	0	43	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2011	14	7					933	U165		10.1038/nn.2856	http://dx.doi.org/10.1038/nn.2856			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	783KR	21642973	Green Accepted			2022-12-28	WOS:000292081700023
J	Liu, WW; Liang, XH; Gong, JX; Yang, Z; Zhang, YH; Zhang, JX; Rao, Y				Liu, Weiwei; Liang, Xinhua; Gong, Jianxian; Yang, Zhen; Zhang, Yao-Hua; Zhang, Jian-Xu; Rao, Yi			Social regulation of aggression by pheromonal activation of Or65a olfactory neurons in Drosophila	NATURE NEUROSCIENCE			English	Article							ANTENNAL LOBE; CAENORHABDITIS-ELEGANS; MELANOGASTER; BEHAVIOR; EXPERIENCE; CIRCUIT; SYSTEM; REPRESENTATION; STIMULATION; ADAPTATION	When two socially naive Drosophila males meet, they will fight. However, prior social grouping of males reduces their aggression. We found olfactory communication to be important for modulating Drosophila aggression. Although acute exposure to the male-specific pheromone 11-cis-vaccenyl acetate (cVA) elicited aggression through Or67d olfactory receptor neurons (ORNs), chronic cVA exposure reduced aggression through Or65a ORNs. Or65a ORNs were not acutely involved in aggression, but blockade of synaptic transmission of Or65a ORNs during social grouping or prior chronic cVA exposure eliminated social modulation of aggression. Artificial activation of Or65a ORNs by ectopic expression of the Drosophila gene TrpA1 was sufficient to reduce aggression. Social suppression of aggression requires subsets of local interneurons in the antennal lobe. Our results indicate that activation of Or65a ORNs is important for social modulation of male aggression, demonstrate that the acute and chronic effects of a single pheromone are mediated by two distinct types of ORNs, reveal a behaviorally important role for interneurons and suggest a chemical method to reduce aggression in animals.	[Liu, Weiwei; Liang, Xinhua; Rao, Yi] Natl Inst Biol Sci, Beijing, Peoples R China; [Liang, Xinhua] Chinese Acad Sci, Inst Neurosci, Shanghai Inst Biol Sci, Shanghai, Peoples R China; [Liang, Xinhua] Chinese Acad Sci, Grad Sch, Shanghai, Peoples R China; [Liu, Weiwei] Beijing Normal Univ, Coll Life Sci, Beijing 100875, Peoples R China; [Gong, Jianxian; Yang, Zhen] Peking Univ, Sch Chem & Mol Engn, Beijing 100871, Peoples R China; [Zhang, Yao-Hua; Zhang, Jian-Xu] Chinese Acad Sci, Inst Zool, State Key Lab Integrated Management Pest Insects, Beijing, Peoples R China; [Rao, Yi] Peking Univ, Sch Life Sci, State Key Lab Membrane Biol, Beijing 100871, Peoples R China	National Institute of Biological Sciences, Beijing; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Beijing Normal University; Peking University; Chinese Academy of Sciences; Institute of Zoology, CAS; Peking University	Rao, Y (corresponding author), Natl Inst Biol Sci, Beijing, Peoples R China.	yrao@pku.edu.cn	Yang, Zhen/J-6306-2015; Gong, Jianxian/J-5946-2015	Yang, Zhen/0000-0001-8036-934X; Rao, Yi/0000-0002-0405-5426; Gong, Jianxian/0000-0001-8285-1420; Zhang, Yao-Hua/0000-0002-6318-413X; Liu, Weiwei/0000-0001-5082-9114	Ministry of Science and Technology [2010CB833900]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea)	We are grateful to B. Dickson (Research Institute of Molecular Pathology), P. Garrity (Brandeis University), T. Lee (Janelia Farm Research Campus), L. Luo (Stanford University), P. Shen (University of Georgia) and L. Vosshall (Rockefeller University) for providing stocks, W. Guo, C. Zhou and other members of the Rao laboratory for helpful discussions and technical assistance, and J. Tan and M. Luo for help with electrophysiology. This work was supported by the Ministry of Science and Technology (973 program No. 2010CB833900).	AYER RK, 1992, J NEUROBIOL, V23, P965, DOI 10.1002/neu.480230804; BARTELT RJ, 1985, J CHEM ECOL, V11, P1747, DOI 10.1007/BF01012124; BRIEGER G, 1970, Science (Washington D C), V167, P1262, DOI 10.1126/science.167.3922.1262; Cacioppo JT, 2009, TRENDS COGN SCI, V13, P447, DOI 10.1016/j.tics.2009.06.005; Chen S, 2002, P NATL ACAD SCI USA, V99, P5664, DOI 10.1073/pnas.082102599; Chou YH, 2010, NAT NEUROSCI, V13, P439, DOI 10.1038/nn.2489; Couto A, 2005, CURR BIOL, V15, P1535, DOI 10.1016/j.cub.2005.07.034; Dacks AM, 2009, J NEUROGENET, V23, P366, DOI 10.3109/01677060903085722; Datta SR, 2008, NATURE, V452, P473, DOI 10.1038/nature06808; Devaud JM, 2001, J NEUROSCI, V21, P6274, DOI 10.1523/JNEUROSCI.21-16-06274.2001; Dierick HA, 2006, NAT GENET, V38, P1023, DOI 10.1038/ng1864; Ejima A, 2007, CURR BIOL, V17, P599, DOI 10.1016/j.cub.2007.01.053; Fishilevich E, 2005, CURR BIOL, V15, P1548, DOI 10.1016/j.cub.2005.07.066; Fone KCF, 2008, NEUROSCI BIOBEHAV R, V32, P1087, DOI 10.1016/j.neubiorev.2008.03.003; Fujii S, 2007, CURR BIOL, V17, P244, DOI 10.1016/j.cub.2006.11.049; Ganguly-Fitzgerald I, 2006, SCIENCE, V313, P1775, DOI 10.1126/science.1130408; GETCHELL TV, 1978, J PHYSIOL-LONDON, V282, P541, DOI 10.1113/jphysiol.1978.sp012480; Ha TS, 2006, J NEUROSCI, V26, P8727, DOI 10.1523/JNEUROSCI.0876-06.2006; Hamada FN, 2008, NATURE, V454, P217, DOI 10.1038/nature07001; Han DD, 2000, DEVELOPMENT, V127, P573; HOFFMANN AA, 1990, J INSECT BEHAV, V3, P1, DOI 10.1007/BF01049191; Jefferis GSXE, 2007, CELL, V128, P1187, DOI 10.1016/j.cell.2007.01.040; Kazama H, 2008, NEURON, V58, P401, DOI 10.1016/j.neuron.2008.02.030; Kitamoto T, 2001, J NEUROBIOL, V47, P81, DOI 10.1002/neu.1018; Kurtovic A, 2007, NATURE, V446, P542, DOI 10.1038/nature05672; Levine JD, 2002, SCIENCE, V298, P2010, DOI 10.1126/science.1076008; Lieber T, 2011, NEURON, V69, P468, DOI 10.1016/j.neuron.2010.12.015; Lin HH, 2007, CELL, V128, P1205, DOI 10.1016/j.cell.2007.03.006; McGuire SE, 2003, SCIENCE, V302, P1765, DOI 10.1126/science.1089035; Rai S, 2007, DEV NEUROBIOL, V67, P1443, DOI 10.1002/dneu.20522; Ronderos DS, 2010, J NEUROSCI, V30, P2595, DOI 10.1523/JNEUROSCI.4819-09.2010; Root CM, 2008, NEURON, V59, P311, DOI 10.1016/j.neuron.2008.07.003; Rose JK, 2005, J NEUROSCI, V25, P7159, DOI 10.1523/JNEUROSCI.1833-05.2005; Ruta V, 2010, NATURE, V468, P686, DOI 10.1038/nature09554; Rutter M, 2006, J CHILD PSYCHOL PSYC, V47, P226, DOI 10.1111/j.1469-7610.2005.01557.x; Silbering AF, 2007, J NEUROSCI, V27, P11966, DOI 10.1523/JNEUROSCI.3099-07.2007; Sokolowski MB, 2010, NEURON, V65, P780, DOI 10.1016/j.neuron.2010.03.007; Stortkuhl KF, 1999, J NEUROSCI, V19, P4839; Svetec N, 2005, J EXP BIOL, V208, P891, DOI 10.1242/jeb.01454; Tan J, 2010, NEURON, V65, P912, DOI 10.1016/j.neuron.2010.02.011; Tanaka NK, 2004, CURR BIOL, V14, P449, DOI 10.1016/j.cub.2004.03.006; Valzelli L, 1978, Ann Ist Super Sanita, V14, P173; VALZELLI L, 1973, PSYCHOPHARMACOLOGIA, V31, P305, DOI 10.1007/BF00421275; van Naters WVG, 2007, CURR BIOL, V17, P606, DOI 10.1016/j.cub.2007.02.043; Veenema AH, 2009, FRONT NEUROENDOCRIN, V30, P497, DOI 10.1016/j.yfrne.2009.03.003; Wang LM, 2008, P NATL ACAD SCI USA, V105, P5657, DOI 10.1073/pnas.0801327105; Wang LM, 2010, NATURE, V463, P227, DOI 10.1038/nature08678; Yurkovic A, 2006, P NATL ACAD SCI USA, V103, P17519, DOI 10.1073/pnas.0608211103; Zhou C, 2008, NAT NEUROSCI, V11, P1059, DOI 10.1038/nn.2164	49	98	103	1	81	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2011	14	7					896	U119		10.1038/nn.2836	http://dx.doi.org/10.1038/nn.2836			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	783KR	21685916				2022-12-28	WOS:000292081700018
J	Baseler, HA; Gouws, A; Haak, KV; Racey, C; Crossland, MD; Tufail, A; Rubin, GS; Cornelissen, FW; Morland, AB				Baseler, Heidi A.; Gouws, Andre; Haak, Koen V.; Racey, Christopher; Crossland, Michael D.; Tufail, Adnan; Rubin, Gary S.; Cornelissen, Frans W.; Morland, Antony B.			Large-scale remapping of visual cortex is absent in adult humans with macular degeneration	NATURE NEUROSCIENCE			English	Article							OCULAR DOMINANCE COLUMNS; RECEPTIVE-FIELD; STRIATE CORTEX; CORTICAL MAPS; FUNCTIONAL MRI; RETINAL LESIONS; V1 NEURONS; MACAQUE V1; REORGANIZATION; MONKEY	The occipital lobe contains retinotopic representations of the visual field. The representation of the central retina in early visual areas (V1-3) is found at the occipital pole. When the central retina is lesioned in both eyes by macular degeneration, this region of visual cortex at the occipital pole is accordingly deprived of input. However, even when such lesions occur in adulthood, some visually driven activity in and around the occipital pole can be observed. It has been suggested that this activity is a result of remapping of this area so that it now responds to inputs from intact, peripheral retina. We evaluated whether or not remapping of visual cortex underlies this activity. Our functional magnetic resonance imaging results provide no evidence of remapping, questioning the contemporary view that early visual areas of the adult human brain have the capacity to reorganize extensively.	[Baseler, Heidi A.; Gouws, Andre; Racey, Christopher; Morland, Antony B.] Univ York, Dept Psychol, York Neuroimaging Ctr, York YO10 5DD, N Yorkshire, England; [Haak, Koen V.; Cornelissen, Frans W.] Univ Groningen, Lab Expt Ophthalmol, Univ Med Ctr Groningen, Groningen, Netherlands; [Haak, Koen V.; Cornelissen, Frans W.] Univ Groningen, BCN Neuroimaging Ctr, Univ Med Ctr Groningen, Groningen, Netherlands; [Crossland, Michael D.; Tufail, Adnan; Rubin, Gary S.] UCL, Inst Ophthalmol, London, England; [Crossland, Michael D.; Tufail, Adnan] Moorfields Eye Hosp NHS Fdn Trust, London, England; [Morland, Antony B.] Hull York Med Sch, York, N Yorkshire, England	University of York - UK; University of Groningen; University of Groningen; University of London; University College London; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of Hull; University of York - UK	Morland, AB (corresponding author), Univ York, Dept Psychol, York Neuroimaging Ctr, York YO10 5DD, N Yorkshire, England.	a.morland@psychology.york.ac.uk	Baseler, Heidi/AAI-7387-2020; Haak, Koen/AAM-5500-2020; Haak, Koen V/G-6417-2018; Crossland, Michael D/B-5600-2008	Baseler, Heidi/0000-0003-0995-8453; Haak, Koen/0000-0001-9309-1906; Haak, Koen V/0000-0001-9309-1906; Crossland, Michael D/0000-0001-6833-6043; Tufail, Adnan/0000-0001-6131-7640; Morland, Antony/0000-0002-6754-5545; Gouws, Andre/0000-0003-0674-7829	Medical Research Council [G0401339]; Stichting Nederlands Oogheelkundig Onderzoek; European Union [043157, 043261]; Department of Health; MRC [G0401339] Funding Source: UKRI; Medical Research Council [G0700729B] Funding Source: researchfish; Fight for Sight [1777/78] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Stichting Nederlands Oogheelkundig Onderzoek; European Union(European Commission); Department of Health; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Fight for Sight	We would like to thank all of our participants. We thank Edward Silson for constructive discussion of the manuscript. We are also grateful to the Medical Research Council for funding this study (G0401339). K. V. H. and F. W. C. were supported by a grant from Stichting Nederlands Oogheelkundig Onderzoek and by European Union grants #043157 (Syntex) and #043261 (Percept). A. T., G. S. R. and M. D. C. also received financial support from the Department of Health through an award made by the National Institute for Health Research to Moorfields Eye Hospital National Health Service (NHS) Foundation Trust and University College London Institute of Ophthalmology for a Specialist Biomedical Research Centre for Ophthalmology. The views expressed in this publication are those of the authors and not necessarily those of the NHS, the National Institute for Health Research, the Department of Health or the EU commission.	Andrews TJ, 1997, J NEUROSCI, V17, P2859; Angelucci A, 2003, J PHYSIOL-PARIS, V97, P141, DOI 10.1016/j.jphysparis.2003.09.001; Angelucci A, 2006, J COMP NEUROL, V498, P330, DOI 10.1002/cne.21060; Baker CI, 2008, VISION RES, V48, P1910, DOI 10.1016/j.visres.2008.05.020; Baker CI, 2005, J NEUROSCI, V25, P614, DOI 10.1523/JNEUROSCI.3476-04.2005; Baseler HA, 2002, NAT NEUROSCI, V5, P364, DOI 10.1038/nn817; Boucard CC, 2009, BRAIN, V132, P1898, DOI 10.1093/brain/awp119; Cavanaugh JR, 2002, J NEUROPHYSIOL, V88, P2530, DOI 10.1152/jn.00692.2001; CHINO YM, 1992, VISION RES, V32, P789, DOI 10.1016/0042-6989(92)90021-A; Cowey A, 2000, NEUROREPORT, V11, P3269, DOI 10.1097/00001756-200009280-00044; Crossland MD, 2008, INVEST OPHTH VIS SCI, V49, P3734, DOI 10.1167/iovs.07-1621; DARIANSMITH C, 1995, J NEUROSCI, V15, P1631, DOI 10.1523/JNEUROSCI.15-03-01631.1995; DeYoe EA, 1996, P NATL ACAD SCI USA, V93, P2382, DOI 10.1073/pnas.93.6.2382; Dougherty RF, 2003, J VISION, V3, P586, DOI 10.1167/3.10.1; Dumoulin SO, 2008, NEUROIMAGE, V39, P647, DOI 10.1016/j.neuroimage.2007.09.034; ENGEL SA, 1994, NATURE, V369, P525, DOI 10.1038/369525a0; Engel SA, 1997, CEREB CORTEX, V7, P181, DOI 10.1093/cercor/7.2.181; Giannikopoulos DV, 2006, P NATL ACAD SCI USA, V103, P10805, DOI 10.1073/pnas.0604539103; GILBERT CD, 1979, NATURE, V280, P120, DOI 10.1038/280120a0; GILBERT CD, 1992, NATURE, V356, P150, DOI 10.1038/356150a0; HEINEN SJ, 1991, EXP BRAIN RES, V83, P670; Hoffmann MB, 2003, J NEUROSCI, V23, P8921; Horton JC, 1997, J NEUROSCI, V17, P3684; Horton JC, 1998, J NEUROSCI, V18, P5433, DOI 10.1523/JNEUROSCI.18-14-05433.1998; HUBEL DH, 1970, J PHYSIOL-LONDON, V206, P419, DOI 10.1113/jphysiol.1970.sp009022; HUBEL DH, 1977, PHILOS T ROY SOC B, V278, P377, DOI 10.1098/rstb.1977.0050; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Kaas JH, 2002, PROG BRAIN RES, V138, P167, DOI 10.1016/S0079-6123(02)38077-4; KAAS JH, 1990, SCIENCE, V248, P229, DOI 10.1126/science.2326637; LEVAY S, 1980, J COMP NEUROL, V191, P1, DOI 10.1002/cne.901910102; Levin N, 2010, NEURON, V65, P21, DOI 10.1016/j.neuron.2009.12.006; Lewis SM, 2005, EXP BRAIN RES, V165, P447, DOI 10.1007/s00221-005-2336-4; Liu TT, 2010, INVEST OPHTH VIS SCI, V51, P6826, DOI 10.1167/iovs.09-4926; LUND JS, 1988, ANNU REV NEUROSCI, V11, P253, DOI 10.1146/annurev.ne.11.030188.001345; Masuda Y, 2008, CEREB CORTEX, V18, P2483, DOI 10.1093/cercor/bhm256; Masuda Y, 2010, INVEST OPHTH VIS SCI, V51, P5356, DOI 10.1167/iovs.09-4775; Morland AB, 2001, ACTA PSYCHOL, V107, P229, DOI 10.1016/S0001-6918(01)00025-7; Muckli L, 2009, P NATL ACAD SCI USA, V106, P13034, DOI 10.1073/pnas.0809688106; Parrish TB, 2000, MAGNET RESON MED, V44, P925, DOI 10.1002/1522-2594(200012)44:6<925::AID-MRM14>3.0.CO;2-M; Schumacher EH, 2008, RESTOR NEUROL NEUROS, V26, P391; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; Smirnakis SM, 2005, NATURE, V435, P300, DOI 10.1038/nature03495; Sunness JS, 2004, OPHTHALMOLOGY, V111, P1595, DOI 10.1016/j.ophtha.2003.12.050; Teo PC, 1997, IEEE T MED IMAGING, V16, P852, DOI 10.1109/42.650881; Wandell BA, 2005, PHILOS T R SOC B, V360, P693, DOI 10.1098/rstb.2005.1628; Wandell BA, 2000, J COGNITIVE NEUROSCI, V12, P739, DOI 10.1162/089892900562561; Wandell BA, 2007, NEURON, V56, P366, DOI 10.1016/j.neuron.2007.10.012; Wandell BA, 2009, NAT REV NEUROSCI, V10, P873, DOI 10.1038/nrn2741; Williams MA, 2008, NAT NEUROSCI, V11, P1439, DOI 10.1038/nn.2218; Winawer J, 2010, J VISION, V10, DOI 10.1167/10.5.1	50	128	131	0	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2011	14	5					649	U148		10.1038/nn.2793	http://dx.doi.org/10.1038/nn.2793			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	754VU	21441924				2022-12-28	WOS:000289886600022
J	Jacob, C; Christen, CN; Pereira, JA; Somandin, C; Baggiolini, A; Lotscher, P; Ozcelik, M; Tricaud, N; Meijer, D; Yamaguchi, T; Matthias, P; Suter, U				Jacob, Claire; Christen, Carlos N.; Pereira, Jorge A.; Somandin, Christian; Baggiolini, Arianna; Loetscher, Pirmin; Oezcelik, Murat; Tricaud, Nicolas; Meijer, Dies; Yamaguchi, Teppei; Matthias, Patrick; Suter, Ueli			HDAC1 and HDAC2 control the transcriptional program of myelination and the survival of Schwann cells	NATURE NEUROSCIENCE			English	Article							HISTONE DEACETYLASE INHIBITORS; PERIPHERAL NERVOUS-SYSTEM; BETA-CATENIN; GENE-EXPRESSION; DIFFERENTIATION; SOX10; REVEALS; MOUSE; REMYELINATION; PROGRESSION	Histone deacetylases (HDACs) are major epigenetic regulators. We show that HDAC1 and HDAC2 functions are critical for myelination of the peripheral nervous system. Using mouse genetics, we have ablated Hdac1 and Hdac2 specifically in Schwann cells, resulting in massive Schwann cell loss and virtual absence of myelin in mutant sciatic nerves. Expression of Sox10 and Krox20, the main transcriptional regulators of Schwann cell myelination, was greatly reduced. We demonstrate that in Schwann cells, HDAC1 and HDAC2 exert specific primary functions: HDAC2 activates the transcriptional program of myelination in synergy with Sox10, whereas HDAC1 controls Schwann cell survival by regulating the levels of active beta-catenin.	[Jacob, Claire; Christen, Carlos N.; Pereira, Jorge A.; Somandin, Christian; Baggiolini, Arianna; Loetscher, Pirmin; Oezcelik, Murat; Tricaud, Nicolas; Suter, Ueli] Swiss Fed Inst Technol, Dept Biol, Inst Cell Biol, Zurich, Switzerland; [Meijer, Dies] Erasmus Univ, Dept Cell Biol & Genet, Med Ctr, NL-3000 DR Rotterdam, Netherlands; [Yamaguchi, Teppei; Matthias, Patrick] Novartis Res Fdn, Friedrich Miescher Inst Biomed Res, Basel, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Erasmus University Rotterdam; Erasmus MC; Friedrich Miescher Institute for Biomedical Research; Novartis	Jacob, C (corresponding author), Swiss Fed Inst Technol, Dept Biol, Inst Cell Biol, Zurich, Switzerland.	claire.jacob@cell.biol.ethz.ch; usuter@cell.biol.ethz.ch	Suter, Ueli/A-1624-2010; Jacob, Claire/C-1485-2012; Meijer, Dies/C-7786-2012	Jacob, Claire/0000-0001-9567-3950; Meijer, Dies/0000-0002-8461-6341; Tricaud, Nicolas/0000-0002-1620-4046; Baggiolini, Arianna/0000-0002-2476-561X	Swiss National Science Foundation (SNSF) [PMPDP3_122738/1]; Swiss National Center for Competence in Research (NCCR) Neural Plasticity and Repair; Novartis Research Foundation	Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF)); Swiss National Center for Competence in Research (NCCR) Neural Plasticity and Repair(Swiss National Science Foundation (SNSF)); Novartis Research Foundation	We thank M. Wegner (Universtat Erlangen-Nurnberg), E. Seto (Moffitt Cancer Center), S. Schreiber (Harvard University), Z. Werb and B. Welm (University of Utah), J. Crabtree (Stanford University), T. Reya (Duke University Medical Center), W. J. Pavan (US National Institutes of Health), A. McCallion and M. Prasad (Johns Hopkins University School of Medicine) and D. R. Colman (McGill University) for providing constructs and antibodies, T. Meier, W. Seufert and N. Mantei for critically reading the manuscript and the Functional Genomic Center Zurich for gene array analyses. These studies were supported by two Swiss National Science Foundation (SNSF) grants, a Marie-Heim Vogtlin subsidy (PMPDP3_122738/1) to C. Jacob, and another SNSF grant to U. Suter, and by a grant from the Swiss National Center for Competence in Research (NCCR) Neural Plasticity and Repair to U. Suter. The work in the laboratory of P. Matthias was supported by the Novartis Research Foundation.	Antonellis A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000174; Barth AIM, 1999, P NATL ACAD SCI USA, V96, P4947, DOI 10.1073/pnas.96.9.4947; Bordonaro M, 2007, EXP CELL RES, V313, P1652, DOI 10.1016/j.yexcr.2007.02.008; Bunge MB, 2008, J SPINAL CORD MED, V31, P262, DOI 10.1080/10790268.2008.11760720; Chen Y, 2011, NAT NEUROSCI, V14, P437, DOI 10.1038/nn.2780; Chuang DM, 2009, TRENDS NEUROSCI, V32, P591, DOI 10.1016/j.tins.2009.06.002; Clevers H, 1997, TRENDS GENET, V13, P485, DOI 10.1016/S0168-9525(97)01305-X; Dutton JR, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-105; Ferner RE, 2007, LANCET NEUROL, V6, P340, DOI 10.1016/S1474-4422(07)70075-3; Finzsch M, 2010, J CELL BIOL, V189, P701, DOI 10.1083/jcb.200912142; Ghazvini M, 2002, EMBO J, V21, P4612, DOI 10.1093/emboj/cdf475; Ghislain J, 2006, EMBO REP, V7, P52, DOI 10.1038/sj.embor.7400573; Glozak MA, 2005, GENE, V363, P15, DOI 10.1016/j.gene.2005.09.010; Jacob C, 2008, J CELL BIOL, V182, P519, DOI 10.1083/jcb.200710161; Jaegle M, 2003, GENE DEV, V17, P1380, DOI 10.1101/gad.258203; Jessen KR, 2005, NAT REV NEUROSCI, V6, P671, DOI 10.1038/nrn1746; Jessen KR, 2008, GLIA, V56, P1552, DOI 10.1002/glia.20761; Joseph NM, 2004, DEVELOPMENT, V131, P5599, DOI 10.1242/dev.01429; Kadosh D, 1997, CELL, V89, P365, DOI 10.1016/S0092-8674(00)80217-2; Kao SC, 2009, SCIENCE, V323, P651, DOI 10.1126/science.1166562; Kazantsev AG, 2008, NAT REV DRUG DISCOV, V7, P854, DOI 10.1038/nrd2681; LeBlanc SE, 2006, J BIOL CHEM, V281, P5453, DOI 10.1074/jbc.M512159200; Lindeboom F, 2003, NUCLEIC ACIDS RES, V31, P5405, DOI 10.1093/nar/gkg723; Montgomery RL, 2007, GENE DEV, V21, P1790, DOI 10.1101/gad.1563807; Parmantier E, 1999, NEURON, V23, P713, DOI 10.1016/S0896-6273(01)80030-1; Pereira JA, 2010, J NEUROSCI, V30, P6763, DOI 10.1523/JNEUROSCI.0801-10.2010; Pereira JA, 2009, J CELL BIOL, V185, P147, DOI 10.1083/jcb.200809008; Reiprich S, 2010, J NEUROCHEM, V112, P744, DOI 10.1111/j.1471-4159.2009.06498.x; Rundlett SE, 1998, NATURE, V392, P831, DOI 10.1038/33952; Ryu EJ, 2007, J NEUROSCI, V27, P11552, DOI 10.1523/JNEUROSCI.5497-06.2007; Shen SM, 2008, NAT NEUROSCI, V11, P1024, DOI 10.1038/nn.2172; Shen SM, 2005, J CELL BIOL, V169, P577, DOI 10.1083/jcb.200412101; Suter U, 2003, NAT REV NEUROSCI, V4, P714, DOI 10.1038/nrn1196; Svaren J, 2008, GLIA, V56, P1541, DOI 10.1002/glia.20767; Taunton J, 1996, SCIENCE, V272, P408, DOI 10.1126/science.272.5260.408; TOPILKO P, 1994, NATURE, V371, P796, DOI 10.1038/371796a0; Wang ZB, 2009, CELL, V138, P1019, DOI 10.1016/j.cell.2009.06.049; Welm Bryan E, 2008, Cell Stem Cell, V2, P90, DOI 10.1016/j.stem.2007.10.002; Werner T, 2007, NUCLEIC ACIDS RES, V35, P6526, DOI 10.1093/nar/gkm727; Yamaguchi T, 2010, GENE DEV, V24, P455, DOI 10.1101/gad.552310; Ye F, 2009, NAT NEUROSCI, V12, P829, DOI 10.1038/nn.2333; Zhang JM, 2002, NATURE, V420, P198, DOI 10.1038/nature01150; Zorick TS, 1999, DEVELOPMENT, V126, P1397; Zupkovitz G, 2006, MOL CELL BIOL, V26, P7913, DOI 10.1128/MCB.01220-06	44	129	131	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2011	14	4					429	U53		10.1038/nn.2762	http://dx.doi.org/10.1038/nn.2762			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	741FQ	21423190				2022-12-28	WOS:000288849400013
J	Carr, MF; Jadhav, SP; Frank, LM				Carr, Margaret F.; Jadhav, Shantanu P.; Frank, Loren M.			Hippocampal replay in the awake state: a potential substrate for memory consolidation and retrieval	NATURE NEUROSCIENCE			English	Review							MEDIAL TEMPORAL-LOBE; CA1 PYRAMIDAL CELLS; SLOW-WAVE SLEEP; SHARP WAVES; RETROGRADE-AMNESIA; SPATIAL MEMORY; PLACE CELLS; SEQUENTIAL EXPERIENCE; THETA OSCILLATIONS; PREFRONTAL CORTEX	The hippocampus is required for the encoding, consolidation and retrieval of event memories. Although the neural mechanisms that underlie these processes are only partially understood, a series of recent papers point to awake memory replay as a potential contributor to both consolidation and retrieval. Replay is the sequential reactivation of hippocampal place cells that represent previously experienced behavioral trajectories and occurs frequently in the awake state, particularly during periods of relative immobility. Awake replay may reflect trajectories through either the current environment or previously visited environments that are spatially remote. The repetition of learned sequences on a compressed time scale is well suited to promote memory consolidation in distributed circuits beyond the hippocampus, suggesting that consolidation occurs in both the awake and sleeping animal. Moreover, sensory information can influence the content of awake replay, suggesting a role for awake replay in memory retrieval.	[Carr, Margaret F.; Jadhav, Shantanu P.; Frank, Loren M.] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; [Carr, Margaret F.; Jadhav, Shantanu P.; Frank, Loren M.] Univ Calif San Francisco, WM Keck Ctr Integrat Neurosci, San Francisco, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Frank, LM (corresponding author), Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA.	loren@phy.ucsf.edu	Jadhav, Shantanu/H-6654-2013	Jadhav, Shantanu/0000-0001-5821-0551; Frank, Loren/0000-0002-1752-5677	NIMH NIH HHS [R01 MH080283-04, R01 MH080283] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH080283] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Abel T, 2001, CURR OPIN NEUROBIOL, V11, P180, DOI 10.1016/S0959-4388(00)00194-X; AMARAL DG, 1990, PROG BRAIN RES, V83, P1; Benchenane K, 2010, NEURON, V66, P921, DOI 10.1016/j.neuron.2010.05.013; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; Bouret S, 2005, TRENDS NEUROSCI, V28, P574, DOI 10.1016/j.tins.2005.09.002; BUZSAKI G, 1986, BRAIN RES, V398, P242, DOI 10.1016/0006-8993(86)91483-6; Buzsaki G, 1996, CEREB CORTEX, V6, P81, DOI 10.1093/cercor/6.2.81; BUZSAKI G, 1983, BRAIN RES REV, V6, P139, DOI 10.1016/0165-0173(83)90037-1; BUZSAKI G, 1989, NEUROSCIENCE, V31, P551, DOI 10.1016/0306-4522(89)90423-5; Cheng S, 2008, NEURON, V57, P303, DOI 10.1016/j.neuron.2007.11.035; CHROBAK JJ, 1994, J NEUROSCI, V14, P6160; Chrobak JJ, 1996, J NEUROSCI, V16, P3056; Cohen N. J., 1993, MEMORY AMNESIA HIPPO; Csicsvari J, 2000, NEURON, V28, P585, DOI 10.1016/S0896-6273(00)00135-5; Csicsvari J, 1999, J NEUROSCI, V19, P274, DOI 10.1523/JNEUROSCI.19-01-00274.1999; Csicsvari J, 2007, EUR J NEUROSCI, V26, P704, DOI 10.1111/j.1460-9568.2007.05684.x; Davidson TJ, 2009, NEURON, V63, P497, DOI 10.1016/j.neuron.2009.07.027; de Hoz L, 2006, HIPPOCAMPUS, V16, P704, DOI 10.1002/hipo.20207; Diba K, 2007, NAT NEUROSCI, V10, P1241, DOI 10.1038/nn1961; Diekelmann S, 2010, NAT REV NEUROSCI, V11, P114, DOI 10.1038/nrn2762; Dudai Y, 2004, ANNU REV PSYCHOL, V55, P51, DOI 10.1146/annurev.psych.55.090902.142050; Dupret D, 2010, NAT NEUROSCI, V13, P995, DOI 10.1038/nn.2599; Ego-Stengel V, 2010, HIPPOCAMPUS, V20, P1, DOI 10.1002/hipo.20707; Eichenbaum HE, 2001, CONDITIONING CONSCIO; Eldridge LL, 2000, NAT NEUROSCI, V3, P1149, DOI 10.1038/80671; Euston DR, 2007, SCIENCE, V318, P1147, DOI 10.1126/science.1148979; Fortin NJ, 2004, NATURE, V431, P188, DOI 10.1038/nature02853; Foster DJ, 2006, NATURE, V440, P680, DOI 10.1038/nature04587; Frank LM, 2004, J NEUROSCI, V24, P7681, DOI 10.1523/JNEUROSCI.1958-04.2004; FREY U, 1990, BRAIN RES, V522, P69, DOI 10.1016/0006-8993(90)91578-5; Giovannini MG, 2001, NEUROSCIENCE, V106, P43, DOI 10.1016/S0306-4522(01)00266-4; Girardeau G, 2009, NAT NEUROSCI, V12, P1222, DOI 10.1038/nn.2384; Gupta AS, 2010, NEURON, V65, P695, DOI 10.1016/j.neuron.2010.01.034; Hasselmo ME, 2006, CURR OPIN NEUROBIOL, V16, P710, DOI 10.1016/j.conb.2006.09.002; Hebb Donald O., 1949, ORG BEHAV; Hoffman KL, 2002, SCIENCE, V297, P2070, DOI 10.1126/science.1073538; HUANG YY, 1995, P NATL ACAD SCI USA, V92, P2446, DOI 10.1073/pnas.92.7.2446; Jackson JC, 2006, J NEUROSCI, V26, P12415, DOI 10.1523/JNEUROSCI.4118-06.2006; Jarrard LE, 2001, HIPPOCAMPUS, V11, P43, DOI 10.1002/1098-1063(2001)11:1<43::AID-HIPO1018>3.0.CO;2-B; Jay TM, 2003, PROG NEUROBIOL, V69, P375, DOI 10.1016/S0301-0082(03)00085-6; Johnson A, 2007, J NEUROSCI, V27, P12176, DOI 10.1523/JNEUROSCI.3761-07.2007; Jones MW, 2005, PLOS BIOL, V3, P2187, DOI 10.1371/journal.pbio.0030402; Karlsson MP, 2009, NAT NEUROSCI, V12, P913, DOI 10.1038/nn.2344; Karlsson MP, 2008, J NEUROSCI, V28, P14271, DOI 10.1523/JNEUROSCI.4261-08.2008; KIM JJ, 1992, SCIENCE, V256, P675, DOI 10.1126/science.1585183; Kjelstrup KB, 2008, SCIENCE, V321, P140, DOI 10.1126/science.1157086; Kudrimoti HS, 1999, J NEUROSCI, V19, P4090; Lansink CS, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000173; Lee AK, 2002, NEURON, V36, P1183, DOI 10.1016/S0896-6273(02)01096-6; Leutgeb S, 2004, SCIENCE, V305, P1295, DOI 10.1126/science.1100265; Li SM, 2003, NAT NEUROSCI, V6, P526, DOI 10.1038/nn1049; Lubenov EV, 2009, NATURE, V459, P534, DOI 10.1038/nature08010; MARR D, 1971, PHILOS T ROY SOC B, V262, P23, DOI 10.1098/rstb.1971.0078; MCNAUGHTON BL, 1987, TRENDS NEUROSCI, V10, P408, DOI 10.1016/0166-2236(87)90011-7; Muller RU, 1996, HIPPOCAMPUS, V6, P709, DOI 10.1002/(SICI)1098-1063(1996)6:6<709::AID-HIPO13>3.0.CO;2-4; Nadel L, 2001, TRENDS COGN SCI, V5, P228, DOI 10.1016/S1364-6613(00)01664-8; Nakashiba T, 2009, NEURON, V62, P781, DOI 10.1016/j.neuron.2009.05.013; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; O'Neill J, 2006, NEURON, V49, P143, DOI 10.1016/j.neuron.2005.10.037; O'Neill J, 2008, NAT NEUROSCI, V11, P209, DOI 10.1038/nn2037; O'Neill J, 2010, TRENDS NEUROSCI, V33, P220, DOI 10.1016/j.tins.2010.01.006; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; Pennartz CMA, 2004, J NEUROSCI, V24, P6446, DOI 10.1523/JNEUROSCI.0575-04.2004; Peyrache A, 2009, NAT NEUROSCI, V12, P919, DOI 10.1038/nn.2337; Rudy JW, 1995, HIPPOCAMPUS, V5, P375, DOI 10.1002/hipo.450050502; Sara SJ, 2009, NAT REV NEUROSCI, V10, P211, DOI 10.1038/nrn2573; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; Siapas AG, 1998, NEURON, V21, P1123, DOI 10.1016/S0896-6273(00)80629-7; Singer AC, 2009, NEURON, V64, P910, DOI 10.1016/j.neuron.2009.11.016; Skaggs WE, 1996, SCIENCE, V271, P1870, DOI 10.1126/science.271.5257.1870; Skaggs WE, 1996, HIPPOCAMPUS, V6, P149, DOI 10.1002/(SICI)1098-1063(1996)6:2<149::AID-HIPO6>3.0.CO;2-K; SQUIRE LR, 1982, ANNU REV NEUROSCI, V5, P241, DOI 10.1146/annurev.ne.05.030182.001325; SQUIRE LR, 1991, SCIENCE, V253, P1380, DOI 10.1126/science.1896849; Squire LR, 2001, HIPPOCAMPUS, V11, P50, DOI 10.1002/1098-1063(2001)11:1<50::AID-HIPO1019>3.0.CO;2-G; Sutherland GR, 2000, CURR OPIN NEUROBIOL, V10, P180, DOI 10.1016/S0959-4388(00)00079-9; Tse D, 2007, SCIENCE, V316, P76, DOI 10.1126/science.1135935; Tulving E, 1998, HIPPOCAMPUS, V8, P198, DOI 10.1002/(SICI)1098-1063(1998)8:3<198::AID-HIPO2>3.0.CO;2-G; van der Meer MAA, 2010, NEURON, V67, P25, DOI 10.1016/j.neuron.2010.06.023; Wierzynski CM, 2009, NEURON, V61, P587, DOI 10.1016/j.neuron.2009.01.011; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517; YLINEN A, 1995, HIPPOCAMPUS, V5, P78, DOI 10.1002/hipo.450050110	82	489	497	2	116	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2011	14	2					147	153		10.1038/nn.2732	http://dx.doi.org/10.1038/nn.2732			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	711MJ	21270783	Green Accepted			2022-12-28	WOS:000286595400010
J	Jaramillo, S; Zador, AM				Jaramillo, Santiago; Zador, Anthony M.			The auditory cortex mediates the perceptual effects of acoustic temporal expectation	NATURE NEUROSCIENCE			English	Article							ATTENTION; RESPONSES; NEURONS; TIME; DISCRIMINATION; CONTEXT; RAT	When events occur at predictable instants, anticipation improves performance. Knowledge of event timing modulates motor circuits and thereby improves response speed. By contrast, the neuronal mechanisms that underlie changes in sensory perception resulting from expectation are not well understood. We developed a behavioral procedure for rats in which we manipulated expectations about sound timing. Valid expectations improved both the speed and the accuracy of the subjects' performance, indicating not only improved motor preparedness but also enhanced perception. Single-neuron recordings in primary auditory cortex showed enhanced representation of sounds during periods of heightened expectation. Furthermore, we found that activity in auditory cortex was causally linked to the performance of the task and that changes in the neuronal representation of sounds predicted performance on a trial-by-trial basis. Our results indicate that changes in neuronal representation as early as primary sensory cortex mediate the perceptual advantage conferred by temporal expectation.	[Jaramillo, Santiago; Zador, Anthony M.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory	Zador, AM (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	zador@cshl.edu		Zador, Anthony/0000-0002-8431-9136	Swartz Foundation; US National Institutes of Health; Marie Robertson Fund; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005415] Funding Source: NIH RePORTER	Swartz Foundation; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Marie Robertson Fund; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank G. H. Otazu, A. E. Baker, J.M. Abolafia and B.J. Burbach for assistance with preliminary studies. This research was supported by a postdoctoral fellowship from the Swartz Foundation and by grants from the Swartz Foundation, the US National Institutes of Health and the Marie Robertson Fund.	Anderson B, 2008, NEUROPSYCHOLOGIA, V46, P947, DOI 10.1016/j.neuropsychologia.2007.11.025; Asari H, 2009, J NEUROPHYSIOL, V102, P2638, DOI 10.1152/jn.00577.2009; Bar-Yosef O, 2002, J NEUROSCI, V22, P8619; Bialek W., 1996, SPIKES EXPLORING NEU; Britten KH, 1996, VISUAL NEUROSCI, V13, P87, DOI 10.1017/S095252380000715X; Brosch M, 1997, J NEUROPHYSIOL, V77, P923, DOI 10.1152/jn.1997.77.2.923; Correa A, 2006, BRAIN RES, V1076, P116, DOI 10.1016/j.brainres.2005.11.074; Correa A, 2005, PSYCHON B REV, V12, P328, DOI 10.3758/BF03196380; Fritz J, 2003, NAT NEUROSCI, V6, P1216, DOI 10.1038/nn1141; Ghose GM, 2002, NATURE, V419, P616, DOI 10.1038/nature01057; Haykin S., 2001, ADAPTIVE FILTER THEO; Hromadka T, 2008, PLOS BIOL, V6, P124, DOI 10.1371/journal.pbio.0060016; Janssen P, 2005, NAT NEUROSCI, V8, P234, DOI 10.1038/nn1386; Kilgard MP, 1998, SCIENCE, V279, P1714, DOI 10.1126/science.279.5357.1714; Lange K, 2003, PSYCHOPHYSIOLOGY, V40, P806, DOI 10.1111/1469-8986.00081; McAdams CJ, 1999, J NEUROSCI, V19, P431, DOI 10.1523/JNEUROSCI.19-01-00431.1999; NEWSOME WT, 1988, J NEUROSCI, V8, P2201; NIEMI P, 1981, PSYCHOL BULL, V89, P133, DOI 10.1037/0033-2909.89.1.133; Nobre AC, 2001, NEUROPSYCHOLOGIA, V39, P1317; Nobrel AC, 2007, CURR OPIN NEUROBIOL, V17, P465, DOI 10.1016/j.conb.2007.07.006; Ohl FW, 1999, LEARN MEMORY, V6, P347; Otazu GH, 2009, NAT NEUROSCI, V12, P646, DOI 10.1038/nn.2306; Paxinos G., 2005, RAT BRAIN STEREOTAXI, V5th Edn, DOI 10.1016/c2009-0-63235-9; Rao SM, 2001, NAT NEUROSCI, V4, P317, DOI 10.1038/85191; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; Shuler MG, 2006, SCIENCE, V311, P1606, DOI 10.1126/science.1123513; Syka J, 2002, HEARING RES, V172, P151, DOI 10.1016/S0378-5955(02)00578-6; TAI L, 2008, NATURE PRECEDINGS; Talwar SK, 2001, J NEUROPHYSIOL, V85, P2350, DOI 10.1152/jn.2001.85.6.2350; Tremblay L, 1999, NATURE, V398, P704, DOI 10.1038/19525; Treue S, 1999, NATURE, V399, P575, DOI 10.1038/21176; Uchida N, 2003, NAT NEUROSCI, V6, P1224, DOI 10.1038/nn1142; Ulanovsky N, 2003, NAT NEUROSCI, V6, P391, DOI 10.1038/nn1032; Wang XQ, 2005, NATURE, V435, P341, DOI 10.1038/nature03565; Wehr M, 2005, NEURON, V47, P437, DOI 10.1016/j.neuron.2005.06.009; Winkler I, 2009, TRENDS COGN SCI, V13, P532, DOI 10.1016/j.tics.2009.09.003	38	179	183	1	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2011	14	2					246	U340		10.1038/nn.2688	http://dx.doi.org/10.1038/nn.2688			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	711MJ	21170056	Green Accepted			2022-12-28	WOS:000286595400023
J	Gu, JP; Lee, CW; Fan, YJ; Komlos, D; Tang, X; Sun, CC; Yu, KA; Hartzell, HC; Chen, G; Bamburg, JR; Zheng, JQ				Gu, Jiaping; Lee, Chi Wai; Fan, Yanjie; Komlos, Daniel; Tang, Xin; Sun, Chicheng; Yu, Kuai; Hartzell, H. Criss; Chen, Gong; Bamburg, James R.; Zheng, James Q.			ADF/cofilin-mediated actin dynamics regulate AMPA receptor trafficking during synaptic plasticity	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; DENDRITIC SPINE MORPHOGENESIS; HIPPOCAMPAL SYNAPSES; RECYCLING ENDOSOMES; LIM-KINASE; F-ACTIN; COFILIN; LTP; PHOSPHORYLATION; MORPHOLOGY	Dendritic spines undergo actin-based growth and shrinkage during synaptic plasticity, in which the actin depolymerizing factor (ADF)/cofilin family of actin-associated proteins are important. Elevated ADF/cofilin activities often lead to reduced spine size and immature spine morphology but can also enhance synaptic potentiation in some cases. Thus, ADF/cofilin may have distinct effects on postsynaptic structure and function. We found that ADF/cofilin-mediated actin dynamics regulated AMPA receptor (AMPAR) trafficking during synaptic potentiation, which was distinct from actin's structural role in spine morphology. Specifically, elevated ADF/cofilin activity markedly enhanced surface addition of AMPARs after chemically induced long-term potentiation (LTP), whereas inhibition of ADF/cofilin abolished AMPAR addition. We found that chemically induced LTP elicited a temporal sequence of ADF/cofilin dephosphorylation and phosphorylation that underlies AMPAR trafficking and spine enlargement. These findings suggest that temporally regulated ADF/cofilin activities function in postsynaptic modifications of receptor number and spine size during synaptic plasticity.	[Gu, Jiaping; Lee, Chi Wai; Fan, Yanjie; Yu, Kuai; Hartzell, H. Criss; Zheng, James Q.] Emory Univ, Sch Med, Dept Cell Biol, Atlanta, GA 30322 USA; [Gu, Jiaping; Lee, Chi Wai; Fan, Yanjie; Yu, Kuai; Hartzell, H. Criss; Zheng, James Q.] Emory Univ, Sch Med, Dept Neurol, Ctr Neurodegenerat Dis, Atlanta, GA 30322 USA; [Komlos, Daniel] Rutgers State Univ, Dept Cell Biol & Neurosci, Piscataway, NJ USA; [Tang, Xin; Sun, Chicheng; Chen, Gong] Penn State Univ, Dept Biol, Huck Inst Life Sci, University Pk, PA 16802 USA; [Bamburg, James R.] Colorado State Univ, Dept Biochem & Mol Biol, Ft Collins, CO 80523 USA	Emory University; Emory University; Rutgers State University New Brunswick; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Colorado State University	Zheng, JQ (corresponding author), Emory Univ, Sch Med, Dept Cell Biol, Atlanta, GA 30322 USA.	james.zheng@emory.edu	Sun, Chicheng/C-9980-2016; Lee, Chi Wai/D-3186-2013; Tang, Xin/E-8191-2016; Lee, Chi Wai/G-5098-2013	Sun, Chicheng/0000-0003-3837-2267; Lee, Chi Wai/0000-0002-9384-2308; Chen JNU, Gong/0000-0002-1857-3670; Lee, Chi Wai/0000-0003-4619-3189	US National Institutes of Health [GM083889 GM084363, HD023315, NS40371, NS054858, EY014852, GM60448]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD023315] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY014852] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060448, R01GM084363, R01GM083889] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040371, R21NS054858] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by grants from the US National Institutes of Health to J.Q.Z. (GM083889 GM084363, and HD023315), J.R.B. (NS40371), G.C. (NS054858) and H.C.H. (EY014852 and GM60448).	Aizawa H, 2001, NAT NEUROSCI, V4, P367, DOI 10.1038/86011; Allison DW, 1998, J NEUROSCI, V18, P2423; ANIKSZTEJN L, 1991, NATURE, V349, P67, DOI 10.1038/349067a0; Ashby MC, 2006, J NEUROSCI, V26, P7046, DOI 10.1523/JNEUROSCI.1235-06.2006; AUNIS D, 1988, J EXP BIOL, V139, P253; Bernstein BW, 2010, TRENDS CELL BIOL, V20, P187, DOI 10.1016/j.tcb.2010.01.001; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; BUBB MR, 1994, J BIOL CHEM, V269, P14869; Chen LY, 2007, J NEUROSCI, V27, P5363, DOI 10.1523/JNEUROSCI.0164-07.2007; Cingolani LA, 2008, NAT REV NEUROSCI, V9, P344, DOI 10.1038/nrn2373; Collingridge GL, 2004, NAT REV NEUROSCI, V5, P952, DOI 10.1038/nrn1556; Eitzen G, 2003, BBA-MOL CELL RES, V1641, P175, DOI 10.1016/S0167-4889(03)00087-9; Fukazawa' Y, 2003, NEURON, V38, P447, DOI 10.1016/S0896-6273(03)00206-X; Han L, 2007, EMBO J, V26, P4189, DOI 10.1038/sj.emboj.7601852; Heine M, 2008, SCIENCE, V320, P201, DOI 10.1126/science.1152089; Heredia L, 2006, J NEUROSCI, V26, P6533, DOI 10.1523/JNEUROSCI.5567-05.2006; Hoogenraad SC, 2004, BIOESSAYS, V26, P141, DOI 10.1002/bies.10402; Hotulainen P, 2010, J CELL BIOL, V189, P619, DOI 10.1083/jcb.201003008; Hotulainen P, 2009, J CELL BIOL, V185, P323, DOI 10.1083/jcb.200809046; Kim CH, 1999, J NEUROSCI, V19, P4314; Lanzetti L, 2007, CURR OPIN CELL BIOL, V19, P453, DOI 10.1016/j.ceb.2007.04.017; Lee CW, 2009, NAT NEUROSCI, V12, P848, DOI 10.1038/nn.2322; Lin DT, 2007, J NEUROSCI, V27, P13903, DOI 10.1523/JNEUROSCI.1750-07.2007; Makino H, 2009, NEURON, V64, P381, DOI 10.1016/j.neuron.2009.08.035; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Meng YH, 2002, NEURON, V35, P121, DOI 10.1016/S0896-6273(02)00758-4; Nimchinsky EA, 2002, ANNU REV PHYSIOL, V64, P313, DOI 10.1146/annurev.physiol.64.081501.160008; Okamoto KI, 2004, NAT NEUROSCI, V7, P1104, DOI 10.1038/nn1311; Onuma H, 1998, NEUROSCI RES, V30, P313, DOI 10.1016/S0168-0102(98)00012-1; Park M, 2006, NEURON, V52, P817, DOI 10.1016/j.neuron.2006.09.040; Racz B, 2006, NEUROSCIENCE, V138, P447, DOI 10.1016/j.neuroscience.2005.11.025; Rex CS, 2009, J CELL BIOL, V186, P85, DOI 10.1083/jcb.200901084; Rust MB, 2010, EMBO J, V29, P1889, DOI 10.1038/emboj.2010.72; Sankaranarayanan S, 2000, BIOPHYS J, V79, P2199, DOI 10.1016/S0006-3495(00)76468-X; Schulz TW, 2004, J NEUROSCI, V24, P8584, DOI 10.1523/JNEUROSCI.2100-04.2004; Segal M, 2005, NAT REV NEUROSCI, V6, P277, DOI 10.1038/nrn1649; Song I, 2002, TRENDS NEUROSCI, V25, P578, DOI 10.1016/S0166-2236(02)02270-1; SPECTOR I, 1983, SCIENCE, V219, P493, DOI 10.1126/science.6681676; Tada T, 2006, CURR OPIN NEUROBIOL, V16, P95, DOI 10.1016/j.conb.2005.12.001; Takumi Y, 1999, NAT NEUROSCI, V2, P618, DOI 10.1038/10172; Van Troys M, 2008, EUR J CELL BIOL, V87, P649, DOI 10.1016/j.ejcb.2008.04.001; Wang ZP, 2008, CELL, V135, P535, DOI 10.1016/j.cell.2008.09.057; Yuen EY, 2010, J PHYSIOL-LONDON, V588, P2361, DOI 10.1113/jphysiol.2009.186353; Yuste R, 2001, ANNU REV NEUROSCI, V24, P1071, DOI 10.1146/annurev.neuro.24.1.1071; Zhou Q, 2004, NEURON, V44, P749, DOI 10.1016/j.neuron.2004.11.011	46	234	245	2	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2010	13	10					1208	1215		10.1038/nn.2634	http://dx.doi.org/10.1038/nn.2634			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	654MB	20835250	Green Accepted			2022-12-28	WOS:000282171300012
J	Foldy, C; Lee, SH; Morgan, RJ; Soltesz, I				Foldy, Csaba; Lee, Sang-Hun; Morgan, Robert J.; Soltesz, Ivan			Regulation of fast-spiking basket cell synapses by the chloride channel ClC-2	NATURE NEUROSCIENCE			English	Article							POSTSYNAPTIC INHIBITION; PERISOMATIC INHIBITION; CONDUCTANCE; HIPPOCAMPUS	Parvalbumin-expressing, fast-spiking basket cells are important for the generation of synchronous, rhythmic population activities in the hippocampus. We found that GABA(A) receptor-mediated synaptic inputs from murine parvalbumin-expressing basket cells were selectively modulated by the membrane voltage-and intracellular chloride-dependent chloride channel ClC-2. Our data reveal a previously unknown cell type-specific regulation of intracellular chloride homeostasis in the perisomatic region of hippocampal pyramidal neurons.	[Foldy, Csaba; Lee, Sang-Hun; Morgan, Robert J.; Soltesz, Ivan] Univ Calif Irvine, Dept Anat & Neurobiol, Irvine, CA 92717 USA	University of California System; University of California Irvine	Foldy, C (corresponding author), Stanford Univ, Dept Mol & Cellular Physiol, Palo Alto, CA 94304 USA.	foldy@stanford.edu	lee, sang hun/Q-4650-2019	lee, sang hun/0000-0002-9005-5966; Foldy, Csaba/0000-0001-8709-8490	US National Institutes of Health [NS38580]; Epilepsy Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038580] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Epilepsy Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank R. Zhu for excellent technical assistance, K. Ding and D. Szabadics for camera lucida reconstructions, M. Case for genotyping, J.E. Melvin for the ClC-2 knockout mouse and L. Hilgenberg, M.A. Smith, M. Cahalan, M.V. Jones, Z. Nusser and R.L. McDonald for discussions. This work was supported by US National Institutes of Health grant NS38580 (to I.S.) and the Epilepsy Foundation through the generous support of the Eric W. Lothman Training Fellowship (to S.-H.L.).	Bartos M, 2007, NAT REV NEUROSCI, V8, P45, DOI 10.1038/nrn2044; Blaesse P, 2009, NEURON, V61, P820, DOI 10.1016/j.neuron.2009.03.003; Duebel J, 2006, NEURON, V49, P81, DOI 10.1016/j.neuron.2005.10.035; Foldy C, 2007, NAT NEUROSCI, V10, P1128, DOI 10.1038/nn1952; Freund TF, 2007, NEURON, V56, P33, DOI 10.1016/j.neuron.2007.09.012; Inglefield JR, 1997, J NEUROSCI METH, V75, P127, DOI 10.1016/S0165-0270(97)00054-X; Jentsch TJ, 2008, CRIT REV BIOCHEM MOL, V43, P3, DOI [10.1080/10409230701829110, 10.1080/10409230701829110 ]; Klausberger T, 2002, J NEUROSCI, V22, P2513, DOI 10.1523/JNEUROSCI.22-07-02513.2002; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; MADISON DV, 1986, NATURE, V321, P695, DOI 10.1038/321695a0; Nehrke K, 2002, J BIOL CHEM, V277, P23604, DOI 10.1074/jbc.M202900200; Sik A, 2000, NEUROSCIENCE, V101, P51, DOI 10.1016/S0306-4522(00)00360-2; SMITH RL, 1995, J NEUROSCI, V15, P4057; STALEY K, 1994, J NEUROPHYSIOL, V72, P273, DOI 10.1152/jn.1994.72.1.273; Szabadics J, 2006, SCIENCE, V311, P233, DOI 10.1126/science.1121325	15	65	66	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2010	13	9					1047	1049		10.1038/nn.2609	http://dx.doi.org/10.1038/nn.2609			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	643XC	20676104	Green Accepted, Green Submitted			2022-12-28	WOS:000281332600006
J	Zhang, XF; Bertaso, F; Yoo, JW; Baumgartel, K; Clancy, SM; Lee, V; Cienfuegos, C; Wilmot, C; Avis, J; Hunyh, T; Daguia, C; Schmedt, C; Noebels, J; Jegla, T				Zhang, Xiaofei; Bertaso, Federica; Yoo, Jong W.; Baumgaertel, Karsten; Clancy, Sinead M.; Lee, Van; Cienfuegos, Cynthia; Wilmot, Carly; Avis, Jacqueline; Hunyh, Truc; Daguia, Catherine; Schmedt, Christian; Noebels, Jeffrey; Jegla, Timothy			Deletion of the potassium channel Kv12.2 causes hippocampal hyperexcitability and epilepsy	NATURE NEUROSCIENCE			English	Article							K+ CHANNEL; BRAIN; BEHAVIOR; GENOME; GENES	We found the voltage-gated K(+) channel Kv12.2 to be a potent regulator of excitability in hippocampal pyramidal neurons. Genetic deletion and pharmacologic block of Kv12.2 substantially reduced the firing threshold of these neurons. Kv12.2(-/-) (also known as Kcnh3(-/-)) mice showed signs of persistent neuronal hyperexcitability including frequent interictal spiking, spontaneous seizures and increased sensitivity to the chemoconvulsant pentylenetetrazol.	[Zhang, Xiaofei; Bertaso, Federica; Baumgaertel, Karsten; Clancy, Sinead M.; Jegla, Timothy] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; [Yoo, Jong W.; Noebels, Jeffrey] Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; [Lee, Van; Cienfuegos, Cynthia; Wilmot, Carly; Avis, Jacqueline; Hunyh, Truc; Daguia, Catherine; Schmedt, Christian] Novartis Res Fdn, Genom Inst, San Diego, CA USA	Scripps Research Institute; Baylor College of Medicine; Novartis	Jegla, T (corresponding author), Penn State Univ, Dept Biol, University Pk, PA 16802 USA.	tjj3@psu.edu	Bertaso, Federica/C-9942-2019	Bertaso, Federica/0000-0003-3140-019X; Jegla, Timothy/0000-0001-8616-2390; Noebels, Jeffrey/0000-0002-2887-0839	Genomics Institute of the Novartis Research Foundation; US National Institute of Neurological Disorders and Stroke; American Heart Association; INSERM; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS057000, R01NS069842] Funding Source: NIH RePORTER	Genomics Institute of the Novartis Research Foundation; US National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); American Heart Association(American Heart Association); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Lentivirus vectors were kindly provided by A. Maximov. The project was funded by the Genomics Institute of the Novartis Research Foundation, US National Institute of Neurological Disorders and Stroke grants awarded to T.J. and J.N., an American Heart Association fellowship supporting X.Z. and INSERM funds supporting F.B.	Becchetti A, 2002, EUR J NEUROSCI, V16, P415, DOI 10.1046/j.1460-9568.2002.02079.x; Ho A, 2006, J NEUROSCI, V26, P13089, DOI 10.1523/JNEUROSCI.2855-06.2006; Holmes GL, 2007, NEUROLOGY, V69, pS28, DOI 10.1212/01.wnl.0000302369.24230.c6; Jegla TJ, 2009, COMB CHEM HIGH T SCR, V12, P2, DOI 10.2174/138620709787047957; KIM JJ, 1992, SCIENCE, V256, P675, DOI 10.1126/science.1585183; McCormick DA, 2001, ANNU REV PHYSIOL, V63, P815, DOI 10.1146/annurev.physiol.63.1.815; Miyake A, 2009, J NEUROSCI, V29, P14637, DOI 10.1523/JNEUROSCI.0901-09.2009; Noebels JL, 2003, ANNU REV NEUROSCI, V26, P599, DOI 10.1146/annurev.neuro.26.010302.081210; Nolan MF, 2003, CELL, V115, P551, DOI 10.1016/S0092-8674(03)00884-5; Peters HC, 2005, NAT NEUROSCI, V8, P51, DOI 10.1038/nn1375; Putnam NH, 2007, SCIENCE, V317, P86, DOI 10.1126/science.1139158; Saganich MJ, 2001, J NEUROSCI, V21, P4609, DOI 10.1523/JNEUROSCI.21-13-04609.2001; Srivastava M, 2008, NATURE, V454, P955, DOI 10.1038/nature07191; STRENG J, 1971, CAN J PSYCHOLOGY, V25, P62, DOI 10.1037/h0082368; Trudeau MC, 1999, J NEUROSCI, V19, P2906	15	46	46	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2010	13	9					1056	1058		10.1038/nn.2610	http://dx.doi.org/10.1038/nn.2610			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	643XC	20676103	Green Accepted			2022-12-28	WOS:000281332600009
J	Palop, JJ; Mucke, L				Palop, Jorge J.; Mucke, Lennart			Amyloid-beta-induced neuronal dysfunction in Alzheimer's disease: from synapses toward neural networks	NATURE NEUROSCIENCE			English	Review							HIPPOCAMPAL SYNAPTIC PLASTICITY; PROTEIN TRANSGENIC MICE; LONG-TERM POTENTIATION; PRECURSOR PROTEIN; MOUSE MODEL; IN-VIVO; COGNITIVE IMPAIRMENTS; NATURAL OLIGOMERS; LOBE EPILEPSY; MEMORY	Alzheimer's disease is the most frequent neurodegenerative disorder and the most common cause of dementia in the elderly. Diverse lines of evidence suggest that amyloid-beta (A beta) peptides have a causal role in its pathogenesis, but the underlying mechanisms remain uncertain. Here we discuss recent evidence that A beta may be part of a mechanism controlling synaptic activity, acting as a positive regulator presynaptically and a negative regulator postsynaptically. The pathological accumulation of oligomeric A beta assemblies depresses excitatory transmission at the synaptic level, but also triggers aberrant patterns of neuronal circuit activity and epileptiform discharges at the network level. A beta-induced dysfunction of inhibitory interneurons likely increases synchrony among excitatory principal cells and contributes to the destabilization of neuronal networks. Strategies that block these A beta effects may prevent cognitive decline in Alzheimer's disease. Potential obstacles and next steps toward this goal are discussed.	[Palop, Jorge J.] Univ Calif San Francisco, Gladstone Inst Neurol Dis, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco	Palop, JJ (corresponding author), Univ Calif San Francisco, Gladstone Inst Neurol Dis, San Francisco, CA 94143 USA.	jpalop@gladstone.ucsf.edu; lmucke@gladstone.ucsf.edu	Palop, Jorge/AAH-9014-2020; Palop, Jorge J./D-8128-2011	Palop, Jorge/0000-0001-6086-1070; Mucke, Lennart/0000-0001-6256-9559	Stephen D. Bechtel, Jr. Foundation; US National Institutes of Health [AG022074, NS041787]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041787] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG022074] Funding Source: NIH RePORTER	Stephen D. Bechtel, Jr. Foundation; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by a Stephen D. Bechtel, Jr. Foundation Young Investigator Award to J.J.P. and US National Institutes of Health grants AG022074 and NS041787 to L.M. We thank A. Kreitzer for comments on the manuscript and G. Howard and S. Ordway for editorial review.	Abramov E, 2009, NAT NEUROSCI, V12, P1567, DOI 10.1038/nn.2433; Bertram L, 2008, NAT REV NEUROSCI, V9, P768, DOI 10.1038/nrn2494; Blennow K, 2006, LANCET, V368, P387, DOI 10.1016/S0140-6736(06)69113-7; Buckner RL, 2005, J NEUROSCI, V25, P7709, DOI 10.1523/JNEUROSCI.2177-05.2005; Busche MA, 2008, SCIENCE, V321, P1686, DOI 10.1126/science.1162844; Cabrejo L, 2006, BRAIN, V129, P2966, DOI 10.1093/brain/awl237; Chapman PF, 1999, NAT NEUROSCI, V2, P271, DOI 10.1038/6374; Cheng IH, 2007, J BIOL CHEM, V282, P23818, DOI 10.1074/jbc.M701078200; Chin J, 2005, J NEUROSCI, V25, P9694, DOI 10.1523/JNEUROSCI.2980-05.2005; Cirrito JR, 2005, NEURON, V48, P913, DOI 10.1016/j.neuron.2005.10.028; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; DEKOSKY ST, 1990, ANN NEUROL, V27, P457, DOI 10.1002/ana.410270502; Dineley KT, 2002, J BIOL CHEM, V277, P25056, DOI 10.1074/jbc.M200066200; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.1997.03550160069041; Fellin T, 2004, NEURON, V43, P729, DOI 10.1016/j.neuron.2004.08.011; Frisoni GB, 2007, BRAIN, V130, P720, DOI 10.1093/brain/awl377; Glabe CG, 2008, J BIOL CHEM, V283, P29639, DOI 10.1074/jbc.R800016200; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Henry TR, 2004, NEUROIMAG CLIN N AM, V14, P517, DOI 10.1016/j.nic.2004.04.011; Hsia AY, 1999, P NATL ACAD SCI USA, V96, P3228, DOI 10.1073/pnas.96.6.3228; Hsieh H, 2006, NEURON, V52, P831, DOI 10.1016/j.neuron.2006.10.035; Jayadev S, 2010, BRAIN, V133, P1143, DOI 10.1093/brain/awq033; Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7; Kang JE, 2009, SCIENCE, V326, P1005, DOI 10.1126/science.1180962; Kayed R, 2009, J BIOL CHEM, V284, P4230, DOI 10.1074/jbc.M808591200; Kim JH, 2001, J NEUROSCI, V21, P1327; Klaassen A, 2006, P NATL ACAD SCI USA, V103, P19152, DOI 10.1073/pnas.0608215103; Klein WL, 2001, TRENDS NEUROSCI, V24, P219, DOI 10.1016/S0166-2236(00)01749-5; Kuchibhotla KV, 2009, SCIENCE, V323, P1211, DOI 10.1126/science.1169096; Kullmann DM, 2007, NAT REV NEUROSCI, V8, P687, DOI 10.1038/nrn2207; Kumar-Singh S, 2000, NEUROBIOL DIS, V7, P9, DOI 10.1006/nbdi.1999.0272; LAI F, 1989, ARCH NEUROL-CHICAGO, V46, P849, DOI 10.1001/archneur.1989.00520440031017; Laird FM, 2005, J NEUROSCI, V25, P11693, DOI 10.1523/JNEUROSCI.2766-05.2005; Lalonde R, 2005, BEHAV BRAIN RES, V157, P91, DOI 10.1016/j.bbr.2004.06.020; Larner AJ, 2006, J NEUROL, V253, P139, DOI 10.1007/s00415-005-0019-5; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Leonard AS, 2007, NEURON, V55, P677, DOI 10.1016/j.neuron.2007.08.014; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Li G, 2009, CELL STEM CELL, V5, P634, DOI 10.1016/j.stem.2009.10.015; Liu LD, 2004, SCIENCE, V304, P1021, DOI 10.1126/science.1096615; MACKENZIE IRA, 1994, ACTA NEUROPATHOL, V87, P504; Mahley RW, 2006, P NATL ACAD SCI USA, V103, P5644, DOI 10.1073/pnas.0600549103; Meilandt WJ, 2008, J NEUROSCI, V28, P5007, DOI 10.1523/JNEUROSCI.0590-08.2008; Minkeviciene R, 2009, J NEUROSCI, V29, P3453, DOI 10.1523/JNEUROSCI.5215-08.2009; Minoshima S, 1997, ANN NEUROL, V42, P85, DOI 10.1002/ana.410420114; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; Mucke L, 2009, NATURE, V461, P895, DOI 10.1038/461895a; Origlia N, 2009, EXPERT REV NEUROTHER, V9, P1635, DOI [10.1586/ern.09.107, 10.1586/ERN.09.107]; Palop JJ, 2005, J NEUROSCI, V25, P9686, DOI 10.1523/JNEUROSCI.2829-05.2005; Palop JJ, 2003, P NATL ACAD SCI USA, V100, P9572, DOI 10.1073/pnas.1133381100; Palop JJ, 2007, NEURON, V55, P697, DOI 10.1016/j.neuron.2007.07.025; Palop JJ, 2006, NATURE, V443, P768, DOI 10.1038/nature05289; Palop JJ, 2009, ARCH NEUROL-CHICAGO, V66, P435, DOI 10.1001/archneurol.2009.15; Perea G, 2007, SCIENCE, V317, P1083, DOI 10.1126/science.1144640; Roberson ED, 2007, SCIENCE, V316, P750, DOI 10.1126/science.1141736; Saura CA, 2004, NEURON, V42, P23, DOI 10.1016/S0896-6273(04)00182-5; Seabrook GR, 1999, NEUROPHARMACOLOGY, V38, P349, DOI 10.1016/S0028-3908(98)00204-4; Selkoe DJ, 2008, BEHAV BRAIN RES, V192, P106, DOI 10.1016/j.bbr.2008.02.016; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Snider BJ, 2005, ARCH NEUROL-CHICAGO, V62, P1821, DOI 10.1001/archneur.62.12.1821; Snyder EM, 2005, NAT NEUROSCI, V8, P1051, DOI 10.1038/nn1503; Sperling RA, 2009, NEURON, V63, P178, DOI 10.1016/j.neuron.2009.07.003; Tackenberg C, 2009, J NEUROSCI, V29, P14439, DOI 10.1523/JNEUROSCI.3590-09.2009; Tanzi RE, 2005, CELL, V120, P545, DOI 10.1016/j.cell.2005.02.008; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Tomiyama T, 2010, J NEUROSCI, V30, P4845, DOI 10.1523/JNEUROSCI.5825-09.2010; Vezzani A, 2005, EPILEPSIA, V46, P1724, DOI 10.1111/j.1528-1167.2005.00298.x; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Wang QW, 2004, J NEUROSCI, V24, P3370, DOI 10.1523/JNEUROSCI.1633-03.2004; Wei W, 2010, NAT NEUROSCI, V13, P190, DOI 10.1038/nn.2476; Yang L, 2009, J NEUROSCI, V29, P15660, DOI 10.1523/JNEUROSCI.4104-09.2009; Zhu YJ, 2000, FASEB J, V14, P1244, DOI 10.1096/fasebj.14.9.1244	75	1107	1169	5	325	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2010	13	7					812	818		10.1038/nn.2583	http://dx.doi.org/10.1038/nn.2583			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	615YF	20581818	Green Accepted			2022-12-28	WOS:000279173900011
J	Carter, BD				Carter, Bruce D.			Degeneration keeps axons on the straight and narrow	NATURE NEUROSCIENCE			English	Editorial Material							NOGO RECEPTOR; REGENERATION; CASPASES; NEURONS; MYELIN; DEATH		[Carter, Bruce D.] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37212 USA; [Carter, Bruce D.] Vanderbilt Univ, Sch Med, Ctr Mol Neurosci, Nashville, TN 37212 USA	Vanderbilt University; Vanderbilt University	Carter, BD (corresponding author), Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37212 USA.	bruce.carter@vanderbilt.edu						Cai DM, 1999, NEURON, V22, P89, DOI 10.1016/S0896-6273(00)80681-9; Kenchappa RS, 2006, NEURON, V50, P219, DOI 10.1016/j.neuron.2006.03.011; Kohn J, 1999, J NEUROSCI, V19, P5393; McGee AW, 2005, SCIENCE, V309, P2222, DOI 10.1126/science.1114362; Nikolaev A, 2009, NATURE, V457, P981, DOI 10.1038/nature07767; Nykjaer A, 2005, CURR OPIN NEUROBIOL, V15, P49, DOI 10.1016/j.conb.2005.01.004; Park KJ, 2010, NAT NEUROSCI, V13, P559, DOI 10.1038/nn.2513; Singh KK, 2008, NAT NEUROSCI, V11, P649, DOI 10.1038/nn.2114; Troy CM, 2002, J BIOL CHEM, V277, P34295, DOI 10.1074/jbc.M205167200; Yamagishi S, 2005, J BIOL CHEM, V280, P20384, DOI 10.1074/jbc.M501945200; Yamashita T, 2005, MOL NEUROBIOL, V32, P105, DOI 10.1385/MN:32:2:105; Yang F, 2009, J CELL BIOL, V185, P727, DOI 10.1083/jcb.200811147; Yano H, 2009, J NEUROSCI, V29, P14790, DOI 10.1523/JNEUROSCI.2059-09.2009	13	0	0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2010	13	5					526	528		10.1038/nn0510-526	http://dx.doi.org/10.1038/nn0510-526			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	588JM	20421896				2022-12-28	WOS:000277065700004
J	Hama, H; Kurokawa, H; Kawano, H; Ando, R; Shimogori, T; Noda, H; Fukami, K; Sakaue-Sawano, A; Miyawaki, A				Hama, Hiroshi; Kurokawa, Hiroshi; Kawano, Hiroyuki; Ando, Ryoko; Shimogori, Tomomi; Noda, Hisayori; Fukami, Kiyoko; Sakaue-Sawano, Asako; Miyawaki, Atsushi			Scale: a chemical approach for fluorescence imaging and reconstruction of transparent mouse brain	NATURE NEUROSCIENCE			English	Article							OPTICAL PROJECTION TOMOGRAPHY; VASCULAR NICHE; TOOL; VISUALIZATION; PROTEINS; DEEP	Optical methods for viewing neuronal populations and projections in the intact mammalian brain are needed, but light scattering prevents imaging deep into brain structures. We imaged fixed brain tissue using Scale, an aqueous reagent that renders biological samples optically transparent but completely preserves fluorescent signals in the clarified structures. In Scale-treated mouse brain, neurons labeled with genetically encoded fluorescent proteins were visualized at an unprecedented depth in millimeter-scale networks and at subcellular resolution. The improved depth and scale of imaging permitted comprehensive three-dimensional reconstructions of cortical, callosal and hippocampal projections whose extent was limited only by the working distance of the objective lenses. In the intact neurogenic niche of the dentate gyrus, Scale allowed the quantitation of distances of neural stem cells to blood vessels. Our findings suggest that the Scale method will be useful for light microscopy-based connectomics of cellular networks in brain and other tissues.	[Hama, Hiroshi; Kurokawa, Hiroshi; Kawano, Hiroyuki; Ando, Ryoko; Shimogori, Tomomi; Noda, Hisayori; Sakaue-Sawano, Asako; Miyawaki, Atsushi] RIKEN, Brain Sci Inst, Wako, Saitama, Japan; [Kurokawa, Hiroshi; Fukami, Kiyoko] Tokyo Univ Pharm & Life Sci, Sch Life Sci, Tokyo, Japan; [Kawano, Hiroyuki; Sakaue-Sawano, Asako; Miyawaki, Atsushi] Japan Sci & Technol Agcy, Wako, Saitama, Japan; [Noda, Hisayori] Tokyo Inst Technol, Meguro Ku, Tokyo 152, Japan	RIKEN; Tokyo University of Pharmacy & Life Sciences; Japan Science & Technology Agency (JST); Tokyo Institute of Technology	Miyawaki, A (corresponding author), RIKEN, Brain Sci Inst, Wako, Saitama, Japan.	matsushi@brain.riken.jp	Shimogori, Tomomi/L-2893-2013; Tuluc, Petronel/C-2527-2011; Miyawaki, Atsushi/K-3569-2014	Shimogori, Tomomi/0000-0002-6931-5401; Miyawaki, Atsushi/0000-0002-2329-3235; Sakaue-Sawano, Asako/0000-0002-6975-0390	Japan Ministry of Education, Culture, Sports, Science and Technology; Human Frontier Science Program; Grants-in-Aid for Scientific Research [10J08371] Funding Source: KAKEN	Japan Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Human Frontier Science Program(Human Frontier Science Program); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank H. Sakurai, H. Otsuka and M. Hirano for general assistance, F. Ishidate, B. Zimmermann, R. Wolleschensky, Y. Watanabe, E. Nakasho, H. Kimura, T. Tajima and S. Horie for help with acquiring and analyzing images, RIKEN BSI-Olympus Collaboration Center for technical support, Y. Yoshihara (RIKEN), M. Yamaguchi and K. Mori (The University of Tokyo) for the Nestin promoter-GFP transgenic mice, J.R. Sanes (Harvard) for the YFP-H and GFP-M lines, E. Takahashi (RIKEN) for helpful advice on transgenic mice, S. J. Smith (Stanford) and J. W. Lichtman (Harvard) for helpful advice on tissue clearing, and D. Mou (Harvard), A. Govindarajan, K. Rockland and S. Tonegawa (Massachusetts Institute of Technology), A. Moore and C. Yokoyama (RIKEN) for critical comments. This work was partly supported by grants from Japan Ministry of Education, Culture, Sports, Science and Technology Grant-in-Aid for Scientific Research on Priority Areas and the Human Frontier Science Program.	Alkaabi KM, 2005, APPL BIOCHEM BIOTECH, V126, P149, DOI 10.1385/ABAB:126:2:149; Barth AL, 2004, J NEUROSCI, V24, P6466, DOI 10.1523/JNEUROSCI.4737-03.2004; Chiang AS, 2002, P NATL ACAD SCI USA, V99, P37, DOI 10.1073/pnas.012318899; Denk W, 2004, PLOS BIOL, V2, P1900, DOI 10.1371/journal.pbio.0020329; DENK W, 1994, J NEUROSCI METH, V54, P151, DOI 10.1016/0165-0270(94)90189-9; Denk W, 1997, NEURON, V18, P351, DOI 10.1016/S0896-6273(00)81237-4; Denk Winfried, 1995, P445; Dodt HU, 2007, NAT METHODS, V4, P331, DOI 10.1038/NMETH1036; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Fritzsch B, 2005, BRAIN RES BULL, V66, P249, DOI 10.1016/j.brainresbull.2005.05.016; Helmchen F, 2005, NAT METHODS, V2, P932, DOI 10.1038/NMETH818; Helmstaedter M, 2008, CURR OPIN NEUROBIOL, V18, P633, DOI 10.1016/j.conb.2009.03.005; Huisken J, 2004, SCIENCE, V305, P1007, DOI 10.1126/science.1100035; Jahrling N, 2009, ORGANOGENESIS, V5, P227, DOI 10.4161/org.5.4.10403; KELLER HE, 2001, CURR PROTOC CYTOM; Lichtman JW, 2008, NEURON, V60, P441, DOI 10.1016/j.neuron.2008.10.040; Lichtman JW, 2008, CURR OPIN NEUROBIOL, V18, P346, DOI 10.1016/j.conb.2008.08.010; Lin HH, 2007, CELL, V128, P1205, DOI 10.1016/j.cell.2007.03.006; Lindwall C, 2007, CURR OPIN NEUROBIOL, V17, P3, DOI 10.1016/j.conb.2007.01.008; Liu YC, 2003, METHODS, V30, P86, DOI 10.1016/S1046-2023(03)00010-0; Livet J, 2007, NATURE, V450, P56, DOI 10.1038/nature06293; Micheva KD, 2007, NEURON, V55, P25, DOI 10.1016/j.neuron.2007.06.014; Nimmerjahn A, 2004, NAT METHODS, V1, P31, DOI 10.1038/nmeth706; Parra SG, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3454391; Porrero C, 2010, BRAIN RES, V1345, P59, DOI 10.1016/j.brainres.2010.05.061; Richards LJ, 2004, CLIN GENET, V66, P276, DOI 10.1111/j.1399-0004.2004.00354.x; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; Sasaki E, 2009, NATURE, V459, P523, DOI 10.1038/nature08090; Seung HS, 2009, NEURON, V62, P17, DOI 10.1016/j.neuron.2009.03.020; Sharpe J, 2003, J ANAT, V202, P175, DOI 10.1046/j.1469-7580.2003.00155.x; Sharpe J, 2002, SCIENCE, V296, P541, DOI 10.1126/science.1068206; Shen Q, 2008, CELL STEM CELL, V3, P289, DOI 10.1016/j.stem.2008.07.026; Shimogori T, 2008, DEV GROWTH DIFFER, V50, P499, DOI [10.1111/j.1440-169x.2008.01045.x, 10.1111/j.1440-169X.2008.01045.x]; Tavazoie M, 2008, CELL STEM CELL, V3, P279, DOI 10.1016/j.stem.2008.07.025; Theer P, 2006, J OPT SOC AM A, V23, P3139, DOI 10.1364/JOSAA.23.003139; Tsai PS, 2009, J NEUROSCI, V29, P14553, DOI 10.1523/JNEUROSCI.3287-09.2009; VOIE AH, 1993, J MICROSC-OXFORD, V170, P229, DOI 10.1111/j.1365-2818.1993.tb03346.x; Wang CL, 2007, J NEUROSCI, V27, P11334, DOI 10.1523/JNEUROSCI.3380-07.2007; Wang KH, 2006, CELL, V126, P389, DOI 10.1016/j.cell.2006.06.038; Yamaguchi M, 2000, NEUROREPORT, V11, P1991, DOI 10.1097/00001756-200006260-00037; Zacharakis G, 2005, P NATL ACAD SCI USA, V102, P18252, DOI 10.1073/pnas.0504628102; Zipfel WR, 2003, NAT BIOTECHNOL, V21, P1368, DOI 10.1038/nbt899	42	796	837	5	196	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2011	14	11					1481	U166		10.1038/nn.2928	http://dx.doi.org/10.1038/nn.2928			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	841NI	21878933				2022-12-28	WOS:000296518600026
J	Mormann, F; Dubois, J; Kornblith, S; Milosavljevic, M; Cerf, M; Ison, M; Tsuchiya, N; Kraskov, A; Quiroga, RQ; Adolphs, R; Fried, I; Koch, C				Mormann, Florian; Dubois, Julien; Kornblith, Simon; Milosavljevic, Milica; Cerf, Moran; Ison, Matias; Tsuchiya, Naotsugu; Kraskov, Alexander; Quiroga, Rodrigo Quian; Adolphs, Ralph; Fried, Itzhak; Koch, Christof			A category-specific response to animals in the right human amygdala	NATURE NEUROSCIENCE			English	Article							MEDIAL TEMPORAL-LOBE; SINGLE NEURONS; MONKEY; EMOTION	The amygdala is important in emotion, but it remains unknown whether it is specialized for certain stimulus categories. We analyzed responses recorded from 489 single neurons in the amygdalae of 41 neurosurgical patients and found a categorical selectivity for pictures of animals in the right amygdala. This selectivity appeared to be independent of emotional valence or arousal and may reflect the importance that animals held throughout our evolutionary past.	[Mormann, Florian; Dubois, Julien; Kornblith, Simon; Milosavljevic, Milica; Cerf, Moran; Tsuchiya, Naotsugu; Kraskov, Alexander; Quiroga, Rodrigo Quian; Adolphs, Ralph; Koch, Christof] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Mormann, Florian; Cerf, Moran; Ison, Matias; Fried, Itzhak] Univ Calif Los Angeles, Dept Neurosurg, Los Angeles, CA USA; [Mormann, Florian; Cerf, Moran; Ison, Matias; Fried, Itzhak] Univ Calif Los Angeles, Semel Inst Neurosci & Human Behav, Los Angeles, CA USA; [Mormann, Florian] Univ Bonn, Dept Epileptol, D-5300 Bonn, Germany; [Ison, Matias; Quiroga, Rodrigo Quian] Univ Leicester, Dept Engn, Leicester LE1 7RH, Leics, England; [Kraskov, Alexander] UCL, Inst Neurol, London, England; [Fried, Itzhak] Tel Aviv Med Ctr & Sch Med, Funct Neurosurg Unit, Tel Aviv, Israel; [Fried, Itzhak] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel; [Koch, Christof] Korea Univ, Dept Brain & Cognit Engn, Seoul, South Korea	California Institute of Technology; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of Bonn; University of Leicester; University of London; University College London; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Sackler Faculty of Medicine; Korea University	Mormann, F (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	fmormann@yahoo.de	Kraskov, Alexander/J-7964-2012; Mormann, Florian/K-1582-2014; Mormann, Milica/GSN-2988-2022; Tsuchiya, Naotsugu/N-8153-2014	Kraskov, Alexander/0000-0002-3576-4719; Mormann, Florian/0000-0003-1305-8028; Ison, Matias/0000-0003-2937-8069; Tsuchiya, Naotsugu/0000-0003-4216-8701; Kornblith, Simon/0000-0002-9088-2443; Dubois, Julien/0000-0002-3029-173X; Koch, Christof/0000-0001-6482-8067	European Commission [OIF 040445]; World Class University through the National Research Foundation of Korea; Ministry of Education, Science and Technology [R31-10008]; US National Institute of Neurological Disorders and Stroke; G. Harold and Leila Y. Mathers Foundation; Gimbel Discovery Fund; Dana Foundation; MRC [G0701038] Funding Source: UKRI; Medical Research Council [G0701038] Funding Source: researchfish; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS019632] Funding Source: NIH RePORTER	European Commission(European CommissionEuropean Commission Joint Research Centre); World Class University through the National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); US National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); G. Harold and Leila Y. Mathers Foundation; Gimbel Discovery Fund; Dana Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank all of our subjects for their participation, E. Behnke, T. Fields, E. Ho, V. Isiaka, E. Isham, K. Laird, N. Parikshak and A. Postolova for technical assistance with the electrophysiological recordings, and D. Tsao, I. Riedel-Kruse, U. Rutishauser and K. Fliessbach for useful discussion and comments on the manuscript. This research was supported by grants from the European Commission (Marie Curie OIF 040445, to F. M.), World Class University program through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology (R31-10008, to C. K.), the US National Institute of Neurological Disorders and Stroke, the G. Harold and Leila Y. Mathers Foundation, the Gimbel Discovery Fund, and the Dana Foundation.	Bar M, 2007, NEUROPSYCHOLOGIA, V45, P2191, DOI 10.1016/j.neuropsychologia.2007.03.008; Gothard KM, 2007, J NEUROPHYSIOL, V97, P1671, DOI 10.1152/jn.00714.2006; Herry C, 2007, J NEUROSCI, V27, P5958, DOI 10.1523/JNEUROSCI.5218-06.2007; Kreiman G, 2000, NAT NEUROSCI, V3, P946, DOI 10.1038/78868; Kriegeskorte N, 2008, NEURON, V60, P1126, DOI 10.1016/j.neuron.2008.10.043; LEONARD CM, 1985, BEHAV BRAIN RES, V15, P159, DOI 10.1016/0166-4328(85)90062-2; Mormann F, 2008, J NEUROSCI, V28, P8865, DOI 10.1523/JNEUROSCI.1640-08.2008; Murray EA, 2007, TRENDS COGN SCI, V11, P489, DOI 10.1016/j.tics.2007.08.013; New J, 2007, P NATL ACAD SCI USA, V104, P16598, DOI 10.1073/pnas.0703913104; NISHIJO H, 1988, J NEUROSCI, V8, P3570; Paton JJ, 2006, NATURE, V439, P865, DOI 10.1038/nature04490; Pessoa L, 2010, NAT REV NEUROSCI, V11, P773, DOI 10.1038/nrn2920; Phelps EA, 2005, NEURON, V48, P175, DOI 10.1016/j.neuron.2005.09.025; Vallortigara G, 2005, BEHAV BRAIN SCI, V28, P575, DOI 10.1017/S0140525X05000105; Whalen P.J., 2009, HUMAN AMYGDALA	15	101	101	0	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2011	14	10					1247	1249		10.1038/nn.2899	http://dx.doi.org/10.1038/nn.2899			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	825EQ	21874014	Green Accepted			2022-12-28	WOS:000295254200011
J	Pratt, KG; Zimmerman, EC; Cook, DG; Sullivan, JM				Pratt, Kara G.; Zimmerman, Eric C.; Cook, David G.; Sullivan, Jane M.			Presenilin 1 regulates homeostatic synaptic scaling through Akt signaling	NATURE NEUROSCIENCE			English	Article							ALZHEIMERS-DISEASE; ACTIVATION; SYNAPSES	Neurons adapt to long-lasting changes in network activity, both in vivo and in vitro, by adjusting their synaptic strengths to stabilize firing rates. We found that homeostatic scaling of excitatory synapses was impaired in hippocampal neurons derived from mice lacking presenilin 1 (Psen1(-/-) mice) or expressing a familial Alzheimer's disease-linked Psen1 mutation (Psen1(M146V)). These findings suggest that deficits in synaptic homeostasis may contribute to brain dysfunction in Alzheimer's disease.	[Pratt, Kara G.; Zimmerman, Eric C.; Sullivan, Jane M.] Univ Washington, Sch Med, Dept Physiol & Biophys, Seattle, WA 98195 USA; [Cook, David G.] Geriatr Res Educ & Clin Ctr, Vet Affairs Med Ctr, Seattle, WA USA; [Cook, David G.] Univ Washington, Sch Med, Dept Med, Seattle, WA 98195 USA; [Cook, David G.] Univ Washington, Sch Med, Dept Pharmacol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Sullivan, JM (corresponding author), Univ Washington, Sch Med, Dept Physiol & Biophys, Seattle, WA 98195 USA.	jmsull@u.washington.edu			American Health Assistance Foundation; US National Institutes of Health/National Institute of Neurological Disorders and Stroke [R01 NS55804]; Veteran's Affairs Office of Research and Development Medical Research Service; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS055804] Funding Source: NIH RePORTER	American Health Assistance Foundation(BrightFocus Foundation); US National Institutes of Health/National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Veteran's Affairs Office of Research and Development Medical Research Service(US Department of Veterans Affairs); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank R. M. Ahlquist and N. Li for excellent technical assistance and R.L. Neve for generously providing the viral constructs. This work was supported by the American Health Assistance Foundation and the US National Institutes of Health/National Institute of Neurological Disorders and Stroke (R01 NS55804, J.M.S.), and the Veteran's Affairs Office of Research and Development Medical Research Service (D.G.C.).	Baki L, 2004, EMBO J, V23, P2586, DOI 10.1038/sj.emboj.7600251; Baki L, 2008, J NEUROSCI, V28, P483, DOI 10.1523/JNEUROSCI.4067-07.2008; Bezprozvanny I, 2008, TRENDS NEUROSCI, V31, P454, DOI 10.1016/j.tins.2008.06.005; De Strooper B, 2003, NEURON, V38, P9, DOI 10.1016/S0896-6273(03)00205-8; Goold CP, 2010, NEURON, V68, P512, DOI 10.1016/j.neuron.2010.09.020; Guo Q, 1999, NAT MED, V5, P101, DOI 10.1038/4789; Hou Q, 2008, P NATL ACAD SCI USA, V105, P775, DOI 10.1073/pnas.0706447105; Hyman BT, 2011, NAT NEUROSCI, V14, P5, DOI 10.1038/nn0111-5; Ibata K, 2008, NEURON, V57, P819, DOI 10.1016/j.neuron.2008.02.031; Kang DE, 2005, J BIOL CHEM, V280, P31537, DOI 10.1074/jbc.M500833200; LaFerla FM, 2002, NAT REV NEUROSCI, V3, P862, DOI 10.1038/nrn960; Pozo K, 2010, NEURON, V66, P337, DOI 10.1016/j.neuron.2010.04.028; Qin Y, 2005, GENE DEV, V19, P2000, DOI 10.1101/gad.342205; Tanzi RE, 2001, NEURON, V32, P181, DOI 10.1016/S0896-6273(01)00476-7; Turrigiano GG, 2008, CELL, V135, P422, DOI 10.1016/j.cell.2008.10.008	15	55	55	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2011	14	9					1112	1114		10.1038/nn.2893	http://dx.doi.org/10.1038/nn.2893			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	812ID	21841774	Green Accepted			2022-12-28	WOS:000294284900008
J	Kristensen, AS; Jenkins, MA; Banke, TG; Schousboe, A; Makino, Y; Johnson, RC; Huganir, R; Traynelis, SF				Kristensen, Anders S.; Jenkins, Meagan A.; Banke, Tue G.; Schousboe, Arne; Makino, Yuichi; Johnson, Richard C.; Huganir, Richard; Traynelis, Stephen F.			Mechanism of Ca2+/calmodulin-dependent kinase II regulation of AMPA receptor gating	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; BIDIRECTIONAL SYNAPTIC PLASTICITY; LIGAND-BINDING CORE; PROTEIN-KINASE; PHOSPHORYLATION SITE; GLUTAMATE RECEPTORS; GLUR1 SUBUNIT; UNITARY CONDUCTANCE; STRUCTURAL BASIS; TRAFFICKING	The function, trafficking and synaptic signaling of AMPA receptors are tightly regulated by phosphorylation. Ca2+/calmodulin-dependent kinase II (CaMKII) phosphorylates the GluA1 AMPA receptor subunit at Ser831 to increase single-channel conductance. We show that CaMKII increases the conductance of native heteromeric AMPA receptors in mouse hippocampal neurons through phosphorylation of Ser831. In addition, co-expression of transmembrane AMPA receptor regulatory proteins (TARPs) with recombinant receptors is required for phospho-Ser831 to increase conductance of heteromeric GluA1-GluA2 receptors. Finally, phosphorylation of Ser831 increases the efficiency with which each subunit can activate, independent of agonist efficacy, thereby increasing the likelihood that more receptor subunits will be simultaneously activated during gating. This underlies the observation that phospho-Ser831 increases the frequency of openings to larger conductances rather than altering unitary conductance. Together, these findings suggest that CaMKII phosphorylation of GluA1-Ser831 decreases the activation energy for an intrasubunit conformational change that regulates the conductance of the receptor when the channel pore opens.	[Kristensen, Anders S.; Jenkins, Meagan A.; Banke, Tue G.; Traynelis, Stephen F.] Emory Univ, Sch Med, Dept Pharmacol, Atlanta, GA 30322 USA; [Kristensen, Anders S.] Univ Copenhagen, Dept Med Chem, Copenhagen, Denmark; [Schousboe, Arne] Univ Copenhagen, Dept Pharmacol & Pharmacotherapy, Copenhagen, Denmark; [Makino, Yuichi; Johnson, Richard C.; Huganir, Richard] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; [Makino, Yuichi; Johnson, Richard C.; Huganir, Richard] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA	Emory University; University of Copenhagen; University of Copenhagen; Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University	Traynelis, SF (corresponding author), Emory Univ, Sch Med, Dept Pharmacol, Atlanta, GA 30322 USA.	strayne@emory.edu	Kristensen, Anders Skov/B-4414-2009	Kristensen, Anders Skov/0000-0001-8955-6790; Banke, Tue/0000-0001-8417-4400; Schousboe, Arne/0000-0001-9600-402X	US National Institutes of Health [NS068464, NS036654]; Howard Hughes Medical Institute; Alfred Benzon Foundation; Lundbeck Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS036654, R01NS068464, R01NS036654] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Alfred Benzon Foundation; Lundbeck Foundation(Lundbeckfonden); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank V. Derkach and J. Howe for comments on the manuscript. We thank D. Colquhoun (University College London) for providing software for time course fitting and single channel dwell time and amplitude analysis (SCAN, EKDIST). GluA1 and GluA2 cDNA was provided by P. Seeburg (Max-Planck-Institut fur medizinische Forschung) and gamma 8 cDNA by R. Nicoll (University of California, San Francisco). This work was supported by the US National Institutes of Health (NS068464, NS036654; S.F.T.), the Howard Hughes Medical Institute (R.H.), the Alfred Benzon Foundation (A.S.K., T.G.B.) and the Lundbeck Foundation (A.S.).	Banke TG, 2000, J NEUROSCI, V20, P89, DOI 10.1523/JNEUROSCI.20-01-00089.2000; Barria A, 1997, J BIOL CHEM, V272, P32727, DOI 10.1074/jbc.272.52.32727; Barria A, 1997, SCIENCE, V276, P2042, DOI 10.1126/science.276.5321.2042; Benke TA, 1998, NATURE, V393, P793, DOI 10.1038/31709; Boehm J, 2006, NEURON, V51, P213, DOI 10.1016/j.neuron.2006.06.013; Delgado JY, 2007, J NEUROSCI, V27, P13210, DOI 10.1523/JNEUROSCI.3056-07.2007; Deng F, 2006, J NEUROSCI, V26, P7875, DOI 10.1523/JNEUROSCI.1851-06.2006; Derkach V, 1999, P NATL ACAD SCI USA, V96, P3269, DOI 10.1073/pnas.96.6.3269; Derkach VA, 2003, BIOPHYS J, V84, P1701, DOI 10.1016/S0006-3495(03)74978-9; Frandsen A, 2005, MOL PHARMACOL, V67, P703, DOI 10.1124/mol.104.002931; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; Hogner A, 2002, J MOL BIOL, V322, P93, DOI 10.1016/S0022-2836(02)00650-2; Holmes WR, 2006, J NEUROPHYSIOL, V96, P1478, DOI 10.1152/jn.00248.2006; Jin RS, 2003, NAT NEUROSCI, V6, P803, DOI 10.1038/nn1091; Lamsa K, 2007, J PHYSIOL-LONDON, V584, P885, DOI 10.1113/jphysiol.2007.137380; Lee HK, 2007, MOL CELL NEUROSCI, V36, P86, DOI 10.1016/j.mcn.2007.06.003; Lee HK, 2010, J NEUROPHYSIOL, V103, P479, DOI 10.1152/jn.00835.2009; Lee HK, 2003, CELL, V112, P631, DOI 10.1016/S0092-8674(03)00122-3; Lee HK, 2000, NATURE, V405, P955, DOI 10.1038/35016089; Lin DT, 2009, NAT NEUROSCI, V12, P879, DOI 10.1038/nn.2351; Lisman J., 2006, SCI STKE, V2006, pr; Luthi A, 2004, BMC NEUROSCI, V5, DOI 10.1186/1471-2202-5-44; MALENKA RC, 1988, SCIENCE, V242, P81, DOI 10.1126/science.2845577; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Mammen AL, 1997, J BIOL CHEM, V272, P32528, DOI 10.1074/jbc.272.51.32528; Milstein AD, 2007, NEURON, V55, P905, DOI 10.1016/j.neuron.2007.08.022; Milstein AD, 2009, P NATL ACAD SCI USA, V106, P11348, DOI 10.1073/pnas.0905570106; Nicoll RA, 2006, SCIENCE, V311, P1253, DOI 10.1126/science.1123339; Oh MC, 2005, NAT NEUROSCI, V8, P853, DOI 10.1038/nn1476; Palmer MJ, 2004, J NEUROSCI, V24, P4903, DOI 10.1523/JNEUROSCI.0170-04.2004; Poncer JC, 2002, J NEUROSCI, V22, P4406, DOI 10.1523/JNEUROSCI.22-11-04406.2002; Poon K, 2010, BIOPHYS J, V99, P1437, DOI 10.1016/j.bpj.2010.06.058; Prieto ML, 2010, J NEUROSCI, V30, P4449, DOI 10.1523/JNEUROSCI.5613-09.2010; Roche KW, 1996, NEURON, V16, P1179, DOI 10.1016/S0896-6273(00)80144-0; Rosenmund C, 1998, SCIENCE, V280, P1596, DOI 10.1126/science.280.5369.1596; Serulle Y, 2007, NEURON, V56, P670, DOI 10.1016/j.neuron.2007.09.016; Shepherd JD, 2007, ANNU REV CELL DEV BI, V23, P613, DOI 10.1146/annurev.cellbio.23.090506.123516; SILVA AJ, 1992, SCIENCE, V257, P201, DOI 10.1126/science.1378648; Smith TC, 2000, NAT NEUROSCI, V3, P992, DOI 10.1038/79931; Sobolevsky AI, 2009, NATURE, V462, P745, DOI 10.1038/nature08624; Soto D, 2007, NAT NEUROSCI, V10, P1260, DOI 10.1038/nn1966; Stern-Bach Y, 1998, NEURON, V21, P907, DOI 10.1016/S0896-6273(00)80605-4; Swanson GT, 1997, J NEUROSCI, V17, P58, DOI 10.1523/JNEUROSCI.17-01-00058.1997; Tavalin SJ, 2008, J BIOL CHEM, V283, P11445, DOI 10.1074/jbc.M709253200; Tomita S, 2005, NATURE, V435, P1052, DOI 10.1038/nature03624; Tomita S, 2005, NEURON, V45, P269, DOI 10.1016/j.neuron.2005.01.009; Traynelis SF, 1997, J PHYSIOL-LONDON, V503, P513, DOI 10.1111/j.1469-7793.1997.513bg.x; Traynelis SF, 1998, TRENDS NEUROSCI, V21, P137, DOI 10.1016/S0166-2236(98)01238-7; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Wenthold RJ, 1996, J NEUROSCI, V16, P1982	50	182	187	1	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2011	14	6					727	U327		10.1038/nn.2804	http://dx.doi.org/10.1038/nn.2804			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	768SH	21516102	Green Accepted			2022-12-28	WOS:000290958000015
J	Teichmann, HM; Shen, K				Teichmann, Hannah M.; Shen, Kang			UNC-6 and UNC-40 promote dendritic growth through PAR-4 in Caenorhabditis elegans neurons	NATURE NEUROSCIENCE			English	Article							COMMISSURAL AXON GUIDANCE; C-ELEGANS; CYTOPLASMIC LOCALIZATION; NERVOUS-SYSTEM; NETRIN UNC-6; DROSOPHILA; RECEPTORS; OUTGROWTH; CELLS; ASYMMETRY	Axons navigating through the developing nervous system are instructed by external attractive and repulsive cues. Emerging evidence suggests the same cues control dendrite development, but it is not understood how they differentially instruct axons and dendrites. We studied a C. elegans motor neuron whose axon and dendrite adopt different trajectories and lengths. We found that the guidance cue UNC-6 (Netrin) is required for both axon and dendrite development. Its repulsive receptor UNC-5 repelled the axon from the ventral cell body, whereas the attractive receptor UNC-40 (DCC) was dendritically enriched and promotes anteroposterior dendritic growth. Although the endogenous ventrally secreted UNC-6 instructs axon guidance, dorsal or even membrane-tethered UNC-6 could support dendrite development. Unexpectedly, the serine-threonine kinase PAR-4 (LKB1) was selectively required for the activity of the UNC-40 pathway in dendrite outgrowth. These data suggest that axon and dendrite of one neuron interpret common environmental cues with different receptors and downstream signaling pathways.	[Teichmann, Hannah M.; Shen, Kang] Stanford Univ, Dept Biol, Howard Hughes Med Inst, Stanford, CA 94305 USA	Howard Hughes Medical Institute; Stanford University	Shen, K (corresponding author), Stanford Univ, Dept Biol, Howard Hughes Med Inst, Stanford, CA 94305 USA.	kangshen@stanford.edu			Human Frontier Science Foundation; W.M. Keck Foundation; Howard Hughes Medical Institute; Boehringer Ingelheim; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048392] Funding Source: NIH RePORTER	Human Frontier Science Foundation(Human Frontier Science Program); W.M. Keck Foundation(W.M. Keck Foundation); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Boehringer Ingelheim(Boehringer Ingelheim); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the International Caenorhabditis Genetic Center and the C. Kenyon (University of California, San Francisco), E. Lundquist (University of Kansas) and C. Bargmann (Rockefeller University) laboratories for strains and K. Kemphues laboratory (Cornell University) for par-4 cDNA, as well as C. Gao and Y. Fu for technical assistance. This work was supported by the Human Frontier Science Foundation, the W.M. Keck Foundation and the Howard Hughes Medical Institute (K. S.) and a Boehringer Ingelheim graduate fellowship (H. M. T.).	Adler CE, 2006, NAT NEUROSCI, V9, P511, DOI 10.1038/nn1666; Asada N, 2007, J NEUROSCI, V27, P11769, DOI 10.1523/JNEUROSCI.1938-07.2007; Barnes AP, 2007, CELL, V129, P549, DOI 10.1016/j.cell.2007.03.025; Brankatschk M, 2006, NAT NEUROSCI, V9, P188, DOI 10.1038/nn1625; Chan SSY, 1996, CELL, V87, P187, DOI 10.1016/S0092-8674(00)81337-9; Chang C, 2006, CURR BIOL, V16, P854, DOI 10.1016/j.cub.2006.03.083; Colon-Ramos DA, 2007, SCIENCE, V318, P103, DOI 10.1126/science.1143762; Finger JH, 2002, J NEUROSCI, V22, P10346; FIRE A, 1990, NUCLEIC ACIDS RES, V18, P4269, DOI 10.1093/nar/18.14.4269; Furrer MP, 2007, DEVELOPMENT, V134, P3795, DOI 10.1242/dev.02882; Furrer MP, 2003, NAT NEUROSCI, V6, P223, DOI 10.1038/nn1017; GERTLER FB, 1995, GENE DEV, V9, P521, DOI 10.1101/gad.9.5.521; Gitai Z, 2003, NEURON, V37, P53, DOI 10.1016/S0896-6273(02)01149-2; Hagedorn EJ, 2009, DEV CELL, V17, P187, DOI 10.1016/j.devcel.2009.06.006; HAMELIN M, 1993, NATURE, V364, P327, DOI 10.1038/364327a0; HEDGECOCK EM, 1990, NEURON, V4, P61, DOI 10.1016/0896-6273(90)90444-K; KEMPHUES KJ, 1988, CELL, V52, P311, DOI 10.1016/S0092-8674(88)80024-2; Kidd T, 1999, CELL, V96, P785, DOI 10.1016/S0092-8674(00)80589-9; Klassen MP, 2007, CELL, V130, P704, DOI 10.1016/j.cell.2007.06.046; Kolodziej PA, 1996, CELL, V87, P197, DOI 10.1016/S0092-8674(00)81338-0; Komiyama T, 2007, CELL, V128, P399, DOI 10.1016/j.cell.2006.12.028; Li XL, 2008, NAT NEUROSCI, V11, P28, DOI 10.1038/nn2022; Lim YS, 1999, J NEUROSCI, V19, P7048, DOI 10.1523/JNEUROSCI.19-16-07048.1999; Liu GF, 2004, NAT NEUROSCI, V7, P1222, DOI 10.1038/nn1331; Liu GF, 2007, J NEUROSCI, V27, P957, DOI 10.1523/JNEUROSCI.4616-06.2007; Margeta MA, 2009, P NATL ACAD SCI USA, V106, P1632, DOI 10.1073/pnas.0812078106; Martin SG, 2003, NATURE, V421, P379, DOI 10.1038/nature01296; Mello C, 1995, METHOD CELL BIOL, V48, P451; Ming GI, 1999, NEURON, V23, P139, DOI 10.1016/S0896-6273(00)80760-6; Moore SW, 2009, SCIENCE, V325, P166, DOI 10.1126/science.1173851; MORTON DG, 1992, GENETICS, V130, P771; Polleux F, 1998, SCIENCE, V282, P1904, DOI 10.1126/science.282.5395.1904; Polleux F, 2000, NATURE, V404, P567, DOI 10.1038/35007001; Poon VY, 2008, NATURE, V455, P669, DOI 10.1038/nature07291; Serafini T, 1996, CELL, V87, P1001, DOI 10.1016/S0092-8674(00)81795-X; SERAFINI T, 1994, CELL, V78, P409, DOI 10.1016/0092-8674(94)90420-0; Shelly M, 2007, CELL, V129, P565, DOI 10.1016/j.cell.2007.04.012; Suli A, 2006, J NEUROSCI, V26, P13328, DOI 10.1523/JNEUROSCI.2858-06.2006; Suzuki A, 2006, J CELL SCI, V119, P979, DOI 10.1242/jcs.02898; Sym M, 1999, CELL, V98, P25, DOI 10.1016/S0092-8674(00)80603-0; Tenlen JR, 2008, DEVELOPMENT, V135, P3665, DOI 10.1242/dev.027060; Wadsworth WG, 1996, NEURON, V16, P35, DOI 10.1016/S0896-6273(00)80021-5; Wadsworth WG, 2002, TRENDS NEUROSCI, V25, P423, DOI 10.1016/S0166-2236(02)02206-3; Watts JL, 2000, DEVELOPMENT, V127, P1467; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Yu TW, 2002, NAT NEUROSCI, V5, P1147, DOI 10.1038/nn956; Zhou PC, 2007, NEURON, V55, P53, DOI 10.1016/j.neuron.2007.05.030; Zhu XJ, 2007, NAT CELL BIOL, V9, P184, DOI 10.1038/ncb1535	48	31	41	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2011	14	2					165	U364		10.1038/nn.2717	http://dx.doi.org/10.1038/nn.2717			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	711MJ	21186357	Green Accepted			2022-12-28	WOS:000286595400013
J	Bayes, A; van de Lagemaat, LN; Collins, MO; Croning, MDR; Whittle, IR; Choudhary, JS; Grant, SGN				Bayes, Alex; van de Lagemaat, Louie N.; Collins, Mark O.; Croning, Mike D. R.; Whittle, Ian R.; Choudhary, Jyoti S.; Grant, Seth G. N.			Characterization of the proteome, diseases and evolution of the human postsynaptic density	NATURE NEUROSCIENCE			English	Article							PHENOTYPE ONTOLOGY; SCHIZOPHRENIA; TOOL	We isolated the postsynaptic density from human neocortex (hPSD) and identified 1,461 proteins. hPSD mutations cause 133 neurological and psychiatric diseases and were enriched in cognitive, affective and motor phenotypes underpinned by sets of genes. Strong protein sequence conservation in mammalian lineages, particularly in hub proteins, indicates conserved function and organization in primate and rodent models. The hPSD is an important structure for nervous system disease and behavior.	[Bayes, Alex; van de Lagemaat, Louie N.; Croning, Mike D. R.; Grant, Seth G. N.] Wellcome Trust Sanger Inst, Genes Cognit Programme, Hinxton, Cambs, England; [Whittle, Ian R.] Univ Edinburgh, Div Clin Neurosci, Edinburgh, Midlothian, Scotland	Wellcome Trust Sanger Institute; University of Edinburgh	Grant, SGN (corresponding author), Wellcome Trust Sanger Inst, Genes Cognit Programme, Hinxton, Cambs, England.	sg3@sanger.ac.uk	Bayés, Àlex/H-2854-2015; whittle, ian/AAX-7309-2021; Collins, Mark/AAB-7484-2021; Collins, Mark/A-3752-2012; Choudhary, Jyoti/S-1232-2017	Bayés, Àlex/0000-0002-5265-6306; Collins, Mark/0000-0002-7656-4975; Choudhary, Jyoti/0000-0003-0881-5477; Grant, Seth/0000-0001-8732-8735	EMBO; European Commission; Wellcome Trust; Scottish Higher Education Funding Council; Medical Research Council; US National Institutes of Health; Melville Trust; MRC [G0802238] Funding Source: UKRI; Medical Research Council [G0802238] Funding Source: researchfish; Chief Scientist Office [CZB/4/486] Funding Source: researchfish	EMBO(European Molecular Biology Organization (EMBO)); European Commission(European CommissionEuropean Commission Joint Research Centre); Wellcome Trust(Wellcome Trust); Scottish Higher Education Funding Council; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Melville Trust; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Chief Scientist Office	We thank C.P. Ponting, P.J. Brophy, R.A.W. Frank, N.H. Komiyama, M.V. Kopanitsa, T.J. Ryan and members of the Genes to Cognition Programme for critical comments on the manuscript and for discussions. We thank the tissue donors, without whom this study would have been impossible. A.B. is supported by EMBO and the European Commission. L.N.v.L., M.O.C., M.D.R.C., J.S.C. and S.G.N.G. are supported by the Wellcome Trust. I.R.W. is supported by Scottish Higher Education Funding Council and by grants from the Medical Research Council, the US National Institutes of Health and the Melville Trust.	Fernandez E, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.27; Fraser HB, 2003, BMC EVOL BIOL, V3, DOI 10.1186/1471-2148-3-11; Harris LW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003964; Hedges SB, 2006, BIOINFORMATICS, V22, P2971, DOI 10.1093/bioinformatics/btl505; Hurst LD, 2002, TRENDS GENET, V18, P486, DOI 10.1016/S0168-9525(02)02722-1; Khaitovich P, 2005, SCIENCE, V309, P1850, DOI 10.1126/science.1108296; McKusick VA, 2007, AM J HUM GENET, V80, P588, DOI 10.1086/514346; Miao HX, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002847; Pocklington AJ, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100041; Robinson PN, 2008, AM J HUM GENET, V83, P610, DOI 10.1016/j.ajhg.2008.09.017; Smith CL, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2004-6-1-r7; Wang HY, 2007, PLOS BIOL, V5, P335, DOI 10.1371/journal.pbio.0050013; Wang HX, 2006, J PROTEOME RES, V5, P361, DOI 10.1021/pr0503681; Winter EE, 2004, GENOME RES, V14, P54, DOI 10.1101/gr.1924004	14	323	325	1	37	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2011	14	1					19	21		10.1038/nn.2719	http://dx.doi.org/10.1038/nn.2719			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	699TE	21170055	Green Accepted			2022-12-28	WOS:000285684900007
J	Sumner, P; Edden, RAE; Bompas, A; Evans, CJ; Singh, KD				Sumner, Petroc; Edden, Richard A. E.; Bompas, Aline; Evans, C. John; Singh, Krish D.			More GABA, less distraction: a neurochemical predictor of motor decision speed	NATURE NEUROSCIENCE			English	Article							CORTEX	People vary markedly in the efficiency with which they can resolve competitive action decisions, even simple ones such as shifting gaze to one stimulus rather than another. We found that an individual's ability to rapidly resolve such competition is predicted by the concentration of GABA, the main inhibitory neurotransmitter, in a region of frontal cortex that is relevant for eye movements, but not in a control region (occipital cortex).	[Sumner, Petroc; Edden, Richard A. E.; Bompas, Aline; Evans, C. John; Singh, Krish D.] Cardiff Univ, Sch Psychol, Brain Res Imaging Ctr, Cardiff, S Glam, Wales; [Edden, Richard A. E.] Johns Hopkins Univ, Russell H Morgan Dept Radiol & Radiol Sci, Baltimore, MD USA; [Edden, Richard A. E.] Kennedy Krieger Inst, FM Kirby Res Ctr Funct Magnet Resonance Imaging, Baltimore, MD USA	Cardiff University; Johns Hopkins University; Kennedy Krieger Institute	Sumner, P (corresponding author), Cardiff Univ, Sch Psychol, Brain Res Imaging Ctr, Cardiff, S Glam, Wales.	sumnerp@cardiff.ac.uk	Sumner, Petroc/A-3563-2010; Edden, Richard A/G-5538-2012; Singh, Krish/D-1066-2009; Evans, C. John/A-8054-2010	Evans, C. John/0000-0002-6619-4245; Edden, Richard/0000-0002-0671-7374; Singh, Krishna/0000-0002-3094-2475; Bompas, Aline/0000-0002-6957-2694	ESRC; Wellcome Trust; Wales Institute of Cognitive Neuroscience; Schools of Psychology, Biosciences and Chemistry at Cardiff University; UK Department of Trade and Industry, Cardiff University; Welsh Assembly government; RCUK; Biotechnology and Biological Sciences Research Council [BB/C515271/2, BB/C515271/1] Funding Source: researchfish; Economic and Social Research Council [ES/G032211/1] Funding Source: researchfish; ESRC [ES/G032211/1] Funding Source: UKRI	ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Wales Institute of Cognitive Neuroscience; Schools of Psychology, Biosciences and Chemistry at Cardiff University; UK Department of Trade and Industry, Cardiff University; Welsh Assembly government; RCUK(UK Research & Innovation (UKRI)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	We thank F. Boy, S. Muthukumaraswamy, B. Taud, M. Husain, C. Chambers, T. Freeman, R. Honey and L. Wilkinson. R.A.E.E. thanks G. Barker and D. Shungu for pulse programming advice. This work was supported by the ESRC, the Wellcome Trust, the Wales Institute of Cognitive Neuroscience and the Schools of Psychology, Biosciences and Chemistry at Cardiff University. Cardiff University Brain Research Imaging Centre was established with support from the UK Department of Trade and Industry, Cardiff University and the Welsh Assembly government. R.A.E.E. held an RCUK fellowship.	Bompas A, 2009, J VISION, V9, DOI 10.1167/9.9.17; Evans CJ, 2010, J MAGN RESON IMAGING, V31, P204, DOI 10.1002/jmri.21996; Godijn R, 2002, J EXP PSYCHOL HUMAN, V28, P1039, DOI 10.1037//0096-1523.28.5.1039; Lewis DA, 2005, NAT REV NEUROSCI, V6, P312, DOI 10.1038/nrn1648; McSorley E, 2006, J NEUROPHYSIOL, V96, P1420, DOI 10.1152/jn.00315.2006; Mescher M, 1998, NMR BIOMED, V11, P266, DOI 10.1002/(SICI)1099-1492(199810)11:6<266::AID-NBM530>3.0.CO;2-J; Muthukumaraswamy SD, 2009, P NATL ACAD SCI USA, V106, P8356, DOI 10.1073/pnas.0900728106; Olivier E, 1999, BEHAV BRAIN SCI, V22, P694, DOI 10.1017/S0140525X99432157; Pouget P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005208; Rommelse NNJ, 2008, BRAIN COGNITION, V68, P391, DOI 10.1016/j.bandc.2008.08.025; Schlag J, 1998, J NEUROPHYSIOL, V79, P64, DOI 10.1152/jn.1998.79.1.64; THAKER GK, 1989, BIOL PSYCHIAT, V25, P49, DOI 10.1016/0006-3223(89)90146-7; Walker R, 2000, P ROY SOC B-BIOL SCI, V267, P431, DOI 10.1098/rspb.2000.1018	13	112	116	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2010	13	7					825	827		10.1038/nn.2559	http://dx.doi.org/10.1038/nn.2559			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	615YF	20512136				2022-12-28	WOS:000279173900014
J	Garcia-Moreno, F; Pedraza, M; Di Giovannantonio, LG; Di Salvio, M; Lopez-Mascaraque, L; Simeone, A; De Carlos, JA				Garcia-Moreno, Fernando; Pedraza, Maria; Di Giovannantonio, Luca G.; Di Salvio, Michela; Lopez-Mascaraque, Laura; Simeone, Antonio; De Carlos, Juan A.			A neuronal migratory pathway crossing from diencephalon to telencephalon populates amygdala nuclei	NATURE NEUROSCIENCE			English	Article							LATERAL GANGLIONIC EMINENCE; EXPRESSION PATTERNS; HOMEODOMAIN PROTEIN; CELL LINEAGES; MOUSE; GENES; ORGANIZATION; SPECIFICATION; HYPOTHALAMUS; ORTHOPEDIA	Neurons usually migrate and differentiate in one particular encephalic vesicle. We identified a murine population of diencephalic neurons that colonized the telencephalic amygdaloid complex, migrating along a tangential route that crosses a boundary between developing brain vesicles. The diencephalic transcription factor OTP was necessary for this migratory behavior.	[Garcia-Moreno, Fernando; Pedraza, Maria; Lopez-Mascaraque, Laura; De Carlos, Juan A.] CSIC, Inst Cajal, Mol Cellular & Dev Neurobiol Dept, Lab Telencephal Dev, E-28002 Madrid, Spain; [Di Giovannantonio, Luca G.; Di Salvio, Michela; Simeone, Antonio] CEINGE Biotecnol Avanzate, Naples, Italy; [Simeone, Antonio] Scuola Europea Med Mol, Naples, Italy; [Simeone, Antonio] CNR, Inst Genet & Biophys A Buzzati Traverso, I-80125 Naples, Italy	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Cajal (IC); CEINGE Biotecnologie Avanzate; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR)	De Carlos, JA (corresponding author), CSIC, Inst Cajal, Mol Cellular & Dev Neurobiol Dept, Lab Telencephal Dev, E-28002 Madrid, Spain.	decarlos@cajal.csic.es	Lopez-Mascaraque, Laura/M-2448-2014; Di Salvio, Michela/J-8982-2018; Simeone, Antonio/ABG-5269-2020; De Carlos, Juan A./Q-8999-2018	Lopez-Mascaraque, Laura/0000-0002-7154-5687; Di Salvio, Michela/0000-0002-5817-1297; Simeone, Antonio/0000-0003-2693-9836; De Carlos, Juan A./0000-0001-9096-5372; di giovannantonio, luca giovanni/0000-0003-4348-6082; Pedraza, Maria/0000-0002-1973-3269; Garcia-Moreno, Fernando/0000-0001-9048-4237	Ministerio de Ciencia e Innovacion [BFU2007-60351/BFI]; OLFACTOSENSE Consortium of the Comunidad Autonoma de Madrid [P-SEM-0255-2006]; Castilla-La Mancha Health Research Foundation [FISCAM PI2007-66]; EUTRACC Integrate Project [LSHG-CT-2007-037445]; Fondazione Roma and the Italian Association for Cancer Research; Fundacion Centro de Investigaciones de Enfermedades Neurologicas [PI006-08]	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); OLFACTOSENSE Consortium of the Comunidad Autonoma de Madrid; Castilla-La Mancha Health Research Foundation; EUTRACC Integrate Project; Fondazione Roma and the Italian Association for Cancer Research(Fondazione AIRC per la ricerca sul cancro); Fundacion Centro de Investigaciones de Enfermedades Neurologicas	We thank J. Lerma, A. Nieto, M.L. Ceci, A. Blanchart and J. Garcia-Marques for helpful comments; P. Bovolenta and C. Sanchez-Camacho for their kind gift of the pCAG plasmid; F. Vaccarino and G. Corte for the generous gift of antibodies to Otp and Foxg1; L. Menendez de la Prida for providing the GAD-GFP transgenic mice; A. Kastanauskaite and L. Mar a Suarez for their help with the intracellular injections of Lucifer Yellow and M. Sefton for editorial assistance. This work was supported by grants from the Ministerio de Ciencia e Innovacion (BFU2007-60351/BFI), the OLFACTOSENSE Consortium of the Comunidad Autonoma de Madrid (P-SEM-0255-2006) and the Castilla-La Mancha Health Research Foundation (FISCAM PI2007-66) to J.A.DC., and the FP6 for the EUTRACC Integrate Project (LSHG-CT-2007-037445), the 'Stem Cell Project' of Fondazione Roma and the Italian Association for Cancer Research to A.S.Funding for M.P. was provided by Fundacion Centro de Investigaciones de Enfermedades Neurologicas (PI006-08).	Acampora D, 2000, INT J DEV BIOL, V44, P669; Acampora D, 1999, GENE DEV, V13, P2787, DOI 10.1101/gad.13.21.2787; ALHEID GF, 1988, NEUROSCIENCE, V27, P1, DOI 10.1016/0306-4522(88)90217-5; ALTMAN J, 1978, J COMP NEUROL, V182, P945, DOI 10.1002/cne.901820511; ALTMAN J, 1978, J COMP NEUROL, V182, P973, DOI 10.1002/cne.901820512; Anderson S, 1999, CEREB CORTEX, V9, P646, DOI 10.1093/cercor/9.6.646; Bardet SM, 2008, BRAIN RES BULL, V75, P231, DOI 10.1016/j.brainresbull.2007.10.037; Blechman J, 2007, DEVELOPMENT, V134, P4417, DOI 10.1242/dev.011262; CANTERAS NS, 1995, J COMP NEUROL, V360, P213, DOI 10.1002/cne.903600203; Caqueret A, 2006, DEV BIOL, V298, P95, DOI 10.1016/j.ydbio.2006.06.019; Cassell MD, 1999, ANN NY ACAD SCI, V877, P217, DOI 10.1111/j.1749-6632.1999.tb09270.x; Choi GB, 2005, NEURON, V46, P647, DOI 10.1016/j.neuron.2005.04.011; DeCarlos JA, 1996, J NEUROSCI, V16, P6146; Fan CM, 1996, MOL CELL NEUROSCI, V7, P1, DOI 10.1006/mcne.1996.0001; Flames N, 2007, J NEUROSCI, V27, P9682, DOI 10.1523/JNEUROSCI.2750-07.2007; Moreno FG, 2008, CEREB CORTEX, V18, P1239, DOI 10.1093/cercor/bhm154; Garcia-Lopez M, 2008, J COMP NEUROL, V506, P46, DOI 10.1002/cne.21524; Garcia-Moreno F, 2007, J COMP NEUROL, V500, P419, DOI 10.1002/cne.21128; Hirata T, 2009, NAT NEUROSCI, V12, P141, DOI 10.1038/nn.2241; Holmgren N., 1925, Acta Zoologica Stockholm, V6, pbis; Lavdas AA, 1999, J NEUROSCI, V19, P7881; Letinic K, 2001, NAT NEUROSCI, V4, P931, DOI 10.1038/nn0901-931; Martinez-Garcia F, 2002, BRAIN RES BULL, V57, P463, DOI 10.1016/S0361-9230(01)00665-7; Medina L, 2004, J COMP NEUROL, V474, P504, DOI 10.1002/cne.20141; Medina L, 2005, BRAIN RES BULL, V66, P297, DOI 10.1016/j.brainresbull.2005.02.003; Michaud JL, 1998, GENE DEV, V12, P3264, DOI 10.1101/gad.12.20.3264; Nakai S, 1995, GENE DEV, V9, P3109, DOI 10.1101/gad.9.24.3109; Puelles L, 2000, J COMP NEUROL, V424, P409, DOI 10.1002/1096-9861(20000828)424:3<409::AID-CNE3>3.0.CO;2-7; Puelles L, 2003, TRENDS NEUROSCI, V26, P469, DOI 10.1016/S0166-2236(03)00234-0; Puelles L, 2001, BRAIN RES BULL, V55, P695, DOI 10.1016/S0361-9230(01)00588-3; RAKIC P, 1990, EXPERIENTIA, V46, P882, DOI 10.1007/BF01939380; Remedios R, 2004, J NEUROSCI, V24, P6986, DOI 10.1523/JNEUROSCI.0001-04.2004; Ryu S, 2007, CURR BIOL, V17, P873, DOI 10.1016/j.cub.2007.04.003; Shammah-Lagnado SJ, 2000, J COMP NEUROL, V422, P533, DOI 10.1002/1096-9861(20000710)422:4<533::AID-CNE5>3.0.CO;2-7; Sheng HZ, 1997, DEV DYNAM, V208, P266, DOI 10.1002/(SICI)1097-0177(199702)208:2<266::AID-AJA13>3.0.CO;2-1; SIMEONE A, 1994, NEURON, V13, P83, DOI 10.1016/0896-6273(94)90461-8; Soma M, 2009, J COMP NEUROL, V513, P113, DOI 10.1002/cne.21945; Stenman J, 2003, J NEUROSCI, V23, P167; Swanson L., 2009, DEV DEGENERATION REG, P69; Swanson LW, 2000, BRAIN RES, V886, P113, DOI 10.1016/S0006-8993(00)02905-X; Swanson LW, 1998, TRENDS NEUROSCI, V21, P323, DOI 10.1016/S0166-2236(98)01265-X; Tole S, 2005, J NEUROSCI, V25, P2753, DOI 10.1523/JNEUROSCI.3014-04.2005; Valverde F, 1970, CONT RES METHODS NEU, P12, DOI [10.1007/978-3-642-85986-1_2, DOI 10.1007/978-3-642-85986-1_2]; Wang WD, 2000, DEV BIOL, V227, P432, DOI 10.1006/dbio.2000.9902; Wichterle H, 2001, DEVELOPMENT, V128, P3759; Zhao TY, 2008, EUR J NEUROSCI, V28, P1941, DOI 10.1111/j.1460-9568.2008.06503.x	46	73	73	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2010	13	6					680	U50		10.1038/nn.2556	http://dx.doi.org/10.1038/nn.2556			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	600QY	20495559	Green Submitted			2022-12-28	WOS:000278003300012
J	Xie, KQ; Allen, KL; Kourrich, S; Colon-Saez, J; Thomas, MJ; Wickman, K; Martemyanov, KA				Xie, Keqiang; Allen, Kevin L.; Kourrich, Said; Colon-Saez, Jose; Thomas, Mark J.; Wickman, Kevin; Martemyanov, Kirill A.			G beta 5 recruits R7 RGS proteins to GIRK channels to regulate the timing of neuronal inhibitory signaling	NATURE NEUROSCIENCE			English	Article							MICE LACKING; K+ CHANNEL; SUBUNIT	The type 5 G protein beta subunit (G beta 5) can form complexes with members of the regulator of G protein signaling 7 (RGS7) family, but its relevance to neuronal G protein signaling is unclear. We found that mouse RGS7-G beta 5 complexes bound to G protein-gated potassium channels and facilitated their functional coupling to GABA(B) receptors in neurons. Our findings identify a compartmentalization mechanism that is critical for ensuring high temporal resolution of neuronal G protein signaling.	[Xie, Keqiang; Allen, Kevin L.; Colon-Saez, Jose; Wickman, Kevin; Martemyanov, Kirill A.] Univ Minnesota, Dept Pharmacol, Minneapolis, MN 55455 USA; [Kourrich, Said; Thomas, Mark J.] Univ Minnesota, Dept Neurosci, Minneapolis, MN 55455 USA; [Kourrich, Said; Thomas, Mark J.] Univ Minnesota, Dept Psychol, Minneapolis, MN 55455 USA; [Kourrich, Said; Thomas, Mark J.] Univ Minnesota, Inst Human Genet, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Wickman, K (corresponding author), Univ Minnesota, Dept Pharmacol, 3-249 Millard Hall, Minneapolis, MN 55455 USA.	wickm002@umn.edu; martemyanov@umn.edu	Kourrich, Said/M-3916-2014; Xie, Keqiang/J-9668-2012; Thomas, Mark John/HHC-7509-2022; Xie, Keqiang/D-4437-2015	Thomas, Mark John/0000-0001-5721-5350; Wickman, Kevin/0000-0002-5179-9540; Colon-Saez, Jose/0000-0003-4913-0300	US National Institutes of Health [DA021743, DA026405, EY018139, MH061933, DA011806, DA019666, MII078291]; McKnight Land-Grant Award; Whitehall Foundation; NATIONAL EYE INSTITUTE [R01EY018139] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH061933, F31MH078291] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P50DA011806, R01DA019666, R01DA021743, K02DA026405] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); McKnight Land-Grant Award; Whitehall Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank J. Chen for providing the G beta 5<SUP>-/-</SUP> mice, W. Simonds for the gift of antibodies to G beta 5 and RGS7 and M. Parent for assistance with the hippocampal slicing technique. This work was supported by US National Institutes of Health grants DA021743 (K.A.M.), DA026405 (K.A.M.), EY018139 (K.A.M.), MH061933 (K.W.), DA011806 (K.W.), DA019666 (M.J.T.) and MII078291 (J.C.- S.), a McKnight Land-Grant Award (K.A.M), and an award from the Whitehall Foundation (M.J.T.).	Andernacht M, 2009, ATW-INT J NUCL POWER, V54, P33; Cheever ML, 2008, NAT STRUCT MOL BIOL, V15, P155, DOI 10.1038/nsmb.1377; Chen CK, 2003, P NATL ACAD SCI USA, V100, P6604, DOI 10.1073/pnas.0631825100; Chung HJ, 2009, P NATL ACAD SCI USA, V106, P635, DOI 10.1073/pnas.0811685106; Chung HJ, 2009, P NATL ACAD SCI USA, V106, P629, DOI 10.1073/pnas.0811615106; Costa ACS, 2005, J NEUROSCI, V25, P7801, DOI 10.1523/JNEUROSCI.1699-05.2005; Drenan RM, 2006, J BIOL CHEM, V281, P28222, DOI 10.1074/jbc.M604428200; Karschin C, 1996, J NEUROSCI, V16, P3559; Keren-Raifman T, 2001, FEBS LETT, V492, P20, DOI 10.1016/S0014-5793(01)02220-7; Kovoor A, 2000, J BIOL CHEM, V275, P3397, DOI 10.1074/jbc.275.5.3397; Luscher C, 1997, NEURON, V19, P687, DOI 10.1016/S0896-6273(00)80381-5; Pravetoni M, 2008, GENES BRAIN BEHAV, V7, P523, DOI 10.1111/j.1601-183X.2008.00388.x; Rahman Z, 2003, NEURON, V38, P941, DOI 10.1016/S0896-6273(03)00321-0; Sondek J, 2001, BIOCHEM PHARMACOL, V61, P1329, DOI 10.1016/S0006-2952(01)00633-5; Vacher CM, 2003, CNS NEUROL DISORD-DR, V2, P248, DOI 10.2174/1568007033482814	15	51	52	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2010	13	6					661	663		10.1038/nn.2549	http://dx.doi.org/10.1038/nn.2549			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	600QY	20453851	Green Accepted			2022-12-28	WOS:000278003300007
J	Ortinski, PI; Dong, JH; Mungenast, A; Yue, CY; Takano, H; Watson, DJ; Haydon, PG; Coulter, DA				Ortinski, Pavel I.; Dong, Jinghui; Mungenast, Alison; Yue, Cuiyong; Takano, Hajime; Watson, Deborah J.; Haydon, Philip G.; Coulter, Douglas A.			Selective induction of astrocytic gliosis generates deficits in neuronal inhibition	NATURE NEUROSCIENCE			English	Article							TEMPORAL-LOBE EPILEPSY; NEUROTRANSMITTER GABA SYNTHESIS; GLUTAMATE-GLUTAMINE CYCLE; RAT HIPPOCAMPAL-NEURONS; SYNAPTIC-TRANSMISSION; NEUROLOGICAL DISORDERS; AREA CA1; BRAIN; SYNTHETASE; SUSCEPTIBILITY	Reactive astrocytosis develops in many neurologic diseases, including epilepsy. Astrocytotic contributions to pathophysiology are poorly understood. Studies examining this are confounded by comorbidities accompanying reactive astrocytosis. We found that high-titer transduction of astrocytes with enhanced green fluorescent protein (eGFP) via adeno-associated virus induced reactive astrocytosis without altering the intrinsic properties or anatomy of neighboring neurons. We examined the consequences of selective astrocytosis induction on synaptic transmission in mouse CA1 pyramidal neurons. Neurons near eGFP-labeled reactive astrocytes had reduced inhibitory, but not excitatory, synaptic currents. This inhibitory postsynaptic current (IPSC) erosion resulted from a failure of the astrocytic glutamate-glutamine cycle. Reactive astrocytes downregulated expression of glutamine synthetase. Blockade of this enzyme normally induces rapid synaptic GABA depletion. In astrocytotic regions, residual inhibition lost sensitivity to glutamine synthetase blockade, whereas exogenous glutamine administration enhanced IPSCs. Astrocytosis-mediated deficits in inhibition triggered glutamine-reversible hyperexcitability in hippocampal circuits. Thus, reactive astrocytosis could generate local synaptic perturbations, leading to broader functional deficits associated with neurologic disease.	[Ortinski, Pavel I.; Yue, Cuiyong; Takano, Hajime; Coulter, Douglas A.] Childrens Hosp Philadelphia, Div Neurol, Philadelphia, PA 19104 USA; [Dong, Jinghui; Mungenast, Alison; Haydon, Philip G.] Tufts Univ, Sch Med, Dept Neurosci, Boston, MA 02111 USA; [Watson, Deborah J.] Univ Penn, Sch Med, Dept Neurosurg, Philadelphia, PA 19104 USA; [Coulter, Douglas A.] Univ Penn, Sch Med, Dept Pediat, Philadelphia, PA 19104 USA; [Coulter, Douglas A.] Univ Penn, Sch Med, Dept Neurosci, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Tufts University; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Coulter, DA (corresponding author), Childrens Hosp Philadelphia, Div Neurol, Philadelphia, PA 19104 USA.	coulterd@email.chop.edu	Takano, Hajime/AAD-4589-2019; Ortinski, Pavel/N-7195-2017	Ortinski, Pavel/0000-0003-0814-4490; Coulter, Douglas/0000-0002-1486-119X; Mungenast, Alison/0000-0003-1020-0471; Takano, Hajime/0000-0003-3033-2412	US National Institutes of Health [P01 NS054900, P20 MH071705, P01NS054900, R01NS054770, R01NS037585, R01NS040978]; Epilepsy Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [P20MH071705] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038572, R01NS054770, R01NS037585, P01NS054900, R01NS040978] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Epilepsy Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by US National Institutes of Health grants P01 NS054900 and P20 MH071705 to D. A. C., P01NS054900, R01NS054770 and R01NS037585 to P. G. H., R01NS040978 to D. J.W. and by an Epilepsy Foundation Research Fellowship to P.I.O.	Ang CW, 2006, J NEUROSCI, V26, P11850, DOI 10.1523/JNEUROSCI.2354-06.2006; Ang CW, 2005, J NEUROSCI, V25, P9567, DOI 10.1523/JNEUROSCI.2992-05.2005; Bak LK, 2006, J NEUROCHEM, V98, P641, DOI 10.1111/j.1471-4159.2006.03913.x; Barberis A, 2004, EUR J NEUROSCI, V20, P1803, DOI 10.1111/j.1460-9568.2004.03624.x; Binder DK, 2006, GLIA, V54, P358, DOI 10.1002/glia.20394; Burrone J, 2006, NAT PROTOC, V1, P2970, DOI 10.1038/nprot.2006.449; Bushong EA, 2002, J NEUROSCI, V22, P183, DOI 10.1523/JNEUROSCI.22-01-00183.2002; Cameron H.A., 2006, CURRENT PROTOCOLS NE; Chaudhry FA, 2002, J CELL BIOL, V157, P349, DOI 10.1083/jcb.200201070; Cohen AS, 2000, J NEUROPHYSIOL, V84, P2465, DOI 10.1152/jn.2000.84.5.2465; Reis RAD, 2008, NEUROCHEM RES, V33, P1466, DOI 10.1007/s11064-008-9604-1; Eid T, 2004, LANCET, V363, P28, DOI 10.1016/S0140-6736(03)15166-5; Eid T, 2008, EPILEPSIA, V49, P42, DOI 10.1111/j.1528-1167.2008.01492.x; Fricke MN, 2007, J NEUROCHEM, V102, P1895, DOI 10.1111/j.1471-4159.2007.04649.x; Galic MA, 2008, J NEUROSCI, V28, P6904, DOI 10.1523/JNEUROSCI.1901-08.2008; Haydon PG, 2006, PHYSIOL REV, V86, P1009, DOI 10.1152/physrev.00049.2005; Jakubs K, 2008, J NEUROSCI, V28, P12477, DOI 10.1523/JNEUROSCI.3240-08.2008; Kam K, 2007, J NEUROSCI, V27, P9192, DOI 10.1523/JNEUROSCI.1198-07.2007; Liang SL, 2006, J NEUROSCI, V26, P8537, DOI 10.1523/JNEUROSCI.0329-06.2006; Mozrzymas JW, 2007, J PHYSIOL-LONDON, V585, P29, DOI 10.1113/jphysiol.2007.143602; Oliva AA, 2000, J NEUROSCI, V20, P3354, DOI 10.1523/JNEUROSCI.20-09-03354.2000; Ortinski PI, 2004, J NEUROPHYSIOL, V92, P1718, DOI 10.1152/jn.00243.2004; PARPURA V, 1994, NATURE, V369, P744, DOI 10.1038/369744a0; Pascual O, 2005, SCIENCE, V310, P113, DOI 10.1126/science.1116916; Pekny M, 2005, GLIA, V50, P427, DOI 10.1002/glia.20207; Rizzoli SO, 2005, NAT REV NEUROSCI, V6, P57, DOI 10.1038/nrn1583; Robinson SR, 2001, J NEUROSCI RES, V66, P972, DOI 10.1002/jnr.10057; Rosati A, 2009, J NEURO-ONCOL, V93, P319, DOI 10.1007/s11060-008-9794-z; Seifert G, 2006, NAT REV NEUROSCI, V7, P194, DOI 10.1038/nrn1870; Sepkuty JP, 2002, J NEUROSCI, V22, P6372; Steffens M, 2005, NEUROCHEM INT, V47, P379, DOI 10.1016/j.neuint.2005.06.001; Sun HY, 2005, J PHYSIOL-LONDON, V568, P815, DOI 10.1113/jphysiol.2005.093948; Sykova E, 2008, PHYSIOL REV, V88, P1277, DOI 10.1152/physrev.00027.2007; Tilleux S, 2007, J NEUROSCI RES, V85, P2059, DOI 10.1002/jnr.21325; Volterra A, 2005, NAT REV NEUROSCI, V6, P626, DOI 10.1038/nrn1722; Wetherington J, 2008, NEURON, V58, P168, DOI 10.1016/j.neuron.2008.04.002; Wilhelmsson U, 2004, J NEUROSCI, V24, P5016, DOI 10.1523/JNEUROSCI.0820-04.2004	37	308	314	1	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2010	13	5					584	U93		10.1038/nn.2535	http://dx.doi.org/10.1038/nn.2535			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	588JM	20418874	Green Accepted			2022-12-28	WOS:000277065700016
J	Miyata, S; Komatsu, Y; Yoshimura, Y; Taya, C; Kitagawa, H				Miyata, Shinji; Komatsu, Yukio; Yoshimura, Yumiko; Taya, Choji; Kitagawa, Hiroshi			Persistent cortical plasticity by upregulation of chondroitin 6-sulfation	NATURE NEUROSCIENCE			English	Article							EXPERIENCE-DEPENDENT PLASTICITY; OCULAR DOMINANCE PLASTICITY; ADULT VISUAL-CORTEX; CENTRAL-NERVOUS-SYSTEM; RAT FRONTAL-CORTEX; PERINEURONAL NETS; CRITICAL PERIOD; INHIBITORY NEURONS; SULFATE; PARVALBUMIN	Cortical plasticity is most evident during a critical period in early life, but the mechanisms that restrict plasticity after the critical period are poorly understood. We found that a developmental increase in the 4- sulfation/6-sulfation (4S/6S) ratio of chondroitin sulfate proteoglycans (CSPGs), which are components of the brain extracellular matrix, leads to the termination of the critical period for ocular dominance plasticity in the mouse visual cortex. Condensation of CSPGs into perineuronal nets that enwrapped synaptic contacts on parvalbumin-expressing interneurons was prevented by cell-autonomous overexpression of chondroitin 6-sulfation, which maintains a low 4S/6S ratio. Furthermore, the increase in the 4S/6S ratio was required for the accumulation of Otx2, a homeoprotein that activates the development of parvalbumin-expressing interneurons, and for functional maturation of the electrophysiological properties of these cells. Our results indicate that the critical period for cortical plasticity is regulated by the 4S/6S ratio of CSPGs, which determines the maturation of parvalbumin-expressing interneurons.	[Miyata, Shinji; Kitagawa, Hiroshi] Kobe Pharmaceut Univ, Dept Biochem, Higashinada Ku, Kobe, Hyogo 658, Japan; [Miyata, Shinji; Kitagawa, Hiroshi] Kobe Univ, Global Ctr Excellence, Program Signal Transduct Med, Grad Sch Med,Chuo Ku, Kobe, Hyogo 657, Japan; [Komatsu, Yukio] Nagoya Univ, Environm Med Res Inst, Dept Neurosci, Nagoya, Aichi 464, Japan; [Yoshimura, Yumiko] Natl Inst Nat Sci, Okazaki Inst Integrat Biosci, Natl Inst Physiol Sci, Div Dev Neurophysiol, Okazaki, Aichi 4448787, Japan; [Taya, Choji] Tokyo Metropolitan Inst Med Sci, Lab Transgen Technol, Tokyo 113, Japan	Kobe Pharmaceutical University; Kobe University; Nagoya University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Okazaki Institute for Integrative Bioscience (OIIB); Tokyo Metropolitan Institute of Medical Science	Kitagawa, H (corresponding author), Kobe Pharmaceut Univ, Dept Biochem, Higashinada Ku, Kobe, Hyogo 658, Japan.	kitagawa@kobepharma-u.ac.jp	Miyata, Shinji/S-6000-2019; Kitagawa, Hiroshi/AAJ-1344-2020	Miyata, Shinji/0000-0001-6635-1645; Kitagawa, Hiroshi/0000-0002-9307-7079; Yoshimura, Yumiko/0000-0002-7526-4153	Ministry of Education, Culture, Sports, Science & Technology, Japan [21390025, 23110003, 23110004, 21890286]	Ministry of Education, Culture, Sports, Science & Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank T. Maruyama and F. Murakami for technical advises on the VEP recordings and in utero electroporation, respectively. This work was funded by a Grant-in-Aid for Scientific Research-B 21390025 (to H. K.), grants from the Scientific Research on Innovative Areas (23110003 and 23110004 to H.K. and Y.K.), and a Young Scientists grant (21890286 to S.M.) from Ministry of Education, Culture, Sports, Science & Technology, Japan.	Bavelier D, 2010, J NEUROSCI, V30, P14964, DOI 10.1523/JNEUROSCI.4812-10.2010; Borrell V, 2005, J NEUROSCI METH, V143, P151, DOI 10.1016/j.jneumeth.2004.09.027; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; Carulli D, 2006, J COMP NEUROL, V494, P559, DOI 10.1002/cne.20822; Carulli D, 2010, BRAIN, V133, P2331, DOI 10.1093/brain/awq145; Celio MR, 1998, TRENDS NEUROSCI, V21, P510, DOI 10.1016/S0166-2236(98)01298-3; Chang MC, 2010, NAT NEUROSCI, V13, P1090, DOI 10.1038/nn.2621; CONNORS BW, 1990, TRENDS NEUROSCI, V13, P99, DOI 10.1016/0166-2236(90)90185-D; Erisir A, 2005, J COMP NEUROL, V485, P11, DOI 10.1002/cne.20507; Fox K, 2005, NEURON, V48, P465, DOI 10.1016/j.neuron.2005.10.013; Frenkel MY, 2004, NEURON, V44, P917, DOI 10.1016/j.neuron.2004.12.003; Galtrey CM, 2007, BRAIN RES REV, V54, P1, DOI 10.1016/j.brainresrev.2006.09.006; Gama CI, 2006, NAT CHEM BIOL, V2, P467, DOI 10.1038/nchembio810; GODEMENT P, 1984, J COMP NEUROL, V230, P552, DOI 10.1002/cne.902300406; Goldberg EM, 2011, CEREB CORTEX, V21, P666, DOI 10.1093/cercor/bhq138; Gordon JA, 1996, J NEUROSCI, V16, P3274; Harauzov A, 2010, J NEUROSCI, V30, P361, DOI 10.1523/JNEUROSCI.2233-09.2010; HARTIG W, 1992, NEUROREPORT, V3, P869; Hensch TK, 2005, NAT REV NEUROSCI, V6, P877, DOI 10.1038/nrn1787; Hensch TK, 1998, SCIENCE, V282, P1504, DOI 10.1126/science.282.5393.1504; Jiang B, 2005, BRAIN RES REV, V50, P126, DOI 10.1016/j.brainresrev.2005.05.007; KAWAGUCHI Y, 1995, J NEUROSCI, V15, P2638; Kawaguchi Y, 2002, J NEUROCYTOL, V31, P277, DOI 10.1023/A:1024126110356; Kitagawa H, 1997, J BIOL CHEM, V272, P31377, DOI 10.1074/jbc.272.50.31377; KITAGAWA H, 1995, ANAL BIOCHEM, V232, P114, DOI 10.1006/abio.1995.9952; Lander C, 1998, J NEUROSCI, V18, P174; Lewis DA, 2005, NAT REV NEUROSCI, V6, P312, DOI 10.1038/nrn1648; Maeda N, 2003, J BIOL CHEM, V278, P35805, DOI 10.1074/jbc.M305530200; Marin O, 2001, NAT REV NEUROSCI, V2, P780, DOI 10.1038/35097509; Matthews RT, 2002, J NEUROSCI, V22, P7536; McGee AW, 2005, SCIENCE, V309, P2222, DOI 10.1126/science.1114362; Mikami T, 2009, J BIOL CHEM, V284, P4494, DOI 10.1074/jbc.M809227200; Miyata S, 2005, NEUROSCIENCE, V136, P95, DOI 10.1016/j.neuroscience.2005.07.031; Morishita H, 2010, SCIENCE, V330, P1238, DOI 10.1126/science.1195320; Nadanaka S, 2008, J BIOL CHEM, V283, P27333, DOI 10.1074/jbc.M802997200; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Pantazopoulos H, 2010, ARCH GEN PSYCHIAT, V67, P155, DOI 10.1001/archgenpsychiatry.2009.196; Pizzorusso T, 2002, SCIENCE, V298, P1248, DOI 10.1126/science.1072699; Properzi F, 2005, EUR J NEUROSCI, V21, P378, DOI 10.1111/j.1460-9568.2005.03876.x; Rudy B, 2001, TRENDS NEUROSCI, V24, P517, DOI 10.1016/S0166-2236(00)01892-0; Sato M, 2008, J NEUROSCI, V28, P10278, DOI 10.1523/JNEUROSCI.2451-08.2008; Schwaller B, 2004, MOL CELL NEUROSCI, V25, P650, DOI 10.1016/j.mcn.2003.12.006; Sugahara K, 2007, CURR OPIN STRUC BIOL, V17, P536, DOI 10.1016/j.sbi.2007.08.015; Sugiyama S, 2008, CELL, V134, P508, DOI 10.1016/j.cell.2008.05.054; Tanaka DH, 2009, J NEUROSCI, V29, P1300, DOI 10.1523/JNEUROSCI.5446-08.2009; Tropea D, 2006, NAT NEUROSCI, V9, P660, DOI 10.1038/nn1689; WIESEL TN, 1963, J NEUROPHYSIOL, V26, P1003, DOI 10.1152/jn.1963.26.6.1003; Yazaki-Sugiyama Y, 2009, NATURE, V462, P218, DOI 10.1038/nature08485; Yoshimura Y, 2008, EUR J NEUROSCI, V28, P730, DOI 10.1111/j.1460-9568.2008.06384.x	49	230	236	3	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2012	15	3					414	U100		10.1038/nn.3023	http://dx.doi.org/10.1038/nn.3023			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	899CY	22246436				2022-12-28	WOS:000300793100015
J	Baudet, ML; Zivraj, KH; Abreu-Goodger, C; Muldal, A; Armisen, J; Blenkiron, C; Goldstein, LD; Miska, EA; Holt, CE				Baudet, Marie-Laure; Zivraj, Krishna H.; Abreu-Goodger, Cei; Muldal, Alistair; Armisen, Javier; Blenkiron, Cherie; Goldstein, Leonard D.; Miska, Eric A.; Holt, Christine E.			miR-124 acts through CoREST to control onset of Sema3A sensitivity in navigating retinal growth cones	NATURE NEUROSCIENCE			English	Article							AXON GUIDANCE; CAENORHABDITIS-ELEGANS; INTERMEDIATE TARGET; DEVELOPMENTAL TIME; MESSENGER-RNAS; SEMAPHORIN 3A; EMBRYONIC CNS; C-ELEGANS; MICRORNAS; EXPRESSION	During axon pathfinding, growth cones commonly show changes in sensitivity to guidance cues that follow a cell-intrinsic timetable. The cellular timer mechanisms that regulate such changes are, however, poorly understood. Here we have investigated microRNAs (miRNAs) in the timing control of sensitivity to the semaphorin Sema3A in Xenopus laevis retinal ganglion cell (RGC) growth cones. A developmental profiling screen identified miR-124 as a candidate timer. Loss of miR-124 delayed the onset of Sema3A sensitivity and concomitant neuropilin-1 (NRP1) receptor expression and caused cell-autonomous pathfinding errors. CoREST, a cofactor of a NRP1 repressor, was newly identified as a target and mediator of miR-124 for this highly specific temporal aspect of RGC growth cone responsiveness. Our findings indicate that miR-124 is important in regulating the intrinsic temporal changes in RGC growth cone sensitivity and suggest that miRNAs may act broadly as linear timers in vertebrate neuronal development.	[Baudet, Marie-Laure; Zivraj, Krishna H.; Muldal, Alistair; Holt, Christine E.] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, England; [Abreu-Goodger, Cei] CINVESTAV, Natl Lab Genom Biodivers Langebio, Guanajuato, Mexico; [Armisen, Javier; Blenkiron, Cherie; Goldstein, Leonard D.; Miska, Eric A.] Univ Cambridge, Wellcome Trust Canc Res UK Gurdon Inst, Cambridge, England	University of Cambridge; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; University of Cambridge	Holt, CE (corresponding author), Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, England.	ceh@mole.bio.cam.ac.uk	Blenkiron, Cherie/H-8468-2019; Abreu-Goodger, Cei/A-1268-2010; Baudet, Marie-Laure/H-6343-2019; Baudet, Marie-Laure/B-1437-2015	Blenkiron, Cherie/0000-0002-0217-3808; Abreu-Goodger, Cei/0000-0001-8302-9893; Baudet, Marie-Laure/0000-0001-8957-5545; Baudet, Marie-Laure/0000-0001-8957-5545; Muldal, Alistair/0000-0002-0387-135X; Miska, Eric/0000-0002-4450-576X; Holt, Christine Elizabeth/0000-0003-2829-121X	National Research Council of Canada; Alberta Heritage Foundation for Medical Research; Wellcome Trust; UK Medical Research Council; SIROCCO; Cancer Research UK [11832] Funding Source: researchfish	National Research Council of Canada; Alberta Heritage Foundation for Medical Research(Alberta Heritage Foundation for Medical ResearchGeneral Electric); Wellcome Trust(Wellcome TrustEuropean Commission); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); SIROCCO; Cancer Research UK(Cancer Research UK)	The authors wish to thank J. Woolford for her contribution to the analysis of high-throughput sequencing data, H. Lynn for help on cloning and M. Wood for participation in collapse analysis. We also thank A. Dwivedy, L. Strochlic, J. Falk, K. Leung, M. Agathocleous, A. Lin, S. McFarlane and A. Almeida for technical assistance. We thank W. Harris, A. C. Lee, J. Yoon and M. Agathocleous for critically reading the manuscript, as well as all the members of the Harris/Holt laboratory for their input. This work was supported by postdoctoral fellowships from the National Research Council of Canada (M.-L. B.) and Alberta Heritage Foundation for Medical Research (M.-L. B.), by Wellcome Trust Programme and UK Medical Research Council grants (C. E. H.) and by a European Framework 6 grant (SIROCCO) (E. A. M.).	Atkinson-Leadbeater K, 2010, J NEUROSCI, V30, P685, DOI 10.1523/JNEUROSCI.4165-09.2010; Aulehla A, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000869; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Brittis PA, 2002, CELL, V110, P223, DOI 10.1016/S0092-8674(02)00813-9; Campbell DS, 2001, J NEUROSCI, V21, P8538, DOI 10.1523/JNEUROSCI.21-21-08538.2001; Cao XW, 2007, GENE DEV, V21, P531, DOI 10.1101/gad.1519207; Chen H, 1998, NEURON, V21, P1283, DOI 10.1016/S0896-6273(00)80648-0; Cheng LC, 2009, NAT NEUROSCI, V12, P399, DOI 10.1038/nn.2294; Clark AM, 2010, NUCLEIC ACIDS RES, V38, P3780, DOI 10.1093/nar/gkq083; CORNEL E, 1992, NEURON, V9, P1001, DOI 10.1016/0896-6273(92)90061-H; Decembrini S, 2009, P NATL ACAD SCI USA, V106, P21179, DOI 10.1073/pnas.0909167106; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; Diefenbach TJ, 2000, J NEUROSCI, V20, P1484; Faber J., 1994, NORMAL TABLE XENOPUS, P2; Falk J, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-107; Feldheim DA, 2000, NEURON, V25, P563, DOI 10.1016/S0896-6273(00)81060-0; Gao FB, 2010, NEURAL DEV, V5, DOI 10.1186/1749-8104-5-25; Giraldez AJ, 2006, SCIENCE, V312, P75, DOI 10.1126/science.1122689; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Hocking JC, 2010, MECH DEVELOP, V127, P36, DOI 10.1016/j.mod.2009.11.002; HOLT CE, 1989, J NEUROSCI, V9, P3123; HOLT CE, 1984, J NEUROSCI, V4, P1130; Johnson MH, 2000, BIOESSAYS, V22, P57, DOI 10.1002/(SICI)1521-1878(200001)22:1&lt;57::AID-BIES10&gt;3.0.CO;2-L; Jung H, 2011, CURR OPIN GENET DEV, V21, P458, DOI 10.1016/j.gde.2011.04.004; Keleman K, 2002, CELL, V110, P415, DOI 10.1016/S0092-8674(02)00901-7; Kloosterman WP, 2007, PLOS BIOL, V5, P1738, DOI 10.1371/journal.pbio.0050203; Krichevsky AM, 2003, RNA, V9, P1274, DOI 10.1261/rna.5980303; Kurschat P, 2006, J BIOL CHEM, V281, P2721, DOI 10.1074/jbc.M507860200; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Leung KM, 2006, NAT NEUROSCI, V9, P1247, DOI 10.1038/nn1775; Mann F, 2004, INT J DEV BIOL, V48, P957, DOI 10.1387/ijdb.041899fm; Moss EG, 2007, CURR BIOL, V17, pR425, DOI 10.1016/j.cub.2007.03.043; Obernosterer G, 2007, NAT PROTOC, V2, P1508, DOI 10.1038/nprot.2007.153; Pinter R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010021; Piper M, 2006, NEURON, V49, P215, DOI 10.1016/j.neuron.2005.12.008; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Sempere LF, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r13; Shewan D, 2002, NAT NEUROSCI, V5, P955, DOI 10.1038/nn919; Shirasaki R, 1998, SCIENCE, V279, P105, DOI 10.1126/science.279.5347.105; Smirnova L, 2005, EUR J NEUROSCI, V21, P1469, DOI 10.1111/j.1460-9568.2005.03978.x; Stein E, 2001, SCIENCE, V291, P1928, DOI 10.1126/science.1058445; Taranova OV, 2006, GENE DEV, V20, P1187, DOI 10.1101/gad.1407906; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Visvanathan J, 2007, GENE DEV, V21, P744, DOI 10.1101/gad.1519107; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Wu KY, 2005, NATURE, V436, P1020, DOI 10.1038/nature03885; Zivraj KH, 2010, J NEUROSCI, V30, P15464, DOI 10.1523/JNEUROSCI.1800-10.2010; Zoo YM, 2000, CELL, V102, P363, DOI 10.1016/S0092-8674(00)00041-6	50	88	94	1	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2012	15	1					29	U213		10.1038/nn.2979	http://dx.doi.org/10.1038/nn.2979			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	866VO	22138647	Green Accepted			2022-12-28	WOS:000298414400011
J	State, MW; Levitt, P				State, Matthew W.; Levitt, Pat			The conundrums of understanding genetic risks for autism spectrum disorders	NATURE NEUROSCIENCE			English	Review							COPY-NUMBER VARIATION; RECEPTOR TYROSINE KINASE; RARE DE-NOVO; MET; ASSOCIATION; MUTATIONS; 16P11.2; DELETIONS; VARIANTS; REVEALS	Recent advances in the genetics of autism spectrum disorders (ASDs) are offering new valuable insights into molecular and cellular mechanisms of pathology. At the same time, the emerging data challenge long-standing diagnostic conventions and the notion of phenotypic specificity. This review addresses the particular issues that attend gene discovery in neuropsychiatric and neurodevelopmental disorders and ASDs in particular, summarizes recent findings in human genetics broadly that are driving the reevaluation of the conventional wisdom regarding the allelic architecture of common psychiatric conditions, reviews selected discoveries in ASDs and their relevance to models of pathology, highlights the conceptual and practical issues raised by the observation of a convergence of ASD genetic risks with distinct psychiatric disorders, and considers the important interplay of studies of neurobiology and genetics in clarifying and extending our understanding of social disability syndromes.	[State, Matthew W.] Yale Univ, Sch Med, Dept Child Psychiat, Program Neurogenet, New Haven, CT 06520 USA; [State, Matthew W.] Yale Univ, Sch Med, Dept Psychiat, Program Neurogenet, New Haven, CT USA; [State, Matthew W.] Yale Univ, Sch Med, Dept Genet, Program Neurogenet, New Haven, CT USA; [Levitt, Pat] Univ So Calif, Keck Sch Med, Dept Cell & Neurobiol, Zilkha Neurogenet Inst, Los Angeles, CA 90033 USA	Yale University; Yale University; Yale University; University of Southern California	State, MW (corresponding author), Yale Univ, Sch Med, Dept Child Psychiat, Program Neurogenet, New Haven, CT 06520 USA.	matthew.state@yale.edu; plevitt@usc.edu	State, Matthew/W-2256-2019	State, Matthew/0000-0003-1624-8302	Simons Foundation; National Institute of Mental Health [MH067842, MH080759, MH089956, MH081754]; NATIONAL INSTITUTE OF MENTAL HEALTH [RC2MH089956, R01MH067842, R01MH081754, R01MH080759] Funding Source: NIH RePORTER	Simons Foundation; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work has been supported in part by grants from the Simons Foundation (to M.W.S. and P.L.) and the National Institute of Mental Health (MH067842 and MH080759 to P.L. and MH089956 and MH081754 to M.W.S.).	Akil H, 2010, SCIENCE, V327, P1580, DOI 10.1126/science.1188654; Alarcon M, 2008, AM J HUM GENET, V82, P150, DOI 10.1016/j.ajhg.2007.09.005; Altshuler D, 2008, SCIENCE, V322, P881, DOI 10.1126/science.1156409; American Psychiatric Association. American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Anney R, 2010, HUM MOL GENET, V19, P4072, DOI 10.1093/hmg/ddq307; Arking DE, 2008, AM J HUM GENET, V82, P160, DOI 10.1016/j.ajhg.2007.09.015; Ayhan Y, 2009, BEHAV BRAIN RES, V204, P274, DOI 10.1016/j.bbr.2009.04.010; Bachman P, 2008, SCHIZOPHR RES, V103, P293, DOI 10.1016/j.schres.2008.04.006; Bakkaloglu B, 2008, AM J HUM GENET, V82, P165, DOI 10.1016/j.ajhg.2007.09.017; Berkel S, 2010, NAT GENET, V42, P489, DOI 10.1038/ng.589; Bill BR, 2009, CURR OPIN GENET DEV, V19, P271, DOI 10.1016/j.gde.2009.04.004; Bochukova EG, 2010, NATURE, V463, P666, DOI 10.1038/nature08689; Bourgeron T, 2009, CURR OPIN NEUROBIOL, V19, P231, DOI 10.1016/j.conb.2009.06.003; Buie T, 2010, PEDIATRICS, V125, pS1, DOI 10.1542/peds.2009-1878C; Campbell DB, 2007, ANN NEUROL, V62, P243, DOI 10.1002/ana.21180; Campbell DB, 2006, P NATL ACAD SCI USA, V103, P16834, DOI 10.1073/pnas.0605296103; Campbell DB, 2009, PEDIATRICS, V123, P1018, DOI 10.1542/peds.2008-0819; Campbell DB, 2008, AUTISM RES, V1, P159, DOI 10.1002/aur.27; Chakravarti A, 1999, NAT GENET, V21, P56, DOI 10.1038/4482; Ching MSL, 2010, AM J MED GENET B, V153B, P937, DOI 10.1002/ajmg.b.31063; Cirulli ET, 2010, NAT REV GENET, V11, P415, DOI 10.1038/nrg2779; Devlin B, 2011, BRAIN RES, V1380, P78, DOI 10.1016/j.brainres.2010.11.026; Durand CM, 2007, NAT GENET, V39, P25, DOI 10.1038/ng1933; Ehninger D, 2008, NEURON, V60, P950, DOI 10.1016/j.neuron.2008.12.007; Fernandez T, 2004, AM J HUM GENET, V74, P1286, DOI 10.1086/421474; Fernandez T, 2008, AM J HUM GENET, V82, P1385, DOI 10.1016/j.ajhg.2008.04.021; Friedman JI, 2008, MOL PSYCHIATR, V13, P261, DOI 10.1038/sj.mp.4002049; Gauthier J, 2009, AM J MED GENET B, V150B, P421, DOI 10.1002/ajmg.b.30822; Geschwind DH, 2007, CURR OPIN NEUROBIOL, V17, P103, DOI 10.1016/j.conb.2007.01.009; Geschwind DH, 2009, NATURE, V461, P908, DOI 10.1038/nature08537; Geschwind DH, 2009, ANNU REV MED, V60, P367, DOI 10.1146/annurev.med.60.053107.121225; Gilman SR, 2011, NEURON, V70, P898, DOI 10.1016/j.neuron.2011.05.021; Glessner JT, 2009, NATURE, V459, P569, DOI 10.1038/nature07953; Goldstein DB, 2009, NEW ENGL J MED, V360, P1696, DOI 10.1056/NEJMp0806284; Gutierrez H, 2004, DEVELOPMENT, V131, P3717, DOI 10.1242/dev.01209; Guy J, 2007, SCIENCE, V315, P1143, DOI 10.1126/science.1138389; Hammock EAD, 2006, HUM DEV, V49, P294, DOI 10.1159/000095581; Hindorff L.A., 2010, CATALOGUE PUBLISHED; Hoekstra RA, 2009, BRIT J PSYCHIAT, V195, P531, DOI 10.1192/bjp.bp.108.060889; Ivleva EI, 2010, NEUROSCI BIOBEHAV R, V34, P897, DOI 10.1016/j.neubiorev.2009.11.022; Jackson PB, 2009, AUTISM RES, V2, P232, DOI 10.1002/aur.87; Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136; Ji WZ, 2008, NAT GENET, V40, P592, DOI 10.1038/ng.118; Judson MC, 2011, J NEURODEV DISORD, V3, P282, DOI 10.1007/s11689-011-9081-8; Judson MC, 2011, CEREB CORTEX, V21, P1613, DOI 10.1093/cercor/bhq223; Judson MC, 2010, J COMP NEUROL, V518, P4463, DOI 10.1002/cne.22467; Judson MC, 2009, J COMP NEUROL, V513, P511, DOI 10.1002/cne.21969; King BH, 2011, BRAIN RES, V1380, P34, DOI 10.1016/j.brainres.2010.11.031; Krab LC, 2008, JAMA-J AM MED ASSOC, V300, P287, DOI 10.1001/jama.300.3.287; Kumar RA, 2008, HUM MOL GENET, V17, P628, DOI 10.1093/hmg/ddm376; Kumar RA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004582; Laumonnier F, 2004, AM J HUM GENET, V74, P552, DOI 10.1086/382137; Levitt P, 2009, J CLIN INVEST, V119, P747, DOI 10.1172/JCI37934; Levy D, 2011, NEURON, V70, P886, DOI 10.1016/j.neuron.2011.05.015; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; McCarthy SE, 2009, NAT GENET, V41, P1223, DOI 10.1038/ng.474; Mefford HC, 2008, NEW ENGL J MED, V359, P1685, DOI 10.1056/NEJMoa0805384; Moreno-De-Luca D, 2010, AM J HUM GENET, V87, P618, DOI 10.1016/j.ajhg.2010.10.004; Moss J, 2009, J INTELL DISABIL RES, V53, P852, DOI 10.1111/j.1365-2788.2009.01197.x; Mukamel Z, 2011, J NEUROSCI, V31, P11437, DOI 10.1523/JNEUROSCI.0181-11.2011; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Pober BR, 2010, NEW ENGL J MED, V362, P239, DOI 10.1056/NEJMra0903074; Qiu SF, 2011, J NEUROSCI, V31, P5855, DOI 10.1523/JNEUROSCI.6569-10.2011; Rakic P, 2009, NAT REV NEUROSCI, V10, P724, DOI 10.1038/nrn2719; Reich DE, 2001, TRENDS GENET, V17, P502, DOI 10.1016/S0168-9525(01)02410-6; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Roll P, 2010, HUM MOL GENET, V19, P4848, DOI 10.1093/hmg/ddq415; Roohi J, 2009, J MED GENET, V46, P176, DOI 10.1136/jmg.2008.057505; Sanders SJ, 2011, NEURON, V70, P863, DOI 10.1016/j.neuron.2011.05.002; Scala E, 2007, AM J MED GENET A, V143A, P2775, DOI 10.1002/ajmg.a.32002; Scott-Van Zeeland AA, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001344; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Sebat J, 2009, TRENDS GENET, V25, P528, DOI 10.1016/j.tig.2009.10.004; Skuse DH, 2007, TRENDS GENET, V23, P387, DOI 10.1016/j.tig.2007.06.003; Sousa I, 2009, EUR J HUM GENET, V17, P749, DOI 10.1038/ejhg.2008.215; State MW, 2010, NEURON, V68, P254, DOI 10.1016/j.neuron.2010.10.004; Stein MB, 2011, BIOL PSYCHIAT, V69, P825, DOI 10.1016/j.biopsych.2010.11.008; Strauss KA, 2006, NEW ENGL J MED, V354, P1370, DOI 10.1056/NEJMoa052773; Szatmari P, 2007, NAT GENET, V39, P319, DOI 10.1038/ng1985; Tyndall SJ, 2007, J NEUROSCI RES, V85, P2343, DOI 10.1002/jnr.21390; Vernes SC, 2008, NEW ENGL J MED, V359, P2337, DOI 10.1056/NEJMoa0802828; Voineagu I, 2011, NATURE, V474, P380, DOI 10.1038/nature10110; Wang K, 2009, NATURE, V459, P528, DOI 10.1038/nature07999; Weiss LA, 2008, NEW ENGL J MED, V358, P667, DOI 10.1056/NEJMoa075974; Weiss LA, 2009, NATURE, V461, P802, DOI 10.1038/nature08490	86	203	207	1	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2011	14	12					1499	1506		10.1038/nn.2924	http://dx.doi.org/10.1038/nn.2924			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	855EJ	22037497	Green Accepted			2022-12-28	WOS:000297546300006
J	Li, J; Schiller, D; Schoenbaum, G; Phelps, EA; Daw, ND				Li, Jian; Schiller, Daniela; Schoenbaum, Geoffrey; Phelps, Elizabeth A.; Daw, Nathaniel D.			Differential roles of human striatum and amygdala in associative learning	NATURE NEUROSCIENCE			English	Article							HUMAN BRAIN; REWARD; PREDICTION; STIMULI; WORLD	Although the human amygdala and striatum have both been implicated in associative learning, only the striatum's contribution has been consistently computationally characterized. Using a reversal learning task, we found that amygdala blood oxygen level-dependent activity tracked associability as estimated by a computational model, and dissociated it from the striatal representation of reinforcement prediction error. These results extend the computational learning approach from striatum to amygdala, demonstrating their complementary roles in aversive learning.	[Li, Jian; Phelps, Elizabeth A.; Daw, Nathaniel D.] NYU, Dept Psychol, New York, NY 10003 USA; [Li, Jian; Phelps, Elizabeth A.; Daw, Nathaniel D.] NYU, Ctr Neural Sci, New York, NY 10003 USA; [Schiller, Daniela] Mt Sinai Sch Med, Dept Psychiat, New York, NY USA; [Schiller, Daniela] Mt Sinai Sch Med, Dept Neurosci, New York, NY USA; [Schiller, Daniela] Mt Sinai Sch Med, Friedman Brain Inst, New York, NY USA; [Schoenbaum, Geoffrey] Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA; [Schoenbaum, Geoffrey] Univ Maryland, Sch Med, Dept Psychiat, Baltimore, MD 21201 USA; [Schoenbaum, Geoffrey] Natl Inst Drug Abuse, Intramural Res Program, Baltimore, MD USA	New York University; New York University; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA)	Li, J (corresponding author), NYU, Dept Psychol, 6 Washington Pl, New York, NY 10003 USA.	lijian@nyu.edu	Schiller, Daniela/Q-2431-2018	Schiller, Daniela/0000-0002-0357-7724	McKnight Foundation; Human Frontiers Science Program [RGP0036/2009-C]; US National Institutes of Health (NIH) [MH087882]; James S. McDonnell Foundation; NIH [MH080756, DA015718, AG027097]; Seaver Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH080756, R01MH087882] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG027097] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [ZIADA000587, R01DA015718] Funding Source: NIH RePORTER	McKnight Foundation; Human Frontiers Science Program(Human Frontier Science Program); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); James S. McDonnell Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Seaver Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank P. Glimcher, R. Rutledge and E. DeWitt for discussions and comments. This research was supported by a McKnight Foundation Scholar Award, Human Frontiers Science Program grant RGP0036/2009-C, US National Institutes of Health (NIH) grant MH087882 (part of the CRCNS program, to N.D.D.), a James S. McDonnell Foundation grant and NIH grant MH080756 to E. A. P., and NIH grants DA015718 and AG027097 to G. S. This work was also supported by a Seaver Foundation grant to the Center for Brain Imaging.	Baxter MG, 2002, NAT REV NEUROSCI, V3, P563, DOI 10.1038/nrn875; Behrens TEJ, 2007, NAT NEUROSCI, V10, P1214, DOI 10.1038/nn1954; Belova MA, 2007, NEURON, V55, P970, DOI 10.1016/j.neuron.2007.08.004; Courville AC, 2006, TRENDS COGN SCI, V10, P294, DOI 10.1016/j.tics.2006.05.004; Davis M, 2001, MOL PSYCHIATR, V6, P13, DOI 10.1038/sj.mp.4000812; Delgado MR, 2008, PHILOS T R SOC B, V363, P3787, DOI 10.1098/rstb.2008.0161; Holland PC, 1999, TRENDS COGN SCI, V3, P65, DOI 10.1016/S1364-6613(98)01271-6; O'Doherty JP, 2003, NEURON, V38, P329, DOI 10.1016/S0896-6273(03)00169-7; PEARCE JM, 1980, PSYCHOL REV, V87, P532, DOI 10.1037/0033-295X.87.6.532; Phelps, 2009, HUMAN AMYGDALA, P204; Preuschoff K, 2007, ANN NY ACAD SCI, V1104, P135, DOI 10.1196/annals.1390.005; ROBBINS TW, 1989, NEUROSCI BIOBEHAV R, V13, P155, DOI 10.1016/S0149-7634(89)80025-9; Roesch MR, 2010, J NEUROSCI, V30, P2464, DOI 10.1523/JNEUROSCI.5781-09.2010; Schiller D, 2008, J NEUROSCI, V28, P11517, DOI 10.1523/JNEUROSCI.2265-08.2008; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593	15	218	220	1	52	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2011	14	10					1250	1252		10.1038/nn.2904	http://dx.doi.org/10.1038/nn.2904			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	825EQ	21909088	Green Accepted			2022-12-28	WOS:000295254200012
J	Peelen, MV; Kastner, S				Peelen, Marius V.; Kastner, Sabine			Is that a bathtub in your kitchen?	NATURE NEUROSCIENCE			English	Editorial Material							SCENE PERCEPTION; VISUAL-CORTEX; REPRESENTATIONS; CATEGORIES; OBJECTS		[Peelen, Marius V.] Univ Trent, Ctr Mind Brain Sci, Rovereto, Italy; [Kastner, Sabine] Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA; [Kastner, Sabine] Princeton Univ, Princeton Neurosci Inst, Princeton, NJ 08544 USA	University of Trento; Princeton University; Princeton University	Peelen, MV (corresponding author), Univ Trent, Ctr Mind Brain Sci, Rovereto, Italy.	marius.peelen@unitn.it; skastner@princeton.edu	Peelen, Marius V/D-1780-2010	Peelen, Marius V/0000-0002-4026-7303; Kastner, Sabine/0000-0002-9742-965X	NATIONAL EYE INSTITUTE [R01EY017699] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH064043] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY017699] Funding Source: Medline; NIMH NIH HHS [R01 MH064043] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		BIEDERMAN I, 1982, COGNITIVE PSYCHOL, V14, P143, DOI 10.1016/0010-0285(82)90007-X; Davenport JL, 2004, PSYCHOL SCI, V15, P559, DOI 10.1111/j.0956-7976.2004.00719.x; Epstein R, 1998, NATURE, V392, P598, DOI 10.1038/33402; Evans KK, 2011, PSYCHOL SCI, V22, P739, DOI 10.1177/0956797611407930; Goh JOS, 2004, J NEUROSCI, V24, P10223, DOI 10.1523/JNEUROSCI.3373-04.2004; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; Kravitz DJ, 2011, J NEUROSCI, V31, P7322, DOI 10.1523/JNEUROSCI.4588-10.2011; MacEvoy SP, 2011, NAT NEUROSCI, V14, P1323, DOI 10.1038/nn.2903; MacEvoy SP, 2009, CURR BIOL, V19, P943, DOI 10.1016/j.cub.2009.04.020; Park S, 2011, J NEUROSCI, V31, P1333, DOI 10.1523/JNEUROSCI.3885-10.2011; Peelen MV, 2009, NATURE, V460, P94, DOI 10.1038/nature08103; Peelena MV, 2011, P NATL ACAD SCI USA, V108, P12125, DOI 10.1073/pnas.1101042108; Thorpe S, 1996, NATURE, V381, P520, DOI 10.1038/381520a0; Walther DB, 2011, P NATL ACAD SCI USA, V108, P9661, DOI 10.1073/pnas.1015666108	14	2	2	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2011	14	10					1224	1226		10.1038/nn.2936	http://dx.doi.org/10.1038/nn.2936			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	825EQ	21952264	Green Accepted			2022-12-28	WOS:000295254200004
J	Gregory, FD; Bryan, KE; Pangrsic, T; Calin-Jageman, IE; Moser, T; Lee, A				Gregory, Frederick D.; Bryan, Keith E.; Pangrsic, Tina; Calin-Jageman, Irina E.; Moser, Tobias; Lee, Amy			Harmonin inhibits presynaptic Ca(v)1.3 Ca2+ channels in mouse inner hair cells	NATURE NEUROSCIENCE			English	Article							MUTATIONS; COMPLEXES; DOMAIN	Harmonin is a scaffolding protein that is required for normal mechanosensory function in hair cells. We found a presynaptic association of harmonin and Ca(v)1.3 Ca2+ channels at the mouse inner hair cell synapse, which limits channel availability through a ubiquitin-dependent pathway.	[Gregory, Frederick D.; Bryan, Keith E.; Lee, Amy] Univ Iowa, Dept Mol Physiol & Biophys, Iowa City, IA 52242 USA; [Gregory, Frederick D.; Bryan, Keith E.; Lee, Amy] Univ Iowa, Dept Otolaryngol Head & Neck Surg, Iowa City, IA 52242 USA; [Gregory, Frederick D.; Bryan, Keith E.; Lee, Amy] Univ Iowa, Dept Neurol, Iowa City, IA 52242 USA; [Gregory, Frederick D.; Calin-Jageman, Irina E.] Emory Univ, Dept Pharmacol, Atlanta, GA 30322 USA; [Gregory, Frederick D.; Calin-Jageman, Irina E.] Emory Univ, Dept Physiol, Atlanta, GA 30322 USA; [Pangrsic, Tina; Moser, Tobias] Univ Gottingen, Dept Otolaryngol, InnerEarLab, Gottingen, Germany; [Pangrsic, Tina; Moser, Tobias] Univ Gottingen, Ctr Mol Physiol Brain, Bernstein Ctr Computat Neurosci, Gottingen, Germany	University of Iowa; University of Iowa; University of Iowa; Emory University; Emory University; University of Gottingen; University of Gottingen	Lee, A (corresponding author), Univ Iowa, Dept Mol Physiol & Biophys, Iowa City, IA 52242 USA.	amy-lee@uiowa.edu	889, CRC/L-1607-2018; Moser, Tobias/L-5068-2014	889, CRC/0000-0002-6678-3138; Moser, Tobias/0000-0001-7145-0533; Lee, Amy/0000-0001-8021-0443; Calin-Jageman, Irina/0000-0002-2529-4223	US National Institutes of Health [DC009433, HL087120, DC010362, DC008417, DA015040, K12/GM000680]; Deafness Research Foundation; German Research Foundation (Collaborative Research Center) [889, A5]; German Research Foundation (Center for Molecular Physiology of the Brain) [FZT-103]; German Federal Ministry for Research and Technology (Bernstein Center for Computational Neuroscience Goettingen) [01GQ1005A]; Alexander von Humboldt fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087120] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM000680] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R03DC008417, R01DC009433, P30DC010362, R55DC009433] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA015040] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deafness Research Foundation; German Research Foundation (Collaborative Research Center)(German Research Foundation (DFG)); German Research Foundation (Center for Molecular Physiology of the Brain)(German Research Foundation (DFG)); German Federal Ministry for Research and Technology (Bernstein Center for Computational Neuroscience Goettingen); Alexander von Humboldt fellowship(Alexander von Humboldt Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The authors thank J. Striessnig for Cacna1d<SUP>-/-</SUP> mice, U. Mueller and U. Wolfrum for cDNAs and antibodies, Q. Zheng for Ush1c<SUP>-/-</SUP> tissue, H. Couchoux and A. Inagaki for contributing data, B. Fritzsch, C. Harata, M. Stamnes and R. Piper for advice and discussion, and J. Diamond for comments on the manuscript. This work was supported by the US National Institutes of Health (DC009433, HL087120 and DC010362 to A. L., DC008417 to I.E.C.-J., and DA015040 and K12/GM000680 to F. D. G.), the Deafness Research Foundation (A. L. and I.E.C.-J.), the German Research Foundation (Collaborative Research Center 889, project A5, Center for Molecular Physiology of the Brain, FZT-103, T. M.), the German Federal Ministry for Research and Technology (Bernstein Center for Computational Neuroscience Goettingen, 01GQ1005A, T. M.), and an Alexander von Humboldt fellowship to T.P.	Abriel H, 2005, PHYSIOLOGY, V20, P398, DOI 10.1152/physiol.00033.2005; Altier C, 2011, NAT NEUROSCI, V14, P173, DOI 10.1038/nn.2712; Beutner D, 2001, J NEUROSCI, V21, P4593, DOI 10.1523/JNEUROSCI.21-13-04593.2001; Boeda B, 2002, EMBO J, V21, P6689, DOI 10.1093/emboj/cdf689; Brandt A, 2005, J NEUROSCI, V25, P11577, DOI 10.1523/JNEUROSCI.3411-05.2005; Calin-Jageman I, 2008, J NEUROCHEM, V105, P573, DOI 10.1111/j.1471-4159.2008.05286.x; Calin-Jageman I, 2007, J NEUROSCI, V27, P1374, DOI 10.1523/JNEUROSCI.5191-06.2007; Frank T, 2009, P NATL ACAD SCI USA, V106, P4483, DOI 10.1073/pnas.0813213106; Grillet N, 2009, NEURON, V62, P375, DOI 10.1016/j.neuron.2009.04.006; Johnson KR, 2003, HUM MOL GENET, V12, P3075, DOI 10.1093/hmg/ddg332; Michalski N, 2009, PFLUG ARCH EUR J PHY, V459, P115, DOI 10.1007/s00424-009-0711-x; Platzer J, 2000, CELL, V102, P89, DOI 10.1016/S0092-8674(00)00013-1; Reiners J, 2003, INVEST OPHTH VIS SCI, V44, P5006, DOI 10.1167/iovs.03-0483; Verpy E, 2000, NAT GENET, V26, P51, DOI 10.1038/79171; Waithe D, 2011, J BIOL CHEM, V286, P9598, DOI 10.1074/jbc.M110.195909	15	61	63	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2011	14	9					1109	1111		10.1038/nn.2895	http://dx.doi.org/10.1038/nn.2895			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	812ID	21822269	Green Accepted			2022-12-28	WOS:000294284900007
J	Plotkin, JL; Day, M; Surmeier, DJ				Plotkin, Joshua L.; Day, Michelle; Surmeier, D. James			Synaptically driven state transitions in distal dendrites of striatal spiny neurons	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; CA1 PYRAMIDAL NEURONS; IN-VIVO; BASAL GANGLIA; INTRACELLULAR-RECORDINGS; DOPAMINERGIC CONTROL; RECEPTOR ACTIVATION; NEOSTRIATAL NEURONS; PROJECTION NEURONS; CALCIUM-CHANNELS	Striatal spiny neurons (SPNs) associate a diverse array of cortically processed information to regulate action selection. But how this is done by SPNs is poorly understood. A key step in this process is the transition of SPNs from a hyperpolarized 'down state' to a sustained, depolarized 'up state'. These transitions are thought to reflect a sustained synaptic barrage, involving the coordination of hundreds of pyramidal neurons. Indeed, in mice, simulation of cortical input by glutamate uncaging on proximal dendritic spines produced potential changes in SPNs that tracked input time course. However, brief glutamate uncaging at spines on distal dendrites evoked somatic up states lasting hundreds of milliseconds. These regenerative events depended upon both NMDA receptors and voltage-dependent Ca(2+) channels. Moreover, they were bidirectionally regulated by dopamine receptor signaling. This capacity not only changes our model of how up states are generated in SPNs, it also has fundamental implications for the associative process underlying action selection.	[Plotkin, Joshua L.; Day, Michelle; Surmeier, D. James] Northwestern Univ, Feinberg Sch Med, Dept Physiol, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Surmeier, DJ (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Physiol, Chicago, IL 60611 USA.	j-surmeier@northwestern.edu	Plotkin, Joshua/AAJ-5043-2021	Plotkin, Joshua/0000-0001-6232-7613	US National Institutes of Health [NS 034696, MH074866]; Picower Foundation; CHDI Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH074866, P50MH090963] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS034696, R01NS034696] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Picower Foundation; CHDI Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The US National Institutes of Health (NS 034696, MH074866), the Picower Foundation and CHDI Foundation supported this work. We thank J. Dempster, K. Saporito, N. Schwarz, S. Ulrich and D. Wokosin for technical assistance.	BARGAS J, 1991, BRAIN RES, V539, P159, DOI 10.1016/0006-8993(91)90700-6; BARGAS J, 1994, J NEUROSCI, V14, P6667; Bloodgood BL, 2007, NEURON, V53, P249, DOI 10.1016/j.neuron.2006.12.017; Branco T, 2010, SCIENCE, V329, P1671, DOI 10.1126/science.1189664; Carter AG, 2004, NEURON, V44, P483, DOI 10.1016/j.neuron.2004.10.013; Centonze D, 2001, EUR J NEUROSCI, V13, P1071, DOI 10.1046/j.0953-816x.2001.01485.x; CEPEDA C, 1993, P NATL ACAD SCI USA, V90, P9576, DOI 10.1073/pnas.90.20.9576; Charpier S, 1999, NEUROSCIENCE, V91, P1209, DOI 10.1016/S0306-4522(98)00719-2; Crandall SR, 2010, J NEUROSCI, V30, P15419, DOI 10.1523/JNEUROSCI.3636-10.2010; Czubayko U, 2002, P NATL ACAD SCI USA, V99, P15764, DOI 10.1073/pnas.242428599; Day M, 2006, NAT NEUROSCI, V9, P251, DOI 10.1038/nn1632; Day M, 2008, J NEUROSCI, V28, P11603, DOI 10.1523/JNEUROSCI.1840-08.2008; Ding J, 2008, J NEUROSCI, V28, P6483, DOI 10.1523/JNEUROSCI.0435-08.2008; Galarraga E, 1997, NEUROREPORT, V8, P2183, DOI 10.1097/00001756-199707070-00019; GERFEN CR, 1992, TRENDS NEUROSCI, V15, P133, DOI 10.1016/0166-2236(92)90355-C; Gertler TS, 2008, J NEUROSCI, V28, P10814, DOI 10.1523/JNEUROSCI.2660-08.2008; Golding NL, 2002, NATURE, V418, P326, DOI 10.1038/nature00854; GRAYBIEL AM, 1994, SCIENCE, V265, P1826, DOI 10.1126/science.8091209; Higley MJ, 2010, NAT NEUROSCI, V13, P958, DOI 10.1038/nn.2592; Hines ML, 1997, NEURAL COMPUT, V9, P1179, DOI 10.1162/neco.1997.9.6.1179; Holthoff K, 2006, CELL TISSUE RES, V326, P369, DOI 10.1007/s00441-006-0263-8; Kaczorowski CC, 2007, J PHYSIOL-LONDON, V578, P799, DOI 10.1113/jphysiol.2006.124586; Kampa BM, 2006, J NEUROSCI, V26, P7424, DOI 10.1523/JNEUROSCI.3062-05.2006; Kasanetz F, 2006, J PHYSIOL-LONDON, V577, P97, DOI 10.1113/jphysiol.2006.113050; KAWAGUCHI Y, 1995, TRENDS NEUROSCI, V18, P527, DOI 10.1016/0166-2236(95)98374-8; Larkum ME, 2009, SCIENCE, V325, P756, DOI 10.1126/science.1171958; Lee SJR, 2009, NATURE, V458, P299, DOI 10.1038/nature07842; Losonczy A, 2006, NEURON, V50, P291, DOI 10.1016/j.neuron.2006.03.016; Mahon S, 2003, J PHYSIOL-PARIS, V97, P557, DOI 10.1016/j.jphysparis.2004.01.013; McRory JE, 2001, J BIOL CHEM, V276, P3999, DOI 10.1074/jbc.M008215200; Pawlak V, 2008, J NEUROSCI, V28, P2435, DOI 10.1523/JNEUROSCI.4402-07.2008; Pidoux M, 2011, J PHYSIOL-LONDON, V589, P263, DOI 10.1113/jphysiol.2010.199646; Plenz D, 1998, J NEUROSCI, V18, P266; Poirazi P, 2001, NEURON, V29, P779, DOI 10.1016/S0896-6273(01)00252-5; Pomata PE, 2008, J NEUROSCI, V28, P13384, DOI 10.1523/JNEUROSCI.4343-08.2008; Schultz W, 2007, ANNU REV NEUROSCI, V30, P259, DOI 10.1146/annurev.neuro.28.061604.135722; Schwarzschild MA, 2006, TRENDS NEUROSCI, V29, P647, DOI 10.1016/j.tins.2006.09.004; Shen WX, 2008, SCIENCE, V321, P848, DOI 10.1126/science.1160575; Sjostrom PJ, 2008, PHYSIOL REV, V88, P769, DOI 10.1152/physrev.00016.2007; SMITH AD, 1990, TRENDS NEUROSCI, V13, P259; Stern EA, 1998, NATURE, V394, P475, DOI 10.1038/28848; Surmeier DJ, 2007, TRENDS NEUROSCI, V30, P228, DOI 10.1016/j.tins.2007.03.008; Surmeier DJ, 2010, PROG BRAIN RES, V183, P149, DOI 10.1016/S0079-6123(10)83008-0; Surmeier DJ, 1996, J NEUROSCI, V16, P6579, DOI 10.1523/jneurosci.16-20-06579.1996; Tepper JM, 2008, BRAIN RES REV, V58, P272, DOI 10.1016/j.brainresrev.2007.10.008; Vergara R, 2003, J PHYSIOL-LONDON, V553, P169, DOI 10.1113/jphysiol.2003.050799; West AR, 2002, J NEUROSCI, V22, P294, DOI 10.1523/JNEUROSCI.22-01-00294.2002; Wilson C. J., 1992, SINGLE NEURON COMPUT, P141, DOI [10.1016/B978-0-12-484815-3.50012-8, DOI 10.1016/B978-0-12-484815-3.50012-8]; Wilson CJ, 1996, J NEUROSCI, V16, P2397; Yin HH, 2006, NAT REV NEUROSCI, V7, P464, DOI 10.1038/nrn1919	50	96	97	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2011	14	7					881	U101		10.1038/nn.2848	http://dx.doi.org/10.1038/nn.2848			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	783KR	21666674	Green Accepted			2022-12-28	WOS:000292081700016
J	Huberfeld, G; de la Prida, LM; Pallud, J; Cohen, I; Le Van Quyen, M; Adam, C; Clemenceau, S; Baulac, M; Miles, R				Huberfeld, Gilles; de la Prida, Liset Menendez; Pallud, Johan; Cohen, Ivan; Le Van Quyen, Michel; Adam, Claude; Clemenceau, Stephane; Baulac, Michel; Miles, Richard			Glutamatergic pre-ictal discharges emerge at the transition to seizure in human epilepsy	NATURE NEUROSCIENCE			English	Article							TEMPORAL-LOBE EPILEPSY; RAT HIPPOCAMPAL SLICE; SYSTEM IN-VITRO; EPILEPTIFORM ACTIVITY; MOUSE HIPPOCAMPUS; LIMBIC NETWORKS; DENTATE GYRUS; NEURONS; CORTEX; PROPAGATION	The mechanisms involved in the transition to an epileptic seizure remain unclear. To examine them, we used tissue slices from human subjects with mesial temporal lobe epilepsies. Ictal-like discharges were induced in the subiculum by increasing excitability along with alkalinization or low Mg2+. During the transition, distinct pre-ictal discharges emerged concurrently with interictal events. Intracranial recordings from the mesial temporal cortex of subjects with epilepsy revealed that similar discharges before seizures were restricted to seizure onset sites. In vitro, pre-ictal events spread faster and had larger amplitudes than interictal discharges and had a distinct initiation site. These events depended on glutamatergic mechanisms and were preceded by pyramidal cell firing, whereas interneuron firing preceded interictal events that depended on both glutamatergic and depolarizing GABAergic transmission. Once established, recurrence of these pre-ictal discharges triggered seizures. Thus, the subiculum supports seizure generation, and the transition to seizure involves an emergent glutamatergic population activity.	[Huberfeld, Gilles; de la Prida, Liset Menendez; Pallud, Johan; Cohen, Ivan; Clemenceau, Stephane; Baulac, Michel; Miles, Richard] Univ Paris 06, Inst Cerveau & Moelle Epiniere, Ctr Natl Rech Sci CNRS, Ctr Rech,INSERM,UMRS975,UMR7225, Paris, France; [Huberfeld, Gilles; Adam, Claude; Clemenceau, Stephane; Baulac, Michel] Ctr Hosp Univ Pitie Salpetriere, AP HP, Unite Epileptol, Paris, France; [Huberfeld, Gilles] UPMC, Dept Neurophysiol, Ctr Hosp Univ Pitie Salptriere, Paris, France; [de la Prida, Liset Menendez] CSIC, Lab Circuitos Neuronales, Inst Cajal, Madrid, Spain; [Pallud, Johan] Univ Paris 05, Serv Neurochirurg, Ctr Hosp Ste Anne, Paris, France; [Le Van Quyen, Michel] UPMC, Network Dynam & Cellular Excitabil, Ctr Rech Inst Cerveau & Moelle Epiniere, INSERM,CNRS,UMRS975,UMR7225, Paris, France; [Clemenceau, Stephane] Ctr Hosp Univ Pitie Salpetriere, AP HP, Serv Neurochirurg, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Cajal (IC); GHU PARIS Psychiatrie Neurosciences; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Huberfeld, G (corresponding author), Univ Paris 06, Inst Cerveau & Moelle Epiniere, Ctr Natl Rech Sci CNRS, Ctr Rech,INSERM,UMRS975,UMR7225, Paris, France.	gilles.huberfeld@upmc.fr; richard.miles@upmc.fr	de la Prida, Liset M/O-1342-2013	de la Prida, Liset M/0000-0002-0160-6472; Pallud, Johan/0000-0002-1652-9844; Cohen, Ivan/0000-0001-6046-5289; Miles, Richard/0000-0001-7303-0233	INSERM; CNRS; AP-HP; Federation pour la Recherche Medicale; Federation pour la Recherche sur le Cerveau; Agence Nationale de la Recherche; European Community (EPICURE) [LSH-037315]; Spain-France Joint Action [HF2006-0082]; Spanish National Research Council (Consejo Superior de Investigaciones Cientificas) [200720I023]; Spanish Ministry of Innovation and Science [BFU2006-10584-BFI, BFU2009-07989]	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); AP-HP; Federation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Federation pour la Recherche sur le Cerveau; Agence Nationale de la Recherche(French National Research Agency (ANR)); European Community (EPICURE)(European Commission); Spain-France Joint Action; Spanish National Research Council (Consejo Superior de Investigaciones Cientificas); Spanish Ministry of Innovation and Science(Spanish Government)	We wish to thank M. Noulhiane for her help with imaging and statistics, M.-L. Tanguy for help with statistical analysis, E. Eugene for his technical assistance, M. Valderrama for software assistance and L. Wittner for participating in initial recordings. We gratefully acknowledge financial support from INSERM, the CNRS, the AP-HP, the Federation pour la Recherche Medicale, the Federation pour la Recherche sur le Cerveau, the Agence Nationale de la Recherche, the European Community (EPICURE, LSH-037315), Spain-France Joint Action (HF2006-0082), the Spanish National Research Council (Consejo Superior de Investigaciones Cientificas 200720I023) and the Spanish Ministry of Innovation and Science (BFU2006-10584-BFI and BFU2009-07989).	ALGER BE, 1982, J PHYSIOL-LONDON, V328, P125, DOI 10.1113/jphysiol.1982.sp014256; Avoli M, 2002, PROG NEUROBIOL, V68, P167, DOI 10.1016/S0301-0082(02)00077-1; Avoli M, 1996, J NEUROSCI, V16, P3912; Bartho P, 2004, J NEUROPHYSIOL, V92, P600, DOI 10.1152/jn.01170.2003; Bartolomei F, 2005, EPILEPSIA, V46, P677, DOI 10.1111/j.1528-1167.2005.43804.x; Bartolomei F, 2004, EPILEPSY RES, V61, P89, DOI 10.1016/j.eplepsyres.2004.06.006; Bartolomei F, 2008, BRAIN, V131, P1818, DOI 10.1093/brain/awn111; Bragin A, 2005, EPILEPSIA, V46, P1592, DOI 10.1111/j.1528-1167.2005.00268.x; Bragin A, 2009, J NEUROSCI, V29, P3660, DOI 10.1523/JNEUROSCI.5309-08.2009; Chabardes S, 2005, BRAIN, V128, P1818, DOI 10.1093/brain/awh512; Chassoux F, 2008, EPILEPSIA, V49, P51, DOI 10.1111/j.1528-1167.2007.01267.x; CLARK KA, 1995, J PHYSIOL-LONDON, V482, P39, DOI 10.1113/jphysiol.1995.sp020498; Cohen I, 2002, SCIENCE, V298, P1418, DOI 10.1126/science.1076510; Cohen I, 2000, J PHYSIOL-LONDON, V524, P485, DOI 10.1111/j.1469-7793.2000.00485.x; D'Antuono M, 2004, BRAIN, V127, P1626, DOI 10.1093/brain/awh181; de Curtis M, 2001, PROG NEUROBIOL, V63, P541, DOI 10.1016/S0301-0082(00)00026-5; de la Prida LM, 2003, HIPPOCAMPUS, V13, P728, DOI 10.1002/hipo.10123; de la Prida LM, 2002, NEUROREPORT, V13, P1421, DOI 10.1097/00001756-200208070-00015; Derchansky M, 2008, J PHYSIOL-LONDON, V586, P477, DOI 10.1113/jphysiol.2007.143065; Derchansky M, 2004, HIPPOCAMPUS, V14, P935, DOI 10.1002/hipo.20007; Dzhala VI, 2003, J NEUROSCI, V23, P7873; Ebersole JS, 1996, EPILEPSIA, V37, P386, DOI 10.1111/j.1528-1157.1996.tb00577.x; Fabo D, 2008, BRAIN, V131, P485, DOI 10.1093/brain/awm297; Gabriel S, 2004, J NEUROSCI, V24, P10416, DOI 10.1523/JNEUROSCI.2074-04.2004; Gavaret M, 2004, J CLIN NEUROPHYSIOL, V21, P267, DOI 10.1097/01.WNP.0000139929.06455.82; Gnatkovsky V, 2008, ANN NEUROL, V64, P674, DOI 10.1002/ana.21519; Henze DA, 2000, J NEUROPHYSIOL, V84, P390, DOI 10.1152/jn.2000.84.1.390; Huberfeld G, 2007, J NEUROSCI, V27, P9866, DOI 10.1523/JNEUROSCI.2761-07.2007; Jandova K, 2006, BRAIN, V129, P3290, DOI 10.1093/brain/awl218; Jensen MS, 1997, J NEUROPHYSIOL, V77, P1224, DOI 10.1152/jn.1997.77.3.1224; Kaila K, 1997, J NEUROSCI, V17, P7662; Khalilov I, 2003, NAT NEUROSCI, V6, P1079, DOI 10.1038/nn1125; Lachaux JP, 2003, J PHYSIOLOGY-PARIS, V97, P613, DOI 10.1016/j.jphysparis.2004.01.018; Le Van Quyen M, 2007, TRENDS NEUROSCI, V30, P365, DOI 10.1016/j.tins.2007.05.006; LEHNERTZ K, 2007, EPILEPSY COMPREHENSI; McGonigal A, 2007, BRAIN, V130, P3169, DOI 10.1093/brain/awm218; MILES R, 1983, NATURE, V306, P371, DOI 10.1038/306371a0; MILES R, 1988, J NEUROPHYSIOL, V60, P1481, DOI 10.1152/jn.1988.60.4.1481; Pinault D, 1996, J NEUROSCI METH, V65, P113, DOI 10.1016/0165-0270(95)00144-1; Spencer SS, 1999, EPILEPSIA, V40, P708, DOI 10.1111/j.1528-1157.1999.tb00767.x; SPENCER SS, 1992, EPILEPSIA, V33, P537, DOI 10.1111/j.1528-1157.1992.tb01706.x; Staba RJ, 2004, ANN NEUROL, V56, P108, DOI 10.1002/ana.20164; STALEY KJ, 1995, SCIENCE, V269, P977, DOI 10.1126/science.7638623; TRAYNELIS SF, 1988, J NEUROPHYSIOL, V59, P259, DOI 10.1152/jn.1988.59.1.259; Trevelyan AJ, 2007, J NEUROSCI, V27, P3383, DOI 10.1523/JNEUROSCI.0145-07.2007; Trevelyan AJ, 2006, J NEUROSCI, V26, P12447, DOI 10.1523/JNEUROSCI.2787-06.2006; Van Quyen ML, 2008, J NEUROSCI, V28, P6104, DOI 10.1523/JNEUROSCI.0437-08.2008; Wennberg R, 2002, EPILEPSIA, V43, P716, DOI 10.1046/j.1528-1157.2002.31101.x; Wittner L, 2007, J PHYSIOL-LONDON, V584, P867, DOI 10.1113/jphysiol.2007.138131; Ziburkus J, 2006, J NEUROPHYSIOL, V95, P3948, DOI 10.1152/jn.01378.2005	50	201	202	0	36	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2011	14	5					627	U121		10.1038/nn.2790	http://dx.doi.org/10.1038/nn.2790			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	754VU	21460834	Green Submitted			2022-12-28	WOS:000289886600019
J	Wang, XQ; Tsai, JW; LaMonica, B; Kriegstein, AR				Wang, Xiaoqun; Tsai, Jin-Wu; LaMonica, Bridget; Kriegstein, Arnold R.			A new subtype of progenitor cell in the mouse embryonic neocortex	NATURE NEUROSCIENCE			English	Article							RADIAL GLIAL-CELLS; MAMMALIAN NEUROEPITHELIAL CELLS; NEURAL STEM; CORTICAL NEUROGENESIS; ASYMMETRIC INHERITANCE; NEURONAL MIGRATION; RNA INTERFERENCE; CORTEX; DIVISION; EVOLUTION	A hallmark of mammalian brain evolution is cortical expansion, which reflects an increase in the number of cortical neurons established by the progenitor cell subtypes present and the number of their neurogenic divisions. Recent studies have revealed a new class of radial glia-like (oRG) progenitor cells in the human brain, which reside in the outer subventricular zone. Expansion of the subventricular zone and appearance of oRG cells may have been essential evolutionary steps leading from lissencephalic to gyrencephalic neocortex. Here we show that oRG-like progenitor cells are present in the mouse embryonic neocortex. They arise from asymmetric divisions of radial glia and undergo self-renewing asymmetric divisions to generate neurons. Moreover, mouse oRG cells undergo mitotic somal translocation whereby centrosome movement into the basal process during interphase precedes nuclear translocation. Our finding of oRG cells in the developing rodent brain fills a gap in our understanding of neocortical expansion.	[Wang, Xiaoqun; Tsai, Jin-Wu; LaMonica, Bridget] Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA; [Wang, Xiaoqun; Tsai, Jin-Wu; LaMonica, Bridget; Kriegstein, Arnold R.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [LaMonica, Bridget] Univ Calif San Francisco, Grad Program Neurosci, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Wang, XQ (corresponding author), Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA.	wangx2@stemcell.ucsf.edu; kriegsteina@stemcell.ucsf.edu		Tsai, Jin-Wu/0000-0003-0135-759X; Ostrem, Bridget/0000-0003-2107-3930	Bernard Osher Foundation; US National Institute of Neurological Disorders and Stroke; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007618] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS021223, R01NS035710, R01NS072630] Funding Source: NIH RePORTER	Bernard Osher Foundation; US National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank A. Alvarez-Buylla, D. Lim, C. Harwell, W. P. Ge and L. Fuentealba for comments on the manuscript and members of the Kriegstein laboratory for discussions. We thank W. Walantus and Y.Y. Wang for mouse surgery and technical support and D. V. Hansen and J.H. Lui for ideas and discussion. We thank F. Gage (Salk Institute) for GFP-retrovirus reagents. This work was supported by grants from the Bernard Osher Foundation and the US National Institute of Neurological Disorders and Stroke (to A.R.K.).	Abdel-Mannan O, 2008, BRAIN RES BULL, V75, P398, DOI 10.1016/j.brainresbull.2007.10.047; Carney RSE, 2007, BRAIN STRUCT FUNCT, V212, P37, DOI 10.1007/s00429-007-0142-4; Chenn A, 1998, MOL CELL NEUROSCI, V11, P183, DOI 10.1006/mcne.1998.0680; Cheung AFP, 2007, J ANAT, V211, P164, DOI 10.1111/j.1469-7580.2007.00769.x; Elias LAB, 2007, NATURE, V448, P901, DOI 10.1038/nature06063; Englund C, 2005, J NEUROSCI, V25, P247, DOI 10.1523/JNEUROSCI.2899-04.2005; Fietz SA, 2010, NAT NEUROSCI, V13, P690, DOI 10.1038/nn.2553; Fish JL, 2008, J CELL SCI, V121, P2783, DOI 10.1242/jcs.023465; Fishell G, 2003, CURR OPIN NEUROBIOL, V13, P34, DOI 10.1016/S0959-4388(03)00013-8; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Hansen DV, 2010, NATURE, V464, P554, DOI 10.1038/nature08845; Haubensak W, 2004, P NATL ACAD SCI USA, V101, P3196, DOI 10.1073/pnas.0308600100; Kamei Y, 1998, GLIA, V23, P191, DOI 10.1002/(SICI)1098-1136(199807)23:3<191::AID-GLIA2>3.0.CO;2-8; Kanda T, 1998, CURR BIOL, V8, P377, DOI 10.1016/S0960-9822(98)70156-3; Kosodo Y, 2004, EMBO J, V23, P2314, DOI 10.1038/sj.emboj.7600223; Kriegstein AR, 2004, TRENDS NEUROSCI, V27, P392, DOI 10.1016/j.tins.2004.05.001; Kriegstein A, 2006, NAT REV NEUROSCI, V7, P883, DOI 10.1038/nrn2008; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Malatesta P, 2000, DEVELOPMENT, V127, P5253; Matsuda T, 2004, P NATL ACAD SCI USA, V101, P16, DOI 10.1073/pnas.2235688100; Miyata T, 2004, DEVELOPMENT, V131, P3133, DOI 10.1242/dev.01173; Miyata T, 2001, NEURON, V31, P727, DOI 10.1016/S0896-6273(01)00420-2; Noctor S.C., 2007, NOVART FDN SYMP, V288, P73; Noctor SC, 2001, NATURE, V409, P714, DOI 10.1038/35055553; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; Noctor SC, 2007, NOVART FDN SYMP, V288, P96; Noctor Stephen C, 2007, Novartis Found Symp, V288, P59; Noctor SC, 2008, J COMP NEUROL, V508, P28, DOI 10.1002/cne.21669; Pulvers JN, 2010, P NATL ACAD SCI USA, V107, P16595, DOI 10.1073/pnas.1010494107; Rakic P, 2003, GLIA, V43, P19, DOI 10.1002/glia.10244; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; RAKIC P, 1974, SCIENCE, V183, P425, DOI 10.1126/science.183.4123.425; Rakic P, 2009, NAT REV NEUROSCI, V10, P724, DOI 10.1038/nrn2719; Reillo I, 2011, CEREB CORTEX, V21, P1674, DOI 10.1093/cercor/bhq238; Smart IHM, 2002, CEREB CORTEX, V12, P37, DOI 10.1093/cercor/12.1.37; Tabata H, 2001, NEUROSCIENCE, V103, P865, DOI 10.1016/S0306-4522(01)00016-1; Tsai JW, 2005, J CELL BIOL, V170, P935, DOI 10.1083/jcb.200505166; Walantus William, 2007, J Vis Exp, P239, DOI 10.3791/239; Wang XQ, 2009, NATURE, V461, P947, DOI 10.1038/nature08435	39	333	339	0	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2011	14	5					555	U34		10.1038/nn.2807	http://dx.doi.org/10.1038/nn.2807			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	754VU	21478886	Green Accepted			2022-12-28	WOS:000289886600010
J	Browne, LE; Cao, LS; Broomhead, HE; Bragg, L; Wilkinson, WJ; North, RA				Browne, Liam E.; Cao, Lishuang; Broomhead, Helen E.; Bragg, Laricia; Wilkinson, William J.; North, R. Alan			P2X receptor channels show threefold symmetry in ionic charge selectivity and unitary conductance	NATURE NEUROSCIENCE			English	Article							2ND TRANSMEMBRANE DOMAIN; POLAR RESIDUES; PORE; RECTIFICATION	In the closed structure of the P2X cation channel, three alpha-helical transmembrane domains cross the membrane obliquely. In rat P2X2 receptors, these intersect at Thr(339). Replacing Thr(339) by lysine in one, two or three subunits progressively increased chloride permeability and reduced unitary conductance. This implies that the closed-open transition involves a symmetrical separation of the three subunits and that Thr(339) from each subunit contributes symmetrically to the open channel permeation pathway.	[Browne, Liam E.; Cao, Lishuang; Broomhead, Helen E.; Bragg, Laricia; Wilkinson, William J.; North, R. Alan] Univ Manchester, Fac Med & Human Sci, Manchester, Lancs, England; [Browne, Liam E.; Cao, Lishuang; Broomhead, Helen E.; Bragg, Laricia; Wilkinson, William J.; North, R. Alan] Univ Manchester, Fac Life Sci, Manchester, Lancs, England	University of Manchester; University of Manchester	North, RA (corresponding author), Univ Manchester, Fac Med & Human Sci, Manchester, Lancs, England.	r.a.north@manchester.ac.uk	North, Richard/GQA-6156-2022	Browne, Liam/0000-0002-5693-7703	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Wellcome Trust.	Bo XN, 2003, MOL PHARMACOL, V63, P1407, DOI 10.1124/mol.63.6.1407; Browne LE, 2010, TRENDS PHARMACOL SCI, V31, P229, DOI 10.1016/j.tips.2010.02.004; Cao LS, 2007, J NEUROSCI, V27, P12916, DOI 10.1523/JNEUROSCI.4036-07.2007; Cao LS, 2009, J NEUROSCI, V29, P14257, DOI 10.1523/JNEUROSCI.4403-09.2009; Egan TM, 1998, J NEUROSCI, V18, P2350; GALZI JL, 1992, NATURE, V359, P500, DOI 10.1038/359500a0; Kawate T, 2009, NATURE, V460, P592, DOI 10.1038/nature08198; Kracun S, 2010, J BIOL CHEM, V285, P10110, DOI 10.1074/jbc.M109.089185; Li MF, 2008, NAT NEUROSCI, V11, P883, DOI 10.1038/nn.2151; Migita K, 2001, J BIOL CHEM, V276, P30934, DOI 10.1074/jbc.M103366200; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Qu W, 2006, J GEN PHYSIOL, V127, P375, DOI 10.1085/jgp.200509378; Rassendren F, 1997, EMBO J, V16, P3446, DOI 10.1093/emboj/16.12.3446; Silberberg SD, 2007, NEURON, V54, P263, DOI 10.1016/j.neuron.2007.03.020; Zhou Z, 1998, J PHYSIOL-LONDON, V507, P353, DOI 10.1111/j.1469-7793.1998.353bt.x	15	33	34	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2011	14	1					17	18		10.1038/nn.2705	http://dx.doi.org/10.1038/nn.2705			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	699TE	21170052	Green Accepted			2022-12-28	WOS:000285684900006
J	Charrier, C; Machado, P; Tweedie-Cullen, RY; Rutishauser, D; Mansuy, IM; Triller, A				Charrier, Cecile; Machado, Patricia; Tweedie-Cullen, Ry Y.; Rutishauser, Dorothea; Mansuy, Isabelle M.; Triller, Antoine			A crosstalk between beta 1 and beta 3 integrins controls glycine receptor and gephyrin trafficking at synapses	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; SINGLE-PARTICLE TRACKING; FACIAL MOTOR NUCLEUS; SYNAPTIC PLASTICITY; POSTSYNAPTIC DENSITY; INHIBITORY SYNAPSES; NEURITE OUTGROWTH; LATERAL DIFFUSION; PLASMA-MEMBRANE; PHOSPHORYLATION	The regulation of glycine receptor (GlyR) number at synapses is necessary for the efficacy of inhibition and the control of neuronal excitability in the spinal cord. GlyR accumulation at synapses depends on the scaffolding molecule gephyrin and is linked to GlyR synaptic dwell time. However, the mechanisms that tune GlyR synaptic exchanges in response to different neuronal environments are unknown. Integrins are cell adhesion molecules and signaling receptors. Using single quantum dot imaging and fluorescence recovery after photobleaching, we found in rats that beta 1 and beta 3 integrins adjust synaptic strength by regulating the synaptic dwell time of both GlyRs and gephyrin. beta 1 and beta 3 integrins crosstalked via calcium/calmodulin-dependent protein kinase II and adapted GlyR lateral diffusion and gephyrin-dependent trapping at synapses. This provides a mechanism for maintaining or adjusting the steady state of postsynaptic molecule exchanges and the level of glycinergic inhibition in response to neuron-and glia-derived signals or extracellular matrix remodeling.	[Charrier, Cecile; Machado, Patricia; Triller, Antoine] Ecole Normale Super, CNRS, UMR8197, Inserm U1024,IBENS, Paris, France; [Tweedie-Cullen, Ry Y.; Mansuy, Isabelle M.] Univ Zurich, Brain Res Inst, Swiss Fed Inst Technol, Zurich, Switzerland; [Rutishauser, Dorothea] Univ Zurich, Swiss Fed Inst Technol, Funct Genom Ctr Zurich, CH-8057 Zurich, Switzerland	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich	Triller, A (corresponding author), Ecole Normale Super, CNRS, UMR8197, Inserm U1024,IBENS, Paris, France.	triller@biologie.ens.fr	Mansuy, Isabelle M/N-3042-2015	Mansuy, Isabelle M/0000-0001-7785-5371; TRILLER, Antoine/0000-0002-7530-1233; Charrier, Cecile/0000-0002-9053-1715; Rutishauser, Dorothea/0000-0003-2303-103X	INSERM; Agence Nationale de la Recherche [ANR08BLAN0282]; Fondation Pierre-Gilles de Gennes; Institut pour la Recherche sur la Moelle epiniere et l'Encephale; Ministere de la Recherche et de la Technologie; Association Francaise contre les Myopathies	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Agence Nationale de la Recherche(French National Research Agency (ANR)); Fondation Pierre-Gilles de Gennes; Institut pour la Recherche sur la Moelle epiniere et l'Encephale; Ministere de la Recherche et de la Technologie; Association Francaise contre les Myopathies(Association Francaise contre les Myopathies)	We thank members of the Triller laboratory, S. Supplisson, K. Aubrey, L. Wang and O. Pascual for kindly providing access to their patch-clamp rig and for helpful discussions, Y. Goda and L. Cingolani for integrin constructs and C. Specht, B. Barbour and R. Miles for critical reading of the manuscript. This work was supported by INSERM (A. T.), Agence Nationale de la Recherche (ANR08BLAN0282; A. T.), Fondation Pierre-Gilles de Gennes (A. T.), Institut pour la Recherche sur la Moelle epiniere et l'Encephale (A. T.), Ministere de la Recherche et de la Technologie (C. C. and P. M.) and Association Francaise contre les Myopathies (C.C.).	Bedet C, 2006, J BIOL CHEM, V281, P30046, DOI 10.1074/jbc.M602155200; Betz H, 2006, J NEUROCHEM, V97, P1600, DOI 10.1111/j.1471-4159.2006.03908.x; Blystone SD, 1999, J CELL BIOL, V145, P889, DOI 10.1083/jcb.145.4.889; Calamai M, 2009, J NEUROSCI, V29, P7639, DOI 10.1523/JNEUROSCI.5711-08.2009; Chan CS, 2006, J NEUROSCI, V26, P223, DOI 10.1523/JNEUROSCI.4110-05.2006; Chan CS, 2003, J NEUROSCI, V23, P7107, DOI 10.1523/JNEUROSCI.23-18-07107.2003; Charrier C, 2006, J NEUROSCI, V26, P8502, DOI 10.1523/JNEUROSCI.1758-06.2006; Chavis P, 2001, NATURE, V411, P317, DOI 10.1038/35077101; Cingolani LA, 2008, NEURON, V58, P749, DOI 10.1016/j.neuron.2008.04.011; Dahan M, 2003, SCIENCE, V302, P442, DOI 10.1126/science.1088525; DEFREITAS MF, 1995, NEURON, V15, P333, DOI 10.1016/0896-6273(95)90038-1; Dumoulin A, 2000, EUR J NEUROSCI, V12, P3883, DOI 10.1046/j.1460-9568.2000.00271.x; Ehrensperger MV, 2007, BIOPHYS J, V92, P3706, DOI 10.1529/biophysj.106.095596; Gray NW, 2006, PLOS BIOL, V4, P2065, DOI 10.1371/journal.pbio.0040370; Grillner S, 2003, NAT REV NEUROSCI, V4, P573, DOI 10.1038/nrn1137; Hanus C, 2006, J NEUROSCI, V26, P4586, DOI 10.1523/JNEUROSCI.5123-05.2006; Hanus C, 2004, J NEUROSCI, V24, P1119, DOI 10.1523/JNEUROSCI.4380-03.2004; Harvey RJ, 2004, SCIENCE, V304, P884, DOI 10.1126/science.1094925; Hayashi MK, 2009, CELL, V137, P159, DOI 10.1016/j.cell.2009.01.050; Huang Z, 2006, J NEUROSCI, V26, P11208, DOI 10.1523/JNEUROSCI.3526-06.2006; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Kaneko M, 2008, NEURON, V58, P673, DOI 10.1016/j.neuron.2008.04.023; Kloss CUA, 1999, J COMP NEUROL, V411, P162, DOI 10.1002/(SICI)1096-9861(19990816)411:1<162::AID-CNE12>3.0.CO;2-W; Kramar EA, 2006, P NATL ACAD SCI USA, V103, P5579, DOI 10.1073/pnas.0601354103; KUSUMI A, 1993, BIOPHYS J, V65, P2021, DOI 10.1016/S0006-3495(93)81253-0; Levi S, 1998, J CELL SCI, V111, P335; Levi S, 2008, NEURON, V59, P261, DOI 10.1016/j.neuron.2008.05.030; Liauw J, 2008, J CEREBR BLOOD F MET, V28, P1722, DOI 10.1038/jcbfm.2008.65; Lin TN, 2003, STROKE, V34, P177, DOI 10.1161/01.STR.0000047100.84604.BA; Meier J, 2000, MOL CELL NEUROSCI, V16, P566, DOI 10.1006/mcne.2000.0899; Meier J, 2000, J CELL SCI, V113, P2783; Miranti CK, 2002, NAT CELL BIOL, V4, pE83, DOI 10.1038/ncb0402-e83; Moller JC, 1996, GLIA, V17, P121; Paarmann I, 2006, J BIOL CHEM, V281, P34918, DOI 10.1074/jbc.M607764200; PFAFF M, 1994, CELL ADHES COMMUN, V2, P491, DOI 10.3109/15419069409014213; Pinkstaff JK, 1999, J NEUROSCI, V19, P1541; Saiyed T, 2007, J BIOL CHEM, V282, P5625, DOI 10.1074/jbc.M610290200; Saxton MJ, 1997, BIOPHYS J, V72, P1744, DOI 10.1016/S0006-3495(97)78820-9; Schachtrup C, 2007, P NATL ACAD SCI USA, V104, P11814, DOI 10.1073/pnas.0704045104; Specht CG, 2008, BIOESSAYS, V30, P1062, DOI 10.1002/bies.20831; STAUBLI U, 1990, BEHAV NEURAL BIOL, V53, P1, DOI 10.1016/0163-1047(90)90712-F; Steiner P, 2008, NEURON, V60, P788, DOI 10.1016/j.neuron.2008.10.014; Stellwagen D, 2006, NATURE, V440, P1054, DOI 10.1038/nature04671; Triller A, 2008, NEURON, V59, P359, DOI 10.1016/j.neuron.2008.06.022; Trinidad JC, 2006, MOL CELL PROTEOMICS, V5, P914, DOI 10.1074/mcp.T500041-MCP200; Tweedie-Cullen RY, 2009, J PROTEOME RES, V8, P4966, DOI 10.1021/pr9003739; Wang XB, 2008, P NATL ACAD SCI USA, V105, P19520, DOI 10.1073/pnas.0807248105; Woolf CJ, 2000, SCIENCE, V288, P1765, DOI 10.1126/science.288.5472.1765; Wu X, 1998, J CELL BIOL, V143, P241, DOI 10.1083/jcb.143.1.241; Zita MM, 2007, EMBO J, V26, P1761, DOI 10.1038/sj.emboj.7601625	50	72	73	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2010	13	11					1388	U182		10.1038/nn.2645	http://dx.doi.org/10.1038/nn.2645			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	673KI	20935643	Green Submitted			2022-12-28	WOS:000283658200020
J	Elliott, E; Ezra-Nevo, G; Regev, L; Neufeld-Cohen, A; Chen, A				Elliott, Evan; Ezra-Nevo, Gili; Regev, Limor; Neufeld-Cohen, Adi; Chen, Alon			Resilience to social stress coincides with functional DNA methylation of the Crf gene in adult mice	NATURE NEUROSCIENCE			English	Article							BRAIN; CORTICOTROPIN; ADAPTATION	DNA methylation regulates gene transcription and has been suggested to encode psychopathologies derived from early life stress. We found that methylation regulated the expression of the Crf (also known as Crh) gene and that chronic social stress in adult mice induced long-term demethylation of this genomic region. Demethylation was observed only in the subset of defeated mice that displayed social avoidance and site-specific knockdown of Crf attenuated the stress-induced social avoidance.	[Elliott, Evan; Ezra-Nevo, Gili; Regev, Limor; Neufeld-Cohen, Adi; Chen, Alon] Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Chen, A (corresponding author), Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel.	alon.chen@weizmann.ac.il		Chen, Alon/0000-0003-3625-8233; Ezra-Nevo, Gili/0000-0002-7617-6139; Elliott, Evan/0000-0002-1630-969X	Pratt Foundation; Israel Science Foundation; Nella and Leon Benoziyo Center for Neurosciences; Nella and Leon Benoziyo Center for Neurological Diseases; Carl and Micaela Einhorn-Dominic Brain Research Institute; Irwin Green Alzheimer's Research Fund; Gerhard and Hannah Bacharach	Pratt Foundation; Israel Science Foundation(Israel Science Foundation); Nella and Leon Benoziyo Center for Neurosciences; Nella and Leon Benoziyo Center for Neurological Diseases; Carl and Micaela Einhorn-Dominic Brain Research Institute; Irwin Green Alzheimer's Research Fund; Gerhard and Hannah Bacharach	This work was supported by Roberto and Renata Ruhman, Mark Besen and the Pratt Foundation, the Israel Science Foundation, the Legacy Heritage Biomedical Science program of the Israel Science Foundation, the Nella and Leon Benoziyo Center for Neurosciences, the Nella and Leon Benoziyo Center for Neurological Diseases, the Carl and Micaela Einhorn-Dominic Brain Research Institute, the Irwin Green Alzheimer's Research Fund, and Gerhard and Hannah Bacharach. A. C. is incumbent of the Philip Harris and Gerald Ronson Career Development Chair.	Aguilera G, 2007, STRESS, V10, P153, DOI 10.1080/10253890701391192; Bale TL, 2004, ANNU REV PHARMACOL, V44, P525, DOI 10.1146/annurev.pharmtox.44.101802.121410; de Kloet ER, 2005, NAT REV NEUROSCI, V6, P463, DOI 10.1038/nrn1683; Joels M, 2009, NAT REV NEUROSCI, V10, P459, DOI 10.1038/nrn2632; Krishnan V, 2007, CELL, V131, P391, DOI 10.1016/j.cell.2007.09.018; Ma DK, 2009, SCIENCE, V323, P1074, DOI 10.1126/science.1166859; McEwen BS, 2007, PHYSIOL REV, V87, P873, DOI 10.1152/physrev.00041.2006; McGowan PO, 2009, NAT NEUROSCI, V12, P342, DOI 10.1038/nn.2270; Mueller BR, 2008, J NEUROSCI, V28, P9055, DOI 10.1523/JNEUROSCI.1424-08.2008; Murgatroyd C, 2009, NAT NEUROSCI, V12, P1559, DOI 10.1038/nn.2436; PAXINOS F, 2001, MOUSE BRAIN STEREOTA; Roth TL, 2009, BIOL PSYCHIAT, V65, P760, DOI 10.1016/j.biopsych.2008.11.028; Tsankova NM, 2006, NAT NEUROSCI, V9, P519, DOI 10.1038/nn1659; VALE W, 1981, SCIENCE, V213, P1394, DOI 10.1126/science.6267699; Zhang XM, 2005, P NATL ACAD SCI USA, V102, P4459, DOI 10.1073/pnas.0501076102	15	315	322	2	49	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2010	13	11					1351	1353		10.1038/nn.2642	http://dx.doi.org/10.1038/nn.2642			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	673KI	20890295				2022-12-28	WOS:000283658200014
J	Weber, AM; Wong, FK; Tufford, AR; Schlichter, LC; Matveev, V; Stanley, EF				Weber, Alexander M.; Wong, Fiona K.; Tufford, Adele R.; Schlichter, Lyanne C.; Matveev, Victor; Stanley, Elise F.			N-type Ca2+ channels carry the largest current: implications for nanodomains and transmitter release	NATURE NEUROSCIENCE			English	Article							CALCIUM-CHANNEL; ACTIVE ZONE; NEURONS; SYNAPSE; VESICLE	Presynaptic terminals favor intermediate-conductance Ca(V)2.2 (N type) over high-conductance Ca(V)1 (L type) channels for single-channel, Ca2+ nanodomain-triggered synaptic vesicle fusion. However, the standard Ca(V)1>Ca(V)2>Ca(V)3 conductance hierarchy is based on recordings using nonphysiological divalent ion concentrations. We found that, with physiological Ca2+ gradients, the hierarchy was Ca(V)2.2>Ca(V)1>Ca(V)3. Mathematical modeling predicts that the Ca(V)2.2 Ca2+ nanodomain, which is similar to 25% more extensive than that generated by Ca(V)1, can activate a calcium-fusion sensor located on the proximal face of the synaptic vesicle.	[Weber, Alexander M.; Wong, Fiona K.; Tufford, Adele R.; Stanley, Elise F.] Toronto Western Res Inst, Lab Synapt Transmiss, Toronto, ON, Canada; [Weber, Alexander M.; Wong, Fiona K.; Tufford, Adele R.; Schlichter, Lyanne C.; Stanley, Elise F.] Toronto Western Res Inst, Genes & Dev Div, Toronto, ON, Canada; [Matveev, Victor] New Jersey Inst Technol, Dept Math Sci, Newark, NJ 07102 USA	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; New Jersey Institute of Technology	Stanley, EF (corresponding author), Toronto Western Res Inst, Lab Synapt Transmiss, Toronto, ON, Canada.	estanley@uhnres.utoronto.ca		Weber, Alexander/0000-0001-7295-0775; Matveev, Victor/0000-0002-9867-5190; Tufford, Adele/0000-0002-3631-2562	Canadian Institutes for Health Research [MOP-86643, MT-13657]; Canada Research Chair; Ontario Graduate Scholarship; National Science Foundation [DMS-0817703]; Division Of Mathematical Sciences [0817703] Funding Source: National Science Foundation	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); Ontario Graduate Scholarship(Ontario Graduate Scholarship); National Science Foundation(National Science Foundation (NSF)); Division Of Mathematical Sciences(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We thank G. Zamponi, P. Backx, S. Ikeda and A. Chan for critique of the manuscript, and Q. Li and X. P. Zhu for technical assistance. This work was supported primarily by Canadian Institutes for Health Research (MOP-86643) and a Canada Research Chair (E. F. S.). We also received funding from the Canadian Institutes for Health Research (MT-13657, L. C. S.), Ontario Graduate Scholarship (F. K. W.) and National Science Foundation (DMS-0817703, V.M.).	Augustine GJ, 2003, NEURON, V40, P331, DOI 10.1016/S0896-6273(03)00639-1; Brandt A, 2005, J NEUROSCI, V25, P11577, DOI 10.1523/JNEUROSCI.3411-05.2005; Bucurenciu I, 2010, NAT NEUROSCI, V13, P19, DOI 10.1038/nn.2461; Church PJ, 1996, J PHYSIOL-LONDON, V496, P59, DOI 10.1113/jphysiol.1996.sp021665; FOX AP, 1987, J PHYSIOL-LONDON, V394, P173, DOI 10.1113/jphysiol.1987.sp016865; Gentile L, 2005, EUR J NEUROSCI, V21, P278, DOI 10.1111/j.1460-9568.2004.03841.x; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Khanna R, 2007, EUR J NEUROSCI, V26, P547, DOI 10.1111/j.1460-9568.2007.05680.x; LLINAS R, 1982, P NATL ACAD SCI-BIOL, V79, P2415, DOI 10.1073/pnas.79.7.2415; Shahrezaei V, 2005, J NEUROPHYSIOL, V94, P1912, DOI 10.1152/jn.00256.2005; Shahrezaei V, 2006, J NEUROSCI, V26, P13240, DOI 10.1523/JNEUROSCI.1418-06.2006; SIMON SM, 1985, BIOPHYS J, V48, P485, DOI 10.1016/S0006-3495(85)83804-2; Stanley EF, 1997, TRENDS NEUROSCI, V20, P404, DOI 10.1016/S0166-2236(97)01091-6; STANLEY EF, 1993, NEURON, V11, P1007, DOI 10.1016/0896-6273(93)90214-C; Wachman ES, 2004, J NEUROSCI, V24, P2877, DOI 10.1523/JNEUROSCI.1660-03.2004	15	72	73	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2010	13	11					1348	1350		10.1038/nn.2657	http://dx.doi.org/10.1038/nn.2657			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	673KI	20953196				2022-12-28	WOS:000283658200013
J	Richards, BA; Voss, OP; Akerman, CJ				Richards, Blake A.; Voss, Oliver P.; Akerman, Colin J.			GABAergic circuits control stimulus-instructed receptive field development in the optic tectum	NATURE NEUROSCIENCE			English	Article							DEVELOPING RETINOTECTAL SYNAPSES; EXPERIENCE-DEPENDENT PLASTICITY; CORRELATED NEURONAL-ACTIVITY; VISUAL-CORTEX; FEEDFORWARD INHIBITION; GLUTAMATERGIC SYNAPSES; HYPOTHALAMIC NEURONS; SYNAPTIC PLASTICITY; EXCITATORY ACTIONS; ORIENTATION MAPS	During the development of sensory systems, receptive fields are modified by stimuli in the environment. This is thought to rely on learning algorithms that are sensitive to correlations in spike timing between cells, but the manner in which developing circuits selectively exploit correlations that are related to sensory inputs is unknown. We recorded from neurons in the developing optic tectum of Xenopus laevis and found that repeated presentation of moving visual stimuli induced receptive field changes that reflected the properties of the stimuli and that this form of learning was disrupted when GABAergic transmission was blocked. Consistent with a role for spike timing-dependent mechanisms, GABA blockade altered spike-timing patterns in the tectum and increased correlations between cells that would affect plasticity at intratectal synapses. This is a previously unknown role for GABAergic signals in development and highlights the importance of regulating the statistics of spiking activity for learning.	[Richards, Blake A.; Voss, Oliver P.; Akerman, Colin J.] Univ Oxford, Dept Pharmacol, Oxford OX1 3QT, England	University of Oxford	Akerman, CJ (corresponding author), Univ Oxford, Dept Pharmacol, S Parks Rd, Oxford OX1 3QT, England.	colin.akerman@pharm.ox.ac.uk		Richards, Blake/0000-0001-9662-2151	Biotechnology and Biological Sciences Research Council [BB/E0154761]; Medical Research Council [G0601503]; European Research Council under the European Community [243273]; Research Councils UK; British Pharmacological Society; Wellcome Trust; Natural Sciences and Engineering Research Council of Canada; Biotechnology and Biological Sciences Research Council [BB/E015476/1] Funding Source: researchfish; BBSRC [BB/E015476/1] Funding Source: UKRI; MRC [G0601503] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Research Council under the European Community(European Research Council (ERC)); Research Councils UK(UK Research & Innovation (UKRI)); British Pharmacological Society; Wellcome Trust(Wellcome Trust); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We would like to thank H. Cline, K. Lamsa and O. Paulsen for helpful discussions and for comments on the manuscript. This work was supported by grants from the Biotechnology and Biological Sciences Research Council (BB/E0154761) and the Medical Research Council (G0601503). The research leading to these results has received funding from the European Research Council under the European Community's Seventh Framework Programme (FP7/2007-2013), ERC grant agreement number 243273. In addition, C.J.A. was supported by a Fellowship from the Research Councils UK and British Pharmacological Society, and B.A.R. was supported by a Wellcome Trust Doctoral Fellowship and a Post Graduate Scholarship from the Natural Sciences and Engineering Research Council of Canada.	Akerman CJ, 2007, TRENDS NEUROSCI, V30, P382, DOI 10.1016/j.tins.2007.06.002; Akerman CJ, 2006, J NEUROSCI, V26, P5117, DOI 10.1523/JNEUROSCI.0319-06.2006; Chen G, 1996, J PHYSIOL-LONDON, V494, P451, DOI 10.1113/jphysiol.1996.sp021505; COBB SR, 1995, NATURE, V378, P75, DOI 10.1038/378075a0; DAYAN P, 2003, THEORETICAL NEUROSCI, P3; Dunning DD, 1999, J NEUROPHYSIOL, V82, P3286, DOI 10.1152/jn.1999.82.6.3286; Engert F, 2002, NATURE, V419, P470, DOI 10.1038/nature00988; Froemke RC, 2002, NATURE, V416, P433, DOI 10.1038/416433a; Gabernet L, 2005, NEURON, V48, P315, DOI 10.1016/j.neuron.2005.09.022; Gao XB, 2001, J NEUROPHYSIOL, V85, P425, DOI 10.1152/jn.2001.85.1.425; GOODMAN CS, 1993, CELL, V72, P77, DOI 10.1016/S0092-8674(05)80030-3; Gulledge AT, 2003, NEURON, V37, P299, DOI 10.1016/S0896-6273(02)01146-7; Hensch TK, 1998, SCIENCE, V282, P1504, DOI 10.1126/science.282.5393.1504; Hollrigel GS, 1997, J NEUROSCI, V17, P5119; HOLT CE, 1983, NATURE, V301, P150, DOI 10.1038/301150a0; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Khawaled R, 1999, PFLUG ARCH EUR J PHY, V438, P314, DOI 10.1007/s004240050915; Li Y, 2008, NATURE, V456, P952, DOI 10.1038/nature07417; Liu Y, 2007, J NEUROSCI, V27, P5301, DOI 10.1523/JNEUROSCI.0376-07.2007; LUHMANN HJ, 1991, J NEUROPHYSIOL, V65, P247, DOI 10.1152/jn.1991.65.2.247; Meliza CD, 2006, NEURON, V49, P183, DOI 10.1016/j.neuron.2005.12.009; Mu Y, 2006, NEURON, V50, P115, DOI 10.1016/j.neuron.2006.03.009; MUELLER AL, 1984, J NEUROSCI, V4, P860; Niell CM, 2005, NEURON, V45, P941, DOI 10.1016/j.neuron.2005.01.047; Nieuwkoop P.D., 1967, NORMAL TABLE XENOPUS; Pavlov I, 2004, EUR J NEUROSCI, V20, P3019, DOI 10.1111/j.1460-9568.2004.03806.x; Pouille F, 2001, SCIENCE, V293, P1159, DOI 10.1126/science.1060342; Pratt KG, 2008, NAT NEUROSCI, V11, P467, DOI 10.1038/nn2076; RAMOA AS, 1988, EXP BRAIN RES, V73, P285; Schuett S, 2001, NEURON, V32, P325, DOI 10.1016/S0896-6273(01)00472-X; Sengpiel F, 1999, NAT NEUROSCI, V2, P727, DOI 10.1038/11192; Shon AP, 2004, NETWORK-COMP NEURAL, V15, P179, DOI 10.1088/0954-898X/15/3/002; Sjostrom PJ, 2001, NEURON, V32, P1149, DOI 10.1016/S0896-6273(01)00542-6; Song S, 2000, NAT NEUROSCI, V3, P919, DOI 10.1038/78829; STALEY KJ, 1992, J NEUROPHYSIOL, V68, P197, DOI 10.1152/jn.1992.68.1.197; STRYKER MP, 1989, PROBLEMS CONCEPTS DE, P110; Tao HW, 2005, NEURON, V45, P829, DOI 10.1016/j.neuron.2005.01.046; Tao HZW, 2001, NEURON, V31, P569, DOI 10.1016/S0896-6273(01)00393-2; Tyzio R, 1999, J NEUROSCI, V19, P10372; Ulrich D, 2003, EUR J NEUROSCI, V18, P2159, DOI 10.1046/j.1460-9568.2003.02942.x; Vislay-Meltzer R, 2006, NEURON, V50, P101, DOI 10.1016/j.neuron.2006.02.016; Wang DD, 2008, J NEUROSCI, V28, P5547, DOI 10.1523/JNEUROSCI.5599-07.2008; Wehr M, 2003, NATURE, V426, P442, DOI 10.1038/nature02116; Weliky M, 1997, NATURE, V386, P680, DOI 10.1038/386680a0; Weliky M, 2000, NEURON, V27, P427, DOI 10.1016/S0896-6273(00)00053-2; Wenisch OG, 2005, BIOL CYBERN, V93, P239, DOI 10.1007/s00422-005-0006-z; WIESEL TN, 1963, J NEUROPHYSIOL, V26, P1003, DOI 10.1152/jn.1963.26.6.1003; Wulff P, 2009, NAT NEUROSCI, V12, P1042, DOI 10.1038/nn.2348; Zhang LI, 1998, NATURE, V395, P37, DOI 10.1038/25665; Zhang LI, 2000, NAT NEUROSCI, V3, P708, DOI 10.1038/76665	50	20	20	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2010	13	9					1098	U95		10.1038/nn.2612	http://dx.doi.org/10.1038/nn.2612			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	643XC	20694002	Green Submitted, Green Accepted			2022-12-28	WOS:000281332600015
J	Tost, H; Braus, DF; Hakimi, S; Ruf, M; Vollmert, C; Hohn, F; Meyer-Lindenberg, A				Tost, Heike; Braus, Dieter F.; Hakimi, Shabnam; Ruf, Matthias; Vollmert, Christian; Hohn, Fabian; Meyer-Lindenberg, Andreas			Acute D-2 receptor blockade induces rapid, reversible remodeling in human cortical-striatal circuits	NATURE NEUROSCIENCE			English	Article							HALOPERIDOL; NEURONS; BRAIN; GENE	Structural remodeling has been observed in the human brain over periods of weeks to months, but the molecular mechanisms governing this process remain incompletely characterized. Using multimodal pharmaco-neuroimaging, we found that acute D-2 receptor blockade induced reversible striatal volume changes and structural-functional decoupling in motor circuits within hours; these alterations predicted acute extrapyramidal motor symptoms with high precision. Our findings suggest a role for D-2 receptors in short-term neural plasticity and identify a potential biomarker for neuroleptic side effects in humans.	[Tost, Heike; Braus, Dieter F.; Ruf, Matthias; Vollmert, Christian; Hohn, Fabian; Meyer-Lindenberg, Andreas] Heidelberg Univ, Med Fac Mannheim, Cent Inst Mental Hlth, Dept Psychiat & Psychotherapy, D-6800 Mannheim, Germany; [Tost, Heike; Hakimi, Shabnam] NIMH, Clin Brain Disorders Branch, Genes Cognit & Psychosis Program, NIH,Dept Hlth & Human Serv, Bethesda, MD 20892 USA; [Braus, Dieter F.] Clin Psychiat & Psychotherapy, Dr Horst Schmidt Clin, Wiesbaden, Germany; [Ruf, Matthias] Heidelberg Univ, Med Fac Mannheim, Dept Neuroimaging, Cent Inst Mental Hlth, D-6800 Mannheim, Germany; [Vollmert, Christian] Heidelberg Univ, Med Fac Mannheim, Dept Addict Behav & Addict Med, Cent Inst Mental Hlth, D-6800 Mannheim, Germany	Central Institute of Mental Health; Ruprecht Karls University Heidelberg; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Central Institute of Mental Health; Ruprecht Karls University Heidelberg; Central Institute of Mental Health; Ruprecht Karls University Heidelberg	Tost, H (corresponding author), Heidelberg Univ, Med Fac Mannheim, Cent Inst Mental Hlth, Dept Psychiat & Psychotherapy, D-6800 Mannheim, Germany.	tosth@mail.nih.gov	Tost, med. Dr. phil. Heike/AAX-8305-2020; Meyer-Lindenberg, Andreas/H-1076-2011	Meyer-Lindenberg, Andreas/0000-0001-5619-1123; Hakimi, Shabnam/0000-0003-4122-6041	National Institute of Mental Health; US National Institutes of Health; Deutsche Forschungsgemeinschaft-National Institutes of Health [To 539/1-1]	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft-National Institutes of Health	We thank A. Tenckhoff, J. Rauschenberg, A. Schmitt, M. Hoerst and I. Wolf for research assistance. This research was supported in part by the Intramural Research Program of the National Institute of Mental Health, the US National Institutes of Health and a Deutsche Forschungsgemeinschaft-National Institutes of Health scholarship grant to H. T. (To 539/1-1).	ALEXANDER GE, 1990, PROG BRAIN RES, V85, P119; Chartoff EH, 1999, J PHARMACOL EXP THER, V291, P531; Dawson NM, 2001, SYNAPSE, V39, P70, DOI 10.1002/1098-2396(20010101)39:1<70::AID-SYN10>3.0.CO;2-J; Driemeyer J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002669; Kamin J, 2000, PSYCHIAT SERV, V51, P287, DOI 10.1176/appi.ps.51.3.287; Kovacs KJ, 2001, NEUROPHARMACOLOGY, V40, P383, DOI 10.1016/S0028-3908(00)00163-5; Marchese G, 2002, EUR J NEUROSCI, V15, P1187, DOI 10.1046/j.1460-9568.2002.01944.x; Meyer-Lindenberg A, 2007, J CLIN INVEST, V117, P672, DOI 10.1172/JCI30413; Miyashita T, 2008, NEUROBIOL LEARN MEM, V89, P269, DOI 10.1016/j.nlm.2007.08.012; Parish CL, 2002, EUR J NEUROSCI, V16, P787, DOI 10.1046/j.1460-9568.2002.02132.x; Parish CL, 2001, J NEUROSCI, V21, P5147, DOI 10.1523/JNEUROSCI.21-14-05147.2001; Samaha AN, 2008, BIOL PSYCHIAT, V64, P145, DOI 10.1016/j.biopsych.2008.01.010; Tost H, 2006, BIOL PSYCHIAT, V60, P1196, DOI 10.1016/j.biopsych.2006.04.014; Wong DF, 2007, INT REV PSYCHIATR, V19, P541, DOI 10.1080/09540260701564849; Xu MQ, 2008, PHARMACOGENET GENOM, V18, P449, DOI 10.1097/FPC.0b013e3282f85e26	15	98	98	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2010	13	8					920	922		10.1038/nn.2572	http://dx.doi.org/10.1038/nn.2572			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	632DK	20526332				2022-12-28	WOS:000280400600008
J	Fleidervish, IA; Lasser-Ross, N; Gutnick, MJ; Ross, WN				Fleidervish, Ilya A.; Lasser-Ross, Nechama; Gutnick, Michael J.; Ross, William N.			Na+ imaging reveals little difference in action potential-evoked Na+ influx between axon and soma	NATURE NEUROSCIENCE			English	Article							NEOCORTICAL PYRAMIDAL NEURONS; CEREBELLAR PURKINJE NEURONS; PERSISTENT SODIUM CURRENT; INITIAL SEGMENT; SYNAPTIC EFFICACY; BASAL DENDRITES; OPTIC NERVES; CHANNELS; RAT; CALCIUM	In cortical pyramidal neurons, the axon initial segment (AIS) is pivotal in synaptic integration. It has been asserted that this is because there is a high density of Na+ channels in the AIS. However, we found that action potential-associated Na+ flux, as measured by high-speed fluorescence Na+ imaging, was about threefold larger in the rat AIS than in the soma. Spike-evoked Na+ flux in the AIS and the first node of Ranvier was similar and was eightfold lower in basal dendrites. At near-threshold voltages, persistent Na+ conductance was almost entirely axonal. On a time scale of seconds, passive diffusion, and not pumping, was responsible for maintaining transmembrane Na+ gradients in thin axons during high-frequency action potential firing. In computer simulations, these data were consistent with the known features of action potential generation in these neurons.	[Fleidervish, Ilya A.] Ben Gurion Univ Negev, Fac Hlth Sci, Dept Physiol, Beer Sheva, Israel; [Fleidervish, Ilya A.; Lasser-Ross, Nechama; Gutnick, Michael J.; Ross, William N.] Marine Biol Lab, Woods Hole, MA 02543 USA; [Fleidervish, Ilya A.; Gutnick, Michael J.] Hebrew Univ Jerusalem, Koret Sch Vet Med, IL-76100 Rehovot, Israel; [Lasser-Ross, Nechama; Ross, William N.] New York Med Coll, Dept Physiol, Valhalla, NY 10595 USA	Ben Gurion University; Marine Biological Laboratory - Woods Hole; Hebrew University of Jerusalem; New York Medical College	Fleidervish, IA (corresponding author), Ben Gurion Univ Negev, Fac Hlth Sci, Dept Physiol, Beer Sheva, Israel.	ilya@bgu.ac.il	FLEIDERVISH, Ilya/F-2324-2012; Gutnick, Michael/P-7910-2019	Fleidervish, Ilya/0000-0002-5501-726X; Gutnick, Michael/0000-0003-2564-5094	US-Israel Binational Science Foundation [2003082]; Israel Science Foundation [1376-06]; Marine Biological Laboratory; US National Institutes of Health [NS16295]; Multiple Sclerosis Society [PP1367]; Gruss Lipper Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS016295, R01NS016295] Funding Source: NIH RePORTER	US-Israel Binational Science Foundation(US-Israel Binational Science Foundation); Israel Science Foundation(Israel Science Foundation); Marine Biological Laboratory; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Multiple Sclerosis Society(National Multiple Sclerosis Society); Gruss Lipper Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank S. Manita for excellent help with the preparation of slices. This work was supported by a US-Israel Binational Science Foundation grant (2003082), a grant from the Israel Science Foundation (1376-06), a Grass Faculty grant from the Marine Biological Laboratory, a US National Institutes of Health grant (NS16295), a Multiple Sclerosis Society grant (PP1367) and a fellowship from the Gruss Lipper Foundation.	Acker CD, 2009, J NEUROPHYSIOL, V101, P1524, DOI 10.1152/jn.00651.2007; Alle H, 2009, SCIENCE, V325, P1405, DOI 10.1126/science.1174331; ALZHEIMER C, 1993, J NEUROSCI, V13, P660; Astman N, 2006, J NEUROSCI, V26, P3465, DOI 10.1523/JNEUROSCI.4907-05.2006; Attwell D, 2002, TRENDS NEUROSCI, V25, P621, DOI 10.1016/S0166-2236(02)02264-6; Bean BP, 2007, NAT REV NEUROSCI, V8, P451, DOI 10.1038/nrn2148; Bender KJ, 2009, NEURON, V61, P259, DOI 10.1016/j.neuron.2008.12.004; Callaway JC, 1997, J NEUROPHYSIOL, V77, P145, DOI 10.1152/jn.1997.77.1.145; Carter BC, 2009, NEURON, V64, P898, DOI 10.1016/j.neuron.2009.12.011; Clark BA, 2005, NAT NEUROSCI, V8, P137, DOI 10.1038/nn1390; Colbert CM, 1996, J NEUROSCI, V16, P6676; Colbert CM, 2002, NAT NEUROSCI, V5, P533, DOI 10.1038/nn857; Engel D, 2005, NEURON, V45, P405, DOI 10.1016/j.neuron.2004.12.048; Fleidervish IA, 1996, J NEUROPHYSIOL, V76, P2125, DOI 10.1152/jn.1996.76.3.2125; Helmchen F, 1996, BIOPHYS J, V70, P1069, DOI 10.1016/S0006-3495(96)79653-4; Hines ML, 1997, NEURAL COMPUT, V9, P1179, DOI 10.1162/neco.1997.9.6.1179; HODGKIN AL, 1956, J PHYSIOL-LONDON, V131, P592, DOI 10.1113/jphysiol.1956.sp005485; Hu WQ, 2009, NAT NEUROSCI, V12, P996, DOI 10.1038/nn.2359; Kole MHP, 2008, NAT NEUROSCI, V11, P1253, DOI 10.1038/nn.2203; Kole MHP, 2008, NAT NEUROSCI, V11, P178, DOI 10.1038/nn2040; Kole MHP, 2007, NEURON, V55, P633, DOI 10.1016/j.neuron.2007.07.031; KUSHMERICK MJ, 1969, SCIENCE, V166, P1297, DOI 10.1126/science.166.3910.1297; Larkum ME, 2003, J PHYSIOL-LONDON, V549, P471, DOI 10.1113/jphysiol.2002.037614; LASSERROSS N, 1992, P ROY SOC B-BIOL SCI, V247, P35, DOI 10.1098/rspb.1992.0006; LELIEVRE L, 1979, BIOCHIM BIOPHYS ACTA, V557, P399, DOI 10.1016/0005-2736(79)90338-9; Mainen ZF, 1995, NEURON, V15, P1427, DOI 10.1016/0896-6273(95)90020-9; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; MATA M, 1991, J NEUROCHEM, V57, P184, DOI 10.1111/j.1471-4159.1991.tb02114.x; MINTA A, 1989, J BIOL CHEM, V264, P19449; NEHER E, 1992, J PHYSIOL-LONDON, V450, P273, DOI 10.1113/jphysiol.1992.sp019127; Nevian T, 2007, NAT NEUROSCI, V10, P206, DOI 10.1038/nn1826; Palmer LM, 2006, J NEUROSCI, V26, P1854, DOI 10.1523/JNEUROSCI.4812-05.2006; PETERS A, 1966, Q J EXP PHYSIOL CMS, V51, P229, DOI 10.1113/expphysiol.1966.sp001852; Rose CR, 1999, PFLUG ARCH EUR J PHY, V439, P201, DOI 10.1007/s004240051145; Royeck M, 2008, J NEUROPHYSIOL, V100, P2361, DOI 10.1152/jn.90332.2008; SHRAGER P, 1987, J PHYSIOL-LONDON, V392, P587, DOI 10.1113/jphysiol.1987.sp016798; STUART G, 1995, NEURON, V15, P1065, DOI 10.1016/0896-6273(95)90095-0; Stuart G, 1997, J PHYSIOL-LONDON, V505, P617, DOI 10.1111/j.1469-7793.1997.617ba.x; STUART GJ, 1993, PFLUG ARCH EUR J PHY, V423, P511, DOI 10.1007/BF00374949; SUGIHARA I, 1993, J PHYSIOL-LONDON, V470, P243, DOI 10.1113/jphysiol.1993.sp019857; Zhang CL, 2006, J NEUROPHYSIOL, V96, P695, DOI 10.1152/jn.00083.2006	41	128	130	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2010	13	7					852	U96		10.1038/nn.2574	http://dx.doi.org/10.1038/nn.2574			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	615YF	20543843	Green Accepted, Green Submitted			2022-12-28	WOS:000279173900018
J	Shimogori, T; Lee, DA; Miranda-Angulo, A; Yang, YQ; Wang, H; Jiang, LZ; Yoshida, AC; Kataoka, A; Mashiko, H; Avetisyan, M; Qi, LX; Qian, J; Blackshaw, S				Shimogori, Tomomi; Lee, Daniel A.; Miranda-Angulo, Ana; Yang, Yanqin; Wang, Hong; Jiang, Lizhi; Yoshida, Aya C.; Kataoka, Ayane; Mashiko, Hiromi; Avetisyan, Marina; Qi, Lixin; Qian, Jiang; Blackshaw, Seth			A genomic atlas of mouse hypothalamic development	NATURE NEUROSCIENCE			English	Article							AREA ANTERIOR HYPOTHALAMUS; SONIC-HEDGEHOG; SEX-DIFFERENCES; CIRCADIAN-RHYTHMS; REGIONAL IDENTITY; GENE-EXPRESSION; MICE LACKING; BRAIN; DIENCEPHALON; FOREBRAIN	The hypothalamus is a central regulator of many behaviors that are essential for survival, such as temperature regulation, food intake and circadian rhythms. However, the molecular pathways that mediate hypothalamic development are largely unknown. To identify genes expressed in developing mouse hypothalamus, we performed microarray analysis at 12 different developmental time points. We then conducted developmental in situ hybridization for 1,045 genes that were dynamically expressed over the course of hypothalamic neurogenesis. We identified markers that stably labeled each major hypothalamic nucleus over the entire course of neurogenesis and constructed a detailed molecular atlas of the developing hypothalamus. As a proof of concept of the utility of these data, we used these markers to analyze the phenotype of mice in which Sonic Hedgehog (Shh) was selectively deleted from hypothalamic neuroepithelium and found that Shh is essential for anterior hypothalamic patterning. Our results serve as a resource for functional investigations of hypothalamic development, connectivity, physiology and dysfunction.	[Shimogori, Tomomi; Yoshida, Aya C.; Kataoka, Ayane; Mashiko, Hiromi] RIKEN BSI, Wako, Saitama, Japan; [Lee, Daniel A.; Miranda-Angulo, Ana; Wang, Hong; Jiang, Lizhi; Avetisyan, Marina; Qi, Lixin; Blackshaw, Seth] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD USA; [Yang, Yanqin; Qian, Jiang; Blackshaw, Seth] Johns Hopkins Univ, Sch Med, Dept Ophthalmol, Baltimore, MD 21205 USA; [Blackshaw, Seth] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Blackshaw, Seth] Johns Hopkins Univ, Sch Med, Ctr High Throughput Biol, Baltimore, MD USA; [Blackshaw, Seth] Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD USA	RIKEN; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Shimogori, T (corresponding author), RIKEN BSI, 2-1 Hirosawa, Wako, Saitama, Japan.	tshimogori@brain.riken.jp; sblack@jhmi.edu	Shimogori, Tomomi/L-2893-2013	Shimogori, Tomomi/0000-0002-6931-5401; Avetisyan, Marina/0000-0001-9836-5005; Lee, Daniel/0000-0001-7411-2740; Miranda-Angulo, Ana L./0000-0003-4938-3033	RIKEN Brain Science Institute and Human Frontier Science Project; National Science Foundation; March of Dimes; Klingenstein Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS067393] Funding Source: NIH RePORTER	RIKEN Brain Science Institute and Human Frontier Science Project; National Science Foundation(National Science Foundation (NSF)); March of Dimes(March of Dimes); Klingenstein Fund(Klingenstein Philanthropies); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We would like to thank C.-M. Fan for guidance concerning dissection of embryonic hypothalamus and S. Hattar, A. Moore and B. Nelson for comments on the manuscript. This work was supported by the RIKEN Brain Science Institute and Human Frontier Science Project (T.S.), a National Science Foundation Predoctoral Fellowship (D.A L.), a Basil O'Connor Starter Scholar Award from the March of Dimes (S.B.) and an award from the Klingenstein Fund (S.B.). S.B. is a W.M. Keck Distinguished Young Investigator in Medical Science.	Acampora D, 1999, GENE DEV, V13, P2787, DOI 10.1101/gad.13.21.2787; Alvarez-Bolado G, 2006, J PHYSIOL-LONDON, V575, P347, DOI 10.1113/jphysiol.2006.112763; Blackshaw S, 2004, PLOS BIOL, V2, P1411, DOI 10.1371/journal.pbio.0020247; Brown AE, 1999, DEV BRAIN RES, V115, P171, DOI 10.1016/S0165-3806(99)00061-9; Budefeld T, 2008, DEV NEUROBIOL, V68, P981, DOI 10.1002/dneu.20638; Caqueret A, 2005, HORM RES, V64, P222, DOI 10.1159/000088977; Charlton H, 2008, J NEUROENDOCRINOL, V20, P641, DOI 10.1111/j.1365-2826.2008.01718.x; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; Dale JK, 1997, CELL, V90, P257, DOI 10.1016/S0092-8674(00)80334-7; Dassule HR, 2000, DEVELOPMENT, V127, P4775; Davis AM, 2004, J NEUROBIOL, V60, P424, DOI 10.1002/neu.20030; Elmquist JK, 1999, NEURON, V22, P221, DOI 10.1016/S0896-6273(00)81084-3; Fuller PM, 2008, SCIENCE, V320, P1074, DOI 10.1126/science.1153277; Fyffe SL, 2008, NEURON, V59, P947, DOI 10.1016/j.neuron.2008.07.030; Goshu E, 2004, MOL ENDOCRINOL, V18, P1251, DOI 10.1210/me.2003-0372; Gray PA, 2004, SCIENCE, V306, P2255, DOI 10.1126/science.1104935; Grove EA, 1998, DEVELOPMENT, V125, P2315; HATINI V, 1994, J NEUROBIOL, V25, P1293, DOI 10.1002/neu.480251010; Herrera E, 2004, DEVELOPMENT, V131, P5727, DOI 10.1242/dev.01431; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Ino H, 2004, J HISTOCHEM CYTOCHEM, V52, P311, DOI 10.1177/002215540405200302; Kataoka A, 2008, DEVELOPMENT, V135, P2873, DOI 10.1242/dev.021618; Kiecker C, 2004, NAT NEUROSCI, V7, P1242, DOI 10.1038/nn1338; Kruk MR, 1998, NEUROSCI BIOBEHAV R, V23, P163, DOI 10.1016/S0149-7634(98)00018-9; Labosky PA, 1997, DEVELOPMENT, V124, P1263; Lee JE, 2006, DEVELOPMENT, V133, P4451, DOI 10.1242/dev.02613; Manning L, 2006, DEV CELL, V11, P873, DOI 10.1016/j.devcel.2006.09.021; Mathieu J, 2002, DEVELOPMENT, V129, P3055; McGill BE, 2006, P NATL ACAD SCI USA, V103, P18267, DOI 10.1073/pnas.0608702103; Michaud JL, 1998, GENE DEV, V12, P3264, DOI 10.1101/gad.12.20.3264; Miura H, 1997, MECH DEVELOP, V65, P99, DOI 10.1016/S0925-4773(97)00062-2; Moga MM, 1997, J COMP NEUROL, V389, P508, DOI 10.1002/(SICI)1096-9861(19971222)389:3<508::AID-CNE11>3.0.CO;2-H; O'Rahilly S, 2009, NATURE, V462, P307, DOI 10.1038/nature08532; Ohyama K, 2008, DEVELOPMENT, V135, P3325, DOI 10.1242/dev.027078; Peinado JR, 2005, ENDOCRINOLOGY, V146, P3438, DOI 10.1210/en.2004-1289; Pera EM, 1998, DEV GENES EVOL, V208, P168, DOI 10.1007/s004270050170; PORTEUS MH, 1994, J NEUROSCI, V14, P6370; Rinn JL, 2005, TRENDS GENET, V21, P298, DOI 10.1016/j.tig.2005.03.005; Saper CB, 2005, NATURE, V437, P1257, DOI 10.1038/nature04284; Scholpp S, 2006, DEVELOPMENT, V133, P855, DOI 10.1242/dev.02248; Schonemann MD, 1995, GENE DEV, V9, P3122, DOI 10.1101/gad.9.24.3122; SHIMADA M, 1973, EXP NEUROL, V41, P163, DOI 10.1016/0014-4886(73)90187-8; Szabo NE, 2009, J NEUROSCI, V29, P6989, DOI 10.1523/JNEUROSCI.1089-09.2009; Szabo NE, 2009, J NEUROSCI, V29, P2453, DOI 10.1523/JNEUROSCI.4524-08.2009; Tobet S, 2009, J NEUROENDOCRINOL, V21, P387, DOI 10.1111/j.1365-2826.2009.01834.x; TOBET SA, 1995, J NEUROBIOL, V26, P75, DOI 10.1002/neu.480260107; Ulrich-Lai YM, 2009, NAT REV NEUROSCI, V10, P397, DOI 10.1038/nrn2647; WATSON SJ, 1977, P NATL ACAD SCI USA, V74, P5155, DOI 10.1073/pnas.74.11.5155; Wehr R, 1997, DEVELOPMENT, V124, P4447; Xu Q, 2008, J COMP NEUROL, V506, P16, DOI 10.1002/cne.21529	50	268	271	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2010	13	6					767	U153		10.1038/nn.2545	http://dx.doi.org/10.1038/nn.2545			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	600QY	20436479	Green Accepted			2022-12-28	WOS:000278003300023
J	Smetana, R; Juvin, L; Dubuc, R; Alford, S				Smetana, Roy; Juvin, Laurent; Dubuc, Rejean; Alford, Simon			A parallel cholinergic brainstem pathway for enhancing locomotor drive	NATURE NEUROSCIENCE			English	Article							LAYER II NEURONS; ENTORHINAL CORTEX; PEDUNCULOPONTINE NUCLEUS; RETICULOSPINAL NEURONS; PERSISTENT ACTIVITY; REGION; STIMULATION; ACTIVATION; PROJECTIONS; INITIATION	The brainstem locomotor system is believed to be organized serially from the mesencephalic locomotor region (MLR) to reticulospinal neurons, which in turn project to locomotor neurons in the spinal cord. We identified brainstem muscarinoceptive neurons in lampreys (Petromyzon marinus) that received parallel inputs from the MLR and projected back to reticulospinal cells to amplify and extend the duration of locomotor output. These cells responded to muscarine with extended periods of excitation, received direct muscarinic excitation from the MLR and projected glutamatergic excitation to reticulospinal neurons. Targeted blockade of muscarine receptors over these neurons profoundly reduced MLR-induced excitation of reticulospinal neurons and markedly slowed MLR-evoked locomotion. The presence of these neurons forces us to rethink the organization of supraspinal locomotor control, to include a sustained feedforward loop that boosts locomotor output.	[Smetana, Roy; Alford, Simon] Univ Illinois, Dept Biol Sci, Chicago, IL 60680 USA; [Smetana, Roy; Alford, Simon] Univ Illinois, Neurobiol Lab, Chicago, IL 60680 USA; [Juvin, Laurent; Dubuc, Rejean] Univ Montreal, Dept Physiol, Grp Rech Syst Nerveux Cent, Montreal, PQ H3C 3J7, Canada; [Dubuc, Rejean] Univ Quebec, Dept Kinanthropol, Montreal, PQ H3C 3P8, Canada	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Universite de Montreal; University of Quebec; University of Quebec Montreal	Alford, S (corresponding author), Univ Illinois, Dept Biol Sci, Chicago, IL 60680 USA.	sta@uic.edu	Juvin, Laurent/K-8532-2016	Juvin, Laurent/0000-0001-8847-1891; Alford, Simon/0000-0002-0454-4246	National Institute of Neurological Disorders and Stroke [R01 NS052699]; Canadian Institutes of Health Research [15129, 15176]; Natural Sciences and Engineering Research Council of Canada [217435-01]; Fonds de la Recherche en Sante du Quebec [5249]; Groupe de recherche sur le systeme nerveux central; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH084874] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS052699] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Fonds de la Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec); Groupe de recherche sur le systeme nerveux central; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank D. Veilleux for assistance with experiments, C. Valiquette for his expertise in computer programming and F. Bernard for help with the figures. We also thank E. Hamid and M. Alpert for comments and critical discussion of this manuscript. This work was funded by a grant from the National Institute of Neurological Disorders and Stroke (R01 NS052699) to S. A. and Individual and Group grants from the Canadian Institutes of Health Research (grant numbers 15129 and 15176), the Natural Sciences and Engineering Research Council of Canada (grant number 217435-01) and the Groupe de recherche sur le systeme nerveux central from the Fonds de la Recherche en Sante du Quebec (grant number 5249 to R D.). L.J. received a Jasper fellowship from the Groupe de recherche sur le systeme nerveux central.	Abr?moff M.D., 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; ARMSTRONG DM, 1986, PROG NEUROBIOL, V26, P273, DOI 10.1016/0301-0082(86)90021-3; BERNAU NA, 1991, BRAIN RES, V557, P83, DOI 10.1016/0006-8993(91)90119-G; BLANTON MG, 1989, J NEUROSCI METH, V30, P203, DOI 10.1016/0165-0270(89)90131-3; Brocard F, 2003, J NEUROPHYSIOL, V90, P1714, DOI 10.1152/jn.00202.2003; Brocard F, 2010, J NEUROSCI, V30, P523, DOI 10.1523/JNEUROSCI.3433-09.2010; Cabelguen JM, 2003, J NEUROSCI, V23, P2434; Deliagina TG, 2002, BRAIN RES REV, V40, P166, DOI 10.1016/S0165-0173(02)00199-6; Dickson CT, 2000, J NEUROPHYSIOL, V83, P2562, DOI 10.1152/jn.2000.83.5.2562; Dickson CT, 1997, J NEUROSCI, V17, P6729; DiPrisco GV, 1997, SCIENCE, V278, P1122, DOI 10.1126/science.278.5340.1122; DOSSI RC, 1991, J NEUROPHYSIOL, V65, P393, DOI 10.1152/jn.1991.65.3.393; Dubuc R, 2008, BRAIN RES REV, V57, P172, DOI 10.1016/j.brainresrev.2007.07.016; Egorov AV, 2002, NATURE, V420, P173, DOI 10.1038/nature01171; GARCIARILL E, 1986, BRAIN RES BULL, V17, P33, DOI 10.1016/0361-9230(86)90158-9; GARCIARILL E, 1987, BRAIN RES, V411, P13, DOI 10.1016/0006-8993(87)90676-7; GARCIARILL E, 1987, BRAIN RES, V411, P1, DOI 10.1016/0006-8993(87)90675-5; Grillner S, 1997, SCIENCE, V278, P1087, DOI 10.1126/science.278.5340.1087; Grillner S, 2008, BRAIN RES REV, V57, P2, DOI 10.1016/j.brainresrev.2007.06.027; Homma Y, 2002, J NEUROPHYSIOL, V87, P3033, DOI 10.1152/jn.2002.87.6.3033; Jahn K, 2008, NEUROIMAGE, V39, P786, DOI 10.1016/j.neuroimage.2007.09.047; Jahn K, 2008, PROG BRAIN RES, V171, P353, DOI 10.1016/S0079-6123(08)00652-3; Klink R, 1997, J NEUROPHYSIOL, V77, P1829, DOI 10.1152/jn.1997.77.4.1829; Le Ray D, 2003, EUR J NEUROSCI, V17, P137, DOI 10.1046/j.1460-9568.2003.02417.x; Mamiya K, 2005, J APPL PHYSIOL, V99, P1127, DOI 10.1152/japplphysiol.00253.2005; MCCLELLAN AD, 1994, BRAIN RES, V663, P61, DOI 10.1016/0006-8993(94)90462-6; ORLOVSKY GN, 1970, BIOFIZIKA, V1, P171; Pombal MA, 2001, J COMP NEUROL, V431, P105, DOI 10.1002/1096-9861(20010226)431:1<105::AID-CNE1058>3.0.CO;2-P; ROVAINEN CM, 1967, J NEUROPHYSIOL, V30, P1000, DOI 10.1152/jn.1967.30.5.1000; RYE DB, 1988, J COMP NEUROL, V269, P315, DOI 10.1002/cne.902690302; SHIK M. L., 1966, BLOFIZIKA, V11, P659; SHOLOMENKO GN, 1991, EXP BRAIN RES, V85, P659, DOI 10.1007/BF00231752; Sirota MG, 2000, EUR J NEUROSCI, V12, P4081, DOI 10.1046/j.1460-9568.2000.00301.x; SKINNER RD, 1984, BRAIN RES, V323, P385, DOI 10.1016/0006-8993(84)90319-6; Smetana RW, 2007, J NEUROPHYSIOL, V97, P3181, DOI 10.1152/jn.00954.2006; STEEVES JD, 1984, BRAIN RES, V307, P263, DOI 10.1016/0006-8993(84)90480-3; Tahvildari B, 2008, J NEUROPHYSIOL, V99, P2006, DOI 10.1152/jn.00911.2007	37	45	46	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2010	13	6					731	U108		10.1038/nn.2548	http://dx.doi.org/10.1038/nn.2548			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	600QY	20473293	Green Accepted			2022-12-28	WOS:000278003300018
J	Shi, YC; Kirwan, P; Smith, J; Robinson, HPC; Livesey, FJ				Shi, Yichen; Kirwan, Peter; Smith, James; Robinson, Hugh P. C.; Livesey, Frederick J.			Human cerebral cortex development from pluripotent stem cells to functional excitatory synapses	NATURE NEUROSCIENCE			English	Article							NEOCORTICAL NEURONOGENESIS; SUBVENTRICULAR ZONE; HUMAN ES; NEURONS; SPECIFICATION; SUBTYPE; DIFFERENTIATION; NEUROGENESIS; EVOLUTION; MODEL	Efforts to study the development and function of the human cerebral cortex in health and disease have been limited by the availability of model systems. Extrapolating from our understanding of rodent cortical development, we have developed a robust, multistep process for human cortical development from pluripotent stem cells: directed differentiation of human embryonic stem (ES) and induced pluripotent stem (iPS) cells to cortical stem and progenitor cells, followed by an extended period of cortical neurogenesis, neuronal terminal differentiation to acquire mature electrophysiological properties, and functional excitatory synaptic network formation. We found that induction of cortical neuroepithelial stem cells from human ES cells and human iPS cells was dependent on retinoid signaling. Furthermore, human ES cell and iPS cell differentiation to cerebral cortex recapitulated in vivo development to generate all classes of cortical projection neurons in a fixed temporal order. This system enables functional studies of human cerebral cortex development and the generation of individual-specific cortical networks ex vivo for disease modeling and therapeutic purposes.	[Shi, Yichen; Kirwan, Peter; Smith, James; Livesey, Frederick J.] Univ Cambridge, Gurdon Inst, Cambridge, England; [Shi, Yichen; Kirwan, Peter; Smith, James; Livesey, Frederick J.] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England; [Robinson, Hugh P. C.] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, England	University of Cambridge; University of Cambridge; University of Cambridge	Livesey, FJ (corresponding author), Univ Cambridge, Gurdon Inst, Cambridge, England.	rick@gurdon.cam.ac.uk		Smith, James/0000-0001-9131-5849; Livesey, Rick/0000-0001-6128-3372; Robinson, Hugh/0000-0002-5048-9954; Kirwan, Peter/0000-0003-1446-7544	Biotechnology and Biological Sciences Research Council; University of Cambridge/Wellcome Trust; Wellcome Trust; Alzheimer's Research UK; MRC [G0800784] Funding Source: UKRI; Medical Research Council [G0800784, G0800784B] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); University of Cambridge/Wellcome Trust; Wellcome Trust(Wellcome TrustEuropean Commission); Alzheimer's Research UK(Alzheimer's Research UK (ARUK)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank L. Vallier (Cambridge) and Y. Takashima for kindly providing human iPS cell lines and J. Nichols (Cambridge Centre for Stem Cell Research, Cambridge) for providing the Edi2 human ES cell line. We also thank the members of the Livesey laboratory for their contributions, comments and input to this research. Y. S. was supported by a Biotechnology and Biological Sciences Research Council Dorothy Hodgkin Studentship. P. K. was supported by the University of Cambridge/Wellcome Trust PhD Programme in Developmental Biology. This research benefits from core support to the Gurdon Institute from the Wellcome Trust and Cancer Research UK and grants to F. J. L. from the Wellcome Trust and Alzheimer's Research UK.	Alcamo EA, 2008, NEURON, V57, P364, DOI 10.1016/j.neuron.2007.12.012; Arlotta P, 2005, NEURON, V45, P207, DOI 10.1016/j.neuron.2004.12.036; Au E, 2008, CELL STEM CELL, V3, P472, DOI 10.1016/j.stem.2008.10.013; Bedogni F, 2010, P NATL ACAD SCI USA, V107, P13129, DOI 10.1073/pnas.1002285107; Bibel M, 2004, NAT NEUROSCI, V7, P1003, DOI 10.1038/nn1301; Britanova O, 2008, NEURON, V57, P378, DOI 10.1016/j.neuron.2007.12.028; BULFONE A, 1995, NEURON, V15, P63, DOI 10.1016/0896-6273(95)90065-9; Bystron I, 2008, NAT REV NEUROSCI, V9, P110, DOI 10.1038/nrn2252; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; CAVINESS VS, 1995, TRENDS NEUROSCI, V18, P379, DOI 10.1016/0166-2236(95)93933-O; Caviness VS, 2003, CEREB CORTEX, V13, P592, DOI 10.1093/cercor/13.6.592; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; CONNORS BW, 1982, J NEUROPHYSIOL, V48, P1302, DOI 10.1152/jn.1982.48.6.1302; Douglas RJ, 2004, ANNU REV NEUROSCI, V27, P419, DOI 10.1146/annurev.neuro.27.070203.144152; Eiraku M, 2008, CELL STEM CELL, V3, P519, DOI 10.1016/j.stem.2008.09.002; Elkabetz Y, 2008, GENE DEV, V22, P152, DOI 10.1101/gad.1616208; Fame RM, 2011, TRENDS NEUROSCI, V34, P41, DOI 10.1016/j.tins.2010.10.002; Fietz SA, 2011, CURR OPIN NEUROBIOL, V21, P23, DOI 10.1016/j.conb.2010.10.002; Fietz SA, 2010, NAT NEUROSCI, V13, P690, DOI 10.1038/nn.2553; FINLAY BL, 1995, SCIENCE, V268, P1578, DOI 10.1126/science.7777856; Gaspard N, 2008, NATURE, V455, P351, DOI 10.1038/nature07287; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Groc L, 2006, TRENDS NEUROSCI, V29, P132, DOI 10.1016/j.tins.2006.01.005; Hansen DV, 2011, NEURON, V70, P645, DOI 10.1016/j.neuron.2011.05.006; Hansen DV, 2010, NATURE, V464, P554, DOI 10.1038/nature08845; Hill RS, 2005, NATURE, V437, P64, DOI 10.1038/nature04103; Hu BY, 2010, METHODS MOL BIOL, V636, P123, DOI 10.1007/978-1-60761-691-7_8; Livesey FJ, 2001, NAT REV NEUROSCI, V2, P109, DOI 10.1038/35053522; Lopez-Bendito G, 2003, NAT REV NEUROSCI, V4, P276, DOI 10.1038/nrn1075; Maden M, 1996, CURR BIOL, V6, P417, DOI 10.1016/S0960-9822(02)00509-2; MCCORMICK DA, 1987, J PHYSIOL-LONDON, V393, P743, DOI 10.1113/jphysiol.1987.sp016851; Molyneaux BJ, 2007, NAT REV NEUROSCI, V8, P427, DOI 10.1038/nrn2151; Mountcastle V. B., 1998, CEREBRAL CORTEX; Nieto M, 2004, J COMP NEUROL, V479, P168, DOI 10.1002/cne.20322; POLLEUX F, 2002, SCI STKE, V136, pPL9; Rakic P, 2009, NAT REV NEUROSCI, V10, P724, DOI 10.1038/nrn2719; Rashid ST, 2010, J CLIN INVEST, V120, P3127, DOI 10.1172/JCI43122; Shen Q, 2006, NAT NEUROSCI, V9, P743, DOI 10.1038/nn1694; Siegenthaler JA, 2009, CELL, V139, P597, DOI 10.1016/j.cell.2009.10.004; Takahashi T, 1996, J NEUROSCI, V16, P6183; Vallier L, 2009, STEM CELLS, V27, P2655, DOI 10.1002/stem.199; Vallier L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006082; Wang XQ, 2011, NAT NEUROSCI, V14, P555, DOI 10.1038/nn.2807; Wonders CP, 2006, NAT REV NEUROSCI, V7, P687, DOI 10.1038/nrn1954; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780; Zhang SC, 2001, NAT BIOTECHNOL, V19, P1129, DOI 10.1038/nbt1201-1129	46	534	552	10	124	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2012	15	3					477	U180		10.1038/nn.3041	http://dx.doi.org/10.1038/nn.3041			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	899CY	22306606	Green Accepted			2022-12-28	WOS:000300793100023
J	Yao, J; Kwon, SE; Gaffaney, JD; Dunning, FM; Chapman, ER				Yao, Jun; Kwon, Sung E.; Gaffaney, Jon D.; Dunning, F. Mark; Chapman, Edwin R.			Uncoupling the roles of synaptotagmin I during endo- and exocytosis of synaptic vesicles	NATURE NEUROSCIENCE			English	Article							ENDOCYTIC SORTING ADAPTER; ADRENAL CHROMAFFIN CELLS; NEUROTRANSMITTER RELEASE; NERVE-TERMINALS; TRANSMITTER RELEASE; C2B DOMAIN; HIPPOCAMPAL-NEURONS; RAPID ENDOCYTOSIS; MEMBRANE-FUSION; CA2+ SENSOR	Synaptotagmin I (syt1) is required for normal rates of synaptic vesicle endo- and exocytosis. However, whether the kinetic defects observed during endocytosis in Syt1 knockout neurons are secondary to defective exocytosis or whether syt1 directly regulates the rate of vesicle retrieval remains unknown. To address this question, we sought to dissociate these two activities. We uncoupled the function of syt1 in exo- and endocytosis in mouse neurons either by re-targeting the protein or via mutagenesis of its tandem C2 domains. The effect of these manipulations on exo- and endocytosis were analyzed using electrophysiology, in conjunction with optical imaging of the vesicle cycle. Our results indicate that syt1 is directly involved in endocytosis. Notably, either of the C2 domains of syt1, C2A or C2B, was able to function as a Ca2+ sensor for endocytosis. Thus, syt1 functions as a dual Ca2+ sensor for both endo- and exocytosis, potentially coupling these two components of the vesicle cycle.	[Yao, Jun; Kwon, Sung E.; Gaffaney, Jon D.; Dunning, F. Mark; Chapman, Edwin R.] Univ Wisconsin, Howard Hughes Med Inst, Madison, WI 53715 USA; [Yao, Jun; Kwon, Sung E.; Gaffaney, Jon D.; Dunning, F. Mark; Chapman, Edwin R.] Univ Wisconsin, Dept Neurosci, Madison, WI USA	Howard Hughes Medical Institute; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Chapman, ER (corresponding author), Univ Wisconsin, Howard Hughes Med Inst, Madison, WI 53715 USA.	chapman@wisc.edu		Chapman, Edwin/0000-0001-9787-8140; Yao, Jun/0000-0002-4916-3412	US National Institutes of Health [MH 61876]; American Heart Association [11POST5720016]; Epilepsy Foundation [09PRE2060819]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH061876] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Epilepsy Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank E. Hui for providing constructs used for the electrophysiology experiments shown in Figure 3. We also thank M.B. Jackson, X. Lou and members of the Chapman laboratory for their comments on this manuscript. This study was supported by a grant from the US National Institutes of Health (MH 61876). J.Y. is supported by an American Heart Association postdoctoral fellowship (11POST5720016). S.E.K. was supported by an Epilepsy Foundation predoctoral fellowship (09PRE2060819). E.R.C. is an Investigator of the Howard Hughes Medical Institute.	Artalejo CR, 1996, NEURON, V16, P195, DOI 10.1016/S0896-6273(00)80036-7; ARTALEJO CR, 1995, P NATL ACAD SCI USA, V92, P8328, DOI 10.1073/pnas.92.18.8328; Balaji J, 2008, J NEUROSCI, V28, P6742, DOI 10.1523/JNEUROSCI.1082-08.2008; Chapman ER, 2008, ANNU REV BIOCHEM, V77, P615, DOI 10.1146/annurev.biochem.77.062005.101135; Chicka MC, 2008, NAT STRUCT MOL BIOL, V15, P827, DOI 10.1038/nsmb.1463; Clayton EL, 2007, J PHYSIOL-LONDON, V585, P687, DOI 10.1113/jphysiol.2007.137539; Cousin MA, 2001, TRENDS NEUROSCI, V24, P659, DOI 10.1016/S0166-2236(00)01930-5; Diril MK, 2006, DEV CELL, V10, P233, DOI 10.1016/j.devcel.2005.12.011; Earles CA, 2001, J CELL BIOL, V154, P1117, DOI 10.1083/jcb.200105020; Fernandez-Alfonso T, 2004, NEURON, V41, P943, DOI 10.1016/S0896-6273(04)00113-8; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; GODA Y, 1994, P NATL ACAD SCI USA, V91, P12942, DOI 10.1073/pnas.91.26.12942; Granseth B, 2006, NEURON, V51, P773, DOI 10.1016/j.neuron.2006.08.029; Grass I, 2004, J BIOL CHEM, V279, P54872, DOI 10.1074/jbc.M409995200; Haucke V, 2000, EMBO J, V19, P6011, DOI 10.1093/emboj/19.22.6011; Hosoi N, 2009, NEURON, V63, P216, DOI 10.1016/j.neuron.2009.06.010; Hui EF, 2005, P NATL ACAD SCI USA, V102, P5210, DOI 10.1073/pnas.0500941102; Hui EF, 2009, CELL, V138, P709, DOI 10.1016/j.cell.2009.05.049; JORGENSEN EM, 1995, NATURE, V378, P196, DOI 10.1038/378196a0; Jung N, 2007, J CELL BIOL, V179, P1497, DOI 10.1083/jcb.200708107; Koh TW, 2003, TRENDS NEUROSCI, V26, P413, DOI 10.1016/S0166-2236(03)00195-4; Kuromi H, 1997, NEUROSCI RES, V27, P101, DOI 10.1016/S0168-0102(96)01132-7; Liu HS, 2009, J NEUROSCI, V29, P7395, DOI 10.1523/JNEUROSCI.1341-09.2009; Mackler JM, 2002, NATURE, V418, P340, DOI 10.1038/nature00846; Mackler JM, 2001, J COMP NEUROL, V436, P4, DOI 10.1002/cne.1049; Mani M, 2007, NEURON, V56, P1004, DOI 10.1016/j.neuron.2007.10.032; Marek KW, 2002, NEURON, V36, P805, DOI 10.1016/S0896-6273(02)01068-1; Marks B, 1998, CURR BIOL, V8, P740, DOI 10.1016/S0960-9822(98)70297-0; Martens S, 2007, SCIENCE, V316, P1205, DOI 10.1126/science.1142614; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Neale EA, 1999, J CELL BIOL, V147, P1249, DOI 10.1083/jcb.147.6.1249; Neves G, 2001, P NATL ACAD SCI USA, V98, P15282, DOI 10.1073/pnas.261311698; Nicholson-Tomishima K, 2004, P NATL ACAD SCI USA, V101, P16648, DOI 10.1073/pnas.0406968101; Nishiki T, 2004, J NEUROSCI, V24, P6127, DOI 10.1523/JNEUROSCI.1563-04.2004; Nishiki T, 2004, J NEUROSCI, V24, P8542, DOI 10.1523/JNEUROSCI.2545-04.2004; Poskanzer KE, 2006, NEURON, V50, P49, DOI 10.1016/j.neuron.2006.02.021; Poskanzer KE, 2003, NATURE, V426, P559, DOI 10.1038/nature02184; Rhee JS, 2005, P NATL ACAD SCI USA, V102, P18664, DOI 10.1073/pnas.0509153102; Schmidt A, 1999, NATURE, V401, P133, DOI 10.1038/43613; Stevens CF, 2003, NEURON, V39, P299, DOI 10.1016/S0896-6273(03)00432-X; Walther K, 2004, P NATL ACAD SCI USA, V101, P964, DOI 10.1073/pnas.0307862100; Walther K, 2001, EMBO REP, V2, P634, DOI 10.1093/embo-reports/kve134; Wu W, 2005, J NEUROSCI, V25, P11676, DOI 10.1523/JNEUROSCI.2972-05.2005; Wu XS, 2009, NAT NEUROSCI, V12, P1003, DOI 10.1038/nn.2355; Zhang B, 2002, TRAFFIC, V3, P452, DOI 10.1034/j.1600-0854.2002.30702.x; ZHANG JZ, 1994, CELL, V78, P751, DOI 10.1016/S0092-8674(94)90442-1; Zhu YL, 2009, NEURON, V61, P397, DOI 10.1016/j.neuron.2008.12.024	47	85	86	0	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2012	15	2					243	249		10.1038/nn.3013	http://dx.doi.org/10.1038/nn.3013			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	882ZX	22197832	Green Accepted			2022-12-28	WOS:000299603500015
J	Shigetomi, E; Tong, XP; Kwan, KY; Corey, DP; Khakh, BS				Shigetomi, Eiji; Tong, Xiaoping; Kwan, Kelvin Y.; Corey, David P.; Khakh, Baljit S.			TRPA1 channels regulate astrocyte resting calcium and inhibitory synapse efficacy through GAT-3	NATURE NEUROSCIENCE			English	Article							GABA TRANSPORTERS; NEURAL ACTIVITY; GLIAL-CELLS; CA2+ ENTRY; ACTIVATION; RELEASE; MICE; CONTRIBUTES; EXCITATION; INDICATORS	Astrocytes contribute to the formation and function of synapses and are found throughout the brain, where they show intracellular store-mediated Ca(2+) signals. Here, using a membrane-tethered, genetically encoded calcium indicator (Lck-GCaMP3), we report the serendipitous discovery of a new type of Ca(2+) signal in rat hippocampal astrocyte-neuron cocultures. We found that Ca(2+) fluxes mediated by transient receptor potential A1 (TRPA1) channels gave rise to frequent and highly localized 'spotty' Ca(2+) microdomains near the membrane that contributed appreciably to resting Ca(2+) in astrocytes. Mechanistic evaluations in brain slices showed that decreases in astrocyte resting Ca(2+) concentrations mediated by TRPA1 channels decreased interneuron inhibitory synapse efficacy by reducing GABA transport by GAT-3, thus elevating extracellular GABA. Our data show how a transmembrane Ca(2+) source (TRPA1) targets a transporter (GAT-3) in astrocytes to regulate inhibitory synapses.	[Shigetomi, Eiji; Tong, Xiaoping; Khakh, Baljit S.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Physiol, Los Angeles, CA 90095 USA; [Kwan, Kelvin Y.; Corey, David P.] Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Neurobiol, Boston, MA 02115 USA; [Khakh, Baljit S.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Khakh, BS (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Physiol, Los Angeles, CA 90095 USA.	bkhakh@mednet.ucla.edu	SHIGETOMI, EIJI/I-2372-2012	Corey, David/0000-0003-4497-6016; Tong, Xiaoping/0000-0002-0908-8091; Kwan, Kelvin/0000-0002-8617-5543; Shigetomi, Eiji/0000-0002-5267-6155	US National Institutes of Health National Institute of Neurological Disorders and Stroke [NS060677]; Whitehall Foundation [NS071292, NS063186]; Stein-Oppenheimer Endowment; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS071292, R01NS060677, R21NS063186] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC000304] Funding Source: NIH RePORTER	US National Institutes of Health National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Whitehall Foundation; Stein-Oppenheimer Endowment; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	The authors are indebted to T.J. O'Dell and M. V. Sofroniew for discussions during the course of these experiments. The authors are grateful to E. Toulme for assistance with western blots, to M. Hamby for tips on astrocyte-enriched cultures and to S. Kracun for molecular biology help and discussions. Thanks to M. Nedergaard for discussions during the early stages of this project. Special thanks to members of the Astrocyte Biology and Biophysics Affinity Group at UCLA for discussions. Thanks to A. Patapoutian (mouse TRPA1; The Scripps Research Institute), D. Julius (rat TRPA1; University of California San Francisco) and Y. Gwack (mCherry; University of California Los Angeles) for sharing plasmids. Thanks to N. Brecha (University of California Los Angeles) for GAT-1 and GAT-3 antibodies. Our work was supported mainly by US National Institutes of Health National Institute of Neurological Disorders and Stroke grant NS060677 and partly by grants NS071292 and NS063186, the Whitehall Foundation and a Stein-Oppenheimer Endowment Award (to B. S. K.).	Agulhon C, 2008, NEURON, V59, P932, DOI 10.1016/j.neuron.2008.09.004; Agulhon C, 2010, SCIENCE, V327, P1250, DOI 10.1126/science.1184821; Attwell D, 2010, NATURE, V468, P232, DOI 10.1038/nature09613; Bandell M, 2004, NEURON, V41, P849, DOI 10.1016/S0896-6273(04)00150-3; Bomben VC, 2011, J CELL PHYSIOL, V226, P1879, DOI 10.1002/jcp.22518; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Chen J, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-3; Chiu CS, 2002, J NEUROSCI, V22, P10251; Clapham D. E., 2009, ENCY NEUROSCIENCE, P1109; Deken SL, 2003, J NEUROSCI, V23, P1563; Everaerts W, 2011, CURR BIOL, V21, P316, DOI 10.1016/j.cub.2011.01.031; Garcia-Anoveros J., 2007, V179, P347; Glykys J, 2007, NEURON, V56, P763, DOI 10.1016/j.neuron.2007.11.002; Golovina VA, 2005, J PHYSIOL-LONDON, V564, P737, DOI 10.1113/jphysiol.2005.085035; Gordon GRJ, 2009, NEURON, V64, P391, DOI 10.1016/j.neuron.2009.10.021; Grimaldi M, 2003, J NEUROSCI, V23, P4737; Halassa MM, 2007, J NEUROSCI, V27, P6473, DOI 10.1523/JNEUROSCI.1419-07.2007; Halassa MM, 2010, ANNU REV PHYSIOL, V72, P335, DOI 10.1146/annurev-physiol-021909-135843; Henneberger C, 2010, NATURE, V463, P232, DOI 10.1038/nature08673; Hill K, 2009, CELL CALCIUM, V45, P155, DOI 10.1016/j.ceca.2008.08.001; Hires SA, 2008, BRAIN CELL BIOL, V36, P69, DOI 10.1007/s11068-008-9029-4; Jordt SE, 2004, NATURE, V427, P260, DOI 10.1038/nature02282; Karashima Y, 2007, J NEUROSCI, V27, P9874, DOI 10.1523/JNEUROSCI.2221-07.2007; Kuchibhotla KV, 2009, SCIENCE, V323, P1211, DOI 10.1126/science.1169096; Kwan KY, 2006, NEURON, V50, P277, DOI 10.1016/j.neuron.2006.03.042; Lee S, 2010, SCIENCE, V330, P790, DOI 10.1126/science.1184334; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Malarkey EB, 2008, GLIA, V56, P821, DOI 10.1002/glia.20656; McNamara CR, 2007, P NATL ACAD SCI USA, V104, P13525, DOI 10.1073/pnas.0705924104; Moss FJ, 2009, J GEN PHYSIOL, V134, P489, DOI 10.1085/jgp.200910314; Nilius B, 2011, J PHYSIOL-LONDON, V589, P1543, DOI 10.1113/jphysiol.2010.200717; Ortinski PI, 2010, NAT NEUROSCI, V13, P584, DOI 10.1038/nn.2535; Overstreet LS, 2000, J NEUROSCI, V20, P7914; Reeves AMB, 2011, J NEUROSCI, V31, P9353, DOI 10.1523/JNEUROSCI.0127-11.2011; Ribak CE, 1996, J COMP NEUROL, V367, P595, DOI 10.1002/(SICI)1096-9861(19960415)367:4<595::AID-CNE9>3.0.CO;2-#; Shigetomi E, 2009, J VIS EXP, V26, P1142; Shigetomi E, 2008, J NEUROSCI, V28, P6659, DOI 10.1523/JNEUROSCI.1717-08.2008; Shigetomi E, 2010, NEURON GLIA BIOL, V6, P183, DOI 10.1017/S1740925X10000219; Shigetomi E, 2010, NAT NEUROSCI, V13, P759, DOI 10.1038/nn.2557; Shirakawa H, 2010, J NEUROSCI, V30, P13116, DOI 10.1523/JNEUROSCI.1890-10.2010; Soeller C, 2004, PROG BIOPHYS MOL BIO, V85, P141, DOI 10.1016/j.pbiomolbio.2003.12.006; Song IS, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1377; SONTHEIMER H, 1994, GLIA, V11, P156, DOI 10.1002/glia.440110210; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Wang D, 2005, J BIOL CHEM, V280, P18703, DOI 10.1074/jbc.M500381200; Wang YY, 2008, J BIOL CHEM, V283, P32691, DOI 10.1074/jbc.M803568200; Wu LJ, 2010, PHARMACOL REV, V62, P381, DOI 10.1124/pr.110.002725; Xiang Y, 2010, NATURE, V468, P921, DOI 10.1038/nature09576; Xu HX, 2006, NAT NEUROSCI, V9, P628, DOI 10.1038/nn1692; Zurborg S, 2007, NAT NEUROSCI, V10, P277, DOI 10.1038/nn1843	50	308	317	1	54	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2012	15	1					70	U215		10.1038/nn.3000	http://dx.doi.org/10.1038/nn.3000			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	866VO	22158513	Green Accepted			2022-12-28	WOS:000298414400016
J	Sumioka, A; Brown, TE; Kato, AS; Bredt, DS; Kauer, JA; Tomita, S				Sumioka, Akio; Brown, Travis E.; Kato, Akihiko S.; Bredt, David S.; Kauer, Julie A.; Tomita, Susumu			PDZ binding of TARP gamma-8 controls synaptic transmission but not synaptic plasticity	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; AMPA RECEPTORS; TARP GAMMA-8; HIPPOCAMPAL; STARGAZIN; SURFACE; PSD-95	The reduction in synaptic transmission and plasticity in mice lacking the hippocampus-enriched AMPA receptor (AMPAR) auxiliary subunit TARP gamma-8 could be a result of a reduction in AMPAR expression or of the direct action of gamma-8. We generated TARP gamma-8 Delta 4 knock-in mice lacking the C-terminal PDZ ligand. We found that synaptic transmission and AMPARs were reduced in the mutant mice, but extrasynaptic AMPAR expression and long-term potentiation (LTP) were unaltered. Our findings suggest that there are distinct TARP-dependent mechanisms for synaptic transmission and LTP.	[Sumioka, Akio; Tomita, Susumu] Yale Univ, Sch Med, Program Cellular Neurosci Neurodegenerat & Repair, New Haven, CT 06520 USA; [Sumioka, Akio; Tomita, Susumu] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06510 USA; [Brown, Travis E.; Kauer, Julie A.] Brown Univ, Dept Neurosci, Providence, RI 02912 USA; [Kato, Akihiko S.; Bredt, David S.] Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA	Yale University; Yale University; Brown University; Eli Lilly	Tomita, S (corresponding author), Yale Univ, Sch Med, Program Cellular Neurosci Neurodegenerat & Repair, New Haven, CT 06520 USA.	julie_kauer@brown.edu; susumu.tomita@yale.edu		Kauer, Julie/0000-0002-3362-1642	National Institute of Mental Health [MH077939]; US National Institutes of Health [NS050570, NS065251]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH077939, R56MH077939] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050570, R01NS065251] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank R. Nicoll (University of California, San Francisco) for providing the gamma-8<SUP>-/-</SUP> mouse. The monoclonal antibody to SynDIG1 was developed by and/or obtained from the UC Davis/US National Institutes of Health NeuroMab. This work is supported by grants from the National Institute of Mental Health (MH077939 to S. T.) and from the US National Institutes of Health (NS050570 and NS065251 to J.A.K.).	Chen L, 2000, NATURE, V408, P936, DOI 10.1038/35050030; Ehrlich I, 2004, J NEUROSCI, V24, P916, DOI 10.1523/JNEUROSCI.4733-03.2004; Fukaya M, 2006, EUR J NEUROSCI, V24, P2177, DOI 10.1111/j.1460-9568.2006.05081.x; Hashimoto K, 1999, J NEUROSCI, V19, P6027, DOI 10.1523/JNEUROSCI.19-14-06027.1999; Inamura M, 2006, NEUROSCI RES, V55, P45, DOI 10.1016/j.neures.2006.01.004; Jackson AC, 2011, NEURON, V70, P178, DOI 10.1016/j.neuron.2011.04.007; Kato AS, 2010, NEURON, V68, P1082, DOI 10.1016/j.neuron.2010.11.026; Milstein AD, 2009, P NATL ACAD SCI USA, V106, P11348, DOI 10.1073/pnas.0905570106; Opazo P, 2010, NEURON, V67, P239, DOI 10.1016/j.neuron.2010.06.007; Rouach N, 2005, NAT NEUROSCI, V8, P1525, DOI 10.1038/nn1551; Schnell E, 2002, P NATL ACAD SCI USA, V99, P13902, DOI 10.1073/pnas.172511199; Stein V, 2003, J NEUROSCI, V23, P5503; Xu W, 2008, NEURON, V57, P248, DOI 10.1016/j.neuron.2007.11.027; Zamanillo D, 1999, SCIENCE, V284, P1805, DOI 10.1126/science.284.5421.1805	14	51	52	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2011	14	11					1410	1412		10.1038/nn.2952	http://dx.doi.org/10.1038/nn.2952			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	841NI	22002768	Green Accepted			2022-12-28	WOS:000296518600014
J	Winkler, EA; Bell, RD; Zlokovic, BV				Winkler, Ethan A.; Bell, Robert D.; Zlokovic, Berislav V.			Central nervous system pericytes in health and disease	NATURE NEUROSCIENCE			English	Review							BLOOD-BRAIN-BARRIER; SMOOTH-MUSCLE-CELLS; PDGF BETA-RECEPTOR; ALZHEIMERS-DISEASE; DIABETIC-RETINOPATHY; TGF-BETA; BONE-MARROW; N-CADHERIN; ENDOTHELIAL SURVIVAL; FUNCTIONAL HYPEREMIA	Pericytes are uniquely positioned within the neurovascular unit to serve as vital integrators, coordinators and effectors of many neurovascular functions, including angiogenesis, blood-brain barrier (BBB) formation and maintenance, vascular stability and angioarchitecture, regulation of capillary blood flow and clearance of toxic cellular byproducts necessary for proper CNS homeostasis and neuronal function. New studies have revealed that pericyte deficiency in the CNS leads to BBB breakdown and brain hypoperfusion resulting in secondary neurodegenerative changes. Here we review recent progress in understanding the biology of CNS pericytes and their role in health and disease.	[Winkler, Ethan A.; Bell, Robert D.; Zlokovic, Berislav V.] Univ Rochester, Med Ctr, Dept Neurol & Neurosurg, Ctr Neurodegenerat & Vasc Brain Disorders, Rochester, NY 14642 USA	University of Rochester	Zlokovic, BV (corresponding author), Univ Rochester, Med Ctr, Dept Neurol & Neurosurg, Ctr Neurodegenerat & Vasc Brain Disorders, Rochester, NY 14642 USA.	berislav_zlokovic@urmc.rochester.edu			US National Institutes of Health [R37 AG023084, R37 NS34467, HL63290]; Zilkha family; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL063290] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS034467, R01NS034467] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG023084] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Zilkha family; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors thank the US National Institutes of Health (grants R37 AG023084, R37 NS34467 and HL63290) and the Zilkha family for the research support.	Abramsson A, 2003, J CLIN INVEST, V112, P1142, DOI 10.1172/JCI200318549; Abramsson A, 2007, GENE DEV, V21, P316, DOI 10.1101/gad.398207; Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708; Armulik A, 2010, NATURE, V468, P557, DOI 10.1038/nature09522; Ballabh P, 2010, PEDIATR RES, V67, P1, DOI 10.1203/PDR.0b013e3181c1b176; Bautch VL, 2009, CELL ADHES MIGR, V3, P199, DOI 10.4161/cam.3.2.8397; Bell RD, 2010, NEURON, V68, P409, DOI 10.1016/j.neuron.2010.09.043; Bell RD, 2009, NAT CELL BIOL, V11, P143, DOI 10.1038/ncb1819; Bjarnegard M, 2004, DEVELOPMENT, V131, P1847, DOI 10.1242/dev.01080; Bobbie MW, 2010, INVEST OPHTH VIS SCI, V51, P3758, DOI 10.1167/iovs.09-4489; Braun A, 2007, J NEUROSCI, V27, P12012, DOI 10.1523/JNEUROSCI.3281-07.2007; Candelario-Jalil E, 2009, NEUROSCIENCE, V158, P983, DOI 10.1016/j.neuroscience.2008.06.025; Carvalho RLC, 2007, J CELL SCI, V120, P4269, DOI 10.1242/jcs.013169; Chen B, 2010, STROKE, V41, P2348, DOI 10.1161/STROKEAHA.110.584920; Chen ZL, 1997, CELL, V91, P917, DOI 10.1016/S0092-8674(00)80483-3; Chew SSL, 2010, EXP NEUROL, V225, P250, DOI 10.1016/j.expneurol.2010.07.014; Chow N, 2007, P NATL ACAD SCI USA, V104, P823, DOI 10.1073/pnas.0608251104; Daneman R, 2010, NATURE, V468, P562, DOI 10.1038/nature09513; Darland DC, 2003, DEV BIOL, V264, P275, DOI 10.1016/j.ydbio.2003.08.015; Dohgu S, 2005, BRAIN RES, V1038, P208, DOI 10.1016/j.brainres.2005.01.027; Dore-Duffy P, 2000, MICROVASC RES, V60, P55, DOI 10.1006/mvre.2000.2244; Dore-Duffy P, 2006, J CEREBR BLOOD F MET, V26, P613, DOI 10.1038/sj.jcbfm.9600272; Enge M, 2002, EMBO J, V21, P4307, DOI 10.1093/emboj/cdf418; Etchevers HC, 2001, DEVELOPMENT, V128, P1059; Farkas E, 2001, PROG NEUROBIOL, V64, P575, DOI 10.1016/S0301-0082(00)00068-X; Fernandez-Klett F, 2010, P NATL ACAD SCI USA, V107, P22290, DOI 10.1073/pnas.1011321108; FLORES LD, 2009, HISTOL HISTOPATHOL, V24, P909; Gaengel K, 2009, ARTERIOSCL THROM VAS, V29, P630, DOI 10.1161/ATVBAHA.107.161521; Gariano RF, 2005, NATURE, V438, P960, DOI 10.1038/nature04482; Geraldes P, 2009, NAT MED, V15, P1298, DOI 10.1038/nm.2052; Gerhardt H, 2000, DEV DYNAM, V218, P472, DOI 10.1002/1097-0177(200007)218:3<472::AID-DVDY1008>3.0.CO;2-#; Gerhardt H, 2003, CELL TISSUE RES, V314, P15, DOI 10.1007/s00441-003-0745-x; Goumans MJ, 2002, EMBO J, V21, P1743, DOI 10.1093/emboj/21.7.1743; Hamilton Nicola B, 2010, Front Neuroenergetics, V2, DOI 10.3389/fnene.2010.00005; Hammes HP, 2011, DIABETES, V60, P9, DOI 10.2337/db10-0454; Hammes HP, 2004, DIABETES, V53, P1104, DOI 10.2337/diabetes.53.4.1104; Hellstrom M, 1999, DEVELOPMENT, V126, P3047; Hellstrom M, 2001, J CELL BIOL, V153, P543, DOI 10.1083/jcb.153.3.543; Hirase H, 2004, GLIA, V46, P95, DOI 10.1002/glia.10295; Hofmann JJ, 2007, CIRC RES, V100, P1556, DOI 10.1161/01.RES.0000266408.42939.e4; Iadecola C, 2004, NAT REV NEUROSCI, V5, P347, DOI 10.1038/nrn1387; Iadecola C, 1999, NAT NEUROSCI, V2, P157, DOI 10.1038/5715; Jeansson M, 2011, J CLIN INVEST, V121, P2278, DOI 10.1172/JCI46322; Jin S, 2008, CIRC RES, V102, P1483, DOI 10.1161/CIRCRESAHA.107.167965; Kamouchi M, 2004, MOL BRAIN RES, V126, P114, DOI 10.1016/j.molbrainres.2004.03.008; Kokovay E, 2006, J CEREBR BLOOD F MET, V26, P545, DOI 10.1038/sj.jcbfm.9600214; Korn J, 2002, J COMP NEUROL, V442, P78, DOI 10.1002/cne.1423; Kurz H, 2009, CELL ADHES MIGR, V3, P205, DOI 10.4161/cam.3.2.7855; Lamagna C, 2006, J LEUKOCYTE BIOL, V80, P677, DOI 10.1189/jlb.0506309; Lebrin F, 2005, CARDIOVASC RES, V65, P599, DOI 10.1016/j.cardiores.2004.10.036; LEVEEN P, 1994, GENE DEV, V8, P1875, DOI 10.1101/gad.8.16.1875; Li FF, 2011, DEV CELL, V20, P291, DOI 10.1016/j.devcel.2011.01.011; Lindahl P, 1997, SCIENCE, V277, P242, DOI 10.1126/science.277.5323.242; Lindblom P, 2003, GENE DEV, V17, P1835, DOI 10.1101/gad.266803; Liu H, 2010, CIRC RES, V107, P860, DOI 10.1161/CIRCRESAHA.110.218271; Liu H, 2009, CIRC RES, V104, P466, DOI 10.1161/CIRCRESAHA.108.184846; Mhatre M, 2004, NEUROBIOL AGING, V25, P783, DOI 10.1016/j.neurobiolaging.2003.07.007; Moskowitz MA, 2010, NEURON, V67, P181, DOI 10.1016/j.neuron.2010.07.002; Niwa K, 2000, P NATL ACAD SCI USA, V97, P9735, DOI 10.1073/pnas.97.17.9735; Ozerdem Ugur, 2004, Angiogenesis, V7, P269, DOI 10.1007/s10456-004-4182-6; Ozerdem Ugur, 2003, Angiogenesis, V6, P241, DOI 10.1023/B:AGEN.0000021401.58039.a9; Paik JH, 2004, GENE DEV, V18, P2392, DOI 10.1101/gad.1227804; Paul J, 2007, J EXP MED, V204, P1999, DOI 10.1084/jem.20070304; Peppiatt CM, 2006, NATURE, V443, P700, DOI 10.1038/nature05193; Pfister F, 2010, ACTA DIABETOL, V47, P59, DOI 10.1007/s00592-009-0099-2; Piquer-Gil M, 2009, J CEREBR BLOOD F MET, V29, P480, DOI 10.1038/jcbfm.2008.150; Quaegebeur A, 2010, NEURON, V68, P321, DOI 10.1016/j.neuron.2010.10.024; Regan JN, 2009, CIRC RES, V104, P419, DOI 10.1161/CIRCRESAHA.109.194233; Saharinen P, 2008, NAT CELL BIOL, V10, P527, DOI 10.1038/ncb1715; Saunders WB, 2006, J CELL BIOL, V175, P179, DOI 10.1083/jcb.200603176; SHEPRO D, 1993, FASEB J, V7, P1031, DOI 10.1096/fasebj.7.11.8370472; Sieczkiewicz GJ, 2003, MICROVASC RES, V66, P190, DOI 10.1016/S0026-2862(03)00055-4; SORIANO P, 1994, GENE DEV, V8, P1888, DOI 10.1101/gad.8.16.1888; Stenzel D, 2009, BLOOD, V114, P915, DOI 10.1182/blood-2008-10-186239; Stewart KS, 2011, BLOOD, V117, P719, DOI 10.1182/blood-2010-05-284869; Stratman AN, 2010, BLOOD, V116, P4720, DOI 10.1182/blood-2010-05-286872; Stratman AN, 2009, BLOOD, V114, P5091, DOI 10.1182/blood-2009-05-222364; Tallquist MD, 2003, PLOS BIOL, V1, P288, DOI 10.1371/journal.pbio.0000052; Tsai PS, 2009, J NEUROSCI, V29, P14553, DOI 10.1523/JNEUROSCI.3287-09.2009; Van Geest RJ, 2010, INVEST OPHTH VIS SCI, V51, P1857, DOI 10.1167/iovs.09-4181; VERBEEK MM, 1995, J IMMUNOL, V154, P5876; VINTERS HV, 1994, ULTRASTRUCT PATHOL, V18, P333, DOI 10.3109/01913129409023202; Vinukonda G, 2010, STROKE, V41, P1766, DOI 10.1161/STROKEAHA.110.588400; Virgintino Daniela, 2007, Angiogenesis, V10, P35, DOI 10.1007/s10456-006-9061-x; Wakui S, 2006, LAB INVEST, V86, P1172, DOI 10.1038/labinvest.3700476; Walshe TE, 2011, INVEST OPHTH VIS SCI, V52, P4472, DOI 10.1167/iovs.10-7061; Walshe TE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005149; Weiss N, 2009, BBA-BIOMEMBRANES, V1788, P842, DOI 10.1016/j.bbamem.2008.10.022; Wilhelmus MMM, 2007, AM J PATHOL, V171, P1989, DOI 10.2353/ajpath.2007.070050; Winkler EA, 2011, DEV CELL, V20, P279, DOI 10.1016/j.devcel.2011.03.002; Winkler EA, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-32; WISNIEWSKI HM, 1992, ACTA NEUROPATHOL, V84, P117, DOI 10.1007/BF00311383; Wu ZH, 2005, NAT MED, V11, P959, DOI 10.1038/nm1287; Yemisci M, 2009, NAT MED, V15, P1031, DOI 10.1038/nm.2022; Zachariah MA, 2010, SCIENCE, V328, P1129, DOI 10.1126/science.1188222; Zhong ZH, 2008, NAT NEUROSCI, V11, P420, DOI 10.1038/nn2073; Zhong ZH, 2009, J CLIN INVEST, V119, P3437, DOI 10.1172/JCI38476; Zlokovic BV, 2008, NEUROTHERAPEUTICS, V5, P409, DOI 10.1016/j.nurt.2008.05.011; Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003; Zlokovic BV, 2005, TRENDS NEUROSCI, V28, P202, DOI 10.1016/j.tins.2005.02.001	100	621	646	6	121	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2011	14	11					1398	1405		10.1038/nn.2946	http://dx.doi.org/10.1038/nn.2946			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	841NI	22030551	Green Accepted			2022-12-28	WOS:000296518600012
J	Xu, NJ; Sun, SY; Gibson, JR; Henkemeyer, M				Xu, Nan-Jie; Sun, Suya; Gibson, Jay R.; Henkemeyer, Mark			A dual shaping mechanism for postsynaptic ephrin-B3 as a receptor that sculpts dendrites and synapses	NATURE NEUROSCIENCE			English	Article							REVERSE; EPHB; BINDING; SYNTENIN; SPINES; PICK1; GRB4; PHOSPHORYLATION; TRAFFICKING; MODULATION	As the neural network becomes wired, postsynaptic signaling molecules are thought to control the growth of dendrites and synapses. However, how these molecules are coordinated to sculpt postsynaptic structures is less well understood. We find that ephrin-B3, a transmembrane ligand for Eph receptors, functions postsynaptically as a receptor to transduce reverse signals into developing dendrites of mouse hippocampal neurons. Both tyrosine phosphorylation-dependent GRB4 SH2/SH3 adaptor-mediated signals and PSD-95-discs large-zona occludens-1 (PDZ) domain-dependent signals are required for inhibition of dendrite branching, whereas only PDZ interactions are necessary for spine formation and excitatory synaptic function. PICK1 and syntenin, two PDZ domain proteins, participate with ephrin-B3 in these postsynaptic activities. PICK1 has a specific role in spine and synapse formation, and syntenin promotes both dendrite pruning and synapse formation to build postsynaptic structures that are essential for neural circuits. The study thus dissects ephrin-B reverse signaling into three distinct intracellular pathways and protein-protein interactions that mediate the maturation of postsynaptic neurons.	[Xu, Nan-Jie; Henkemeyer, Mark] Univ Texas SW Med Ctr Dallas, Dept Dev Biol, Dallas, TX 75390 USA; [Xu, Nan-Jie; Henkemeyer, Mark] Univ Texas SW Med Ctr Dallas, Kent Waldrep Ctr Basic Res Nerve Growth & Regener, Dallas, TX 75390 USA; [Sun, Suya] Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA; [Gibson, Jay R.] Univ Texas SW Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Henkemeyer, M (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Dev Biol, Dallas, TX 75390 USA.	Mark.Henkemeyer@UTSouthwestern.edu	XU, Nan-Jie/AAJ-4363-2020; Xu, Nan-Jie/N-3391-2016	XU, Nan-Jie/0000-0003-2147-3352; Xu, Nan-Jie/0000-0003-2147-3352; Henkemeyer, Mark/0000-0002-7525-1061	US National Institutes of Health [R01 MH66332]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH066332] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank J. Sanes (Harvard University) for Thy1-GFP-M transgenic mice, G. Chenaux (University of Texas Southwestern Medical Center) for Efnb2<SUP>6F Delta V</SUP> mice, H. Zeng (Allen Institute for Brain Science) for CAGG-tdTomato transgenic mice, A. McMahon (Harvard University) for CAGG-Cre-ER (TM) transgenic mice, A. Bergemann (Mount Sinai Medical Center) for eB3 cDNA pEXPRmELF3, I. M. Ethell (University of California, Riverside) for HA-syndecan-2 plasmid, I. Bezprozvanny, B. Miller and A. Patel (University of Texas Southwestern) for electrophysiological recording setups and assistance with electrophysiology, and F. Sprouse (University of Texas Southwestern Medical Center) for genotyping. This research was supported by a US National Institutes of Health grant (R01 MH66332) to M. H.	Antion MD, 2010, MOL CELL NEUROSCI, V45, P378, DOI 10.1016/j.mcn.2010.07.011; Aoto J, 2007, J NEUROSCI, V27, P7508, DOI 10.1523/JNEUROSCI.0705-07.2007; Beekman JM, 2008, J CELL SCI, V121, P1349, DOI 10.1242/jcs.026401; Boukerche H, 2005, CANCER RES, V65, P10901, DOI 10.1158/0008-5472.CAN-05-1614; Bouzioukh F, 2007, J NEUROSCI, V27, P11279, DOI 10.1523/JNEUROSCI.3393-07.2007; Bush JO, 2009, GENE DEV, V23, P1586, DOI 10.1101/gad.1807209; Citri A, 2010, J NEUROSCI, V30, P16437, DOI 10.1523/JNEUROSCI.4478-10.2010; Contractor A, 2002, SCIENCE, V296, P1864, DOI 10.1126/science.1069081; Cowan CA, 2002, TRENDS CELL BIOL, V12, P339, DOI 10.1016/S0962-8924(02)02317-6; Cowan CA, 2001, NATURE, V413, P174, DOI 10.1038/35093123; Dalva MB, 2000, CELL, V103, P945, DOI 10.1016/S0092-8674(00)00197-5; Dravis C, 2004, DEV BIOL, V271, P272, DOI 10.1016/j.ydbio.2004.03.027; Essmann CL, 2008, NAT NEUROSCI, V11, P1035, DOI 10.1038/nn.2171; Ethell IM, 2005, PROG NEUROBIOL, V75, P161, DOI 10.1016/j.pneurobio.2005.02.003; Ethell IM, 1999, J CELL BIOL, V144, P575, DOI 10.1083/jcb.144.3.575; Ethell IM, 2001, NEURON, V31, P1001, DOI 10.1016/S0896-6273(01)00440-8; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Grootjans JJ, 2000, J BIOL CHEM, V275, P19933, DOI 10.1074/jbc.M002459200; Grunwald IC, 2004, NAT NEUROSCI, V7, P33, DOI 10.1038/nn1164; Grunwald IC, 2001, NEURON, V32, P1027, DOI 10.1016/S0896-6273(01)00550-5; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Henderson JT, 2001, NEURON, V32, P1041, DOI 10.1016/S0896-6273(01)00553-0; Henkemeyer M, 2003, J CELL BIOL, V163, P1313, DOI 10.1083/jcb.200306033; Henkemeyer M, 1996, CELL, V86, P35, DOI 10.1016/S0092-8674(00)80075-6; Hirbec H, 2005, MOL CELL NEUROSCI, V28, P737, DOI 10.1016/j.mcn.2004.12.005; Holland SJ, 1996, NATURE, V383, P722, DOI 10.1038/383722a0; Jin WY, 2006, J NEUROSCI, V26, P2380, DOI 10.1523/JNEUROSCI.3503-05.2006; Klein R, 2009, NAT NEUROSCI, V12, P15, DOI 10.1038/nn.2231; Lai KO, 2009, CURR OPIN NEUROBIOL, V19, P275, DOI 10.1016/j.conb.2009.04.009; Lim BK, 2008, NAT NEUROSCI, V11, P160, DOI 10.1038/nn2033; Lin D, 1999, J BIOL CHEM, V274, P3726, DOI 10.1074/jbc.274.6.3726; Lin YL, 2007, J CELL BIOL, V177, P829, DOI 10.1083/jcb.200608121; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; McClelland AC, 2010, P NATL ACAD SCI USA, V107, P8830, DOI 10.1073/pnas.0910644107; McClelland AC, 2009, P NATL ACAD SCI USA, V106, P20487, DOI 10.1073/pnas.0811862106; Nakamura Y, 2011, EMBO J, V30, P719, DOI 10.1038/emboj.2010.357; Parrish JZ, 2007, ANNU REV NEUROSCI, V30, P399, DOI 10.1146/annurev.neuro.29.051605.112907; Pasquale EB, 2008, CELL, V133, P38, DOI 10.1016/j.cell.2008.03.011; Rodenas-Ruano A, 2006, DEV BIOL, V292, P34, DOI 10.1016/j.ydbio.2006.01.004; Rodriguez A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001997; Segura I, 2007, NAT NEUROSCI, V10, P301, DOI 10.1038/nn1858; Takasu MA, 2002, SCIENCE, V295, P491, DOI 10.1126/science.1065983; Thakar S, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1445; Threadgill R, 1997, NEURON, V19, P625, DOI 10.1016/S0896-6273(00)80376-1; Torres R, 1998, NEURON, V21, P1453, DOI 10.1016/S0896-6273(00)80663-7; Williams SE, 2003, NEURON, V39, P919, DOI 10.1016/j.neuron.2003.08.017; Xu JY, 2006, NEUROSIGNALS, V15, P190, DOI 10.1159/000098482; Xu NJ, 2009, NAT NEUROSCI, V12, P268, DOI 10.1038/nn.2254; Yokoyama N, 2001, NEURON, V29, P85, DOI 10.1016/S0896-6273(01)00182-9; Zimmermann P, 2005, DEV CELL, V9, P377, DOI 10.1016/j.devcel.2005.07.011	50	56	61	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2011	14	11					1421	U92		10.1038/nn.2931	http://dx.doi.org/10.1038/nn.2931			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	841NI	21964490	Green Accepted			2022-12-28	WOS:000296518600018
J	Tian, XL; Li, J; Valakh, V; DiAntonio, A; Wu, CL				Tian, Xiaolin; Li, Jing; Valakh, Vera; DiAntonio, Aaron; Wu, Chunlai			Drosophila Rae1 controls the abundance of the ubiquitin ligase Highwire in post-mitotic neurons	NATURE NEUROSCIENCE			English	Article							MESSENGER-RNA STABILITY; MAP KINASE PATHWAY; C-ELEGANS RPM-1; SYNAPTIC GROWTH; WALLENDA/DLK KINASE; AXON REGENERATION; FORMATION REVEALS; MYC PAM; PROTEIN; COMPLEX	The evolutionarily conserved Highwire (Hiw)/Drosophila Fsn E3 ubiquitin ligase complex is required for normal synaptic morphology during development and axonal regeneration after injury. However, little is known about the molecular mechanisms that regulate the Hiw E3 ligase complex. Using tandem affinity purification techniques, we identified Drosophila Rae1 as a previously unknown component of the Hiw/Fsn complex. Loss of Rae1 function in neurons results in morphological defects at the neuromuscular junction that are similar to those seen in hiw mutants. We found that Rae1 physically and genetically interacts with Hiw and restrains synaptic terminal growth by regulating the MAP kinase kinase kinase Wallenda. Moreover, we found that the Rae1 is both necessary and sufficient to promote Hiw protein abundance, and it does so by binding to Hiw and protecting Hiw from autophagy-mediated degradation. These results describe a previously unknown mechanism that selectively controls Hiw protein abundance during synaptic development.	[Tian, Xiaolin; Li, Jing; Wu, Chunlai] Louisiana State Univ, Neurosci Ctr Excellence, Hlth Sci Ctr, New Orleans, LA USA; [Valakh, Vera; DiAntonio, Aaron] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Washington University (WUSTL)	Wu, CL (corresponding author), Louisiana State Univ, Neurosci Ctr Excellence, Hlth Sci Ctr, New Orleans, LA USA.	cwu@lsuhsc.edu		DiAntonio, Aaron/0000-0002-7262-0968	US National Institutes of Health [NS070962, DA020812]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS070962] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA020812] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We are particularly grateful to D. Sitterlin for providing the antibody to Rae1. We would like to thank the A.J. Siteman Cancer Center at the Washington University School of Medicine and Barnes-Jewish Hospital in St. Louis, Missouri, and the Department of Physiology at the Louisiana State University Health Sciences Center in New Orleans for the use of their proteomic core facilities. We are grateful to T. Neufeld and the Bloomington Stock Center for fly stocks, and the Developmental Studies Hybridoma Bank for antibodies. We also thank B. Grill and Y. Jin for helpful comments. This work is supported by grants from the US National Institutes of Health (NS070962 to C. W. and DA020812 to A.D.).	Abrams B, 2008, DEV DYNAM, V237, P630, DOI 10.1002/dvdy.21446; Bloom AJ, 2007, GENE DEV, V21, P2593, DOI 10.1101/gad.1592107; Bolognani F, 2008, J NEUROSCI RES, V86, P481, DOI 10.1002/jnr.21473; BROWN JA, 1995, J BIOL CHEM, V270, P7411, DOI 10.1074/jbc.270.13.7411; Burgess RW, 2004, MOL CELL BIOL, V24, P1096, DOI 10.1128/MCB.24.3.1096-1105.2004; Candiano G, 2004, ELECTROPHORESIS, V25, P1327, DOI 10.1002/elps.200305844; Collins CA, 2006, NEURON, V51, P57, DOI 10.1016/j.neuron.2006.05.026; Conne B, 2000, NAT MED, V6, P637, DOI 10.1038/76211; Culican SM, 2009, MOL CELL NEUROSCI, V41, P304, DOI 10.1016/j.mcn.2009.04.001; D'Souza J, 2005, DEVELOPMENT, V132, P247, DOI 10.1242/dev.01578; Daniels RW, 2006, NEURON, V49, P11, DOI 10.1016/j.neuron.2005.11.032; DiAntonio A, 2001, NATURE, V412, P449, DOI 10.1038/35086595; Garbarini N, 2008, CELL PHYSIOL BIOCHEM, V22, P31, DOI 10.1159/000149781; Grill B, 2007, NEURON, V55, P587, DOI 10.1016/j.neuron.2007.07.009; Guo QB, 1998, P NATL ACAD SCI USA, V95, P9172, DOI 10.1073/pnas.95.16.9172; Hammarlund M, 2009, SCIENCE, V323, P802, DOI 10.1126/science.1165527; Jeganathan KB, 2005, NATURE, V438, P1036, DOI 10.1038/nature04221; Johansen T, 2011, AUTOPHAGY, V7, P279, DOI 10.4161/auto.7.3.14487; Kraemer D, 2001, EUR J CELL BIOL, V80, P733, DOI 10.1078/0171-9335-00216; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Lewcock JW, 2007, NEURON, V56, P604, DOI 10.1016/j.neuron.2007.09.009; Liao EH, 2004, NATURE, V430, P345, DOI 10.1038/nature02647; Loureiro J, 1998, CURR BIOL, V8, P622, DOI 10.1016/S0960-9822(98)70249-0; McCabe BD, 2004, NEURON, V41, P891, DOI 10.1016/S0896-6273(04)00073-X; Murthy V, 2004, J BIOL CHEM, V279, P1351, DOI 10.1074/jbc.M310208200; Nakata K, 2005, CELL, V120, P407, DOI 10.1016/j.cell.2004.12.017; Petersen SA, 1997, NEURON, V19, P1237, DOI 10.1016/S0896-6273(00)80415-8; Pierre SC, 2004, EMBO J, V23, P3031, DOI 10.1038/sj.emboj.7600321; Po MD, 2010, CURR OPIN NEUROBIOL, V20, P100, DOI 10.1016/j.conb.2009.12.007; Pritchard CEJ, 1999, J CELL BIOL, V145, P237, DOI 10.1083/jcb.145.2.237; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Saiga T, 2009, MOL CELL BIOL, V29, P3529, DOI 10.1128/MCB.00364-09; Schaefer AM, 2000, NEURON, V26, P345, DOI 10.1016/S0896-6273(00)81168-X; Scholich K, 2001, J BIOL CHEM, V276, P47583, DOI 10.1074/jbc.M107816200; Scott RC, 2007, CURR BIOL, V17, P1, DOI 10.1016/j.cub.2006.10.053; Shen W, 2009, J CELL BIOL, V187, P71, DOI 10.1083/jcb.200907109; Sitterlin D, 2004, GENE, V326, P107, DOI 10.1016/j.gene.2003.10.024; Tian XL, 2010, MOL CELL BIOL, V30, P1269, DOI 10.1128/MCB.01328-09; Uthaman SB, 2008, J NEUROSCI, V28, P8615, DOI 10.1523/JNEUROSCI.2990-08.2008; Wairkar YP, 2009, J NEUROSCI, V29, P517, DOI 10.1523/JNEUROSCI.3848-08.2009; Wan HI, 2000, NEURON, V26, P313, DOI 10.1016/S0896-6273(00)81166-6; Wu CL, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-16; Wu CL, 2005, J NEUROSCI, V25, P9557, DOI 10.1523/JNEUROSCI.2532-05.2005; Xiong X, 2010, J CELL BIOL, V191, P211, DOI 10.1083/jcb.201006039; Yan D, 2009, CELL, V138, P1005, DOI 10.1016/j.cell.2009.06.023; Zhen M, 2000, NEURON, V26, P331, DOI 10.1016/S0896-6273(00)81167-8	46	33	37	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2011	14	10					1267	U193		10.1038/nn.2922	http://dx.doi.org/10.1038/nn.2922			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	825EQ	21874015	Green Accepted			2022-12-28	WOS:000295254200015
J	Casaccia, P				Casaccia, Patrizia			Anti-TANKyrase weapons promote myelination	NATURE NEUROSCIENCE			English	Editorial Material							PATHWAY; AXIN	A study identifies mechanisms responsible for the inability to form new myelin after neonatal hypoxia. It identifies Axin2 as a potential therapeutic target for reversing the 'differentiation block' of oligodendrocyte-lineage cells.	[Casaccia, Patrizia] Mt Sinai Sch Med, Dept Neurosci, New York, NY USA; [Casaccia, Patrizia] Mt Sinai Sch Med, Friedman Brain Inst, New York, NY USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Casaccia, P (corresponding author), Mt Sinai Sch Med, Dept Neurosci, New York, NY USA.	patrizia.casaccia@mssm.edu			NINDS NIH HHS [R01 NS042925, R01 NS042925-09] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042925] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Azim K, 2011, GLIA, V59, P540, DOI 10.1002/glia.21122; Chang P, 2005, NAT CELL BIOL, V7, P1133, DOI 10.1038/ncb1322; Chiang YJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002639; Fancy SPJ, 2011, NAT NEUROSCI, V14, P1009, DOI 10.1038/nn.2855; Fancy SPJ, 2009, GENE DEV, V23, P1571, DOI 10.1101/gad.1806309; Feigenson K, 2009, MOL CELL NEUROSCI, V42, P255, DOI 10.1016/j.mcn.2009.07.010; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Liu J, 2010, TRENDS NEUROSCI, V33, P193, DOI 10.1016/j.tins.2010.01.007; Seimiya H, 2005, CANCER CELL, V7, P25, DOI 10.1016/j.ccr.2004.11.021; Tawk M, 2011, J NEUROSCI, V31, P3729, DOI 10.1523/JNEUROSCI.4270-10.2011; Ye F, 2009, NAT NEUROSCI, V12, P829, DOI 10.1038/nn.2333; Zhang Y, 2011, NAT CELL BIOL, V13, P623, DOI 10.1038/ncb2222	13	8	8	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2011	14	8					945	947		10.1038/nn.2885	http://dx.doi.org/10.1038/nn.2885			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	797KC	21792189	Green Accepted			2022-12-28	WOS:000293123700003
J	Saito, T; Suemoto, T; Brouwers, N; Sleegers, K; Funamoto, S; Mihira, N; Matsuba, Y; Yamada, K; Nilsson, P; Takano, J; Nishimura, M; Iwata, N; Van Broeckhoven, C; Ihara, Y; Saido, TC				Saito, Takashi; Suemoto, Takahiro; Brouwers, Nathalie; Sleegers, Kristel; Funamoto, Satoru; Mihira, Naomi; Matsuba, Yukio; Yamada, Kazuyuki; Nilsson, Per; Takano, Jiro; Nishimura, Masaki; Iwata, Nobuhisa; Van Broeckhoven, Christine; Ihara, Yasuo; Saido, Takaomi C.			Potent amyloidogenicity and pathogenicity of A beta 43	NATURE NEUROSCIENCE			English	Article							AMYLOID-BETA-PROTEIN; GAMMA-SECRETASE ACTIVITY; DISEASE-LIKE PATHOLOGY; ALZHEIMERS-DISEASE; A-BETA; PRECURSOR PROTEIN; SENILE PLAQUES; IN-VIVO; PRESENILIN MUTATIONS; TERMINAL FRAGMENT	The amyloid-beta peptide A beta 42 is known to be a primary amyloidogenic and pathogenic agent in Alzheimer's disease. However, the role of A beta 43, which is found just as frequently in the brains of affected individuals, remains unresolved. We generated knock-in mice containing a pathogenic presenilin-1 R278I mutation that causes overproduction of A beta 43. Homozygosity was embryonic lethal, indicating that the mutation involves a loss of function. Crossing amyloid precursor protein transgenic mice with heterozygous mutant mice resulted in elevated A beta 43, impairment of short-term memory and acceleration of amyloid-b pathology, which accompanied pronounced accumulation of A beta 43 in plaque cores similar in biochemical composition to those observed in the brains of affected individuals. Consistently, A beta 43 showed a higher propensity to aggregate and was more neurotoxic than A beta 42. Other pathogenic presenilin mutations also caused overproduction of A beta 43 in a manner correlating with A beta 42 and with the age of disease onset. These findings indicate that A beta 43, an overlooked species, is potently amyloidogenic, neurotoxic and abundant in vivo.	[Saito, Takashi; Suemoto, Takahiro; Mihira, Naomi; Matsuba, Yukio; Nilsson, Per; Takano, Jiro; Iwata, Nobuhisa; Saido, Takaomi C.] RIKEN, Lab Proteolyt Neurosci, Brain Sci Inst, Wako, Saitama, Japan; [Brouwers, Nathalie; Sleegers, Kristel; Van Broeckhoven, Christine] Flanders Interunivers Inst Biotechnol, Neurodegenerat Brain Dis Grp, Dept Mol Genet, Antwerp, Belgium; [Brouwers, Nathalie; Sleegers, Kristel; Van Broeckhoven, Christine] Univ Antwerp, Inst Born Bunge, Lab Neurogenet, B-2020 Antwerp, Belgium; [Funamoto, Satoru; Ihara, Yasuo] Doshisha Univ, Fac Life Sci, Kyoto 602, Japan; [Yamada, Kazuyuki] RIKEN, Brain Sci Inst, Res Resource Ctr, Wako, Saitama, Japan; [Nishimura, Masaki] Shiga Univ Med Sci, Mol Neurosci Res Ctr, Shiga, Japan; [Iwata, Nobuhisa] Nagasaki Univ, Dept Mol Med Sci, Div Biotechnol, Grad Sch Biomed Sci, Nagasaki 852, Japan	RIKEN; University of Antwerp; Doshisha University; RIKEN; Shiga University of Medical Science; Nagasaki University	Saido, TC (corresponding author), RIKEN, Lab Proteolyt Neurosci, Brain Sci Inst, Wako, Saitama, Japan.	saido@brain.riken.jp	Sado, Takaomi/AAN-2759-2021; Saito, Takashi/G-2563-2015; Van Broeckhoven, Christine/M-7853-2019; Van Broeckhoven, Christine/G-8362-2017; Saido, Takaomi C/N-5472-2015; Brouwers, Nathalie/L-2089-2014	Sado, Takaomi/0000-0003-1970-6903; Saito, Takashi/0000-0002-9659-9251; Van Broeckhoven, Christine/0000-0003-0183-7665; Van Broeckhoven, Christine/0000-0003-0183-7665; Saido, Takaomi C/0000-0003-1970-6903; Brouwers, Nathalie/0000-0002-9808-9394	RIKEN Brain Science Institute; Ministry of Education, Culture, Sports, Science and Technology; Ministry of Health, Labor and Welfare of Japan; TAKEDA Science Foundation; Fund for Scientific Research - Flanders (FWO-V); Belgian Federal Science Policy Office [P6/43]; Flemish Government; Grants-in-Aid for Scientific Research [22700379] Funding Source: KAKEN	RIKEN Brain Science Institute; Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); TAKEDA Science Foundation(Takeda Science Foundation (TSF)); Fund for Scientific Research - Flanders (FWO-V)(FWO); Belgian Federal Science Policy Office(Belgian Federal Science Policy Office); Flemish Government(European Commission); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank M.N. Rossor (University College London) for sharing clinical information about the R278I mutation carriers, J.Q. Trojanowski and V.M.-Y. Lee (University of Pennsylvania) for providing postmortem brain tissues, R. Kopan (Washington University) for providing Myc-tagged Delta Notch1 plasmid, A. Takashima (RIKEN Brain Science Institute) for providing antibody to Aph-1, and J. Hardy (University College London) for valuable discussions. This work was supported by research grants from RIKEN Brain Science Institute, the Ministry of Education, Culture, Sports, Science and Technology, the Ministry of Health, Labor and Welfare of Japan, the TAKEDA Science Foundation, the Fund for Scientific Research - Flanders (FWO-V), the Interuniversity Attraction Poles program P6/43 of the Belgian Federal Science Policy Office and a Methusalem Excellence Grant of the Flemish Government to C.V.B. N.B receives a FWO-V postdoctoral fellowship.	Arango D, 2001, AM J MED GENET, V103, P138, DOI 10.1002/1096-8628(20011001)103:2<138::AID-AJMG1529>3.0.CO;2-8; Bentahir M, 2006, J NEUROCHEM, V96, P732, DOI 10.1111/j.1471-4159.2005.03578.x; Bitan G, 2003, P NATL ACAD SCI USA, V100, P330, DOI 10.1073/pnas.222681699; Blennow K, 2006, LANCET, V368, P387, DOI 10.1016/S0140-6736(06)69113-7; Culvenor JG, 2004, EUR J BIOCHEM, V271, P375, DOI 10.1046/j.1432-1033.2003.03936.x; Deng Y, 2006, J NEUROSCI, V26, P3845, DOI 10.1523/JNEUROSCI.5384-05.2006; Enya M, 1999, AM J PATHOL, V154, P271, DOI 10.1016/S0002-9440(10)65273-X; Evin G, 2005, BIOCHEMISTRY-US, V44, P4332, DOI 10.1021/bi0481702; Godbolt AK, 2004, NEUROLOGY, V63, P1702, DOI 10.1212/01.WNL.0000143060.98164.1A; Hama E, 2004, J BIOL CHEM, V279, P30259, DOI 10.1074/jbc.M401891200; Hara H, 2004, J ALZHEIMERS DIS, V6, P483; Huang SM, 2006, J BIOL CHEM, V281, P17941, DOI 10.1074/jbc.M601372200; Huppert SS, 2000, NATURE, V405, P966, DOI 10.1038/35016111; IIZUKA T, 1995, BRAIN RES, V702, P275, DOI 10.1016/0006-8993(95)01163-2; Ikeuchi T, 2003, J BIOL CHEM, V278, P7010, DOI 10.1074/jbc.M209252200; Iwata N, 2004, J NEUROSCI, V24, P991, DOI 10.1523/JNEUROSCI.4792-03.2004; IWATSUBO T, 1994, NEURON, V13, P45, DOI 10.1016/0896-6273(94)90458-8; Jan A, 2008, J BIOL CHEM, V283, P28176, DOI 10.1074/jbc.M803159200; JARRETT JT, 1993, BIOCHEMISTRY-US, V32, P4693, DOI 10.1021/bi00069a001; Kaneko H, 2007, J NEUROSCI, V27, P13092, DOI 10.1523/JNEUROSCI.4244-07.2007; Keller L, 2010, EUR J HUM GENET, V18, P1202, DOI 10.1038/ejhg.2010.107; Kim J, 2007, J NEUROSCI, V27, P627, DOI 10.1523/JNEUROSCI.4849-06.2007; Kimura N, 2001, EXP ANIM TOKYO, V50, P77, DOI 10.1538/expanim.50.77; Kopan R, 1996, P NATL ACAD SCI USA, V93, P1683, DOI 10.1073/pnas.93.4.1683; Kumar-Singh S, 2006, HUM MUTAT, V27, P686, DOI 10.1002/humu.20336; Lee MK, 1997, NAT MED, V3, P756, DOI 10.1038/nm0797-756; Maeda J, 2007, J NEUROSCI, V27, P10957, DOI 10.1523/JNEUROSCI.0673-07.2007; McGowan E, 2005, NEURON, V47, P191, DOI 10.1016/j.neuron.2005.06.030; Miravalle L, 2005, BIOCHEMISTRY-US, V44, P10810, DOI 10.1021/bi0508237; Mouri A, 2007, FASEB J, V21, P2135, DOI 10.1096/fj.06-7685com; Nakaya Y, 2005, J BIOL CHEM, V280, P19070, DOI 10.1074/jbc.M501130200; Ono K, 2010, J BIOL CHEM, V285, P23184, DOI 10.1074/jbc.M109.086496; Parvathy S, 2001, ARCH NEUROL-CHICAGO, V58, P2025, DOI 10.1001/archneur.58.12.2025; Qi-Takahara Y, 2005, J NEUROSCI, V25, P436, DOI 10.1523/JNEUROSCI.1575-04.2005; Russo C, 2000, NATURE, V405, P531, DOI 10.1038/35014735; Ryan DA, 2010, J NEUROSCI METH, V190, P171, DOI 10.1016/j.jneumeth.2010.05.001; Schilling S, 2008, NAT MED, V14, P1106, DOI 10.1038/nm.1872; Schroeter EH, 2003, P NATL ACAD SCI USA, V100, P13075, DOI 10.1073/pnas.1735338100; Serneels L, 2009, SCIENCE, V324, P639, DOI 10.1126/science.1171176; Shen J, 1997, CELL, V89, P629, DOI 10.1016/S0092-8674(00)80244-5; Shimojo M, 2008, J BIOL CHEM, V283, P16488, DOI 10.1074/jbc.M801279200; SturchlerPierrat C, 1997, P NATL ACAD SCI USA, V94, P13287, DOI 10.1073/pnas.94.24.13287; Takami M, 2009, J NEUROSCI, V29, P13042, DOI 10.1523/JNEUROSCI.2362-09.2009; Thinakaran G, 1996, NEURON, V17, P181, DOI 10.1016/S0896-6273(00)80291-3; Van Vickle GD, 2007, BIOCHEMISTRY-US, V46, P10317, DOI 10.1021/bi700951u; Wang RS, 2006, J BIOL CHEM, V281, P15330, DOI 10.1074/jbc.M512574200; Welander H, 2009, J NEUROCHEM, V110, P697, DOI 10.1111/j.1471-4159.2009.06170.x; Wong PC, 1997, NATURE, V387, P288, DOI 10.1038/387288a0; Zhang C, 2009, NATURE, V460, P632, DOI 10.1038/nature08177	50	200	204	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2011	14	8					1023	U120		10.1038/nn.2858	http://dx.doi.org/10.1038/nn.2858			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	797KC	21725313	Green Submitted			2022-12-28	WOS:000293123700016
J	Altier, C; Garcia-Caballero, A; Simms, B; You, HT; Chen, LN; Walcher, J; Tedford, HW; Hermosilla, T; Zamponi, GW				Altier, Christophe; Garcia-Caballero, Agustin; Simms, Brett; You, Haitao; Chen, Lina; Walcher, Jan; Tedford, H. William; Hermosilla, Tamara; Zamponi, Gerald W.			The Cav beta subunit prevents RFP2-mediated ubiquitination and proteasomal degradation of L-type channels	NATURE NEUROSCIENCE			English	Article							CALCIUM-CHANNEL; ENDOPLASMIC-RETICULUM; RETRO-TRANSLOCATION; ALPHA(1) SUBUNIT; GENE RFP2; COMPLEX; TRAFFICKING; CONTRACTION; EXPRESSION; PROTEINS	It is well established that the auxiliary Cav beta subunit regulates calcium channel density in the plasma membrane, but the cellular mechanism by which this occurs has remained unclear. We found that the Cav beta subunit increased membrane expression of Cav1.2 channels by preventing the entry of the channels into the endoplasmic reticulum-associated protein degradation (ERAD) complex. Without Cav beta, Cav1.2 channels underwent robust ubiquitination by the RFP2 ubiquitin ligase and interacted with the ERAD complex proteins derlin-1 and p97, culminating in targeting of the channels to the proteasome for degradation. On treatment with the proteasomal inhibitor MG132, Cav beta-free channels were rescued from degradation and trafficked to the plasma membrane. The coexpression of Cav beta interfered with ubiquitination and targeting of the channel to the ERAD complex, thereby facilitating export from the endoplasmic reticulum and promoting expression on the cell surface. Thus, Cav beta regulates the ubiquitination and stability of the calcium channel complex.	[Altier, Christophe; Garcia-Caballero, Agustin; Simms, Brett; You, Haitao; Chen, Lina; Walcher, Jan; Tedford, H. William; Hermosilla, Tamara; Zamponi, Gerald W.] Univ Calgary, Hotchkiss Brain Inst, Dept Physiol & Pharmacol, Calgary, AB, Canada	University of Calgary	Zamponi, GW (corresponding author), Univ Calgary, Hotchkiss Brain Inst, Dept Physiol & Pharmacol, Calgary, AB, Canada.	zamponi@ucalgary.ca		Zamponi, Gerald W./0000-0002-0644-9066	Heart and Stroke Foundation of Alberta; Northwest Territories and Nunavut; Canadian Institutes for Health Research; AFHMR; AHFMR	Heart and Stroke Foundation of Alberta; Northwest Territories and Nunavut; Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); AFHMR; AHFMR(Alberta Heritage Foundation for Medical Research)	We thank J. Striessnig, S. Ferguson, J. Stutts, B. Schwappach, E. Bourinet and T. Snutch for cDNA constructs, and E. Stanley for help with the ICQ colocalization analysis. This work was supported by operating grants to G. W. Z. from the Heart and Stroke Foundation of Alberta, the Northwest Territories and Nunavut, and the Canadian Institutes for Health Research. G. W. Z. is a Scientist of the Alberta Heritage Foundation for Medical Research (AHFMR) and a Canada Research Chair in Molecular Neurobiology. H.Y. is supported by an AFHMR fellowship and B. S. is supported by an AHFMR studentship.	Abriel H, 2005, PHYSIOLOGY, V20, P398, DOI 10.1152/physiol.00033.2005; Altier C, 2002, J BIOL CHEM, V277, P33598, DOI 10.1074/jbc.M202476200; Altier C, 2006, NAT NEUROSCI, V9, P31, DOI 10.1038/nn1605; Baranova A, 2003, GENE, V321, P103, DOI 10.1016/j.gene.2003.08.007; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Bichet D, 2000, NEURON, V25, P177, DOI 10.1016/S0896-6273(00)80881-8; Birnbaumer L, 1998, J BIOENERG BIOMEMBR, V30, P357, DOI 10.1023/A:1021989622656; Burgess DL, 1997, CELL, V88, P385, DOI 10.1016/S0092-8674(00)81877-2; Catterall WA, 2005, PHARMACOL REV, V57, P411, DOI 10.1124/pr.57.4.5; Chen YH, 2004, NATURE, V429, P675, DOI 10.1038/nature02641; Corcoran MM, 2004, GENE CHROMOSOME CANC, V40, P285, DOI 10.1002/gcc.20046; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Dolmetsch RE, 2001, SCIENCE, V294, P333, DOI 10.1126/science.1063395; Dolphin AC, 2003, J BIOENERG BIOMEMBR, V35, P599, DOI 10.1023/B:JOBB.0000008026.37790.5a; Gao YJ, 2008, J BIOL CHEM, V283, P9049, DOI 10.1074/jbc.M708022200; Gregg RG, 1996, P NATL ACAD SCI USA, V93, P13961, DOI 10.1073/pnas.93.24.13961; Hidalgo P, 2007, CELL CALCIUM, V42, P389, DOI 10.1016/j.ceca.2007.05.009; Hullin R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000292; Kisilevsky AE, 2008, NEURON, V58, P557, DOI 10.1016/j.neuron.2008.03.002; Lerner M, 2007, MOL BIOL CELL, V18, P1670, DOI 10.1091/mbc.E06-03-0248; Leroy J, 2005, J NEUROSCI, V25, P6984, DOI 10.1523/JNEUROSCI.1137-05.2005; Li Q, 2004, J NEUROSCI, V24, P4070, DOI 10.1523/JNEUROSCI.0346-04.2004; Lie AA, 1999, NEUROSCIENCE, V93, P449, DOI 10.1016/S0306-4522(99)00162-1; Lilley BN, 2004, NATURE, V429, P834, DOI 10.1038/nature02592; Maltez JM, 2005, NAT STRUCT MOL BIOL, V12, P372, DOI 10.1038/nsmb909; Obermair GJ, 2010, J BIOL CHEM, V285, P5776, DOI 10.1074/jbc.M109.044271; Opatowsky Y, 2004, NEURON, V42, P387, DOI 10.1016/S0896-6273(04)00250-8; PRAGNELL M, 1994, NATURE, V368, P67, DOI 10.1038/368067a0; Romisch K, 2005, ANNU REV CELL DEV BI, V21, P435, DOI 10.1146/annurev.cellbio.21.012704.133250; Sun F, 2006, J BIOL CHEM, V281, P36856, DOI 10.1074/jbc.M607085200; Tsai B, 2002, NAT REV MOL CELL BIO, V3, P246, DOI 10.1038/nrm780; Van Petegem F, 2004, NATURE, V429, P671, DOI 10.1038/nature02588; Vance CL, 1998, J BIOL CHEM, V273, P14495, DOI 10.1074/jbc.273.23.14495; Wang B, 2008, CELL, V133, P1080, DOI 10.1016/j.cell.2008.04.042; Weissgerber P, 2006, CIRC RES, V99, P749, DOI 10.1161/01.RES.0000243978.15182.c1; Yasuda T, 2004, EUR J NEUROSCI, V20, P1, DOI 10.1111/j.1460-9568.2004.03434.x; Ye YH, 2004, NATURE, V429, P841, DOI 10.1038/nature02656; Younger JM, 2006, CELL, V126, P571, DOI 10.1016/j.cell.2006.06.041; Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4; Zerangue N, 2001, P NATL ACAD SCI USA, V98, P2431, DOI 10.1073/pnas.051630198	40	175	177	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2011	14	2					173	U252		10.1038/nn.2712	http://dx.doi.org/10.1038/nn.2712			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	711MJ	21186355	Green Published			2022-12-28	WOS:000286595400014
J	Maia, TV; Frank, MJ				Maia, Tiago V.; Frank, Michael J.			From reinforcement learning models to psychiatric and neurological disorders	NATURE NEUROSCIENCE			English	Review							ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; BASAL GANGLIA; PREFRONTAL CORTEX; PREDICTION-ERROR; DECISION-MAKING; COMPUTATIONAL MODELS; NUCLEUS-ACCUMBENS; WORKING-MEMORY; DOPAMINE MODULATION; OPTOGENETIC CONTROL	Over the last decade and a half, reinforcement learning models have fostered an increasingly sophisticated understanding of the functions of dopamine and cortico-basal ganglia-thalamo-cortical (CBGTC) circuits. More recently, these models, and the insights that they afford, have started to be used to understand important aspects of several psychiatric and neurological disorders that involve disturbances of the dopaminergic system and CBGTC circuits. We review this approach and its existing and potential applications to Parkinson's disease, Tourette's syndrome, attention-deficit/hyperactivity disorder, addiction, schizophrenia and preclinical animal models used to screen new antipsychotic drugs. The approach's proven explanatory and predictive power bodes well for the continued growth of computational psychiatry and computational neurology.	[Maia, Tiago V.] Columbia Univ, Dept Psychiat, New York, NY 10027 USA; [Maia, Tiago V.] New York State Psychiat Inst & Hosp, New York, NY 10032 USA; [Frank, Michael J.] Brown Univ, Dept Cognit Linguist & Psychol Sci, Providence, RI 02912 USA; [Frank, Michael J.] Brown Univ, Dept Psychiat & Human Behav, Providence, RI 02912 USA; [Frank, Michael J.] Brown Univ, Brown Inst Brain Sci, Providence, RI 02912 USA	Columbia University; New York State Psychiatry Institute; Brown University; Brown University; Brown University	Maia, TV (corresponding author), Columbia Univ, Dept Psychiat, New York, NY 10027 USA.	tmaia@columbia.edu; michael_frank@brown.edu		Maia, Tiago/0000-0002-5254-0389	New York State Psychiatric Institute; Research Foundation for Mental Hygiene; National Institute of Mental Health [R01 MH080066]; Michael J. Fox Foundation for Parkinson's Research; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH080066] Funding Source: NIH RePORTER	New York State Psychiatric Institute; Research Foundation for Mental Hygiene; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Michael J. Fox Foundation for Parkinson's Research; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Preparation of this article was funded by a Research Associate Award from the New York State Psychiatric Institute and the Research Foundation for Mental Hygiene, by National Institute of Mental Health grant R01 MH080066 and by a grant from the Michael J. Fox Foundation for Parkinson's Research.	ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Baier B, 2010, J NEUROSCI, V30, P9788, DOI 10.1523/JNEUROSCI.1513-10.2010; Barkley RA, 1997, PSYCHOL BULL, V121, P65, DOI 10.1037/0033-2909.121.1.65; Bayer HM, 2007, J NEUROPHYSIOL, V98, P1428, DOI 10.1152/jn.01140.2006; Bayer HM, 2005, NEURON, V47, P129, DOI 10.1016/j.neuron.2005.05.020; Berridge KC, 1998, BRAIN RES REV, V28, P309, DOI 10.1016/S0165-0173(98)00019-8; Biederman J, 1999, BIOL PSYCHIAT, V46, P1234, DOI 10.1016/S0006-3223(99)00192-4; Bogacz R, 2007, NEURAL COMPUT, V19, P442, DOI 10.1162/neco.2007.19.2.442; Bohlhalter S, 2006, BRAIN, V129, P2029, DOI 10.1093/brain/awl050; Brown JW, 2004, NEURAL NETWORKS, V17, P471, DOI 10.1016/j.neunet.2003.08.006; Charney DS, 2002, RESEARCH AGENDA FOR DSM-V, P31; Cools R, 2010, BRAIN, V133, P225, DOI 10.1093/brain/awp301; Cools R, 2006, NEUROSCI BIOBEHAV R, V30, P1, DOI 10.1016/j.neubiorev.2005.03.024; Corlett PR, 2007, BRAIN, V130, P2387, DOI 10.1093/brain/awm173; Corlett PR, 2007, J PSYCHOPHARMACOL, V21, P238, DOI 10.1177/0269881107077716; CREESE I, 1983, ANNU REV NEUROSCI, V6, P43, DOI 10.1146/annurev.ne.06.030183.000355; Daw ND, 2002, NEURAL NETWORKS, V15, P603, DOI 10.1016/S0893-6080(02)00052-7; Dayan P, 2002, NEURON, V36, P285, DOI 10.1016/S0896-6273(02)00963-7; Dayan P, 2006, NEURAL NETWORKS, V19, P1153, DOI 10.1016/j.neunet.2006.03.002; Dayan P, 2000, NAT NEUROSCI, V3, P1218, DOI 10.1038/81504; DELFS JM, 1990, NEUROSCIENCE, V39, P59, DOI 10.1016/0306-4522(90)90221-O; DELONG MR, 1990, TRENDS NEUROSCI, V13, P281, DOI 10.1016/0166-2236(90)90110-V; Dezfouli A, 2009, NEURAL COMPUT, V21, P2869, DOI 10.1162/neco.2009.10-08-882; Durstewitz D, 2000, J NEUROPHYSIOL, V83, P1733, DOI 10.1152/jn.2000.83.3.1733; FANTIN G, 1984, EXPERIENTIA, V40, P573, DOI 10.1007/BF01982337; FIBIGER HC, 1974, PHARMACOL BIOCHEM BE, V2, P87, DOI 10.1016/0091-3057(74)90139-7; Figner B, 2010, NAT NEUROSCI, V13, P538, DOI 10.1038/nn.2516; Frank MJ, 2001, COGN AFFECT BEHAV NE, V1, P137, DOI 10.3758/CABN.1.2.137; Frank MJ, 2007, SCIENCE, V318, P1309, DOI 10.1126/science.1146157; Frank MJ, 2007, PHILOS T R SOC B, V362, P1641, DOI 10.1098/rstb.2007.2058; Frank MJ, 2007, NEUROPSYCHOPHARMACOL, V32, P1583, DOI 10.1038/sj.npp.1301278; Frank MJ, 2006, NEURAL NETWORKS, V19, P1120, DOI 10.1016/j.neunet.2006.03.006; Frank MJ, 2011, NEUROPSYCHOPHARMACOL, V36, P133, DOI 10.1038/npp.2010.96; Frank MJ, 2006, PSYCHOL REV, V113, P300, DOI 10.1037/0033-295X.113.2.300; Frank MJ, 2004, SCIENCE, V306, P1940, DOI 10.1126/science.1102941; Frank MJ, 2005, J COGNITIVE NEUROSCI, V17, P51, DOI 10.1162/0898929052880093; Gerfen CR, 2000, TRENDS NEUROSCI, V23, pS64, DOI 10.1016/S1471-1931(00)00019-7; Gershman SJ, 2010, PSYCHOL REV, V117, P197, DOI 10.1037/a0017808; Guillin O, 2007, INT REV NEUROBIOL, V78, P1, DOI 10.1016/S0074-7742(06)78001-1; Gurney K, 2001, BIOL CYBERN, V84, P411, DOI 10.1007/PL00007985; Haber SN, 2003, J CHEM NEUROANAT, V26, P317, DOI 10.1016/j.jchemneu.2003.10.003; Hikida T, 2010, NEURON, V66, P896, DOI 10.1016/j.neuron.2010.05.011; Hyman SE, 2007, NAT REV NEUROSCI, V8, P725, DOI 10.1038/nrn2218; Kalanithi PSA, 2005, P NATL ACAD SCI USA, V102, P13307, DOI 10.1073/pnas.0502624102; Kapur S, 2003, AM J PSYCHIAT, V160, P13, DOI 10.1176/appi.ajp.160.1.13; Kheramin S, 2004, PSYCHOPHARMACOLOGY, V175, P206, DOI 10.1007/s00213-004-1813-y; Kravitz AV, 2010, NATURE, V466, P622, DOI 10.1038/nature09159; Lobo MK, 2010, SCIENCE, V330, P385, DOI 10.1126/science.1188472; Maia TV, 2008, DEV PSYCHOPATHOL, V20, P1251, DOI 10.1017/S0954579408000606; Maia TV, 2010, LEARN BEHAV, V38, P50, DOI 10.3758/LB.38.1.50; Maia TV, 2009, COGN AFFECT BEHAV NE, V9, P343, DOI 10.3758/CABN.9.4.343; Maia TV, 2009, COGNITIVE SCI, V33, P1232, DOI 10.1111/j.1551-6709.2009.01054.x; Maia TV, 2005, TRENDS COGN SCI, V9, P397, DOI 10.1016/j.tics.2005.06.016; McClure SM, 2003, TRENDS NEUROSCI, V26, P423, DOI 10.1016/S0166-2236(03)00177-2; Mink JW, 1996, PROG NEUROBIOL, V50, P381, DOI 10.1016/S0301-0082(96)00042-1; Mink JW, 2001, PEDIATR NEUROL, V25, P190, DOI 10.1016/S0887-8994(01)00262-4; Morris G, 2010, EXP BRAIN RES, V200, P307, DOI 10.1007/s00221-009-2060-6; Moustafa AA, 2008, NEUROPSYCHOLOGIA, V46, P3144, DOI 10.1016/j.neuropsychologia.2008.07.011; Murray GK, 2008, MOL PSYCHIATR, V13, P267, DOI 10.1038/sj.mp.4002058; Nambu A, 2002, NEUROSCI RES, V43, P111, DOI 10.1016/S0168-0102(02)00027-5; Nikolaus S, 2009, BEHAV BRAIN RES, V204, P32, DOI 10.1016/j.bbr.2009.06.009; Niv Y, 2007, PSYCHOPHARMACOLOGY, V191, P507, DOI 10.1007/s00213-006-0502-4; O'Doherty J, 2004, SCIENCE, V304, P452, DOI 10.1126/science.1094285; O'Reilly RC, 2006, NEURAL COMPUT, V18, P283, DOI 10.1162/089976606775093909; Palminteri S, 2009, P NATL ACAD SCI USA, V106, P19179, DOI 10.1073/pnas.0904035106; Panlilio LV, 2007, PHARMACOL BIOCHEM BE, V86, P774, DOI 10.1016/j.pbb.2007.03.005; Pattij T, 2008, TRENDS PHARMACOL SCI, V29, P192, DOI 10.1016/j.tips.2008.01.002; Peterson BS, 1999, TOURETTES SYNDROME T, P230; Postuma RB, 2006, CEREB CORTEX, V16, P1508, DOI 10.1093/cercor/bhj088; Prescott T., 2003, HDB BRAIN THEORY NEU, P147; Redish A. D., 2008, BEHAV BRAIN SCI, V31, P437, DOI DOI 10.1017/S0110525X0100472X; Redish AD, 2008, BEHAV BRAIN SCI, V31, P415, DOI 10.1017/S0140525X0800472X; Redish AD, 2004, SCIENCE, V306, P1944, DOI 10.1126/science.1102384; Rolls ET, 2008, NAT REV NEUROSCI, V9, P696, DOI 10.1038/nrn2462; Sagvolden T, 1998, BEHAV BRAIN RES, V94, P1; Sagvolden T, 2005, BEHAV BRAIN SCI, V28, P397, DOI 10.1017/S0140525X05000075; Salamone JD, 2002, BEHAV BRAIN RES, V137, P3, DOI 10.1016/S0166-4328(02)00282-6; Samejima K, 2005, SCIENCE, V310, P1337, DOI 10.1126/science.1115270; Schoenbaum G, 2006, TRENDS NEUROSCI, V29, P116, DOI 10.1016/j.tins.2005.12.006; Schultz W, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-24; Shen WX, 2008, SCIENCE, V321, P848, DOI 10.1126/science.1160575; Smith AJ, 2005, NEURAL COMPUT, V17, P361, DOI 10.1162/0899766053011546; Sonuga-Barke EJS, 2005, BIOL PSYCHIAT, V57, P1231, DOI 10.1016/j.biopsych.2004.09.008; Stahl SM, 2007, CNS SPECTRUMS, V12, P265, DOI 10.1017/S1092852900021015; Steeves TDL, 2008, PROG BRAIN RES, V172, P495, DOI 10.1016/S0079-6123(08)00924-2; STRAUSS GP, BIOL PSYCHI IN PRESS; Tsai HC, 2009, SCIENCE, V324, P1080, DOI 10.1126/science.1168878; Tzschentke TM, 1998, PROG NEUROBIOL, V56, P613, DOI 10.1016/S0301-0082(98)00060-4; Volkow ND, 2007, ARCH NEUROL-CHICAGO, V64, P1575, DOI 10.1001/archneur.64.11.1575; WADENBERG ML, 1990, BIOL PSYCHIAT, V28, P297, DOI 10.1016/0006-3223(90)90657-N; Wadenberg MLG, 1999, NEUROSCI BIOBEHAV R, V23, P851, DOI 10.1016/S0149-7634(99)00037-8; WALTERS JR, 1987, SCIENCE, V236, P719; Waltz JA, 2007, BIOL PSYCHIAT, V62, P756, DOI 10.1016/j.biopsych.2006.09.042; Waltz JA, 2011, NEUROPSYCHOLOGY, V25, P86, DOI 10.1037/a0020882; Waltz JA, 2009, NEUROPSYCHOPHARMACOL, V34, P1567, DOI 10.1038/npp.2008.214; Wiecki TV, 2010, PROG BRAIN RES, V183, P275, DOI 10.1016/S0079-6123(10)83014-6; Winstanley CA, 2005, NEUROPSYCHOPHARMACOL, V30, P669, DOI 10.1038/sj.npp.1300610; Yin HH, 2008, EUR J NEUROSCI, V28, P1437, DOI 10.1111/j.1460-9568.2008.06422.x; Yin HH, 2006, NAT REV NEUROSCI, V7, P464, DOI 10.1038/nrn1919	101	425	434	2	174	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2011	14	2					154	162		10.1038/nn.2723	http://dx.doi.org/10.1038/nn.2723			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	711MJ	21270784	Green Accepted			2022-12-28	WOS:000286595400011
J	Liu, J; Wu, DC; Wang, YT				Liu, Jun; Wu, Dong Chuan; Wang, Yu Tian			Allosteric potentiation of glycine receptor chloride currents by glutamate	NATURE NEUROSCIENCE			English	Article							GAMMA-AMINOBUTYRIC-ACID; SYNAPSES; CHANNELS; NEURONS; GABA; CLEARANCE	Neuronal excitability in the CNS is primarily controlled by a balance between synaptic excitation and inhibition. In the brainstem and spinal cord, synaptic excitation and inhibition are mediated by the excitatory transmitter glutamate acting on ionotropic glutamate receptor-gated cationic channels and the inhibitory transmitter glycine acting on glycine receptor (GlyR)-gated chloride channels. We found that glutamate and its analog ligands potentiated GlyR-mediated currents in both cultured spinal neurons and spinal cord slices of rats. This potentiation was not dependent on activation of any known glutamate receptor and manifested as an increase in single-channel open probability. Moreover, this glutamate potentiation was seen in HEK293 cells that transiently expressed GlyRs. Our data strongly suggest that glutamate allosterically potentiates GlyR-gated chloride channels, thereby blurring the traditional distinction between excitatory and inhibitory transmitters. Such a rapid homeostatic regulatory mechanism may be important for tuning functional balance between synaptic excitation and inhibition in the CNS.	[Liu, Jun; Wu, Dong Chuan; Wang, Yu Tian] Univ British Columbia, Brain Res Ctr, Vancouver, BC V5Z 1M9, Canada; [Liu, Jun; Wu, Dong Chuan; Wang, Yu Tian] Univ British Columbia, Dept Med, Vancouver Coastal Hlth Res Inst, Vancouver, BC V5Z 1M9, Canada; [Wu, Dong Chuan; Wang, Yu Tian] China Med Univ Hosp, Translat Med Res Ctr, Taichung, Taiwan; [Wu, Dong Chuan; Wang, Yu Tian] China Med Univ Hosp, Ctr Neuropsychiat, Taichung, Taiwan; [Wu, Dong Chuan; Wang, Yu Tian] China Med Univ Hosp, Grad Inst Immunol, Taichung, Taiwan	University of British Columbia; University of British Columbia; Vancouver Coastal Health Research Institute; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan	Wang, YT (corresponding author), Univ British Columbia, Brain Res Ctr, Vancouver, BC V5Z 1M9, Canada.	ytwang@interchange.ubc.ca	Wang, Yu Tian/J-8255-2015; Wang, Yu Tian/A-4729-2008; Wu, Dong Chuan/O-3909-2015	WU, DONG CHUAN/0000-0002-9539-5935	Canadian Institutes for Health Research; Heart and Stroke Foundation of British Columbia and Yukon; Taiwan Department of Health Clinical Trial and Research Center of Excellence [DOH99-TD-B-111-004]; National Sciences and Engineering Research Council; Michael Smith Foundation for Health Research; British Columbia Epilepsy Society	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of British Columbia and Yukon; Taiwan Department of Health Clinical Trial and Research Center of Excellence; National Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); British Columbia Epilepsy Society	We thank Y.P. Li for preparation and maintenance of spinal cord neuronal cultures and L. Oschipok for his excellent editorial assistance. This work was supported by the Canadian Institutes for Health Research, the Heart and Stroke Foundation of British Columbia and Yukon, and the Taiwan Department of Health Clinical Trial and Research Center of Excellence (DOH99-TD-B-111-004). J.L. was supported by postdoctoral fellowships from National Sciences and Engineering Research Council, the Michael Smith Foundation for Health Research and the British Columbia Epilepsy Society. Y.T.W. is a Howard Hughes Medical Institute International Scholar and the holder of the Heart and Stroke Foundation of British Columbia and Yukon chair in stroke research.	Baker DA, 2002, J NEUROSCI, V22, P9134; Barbour B, 1997, TRENDS NEUROSCI, V20, P377; Bergles DE, 1999, CURR OPIN NEUROBIOL, V9, P293, DOI 10.1016/S0959-4388(99)80043-9; Betz H, 2006, J NEUROCHEM, V97, P1600, DOI 10.1111/j.1471-4159.2006.03908.x; BORMANN J, 1987, J PHYSIOL-LONDON, V385, P243, DOI 10.1113/jphysiol.1987.sp016493; CLEMENTS JD, 1992, SCIENCE, V258, P1498, DOI 10.1126/science.1359647; Collingridge GL, 2004, NAT REV NEUROSCI, V5, P952, DOI 10.1038/nrn1556; Conn PJ, 1997, ANNU REV PHARMACOL, V37, P205, DOI 10.1146/annurev.pharmtox.37.1.205; Dingledine R, 1990, Adv Exp Med Biol, V268, P17; Dingledine R, 1999, PHARMACOL REV, V51, P7; Fucile S, 2000, NEURON, V28, P571, DOI 10.1016/S0896-6273(00)00134-3; Grillner S, 2003, NAT REV NEUROSCI, V4, P573, DOI 10.1038/nrn1137; Hartmann K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002979; JOHNSON JW, 1987, NATURE, V325, P529, DOI 10.1038/325529a0; Keller AF, 2001, J NEUROSCI, V21, P7871, DOI 10.1523/JNEUROSCI.21-20-07871.2001; KLECKNER NW, 1988, SCIENCE, V241, P835, DOI 10.1126/science.2841759; Lynch JW, 2004, PHYSIOL REV, V84, P1051, DOI 10.1152/physrev.00042.2003; Mayer ML, 2004, ANNU REV PHYSIOL, V66, P161, DOI 10.1146/annurev.physiol.66.050802.084104; MODY I, 1994, TRENDS NEUROSCI, V17, P517, DOI 10.1016/0166-2236(94)90155-4; Nyitrai G, 2006, CURR TOP MED CHEM, V6, P935, DOI 10.2174/156802606777323674; OBrien RJ, 1997, J NEUROSCI, V17, P7339; Otis TS, 1996, J NEUROSCI, V16, P1634, DOI 10.1523/jneurosci.16-05-01634.1996; Stafford MM, 2010, HIPPOCAMPUS, V20, P134, DOI 10.1002/hipo.20600; STELZER A, 1989, NATURE, V337, P170, DOI 10.1038/337170a0; Turrigiano G, 2007, CURR OPIN NEUROBIOL, V17, P318, DOI 10.1016/j.conb.2007.04.004; TWYMAN RE, 1991, J PHYSIOL-LONDON, V435, P303, DOI 10.1113/jphysiol.1991.sp018512; Vogt KE, 1999, P NATL ACAD SCI USA, V96, P1118, DOI 10.1073/pnas.96.3.1118; Windhorst U, 1996, PROG NEUROBIOL, V49, P517, DOI 10.1016/0301-0082(96)00023-8; WONG EHF, 1986, P NATL ACAD SCI USA, V83, P7104, DOI 10.1073/pnas.83.18.7104; Xu TL, 2000, EUR J NEUROSCI, V12, P1647; Zhu L, 2002, J PHARMACOL EXP THER, V302, P1193, DOI 10.1124/jpet.102.033894	31	28	28	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2010	13	10					1225	1232		10.1038/nn.2633	http://dx.doi.org/10.1038/nn.2633			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	654MB	20835251				2022-12-28	WOS:000282171300014
J	Wilson, RI				Wilson, Rachel I.			It takes all kinds to make a brain	NATURE NEUROSCIENCE			English	Editorial Material							OLFACTORY-BULB; GANGLION-CELLS; ORGANIZATION; INFORMATION; EVOLUTION; CIRCUIT		[Wilson, Rachel I.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Wilson, Rachel I.] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Wilson, RI (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA.	rachel_wilson@hms.harvard.edu		Wilson, Rachel/0000-0001-8573-9266				Chen TW, 2009, P NATL ACAD SCI USA, V106, P2401, DOI 10.1073/pnas.0810151106; Drake JW, 1998, GENETICS, V148, P1667; Gerhart J, 2007, P NATL ACAD SCI USA, V104, P8582, DOI 10.1073/pnas.0701035104; Goldman MS, 2001, J NEUROSCI, V21, P5229, DOI 10.1523/JNEUROSCI.21-14-05229.2001; Kazama H, 2009, NAT NEUROSCI, V12, P1136, DOI 10.1038/nn.2376; Luo LQ, 2007, NEURON, V56, P284, DOI 10.1016/j.neuron.2007.10.014; Padmanabhan K, 2010, NAT NEUROSCI, V13, P1276, DOI 10.1038/nn.2630; Prinz AA, 2004, NAT NEUROSCI, V7, P1345, DOI 10.1038/nn1352; Rakic P, 2009, NAT REV NEUROSCI, V10, P724, DOI 10.1038/nrn2719; RESSLER KJ, 1994, CELL, V79, P1245, DOI 10.1016/0092-8674(94)90015-9; Ryan TJ, 2009, NAT REV NEUROSCI, V10, P701, DOI 10.1038/nrn2717; Segev R, 2006, J NEUROPHYSIOL, V95, P2277, DOI 10.1152/jn.00928.2005; Shepherd G.M., 1998, SYNAPTIC ORG BRAIN, P159; VASSAR R, 1994, CELL, V79, P981, DOI 10.1016/0092-8674(94)90029-9; Warland DK, 1997, J NEUROPHYSIOL, V78, P2336, DOI 10.1152/jn.1997.78.5.2336	15	3	3	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2010	13	10					1158	1160		10.1038/nn1010-1158	http://dx.doi.org/10.1038/nn1010-1158			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	654MB	20877278				2022-12-28	WOS:000282171300005
J	Mosca, TJ; Schwarz, TL				Mosca, Timothy J.; Schwarz, Thomas L.			The nuclear import of Frizzled2-C by Importins-beta 11 and alpha 2 promotes postsynaptic development	NATURE NEUROSCIENCE			English	Article							DROSOPHILA NEUROMUSCULAR-JUNCTION; REGULATES SYNAPTIC GROWTH; RECEPTOR SUBUNIT COMPOSITION; TUMOR-SUPPRESSOR GENE; NEUROTRANSMITTER RELEASE; II RECEPTOR; WNT; WINGLESS; PROTEIN; TRANSPORT	Synapse-to-nucleus signaling is critical for synaptic development and plasticity. In Drosophila, the ligand Wingless causes the C terminus of its Frizzled2 receptor (Fz2-C) to be cleaved and translocated from the postsynaptic density to nuclei. The mechanism of nuclear import is unknown and the developmental consequences of this translocation are uncertain. We found that Fz2-C localization to muscle nuclei required the nuclear import factors Importin-beta 11 and Importin-alpha 2 and that this pathway promoted the postsynaptic development of the subsynaptic reticulum (SSR), an elaboration of the postsynaptic plasma membrane. importin-beta 11 (imp-beta 11) and dfz2 mutants had less SSR, and some boutons lacked the postsynaptic marker Discs Large. These developmental defects in imp-beta 11 mutants could be overcome by expression of Fz2-C fused to a nuclear localization sequence that can bypass Importin-beta 11. Thus, Wnt-activated growth of the postsynaptic membrane is mediated by the synapse-to-nucleus translocation and active nuclear import of Fz2-C via a selective Importin-beta 11/alpha 2 pathway.	[Mosca, Timothy J.; Schwarz, Thomas L.] Childrens Hosp, FM Kirby Neurobiol Ctr, Boston, MA 02115 USA; [Mosca, Timothy J.; Schwarz, Thomas L.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Schwarz, TL (corresponding author), Childrens Hosp, FM Kirby Neurobiol Ctr, 300 Longwood Ave, Boston, MA 02115 USA.	thomas.schwarz@childrens.harvard.edu		Mosca, Timothy/0000-0003-3485-0719	US National Institutes of Health [RO1 NS041062, MH075058]; National Defense Science and Engineering Graduate Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH075058] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041062] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Defense Science and Engineering Graduate Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We gratefully acknowledge V. Budnik and colleagues for generously providing antibodies and fly stocks and helpful discussions. We thank S. Cotterrill, R. Fleming, I. Kiss, P. Macdonald, B. Mechler, H. Bellen, M. Noll, M. Ramaswami, H. Saumweber, D. Schmucker, G. Struhl, J. Szabad, J. P. Vincent, S. Wasserman, Y. Jan, L. Zipursky, the Bloomington Stock Center and the Developmental Studies Hybridoma Bank for fly stocks and antibodies. We also thank M. Kovtun and members of the Schwarz laboratory for helpful discussions and critical readings of the manuscript, as well as M. Liana and L. Bu of the Intellectual and Developmental Disability Research Center Histology (grant number P30HD18655) and Imaging Cores for technical assistance. This work was supported by US National Institutes of Health grants RO1 NS041062 and MH075058 (T. L. S.) and a predoctoral fellowship from the National Defense Science and Engineering Graduate Foundation (T. J. M.).	Aberle H, 2002, NEURON, V33, P545, DOI 10.1016/S0896-6273(02)00589-5; Ahmad-Annuar A, 2006, J CELL BIOL, V174, P127, DOI 10.1083/jcb.200511054; Ataman B, 2008, NEURON, V57, P705, DOI 10.1016/j.neuron.2008.01.026; Ataman B, 2006, P NATL ACAD SCI USA, V103, P7841, DOI 10.1073/pnas.0600387103; Cadigan KM, 2008, CURR BIOL, V18, pR943, DOI 10.1016/j.cub.2008.08.017; Cantera R, 1999, MOL CELL NEUROSCI, V13, P131, DOI 10.1006/mcne.1999.0739; Chen CM, 1999, DEVELOPMENT, V126, P5441; Chen KY, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-1; Coyle IP, 2004, NEURON, V41, P521, DOI 10.1016/S0896-6273(04)00016-9; Davis EK, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-32; EHEBAUER M, 2006, SCI STKE, pCM7, DOI DOI 10.1126/STKE.3642006CM7; FAEDER IR, 1970, J CELL BIOL, V46, P300, DOI 10.1083/jcb.46.2.300; Freedman ND, 2004, MOL BIOL CELL, V15, P2276, DOI 10.1091/mbc.E03-11-0839; Giagtzoglou N, 2009, J NEUROSCI, V29, P5628, DOI 10.1523/JNEUROSCI.0794-09.2009; Goldfarb DS, 2004, TRENDS CELL BIOL, V14, P505, DOI 10.1016/j.tcb.2004.07.016; Guan B, 1996, CURR BIOL, V6, P695, DOI 10.1016/S0960-9822(09)00451-5; Higashi-Kovtun ME, 2010, J NEUROSCI, V30, P5253, DOI 10.1523/JNEUROSCI.3739-09.2010; Hummel T, 2000, NEURON, V26, P357, DOI 10.1016/S0896-6273(00)81169-1; Jordan BA, 2009, TRENDS NEUROSCI, V32, P392, DOI 10.1016/j.tins.2009.04.001; Kumar V, 2009, MOL BIOL CELL, V20, P2254, DOI 10.1091/mbc.E08-10-1072; LAHEY T, 1994, NEURON, V13, P823, DOI 10.1016/0896-6273(94)90249-6; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; Lyu J, 2008, DEV CELL, V15, P773, DOI 10.1016/j.devcel.2008.10.004; Marques G, 2002, NEURON, V33, P529, DOI 10.1016/S0896-6273(02)00595-0; Marrus SB, 2004, CURR BIOL, V14, P924, DOI 10.1016/j.cub.2004.05.047; Mathew D, 2005, SCIENCE, V310, P1344, DOI 10.1126/science.1117051; McCabe BD, 2003, NEURON, V39, P241, DOI 10.1016/S0896-6273(03)00426-4; Menon KP, 2009, J NEUROSCI, V29, P5558, DOI 10.1523/JNEUROSCI.0520-09.2009; Miech C, 2008, J NEUROSCI, V28, P10875, DOI 10.1523/JNEUROSCI.0164-08.2008; Mosca TJ, 2005, P NATL ACAD SCI USA, V102, P3477, DOI 10.1073/pnas.0406164102; Nimchinsky EA, 2002, ANNU REV PHYSIOL, V64, P313, DOI 10.1146/annurev.physiol.64.081501.160008; Otis KO, 2006, CURR OPIN NEUROBIOL, V16, P329, DOI 10.1016/j.conb.2006.05.001; Pack-Chung E, 2007, NAT NEUROSCI, V10, P980, DOI 10.1038/nn1936; Packard M, 2002, CELL, V111, P319, DOI 10.1016/S0092-8674(02)01047-4; Parnas D, 2001, NEURON, V32, P415, DOI 10.1016/S0896-6273(01)00485-8; Perry RBT, 2009, SEMIN CELL DEV BIOL, V20, P600, DOI 10.1016/j.semcdb.2009.04.014; Piddini E, 2005, DEVELOPMENT, V132, P5479, DOI 10.1242/dev.02145; Pielage J, 2006, J CELL BIOL, V175, P491, DOI 10.1083/jcb.200607036; Rheuben MB, 1999, INT REV NEUROBIOL, V43, P69, DOI 10.1016/S0074-7742(08)60541-3; Roos J, 2000, NEURON, V26, P371, DOI 10.1016/S0896-6273(00)81170-8; Salinas PC, 2008, ANNU REV NEUROSCI, V31, P339, DOI 10.1146/annurev.neuro.31.060407.125649; Sigrist SJ, 2000, NATURE, V405, P1062, DOI 10.1038/35016598; Speese SD, 2007, TRENDS NEUROSCI, V30, P268, DOI 10.1016/j.tins.2007.04.003; Thompson KR, 2004, NEURON, V44, P997, DOI 10.1016/j.neuron.2004.11.025; Ting CY, 2007, NEURON, V56, P793, DOI 10.1016/j.neuron.2007.09.033; Wairkar YP, 2009, J NEUROSCI, V29, P517, DOI 10.1523/JNEUROSCI.3848-08.2009; Weis K, 2002, CURR OPIN CELL BIOL, V14, P328, DOI 10.1016/S0955-0674(02)00337-X; Wong HC, 2003, MOL CELL, V12, P1251, DOI 10.1016/S1097-2765(03)00427-1; Wong K, 1999, J NEUROPHYSIOL, V82, P1497, DOI 10.1152/jn.1999.82.3.1497; Zhang YL, 2007, NEURON, V53, P201, DOI 10.1016/j.neuron.2006.12.016	50	67	68	2	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2010	13	8					935	U50		10.1038/nn.2593	http://dx.doi.org/10.1038/nn.2593			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	632DK	20601947	Green Accepted			2022-12-28	WOS:000280400600011
J	Ronesi, JA; Collins, KA; Hays, SA; Tsai, NP; Guo, WR; Birnbaum, SG; Hu, JH; Worley, PF; Gibson, JR; Huber, KM				Ronesi, Jennifer A.; Collins, Katie A.; Hays, Seth A.; Tsai, Nien-Pei; Guo, Weirui; Birnbaum, Shari G.; Hu, Jia-Hua; Worley, Paul F.; Gibson, Jay R.; Huber, Kimberly M.			Disrupted Homer scaffolds mediate abnormal mGluR5 function in a mouse model of fragile X syndrome	NATURE NEUROSCIENCE			English	Article							METABOTROPIC GLUTAMATE RECEPTORS; LONG-TERM DEPRESSION; PROTEIN-SYNTHESIS; SELECT BEHAVIORS; MESSENGER-RNAS; TRANSLATION; PHOSPHORYLATION; ACTIVATION; INHIBITION; MECHANISMS	Enhanced metabotropic glutamate receptor subunit 5 (mGluR5) function is causally associated with the pathophysiology of fragile X syndrome, a leading inherited cause of intellectual disability and autism. Here we provide evidence that altered mGluR5-Homer scaffolds contribute to mGluR5 dysfunction and phenotypes in the fragile X syndrome mouse model, Fmr1 knockout (Fmr1(-/y)). In Fmr1(-/y) mice, mGluR5 was less associated with long Homer isoforms but more associated with the short Homer1a. Genetic deletion of Homer1a restored mGluR5-long Homer scaffolds and corrected several phenotypes in Fmr1(-/y) mice, including altered mGluR5 signaling, neocortical circuit dysfunction and behavior. Acute, peptide-mediated disruption of mGluR5-Homer scaffolds in wild-type mice mimicked many Fmr1(-/y) phenotypes. In contrast, Homer1a deletion did not rescue altered mGluR-dependent long-term synaptic depression or translational control of target mRNAs of fragile X mental retardation protein, the gene product of Fmr1. Our findings reveal new functions for mGluR5-Homer interactions in the brain and delineate distinct mechanisms of mGluR5 dysfunction in a mouse model of cognitive dysfunction and autism.	[Ronesi, Jennifer A.; Collins, Katie A.; Hays, Seth A.; Tsai, Nien-Pei; Guo, Weirui; Gibson, Jay R.; Huber, Kimberly M.] Univ Texas SW Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA; [Birnbaum, Shari G.] Univ Texas SW Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA; [Hu, Jia-Hua; Worley, Paul F.] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Johns Hopkins University	Huber, KM (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA.	kimberly.huber@utsouthwestern.edu	Guo, Weirui/G-2868-2015; Huber, Kimberly/X-5534-2019; Hays, Seth/U-4701-2019	Hays, Seth/0000-0003-4225-241X	US National Institutes of Health [NS045711, HD052731, HD056370, GM008203]; Autism Speaks; FRAXA Research Foundation; The Hartwell Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD052731, R01HD056370] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008203] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045711] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Autism Speaks; FRAXA Research Foundation; The Hartwell Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We would like to thank L. Ormazabal and N. Cabalo for technical assistance. This research was supported by the grants from the US National Institutes of Health NS045711, HD052731 (K.M.H.), HD056370 (J.R.G.), GM008203 (S.A.H.), Autism Speaks (K.M.H.), FRAXA Research Foundation and The Hartwell Foundation (J.A.R.).	Abrahams BS, 2008, NAT REV GENET, V9, P341, DOI 10.1038/nrg2346; Ango F, 2001, NATURE, V411, P962, DOI 10.1038/35082096; BAKKER CE, 1994, CELL, V78, P23; Bangash MA, 2011, CELL, V145, P758, DOI 10.1016/j.cell.2011.03.052; Banko JL, 2006, J NEUROSCI, V26, P2167, DOI 10.1523/JNEUROSCI.5196-05.2006; Bassell GJ, 2008, NEURON, V60, P201, DOI 10.1016/j.neuron.2008.10.004; Bear MF, 2004, TRENDS NEUROSCI, V27, P370, DOI 10.1016/j.tins.2004.04.009; Berry-Kravis E, 2002, DEV MED CHILD NEUROL, V44, P724; Billuart P, 1998, NATURE, V392, P923, DOI 10.1038/31940; Brown MR, 2010, NAT NEUROSCI, V13, P819, DOI 10.1038/nn.2563; Darnell JC, 2011, CELL, V146, P247, DOI 10.1016/j.cell.2011.06.013; Dolen G, 2007, NEURON, V56, P955, DOI 10.1016/j.neuron.2007.12.001; Dolen G, 2010, PHARMACOL THERAPEUT, V127, P78, DOI 10.1016/j.pharmthera.2010.02.008; Gibson JR, 2008, J NEUROPHYSIOL, V100, P2615, DOI 10.1152/jn.90752.2008; Giuffrida R, 2005, J NEUROSCI, V25, P8908, DOI 10.1523/JNEUROSCI.0932-05.2005; Gross C, 2010, J NEUROSCI, V30, P10624, DOI 10.1523/JNEUROSCI.0402-10.2010; Hagerman RJ, 2002, FRAGILE X SYNDROME D, P3; Haider B, 2009, NEURON, V62, P171, DOI 10.1016/j.neuron.2009.04.008; Hays SA, 2011, J NEUROSCI, V31, P14223, DOI 10.1523/JNEUROSCI.3157-11.2011; Herbert TP, 2002, J BIOL CHEM, V277, P11591, DOI 10.1074/jbc.M110367200; Hu JH, 2010, NEURON, V68, P1128, DOI 10.1016/j.neuron.2010.11.008; Huang GN, 2008, SCIENCE, V319, P476, DOI 10.1126/science.1151227; Jacquemont S, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001708; Kelleher RJ, 2004, CELL, V116, P467, DOI 10.1016/S0092-8674(04)00115-1; Liu ZH, 2009, NEUROSCI LETT, V454, P62, DOI 10.1016/j.neulet.2009.02.066; Luscher C, 2010, NEURON, V65, P445, DOI 10.1016/j.neuron.2010.01.016; Mackiewicz M, 2008, PHYSIOL GENOMICS, V33, P91, DOI 10.1152/physiolgenomics.00189.2007; Mao LM, 2005, J NEUROSCI, V25, P2741, DOI 10.1523/JNEUROSCI.4360-04.2005; Mizutani A, 2008, J NEUROSCI, V28, P5369, DOI 10.1523/JNEUROSCI.4738-07.2008; Muddashetty RS, 2011, MOL CELL, V42, P673, DOI 10.1016/j.molcel.2011.05.006; Orlando LR, 2009, J NEUROCHEM, V110, P557, DOI 10.1111/j.1471-4159.2009.06139.x; Osterweil EK, 2010, J NEUROSCI, V30, P15616, DOI 10.1523/JNEUROSCI.3888-10.2010; Park S, 2008, NEURON, V59, P70, DOI 10.1016/j.neuron.2008.05.023; Potschka H, 2002, EUR J NEUROSCI, V16, P2157, DOI 10.1046/j.1460-9568.2002.02265.x; Proud CG, 2007, BIOCHEM J, V403, P217, DOI 10.1042/BJ20070024; Ronesi JA, 2008, SCI SIGNAL, V1, DOI 10.1126/stke.15pe6; Ronesi JA, 2008, J NEUROSCI, V28, P543, DOI 10.1523/JNEUROSCI.5019-07.2008; Rubenstein JLR, 2003, GENES BRAIN BEHAV, V2, P255, DOI 10.1034/j.1601-183X.2003.00037.x; Sanchez-Vives MV, 2000, NAT NEUROSCI, V3, P1027, DOI 10.1038/79848; Scheetz AJ, 2000, NAT NEUROSCI, V3, P211, DOI 10.1038/72915; Sharma A, 2010, J NEUROSCI, V30, P694, DOI 10.1523/JNEUROSCI.3696-09.2010; Shiraishi-Yamaguchi Y, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-206; Thomas AM, 2012, PSYCHOPHARMACOLOGY, V219, P47, DOI 10.1007/s00213-011-2375-4; Thomas AM, 2011, BEHAV BRAIN RES, V223, P310, DOI 10.1016/j.bbr.2011.04.049; Tu JC, 1998, NEURON, V21, P717, DOI 10.1016/S0896-6273(00)80589-9; Uhhaas PJ, 2006, NEURON, V52, P155, DOI 10.1016/j.neuron.2006.09.020; Waung MW, 2008, NEURON, V59, P84, DOI 10.1016/j.neuron.2008.05.014; Waung MW, 2009, CURR OPIN NEUROBIOL, V19, P319, DOI 10.1016/j.conb.2009.03.011; Xiao B, 1998, NEURON, V21, P707, DOI 10.1016/S0896-6273(00)80588-7; Zalfa F, 2003, CELL, V112, P317, DOI 10.1016/S0092-8674(03)00079-5	50	188	189	6	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2012	15	3					431	U122		10.1038/nn.3033	http://dx.doi.org/10.1038/nn.3033			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	899CY	22267161	Green Accepted			2022-12-28	WOS:000300793100017
J	Tissir, F; Goffinet, AM				Tissir, Fadel; Goffinet, Andre M.			Cilia: conductors' batons of neuronal maturation	NATURE NEUROSCIENCE			English	Editorial Material								The primary cilium, a signal transduction organelle, is present on the cell bodies of adult-born dentate gyrus granule cells as they begin maturation. In its absence, their maturation and integration are impaired.	[Tissir, Fadel; Goffinet, Andre M.] Univ Louvain, Inst Neurosci, Brussels, Belgium	Universite Catholique Louvain	Tissir, F (corresponding author), Univ Louvain, Inst Neurosci, Brussels, Belgium.	andre.goffinet@uclouvain.be		Tissir, Fadel/0000-0002-9292-6622				Arellano JI, 2012, J COMP NEUROL, V520, P848, DOI 10.1002/cne.22793; Baldari CT, 2010, CURR OPIN CELL BIOL, V22, P75, DOI 10.1016/j.ceb.2009.10.010; Breunig JJ, 2008, P NATL ACAD SCI USA, V105, P13127, DOI 10.1073/pnas.0804558105; Han YG, 2008, NAT NEUROSCI, V11, P277, DOI 10.1038/nn2059; Jonassen JA, 2008, J CELL BIOL, V183, P377, DOI 10.1083/jcb.200808137; Kumamoto N, 2012, NAT NEUROSCI, V15, P399, DOI 10.1038/nn.3042; Lancaster MA, 2011, NAT CELL BIOL, V13, P700, DOI 10.1038/ncb2259; Metin C, 2007, DEVELOPMENT, V134, P2815, DOI 10.1242/dev.02869; Suh H, 2009, ANNU REV CELL DEV BI, V25, P253, DOI 10.1146/annurev.cellbio.042308.113256; Wilsch-Brauninger M, 2012, DEVELOPMENT, V139, P95, DOI 10.1242/dev.069294	10	1	1	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2012	15	3					344	345		10.1038/nn.3050	http://dx.doi.org/10.1038/nn.3050			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	899CY	22362103				2022-12-28	WOS:000300793100004
J	Heidenreich, M; Lechner, SG; Vardanyan, V; Wetzel, C; Cremers, CW; De Leenheer, EM; Aranguez, G; Moreno-Pelayo, MA; Jentsch, TJ; Lewin, GR				Heidenreich, Matthias; Lechner, Stefan G.; Vardanyan, Vitya; Wetzel, Christiane; Cremers, Cor W.; De Leenheer, Els M.; Aranguez, Gracia; Angel Moreno-Pelayo, Miguel; Jentsch, Thomas J.; Lewin, Gary R.			KCNQ4 K+ channels tune mechanoreceptors for normal touch sensation in mouse and man	NATURE NEUROSCIENCE			English	Article							RAPIDLY ADAPTING MECHANORECEPTORS; STIMULUS-RESPONSE FUNCTIONS; GLABROUS SKIN AREA; OUTER HAIR-CELLS; SENSORY NEURONS; POTASSIUM CHANNELS; DOMINANT DEAFNESS; MAMMALIAN-CELLS; AFFERENTS; CURRENTS	Mutations inactivating the potassium channel KCNQ4 (K(v)7.4) lead to deafness in humans and mice. In addition to its expression in mechanosensitive hair cells of the inner ear, KCNQ4 is found in the auditory pathway and in trigeminal nuclei that convey somatosensory information. We have now detected KCNQ4 in the peripheral nerve endings of cutaneous rapidly adapting hair follicle and Meissner corpuscle mechanoreceptors from mice and humans. Electrophysiological recordings from single afferents from Kcnq4(-/-) mice and mice carrying a KCNQ4 mutation found in DFNA2-type monogenic dominant human hearing loss showed elevated mechanosensitivity and altered frequency response of rapidly adapting, but not of slowly adapting nor of D-hair, mechanoreceptor neurons. Human subjects from independent DFNA2 pedigrees outperformed age-matched control subjects when tested for vibrotactile acuity at low frequencies. This work describes a gene mutation that modulates touch sensitivity in mice and humans and establishes KCNQ4 as a specific molecular marker for rapidly adapting Meissner and a subset of hair follicle afferents.	[Heidenreich, Matthias; Vardanyan, Vitya; Jentsch, Thomas J.] Leibniz Inst Mol Pharmakol FMP, Berlin, Germany; [Heidenreich, Matthias; Lechner, Stefan G.; Vardanyan, Vitya; Wetzel, Christiane; Jentsch, Thomas J.; Lewin, Gary R.] Max Delbruck Ctr Mol Med MDC, Berlin, Germany; [Cremers, Cor W.] Radboud Univ Nijmegen, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [De Leenheer, Els M.] Ghent Univ Hosp, Dept Otorhinolaryngol Head & Neck Surg, Ghent, Belgium; [De Leenheer, Els M.] Univ Ghent, B-9000 Ghent, Belgium; [Aranguez, Gracia] Hosp Gen Univ Gregorio Maranon, Serv Otorrinolaringol, Madrid, Spain; [Angel Moreno-Pelayo, Miguel] Hosp Ramon & Cajal, IRYCIS, CIBERER, Unidad Genet Mol, E-28034 Madrid, Spain; [Jentsch, Thomas J.; Lewin, Gary R.] Charite, D-13353 Berlin, Germany	Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP); Helmholtz Association; Max Delbruck Center for Molecular Medicine; Radboud University Nijmegen; Ghent University; Ghent University Hospital; Ghent University; General University Gregorio Maranon Hospital; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Hospital Universitario Ramon y Cajal; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Jentsch, TJ (corresponding author), Leibniz Inst Mol Pharmakol FMP, Berlin, Germany.	jentsch@fmp-berlin.de; glewin@mdc-berlin.de	De Leenheer, Els/AGB-3503-2022; Lewin, Gary R/B-8028-2011; Cremers, C.W.R.J./L-4254-2015	De Leenheer, Els/0000-0002-2789-3529; Jentsch, Thomas/0000-0002-3509-2553; Lewin, Gary/0000-0002-2890-6352; Lechner, Stefan/0000-0001-9402-9127; Wetzel, Christiane/0000-0003-0587-8018; MORENO-PELAYO, MIGUEL ANGEL/0000-0003-3839-5098	Leibniz Gemeinschaft; Prix Louis-Jeantet de Medecine; Ernst-Jung Preis fur Medizin; Deutsche Forschungsgemeinschaft (DFG) [SFB665]; DFG [Exc 257 NeuroCure]	Leibniz Gemeinschaft; Prix Louis-Jeantet de Medecine; Ernst-Jung Preis fur Medizin; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); DFG(German Research Foundation (DFG))	We thank P. Seidler and H. Thraenhardt for technical assistance, the DFNA2 families for their collaboration, C. Birchmeier (MDC Berlin) for the MafA antibody, M. Maurer (Charite Berlin) for human skin biopsies and B. Purfuerst for electron microscopy. Supported by an SAW (Senatsausschuss Wettbewerb) grant of the Leibniz Gemeinschaft to T.J.J. and G. R. L., the Prix Louis-Jeantet de Medecine and the Ernst-Jung Preis fur Medizin to T.J.J. and grants from the Deutsche Forschungsgemeinschaft (DFG) (SFB665) to G. R. L.; additional funding (T.J.J. and G. R. L.) was provided by the DFG (Exc 257 NeuroCure).	Bensmaia SJ, 2003, SOMATOSENS MOT RES, V20, P33, DOI 10.1080/0899022031000083825; Bensmaia SJ, 2008, J NEUROSCI, V28, P776, DOI 10.1523/JNEUROSCI.4162-07.2008; Biervert C, 1998, SCIENCE, V279, P403, DOI 10.1126/science.279.5349.403; Blake DT, 1997, J NEUROSCI, V17, P7480; BOLANOWSKI SJ, 1984, J NEUROPHYSIOL, V51, P793, DOI 10.1152/jn.1984.51.4.793; Bourane S, 2009, NEURON, V64, P857, DOI 10.1016/j.neuron.2009.12.004; Brown DA, 2009, BRIT J PHARMACOL, V156, P1185, DOI 10.1111/j.1476-5381.2009.00111.x; Charlier C, 1998, NAT GENET, V18, P53, DOI 10.1038/ng0198-53; DARIANSMITH I, 1980, J PHYSIOL-LONDON, V309, P135, DOI 10.1113/jphysiol.1980.sp013499; De Leenheer EMR, 2002, ANN OTO RHINOL LARYN, V111, P267, DOI 10.1177/000348940211100312; French AS, 2004, CAN J PHYSIOL PHARM, V82, P541, DOI 10.1139/Y04-031; Hammami S, 2009, J PHYSIOL-LONDON, V587, P2225, DOI 10.1113/jphysiol.2008.163550; Hu J, 2010, EMBO J, V29, P855, DOI 10.1038/emboj.2009.398; Hu J, 2006, J PHYSIOL-LONDON, V577, P815, DOI 10.1113/jphysiol.2006.117648; Jentsch TJ, 2000, NAT REV NEUROSCI, V1, P21, DOI 10.1038/35036198; Johansson RS, 2009, NAT REV NEUROSCI, V10, P345, DOI 10.1038/nrn2621; Johansson RS, 2004, NAT NEUROSCI, V7, P170, DOI 10.1038/nn1177; JOHANSSON RS, 1979, J PHYSIOL-LONDON, V297, P405, DOI 10.1113/jphysiol.1979.sp013048; Johnson KO, 2001, CURR OPIN NEUROBIOL, V11, P455, DOI 10.1016/S0959-4388(00)00234-8; Kharkovets T, 2006, EMBO J, V25, P642, DOI 10.1038/sj.emboj.7600951; Kharkovets T, 2000, P NATL ACAD SCI USA, V97, P4333, DOI 10.1073/pnas.97.8.4333; Kim HJ, 2011, J BIOL CHEM, V286, P1517, DOI 10.1074/jbc.M110.179010; KNIBESTO.M, 1973, J PHYSIOL-LONDON, V232, P427, DOI 10.1113/jphysiol.1973.sp010279; KNIBESTOL M, 1975, J PHYSIOL-LONDON, V245, P63, DOI 10.1113/jphysiol.1975.sp010835; Koltzenburg M, 1997, J NEUROPHYSIOL, V78, P1841, DOI 10.1152/jn.1997.78.4.1841; Kubisch C, 1999, CELL, V96, P437, DOI 10.1016/S0092-8674(00)80556-5; Lechner SG, 2003, J PHYSIOL-LONDON, V553, P789, DOI 10.1113/jphysiol.2003.052449; Lechner SG, 2009, J PHYSIOL-LONDON, V587, P3493, DOI 10.1113/jphysiol.2009.175059; Lewin GR, 2004, J NEUROBIOL, V61, P30, DOI 10.1002/neu.20078; Linley JE, 2008, J NEUROSCI, V28, P11240, DOI 10.1523/JNEUROSCI.2297-08.2008; LOEWENSTEIN WR, 1958, J GEN PHYSIOL, V41, P1245, DOI 10.1085/jgp.41.6.1245; Luo WQ, 2009, NEURON, V64, P841, DOI 10.1016/j.neuron.2009.11.003; Maricich SM, 2009, SCIENCE, V324, P1580, DOI 10.1126/science.1172890; Mencia A, 2008, HUM GENET, V123, P41, DOI 10.1007/s00439-007-0447-7; Milenkovic N, 2008, J NEUROPHYSIOL, V100, P2771, DOI 10.1152/jn.90799.2008; Passmore GM, 2003, J NEUROSCI, V23, P7227, DOI 10.1523/JNEUROSCI.23-18-07227.2003; Peters HC, 2005, NAT NEUROSCI, V8, P51, DOI 10.1038/nn1375; Schroeder BC, 2000, J BIOL CHEM, V275, P24089, DOI 10.1074/jbc.M003245200; Selyanko AA, 2000, J PHYSIOL-LONDON, V522, P349, DOI 10.1111/j.1469-7793.2000.t01-2-00349.x; Sogaard R, 2001, AM J PHYSIOL-CELL PH, V280, pC859; TALBOT WH, 1968, J NEUROPHYSIOL, V31, P301, DOI 10.1152/jn.1968.31.2.301; Trulsson M, 2010, J NEUROPHYSIOL, V103, P1741, DOI 10.1152/jn.01146.2009; Tsunozaki M, 2009, CURR OPIN NEUROBIOL, V19, P362, DOI 10.1016/j.conb.2009.07.008; Tzingounis AV, 2010, P NATL ACAD SCI USA, V107, P10232, DOI 10.1073/pnas.1004644107; VALLBO AB, 1995, J PHYSIOL-LONDON, V483, P783, DOI 10.1113/jphysiol.1995.sp020622; VANBOVEN RW, 1994, NEUROLOGY, V44, P2361, DOI 10.1212/WNL.44.12.2361; Wang HS, 1998, SCIENCE, V282, P1890, DOI 10.1126/science.282.5395.1890; Watanabe H, 2000, J NEUROCHEM, V75, P28, DOI 10.1046/j.1471-4159.2000.0750028.x; Wetzel C, 2007, NATURE, V445, P206, DOI 10.1038/nature05394; Yeung SYM, 2007, BRIT J PHARMACOL, V151, P758, DOI 10.1038/sj.bjp.0707284	50	73	77	1	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2012	15	1					138	U217		10.1038/nn.2985	http://dx.doi.org/10.1038/nn.2985			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	866VO	22101641				2022-12-28	WOS:000298414400024
J	Croxson, PL; Kyriazis, DA; Baxter, MG				Croxson, Paula L.; Kyriazis, Diana A.; Baxter, Mark G.			Cholinergic modulation of a specific memory function of prefrontal cortex	NATURE NEUROSCIENCE			English	Article							PERSISTENT ACTIVITY; ALZHEIMERS-DISEASE; ATTENTION; LESIONS	Deficits in prefrontal cholinergic function are implicated in cognitive impairment in many neuropsychiatric diseases, but acetylcholine's specific role remains elusive. Rhesus monkeys with selective lesions of cholinergic input to prefrontal cortex (PFC) were unimpaired in tests of decision making and episodic memory that require intact PFC, but were severely impaired on a spatial working memory task. These observations are consistent with a specific role for prefrontal acetylcholine in working memory.	[Croxson, Paula L.; Baxter, Mark G.] Mt Sinai Sch Med, Dept Neurosci, Glickenhaus Lab Neuropsychol, New York, NY 10029 USA; [Croxson, Paula L.; Baxter, Mark G.] Mt Sinai Sch Med, Dept Neurosci, Friedman Brain Inst, New York, NY USA; [Croxson, Paula L.; Kyriazis, Diana A.; Baxter, Mark G.] Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University of Oxford	Baxter, MG (corresponding author), Mt Sinai Sch Med, Dept Neurosci, Glickenhaus Lab Neuropsychol, New York, NY 10029 USA.	mark.baxter@mssm.edu		Croxson, Paula/0000-0002-4649-980X	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	We thank D. Gaffan for advice and support, and C. Bergmann, G. Daubney, C. Rae and K. Murphy for technical assistance. This research was supported by a grant from the Wellcome Trust (M.G.B.).	BACHEVALIER J, 1986, BEHAV BRAIN RES, V20, P249, DOI 10.1016/0166-4328(86)90225-1; Bartus RT, 2009, PSYCHOPHARMACOLOGY, V202, P15, DOI 10.1007/s00213-008-1365-7; Bartus RT, 2000, EXP NEUROL, V163, P495, DOI 10.1006/exnr.2000.7397; Baxter MG, 1996, BEHAV NEUROSCI, V110, P898, DOI 10.1037/0735-7044.110.5.898; BIERER LM, 1995, J NEUROCHEM, V64, P749; Browning PGF, 2010, CEREB CORTEX, V20, P282, DOI 10.1093/cercor/bhp097; Chudasama Y, 2004, LEARN MEMORY, V11, P78, DOI 10.1101/lm.70904; Egorov AV, 2002, NATURE, V420, P173, DOI 10.1038/nature01171; Furey ML, 2000, SCIENCE, V290, P2315, DOI 10.1126/science.290.5500.2315; Johnson JK, 1999, ARCH NEUROL-CHICAGO, V56, P1233, DOI 10.1001/archneur.56.10.1233; Parikh V, 2008, ANN NY ACAD SCI, V1129, P225, DOI 10.1196/annals.1417.021; Robbins TW, 2009, ANNU REV NEUROSCI, V32, P267, DOI 10.1146/annurev.neuro.051508.135535; Schon K, 2005, J NEUROSCI, V25, P9112, DOI 10.1523/JNEUROSCI.1982-05.2005; Turchi J, 2005, P NATL ACAD SCI USA, V102, P2158, DOI 10.1073/pnas.0409708102; Wilson CRE, 2010, TRENDS NEUROSCI, V33, P533, DOI 10.1016/j.tins.2010.08.001	15	101	104	1	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2011	14	12					1510	1512		10.1038/nn.2971	http://dx.doi.org/10.1038/nn.2971			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	855EJ	22057191	Green Accepted			2022-12-28	WOS:000297546300008
J	Spencer, T				Spencer, Timothy			Maintaining a Highwire act (vol 14, pg 1226, 2011)	NATURE NEUROSCIENCE			English	Correction													Spencer, Tim/AAK-2094-2020					Spencer T, 2011, NAT NEUROSCI, V14, DOI 10.1038/nn1011-1226	1	1	1	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2011	14	10								10.1038/nn1011-1226	http://dx.doi.org/10.1038/nn1011-1226			1	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	825EQ	21952265	Bronze			2022-12-28	WOS:000295254200005
J	Wannig, A; Stanisor, L; Roelfsema, PR				Wannig, Aurel; Stanisor, Liviu; Roelfsema, Pieter R.			Automatic spread of attentional response modulation along Gestalt criteria in primary visual cortex	NATURE NEUROSCIENCE			English	Article							OBJECT-BASED ATTENTION	Visual attention can select spatial locations, features and objects. Theories of object-based attention claim that attention enhances the representation of all parts of an object, even parts that are not task relevant. We recorded neuronal activity in area V1 of macaque monkeys and observed an automatic spread of attention to image elements outside of the attentional focus when they were bound to an attended stimulus by Gestalt criteria.	[Wannig, Aurel; Stanisor, Liviu; Roelfsema, Pieter R.] Royal Netherlands Acad Arts & Sci, Dept Vis & Cognit, Netherlands Inst Neurosci, Amsterdam, Netherlands; [Roelfsema, Pieter R.] Vrije Univ Amsterdam, Dept Integrat Neurophysiol, Ctr Neurogenom & Cognit Res, Amsterdam, Netherlands	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); Vrije Universiteit Amsterdam	Roelfsema, PR (corresponding author), Royal Netherlands Acad Arts & Sci, Dept Vis & Cognit, Netherlands Inst Neurosci, Amsterdam, Netherlands.	p.roelfsema@nin.knaw.nl	Roelfsema, Pieter/J-6903-2013	Roelfsema, Pieter/0000-0002-1625-0034	NWO-ALW [816.02.018]; NWO-VICI [016.075.608]	NWO-ALW(Netherlands Organization for Scientific Research (NWO)); NWO-VICI(Netherlands Organization for Scientific Research (NWO))	We thank J. Poort, B. Dagnino, B. van Vugt and J. Fecteau for additional data collection, and K. Brandsma and D. Vleesenbeek for biotechnical support. This work was supported by NWO-ALW grant 816.02.018 and by an NWO-VICI grant 016.075.608 awarded to P.R.R.	Conner CE, 1997, J NEUROSCI, V17, P3201; Driver J, 2001, COGNITION, V80, P61, DOI 10.1016/S0010-0277(00)00151-7; DUNCAN J, 1984, J EXP PSYCHOL GEN, V113, P501, DOI 10.1037/0096-3445.113.4.501; EGLY R, 1994, J EXP PSYCHOL GEN, V123, P161, DOI 10.1037/0096-3445.123.2.161; Freeman E, 2001, NAT NEUROSCI, V4, P1032, DOI 10.1038/nn728; HOFFMAN JE, 1995, PERCEPT PSYCHOPHYS, V57, P787, DOI 10.3758/BF03206794; Lamy D, 2002, PERCEPT PSYCHOPHYS, V64, P52, DOI 10.3758/BF03194557; Li W, 2006, NEURON, V50, P951, DOI 10.1016/j.neuron.2006.04.035; Martinez-Trujillo JC, 2004, CURR BIOL, V14, P744, DOI 10.1016/j.cub.2004.04.028; Richard AM, 2008, J EXP PSYCHOL HUMAN, V34, P842, DOI 10.1037/0096-1523.34.4.842; Roelfsema PR, 1998, NATURE, V395, P376, DOI 10.1038/26475; Shomstein S, 2002, PERCEPT PSYCHOPHYS, V64, P41, DOI 10.3758/BF03194556; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; Wannig A, 2007, NEURON, V54, P639, DOI 10.1016/j.neuron.2007.05.001; Wertheimer M, 1923, PSYCHOL FORSCH, V4, P301, DOI 10.1007/BF00410640	15	79	81	1	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2011	14	10					1243	1244		10.1038/nn.2910	http://dx.doi.org/10.1038/nn.2910			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	825EQ	21926984				2022-12-28	WOS:000295254200009
J	Aponte, Y; Atasoy, D; Sternson, SM				Aponte, Yexica; Atasoy, Deniz; Sternson, Scott M.			AGRP neurons are sufficient to orchestrate feeding behavior rapidly and without training	NATURE NEUROSCIENCE			English	Article							AGOUTI-RELATED-PROTEIN; NEUROPEPTIDE-Y; ARCUATE NUCLEUS; IN-VIVO; HYPOTHALAMIC CART; MICE; LEPTIN; MELANOCORTIN; RATS; STIMULATION	Two intermingled hypothalamic neuron populations specified by expression of agouti-related peptide (AGRP) or proopiomelanocortin (POMC) positively and negatively influence feeding behavior, respectively, possibly by reciprocally regulating downstream melanocortin receptors. However, the sufficiency of these neurons to control behavior and the relationship of their activity to the magnitude and dynamics of feeding are unknown. To measure this, we used channelrhodopsin-2 for cell type-specific photostimulation. Activation of only 800 AGRP neurons in mice evoked voracious feeding within minutes. The behavioral response increased with photoexcitable neuron number, photostimulation frequency and stimulus duration. Conversely, POMC neuron stimulation reduced food intake and body weight, which required melanocortin receptor signaling. However, AGRP neuron-mediated feeding was not dependent on suppressing this melanocortin pathway, indicating that AGRP neurons directly engage feeding circuits. Furthermore, feeding was evoked selectively over drinking without training or prior photostimulus exposure, which suggests that AGRP neurons serve a dedicated role coordinating this complex behavior.	[Aponte, Yexica; Atasoy, Deniz; Sternson, Scott M.] Howard Hughes Med Inst, Ashburn, VA USA	Howard Hughes Medical Institute	Sternson, SM (corresponding author), Howard Hughes Med Inst, Janelia Farm Res Campus, Ashburn, VA USA.	sternsons@janelia.hhmi.org	Aponte, Yeka/AAL-4643-2020; Atasoy, Deniz/AAR-7917-2020; Atasoy, Deniz/B-3414-2018	Aponte, Yeka/0000-0002-5967-2579; Atasoy, Deniz/0000-0002-3325-8820; Sternson, Scott/0000-0002-0835-444X	Howard Hughes Medical Institute	Howard Hughes Medical Institute(Howard Hughes Medical Institute)	We thank G. Shtengel for assistance with photostimulation equipment and software, R. Shusterman for assistance with data analysis, H. Peng for image analysis tools, J. Osborne and T. Tabachnik for equipment design and fabrication, A. Arnold for imaging support, B. Shields and A. Hu for histology support, and J. Cox for mouse breeding and genotyping support. K. Svoboda, G. Murphy, J. Dudman, A. Lee, and S.E.R. Egnor commented on the manuscript. This research was funded by the Howard Hughes Medical Institute.	Abbott SBG, 2009, J NEUROSCI, V29, P5806, DOI 10.1523/JNEUROSCI.1106-09.2009; Adamantidis AR, 2007, NATURE, V450, P420, DOI 10.1038/nature06310; Atasoy D, 2008, J NEUROSCI, V28, P7025, DOI 10.1523/JNEUROSCI.1954-08.2008; Balthasar N, 2004, NEURON, V42, P983, DOI 10.1016/j.neuron.2004.06.004; Belgardt BF, 2009, J PHYSIOL-LONDON, V587, P5305, DOI 10.1113/jphysiol.2009.179192; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Broberger C, 1998, P NATL ACAD SCI USA, V95, P15043, DOI 10.1073/pnas.95.25.15043; CLARK JT, 1984, ENDOCRINOLOGY, V115, P427, DOI 10.1210/endo-115-1-427; Cowley MA, 2003, ANN NY ACAD SCI, V994, P175, DOI 10.1111/j.1749-6632.2003.tb03178.x; Cowley MA, 2001, NATURE, V411, P480, DOI 10.1038/35078085; Elias CF, 1998, NEURON, V21, P1375, DOI 10.1016/S0896-6273(00)80656-X; Fan W, 1997, NATURE, V385, P165, DOI 10.1038/385165a0; Houweling AR, 2008, NATURE, V451, P65, DOI 10.1038/nature06447; Huber D, 2008, NATURE, V451, P61, DOI 10.1038/nature06445; Kaelin CB, 2004, ENDOCRINOLOGY, V145, P5798, DOI 10.1210/en.2004-0956; Kristensen P, 1998, NATURE, V393, P72, DOI 10.1038/29993; LEVINE AS, 1984, PEPTIDES, V5, P1025, DOI 10.1016/0196-9781(84)90165-7; Li X, 2005, P NATL ACAD SCI USA, V102, P17816, DOI 10.1073/pnas.0509030102; Luquet S, 2005, SCIENCE, V310, P683, DOI 10.1126/science.1115524; MILLER MW, 1993, GENE DEV, V7, P454, DOI 10.1101/gad.7.3.454; Morton GJ, 2006, NATURE, V443, P289, DOI 10.1038/nature05026; Ollmann MM, 1997, SCIENCE, V278, P135, DOI 10.1126/science.278.5335.135; Roseberry AG, 2004, NEURON, V41, P711, DOI 10.1016/S0896-6273(04)00074-1; Rossi M, 1998, ENDOCRINOLOGY, V139, P4428, DOI 10.1210/en.139.10.4428; STANLEY BG, 1984, LIFE SCI, V35, P2635, DOI 10.1016/0024-3205(84)90032-8; Takahashi KA, 2005, ENDOCRINOLOGY, V146, P1043, DOI 10.1210/en.2004-1397; Tolkamp BJ, 1999, ANIM BEHAV, V57, P807, DOI 10.1006/anbe.1998.1022; Tolkamp BJ, 1998, J THEOR BIOL, V194, P235, DOI 10.1006/jtbi.1998.0759; Tsai HC, 2009, SCIENCE, V324, P1080, DOI 10.1126/science.1168878; TSUJII S, 1989, BRAIN RES BULL, V23, P165, DOI 10.1016/0361-9230(89)90142-1; van den Top M, 2004, NAT NEUROSCI, V7, P493, DOI 10.1038/nn1226; Wu Q, 2008, P NATL ACAD SCI USA, V105, P2687, DOI 10.1073/pnas.0712062105; Wu Q, 2009, CELL, V137, P1225, DOI 10.1016/j.cell.2009.04.022; Yaswen L, 1999, NAT MED, V5, P1066, DOI 10.1038/12506	34	694	708	9	90	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2011	14	3					351	355		10.1038/nn.2739	http://dx.doi.org/10.1038/nn.2739			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	725MW	21209617	Green Accepted			2022-12-28	WOS:000287650100016
J	Bernacchia, A; Seo, H; Lee, D; Wang, XJ				Bernacchia, Alberto; Seo, Hyojung; Lee, Daeyeol; Wang, Xiao-Jing			A reservoir of time constants for memory traces in cortical neurons	NATURE NEUROSCIENCE			English	Article							ANTERIOR CINGULATE CORTEX; MIXED-STRATEGY GAME; PRIMATE PREFRONTAL CORTEX; DECISION-MAKING; WORKING-MEMORY; COMPETITIVE GAME; DOPAMINE NEURONS; NEURAL-NETWORKS; RHESUS-MONKEYS; REWARD SIGNALS	According to reinforcement learning theory of decision making, reward expectation is computed by integrating past rewards with a fixed timescale. In contrast, we found that a wide range of time constants is available across cortical neurons recorded from monkeys performing a competitive game task. By recognizing that reward modulates neural activity multiplicatively, we found that one or two time constants of reward memory can be extracted for each neuron in prefrontal, cingulate and parietal cortex. These timescales ranged from hundreds of milliseconds to tens of seconds, according to a power law distribution, which is consistent across areas and reproduced by a 'reservoir' neural network model. These neuronal memory timescales were weakly, but significantly, correlated with those of monkey's decisions. Our findings suggest a flexible memory system in which neural subpopulations with distinct sets of long or short memory timescales may be selectively deployed according to the task demands.	[Wang, Xiao-Jing] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06520 USA; Yale Univ, Sch Med, Kavli Inst Neurosci, New Haven, CT USA	Yale University; Yale University	Wang, XJ (corresponding author), Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06520 USA.	xjwang@yale.edu	Lee, Daeyeol/A-6794-2008; Seo, Hyojung/A-6860-2008; Wang, Xiao-Jing/D-2722-2009	Lee, Daeyeol/0000-0003-3474-019X; 	US National Institutes of Health [R01 MH062349, R01 MH073246, DA029330]; Swartz Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH062349, R01MH073246] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA029330] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swartz Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank J. Mazer and M. W. Jung for comments on an earlier version of the manuscript, and R. Chaudhuri, M. Harre and J. Murray for discussions. This work was supported by the US National Institutes of Health grant R01 MH062349 and the Swartz Foundation (A. B. and X.-J.W.), and by US National Institutes of Health grants R01 MH073246 (X.-J.W. and D. L.) and DA029330 (D.L.).	Barraclough DJ, 2004, NAT NEUROSCI, V7, P404, DOI 10.1038/nn1209; Bayer HM, 2005, NEURON, V47, P129, DOI 10.1016/j.neuron.2005.05.020; Behrens TEJ, 2007, NAT NEUROSCI, V10, P1214, DOI 10.1038/nn1954; Bertschinger N, 2004, NEURAL COMPUT, V16, P1413, DOI 10.1162/089976604323057443; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Brody CD, 2003, CEREB CORTEX, V13, P1196, DOI 10.1093/cercor/bhg100; Bromberg-Martin ES, 2010, NEURON, V67, P499, DOI 10.1016/j.neuron.2010.06.031; Brunel N, 2004, NEURON, V43, P745, DOI 10.1016/S0896-6273(04)00528-8; Corrado GS, 2005, J EXP ANAL BEHAV, V84, P581, DOI 10.1901/jeab.2005.23-05; Curtis CE, 2010, TRENDS COGN SCI, V14, P216, DOI 10.1016/j.tics.2010.03.006; Daw ND, 2006, NATURE, V441, P876, DOI 10.1038/nature04766; Duncan J, 2001, NAT REV NEUROSCI, V2, P820, DOI 10.1038/35097575; FUNAHASHI S, 1993, NATURE, V365, P753, DOI 10.1038/365753a0; Ganguli S, 2008, NEURON, V58, P15, DOI 10.1016/j.neuron.2008.01.038; Ganguli S, 2008, P NATL ACAD SCI USA, V105, P18970, DOI 10.1073/pnas.0804451105; Goldman MS, 2009, NEURON, V61, P621, DOI 10.1016/j.neuron.2008.12.012; Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI 10.1037/0033-295X.109.4.679; Jaegera H, 2007, NEURAL NETWORKS, V20, P335, DOI 10.1016/j.neunet.2007.04.016; Jin DZZ, 2009, P NATL ACAD SCI USA, V106, P19156, DOI 10.1073/pnas.0909881106; Kable JW, 2009, NEURON, V63, P733, DOI 10.1016/j.neuron.2009.09.003; Kennerley SW, 2006, NAT NEUROSCI, V9, P940, DOI 10.1038/nn1724; Kim S, 2009, NEURAL NETWORKS, V22, P294, DOI 10.1016/j.neunet.2009.03.010; LANGTON CG, 1990, PHYSICA D, V42, P12, DOI 10.1016/0167-2789(90)90064-V; Lapish CC, 2008, P NATL ACAD SCI USA, V105, P11963, DOI 10.1073/pnas.0804045105; Lau B, 2005, J EXP ANAL BEHAV, V84, P555, DOI 10.1901/jeab.2005.110-04; Lebedev MA, 2004, PLOS BIOL, V2, P1919, DOI 10.1371/journal.pbio.0020365; Lee D, 2004, COGNITIVE BRAIN RES, V22, P45, DOI 10.1016/j.cogbrainres.2004.07.007; Maass W, 2002, NEURAL COMPUT, V14, P2531, DOI 10.1162/089976602760407955; Machens CK, 2010, J NEUROSCI, V30, P350, DOI 10.1523/JNEUROSCI.3276-09.2010; Murphy BK, 2009, NEURON, V61, P635, DOI 10.1016/j.neuron.2009.02.005; Passingham D, 2004, CURR OPIN NEUROBIOL, V14, P163, DOI 10.1016/j.conb.2004.03.003; Platt ML, 1999, NATURE, V400, P233, DOI 10.1038/22268; Rainer G, 1999, J NEUROSCI, V19, P5493; Rainer G, 2002, EUR J NEUROSCI, V15, P1244, DOI 10.1046/j.1460-9568.2002.01958.x; Rigotti M, 2010, FRONT COMPUT NEUROSC, V4, DOI 10.3389/fncom.2010.00024; Roitman JD, 2002, J NEUROSCI, V22, P9475; Rushworth MFS, 2008, NAT NEUROSCI, V11, P389, DOI 10.1038/nn2066; Schneidman E, 2006, NATURE, V440, P1007, DOI 10.1038/nature04701; Seo H, 2007, CEREB CORTEX, V17, pI110, DOI 10.1093/cercor/bhm064; Seo H, 2007, J NEUROSCI, V27, P8366, DOI 10.1523/JNEUROSCI.2369-07.2007; Seo H, 2009, J NEUROSCI, V29, P7278, DOI 10.1523/JNEUROSCI.1479-09.2009; Shafi M, 2007, NEUROSCIENCE, V146, P1082, DOI 10.1016/j.neuroscience.2006.12.072; Sigala N, 2008, P NATL ACAD SCI USA, V105, P11969, DOI 10.1073/pnas.0802569105; Soltani A, 2006, NEURAL NETWORKS, V19, P1075, DOI 10.1016/j.neunet.2006.05.044; Sussillo D, 2009, NEURON, V63, P544, DOI 10.1016/j.neuron.2009.07.018; Trefethen L. N., 2005, SPECTRA PSEUDOSPECTR; Verstraeten D, 2007, NEURAL NETWORKS, V20, P391, DOI 10.1016/j.neunet.2007.04.003; Wallis JD, 2010, CURR OPIN NEUROBIOL, V20, P191, DOI 10.1016/j.conb.2010.02.009; Wang XJ, 2008, NEURON, V60, P215, DOI 10.1016/j.neuron.2008.09.034	50	183	183	3	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2011	14	3					366	372		10.1038/nn.2752	http://dx.doi.org/10.1038/nn.2752			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	725MW	21317906	Green Accepted			2022-12-28	WOS:000287650100018
J	Diekelmann, S; Buchel, C; Born, J; Rasch, B				Diekelmann, Susanne; Buechel, Christian; Born, Jan; Rasch, Bjoern			Labile or stable: opposing consequences for memory when reactivated during waking and sleep	NATURE NEUROSCIENCE			English	Article							LONG-TERM-MEMORY; SLOW-WAVE SLEEP; PROTEIN-SYNTHESIS; DECLARATIVE MEMORY; PREFRONTAL CORTEX; FEAR MEMORIES; RECONSOLIDATION; CONSOLIDATION; HIPPOCAMPUS; RETRIEVAL	Memory consolidation is a dynamic process. Reconsolidation theory assumes that reactivation during wakefulness transiently destabilizes memories, requiring them to reconsolidate in order to persist. Memory reactivation also occurs during slow-wave sleep (SWS) and is assumed to underlie the consolidating effect of sleep. Here, we tested whether the same principle of transient destabilization applies to memory reactivation during SWS. We reactivated memories in humans by presenting associated odor cues either during SWS or wakefulness. Reactivation was followed by an interference task to probe memory stability. As we expected, reactivation during waking destabilized memories. In contrast, reactivation during SWS immediately stabilized memories, thereby directly increasing their resistance to interference. Functional magnetic resonance imaging revealed that reactivation during SWS mainly activated hippocampal and posterior cortical regions, whereas reactivation during wakefulness primarily activated prefrontal cortical areas. Our results show that reactivation of memory serves distinct functions depending on the brain state of wakefulness or sleep.	[Diekelmann, Susanne; Born, Jan; Rasch, Bjoern] Univ Tubingen, Dept Med Psychol & Neurobiol, Tubingen, Germany; [Diekelmann, Susanne; Born, Jan] Med Univ Lubeck, Dept Neuroendocrinol, D-23538 Lubeck, Germany; [Buechel, Christian] Univ Med Ctr Hamburg Eppendorf, Dept Syst Neurosci, Hamburg, Germany; [Rasch, Bjoern] Univ Basel, Div Cognit Neurosci, Basel, Switzerland	Eberhard Karls University of Tubingen; University of Lubeck; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Basel	Rasch, B (corresponding author), Univ Tubingen, Dept Med Psychol & Neurobiol, Tubingen, Germany.	born@kfg.mu-luebeck.de; bjoern.rasch@unibas.ch	Born, Jan/K-2596-2016; Rasch, Bjorn/A-3119-2015	Born, Jan/0000-0002-1847-6248; Rasch, Bjorn/0000-0001-7607-3415	Deutsche Forschungsgemeinschaft [SFB 654, SFB TR 58]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank I. Wilhelm for helpful discussions and J. Martens, F. Hobrack, M. Palm and K. Muller for assistance with data collection. This work was supported by grants from the Deutsche Forschungsgemeinschaft (SFB 654 and SFB TR 58).	Alberini CM, 2005, TRENDS NEUROSCI, V28, P51, DOI 10.1016/j.tins.2004.11.001; Bozon B, 2003, NEURON, V40, P695, DOI 10.1016/S0896-6273(03)00674-3; Buzsaki G, 1998, J SLEEP RES, V7, P17, DOI 10.1046/j.1365-2869.7.s1.3.x; Diekelmann S, 2010, NAT REV NEUROSCI, V11, P114, DOI 10.1038/nrn2762; Doyere V, 2007, NAT NEUROSCI, V10, P414, DOI 10.1038/nn1871; Dudai Y, 2004, ANNU REV PSYCHOL, V55, P51, DOI 10.1146/annurev.psych.55.090902.142050; Duncan J, 2000, TRENDS NEUROSCI, V23, P475, DOI 10.1016/S0166-2236(00)01633-7; Euston DR, 2007, SCIENCE, V318, P1147, DOI 10.1126/science.1148979; Fonseca R, 2006, NAT NEUROSCI, V9, P478, DOI 10.1038/nn1667; Forcato C, 2007, LEARN MEMORY, V14, P295, DOI 10.1101/lm.486107; Foricato C, 2009, NEUROBIOL LEARN MEM, V91, P50, DOI 10.1016/j.nlm.2008.09.011; Gais S, 2007, P NATL ACAD SCI USA, V104, P18778, DOI 10.1073/pnas.0705454104; Huber R, 2004, NATURE, V430, P78, DOI 10.1038/nature02663; Hupbach A, 2007, LEARN MEMORY, V14, P47, DOI 10.1101/lm.365707; Ji DY, 2007, NAT NEUROSCI, V10, P100, DOI 10.1038/nn1825; Karpicke JD, 2008, SCIENCE, V319, P966, DOI 10.1126/science.1152408; Kuhl BA, 2010, NAT NEUROSCI, V13, P501, DOI 10.1038/nn.2498; Lee JLC, 2009, TRENDS NEUROSCI, V32, P413, DOI 10.1016/j.tins.2009.05.002; MCCLELLAND JL, 1995, PSYCHOL REV, V102, P419, DOI 10.1037/0033-295X.102.3.419; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; Milekic MH, 2002, NEURON, V36, P521, DOI 10.1016/S0896-6273(02)00976-5; MISANIN JR, 1968, SCIENCE, V160, P554, DOI 10.1126/science.160.3827.554; Morris RGM, 2006, NEURON, V50, P479, DOI 10.1016/j.neuron.2006.04.012; Nader K, 2003, TRENDS NEUROSCI, V26, P65, DOI 10.1016/S0166-2236(02)00042-5; Nader K, 2000, NATURE, V406, P722, DOI 10.1038/35021052; Nader K, 2009, NAT REV NEUROSCI, V10, P224, DOI 10.1038/nrn2590; Payne JD, 2009, NEUROBIOL LEARN MEM, V92, P327, DOI 10.1016/j.nlm.2009.03.007; Pedreira ME, 2003, NEURON, V38, P863, DOI 10.1016/S0896-6273(03)00352-0; Pedreira ME, 2002, J NEUROSCI, V22, P8305; Peigneux P, 2004, NEURON, V44, P535, DOI 10.1016/j.neuron.2004.10.007; Petrides M, 2005, PHILOS T ROY SOC B, V360, P781, DOI 10.1098/rstb.2005.1631; Polyn SM, 2008, TRENDS COGN SCI, V12, P24, DOI 10.1016/j.tics.2007.10.010; Rasch B, 2007, CURR OPIN NEUROBIOL, V17, P698, DOI 10.1016/j.conb.2007.11.007; Rasch B, 2007, SCIENCE, V315, P1426, DOI 10.1126/science.1138581; Rodriguez WA, 1999, PROG NEURO-PSYCHOPH, V23, P1285, DOI 10.1016/S0278-5846(99)00063-9; Rudoy JD, 2009, SCIENCE, V326, P1079, DOI 10.1126/science.1179013; Sara SJ, 2000, LEARN MEMORY, V7, P73, DOI 10.1101/lm.7.2.73; Schacter DL, 1999, AM PSYCHOL, V54, P182, DOI 10.1037/0003-066X.54.3.182; Schiller D, 2010, NATURE, V463, P49, DOI 10.1038/nature08637; Schwabe L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007519; Simons JS, 2003, NAT REV NEUROSCI, V4, P637, DOI 10.1038/nrn1178; Stickgold R, 2007, NAT NEUROSCI, V10, P540, DOI 10.1038/nn0507-540; Takashima A, 2006, P NATL ACAD SCI USA, V103, P756, DOI 10.1073/pnas.0507774103; Tse D, 2007, SCIENCE, V316, P76, DOI 10.1126/science.1135935; Walker MP, 2003, NATURE, V425, P616, DOI 10.1038/nature01930; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517	46	232	239	3	64	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2011	14	3					381	386		10.1038/nn.2744	http://dx.doi.org/10.1038/nn.2744			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	725MW	21258327				2022-12-28	WOS:000287650100020
J	Bickart, KC; Wright, CI; Dautoff, RJ; Dickerson, BC; Barrett, LF				Bickart, Kevin C.; Wright, Christopher I.; Dautoff, Rebecca J.; Dickerson, Bradford C.; Barrett, Lisa Feldman			Amygdala volume and social network size in humans	NATURE NEUROSCIENCE			English	Article							BRAIN; PRIMATES	We found that amygdala volume correlates with the size and complexity of social networks in adult humans. An exploratory analysis of subcortical structures did not find strong evidence for similar relationships with any other structure, but there were associations between social network variables and cortical thickness in three cortical areas, two of them with amygdala connectivity. These findings indicate that the amygdala is important in social behavior.	[Wright, Christopher I.; Dautoff, Rebecca J.; Dickerson, Bradford C.; Barrett, Lisa Feldman] Massachusetts Gen Hosp, Psychiat Neuroimaging Res Program, Charlestown, MA 02129 USA; [Wright, Christopher I.; Dautoff, Rebecca J.; Dickerson, Bradford C.; Barrett, Lisa Feldman] Harvard Univ, Sch Med, Charlestown, MA USA; [Bickart, Kevin C.] Boston Univ, Sch Med, Dept Anat & Neurobiol, Boston, MA 02118 USA; [Wright, Christopher I.; Dautoff, Rebecca J.; Dickerson, Bradford C.; Barrett, Lisa Feldman] Massachusetts Gen Hosp, Martinos Ctr Biomed Imaging, Charlestown, MA USA; [Dickerson, Bradford C.] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Dickerson, Bradford C.] Harvard Univ, Sch Med, Boston, MA USA; [Barrett, Lisa Feldman] Northeastern Univ, Dept Psychol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Boston University; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Northeastern University	Barrett, LF (corresponding author), Massachusetts Gen Hosp, Psychiat Neuroimaging Res Program, Charlestown, MA 02129 USA.	l.barrett@neu.edu	Barrett, Lisa Feldman/ABC-8157-2020		US National Institutes of Health [DP1OD003312]; US National Institute on Aging [R01-AG030311, R01-AG029411, R21-AG29840]; NATIONAL INSTITUTE ON AGING [R01AG029411, R21AG029840, R01AG030311] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003312] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors thank Michael Brickhouse for assistance with morphometric analyses. This study was supported by grants from the US National Institutes of Health Director's Pioneer Award (DP1OD003312) and the US National Institute on Aging (R01-AG030311, R01-AG029411 and R21-AG29840).	Adolphs R, 2009, ANNU REV PSYCHOL, V60, P693, DOI 10.1146/annurev.psych.60.110707.163514; Barger N, 2007, AM J PHYS ANTHROPOL, V134, P392, DOI 10.1002/ajpa.20684; Barton RA, 1998, P ROY SOC B-BIOL SCI, V265, P1933, DOI 10.1098/rspb.1998.0523; Barton RA., 2000, AMYGDALA FUNCTIONAL, P480; Buchanan T., 2009, HUMAN AMYGDALA, P289; Cohen Sheldon, 1997, JAMA (Journal of the American Medical Association), V277, P1940, DOI 10.1001/jama.277.24.1940; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Dunbar RIM, 1998, EVOL ANTHROPOL, V6, P178, DOI 10.1002/(SICI)1520-6505(1998)6:5<178::AID-EVAN5>3.0.CO;2-8; Freese J. L., 2009, HUMAN AMYGDALA, P3; Gurung RAR, 2003, PSYCHOL AGING, V18, P487, DOI 10.1037/0882-7974.18.3.487; Lewis KP, 2006, J COMP PSYCHOL, V120, P31, DOI 10.1037/0735-7036.120.1.31; O'Brien LM, 2006, HARVARD REV PSYCHIAT, V14, P141, DOI 10.1080/10673220600784119; RUSSELL D, 1984, J PERS SOC PSYCHOL, V46, P1313, DOI 10.1037/0022-3514.46.6.1313; Silk JB, 2007, SCIENCE, V317, P1347, DOI 10.1126/science.1140734; Wright CI, 2006, CEREB CORTEX, V16, P1809, DOI 10.1093/cercor/bhj118	15	322	323	4	72	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2011	14	2					163	164		10.1038/nn.2724	http://dx.doi.org/10.1038/nn.2724			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	711MJ	21186358	Green Published, Green Accepted			2022-12-28	WOS:000286595400012
J	Wang, X; Vaingankar, V; Soto-Sanchez, C; Sommer, FT; Hirsch, JA				Wang, Xin; Vaingankar, Vishal; Soto-Sanchez, Cristina; Sommer, Friedrich T.; Hirsch, Judith A.			Thalamic interneurons and relay cells use complementary synaptic mechanisms for visual processing	NATURE NEUROSCIENCE			English	Article							LATERAL GENICULATE-NUCLEUS; RECEPTIVE-FIELD PROPERTIES; METABOTROPIC GLUTAMATE RECEPTORS; A-LAMINAE; PERIGENICULATE NUCLEUS; AXON COLLATERALS; CAT; NEURONS; INHIBITION; ORGANIZATION	Synapses made by local interneurons dominate the thalamic circuits that process signals traveling from the eye downstream. The anatomical and physiological differences between interneurons and the (relay) cells that project to cortex are vast. To explore how these differences might influence visual processing, we made intracellular recordings from both classes of cells in vivo in cats. Macroscopically, all receptive fields were similar, consisting of two concentrically arranged subregions in which dark and bright stimuli elicited responses of the reverse sign. Microscopically, however, the responses of the two types of cells had opposite profiles. Excitatory stimuli drove trains of single excitatory postsynaptic potentials in relay cells, but graded depolarizations in interneurons. Conversely, suppressive stimuli evoked smooth hyperpolarizations in relay cells and unitary inhibitory postsynaptic potentials in interneurons. Computational analyses suggested that these complementary patterns of response help to preserve information encoded in the fine timing of retinal spikes and to increase the amount of information transmitted to cortex.	[Wang, Xin; Vaingankar, Vishal; Soto-Sanchez, Cristina; Hirsch, Judith A.] Univ So Calif, Dept Biol Sci, Los Angeles, CA 90089 USA; [Wang, Xin; Vaingankar, Vishal; Soto-Sanchez, Cristina; Hirsch, Judith A.] Univ So Calif, Grad Program Neurosci, Los Angeles, CA 90089 USA; [Sommer, Friedrich T.] Univ Calif Berkeley, Redwood Ctr Theoret Neurosci, Berkeley, CA 94720 USA	University of Southern California; University of Southern California; University of California System; University of California Berkeley	Hirsch, JA (corresponding author), Univ So Calif, Dept Biol Sci, Los Angeles, CA 90089 USA.	jhirsch@usc.edu	Hirsch, Judith/E-9006-2013; Sánchez, Cristina Soto/Y-8008-2018	Soto-Sanchez, Cristina/0000-0003-4447-5967	US National Institutes of Health [EY09593]; Redwood Center for Theoretical Neuroscience; National Science Foundation [IIS-0713657]; NATIONAL EYE INSTITUTE [R01EY009593, R29EY009593] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Redwood Center for Theoretical Neuroscience; National Science Foundation(National Science Foundation (NSF)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We are grateful to L. M. Martinez for discussions throughout the project and thank Q. Wang for custom software. J. Provost, S. X. X. Xing, B. Gary, M. Bathen and M. Gerstmar reconstructed labeled cells, and M. Gerstmar also assisted with event sorting. This work was supported by the US National Institutes of Health (EY09593, J. A. H.), the Redwood Center for Theoretical Neuroscience (F. T. S.) and the National Science Foundation (IIS-0713657, F. T. S.).	Acuna-Goycolea C, 2008, NEURON, V57, P420, DOI 10.1016/j.neuron.2007.12.022; Bickford ME, 2008, J COMP NEUROL, V508, P264, DOI 10.1002/cne.21671; Blitz DM, 2005, NEURON, V45, P917, DOI 10.1016/j.neuron.2005.01.033; Blitz DM, 2003, J NEUROPHYSIOL, V90, P2438, DOI 10.1152/jn.00562.2003; BLOOMFIELD SA, 1989, P NATL ACAD SCI USA, V86, P3911, DOI 10.1073/pnas.86.10.3911; BULLIER J, 1979, J NEUROPHYSIOL, V42, P274, DOI 10.1152/jn.1979.42.1.274; Butts DA, 2007, NATURE, V449, P92, DOI [10.1038/nature06105, 10.1038/natureO6105]; CONTRERAS D, 1993, J PHYSIOL-LONDON, V470, P273, DOI 10.1113/jphysiol.1993.sp019858; Coomes DL, 2002, J COMP NEUROL, V453, P45, DOI 10.1002/cne.10387; Cox CL, 2003, J NEUROSCI, V23, P7642; CUCCHIARO JB, 1991, J COMP NEUROL, V310, P316, DOI 10.1002/cne.903100304; Dan Y, 1996, J NEUROSCI, V16, P3351; Datskovskaia A, 2001, J COMP NEUROL, V430, P85, DOI 10.1002/1096-9861(20010129)430:1<85::AID-CNE1016>3.0.CO;2-K; Denning KS, 2005, J NEUROSCI, V25, P3531, DOI 10.1523/JNEUROSCI.4417-04.2005; Destexhe A, 1998, J NEUROSCI, V18, P3574, DOI 10.1523/jneurosci.18-10-03574.1998; DUBIN MW, 1977, J NEUROPHYSIOL, V40, P410, DOI 10.1152/jn.1977.40.2.410; FITZPATRICK D, 1984, J NEUROSCI, V4, P1809; FRIEDLANDER MJ, 1981, J NEUROPHYSIOL, V46, P80, DOI 10.1152/jn.1981.46.1.80; FRISHMAN LJ, 1983, J PHYSIOL-LONDON, V339, P475, DOI 10.1113/jphysiol.1983.sp014728; GILBERT CD, 1977, J PHYSIOL-LONDON, V268, P391, DOI 10.1113/jphysiol.1977.sp011863; Godwin DW, 1996, J NEUROSCI, V16, P8181; Govindaiah G, 2006, J NEUROSCI, V26, P13443, DOI 10.1523/JNEUROSCI.3578-06.2006; Granseth B, 2003, J NEUROPHYSIOL, V89, P2952, DOI 10.1152/jn.01160.2002; GUILLERY RW, 1966, J COMP NEUROL, V128, P21, DOI 10.1002/cne.901280104; GUILLERY RW, 1969, Z ZELLFORSCH MIK ANA, V96, P39, DOI 10.1007/BF00321475; HAMOS JE, 1985, NATURE, V317, P618, DOI 10.1038/317618a0; Hirsch JA, 1998, J NEUROSCI, V18, P9517; Hirsch JA, 2003, NAT NEUROSCI, V6, P1300, DOI 10.1038/nn1152; HIRSCH JC, 1987, NEUROSCIENCE, V23, P457, DOI 10.1016/0306-4522(87)90069-8; HUBEL DH, 1961, J PHYSIOL-LONDON, V155, P385, DOI 10.1113/jphysiol.1961.sp006635; HUMPHREY AL, 1988, J COMP NEUROL, V268, P448, DOI 10.1002/cne.902680312; Koepsell K, 2009, FRONT SYST NEUROSCI, V3, DOI 10.3389/neuro.06.004.2009; Landisman CE, 2002, J NEUROSCI, V22, P1002, DOI 10.1523/JNEUROSCI.22-03-01002.2002; LEVICK WR, 1972, INVEST OPHTH VISUAL, V11, P302; Lorincz ML, 2009, NEURON, V63, P683, DOI 10.1016/j.neuron.2009.08.012; Mante V, 2008, NEURON, V58, P625, DOI 10.1016/j.neuron.2008.03.011; Martinez LM, 2005, NAT NEUROSCI, V8, P372, DOI 10.1038/nn1404; MASTRONARDE DN, 1992, VISUAL NEUROSCI, V8, P407, DOI 10.1017/S0952523800004934; MONTERO VM, 1991, EXP BRAIN RES, V86, P257; MONTERO VM, 1986, J COMP NEUROL, V254, P228, DOI 10.1002/cne.902540207; PAPE HC, 1995, NEUROSCIENCE, V68, P1105, DOI 10.1016/0306-4522(95)00205-W; PASIK P, 1976, EXP BRAIN RES, V25, P1; Person AL, 2005, NEURON, V46, P129, DOI 10.1016/j.neuron.2004.12.057; Schwartz O, 2006, J VISION, V6, P484, DOI 10.1167/6.4.13; SHERMAN SM, 1988, EXP BRAIN RES, V73, P384; Usrey WM, 1999, J NEUROPHYSIOL, V82, P3527, DOI 10.1152/jn.1999.82.6.3527; Van Horn SC, 2000, J COMP NEUROL, V416, P509; Wang X, 2007, NEURON, V55, P465, DOI 10.1016/j.neuron.2007.06.039; WILSON JR, 1989, J NEUROSCI, V9, P2931; Wilson JR, 1996, VISUAL NEUROSCI, V13, P1129, DOI 10.1017/S095252380000777X	50	42	42	1	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2011	14	2					224	+		10.1038/nn.2707	http://dx.doi.org/10.1038/nn.2707			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	711MJ	21170053	Green Accepted			2022-12-28	WOS:000286595400020
J	Chavez, AE; Chiu, CQ; Castillo, PE				Chavez, Andres E.; Chiu, Chiayu Q.; Castillo, Pablo E.			TRPV1 activation by endogenous anandamide triggers postsynaptic long-term depression in dentate gyrus	NATURE NEUROSCIENCE			English	Article							VANILLOID RECEPTOR; SYNAPTIC-TRANSMISSION; CAPSAICIN RECEPTOR; IMMUNOHISTOCHEMICAL LOCALIZATION; SYNAPSES; RAT; CHANNELS; PLASTICITY; ENDOCANNABINOIDS; POTENTIATION	The transient receptor potential TRPV1 is a nonselective cation channel that mediates pain sensations and is commonly activated by a wide variety of exogenous and endogenous, physical and chemical stimuli. Although TRPV1 receptors are mainly found in nociceptive neurons of the peripheral nervous system, these receptors have also been found in the brain, where their role is far less understood. Activation of TRPV1 reportedly regulates neurotransmitter release at several central synapses. However, we found that TRPV1 suppressed excitatory transmission in rat and mouse dentate gyrus by regulating postsynaptic function in an input-specific manner. This suppression was a result of Ca2+-calcineurin and clathrin-dependent internalization of AMPA receptors. Moreover, synaptic activation of TRPV1 triggered a form of long-term depression (TRPV1-LTD) mediated by the endocannabinoid anandamide in a type 1 cannabinoid receptor-independent manner. Thus, our findings reveal a previously unknown form of endocannabinoid- and TRPV1-mediated regulation of synaptic strength at central synapses.	[Chavez, Andres E.; Chiu, Chiayu Q.; Castillo, Pablo E.] Albert Einstein Coll Med, Dept Neurosci, New York, NY USA	Yeshiva University	Castillo, PE (corresponding author), Albert Einstein Coll Med, Dept Neurosci, New York, NY USA.	pablo.castillo@einstein.yu.edu		Chiu, Chiayu/0000-0001-5809-6306; Castillo, Pablo/0000-0002-9834-1801	US National Institutes of Health [DA017392, MH081935]; Ruth L. Kirschstein Award [F32 NS071821]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH081935] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS053059, F32NS071821] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA017392] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ruth L. Kirschstein Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank all members of the Castillo laboratory for comments on the manuscript, B. Connors and S. Nawy for kindly providing Trpv1<SUP>-/-</SUP> mice, and R. Carroll and A. Rodenas-Ruano for providing DGC cultures. This work was supported by US National Institutes of Health grants to P.E.C. (DA017392, MH081935). A.E.C. was partially supported by a Ruth L. Kirschstein Award (F32 NS071821).	Bacci A, 2004, NATURE, V431, P312, DOI 10.1038/nature02913; Benninger F, 2008, NEUROCHEM INT, V52, P89, DOI 10.1016/j.neuint.2007.06.008; Carroll RC, 1999, P NATL ACAD SCI USA, V96, P14112, DOI 10.1073/pnas.96.24.14112; Caterina MJ, 2001, ANNU REV NEUROSCI, V24, P487, DOI 10.1146/annurev.neuro.24.1.487; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Chevaleyre V, 2003, NEURON, V38, P461, DOI 10.1016/S0896-6273(03)00235-6; Chevaleyre V, 2006, ANNU REV NEUROSCI, V29, P37, DOI 10.1146/annurev.neuro.29.051605.112834; Chiu CYQ, 2008, NEUROPHARMACOLOGY, V54, P68, DOI 10.1016/j.neuropharm.2007.06.026; Cristino L, 2008, NEUROSCIENCE, V151, P955, DOI 10.1016/j.neuroscience.2007.11.047; Cristino L, 2006, NEUROSCIENCE, V139, P1405, DOI 10.1016/j.neuroscience.2006.02.074; DIMARZO V, 1994, NATURE, V372, P686, DOI 10.1038/372686a0; Doyle MW, 2002, J NEUROSCI, V22, P8222; ERRINGTON ML, 1987, NEUROSCIENCE, V20, P279, DOI 10.1016/0306-4522(87)90019-4; Fagni L, 2000, TRENDS NEUROSCI, V23, P80, DOI 10.1016/S0166-2236(99)01492-7; Gibson HE, 2008, NEURON, V57, P746, DOI 10.1016/j.neuron.2007.12.027; Golech SA, 2004, MOL BRAIN RES, V132, P87, DOI 10.1016/j.molbrainres.2004.08.025; Grueter BA, 2010, NAT NEUROSCI, V13, P1519, DOI 10.1038/nn.2685; Hu HJ, 2002, J NEUROSCI, V22, P7444; Kano M, 2009, PHYSIOL REV, V89, P309, DOI 10.1152/physrev.00019.2008; Kauer JA, 2009, TRENDS NEUROSCI, V32, P215, DOI 10.1016/j.tins.2008.12.006; Kim J, 2010, NAT NEUROSCI, V13, P592, DOI 10.1038/nn.2517; Kim YH, 2009, J NEUROSCI, V29, P10000, DOI 10.1523/JNEUROSCI.5030-08.2009; Lai MM, 1999, J BIOL CHEM, V274, P25963, DOI 10.1074/jbc.274.37.25963; Li H, 2008, ACTA CRYSTALLOGR E, V64, pM770, DOI 10.1107/S1600536808011793; Maccarrone M, 2008, NAT NEUROSCI, V11, P152, DOI 10.1038/nn2042; Maione S, 2009, J PHYSIOL-LONDON, V587, P2521, DOI 10.1113/jphysiol.2009.171900; Marinelli S, 2003, J NEUROSCI, V23, P3136; Marinelli S, 2002, J PHYSIOL-LONDON, V543, P531, DOI 10.1113/jphysiol.2002.022863; Marsch R, 2007, J NEUROSCI, V27, P832, DOI 10.1523/JNEUROSCI.3303-06.2007; Marsden KC, 2007, J NEUROSCI, V27, P14326, DOI 10.1523/JNEUROSCI.4433-07.2007; Mezey E, 2000, P NATL ACAD SCI USA, V97, P3655, DOI 10.1073/pnas.060496197; MULKEY RM, 1994, NATURE, V369, P486, DOI 10.1038/369486a0; Musella A, 2009, MOL CELL NEUROSCI, V40, P89, DOI 10.1016/j.mcn.2008.09.001; Pingle S. C., 2007, V179, P155; Piomelli D, 2003, NAT REV NEUROSCI, V4, P873, DOI 10.1038/nrn1247; Ramsey IS, 2006, ANNU REV PHYSIOL, V68, P619, DOI 10.1146/annurev.physiol.68.040204.100431; Regehr WG, 2009, NEURON, V63, P154, DOI 10.1016/j.neuron.2009.06.021; Roberts JC, 2004, BRAIN RES, V995, P176, DOI 10.1016/j.brainres.2003.10.001; Ross RA, 2003, BRIT J PHARMACOL, V140, P790, DOI 10.1038/sj.bjp.0705467; Sanchez JF, 2001, NEUROSCIENCE, V107, P373, DOI 10.1016/S0306-4522(01)00373-6; Sasamura T, 1998, NEUROREPORT, V9, P2045, DOI 10.1097/00001756-199806220-00025; Smart D, 2000, BRIT J PHARMACOL, V129, P227, DOI 10.1038/sj.bjp.0703050; Starowicz K, 2007, PHARMACOL THERAPEUT, V114, P13, DOI 10.1016/j.pharmthera.2007.01.005; TATH A, 2005, BRAIN RES MOL BRAIN, V135, P162; Tominaga M, 1998, NEURON, V21, P531, DOI 10.1016/S0896-6273(00)80564-4; van der Stelt M, 2005, EMBO J, V24, P3026, DOI 10.1038/sj.emboj.7600784; Winder DG, 2001, NAT REV NEUROSCI, V2, P461, DOI 10.1038/35081514; Wong GY, 2009, BRAIN RES REV, V60, P267, DOI 10.1016/j.brainresrev.2008.12.006; Yang K, 1998, NEUROSCI LETT, V255, P135, DOI 10.1016/S0304-3940(98)00730-7; Zygmunt PM, 1999, NATURE, V400, P452, DOI 10.1038/22761	50	236	242	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2010	13	12					1511	U99		10.1038/nn.2684	http://dx.doi.org/10.1038/nn.2684			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	684CW	21076423	Green Accepted			2022-12-28	WOS:000284525800016
J	Chakrabarti, L; Best, TK; Cramer, NP; Carney, RSE; Isaac, JTR; Galdzicki, Z; Haydar, TF				Chakrabarti, Lina; Best, Tyler K.; Cramer, Nathan P.; Carney, Rosalind S. E.; Isaac, John T. R.; Galdzicki, Zygmunt; Haydar, Tarik F.			Olig1 and Olig2 triplication causes developmental brain defects in Down syndrome	NATURE NEUROSCIENCE			English	Article							TS65DN MOUSE MODEL; LONG-TERM POTENTIATION; CORTICAL INTERNEURONS; FRONTAL-CORTEX; SPECIFICATION; EXPRESSION; HIPPOCAMPUS; FOREBRAIN; PHENOTYPE; DEFICITS	Over-inhibition is thought to be one of the underlying causes of the cognitive deficits in Ts65Dn mice, the most widely used model of Down syndrome. We found a direct link between gene triplication and defects in neuron production during embryonic development. These neurogenesis defects led to an imbalance between excitatory and inhibitory neurons and to increased inhibitory drive in the Ts65Dn forebrain. We discovered that Olig1 and Olig2, two genes that are triplicated in Down syndrome and in Ts65Dn mice, were overexpressed in the Ts65Dn forebrain. To test the hypothesis that Olig triplication causes the neurological phenotype, we used a genetic approach to normalize the dosage of these two genes and thereby rescued the inhibitory neuron phenotype in the Ts65Dn brain. These data identify seminal alterations during brain development and suggest a mechanistic relationship between triplicated genes and these brain abnormalities in the Ts65Dn mouse.	[Chakrabarti, Lina; Carney, Rosalind S. E.; Haydar, Tarik F.] Childrens Natl Med Ctr, Neurosci Res Ctr, Washington, DC 20010 USA; [Best, Tyler K.; Cramer, Nathan P.; Galdzicki, Zygmunt] Uniformed Serv Univ Hlth Sci, Sch Med, Dept Anat Physiol & Genet, Bethesda, MD 20814 USA; [Isaac, John T. R.] NINDS, Dev Synapt Plast Sect, Bethesda, MD 20892 USA	Children's National Health System; Uniformed Services University of the Health Sciences - USA; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Haydar, TF (corresponding author), Boston Univ, Sch Med, Dept Anat & Neurobiol, Boston, MA 02118 USA.	thaydar@bu.edu		Cramer, Nathan/0000-0001-6146-3664; Haydar, Tarik/0000-0001-6772-3076	Dana Foundation; National Down Syndrome Society; Jerome Lejeune Foundation; Uniformed Services University of the Health Sciences; Intellectual and Developmental Disabilities Research Center [P30 HD40677];  [RO1 HD05780]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD040677] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD057580] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003011, R01NS076503] Funding Source: NIH RePORTER	Dana Foundation; National Down Syndrome Society; Jerome Lejeune Foundation; Uniformed Services University of the Health Sciences; Intellectual and Developmental Disabilities Research Center; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We wish to thank V. Gallo, J. Corbin, and members of Corbin and Haydar laboratories for discussions and critical reading of the manuscript. This work was supported by a Dana Foundation Neuro-Immuno Imaging grant (T. F. H.), RO1 HD05780 (T. F. H. and Z.G.), the National Down Syndrome Society (L. C.), the Jerome Lejeune Foundation (Z.G.), Uniformed Services University of the Health Sciences (Z.G.) and a gift from Robin and Rob Wilder. Imaging was supported by the Intellectual and Developmental Disabilities Research Center (P30 HD40677).	Alifragis P, 2004, J NEUROSCI, V24, P5643, DOI 10.1523/JNEUROSCI.1245-04.2004; Baxter LL, 2000, HUM MOL GENET, V9, P195, DOI 10.1093/hmg/9.2.195; Belichenko PV, 2009, J COMP NEUROL, V512, P453, DOI 10.1002/cne.21895; Belichenko PV, 2004, J COMP NEUROL, V480, P281, DOI 10.1002/cne.20337; Bertrand N, 2002, NAT REV NEUROSCI, V3, P517, DOI 10.1038/nrn874; Chakrabarti L, 2007, J NEUROSCI, V27, P11483, DOI 10.1523/JNEUROSCI.3406-07.2007; Clark S, 2006, EXP NEUROL, V200, P256, DOI 10.1016/j.expneurol.2006.02.005; Contestabile A, 2007, HIPPOCAMPUS, V17, P665, DOI 10.1002/hipo.20308; Cortez MA, 2009, PEDIATR RES, V65, P499, DOI 10.1203/PDR.0b013e31819d9076; Costa ACS, 1999, PHYSIOL BEHAV, V68, P211, DOI 10.1016/S0031-9384(99)00178-X; Costa ACS, 2005, NEUROSCI LETT, V382, P317, DOI 10.1016/j.neulet.2005.03.031; DEFELIPE J, 1993, CEREB CORTEX, V3, P273, DOI 10.1093/cercor/3.4.273; Dierssen M, 2003, CEREB CORTEX, V13, P758, DOI 10.1093/cercor/13.7.758; Eisenstat DD, 1999, J COMP NEUROL, V414, P217, DOI 10.1002/(SICI)1096-9861(19991115)414:2<217::AID-CNE6>3.0.CO;2-I; EPSTEIN CJ, 1986, EXPERIENTIA, V42, P1117, DOI 10.1007/BF01941286; Fernandez F, 2007, NAT NEUROSCI, V10, P411, DOI 10.1038/nn1860; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Gibson JR, 2008, J NEUROPHYSIOL, V100, P2615, DOI 10.1152/jn.90752.2008; GOLDEN JA, 1994, J NEUROPATH EXP NEUR, V53, P513, DOI 10.1097/00005072-199409000-00011; Grigoriou M, 1998, DEVELOPMENT, V125, P2063; Harashima C, 2006, J COMP NEUROL, V494, P815, DOI 10.1002/cne.20844; Haydar TF, 2005, MENT RETARD DEV D R, V11, P303, DOI 10.1002/mrdd.20088; Hobert O, 2000, TRENDS GENET, V16, P75, DOI 10.1016/S0168-9525(99)01883-1; Hyde LA, 2001, BEHAV BRAIN RES, V118, P53, DOI 10.1016/S0166-4328(00)00313-2; Kahlem P, 2004, GENOME RES, V14, P1258, DOI 10.1101/gr.1951304; Kawaguchi Y, 1997, CEREB CORTEX, V7, P476, DOI 10.1093/cercor/7.6.476; Kleschevnikov AM, 2004, J NEUROSCI, V24, P8153, DOI 10.1523/JNEUROSCI.1766-04.2004; KORENBERG JR, 1990, AM J MED GENET, P91; Kurt MA, 2000, BRAIN RES, V858, P191, DOI 10.1016/S0006-8993(00)01984-3; Liodis P, 2007, J NEUROSCI, V27, P3078, DOI 10.1523/JNEUROSCI.3055-06.2007; Lorenzi HA, 2006, BRAIN RES, V1104, P153, DOI 10.1016/j.brainres.2006.05.022; Lu QR, 2002, CELL, V109, P75, DOI 10.1016/S0092-8674(02)00678-5; Ma QF, 2006, J PHYSIOL-LONDON, V575, P379, DOI 10.1113/jphysiol.2006.113449; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; MILLER MW, 1985, DEV BRAIN RES, V23, P187, DOI 10.1016/0165-3806(85)90040-9; Miyoshi G, 2007, J NEUROSCI, V27, P7786, DOI 10.1523/JNEUROSCI.1807-07.2007; Perez-Cremades D, 2010, J NEURAL TRANSM, V117, P445, DOI 10.1007/s00702-010-0376-9; Polleux F, 2004, MENT RETARD DEV D R, V10, P303, DOI 10.1002/mrdd.20044; PORTEUS MH, 1991, NEURON, V7, P221, DOI 10.1016/0896-6273(91)90260-7; REEVES RH, 1995, NAT GENET, V11, P177, DOI 10.1038/ng1095-177; SCHMIDTSIDOR B, 1990, CLIN NEUROPATHOL, V9, P181; SEGAL DJ, 1974, J CELL PHYSL, V90, P83; Shirasaki R, 2002, ANNU REV NEUROSCI, V25, P251, DOI 10.1146/annurev.neuro.25.112701.142916; Siarey RJ, 1997, NEUROPHARMACOLOGY, V36, P1549, DOI 10.1016/S0028-3908(97)00157-3; Sussel L, 1999, DEVELOPMENT, V126, P3359; Takebayashi H, 2000, MECH DEVELOP, V99, P143, DOI 10.1016/S0925-4773(00)00466-4; Valcanis H, 2003, J NEUROSCI, V23, P5113; Weitzdoerfer R, 2001, J NEURAL TRANSM-SUPP, P59; Wonders CP, 2006, NAT REV NEUROSCI, V7, P687, DOI 10.1038/nrn1954; Zhou Q, 2002, CELL, V109, P61, DOI 10.1016/S0092-8674(02)00677-3	50	152	152	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2010	13	8					927	U39		10.1038/nn.2600	http://dx.doi.org/10.1038/nn.2600			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	632DK	20639873	Green Accepted			2022-12-28	WOS:000280400600010
J	Kantak, SS; Sullivan, KJ; Fisher, BE; Knowlton, BJ; Winstein, CJ				Kantak, Shailesh S.; Sullivan, Katherine J.; Fisher, Beth E.; Knowlton, Barbara J.; Winstein, Carolee J.			Neural substrates of motor memory consolidation depend on practice structure	NATURE NEUROSCIENCE			English	Article							CORTEX	Motor-skill practice drives subsequent offline activity in functionally related resting human brain networks. We investigated the manner in which offline neural networks are modulated by practice structures that affect motor-skill retention. Interference to dorsolateral-prefrontal cortex (DLPFC), but not to primary motor cortex (M1), after variable practice attenuated motor-skill retention, whereas interference to M1, but not to DLPFC, after constant practice attenuated motor-skill retention. We conclude that neural substrates of motor-memory consolidation are modulated by practice structure.	[Kantak, Shailesh S.; Sullivan, Katherine J.; Fisher, Beth E.; Winstein, Carolee J.] Univ So Calif, Herman Ostrow Sch Dent, Div Biokinesiol & Phys Therapy, Motor Behav & Neurorehabil Lab, Los Angeles, CA 90089 USA; [Kantak, Shailesh S.; Fisher, Beth E.] Univ So Calif, Herman Ostrow Sch Dent, Div Biokinesiol & Phys Therapy, Neuroplast & Imaging Lab, Los Angeles, CA USA; [Knowlton, Barbara J.] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90024 USA; [Winstein, Carolee J.] Univ So Calif, Keck Sch Med, Dept Neurol, Los Angeles, CA 90033 USA	University of Southern California; University of Southern California; University of California System; University of California Los Angeles; University of Southern California	Winstein, CJ (corresponding author), Univ So Calif, Herman Ostrow Sch Dent, Div Biokinesiol & Phys Therapy, Motor Behav & Neurorehabil Lab, Los Angeles, CA 90089 USA.	winstein@usc.edu	Fisher, Beth E/G-5430-2012	Winstein, Carolee/0000-0001-9789-4626	North American Society for the Psychology of Sport and Physical Activity; Graduate School of the University of Southern California	North American Society for the Psychology of Sport and Physical Activity; Graduate School of the University of Southern California	We thank E. M. Robertson for his thoughtful and constructive comments on an earlier version of the manuscript. The research was supported by a grant from the North American Society for the Psychology of Sport and Physical Activity and an Oakley Fellowship from the Graduate School of the University of Southern California.	Albert NB, 2009, CURR BIOL, V19, P1023, DOI 10.1016/j.cub.2009.04.028; Braun DA, 2009, CURR BIOL, V19, P352, DOI 10.1016/j.cub.2009.01.036; Cahill L, 2001, TRENDS NEUROSCI, V24, P578, DOI 10.1016/S0166-2236(00)01885-3; Krakauer JW, 2006, TRENDS NEUROSCI, V29, P58, DOI 10.1016/j.tins.2005.10.003; Lee T.D., 2004, SKILL ACQUISITION SP, P29; Luft AR, 2004, J NEUROSCI, V24, P6515, DOI 10.1523/JNEUROSCI.1034-04.2004; Muellbacher W, 2002, NATURE, V415, P640, DOI 10.1038/nature712; Robertson EM, 2006, NEUROSCIENTIST, V12, P261, DOI 10.1177/1073858406287935; Robertson EM, 2009, PLOS BIOL, V7, P11, DOI 10.1371/journal.pbio.1000019; Robertson EM, 2005, J NEUROSCI, V25, P6372, DOI 10.1523/JNEUROSCI.1851-05.2005; SCHMIDT RA, 1975, PSYCHOL REV, V82, P225, DOI 10.1037/h0076770; SCHMIDT RA, 1992, PSYCHOL SCI, V3, P207, DOI 10.1111/j.1467-9280.1992.tb00029.x; Shadmehr R, 1997, SCIENCE, V277, P821, DOI 10.1126/science.277.5327.821; SHEA CH, 1991, RES Q EXERCISE SPORT, V62, P187, DOI 10.1080/02701367.1991.10608709; Silvanto J, 2008, BRAIN TOPOGR, V21, P1, DOI 10.1007/s10548-008-0067-0	15	128	131	0	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2010	13	8					923	925		10.1038/nn.2596	http://dx.doi.org/10.1038/nn.2596			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	632DK	20622872				2022-12-28	WOS:000280400600009
J	Jablonska, B; Aguirre, A; Raymond, M; Szabo, G; Kitabatake, Y; Sailor, KA; Ming, GL; Song, HJ; Gallo, V				Jablonska, Beata; Aguirre, Adan; Raymond, Matthew; Szabo, Gabor; Kitabatake, Yasuji; Sailor, Kurt A.; Ming, Guo-Li; Song, Hongjun; Gallo, Vittorio			Chordin-induced lineage plasticity of adult SVZ neuroblasts after demyelination	NATURE NEUROSCIENCE			English	Article							BONE MORPHOGENETIC PROTEIN; NEURAL STEM-CELLS; CENTRAL-NERVOUS-SYSTEM; OLIG GENE-FUNCTION; SUBVENTRICULAR ZONE; PROGENITOR CELLS; MULTIPLE-SCLEROSIS; SPINAL-CORD; BRAIN; MOUSE	The mechanisms that regulate the developmental potential of adult neural progenitor populations under physiological and pathological conditions remain poorly defined. Glutamic acid decarboxylase 65 (GAD65)- and Doublecortin (Dcx)-expressing cells constitute major progenitor populations in the adult mouse subventricular zone (SVZ). Under normal physiological conditions, SVZ-derived GAD65-positive and Dcx-positive cells expressed the transcription factor Pax6 and migrated along the rostral migratory stream to the olfactory bulb to generate interneurons. After lysolecithin-induced demyelination of corpus callosum, however, these cells altered their molecular and cellular properties and migratory path. Demyelination upregulated chordin in the SVZ, which redirected GAD65-positive and Dcx-positive progenitors from neuronal to glial fates, generating new oligodendrocytes in the corpus callosum. Our findings suggest that the lineage plasticity of SVZ progenitor cells could be a potential therapeutic strategy for diseased or injured brain.	[Jablonska, Beata; Aguirre, Adan; Raymond, Matthew; Gallo, Vittorio] Childrens Natl Med Ctr, Ctr Neurosci Res, Washington, DC 20010 USA; [Raymond, Matthew] George Washington Univ, Inst Biomed Sci, Washington, DC USA; [Szabo, Gabor] Hungarian Acad Sci, Inst Expt Med, Dept Gene Technol & Dev Neurobiol, Budapest, Hungary; [Kitabatake, Yasuji; Sailor, Kurt A.; Ming, Guo-Li; Song, Hongjun] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA	Children's National Health System; George Washington University; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Institute of Experimental Medicine; Johns Hopkins University	Gallo, V (corresponding author), Childrens Natl Med Ctr, Ctr Neurosci Res, Washington, DC 20010 USA.	vgallo@cnmcresearch.org	Ming, Guo-li/J-7880-2013; Sailor, Kurt/GSO-2237-2022; Szabo, Gabor/A-5087-2008; Sailor, Kurt Andrew/AFN-4046-2022	Sailor, Kurt/0000-0002-9574-6838; Szabo, Gabor/0000-0001-5438-5151; Sailor, Kurt Andrew/0000-0002-9574-6838; Kitabatake, Yasuji/0000-0002-2907-9512; Ming, Guo-li/0000-0002-2517-6075	US National Institutes of Health [R01NS045702, R01NS056427, K99NS057944, R01NS047344, R01AG024984, R01NS048271]; Hungarian National Office for Research and Technology [GVOP-3.1.1.-2004-05-0230-/3.0]; US National Institutes of Health Intellectual and Developmental Disabilities Research Center [P30HD40677]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD040677] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [T32EY017203] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES021957] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P20MH084018, R21MH087874, R33MH087874] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS047344, R56NS047344, R01NS048271, R01NS045702, K99NS057944, R01NS047344, R01NS056427] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG024984] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hungarian National Office for Research and Technology(National Office for Research and Technology); US National Institutes of Health Intellectual and Developmental Disabilities Research Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank F. Gage (Salk Institute) and J. Goldman (Columbia University) for the gift of pNIT-GFP and dS-Red retrovirus and D. Rowitch (University of California San Francisco) for the gift of antibodies to Olig2. We thank T. Hawley for assistance with FACS sorting. We are particularly grateful to J. Corbin for discussion. This work was supported by US National Institutes of Health grants R01NS045702 and R01NS056427 to V. G., K99NS057944 to A. A., R01NS047344 and R01AG024984 to H. S. and R01NS048271 to G. M. and by the Hungarian National Office for Research and Technology GVOP-3.1.1.-2004-05-0230-/3.0 to G. S. and US National Institutes of Health Intellectual and Developmental Disabilities Research Center P30HD40677 to V. G.	Aguirre A, 2005, J NEUROSCI, V25, P11092, DOI 10.1523/JNEUROSCI.2981-05.2005; Aguirre AA, 2004, J CELL BIOL, V165, P575, DOI 10.1083/jcb.200311141; Aguirre A, 2007, NAT NEUROSCI, V10, P990, DOI 10.1038/nn1938; Alvarez-Buylla A, 2002, J NEUROSCI, V22, P629, DOI 10.1523/JNEUROSCI.22-03-00629.2002; Alvarez-Buylla A, 2004, NEURON, V41, P683, DOI 10.1016/S0896-6273(04)00111-4; Ara J, 2008, J NEUROSCI RES, V86, P125, DOI 10.1002/jnr.21462; Bani-Yaghoub M, 2008, BIOCHEM CELL BIOL, V86, P361, DOI [10.1139/O08-116, 10.1139/o08-116]; Baumann N, 2001, PHYSIOL REV, V81, P871, DOI 10.1152/physrev.2001.81.2.871; Buffo A, 2005, P NATL ACAD SCI USA, V102, P18183, DOI 10.1073/pnas.0506535102; Canoll P, 2008, ACTA NEUROPATHOL, V116, P465, DOI 10.1007/s00401-008-0432-9; Chang A, 2008, BRAIN, V131, P2366, DOI 10.1093/brain/awn157; Chen HL, 2007, STEM CELLS, V25, P63, DOI 10.1634/stemcells.2006-0339; Chou J, 2006, J NEUROL SCI, V240, P21, DOI 10.1016/j.jns.2005.08.015; Colak D, 2008, J NEUROSCI, V28, P434, DOI 10.1523/JNEUROSCI.4374-07.2008; Coskun V, 2002, J NEUROSCI RES, V69, P795, DOI 10.1002/jnr.10336; DEININGER M, 1995, ACTA NEUROPATHOL, V90, P76; Doetsch F, 1999, P NATL ACAD SCI USA, V96, P11619, DOI 10.1073/pnas.96.20.11619; Franklin RJM, 2008, NAT REV NEUROSCI, V9, P839, DOI 10.1038/nrn2480; Fuller ML, 2007, ANN NEUROL, V62, P288, DOI 10.1002/ana.21179; Goings GE, 2004, BRAIN RES, V996, P213, DOI 10.1016/j.brainres.2003.10.034; Gomes WA, 2003, DEV BIOL, V255, P164, DOI 10.1016/S0012-1606(02)00037-4; Hack MA, 2005, NAT NEUROSCI, V8, P865, DOI 10.1038/nn1479; Hampton DW, 2007, EUR J NEUROSCI, V26, P3024, DOI 10.1111/j.1460-9568.2007.05940.x; Heins N, 2002, NAT NEUROSCI, V5, P308, DOI 10.1038/nn828; Israelsson C, 2006, J NEUROSCI RES, V84, P47, DOI 10.1002/jnr.20856; Jablonska B, 2007, J CELL BIOL, V179, P1231, DOI 10.1083/jcb.200702031; Jessberger S, 2008, NAT NEUROSCI, V11, P888, DOI 10.1038/nn.2148; Kim Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008122; Kondo Toru, 2009, Brain and Nerve (Tokyo), V61, P741; Levine JM, 2001, TRENDS NEUROSCI, V24, P39, DOI 10.1016/S0166-2236(00)01691-X; Ligon KL, 2006, GLIA, V54, P1, DOI 10.1002/glia.20273; Ligon KL, 2006, P NATL ACAD SCI USA, V103, P7853, DOI 10.1073/pnas.0511001103; Mehler MF, 2000, DEV NEUROSCI-BASEL, V22, P74, DOI 10.1159/000017429; Mekki-Dauriac S, 2002, DEVELOPMENT, V129, P5117; Menn B, 2006, J NEUROSCI, V26, P7907, DOI 10.1523/JNEUROSCI.1299-06.2006; Nait-Oumesmar B, 2008, J NEUROL SCI, V265, P26, DOI 10.1016/j.jns.2007.09.032; Nait-Oumesmar B, 1999, EUR J NEUROSCI, V11, P4357, DOI 10.1046/j.1460-9568.1999.00873.x; Palmer TD, 1999, J NEUROSCI, V19, P8487; Palmer TD, 2000, J COMP NEUROL, V425, P479, DOI 10.1002/1096-9861(20001002)425:4<479::AID-CNE2>3.0.CO;2-3; Samanta J, 2007, J NEUROSCI, V27, P7397, DOI 10.1523/JNEUROSCI.1434-07.2007; Schuurmans C, 2002, CURR OPIN NEUROBIOL, V12, P26, DOI 10.1016/S0959-4388(02)00286-6; See J, 2007, MOL CELL NEUROSCI, V35, P171, DOI 10.1016/j.mcn.2007.02.012; See JM, 2009, J NEUROPATH EXP NEUR, V68, P595, DOI 10.1097/NEN.0b013e3181a66ad9; Shen H, 2008, NEUROSCI LETT, V442, P15, DOI 10.1016/j.neulet.2008.06.052; Shen Q, 2002, DEVELOPMENT, V129, P4843; Staugaitis SM, 2009, NEURON GLIA BIOL, V5, P35, DOI 10.1017/S1740925X09990342; Temple S, 2001, NATURE, V414, P112, DOI 10.1038/35102174; Walker TL, 2007, J NEUROSCI, V27, P3734, DOI 10.1523/JNEUROSCI.5060-06.2007; Wang Y, 2001, STROKE, V32, P2170, DOI 10.1161/hs0901.095650; Zhao C, 2005, J NEUROL SCI, V233, P87, DOI 10.1016/j.jns.2005.03.008	50	162	167	1	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2010	13	5					541	U43		10.1038/nn.2536	http://dx.doi.org/10.1038/nn.2536			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	588JM	20418875	Green Accepted			2022-12-28	WOS:000277065700011
J	Goffin, D; Allen, M; Zhang, L; Amorim, M; Wang, ITJ; Reyes, ARS; Mercado-Berton, A; Ong, C; Cohen, S; Hu, LD; Blendy, JA; Carlson, GC; Siegel, SJ; Greenberg, ME; Zhou, ZL				Goffin, Darren; Allen, Megan; Zhang, Le; Amorim, Maria; Wang, I-Ting Judy; Reyes, Arith-Ruth S.; Mercado-Berton, Amy; Ong, Caroline; Cohen, Sonia; Hu, Linda; Blendy, Julie A.; Carlson, Gregory C.; Siegel, Steve J.; Greenberg, Michael E.; Zhou, Zhaolan			Rett syndrome mutation MeCP2 T158A disrupts DNA binding, protein stability and ERP responses	NATURE NEUROSCIENCE			English	Article							MOUSE MODEL; HISTONE DEACETYLASE; PYRAMIDAL NEURONS; OSCILLATIONS; DEFICIENCY; AUTISM; MICE	Mutations in the MECP2 gene cause the autism spectrum disorder Rett syndrome (RTT). One of the most common MeCP2 mutations associated with RTT occurs at threonine 158, converting it to methionine (T158M) or alanine (T158A). To understand the role of T158 mutations in the pathogenesis of RTT, we generated knockin mice that recapitulate the MeCP2 T158A mutation. We found a causal role for T158A mutation in the development of RTT-like phenotypes, including developmental regression, motor dysfunction, and learning and memory deficits. These phenotypes resemble those present in Mecp2 null mice and manifest through a reduction in MeCP2 binding to methylated DNA and a decrease in MeCP2 protein stability. The age-dependent development of event-related neuronal responses was disrupted by MeCP2 mutation, suggesting that impaired neuronal circuitry underlies the pathogenesis of RTT and that assessment of event-related potentials (ERPs) may serve as a biomarker for RTT and treatment evaluation.	[Goffin, Darren; Allen, Megan; Zhang, Le; Amorim, Maria; Wang, I-Ting Judy; Reyes, Arith-Ruth S.; Zhou, Zhaolan] Univ Penn, Sch Med, Dept Genet, Philadelphia, PA 19104 USA; [Mercado-Berton, Amy; Blendy, Julie A.] Univ Penn, Sch Med, Dept Pharmacol, Philadelphia, PA 19104 USA; [Ong, Caroline; Cohen, Sonia; Hu, Linda; Greenberg, Michael E.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Carlson, Gregory C.; Siegel, Steve J.] Univ Penn, Sch Med, Dept Psychiat, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; Harvard University; Harvard Medical School; University of Pennsylvania	Zhou, ZL (corresponding author), Univ Penn, Sch Med, Dept Genet, Philadelphia, PA 19104 USA.	zhaolan@mail.med.upenn.edu	de Amorim, Maria Galli/K-8259-2016	de Amorim, Maria Galli/0000-0002-1910-8770; Siegel, Steven/0000-0001-8058-9713; Goffin, Darren/0000-0001-6284-1452; Zhang, Le/0000-0002-4860-831X	US National Institutes of Health [R00 NS058391, P30 HD026979]; Philadelphia Foundation; International Rett Syndrome Foundation; Alavi-Dabiri Postdoctoral Fellowship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD026979, P30HD018655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH091850] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R00NS058391] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Philadelphia Foundation; International Rett Syndrome Foundation; Alavi-Dabiri Postdoctoral Fellowship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work is dedicated to the memory of Dr. Tom Kadesch, an inspirational colleague and mentor. We thank A. West, D. Epstein and members of the Zhou laboratory for critical readings of the manuscript, and the Intellectual and Developmental Disability Research Center Gene Manipulation Core (P30 HD18655) at the Children's Hospital Boston for generation of knockin mice (M. Thompson, Y. Zhou and H. Ye). This work was supported by grants from the US National Institutes of Health (R00 NS058391 and P30 HD026979), the Philadelphia Foundation and International Rett Syndrome Foundation to Z.Z. D.G. acknowledges the generous support of the Alavi-Dabiri Postdoctoral Fellowship. Z.Z. is a Pew Scholar in Biomedical Science.	Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Armstrong DD, 2005, J CHILD NEUROL, V20, P747, DOI 10.1177/08830738050200082401; BADER GG, 1989, BRAIN DEV-JPN, V11, P110, DOI 10.1016/S0387-7604(89)80078-6; Ben-Ari Y, 2001, TRENDS NEUROSCI, V24, P353, DOI 10.1016/S0166-2236(00)01813-0; Bienvenu T, 2006, NAT REV GENET, V7, P415, DOI 10.1038/nrg1878; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Chahrour M, 2008, SCIENCE, V320, P1224, DOI 10.1126/science.1153252; Chahrour M, 2007, NEURON, V56, P422, DOI 10.1016/j.neuron.2007.10.001; Chao HT, 2010, NATURE, V468, P263, DOI 10.1038/nature09582; Chen RZ, 2001, NAT GENET, V27, P327, DOI 10.1038/85906; Collins AL, 2004, HUM MOL GENET, V13, P2679, DOI 10.1093/hmg/ddh282; D'Cruz JA, 2010, NEUROBIOL DIS, V38, P8, DOI 10.1016/j.nbd.2009.12.018; Dani VS, 2009, J NEUROSCI, V29, P11263, DOI 10.1523/JNEUROSCI.1019-09.2009; Dani VS, 2005, P NATL ACAD SCI USA, V102, P12560, DOI 10.1073/pnas.0506071102; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Foster BA, 1999, SCIENCE, V286, P2507, DOI 10.1126/science.286.5449.2507; Gandal MJ, 2010, BIOL PSYCHIAT, V68, P1100, DOI 10.1016/j.biopsych.2010.09.031; Gandal MJ, 2011, NEUROPHARMACOLOGY; Guy J, 2001, NAT GENET, V27, P322, DOI 10.1038/85899; Guy J, 2007, SCIENCE, V315, P1143, DOI 10.1126/science.1138389; Ho KL, 2008, MOL CELL, V29, P525, DOI 10.1016/j.molcel.2007.12.028; Jentarra GM, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-19; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; Kerr B, 2008, HUM MOL GENET, V17, P1707, DOI 10.1093/hmg/ddn061; Kishi N, 2004, MOL CELL NEUROSCI, V27, P306, DOI 10.1016/j.mcn.2004.07.006; Lioy DT, 2011, NATURE, V475, P497, DOI 10.1038/nature10214; Nan XS, 1996, MOL CELL BIOL, V16, P414; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Nuber UA, 2005, HUM MOL GENET, V14, P2247, DOI 10.1093/hmg/ddi229; Pelka GJ, 2006, BRAIN, V129, P887, DOI 10.1093/brain/awl022; Roberts TPL, 2010, AUTISM RES, V3, P8, DOI 10.1002/aur.111; Samaco RC, 2008, HUM MOL GENET, V17, P1718, DOI 10.1093/hmg/ddn062; Schanen C, 2004, AM J MED GENET A, V126A, P129, DOI 10.1002/ajmg.a.20571; Shahbazian MD, 2002, NEURON, V35, P243, DOI 10.1016/S0896-6273(02)00768-7; Shahbazian MD, 2002, HUM MOL GENET, V11, P115, DOI 10.1093/hmg/11.2.115; Skene PJ, 2010, MOL CELL, V37, P457, DOI 10.1016/j.molcel.2010.01.030; Stauder JEA, 2006, BRAIN DEV-JPN, V28, P487, DOI 10.1016/j.braindev.2006.02.011; Tallon-Baudry C, 1999, TRENDS COGN SCI, V3, P151, DOI 10.1016/S1364-6613(99)01299-1; Uhhaas PJ, 2006, NEURON, V52, P155, DOI 10.1016/j.neuron.2006.09.020; Uhlhaas PJ, 2011, PROG BIOPHYS MOL BIO, V105, P14, DOI 10.1016/j.pbiomolbio.2010.10.004; Uhlhaas PJ, 2010, NAT REV NEUROSCI, V11, P100, DOI 10.1038/nrn2774; Vacca M, 2001, BRAIN DEV-JPN, V23, pS246, DOI 10.1016/S0387-7604(01)00343-6; Winterer G, 2000, CLIN NEUROPHYSIOL, V111, P837, DOI 10.1016/S1388-2457(99)00322-3; Wood L, 2009, J NEUROSCI, V29, P12440, DOI 10.1523/JNEUROSCI.3321-09.2009	44	151	153	1	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2012	15	2					274	283		10.1038/nn.2997	http://dx.doi.org/10.1038/nn.2997			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	882ZX	22119903	Green Accepted			2022-12-28	WOS:000299603500019
J	Oesch, NW; Diamond, JS				Oesch, Nicholas W.; Diamond, Jeffrey S.			Ribbon synapses compute temporal contrast and encode luminance in retinal rod bipolar cells	NATURE NEUROSCIENCE			English	Article							AII AMACRINE CELLS; TRANSMITTER RELEASE; NEUROTRANSMITTER RELEASE; SYNAPTIC DEPRESSION; VISUAL-ADAPTATION; MAMMALIAN RETINA; MOUSE RETINA; LIGHT RESPONSES; CALCIUM CURRENT; FAST EXOCYTOSIS	Contrast is computed throughout the nervous system to encode changing inputs efficiently. The retina encodes luminance and contrast over a wide range of visual conditions and must adapt its responses to maintain sensitivity and to avoid saturation. We examined the means by which one type of adaptation allows individual synapses to compute contrast and encode luminance in biphasic responses to step changes in light levels. Light-evoked depletion of the readily releasable vesicle pool (RRP) at rod bipolar cell ribbon synapses in rat retina limited the dynamic range available to encode transient, but not sustained, responses, thereby allowing the transient and sustained components of release to compute temporal contrast and encode mean light levels, respectively. A release/replenishment model revealed that a single, homogeneous pool of synaptic vesicles is sufficient to generate this behavior and that a partial depletion of the RRP is the dominant mechanism for shaping the biphasic contrast/luminance response.	[Oesch, Nicholas W.; Diamond, Jeffrey S.] Natl Inst Neurol Disorders & Stroke, Synapt Physiol Sect, US Natl Inst Hlth, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Diamond, JS (corresponding author), Natl Inst Neurol Disorders & Stroke, Synapt Physiol Sect, US Natl Inst Hlth, Bethesda, MD USA.	diamondj@ninds.nih.gov	Diamond, Jeffrey/C-1835-2015	Diamond, Jeffrey/0000-0002-1770-2629; Oesch, Nicholas/0000-0001-6972-0741	National Institute of Neurological Disorders and Stroke [NS002986]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003039] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank G. Murphy for helpful discussions, and W.W. Kothmann, A. Poleg-Polsky and A. Scimemi for comments on the manuscript. This work was supported by the National Institute of Neurological Disorders and Stroke Intramural Research Program (NS002986).	Abbott LF, 1997, SCIENCE, V275, P220, DOI 10.1126/science.275.5297.221; ADELSON EH, 1982, VISION RES, V22, P1299, DOI 10.1016/0042-6989(82)90143-2; Atluri PP, 1998, J NEUROSCI, V18, P8214; BAYLOR DA, 1984, J PHYSIOL-LONDON, V357, P575, DOI 10.1113/jphysiol.1984.sp015518; BAYLOR DA, 1970, J PHYSIOL-LONDON, V207, P77, DOI 10.1113/jphysiol.1970.sp009049; Beaumont V, 2005, P NATL ACAD SCI USA, V102, P10700, DOI 10.1073/pnas.0501961102; Berntson A, 2004, VISUAL NEUROSCI, V21, P913, DOI 10.1017/S095252380421611X; Borst JGG, 1996, NATURE, V383, P431, DOI 10.1038/383431a0; BOYNTON RM, 1970, SCIENCE, V170, P1423, DOI 10.1126/science.170.3965.1423; Burrone J, 2002, NEURON, V33, P101, DOI 10.1016/S0896-6273(01)00565-7; DEVRIES SH, 1995, P NATL ACAD SCI USA, V92, P10658, DOI 10.1073/pnas.92.23.10658; Dunn FA, 2006, J NEUROSCI, V26, P3959, DOI 10.1523/JNEUROSCI.5148-05.2006; Dunn FA, 2008, NEURON, V57, P894, DOI 10.1016/j.neuron.2008.01.031; Euler T, 2000, J NEUROPHYSIOL, V83, P1817, DOI 10.1152/jn.2000.83.4.1817; Field GD, 2002, NEURON, V34, P773, DOI 10.1016/S0896-6273(02)00700-6; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; GODA Y, 1994, P NATL ACAD SCI USA, V91, P12942, DOI 10.1073/pnas.91.26.12942; GREEN DG, 1986, VISION RES, V26, P1417, DOI 10.1016/0042-6989(86)90165-3; Hefft S, 2005, NAT NEUROSCI, V8, P1319, DOI 10.1038/nn1542; Jackman SL, 2009, NAT NEUROSCI, V12, P303, DOI 10.1038/nn.2267; Jarsky T, 2010, J NEUROSCI, V30, P11885, DOI 10.1523/JNEUROSCI.1415-10.2010; Keen EC, 2006, P NATL ACAD SCI USA, V103, P5537, DOI 10.1073/pnas.0601103103; LAND EH, 1971, J OPT SOC AM, V61, P1, DOI 10.1364/JOSA.61.000001; Lu T, 2000, NEURON, V26, P683, DOI 10.1016/S0896-6273(00)81204-0; Mennerick S, 1996, NEURON, V17, P1241, DOI 10.1016/S0896-6273(00)80254-8; NAKA KI, 1966, J PHYSIOL-LONDON, V185, P587, DOI 10.1113/jphysiol.1966.sp008003; Neher E, 2008, NEURON, V59, P861, DOI 10.1016/j.neuron.2008.08.019; NORMANN RA, 1974, J GEN PHYSIOL, V63, P37, DOI 10.1085/jgp.63.1.37; Otsu Y, 2004, J NEUROSCI, V24, P420, DOI 10.1523/JNEUROSCI.4452-03.2004; Pang JJ, 2004, J PHYSIOL-LONDON, V558, P897, DOI 10.1113/jphysiol.2003.059543; Pang ZPP, 2010, CURR OPIN CELL BIOL, V22, P496, DOI 10.1016/j.ceb.2010.05.001; Peters JH, 2010, NEURON, V65, P657, DOI 10.1016/j.neuron.2010.02.017; QUASTEL DMJ, 1992, NEUROSCIENCE, V51, P657, DOI 10.1016/0306-4522(92)90305-L; Rieke F, 2009, NEURON, V64, P605, DOI 10.1016/j.neuron.2009.11.028; Sakaba T, 2001, J NEUROSCI, V21, P462, DOI 10.1523/JNEUROSCI.21-02-00462.2001; Shapley R.M., 1984, PROG RETIN RES, V3, P263, DOI [DOI 10.1016/0278-4327(84)90011-7, 10.1016/0278-4327(84)90011-7]; Singer JH, 2006, J NEUROPHYSIOL, V95, P3191, DOI 10.1152/jn.01309.2005; Singer JH, 2004, NAT NEUROSCI, V7, P826, DOI 10.1038/nn1280; Singer JH, 2003, J NEUROSCI, V23, P10923; Snellman J, 2009, J PHYSIOL-LONDON, V587, P2443, DOI 10.1113/jphysiol.2008.165241; Sun J, 2007, NATURE, V450, P676, DOI 10.1038/nature06308; Tian M, 2010, J NEUROSCI, V30, P4650, DOI 10.1523/JNEUROSCI.4212-09.2010; Trexler EB, 2005, J NEUROPHYSIOL, V93, P1476, DOI 10.1152/jn.00597.2004; VONGERSDORFF H, 1994, NATURE, V367, P735, DOI 10.1038/367735a0; vonGersdorff H, 1997, J NEUROSCI, V17, P1919; Wadel K, 2007, NEURON, V53, P563, DOI 10.1016/j.neuron.2007.01.021; WERNER G, 1965, J NEUROPHYSIOL, V28, P359, DOI 10.1152/jn.1965.28.2.359; Xin DY, 1999, VISUAL NEUROSCI, V16, P653, DOI 10.1017/S0952523899164058	49	80	81	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	2011	14	12					1555	U84		10.1038/nn.2945	http://dx.doi.org/10.1038/nn.2945			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	855EJ	22019730	Green Accepted			2022-12-28	WOS:000297546300015
J	Freeman, J; Simoncelli, EP				Freeman, Jeremy; Simoncelli, Eero P.			Metamers of the ventral stream	NATURE NEUROSCIENCE			English	Article							PRIMARY VISUAL-CORTEX; OBJECT RECOGNITION; AREA V2; NEURONS; SELECTIVITY; MODEL; REPRESENTATION; INTEGRATION; ATTENTION; MASKING	The human capacity to recognize complex visual patterns emerges in a sequence of brain areas known as the ventral stream, beginning with primary visual cortex (V1). We developed a population model for mid-ventral processing, in which nonlinear combinations of V1 responses are averaged in receptive fields that grow with eccentricity. To test the model, we generated novel forms of visual metamers, stimuli that differ physically but look the same. We developed a behavioral protocol that uses metameric stimuli to estimate the receptive field sizes in which the model features are represented. Because receptive field sizes change along the ventral stream, our behavioral results can identify the visual area corresponding to the representation. Measurements in human observers implicate visual area V2, providing a new functional account of neurons in this area. The model also explains deficits of peripheral vision known as crowding, and provides a quantitative framework for assessing the capabilities and limitations of everyday vision.	[Freeman, Jeremy; Simoncelli, Eero P.] NYU, Ctr Neural Sci, New York, NY 10003 USA; [Simoncelli, Eero P.] NYU, Courant Inst Math Sci, New York, NY USA; [Simoncelli, Eero P.] NYU, Howard Hughes Med Inst, New York, NY USA	New York University; New York University; Howard Hughes Medical Institute; New York University	Freeman, J (corresponding author), NYU, Ctr Neural Sci, New York, NY 10003 USA.	freeman@cns.nyu.edu		Simoncelli, Eero/0000-0002-1206-527X	National Science Foundation; Howard Hughes Medical Institute	National Science Foundation(National Science Foundation (NSF)); Howard Hughes Medical Institute(Howard Hughes Medical Institute)	We would like to thank R. Rosenholtz for early inspiration and discussions regarding the relationship between texture and crowding, N. Rust for discussions about the nature of information represented in the ventral stream, C. Anderson for discussions about the scaling of receptive fields with eccentricity, M. Landy, A. Girshick and R. Goris for advice on experimental design, C. Ekanadham and U. Rajashaker for advice on the model and analysis, and D. Ganguli, D. Heeger, J. McDermott, E. Merriam and C. Ziemba for comments on the initial manuscript. This work was supported by a National Science Foundation Graduate Student Fellowship to J. F. and a Howard Hughes Medical Institute Investigatorship to E.P.S.	ADELSON EH, 1985, J OPT SOC AM A, V2, P284, DOI 10.1364/JOSAA.2.000284; Anzai A, 2007, NAT NEUROSCI, V10, P1313, DOI 10.1038/nn1975; Balas B, 2008, PATTERN RECOGN, V41, P972, DOI 10.1016/j.patcog.2007.08.007; Balas B, 2009, J VISION, V9, DOI [10.1167/9.2.16, 10.1167/9.12.13]; BOUMA H, 1970, NATURE, V226, P177, DOI 10.1038/226177a0; Carandini M, 2005, J NEUROSCI, V25, P10577, DOI 10.1523/JNEUROSCI.3726-05.2005; Chen XD, 2007, P NATL ACAD SCI USA, V104, P19120, DOI 10.1073/pnas.0706938104; Chung STL, 2007, VISION RES, V47, P3150, DOI 10.1016/j.visres.2007.08.017; David SV, 2006, J NEUROPHYSIOL, V96, P3492, DOI 10.1152/jn.00575.2006; Dumoulin SO, 2008, NEUROIMAGE, V39, P647, DOI 10.1016/j.neuroimage.2007.09.034; FUKUSHIMA K, 1980, BIOL CYBERN, V36, P193, DOI 10.1007/BF00344251; GATTASS R, 1988, J NEUROSCI, V8, P1831; GATTASS R, 1981, J COMP NEUROL, V201, P519, DOI 10.1002/cne.902010405; GEIGER G, 1992, COGNITIVE BRAIN RES, V1, P39, DOI 10.1016/0926-6410(92)90004-B; Graham N.V.S, 1989, VISUAL PATTERN ANAL; GRANLUND GH, 1978, COMPUT VISION GRAPH, V8, P155, DOI 10.1016/0146-664X(78)90047-3; Greenwood JA, 2009, P NATL ACAD SCI USA, V106, P13130, DOI 10.1073/pnas.0901352106; Hegde J, 2000, J NEUROSCI, V20, part. no.; HUBEL DH, 1982, NATURE, V299, P515, DOI 10.1038/299515a0; Ito M, 2004, J NEUROSCI, V24, P3313, DOI 10.1523/JNEUROSCI.4364-03.2004; Julesz B., 1962, IRE T INFORM THEOR, V8, P84, DOI [10.1109/TIT.1962.1057698, DOI 10.1109/TIT.1962.1057698]; Koenderink J. J., 1997, Algebraic Frames for the Perception-Action Cycle. International Workshop, AFPAC'97. Proceedings, P66, DOI 10.1007/BFb0017861; Kovesi P, 2000, PSYCHOL RES-PSYCH FO, V64, P136, DOI 10.1007/s004260000024; LeCun Y., 1990, ADV NEURAL INFORM PR, V2, P396, DOI DOI 10.1111/DSU.12130; Lettvin JY, 1976, SCIENCES, V16, P10, DOI [10.1002/j.2326-1951.1976.tb01231.x, DOI 10.1002/J.2326-1951.1976.TB01231.X]; Levi DM, 2008, VISION RES, V48, P635, DOI 10.1016/j.visres.2007.12.009; MACMILLAN NA, 1977, PSYCHOL REV, V84, P452, DOI 10.1037/0033-295X.84.5.452; Martelli M, 2009, J VISION, V9, DOI 10.1167/9.4.14; Parkes L, 2001, NAT NEUROSCI, V4, P739, DOI 10.1038/89532; Pelli DG, 2008, NAT NEUROSCI, V11, P1129, DOI 10.1038/nn.2187; Pelli DG, 2007, J VISION, V7, DOI 10.1167/7.2.20; Pelli DG, 2004, J VISION, V4, P1136, DOI 10.1167/4.12.12; Portilla J, 2000, INT J COMPUT VISION, V40, P49, DOI 10.1023/A:1026553619983; Riesenhuber M, 1999, NAT NEUROSCI, V2, P1019, DOI 10.1038/14819; Rodionova EI, 2004, EXP BRAIN RES, V158, P373, DOI 10.1007/s00221-004-1967-1; Rolls E. T., 2009, OBJECT CATEGORIZATIO, P257, DOI [10.1017/CBO9780511635465.015, DOI 10.1017/CB09780511635465.015]; Rust NC, 2005, NAT NEUROSCI, V8, P1647, DOI 10.1038/nn1606; SCHALL JD, 1986, BRAIN RES, V368, P18, DOI 10.1016/0006-8993(86)91037-1; Schmid AM, 2009, FRONT SYST NEUROSCI, V3, DOI 10.3389/neuro.06.015.2009; Scolari M, 2007, J VISION, V7, DOI 10.1167/7.2.7; Serre T, 2007, IEEE T PATTERN ANAL, V29, P411, DOI 10.1109/TPAMI.2007.56; Shushruth S, 2009, J NEUROPHYSIOL, V102, P2069, DOI 10.1152/jn.00512.2009; Simoncelli EP, 1998, VISION RES, V38, P743, DOI 10.1016/S0042-6989(97)00183-1; Tanaka K, 1996, ANNU REV NEUROSCI, V19, P109, DOI 10.1146/annurev.ne.19.030196.000545; TOWNSEND JT, 1971, PERCEPT PSYCHOPHYS, V10, P375, DOI 10.3758/BF03207464; Ungerleider Leslie G., 1994, Current Opinion in Neurobiology, V4, P157, DOI 10.1016/0959-4388(94)90066-3; Wandell B., 1995, FDN VISION; Willmore BDB, 2010, J NEUROSCI, V30, P2102, DOI 10.1523/JNEUROSCI.4099-09.2010; Yeshurun Y, 2010, J VISION, V10, DOI 10.1167/10.10.16; Zoccolan D, 2007, J NEUROSCI, V27, P12292, DOI 10.1523/JNEUROSCI.1897-07.2007	50	345	349	2	59	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2011	14	9					1195	U130		10.1038/nn.2889	http://dx.doi.org/10.1038/nn.2889			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	812ID	21841776	Green Accepted			2022-12-28	WOS:000294284900021
J	Abe, K; Watanabe, D				Abe, Kentaro; Watanabe, Dai			Songbirds possess the spontaneous ability to discriminate syntactic rules	NATURE NEUROSCIENCE			English	Article							MALE ZEBRA FINCHES; LANGUAGE-ACQUISITION; SONG-DISCRIMINATION; NEURAL MECHANISMS; CONSPECIFIC SONG; BIRDSONG; SPEECH; LESIONS; NEUROBIOLOGY; ORGANIZATION	Whether the computational systems in language perception involve specific abilities in humans is debated. The vocalizations of songbirds share many features with human speech, but whether songbirds possess a similar computational ability to process auditory information as humans is unknown. We analyzed their spontaneous discrimination of auditory stimuli and found that the Bengalese finch (Lonchura striata var. domestica) can use the syntactical information processing of syllables to discriminate songs). These finches were also able to acquire artificial grammatical rules from synthesized syllable strings and to discriminate novel auditory information according to them. We found that a specific brain region was involved in such discrimination and that this ability was acquired postnatally through the encounter with various conspecific songs. Our results indicate that passerine songbirds spontaneously acquire the ability to process hierarchical structures, an ability that was previously supposed to be specific to humans.	[Abe, Kentaro; Watanabe, Dai] Kyoto Univ, Grad Sch Biostudies, Dept Mol & Syst Biol, Kyoto, Japan; [Abe, Kentaro] Japan Sci & Technol Agcy, Saitama, Japan; [Watanabe, Dai] Kyoto Univ, Fac Med, Dept Biol Sci, Kyoto, Japan	Kyoto University; Japan Science & Technology Agency (JST); Kyoto University	Abe, K (corresponding author), Kyoto Univ, Grad Sch Biostudies, Dept Mol & Syst Biol, Kyoto, Japan.	k.abe.789@gmail.com	Abe, Kentaro/T-2247-2019	Abe, Kentaro/0000-0002-3923-6323	Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science and Technology in Japan; Japan Science and Technology Agency; Sumitomo Foundation; Inamori Foundation; Takeda Science Foundation	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Sumitomo Foundation; Inamori Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF))	We thank N. Yokoi, M. Wajima and F. Ageta for maintenance of animals, as well as members of Watanabe laboratory for various suggestions and K. Fujita for critical reading of the initial manuscript. This work was supported by Grants-in-Aid for Scientific Research of Japan Society for the Promotion of Science (K.A.) and of the Ministry of Education, Culture, Sports, Science and Technology in Japan (D.W.), the Precursory Research for Embryonic Science and Technology program of Japan Science and Technology Agency (K.A.) and scientific research grants from the Sumitomo Foundation (K.A.), the Inamori Foundation (K.A.) and Takeda Science Foundation (D.W.).	Bahlmann J, 2008, NEUROIMAGE, V42, P525, DOI 10.1016/j.neuroimage.2008.04.249; Bolhuis JJ, 2006, NAT REV NEUROSCI, V7, P347, DOI 10.1038/nrn1904; Bolhuis JJ, 2010, NAT REV NEUROSCI, V11, P747, DOI 10.1038/nrn2931; BOTTJER SW, 1989, J COMP NEUROL, V279, P312, DOI 10.1002/cne.902790211; Burt JM, 2000, J NEUROBIOL, V42, P1, DOI 10.1002/(SICI)1097-4695(200001)42:1<1::AID-NEU1>3.0.CO;2-6; CHEW SJ, 1995, P NATL ACAD SCI USA, V92, P3406, DOI 10.1073/pnas.92.8.3406; Chomsky N., 2002, JANUA LINGUARUM; Chomsky Noam., 1965, ASPECTS THEORY SYNTA; de Vries MH, 2008, COGNITION, V107, P763, DOI 10.1016/j.cognition.2007.09.002; Doupe AJ, 1999, ANNU REV NEUROSCI, V22, P567, DOI 10.1146/annurev.neuro.22.1.567; Feher O, 2009, NATURE, V459, P564, DOI 10.1038/nature07994; Fitch WT, 2004, SCIENCE, V303, P377, DOI 10.1126/science.1089401; Friederici AD, 2006, P NATL ACAD SCI USA, V103, P2458, DOI 10.1073/pnas.0509389103; Friederici AD, 2002, TRENDS COGN SCI, V6, P78, DOI 10.1016/S1364-6613(00)01839-8; Friederici AD, 2004, TRENDS COGN SCI, V8, P245, DOI 10.1016/S1364-6613(04)00116-0; Friederici AD, 2006, NEURON, V52, P941, DOI 10.1016/j.neuron.2006.12.002; Gentner TQ, 2006, NATURE, V440, P1204, DOI 10.1038/nature04675; Gentner TQ, 2000, J NEUROBIOL, V42, P117, DOI 10.1002/(SICI)1097-4695(200001)42:1<117::AID-NEU11>3.0.CO;2-M; Gobes SMH, 2007, CURR BIOL, V17, P789, DOI 10.1016/j.cub.2007.03.059; Grodzinsky Y, 2008, TRENDS COGN SCI, V12, P474, DOI 10.1016/j.tics.2008.09.001; Hauser MD, 2007, LANG LEARN DEV, V3, P101, DOI 10.1080/15475440701225394; Hauser MD, 2002, SCIENCE, V298, P1569, DOI 10.1126/science.298.5598.1569; Hauser MD, 2001, COGNITION, V78, pB53, DOI 10.1016/S0010-0277(00)00132-3; Hickok G, 2004, COGNITION, V92, P67, DOI 10.1016/j.cognition.2003.10.011; Hickok G, 2007, NAT REV NEUROSCI, V8, P393, DOI 10.1038/nrn2113; Hickok G, 2009, PHYS LIFE REV, V6, P121, DOI 10.1016/j.plrev.2009.06.001; Jarvis ED, 2004, ANN NY ACAD SCI, V1016, P749, DOI 10.1196/annals.1298.038; JOHNSON F, 1995, J COMP NEUROL, V358, P260, DOI 10.1002/cne.903580208; Kuhl PK, 2004, NAT REV NEUROSCI, V5, P831, DOI 10.1038/nrn1533; Kuperberg GR, 2007, BRAIN RES, V1146, P23, DOI 10.1016/j.brainres.2006.12.063; MARLER P, 1970, AM SCI, V58, P669; MARLER P, 1985, ANIM BEHAV, V33, P57, DOI 10.1016/S0003-3472(85)80120-2; Mello CV, 2004, ANN NY ACAD SCI, V1016, P263, DOI 10.1196/annals.1298.021; Mooney R, 2009, CURR OPIN NEUROBIOL, V19, P654, DOI 10.1016/j.conb.2009.10.004; Okanoya K, 2004, ANN NY ACAD SCI, V1016, P724, DOI 10.1196/annals.1298.026; Pena M, 2002, SCIENCE, V298, P604, DOI 10.1126/science.1072901; Perruchet P, 2005, PSYCHON B REV, V12, P307, DOI 10.3758/BF03196377; Pinker S, 2005, COGNITION, V95, P201, DOI 10.1016/j.cognition.2004.08.004; Pinker Steven, 1994, LANGUAGE INSTINCT; Prather JF, 2009, NAT NEUROSCI, V12, P221, DOI 10.1038/nn.2246; Saffran J, 2008, COGNITION, V107, P479, DOI 10.1016/j.cognition.2007.10.010; Saffran JR, 1996, SCIENCE, V274, P1926, DOI 10.1126/science.274.5294.1926; Sakai KL, 2005, SCIENCE, V310, P815, DOI 10.1126/science.1113530; Scharff C, 1998, J NEUROBIOL, V36, P81, DOI 10.1002/(SICI)1097-4695(199807)36:1<81::AID-NEU7>3.3.CO;2-8; Stripling R, 2003, NEUROBIOL LEARN MEM, V79, P41, DOI 10.1016/S1074-7427(02)00005-9; Stripling R, 1997, J NEUROSCI, V17, P3883; van Heijningen CAA, 2009, P NATL ACAD SCI USA, V106, P20538, DOI 10.1073/pnas.0908113106; Vicario DS, 2004, ANN NY ACAD SCI, V1016, P246, DOI 10.1196/annals.1298.040; Wahl M, 2008, NEURON, V59, P695, DOI 10.1016/j.neuron.2008.07.011	50	125	129	0	52	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2011	14	8					1067	U173		10.1038/nn.2869	http://dx.doi.org/10.1038/nn.2869			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	797KC	21706017				2022-12-28	WOS:000293123700022
J	Chiang, LY; Poole, K; Oliveira, BE; Duarte, N; Sierra, YAB; Bruckner-Tuderman, L; Koch, M; Hu, J; Lewin, GR				Chiang, Li-Yang; Poole, Kate; Oliveira, Beatriz E.; Duarte, Neuza; Sierra, Yinth Andrea Bernal; Bruckner-Tuderman, Leena; Koch, Manuel; Hu, Jing; Lewin, Gary R.			Laminin-332 coordinates mechanotransduction and growth cone bifurcation in sensory neurons	NATURE NEUROSCIENCE			English	Article							MECHANOSENSITIVE ION CHANNELS; DORSAL-ROOT GANGLION; EPIDERMOLYSIS-BULLOSA; NEURITE OUTGROWTH; EXPRESSION; CELLS; SKIN; CLASSIFICATION; INNERVATION; SUBTYPES	Laminin-332 is a major component of the dermo-epidermal skin basement membrane and maintains skin integrity. The transduction of mechanical force into electrical signals by sensory endings in the skin requires mechanosensitive channels. We found that mouse epidermal keratinocytes produce a matrix that is inhibitory for sensory mechanotransduction and that the active molecular component is laminin-332. Substrate-bound laminin-332 specifically suppressed one type of mechanosensitive current ( rapidly adapting) independently of integrin-receptor activation. This mechanotransduction suppression could be exerted locally and was mediated by preventing the formation of protein tethers necessary for current activation. We also found that laminin-332 could locally control sensory axon branching behavior. Loss of laminin-332 in humans led to increased sensory terminal branching and may lead to a de-repression of mechanosensitive currents. These previously unknown functions for this matrix molecule may explain some of the extreme pain experienced by individuals with epidermolysis bullosa who are deficient in laminin-332.	[Chiang, Li-Yang; Poole, Kate; Duarte, Neuza; Sierra, Yinth Andrea Bernal; Hu, Jing; Lewin, Gary R.] Max Delbruck Ctr Mol Med, Dept Neurosci, Berlin, Germany; [Chiang, Li-Yang; Poole, Kate; Duarte, Neuza; Sierra, Yinth Andrea Bernal; Hu, Jing; Lewin, Gary R.] Charite, D-13353 Berlin, Germany; [Oliveira, Beatriz E.; Koch, Manuel] Univ Cologne, Inst Oral & Musculoskeletal Biol, Ctr Biochem, Dept Dermatol, Cologne, Germany; [Oliveira, Beatriz E.; Koch, Manuel] Univ Cologne, Ctr Mol Med Cologne, Fac Med, Cologne, Germany; [Bruckner-Tuderman, Leena] Univ Freiburg, Dept Dermatol, Freiburg, Germany; [Bruckner-Tuderman, Leena] Univ Freiburg, Freiburg Inst Adv Studies, Sch Life Sci LifeNet, Freiburg, Germany; [Hu, Jing] Ctr Integrat Neurosci, Tubingen, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Cologne; University of Cologne; University of Freiburg; University of Freiburg; Eberhard Karls University of Tubingen	Lewin, GR (corresponding author), Max Delbruck Ctr Mol Med, Dept Neurosci, Berlin, Germany.	jing.hu@cin.uni-tuebingen.de; glewin@mdc-berlin.de	Lewin, Gary R/B-8028-2011; Hu, Jing/G-2092-2011; Poole, Kate/G-1830-2011; Koch, Manuel/AAG-9914-2021	Poole, Kate/0000-0003-0879-6093; Koch, Manuel/0000-0002-2962-7814; Duarte, Neuza/0000-0001-5695-0775; Lewin, Gary/0000-0002-2890-6352	Deutsche Forschungsgemeinschaft; Federal Ministry of Education and Research (BMBF); von Humboldt fellowship	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); von Humboldt fellowship	We thank members of the Lewin laboratory for advice and comments on the manuscript. H. Thranhardt and A. Wegner provided excellent technical support. We thank R. Bonsch for performing the western blot for laminin-332. We also thank M. Bastmeyer and A. von Philipsborn for their help in establishing the micro-contact printing method in the laboratory. We are grateful to B. Erdmann for help and advice with the TEM experiments. This work was supported by grants from the Deutsche Forschungsgemeinschaft (G.R.L. and M.K.), a Network Epidermolysis Bullosa grant from the Federal Ministry of Education and Research (BMBF, L.B.-T.) and a von Humboldt fellowship (J.H.).	Amano S, 2000, J BIOL CHEM, V275, P22728, DOI 10.1074/jbc.M002345200; Aumailley M, 2005, MATRIX BIOL, V24, P326, DOI 10.1016/j.matbio.2005.05.006; Aumailley M, 2003, MATRIX BIOL, V22, P49, DOI 10.1016/S0945-053X(03)00013-1; Aumailley Monique, 2006, Expert Reviews in Molecular Medicine, V8, P1, DOI 10.1017/S1462399406000123; BRUCKERTUDERMAN L, 2003, DERMATOLOGY, P1483; Culley B, 2001, NEUROSCI LETT, V301, P83, DOI 10.1016/S0304-3940(01)01615-9; Dittert I, 2006, J NEUROSCI METH, V151, P178, DOI 10.1016/j.jneumeth.2005.07.005; Drew LJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000515; Drew LJ, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-1; Drew LJ, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-12-j0001.2002; Fine JD, 2004, CLIN EXP DERMATOL, V29, P122, DOI 10.1111/j.1365-2230.2004.01428.x; Fine JD, 2008, J AM ACAD DERMATOL, V58, P931, DOI 10.1016/j.jaad.2008.02.004; Gara SK, 2008, J BIOL CHEM, V283, P10658, DOI 10.1074/jbc.M709540200; Halata Z., 1975, MECHANORECEPTORS MAM; Hao JZ, 2010, J NEUROSCI, V30, P13384, DOI 10.1523/JNEUROSCI.2926-10.2010; HASKO JA, 1988, HEARING RES, V35, P21, DOI 10.1016/0378-5955(88)90037-8; Herod J, 2002, PAEDIATR ANAESTH, V12, P388, DOI 10.1046/j.1460-9592.2002.00768.x; Hu J, 2010, EMBO J, V29, P855, DOI 10.1038/emboj.2009.398; Hu J, 2006, J PHYSIOL-LONDON, V577, P815, DOI 10.1113/jphysiol.2006.117648; Jensen KB, 2003, MOL CELL PROTEOMICS, V2, P61, DOI 10.1074/mcp.M200049-MCP200; Kariya Y, 2004, EXP CELL RES, V297, P508, DOI 10.1016/j.yexcr.2004.03.044; KRUGER L, 1989, J COMP NEUROL, V280, P291, DOI 10.1002/cne.902800210; Lechner SG, 2009, J PHYSIOL-LONDON, V587, P3493, DOI 10.1113/jphysiol.2009.175059; Lechner SG, 2009, EMBO J, V28, P1479, DOI 10.1038/emboj.2009.73; LEWIN GR, 1991, J NEUROPHYSIOL, V66, P1205, DOI 10.1152/jn.1991.66.4.1205; Lewin GR, 2004, J NEUROBIOL, V61, P30, DOI 10.1002/neu.20078; Marinkovich MP, 2007, NAT REV CANCER, V7, P370, DOI 10.1038/nrc2089; Masunaga T, 1996, J HISTOCHEM CYTOCHEM, V44, P1223, DOI 10.1177/44.11.8918896; McCarter GC, 1999, NEUROSCI LETT, V273, P179, DOI 10.1016/S0304-3940(99)00665-5; Nishimune H, 2004, NATURE, V432, P580, DOI 10.1038/nature03112; Paladini RD, 1998, J CELL BIOL, V142, P1035, DOI 10.1083/jcb.142.4.1035; Plopper G, 1996, J CELL SCI, V109, P1965; ROUSSELLE P, 1991, J CELL BIOL, V114, P567, DOI 10.1083/jcb.114.3.567; Sann SB, 2008, J NEUROSCI, V28, P2366, DOI 10.1523/JNEUROSCI.3828-07.2008; Simone DA, 1998, J NEUROSCI, V18, P8947; Sinclair D., 1981, MECH CUTANEOUS SENSA; TOMASELLI KJ, 1993, J NEUROSCI, V13, P4880; Tsuruta D, 2003, J BIOL CHEM, V278, P38707, DOI 10.1074/jbc.M301637200; Uitto J, 2004, AM J MED GENET C, V131C, P61, DOI 10.1002/ajmg.c.30035; VERRANDO P, 1994, LAB INVEST, V71, P567; Von Philipsborn AC, 2006, NAT PROTOC, V1, P1322, DOI 10.1038/nprot.2006.251; von Philipsborn AC, 2006, DEVELOPMENT, V133, P2487, DOI 10.1242/dev.02412; Wetzel C, 2007, NATURE, V445, P206, DOI 10.1038/nature05394; Xia YP, 1996, J CELL BIOL, V132, P727, DOI 10.1083/jcb.132.4.727; Zylka MJ, 2005, NEURON, V45, P17, DOI 10.1016/j.neuron.2004.12.015	45	46	46	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2011	14	8					993	U79		10.1038/nn.2873	http://dx.doi.org/10.1038/nn.2873			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	797KC	21725315				2022-12-28	WOS:000293123700012
J	Fournier, J; Monier, C; Pananceau, M; Fregnac, Y				Fournier, Julien; Monier, Cyril; Pananceau, Marc; Fregnac, Yves			Adaptation of the simple or complex nature of V1 receptive fields to visual statistics	NATURE NEUROSCIENCE			English	Article							CATS STRIATE CORTEX; UNDERLYING CONTRAST ADAPTATION; INFORMATION-TRANSMISSION; RESPONSE MODULATION; INHIBITORY NEURONS; STIMULUS CONTRAST; SPATIAL SUMMATION; SIMPLE CELLS; CONNECTIVITY; SYSTEM	Receptive fields in primary visual cortex (V1) are categorized as simple or complex, depending on their spatial selectivity to stimulus contrast polarity. We studied the dependence of this classification on visual context by comparing, in the same cell, the synaptic responses to three classical receptive field mapping protocols: sparse noise, ternary dense noise and flashed Gabor noise. Intracellular recordings revealed that the relative weights of simple-like and complex-like receptive field components were scaled so as to make the same receptive field more simple-like with dense noise stimulation and more complex-like with sparse or Gabor noise stimulations. However, once these context-dependent receptive fields were convolved with the corresponding stimulus, the balance between simple-like and complex-like contributions to the synaptic responses appeared to be invariant across input statistics. This normalization of the linear/nonlinear input ratio suggests a previously unknown form of homeostatic control of V1 functional properties, optimizing the network nonlinearities to the statistical structure of the visual input.	[Fournier, Julien; Monier, Cyril; Pananceau, Marc; Fregnac, Yves] CNRS, Unite Neurosci Informat & Complexite, UPR 3293, Gif Sur Yvette, France; [Pananceau, Marc] Univ Paris 11, Orsay, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay	Fournier, J (corresponding author), CNRS, Unite Neurosci Informat & Complexite, UPR 3293, Gif Sur Yvette, France.	Fournier@unic.cnrs-gif.fr; fregnac@unic.cnrs-gif.fr		Fournier, Julien/0000-0001-7167-8132	CNRS; Agence Nationale de la Recherche; European community [FP6-2004-IST-FETPI 15879, FP7-2009-ICT-FET 243914]	CNRS(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche(French National Research Agency (ANR)); European community(European Commission)	We are thankful to G. Sadoc for his invaluable technical assistance in developing the stimulation software and kernel analysis library tools. We thank A. Davison for comments and suggestions on the manuscript. We are thankful to Z. Kisvarday and K. Sari for their help in the biocytin labeling protocol. We acknowledge the financial support of CNRS, the Agence Nationale de la Recherche (Natstats and V1-Complex), European community contracts Facets (FP6-2004-IST-FETPI 15879) and Brain-i-nets (FP7-2009-ICT-FET 243914).	AERTSEN AMHJ, 1989, J NEUROPHYSIOL, V61, P900, DOI 10.1152/jn.1989.61.5.900; ALBRECHT DG, 1984, J PHYSIOL-LONDON, V347, P713, DOI 10.1113/jphysiol.1984.sp015092; Bardy C, 2006, J PHYSIOL-LONDON, V574, P731, DOI 10.1113/jphysiol.2006.110320; Brenner N, 2000, NEURON, V26, P695, DOI 10.1016/S0896-6273(00)81205-2; Carandini M, 1997, SCIENCE, V276, P949, DOI 10.1126/science.276.5314.949; CARANDINI M, 1994, SCIENCE, V264, P1333, DOI 10.1126/science.8191289; Carandini M, 2005, J NEUROSCI, V25, P10577, DOI 10.1523/JNEUROSCI.3726-05.2005; Chance FS, 1999, NAT NEUROSCI, V2, P277, DOI 10.1038/6381; Crowder NA, 2007, J NEUROPHYSIOL, V98, P1155, DOI 10.1152/jn.00433.2007; David SV, 2004, J NEUROSCI, V24, P6991, DOI 10.1523/JNEUROSCI.1422-04.2004; DEAN AF, 1983, J PHYSIOL-LONDON, V344, P305, DOI 10.1113/jphysiol.1983.sp014941; DEANGELIS GC, 1993, J NEUROPHYSIOL, V69, P1118, DOI 10.1152/jn.1993.69.4.1118; Debanne D, 1998, J PHYSIOL-LONDON, V508, P523, DOI 10.1111/j.1469-7793.1998.00523.x; EMERSON RC, 1987, J NEUROPHYSIOL, V58, P33, DOI 10.1152/jn.1987.58.1.33; Felsen G, 2005, PLOS BIOL, V3, P1819, DOI 10.1371/journal.pbio.0030342; Felsen G, 2002, NEURON, V36, P945, DOI 10.1016/S0896-6273(02)01011-5; Higley MJ, 2007, J NEUROPHYSIOL, V97, P3819, DOI 10.1152/jn.00098.2007; Hirsch JA, 2003, NAT NEUROSCI, V6, P1300, DOI 10.1038/nn1152; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Lauritzen TZ, 2003, J NEUROSCI, V23, P10201; Lesica NA, 2007, NEURON, V55, P479, DOI 10.1016/j.neuron.2007.07.013; LEVAY S, 1976, BRAIN RES, V113, P1, DOI 10.1016/0006-8993(76)90002-0; Liu BH, 2009, J NEUROSCI, V29, P10520, DOI 10.1523/JNEUROSCI.1915-09.2009; Maravall M, 2007, PLOS BIOL, V5, P323, DOI 10.1371/journal.pbio.0050019; Martinez LM, 2005, NAT NEUROSCI, V8, P372, DOI 10.1038/nn1404; Martinez LM, 2001, NEURON, V32, P515, DOI 10.1016/S0896-6273(01)00489-5; Mata ML, 2005, J NEUROPHYSIOL, V93, P919, DOI 10.1152/jn.00668.2004; MOVSHON JA, 1978, J PHYSIOL-LONDON, V283, P53, DOI 10.1113/jphysiol.1978.sp012488; MOVSHON JA, 1978, J PHYSIOL-LONDON, V283, P79, DOI 10.1113/jphysiol.1978.sp012489; Muller JR, 1999, SCIENCE, V285, P1405, DOI 10.1126/science.285.5432.1405; Nagel KI, 2006, NEURON, V51, P845, DOI 10.1016/j.neuron.2006.08.030; Nauhaus I, 2009, NAT NEUROSCI, V12, P70, DOI 10.1038/nn.2232; OHZAWA I, 1985, J NEUROPHYSIOL, V54, P651, DOI 10.1152/jn.1985.54.3.651; Priebe NJ, 2004, NAT NEUROSCI, V7, P1113, DOI 10.1038/nn1310; Rust NC, 2005, NEURON, V46, P945, DOI 10.1016/j.neuron.2005.05.021; Sanchez-Vives MV, 2000, J NEUROSCI, V20, P4267; Sharpee TO, 2006, NATURE, V439, P936, DOI 10.1038/nature04519; SILLITO AM, 1975, J PHYSIOL-LONDON, V250, P305, DOI 10.1113/jphysiol.1975.sp011056; SKOTTUN BC, 1991, VISION RES, V31, P1079, DOI 10.1016/0042-6989(91)90033-2; SO YT, 1981, J NEUROPHYSIOL, V45, P107, DOI 10.1152/jn.1981.45.1.107; STRYKER M, 1972, VISION RES, V12, P2005, DOI 10.1016/0042-6989(72)90054-5; Tao L, 2004, P NATL ACAD SCI USA, V101, P366, DOI 10.1073/pnas.2036460100; Troyer TW, 1998, J NEUROSCI, V18, P5908; Victor JD, 2006, J NEUROPHYSIOL, V95, P379, DOI 10.1152/jn.00498.2005; Victor JD, 2009, J NEUROPHYSIOL, V102, P3414, DOI 10.1152/jn.00086.2009; Wainwright MJ, 1999, VISION RES, V39, P3960, DOI 10.1016/S0042-6989(99)00101-7; Westwick D. T., 2003, IDENTIFICATION NONLI; Yeh CI, 2009, P NATL ACAD SCI USA, V106, P14652, DOI 10.1073/pnas.0907406106	49	43	43	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2011	14	8					1053	U156		10.1038/nn.2861	http://dx.doi.org/10.1038/nn.2861			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	797KC	21765424	Green Submitted			2022-12-28	WOS:000293123700020
J	La Marca, R; Cerri, F; Horiuchi, K; Bachi, A; Feltri, ML; Wrabetz, L; Blobel, CP; Quattrini, A; Salzer, JL; Taveggia, C				La Marca, Rosa; Cerri, Federica; Horiuchi, Keisuke; Bachi, Angela; Feltri, M. Laura; Wrabetz, Lawrence; Blobel, Carl P.; Quattrini, Angelo; Salzer, James L.; Taveggia, Carla			TACE (ADAM17) inhibits Schwann cell myelination	NATURE NEUROSCIENCE			English	Article							NEUROTROPHIN RECEPTOR P75(NTR); PERIPHERAL-NERVE MYELINATION; AMYLOID PRECURSOR PROTEIN; CONVERTING-ENZYME; ALPHA-SECRETASE; LIPID RAFTS; NEUREGULIN-1; BACE1; REMYELINATION; EXPRESSION	Tumor necrosis factor-alpha-converting enzyme (TACE; also known as ADAM17) is a proteolytic sheddase that is responsible for the cleavage of several membrane-bound molecules. We report that TACE cleaves neuregulin-1 (NRG1) type III in the epidermal growth factor domain, probably inactivating it (as assessed by deficient activation of the phosphatidylinositol-3-OH kinase pathway), and thereby negatively regulating peripheral nervous system (PNS) myelination. Lentivirus-mediated knockdown of TACE in vitro in dorsal root ganglia neurons accelerates the onset of myelination and results in hypermyelination. In agreement, motor neurons of conditional knockout mice lacking TACE specifically in these cells are significantly hypermyelinated, and small-caliber fibers are aberrantly myelinated. Further, reduced TACE activity rescues hypomyelination in NRG1 type III haploinsufficient mice in vivo. We also show that the inhibitory effect of TACE is neuron-autonomous, as Schwann cells lacking TACE elaborate myelin of normal thickness. Thus, TACE is a modulator of NRG1 type III activity and is a negative regulator of myelination in the PNS.	[La Marca, Rosa; Cerri, Federica; Quattrini, Angelo; Taveggia, Carla] Ist Sci San Raffaele, Div Neurosci, I-20132 Milan, Italy; [La Marca, Rosa; Cerri, Federica; Quattrini, Angelo; Taveggia, Carla] Ist Sci San Raffaele, Inst Expt Neurol, I-20132 Milan, Italy; [Horiuchi, Keisuke] Keio Univ, Sch Med, Dept Orthoped Surg, Tokyo, Japan; [Bachi, Angela; Feltri, M. Laura; Wrabetz, Lawrence] Ist Sci San Raffaele, Div Genet & Cell Biol, I-20132 Milan, Italy; [Blobel, Carl P.] Cornell Univ, Hosp Special Surg, Weill Med Coll, Arthrit & Tissue Degenerat Program, New York, NY 10021 USA; [Salzer, James L.] NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA; [Salzer, James L.] NYU, Sch Med, Dept Neurol, New York, NY USA; [Salzer, James L.] NYU, Sch Med, Smilow Neurosci Program, New York, NY USA	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Keio University; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Cornell University; New York University; New York University; New York University	Taveggia, C (corresponding author), Ist Sci San Raffaele, Div Neurosci, I-20132 Milan, Italy.	taveggia.carla@hsr.it	Horiuchi, Keisuke/L-2277-2013; Cerri, Federica/AAO-1670-2020; Messier, Claude/A-2322-2008; Feltri, Maria Laura/J-5286-2018; bachi, angela/B-3527-2015; Taveggia, Carla/AAN-4784-2020; Quattrini, Angelo/J-8373-2018	Horiuchi, Keisuke/0000-0001-7063-9609; Messier, Claude/0000-0002-4791-1763; bachi, angela/0000-0003-4842-6556; Quattrini, Angelo/0000-0002-8226-8320; La Marca, Rosa/0000-0002-9478-5296; Salzer, James/0000-0001-9126-7197	Federazione Italiana Sclerosi Multipla (FISM) [2007/PC/01]; Compagnia di San Paolo; US National Institute of Health [R01-NS045630, R01-NS055256, R01-GM64750, RO1-NS26001]; Telethon Italia [GGP08021, GGP071100, GPP10007]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064750] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS055256, R01NS026001, R01NS045630] Funding Source: NIH RePORTER	Federazione Italiana Sclerosi Multipla (FISM)(Fondazione Italiana Sclerosi Multipla (FISM)); Compagnia di San Paolo(Compagnia di San Paolo); US National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Telethon Italia(Fondazione Telethon); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank S. Arber (University of Basel) for providing the HB9-cre transgenic line, M. Filbin (Hunter College) for antibodies, P. Podini for assistance with electron microscopy, G. Dina and A. Cattaneo for technical support and Y. Poitelon for artwork. This study was supported by the Federazione Italiana Sclerosi Multipla (FISM) (grant 2007/PC/01) and the Compagnia di San Paolo (C. T.); by the US National Institute of Health (grants R01-NS045630 (M. L. F.), R01-NS055256 (L. W.), R01-GM64750 (C. P. B.) and RO1-NS26001 (J.L.S.)); by Telethon Italia (grants GGP08021 (M. L. F.), GGP071100 (L. W.) and GPP10007 (C. T., L. W. and M. L. F.)). C. T. is a recipient of a FISM Transition Career Award.	Blobel CP, 2005, NAT REV MOL CELL BIO, V6, P32, DOI 10.1038/nrm1548; Bozkulak EC, 2009, MOL CELL BIOL, V29, P5679, DOI 10.1128/MCB.00406-09; BURGESS TL, 1995, J BIOL CHEM, V270, P19188, DOI 10.1074/jbc.270.32.19188; Buser AM, 2009, EUR J NEUROSCI, V29, P2276, DOI 10.1111/j.1460-9568.2009.06785.x; Caescu CI, 2009, BIOCHEM J, V424, P79, DOI 10.1042/BJ20090549; Cosgaya JM, 2002, SCIENCE, V298, P1245, DOI 10.1126/science.1076595; Doedens JR, 2000, J BIOL CHEM, V275, P14598, DOI 10.1074/jbc.275.19.14598; DONALD D, 1934, J COMP NEUROL, V60, P437; Feltri ML, 2002, J CELL BIOL, V156, P199, DOI 10.1083/jcb.200109021; Freese C, 2009, FEBS J, V276, P1568, DOI 10.1111/j.1742-4658.2009.06889.x; Frenzel KE, 2001, J NEUROCHEM, V77, P1; Fricker FR, 2011, J NEUROSCI, V31, P3225, DOI 10.1523/JNEUROSCI.2568-10.2011; Fricker FR, 2009, J NEUROSCI, V29, P7667, DOI 10.1523/JNEUROSCI.6053-08.2009; HAASS C, 1992, NATURE, V357, P500, DOI 10.1038/357500a0; Horiuchi K, 2005, DEV BIOL, V283, P459, DOI 10.1016/j.ydbio.2005.05.004; Horiuchi K, 2007, J IMMUNOL, V179, P2686, DOI 10.4049/jimmunol.179.5.2686; Hu XY, 2008, FASEB J, V22, P2970, DOI 10.1096/fj.08-106666; Hu XY, 2006, NAT NEUROSCI, V9, P1520, DOI 10.1038/nn1797; KOO EH, 1994, J BIOL CHEM, V269, P17386; Maurel P, 2000, J NEUROSCI, V20, P4635, DOI 10.1523/JNEUROSCI.20-12-04635.2000; Maurel P, 2007, J CELL BIOL, V178, P861, DOI 10.1083/jcb.200705132; Meyer D, 1997, DEVELOPMENT, V124, P3575; Michailov GV, 2004, SCIENCE, V304, P700, DOI 10.1126/science.1095862; Moss ML, 2008, NAT CLIN PRACT RHEUM, V4, P300, DOI 10.1038/ncprheum0797; Ogata T, 2004, J NEUROSCI, V24, P6724, DOI 10.1523/JNEUROSCI.5520-03.2004; Ohno M, 2009, NAT NEUROSCI, V12, P1506, DOI 10.1038/nn.2438; Ozkaynak E, 2010, J NEUROSCI, V30, P3857, DOI 10.1523/JNEUROSCI.6287-09.2010; Peschon JJ, 1998, SCIENCE, V282, P1281, DOI 10.1126/science.282.5392.1281; Quattrini A, 1996, GLIA, V17, P294, DOI 10.1002/(SICI)1098-1136(199608)17:4<294::AID-GLIA4>3.0.CO;2-#; Sagane K, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-33; Schlondorff J, 2000, BIOCHEM J, V347, P131, DOI 10.1042/0264-6021:3470131; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shirakabe K, 2001, J BIOL CHEM, V276, P9352, DOI 10.1074/jbc.M007913200; Taveggia C, 2005, NEURON, V47, P681, DOI 10.1016/j.neuron.2005.08.017; Tellier E, 2006, EXP CELL RES, V312, P3969, DOI 10.1016/j.yexcr.2006.08.027; Thinakaran G, 2008, J BIOL CHEM, V283, P29615, DOI 10.1074/jbc.R800019200; Tomita K, 2007, GLIA, V55, P1199, DOI 10.1002/glia.20533; van Tetering G, 2009, J BIOL CHEM, V284, P31018, DOI 10.1074/jbc.M109.006775; Wakatsuki S, 2009, J BIOL CHEM, V284, P2957, DOI 10.1074/jbc.M803191200; Weber S, 2011, DEVELOPMENT, V138, P495, DOI 10.1242/dev.055210; Willem M, 2006, SCIENCE, V314, P664, DOI 10.1126/science.1132341; WINDEBANK AJ, 1985, J NEUROSCI, V5, P1563; Woodhoo A, 2009, NAT NEUROSCI, V12, P839, DOI 10.1038/nn.2323; Wrabetz L, 1998, J NEUROBIOL, V34, P10, DOI 10.1002/(SICI)1097-4695(199801)34:1<10::AID-NEU2>3.0.CO;2-F; Yang HC, 2004, J NEUROCHEM, V91, P1249, DOI 10.1111/j.1471-4159.2004.02764.x; Yang P, 2006, PROG NEUROBIOL, V79, P73, DOI 10.1016/j.pneurobio.2006.05.001; Yang X, 2001, NEURON, V30, P399, DOI 10.1016/S0896-6273(01)00287-2; Yokozeki T, 2007, GENES CELLS, V12, P329, DOI 10.1111/j.1365-2443.2007.01060.x; Zampieri N, 2005, J BIOL CHEM, V280, P14563, DOI 10.1074/jbc.M412957200	50	105	106	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2011	14	7					857	U73		10.1038/nn.2849	http://dx.doi.org/10.1038/nn.2849			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	783KR	21666671	Green Accepted			2022-12-28	WOS:000292081700013
J	Renna, JM; Weng, SJ; Berson, DM				Renna, Jordan M.; Weng, Shijun; Berson, David M.			Light acts through melanopsin to alter retinal waves and segregation of retinogeniculate afferents	NATURE NEUROSCIENCE			English	Article							GANGLION-CELLS; PHOTORECEPTORS; NETWORK	Waves of correlated activity sweeping across the early postnatal mouse retina promote the segregation and refinement of retinofugal projections. This process has been thought to be spontaneous and unaffected by visual experience. We found, however, that light prolongs spiking during the waves and enhances the segregation of retinogeniculate afferents, and that it did so by activating melanopsin-expressing, intrinsically photosensitive retinal ganglion cells.	[Renna, Jordan M.; Weng, Shijun; Berson, David M.] Brown Univ, Dept Neurosci, Providence, RI 02912 USA	Brown University	Renna, JM (corresponding author), Brown Univ, Dept Neurosci, Providence, RI 02912 USA.	jordan_renna@brown.edu			US National Institutes of Health [EY012793, EY017137, EY020108]; NATIONAL EYE INSTITUTE [F32EY020108, R01EY012793, R01EY017137] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank S. Hattar for sharing his Opn4<SUP>Cre</SUP> mouse line, J. Gandy for assistance with data processing and D. Boghossian for technical assistance. In addition, we would like to thank M. Crair and O. Dhande for advice on ocular injection techniques. This work was supported by US National Institutes of Health R01 grants EY012793 and EY017137, and F32 grant EY020108.	Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; Butts DA, 2007, PLOS BIOL, V5, P651, DOI 10.1371/journal.pbio.0050061; Chandrasekaran AR, 2005, J NEUROSCI, V25, P6929, DOI 10.1523/JNEUROSCI.1470-05.2005; Do MTH, 2010, PHYSIOL REV, V90, P1547, DOI 10.1152/physrev.00013.2010; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; Huberman AD, 2008, ANNU REV NEUROSCI, V31, P479, DOI 10.1146/annurev.neuro.31.060407.125533; Johnson J, 2010, P NATL ACAD SCI USA, V107, P17374, DOI 10.1073/pnas.1008533107; Lucas RJ, 2003, SCIENCE, V299, P245, DOI 10.1126/science.1077293; Rich KA, 1997, J COMP NEUROL, V388, P47; Sekaran S, 2005, CURR BIOL, V15, P1099, DOI 10.1016/j.cub.2005.05.053; Sekaran S, 2003, CURR BIOL, V13, P1290, DOI 10.1016/S0960-9822(03)00510-4; Torborg CL, 2004, J NEUROSCI METH, V135, P17, DOI 10.1016/j.jneumeth.2003.11.019; Tu DC, 2005, NEURON, V48, P987, DOI 10.1016/j.neuron.2005.09.031; Zhang DQ, 2008, P NATL ACAD SCI USA, V105, P14181, DOI 10.1073/pnas.0803893105; Zheng JJ, 2006, NAT NEUROSCI, V9, P363, DOI 10.1038/nn1644	15	52	52	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2011	14	7					827	829		10.1038/nn.2845	http://dx.doi.org/10.1038/nn.2845			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	783KR	21642974	Green Accepted			2022-12-28	WOS:000292081700008
J	Hua, YF; Sinha, R; Martineau, M; Kahms, M; Klingauf, J				Hua, Yunfeng; Sinha, Raunak; Martineau, Magalie; Kahms, Martin; Klingauf, Juergen			A common origin of synaptic vesicles undergoing evoked and spontaneous fusion	NATURE NEUROSCIENCE			English	Article							SYNAPSES; NEUROTRANSMISSION; PROTEINS; RELEASE; CELLS; POOL; CA2+	There is a longstanding controversy on the identity of synaptic vesicles undergoing spontaneous versus evoked release. A recent study, introducing a new genetic probe, suggested that spontaneous release is driven by a resting pool of synaptic vesicles refractory to stimulation. We found that cross-depletion of spontaneously or actively recycling synaptic vesicle pools occurred on stimulation in rat hippocampal neurons and identified the recycling pool as a major source of spontaneous release.	[Hua, Yunfeng; Sinha, Raunak; Klingauf, Juergen] Max Planck Inst Biophys Chem, Dept Membrane Biophys, Gottingen, Germany; [Hua, Yunfeng; Sinha, Raunak; Martineau, Magalie; Kahms, Martin; Klingauf, Juergen] Univ Munster, Dept Cellular Biophys, Inst Med Phys & Biophys, Munster, Germany	Max Planck Society; University of Munster	Klingauf, J (corresponding author), Max Planck Inst Biophys Chem, Dept Membrane Biophys, Gottingen, Germany.	klingauf@uni-muenster.de		Martineau, Magalie/0000-0003-1817-2372; Hua, Yunfeng/0000-0003-0072-7122	Deutsche Forschungsgemeinschaft [Kl 1334/1-1]; Max Planck foundation; International Max Planck Research School in Neurosciences Gottingen	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Max Planck foundation; International Max Planck Research School in Neurosciences Gottingen	We thank K. Hardes for culturing hippocampal neurons, H. Martens (Synaptic Systems) for providing antibodies and E. Neher for critical reading of the manuscript. This work was supported by the Deutsche Forschungsgemeinschaft (Kl 1334/1-1 to J.K.). Y.H. is supported by a stipend from the Max Planck foundation and R.S. by a stipend from the International Max Planck Research School in Neurosciences Gottingen.	Adie EJ, 2003, ASSAY DRUG DEV TECHN, V1, P251, DOI 10.1089/15406580360545062; Angleson JK, 2001, J NEUROPHYSIOL, V85, P287, DOI 10.1152/jn.2001.85.1.287; Chung C, 2010, J NEUROSCI, V30, P1363, DOI 10.1523/JNEUROSCI.3427-09.2010; Fredj NB, 2009, NAT NEUROSCI, V12, P751, DOI 10.1038/nn.2317; Groemer TW, 2007, NAT NEUROSCI, V10, P145, DOI 10.1038/nn1831; Howarth M, 2008, NAT PROTOC, V3, P534, DOI 10.1038/nprot.2008.20; KATZ B, 1969, J PHYSIOL-LONDON, V203, P689, DOI 10.1113/jphysiol.1969.sp008887; Kim SH, 2010, NEURON, V67, P797, DOI 10.1016/j.neuron.2010.08.003; Lou XL, 2005, NATURE, V435, P497, DOI 10.1038/nature03568; Martens H, 2008, J NEUROSCI, V28, P13125, DOI 10.1523/JNEUROSCI.3887-08.2008; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Murthy VN, 1999, NAT NEUROSCI, V2, P503, DOI 10.1038/9149; Prange O, 1999, J NEUROSCI, V19, P6427; Sankaranarayanan S, 2001, NAT NEUROSCI, V4, P129, DOI 10.1038/83949; Sara Y, 2005, NEURON, V45, P563, DOI 10.1016/j.neuron.2004.12.056	15	66	67	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2010	13	12					1451	1453		10.1038/nn.2695	http://dx.doi.org/10.1038/nn.2695			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	684CW	21102448	Green Published			2022-12-28	WOS:000284525800006
J	Nestler, EJ; Hyman, SE				Nestler, Eric J.; Hyman, Steven E.			Animal models of neuropsychiatric disorders	NATURE NEUROSCIENCE			English	Review							CATECHOL-O-METHYLTRANSFERASE; MOUSE MODELS; LITHIUM ACTION; PSYCHIATRIC-DISORDERS; MENTAL-DISORDERS; DRUG DISCOVERY; SCHIZOPHRENIA; BRAIN; MICE; NEUROBIOLOGY	Modeling of human neuropsychiatric disorders in animals is extremely challenging given the subjective nature of many symptoms, the lack of biomarkers and objective diagnostic tests, and the early state of the relevant neurobiology and genetics. Nonetheless, progress in understanding pathophysiology and in treatment development would benefit greatly from improved animal models. Here we review the current state of animal models of mental illness, with a focus on schizophrenia, depression and bipolar disorder. We argue for areas of focus that might increase the likelihood of creating more useful models, at least for some disorders, and for explicit guidelines when animal models are reported.	[Nestler, Eric J.] Mt Sinai Sch Med, Fishberg Dept Neurosci, New York, NY USA; [Hyman, Steven E.] Harvard Univ, Off Provost, Cambridge, MA 02138 USA	Icahn School of Medicine at Mount Sinai; Harvard University	Nestler, EJ (corresponding author), Mt Sinai Sch Med, Fishberg Dept Neurosci, New York, NY USA.	eric.nestler@mssm.edu	Yan, Shuo/B-8381-2009		NIDA NIH HHS [R01 DA014133] Funding Source: Medline; NIMH NIH HHS [P50 MH090963, R01 MH051399, P50 MH066172] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH066172, P50MH090963, R01MH051399] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA014133] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Aguzzi A, 2008, ANNU REV PATHOL-MECH, V3, P11, DOI 10.1146/annurev.pathmechdis.3.121806.154326; Allen NC, 2008, NAT GENET, V40, P827, DOI 10.1038/ng.171; [Anonymous], 2000, DIAGNOSTIC STAT MANU, V4th; Arguello PA, 2010, DIS MODEL MECH, V3, P22, DOI 10.1242/dmm.003996; Barnett JH, 2008, BIOL PSYCHIAT, V64, P137, DOI 10.1016/j.biopsych.2008.01.005; Beaulieu JM, 2008, CELL, V132, P125, DOI 10.1016/j.cell.2007.11.041; Belforte JE, 2010, NAT NEUROSCI, V13, P76, DOI 10.1038/nn.2447; Belmaker RH, 2007, NEUROSCI BIOBEHAV R, V31, P843, DOI 10.1016/j.neubiorev.2007.05.001; Berton O, 2006, NAT REV NEUROSCI, V7, P137, DOI 10.1038/nrn1846; Brandon NJ, 2009, J NEUROSCI, V29, P12768, DOI 10.1523/JNEUROSCI.3355-09.2009; Buxbaum Joseph D, 2009, Dialogues Clin Neurosci, V11, P35; Cannon TD, 2002, P NATL ACAD SCI USA, V99, P3228, DOI 10.1073/pnas.052023499; Carlezon WA, 2005, TRENDS NEUROSCI, V28, P436, DOI 10.1016/j.tins.2005.06.005; Carlezon WA, 2007, NAT PROTOC, V2, P2987, DOI 10.1038/nprot.2007.441; Chadman KK, 2009, AM J MED GENET B, V150B, P1, DOI 10.1002/ajmg.b.30777; Chen SK, 2010, CELL, V141, P775, DOI 10.1016/j.cell.2010.03.055; Chuang JC, 2010, BIOL PSYCHIAT, V67, P1075, DOI 10.1016/j.biopsych.2009.12.003; Craddock N, 2009, TRENDS GENET, V25, P99, DOI 10.1016/j.tig.2008.12.002; Cryan JF, 2002, TRENDS PHARMACOL SCI, V23, P238, DOI 10.1016/S0165-6147(02)02017-5; Diaz-Asper CM, 2008, BIOL PSYCHIAT, V63, P72, DOI 10.1016/j.biopsych.2007.03.031; Einat H, 2006, BIOL PSYCHIAT, V59, P1160, DOI 10.1016/j.biopsych.2005.11.004; Etherton MR, 2009, P NATL ACAD SCI USA, V106, P17998, DOI 10.1073/pnas.0910297106; Gotz J, 2008, NAT REV NEUROSCI, V9, P532, DOI 10.1038/nrn2420; Gourley SL, 2008, BIOL PSYCHIAT, V64, P884, DOI 10.1016/j.biopsych.2008.06.016; Gradinaru V, 2010, CELL, V141, P154, DOI 10.1016/j.cell.2010.02.037; Green JG, 2010, ARCH GEN PSYCHIAT, V67, P113, DOI 10.1001/archgenpsychiatry.2009.186; Green T, 2009, J AM ACAD CHILD PSY, V48, P1060, DOI 10.1097/CHI.0b013e3181b76683; Hyman SE, 2008, NATURE, V455, P890, DOI 10.1038/nature07454; Hyman SE, 2010, ANNU REV CLIN PSYCHO, V6, P155, DOI 10.1146/annurev.clinpsy.3.022806.091532; Jamain S, 2008, P NATL ACAD SCI USA, V105, P1710, DOI 10.1073/pnas.0711555105; Karayiorgou M, 2010, NAT REV NEUROSCI, V11, P402, DOI 10.1038/nrn2841; Keefe RSE, 2007, ARCH GEN PSYCHIAT, V64, P633, DOI 10.1001/archpsyc.64.6.633; Kegeles LS, 2010, ARCH GEN PSYCHIAT, V67, P231, DOI 10.1001/archgenpsychiatry.2010.10; Kellendonk C, 2006, NEURON, V49, P603, DOI 10.1016/j.neuron.2006.01.023; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Kessler RC, 2007, CURR OPIN PSYCHIATR, V20, P359, DOI 10.1097/YCO.0b013e32816ebc8c; Krishnan V, 2008, NATURE, V455, P894, DOI 10.1038/nature07455; Krishnan V, 2007, CELL, V131, P391, DOI 10.1016/j.cell.2007.09.018; Lewis DA, 2006, ARCH NEUROL-CHICAGO, V63, P1372, DOI 10.1001/archneur.63.10.1372; Lewis DA, 2009, J CLIN INVEST, V119, P706, DOI 10.1172/JCI37335; Maier SF, 2005, NEUROSCI BIOBEHAV R, V29, P829, DOI 10.1016/j.neubiorev.2005.03.021; Malkesman O, 2009, DIS MODEL MECH, V2, P238, DOI 10.1242/dmm.001628; Markou A, 2005, NEUROSCI BIOBEHAV R, V29, P501, DOI 10.1016/j.neubiorev.2005.03.004; Markou A, 2009, NEUROPSYCHOPHARMACOL, V34, P74, DOI 10.1038/npp.2008.173; Meaney MJ, 2001, ANNU REV NEUROSCI, V24, P1161, DOI 10.1146/annurev.neuro.24.1.1161; Morrissette DA, 2009, J BIOL CHEM, V284, P6033, DOI 10.1074/jbc.R800030200; Morrow EM, 2008, SCIENCE, V321, P218, DOI 10.1126/science.1157657; Moy SS, 2008, MOL PSYCHIATR, V13, P4, DOI 10.1038/sj.mp.4002082; Muller MB, 2006, BIOL PSYCHIAT, V59, P1104, DOI 10.1016/j.biopsych.2006.02.008; Nestler E.J., 2009, MOL NEUROPHARMACOLOG, V2nd; Nestler EJ, 2002, BIOL PSYCHIAT, V52, P503, DOI 10.1016/S0006-3223(02)01405-1; O'Donovan MC, 2008, NAT GENET, V40, P1053, DOI 10.1038/ng.201; Patterson PH, 2009, BEHAV BRAIN RES, V204, P313, DOI 10.1016/j.bbr.2008.12.016; Pletnikov MV, 2008, MOL PSYCHIATR, V13, P173, DOI [10.1038/sj.mp.4002079, 10.1038/sj.mp.4002144]; Prickaerts J, 2006, J NEUROSCI, V26, P9022, DOI 10.1523/JNEUROSCI.5216-05.2006; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Roybal K, 2007, P NATL ACAD SCI USA, V104, P6406, DOI 10.1073/pnas.0609625104; Saha S, 2005, PLOS MED, V2, P413, DOI 10.1371/journal.pmed.0020141; Shahbazian MD, 2002, NEURON, V35, P243, DOI 10.1016/S0896-6273(02)00768-7; Shaldubina A, 2001, PROG NEURO-PSYCHOPH, V25, P855, DOI 10.1016/S0278-5846(01)00154-3; Silverman JL, 2010, NAT REV NEUROSCI, V11, P490, DOI 10.1038/nrn2851; Simpson EH, 2010, NEURON, V65, P585, DOI 10.1016/j.neuron.2010.02.014; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239; Swerdlow NR, 2008, PSYCHOPHARMACOLOGY, V199, P331, DOI 10.1007/s00213-008-1072-4; Tabuchi K, 2007, SCIENCE, V318, P71, DOI 10.1126/science.1146221; Tamminga CA, 2006, J CLIN PSYCHIAT, V67, P9; Wallace DL, 2009, NAT NEUROSCI, V12, P200, DOI 10.1038/nn.2257; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Welch JM, 2007, NATURE, V448, P894, DOI 10.1038/nature06104; WHO, 2001, WORLD HLTH REPORT 20; Willner P, 2005, NEUROPSYCHOBIOLOGY, V52, P90, DOI 10.1159/000087097	71	1323	1358	1	318	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2010	13	10					1161	1169		10.1038/nn.2647	http://dx.doi.org/10.1038/nn.2647			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	654MB	20877280	Green Accepted			2022-12-28	WOS:000282171300007
J	Jurado, S; Biou, V; Malenka, RC				Jurado, Sandra; Biou, Virginie; Malenka, Robert C.			A calcineurin/AKAP complex is required for NMDA receptor-dependent long-term depression	NATURE NEUROSCIENCE			English	Article							AKAP SIGNALING COMPLEXES; AKAP150-ANCHORED PKA; AMPA RECEPTORS; DISTINCT; DYNAMICS; BINDING; SITE; LTD	AKAP79/150 is a protein scaffold that is thought to position specific kinases (protein kinase A and C) and phosphastases (calcineurin) in appropriate synaptic domains so that their activities can regulate excitatory synaptic strength. Using a viral-mediated molecular replacement strategy in rat hippocampal slices, we found that AKAP is required for NMDA receptor-dependent long-term depression solely because of its interaction with calcineurin.	[Jurado, Sandra; Biou, Virginie; Malenka, Robert C.] Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Nancy Pritzker Lab, Palo Alto, CA 94304 USA; [Biou, Virginie] Crucell Switzerland AG, Bern, Switzerland	Stanford University; Johnson & Johnson	Malenka, RC (corresponding author), Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Nancy Pritzker Lab, Palo Alto, CA 94304 USA.	malenka@stanford.edu	Jurado, Sandra/S-9936-2017	Jurado, Sandra/0000-0001-9864-9307	US National Institutes of Health [MH63394]; Ramon Areces Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH063394, R01MH063394, P50MH086403] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA008227] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ramon Areces Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank members of the Malenka laboratory for constructive comments on the manuscript and during the course of the experiments. We especially thank D. Goswami for performing the experiments shown in Supplementary Figure 4. This work was supported by a gift from the Morby Charitable Fund for Alzheimer's Research and a grant from the US National Institutes of Health (MH63394). S.J. was supported by a Postdoctoral Fellowship from the Ramon Areces Foundation.	Bauman AL, 2004, NEUROPHARMACOLOGY, V46, P299, DOI 10.1016/j.neuropharm.2003.09.016; Bhattacharyya S, 2009, NAT NEUROSCI, V12, P172, DOI 10.1038/nn.2249; Dell'Acqua ML, 2006, EUR J CELL BIOL, V85, P627, DOI 10.1016/j.ejcb.2006.01.010; Dell'Acqua ML, 2002, J BIOL CHEM, V277, P48796, DOI 10.1074/jbc.M207833200; Hoshi N, 2005, NAT CELL BIOL, V7, P1066, DOI 10.1038/ncb1315; Kashishian A, 1998, J BIOL CHEM, V273, P27412, DOI 10.1074/jbc.273.42.27412; Lu Y, 2008, J PHYSIOL-LONDON, V586, P4155, DOI 10.1113/jphysiol.2008.151662; Lu Y, 2007, EMBO J, V26, P4879, DOI 10.1038/sj.emboj.7601884; MULKEY RM, 1994, NATURE, V369, P486, DOI 10.1038/369486a0; Robertson HR, 2009, J NEUROSCI, V29, P7929, DOI 10.1523/JNEUROSCI.6093-08.2009; Snyder EM, 2005, J BIOL CHEM, V280, P16962, DOI 10.1074/jbc.M409693200; Tavalin SJ, 2002, J NEUROSCI, V22, P3044, DOI 10.1523/JNEUROSCI.22-08-03044.2002; Tunquist BJ, 2008, P NATL ACAD SCI USA, V105, P12557, DOI [10.1073/pnas.0805922105, 10.1073/pnas.0B05922105]; Xu W, 2008, NEURON, V57, P248, DOI 10.1016/j.neuron.2007.11.027; Zhong HN, 2009, NEURON, V62, P363, DOI 10.1016/j.neuron.2009.03.013	15	86	89	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2010	13	9					1053	1055		10.1038/nn.2613	http://dx.doi.org/10.1038/nn.2613			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	643XC	20694001	Green Accepted			2022-12-28	WOS:000281332600008
J	Smith, SL; Hausser, M				Smith, Spencer L.; Haeusser, Michael			Parallel processing of visual space by neighboring neurons in mouse visual cortex	NATURE NEUROSCIENCE			English	Article							RETINAL GANGLION-CELLS; SPATIAL-INTERVAL DISCRIMINATION; RECEPTIVE-FIELD PROPERTIES; IN-VIVO; STRIATE CORTEX; ORIENTATION COLUMNS; INHIBITORY NEURONS; OPTIC TRACT; CAT; ORGANIZATION	Visual cortex shows smooth retinotopic organization on the macroscopic scale, but it is unknown how receptive fields are organized at the level of neighboring neurons. This information is crucial for discriminating among models of visual cortex. We used in vivo two-photon calcium imaging to independently map ON and OFF receptive field subregions of local populations of layer 2/3 neurons in mouse visual cortex. Receptive field subregions were often precisely shared among neighboring neurons. Furthermore, large subregions seem to be assembled from multiple smaller, non-overlapping subregions of other neurons in the same local population. These experiments provide, to our knowledge, the first characterization of the diversity of receptive fields in a dense local network of visual cortex and reveal elementary units of receptive field organization. Our results suggest that a limited pool of afferent receptive fields is available to a local population of neurons and reveal new organizational principles for the neural circuitry of the mouse visual cortex.	[Smith, Spencer L.] UCL, Wolfson Inst Biomed Res, London, England; UCL, Dept Neurosci Physiol & Pharmacol, London, England	University of London; University College London; University of London; University College London	Smith, SL (corresponding author), UCL, Wolfson Inst Biomed Res, London, England.	spencer.smith@wibr.ucl.ac.uk	Hausser, Michael/AAW-6827-2020	Hausser, Michael/0000-0002-2673-8957	Wellcome Trust; Gatsby Charitable Foundation; Human Frontier Science Program; MRC [G0500244] Funding Source: UKRI; Medical Research Council [G0500244] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Gatsby Charitable Foundation; Human Frontier Science Program(Human Frontier Science Program); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We are grateful to B. Clark, M. Carandini, J. Cottam, M. Havenith, J. Jack, B. Judkewitz, P. Latham, M. London, A. Mathy, I. Smith and C. Wilms for discussions and for comments on the manuscript. This work was supported by a Human Frontier Science Program Long-Term Fellowship to S.L.S., and grants by the Wellcome Trust and the Gatsby Charitable Foundation to M.H.	BALKEMA GW, 1982, J NEUROPHYSIOL, V48, P968, DOI 10.1152/jn.1982.48.4.968; Carandini M, 2005, J NEUROSCI, V25, P10577, DOI 10.1523/JNEUROSCI.3726-05.2005; Chen CF, 2000, NEURON, V28, P955, DOI 10.1016/S0896-6273(00)00166-5; DeAngelis GC, 1999, J NEUROSCI, V19, P4046; DRAGER UC, 1975, J COMP NEUROL, V160, P269, DOI 10.1002/cne.901600302; Gandhi SP, 2008, P NATL ACAD SCI USA, V105, P16797, DOI 10.1073/pnas.0806159105; Gao EQ, 2010, J NEUROSCI, V30, P5912, DOI 10.1523/JNEUROSCI.6456-09.2010; Garaschuk O, 2006, NAT PROTOC, V1, P380, DOI 10.1038/nprot.2006.58; Gauthier JL, 2009, PLOS BIOL, V7, P747, DOI 10.1371/journal.pbio.1000063; Gordon JA, 1997, LEARN MEMORY, V4, P245, DOI 10.1101/lm.4.3.245; Grubb MS, 2003, J NEUROPHYSIOL, V90, P3594, DOI 10.1152/jn.00699.2003; HAMMOND P, 1974, J PHYSIOL-LONDON, V242, P99, DOI 10.1113/jphysiol.1974.sp010696; Hebb D.O., 1949, ORG BEHAV NEUROPSYCH; HUBEL DH, 1974, J COMP NEUROL, V158, P295, DOI 10.1002/cne.901580305; HUBEL DH, 1959, J PHYSIOL-LONDON, V148, P574, DOI 10.1113/jphysiol.1959.sp006308; Huberman AD, 2008, NEURON, V59, P425, DOI 10.1016/j.neuron.2008.07.018; Huberman AD, 2009, NEURON, V62, P327, DOI 10.1016/j.neuron.2009.04.014; Jin JZ, 2008, NAT NEUROSCI, V11, P88, DOI 10.1038/nn2029; Kalatsky VA, 2003, NEURON, V38, P529, DOI 10.1016/S0896-6273(03)00286-1; Kitamura K, 2008, NAT METHODS, V5, P61, DOI 10.1038/NMETH1150; LEVI DM, 1987, J OPT SOC AM A, V4, P1304, DOI 10.1364/JOSAA.4.001304; LEVI DM, 1990, VISION RES, V30, P1735, DOI 10.1016/0042-6989(90)90156-F; Liu BH, 2009, J NEUROSCI, V29, P10520, DOI 10.1523/JNEUROSCI.1915-09.2009; MANGINI NJ, 1980, J COMP NEUROL, V193, P203, DOI 10.1002/cne.901930114; Mata ML, 2005, J NEUROPHYSIOL, V93, P919, DOI 10.1152/jn.00668.2004; METIN C, 1988, EXP BRAIN RES, V69, P594; Mrsic-Flogel TD, 2007, NEURON, V54, P961, DOI 10.1016/j.neuron.2007.05.028; Nauhaus I, 2008, NEURON, V57, P673, DOI 10.1016/j.neuron.2008.01.020; Niell CM, 2008, J NEUROSCI, V28, P7520, DOI 10.1523/JNEUROSCI.0623-08.2008; Nimmerjahn A, 2004, NAT METHODS, V1, P31, DOI 10.1038/nmeth706; Ohki K, 2005, NATURE, V433, P597, DOI 10.1038/nature03274; Ohki K, 2007, CURR OPIN NEUROBIOL, V17, P401, DOI 10.1016/j.conb.2007.07.007; Olshausen BA, 2005, NEURAL COMPUT, V17, P1665, DOI 10.1162/0899766054026639; Reich DS, 2001, SCIENCE, V294, P2566, DOI 10.1126/science.1065839; Renart A, 2010, SCIENCE, V327, P587, DOI 10.1126/science.1179850; Ringach DL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000251; Ringach DL, 2004, J NEUROPHYSIOL, V92, P468, DOI 10.1152/jn.01202.2003; Seung HS, 2009, NEURON, V62, P17, DOI 10.1016/j.neuron.2009.03.020; Smith SL, 2007, NAT NEUROSCI, V10, P370, DOI 10.1038/nn1844; Sohya K, 2007, J NEUROSCI, V27, P2145, DOI 10.1523/JNEUROSCI.4641-06.2007; Song S, 2001, NEURON, V32, P339, DOI 10.1016/S0896-6273(01)00451-2; SOODAK RE, 1987, P NATL ACAD SCI USA, V84, P3936, DOI 10.1073/pnas.84.11.3936; Stosiek C, 2003, P NATL ACAD SCI USA, V100, P7319, DOI 10.1073/pnas.1232232100; TORREALBA F, 1982, J COMP NEUROL, V211, P377, DOI 10.1002/cne.902110405; TORREALBA F, 1981, BRAIN RES, V219, P428, DOI 10.1016/0006-8993(81)90305-X; Volgyi B, 2009, J COMP NEUROL, V512, P664, DOI 10.1002/cne.21912; WAGOR E, 1980, J COMP NEUROL, V193, P187, DOI 10.1002/cne.901930113; WASSLE H, 1981, PROC R SOC SER B-BIO, V212, P177, DOI 10.1098/rspb.1981.0033; Yeh CI, 2009, J NEUROSCI, V29, P11753, DOI 10.1523/JNEUROSCI.1991-09.2009; Yen SC, 2007, J NEUROPHYSIOL, V97, P1326, DOI 10.1152/jn.00747.2006	50	136	136	1	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2010	13	9					1144	U149		10.1038/nn.2620	http://dx.doi.org/10.1038/nn.2620			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	643XC	20711183	Green Accepted			2022-12-28	WOS:000281332600021
J	Meyer, K; Kaplan, JT; Essex, R; Webber, C; Damasio, H; Damasio, A				Meyer, Kaspar; Kaplan, Jonas T.; Essex, Ryan; Webber, Cecelia; Damasio, Hanna; Damasio, Antonio			Predicting visual stimuli on the basis of activity in auditory cortices	NATURE NEUROSCIENCE			English	Article							MUSICAL IMAGERY; CORTEX; ACTIVATION; ILLUSION; AREAS; SOUND	Using multivariate pattern analysis of functional magnetic resonance imaging data, we found that the subjective experience of sound, in the absence of auditory stimulation, was associated with content-specific activity in early auditory cortices in humans. As subjects viewed sound-implying, but silent, visual stimuli, activity in auditory cortex differentiated among sounds related to various animals, musical instruments and objects. These results support the idea that early sensory cortex activity reflects perceptual experience, rather than sensory stimulation alone.	[Meyer, Kaspar; Kaplan, Jonas T.; Essex, Ryan; Webber, Cecelia; Damasio, Hanna; Damasio, Antonio] Univ So Calif, Brain & Creat Inst, Los Angeles, CA 90089 USA	University of Southern California	Damasio, A (corresponding author), Univ So Calif, Brain & Creat Inst, Los Angeles, CA 90089 USA.	damasio@usc.edu	Damasio, Antonio/AAD-1342-2019		Mathers Foundation; US National Institutes of Health [5P50NS019632-25]	Mathers Foundation; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	H.D. and A.D. are supported by the Mathers Foundation and the US National Institutes of Health (5P50NS019632-25).	Blankenburg F, 2006, PLOS BIOL, V4, P459, DOI 10.1371/journal.pbio.0040069; Calvert GA, 1997, SCIENCE, V276, P593, DOI 10.1126/science.276.5312.593; Chen LM, 2003, SCIENCE, V302, P881, DOI 10.1126/science.1087846; Dierks T, 1999, NEURON, V22, P615, DOI 10.1016/S0896-6273(00)80715-1; Formisano E, 2008, SCIENCE, V322, P970, DOI 10.1126/science.1164318; Harrison SA, 2009, NATURE, V458, P632, DOI 10.1038/nature07832; KOSSLYN SM, 1995, NATURE, V378, P496, DOI 10.1038/378496a0; Kraemer DJM, 2005, NATURE, V434, P158, DOI 10.1038/434158a; Macknik SL, 1999, P NATL ACAD SCI USA, V96, P15208, DOI 10.1073/pnas.96.26.15208; Serences JT, 2009, PSYCHOL SCI, V20, P207, DOI 10.1111/j.1467-9280.2009.02276.x; Slotnick SD, 2005, CEREB CORTEX, V15, P1570, DOI 10.1093/cercor/bhi035; Staeren N, 2009, CURR BIOL, V19, P498, DOI 10.1016/j.cub.2009.01.066; Thirion B, 2006, NEUROIMAGE, V33, P1104, DOI 10.1016/j.neuroimage.2006.06.062; Watkins S, 2006, NEUROIMAGE, V31, P1247, DOI 10.1016/j.neuroimage.2006.01.016; Zatorre RJ, 2005, NEURON, V47, P9, DOI 10.1016/j.neuron.2005.06.013	15	85	85	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2010	13	6					667	668		10.1038/nn.2533	http://dx.doi.org/10.1038/nn.2533			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	600QY	20436482				2022-12-28	WOS:000278003300009
J	Tan, GH; Liu, YY; Hu, XL; Yin, DM; Mei, L; Xiong, ZQ				Tan, Guo-He; Liu, Yuan-Yuan; Hu, Xiao-Ling; Yin, Dong-Min; Mei, Lin; Xiong, Zhi-Qi			Neuregulin 1 represses limbic epileptogenesis through ErbB4 in parvalbumin-expressing interneurons	NATURE NEUROSCIENCE			English	Article							SCHIZOPHRENIA-LIKE PSYCHOSIS; NMDA RECEPTORS; EPILEPSY; SEIZURES; MODEL; NRG1; TRKB	Epilepsy is a common and refractory neurological disorder, but the neuronal regulatory mechanisms of epileptogenesis remain largely unclear. Activity-dependent transcription of genes for neurotrophins such as brain-derived neurotrophic factor (BDNF) has been shown to promote epileptogenesis; however, little is known about factors that may act as intrinsic, homeostatic or counterbalancing mechanisms. Using rodent models, here we show that limbic seizure activity upregulated NRG1-ErbB4 signaling and that epileptogenesis was inhibited by infusing NRG1 intracerebrally but exacerbated by neutralizing endogenous NRG1 with soluble ErbB4 extracellular domain, by inhibiting ErbB4 activation or by deleting the Erbb4 gene. Furthermore, specific depletion of ErbB4 in parvalbumin-expressing interneurons abolished NRG1-mediated inhibition of epileptogenesis and promoted kindling progression, resulting in increased spontaneous seizures and exuberant mossy fiber sprouting. In contrast, depleting ErbB4 in CaMKII alpha-positive pyramidal neurons had no effect. Thus, NRG1-induced activation of ErbB4 in parvalbumin-expressing inhibitory interneurons may serve as a critical endogenous negative-feedback mechanism to suppress limbic epileptogenesis.	[Yin, Dong-Min; Mei, Lin] Georgias Hlth Sci Univ, Program Dev Neurobiol, Inst Mol Med & Genet, Augusta, GA 30912 USA; [Yin, Dong-Min; Mei, Lin] Georgias Hlth Sci Univ, Dept Neurol, Inst Mol Med & Genet, Augusta, GA USA; [Tan, Guo-He; Liu, Yuan-Yuan; Hu, Xiao-Ling; Xiong, Zhi-Qi] Chinese Acad Sci, Inst Neurosci, Shanghai Inst Biol Sci, Shanghai, Peoples R China; [Tan, Guo-He; Liu, Yuan-Yuan; Hu, Xiao-Ling; Xiong, Zhi-Qi] Chinese Acad Sci, State Key Lab Neurosci, Shanghai Inst Biol Sci, Shanghai, Peoples R China	University System of Georgia; Augusta University; University System of Georgia; Augusta University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Mei, L (corresponding author), Georgias Hlth Sci Univ, Program Dev Neurobiol, Inst Mol Med & Genet, Augusta, GA 30912 USA.	lmei@georgiahealth.edu; xiongzhiqi@ion.ac.cn	Mei, Lin/G-8755-2012		973 Program [2011CBA00407]; National Natural Science Foundation of China [30925016, 31021063]; Chinese Academy of Sciences [XDA01020305]; US National Institutes of Health	973 Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank M. Gassmann (University of Basel) for kindly supplying us with heart-rescued Erbb4<SUP>-/-</SUP> mice, C. Lai (Indiana University) for Erbb4<SUP>loxP/loxP</SUP> mice, S. Arbor (University of Basel) for Pvalb-cre mice and G. Schutz (German Cancer Research Center) for Camk2a-iCre and Camk2a-CreER mice. We also thank T.-m. Gao (Southern Medical University) for help concerning transgenic mice and M. Sliwkowski (Genentech) for NRG1 We are grateful to J.O. McNamara and M.-M. Poo for their comments on this work. We also thank Y.-J. Xin, X.-Y. Feng, L. Huang, B. Lu and Y. Shen for their help on genotyping, animal models and histological experiments. This work was supported in part by grants from the 973 Program (2011CBA00407), National Natural Science Foundation of China (30925016; 31021063) and Chinese Academy of Sciences (XDA01020305) to Z.Q.X. and from the US National Institutes of Health to L.M.	Backx L, 2009, EUR J HUM GENET, V17, P378, DOI 10.1038/ejhg.2008.180; BERTRAM EH, 1993, BRAIN RES, V625, P295, DOI 10.1016/0006-8993(93)91071-Y; Binder DK, 1999, J NEUROSCI, V19, P1424; Bjarnadottir M, 2007, J NEUROSCI, V27, P4519, DOI 10.1523/JNEUROSCI.4314-06.2007; Bob P, 2010, PROG NEURO-PSYCHOPH, V34, P143, DOI 10.1016/j.pnpbp.2009.10.015; BRUTON CJ, 1994, NEUROLOGY, V44, P34, DOI 10.1212/WNL.44.1.34; Cascella NG, 2009, NEUROSCI RES, V63, P227, DOI 10.1016/j.neures.2009.01.002; CHEN MS, 1994, J COMP NEUROL, V349, P389, DOI 10.1002/cne.903490306; Chen Q, 2007, J NEUROSCI, V27, P542, DOI 10.1523/JNEUROSCI.3607-06.2007; Chen Y., P NATL ACAD SCI US; Curia G, 2008, J NEUROSCI METH, V172, P143, DOI 10.1016/j.jneumeth.2008.04.019; Delorenzo RJ, 1999, NEUROSCIENTIST, V5, P86, DOI 10.1177/107385849900500213; Duncan JS, 2006, LANCET, V367, P1087, DOI 10.1016/S0140-6736(06)68477-8; Eilam R, 1998, P NATL ACAD SCI USA, V95, P1888, DOI 10.1073/pnas.95.4.1888; Fazzari P, 2010, NATURE, V464, P1376, DOI 10.1038/nature08928; Fisahn A, 2009, CEREB CORTEX, V19, P612, DOI 10.1093/cercor/bhn107; Garcia-Rivello H, 2005, AM J PHYSIOL-HEART C, V289, pH1153, DOI 10.1152/ajpheart.00048.2005; GODDARD GV, 1969, EXP NEUROL, V25, P295, DOI 10.1016/0014-4886(69)90128-9; Gu ZL, 2005, J NEUROSCI, V25, P4974, DOI 10.1523/JNEUROSCI.1086-05.2005; HAUSER WA, 1993, EPILEPSIA, V34, P453, DOI 10.1111/j.1528-1157.1993.tb02586.x; He XP, 2004, NEURON, V43, P31, DOI 10.1016/j.neuron.2004.06.019; Hughes PE, 1999, PROG NEUROBIOL, V57, P421, DOI 10.1016/S0301-0082(98)00057-4; Iyengar SS, 2008, BRAIN RES, V1208, P67, DOI 10.1016/j.brainres.2008.02.045; KIDO H, 1989, JPN J PSYCHIAT NEUR, V43, P433; Li B, 2007, NEURON, V54, P583, DOI 10.1016/j.neuron.2007.03.028; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; McBain CJ, 2001, NAT REV NEUROSCI, V2, P11, DOI 10.1038/35049047; McNamara James O, 2006, Sci STKE, V2006, pre12, DOI 10.1126/stke.3562006re12; Mei L, 2008, NAT REV NEUROSCI, V9, P437, DOI 10.1038/nrn2392; Morimoto K, 2004, PROG NEUROBIOL, V73, P1, DOI 10.1016/j.pneurobio.2004.03.009; Neddens J, 2010, HIPPOCAMPUS, V20, P724, DOI 10.1002/hipo.20675; Ozaki M, 2004, J NEUROCHEM, V91, P176, DOI 10.1111/j.1471-4159.2004.02719.x; Pitcher G.M, NAT MED; Qin P, 2005, BMJ-BRIT MED J, V331, P23, DOI 10.1136/bmj.38488.462037.8F; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Rice AC, 1998, ADV BEHAV BIOL, V48, P267; Roysommuti S, 2003, NEUROSCIENCE, V121, P779, DOI 10.1016/S0306-4522(03)00503-7; Sachdev P, 1998, AM J PSYCHIAT, V155, P325, DOI 10.1176/ajp.155.3.325; Steiner H, 1999, EXP NEUROL, V159, P494, DOI 10.1006/exnr.1999.7163; STEVENS JR, 1988, SCHIZOPHR RES, V1, P79, DOI 10.1016/0920-9964(88)90044-8; Stoll SW, 2001, NEOPLASIA, V3, P339, DOI 10.1038/sj.neo.7900170; Tidcombe H, 2003, P NATL ACAD SCI USA, V100, P8281, DOI 10.1073/pnas.1436402100; Ting AK, 2011, J NEUROSCI, V31, P15, DOI 10.1523/JNEUROSCI.2538-10.2011; Vullhorst D, 2009, J NEUROSCI, V29, P12255, DOI 10.1523/JNEUROSCI.2454-09.2009; Wen L, 2010, P NATL ACAD SCI USA, V107, P1211, DOI 10.1073/pnas.0910302107; Woo RS, 2007, NEURON, V54, P599, DOI 10.1016/j.neuron.2007.04.009	46	78	83	2	46	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2012	15	2					258	266		10.1038/nn.3005	http://dx.doi.org/10.1038/nn.3005			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	882ZX	22158510				2022-12-28	WOS:000299603500017
J	Iadecola, C; Anrather, J				Iadecola, Costantino; Anrather, Josef			Stroke research at a crossroad: asking the brain for directions	NATURE NEUROSCIENCE			English	Article							ISCHEMIC TOLERANCE; CEREBRAL-ISCHEMIA; NEUROTROPHIC FACTOR; NITRIC-OXIDE; EXERCISE; MECHANISMS; PROTECTION; NEUROPROTECTION; INJURY; NEUROBIOLOGY	Ischemic stroke remains a vexing public health problem. Although progress has been made in prevention and supportive care, efforts to protect the brain from ischemic cell death have failed. Thus, no new treatment has made it from bench to bedside since tissue plasminogen activator was introduced in 1996. The brain has a remarkable capacity for self-preservation, illustrated by the protective responses induced by ischemia, preconditioning and exercise. Here we describe the mechanisms underlying brain self-protection, with the goal of identifying features that could provide insight into stroke therapy. Unlike traditional therapeutic approaches based on counteracting selected pathways of the ischemic cascade, endogenous neuroprotection relies on coordinated neurovascular programs that support cerebral perfusion, mitigate the harmful effects of cerebral ischemia and promote tissue restoration. Learning how the brain triggers and implements these protective measures may advance our quest to treat stroke.	[Iadecola, Costantino; Anrather, Josef] Weill Cornell Med Coll, Dept Neurol & Neurosci, Div Neurobiol, New York, NY USA	Cornell University	Iadecola, C (corresponding author), Weill Cornell Med Coll, Dept Neurol & Neurosci, Div Neurobiol, New York, NY USA.	coi2001@med.cornell.edu	Iadecola, c/ABB-8377-2020	Iadecola, Costantino/0000-0001-9797-073X	US National Institutes of Health [R37-NS34179, NS35806]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS034179, R01NS035806] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by US National Institutes of Health grants R37-NS34179 and NS35806.	Andjelkovic AV, 2003, J CEREBR BLOOD F MET, V23, P1348, DOI 10.1097/01.WCB.0000091762.61714.FE; Bath PMW, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005207.pub3; Clarkson AN, 2010, NATURE, V468, P305, DOI 10.1038/nature09511; Cotman CW, 2007, TRENDS NEUROSCI, V30, P464, DOI 10.1016/j.tins.2007.06.011; Digicaylioglu M, 2010, EXPERT OPIN BIOL TH, V10, P937, DOI 10.1517/14712598.2010.481435; Dirnagl U, 2003, TRENDS NEUROSCI, V26, P248, DOI 10.1016/S0166-2236(03)00071-7; Dirnagl U, 2009, LANCET NEUROL, V8, P398, DOI 10.1016/S1474-4422(09)70054-7; Dishman RK, 2006, OBESITY, V14, P345, DOI 10.1038/oby.2006.46; Dreixler JC, 2011, EXP EYE RES, V92, P521, DOI 10.1016/j.exer.2011.03.015; Ehrenreich H, 2009, STROKE, V40, pE647, DOI 10.1161/STROKEAHA.109.564872; Endres M, 2003, ANN NEUROL, V54, P582, DOI 10.1002/ana.10722; Fagan SC, 2011, TRANSL STROKE RES, V2, P202, DOI 10.1007/s12975-011-0072-6; Fonarow GC, 2011, CIRCULATION, V123, P750, DOI 10.1161/CIRCULATIONAHA.110.974675; Gesuete R, 2011, STROKE, V42, P1445, DOI 10.1161/STROKEAHA.110.603266; GomezPinilla F, 1997, BRAIN RES, V764, P1, DOI 10.1016/S0006-8993(97)00375-2; Greenberg David A, 2006, NeuroRx, V3, P458, DOI 10.1016/j.nurx.2006.08.003; Hachinski V, 2010, STROKE, V41, P1084, DOI 10.1161/STROKEAHA.110.586156; Hardingham GE, 2011, ANTIOXID REDOX SIGN, V14, P1421, DOI 10.1089/ars.2010.3573; Hemmen TM, 2010, STROKE, V41, P2265, DOI 10.1161/STROKEAHA.110.592295; Huang SS, 2006, CIRC J, V70, P1070, DOI 10.1253/circj.70.1070; Iadecola C, 2011, NAT MED, V17, P796, DOI 10.1038/nm.2399; Johansson A, 2000, J INTERN MED, V247, P179, DOI 10.1046/j.1365-2796.2000.00600.x; Kernie SG, 2010, NEUROBIOL DIS, V37, P267, DOI 10.1016/j.nbd.2009.11.002; Kitagawa K, 2007, FEBS J, V274, P3210, DOI 10.1111/j.1742-4658.2007.05890.x; Koch S, 2011, STROKE, V42, P1387, DOI 10.1161/STROKEAHA.110.605840; Kunz A., 2008, HDB CLIN NEUROL, V92, P283, DOI 10.1016/S0072-9752(08)01914-3; Kunz A, 2007, J NEUROSCI, V27, P7083, DOI 10.1523/JNEUROSCI.1645-07.2007; Liebeskind DS, 2010, CURR OPIN NEUROL, V23, P36, DOI 10.1097/WCO.0b013e328334da32; LLorens-Martin M, 2010, MOL CELL NEUROSCI, V44, P109, DOI 10.1016/j.mcn.2010.02.006; Marsh B, 2009, J NEUROSCI, V29, P9839, DOI 10.1523/JNEUROSCI.2496-09.2009; Morris KC, 2011, J CEREBR BLOOD F MET, V31, P1003, DOI 10.1038/jcbfm.2010.229; Moskowitz MA, 2010, STROKE, V41, pS85, DOI 10.1161/STROKEAHA.110.598458; Moskowitz MA, 2010, NEURON, V67, P181, DOI 10.1016/j.neuron.2010.07.002; Paschen W, 2003, J CEREBR BLOOD F MET, V23, P773, DOI 10.1097/01.WCB.0000075009.47474.F9; Pedersen BK, 2008, PHYSIOL REV, V88, P1379, DOI 10.1152/physrev.90100.2007; Pedersen CM, 2011, J THROMB HAEMOST, V9, P404, DOI 10.1111/j.1538-7836.2010.04142.x; Rasmussen P, 2009, EXP PHYSIOL, V94, P1062, DOI 10.1113/expphysiol.2009.048512; Ren CC, 2009, BRAIN RES, V1288, P88, DOI 10.1016/j.brainres.2009.07.029; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; Saxena P, 2010, J CARDIAC SURG, V25, P127, DOI 10.1111/j.1540-8191.2009.00820.x; Sharp FR, 2001, ADV EXP MED BIOL, V502, P273; Stapels M, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000502; Stenzel-Poore MP, 2003, LANCET, V362, P1028, DOI 10.1016/S0140-6736(03)14412-1; Tang XN, 2010, AGEING RES REV, V9, P61, DOI 10.1016/j.arr.2009.10.002; Torres-Aleman I, 2010, DEV NEUROBIOL, V70, P384, DOI 10.1002/dneu.20778; Yenari MA, 2002, ADV EXP MED BIOL, V513, P281; Zaheer A, 2006, NEUROCHEM RES, V31, P579, DOI 10.1007/s11064-006-9049-3; Zhang F, 2011, NEUROSCIENCE, V177, P170, DOI 10.1016/j.neuroscience.2011.01.018; Zhang YH, 2007, AM J PHYSIOL-HEART C, V292, pH2573, DOI 10.1152/ajpheart.01098.2006; Zhang ZG, 2002, CIRC RES, V90, P284, DOI 10.1161/hh0302.104460	50	281	294	1	41	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2011	14	11					1363	1368		10.1038/nn.2953	http://dx.doi.org/10.1038/nn.2953			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	841NI	22030546	Green Accepted			2022-12-28	WOS:000296518600007
J	Maret, S; Faraguna, U; Nelson, AB; Cirelli, C; Tononi, G				Maret, Stephanie; Faraguna, Ugo; Nelson, Aaron B.; Cirelli, Chiara; Tononi, Giulio			Sleep and waking modulate spine turnover in the adolescent mouse cortex	NATURE NEUROSCIENCE			English	Article							SYNAPTIC HOMEOSTASIS; PLASTICITY; INCREASES; WAKE	Cortical development involves synaptic formation and elimination. Although synaptogenesis predominates in the early stages and pruning in the later stages, the two processes are thought to happen concurrently. In adults, synaptic strength is modulated by behavioral state, and we asked whether synaptic remodeling may be affected by sleep and waking states. Using two-photon microscopy in adolescent mice, we found that waking results in a net increase in cortical spines, whereas sleep is associated with net spine loss.	[Maret, Stephanie; Faraguna, Ugo; Nelson, Aaron B.; Cirelli, Chiara; Tononi, Giulio] Univ Wisconsin, Dept Psychiat, Madison, WI 53706 USA; [Nelson, Aaron B.] Univ Wisconsin, Neurosci Training Program, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Cirelli, C (corresponding author), Univ Wisconsin, Dept Psychiat, Madison, WI 53706 USA.	ccirelli@wisc.edu; gtononi@wisc.edu	Faraguna, Ugo/J-6805-2012	Faraguna, Ugo/0000-0002-4814-7218	US National Institutes of Health; National Institute of Mental Health [1R01MH091326]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH091326] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000579] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by a US National Institutes of Health Director's Pioneer award (to G. T.) and the National Institute of Mental Health (1R01MH091326 to G. T. and C. C.).	Appelbaum L, 2010, NEURON, V68, P87, DOI 10.1016/j.neuron.2010.09.006; Bushey D, 2011, SCIENCE, V332, P1576, DOI 10.1126/science.1202839; Cirelli C, 2006, J NEUROCHEM, V98, P1632, DOI 10.1111/j.1471-4159.2006.04058.x; DASH MB, 2009, NEUROSCIENCE, V29, P620; DeFelipe J, 1997, CEREB CORTEX, V7, P619, DOI 10.1093/cercor/7.7.619; Hua JYY, 2004, NAT NEUROSCI, V7, P327, DOI 10.1038/nn1218; Liu ZW, 2010, J NEUROSCI, V30, P8671, DOI 10.1523/JNEUROSCI.1409-10.2010; Nikonova EV, 2010, SLEEP, V33, P889, DOI 10.1093/sleep/33.7.889; Paus T, 2008, NAT REV NEUROSCI, V9, P947, DOI 10.1038/nrn2513; RAKIC P, 1994, PROG BRAIN RES, V102, P227; Tononi G, 2006, SLEEP MED REV, V10, P49, DOI 10.1016/j.smrv.2005.05.002; Vyazovskiy VV, 2008, NAT NEUROSCI, V11, P200, DOI 10.1038/nn2035; Vyazovskiy VV, 2011, NATURE, V472, P443, DOI 10.1038/nature10009; Yang G, 2009, NATURE, V462, P920, DOI 10.1038/nature08577; Yu XZ, 2011, CURR OPIN NEUROBIOL, V21, P169, DOI 10.1016/j.conb.2010.07.010	15	188	189	1	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2011	14	11					1418	1420		10.1038/nn.2934	http://dx.doi.org/10.1038/nn.2934			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	841NI	21983682	Green Accepted			2022-12-28	WOS:000296518600017
J	Bloomfield, TC; Gentner, TQ; Margoliash, D				Bloomfield, Tiffany C.; Gentner, Timothy Q.; Margoliash, Daniel			What birds have to say about language	NATURE NEUROSCIENCE			English	Editorial Material							CONSTRAINTS; LEARNABILITY	Controversy surrounds the suggestion that recursion is a uniquely human computational ability that enables language. A study now finds this ability in a songbird and takes steps toward a model system for syntactic competence.	[Bloomfield, Tiffany C.; Margoliash, Daniel] Univ Chicago, Dept Psychol, Chicago, IL 60637 USA; [Margoliash, Daniel] Univ Chicago, Dept Organismal Biol & Anat, Chicago, IL 60637 USA; [Gentner, Timothy Q.] Univ Calif San Diego, Dept Psychol, La Jolla, CA 92093 USA; [Gentner, Timothy Q.] Univ Chicago, Kavli Inst Brain & Mind, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of California System; University of California San Diego; University of Chicago	Bloomfield, TC (corresponding author), Univ Chicago, Dept Psychol, 5848 S Univ Ave, Chicago, IL 60637 USA.	dan@bigbird.uchicago.edu			NIDCD NIH HHS [R01 DC008358] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC008358] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Abe K, 2011, NAT NEUROSCI, V14, P1067, DOI 10.1038/nn.2869; Chomsky Noam., 1965, ASPECTS THEORY SYNTA; de Vries MH, 2008, COGNITION, V107, P763, DOI 10.1016/j.cognition.2007.09.002; Fitch WT, 2004, SCIENCE, V303, P377, DOI 10.1126/science.1089401; Gentner TQ, 2006, NATURE, V440, P1204, DOI 10.1038/nature04675; Hauser MD, 2002, SCIENCE, V298, P1569, DOI 10.1126/science.298.5598.1569; Karlsson F, 2007, J LINGUIST, V43, P365, DOI 10.1017/S0022226707004616; Lai J, 2011, COGNITION, V118, P265, DOI 10.1016/j.cognition.2010.11.011; LIEBERMAN P, 2006, EVOLUTIONARY BIOL LA; Margoliash D, 2009, TRENDS COGN SCI, V13, P505, DOI 10.1016/j.tics.2009.10.003; Mueller JL, 2010, COGNITIVE SCI, V34, P338, DOI 10.1111/j.1551-6709.2009.01093.x; Perruchet P, 2005, PSYCHON B REV, V12, P307, DOI 10.3758/BF03196377; Saffran J, 2008, COGNITION, V107, P479, DOI 10.1016/j.cognition.2007.10.010; Saffran JR, 2002, J MEM LANG, V47, P172, DOI 10.1006/jmla.2001.2839; Thomas M, 2002, LINGUIST REV, V19, P51, DOI 10.1515/tlir.19.1-2.51	15	14	15	0	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2011	14	8					947	948		10.1038/nn.2884	http://dx.doi.org/10.1038/nn.2884			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	797KC	21792190	Green Accepted			2022-12-28	WOS:000293123700004
J	Fancy, SPJ; Harrington, EP; Yuen, TJ; Silbereis, JC; Zhao, C; Baranzini, SE; Bruce, CC; Otero, JJ; Huang, EJ; Nusse, R; Franklin, RJM; Rowitch, DH				Fancy, Stephen P. J.; Harrington, Emily P.; Yuen, Tracy J.; Silbereis, John C.; Zhao, Chao; Baranzini, Sergio E.; Bruce, Charlotte C.; Otero, Jose J.; Huang, Eric J.; Nusse, Roel; Franklin, Robin J. M.; Rowitch, David H.			Axin2 as regulatory and therapeutic target in newborn brain injury and remyelination	NATURE NEUROSCIENCE			English	Article							WHITE-MATTER INJURY; BETA-CATENIN; MULTIPLE-SCLEROSIS; CNS REMYELINATION; FUNCTIONAL INTERACTION; NEGATIVE REGULATOR; SIGNALING PATHWAY; DIFFERENTIATION; TRANSCRIPTION; MYELINATION	Permanent damage to white matter tracts, comprising axons and myelinating oligodendrocytes, is an important component of brain injuries of the newborn that cause cerebral palsy and cognitive disabilities, as well as multiple sclerosis in adults. However, regulatory factors relevant in human developmental myelin disorders and in myelin regeneration are unclear. We found that AXIN2 was expressed in immature oligodendrocyte progenitor cells (OLPs) in white matter lesions of human newborns with neonatal hypoxic-ischemic and gliotic brain damage, as well as in active multiple sclerosis lesions in adults. Axin2 is a target of Wnt transcriptional activation that negatively feeds back on the pathway, promoting beta-catenin degradation. We found that Axin2 function was essential for normal kinetics of remyelination. The small molecule inhibitor XAV939, which targets the enzymatic activity of tankyrase, acted to stabilize Axin2 levels in OLPs from brain and spinal cord and accelerated their differentiation and myelination after hypoxic and demyelinating injury. Together, these findings indicate that Axin2 is an essential regulator of remyelination and that it might serve as a pharmacological checkpoint in this process.	[Fancy, Stephen P. J.; Harrington, Emily P.; Yuen, Tracy J.; Silbereis, John C.; Otero, Jose J.; Rowitch, David H.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; [Fancy, Stephen P. J.; Harrington, Emily P.; Yuen, Tracy J.; Silbereis, John C.; Otero, Jose J.; Rowitch, David H.] Univ Calif San Francisco, Dept Neurosurg, Eli & Edythe Broad Inst Stem Cell Res & Regenerat, San Francisco, CA USA; [Fancy, Stephen P. J.; Harrington, Emily P.; Yuen, Tracy J.; Silbereis, John C.; Otero, Jose J.; Rowitch, David H.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA USA; [Harrington, Emily P.] Univ Calif San Francisco, Med Scientist Training Program, San Francisco, CA 94143 USA; [Zhao, Chao; Bruce, Charlotte C.; Franklin, Robin J. M.] Univ Cambridge, MRC Ctr Stem Cell Biol & Regenerat Med, Cambridge, England; [Zhao, Chao; Bruce, Charlotte C.; Franklin, Robin J. M.] Univ Cambridge, Dept Vet Med, Cambridge, England; [Baranzini, Sergio E.] Univ Cambridge, Dept Neurol, Cambridge, England; [Otero, Jose J.; Huang, Eric J.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94140 USA; [Nusse, Roel] Stanford Univ, Dept Dev Biol, Stanford, CA 94305 USA; [Nusse, Roel] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Rowitch, David H.] Univ Calif San Francisco, Div Neonatol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Cambridge; University of Cambridge; University of Cambridge; University of California System; University of California San Francisco; Stanford University; Howard Hughes Medical Institute; Stanford University; University of California System; University of California San Francisco	Rowitch, DH (corresponding author), Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA.	rowitchd@peds.ucsf.edu	Huang, Eric J./AAH-7997-2019; Otero, Jose/AAI-4891-2020; Baranzini, Sergio/A-9422-2013; Otero, Jose Javier/B-8955-2013	Huang, Eric J./0000-0002-5381-3801; Otero, Jose/0000-0003-0680-4520; Baranzini, Sergio/0000-0003-0067-194X; Harrington, Emily P/0000-0001-6352-8687; Franklin, Robin/0000-0001-6522-2104; Rowitch, David/0000-0002-0079-0060; Yuen, Tracy/0000-0002-3451-9279	National Multiple Sclerosis Society; United Kingdom Multiple Sclerosis Society; US National Institutes of Health [NS040511, NS047572]; University of California, San Francisco; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS047572, R01NS040511] Funding Source: NIH RePORTER	National Multiple Sclerosis Society(National Multiple Sclerosis Society); United Kingdom Multiple Sclerosis Society; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California, San Francisco(University of California System); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank W. Birchmeier for Axin2-lacZ mice. This work was supported by a Promise 2010 grant from the National Multiple Sclerosis Society (to R.J.M.F. and D.H.R.), the United Kingdom Multiple Sclerosis Society (to R.J.M.F.), the US National Institutes of Health (NS040511 and NS047572 to D.H.R.) and the Medical Scientist Training Program at the University of California, San Francisco (to E.P.H.). S.E.B. is a Harry Weaver Neuroscience Scholar of the National Multiple Sclerosis Society. R.N. and D.H.R. are Howard Hughes Medical Institute Investigators.	Arnett HA, 2004, SCIENCE, V306, P2111, DOI 10.1126/science.1103709; Back SA, 2002, J NEUROSCI, V22, P455, DOI 10.1523/JNEUROSCI.22-02-00455.2002; Behrens J, 1998, SCIENCE, V280, P596, DOI 10.1126/science.280.5363.596; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Billiards SS, 2008, BRAIN PATHOL, V18, P153, DOI 10.1111/j.1750-3639.2007.00107.x; Birgbauer E, 2004, J NEUROSCI RES, V78, P157, DOI 10.1002/jnr.20248; Chang A, 2002, NEW ENGL J MED, V346, P165, DOI 10.1056/NEJMoa010994; Compston A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7; Dao DY, 2010, J ORTHOP RES, V28, P89, DOI 10.1002/jor.20954; Dessaud E, 2008, DEVELOPMENT, V135, P2489, DOI 10.1242/dev.009324; Duncan ID, 2009, P NATL ACAD SCI USA, V106, P6832, DOI 10.1073/pnas.0812500106; Emery B, 2009, CELL, V138, P172, DOI 10.1016/j.cell.2009.04.031; Fancy SPJ, 2009, GENE DEV, V23, P1571, DOI 10.1101/gad.1806309; Feigenson K, 2009, MOL CELL NEUROSCI, V42, P255, DOI 10.1016/j.mcn.2009.07.010; Franklin RJM, 2008, NAT REV NEUROSCI, V9, P839, DOI 10.1038/nrn2480; Harada N, 1999, EMBO J, V18, P5931, DOI 10.1093/emboj/18.21.5931; Harrington EP, 2010, ANN NEUROL, V68, P703, DOI 10.1002/ana.22090; Huang JK, 2011, NAT NEUROSCI, V14, P45, DOI 10.1038/nn.2702; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Ikeda S, 1998, EMBO J, V17, P1371, DOI 10.1093/emboj/17.5.1371; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Karadottir R, 2005, NATURE, V438, P1162, DOI 10.1038/nature04302; Khwaja O, 2008, ARCH DIS CHILD-FETAL, V93, pF153, DOI 10.1136/adc.2006.108837; Kotter MR, 2006, J NEUROSCI, V26, P328, DOI 10.1523/JNEUROSCI.2615-05.2006; Kuhlmann T, 2008, BRAIN, V131, P1749, DOI 10.1093/brain/awn096; Lock C, 2002, NAT MED, V8, P500, DOI 10.1038/nm0502-500; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; Mi S, 2005, NAT NEUROSCI, V8, P745, DOI 10.1038/nn1460; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; Schuller U, 2008, CANCER CELL, V14, P123, DOI 10.1016/j.ccr.2008.07.005; Segovia KN, 2008, ANN NEUROL, V63, P520, DOI 10.1002/ana.21359; Silbereis JC, 2010, DIS MODEL MECH, V3, P678, DOI 10.1242/dmm.002915; Watkins TA, 2008, NEURON, V60, P555, DOI 10.1016/j.neuron.2008.09.011; Woodward LJ, 2006, NEW ENGL J MED, V355, P685, DOI 10.1056/NEJMoa053792; Ye F, 2009, NAT NEUROSCI, V12, P829, DOI 10.1038/nn.2333; Zeng YA, 2010, CELL STEM CELL, V6, P568, DOI 10.1016/j.stem.2010.03.020; Zhang Y, 2009, P NATL ACAD SCI USA, V106, P19162, DOI 10.1073/pnas.0902834106	37	255	271	1	44	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2011	14	8					1009	U99		10.1038/nn.2855	http://dx.doi.org/10.1038/nn.2855			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	797KC	21706018	Green Submitted, Green Accepted			2022-12-28	WOS:000293123700014
J	Parsons, RG; Davis, M				Parsons, Ryan G.; Davis, Michael			Temporary disruption of fear-potentiated startle following PKM zeta inhibition in the amygdala	NATURE NEUROSCIENCE			English	Article							MEMORY; MAINTENANCE; STORAGE; RATS; LTP	We examined whether protein kinase M zeta (PKM zeta) inhibition in the amygdala permanently disrupts fear memory by testing retention at various intervals after PKM zeta blockade. Although the expression of fear memory was disrupted when the inhibitor was applied shortly before testing, it had no effect when rats were tested with longer retention intervals. These results suggest that PKM zeta inhibition does not erase memory, but temporarily disrupts expression of memory.	[Parsons, Ryan G.; Davis, Michael] Emory Univ, Dept Psychiat & Behav Sci, Atlanta, GA 30322 USA	Emory University	Parsons, RG (corresponding author), Emory Univ, Dept Psychiat & Behav Sci, Atlanta, GA 30322 USA.	rparso3@emory.edu		Parsons, Ryan/0000-0001-8136-9413	US National Institutes of Health [R37 MH047840, F32 MH090700]; Center for Behavioral Neuroscience (National Science Foundation) [IBN-987675]; US National Institutes of Health/National Center for Research Resources [P51RR000165]; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000165] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH047840, R37MH047840, F32MH090700] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Behavioral Neuroscience (National Science Foundation)(National Science Foundation (NSF)); US National Institutes of Health/National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank G. Gafford for comments on the manuscript. This research was supported by grants R37 MH047840 (to M. D.) and F32 MH090700 (to R. G. P.) from the US National Institutes of Health. Support was also provided by the Center for Behavioral Neuroscience (National Science Foundation agreement IBN-987675) and by an US National Institutes of Health/National Center for Research Resources base grant (P51RR000165) to Yerkes National Primate Research Center.	Estes WK, 1997, PSYCHOL REV, V104, P148, DOI 10.1037/0033-295X.104.1.148; Gale GD, 2004, J NEUROSCI, V24, P3810, DOI 10.1523/JNEUROSCI.4100-03.2004; Jones SV, 2005, BEHAV NEUROSCI, V119, P329, DOI 10.1037/0735-7044.119.1.329; Kwapis JL, 2009, BEHAV NEUROSCI, V123, P844, DOI 10.1037/a0016343; Ling DSF, 2002, NAT NEUROSCI, V5, P295, DOI 10.1038/nn829; Migues PV, 2010, NAT NEUROSCI, V13, P630, DOI 10.1038/nn.2531; Paschall GY, 2002, BEHAV NEUROSCI, V116, P4, DOI 10.1037//0735-7044.116.1.4; Pastalkova E, 2006, SCIENCE, V313, P1141, DOI 10.1126/science.1128657; Sacco T, 2010, SCIENCE, V329, P649, DOI 10.1126/science.1183165; SACKTOR TC, 1993, P NATL ACAD SCI USA, V90, P8342, DOI 10.1073/pnas.90.18.8342; Serrano P, 2008, PLOS BIOL, V6, P2698, DOI 10.1371/journal.pbio.0060318; Shema R, 2007, SCIENCE, V317, P951, DOI 10.1126/science.1144334; Sossin WS, 2008, TRENDS NEUROSCI, V31, P170, DOI 10.1016/j.tins.2008.01.001; Stafford JM, 2009, LEARN MEMORY, V16, P494, DOI 10.1101/lm.1452209	14	48	49	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2011	14	3					295	296		10.1038/nn.2745	http://dx.doi.org/10.1038/nn.2745			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	725MW	21258326	Green Accepted			2022-12-28	WOS:000287650100007
J	Agetsuma, M; Aizawa, H; Aoki, T; Nakayama, R; Takahoko, M; Goto, M; Sassa, T; Amo, R; Shiraki, T; Kawakami, K; Hosoya, T; Higashijima, S; Okamoto, H				Agetsuma, Masakazu; Aizawa, Hidenori; Aoki, Tazu; Nakayama, Ryoko; Takahoko, Mikako; Goto, Midori; Sassa, Takayuki; Amo, Ryunosuke; Shiraki, Toshiyuki; Kawakami, Koichi; Hosoya, Toshihiko; Higashijima, Shin-ichi; Okamoto, Hitoshi			The habenula is crucial for experience-dependent modification of fear responses in zebrafish	NATURE NEUROSCIENCE			English	Article							NUCLEUS; CONNECTIONS; EXPRESSION	The zebrafish dorsal habenula (dHb) shows conspicuous asymmetry in its connection with the interpeduncular nucleus (IPN) and is equivalent to the mammalian medial habenula. Genetic inactivation of the lateral subnucleus of dHb (dHbL) biased fish towards freezing rather than the normal flight response to a conditioned fear stimulus, suggesting that the dHbL-IPN pathway is important for controlling experience-dependent modification of fear responses.	[Nakayama, Ryoko; Takahoko, Mikako; Shiraki, Toshiyuki] RIKEN Brain Sci Inst, Res Resource Ctr, Wako, Saitama, Japan; [Amo, Ryunosuke] Waseda Univ, Grad Sch Adv Sci & Engn, Dept Life Sci & Med Biosci, Shinjuku Ku, Tokyo, Japan; [Kawakami, Koichi] Natl Inst Genet, Div Mol & Dev Biol, Shizuoka, Japan; [Kawakami, Koichi] Grad Univ Adv Studies, Dept Genet, Shizuoka, Japan; [Higashijima, Shin-ichi] Natl Inst Physiol Sci, Okazaki Inst Integrat Biosci, Natl Inst Nat Sci, Aichi, Japan; [Okamoto, Hitoshi] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Chiyoda Ku, Tokyo, Japan	RIKEN; Waseda University; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Graduate University for Advanced Studies - Japan; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Okazaki Institute for Integrative Bioscience (OIIB); Japan Science & Technology Agency (JST)	Okamoto, H (corresponding author), RIKEN Brain Sci Inst, Res Resource Ctr, Wako, Saitama, Japan.	hitoshi@brain.riken.jp	Aoki, Tazu/F-5051-2011; Agetsuma, Masakazu/AAD-1654-2019; Hosoya, Toshihiko/Q-2514-2018; Kawakami, Koichi/AAF-1380-2019; Okamoto, Hitoshi/P-9767-2015; SASSA, Takayuki/B-2519-2012	Agetsuma, Masakazu/0000-0002-8606-4886; Hosoya, Toshihiko/0000-0001-8559-8344; Okamoto, Hitoshi/0000-0002-7512-8549; SASSA, Takayuki/0000-0003-3145-9829; Higashijima, Shin-ichi/0000-0001-6350-4992; Aizawa, Hidenori/0000-0002-2896-1298; Amo, Ryunosuke/0000-0001-8644-2296	Ministry of Education, Culture, Sports, Science and Technology of Japan; Core Research for Evolutional Science and Technology of Japan Science and Technology Agency; Okamoto laboratory	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Core Research for Evolutional Science and Technology of Japan Science and Technology Agency(Core Research for Evolutional Science and Technology (CREST)); Okamoto laboratory	We thank Y. Yoshihara, T. Koide and other members of the Yoshihara laboratory for transgenic fish and advice on the behavioral experiments, S. Watanabe for help in setting up the behavioral experiments, N. Copeland for the BAC homologous recombination system, S. Fraser for GAL4VP16 and UAS plasmids, M. Parsons for the UAS:nfsB-mCherry plasmid, A. Thomson for correction of the manuscript and S. Jesuthasan for communication of unpublished data. We are grateful to all of the members of the Okamoto laboratory for support and advice, the Research Resource Center of RIKEN BSI for animal care and the National BioResource Project of Japan for fish strains. This work was supported by Grant-in-Aids from the Ministry of Education, Culture, Sports, Science and Technology of Japan to H.O. and H. A. and by the Core Research for Evolutional Science and Technology of Japan Science and Technology Agency to H.O.	Aizawa H, 2005, CURR BIOL, V15, P238, DOI 10.1016/j.cub.2005.01.014; Amo R, 2010, J NEUROSCI, V30, P1566, DOI 10.1523/JNEUROSCI.3690-09.2010; Bandler R, 2000, BRAIN RES BULL, V53, P95, DOI 10.1016/S0361-9230(00)00313-0; Bianco IH, 2009, PHILOS T R SOC B, V364, P1005, DOI 10.1098/rstb.2008.0213; Curado S, 2007, DEV DYNAM, V236, P1025, DOI 10.1002/dvdy.21100; Eisenberg M, 2003, SCIENCE, V301, P1102, DOI 10.1126/science.1086881; Goto M, 2001, J COMP NEUROL, V438, P86, DOI 10.1002/cne.1303; HERKENHAM M, 1979, J COMP NEUROL, V187, P19, DOI 10.1002/cne.901870103; Hikosaka O, 2010, NAT REV NEUROSCI, V11, P503, DOI 10.1038/nrn2866; Maier SF, 2005, NEUROSCI BIOBEHAV R, V29, P829, DOI 10.1016/j.neubiorev.2005.03.021; Mongeau R, 2003, J NEUROSCI, V23, P3855; Ressler KJ, 2002, J NEUROSCI, V22, P7892; Reti IM, 2002, J NEUROCHEM, V82, P935, DOI 10.1046/j.1471-4159.2002.01051.x; SWEENEY ST, 1995, NEURON, V14, P341, DOI 10.1016/0896-6273(95)90290-2; Wullimann MF, 1996, NEUROANATOMY ZEBRAFI, DOI 10.1007/978-3-0348-8979-7_6	15	249	253	3	48	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2010	13	11					1354	1356		10.1038/nn.2654	http://dx.doi.org/10.1038/nn.2654			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	673KI	20935642				2022-12-28	WOS:000283658200015
J	Chang, EF; Rieger, JW; Johnson, K; Berger, MS; Barbaro, NM; Knight, RT				Chang, Edward F.; Rieger, Jochem W.; Johnson, Keith; Berger, Mitchel S.; Barbaro, Nicholas M.; Knight, Robert T.			Categorical speech representation in human superior temporal gyrus	NATURE NEUROSCIENCE			English	Article							PERCEPTUAL MAGNET; AUDITORY-CORTEX; LOBE; ACTIVATION; NONSPEECH; LANGUAGE; SOUNDS; CONSONANTS	Speech perception requires the rapid and effortless extraction of meaningful phonetic information from a highly variable acoustic signal. A powerful example of this phenomenon is categorical speech perception, in which a continuum of acoustically varying sounds is transformed into perceptually distinct phoneme categories. We found that the neural representation of speech sounds is categorically organized in the human posterior superior temporal gyrus. Using intracranial high-density cortical surface arrays, we found that listening to synthesized speech stimuli varying in small and acoustically equal steps evoked distinct and invariant cortical population response patterns that were organized by their sensitivities to critical acoustic features. Phonetic category boundaries were similar between neurometric and psychometric functions. Although speech-sound responses were distributed, spatially discrete cortical loci were found to underlie specific phonetic discrimination. Our results provide direct evidence for acoustic-to-higher order phonetic level encoding of speech sounds in human language receptive cortex.	[Chang, Edward F.; Berger, Mitchel S.; Barbaro, Nicholas M.; Knight, Robert T.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA; [Chang, Edward F.; Rieger, Jochem W.; Knight, Robert T.] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; [Rieger, Jochem W.] Otto Von Guericke Univ, Dept Neurol, Magdeburg, Germany; [Johnson, Keith] Univ Calif Berkeley, Dept Linguist, Berkeley, CA 94720 USA; [Knight, Robert T.] Univ Calif Berkeley, Dept Psychol, Berkeley, CA 94720 USA	University of California System; University of California San Francisco; University of California System; University of California Berkeley; Otto von Guericke University; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Chang, EF (corresponding author), Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA.	changed@neurosurg.ucsf.edu; jochem.rieger@med.ovgu.de	Johnson, Keith/AAM-6322-2020	Johnson, Keith/0000-0002-2569-8121; Rieger, Jochem/0000-0003-0955-2306	US National Institutes of Health [NS21135, PO4813, F32NS061552, K99NS065120, FKZ-MK48-2009/003, RI1511/1-3]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K99NS065120, R01NS021135, R00NS065120, F32NS061552] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are grateful to the four individuals who participated in this experiment and to A. Flinker for help with data acquisition. This research was supported by US National Institutes of Health grants NS21135 (R. T. K.), PO4813 (R. T. K.), F32NS061552 (E. F. C.), K99NS065120 (E. F. C.), FKZ-MK48-2009/003 (J.W.R.) and RI1511/1-3 (J.W.R.).	Benson RR, 2006, NEUROIMAGE, V31, P342, DOI 10.1016/j.neuroimage.2005.11.029; Binder JR, 2000, CEREB CORTEX, V10, P512, DOI 10.1093/cercor/10.5.512; BLUMSTEIN SE, 1980, J ACOUST SOC AM, V67, P648, DOI 10.1121/1.383890; Blumstein SE, 2005, J COGNITIVE NEUROSCI, V17, P1353, DOI 10.1162/0898929054985473; BOATMAN D, 1995, BRAIN LANG, V51, P269, DOI 10.1006/brln.1995.1061; CREUTZFELDT O, 1989, EXP BRAIN RES, V77, P451, DOI 10.1007/BF00249600; Crone NE, 2001, CLIN NEUROPHYSIOL, V112, P565, DOI 10.1016/S1388-2457(00)00545-9; Desai R, 2008, J COGNITIVE NEUROSCI, V20, P1174, DOI 10.1162/jocn.2008.20081; Diehl RL, 2004, ANNU REV PSYCHOL, V55, P149, DOI 10.1146/annurev.psych.55.090902.142028; Edwards E, 2010, NEUROIMAGE, V50, P291, DOI 10.1016/j.neuroimage.2009.12.035; HAGLUND MM, 1994, NEUROSURGERY, V34, P567, DOI 10.1227/00006123-199404000-00001; Harnad Stevan, 1987, CATEGORICAL PERCEPTI; Hickok G, 2004, COGNITION, V92, P67, DOI 10.1016/j.cognition.2003.10.011; Howard MA, 2000, J COMP NEUROL, V416, P79, DOI 10.1002/(SICI)1096-9861(20000103)416:1<79::AID-CNE6>3.0.CO;2-2; IVERSON P, 1995, J ACOUST SOC AM, V97, P553, DOI 10.1121/1.412280; Iverson P, 2000, PERCEPT PSYCHOPHYS, V62, P874, DOI 10.3758/BF03206929; Jancke L, 2002, NEUROIMAGE, V15, P733, DOI 10.1006/nimg.2001.1027; Koh KM, 2007, J MACH LEARN RES, V8, P1519; Kruskal J, 1978, MULTIDIMENSIONAL SCA; Liberman AM, 2000, TRENDS COGN SCI, V4, P187, DOI 10.1016/S1364-6613(00)01471-6; LIBERMAN AM, 1957, J EXP PSYCHOL, V54, P358, DOI 10.1037/h0044417; LIBERMAN AM, 1989, SCIENCE, V243, P489, DOI 10.1126/science.2643163; LIBERMAN AM, 1967, PSYCHOL REV, V74, P431, DOI 10.1037/h0020279; Liebenthal E, 2005, CEREB CORTEX, V15, P1621, DOI 10.1093/cercor/bhi040; MERZENICH MM, 1973, BRAIN RES, V50, P275, DOI 10.1016/0006-8993(73)90731-2; MILLER GA, 1955, J ACOUST SOC AM, V27, P338, DOI 10.1121/1.1907526; Penfield W, 1954, EPILEPSY FUNCTIONAL; Perkell J.S., 1986, INVARIANCE VARIABILI; Raizada RDS, 2007, NEURON, V56, P726, DOI 10.1016/j.neuron.2007.11.001; Scott SK, 2004, COGNITION, V92, P13, DOI 10.1016/j.cognition.2002.12.002; SHEPARD RN, 1980, SCIENCE, V210, P390, DOI 10.1126/science.210.4468.390; Uppenkamp S, 2006, NEUROIMAGE, V31, P1284, DOI 10.1016/j.neuroimage.2006.01.004; Vihman M. M., 1996, PHONOLOGICAL DEV ORI; Vouloumanos A, 2001, J COGNITIVE NEUROSCI, V13, P994, DOI 10.1162/089892901753165890; Whalen DH, 2006, J ACOUST SOC AM, V119, P575, DOI 10.1121/1.2139627	35	346	353	4	58	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2010	13	11					1428	U169		10.1038/nn.2641	http://dx.doi.org/10.1038/nn.2641			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	673KI	20890293	Green Accepted, Green Submitted			2022-12-28	WOS:000283658200025
J	Oviedo, HV; Bureau, I; Svoboda, K; Zador, AM				Oviedo, Hysell V.; Bureau, Ingrid; Svoboda, Karel; Zador, Anthony M.			The functional asymmetry of auditory cortex is reflected in the organization of local cortical circuits	NATURE NEUROSCIENCE			English	Article							IN-VIVO; SPECTRAL INTEGRATION; RECEPTIVE-FIELDS; VISUAL-CORTEX; NEURONS; MOUSE; LAMINAR; ARCHITECTURE; CONNECTIONS; PROJECTIONS	The primary auditory cortex (A1) is organized tonotopically, with neurons sensitive to high and low frequencies arranged in a rostro-caudal gradient. We used laser scanning photostimulation in acute slices to study the organization of local excitatory connections onto layers 2 and 3 (L2/3) of the mouse A1. Consistent with the organization of other cortical regions, synaptic inputs along the isofrequency axis (orthogonal to the tonotopic axis) arose predominantly within a column. By contrast, we found that local connections along the tonotopic axis differed from those along the isofrequency axis: some input pathways to L3 (but not L2) arose predominantly out-of-column. In vivo cell-attached recordings revealed differences between the sound-responsiveness of neurons in L2 and L3. Our results are consistent with the hypothesis that auditory cortical microcircuitry is specialized to the one-dimensional representation of frequency in the auditory cortex.	[Oviedo, Hysell V.; Zador, Anthony M.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Bureau, Ingrid] Inst Neurobiol Mediterranee, INSERM, U901, Marseille, France; [Svoboda, Karel] Howard Hughes Med Inst, Ashburn, VA USA	Cold Spring Harbor Laboratory; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Howard Hughes Medical Institute	Zador, AM (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	zador@cshl.edu	; Bureau, Ingrid/O-3941-2016	Zador, Anthony/0000-0002-8431-9136; Bureau, Ingrid/0000-0001-9166-2250	US National Institutes of Health; Patterson Foundation; Swartz Foundation; Autism Speaks; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005415] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Patterson Foundation; Swartz Foundation; Autism Speaks; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank B. Burbach for invaluable technical help, S. Joshi for invaluable input on juxtacellular labeling, N. Gray, G. Otazu and T. Hackett for discussions, and W. Bair (Department of Physiology, Anatomy and Genetics, University of Oxford) for spike detection software. This work was supported by grants from the US National Institutes of Health, the Patterson Foundation (H.V.O.) the Swartz Foundation and Autism Speaks.	Anderson LA, 2009, BRAIN RES, V1252, P130, DOI 10.1016/j.brainres.2008.11.037; ARMSTRONGJAMES M, 1992, J NEUROPHYSIOL, V68, P1345, DOI 10.1152/jn.1992.68.4.1345; Bandyopadhyay S, 2010, NAT NEUROSCI, V13, P361, DOI 10.1038/nn.2490; Bar-Yosef O, 2002, J NEUROSCI, V22, P8619; Barbour DL, 2008, J NEUROSCI, V28, P11174, DOI 10.1523/JNEUROSCI.2093-08.2008; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Bureau I, 2006, PLOS BIOL, V4, P2361, DOI 10.1371/journal.pbio.0040382; CALLAWAY EM, 1993, P NATL ACAD SCI USA, V90, P7661, DOI 10.1073/pnas.90.16.7661; Chechik G, 2006, NEURON, V51, P359, DOI 10.1016/j.neuron.2006.06.030; Cruikshank SJ, 2002, J NEUROPHYSIOL, V87, P361, DOI 10.1152/jn.00549.2001; Dantzker JL, 2000, NAT NEUROSCI, V3, P701, DOI 10.1038/76656; DeWeese MR, 2003, J NEUROSCI, V23, P7940; Douglas RJ, 2004, ANNU REV NEUROSCI, V27, P419, DOI 10.1146/annurev.neuro.27.070203.144152; GAMES KD, 1988, HEARING RES, V34, P1, DOI 10.1016/0378-5955(88)90047-0; Hromadka T, 2008, PLOS BIOL, V6, P124, DOI 10.1371/journal.pbio.0060016; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; IMIG TJ, 1978, J COMP NEUROL, V182, P637, DOI 10.1002/cne.901820406; Joshi S, 2006, J NEUROSCI METH, V156, P37, DOI 10.1016/j.jneumeth.2006.02.004; Kaur S, 2005, NEUROSCIENCE, V134, P1033, DOI 10.1016/j.neuroscience.2005.04.052; Kimura A, 2003, NEUROSCIENCE, V117, P1003, DOI 10.1016/S0306-4522(02)00949-1; Koulakov AA, 2001, NEURON, V29, P519, DOI 10.1016/S0896-6273(01)00223-9; KOWALSKI N, 1995, J NEUROPHYSIOL, V73, P1513, DOI 10.1152/jn.1995.73.4.1513; Lefort S, 2009, NEURON, V61, P301, DOI 10.1016/j.neuron.2008.12.020; Lima SQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006099; Linden JF, 2003, J NEUROPHYSIOL, V90, P2660, DOI 10.1152/jn.00751.2002; MATSUBARA JA, 1988, J COMP NEUROL, V268, P38, DOI 10.1002/cne.902680105; Metherate R, 2005, HEARING RES, V206, P146, DOI 10.1016/j.heares.2005.01.014; Nelken I, 2008, CURR OPIN NEUROBIOL, V18, P413, DOI 10.1016/j.conb.2008.08.014; Ohki K, 2005, NATURE, V433, P597, DOI 10.1038/nature03274; Pinault D, 1996, J NEUROSCI METH, V65, P113, DOI 10.1016/0165-0270(95)00144-1; Read HL, 2002, CURR OPIN NEUROBIOL, V12, P433, DOI 10.1016/S0959-4388(02)00342-2; ROCKLAND KS, 1982, SCIENCE, V215, P1532, DOI 10.1126/science.7063863; Rothschild G, 2010, NAT NEUROSCI, V13, P353, DOI 10.1038/nn.2484; Shepherd GMG, 2005, J NEUROSCI, V25, P5670, DOI 10.1523/JNEUROSCI.1173-05.2005; Shepherd GMG, 2003, NEURON, V38, P277, DOI 10.1016/S0896-6273(03)00152-1; Smith PH, 2001, J COMP NEUROL, V436, P508, DOI 10.1002/cne.1084; Stiebler I, 1997, J COMP PHYSIOL A, V181, P559, DOI 10.1007/s003590050140; TSO DY, 1986, J NEUROSCI, V6, P1160; Van Hooser SD, 2005, J NEUROSCI, V25, P19, DOI 10.1523/JNEUROSCI.4042-04.2005; Van Hooser SD, 2006, J NEUROSCI, V26, P7680, DOI 10.1523/JNEUROSCI.0108-06.2006; Velenovsky DS, 2003, J NEUROSCI, V23, P308; Weiler N, 2008, NAT NEUROSCI, V11, P360, DOI 10.1038/nn2049; Yoshimura Y, 2005, NATURE, V433, P868, DOI 10.1038/nature03252	43	77	77	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2010	13	11					1413	U154		10.1038/nn.2659	http://dx.doi.org/10.1038/nn.2659			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	673KI	20953193	Green Accepted			2022-12-28	WOS:000283658200023
J	Dieterich, DC; Hodas, JJL; Gouzer, G; Shadrin, IY; Ngo, JT; Triller, A; Tirrell, DA; Schuman, EM				Dieterich, Daniela C.; Hodas, Jennifer J. L.; Gouzer, Geraldine; Shadrin, Ilya Y.; Ngo, John T.; Triller, Antoine; Tirrell, David A.; Schuman, Erin M.			In situ visualization and dynamics of newly synthesized proteins in rat hippocampal neurons	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; MAMMALIAN-CELLS; TRANSLATION MACHINERY; SYNAPTIC PLASTICITY; TETANIC STIMULATION; LATE-PHASE; KINASE-II; MEMBRANE; MEMORY; IDENTIFICATION	Protein translation has been implicated in different forms of synaptic plasticity, but direct in situ visualization of new proteins is limited to one or two proteins at a time. Here we describe a metabolic labeling approach based on incorporation of noncanonical amino acids into proteins followed by chemoselective fluorescence tagging by means of 'click chemistry'. After a brief incubation with azidohomoalanine or homopropargylglycine, a robust fluorescent signal was detected in somata and dendrites. Pulse-chase application of azidohomoalanine and homopropargylglycine allowed visualization of proteins synthesized in two sequential time periods. This technique can be used to detect changes in protein synthesis and to evaluate the fate of proteins synthesized in different cellular compartments. Moreover, using strain-promoted cycloaddition, we explored the dynamics of newly synthesized membrane proteins using single-particle tracking and quantum dots. The newly synthesized proteins showed a broad range of diffusive behaviors, as would be expected for a pool of labeled proteins that is heterogeneous.	[Dieterich, Daniela C.; Hodas, Jennifer J. L.; Shadrin, Ilya Y.; Schuman, Erin M.] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Dieterich, Daniela C.] Leibniz Inst Neurobiol, Magdeburg, Germany; [Gouzer, Geraldine; Triller, Antoine] Ecole Normale Super, CNRS, INSERM, Inst Biol,U1024,UMR8197, Paris, France; [Ngo, John T.; Tirrell, David A.] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA; [Schuman, Erin M.] Max Planck Inst Brain Res, D-60528 Frankfurt, Germany	California Institute of Technology; Leibniz Institut fur Neurobiologie (LIN); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); California Institute of Technology; Max Planck Society	Schuman, EM (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	schumane@brain.mpg.de	Schuman, Erin M/D-6204-2011	Gouzer, Geraldine/0000-0002-4578-6567; Dieterich, Daniela C./0000-0002-9880-1214; Ngo, John/0000-0003-3508-1915; TRILLER, Antoine/0000-0002-7530-1233; Shadrin, Ilya/0000-0002-4501-0400	German Academy for Natural Scientists Leopoldina; US National Institutes of Health; Howard Hughes Medical Institute; Ministere de l'Enseignement Superieur et de la Recherche; Nationale de la Recherche MorphoSynDiff-INSERM; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062523] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA020589] Funding Source: NIH RePORTER	German Academy for Natural Scientists Leopoldina; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Ministere de l'Enseignement Superieur et de la Recherche; Nationale de la Recherche MorphoSynDiff-INSERM; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank L. Chen for making beautiful cultured hippocampal neurons. We thank A.J. Link for discussions and help with the tag syntheses. We are grateful to O. Kobler for help with Imaris software. We are extremely grateful to both C. Bertozzi and J. Baskin for providing the difluorinated cyclooctyne-biotin and advising on its use. This work was supported by the German Academy for Natural Scientists Leopoldina (D.C.D.), the US National Institutes of Health (E.M.S. and D.A.T.), the Howard Hughes Medical Institute (E.M.S.), the Ministere de l'Enseignement Superieur et de la Recherche (G.G.) and the Nationale de la Recherche MorphoSynDiff-INSERM (A.T.).	Aakalu G, 2001, NEURON, V30, P489, DOI 10.1016/S0896-6273(01)00295-1; Agard NJ, 2004, J AM CHEM SOC, V126, P15046, DOI 10.1021/ja044996f; AGRANOFF BW, 1964, SCIENCE, V146, P952, DOI 10.1126/science.146.3646.952; Alcor D, 2009, EUR J NEUROSCI, V30, P987, DOI 10.1111/j.1460-9568.2009.06927.x; Bannai H, 2006, NAT PROTOC, V1, P2628, DOI 10.1038/nprot.2006.429; Baskin JM, 2007, P NATL ACAD SCI USA, V104, P16793, DOI 10.1073/pnas.0707090104; Beatty KE, 2008, BIOORG MED CHEM LETT, V18, P5995, DOI 10.1016/j.bmcl.2008.08.046; Beatty KE, 2006, ANGEW CHEM INT EDIT, V45, P7364, DOI 10.1002/anie.200602114; Bito H, 1996, CELL, V87, P1203, DOI 10.1016/S0092-8674(00)81816-4; Casadio A, 1999, CELL, V99, P221, DOI 10.1016/S0092-8674(00)81653-0; Dahan M, 2003, SCIENCE, V302, P442, DOI 10.1126/science.1088525; Dieterich DC, 2007, NAT PROTOC, V2, P532, DOI 10.1038/nprot.2007.52; Dieterich DC, 2006, P NATL ACAD SCI USA, V103, P9482, DOI 10.1073/pnas.0601637103; FLEXNER JB, 1963, SCIENCE, V141, P57, DOI 10.1126/science.141.3575.57; Frey U, 1997, NATURE, V385, P533, DOI 10.1038/385533a0; Gogolla N, 2006, NAT PROTOC, V1, P1223, DOI 10.1038/nprot.2006.169; Huang T, 2006, EUR J CELL BIOL, V85, P635, DOI 10.1016/j.ejcb.2006.02.005; Kang HJ, 1996, SCIENCE, V273, P1402, DOI 10.1126/science.273.5280.1402; Kiick KL, 2002, P NATL ACAD SCI USA, V99, P19, DOI 10.1073/pnas.012583299; Lewin GR, 1996, ANNU REV NEUROSCI, V19, P289, DOI 10.1146/annurev.ne.19.030196.001445; Liao L, 2007, J PROTEOME RES, V6, P1059, DOI 10.1021/pr060358f; Lin MZ, 2008, P NATL ACAD SCI USA, V105, P7744, DOI 10.1073/pnas.0803060105; Link AJ, 2003, CURR OPIN BIOTECH, V14, P603, DOI 10.1016/j.copbio.2003.10.011; Link AJ, 2003, J AM CHEM SOC, V125, P11164, DOI 10.1021/ja036765z; Macchi P, 2003, MOL BIOL CELL, V14, P1570, DOI 10.1091/mbc.E02-08-0505; Manadas B, 2009, J PROTEOME RES, V8, P4536, DOI 10.1021/pr900366x; Martin KC, 1997, CELL, V91, P927, DOI 10.1016/S0092-8674(00)80484-5; NGUYEN PV, 1994, SCIENCE, V265, P1104, DOI 10.1126/science.8066450; Ouyang Y, 1997, J NEUROSCI, V17, P5416; Ouyang Y, 1999, J NEUROSCI, V19, P7823; RENNER M, 2005, NEURON IN PRESS; Renner M, 2009, J NEUROSCI, V29, P2926, DOI 10.1523/JNEUROSCI.4445-08.2009; Renner M, 2008, CURR OPIN NEUROBIOL, V18, P532, DOI 10.1016/j.conb.2008.09.009; Renner ML, 2009, NEUROPHARMACOLOGY, V56, P30, DOI 10.1016/j.neuropharm.2008.07.022; Rostovtsev VV, 2002, ANGEW CHEM INT EDIT, V41, P2596, DOI 10.1002/1521-3773(20020715)41:14<2596::AID-ANIE2596>3.0.CO;2-4; Sajikumar S, 2007, J NEUROSCI, V27, P5068, DOI 10.1523/JNEUROSCI.4940-06.2007; Serge A, 2002, J NEUROSCI, V22, P3910, DOI 10.1523/JNEUROSCI.22-10-03910.2002; Steward O, 1997, NEURON, V18, P9, DOI 10.1016/S0896-6273(01)80041-6; Sutton MA, 2006, CELL, V127, P49, DOI 10.1016/j.cell.2006.09.014; Takei N, 2004, J NEUROSCI, V24, P9760, DOI 10.1523/JNEUROSCI.1427-04.2004; Taylor AM, 2010, NEURON, V66, P57, DOI 10.1016/j.neuron.2010.03.022; Villareal G, 2007, CURR BIOL, V17, P2073, DOI 10.1016/j.cub.2007.10.053; Wang DO, 2009, SCIENCE, V324, P1536, DOI 10.1126/science.1173205; Wang Q, 2003, J AM CHEM SOC, V125, P3192, DOI 10.1021/ja021381e; Waung MW, 2008, NEURON, V59, P84, DOI 10.1016/j.neuron.2008.05.014; WEILER IJ, 1994, PROG BRAIN RES, V100, P189; WHITAKER JE, 1992, ANAL BIOCHEM, V207, P267, DOI 10.1016/0003-2697(92)90011-U; Zhang ZW, 2003, BIOCHEMISTRY-US, V42, P6735, DOI 10.1021/bi0300231	48	302	309	5	76	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2010	13	7					897	U149		10.1038/nn.2580	http://dx.doi.org/10.1038/nn.2580			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	615YF	20543841	Green Accepted			2022-12-28	WOS:000279173900024
J	Wong, E; Cuervo, AM				Wong, Esther; Cuervo, Ana Maria			Autophagy gone awry in neurodegenerative diseases	NATURE NEUROSCIENCE			English	Review							CHAPERONE-MEDIATED AUTOPHAGY; AGGREGATE-PRONE PROTEINS; ALPHA-SYNUCLEIN; CELL-DEATH; REGULATES AUTOPHAGY; SIGNALING PATHWAYS; MUTANT HUNTINGTIN; ALZHEIMER-DISEASE; UP-REGULATION; C MICE	Autophagy is essential for neuronal homeostasis, and its dysfunction has been directly linked to a growing number of neurodegenerative disorders. The reasons behind autophagic failure in degenerating neurons can be very diverse because of the different steps required for autophagy and the characterization of the molecular players involved in each of them. Understanding the step(s) affected in the autophagic process in each disorder could explain differences in the course of these pathologies and will be essential to developing targeted therapeutic approaches for each disease based on modulation of autophagy. Here we present examples of different types of autophagic dysfunction described in common neurodegenerative disorders and discuss the prospect of exploring some of the recently identified autophagic variants and the interactions among autophagic and non-autophagic proteolytic systems as possible future therapeutic targets.	[Cuervo, Ana Maria] Albert Einstein Coll Med, Marion Bessin Liver Res Ctr, Dept Dev & Mol Biol, Bronx, NY 10467 USA; Albert Einstein Coll Med, Inst Aging Studies, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Cuervo, AM (corresponding author), Albert Einstein Coll Med, Marion Bessin Liver Res Ctr, Dept Dev & Mol Biol, Bronx, NY 10467 USA.	ana-maria.cuervo@einstein.yu.edu	Wong, Esther/E-1344-2011	Wong, Esther/0000-0003-2421-7346; Cuervo, Ana Maria/0000-0002-0771-700X	US National Institutes of Health, National Institute on Aging [AG021904, AG031782]; National Institute of Diabetes and Digestive and Kidney Diseases [DK041918]; National Institute of Neurological Disorders and Stroke [NS038370]; Glenn Foundation; Hirsch/Weill-Caulier Career Scientist Award; Hereditary Disease Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK041918] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS038370] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG021904, R01AG021904, P01AG031782] Funding Source: NIH RePORTER	US National Institutes of Health, National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Glenn Foundation; Hirsch/Weill-Caulier Career Scientist Award; Hereditary Disease Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank the numerous colleagues in the field of autophagy who through their animated discussions have helped shape this review and S. Kaushik and S. Orenstein for critically reading the manuscript. Work in our laboratory is supported by US National Institutes of Health grants from the National Institute on Aging (AG021904, AG031782), the National Institute of Diabetes and Digestive and Kidney Diseases (DK041918), the National Institute of Neurological Disorders and Stroke (NS038370), a Glenn Foundation Award and a Hirsch/Weill-Caulier Career Scientist Award. E. W. is supported by a Hereditary Disease Foundation Fellowship.	Axe EL, 2008, J CELL BIOL, V182, P685, DOI 10.1083/jcb.200803137; Bi XN, 2007, AUTOPHAGY, V3, P646, DOI 10.4161/auto.5074; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Boland B, 2008, J NEUROSCI, V28, P6926, DOI 10.1523/JNEUROSCI.0800-08.2008; Cherra SJ, 2008, FUTUR NEUROL, V3, P309, DOI 10.2217/14796708.3.3.309; Chu CT, 2007, AUTOPHAGY, V3, P663, DOI 10.4161/auto.4625; Cuervo AM, 2004, SCIENCE, V305, P1292, DOI 10.1126/science.1101738; Cuervo AM, 2010, TRENDS ENDOCRIN MET, V21, P142, DOI 10.1016/j.tem.2009.10.003; Dagda RK, 2009, J BIOL CHEM, V284, P13843, DOI 10.1074/jbc.M808515200; Dice JF, 2007, AUTOPHAGY, V3, P295, DOI 10.4161/auto.4144; Ding QX, 2003, J NEUROCHEM, V86, P489, DOI 10.1046/j.1471-4159.2003.01885.x; Erlich S, 2006, AUTOPHAGY, V2, P49, DOI 10.4161/auto.2156; Eskelinen EL, 2002, MOL BIOL CELL, V13, P3355, DOI 10.1091/mbc.E02-02-0114; Filimonenko M, 2007, J CELL BIOL, V179, P485, DOI 10.1083/jcb.200702115; Fimia GM, 2007, NATURE, V447, P1121, DOI 10.1038/nature05925; Frost B, 2010, NAT REV NEUROSCI, V11, P155, DOI 10.1038/nrn2786; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; Heiseke A, 2010, CURR ISSUES MOL BIOL, V12, P87; Ichimura Y, 2008, AUTOPHAGY, V4, P1063, DOI 10.4161/auto.6826; Iwata A, 2005, P NATL ACAD SCI USA, V102, P13135, DOI 10.1073/pnas.0505801102; Iwata A, 2005, J BIOL CHEM, V280, P40282, DOI 10.1074/jbc.M508786200; Jeong H, 2009, CELL, V137, P60, DOI 10.1016/j.cell.2009.03.018; Kaasik A, 2005, EUR J NEUROSCI, V22, P1023, DOI 10.1111/j.1460-9568.2005.04279.x; Kanazawa T, 2004, J BIOL CHEM, V279, P8452, DOI 10.1074/jbc.M306337200; Kaushik S, 2008, MOL BIOL CELL, V19, P2179, DOI 10.1091/mbc.E07-11-1155; Kegel KB, 2000, J NEUROSCI, V20, P7268, DOI 10.1523/jneurosci.20-19-07268.2000; Kihara A, 2001, EMBO REP, V2, P330, DOI 10.1093/embo-reports/kve061; Kim PK, 2008, P NATL ACAD SCI USA, V105, P20567, DOI 10.1073/pnas.0810611105; Kimura S, 2008, CELL STRUCT FUNCT, V33, P109, DOI 10.1247/csf.08005; Kirkin V, 2009, AUTOPHAGY, V5, P732, DOI 10.4161/auto.5.5.8566; Kirkin V, 2009, MOL CELL, V34, P259, DOI 10.1016/j.molcel.2009.04.026; Kirkin V, 2009, MOL CELL, V33, P505, DOI 10.1016/j.molcel.2009.01.020; Klionsky DJ, 2007, NAT REV MOL CELL BIO, V8, P931, DOI 10.1038/nrm2245; Kochl R, 2006, TRAFFIC, V7, P129, DOI 10.1111/j.1600-0854.2005.00368.x; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Komatsu M, 2007, P NATL ACAD SCI USA, V104, P14489, DOI 10.1073/pnas.0701311104; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Korolchuk VI, 2009, MOL CELL, V33, P517, DOI 10.1016/j.molcel.2009.01.021; Kovacs GG, 2008, AM J PATHOL, V172, P555, DOI 10.2353/ajpath.2008.070442; Kraft C, 2009, BBA-MOL CELL RES, V1793, P1404, DOI 10.1016/j.bbamcr.2009.02.006; LEE JH, CELL IN PRESS; Lee JA, 2009, J NEUROSCI, V29, P8506, DOI 10.1523/JNEUROSCI.0924-09.2009; Lee JY, 2010, EMBO J, V29, P969, DOI 10.1038/emboj.2009.405; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Li L, 2008, AUTOPHAGY, V4, P290, DOI 10.4161/auto.5524; Martinez-Vicente M, 2008, J CLIN INVEST, V118, P777, DOI 10.1172/JCI32806; Martinez-Vicente M, 2010, NAT NEUROSCI, V13, P567, DOI 10.1038/nn.2528; Massey AC, 2006, P NATL ACAD SCI USA, V103, P5805, DOI 10.1073/pnas.0507436103; Massey AC, 2008, AUTOPHAGY, V4, P442, DOI 10.4161/auto.5654; Meijer AJ, 2009, CRIT REV CL LAB SCI, V46, P210, DOI 10.1080/10408360903044068; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mookerjee S, 2009, J NEUROSCI, V29, P15134, DOI 10.1523/JNEUROSCI.4720-09.2009; Morimoto N, 2007, BRAIN RES, V1167, P112, DOI 10.1016/j.brainres.2007.06.045; MORTIMORE GE, 1989, DIABETES METAB REV, V5, P49, DOI 10.1002/dmr.5610050105; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Nedelsky NB, 2008, BBA-MOL BASIS DIS, V1782, P691, DOI 10.1016/j.bbadis.2008.10.002; Nishida Y, 2009, NATURE, V461, P654, DOI 10.1038/nature08455; Nixon RA, 2005, J NEUROPATH EXP NEUR, V64, P113, DOI 10.1093/jnen/64.2.113; Nixon RA, 2008, AUTOPHAGY, V4, P590, DOI 10.4161/auto.6259; Ohsumi Y, 2004, SEMIN CELL DEV BIOL, V15, P231, DOI 10.1016/j.semcdb.2003.12.004; Pacheco CD, 2009, HUM MOL GENET, V18, P956, DOI 10.1093/hmg/ddn423; Pan TH, 2008, NEUROBIOL DIS, V32, P16, DOI 10.1016/j.nbd.2008.06.003; Pandey UB, 2007, NATURE, V447, P859, DOI 10.1038/nature05853; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Pattingre S, 2009, J BIOL CHEM, V284, P2719, DOI 10.1074/jbc.M805920200; Pickford F, 2008, J CLIN INVEST, V118, P2190, DOI 10.1172/JCI33585; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Ravikumar B, 2002, HUM MOL GENET, V11, P1107, DOI 10.1093/hmg/11.9.1107; Rosenbluth JM, 2009, AUTOPHAGY, V5, P114, DOI 10.4161/auto.5.1.7294; Rubinsztein DC, 2007, NAT REV DRUG DISCOV, V6, P304, DOI 10.1038/nrd2272; Rubinsztein DC, 2009, AUTOPHAGY, V5, P585, DOI 10.4161/auto.5.5.8823; Rusten TE, 2007, CURR BIOL, V17, P1817, DOI 10.1016/j.cub.2007.09.032; Samara C, 2008, CELL DEATH DIFFER, V15, P105, DOI 10.1038/sj.cdd.4402231; Sardiello M, 2009, SCIENCE, V325, P473, DOI 10.1126/science.1174447; Sarkar S, 2008, HUM MOL GENET, V17, P170, DOI 10.1093/hmg/ddm294; Sarkar S, 2009, METHOD ENZYMOL, V453, P83, DOI 10.1016/S0076-6879(08)04005-6; Scarlatti F, 2008, CELL DEATH DIFFER, V15, P1318, DOI 10.1038/cdd.2008.51; Settembre C, 2008, HUM MOL GENET, V17, P119, DOI 10.1093/hmg/ddm289; Shibata M, 2006, J BIOL CHEM, V281, P14474, DOI 10.1074/jbc.M600364200; Simonsen A, 2008, AUTOPHAGY, V4, P176, DOI 10.4161/auto.5269; Stefanis L, 2001, J NEUROSCI, V21, P9549, DOI 10.1523/JNEUROSCI.21-24-09549.2001; Tan JMM, 2008, AUTOPHAGY, V4, P251, DOI 10.4161/auto.5444; Thurston TLM, 2009, NAT IMMUNOL, V10, P1215, DOI 10.1038/ni.1800; Uchiyama Y, 2009, METHOD ENZYMOL, V453, P33, DOI 10.1016/S0076-6879(08)04003-2; Urwin H, 2009, BIOCHEM SOC T, V37, P208, DOI 10.1042/BST0370208; Vergarajauregui S, 2008, HUM MOL GENET, V17, P2723, DOI 10.1093/hmg/ddn174; Wang QJ, 2006, J NEUROSCI, V26, P8057, DOI 10.1523/JNEUROSCI.2261-06.2006; Wang YP, 2009, HUM MOL GENET, V18, P4153, DOI 10.1093/hmg/ddp367; Webb JL, 2003, J BIOL CHEM, V278, P25009, DOI 10.1074/jbc.M300227200; Webb JL, 2004, INT J BIOCHEM CELL B, V36, P2541, DOI 10.1016/j.biocel.2004.02.003; Winslow AR, 2008, BBA-MOL BASIS DIS, V1782, P723, DOI 10.1016/j.bbadis.2008.06.010; Wong ESP, 2008, HUM MOL GENET, V17, P2570, DOI 10.1093/hmg/ddn157; Yang Y, 2007, EUR J NEUROSCI, V26, P2979, DOI 10.1111/j.1460-9568.2007.05914.x; Yu WH, 2005, J CELL BIOL, V171, P87, DOI 10.1083/jcb.200505082; Zhang XD, 2009, AUTOPHAGY, V5, P339, DOI 10.4161/auto.5.3.8174; Zheng YT, 2009, J IMMUNOL, V183, P5909, DOI 10.4049/jimmunol.0900441; Zhong Y, 2009, NAT CELL BIOL, V11, P468, DOI 10.1038/ncb1854	99	697	717	1	125	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2010	13	7					805	811		10.1038/nn.2575	http://dx.doi.org/10.1038/nn.2575			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	615YF	20581817	Green Accepted			2022-12-28	WOS:000279173900010
J	Cohen, JR; Asarnow, RF; Sabb, FW; Bilder, RM; Bookheimer, SY; Knowlton, BJ; Poldrack, RA				Cohen, Jessica R.; Asarnow, Robert F.; Sabb, Fred W.; Bilder, Robert M.; Bookheimer, Susan Y.; Knowlton, Barbara J.; Poldrack, Russell A.			A unique adolescent response to reward prediction errors	NATURE NEUROSCIENCE			English	Article							ORBITOFRONTAL CORTEX; DECISION; BRAIN; RISK; ACCUMBENS; STRIATUM; VALUES; ADULTS	Previous work has shown that human adolescents may be hypersensitive to rewards, but it is not known which aspect of reward processing is responsible for this. We separated decision value and prediction error signals and found that neural prediction error signals in the striatum peaked in adolescence, whereas neural decision value signals varied depending on how value was modeled. This suggests that heightened dopaminergic prediction error responsivity contributes to adolescent reward seeking.	[Asarnow, Robert F.; Sabb, Fred W.; Bilder, Robert M.; Bookheimer, Susan Y.; Poldrack, Russell A.] Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90024 USA; [Sabb, Fred W.; Bilder, Robert M.; Bookheimer, Susan Y.; Knowlton, Barbara J.; Poldrack, Russell A.] Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90024 USA; [Cohen, Jessica R.; Bilder, Robert M.; Bookheimer, Susan Y.; Knowlton, Barbara J.; Poldrack, Russell A.] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Cohen, JR (corresponding author), Univ Calif Berkeley, Berkeley, CA 94720 USA.	jrcohen@berkeley.edu	Bilder, Robert M/A-8894-2008	Bilder, Robert M/0000-0001-5085-7852; Bookheimer, Susan/0000-0002-3417-5891; Poldrack, Russell/0000-0001-6755-0259	National Institute of Mental Health [(5R24 MH072697]; National Institute of Drug Abuse [5F31 DA024534]; James S. McDonnell Foundation; Della Martin Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R24MH072697] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [F31DA024534] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); James S. McDonnell Foundation; Della Martin Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research was supported by the National Institute of Mental Health (5R24 MH072697), the National Institute of Drug Abuse (5F31 DA024534), the James S. McDonnell Foundation and the Della Martin Foundation.	Berridge KC, 1998, BRAIN RES REV, V28, P309, DOI 10.1016/S0165-0173(98)00019-8; Bjork JM, 2004, J NEUROSCI, V24, P1793, DOI 10.1523/JNEUROSCI.4862-03.2004; Casey BJ, 2008, DEV REV, V28, P62, DOI [10.1016/j.dr.2007.08.003, 10.1196/annals.1440.010]; Chib VS, 2009, J NEUROSCI, V29, P12315, DOI 10.1523/JNEUROSCI.2575-09.2009; D'Ardenne K, 2008, SCIENCE, V319, P1264, DOI 10.1126/science.1150605; Ernst M, 2005, NEUROIMAGE, V25, P1279, DOI 10.1016/j.neuroimage.2004.12.038; Galvan A, 2006, J NEUROSCI, V26, P6885, DOI 10.1523/JNEUROSCI.1062-06.2006; Hare TA, 2008, J NEUROSCI, V28, P5623, DOI 10.1523/JNEUROSCI.1309-08.2008; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Knowlton BJ, 1996, SCIENCE, V273, P1399, DOI 10.1126/science.273.5280.1399; May JC, 2004, BIOL PSYCHIAT, V55, P359, DOI 10.1016/j.biopsych.2003.11.008; Pagnoni G, 2002, NAT NEUROSCI, V5, P97, DOI 10.1038/nn802; Rescorla R.A., 1972, CLASSICAL CONDITION, P64, DOI DOI 10.1101/GR.110528.110; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Tom SM, 2007, SCIENCE, V315, P515, DOI 10.1126/science.1134239	15	189	189	3	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2010	13	6					669	671		10.1038/nn.2558	http://dx.doi.org/10.1038/nn.2558			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	600QY	20473290	Green Submitted, Green Accepted			2022-12-28	WOS:000278003300010
J	Anikeeva, P; Andalman, AS; Witten, I; Warden, M; Goshen, I; Grosenick, L; Gunaydin, LA; Frank, LM; Deisseroth, K				Anikeeva, Polina; Andalman, Aaron S.; Witten, Ilana; Warden, Melissa; Goshen, Inbal; Grosenick, Logan; Gunaydin, Lisa A.; Frank, Loren M.; Deisseroth, Karl			Optetrode: a multichannel readout for optogenetic control in freely moving mice	NATURE NEUROSCIENCE			English	Article							NEURAL CIRCUITRY; IN-VIVO; CRE RECOMBINASE; TRANSGENIC MICE; NEURONS; LIGHT; RECORDINGS; CORTEX; HIPPOCAMPUS; POPULATIONS	Recent advances in optogenetics have improved the precision with which defined circuit elements can be controlled optically in freely moving mammals; in particular, recombinase-dependent opsin viruses, used with a growing pool of transgenic mice expressing recombinases, allow manipulation of specific cell types. However, although optogenetic control has allowed neural circuits to be manipulated in increasingly powerful ways, combining optogenetic stimulation with simultaneous multichannel electrophysiological readout of isolated units in freely moving mice remains a challenge. We designed and validated the optetrode, a device that allows for colocalized multi-tetrode electrophysiological recording and optical stimulation in freely moving mice. Optetrode manufacture employs a unique optical fiber-centric coaxial design approach that yields a lightweight (2 g), compact and robust device that is suitable for behaving mice. This low-cost device is easy to construct (2.5 h to build without specialized equipment). We found that the drive design produced stable high-quality recordings and continued to do so for at least 6 weeks following implantation. We validated the optetrode by quantifying, for the first time, the response of cells in the medial prefrontal cortex to local optical excitation and inhibition, probing multiple different genetically defined classes of cells in the mouse during open field exploration.	[Anikeeva, Polina; Andalman, Aaron S.; Witten, Ilana; Warden, Melissa; Goshen, Inbal; Grosenick, Logan; Gunaydin, Lisa A.; Deisseroth, Karl] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Frank, Loren M.] Univ Calif San Francisco, Dept Physiol, San Francisco, CA USA; [Deisseroth, Karl] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA	Stanford University; University of California System; University of California San Francisco; Stanford University; Howard Hughes Medical Institute; Stanford University	Deisseroth, K (corresponding author), Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.	deissero@stanford.edu	Goshen, Inbal/GQI-2230-2022; Andalman, Aaron S/C-7694-2011; Warden, Melissa R/M-9300-2016	Goshen, Inbal/0000-0001-7578-2615; Warden, Melissa R/0000-0003-2240-3997; Frank, Loren/0000-0002-1752-5677	Stanford University School of Medicine; Helen Hay Whitney Foundation; Machiah fellowship; Weizmann Institute Women in Science award; National Science Foundation; Stanford University; National Institute of Neurological Disorders and Stroke; Gatsby Charitable Foundation; Defense Advanced Research Projects Agency; California Institute for Regenerative Medicine; McKnight Foundation; National Institute of Mental Health; National Institute on Drug Abuse; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH086373, R01MH075957] Funding Source: NIH RePORTER	Stanford University School of Medicine; Helen Hay Whitney Foundation; Machiah fellowship; Weizmann Institute Women in Science award; National Science Foundation(National Science Foundation (NSF)); Stanford University(Stanford University); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Gatsby Charitable Foundation; Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); McKnight Foundation; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank S. Arber for the PV::Cre transgenic mouse line. P. A. thanks D. G. Walker for advice on mechanical design. P. A. was supported by a Dean's fellowship from Stanford University School of Medicine, I. W. was supported by the Helen Hay Whitney Foundation, I. G. was supported by a Machiah fellowship and the Weizmann Institute Women in Science award, L. G. was supported by a National Science Foundation Integrative Graduate Education and Research Traineeship Award, and L. A. G. was supported by a BioX fellowship from Stanford University. L. M. F. and K. D. received support from a GO grant from the National Institute of Neurological Disorders and Stroke. Full funding information for K. D. is listed at http://www.stanford.edu/group/dlab/optogenetics/funding/ and includes the Gatsby Charitable Foundation, the Defense Advanced Research Projects Agency Reorganization and Plasticity to Accelerate Injury Recovery Program, the California Institute for Regenerative Medicine, the McKnight Foundation, the National Institute of Mental Health, and the National Institute on Drug Abuse.	Adamantidis AR, 2007, NATURE, V450, P420, DOI 10.1038/nature06310; Aravanis AM, 2007, J NEURAL ENG, V4, pS143, DOI 10.1088/1741-2560/4/3/S02; Arenkiel BR, 2007, NEURON, V54, P205, DOI 10.1016/j.neuron.2007.03.005; Bacon SJ, 1996, BRAIN RES, V720, P211, DOI 10.1016/0006-8993(96)00155-2; Benabid AL, 2009, LANCET NEUROL, V8, P67, DOI 10.1016/S1474-4422(08)70291-6; Bjorklund A, 2010, PROG BRAIN RES, V184, P311, DOI [10.1016/S0079-6123(16)8401-6, 10.1016/S0079-6123(10)84016-6]; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; BRITTON DR, 1981, PHARMACOL BIOCHEM BE, V15, P577, DOI 10.1016/0091-3057(81)90212-4; Brown EN, 2011, ANNU REV NEUROSCI, V34, P601, DOI 10.1146/annurev-neuro-060909-153200; Chawla MK, 2007, PROG BRAIN RES, V163, P661, DOI 10.1016/S0079-6123(07)63036-2; Costa RM, 2002, NATURE, V415, P526, DOI 10.1038/nature711; Diester I, 2011, NAT NEUROSCI, V14, P387, DOI 10.1038/nn.2749; Gerrard JL, 2008, J NEUROSCI, V28, P7883, DOI 10.1523/JNEUROSCI.1265-08.2008; Gong SC, 2007, J NEUROSCI, V27, P9817, DOI 10.1523/JNEUROSCI.2707-07.2007; Gradinaru V, 2007, J NEUROSCI, V27, P14231, DOI 10.1523/JNEUROSCI.3578-07.2007; Gradinaru V, 2010, CELL, V141, P154, DOI 10.1016/j.cell.2010.02.037; Gradinaru V, 2009, SCIENCE, V324, P354, DOI 10.1126/science.1167093; Gray CM, 1995, J NEUROSCI METH, V63, P43, DOI 10.1016/0165-0270(95)00085-2; Halassa MM, 2011, NAT NEUROSCI, V14, P1118, DOI 10.1038/nn.2880; Hippenmeyer S, 2005, PLOS BIOL, V3, P878, DOI 10.1371/journal.pbio.0030159; Histed MH, 2009, NEURON, V63, P508, DOI 10.1016/j.neuron.2009.07.016; Huang ZJ, 2002, GENESIS, V32, P209, DOI 10.1002/gene.10054; Jeantet Y, 2003, J NEUROSCI METH, V129, P129, DOI 10.1016/S0165-0270(03)00172-9; Jog MS, 2002, J NEUROSCI METH, V117, P141, DOI 10.1016/S0165-0270(02)00092-4; Leypold BG, 2002, P NATL ACAD SCI USA, V99, P6376, DOI 10.1073/pnas.082127599; Lindeberg J, 2004, GENESIS, V40, P67, DOI 10.1002/gene.20065; Mayberg HS, 2009, J CLIN INVEST, V119, P717, DOI 10.1172/JCI38454; McHugh TJ, 1996, CELL, V87, P1339, DOI 10.1016/S0092-8674(00)81828-0; MCNAUGHTON BL, 1983, J NEUROSCI METH, V8, P391, DOI 10.1016/0165-0270(83)90097-3; Nakazawa K, 2002, SCIENCE, V297, P211, DOI 10.1126/science.1071795; Nestler EJ, 2010, NAT NEUROSCI, V13, P1161, DOI 10.1038/nn.2647; Petreanu L, 2007, NAT NEUROSCI, V10, P663, DOI 10.1038/nn1891; Royer S, 2010, EUR J NEUROSCI, V31, P2279, DOI 10.1111/j.1460-9568.2010.07250.x; Scanziani M, 2009, NATURE, V461, P930, DOI 10.1038/nature08540; Schmitzer-Torbert N, 2005, NEUROSCIENCE, V131, P1, DOI 10.1016/j.neuroscience.2004.09.066; Sohal VS, 2009, NATURE, V459, P698, DOI 10.1038/nature07991; THIEL G, 1991, P NATL ACAD SCI USA, V88, P3431, DOI 10.1073/pnas.88.8.3431; Tsai HC, 2009, SCIENCE, V324, P1080, DOI 10.1126/science.1168878; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520; Wiltgen BJ, 2004, NEURON, V44, P101, DOI 10.1016/j.neuron.2004.09.015; Yizhar O, 2011, NATURE, V477, P171, DOI 10.1038/nature10360; Young P, 2008, NAT NEUROSCI, V11, P721, DOI 10.1038/nn.2118; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744	43	246	255	1	102	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2012	15	1					163	U204		10.1038/nn.2992	http://dx.doi.org/10.1038/nn.2992			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	866VO	22138641	Green Accepted			2022-12-28	WOS:000298414400027
J	Lin, Q; Wei, W; Coelho, CM; Li, X; Baker-Andresen, D; Dudley, K; Ratnu, VS; Boskovic, Z; Kobor, MS; Sun, YE; Bredy, TW				Lin, Quan; Wei, Wei; Coelho, Carlos M.; Li, Xiang; Baker-Andresen, Danay; Dudley, Kevin; Ratnu, Vikram S.; Boskovic, Zoran; Kobor, Michael S.; Sun, Yi E.; Bredy, Timothy W.			The brain-specific microRNA miR-128b regulates the formation of fear-extinction memory	NATURE NEUROSCIENCE			English	Article							CALCINEURIN; PLASTICITY; RECEPTORS; CREB; RNAS	MicroRNAs are small non-coding RNAs that mediate post-transcriptional gene silencing. Fear-extinction learning in C57/Bl6J mice led to increased expression of the brain-specific microRNA miR-128b, which disrupted stability of several plasticity-related target genes and regulated formation of fear-extinction memory. Increased miR-128b activity may therefore facilitate the transition from retrieval of the original fear memory toward the formation of a new fear-extinction memory.	[Wei, Wei; Coelho, Carlos M.; Li, Xiang; Baker-Andresen, Danay; Dudley, Kevin; Ratnu, Vikram S.; Boskovic, Zoran; Bredy, Timothy W.] Univ Queensland, Psychiat Epigenom Lab, Queensland Brain Inst, Brisbane, Qld, Australia; [Lin, Quan; Sun, Yi E.] Univ Calif Los Angeles, David Geffen Sch Med, Intellectual Dev & Disabil Res Ctr, Los Angeles, CA 90095 USA; [Kobor, Michael S.] Univ British Columbia, Ctr Mol Med & Therapeut, Vancouver, BC V5Z 1M9, Canada	University of Queensland; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of British Columbia	Bredy, TW (corresponding author), Univ Queensland, Psychiat Epigenom Lab, Queensland Brain Inst, Brisbane, Qld, Australia.	t.bredy@uq.edu.au	Wei, Wei/C-3471-2016; Coelho, Carlos/A-5065-2010; Boskovic, Zoran/Y-2764-2018	Wei, Wei/0000-0001-5768-7729; Coelho, Carlos/0000-0002-2320-7931; Boskovic, Zoran/0000-0002-9867-1827; Kobor, Michael/0000-0003-4140-1743; Dudley, Kevin/0000-0001-5762-1068; Bredy, Timothy/0000-0003-3280-126X	Michael Smith Foundation for Health Research; US National Institutes of Health [R01 MH084095]; Canadian Institutes of Health Research; National Institute on Drug Abuse [K99DA026503-01]; Australian Research Council [DP1096148]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH084095] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K99DA026503] Funding Source: NIH RePORTER	Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Australian Research Council(Australian Research Council); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank P. Greengard and A. Nairn for their comments and the generous gift of RCS antibody, G. Quirk and C. Stevenson for suggestions, and R. Tweedale for editing the manuscript. This work was supported by a scholar award from the Michael Smith Foundation for Health Research (M. S. K.), a US National Institutes of Health EUREKA grant (R01 MH084095, Y.E.S.), and previous grants from the Canadian Institutes of Health Research, the Michael Smith Foundation for Health Research and the National Institute on Drug Abuse (K99DA026503-01), and a current grant from the Australian Research Council (DP1096148, T.W.B.).	Baumgartel K, 2008, NAT NEUROSCI, V11, P572, DOI 10.1038/nn.2113; Chandrasekar V, 2009, MOL CELL NEUROSCI, V42, P350, DOI 10.1016/j.mcn.2009.08.009; Gao J, 2010, NATURE, V466, P1105, DOI 10.1038/nature09271; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Hollander JA, 2010, NATURE, V466, P197, DOI 10.1038/nature09202; Lai EC, 2002, NAT GENET, V30, P363, DOI 10.1038/ng865; Lauzon NM, 2009, J NEUROSCI, V29, P4836, DOI 10.1523/JNEUROSCI.0178-09.2009; Lin CH, 2003, J NEUROSCI, V23, P1574; Monteys AM, 2010, RNA, V16, P495, DOI 10.1261/rna.1731910; Mueller D, 2010, BIOL PSYCHIAT, V68, P1055, DOI 10.1016/j.biopsych.2010.08.014; Quirk GJ, 2008, NEUROPSYCHOPHARMACOL, V33, P56, DOI 10.1038/sj.npp.1301555; Rajasethupathy P, 2009, NEURON, V63, P803, DOI 10.1016/j.neuron.2009.05.029; Rakhilin SV, 2004, SCIENCE, V306, P698, DOI 10.1126/science.1099961; Rossato JI, 2009, SCIENCE, V325, P1017, DOI 10.1126/science.1172545; Schaefer A, 2010, J EXP MED, V207, P1843, DOI 10.1084/jem.20100451	15	133	136	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2011	14	9					1115	1117		10.1038/nn.2891	http://dx.doi.org/10.1038/nn.2891			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	812ID	21841775	Green Submitted			2022-12-28	WOS:000294284900009
J	Cohen, DA; Robertson, EM				Cohen, Daniel A.; Robertson, Edwin M.			Preventing interference between different memory tasks	NATURE NEUROSCIENCE			English	Article							STATE-DEPENDENCY; MOTOR MEMORY; CONSOLIDATION; SLEEP; STIMULATION	When learned in quick succession, declarative and motor skill tasks interfere with one another and subsequent recall is impaired. Depending on the order of the tasks, we were able to prevent memory interference in humans by applying transcranial magnetic stimulation to either the dorsolateral prefrontal or the primary motor cortex, and neither memory was impaired. Our observations suggest that distinct mechanisms support the communication between different types of memory processing.	[Cohen, Daniel A.; Robertson, Edwin M.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Berenson Allen Ctr Non Invas Brain Stimulat, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Robertson, EM (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Berenson Allen Ctr Non Invas Brain Stimulat, Boston, MA 02215 USA.	emrobert@bidmc.harvard.edu			US National Institutes of Health [R01 NS051446, NS051446-03S1]; National Science Foundation (Division of Behavioral and Cognitive Sciences) [0921177]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025758, M01RR001032] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051446] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation (Division of Behavioral and Cognitive Sciences)(National Science Foundation (NSF)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are grateful to R. Brown, L. Iguichi, N. Mosha and S. Tunovic for their assistance with the experiments, and to A. Galaburda, A. Pascual-Leone and R. Stickgold for their encouraging and constructive comments. This work was supported by the US National Institutes of Health (R01 NS051446 and NS051446-03S1, E.M.R.) and the National Science Foundation (Division of Behavioral and Cognitive Sciences 0921177, E.M.R.). Our work also benefited from the infrastructure supplied by the Harvard Clinical and Translational Science Center (from the National Center for Research Resources, UL1 RR025758 and M01 RR01032).	Brashers-Krug T, 1995, ADV NEURAL INFORMATI, V7, P19; BrashersKrug T, 1996, NATURE, V382, P252, DOI 10.1038/382252a0; Brown RM, 2007, J NEUROSCI, V27, P10468, DOI 10.1523/JNEUROSCI.2799-07.2007; Diekelmann S, 2010, NAT REV NEUROSCI, V11, P114, DOI 10.1038/nrn2762; Keisler A, 2010, J NEUROSCI, V30, P14817, DOI 10.1523/JNEUROSCI.4160-10.2010; Lechner HA, 1999, LEARN MEMORY, V6, P77; Robertson EM, 2007, J NEUROSCI, V27, P10073, DOI 10.1523/JNEUROSCI.2747-07.2007; Robertson EM, 2009, PLOS BIOL, V7, P11, DOI 10.1371/journal.pbio.1000019; Robertson EM, 2004, CURR BIOL, V14, P208, DOI 10.1016/j.cub.2004.01.027; Robertson EM, 2005, J NEUROSCI, V25, P6372, DOI 10.1523/JNEUROSCI.1851-05.2005; Silvanto J, 2008, BRAIN TOPOGR, V21, P1, DOI 10.1007/s10548-008-0067-0; Silvanto J, 2008, TRENDS COGN SCI, V12, P447, DOI 10.1016/j.tics.2008.09.004; Spencer RMC, 2006, CURR BIOL, V16, P1001, DOI 10.1016/j.cub.2006.03.094; Walker MP, 2003, NATURE, V425, P616, DOI 10.1038/nature01930	14	48	48	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2011	14	8					953	955		10.1038/nn.2840	http://dx.doi.org/10.1038/nn.2840			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	797KC	21706019	Green Accepted			2022-12-28	WOS:000293123700007
J	Kay, JN; Voinescu, PE; Chu, MW; Sanes, JR				Kay, Jeremy N.; Voinescu, P. Emanuela; Chu, Monica W.; Sanes, Joshua R.			Neurod6 expression defines new retinal amacrine cell subtypes and regulates their fate	NATURE NEUROSCIENCE			English	Article							HORIZONTAL CELLS; MOUSE RETINA; SPECIFICATION; DIVERSITY; PTF1A; INTERNEURONS; INTEGRATION; INHIBITION; SUBSETS; BIASES	Most regions of the CNS contain many subtypes of inhibitory interneurons with specialized roles in circuit function. In the mammalian retina, the similar to 30 subtypes of inhibitory interneurons called amacrine cells (ACs) are generally divided into two groups: wide/medium-field GABAergic ACs and narrow-field glycinergic ACs, which mediate lateral and vertical interactions, respectively, within the inner plexiform layer. We used expression profiling and mouse transgenic lines to identify and characterize two closely related narrow-field AC subtypes. Both arise postnatally and one is neither glycinergic nor GABAergic (nGnG). Two transcription factors selectively expressed by these subtypes, Neurod6 and special AT-rich-sequence-binding protein 2 (Satb2), regulate a postmitotic cell fate choice between these subtypes. Satb2 induces Neurod6, which persists in nGnG ACs and promotes their fate but is downregulated in the related glycinergic AC subtype. Our results support the view that cell fate decisions made in progenitors and their progeny act together to diversify ACs.	[Kay, Jeremy N.; Voinescu, P. Emanuela; Chu, Monica W.; Sanes, Joshua R.] Harvard Univ, Ctr Brain Sci, Cambridge, MA 02138 USA; [Kay, Jeremy N.; Voinescu, P. Emanuela; Chu, Monica W.; Sanes, Joshua R.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Harvard University; Harvard University	Sanes, JR (corresponding author), Harvard Univ, Ctr Brain Sci, Cambridge, MA 02138 USA.	sanesj@mcb.harvard.edu	Kay, Jeremy/G-9309-2011		Life Sciences Research Foundation; US National Institutes of Health; Howard Hughes Medical Institute [43667]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS029169] Funding Source: NIH RePORTER	Life Sciences Research Foundation; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank R. Reed (Johns Hopkins University) for providing anti-Ebf, D. Pow (University of Queensland) for anti-glycine, L. Reichardt (University of California San Francisco) and K. Nave (Max Planck Institute, Gottingen) for Neurod6<SUP>cre</SUP> mice, T. Misgeld and J. Lichtman (Harvard University) for MP mice, R. Born and V. Berezovskii (Harvard University) for macaque retinal tissue and X. Duan for advice and assistance with the retrovirus. J.N.K. was supported by a Life Sciences Research Foundation postdoctoral fellowship. This work was supported by a grant from the US National Institutes of Health to J.R.S. and by Collaborative Innovation Award number 43667 from the Howard Hughes Medical Institute.	Alcamo EA, 2008, NEURON, V57, P364, DOI 10.1016/j.neuron.2007.12.012; Alexiades MR, 1997, DEVELOPMENT, V124, P1119; Apostolova G, 2010, J NEUROSCI, V30, P16356, DOI 10.1523/JNEUROSCI.3502-10.2010; Badea TC, 2004, J COMP NEUROL, V480, P331, DOI 10.1002/cne.20304; BARNSTABLE CJ, 1985, DEV BRAIN RES, V20, P286, DOI 10.1016/0165-3806(85)90116-6; Batista-Brito R, 2009, CURR TOP DEV BIOL, V87, P81, DOI 10.1016/S0070-2153(09)01203-4; Britanova O, 2008, NEURON, V57, P378, DOI 10.1016/j.neuron.2007.12.028; Brohl D, 2008, DEV BIOL, V322, P381, DOI 10.1016/j.ydbio.2008.08.002; Buffelli M, 2003, NATURE, V424, P430, DOI 10.1038/nature01844; Cepko CL, 1996, P NATL ACAD SCI USA, V93, P589, DOI 10.1073/pnas.93.2.589; Cherry TJ, 2009, P NATL ACAD SCI USA, V106, P9495, DOI 10.1073/pnas.0903264106; Cossart R, 2011, CURR OPIN NEUROBIOL, V21, P160, DOI 10.1016/j.conb.2010.10.003; Davis JA, 1996, J NEUROSCI, V16, P5082; Duan X, 2007, CELL, V130, P1146, DOI 10.1016/j.cell.2007.07.010; Elshatory Y, 2007, J COMP NEUROL, V503, P182, DOI 10.1002/cne.21390; Emanuela P, 2009, J COMP NEUROL, V517, P737, DOI 10.1002/cne.22200; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Feng L, 2006, DEVELOPMENT, V133, P4815, DOI 10.1242/dev.02664; Fujitani Y, 2006, DEVELOPMENT, V133, P4439, DOI 10.1242/dev.02598; Goebbels S, 2006, GENESIS, V44, P611, DOI 10.1002/dvg.20256; Goulding M, 2005, CURR OPIN NEUROBIOL, V15, P14, DOI 10.1016/j.conb.2005.01.017; Haverkamp S, 2000, J COMP NEUROL, V424, P1; Heinze L, 2007, J COMP NEUROL, V500, P693, DOI 10.1002/cne.21201; Hsueh HA, 2008, J NEUROPHYSIOL, V100, P2077, DOI 10.1152/jn.90417.2008; Inoue T, 2002, DEVELOPMENT, V129, P831; Jiang HS, 2009, J NEUROSCI, V29, P10449, DOI 10.1523/JNEUROSCI.3048-09.2009; Jin KX, 2010, J NEUROSCI, V30, P11902, DOI 10.1523/JNEUROSCI.2187-10.2010; Jusuf PR, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-34; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; Lefebvre JL, 2008, DEVELOPMENT, V135, P4141, DOI 10.1242/dev.027912; Li C, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-231; Li SG, 2004, NEURON, V43, P795, DOI 10.1016/j.neuron.2004.08.041; Macneil MA, 1999, J COMP NEUROL, V413, P305; MacNeil MA, 1998, NEURON, V20, P971, DOI 10.1016/S0896-6273(00)80478-X; Marquardt T, 2001, CELL, V105, P43, DOI 10.1016/S0092-8674(01)00295-1; Matsuda T, 2004, P NATL ACAD SCI USA, V101, P16, DOI 10.1073/pnas.2235688100; Menger N, 1998, J COMP NEUROL, V401, P34, DOI 10.1002/(SICI)1096-9861(19981109)401:1<34::AID-CNE3>3.0.CO;2-P; Misgeld T, 2007, NAT METHODS, V4, P559, DOI 10.1038/NMETH1055; Nakhai H, 2007, DEVELOPMENT, V134, P1151, DOI 10.1242/dev.02781; Pow DV, 1999, VISUAL NEUROSCI, V16, P231, DOI 10.1017/S0952523899162047; Schubert T, 2008, J NEUROPHYSIOL, V100, P304, DOI 10.1152/jn.90202.2008; SHIMIZU C, 1995, EUR J BIOCHEM, V229, P239, DOI 10.1111/j.1432-1033.1995.0239l.x; Singh H, 2005, P NATL ACAD SCI USA, V102, P4949, DOI 10.1073/pnas.0500480102; Sousa VH, 2009, CEREB CORTEX, V19, pI1, DOI 10.1093/cercor/bhp038; Stacy RC, 2003, J COMP NEUROL, V456, P154, DOI 10.1002/cne.10509; Strettoi E, 1996, P NATL ACAD SCI USA, V93, P14906, DOI 10.1073/pnas.93.25.14906; Vaney D.I., 1990, PROGR RETINAL RES, V9, P49, DOI [10.1016/0278-4327(90)90004-2, DOI 10.1016/0278-4327(90)90004-2]; Wang SS, 2004, DEVELOPMENT, V131, P1377, DOI 10.1242/dev.01009; Yamagata M, 2002, CELL, V110, P649, DOI 10.1016/S0092-8674(02)00910-8	49	86	87	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2011	14	8					965	U45		10.1038/nn.2859	http://dx.doi.org/10.1038/nn.2859			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	797KC	21743471	Green Accepted			2022-12-28	WOS:000293123700009
J	Mittmann, W; Wallace, DJ; Czubayko, U; Herb, JT; Schaefer, AT; Looger, LL; Denk, W; Kerr, JND				Mittmann, Wolfgang; Wallace, Damian J.; Czubayko, Uwe; Herb, Jan T.; Schaefer, Andreas T.; Looger, Loren L.; Denk, Winfried; Kerr, Jason N. D.			Two-photon calcium imaging of evoked activity from L5 somatosensory neurons in vivo	NATURE NEUROSCIENCE			English	Article							CELLULAR RESOLUTION; PYRAMIDAL NEURONS; VISUAL-CORTEX; NEURAL ACTIVITY; MICROSCOPY; DENDRITES; BRAIN; AWAKE; MICE; ORGANIZATION	Multiphoton imaging (MPI) is widely used for recording activity simultaneously from many neurons in superficial cortical layers in vivo. We combined regenerative amplification multiphoton microscopy (RAMM) with genetically encoded calcium indicators to extend MPI of neuronal population activity into layer 5 (L5) of adult mouse somatosensory cortex. We found that this approach could be used to record and quantify spontaneous and sensory-evoked activity in populations of L5 neuronal somata located as much as 800. m below the pia. In addition, we found that RAMM could be used to simultaneously image activity from large (similar to 80) populations of apical dendrites and follow these dendrites down to their somata of origin.	[Mittmann, Wolfgang; Wallace, Damian J.; Czubayko, Uwe; Kerr, Jason N. D.] Max Planck Inst Biol Cybernet, Network Imaging Grp, Tubingen, Germany; [Mittmann, Wolfgang; Denk, Winfried] Max Planck Inst Med Res, Dept Biomed Opt, Heidelberg, Germany; [Looger, Loren L.] Howard Hughes Med Inst, Ashburn, VA USA	Max Planck Society; Max Planck Society; Howard Hughes Medical Institute	Kerr, JND (corresponding author), Max Planck Inst Biol Cybernet, Network Imaging Grp, Tubingen, Germany.	jason@tuebingen.mpg.de	denk, winfried/I-6627-2012	Schaefer, Andreas/0000-0002-4677-8788; Kerr, Jason/0000-0001-9459-883X	Max Planck Society	Max Planck Society(Max Planck Society)	We would like to thank P. Theer for technical help with the RegA, J. Sawinski for help with detection system fabrication and D. S. Greenberg for dendrite morphology analysis. This work was supported by the Max Planck Society.	de Kock CPJ, 2007, J PHYSIOL-LONDON, V581, P139, DOI 10.1113/jphysiol.2006.124321; de la Rocha J, 2007, NATURE, V448, P802, DOI 10.1038/nature06028; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; DENK W, 2001, Patent No. 6249379; Dombeck DA, 2007, NEURON, V56, P43, DOI 10.1016/j.neuron.2007.08.003; Dombeck DA, 2009, J NEUROSCI, V29, P13751, DOI 10.1523/JNEUROSCI.2985-09.2009; Greenberg DS, 2008, NAT NEUROSCI, V11, P749, DOI 10.1038/nn.2140; Grewe BF, 2010, NAT METHODS, V7, P399, DOI 10.1038/nmeth.1453; Hasan MT, 2004, PLOS BIOL, V2, P763, DOI 10.1371/journal.pbio.0020163; Helmchen F, 1999, NAT NEUROSCI, V2, P989, DOI 10.1038/14788; Ji N, 2010, NAT METHODS, V7, P141, DOI 10.1038/NMETH.1411; Kerr JND, 2008, NAT REV NEUROSCI, V9, P195, DOI 10.1038/nrn2338; Kerr JND, 2007, J NEUROSCI, V27, P13316, DOI 10.1523/JNEUROSCI.2210-07.2007; Kerr JND, 2005, P NATL ACAD SCI USA, V102, P14063, DOI 10.1073/pnas.0506029102; Larkum ME, 2009, SCIENCE, V325, P756, DOI 10.1126/science.1171958; Lavis LD, 2008, ACS CHEM BIOL, V3, P142, DOI 10.1021/cb700248m; Margrie TW, 2003, NEURON, V39, P911, DOI 10.1016/j.neuron.2003.08.012; Meyer HS, 2010, CEREB CORTEX, V20, P2277, DOI 10.1093/cercor/bhq067; Mrsic-Flogel TD, 2007, NEURON, V54, P961, DOI 10.1016/j.neuron.2007.05.028; Nimmerjahn A, 2004, NAT METHODS, V1, P31, DOI 10.1038/nmeth706; Oheim M, 2001, J NEUROSCI METH, V111, P29, DOI 10.1016/S0165-0270(01)00438-1; Ohki K, 2005, NATURE, V433, P597, DOI 10.1038/nature03274; Polsky A, 2004, NAT NEUROSCI, V7, P621, DOI 10.1038/nn1253; Rothschild G, 2010, NAT NEUROSCI, V13, P353, DOI 10.1038/nn.2484; Rueckel M, 2006, P NATL ACAD SCI USA, V103, P17137, DOI 10.1073/pnas.0604791103; Sato TR, 2007, PLOS BIOL, V5, P1440, DOI 10.1371/journal.pbio.0050189; Sawinski J, 2009, P NATL ACAD SCI USA, V106, P19557, DOI 10.1073/pnas.0903680106; Shevtsova Z, 2005, EXP PHYSIOL, V90, P53, DOI 10.1113/expphysiol.2004.028159; Stosiek C, 2003, P NATL ACAD SCI USA, V100, P7319, DOI 10.1073/pnas.1232232100; Stuart G, 1997, J PHYSIOL-LONDON, V505, P617, DOI 10.1111/j.1469-7793.1997.617ba.x; STUART GJ, 1994, NATURE, V367, P69, DOI 10.1038/367069a0; Theer P, 2003, OPT LETT, V28, P1022, DOI 10.1364/OL.28.001022; THEER P, 2004, COMBINED FACULTIES N, V100; Theer P, 2006, J OPT SOC AM A, V23, P3139, DOI 10.1364/JOSAA.23.003139; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Tsai PS, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2804014; Wallace DJ, 2008, NAT METHODS, V5, P797, DOI 10.1038/NMETH.1242; Zolotukhin S, 2002, METHODS, V28, P158, DOI 10.1016/S1046-2023(02)00220-7	38	135	139	0	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2011	14	8					1089	U195		10.1038/nn.2879	http://dx.doi.org/10.1038/nn.2879			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	797KC	21743473				2022-12-28	WOS:000293123700025
J	Bejjanki, VR; Beck, JM; Lu, ZL; Pouget, A				Bejjanki, Vikranth R.; Beck, Jeffrey M.; Lu, Zhong-Lin; Pouget, Alexandre			Perceptual learning as improved probabilistic inference in early sensory areas	NATURE NEUROSCIENCE			English	Article							ORIENTATION SELECTIVITY; V1; DISCRIMINATION; MECHANISMS; MODEL; REPRESENTATION; SPECIFICITY; PLASTICITY; EFFICIENCY; NETWORK	Extensive training on simple tasks such as fine orientation discrimination results in large improvements in performance, a form of learning known as perceptual learning. Previous models have argued that perceptual learning is due to either sharpening and amplification of tuning curves in early visual areas or to improved probabilistic inference in later visual areas (at the decision stage). However, early theories are inconsistent with the conclusions of psychophysical experiments manipulating external noise, whereas late theories cannot explain the changes in neural responses that have been reported in cortical areas V1 and V4. Here we show that we can capture both the neurophysiological and behavioral aspects of perceptual learning by altering only the feedforward connectivity in a recurrent network of spiking neurons so as to improve probabilistic inference in early visual areas. The resulting network shows modest changes in tuning curves, in line with neurophysiological reports, along with a marked reduction in the amplitude of pairwise noise correlations.	[Bejjanki, Vikranth R.; Beck, Jeffrey M.; Pouget, Alexandre] Univ Rochester, Dept Brain & Cognit Sci, Rochester, NY 14627 USA; [Beck, Jeffrey M.] Gatsby Computat Neurosci Unit, London, England; [Lu, Zhong-Lin] Univ So Calif, Dept Psychol, Los Angeles, CA 90089 USA	University of Rochester; University of London; University College London; University of Southern California	Pouget, A (corresponding author), Univ Rochester, Dept Brain & Cognit Sci, Rochester, NY 14627 USA.	alex@bcs.rochester.edu		Pouget, Alexandre/0000-0003-3054-6365; Lu, Zhong-Lin/0000-0002-7295-727X	Gatsby Charitable Foundation; US National Eye Institute [9 R01 EY017491-05, P30 EY001319]; Multidisciplinary University Research Initiative [N00014-07-1-0937]; US National Institute on Drug Abuse [BCS0346785]; James S. McDonnell Foundation; NATIONAL EYE INSTITUTE [R01EY017491, P30EY001319] Funding Source: NIH RePORTER	Gatsby Charitable Foundation; US National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Multidisciplinary University Research Initiative(MURI); US National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); James S. McDonnell Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	J.M.B. was supported by the Gatsby Charitable Foundation. Z.-L.L. is supported by US National Eye Institute grant 9 R01 EY017491-05 and A. P. by Multidisciplinary University Research Initiative grant N00014-07-1-0937, US National Institute on Drug Abuse grant BCS0346785 and a research grant from the James S. McDonnell Foundation. This work was also partially supported by award P30 EY001319 from the US National Eye Institute.	Ahissar M, 1997, NATURE, V387, P401, DOI 10.1038/387401a0; Averbeck BB, 2006, NAT REV NEUROSCI, V7, P358, DOI 10.1038/nrn1888; Beck JM, 2008, NEURON, V60, P1142, DOI 10.1016/j.neuron.2008.09.021; BECK JM, NEURAL COMP IN PRESS; Cohen MR, 2009, NAT NEUROSCI, V12, P1594, DOI 10.1038/nn.2439; Dosher BA, 1998, P NATL ACAD SCI USA, V95, P13988, DOI 10.1073/pnas.95.23.13988; Dosher BA, 1999, VISION RES, V39, P3197, DOI 10.1016/S0042-6989(99)00059-0; FAHLE M, 1995, VISION RES, V35, P3003, DOI 10.1016/0042-6989(95)00044-Z; Fahle M, 1996, CURR BIOL, V6, P292, DOI 10.1016/S0960-9822(02)00479-7; Ferster D, 2000, ANNU REV NEUROSCI, V23, P441, DOI 10.1146/annurev.neuro.23.1.441; Fine I, 2002, J VISION, V2, P190, DOI 10.1167/2.2.5; FIORENTINI A, 1980, NATURE, V287, P43, DOI 10.1038/287043a0; Gerstner W, 2002, SPIKING NEURON MODEL; Ghose GM, 2002, J NEUROPHYSIOL, V87, P1867, DOI 10.1152/jn.00690.2001; Gold J, 1999, NATURE, V402, P176, DOI 10.1038/46027; Gold JI, 2001, TRENDS COGN SCI, V5, P10, DOI 10.1016/S1364-6613(00)01567-9; Gutnisky DA, 2008, NATURE, V452, P220, DOI 10.1038/nature06563; Hua TM, 2010, CURR BIOL, V20, P887, DOI 10.1016/j.cub.2010.03.066; Jacobs RA, 2009, J VISION, V9, DOI 10.1167/9.4.22; KARNI A, 1991, P NATL ACAD SCI USA, V88, P4966, DOI 10.1073/pnas.88.11.4966; Law CT, 2008, NAT NEUROSCI, V11, P505, DOI 10.1038/nn2070; Law CT, 2009, NAT NEUROSCI, V12, P655, DOI 10.1038/nn.2304; Levi DM, 2003, J NEUROSCI, V23, P2522; Li RW, 2004, NAT NEUROSCI, V7, P178, DOI 10.1038/nn1183; Lu ZL, 2010, VISION RES, V50, P375, DOI 10.1016/j.visres.2009.08.027; Ma WJ, 2006, NAT NEUROSCI, V9, P1432, DOI 10.1038/nn1790; Montani F, 2007, J NEUROSCI, V27, P2338, DOI 10.1523/JNEUROSCI.3417-06.2007; Petrov AA, 2005, PSYCHOL REV, V112, P715, DOI 10.1037/0033-295X.112.4.715; Pouget A, 2001, VISUAL ATTENTION AND CORTICAL CIRCUITS, P265; Raiguel S, 2006, J NEUROSCI, V26, P6589, DOI 10.1523/JNEUROSCI.0457-06.2006; RAMACHANDRAN VS, 1973, PERCEPTION, V2, P371, DOI 10.1068/p020371; RECANZONE GH, 1993, J NEUROSCI, V13, P87; RECANZONE GH, 1992, J NEUROPHYSIOL, V67, P1031, DOI 10.1152/jn.1992.67.5.1031; Schoups A, 2001, NATURE, V412, P549, DOI 10.1038/35087601; Schwabe L, 2005, J NEUROSCI, V25, P3323, DOI 10.1523/JNEUROSCI.4493-04.2005; Series P, 2004, NAT NEUROSCI, V7, P1129, DOI 10.1038/nn1321; SIMONCELLI EP, 1991, IEEE C COMP VIS PATT, P310, DOI 10.1109/CVPR.1991.139707; Smith MA, 2008, J NEUROSCI, V28, P12591, DOI 10.1523/JNEUROSCI.2929-08.2008; SOMERS DC, 1995, J NEUROSCI, V15, P5448; Spiridon M, 2001, NETWORK-COMP NEURAL, V12, P409, DOI 10.1088/0954-898X/12/4/301; SPITZER H, 1988, SCIENCE, V240, P338, DOI 10.1126/science.3353728; Teich AF, 2003, J NEUROPHYSIOL, V89, P2086, DOI 10.1152/jn.00970.2002; TOLHURST DJ, 1983, VISION RES, V23, P775, DOI 10.1016/0042-6989(83)90200-6; Treue S, 1996, NATURE, V382, P539, DOI 10.1038/382539a0; Watanabe T, 2002, NAT NEUROSCI, V5, P1003, DOI 10.1038/nn915; Wu S, 2001, NEURAL COMPUT, V13, P775, DOI 10.1162/089976601300014349; Xiao LQ, 2008, CURR BIOL, V18, P1922, DOI 10.1016/j.cub.2008.10.030; Yang TM, 2004, J NEUROSCI, V24, P1617, DOI 10.1523/JNEUROSCI.4442-03.2004; Zhang JY, 2010, J NEUROSCI, V30, P12323, DOI 10.1523/JNEUROSCI.0704-10.2010; ZOHARY E, 1994, NATURE, V370, P140, DOI 10.1038/370140a0	50	88	89	1	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2011	14	5					642	U139		10.1038/nn.2796	http://dx.doi.org/10.1038/nn.2796			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	754VU	21460833	Green Accepted			2022-12-28	WOS:000289886600021
J	Tollervey, JR; Curk, T; Rogelj, B; Briese, M; Cereda, M; Kayikci, M; Konig, J; Hortobagyi, T; Nishimura, AL; Zupunski, V; Patani, R; Chandran, S; Rot, G; Zupan, B; Shaw, CE; Ule, J				Tollervey, James R.; Curk, Tomaz; Rogelj, Boris; Briese, Michael; Cereda, Matteo; Kayikci, Melis; Koenig, Julian; Hortobagyi, Tibor; Nishimura, Agnes L.; Zupunski, Vera; Patani, Rickie; Chandran, Siddharthan; Rot, Gregor; Zupan, Blaz; Shaw, Christopher E.; Ule, Jernej			Characterizing the RNA targets and position-dependent splicing regulation by TDP-43	NATURE NEUROSCIENCE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; NUCLEAR FACTOR TDP-43; BINDING PROTEIN; BCL-2 FAMILY; ROLES; PHOSPHORYLATION; IDENTIFICATION; EXPRESSION; EVOLUTION; APOPTOSIS	TDP-43 is a predominantly nuclear RNA-binding protein that forms inclusion bodies in frontotemporal lobar degeneration (FTLD) and amyotrophic lateral sclerosis (ALS). The mRNA targets of TDP-43 in the human brain and its role in RNA processing are largely unknown. Using individual nucleotide-resolution ultraviolet cross-linking and immunoprecipitation (ICLIP), we found that TDP-43 preferentially bound long clusters of UG-rich sequences in vivo. Analysis of RNA binding by TDP-43 in brains from subjects with FTLD revealed that the greatest increases in binding were to the MALAT1 and NEAT1 noncoding RNAs. We also found that binding of TDP-43 to pre-mRNAs influenced alternative splicing in a similar position-dependent manner to Nova proteins. In addition, we identified unusually long clusters of TDP-43 binding at deep intronic positions downstream of silenced exons. A substantial proportion of alternative mRNA isoforms regulated by TDP-43 encode proteins that regulate neuronal development or have been implicated in neurological diseases, highlighting the importance of TDP-43 for the regulation of splicing in the brain.	[Tollervey, James R.; Briese, Michael; Cereda, Matteo; Kayikci, Melis; Koenig, Julian; Ule, Jernej] MRC, Mol Biol Lab, Cambridge CB2 2QH, England; [Curk, Tomaz; Rot, Gregor; Zupan, Blaz] Univ Ljubljana, Fac Comp & Informat Sci, Ljubljana, Slovenia; [Rogelj, Boris; Hortobagyi, Tibor; Nishimura, Agnes L.; Zupunski, Vera; Shaw, Christopher E.] Kings Coll London, MRC, Ctr Neurodegenerat Res, London WC2R 2LS, England; [Cereda, Matteo] Sci Inst IRCCS E Medea, Bosisio Parini, LC, Italy; [Zupunski, Vera] Univ Ljubljana, Fac Chem & Chem Technol, Ljubljana, Slovenia; [Patani, Rickie; Chandran, Siddharthan] MRC, Lab Regenerat Med, Dept Clin Neurosci, Cambridge, England; [Chandran, Siddharthan] Univ Edinburgh, Ctr Clin Brain Sci, Edinburgh EH8 9YL, Midlothian, Scotland	MRC Laboratory Molecular Biology; University of Ljubljana; University of London; King's College London; IRCCS Eugenio Medea; University of Ljubljana; University of Edinburgh	Ule, J (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.	jule@mrc-lmb.cam.ac.uk	Cereda, Matteo/V-5988-2019; Curk, Tomaž/D-9836-2015; Zupan, Blaz/L-1595-2019; Rogelj, Boris/G-9252-2011; Ule, Jernej/C-6315-2013; Patani, R/J-3107-2018; Nishimura, Agnes L/B-2905-2011	Cereda, Matteo/0000-0003-1799-5537; Curk, Tomaž/0000-0003-4888-7256; Rogelj, Boris/0000-0003-3898-1943; Ule, Jernej/0000-0002-2452-4277; Patani, R/0000-0002-3825-7675; Zupan, Blaz/0000-0002-5864-7056; Briese, Michael/0000-0001-7137-8260; Nishimura, Agnes/0000-0001-5295-797X; Konig, Julian/0000-0002-9398-5421; Shaw, Christopher/0000-0003-0251-0146	European Research Council [206726-CLIP]; Slovenian Research Agency [P2-0209, J2-2197, L2-1112, Z7-3665]; Wellcome Trust; MRC [089701/Z/09/Z]; Motor Neuron Disease Association; Heaton-Ellis Trust; Psychiatry Research Trust; MRC [MC_U105185858] Funding Source: UKRI; Medical Research Council [G0500289B, G0700711B, MC_U105185858] Funding Source: researchfish	European Research Council(European Research Council (ERC)European Commission); Slovenian Research Agency(Slovenian Research Agency - Slovenia); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Motor Neuron Disease Association; Heaton-Ellis Trust; Psychiatry Research Trust; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank K. Zarnack for advice and comments on the manuscript, F. Baralle, Y. Ayalla and A. D. Ambrogio for HeLa knockdown RNA, and J. Hadfield and the genomic team at CRI for Illumina sequencing. This work was supported by the European Research Council (206726-CLIP), the MRC, Slovenian Research Agency (P2-0209, J2-2197, L2-1112, Z7-3665), Wellcome Trust and MRC Strategic Grant Award (089701/Z/09/Z), Motor Neuron Disease Association, Heaton-Ellis Trust and Psychiatry Research Trust.	Ayala YM, 2008, P NATL ACAD SCI USA, V105, P3785, DOI 10.1073/pnas.0800546105; Ayala YM, 2011, EMBO J, V30, P277, DOI 10.1038/emboj.2010.310; Becker EBE, 2007, CELL CYCLE, V6, P1332, DOI 10.4161/cc.6.11.4316; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Buratti E, 2001, J BIOL CHEM, V276, P36337, DOI 10.1074/jbc.M104236200; Buratti E, 2008, FRONT BIOSCI-LANDMRK, V13, P867, DOI 10.2741/2727; Buratti E, 2010, FEBS J, V277, P2268, DOI 10.1111/j.1742-4658.2010.07643.x; Clemson CM, 2009, MOL CELL, V33, P717, DOI 10.1016/j.molcel.2009.01.026; Clery A, 2008, CURR OPIN STRUC BIOL, V18, P290, DOI 10.1016/j.sbi.2008.04.002; Cleveland DW, 2001, NAT REV NEUROSCI, V2, P806, DOI 10.1038/35097565; Fiesel FC, 2010, EMBO J, V29, P209, DOI 10.1038/emboj.2009.324; Hung LH, 2008, RNA, V14, P284, DOI 10.1261/rna.725208; Igaz LM, 2009, J BIOL CHEM, V284, P8516, DOI 10.1074/jbc.M809462200; Ishiyama N, 2010, CELL, V141, P117, DOI 10.1016/j.cell.2010.01.017; Johnson BS, 2008, P NATL ACAD SCI USA, V105, P6439, DOI 10.1073/pnas.0802082105; Kametani F, 2009, BIOCHEM BIOPH RES CO, V382, P405, DOI 10.1016/j.bbrc.2009.03.038; Kashi Y, 2006, TRENDS GENET, V22, P253, DOI 10.1016/j.tig.2006.03.005; Konig J, 2010, NAT STRUCT MOL BIOL, V17, P909, DOI 10.1038/nsmb.1838; Kouchi Z, 2009, J BIOL CHEM, V284, P1954, DOI 10.1074/jbc.M806250200; Kuo PH, 2009, NUCLEIC ACIDS RES, V37, P1799, DOI 10.1093/nar/gkp013; Lagier-Tourenne C, 2010, HUM MOL GENET, V19, pR46, DOI 10.1093/hmg/ddq137; Legendre M, 2007, GENOME RES, V17, P1787, DOI 10.1101/gr.6554007; Matter C, 2009, NEURON, V64, P320, DOI 10.1016/j.neuron.2009.09.026; Ness JM, 2006, BRAIN RES, V1099, P150, DOI 10.1016/j.brainres.2006.04.132; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; O'Connor L, 1998, EMBO J, V17, P384, DOI 10.1093/emboj/17.2.384; Polymenidou M, 2011, NAT NEUROSCI, V14, P459, DOI 10.1038/nn.2779; Rockman MV, 2002, MOL BIOL EVOL, V19, P1991, DOI 10.1093/oxfordjournals.molbev.a004023; Sephton CF, 2011, J BIOL CHEM, V286, P1204, DOI 10.1074/jbc.M110.190884; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Strong MJ, 2007, MOL CELL NEUROSCI, V35, P320, DOI 10.1016/j.mcn.2007.03.007; Tripathi V, 2010, MOL CELL, V39, P925, DOI 10.1016/j.molcel.2010.08.011; Ule J, 2003, SCIENCE, V302, P1212, DOI 10.1126/science.1090095; Voigt A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012247; Wang Z, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000530; Witten JT, 2011, TRENDS GENET, V27, P89, DOI 10.1016/j.tig.2010.12.001; Wu LS, 2010, GENESIS, V48, P56, DOI 10.1002/dvg.20584; Yang Q, 2009, SCIENCE, V323, P124, DOI 10.1126/science.1166088	38	708	718	2	103	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2011	14	4					452	U180		10.1038/nn.2778	http://dx.doi.org/10.1038/nn.2778			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	741FQ	21358640	Green Accepted			2022-12-28	WOS:000288849400016
J	Chang, MC; Park, JM; Pelkey, KA; Grabenstatter, HL; Xu, DS; Linden, DJ; Sutula, TP; McBain, CJ; Worley, PF				Chang, Michael C.; Park, Joo Min; Pelkey, Kenneth A.; Grabenstatter, Heidi L.; Xu, Desheng; Linden, David J.; Sutula, Thomas P.; McBain, Chris J.; Worley, Paul F.			Narp regulates homeostatic scaling of excitatory synapses on parvalbumin-expressing interneurons	NATURE NEUROSCIENCE			English	Article							FAST-SPIKING CELLS; AMPA RECEPTORS; MESSENGER-RNAS; PLASTICITY; NEURONS; PENTRAXIN; SUBUNIT; AGGREGATION; INHIBITION; INTERACTS	Homeostatic synaptic scaling alters the strength of synapses to compensate for prolonged changes in network activity and involves both excitatory and inhibitory neurons. The immediate-early gene Narp (neuronal activity-regulated pentraxin) encodes a secreted synaptic protein that can bind to and induce clustering of AMPA receptors (AMPARs). We found that Narp prominently accumulated at excitatory synapses on parvalbumin-expressing interneurons (PV-INs). Increasing network activity resulted in a homeostatic increase of excitatory synaptic strength onto PV-INs that increased inhibitory drive and this response was absent in neurons cultured from Narp(-/-) mice. Activity-dependent changes in the strength of excitatory inputs on PV-INs in acute hippocampal slices were also dependent on Narp and Narp(-/-) mice had increased sensitivity to kindling-induced seizures. We propose that Narp recruits AMPARs at excitatory synapses onto PV-INs to rebalance network excitation/inhibition dynamics following episodes of increased circuit activity.	[Chang, Michael C.; Park, Joo Min; Xu, Desheng; Linden, David J.; Worley, Paul F.] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21218 USA; [Pelkey, Kenneth A.; McBain, Chris J.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Lab Cellular & Synapt Neurophysiol, NIH, Bethesda, MD USA; [Grabenstatter, Heidi L.; Sutula, Thomas P.] Univ Wisconsin, Dept Neurol, Madison, WI 53706 USA; [Worley, Paul F.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA	Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of Wisconsin System; University of Wisconsin Madison; Johns Hopkins University	Worley, PF (corresponding author), Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21218 USA.	pworley@jhmi.edu			US National Institutes of Health [PAR-02-059, NS 39156]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039156] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank M.S. Perin for the Narp<SUP>-/-</SUP> mouse, R.L. Huganir (Johns Hopkins University) for antibodies to GluR1, M. Dehoff and P. Chuang for animal care, M. Papapavlou for administrative assistance and X. Yuan and B. Jeffries for technical assistance. Work in the laboratory of C.J.M. is supported by a US National Institutes of Health intramural award. Work in the laboratory of P.F.W. is supported by US National Institutes of Health grants PAR-02-059 and NS 39156.	Alle H, 2001, P NATL ACAD SCI USA, V98, P14708, DOI 10.1073/pnas.251610898; BEKENSTEIN JW, 1993, SCIENCE, V259, P97, DOI 10.1126/science.8093417; Berke JD, 1998, J NEUROSCI, V18, P5301, DOI 10.1523/JNEUROSCI.18-14-05301.1998; Bjartmar L, 2006, J NEUROSCI, V26, P6269, DOI 10.1523/jneurosci.4212-05.2006; Bruckner G, 1998, EXP BRAIN RES, V121, P300, DOI 10.1007/s002210050463; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; Cho RW, 2008, NEURON, V57, P858, DOI 10.1016/j.neuron.2008.01.010; Chowdhury S, 2006, NEURON, V52, P445, DOI 10.1016/j.neuron.2006.08.033; COLE AJ, 1990, J NEUROCHEM, V55, P1920, DOI 10.1111/j.1471-4159.1990.tb05777.x; Dodds DC, 1997, J BIOL CHEM, V272, P21488, DOI 10.1074/jbc.272.34.21488; Doyle S, 2010, J BIOL CHEM, V285, P14366, DOI 10.1074/jbc.M109.080069; EMSLEY J, 1994, NATURE, V367, P338, DOI 10.1038/367338a0; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Frischknecht R, 2009, NAT NEUROSCI, V12, P897, DOI 10.1038/nn.2338; Fuchs EC, 2007, NEURON, V53, P591, DOI 10.1016/j.neuron.2007.01.031; GEIGER JRP, 1995, NEURON, V15, P193, DOI 10.1016/0896-6273(95)90076-4; Gogolla N, 2009, SCIENCE, V325, P1258, DOI 10.1126/science.1174146; HARTIG W, 1992, NEUROREPORT, V3, P869; Hartig W, 1999, BRAIN RES, V842, P15, DOI 10.1016/S0006-8993(99)01784-9; Hensch TK, 2005, NAT REV NEUROSCI, V6, P877, DOI 10.1038/nrn1787; HONIG MG, 1986, J CELL BIOL, V103, P171, DOI 10.1083/jcb.103.1.171; KAWAGUCHI Y, 1987, BRAIN RES, V416, P369, DOI 10.1016/0006-8993(87)90921-8; Kinney JW, 2006, J NEUROSCI, V26, P1604, DOI 10.1523/JNEUROSCI.4722-05.2006; KOH DS, 1995, J PHYSIOL-LONDON, V485, P383, DOI 10.1113/jphysiol.1995.sp020737; KOSAKA T, 1989, BRAIN RES, V483, P158, DOI 10.1016/0006-8993(89)90048-6; Lewis DA, 2005, NAT REV NEUROSCI, V6, P312, DOI 10.1038/nrn1648; Lin YX, 2008, NATURE, V455, P1198, DOI 10.1038/nature07319; Maffei A, 2006, NATURE, V443, P81, DOI 10.1038/nature05079; Mi RF, 2002, J NEUROSCI, V22, P7606; Morimoto K, 2004, PROG NEUROBIOL, V73, P1, DOI 10.1016/j.pneurobio.2004.03.009; Nissen W, 2010, J NEUROSCI, V30, P1337, DOI 10.1523/JNEUROSCI.3481-09.2010; O'Brien R, 2002, J NEUROSCI, V22, P4487, DOI 10.1523/JNEUROSCI.22-11-04487.2002; O'Brien RJ, 1999, NEURON, V23, P309, DOI 10.1016/S0896-6273(00)80782-5; Park S, 2008, NEURON, V59, P70, DOI 10.1016/j.neuron.2008.05.023; Pelkey KA, 2005, NEURON, V46, P89, DOI 10.1016/j.neuron.2005.02.011; Reti IM, 2000, NEUROPSYCHOPHARMACOL, V23, P439, DOI 10.1016/S0893-133X(00)00120-2; Sayin U, 2003, J NEUROSCI, V23, P2759; Shepherd JD, 2006, NEURON, V52, P475, DOI 10.1016/j.neuron.2006.08.034; Sia GM, 2007, NEURON, V55, P87, DOI 10.1016/j.neuron.2007.06.020; Sloviter R S, 1991, Hippocampus, V1, P41, DOI 10.1002/hipo.450010106; Tsui CC, 1996, J NEUROSCI, V16, P2463; Turrigiano GG, 1999, TRENDS NEUROSCI, V22, P221, DOI 10.1016/S0166-2236(98)01341-1; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; Turrigiano GG, 2000, CURR OPIN NEUROBIOL, V10, P358, DOI 10.1016/S0959-4388(00)00091-X; Watanabe M, 1998, EUR J NEUROSCI, V10, P478, DOI 10.1046/j.1460-9568.1998.00063.x; Xu DS, 2003, NEURON, V39, P513, DOI 10.1016/S0896-6273(03)00463-X	46	187	192	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2010	13	9					1090	U83		10.1038/nn.2621	http://dx.doi.org/10.1038/nn.2621			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	643XC	20729843	Green Accepted			2022-12-28	WOS:000281332600014
J	Boccara, CN; Sargolini, F; Thoresen, VH; Solstad, T; Witter, MP; Moser, EI; Moser, MB				Boccara, Charlotte N.; Sargolini, Francesca; Thoresen, Veslemoy Hult; Solstad, Trygve; Witter, Menno P.; Moser, Edvard I.; Moser, May-Britt			Grid cells in pre- and parasubiculum	NATURE NEUROSCIENCE			English	Article							MEDIAL ENTORHINAL CORTEX; MEMBRANE-POTENTIAL OSCILLATIONS; SPATIAL REPRESENTATION SYSTEM; FREELY MOVING RATS; LAYER-II; RETROHIPPOCAMPAL REGION; HIPPOCAMPAL-FORMATION; PATH-INTEGRATION; DIRECTION CELLS; COGNITIVE MAP	Allocentric space is mapped by a widespread brain circuit of functionally specialized cell types located in interconnected subregions of the hippocampal-parahippocampal cortices. Little is known about the neural architectures required to express this variety of firing patterns. In rats, we found that one of the cell types, the grid cell, was abundant not only in medial entorhinal cortex (MEC), where it was first reported, but also in pre- and parasubiculum. The proportion of grid cells in pre- and parasubiculum was comparable to deep layers of MEC. The symmetry of the grid pattern and its relationship to the theta rhythm were weaker, especially in presubiculum. Pre- and parasubicular grid cells intermingled with head-direction cells and border cells, as in deep MEC layers. The characterization of a common pool of space-responsive cells in architecturally diverse subdivisions of parahippocampal cortex constrains the range of mechanisms that might give rise to their unique functional discharge phenotypes.	[Boccara, Charlotte N.; Sargolini, Francesca; Thoresen, Veslemoy Hult; Solstad, Trygve; Witter, Menno P.; Moser, Edvard I.; Moser, May-Britt] Norwegian Univ Sci & Technol, MTFS, Kavli Inst Syst Neurosci, N-7034 Trondheim, Norway; [Boccara, Charlotte N.; Sargolini, Francesca; Thoresen, Veslemoy Hult; Solstad, Trygve; Witter, Menno P.; Moser, Edvard I.; Moser, May-Britt] Norwegian Univ Sci & Technol, MTFS, Ctr Biol Memory, N-7034 Trondheim, Norway; [Sargolini, Francesca] Univ Aix Marseille 1, CNRS, UMR Pole 3C 6155, Lab Neurobiol Cognit, Marseille, France	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Moser, EI (corresponding author), Norwegian Univ Sci & Technol, MTFS, Kavli Inst Syst Neurosci, N-7034 Trondheim, Norway.	edvard.moser@ntnu.no	Boccara, Charlotte/AAP-8625-2020	Sargolini, Francesca/0000-0002-5038-3746	Kavli Foundation; Norwegian Research Council	Kavli Foundation; Norwegian Research Council(Research Council of NorwayEuropean Commission)	We thank R. Skjerpeng for programming, D. Derdikman for help with code, J. Ainge for donating an implanted rat, and A. M. Amundgard, I. Hammer, K. Haugen, K. Jenssen and H. Waade for technical assistance. This work was supported by the Kavli Foundation and a Centre of Excellence grant from the Norwegian Research Council.	ALONSO A, 1989, NATURE, V342, P175, DOI 10.1038/342175a0; Brun VH, 2008, HIPPOCAMPUS, V18, P1200, DOI 10.1002/hipo.20504; Burak Y, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000291; Burgess N, 2007, HIPPOCAMPUS, V17, P801, DOI 10.1002/hipo.20327; Cacucci F, 2004, J NEUROSCI, V24, P8265, DOI 10.1523/JNEUROSCI.2635-04.2004; Colgin LL, 2008, TRENDS NEUROSCI, V31, P469, DOI 10.1016/j.tins.2008.06.008; Dhillon A, 2000, NEUROSCIENCE, V99, P413, DOI 10.1016/S0306-4522(00)00225-6; Egorov AV, 2002, NATURE, V420, P173, DOI 10.1038/nature01171; Fricker D, 2009, J PHYSIOL-LONDON, V587, P4249, DOI 10.1113/jphysiol.2009.175349; Fuhs MC, 2006, J NEUROSCI, V26, P4266, DOI 10.1523/JNEUROSCI.4353-05.2006; Funahashi M, 1997, J PHYSIOL-LONDON, V501, P387, DOI 10.1111/j.1469-7793.1997.387bn.x; Fyhn M, 2004, SCIENCE, V305, P1258, DOI 10.1126/science.1099901; Fyhn M, 2007, NATURE, V446, P190, DOI 10.1038/nature05601; Giocomo LM, 2007, SCIENCE, V315, P1719, DOI 10.1126/science.1139207; Glasgow SD, 2008, J NEUROPHYSIOL, V100, P2746, DOI 10.1152/jn.90351.2008; Glasgow SD, 2007, J NEUROPHYSIOL, V97, P3868, DOI 10.1152/jn.01306.2006; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Hafting T, 2008, NATURE, V453, P1248, DOI 10.1038/nature06957; Hargreaves EL, 2005, SCIENCE, V308, P1792, DOI 10.1126/science.1110449; Hargreaves EL, 2007, HIPPOCAMPUS, V17, P826, DOI 10.1002/hipo.20316; Hasselmo ME, 2007, HIPPOCAMPUS, V17, P1252, DOI 10.1002/hipo.20374; Hasselmo ME, 2008, HIPPOCAMPUS, V18, P1213, DOI 10.1002/hipo.20512; Klink R, 1997, HIPPOCAMPUS, V7, P571; KOHLER C, 1986, J COMP NEUROL, V246, P149, DOI 10.1002/cne.902460202; KOHLER C, 1985, J COMP NEUROL, V236, P504, DOI 10.1002/cne.902360407; Kumar SS, 2007, J NEUROSCI, V27, P1239, DOI 10.1523/JNEUROSCI.3182-06.2007; Langston RF, 2010, SCIENCE, V328, P1576, DOI 10.1126/science.1188210; Leutgeb S, 2004, SCIENCE, V305, P1295, DOI 10.1126/science.1100265; Lever C, 2009, J NEUROSCI, V29, P9771, DOI 10.1523/JNEUROSCI.1319-09.2009; McNaughton BL, 2006, NAT REV NEUROSCI, V7, P663, DOI 10.1038/nrn1932; Moser EI, 2008, ANNU REV NEUROSCI, V31, P69, DOI 10.1146/annurev.neuro.31.061307.090723; MULLER RU, 1987, J NEUROSCI, V7, P1951; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; OKEEFE J, 1978, EXP BRAIN RES, V31, P573; Ranck J.B., 1985, ELECT ACTIVITY ARCHI, P217; Sargolini F, 2006, SCIENCE, V312, P758, DOI 10.1126/science.1125572; Savelli F, 2008, HIPPOCAMPUS, V18, P1270, DOI 10.1002/hipo.20511; Sharp PE, 1996, CEREB CORTEX, V6, P238, DOI 10.1093/cercor/6.2.238; Solstad T, 2008, SCIENCE, V322, P1865, DOI 10.1126/science.1166466; Taube JS, 2007, ANNU REV NEUROSCI, V30, P181, DOI 10.1146/annurev.neuro.29.051605.112854; Taube JS, 1995, HIPPOCAMPUS, V5, P569, DOI 10.1002/hipo.450050608; TAUBE JS, 1990, J NEUROSCI, V10, P420; TOLMAN EC, 1948, PSYCHOL REV, V55, P189, DOI 10.1037/h0061626; VANGROEN T, 1990, BRAIN RES, V518, P227, DOI 10.1016/0006-8993(90)90976-I; Whitlock JR, 2008, P NATL ACAD SCI USA, V105, P14755, DOI 10.1073/pnas.0804216105; Wills TJ, 2010, SCIENCE, V328, P1573, DOI 10.1126/science.1188224; Witter M. P., 2004, RAT NERVOUS SYSTEM, V3rd, P637; WOUTERLOOD FG, 1995, J NEUROCYTOL, V24, P135, DOI 10.1007/BF01181556; Yoshida M, 2009, J NEUROSCI, V29, P4945, DOI 10.1523/JNEUROSCI.5154-08.2009	50	335	340	1	48	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2010	13	8					987	U112		10.1038/nn.2602	http://dx.doi.org/10.1038/nn.2602			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	632DK	20657591				2022-12-28	WOS:000280400600018
J	Wiechert, MT; Judkewitz, B; Riecke, H; Friedrich, RW				Wiechert, Martin T.; Judkewitz, Benjamin; Riecke, Hermann; Friedrich, Rainer W.			Mechanisms of pattern decorrelation by recurrent neuronal circuits	NATURE NEUROSCIENCE			English	Article							ZEBRAFISH OLFACTORY-BULB; ODOR REPRESENTATIONS; LATERAL INHIBITION; MITRAL CELLS; FIRING RATE; SPIKE; SEPARATION; SYNCHRONY; NETWORKS; DYNAMICS	Decorrelation is a fundamental computation that optimizes the format of neuronal activity patterns. Channel decorrelation by adaptive mechanisms results in efficient coding, whereas pattern decorrelation facilitates the readout and storage of information. Mechanisms achieving pattern decorrelation, however, remain unclear. We developed a theoretical framework that relates high-dimensional pattern decorrelation to neuronal and circuit properties in a mathematically stringent fashion. For a generic class of random neuronal networks, we proved that pattern decorrelation emerges from neuronal nonlinearities and is amplified by recurrent connectivity. This mechanism does not require adaptation of the network, is enhanced by sparse connectivity, depends on the baseline membrane potential and is robust. Connectivity measurements and computational modeling suggest that this mechanism is involved in pattern decorrelation in the zebrafish olfactory bulb. These results reveal a generic relationship between the structure and function of neuronal circuits that is probably relevant for pattern processing in various brain areas.	[Wiechert, Martin T.; Friedrich, Rainer W.] Friedrich Miescher Inst Biomed Res, Basel, Switzerland; [Judkewitz, Benjamin] UCL, Wolfson Inst Biomed Res, London, England; [Riecke, Hermann] Northwestern Univ, Evanston, IL USA	Friedrich Miescher Institute for Biomedical Research; University of London; University College London; Northwestern University	Friedrich, RW (corresponding author), Friedrich Miescher Inst Biomed Res, Basel, Switzerland.	rainer.friedrich@fmi.ch	Judkewitz, Benjamin/C-3645-2014; Riecke, Hermann/AAB-7558-2021; Riecke, Hermann/E-6118-2012; Riecke, Hermann E/B-7388-2009	Judkewitz, Benjamin/0000-0002-8570-3869; Riecke, Hermann/0000-0002-6070-4742; Friedrich, Rainer/0000-0001-9107-0482	Novartis Research Foundation; Max-Planck-Society; Alexander-von-Humboldt Foundation; National Science Foundation [DMS-0719944]; European Union [IST-507610]; Deutsche Forschungsgemeinschaft [SFB 488, FOR 643]	Novartis Research Foundation; Max-Planck-Society(Max Planck SocietyFoundation CELLEX); Alexander-von-Humboldt Foundation(Alexander von Humboldt Foundation); National Science Foundation(National Science Foundation (NSF)); European Union(European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank Y.-P. Zhang and O. Fajardo for help with histological procedures, T. Oertner, B. Roska and J.M. Stix for comments on the manuscript, and members of the Friedrich laboratory for discussions. This work was supported by the Novartis Research Foundation, the Max-Planck-Society, the Alexander-von-Humboldt Foundation, the National Science Foundation (DMS-0719944 to H. R.), the European Union (IST-507610 to R. W. F.) and the Deutsche Forschungsgemeinschaft (SFB 488; FOR 643 to R. W. F.).	Amari S.-i., 1995, INT S NONL THEOR ITS, P37; Arevian AC, 2008, NAT NEUROSCI, V11, P80, DOI 10.1038/nn2030; ATICK JJ, 1993, NEURAL COMPUT, V5, P45, DOI 10.1162/neco.1993.5.1.45; Bapat R.B., 1997, NONNEGATIVE MATRICES, DOI DOI 10.1017/CBO9780511529979; Barlow H, 2001, NETWORK-COMP NEURAL, V12, P241, DOI 10.1088/0954-898X/12/3/301; Barlow H. B., 1961, SENS COMMUN, P217, DOI DOI 10.7551/MITPRESS/9780262518420.003.0013; BAUM RF, 1969, IEEE T INFORM THEORY, V15, P448, DOI 10.1109/TIT.1969.1054328; Braitenberg V, 1998, CORTEX STAT GEOMETRY; Brown GD, 2001, TRENDS NEUROSCI, V24, P54, DOI 10.1016/S0166-2236(00)01683-0; Christie JM, 2005, NEURON, V46, P761, DOI 10.1016/j.neuron.2005.04.030; Cleland TA, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-7; de la Rocha J, 2007, NATURE, V448, P802, DOI 10.1038/nature06028; Egger V, 2005, J NEUROSCI, V25, P3521, DOI 10.1523/JNEUROSCI.4746-04.2005; Fantana AL, 2008, NEURON, V59, P802, DOI 10.1016/j.neuron.2008.07.039; French RM, 1999, TRENDS COGN SCI, V3, P128, DOI 10.1016/S1364-6613(99)01294-2; Friedrich RW, 2004, NAT NEUROSCI, V7, P862, DOI 10.1038/nn1292; Friedrich RW, 2004, J NEUROPHYSIOL, V91, P2658, DOI 10.1152/jn.01143.2003; Friedrich RW, 1997, NEURON, V18, P737, DOI 10.1016/S0896-6273(00)80314-1; Friedrich RW, 2001, SCIENCE, V291, P889, DOI 10.1126/science.291.5505.889; Galassi M., 2009, GNU SCI LIB REFERENC, DOI [10.5555/1538674, DOI 10.5555/1538674]; Hahnloser RHR, 2003, NEURAL COMPUT, V15, P621, DOI 10.1162/089976603321192103; HARTLINE HK, 1957, J GEN PHYSIOL, V40, P357, DOI 10.1085/jgp.40.3.357; HASSELMO ME, 1990, COLD SPRING HARB SYM, V55, P599; Hummel R. A., 1975, COMPUT GRAPH IMAGE P, V4, P209; Isaacson JS, 2001, P NATL ACAD SCI USA, V98, P337, DOI 10.1073/pnas.021445798; Itskov V, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.018101; Jortner RA, 2007, J NEUROSCI, V27, P1659, DOI 10.1523/JNEUROSCI.4171-06.2007; Kapoor V, 2006, J NEUROSCI, V26, P11709, DOI 10.1523/JNEUROSCI.3371-06.2006; Leutgeb JK, 2007, SCIENCE, V315, P961, DOI 10.1126/science.1135801; Lewicki MS, 2002, NAT NEUROSCI, V5, P356, DOI 10.1038/nn831; Li J, 2005, J NEUROSCI, V25, P5784, DOI 10.1523/JNEUROSCI.0922-05.2005; Lisman JE, 1999, NEURON, V22, P233, DOI 10.1016/S0896-6273(00)81085-5; MARR D, 1969, J PHYSIOL-LONDON, V202, P437, DOI 10.1113/jphysiol.1969.sp008820; Meister M, 2001, J NEUROSCI, V21, P1351; Olshausen BA, 1996, NATURE, V381, P607, DOI 10.1038/381607a0; Parra LC, 2001, INDEPENDENT COMPONENT ANALYSIS: PRINCIPLES AND PRACTICE, P135; Perez-Orive J, 2002, SCIENCE, V297, P359, DOI 10.1126/science.1070502; Rinberg D, 2006, J NEUROSCI, V26, P8857, DOI 10.1523/JNEUROSCI.0884-06.2006; Rolls ET, 2006, PROG NEUROBIOL, V79, P1, DOI 10.1016/j.pneurobio.2006.04.005; Soucy ER, 2009, NAT NEUROSCI, V12, P210, DOI 10.1038/nn.2262; Srivastava V, 2008, J THEOR BIOL, V253, P514, DOI 10.1016/j.jtbi.2008.03.031; Urban NN, 2002, J PHYSIOL-LONDON, V542, P355, DOI 10.1113/jphysiol.2001.013491; Vinje WE, 2000, SCIENCE, V287, P1273, DOI 10.1126/science.287.5456.1273; Weinstein E, 1993, IEEE T SPEECH AUDI P, V1, P405, DOI 10.1109/89.242486; Willhite DC, 2006, P NATL ACAD SCI USA, V103, P12592, DOI 10.1073/pnas.0602032103; Wills TJ, 2005, SCIENCE, V308, P873, DOI 10.1126/science.1108905; Wilson RI, 2004, SCIENCE, V303, P366, DOI 10.1126/science.1090782; Yaksi E, 2006, NAT METHODS, V3, P377, DOI 10.1038/NMETH874; Yaksi E, 2007, PLOS BIOL, V5, P1453, DOI 10.1371/journal.pbio.0050178; YOKOI M, 1995, P NATL ACAD SCI USA, V92, P3371, DOI 10.1073/pnas.92.8.3371	50	71	73	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2010	13	8					1003	U132		10.1038/nn.2591	http://dx.doi.org/10.1038/nn.2591			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	632DK	20581841				2022-12-28	WOS:000280400600020
J	Kennerley, SW; Behrens, TEJ; Wallis, JD				Kennerley, Steven W.; Behrens, Timothy E. J.; Wallis, Jonathan D.			Double dissociation of value computations in orbitofrontal and anterior cingulate neurons	NATURE NEUROSCIENCE			English	Article							TEMPORALLY DISCOUNTED VALUES; PREFRONTAL CORTEX; DECISION-MAKING; DOPAMINE NEURONS; ECONOMIC VALUE; INTERTEMPORAL CHOICE; REWARD PREFERENCE; SINGLE NEURONS; DISTINCT ROLES; PERFORMANCE	Damage to prefrontal cortex (PFC) impairs decision-making, but the underlying value computations that might cause such impairments remain unclear. Here we report that value computations are doubly dissociable among PFC neurons. Although many PFC neurons encoded chosen value, they used opponent encoding schemes such that averaging the neuronal population extinguished value coding. However, a special population of neurons in anterior cingulate cortex (ACC), but not in orbitofrontal cortex (OFC), multiplexed chosen value across decision parameters using a unified encoding scheme and encoded reward prediction errors. In contrast, neurons in OFC, but not ACC, encoded chosen value relative to the recent history of choice values. Together, these results suggest complementary valuation processes across PFC areas: OFC neurons dynamically evaluate current choices relative to recent choice values, whereas ACC neurons encode choice predictions and prediction errors using a common valuation currency reflecting the integration of multiple decision parameters.	[Kennerley, Steven W.; Behrens, Timothy E. J.] UCL, Inst Neurol, London, England; [Kennerley, Steven W.] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; [Behrens, Timothy E. J.] Univ Oxford, John Radcliffe Hosp, Oxford Ctr Funct Magnet Resonance Imaging Brain F, Oxford OX3 9DU, England; [Wallis, Jonathan D.] Univ Calif Berkeley, Dept Psychol, Berkeley, CA 94720 USA	University of London; University College London; University of California System; University of California Berkeley; University of Oxford; University of California System; University of California Berkeley	Kennerley, SW (corresponding author), UCL, Inst Neurol, London, England.	s.kennerley@ucl.ac.uk	Kennerley, Steven W/E-3330-2018	Kennerley, Steven W/0000-0002-5696-7507; Behrens, Timothy/0000-0003-0048-1177; Wallis, Joni/0000-0001-7262-7417	US National Institute on Drug Abuse [R01DA19028]; US National Institute of Neurological Disorders and Stroke [P01NS040813]; US National Institute on Mental Health [F32MH081521]; Wellcome Trust; NATIONAL INSTITUTE OF MENTAL HEALTH [F32MH081521] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS040813] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA019028] Funding Source: NIH RePORTER	US National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); US National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); US National Institute on Mental Health; Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The project was funded by US National Institute on Drug Abuse grant R01DA19028, US National Institute of Neurological Disorders and Stroke grant P01NS040813 to J.W. and US National Institute on Mental Health training grant F32MH081521 to S.W.K. T.E.J.B. and S.W.K. are supported by the Wellcome Trust.	Amiez C, 2005, EUR J NEUROSCI, V21, P3447, DOI 10.1111/j.1460-9568.2005.04170.x; Bayer HM, 2005, NEURON, V47, P129, DOI 10.1016/j.neuron.2005.05.020; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; Behrens TEJ, 2007, NAT NEUROSCI, V10, P1214, DOI 10.1038/nn1954; Bernacchia A, 2011, NAT NEUROSCI, V14, P366, DOI 10.1038/nn.2752; Buckley MJ, 2009, SCIENCE, V325, P52, DOI 10.1126/science.1172377; Cai XY, 2011, NEURON, V69, P170, DOI 10.1016/j.neuron.2010.11.041; Daw ND, 2006, NATURE, V441, P876, DOI 10.1038/nature04766; Debener S, 2005, J NEUROSCI, V25, P11730, DOI 10.1523/JNEUROSCI.3286-05.2005; Fellows LK, 2006, BRAIN, V129, P944, DOI 10.1093/brain/awl017; Fiorillo CD, 2003, SCIENCE, V299, P1898, DOI 10.1126/science.1077349; Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI 10.1037/0033-295X.109.4.679; Jessup RK, 2010, J NEUROSCI, V30, P3467, DOI 10.1523/JNEUROSCI.4130-09.2010; Jocham G, 2009, J NEUROSCI, V29, P7489, DOI 10.1523/JNEUROSCI.0349-09.2009; Kennerley SW, 2006, NAT NEUROSCI, V9, P940, DOI 10.1038/nn1724; Kennerley SW, 2009, J NEUROPHYSIOL, V102, P3352, DOI 10.1152/jn.00273.2009; Kennerley SW, 2009, EUR J NEUROSCI, V29, P2061, DOI 10.1111/j.1460-9568.2009.06743.x; Kennerley SW, 2009, J COGNITIVE NEUROSCI, V21, P1162, DOI 10.1162/jocn.2009.21100; Kim S, 2008, NEURON, V59, P161, DOI 10.1016/j.neuron.2008.05.010; Kobayashi S, 2010, J NEUROSCI, V30, P534, DOI 10.1523/JNEUROSCI.4009-09.2010; Machens CK, 2005, SCIENCE, V307, P1121, DOI 10.1126/science.1104171; Matsumoto M, 2007, NAT NEUROSCI, V10, P647, DOI 10.1038/nn1890; Matsumoto M, 2009, NATURE, V459, P837, DOI 10.1038/nature08028; Montague PR, 2002, NEURON, V36, P265, DOI 10.1016/S0896-6273(02)00974-1; Morrison SE, 2009, J NEUROSCI, V29, P11471, DOI 10.1523/JNEUROSCI.1815-09.2009; Noonan MP, 2010, P NATL ACAD SCI USA, V107, P20547, DOI 10.1073/pnas.1012246107; O'Neill M, 2010, NEURON, V68, P789, DOI 10.1016/j.neuron.2010.09.031; Oliveira FTP, 2007, J COGNITIVE NEUROSCI, V19, P1994, DOI 10.1162/jocn.2007.19.12.1994; Padoa-Schioppa C, 2006, NATURE, V441, P223, DOI 10.1038/nature04676; Padoa-Schioppa C, 2008, NAT NEUROSCI, V11, P95, DOI 10.1038/nn2020; Padoa-Schioppa C, 2009, J NEUROSCI, V29, P14004, DOI 10.1523/JNEUROSCI.3751-09.2009; Platt ML, 1999, NATURE, V400, P233, DOI 10.1038/22268; Prevost C, 2010, J NEUROSCI, V30, P14080, DOI 10.1523/JNEUROSCI.2752-10.2010; Rangel A, 2008, NAT REV NEUROSCI, V9, P545, DOI 10.1038/nrn2357; Roesch MR, 2003, J NEUROPHYSIOL, V90, P1766, DOI 10.1152/jn.00019.2003; Rudebeck PH, 2008, J NEUROSCI, V28, P13775, DOI 10.1523/JNEUROSCI.3541-08.2008; Rushworth MFS, 2008, NAT NEUROSCI, V11, P389, DOI 10.1038/nn2066; Sallet J, 2007, COGN AFFECT BEHAV NE, V7, P327, DOI 10.3758/CABN.7.4.327; Seo H, 2007, J NEUROSCI, V27, P8366, DOI 10.1523/JNEUROSCI.2369-07.2007; Seo H, 2009, J NEUROSCI, V29, P3627, DOI 10.1523/JNEUROSCI.4726-08.2009; Shuler MG, 2006, SCIENCE, V311, P1606, DOI 10.1126/science.1123513; Sul JH, 2010, NEURON, V66, P449, DOI 10.1016/j.neuron.2010.03.033; Takahashi YK, 2009, NEURON, V62, P269, DOI 10.1016/j.neuron.2009.03.005; Tobler PN, 2005, SCIENCE, V307, P1642, DOI 10.1126/science.1105370; Tremblay L, 1999, NATURE, V398, P704, DOI 10.1038/19525; Wallis JD, 2003, EUR J NEUROSCI, V18, P2069, DOI 10.1046/j.1460-9568.2003.02922.x; Wallis JD, 2010, CURR OPIN NEUROBIOL, V20, P191, DOI 10.1016/j.conb.2010.02.009; Walton ME, 2010, NEURON, V65, P927, DOI 10.1016/j.neuron.2010.02.027; Walton ME, 2004, NAT NEUROSCI, V7, P1259, DOI 10.1038/nn1339; Williams ZM, 2004, NAT NEUROSCI, V7, P1370, DOI 10.1038/nn1354	50	300	304	1	52	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	2011	14	12					1581	U119		10.1038/nn.2961	http://dx.doi.org/10.1038/nn.2961			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	855EJ	22037498	Green Accepted			2022-12-28	WOS:000297546300019
J	Markwardt, SJ; Dieni, CV; Wadiche, JI; Overstreet-Wadiche, L				Markwardt, Sean J.; Dieni, Cristina V.; Wadiche, Jacques I.; Overstreet-Wadiche, Linda			Ivy/neurogliaform interneurons coordinate activity in the neurogenic niche	NATURE NEUROSCIENCE			English	Article							NEUROGLIAFORM CELLS; NEURONS; HIPPOCAMPUS; INHIBITION; NETWORK; IVY	Depolarization by the neurotransmitter GABA regulates adult neurogenesis. We found interneurons of the neurogliaform cell family to be a primary source of GABA for newborn neurons in mouse dentate gyrus. GABAergic depolarization occurred in concert with reduced synaptic inhibition of mature neurons, suggesting that the local circuitry coordinates the activation of new and pre-existing cells.	[Markwardt, Sean J.; Dieni, Cristina V.; Wadiche, Jacques I.; Overstreet-Wadiche, Linda] Univ Alabama, McKnight Brain Inst, Dept Neurobiol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Overstreet-Wadiche, L (corresponding author), Univ Alabama, McKnight Brain Inst, Dept Neurobiol, Birmingham, AL 35294 USA.	lwadiche@uab.edu	DIENI, Cristina Vittoria/J-7998-2019	DIENI, Cristina Vittoria/0000-0003-1632-5590; Wadiche, Linda/0000-0001-7367-5998; Wadiche, Jacques/0000-0001-8180-2061	US National Institutes of Health [5T32GM008111, 5R01NS064025, 2P30NS047466]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008111] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047466, R01NS064025] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank members of the Wadiche laboratory and A. Tzingounis for helpful comments, and A. Margolies and C. Zhao for technical assistance. This work was supported by grants from the US National Institutes of Health (5T32GM008111, 5R01NS064025 and 2P30NS047466).	Armstrong C, 2011, J COMP NEUROL, V519, P1476, DOI 10.1002/cne.22577; Banks MI, 2000, NEURON, V25, P449, DOI 10.1016/S0896-6273(00)80907-1; Esposito MS, 2005, J NEUROSCI, V25, P10074, DOI 10.1523/JNEUROSCI.3114-05.2005; Fuentealba P, 2008, NEURON, V57, P917, DOI 10.1016/j.neuron.2008.01.034; Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404; Karayannis T, 2010, J NEUROSCI, V30, P9898, DOI 10.1523/JNEUROSCI.5883-09.2010; Markwardt SJ, 2009, J NEUROSCI, V29, P15063, DOI 10.1523/JNEUROSCI.2727-09.2009; MICHELSON HB, 1994, J PHYSIOL-LONDON, V477, P35, DOI 10.1113/jphysiol.1994.sp020169; Olah S, 2009, NATURE, V461, P1278, DOI 10.1038/nature08503; Olah S, 2007, FRONT NEURAL CIRCUIT, V1, DOI [10.3389/neuro.04/004.2007, 10.3389/neuro.04.004.2007]; Price CJ, 2005, J NEUROSCI, V25, P6775, DOI 10.1523/JNEUROSCI.1135-05.2005; SOLTESZ I, 1995, NEURON, V14, P1273, DOI 10.1016/0896-6273(95)90274-0; Szabadics J, 2007, P NATL ACAD SCI USA, V104, P14831, DOI 10.1073/pnas.0707204104; Tamas G, 2003, SCIENCE, V299, P1902, DOI 10.1126/science.1082053; Tricoire L, 2010, J NEUROSCI, V30, P2165, DOI 10.1523/JNEUROSCI.5123-09.2010	15	61	63	1	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2011	14	11					1407	1409		10.1038/nn.2935	http://dx.doi.org/10.1038/nn.2935			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	841NI	21983681	Green Accepted			2022-12-28	WOS:000296518600013
J	Cohen, MR; Kohn, A				Cohen, Marlene R.; Kohn, Adam			Measuring and interpreting neuronal correlations	NATURE NEUROSCIENCE			English	Review							PRIMARY VISUAL-CORTEX; LATERAL INTRAPARIETAL AREA; DECISION-RELATED ACTIVITY; SPIKE-TIME CORRELATIONS; EYE FIELD NEURONS; NOISE CORRELATIONS; SINGLE NEURONS; FUNCTIONAL CONNECTIVITY; SENSORY NEURONS; NEURAL ACTIVITY	Mounting evidence suggests that understanding how the brain encodes information and performs computations will require studying the correlations between neurons. The recent advent of recording techniques such as multielectrode arrays and two-photon imaging has made it easier to measure correlations, opening the door for detailed exploration of their properties and contributions to cortical processing. However, studies have reported discrepant findings, providing a confusing picture. Here we briefly review these studies and conduct simulations to explore the influence of several experimental and physiological factors on correlation measurements. Differences in response strength, the time window over which spikes are counted, spike sorting conventions and internal states can all markedly affect measured correlations and systematically bias estimates. Given these complicating factors, we offer guidelines for interpreting correlation data and a discussion of how best to evaluate the effect of correlations on cortical processing.	[Cohen, Marlene R.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Kohn, Adam] Albert Einstein Coll Med, Dept Neurosci, Bronx, NY 10467 USA; [Kohn, Adam] Albert Einstein Coll Med, Dept Ophthalmol & Visual Sci, Bronx, NY 10467 USA	Harvard University; Harvard Medical School; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Cohen, MR (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA.	cohenm@pitt.edu; adam.kohn@einstein.yu.edu			US National Institutes of Health [R01 EY016774, K99 EY020844-01]; NATIONAL EYE INSTITUTE [R01EY016774, K99EY020844] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We are grateful to P. Latham for analytical descriptions for our simulations and for the derivation of the relationship between measurement window and correlations that are not based on common spikes and to R. Coen-Cagli for the derivation relating correlation to the proportion of spikes discarded during spike sorting. We thank R. Coen-Cagli, B. Cumming, M. Histed, X. Jia, K. Josic, J. Maunsell, A. Ni, H. Nienborg, A. Pouget, O. Schwartz, S. Tanabe, and J. A. Movshon and E. Simoncelli and members of their laboratories for helpful discussions and comments on an earlier version of the manuscript. This work was supported by US National Institutes of Health grants R01 EY016774 (A. K.) and K99 EY020844-01 (M. R. C.).	Abbott LF, 1999, NEURAL COMPUT, V11, P91, DOI 10.1162/089976699300016827; AERTSEN AMHJ, 1989, J NEUROPHYSIOL, V61, P900, DOI 10.1152/jn.1989.61.5.900; AHISSAR E, 1992, SCIENCE, V257, P1412, DOI 10.1126/science.1529342; Alonso JM, 1998, NAT NEUROSCI, V1, P395, DOI 10.1038/1609; Amari S, 2009, NEURAL COMPUT, V21, P960, DOI 10.1162/neco.2008.03-08-729; Averbeck BB, 2006, NAT REV NEUROSCI, V7, P358, DOI 10.1038/nrn1888; Averbeck BB, 2003, J NEUROSCI, V23, P7630; Averbeck BB, 2006, J NEUROPHYSIOL, V95, P3633, DOI 10.1152/jn.00919.2005; Bair W, 1998, VISUAL NEUROSCI, V15, P779, DOI 10.1017/S0952523898154160; Bair W, 2001, J NEUROSCI, V21, P1676, DOI 10.1523/JNEUROSCI.21-05-01676.2001; BARLOW HB, 1989, COMPUTING NEURON; Beck JM, 2008, NEURON, V60, P1142, DOI 10.1016/j.neuron.2008.09.021; Bedenbaugh P, 1997, NEURAL COMPUT, V9, P1265, DOI 10.1162/neco.1997.9.6.1265; Berens P, 2008, FRONT NEUROSCI-SWITZ, V2, P199, DOI 10.3389/neuro.01.037.2008; Bichot NP, 2001, J NEUROSCI, V21, P713, DOI 10.1523/JNEUROSCI.21-02-00713.2001; Bisley JW, 2003, SCIENCE, V299, P81, DOI 10.1126/science.1077395; Bollimunta A, 2008, J NEUROSCI, V28, P9976, DOI 10.1523/JNEUROSCI.2699-08.2008; Britten KH, 1996, VISUAL NEUROSCI, V13, P87, DOI 10.1017/S095252380000715X; Carandini M, 2004, PLOS BIOL, V2, P1483, DOI 10.1371/journal.pbio.0020264; CHEAL ML, 1991, Q J EXP PSYCHOL-A, V43, P859, DOI 10.1080/14640749108400960; Cohen JY, 2010, J NEUROSCI, V30, P3227, DOI 10.1523/JNEUROSCI.4600-09.2010; Cohen MR, 2008, NEURON, V60, P162, DOI 10.1016/j.neuron.2008.08.007; Cohen MR, 2009, NAT NEUROSCI, V12, P1594, DOI 10.1038/nn.2439; Cohen MR, 2009, J NEUROSCI, V29, P6635, DOI 10.1523/JNEUROSCI.5179-08.2009; Constantinidis C, 2002, J NEUROPHYSIOL, V88, P3487, DOI 10.1152/jn.00188.2002; Cook EP, 2002, NAT NEUROSCI, V5, P985, DOI 10.1038/nn924; de la Rocha J, 2007, NATURE, V448, P802, DOI 10.1038/nature06028; Ditterich J, 2003, NAT NEUROSCI, V6, P891, DOI 10.1038/nn1094; Dorn JD, 2003, J NEUROPHYSIOL, V89, P2271, DOI 10.1152/jn.000889.2002; Ecker AS, 2010, SCIENCE, V327, P584, DOI 10.1126/science.1179867; Erickson CA, 2000, NAT NEUROSCI, V3, P1143, DOI 10.1038/80664; ESPINOSA IE, 1988, BRAIN RES, V450, P39, DOI 10.1016/0006-8993(88)91542-9; Fox MD, 2007, NEURON, V56, P171, DOI 10.1016/j.neuron.2007.08.023; Greschner M, 2011, J PHYSIOL-LONDON, V589, P75, DOI 10.1113/jphysiol.2010.193888; Grill-Spector K, 2004, NAT NEUROSCI, V7, P555, DOI 10.1038/nn1224; Gutnisky DA, 2008, NATURE, V452, P220, DOI 10.1038/nature06563; Herrington TM, 2009, J NEUROSCI, V29, P14160, DOI 10.1523/JNEUROSCI.1916-09.2009; Huang X, 2009, J NEUROPHYSIOL, V101, P3012, DOI 10.1152/jn.00010.2009; Huk AC, 2005, J NEUROSCI, V25, P10420, DOI 10.1523/JNEUROSCI.4684-04.2005; Jermakowicz WJ, 2009, J NEUROPHYSIOL, V101, P2279, DOI 10.1152/jn.91207.2008; Kass RE, 2005, J NEUROPHYSIOL, V94, P8, DOI 10.1152/jn.00648.2004; Kazama H, 2009, NAT NEUROSCI, V12, P1136, DOI 10.1038/nn.2376; Kohn A, 2005, J NEUROSCI, V25, P3661, DOI 10.1523/JNEUROSCI.5106-04.2005; Kohn A, 2009, CURR OPIN NEUROBIOL, V19, P434, DOI 10.1016/j.conb.2009.06.007; Komiyama T, 2010, NATURE, V464, P1182, DOI 10.1038/nature08897; KROSE BJA, 1989, VISION RES, V29, P1607, DOI 10.1016/0042-6989(89)90142-9; Lampl I, 1999, NEURON, V22, P361, DOI 10.1016/S0896-6273(00)81096-X; Leber AB, 2010, J NEUROSCI, V30, P11458, DOI 10.1523/JNEUROSCI.0809-10.2010; Lee D, 1998, J NEUROSCI, V18, P1161; Maynard EM, 1999, J NEUROSCI, V19, P8083; Mazurek ME, 2003, CEREB CORTEX, V13, P1257, DOI 10.1093/cercor/bhg097; Mazurek ME, 2002, NAT NEUROSCI, V5, P463, DOI 10.1038/nn836; Mitchell JF, 2009, NEURON, V63, P879, DOI 10.1016/j.neuron.2009.09.013; MULLER HJ, 1989, J EXP PSYCHOL HUMAN, V15, P315, DOI 10.1037/0096-1523.15.2.315; Muller MM, 1998, NAT NEUROSCI, V1, P631, DOI 10.1038/2865; NAKAYAMA K, 1989, VISION RES, V29, P1631, DOI 10.1016/0042-6989(89)90144-2; Nevet A, 2007, J NEUROPHYSIOL, V98, P2232, DOI 10.1152/jn.00190.2007; Nienborg H, 2010, CURR OPIN NEUROBIOL, V20, P376, DOI 10.1016/j.conb.2010.05.002; Nienborg H, 2009, NATURE, V459, P89, DOI 10.1038/nature07821; Nirenberg S, 2003, P NATL ACAD SCI USA, V100, P7348, DOI 10.1073/pnas.1131895100; Okatan M, 2005, NEURAL COMPUT, V17, P1927, DOI 10.1162/0899766054322973; Okun M, 2008, NAT NEUROSCI, V11, P535, DOI 10.1038/nn.2105; Palmer C, 2007, J NEUROSCI, V27, P8122, DOI 10.1523/JNEUROSCI.1940-07.2007; Paninski L, 2010, J COMPUT NEUROSCI, V29, P107, DOI 10.1007/s10827-009-0179-x; Parker AJ, 1998, ANNU REV NEUROSCI, V21, P227, DOI 10.1146/annurev.neuro.21.1.227; Pillow JW, 2008, NATURE, V454, P995, DOI 10.1038/nature07140; Poort J, 2009, CEREB CORTEX, V19, P543, DOI 10.1093/cercor/bhn103; Poulet JFA, 2008, NATURE, V454, P881, DOI 10.1038/nature07150; Price NSC, 2010, J NEUROSCI, V30, P14036, DOI 10.1523/JNEUROSCI.2336-10.2010; Rasch MJ, 2011, J NEUROPHYSIOL, V105, P757, DOI 10.1152/jn.00845.2009; Reich DS, 2001, SCIENCE, V294, P2566, DOI 10.1126/science.1065839; REID RC, 1995, NATURE, V378, P281, DOI 10.1038/378281a0; Renart A, 2010, SCIENCE, V327, P587, DOI 10.1126/science.1179850; Ress D, 2003, NAT NEUROSCI, V6, P414, DOI 10.1038/nn1024; Ress D, 2000, NAT NEUROSCI, V3, P940, DOI 10.1038/78856; Rosenbaum RJ, 2010, FRONT COMPUT NEUROSC, V4, DOI 10.3389/fncom.2010.00009; Samonds JM, 2009, J NEUROSCI, V29, P15780, DOI 10.1523/JNEUROSCI.2305-09.2009; Sapir A, 2005, P NATL ACAD SCI USA, V102, P17810, DOI 10.1073/pnas.0504678102; Series P, 2004, NAT NEUROSCI, V7, P1129, DOI 10.1038/nn1321; Shadlen MN, 1998, J NEUROSCI, V18, P3870; Smith MA, 2008, J NEUROSCI, V28, P12591, DOI 10.1523/JNEUROSCI.2929-08.2008; Stark E, 2008, J NEUROSCI, V28, P10618, DOI 10.1523/JNEUROSCI.3418-08.2008; Thut G, 2006, J NEUROSCI, V26, P9494, DOI 10.1523/JNEUROSCI.0875-06.2006; TOLHURST DJ, 1983, VISION RES, V23, P775, DOI 10.1016/0042-6989(83)90200-6; Truccolo W, 2005, J NEUROPHYSIOL, V93, P1074, DOI 10.1152/jn.00697.2004; Truccolo W, 2010, NAT NEUROSCI, V13, P105, DOI 10.1038/nn.2455; VAADIA E, 1995, NATURE, V373, P515, DOI 10.1038/373515a0; Vinje WE, 2000, SCIENCE, V287, P1273, DOI 10.1126/science.287.5456.1273; Wang XJ, 2002, NEURON, V36, P955, DOI 10.1016/S0896-6273(02)01092-9; Wong KF, 2007, FRONT COMPUT NEUROSC, V1, DOI 10.3389/neuro.10.006.2007; Zhang ML, 2004, J NEUROPHYSIOL, V92, P1464, DOI 10.1152/jn.01272.2003; ZOHARY E, 1994, NATURE, V370, P140, DOI 10.1038/370140a0	92	591	594	3	130	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2011	14	7					811	819		10.1038/nn.2842	http://dx.doi.org/10.1038/nn.2842			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	783KR	21709677	Green Accepted			2022-12-28	WOS:000292081700005
J	Imamura, F; Ayoub, AE; Rakic, P; Greer, CA				Imamura, Fumiaki; Ayoub, Albert E.; Rakic, Pasko; Greer, Charles A.			Timing of neurogenesis is a determinant of olfactory circuitry	NATURE NEUROSCIENCE			English	Article							MITRAL CELL AXONS; PIRIFORM CORTEX; MAP TOPOGRAPHY; TUFTED CELLS; BULB; MOUSE; ORGANIZATION; ODOR; RAT; REPRESENTATIONS	An odorant receptor map in mammals that is constructed by the glomerular coalescence of sensory neuron axons in the olfactory bulb is essential for proper odor information processing. How this map is linked with olfactory cortex is unknown. Using a battery of methods, including various markers of cell division in combination with tracers of neuronal connections and time-lapse live imaging, we found that early-and late-generated mouse mitral cells became differentially distributed in the dorsal and ventral subdivisions of the odorant receptor map. In addition, the late-generated mitral cells extended substantially stronger projections to the olfactory tubercle than did the early-generated cells. Together, these data indicate that the odorant receptor map is developmentally linked to the olfactory cortices in part by the birthdate of mitral cells. Thus, different olfactory cortical regions become involved in processing information from distinct regions of the odorant receptor map.	[Imamura, Fumiaki; Greer, Charles A.] Yale Univ, Sch Med, Dept Neurosurg, New Haven, CT 06520 USA; [Ayoub, Albert E.; Rakic, Pasko; Greer, Charles A.] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT USA; [Ayoub, Albert E.; Rakic, Pasko] Yale Univ, Sch Med, Kavli Inst Neurosci, New Haven, CT USA	Yale University; Yale University; Yale University	Greer, CA (corresponding author), Yale Univ, Sch Med, Dept Neurosurg, New Haven, CT 06520 USA.	charles.greer@yale.edu	Imamura, Fumiaki/F-5041-2012; Ayoub, Albert/G-1783-2011	Ayoub, Albert/0000-0002-5493-1172; Imamura, Fumiaki/0000-0003-1410-3126	US National Institute of Child Health and Human Development; US National Institute of Health; Kavli Institute for Neuroscience at Yale; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS014841] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC000210, R03DC011134] Funding Source: NIH RePORTER	US National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); US National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kavli Institute for Neuroscience at Yale; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank K. Mori for the antibody to OCAM, Y. Yoshihara for the antibody to Tbx21, A. Bordey for the DCX-GFP mice and all of the members of the Greer, Rakic and Treloar laboratories for technical assistance and discussion. The antibody to RC2 developed by M. Yamamoto was obtained from the Developmental Studies Hybridoma Bank developed under the auspices of the US National Institute of Child Health and Human Development and maintained by the Department of Biology, University of Iowa. This work was supported by the US National Institute of Health and the Kavli Institute for Neuroscience at Yale.	Bailey MS, 1999, J COMP NEUROL, V415, P423; Batista-Brito R, 2008, J NEUROSCI, V28, P3966, DOI 10.1523/JNEUROSCI.5625-07.2008; Blanchart A, 2006, J COMP NEUROL, V496, P529, DOI 10.1002/cne.20941; Blanchart A, 2008, EUR J NEUROSCI, V27, P2838, DOI 10.1111/j.1460-9568.2008.06283.x; Bozza T, 2009, NEURON, V61, P220, DOI 10.1016/j.neuron.2008.11.010; Fouquet C, 2007, J NEUROSCI, V27, P3037, DOI 10.1523/JNEUROSCI.0172-07.2007; GRAFE MR, 1982, DEV BRAIN RES, V3, P387, DOI 10.1016/0165-3806(82)90006-2; HABERLY LB, 1977, BRAIN RES, V129, P152, DOI 10.1016/0006-8993(77)90978-7; HINDS JW, 1972, J COMP NEUROL, V146, P253, DOI 10.1002/cne.901460208; HINDS JW, 1968, J COMP NEUROL, V134, P287, DOI 10.1002/cne.901340304; Hirata T, 1999, J NEUROBIOL, V38, P93; Imai T, 2008, CURR OPIN NEUROBIOL, V18, P251, DOI 10.1016/j.conb.2008.07.009; Imai T, 2006, SCIENCE, V314, P657, DOI 10.1126/science.1131794; Imai T, 2009, SCIENCE, V325, P585, DOI 10.1126/science.1173596; Imamura F, 2006, J COMP NEUROL, V495, P754, DOI 10.1002/cne.20896; Inaki K, 2004, J COMP NEUROL, V479, P243, DOI 10.1002/cne.20270; Jefferis GSXE, 2001, NATURE, V414, P204, DOI 10.1038/35102574; Johnson BA, 2007, J COMP NEUROL, V503, P1, DOI 10.1002/cne.21396; Johnson BA, 2009, J COMP NEUROL, V514, P658, DOI 10.1002/cne.22046; Kaneko-Goto T, 2008, NEURON, V57, P834, DOI 10.1016/j.neuron.2008.01.023; Kobayakawa K, 2007, NATURE, V450, P503, DOI 10.1038/nature06281; Lois C, 1996, SCIENCE, V271, P978, DOI 10.1126/science.271.5251.978; Matsumoto H, 2010, J NEUROPHYSIOL, V103, P3490, DOI 10.1152/jn.00035.2010; Miyasaka N, 2009, J NEUROSCI, V29, P4756, DOI 10.1523/JNEUROSCI.0118-09.2009; Molyneaux BJ, 2007, NAT REV NEUROSCI, V8, P427, DOI 10.1038/nrn2151; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Mori K, 2006, PHYSIOL REV, V86, P409, DOI 10.1152/physrev.00021.2005; Mori K, 1999, SCIENCE, V286, P711, DOI 10.1126/science.286.5440.711; Mori K, 2000, PHILOS T R SOC B, V355, P1801, DOI 10.1098/rstb.2000.0736; Murthy M, 2008, NEURON, V59, P1009, DOI 10.1016/j.neuron.2008.07.040; Nagayama S, 2010, FRONT NEURAL CIRCUIT, V4, DOI 10.3389/fncir.2010.00120; OJIMA H, 1984, J COMP NEUROL, V230, P77, DOI 10.1002/cne.902300107; Poo C, 2009, NEURON, V62, P850, DOI 10.1016/j.neuron.2009.05.022; Puche AC, 2001, J COMP NEUROL, V434, P1, DOI 10.1002/cne.1160; Rakic P, 2009, TRENDS NEUROSCI, V32, P291, DOI 10.1016/j.tins.2009.01.007; RESSLER KJ, 1994, CELL, V79, P1245, DOI 10.1016/0092-8674(94)90015-9; Salic A, 2008, P NATL ACAD SCI USA, V105, P2415, DOI 10.1073/pnas.0712168105; SCOTT JW, 1980, J COMP NEUROL, V194, P519, DOI 10.1002/cne.901940304; SCOTT JW, 1981, J NEUROPHYSIOL, V46, P918, DOI 10.1152/jn.1981.46.5.918; Serizawa S, 2006, CELL, V127, P1057, DOI 10.1016/j.cell.2006.10.031; Soucy ER, 2009, NAT NEUROSCI, V12, P210, DOI 10.1038/nn.2262; Soussi-Yanicostas N, 2002, CELL, V109, P217, DOI 10.1016/S0092-8674(02)00713-4; Stettler DD, 2009, NEURON, V63, P854, DOI 10.1016/j.neuron.2009.09.005; Takeuchi H, 2010, CELL, V141, P1056, DOI 10.1016/j.cell.2010.04.041; Treloar HB, 2003, J COMP NEUROL, V458, P389, DOI 10.1002/cne.10590; VASSAR R, 1994, CELL, V79, P981, DOI 10.1016/0092-8674(94)90029-9; Willhite DC, 2006, P NATL ACAD SCI USA, V103, P12592, DOI 10.1073/pnas.0602032103	47	71	71	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2011	14	3					331	337		10.1038/nn.2754	http://dx.doi.org/10.1038/nn.2754			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	725MW	21297629	Green Accepted			2022-12-28	WOS:000287650100013
J	Stevenson, IH; Kording, KP				Stevenson, Ian H.; Kording, Konrad P.			How advances in neural recording affect data analysis	NATURE NEUROSCIENCE			English	Article							FIELD POTENTIALS; ENSEMBLE; PATTERNS; ARRAYS; MODEL; STATE; MOTOR	Over the last five decades, progress in neural recording techniques has allowed the number of simultaneously recorded neurons to double approximately every 7 years, mimicking Moore's law. Such exponential growth motivates us to ask how data analysis techniques are affected by progressively larger numbers of recorded neurons. Traditionally, neurons are analyzed independently on the basis of their tuning to stimuli or movement. Although tuning curve approaches are unaffected by growing numbers of simultaneously recorded neurons, newly developed techniques that analyze interactions between neurons become more accurate and more complex as the number of recorded neurons increases. Emerging data analysis techniques should consider both the computational costs and the potential for more accurate models associated with this exponential growth of the number of recorded neurons.	[Stevenson, Ian H.; Kording, Konrad P.] Northwestern Univ, Dept Phys Med & Rehabil, Chicago, IL 60611 USA; [Stevenson, Ian H.; Kording, Konrad P.] Rehabil Inst Chicago, Chicago, IL 60611 USA; [Kording, Konrad P.] Northwestern Univ, Dept Physiol, Chicago, IL 60611 USA; [Kording, Konrad P.] Northwestern Univ, Dept Appl Math, Chicago, IL 60611 USA	Northwestern University; Shirley Ryan AbilityLab; Northwestern University; Northwestern University	Stevenson, IH (corresponding author), Northwestern Univ, Dept Phys Med & Rehabil, Chicago, IL 60611 USA.	i-stevenson@northwestern.edu	Kording, Konrad P/A-1233-2007	Kording, Konrad P/0000-0001-8408-4499; Stevenson, Ian/0000-0002-1428-5946	Chicago Community Trust; US National Institutes of Health [1R01NS063399, 2P01NS044393]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025741] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY016774] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS044393, R01NS063399] Funding Source: NIH RePORTER	Chicago Community Trust; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Thanks to A. Kohn and members of the Kohn laboratory for providing data from visual cortex (US National Institutes of Health EY016774) and N. Hatsopoulos and J. Reimer for providing data from motor cortex. All animal use procedures were approved by the institutional animal care and use committees at Albert Einstein College of Medicine and the University of Chicago, respectively. Thanks to B. Yu and J. Cunningham for providing the GPFA code and B. Yu for insightful discussions. This work was supported by the Chicago Community Trust and US National Institutes of Health grants 1R01NS063399 and 2P01NS044393.	Averbeck BB, 2006, NAT REV NEUROSCI, V7, P358, DOI 10.1038/nrn1888; Babadi B, 2010, J VISION, V10, DOI 10.1167/10.10.22; BARNA JS, 1981, ELECTROEN CLIN NEURO, V52, P494, DOI 10.1016/0013-4694(81)90035-3; Blanche TJ, 2005, J NEUROPHYSIOL, V93, P2987, DOI 10.1152/jn.01023.2004; Brette R, 2007, J COMPUT NEUROSCI, V23, P349, DOI 10.1007/s10827-007-0038-6; Brockwell AE, 2004, J NEUROPHYSIOL, V91, P1899, DOI 10.1152/jn.00438.2003; Brown EN, 2004, NAT NEUROSCI, V7, P456, DOI 10.1038/nn1228; Churchland MM, 2007, CURR OPIN NEUROBIOL, V17, P609, DOI 10.1016/j.conb.2007.11.001; Churchland MM, 2010, NAT NEUROSCI, V13, P369, DOI 10.1038/nn.2501; Ecker AS, 2010, SCIENCE, V327, P584, DOI 10.1126/science.1179867; Harris KD, 2000, J NEUROPHYSIOL, V84, P401, DOI 10.1152/jn.2000.84.1.401; Harris KD, 2003, NATURE, V424, P552, DOI 10.1038/nature01834; Hatsopoulos N, 2004, J NEUROPHYSIOL, V92, P1165, DOI 10.1152/jn.01245.2003; Kass RE, 2005, J NEUROPHYSIOL, V94, P8, DOI 10.1152/jn.00648.2004; Kelly RC, 2007, J NEUROSCI, V27, P261, DOI 10.1523/JNEUROSCI.4906-06.2007; Kelly RC, 2010, J COMPUT NEUROSCI, V29, P567, DOI 10.1007/s10827-009-0208-9; KRUGER J, 1981, EXP BRAIN RES, V41, P191; Lewicki MS, 1998, NETWORK-COMP NEURAL, V9, pR53, DOI 10.1088/0954-898X/9/4/001; Maynard EM, 1999, J NEUROSCI, V19, P8083; MOORE G, 2006, UNDERSTANDING MOORES, pCH7; Moore GE, 1965, ELECTRONICS, V38, P114; Nicolelis M, 2007, METHODS NEURAL ENSEM, DOI DOI 10.1201/9781420006414; Nicolelis MAL, 2003, P NATL ACAD SCI USA, V100, P11041, DOI 10.1073/pnas.1934665100; Okatan M, 2005, NEURAL COMPUT, V17, P1927, DOI 10.1162/0899766054322973; Paninski L, 2004, NETWORK-COMP NEURAL, V15, P243, DOI 10.1088/0954-898X/15/4/002; PANINSKI L, 2009, J COMPUT NEUROSCI, V29, P1; Paninski L, 2007, PROG BRAIN RES, V165, P493, DOI 10.1016/S0079-6123(06)65031-0; Papadimitriou C.H, 2003, COMPUT COMPLEX; Pillow JW, 2008, NATURE, V454, P995, DOI 10.1038/nature07140; Pouget A, 2000, NAT REV NEUROSCI, V1, P125, DOI 10.1038/35039062; Rebesco JM, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00039; ROUSCHE P, 2002, IEEE T REHABIL ENG, V7, P56; Schneidman E, 2006, NATURE, V440, P1007, DOI 10.1038/nature04701; Shlens J, 2006, J NEUROSCI, V26, P8254, DOI 10.1523/JNEUROSCI.1282-06.2006; Smith MA, 2008, J NEUROSCI, V28, P12591, DOI 10.1523/JNEUROSCI.2929-08.2008; Stevenson IH, 2009, IEEE T NEUR SYS REH, V17, P203, DOI 10.1109/TNSRE.2008.2010471; Stevenson IH, 2008, CURR OPIN NEUROBIOL, V18, P582, DOI 10.1016/j.conb.2008.11.005; Stosiek C, 2003, P NATL ACAD SCI USA, V100, P7319, DOI 10.1073/pnas.1232232100; Truccolo W, 2005, J NEUROPHYSIOL, V93, P1074, DOI 10.1152/jn.00697.2004; Truccolo W, 2010, NAT NEUROSCI, V13, P105, DOI 10.1038/nn.2455; Vogels TP, 2005, ANNU REV NEUROSCI, V28, P357, DOI 10.1146/annurev.neuro.28.061604.135637; Vogelstein JT, 2009, BIOPHYS J, V97, P636, DOI 10.1016/j.bpj.2008.08.005; Yu BM, 2009, J NEUROPHYSIOL, V102, P614, DOI 10.1152/jn.90941.2008	43	305	309	0	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2011	14	2					139	142		10.1038/nn.2731	http://dx.doi.org/10.1038/nn.2731			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	711MJ	21270781	Green Accepted			2022-12-28	WOS:000286595400008
J	Christie, JM; Chiu, DN; Jahr, CE				Christie, Jason M.; Chiu, Delia N.; Jahr, Craig E.			Ca2+-dependent enhancement of release by subthreshold somatic depolarization	NATURE NEUROSCIENCE			English	Article							NEURONAL CALCIUM SENSOR-1; MOSSY FIBER BOUTONS; CEREBELLAR GRANULE CELLS; RAT BRAIN-STEM; TRANSMITTER RELEASE; CENTRAL SYNAPSE; PRESYNAPTIC TERMINALS; PURKINJE-CELLS; CA2+ CHANNELS; CNS SYNAPSE	In many neurons, subthreshold somatic depolarization can spread electrotonically into the axon and modulate subsequent spike-evoked transmission. Although release probability is regulated by intracellular Ca2+, the Ca2+ dependence of this modulatory mechanism has been debated. Using paired recordings from synaptically connected molecular layer interneurons (MLIs) of the rat cerebellum, we observed Ca2+-mediated strengthening of release following brief subthreshold depolarization of the soma. Two-photon microscopy revealed that, at the axon, somatic depolarization evoked Ca2+ influx through voltage-sensitive Ca2+ channels and facilitated spike-evoked Ca2+ entry. Exogenous Ca2+ buffering diminished these Ca2+ transients and eliminated the strengthening of release. Axonal Ca2+ entry elicited by subthreshold somatic depolarization also triggered asynchronous transmission that may deplete vesicle availability and thereby temper release strengthening. In this cerebellar circuit, activity-dependent presynaptic plasticity depends on Ca2+ elevations resulting from both sub-and suprathreshold electrical activity initiated at the soma.	[Christie, Jason M.; Chiu, Delia N.; Jahr, Craig E.] Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97201 USA; [Chiu, Delia N.] Oregon Hlth & Sci Univ, Grad Program Neurosci, Portland, OR 97201 USA	Oregon Health & Science University; Oregon Health & Science University	Christie, JM (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, L474, Portland, OR 97201 USA.	jason.christie@maxplanckflorida.org		Christie, Jason/0000-0003-0276-2554	US National Institutes of Health [NS066037]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS066037] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank M. Herman, M. McGinley, B. Nahir and J. Pugh for their helpful discussions and comments on the manuscript. This work was supported by US National Institutes of Health grant NS066037 (C.E.J.).	Alle H, 2006, SCIENCE, V311, P1290, DOI 10.1126/science.1119055; Atluri PP, 1998, J NEUROSCI, V18, P8214; Atluri PP, 1996, J NEUROSCI, V16, P5661; Awatramani GB, 2005, NEURON, V48, P109, DOI 10.1016/j.neuron.2005.08.038; Bischofberger J, 2002, J NEUROSCI, V22, P10593; Bollmann JH, 2000, SCIENCE, V289, P953, DOI 10.1126/science.289.5481.953; Borst JGG, 1998, J PHYSIOL-LONDON, V513, P149, DOI 10.1111/j.1469-7793.1998.149by.x; Borst JGG, 1996, NATURE, V383, P431, DOI 10.1038/383431a0; Brenowitz SD, 2007, J NEUROSCI, V27, P7888, DOI 10.1523/JNEUROSCI.1064-07.2007; Bucurenciu I, 2008, NEURON, V57, P536, DOI 10.1016/j.neuron.2007.12.026; Bucurenciu I, 2010, NAT NEUROSCI, V13, P19, DOI 10.1038/nn.2461; Christie JM, 2008, NEURON, V60, P298, DOI 10.1016/j.neuron.2008.08.028; Christie JM, 2009, J NEUROSCI, V29, P11441, DOI 10.1523/JNEUROSCI.2387-09.2009; Cuttle MF, 1998, J PHYSIOL-LONDON, V512, P723, DOI 10.1111/j.1469-7793.1998.723bd.x; Diana MA, 2003, J NEUROSCI, V23, P5906; Dittman JS, 2000, J NEUROSCI, V20, P1374; DODT HU, 2002, SCI STKE, V120, P12; Felmy F, 2003, NEURON, V37, P801, DOI 10.1016/S0896-6273(03)00085-0; Forti L, 2000, J PHYSIOL-LONDON, V527, P33, DOI 10.1111/j.1469-7793.2000.00033.x; Geiger JRP, 2000, NEURON, V28, P927, DOI 10.1016/S0896-6273(00)00164-1; Glitsch M, 1999, J NEUROSCI, V19, P511; HEIDELBERGER R, 1994, NATURE, V371, P513, DOI 10.1038/371513a0; Hori T, 2009, J PHYSIOL-LONDON, V587, P2987, DOI 10.1113/jphysiol.2009.168765; Jinno S, 2004, CEREBELLUM, V3, P83, DOI 10.1080/14734220310025187; Jinno S, 2002, NEUROSCIENCE, V113, P449, DOI 10.1016/S0306-4522(02)00172-0; Kole MHP, 2007, NEURON, V55, P633, DOI 10.1016/j.neuron.2007.07.031; Li LY, 2007, J NEUROSCI, V27, P13420, DOI 10.1523/JNEUROSCI.1709-07.2007; Llano I, 1997, J PHYSIOL-LONDON, V502, P509, DOI 10.1111/j.1469-7793.1997.509bj.x; Llano I, 2000, NAT NEUROSCI, V3, P1256, DOI 10.1038/81781; Lu T, 2000, NEURON, V26, P683, DOI 10.1016/S0896-6273(00)81204-0; Mejia-Gervacio S, 2007, NEURON, V53, P843, DOI 10.1016/j.neuron.2007.02.023; Metz AE, 2005, J NEUROSCI, V25, P5763, DOI 10.1523/JNEUROSCI.0624-05.2005; Muller M, 2010, J NEUROSCI, V30, P2007, DOI 10.1523/JNEUROSCI.4378-09.2010; Muller M, 2008, J PHYSIOL-LONDON, V586, P5503, DOI 10.1113/jphysiol.2008.155838; Otsu Y, 2004, J NEUROSCI, V24, P420, DOI 10.1523/JNEUROSCI.4452-03.2004; Palay S. L., 1974, CEREBELLAR CORTEX CY; RAE J, 1991, J NEUROSCI METH, V37, P15, DOI 10.1016/0165-0270(91)90017-T; Sabatini BL, 1997, J NEUROSCI, V17, P3425; Schneggenburger R, 2000, NATURE, V406, P889, DOI 10.1038/35022702; Scott R, 2008, J NEUROSCI, V28, P7765, DOI 10.1523/JNEUROSCI.1296-08.2008; Shu YS, 2006, NATURE, V441, P761, DOI 10.1038/nature04720; Tang YG, 2000, BIOPHYS J, V78, P2735, DOI 10.1016/S0006-3495(00)76819-6; Tottene A, 1996, J NEUROSCI, V16, P6353; Trigo FF, 2010, NEURON, V66, P235, DOI 10.1016/j.neuron.2010.03.030; Tsujimoto T, 2002, SCIENCE, V295, P2276, DOI 10.1126/science.1068278; Turecek R, 2001, NATURE, V411, P587, DOI 10.1038/35079084; Vincent P, 1996, J PHYSIOL-LONDON, V494, P183, DOI 10.1113/jphysiol.1996.sp021484; Wu LG, 1998, P NATL ACAD SCI USA, V95, P4720, DOI 10.1073/pnas.95.8.4720; Wu LG, 1999, NEURON, V23, P821, DOI 10.1016/S0896-6273(01)80039-8; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	50	80	81	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2011	14	1					62	U86		10.1038/nn.2718	http://dx.doi.org/10.1038/nn.2718			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	699TE	21170054	Green Accepted			2022-12-28	WOS:000285684900015
J	Vaegter, CB; Jansen, P; Fjorback, AW; Glerup, S; Skeldal, S; Kjolby, M; Richner, M; Erdmann, B; Nyengaard, JR; Tessarollo, L; Lewin, GR; Willnow, TE; Chao, MV; Nykjaer, A				Vaegter, Christian B.; Jansen, Pernille; Fjorback, Anja W.; Glerup, Simon; Skeldal, Sune; Kjolby, Mads; Richner, Mette; Erdmann, Bettina; Nyengaard, Jens R.; Tessarollo, Lino; Lewin, Gary R.; Willnow, Thomas E.; Chao, Moses V.; Nykjaer, Anders			Sortilin associates with Trk receptors to enhance anterograde transport and neurotrophin signaling	NATURE NEUROSCIENCE			English	Article							DORSAL-ROOT GANGLION; SENSORY NEURONS; NERVOUS-SYSTEM; BIOCHEMICAL-CHARACTERIZATION; TARGETED DISRUPTION; AXONAL-TRANSPORT; MICE LACKING; GENE; PROTEIN; BRAIN	Binding of target-derived neurotrophins to Trk receptors at nerve terminals is required to stimulate neuronal survival, differentiation, innervation and synaptic plasticity. The distance between the soma and nerve terminal is great, making efficient anterograde Trk transport critical for Trk synaptic translocation and signaling. The mechanism responsible for this trafficking remains poorly understood. Here we show that the sorting receptor sortilin interacts with TrkA, TrkB and TrkC and enables their anterograde axonal transport, thereby enhancing neurotrophin signaling. Cultured DRG neurons lacking sortilin showed blunted MAP kinase signaling and reduced neurite outgrowth upon stimulation with NGF. Moreover, deficiency for sortilin markedly aggravated TrkA, TrkB and TrkC phenotypes present in p75(NTR) knockouts, and resulted in increased embryonic lethality and sympathetic neuropathy in mice heterozygous for TrkA. Our findings demonstrate a role for sortilin as an anterograde trafficking receptor for Trk and a positive modulator of neurotrophin-induced neuronal survival.	[Vaegter, Christian B.; Jansen, Pernille; Glerup, Simon; Skeldal, Sune; Kjolby, Mads; Richner, Mette; Nykjaer, Anders] Aarhus Univ, Dept Med Biochem, Lundbeck Fdn, Res Ctr MIND, Aarhus, Denmark; [Fjorback, Anja W.; Nyengaard, Jens R.] Aarhus Univ, Stereol & Electron Microscopy Lab, Lundbeck Fdn, Res Ctr MIND, Aarhus, Denmark; [Erdmann, Bettina; Lewin, Gary R.; Willnow, Thomas E.] Max Delbruck Ctr Mol Med, Berlin, Germany; [Tessarollo, Lino] NCI, Ctr Canc Res, Frederick, MD 21701 USA; [Chao, Moses V.] NYU, Sch Med, Skirball Inst Biomol Med, Kimmel Ctr, New York, NY USA	Aarhus University; Lundbeckfonden; Aarhus University; Lundbeckfonden; Helmholtz Association; Max Delbruck Center for Molecular Medicine; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); New York University	Nykjaer, A (corresponding author), Aarhus Univ, Dept Med Biochem, Lundbeck Fdn, Res Ctr MIND, Aarhus, Denmark.	cv@biokemi.au.dk; an@biokemi.au.dk	Kjolby, Mads/ABB-4210-2020; Kjolby, Mads/F-3672-2011; Vægter, Christian Bjerggaard/A-7909-2008; Vægter, Christian Bjerggaard/AFW-0912-2022; Lewin, Gary R/B-8028-2011	Vægter, Christian Bjerggaard/0000-0001-6573-146X; Vægter, Christian Bjerggaard/0000-0001-6573-146X; Chao, Moses/0000-0002-6969-3744; Nykjaer, Anders/0000-0001-6422-6736; Kjolby, Mads/0000-0002-1043-6137; Willnow, Thomas/0000-0001-9515-7921; Lewin, Gary/0000-0002-2890-6352	Lundbeck Foundation; Danish Medical Research Council; Elvira and Rasmus Rissforts Foundation; MEMORIES (European Union); US National Institutes of Health [NS21072, AG025970, HD23315]; Deutsche Forschungsgemeinschaft; Danish Council for Strategic Research; Center for Stochastic Geometry and Advanced Bioimaging (Villum Foundation); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD023315] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [ZIABC010390] Funding Source: NIH RePORTER; Villum Fonden [00008721] Funding Source: researchfish	Lundbeck Foundation(Lundbeckfonden); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Elvira and Rasmus Rissforts Foundation; MEMORIES (European Union)(European Commission); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF)); Center for Stochastic Geometry and Advanced Bioimaging (Villum Foundation); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Villum Fonden(Villum Fonden)	We thank L. Reichardt (University of California, San Francisco) for the TrkA antibody. The ImageJ KymoToolBox plug-in was kindly provided by F. Cordelieres (Universite Paris-Sud Orsay), and the NeuriteTracer plug-in by M. Pool (Rue University). This work was supported by the Lundbeck Foundation, The Danish Medical Research Council, Elvira and Rasmus Rissforts Foundation, MEMORIES (European Union, Framework Programme 6), US National Institutes of Health (NS21072, AG025970 and HD23315), the Deutsche Forschungsgemeinschaft, Danish Council for Strategic Research, and Center for Stochastic Geometry and Advanced Bioimaging (Villum Foundation).	Arimura N, 2009, DEV CELL, V16, P675, DOI 10.1016/j.devcel.2009.03.005; Arnett MG, 2007, BRAIN RES, V1183, P32, DOI 10.1016/j.brainres.2007.09.051; Ascano M, 2009, J NEUROSCI, V29, P11674, DOI 10.1523/JNEUROSCI.1542-09.2009; Bergmann I, 1997, EUR J NEUROSCI, V9, P18, DOI 10.1111/j.1460-9568.1997.tb01349.x; BLACKSTONE CD, 1992, J NEUROCHEM, V58, P1118, DOI 10.1111/j.1471-4159.1992.tb09370.x; Carroll P, 1998, NAT NEUROSCI, V1, P42, DOI 10.1038/242; Chao MV, 2003, NAT REV NEUROSCI, V4, P299, DOI 10.1038/nrn1078; Chen CL, 2006, NEURON, V49, P365, DOI 10.1016/j.neuron.2005.10.036; Chen ZY, 2005, J NEUROSCI, V25, P6156, DOI 10.1523/JNEUROSCI.1017-05.2005; Chuang HH, 2001, NATURE, V411, P957, DOI 10.1038/35082088; CODERRE TJ, 1986, PAIN, V26, P61, DOI 10.1016/0304-3959(86)90174-0; ERNFORS P, 1994, CELL, V77, P503, DOI 10.1016/0092-8674(94)90213-5; FARINAS I, 1994, NATURE, V369, P658, DOI 10.1038/369658a0; Gomes RA, 2006, J NEUROSCI, V26, P11487, DOI 10.1523/JNEUROSCI.2364-06.2006; Hermans-Borgmeyer I, 1999, MOL BRAIN RES, V65, P216, DOI 10.1016/S0169-328X(99)00022-4; Hirokawa N, 2005, NAT REV NEUROSCI, V6, P201, DOI 10.1038/nrn1624; Hirokawa N, 2009, NAT REV MOL CELL BIO, V10, P682, DOI 10.1038/nrm2774; Holmes FE, 2000, P NATL ACAD SCI USA, V97, P11563, DOI 10.1073/pnas.210221897; Horton AC, 2003, NEURON, V40, P277, DOI 10.1016/S0896-6273(03)00629-9; HUBER LJ, 1995, DEV BIOL, V167, P227, DOI 10.1006/dbio.1995.1019; Jansen P, 2007, NAT NEUROSCI, V10, P1449, DOI 10.1038/nn2000; Jenkins PM, 2009, J NEUROSCI, V29, P10541, DOI 10.1523/JNEUROSCI.1590-09.2009; Kamal A, 2001, NATURE, V414, P643, DOI 10.1038/414643a; Kjolby M, 2010, CELL METAB, V12, P213, DOI 10.1016/j.cmet.2010.08.006; KLEIN R, 1994, NATURE, V368, P249, DOI 10.1038/368249a0; KLEIN R, 1993, CELL, V75, P113, DOI 10.1016/0092-8674(93)90683-H; LEE KF, 1992, CELL, V69, P737, DOI 10.1016/0092-8674(92)90286-L; MARTINZANCA D, 1989, MOL CELL BIOL, V9, P24, DOI 10.1128/MCB.9.1.24; Merianda TT, 2009, MOL CELL NEUROSCI, V40, P128, DOI 10.1016/j.mcn.2008.09.008; Minichiello L, 1995, DEVELOPMENT, V121, P4067; MU XJ, 1993, J NEUROSCI, V13, P4029; Nielsen MS, 2001, EMBO J, V20, P2180, DOI 10.1093/emboj/20.9.2180; Nykjaer A, 2004, NATURE, V427, P843, DOI 10.1038/nature02319; Perez-Pinera P, 2008, NEUROSCI LETT, V433, P43, DOI 10.1016/j.neulet.2007.12.035; Petersen CM, 1999, EMBO J, V18, P595, DOI 10.1093/emboj/18.3.595; Petersen CM, 1997, J BIOL CHEM, V272, P3599, DOI 10.1074/jbc.272.6.3599; Quistgaard EM, 2009, NAT STRUCT MOL BIOL, V16, P96, DOI 10.1038/nsmb.1543; Reichardt LF, 2006, PHILOS T R SOC B, V361, P1545, DOI 10.1098/rstb.2006.1894; Runeberg-Roos P, 2007, ANN MED, V39, P572, DOI 10.1080/07853890701646256; Russell FD, 2000, NEUROSCIENCE, V97, P575, DOI 10.1016/S0306-4522(00)00079-8; Sarret P, 2003, J COMP NEUROL, V461, P483, DOI 10.1002/cne.10708; SILOSSANTIAGO I, 1995, J NEUROSCI, V15, P5929; SMEYNE RJ, 1994, NATURE, V368, P246, DOI 10.1038/368246a0; Sokoloff AJ, 2007, MUSCLE NERVE, V36, P183, DOI 10.1002/mus.20797; Teng HK, 2005, J NEUROSCI, V25, P5455, DOI 10.1523/JNEUROSCI.5123-04.2005; Thang SH, 2000, J NEUROSCI, V20, P2917; Wallrabe H, 2003, BIOPHYS J, V85, P559, DOI 10.1016/S0006-3495(03)74500-7; Wetzel C, 2007, NATURE, V445, P206, DOI 10.1038/nature05394; Willnow TE, 2008, NAT REV NEUROSCI, V9, P899, DOI 10.1038/nrn2516; Zwick M, 2002, J NEUROSCI, V22, P4057, DOI 10.1523/JNEUROSCI.22-10-04057.2002	50	129	136	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2011	14	1					54	U78		10.1038/nn.2689	http://dx.doi.org/10.1038/nn.2689			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	699TE	21102451	Green Accepted			2022-12-28	WOS:000285684900014
J	Di Salvio, M; Di Giovannantonio, LG; Acampora, D; Prosperi, R; Omodei, D; Prakash, N; Wurst, W; Simeone, A				Di Salvio, Michela; Di Giovannantonio, Luca Giovanni; Acampora, Dario; Prosperi, Raffaele; Omodei, Daniela; Prakash, Nilima; Wurst, Wolfgang; Simeone, Antonio			Otx2 controls neuron subtype identity in ventral tegmental area and antagonizes vulnerability to MPTP	NATURE NEUROSCIENCE			English	Article							MIDBRAIN DOPAMINERGIC-NEURONS; GENE-EXPRESSION; MICE LACKING; FATE; TRANSPORTER; DEATH; NURR1; IDENTIFICATION; DEGENERATION; TRAFFICKING	Mesencephalic-diencephalic dopaminergic neurons control locomotor activity and emotion and are affected in neurodegenerative and psychiatric diseases. The homeoprotein Otx2 is restricted to ventral tegmental area (VTA) neurons that are prevalently complementary to those expressing Girk2 and glycosylated active form of the dopamine transporter (Dat). High levels of glycosylated Dat mark neurons with efficient dopamine uptake and pronounced vulnerability to Parkinsonian degeneration. We found that Otx2 controls neuron subtype identity by antagonizing molecular and functional features of dorsal-lateral VTA, such as Girk2 and Dat expression. Otx2 limited the number of VTA neurons with efficient dopamine uptake and conferred resistance to the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-HCI (MPTP) neurotoxin. Ectopic Otx2 expression also provided neurons of the substantia nigra with efficient neuroprotection to MPTP. These findings indicate that Otx2 is required to specify neuron subtype identity in VTA and may antagonize vulnerability to the Parkinsonian toxin MPTP.	[Di Salvio, Michela; Di Giovannantonio, Luca Giovanni; Acampora, Dario; Omodei, Daniela; Simeone, Antonio] CEINGE Biotecnol Avanzate, Naples, Italy; [Acampora, Dario; Simeone, Antonio] SEMM European Sch Mol Med, Naples, Italy; [Acampora, Dario; Simeone, Antonio] CNR, Inst Genet & Biophys A Buzzati Traverso, I-80125 Naples, Italy; [Prosperi, Raffaele] Univ Sannio, Dipartimento Matemat & Stat, Benevento, Italy; [Prakash, Nilima; Wurst, Wolfgang] Tech Univ Munich, Helmholtz Zentrum Munchen, Deutsch Zentrum Neurodegnerat Erkrankungen Munche, Inst Dev Genet, Munich, Germany; [Prakash, Nilima; Wurst, Wolfgang] Max Planck Inst Psychiat, D-80804 Munich, Germany	CEINGE Biotecnologie Avanzate; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR); University of Sannio; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Max Planck Society	Simeone, A (corresponding author), CEINGE Biotecnol Avanzate, Naples, Italy.	simeone@ceinge.unina.it	Prakash, Nilima/AAC-9402-2019; Acampora, Dario/C-2156-2013; Simeone, Antonio/ABG-5269-2020; Di Salvio, Michela/J-8982-2018	Prakash, Nilima/0000-0002-0568-6262; Simeone, Antonio/0000-0003-2693-9836; Di Salvio, Michela/0000-0002-5817-1297; di giovannantonio, luca giovanni/0000-0003-4348-6082; Omodei, Daniela/0000-0001-8710-2971; Wurst, Wolfgang/0000-0003-4422-7410	FP7 [222999]; FP6 [LSHG-CT-2007-037445]; Fondazione Roma; Italian Association for Cancer Research; Federal Ministry of Education and Research in the framework of the National Genome Research Network [FKZ 01GS08174]	FP7; FP6(European Commission); Fondazione Roma(Fondazione RomaEuropean Commission); Italian Association for Cancer Research(Fondazione AIRC per la ricerca sul cancro); Federal Ministry of Education and Research in the framework of the National Genome Research Network	The authors would like to thank D. Grieco and T. Russo for helpful discussions and criticisms on the manuscript, S. Casola for the R26 targeting vector, G. Corte for the Otx2 antibody and the staff of the CEINGE animal house for excellent animal care. We are grateful to E. Bricola for typing the manuscript. This work was supported by the FP7 for the project mdDA NEURODEV (222999) to A.S. and W.W., the FP6 project for the EUTRACC Integrated Project (LSHG-CT-2007-037445) to A.S. and W.W., the 'Stem Cell Project' of Fondazione Roma and the Italian Association for Cancer Research to A.S., and the Federal Ministry of Education and Research in the framework of the National Genome Research Network (NGFN+ Functional Genomics of Parkinson Disease FKZ 01GS08174) to W.W.	Acampora D, 2009, MECH DEVELOP, V126, P882, DOI 10.1016/j.mod.2009.07.003; Afonso-Oramas D, 2009, NEUROBIOL DIS, V36, P494, DOI 10.1016/j.nbd.2009.09.002; Agoston Z, 2009, DEVELOPMENT, V136, P3311, DOI 10.1242/dev.037770; Andersson E, 2006, CELL, V124, P393, DOI [10.1016/j.cell.2005.10.037, 10.1016/J.CELL.2005.10.037]; Andersson E, 2006, DEVELOPMENT, V133, P507, DOI 10.1242/dev.02224; Backman CM, 2006, GENESIS, V44, P383, DOI 10.1002/dvg.20228; Bezard E, 1999, EXP NEUROL, V155, P268, DOI 10.1006/exnr.1998.6995; Bjorklund A., 1984, HDB CHEM NEUROANAT 1, V2, P55; Bjorklund LM, 2002, PROG BRAIN RES, V138, P411, DOI 10.1016/S0079-6123(02)38090-7; Blum D, 2001, PROG NEUROBIOL, V65, P135, DOI 10.1016/S0301-0082(01)00003-X; Castelo-Branco GA, 2003, P NATL ACAD SCI USA, V100, P12747, DOI 10.1073/pnas.1534900100; Chung CY, 2005, HUM MOL GENET, V14, P1709, DOI 10.1093/hmg/ddi178; DAHLSTROM A, 1964, ACTA PHYSIOL SCAND, V62, P1; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Di Salvio M, 2010, INT J DEV BIOL, V54, P939, DOI 10.1387/ijdb.092974ms; Ferri ALM, 2007, DEVELOPMENT, V134, P2761, DOI 10.1242/dev.000141; Greene JG, 2005, NEUROBIOL DIS, V18, P19, DOI 10.1016/j.nbd.2004.10.003; JACKSONLEWIS V, 1995, NEURODEGENERATION, V4, P257, DOI 10.1016/1055-8330(95)90015-2; Jankovic J, 2005, PROG NEUROBIOL, V77, P128, DOI 10.1016/j.pneurobio.2005.09.001; Jellinger KA, 2001, ADV NEUROL, V86, P55; Kadkhodaei B, 2009, J NEUROSCI, V29, P15923, DOI 10.1523/JNEUROSCI.3910-09.2009; Kele J, 2006, DEVELOPMENT, V133, P495, DOI 10.1242/dev.02223; Kittappa R, 2007, PLOS BIOL, V5, P2875, DOI 10.1371/journal.pbio.0050325; Li LB, 2004, J BIOL CHEM, V279, P21012, DOI 10.1074/jbc.M311972200; Liang CL, 1996, NEURODEGENERATION, V5, P313, DOI 10.1006/neur.1996.0042; Marin F, 2005, DEV DYNAM, V234, P709, DOI 10.1002/dvdy.20467; Murer G, 1997, NEUROSCIENCE, V80, P345, DOI 10.1016/S0306-4522(97)00001-8; Nunes I, 2003, P NATL ACAD SCI USA, V100, P4245, DOI 10.1073/pnas.0230529100; Omodei D, 2008, DEVELOPMENT, V135, P3459, DOI 10.1242/dev.027003; Ono Y, 2007, DEVELOPMENT, V134, P3213, DOI 10.1242/dev.02879; PIFL C, 1993, J NEUROSCI, V13, P4246, DOI 10.1523/jneurosci.13-10-04246.1993; Prakash N, 2006, DEVELOPMENT, V133, P89, DOI 10.1242/dev.02181; Prakash N, 2006, CELL MOL LIFE SCI, V63, P187, DOI 10.1007/s00018-005-5387-6; Puelles E, 2004, DEVELOPMENT, V131, P2037, DOI 10.1242/dev.01107; Puelles E, 2003, NAT NEUROSCI, V6, P453, DOI 10.1038/nn1037; RofflerTarlov S, 1996, J NEUROSCI, V16, P1819; Saucedo-Cardenas O, 1998, P NATL ACAD SCI USA, V95, P4013, DOI 10.1073/pnas.95.7.4013; Schein JC, 1998, DEV BIOL, V204, P432, DOI 10.1006/dbio.1998.9076; Sgado P, 2006, P NATL ACAD SCI USA, V103, P15242, DOI 10.1073/pnas.0602116103; Simeone A, 2005, TRENDS NEUROSCI, V28, P62, DOI 10.1016/j.tins.2004.11.007; Simon HH, 2001, J NEUROSCI, V21, P3126, DOI 10.1523/JNEUROSCI.21-09-03126.2001; Smidt MP, 2007, NAT REV NEUROSCI, V8, P21, DOI 10.1038/nrn2039; Smidt MP, 2000, NAT NEUROSCI, V3, P337, DOI 10.1038/73902; Smidt MP, 2004, DEVELOPMENT, V131, P1145, DOI 10.1242/dev.01022; Sonnier L, 2007, J NEUROSCI, V27, P1063, DOI 10.1523/JNEUROSCI.4583-06.2007; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Thompson L, 2005, J NEUROSCI, V25, P6467, DOI 10.1523/JNEUROSCI.1676-05.2005; Torres GE, 2003, J BIOL CHEM, V278, P2731, DOI 10.1074/jbc.M201926200; van den Munckhof P, 2003, DEVELOPMENT, V130, P2535, DOI 10.1242/dev.00464; Zetterstrom RH, 1997, SCIENCE, V276, P248, DOI 10.1126/science.276.5310.248	50	93	93	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2010	13	12					1481	U63		10.1038/nn.2661	http://dx.doi.org/10.1038/nn.2661			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	684CW	21057506				2022-12-28	WOS:000284525800012
J	Cho, M				Cho, Min			Spinal convergence of motor and sensory pathways	NATURE NEUROSCIENCE			English	Editorial Material														Cho, Min/0000-0003-4696-0173					0	0	0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2010	13	10					1160	1160		10.1038/nn1010-1160	http://dx.doi.org/10.1038/nn1010-1160			1	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	654MB	20877279				2022-12-28	WOS:000282171300006
J	Krajbich, I; Armel, C; Rangel, A				Krajbich, Ian; Armel, Carrie; Rangel, Antonio			Visual fixations and the computation and comparison of value in simple choice	NATURE NEUROSCIENCE			English	Article							PERCEPTUAL DECISION-MAKING; 2-CHOICE REACTION-TIME; ORBITOFRONTAL CORTEX; SENSORY STIMULI; FIELD-THEORY; NEURAL BASIS; AREA LIP; MODELS; BEHAVIOR; MICROSTIMULATION	Most organisms facing a choice between multiple stimuli will look repeatedly at them, presumably implementing a comparison process between the items' values. Little is known about the nature of the comparison process in value-based decision-making or about the role of visual fixations in this process. We created a computational model of value-based binary choice in which fixations guide the comparison process and tested it on humans using eye-tracking. We found that the model can quantitatively explain complex relationships between fixation patterns and choices, as well as several fixation-driven decision biases.	[Krajbich, Ian; Rangel, Antonio] CALTECH, Div Humanities & Social Sci, Pasadena, CA 91125 USA; [Armel, Carrie] Stanford Univ, Precourt Inst Energy Efficiency, Palo Alto, CA 94304 USA	California Institute of Technology; Stanford University	Rangel, A (corresponding author), CALTECH, Div Humanities & Social Sci, Pasadena, CA 91125 USA.	rangel@hss.caltech.edu			Moore Foundation	Moore Foundation(Gordon and Betty Moore Foundation)	We thank E. Johnson, P. Bossaerts and C. Koch for comments and J. Pulst-Korenberg for help with data collection. This work received financial support from the Moore Foundation.	Arana FS, 2003, J NEUROSCI, V23, P9632; Armel KC, 2008, JUDGM DECIS MAK, V3, P396; Bogacz R, 2007, TRENDS COGN SCI, V11, P118, DOI 10.1016/j.tics.2006.12.006; Bogacz R, 2006, PSYCHOL REV, V113, P700, DOI 10.1037/0033-295X.113.4.700; Busemeyer J. R., 2004, BLACKWELL HDB JUDGME, P133, DOI DOI 10.1002/9780470752937.CH7; BUSEMEYER JR, 1993, PSYCHOL REV, V100, P432, DOI 10.1037/0033-295X.100.3.432; Churchland AK, 2008, NAT NEUROSCI, V11, P693, DOI 10.1038/nn.2123; Ditterich J, 2003, NAT NEUROSCI, V6, P891, DOI 10.1038/nn1094; Ditterich J, 2006, NEURAL NETWORKS, V19, P981, DOI 10.1016/j.neunet.2006.05.042; Erk S, 2002, NEUROREPORT, V13, P2499, DOI 10.1097/00001756-200212200-00024; Gold JI, 2001, TRENDS COGN SCI, V5, P10, DOI 10.1016/S1364-6613(00)01567-9; Gold JI, 2002, NEURON, V36, P299, DOI 10.1016/S0896-6273(02)00971-6; Gold JI, 2007, ANNU REV NEUROSCI, V30, P535, DOI 10.1146/annurev.neuro.29.051605.113038; Hanks TD, 2006, NAT NEUROSCI, V9, P682, DOI 10.1038/nn1683; Hare TA, 2008, J NEUROSCI, V28, P5623, DOI 10.1523/JNEUROSCI.1309-08.2008; Hare TA, 2009, SCIENCE, V324, P646, DOI 10.1126/science.1168450; Huk AC, 2005, J NEUROSCI, V25, P10420, DOI 10.1523/JNEUROSCI.4684-04.2005; Itti L, 2001, NAT REV NEUROSCI, V2, P194, DOI 10.1038/35058500; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; LAMING D, 1979, ACTA PSYCHOL, V43, P431, DOI 10.1016/0001-6918(79)90001-5; Link SW, 1992, WAVE THEORY DIFFEREN; Luce RD, 1986, RESPONSE TIMES THEIR; Mas-Colell A., 1995, MICROECONOMIC THEORY; Mazurek ME, 2003, CEREB CORTEX, V13, P1257, DOI 10.1093/cercor/bhg097; MCCLELLAND JL, 1981, PSYCHOL REV, V88, P375, DOI 10.1037/0033-295X.88.5.375; Padoa-Schioppa C, 2006, NATURE, V441, P223, DOI 10.1038/nature04676; Palmer J, 2005, J VISION, V5, P376, DOI 10.1167/5.5.1; Paulus MP, 2003, NEUROREPORT, V14, P1311, DOI 10.1097/01.wnr.0000078543.07662.02; Plassmann H, 2007, J NEUROSCI, V27, P9984, DOI 10.1523/JNEUROSCI.2131-07.2007; Rangel A, 2008, NAT REV NEUROSCI, V9, P545, DOI 10.1038/nrn2357; Ratcliff R, 2003, J NEUROPHYSIOL, V90, P1392, DOI 10.1152/jn.01049.2002; Ratcliff R, 2004, PSYCHOL REV, V111, P333, DOI 10.1037/0033-295X.111.2.333; RATCLIFF R, 1978, PSYCHOL REV, V85, P59, DOI 10.1037//0033-295X.85.2.59; Reddi BAJ, 2000, NAT NEUROSCI, V3, P827, DOI 10.1038/77739; Roe RM, 2001, PSYCHOL REV, V108, P370, DOI 10.1037//0033-295X.108.2.370; Roitman JD, 2002, J NEUROSCI, V22, P9475; Shadlen MN, 2001, J NEUROPHYSIOL, V86, P1916, DOI 10.1152/jn.2001.86.4.1916; Shadlen MN, 1996, P NATL ACAD SCI USA, V93, P628, DOI 10.1073/pnas.93.2.628; Shimojo S, 2003, NAT NEUROSCI, V6, P1317, DOI 10.1038/nn1150; Smith PL, 2000, J MATH PSYCHOL, V44, P408, DOI 10.1006/jmps.1999.1260; SMITH PL, 1995, PSYCHOL REV, V102, P567, DOI 10.1037/0033-295X.102.3.567; Spezio ML, 2007, J AUTISM DEV DISORD, V37, P929, DOI 10.1007/s10803-006-0232-9; STONE M, 1960, PSYCHOMETRIKA, V25, P251, DOI 10.1007/BF02289729; Usher M, 2001, PSYCHOL REV, V108, P550, DOI 10.1037//0033-295X.108.3.550; Valentin VV, 2007, J NEUROSCI, V27, P4019, DOI 10.1523/JNEUROSCI.0564-07.2007; Wallis JD, 2007, ANNU REV NEUROSCI, V30, P31, DOI 10.1146/annurev.neuro.30.051606.094334	46	722	733	11	171	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2010	13	10					1292	1298		10.1038/nn.2635	http://dx.doi.org/10.1038/nn.2635			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	654MB	20835253				2022-12-28	WOS:000282171300023
J	Kable, JW				Kable, Joseph W.			Just a little (lateral prefrontal) patience	NATURE NEUROSCIENCE			English	Editorial Material							DECISION-MAKING; CORTEX; DELAY; IMMEDIATE; REWARDS; FUTURE		Univ Penn, Dept Psychol, Philadelphia, PA 19104 USA	University of Pennsylvania	Kable, JW (corresponding author), Univ Penn, Dept Psychol, 3815 Walnut St, Philadelphia, PA 19104 USA.	kable@psych.upenn.edu						Ballard K, 2009, NEUROIMAGE, V45, P143, DOI 10.1016/j.neuroimage.2008.11.004; Bjork JM, 2009, BIOL PSYCHIAT, V65, P710, DOI 10.1016/j.biopsych.2008.11.023; Boettiger CA, 2007, J NEUROSCI, V27, P14383, DOI 10.1523/JNEUROSCI.2551-07.2007; Fellows LK, 2005, NEUROPSYCHOLOGIA, V43, P1214, DOI 10.1016/j.neuropsychologia.2004.07.018; Figner B, 2010, NAT NEUROSCI, V13, P538, DOI 10.1038/nn.2516; Gogtay N, 2004, P NATL ACAD SCI USA, V101, P8174, DOI 10.1073/pnas.0402680101; Hare TA, 2009, SCIENCE, V324, P646, DOI 10.1126/science.1168450; Kable JW, 2007, NAT NEUROSCI, V10, P1625, DOI 10.1038/nn2007; Kable JW, 2009, NEURON, V63, P733, DOI 10.1016/j.neuron.2009.09.003; Knoch D, 2006, SCIENCE, V314, P829, DOI 10.1126/science.1129156; McClure SM, 2004, SCIENCE, V306, P503, DOI 10.1126/science.1100907; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Monterosso JR, 2007, HUM BRAIN MAPP, V28, P383, DOI 10.1002/hbm.20281; Shamosh NA, 2008, PSYCHOL SCI, V19, P904, DOI 10.1111/j.1467-9280.2008.02175.x; Weber BJ, 2008, BRAIN RES, V1234, P104, DOI 10.1016/j.brainres.2008.07.105	15	11	11	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2010	13	5					523	524		10.1038/nn0510-523	http://dx.doi.org/10.1038/nn0510-523			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	588JM	20421894				2022-12-28	WOS:000277065700002
J	Lovett-Barron, M; Turi, GF; Kaifosh, P; Lee, PH; Bolze, F; Sun, XH; Nicoud, JF; Zemelman, BV; Sternson, SM; Losonczy, A				Lovett-Barron, Matthew; Turi, Gergely F.; Kaifosh, Patrick; Lee, Peter H.; Bolze, Frederic; Sun, Xiao-Hua; Nicoud, Jean-Francois; Zemelman, Boris V.; Sternson, Scott M.; Losonczy, Attila			Regulation of neuronal input transformations by tunable dendritic inhibition	NATURE NEUROSCIENCE			English	Article							CA1 PYRAMIDAL NEURONS; HIPPOCAMPAL INTERNEURONS; RAT HIPPOCAMPUS; GABAERGIC INTERNEURONS; PLACE CELLS; IN-VIVO; NETWORK; PLASTICITY; OSCILLATIONS; POTENTIALS	Transforming synaptic input into action potential output is a fundamental function of neurons. The pattern of action potential output from principal cells of the mammalian hippocampus encodes spatial and nonspatial information, but the cellular and circuit mechanisms by which neurons transform their synaptic input into a given output are unknown. Using a combination of optical activation and cell type-specific pharmacogenetic silencing in vitro, we found that dendritic inhibition is the primary regulator of input-output transformations in mouse hippocampal CA1 pyramidal cells, and acts by gating the dendritic electrogenesis driving burst spiking. Dendrite-targeting interneurons are themselves modulated by interneurons targeting pyramidal cell somata, providing a synaptic substrate for tuning pyramidal cell output through interactions in the local inhibitory network. These results provide evidence for a division of labor in cortical circuits, where distinct computational functions are implemented by subtypes of local inhibitory neurons.	[Lovett-Barron, Matthew; Turi, Gergely F.; Kaifosh, Patrick; Losonczy, Attila] Columbia Univ, Dept Neurosci, New York, NY 10027 USA; [Lee, Peter H.; Sternson, Scott M.] Howard Hughes Med Inst, Ashburn, VA USA; [Bolze, Frederic; Sun, Xiao-Hua; Nicoud, Jean-Francois] Univ Strasbourg, Lab Biophoton & Pharmacol, Ctr Natl Rech Sci, UMR 7213, Strasbourg, France; [Zemelman, Boris V.] Univ Texas Austin, Ctr Learning & Memory, Austin, TX 78712 USA	Columbia University; Howard Hughes Medical Institute; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Texas System; University of Texas Austin	Losonczy, A (corresponding author), Columbia Univ, Dept Neurosci, New York, NY 10027 USA.	al2856@columbia.edu	Turi, Gergely/G-5054-2019; Bolze, Frederic/AAX-9871-2021; Turi, Gergely/E-7631-2013	Turi, Gergely/0000-0001-5651-9459; Kaifosh, Patrick/0000-0002-1470-5701; Zemelman, Boris/0000-0003-2463-4887; Lee, Peter H/0000-0003-4177-4099; Lovett-Barron, Matthew/0000-0003-1425-5277; Sternson, Scott/0000-0002-0835-444X	Natural Sciences and Engineering Research Council of Canada; Searle Scholar Program; Gatsby Foundation; Kavli Institute at Columbia University; Howard Hughes Medical Institute; Agence Nationale pour la Recherche (France) [ANR PCV 07 10035]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Searle Scholar Program; Gatsby Foundation; Kavli Institute at Columbia University; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Agence Nationale pour la Recherche (France)(French National Research Agency (ANR))	We thank R. Nyilas, R. Field, A. Qureshi, J.K. Baruni and A. Villacis for help with histology. We thank J.C. Magee, L. F. Abbott, G. Buzsaki, S. A. Siegelbaum and T. M. Jessell for discussions and comments on a previous version of the manuscript. This work was supported by Natural Sciences and Engineering Research Council of Canada Postgraduate Scholarships (M.L.-B. and P. K.), the Searle Scholar Program, the Gatsby Foundation and Kavli Institute at Columbia University (A. L.) and the Howard Hughes Medical Institute (S. M. S.). F. B. thanks the Agence Nationale pour la Recherche (France) for financial support (ANR PCV 07 10035).	Ahmed OJ, 2009, TRENDS NEUROSCI, V32, P329, DOI 10.1016/j.tins.2009.01.009; Atasoy D, 2008, J NEUROSCI, V28, P7025, DOI 10.1523/JNEUROSCI.1954-08.2008; Branco T, 2010, CURR OPIN NEUROBIOL, V20, P494, DOI 10.1016/j.conb.2010.07.009; BUHL EH, 1994, NATURE, V368, P823, DOI 10.1038/368823a0; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; Cobb SR, 1997, NEUROSCIENCE, V79, P629, DOI 10.1016/S0306-4522(97)00055-9; COBB SR, 1995, NATURE, V378, P75, DOI 10.1038/378075a0; Colgin LL, 2008, TRENDS NEUROSCI, V31, P469, DOI 10.1016/j.tins.2008.06.008; Collingridge G.L., 1988, J PHYSIOL-LONDON, V399, P282; Cope DW, 2002, NEUROSCIENCE, V109, P63, DOI 10.1016/S0306-4522(01)00440-7; Epsztein J, 2011, NEURON, V70, P109, DOI 10.1016/j.neuron.2011.03.006; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Fuentealba P, 2008, NEURON, V57, P917, DOI 10.1016/j.neuron.2008.01.034; Gasparini S, 2006, J NEUROSCI, V26, P2088, DOI 10.1523/JNEUROSCI.4428-05.2006; Golding NL, 1999, J NEUROSCI, V19, P8789, DOI 10.1523/JNEUROSCI.19-20-08789.1999; Harvey CD, 2009, NATURE, V461, P941, DOI 10.1038/nature08499; Isaacson JS, 2011, NEURON, V72, P231, DOI 10.1016/j.neuron.2011.09.027; Jarsky T, 2005, NAT NEUROSCI, V8, P1667, DOI 10.1038/nn1599; KANDEL ER, 1961, J NEUROPHYSIOL, V24, P243, DOI 10.1152/jn.1961.24.3.243; Katona I, 1999, J NEUROSCI, V19, P4544; Klausberger T, 2003, NATURE, V421, P844, DOI 10.1038/nature01374; Klausberger T, 2004, NAT NEUROSCI, V7, P41, DOI 10.1038/nn1159; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; Klausberger T, 2009, EUR J NEUROSCI, V30, P947, DOI 10.1111/j.1460-9568.2009.06913.x; KNOWLES WD, 1981, J NEUROSCI, V1, P1236; Larkum ME, 2009, SCIENCE, V325, P756, DOI 10.1126/science.1171958; Larkum ME, 1999, NATURE, V398, P338, DOI 10.1038/18686; Losonczy A, 2006, NEURON, V50, P291, DOI 10.1016/j.neuron.2006.03.016; Losonczy A, 2002, J PHYSIOL-LONDON, V542, P193, DOI 10.1113/jphysiol.2002.020024; Losonczy A, 2008, NATURE, V452, P436, DOI 10.1038/nature06725; Losonczy A, 2010, NAT NEUROSCI, V13, P967, DOI 10.1038/nn.2597; Maccaferri G, 2000, J PHYSIOL-LONDON, V524, P91, DOI 10.1111/j.1469-7793.2000.t01-3-00091.x; Magee JC, 1999, J NEUROPHYSIOL, V82, P1895, DOI 10.1152/jn.1999.82.4.1895; Magnus CJ, 2011, SCIENCE, V333, P1292, DOI 10.1126/science.1206606; Megias M, 2001, NEUROSCIENCE, V102, P527, DOI 10.1016/S0306-4522(00)00496-6; Miles R, 1996, NEURON, V16, P815, DOI 10.1016/S0896-6273(00)80101-4; MULLIGAN KA, 1988, J COMP NEUROL, V270, P86, DOI 10.1002/cne.902700108; Murayama M, 2009, NATURE, V457, P1137, DOI 10.1038/nature07663; Nevian T, 2007, NAT NEUROSCI, V10, P206, DOI 10.1038/nn1826; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; Poirazi P, 2003, NEURON, V37, P977, DOI 10.1016/S0896-6273(03)00148-X; Poirazi P, 2003, NEURON, V37, P989, DOI 10.1016/S0896-6273(03)00149-1; Pouille F, 2001, SCIENCE, V293, P1159, DOI 10.1126/science.1060342; Takahashi H, 2009, NEURON, V62, P102, DOI 10.1016/j.neuron.2009.03.007; THOMPSON LT, 1989, J NEUROSCI, V9, P2382; Varga V, 2009, SCIENCE, V326, P449, DOI 10.1126/science.1178307; Verde EMR, 2008, FRONT NEURAL CIRCUIT, V2, DOI 10.3389/neuro.04.002.2008; Williams SR, 2004, NAT NEUROSCI, V7, P961, DOI 10.1038/nn1305; Williams SR, 2002, SCIENCE, V295, P1907, DOI 10.1126/science.1067903	50	268	268	0	44	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2012	15	3					423	U111		10.1038/nn.3024	http://dx.doi.org/10.1038/nn.3024			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	899CY	22246433				2022-12-28	WOS:000300793100016
J	Weber, F; Machens, CK; Borst, A				Weber, Franz; Machens, Christian K.; Borst, Alexander			Disentangling the functional consequences of the connectivity between optic-flow processing neurons	NATURE NEUROSCIENCE			English	Article							RECEPTIVE-FIELD PROPERTIES; MOTION-SENSITIVE NEURONS; PRIMARY VISUAL-CORTEX; SPIKING NEURONS; POPULATION; SYSTEM; FLY; INTERNEURONS; PERFORMANCE; DEPENDENCE	Typically, neurons in sensory areas are highly interconnected. Coupling two neurons can synchronize their activity and affect a variety of single-cell properties, such as their stimulus tuning, firing rate or gain. All of these factors must be considered to understand how two neurons should be coupled to optimally process stimuli. We quantified the functional effect of an interaction between two optic-flow processing neurons (Vi and H1) in the fly (Lucilia sericata). Using a generative model, we estimated a uni-directional coupling from H1 to Vi. Especially at a low signal-to-noise ratio (SNR), the coupling strongly improved the information about optic-flow in Vi. We identified two constraints confining the strength of the interaction. First, for weak couplings, Vi benefited from inputs by H1 without a concomitant shift of its stimulus tuning. Second, at both low and high SNR, the coupling strength lay in a range in which the information carried by single spikes is optimal.	[Weber, Franz; Borst, Alexander] Max Planck Inst Neurobiol, Dept Syst & Computat Neurobiol, Martinsried, Germany; [Weber, Franz] Univ Munich, Grad Sch Syst Neurosci, Munich, Germany; [Machens, Christian K.] Ecole Normale Super, Grp Neural Theory, Dept Etud Cognit, INSERM,U960, F-75231 Paris, France	Max Planck Society; University of Munich; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS)	Weber, F (corresponding author), Max Planck Inst Neurobiol, Dept Syst & Computat Neurobiol, Martinsried, Germany.	weberf@neuro.mpg.de		Machens, Christian/0000-0003-1717-1562	Deutsche Forschungsgemeinschaft (DFG) [1091]; Max Planck Society	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Max Planck Society(Max Planck Society)	We thank E. Schneidman and G. Tkacik for important discussions during the Methods in Computational Neuroscience course in Woods Hole, Massachusetts. We thank M. Walter for improving the functionality of the LED arena, F. Schwarz for help with the experiments and H. Eichner for critically reading the manuscript. F. W. is supported by a grant from the Deutsche Forschungsgemeinschaft (DFG, Research Training Group 1091) and the Max Planck Society. C. K. M. is funded through the Emmy-Noether program of the DFG and a "Chaire d'excellence" of the Agence National de la Recherche.	Averbeck BB, 2006, NAT REV NEUROSCI, V7, P358, DOI 10.1038/nrn1888; Bair W, 2001, J NEUROSCI, V21, P1676, DOI 10.1523/JNEUROSCI.21-05-01676.2001; BEERSMA DGM, 1977, J COMP PHYSIOL, V119, P207, DOI 10.1007/BF00656634; BIALEK W, 1991, SCIENCE, V252, P1854, DOI 10.1126/science.2063199; Borst A, 1999, NAT NEUROSCI, V2, P947, DOI 10.1038/14731; Borst A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016303; Borst A, 2010, ANNU REV NEUROSCI, V33, P49, DOI 10.1146/annurev-neuro-060909-153155; Brody CD, 1999, NEURAL COMPUT, V11, P1537, DOI 10.1162/089976699300016133; Cafaro J, 2010, NATURE, V468, P964, DOI 10.1038/nature09570; Cohen MR, 2011, NAT NEUROSCI, V14, P811, DOI 10.1038/nn.2842; Cohen MR, 2009, NAT NEUROSCI, V12, P1594, DOI 10.1038/nn.2439; de la Rocha J, 2007, NATURE, V448, P802, DOI 10.1038/nature06028; DEVRIES SH, 1993, CELL, V72, P139, DOI 10.1016/S0092-8674(05)80033-9; Elyada YM, 2009, NAT NEUROSCI, V12, P327, DOI 10.1038/nn.2269; Farrow K, 2005, J NEUROSCI, V25, P3985, DOI 10.1523/JNEUROSCI.0168-05.2005; Gerwinn S, 2010, FRONT COMPUT NEUROSC, V4, DOI 10.3389/fncom.2010.00012; GILBERT CD, 1985, VISION RES, V25, P365, DOI 10.1016/0042-6989(85)90061-6; Haag J, 2004, P NATL ACAD SCI USA, V101, P16333, DOI 10.1073/pnas.0407368101; Haag J, 2004, NAT NEUROSCI, V7, P628, DOI 10.1038/nn1245; Haag J, 2003, J COMP PHYSIOL A, V189, P363, DOI 10.1007/s00359-003-0410-6; Haag J, 2002, J NEUROSCI, V22, P3227, DOI 10.1523/JNEUROSCI.22-08-03227.2002; Haag J, 2007, FRONT NEUROSCI-SWITZ, V1, P111, DOI 10.3389/neuro.01.1.1.008.2007; Hausen K., 1984, PHOTORECEPTION VISIO, P523, DOI [10.1007/978-1-4613-2743-1_15, DOI 10.1007/978-1-4613-2743-1_15]; Ko H, 2011, NATURE, V473, P87, DOI 10.1038/nature09880; Kohn A, 2005, J NEUROSCI, V25, P3661, DOI 10.1523/JNEUROSCI.5106-04.2005; Krapp HG, 1996, NATURE, V384, P463, DOI 10.1038/384463a0; Machens CK, 2001, J NEUROSCI, V21, P3215, DOI 10.1523/JNEUROSCI.21-09-03215.2001; MOORE GP, 1970, BIOPHYS J, V10, P876, DOI 10.1016/S0006-3495(70)86341-X; Nassi JJ, 2009, NAT REV NEUROSCI, V10, P360, DOI 10.1038/nrn2619; Nauhaus I, 2009, NAT NEUROSCI, V12, P70, DOI 10.1038/nn.2232; Okatan M, 2005, NEURAL COMPUT, V17, P1927, DOI 10.1162/0899766054322973; Olsen SR, 2008, NATURE, V452, P956, DOI 10.1038/nature06864; Olsen SR, 2007, NEURON, V54, P89, DOI 10.1016/j.neuron.2007.03.010; Paninski L, 2007, PROG BRAIN RES, V165, P493, DOI 10.1016/S0079-6123(06)65031-0; Pillow JW, 2008, NATURE, V454, P995, DOI 10.1038/nature07140; Read HL, 2002, CURR OPIN NEUROBIOL, V12, P433, DOI 10.1016/S0959-4388(02)00342-2; Reichardt W., 1961, S PRINC SENS COMM, P303; Rieke F., 1999, SPIKES; Schilstra C, 1999, J EXP BIOL, V202, P1481; Schneidman E, 2006, NATURE, V440, P1007, DOI 10.1038/nature04701; Shlens J, 2006, J NEUROSCI, V26, P8254, DOI 10.1523/JNEUROSCI.1282-06.2006; Smith MA, 2008, J NEUROSCI, V28, P12591, DOI 10.1523/JNEUROSCI.2929-08.2008; Stevenson IH, 2011, NAT NEUROSCI, V14, P139, DOI 10.1038/nn.2731; Takeuchi D, 2011, SCIENCE, V331, P1443, DOI 10.1126/science.1199967; Tkacik G, 2010, P NATL ACAD SCI USA, V107, P14419, DOI 10.1073/pnas.1004906107; Usrey WM, 1999, ANNU REV PHYSIOL, V61, P435, DOI 10.1146/annurev.physiol.61.1.435; Weber F, 2010, NEURON, V67, P629, DOI 10.1016/j.neuron.2010.07.017; ZOHARY E, 1994, NATURE, V370, P140, DOI 10.1038/370140a0	48	7	7	1	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2012	15	3					441	U132		10.1038/nn.3044	http://dx.doi.org/10.1038/nn.3044			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	899CY	22327473				2022-12-28	WOS:000300793100018
J	Nazzaro, C; Greco, B; Cerovic, M; Baxter, P; Rubino, T; Trusel, M; Parolaro, D; Tkatch, T; Benfenati, F; Pedarzani, P; Tonini, R				Nazzaro, Cristiano; Greco, Barbara; Cerovic, Milica; Baxter, Paul; Rubino, Tiziana; Trusel, Massimo; Parolaro, Daniela; Tkatch, Tatiana; Benfenati, Fabio; Pedarzani, Paola; Tonini, Raffaella			SK channel modulation rescues striatal plasticity and control over habit in cannabinoid tolerance	NATURE NEUROSCIENCE			English	Article							LONG-TERM DEPRESSION; MEDIUM SPINY NEURONS; SYNAPTIC PLASTICITY; ENDOCANNABINOID RELEASE; DOPAMINERGIC CONTROL; INDUCED DYSKINESIA; NUCLEUS-ACCUMBENS; DORSAL STRIATUM; RECEPTORS; EXPOSURE	Endocannabinoids (eCBs) regulate neuronal activity in the dorso-lateral striatum (DLS), a brain region that is involved in habitual behaviors. How synaptic eCB signaling contributes to habitual behaviors under physiological and pathological conditions remains unclear. Using a mouse model of cannabinoid tolerance, we found that persistent activation of the eCB pathway impaired eCB-mediated long-term depression (LTD) and synaptic depotentiation in the DLS. The loss of eCB LTD, occurring preferentially at cortical connections to striatopallidal neurons, was associated with a shift in behavioral control from goal-directed action to habitual responding. eCB LTD and behavioral alterations were rescued by in vivo modulation of small-conductance calcium activated potassium channel (SK channel) activity in the DLS, which potentiates eCB signaling. Our results reveal a direct relationship between drug tolerance and changes in control of instrumental performance by establishing a central role for eCB LTD in habit expression. In addition, SK channels emerge as molecular targets to fine tune the eCB pathway under pathological conditions.	[Nazzaro, Cristiano; Greco, Barbara; Trusel, Massimo; Tkatch, Tatiana; Benfenati, Fabio; Tonini, Raffaella] IIT, Dept Neurosci & Brain Technol, Genoa, Italy; [Cerovic, Milica] Cardiff Univ, Sch Biosci, Cardiff, S Glam, Wales; [Baxter, Paul; Pedarzani, Paola] UCL, Res Dept Neurosci Physiol & Pharmacol, London, England; [Rubino, Tiziana; Parolaro, Daniela] Univ Insubria, DBSF, Busto Arsizio, VA, Italy	Istituto Italiano di Tecnologia - IIT; Cardiff University; University of London; University College London; University of Insubria	Tonini, R (corresponding author), IIT, Dept Neurosci & Brain Technol, Genoa, Italy.	raffaella.tonini@iit.it	Rubino, Tiziana/AAC-8210-2020; Tonini, Raffaella/J-2960-2012	Cerovic, Milica/0000-0002-8417-0503; Trusel, Massimo/0000-0001-6208-2476; TONINI, Raffaella/0000-0003-1652-4709; Tkatch, Tatiana/0000-0001-6626-7435; RUBINO, Tiziana/0000-0002-3128-6377; Baxter, Paul/0000-0003-2142-1085	Istituto Italiano di Tecnologia; Medical Research Council [CEG G0100066]; MRC [G0100066] Funding Source: UKRI; Medical Research Council [G0100066] Funding Source: researchfish	Istituto Italiano di Tecnologia(Istituto Italiano di Tecnologia - IIT); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We are grateful to V. Di Marzo, L. Gasparini and F. Papaleo for critical reading of the manuscript, and D. Piomelli for helpful discussion of the results. This research was supported by the Istituto Italiano di Tecnologia. P.P. acknowledges support from the Medical Research Council (CEG G0100066).	Adermark L, 2007, J NEUROSCI, V27, P6781, DOI 10.1523/JNEUROSCI.0280-07.2007; Belin D, 2008, NEURON, V57, P432, DOI 10.1016/j.neuron.2007.12.019; CALABRESI P, 1992, J NEUROSCI, V12, P4224; Centonze D, 2006, BIOL PSYCHIAT, V60, P436, DOI 10.1016/j.biopsych.2005.11.018; Chaperon F, 1999, CRIT REV NEUROBIOL, V13, P243, DOI 10.1615/CritRevNeurobiol.v13.i3.20; DeRusso AL, 2010, FRONT INTEGR NEUROSC, V4, DOI 10.3389/fnint.2010.00017; Fino E, 2010, J PHYSIOL-LONDON, V588, P3045, DOI 10.1113/jphysiol.2010.188466; Gerdeman GL, 2002, NAT NEUROSCI, V5, P446, DOI 10.1038/nn832; Grueter BA, 2010, NAT NEUROSCI, V13, P1519, DOI 10.1038/nn.2685; Gulyas AI, 2004, EUR J NEUROSCI, V20, P441, DOI 10.1111/j.1460-9568.2004.03428.x; HERKENHAM M, 1991, J NEUROSCI, V11, P563, DOI 10.1523/jneurosci.11-02-00563.1991; Higley MJ, 2010, NAT NEUROSCI, V13, P958, DOI 10.1038/nn.2592; Hilario MRF, 2008, FRONT NEUROSCI-SWITZ, V2, P208, DOI 10.3389/neuro.01.030.2008; Hilario MRF, 2007, FRONT INTEGR NEUROSC, V1, DOI [10.3389/neuro.07/006.2007, 10.3389/neuro.07.006.2007]; Hoffman AF, 2003, J NEUROSCI, V23, P4815; Kano M, 2009, PHYSIOL REV, V89, P309, DOI 10.1152/physrev.00019.2008; Kathuria S, 2003, NAT MED, V9, P76, DOI 10.1038/nm803; Katona I, 2008, NAT MED, V14, P923, DOI 10.1038/nm.f.1869; Kreitzer AC, 2005, J NEUROSCI, V25, P10537, DOI 10.1523/JNEUROSCI.2959-05.2005; Kreitzer AC, 2007, NATURE, V445, P643, DOI 10.1038/nature05506; Kreitzer AC, 2009, ANNU REV NEUROSCI, V32, P127, DOI 10.1146/annurev.neuro.051508.135422; Lovinger DM, 2010, NEUROPHARMACOLOGY, V58, P951, DOI 10.1016/j.neuropharm.2010.01.008; Maldonado R, 2003, J NEURAL TRANSM-SUPP, P1; Maldonado R, 2002, J NEUROSCI, V22, P3326; Martin BR, 2004, TRENDS PHARMACOL SCI, V25, P325, DOI 10.1016/j.tips.2004.04.005; Mato S, 2005, J NEUROSCI, V25, P11619, DOI 10.1523/JNEUROSCI.2294-05.2005; Mato S, 2004, NAT NEUROSCI, V7, P585, DOI 10.1038/nn1251; Ngo-Anh TJ, 2005, NAT NEUROSCI, V8, P642, DOI 10.1038/nn1449; Picconi B, 2003, NAT NEUROSCI, V6, P501, DOI 10.1038/nn1040; Picconi B, 2011, BRAIN, V134, P375, DOI 10.1093/brain/awq342; Quinn JJ, 2007, NAT NEUROSCI, V10, P1398, DOI 10.1038/nn1994; Ronesi J, 2005, J PHYSIOL-LONDON, V562, P245, DOI 10.1113/jphysiol.2004.068460; Rubino T, 2005, J NEUROCHEM, V93, P984, DOI 10.1111/j.1471-4159.2005.03101.x; Shen WX, 2008, SCIENCE, V321, P848, DOI 10.1126/science.1160575; Stocker M, 2004, NAT REV NEUROSCI, V5, P758, DOI 10.1038/nrn1516; Surmeier DJ, 2009, CURR OPIN NEUROBIOL, V19, P621, DOI 10.1016/j.conb.2009.10.003; Surmeier DJ, 1996, J NEUROSCI, V16, P6579, DOI 10.1523/jneurosci.16-20-06579.1996; Szallasi A, 2007, NAT REV DRUG DISCOV, V6, P357, DOI 10.1038/nrd2280; Thorn CA, 2010, NEURON, V66, P781, DOI 10.1016/j.neuron.2010.04.036; Tonini R, 2006, J NEUROSCI, V26, P5810, DOI 10.1523/JNEUROSCI.5469-05.2006; Uchigashima M, 2007, J NEUROSCI, V27, P3663, DOI 10.1523/JNEUROSCI.0448-07.2007; Wang ZF, 2006, NEURON, V50, P443, DOI 10.1016/j.neuron.2006.04.010; Yin HH, 2006, NAT REV NEUROSCI, V7, P464, DOI 10.1038/nrn1919; Yin HH, 2009, NAT NEUROSCI, V12, P333, DOI 10.1038/nn.2261; Yin HH, 2005, EUR J NEUROSCI, V22, P513, DOI 10.1111/j.1460-9568.2005.04218.x; Yin HH, 2004, EUR J NEUROSCI, V19, P181, DOI 10.1111/j.1460-9568.2004.03095.x	46	81	81	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2012	15	2					284	293		10.1038/nn.3022	http://dx.doi.org/10.1038/nn.3022			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	882ZX	22231426				2022-12-28	WOS:000299603500020
J	Li, SX; Huang, S; Bren, N; Noridomi, K; Dellisanti, CD; Sine, SM; Chen, L				Li, Shu-Xing; Huang, Sun; Bren, Nina; Noridomi, Kaori; Dellisanti, Cosma D.; Sine, Steven M.; Chen, Lin			Ligand-binding domain of an alpha(7)-nicotinic receptor chimera and its complex with agonist	NATURE NEUROSCIENCE			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; GATED ION-CHANNEL; X-RAY-STRUCTURE; CURARIFORM ANTAGONISTS; CRYSTAL-STRUCTURE; PROTEIN REVEALS; ALPHA-7 SUBUNIT; LOOP; MUTAGENESIS; PERMEATION	The alpha(7) acetylcholine receptor (AChR) mediates pre- and postsynaptic neurotransmission in the central nervous system and is a potential therapeutic target in neurodegenerative, neuropsychiatric and inflammatory disorders. We determined the crystal structure of the extracellular domain of a receptor chimera constructed from the human alpha(7) AChR and Lymnaea stagnalis acetylcholine binding protein (AChBP), which shares 64% sequence identity and 71% similarity with native alpha(7). We also determined the structure with bound epibatidine, a potent AChR agonist. Comparison of the structures revealed molecular rearrangements and interactions that mediate agonist recognition and early steps in signal transduction in alpha(7) AChRs. The structures further revealed a ring of negative charge within the central vestibule, poised to contribute to cation selectivity. Structure-guided mutational studies disclosed distinctive contributions to agonist recognition and signal transduction in alpha(7) AChRs. The structures provide a realistic template for structure-aided drug design and for defining structure-function relationships of alpha(7) AChRs.	[Li, Shu-Xing; Noridomi, Kaori; Dellisanti, Cosma D.; Chen, Lin] Univ So Calif, Dept Biol Sci, Los Angeles, CA 90089 USA; [Li, Shu-Xing; Noridomi, Kaori; Dellisanti, Cosma D.; Chen, Lin] Univ So Calif, Dept Chem, Los Angeles, CA 90089 USA; [Huang, Sun; Bren, Nina; Sine, Steven M.] Mayo Clin, Dept Physiol & Biomed Engn, Coll Med, Rochester, MN USA; [Sine, Steven M.] Mayo Clin, Dept Neurol, Coll Med, Rochester, MN USA; [Chen, Lin] Univ So Calif, Keck Sch Med, Kenneth Norris Jr Comprehens Canc Ctr, Los Angeles, CA 90033 USA	University of Southern California; University of Southern California; Mayo Clinic; Mayo Clinic; University of Southern California	Chen, L (corresponding author), Univ So Calif, Dept Biol Sci, Los Angeles, CA 90089 USA.	sine@mayo.edu; linchen@usc.edu	Li, Shu-Xing/C-5370-2011; chen, Lin/A-3392-2008	chen, Lin/0000-0003-4798-6199; Noridomi, Kaori/0000-0002-4303-7511	US National Institutes of Health [NS031744, HL076334, GM064642]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076334] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064642] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS031744, R37NS031744] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Advanced Light Source Berkeley Center for Structural Biology staff members C. Ralston, P. Zwart, C. Bertoldo, A. Rozales and K. Royal for help with data collection, N. Chelyapov and University of Southern California NanoBiophysics Core Facility for help with multi-angle light scattering analyses and P. Taylor for providing cDNA encoding AChBP. This work is supported by US National Institutes of Health grants NS031744 to S. M. S. and HL076334 and GM064642 to L.C.	Alkondon M, 1997, EUR J NEUROSCI, V9, P2734, DOI 10.1111/j.1460-9568.1997.tb01702.x; Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462; Bouzat C, 2004, NATURE, V430, P896, DOI 10.1038/nature02753; Bouzat C, 2008, J NEUROSCI, V28, P7808, DOI 10.1523/JNEUROSCI.0448-08.2008; Breese CR, 1997, J COMP NEUROL, V387, P385, DOI 10.1002/(SICI)1096-9861(19971027)387:3<385::AID-CNE5>3.0.CO;2-X; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Celie PHN, 2004, NEURON, V41, P907, DOI 10.1016/S0896-6273(04)00115-1; D'Andrea MR, 2006, CURR PHARM DESIGN, V12, P677, DOI 10.2174/138161206775474224; Dellisanti CD, 2007, NAT NEUROSCI, V10, P953, DOI 10.1038/nn1942; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fabian-Fine R, 2001, J NEUROSCI, V21, P7993, DOI 10.1523/JNEUROSCI.21-20-07993.2001; Gao F, 2003, J BIOL CHEM, V278, P23020, DOI 10.1074/jbc.M301151200; Gao F, 2006, MOL PHARMACOL, V70, P1230, DOI 10.1124/mol.106.027185; Grosman C, 2000, NATURE, V403, P773, DOI 10.1038/35001586; Grosman C, 2000, J GEN PHYSIOL, V115, P637, DOI 10.1085/jgp.115.5.637; Hansen SB, 2005, EMBO J, V24, P3635, DOI 10.1038/sj.emboj.7600828; Heckman KL, 2007, NAT PROTOC, V2, P924, DOI 10.1038/nprot.2007.132; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; Hilf RJC, 2008, NATURE, V452, P375, DOI 10.1038/nature06717; Hilf RJC, 2009, NATURE, V457, P115, DOI 10.1038/nature07461; JONES DH, 1992, BIOTECHNIQUES, V12, P528; Lee WY, 2005, NATURE, V438, P243, DOI 10.1038/nature04156; Martin LF, 2004, PSYCHOPHARMACOLOGY, V174, P54, DOI 10.1007/s00213-003-1750-1; Metrangolo P, 2005, ACCOUNTS CHEM RES, V38, P386, DOI 10.1021/ar0400995; Mukhtasimova N, 2005, J GEN PHYSIOL, V126, P23, DOI 10.1085/jgp.200509283; Mukhtasimova N, 2007, J NEUROSCI, V27, P4110, DOI 10.1523/JNEUROSCI.0025-07.2007; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; SEGUELA P, 1993, J NEUROSCI, V13, P596; SINE SM, 1994, J BIOL CHEM, V269, P8808; Sine SM, 2002, J NEUROBIOL, V53, P431, DOI 10.1002/neu.10139; Smit AB, 2001, NATURE, V411, P261, DOI 10.1038/35077000; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339; Wang HL, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040041; Williams ME, 2005, J BIOL CHEM, V280, P1257, DOI 10.1074/jbc.M410039200; Zouridakis M, 2009, BBA-PROTEINS PROTEOM, V1794, P355, DOI 10.1016/j.bbapap.2008.11.002	38	158	165	1	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2011	14	10					1253	U173		10.1038/nn.2908	http://dx.doi.org/10.1038/nn.2908			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	825EQ	21909087	Green Accepted			2022-12-28	WOS:000295254200013
J	Valnegri, P; Khelfaoui, M; Dorseuil, O; Bassani, S; Lagneaux, C; Gianfelice, A; Benfante, R; Chelly, J; Billuart, P; Sala, C; Passafaro, M				Valnegri, Pamela; Khelfaoui, Malik; Dorseuil, Olivier; Bassani, Silvia; Lagneaux, Celine; Gianfelice, Antonella; Benfante, Roberta; Chelly, Jamel; Billuart, Pierre; Sala, Carlo; Passafaro, Maria			A circadian clock in hippocampus is regulated by interaction between oligophrenin-1 and Rev-erb alpha	NATURE NEUROSCIENCE			English	Article							LINKED MENTAL-RETARDATION; KAINIC ACID NEUROTOXICITY; CEREBELLAR HYPOPLASIA; RESPONSE ELEMENT; ORPHAN RECEPTOR; GENE-EXPRESSION; INTELLECTUAL DISABILITY; VENTRICULAR ENLARGEMENT; SUPRACHIASMATIC NUCLEUS; PROTEIN OLIGOPHRENIN-1	Oligophrenin-1 regulates dendritic spine morphology in the brain. Mutations in the oligophrenin-1 gene (OPHN1) cause intellectual disability. We discovered a previously unknown partner of oligophrenin-1, Rev-erb alpha, a nuclear receptor that represses the transcription of circadian oscillators. We found that oligophrenin-1 interacts with Rev-erb alpha in the mouse brain, causing it to locate to dendrites, reducing its repressor activity and protecting it from degradation. Our results indicate the presence of a circadian oscillator in the hippocampus, involving the clock gene Bmal1 (also known as Arntl), that is modulated by Rev-erb alpha and requires oligophrenin-1 for normal oscillation. We also found that synaptic activity induced Rev-erb alpha localization to dendrites and spines, a process that is mediated by AMPA receptor activation and requires oligophrenin-1. Our data reveal new interactions between synaptic activity and circadian oscillators, and delineate a new means of communication between nucleus and synapse that may provide insight into normal plasticity and the etiology of intellectual disability.	[Valnegri, Pamela; Bassani, Silvia; Gianfelice, Antonella; Benfante, Roberta; Sala, Carlo; Passafaro, Maria] Univ Milan, Dept Pharmacol, CNR, Inst Neurosci, Milan, Italy; [Valnegri, Pamela; Bassani, Silvia; Passafaro, Maria] Dulbecco Telethon Inst, Milan, Italy; [Khelfaoui, Malik; Dorseuil, Olivier; Lagneaux, Celine; Chelly, Jamel; Billuart, Pierre] INSERM, U1016, Inst Cochin, Paris, France; [Khelfaoui, Malik; Dorseuil, Olivier; Lagneaux, Celine; Chelly, Jamel; Billuart, Pierre] CNRS, UMR8104, Paris, France; [Khelfaoui, Malik; Dorseuil, Olivier; Lagneaux, Celine; Chelly, Jamel; Billuart, Pierre] Univ Paris 05, Paris, France; [Sala, Carlo] Neurol Inst, Milan, Italy; [Sala, Carlo] Fdn Carlo Besta, Milan, Italy	Consiglio Nazionale delle Ricerche (CNR); University of Milan; Fondazione Telethon; Dulbecco Telethon Institute (DTI); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; IRCCS Istituto Neurologico Besta	Passafaro, M (corresponding author), Univ Milan, Dept Pharmacol, CNR, Inst Neurosci, Milan, Italy.	m.passafaro@in.cnr.it	Billuart, Pierre/K-3832-2017; Sala, Carlo/A-2493-2009; Chelly, Jamel/J-7528-2015; Bassani, Silvia/A-7241-2012; Benfante, Roberta/C-1513-2015	Billuart, Pierre/0000-0003-1913-1687; Sala, Carlo/0000-0003-0662-9523; Chelly, Jamel/0000-0002-0939-8719; Bassani, Silvia/0000-0003-0553-7168; Benfante, Roberta/0000-0001-5396-5429	Telethon Italy [S01014TELU, GGP09196]; Fondazione Cariplo [2008-2318, 2009.264]; Fondazione Mariani; Project TerDisMental [16983 - Rif.SAL-50]; Ricerca Scientifica a Tema Libero (RSTL) Consiglio Nazionale delle Ricerche (CNR); Regione Lombardia [SAL-50-16983]; Italian Institute of Technology; French National Research Agency [ANR-06-Neuro-003-02, ANR-08-MNPS-037-04]; European Union [241995]; Fondation Jerome Lejeune; INSERM; Fondation pour La Recherche Medicale	Telethon Italy(Fondazione Telethon); Fondazione Cariplo(Fondazione Cariplo); Fondazione Mariani; Project TerDisMental; Ricerca Scientifica a Tema Libero (RSTL) Consiglio Nazionale delle Ricerche (CNR)(Consiglio Nazionale delle Ricerche (CNR)); Regione Lombardia(Regione Lombardia); Italian Institute of Technology(Istituto Italiano di Tecnologia - IIT); French National Research Agency(French National Research Agency (ANR)); European Union(European Commission); Fondation Jerome Lejeune; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Fondation pour La Recherche Medicale(Fondation pour la Recherche Medicale)	The authors thank D. Ward for assisting with the manuscript. The authors thank E. Challet, D. Ciocca and S. Reibel-Foisset for advice with the circadian experiments. M. P. was supported by Telethon Italy (S01014TELU), Fondazione Cariplo (2008-2318), Fondazione Mariani, Project TerDisMental, ID 16983 - Rif.SAL-50. C. S. was supported by Telethon-Italy grant GGP09196, Fondazione CARIPLO project no. 2009.264, Ricerca Scientifica a Tema Libero (RSTL) Consiglio Nazionale delle Ricerche (CNR), Regione Lombardia Project no. SAL-50-16983 TERDISMENTAL and an Italian Institute of Technology Seed Grant. P. B., O.D. and J.C. are supported by the French National Research Agency (ANR-06-Neuro-003-02, ANR-08-MNPS-037-04), European Union (Gencodys, FP7 241995), Fondation Jerome Lejeune and INSERM. C. L. was supported by the "Fondation pour La Recherche Medicale".	Abe H, 2001, EUR J NEUROSCI, V14, P1121, DOI 10.1046/j.0953-816x.2001.01732.x; Abraham U, 2005, J NEUROSCI, V25, P8620, DOI 10.1523/JNEUROSCI.2225-05.2005; Adelmant G, 1996, P NATL ACAD SCI USA, V93, P3553, DOI 10.1073/pnas.93.8.3553; An JJ, 2008, CELL, V134, P175, DOI 10.1016/j.cell.2008.05.045; Battaglioli E, 1998, J NEUROCHEM, V71, P1261; Bergmann C, 2003, BRAIN, V126, P1537, DOI 10.1093/brain/awg173; Billuart P, 1998, NATURE, V392, P923, DOI 10.1038/31940; Chaudhury D, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-63; Chomez P, 2000, DEVELOPMENT, V127, P1489; Donlea JM, 2009, SCIENCE, V324, P105, DOI 10.1126/science.1166657; Fagni L, 2000, TRENDS NEUROSCI, V23, P80, DOI 10.1016/S0166-2236(99)01492-7; Fauchereau F, 2003, MOL CELL NEUROSCI, V23, P574, DOI 10.1016/S1044-7431(03)00078-2; FERKANY JW, 1984, NATURE, V308, P561, DOI 10.1038/308561a0; Flavell SW, 2008, ANNU REV NEUROSCI, V31, P563, DOI 10.1146/annurev.neuro.31.060407.125631; Flora A, 2001, J NEUROSCI, V21, P7037, DOI 10.1523/JNEUROSCI.21-18-07037.2001; Gecz J, 2009, TRENDS GENET, V25, P308, DOI 10.1016/j.tig.2009.05.002; Gilestro GF, 2009, SCIENCE, V324, P109, DOI 10.1126/science.1166673; Govek EE, 2004, NAT NEUROSCI, V7, P364, DOI 10.1038/nn1210; HARDING HP, 1993, MOL CELL BIOL, V13, P3113, DOI 10.1128/MCB.13.5.3113; Hastings MH, 2003, NAT REV NEUROSCI, V4, P649, DOI 10.1038/nrn1177; Kasri NN, 2009, GENE DEV, V23, P1289, DOI 10.1101/gad.1783809; Kaufman L, 2010, J NEURODEV DISORD, V2, P182, DOI 10.1007/s11689-010-9055-2; Khelfaoui M, 2007, J NEUROSCI, V27, P9439, DOI 10.1523/JNEUROSCI.2029-07.2007; Khelfaoui M, 2009, HUM MOL GENET, V18, P2575, DOI 10.1093/hmg/ddp189; Lamont EW, 2005, P NATL ACAD SCI USA, V102, P4180, DOI 10.1073/pnas.0500901102; Mendoza J, 2010, J NEUROSCI, V30, P1894, DOI 10.1523/JNEUROSCI.5855-09.2010; Nakano-Kobayashi A, 2009, CURR BIOL, V19, P1133, DOI 10.1016/j.cub.2009.05.022; Pardee KI, 2009, PLOS BIOL, V7, P384, DOI 10.1371/journal.pbio.1000043; Passafaro M, 2003, NATURE, V424, P677, DOI 10.1038/nature01781; Philip N, 2003, J MED GENET, V40, P441, DOI 10.1136/jmg.40.6.441; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Raghuram S, 2007, NAT STRUCT MOL BIOL, V14, P1207, DOI 10.1038/nsmb1344; Ropers HH, 2010, ANNU REV GENOM HUM G, V11, P161, DOI 10.1146/annurev-genom-082509-141640; Ropers HH, 2005, NAT REV GENET, V6, P46, DOI 10.1038/nrg1501; Saglietti L, 2007, NEURON, V54, P461, DOI 10.1016/j.neuron.2007.04.012; Sala C, 2001, NEURON, V31, P115, DOI 10.1016/S0896-6273(01)00339-7; Sala C, 2000, J NEUROSCI, V20, P3529, DOI 10.1523/JNEUROSCI.20-10-03529.2000; Tentler D, 1999, EUR J HUM GENET, V7, P541, DOI 10.1038/sj.ejhg.5200320; Thompson KR, 2004, NEURON, V44, P997, DOI 10.1016/j.neuron.2004.11.025; Triqueneaux G, 2004, J MOL ENDOCRINOL, V33, P585, DOI 10.1677/jme.1.01554; Ueda HR, 2002, NATURE, V418, P534, DOI 10.1038/nature00906; Vyazovskiy VV, 2008, NAT NEUROSCI, V11, P200, DOI 10.1038/nn2035; Wakamatsu H, 2001, EUR J NEUROSCI, V13, P1190, DOI 10.1046/j.0953-816x.2001.01483.x; Xiao B, 2000, CURR OPIN NEUROBIOL, V10, P370, DOI 10.1016/S0959-4388(00)00087-8; Yin L, 2006, SCIENCE, V311, P1002, DOI 10.1126/science.1121613; ZACZEK R, 1981, NEUROPHARMACOLOGY, V20, P183, DOI 10.1016/0028-3908(81)90202-1	46	47	52	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2011	14	10					1293	U108		10.1038/nn.2911	http://dx.doi.org/10.1038/nn.2911			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	825EQ	21874017				2022-12-28	WOS:000295254200018
J	Salinas, E				Salinas, Emilio			Prior and prejudice	NATURE NEUROSCIENCE			English	Editorial Material							POPULATION CODES; INFORMATION	To best interpret new sensory information, populations of sensory neurons must represent the lessons of past experience. How do they do this? The same solution to this problem is now reported in two very different sensory systems, providing a classic example of computational convergence.	Wake Forest Sch Med, Dept Neurobiol & Anat, Winston Salem, NC USA	Wake Forest University	Salinas, E (corresponding author), Wake Forest Sch Med, Dept Neurobiol & Anat, Winston Salem, NC USA.	esalinas@wakehealth.edu		Salinas, Emilio/0000-0001-7411-5693				Ashourian P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019551; Berens P, 2011, P NATL ACAD SCI USA, V108, P4423, DOI 10.1073/pnas.1015904108; Bonnasse-Gahot L, 2008, J COMPUT NEUROSCI, V25, P169, DOI 10.1007/s10827-007-0071-5; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; Fischer BJ, 2011, NAT NEUROSCI, V14, P1061, DOI 10.1038/nn.2872; Girshick AR, 2011, NAT NEUROSCI, V14, P926, DOI 10.1038/nn.2831; Kording KP, 2004, NATURE, V427, P244, DOI 10.1038/nature02169; Ma WJ, 2006, NAT NEUROSCI, V9, P1432, DOI 10.1038/nn1790; Miyazaki M, 2006, NAT NEUROSCI, V9, P875, DOI 10.1038/nn1712; PARADISO MA, 1988, BIOL CYBERN, V58, P35, DOI 10.1007/BF00363954; Pouget A, 2000, NAT REV NEUROSCI, V1, P125, DOI 10.1038/35039062; Salinas E, 1994, J Comput Neurosci, V1, P89, DOI 10.1007/BF00962720; Salinas E, 2006, PLOS BIOL, V4, P2383, DOI 10.1371/journal.pbio.0040387; Trommershauser J, 2008, TRENDS COGN SCI, V12, P291, DOI 10.1016/j.tics.2008.04.010; Weiss Y, 2002, NAT NEUROSCI, V5, P598, DOI 10.1038/nn858	15	5	5	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2011	14	8					943	945		10.1038/nn.2883	http://dx.doi.org/10.1038/nn.2883			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	797KC	21792188				2022-12-28	WOS:000293123700002
J	Johnson, SL; Eckrich, T; Kuhn, S; Zampini, V; Franz, C; Ranatunga, KM; Roberts, TP; Masetto, S; Knipper, M; Kros, CJ; Marcotti, W				Johnson, Stuart L.; Eckrich, Tobias; Kuhn, Stephanie; Zampini, Valeria; Franz, Christoph; Ranatunga, Kishani M.; Roberts, Terri P.; Masetto, Sergio; Knipper, Marlies; Kros, Corne J.; Marcotti, Walter			Position-dependent patterning of spontaneous action potentials in immature cochlear inner hair cells	NATURE NEUROSCIENCE			English	Article							SPONTANEOUS DISCHARGE PATTERNS; SPIRAL GANGLION-CELLS; NEUROTRANSMITTER RELEASE; DEVELOPMENTAL REGULATION; MAMMALIAN COCHLEA; RIBBON SYNAPSES; AUDITORY-SYSTEM; HEARING; EXPRESSION; CHANNELS	Spontaneous action potential activity is crucial for mammalian sensory system development. In the auditory system, patterned firing activity has been observed in immature spiral ganglion and brain-stem neurons and is likely to depend on cochlear inner hair cell (IHC) action potentials. It remains uncertain whether spiking activity is intrinsic to developing IHCs and whether it shows patterning. We found that action potentials were intrinsically generated by immature IHCs of altricial rodents and that apical IHCs showed bursting activity as opposed to more sustained firing in basal cells. We show that the efferent neurotransmitter acetylcholine fine-tunes the IHC's resting membrane potential (V(m)), and as such is crucial for the bursting pattern in apical cells. Endogenous extracellular ATP also contributes to the V(m) of apical and basal IHCs by triggering small-conductance Ca(2+)-activated K(+) (SK2) channels. We propose that the difference in firing pattern along the cochlea instructs the tonotopic differentiation of IHCs and auditory pathway.	[Johnson, Stuart L.; Eckrich, Tobias; Kuhn, Stephanie; Zampini, Valeria; Marcotti, Walter] Univ Sheffield, Dept Biomed Sci, Sheffield S10 2TN, S Yorkshire, England; [Zampini, Valeria; Masetto, Sergio] Univ Pavia, Dept Physiol, I-27100 Pavia, Italy; [Franz, Christoph; Knipper, Marlies] Univ Tubingen, Lab Mol Physiol Hearing, Dept Otolaryngol, Tubingen Hearing Res Ctr, Tubingen, Germany; [Ranatunga, Kishani M.; Roberts, Terri P.; Kros, Corne J.] Univ Sussex, Sch Life Sci, Brighton, E Sussex, England	University of Sheffield; University of Pavia; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Sussex	Marcotti, W (corresponding author), Univ Sheffield, Dept Biomed Sci, Sheffield S10 2TN, S Yorkshire, England.	c.j.kros@sussex.ac.uk; w.marcotti@sheffield.ac.uk		, Stephanie/0000-0001-6633-9478	Wellcome Trust [088719]; Royal National Institute for Deaf People [G41]; Deafness Research UK; Medical Research Council [G0100798]; MRC [G0100798] Funding Source: UKRI; RNID [G41] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); Royal National Institute for Deaf People; Deafness Research UK; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); RNID	This work was supported by project grants from the Wellcome Trust (088719), the Royal National Institute for Deaf People (G41) and Deafness Research UK to W.M. and a Medical Research Council Programme Grant (G0100798) to C.J.K. SK2-knockout mice were obtained from J.P. Adelman. W.M. is a Royal Society University Research Fellow.	Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Beutner D, 2001, J NEUROSCI, V21, P4593, DOI 10.1523/JNEUROSCI.21-13-04593.2001; Blankenship AG, 2010, NAT REV NEUROSCI, V11, P18, DOI 10.1038/nrn2759; Brandt N, 2007, J NEUROSCI, V27, P3174, DOI 10.1523/JNEUROSCI.3965-06.2007; Conte I, 2010, P NATL ACAD SCI USA, V107, P15491, DOI 10.1073/pnas.0914785107; ELGOYHEN AB, 1994, CELL, V79, P705, DOI 10.1016/0092-8674(94)90555-X; Elgoyhen AB, 2001, P NATL ACAD SCI USA, V98, P3501, DOI 10.1073/pnas.051622798; Evans MG, 1996, J PHYSIOL-LONDON, V491, P563, DOI 10.1113/jphysiol.1996.sp021240; Fekete DM, 2007, INT J DEV BIOL, V51, P549, DOI 10.1387/ijdb.072341df; Glowatzki E, 2002, NAT NEUROSCI, V5, P147, DOI 10.1038/nn796; Glowatzki E, 2000, SCIENCE, V288, P2366, DOI 10.1126/science.288.5475.2366; Goutman JD, 2005, J PHYSIOL-LONDON, V566, P49, DOI 10.1113/jphysiol.2005.087460; Heidrych P, 2009, HUM MOL GENET, V18, P2779, DOI 10.1093/hmg/ddp213; Housley GD, 2006, J MEMBRANE BIOL, V209, P89, DOI 10.1007/s00232-005-0835-7; Huang LC, 2006, HISTOCHEM CELL BIOL, V125, P681, DOI 10.1007/s00418-005-0119-4; Huberman AD, 2008, ANNU REV NEUROSCI, V31, P479, DOI 10.1146/annurev.neuro.31.060407.125533; Johnson SL, 2008, J NEUROSCI, V28, P7670, DOI 10.1523/JNEUROSCI.0785-08.2008; Johnson SL, 2008, J PHYSIOL-LONDON, V586, P1029, DOI 10.1113/jphysiol.2007.145219; Johnson SL, 2007, J PHYSIOL-LONDON, V583, P631, DOI 10.1113/jphysiol.2007.136630; Johnson SL, 2009, J PHYSIOL-LONDON, V587, P1715, DOI 10.1113/jphysiol.2009.168542; Jones TA, 2000, J NEUROPHYSIOL, V83, P1452, DOI 10.1152/jn.2000.83.3.1452; Jones TA, 2007, J NEUROPHYSIOL, V98, P1898, DOI 10.1152/jn.00472.2007; Kandler K, 2009, NAT NEUROSCI, V12, P711, DOI 10.1038/nn.2332; Katz E, 2004, J NEUROSCI, V24, P7814, DOI 10.1523/JNEUROSCI.2102-04.2004; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Koppl C, 2007, J NEUROPHYSIOL, V98, P1843, DOI 10.1152/jn.00844.2007; Kros CJ, 1998, NATURE, V394, P281, DOI 10.1038/28401; Kros CJ, 2007, HEARING RES, V227, P3, DOI 10.1016/j.heares.2006.12.005; Kuhn S, 2011, P NATL ACAD SCI USA, V108, P2355, DOI 10.1073/pnas.1016646108; Lippe WR, 1995, BRAIN RES, V703, P205, DOI 10.1016/0006-8993(95)01096-3; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Maison SF, 2002, J NEUROSCI, V22, P10838; Marcotti W, 2004, J PHYSIOL-LONDON, V560, P691, DOI 10.1113/jphysiol.2004.072868; Marcotti W, 2003, J PHYSIOL-LONDON, V552, P743, DOI 10.1113/jphysiol.2003.043612; Marcotti W, 2003, J PHYSIOL-LONDON, V548, P383, DOI 10.1113/jphysiol.2002.034801; Moody WJ, 2005, PHYSIOL REV, V85, P883, DOI 10.1152/physrev.00017.2004; Neher E, 1998, NEURON, V20, P389, DOI 10.1016/S0896-6273(00)80983-6; North RA, 2000, ANNU REV PHARMACOL, V40, P563, DOI 10.1146/annurev.pharmtox.40.1.563; PUJOL R, 1998, DEV AUDITORY SYSTEM, P146; SOBKOWICZ HM, 1992, DEV AUDITORY VESTIBU, V2, P59; Sonntag M, 2009, J NEUROSCI, V29, P9510, DOI 10.1523/JNEUROSCI.1377-09.2009; Stellwagen D, 2002, NEURON, V33, P357, DOI 10.1016/S0896-6273(02)00577-9; Sugasawa M, 1996, J PHYSIOL-LONDON, V491, P707, DOI 10.1113/jphysiol.1996.sp021251; Tritsch NX, 2007, NATURE, V450, P50, DOI 10.1038/nature06233; Tritsch NX, 2010, NAT NEUROSCI, V13, P1050, DOI 10.1038/nn.2604; Tritsch NX, 2010, J NEUROSCI, V30, P1539, DOI 10.1523/JNEUROSCI.3875-09.2010; Walsh Edward J., 1992, P161; Wangemann P., 1996, COCHLEA, P130, DOI [10.1007/978-1-4612-0757-3_3, DOI 10.1007/978-1-4612-0757-3_3]; Zampini V, 2010, J PHYSIOL-LONDON, V588, P187, DOI 10.1113/jphysiol.2009.181917; Zhang LI, 2001, NAT NEUROSCI, V4, P1207, DOI 10.1038/nn753	50	112	112	1	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2011	14	6					711	U386		10.1038/nn.2803	http://dx.doi.org/10.1038/nn.2803			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	768SH	21572434	Green Accepted			2022-12-28	WOS:000290958000013
J	Chen, FJ; Liu, Y; Sugiura, Y; Allen, PD; Gregg, RG; Lin, WC				Chen, Fujun; Liu, Yun; Sugiura, Yoshie; Allen, Paul D.; Gregg, Ronald G.; Lin, Weichun			Neuromuscular synaptic patterning requires the function of skeletal muscle dihydropyridine receptors	NATURE NEUROSCIENCE			English	Article							MUTATION MUSCULAR DYSGENESIS; RYANODINE-RECEPTOR; GENE-EXPRESSION; BETA-SUBUNIT; CA2+ CURRENT; DEVELOPMENTAL GENETICS; NEURONAL-ACTIVITY; CHARGE MOVEMENTS; ACH SENSITIVITY; CELL-CULTURE	Developing skeletal myofibers in vertebrates are intrinsically 'pre-patterned' for motor nerve innervation. However, the intrinsic factors that regulate muscle pre-patterning remain unknown. We found that a functional skeletal muscle dihydropyridine receptor (DHPR, the L-type Ca(2+) channel in muscle) was required for muscle pre-patterning during the development of the neuromuscular junction (NMJ). Targeted deletion of the beta 1 subunit of DHPR (Cacnb1) in mice led to muscle pre-patterning defects, aberrant innervation and precocious maturation of the NMJ. Reintroducing Cacnb1 into Cacnb1(-/-) muscles reversed the pre-patterning defects and restored normal development of the NMJ. The mechanism by which DHPRs govern muscle pre-patterning is independent of their role in excitation-contraction coupling, but requires Ca(2+) influx through the L-type Ca(2+) channel. Our findings indicate that the skeletal muscle DHPR retrogradely regulates the patterning and formation of the NMJ.	[Chen, Fujun; Liu, Yun; Sugiura, Yoshie; Lin, Weichun] Univ Texas SW Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA; [Allen, Paul D.] Brigham & Womens Hosp, Dept Anesthesia Perioperat & Pain Med, Boston, MA 02115 USA; [Gregg, Ronald G.] Univ Louisville, Dept Biochem & Mol Biol, Louisville, KY 40292 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Harvard University; Brigham & Women's Hospital; University of Louisville	Lin, WC (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA.	weichun.lin@utsouthwestern.edu	Tuluc, Petronel/C-2527-2011	Liu, Yun/0000-0003-2063-7132; Gregg, Ronald/0000-0001-5805-224X	US National Institutes of Health/National Institute of Neurological Disorders and Stroke [NS 055028]; Edward Mallinckrodt, Jr. Scholar Program; Cain Foundation in Medical Research at University of Texas Southwestern Medical Center; US National Institutes of Health/National Institute of Arthritis and Musculoskeletal and Skin Diseases [P01AR044750]; NATIONAL EYE INSTITUTE [R01EY012354] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR044750, P01AR052354] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS055028] Funding Source: NIH RePORTER	US National Institutes of Health/National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Edward Mallinckrodt, Jr. Scholar Program; Cain Foundation in Medical Research at University of Texas Southwestern Medical Center; US National Institutes of Health/National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank J. Takahashi, E. Olson, B. Szaro, J. Johnson, C. Green, K. Walton, J. Terman, J. McArdle and R. Bassel-Duby for critical reading and commenting on the manuscript, S. Cannon, D. Francis, E. Kavalali and I. Bezprozvanny for valuable suggestions on muscle physiology and S. Burden for AChR alpha and MuSK in situ probes. This study was supported by grants (to W. L.) from the US National Institutes of Health/National Institute of Neurological Disorders and Stroke (NS 055028), the Edward Mallinckrodt, Jr. Scholar Program, and the Cain Foundation in Medical Research at University of Texas Southwestern Medical Center, and by a grant (to P. D. A.) from the US National Institutes of Health/National Institute of Arthritis and Musculoskeletal and Skin Diseases (P01AR044750).	Ahern CA, 2003, BIOPHYS J, V84, P942, DOI 10.1016/S0006-3495(03)74911-X; Arber S, 1999, NEURON, V23, P659, DOI 10.1016/S0896-6273(01)80026-X; Arikkath J, 2003, CURR OPIN NEUROBIOL, V13, P298, DOI 10.1016/S0959-4388(03)00066-7; Ball SL, 2002, INVEST OPHTH VIS SCI, V43, P1595; Barone V, 1998, FEBS LETT, V422, P160, DOI 10.1016/S0014-5793(98)00003-9; Bertocchini F, 1997, EMBO J, V16, P6956, DOI 10.1093/emboj/16.23.6956; Beurg M, 1997, BIOPHYS J, V73, P807, DOI 10.1016/S0006-3495(97)78113-X; BLAU HM, 1983, CELL, V32, P1171, DOI 10.1016/0092-8674(83)90300-8; COHEN SA, 1973, SCIENCE, V181, P76, DOI 10.1126/science.181.4094.76; CORONADO R, 1994, AM J PHYSIOL, V266, pC1485, DOI 10.1152/ajpcell.1994.266.6.C1485; Deisseroth K, 2003, CURR OPIN NEUROBIOL, V13, P354, DOI 10.1016/S0959-4388(03)00076-X; DUCLERT A, 1995, PHYSIOL REV, V75, P339, DOI 10.1152/physrev.1995.75.2.339; FISCHBACH GD, 1971, J CELL PHYSIOL, V78, P289, DOI 10.1002/jcp.1040780218; Flanagan-Steet H, 2005, DEVELOPMENT, V132, P4471, DOI 10.1242/dev.02044; FRANZINIARMSTRONG C, 1994, ANNU REV PHYSIOL, V56, P509, DOI 10.1146/annurev.ph.56.030194.002453; Gomez-Ospina N, 2006, CELL, V127, P591, DOI 10.1016/j.cell.2006.10.017; Gregg RG, 1996, P NATL ACAD SCI USA, V93, P13961, DOI 10.1073/pnas.93.24.13961; HALL ZW, 1993, CELL, V72, P99, DOI 10.1016/S0092-8674(05)80031-5; JORGENSEN AO, 1989, J CELL BIOL, V109, P135, DOI 10.1083/jcb.109.1.135; Kim N, 2008, NAT NEUROSCI, V11, P19, DOI 10.1038/nn2026; KNUDSON CM, 1989, J BIOL CHEM, V264, P1345; KOENIG J, 1982, DEV BIOL, V92, P188, DOI 10.1016/0012-1606(82)90162-2; LEE KS, 1983, NATURE, V302, P790, DOI 10.1038/302790a0; Lin WC, 2001, NATURE, V410, P1057, DOI 10.1038/35074025; Lin WC, 2005, NEURON, V46, P569, DOI 10.1016/j.neuron.2005.04.002; Liu Y, 2008, DEVELOPMENT, V135, P1957, DOI 10.1242/dev.018119; LOMO T, 1972, J PHYSIOL-LONDON, V221, P493, DOI 10.1113/jphysiol.1972.sp009764; LOMO T, 1975, J PHYSIOL-LONDON, V252, P603, DOI 10.1113/jphysiol.1975.sp011161; Mejat A, 2005, NAT NEUROSCI, V8, P313, DOI 10.1038/nn1408; Misgeld T, 2005, P NATL ACAD SCI USA, V102, P11088, DOI 10.1073/pnas.0504806102; Nakai J, 1996, NATURE, V380, P72, DOI 10.1038/380072a0; PAI AC, 1965, DEV BIOL, V11, P82, DOI 10.1016/0012-1606(65)90038-2; PAI AC, 1965, DEV BIOL, V11, P93, DOI 10.1016/0012-1606(65)90039-4; Panzer JA, 2006, J NEUROSCI, V26, P934, DOI 10.1523/JNEUROSCI.3656-05.2006; POWELL JA, 1984, DEV BIOL, V101, P168, DOI 10.1016/0012-1606(84)90127-1; RIEGER F, 1987, NATURE, V330, P563, DOI 10.1038/330563a0; ROTZLER S, 1991, NATURE, V349, P337, DOI 10.1038/349337a0; Sanes JR, 2001, NAT REV NEUROSCI, V2, P791, DOI 10.1038/35097557; Schroder E, 2009, CIRC RES, V104, P1373, DOI 10.1161/CIRCRESAHA.108.191387; SPECTOR I, 1977, P NATL ACAD SCI USA, V74, P5166, DOI 10.1073/pnas.74.11.5166; Strube C, 1996, BIOPHYS J, V71, P2531, DOI 10.1016/S0006-3495(96)79446-8; TAKESHIMA H, 1994, NATURE, V369, P556, DOI 10.1038/369556a0; Tang HB, 2009, MOL BIOL CELL, V20, P1120, DOI 10.1091/mbc.E08-07-0759; TSIEN RW, 1991, TRENDS PHARMACOL SCI, V12, P349, DOI 10.1016/0165-6147(91)90595-J; VALENZUELA DM, 1995, NEURON, V15, P573, DOI 10.1016/0896-6273(95)90146-9; West AE, 2002, NAT REV NEUROSCI, V3, P921, DOI 10.1038/nrn987; WITZEMANN V, 1991, J CELL BIOL, V114, P125, DOI 10.1083/jcb.114.1.125; Yang X, 2001, NEURON, V30, P399, DOI 10.1016/S0896-6273(01)00287-2; Yang X, 2000, SCIENCE, V287, P131, DOI 10.1126/science.287.5450.131; Zhang Y, 2010, J BIOL CHEM, V285, P2527, DOI 10.1074/jbc.M109.022236	50	48	48	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2011	14	5					570	U52		10.1038/nn.2792	http://dx.doi.org/10.1038/nn.2792			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	754VU	21441923	Green Accepted			2022-12-28	WOS:000289886600012
J	Peled, ES; Isacoff, EY				Peled, Einat S.; Isacoff, Ehud Y.			Optical quantal analysis of synaptic transmission in wild-type and rab3-mutant Drosophila motor axons	NATURE NEUROSCIENCE			English	Article							HIPPOCAMPAL SYNAPSES; TRANSMITTER RELEASE; NEUROTRANSMITTER RELEASE; SINGLE SYNAPSES; IN-VIVO; PROBABILITY; PLASTICITY; RAB3; TERMINALS; LARVAE	Synaptic transmission from a neuron to its target cells occurs via neurotransmitter release from dozens to thousands of presynaptic release sites whose strength and plasticity can vary considerably. We report an in vivo imaging method that monitors real-time synaptic transmission simultaneously at many release sites with quantal resolution. We applied this method to the model glutamatergic system of the Drosophila melanogaster larval neuromuscular junction. We find that, under basal conditions, about half of release sites have a very low release probability, but these are interspersed with sites with as much as a 50-fold higher probability. Paired-pulse stimulation depresses high-probability sites, facilitates low-probability sites, and recruits previously silent sites. Mutation of the small GTPase Rab3 substantially increases release probability but still leaves about half of the sites silent. Our findings suggest that basal synaptic strength and short-term plasticity are regulated at the level of release probability at individual sites.	[Peled, Einat S.; Isacoff, Ehud Y.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Isacoff, Ehud Y.] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; [Isacoff, Ehud Y.] Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Isacoff, EY (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	ehud@berkeley.edu	isacoff, ehud/AAP-1459-2020	Isacoff, Ehud Y./0000-0003-4775-9359	US National Science Foundation [FIBR 0623527]; NATIONAL EYE INSTITUTE [PN2EY018241] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060711] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050833] Funding Source: NIH RePORTER	US National Science Foundation(National Science Foundation (NSF)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank R. S. Zucker for helpful discussions, G. Kauwe and G. Agarwal for help generating the SynapGCaMP2 fly line, H. L. Aaron for advice on imaging and J.A. Min for help with testing fly strains. We also thank A. DiAntonio for gifts of fly strains and for the Rab3 antibody. This work was supported by US National Science Foundation grant FIBR 0623527.	ALLEN C, 1994, P NATL ACAD SCI USA, V91, P10380, DOI 10.1073/pnas.91.22.10380; Anderson JC, 2003, NETWORK-COMP NEURAL, V14, P321, DOI 10.1088/0954-898X/14/2/308; Atwood HL, 2002, NAT REV NEUROSCI, V3, P497, DOI 10.1038/nrn876; ATWOOD HL, 1993, J NEUROBIOL, V24, P1008, DOI 10.1002/neu.480240803; Atwood HL, 1999, LEARN MEMORY, V6, P542, DOI 10.1101/lm.6.6.542; BETZ WJ, 1992, SCIENCE, V255, P200, DOI 10.1126/science.1553547; Branco T, 2008, NEURON, V59, P475, DOI 10.1016/j.neuron.2008.07.006; Branco T, 2009, NAT REV NEUROSCI, V10, P373, DOI 10.1038/nrn2634; Budnik V, 2006, FLY NEUROMUSCULAR JU; Davis GW, 1998, NEURON, V20, P305, DOI 10.1016/S0896-6273(00)80458-4; Fouquet W, 2009, J CELL BIOL, V186, P129, DOI 10.1083/jcb.200812150; Geppert M, 1998, ANNU REV NEUROSCI, V21, P75, DOI 10.1146/annurev.neuro.21.1.75; Graf ER, 2009, NEURON, V64, P663, DOI 10.1016/j.neuron.2009.11.002; Guerrero G, 2005, NAT NEUROSCI, V8, P1188, DOI 10.1038/nn1526; Hanse E, 2001, J PHYSIOL-LONDON, V531, P467, DOI 10.1111/j.1469-7793.2001.0467i.x; HARRIS KM, 1989, J NEUROSCI, V9, P2982; Hendel T, 2008, J NEUROSCI, V28, P7399, DOI 10.1523/JNEUROSCI.1038-08.2008; HESSLER NA, 1993, NATURE, V366, P569, DOI 10.1038/366569a0; Hoang B, 2001, DEV BIOL, V229, P55, DOI 10.1006/dbio.2000.9983; Kittel RJ, 2006, SCIENCE, V312, P1051, DOI 10.1126/science.1126308; Koester HJ, 2005, SCIENCE, V308, P863, DOI 10.1126/science.1100815; Lnenicka GA, 2000, J NEUROBIOL, V43, P186, DOI 10.1002/(SICI)1097-4695(200005)43:2<186::AID-NEU8>3.3.CO;2-E; Lnenicka GA, 2006, J NEUROSCI, V26, P12283, DOI 10.1523/JNEUROSCI.2665-06.2006; Marrus SB, 2004, CURR BIOL, V14, P924, DOI 10.1016/j.cub.2004.05.047; Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264; MURPHY TH, 1994, SCIENCE, V263, P529, DOI 10.1126/science.7904774; Murthy VN, 2001, NEURON, V32, P673, DOI 10.1016/S0896-6273(01)00500-1; Murthy VN, 1997, NEURON, V18, P599, DOI 10.1016/S0896-6273(00)80301-3; Oertner TG, 2002, NAT NEUROSCI, V5, P657, DOI 10.1038/nn867; Pelkey KA, 2007, CURR OPIN NEUROBIOL, V17, P366, DOI 10.1016/j.conb.2007.04.008; Prange O, 1999, J NEUROSCI, V19, P6427; Quigley PA, 1999, J NEUROPHYSIOL, V81, P356, DOI 10.1152/jn.1999.81.1.356; REDMAN S, 1983, J PHYSIOL-LONDON, V343, P135, DOI 10.1113/jphysiol.1983.sp014885; ROSENMUND C, 1993, SCIENCE, V262, P754, DOI 10.1126/science.7901909; Ryan TA, 2001, CURR OPIN NEUROBIOL, V11, P544, DOI 10.1016/S0959-4388(00)00247-6; RYAN TA, 1995, NEURON, V14, P983, DOI 10.1016/0896-6273(95)90336-4; Schluter OM, 2006, J NEUROSCI, V26, P1239, DOI 10.1523/JNEUROSCI.3553-05.2006; Schluter OM, 2004, J NEUROSCI, V24, P6629, DOI 10.1523/JNEUROSCI.1610-04.2004; Schuster CM, 1996, NEURON, V17, P641, DOI 10.1016/S0896-6273(00)80197-X; STEVENS CF, 1995, NEURON, V14, P795, DOI 10.1016/0896-6273(95)90223-6; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Tallini YN, 2006, P NATL ACAD SCI USA, V103, P4753, DOI 10.1073/pnas.0509378103; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	43	83	84	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2011	14	4					519	U162		10.1038/nn.2767	http://dx.doi.org/10.1038/nn.2767			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	741FQ	21378971	Green Accepted			2022-12-28	WOS:000288849400024
J	Jin, JZ; Wang, YS; Swadlow, HA; Alonso, JM				Jin, Jianzhong; Wang, Yushi; Swadlow, Harvey A.; Alonso, Jose M.			Population receptive fields of ON and OFF thalamic inputs to an orientation column in visual cortex	NATURE NEUROSCIENCE			English	Article							LATERAL GENICULATE-NUCLEUS; CORTICAL SIMPLE CELLS; CAT STRIATE CORTEX; OFF-CENTER INPUTS; ON-CENTER; SELECTIVITY; NEURONS; AFFERENTS; MODEL; ARCHITECTURE	The primary visual cortex of primates and carnivores is organized into columns of neurons with similar preferences for stimulus orientation, but the developmental origin and function of this organization are still matters of debate. We found that the orientation preference of a cortical column is closely related to the population receptive field of its ON and OFF thalamic inputs. The receptive field scatter from the thalamic inputs was more limited than previously thought and matched the average receptive field size of neurons at the input layers of cortex. Moreover, the thalamic population receptive field (calculated as ON - OFF average) had separate ON and OFF subregions, similar to cortical neurons in layer 4, and provided an accurate prediction of the preferred orientation of the column. These results support developmental models of orientation maps that are based on the receptive field arrangement of ON and OFF visual inputs to cortex.	[Jin, Jianzhong; Wang, Yushi; Swadlow, Harvey A.; Alonso, Jose M.] SUNY Coll Optometry, Dept Biol Sci, New York, NY 10010 USA; [Swadlow, Harvey A.; Alonso, Jose M.] Univ Connecticut, Dept Psychol, Storrs, CT USA	State University of New York (SUNY) System; SUNY Optometry; University of Connecticut	Alonso, JM (corresponding author), SUNY Coll Optometry, Dept Biol Sci, New York, NY 10010 USA.	jalonso@sunyopt.edu			US National Institutes of Health [EY05253, MH085357]; NATIONAL EYE INSTITUTE [R37EY005253, R01EY005253] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH085357] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank C. Weng for helping with some experiments. This work was supported by the US National Institutes of Health (grants EY05253 to J.M.A. and MH085357 to H. A. S.).	Alonso JM, 2001, J NEUROSCI, V21, P4002, DOI 10.1523/JNEUROSCI.21-11-04002.2001; Alonso JM, 1996, NATURE, V383, P815, DOI 10.1038/383815a0; BULLIER J, 1982, J NEUROPHYSIOL, V47, P417, DOI 10.1152/jn.1982.47.3.417; Cardin JA, 2007, J NEUROSCI, V27, P10333, DOI 10.1523/JNEUROSCI.1692-07.2007; CHAPMAN B, 1991, J NEUROSCI, V11, P1347; Chapman B, 2000, J NEUROSCI, V20, P1922; Chatterjee S, 2003, NATURE, V426, P668, DOI 10.1038/nature02163; DeAngelis GC, 1999, J NEUROSCI, V19, P4046; Debanne D, 1998, J PHYSIOL-LONDON, V508, P523, DOI 10.1111/j.1469-7793.1998.00523.x; FERSTER D, 1990, VISUAL NEUROSCI, V4, P135, DOI 10.1017/S0952523800002297; FREEMAN JA, 1975, J NEUROPHYSIOL, V38, P369, DOI 10.1152/jn.1975.38.2.369; Gardner JL, 1999, VISUAL NEUROSCI, V16, P1115, DOI 10.1017/S0952523899166112; Hirsch JA, 1998, J NEUROSCI, V18, P9517; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; HUMPHREY AL, 1985, J COMP NEUROL, V233, P159, DOI 10.1002/cne.902330203; Jin JZ, 2008, NAT NEUROSCI, V11, P88, DOI 10.1038/nn2029; JONES JP, 1987, J NEUROPHYSIOL, V58, P1187, DOI 10.1152/jn.1987.58.6.1187; Katzner S, 2009, NEURON, V61, P35, DOI 10.1016/j.neuron.2008.11.016; Lampl I, 2001, NEURON, V30, P263, DOI 10.1016/S0896-6273(01)00278-1; Martinez LM, 2005, NAT NEUROSCI, V8, P372, DOI 10.1038/nn1404; MCCONNELL SK, 1984, P NATL ACAD SCI-BIOL, V81, P1590, DOI 10.1073/pnas.81.5.1590; McLaughlin D, 2000, P NATL ACAD SCI USA, V97, P8087, DOI 10.1073/pnas.110135097; MILLER KD, 1992, NEUROREPORT, V3, P73, DOI 10.1097/00001756-199201000-00019; Miller KD, 2003, CEREB CORTEX, V13, P73, DOI 10.1093/cercor/13.1.73; MILLER KD, 1994, J NEUROSCI, V14, P409; Monier C, 2003, NEURON, V37, P663, DOI 10.1016/S0896-6273(03)00064-3; Mooser F, 2004, NAT NEUROSCI, V7, P872, DOI 10.1038/nn1287; Nakagama H, 2000, BIOL CYBERN, V83, P85, DOI 10.1007/s004220000148; PEICHL L, 1979, J PHYSIOL-LONDON, V291, P117, DOI 10.1113/jphysiol.1979.sp012803; Pettersen KH, 2006, J NEUROSCI METH, V154, P116, DOI 10.1016/j.jneumeth.2005.12.005; POLLEN DA, 1981, SCIENCE, V212, P1409, DOI 10.1126/science.7233231; Priebe NJ, 2004, NAT NEUROSCI, V7, P1113, DOI 10.1038/nn1310; REID RC, 1995, NATURE, V378, P281, DOI 10.1038/378281a0; Ringach DL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000251; Ringach DL, 2002, J VISION, V2, P12, DOI 10.1167/2.1.2; Ringach DL, 2004, J NEUROPHYSIOL, V92, P468, DOI 10.1152/jn.01202.2003; SOMERS DC, 1995, J NEUROSCI, V15, P5448; Stoelzel CR, 2008, J NEUROSCI, V28, P5018, DOI 10.1523/JNEUROSCI.4726-07.2008; Swadlow HA, 2003, CEREB CORTEX, V13, P25, DOI 10.1093/cercor/13.1.25; Swadlow HA, 2002, J NEUROSCI, V22, P7766; Swadlow HA, 2000, J NEUROPHYSIOL, V83, P2802, DOI 10.1152/jn.2000.83.5.2802; Usrey WM, 2003, J NEUROPHYSIOL, V89, P1003, DOI 10.1152/jn.00749.2002; Yeh CI, 2009, J NEUROPHYSIOL, V101, P2166, DOI 10.1152/jn.91088.2008; ZAHS KR, 1988, J NEUROPHYSIOL, V59, P1410, DOI 10.1152/jn.1988.59.5.1410	44	120	121	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2011	14	2					232	U323		10.1038/nn.2729	http://dx.doi.org/10.1038/nn.2729			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	711MJ	21217765				2022-12-28	WOS:000286595400021
J	Katzel, D; Zemelman, BV; Buetfering, C; Wolfel, M; Miesenbock, G				Kaetzel, Dennis; Zemelman, Boris V.; Buetfering, Christina; Woelfel, Markus; Miesenboeck, Gero			The columnar and laminar organization of inhibitory connections to neocortical excitatory cells	NATURE NEUROSCIENCE			English	Article							PRIMARY VISUAL-CORTEX; SOMATOSENSORY CORTEX; PYRAMIDAL CELLS; BARREL CORTEX; GABAERGIC INTERNEURONS; DISYNAPTIC INHIBITION; CORTICAL-NEURONS; MARTINOTTI CELLS; RAT NEOCORTEX; PHOTOSTIMULATION	The cytoarchitectonic similarities of different neocortical regions have given rise to the idea of 'canonical' connectivity between excitatory neurons of different layers within a column. It is unclear whether similarly general organizational principles also exist for inhibitory neocortical circuits. Here we delineate and compare local inhibitory-to-excitatory wiring patterns in all principal layers of primary motor (M1), somatosensory (S1) and visual (V1) cortex, using genetically targeted photostimulation in a mouse knock-in line that conditionally expresses channelrhodopsin-2 in GABAergic neurons. Inhibitory inputs to excitatory neurons derived largely from the same cortical layer within a three-column diameter. However, subsets of pyramidal cells in layers 2/3 and 5B received extensive translaminar inhibition. These neurons were prominent in V1, where they might correspond to complex cells, less numerous in barrel cortex and absent in M1. Although inhibitory connection patterns were stereotypical, the abundance of individual motifs varied between regions and cells, potentially reflecting functional specializations.	[Kaetzel, Dennis; Buetfering, Christina; Miesenboeck, Gero] Univ Oxford, Dept Physiol Anat & Genet, Oxford, England; [Zemelman, Boris V.; Woelfel, Markus; Miesenboeck, Gero] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06510 USA	University of Oxford; Yale University	Miesenbock, G (corresponding author), Univ Oxford, Dept Physiol Anat & Genet, Oxford, England.	gero.miesenboeck@dpag.ox.ac.uk	Buetfering, Christina/CAG-0104-2022; Buetfering, Christina/I-2879-2014	Miesenboeck, Gero/0000-0003-2940-3228; Zemelman, Boris/0000-0003-2463-4887; Katzel, Dennis/0000-0002-7334-9823	UK Medical Research Council; US National Institutes of Health; Dana Foundation; US Office of Naval Research; Boehringer Ingelheim Fonds; Christopher Welch Scholarship Fund; MRC [G0700888, G0701225] Funding Source: UKRI; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA017297] Funding Source: NIH RePORTER; Medical Research Council [G0701225, G0700888] Funding Source: researchfish; Wellcome Trust [090309/Z/09/Z] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dana Foundation; US Office of Naval Research(Office of Naval Research); Boehringer Ingelheim Fonds(Boehringer Ingelheim); Christopher Welch Scholarship Fund; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission)	We thank P. Chambon (Universite de Strasbourg), F. Costantini (Columbia University), S. Dymecki (Harvard Medical School), G. Nagel (Universitat Wurzburg) and P. Soriano (Mount Sinai School of Medicine) for plasmids and T. Ellender, M. Kohl, K. Lamsa, W. Nissen, T. Nottoli, R. Roorda, Y. Tan and L. Upton for assistance and/or discussions. This work was supported by the UK Medical Research Council (G. M.), the US National Institutes of Health (G.M.), the Dana Foundation (G.M.), the US Office of Naval Research (G.M.), the Boehringer Ingelheim Fonds (D.K.) and the Christopher Welch Scholarship Fund (D.K.).	Barbour DL, 2008, J NEUROSCI, V28, P11174, DOI 10.1523/JNEUROSCI.2093-08.2008; Berger TK, 2009, J PHYSIOL-LONDON, V587, P5411, DOI 10.1113/jphysiol.2009.176552; Binzegger T, 2004, J NEUROSCI, V24, P8441, DOI 10.1523/JNEUROSCI.1400-04.2004; Blatow M, 2005, J PHYSIOL-LONDON, V562, P99, DOI 10.1113/jphysiol.2004.078584; Brill J, 2009, J NEUROSCI, V29, P7413, DOI 10.1523/JNEUROSCI.6098-08.2009; CALLAWAY EM, 1993, P NATL ACAD SCI USA, V90, P7661, DOI 10.1073/pnas.90.16.7661; Chance FS, 1999, NAT NEUROSCI, V2, P277, DOI 10.1038/6381; Chance FS, 2000, NETWORK-COMP NEURAL, V11, P119, DOI 10.1088/0954-898X/11/2/301; Cruikshank SJ, 2010, NEURON, V65, P230, DOI 10.1016/j.neuron.2009.12.025; Dantzker JL, 2000, NAT NEUROSCI, V3, P701, DOI 10.1038/76656; Douglas RJ, 2004, ANNU REV NEUROSCI, V27, P419, DOI 10.1146/annurev.neuro.27.070203.144152; Douglas RJ, 2007, NEURON, V56, P226, DOI 10.1016/j.neuron.2007.10.017; Gibson JR, 1999, NATURE, V402, P75, DOI 10.1038/47035; GILBERT CD, 1979, NATURE, V280, P120, DOI 10.1038/280120a0; GILBERT CD, 1983, PROG BRAIN RES, V58, P209, DOI 10.1016/S0079-6123(08)60022-9; Gupta A, 2000, SCIENCE, V287, P273, DOI 10.1126/science.287.5451.273; Hegemann P, 2001, J PHYCOL, V37, P668, DOI 10.1046/j.1529-8817.2001.01095.x; Helmstaedter M, 2009, CEREB CORTEX, V19, P926, DOI 10.1093/cercor/bhn141; Hirsch JA, 2003, CEREB CORTEX, V13, P63, DOI 10.1093/cercor/13.1.63; Kano M, 2009, PHYSIOL REV, V89, P309, DOI 10.1152/physrev.00019.2008; Kapfer C, 2007, NAT NEUROSCI, V10, P743, DOI 10.1038/nn1909; KORALEK KA, 1988, BRAIN RES, V463, P346, DOI 10.1016/0006-8993(88)90408-8; Kozloski J, 2001, SCIENCE, V293, P868, DOI 10.1126/science.293.5531.868; Lima SQ, 2005, CELL, V121, P141, DOI 10.1016/j.cell.2005.02.004; LLANO I, 1991, NEURON, V6, P565, DOI 10.1016/0896-6273(91)90059-9; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; Miesenbock G, 2005, ANNU REV NEUROSCI, V28, P533, DOI 10.1146/annurev.neuro.28.051804.101610; Miesenbock G, 2009, SCIENCE, V326, P395, DOI 10.1126/science.1174520; Mountcastle V.B., 1978, MINDFUL BRAIN CORTIC, P7; Murayama M, 2009, NATURE, V457, P1137, DOI 10.1038/nature07663; Niell CM, 2008, J NEUROSCI, V28, P7520, DOI 10.1523/JNEUROSCI.0623-08.2008; Otsuka T, 2009, J NEUROSCI, V29, P10533, DOI 10.1523/JNEUROSCI.2219-09.2009; Petersen CCH, 2001, J NEUROSCI, V21, P8435, DOI 10.1523/JNEUROSCI.21-21-08435.2001; Petreanu L, 2007, NAT NEUROSCI, V10, P663, DOI 10.1038/nn1891; Petreanu L, 2009, NATURE, V457, P1142, DOI 10.1038/nature07709; Priebe NJ, 2008, NEURON, V57, P482, DOI 10.1016/j.neuron.2008.02.005; Shepherd GMG, 2005, J NEUROSCI, V25, P5670, DOI 10.1523/JNEUROSCI.1173-05.2005; Silberberg G, 2007, NEURON, V53, P735, DOI 10.1016/j.neuron.2007.02.012; Somogyi P, 2005, J PHYSIOL-LONDON, V562, P9, DOI 10.1113/jphysiol.2004.078915; Sun QQ, 2006, J NEUROSCI, V26, P1219, DOI 10.1523/JNEUROSCI.4727-04.2006; Thomson AM, 2007, FRONT NEUROSCI-SWITZ, V1, P19, DOI 10.3389/neuro.01.1.1.002.2007; Thomson AM, 2002, CEREB CORTEX, V12, P936, DOI 10.1093/cercor/12.9.936; Thomson AM, 1996, J PHYSIOL-LONDON, V496, P81, DOI 10.1113/jphysiol.1996.sp021667; Wang Y, 2004, J PHYSIOL-LONDON, V561, P65, DOI 10.1113/jphysiol.2004.073353; Weiler N, 2008, NAT NEUROSCI, V11, P360, DOI 10.1038/nn2049; Xu XM, 2010, J COMP NEUROL, V518, P389, DOI 10.1002/cne.22229; Xu XM, 2009, J NEUROSCI, V29, P70, DOI 10.1523/JNEUROSCI.4104-08.2009; Yoshimura Y, 2005, NAT NEUROSCI, V8, P1552, DOI 10.1038/nn1565; Zemelman BV, 2002, NEURON, V33, P15, DOI 10.1016/S0896-6273(01)00574-8	49	163	164	1	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2011	14	1					100	U135		10.1038/nn.2687	http://dx.doi.org/10.1038/nn.2687			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	699TE	21076426	Green Accepted			2022-12-28	WOS:000285684900020
J	Day, JJ; Sweatt, JD				Day, Jeremy J.; Sweatt, J. David			DNA methylation and memory formation	NATURE NEUROSCIENCE			English	Article							BDNF GENE; SYNAPTIC PLASTICITY; CHROMATIN-STRUCTURE; ADULT NEUROGENESIS; MOLECULAR TURNOVER; DEMETHYLATION; TRANSCRIPTION; EPIGENETICS; REPAIR; 5-HYDROXYMETHYLCYTOSINE	Memory formation and storage require long-lasting changes in memory-related neuronal circuits. Recent evidence indicates that DNA methylation may serve as a contributing mechanism in memory formation and storage. These emerging findings suggest a role for an epigenetic mechanism in learning and long-term memory maintenance and raise apparent conundrums and questions. For example, it is unclear how DNA methylation might be reversed during the formation of a memory, how changes in DNA methylation alter neuronal function to promote memory formation, and how DNA methylation patterns differ between neuronal structures to enable both consolidation and storage of memories. Here we evaluate the existing evidence supporting a role for DNA methylation in memory, discuss how DNA methylation may affect genetic and neuronal function to contribute to behavior, propose several future directions for the emerging subfield of neuroepigenetics, and begin to address some of the broader implications of this work.	[Sweatt, J. David] Univ Alabama, Dept Neurobiol, Birmingham, AL USA; Univ Alabama, Evelyn F McKnight Brain Inst, Birmingham, AL USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Sweatt, JD (corresponding author), Univ Alabama, Dept Neurobiol, Birmingham, AL USA.	dsweatt@uab.edu	Day, Jeremy/AAW-2464-2020	Day, Jeremy/0000-0002-7361-3399; Sweatt, J. David/0000-0003-3567-485X	NATIONAL INSTITUTE ON DRUG ABUSE [F32DA029419] Funding Source: NIH RePORTER; NIDA NIH HHS [F32 DA029419, F32 DA029419-01A1] Funding Source: Medline	NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		Barreto G, 2007, NATURE, V445, P671, DOI 10.1038/nature05515; Barrett RM, 2008, LEARN MEMORY, V15, P460, DOI 10.1101/lm.917508; Bird A, 2007, NATURE, V447, P396, DOI 10.1038/nature05913; Brown SE, 2008, NEUROSCI LETT, V440, P49, DOI 10.1016/j.neulet.2008.05.028; Chahrour M, 2008, SCIENCE, V320, P1224, DOI 10.1126/science.1153252; CRICK F, 1984, NATURE, V312, P101, DOI 10.1038/312101a0; Dulac C, 2010, NATURE, V465, P728, DOI 10.1038/nature09231; Feng J, 2010, NAT NEUROSCI, V13, P423, DOI 10.1038/nn.2514; Gehring M, 2009, TRENDS GENET, V25, P82, DOI 10.1016/j.tig.2008.12.001; Graff J, 2008, BEHAV BRAIN RES, V192, P70, DOI 10.1016/j.bbr.2008.01.021; Holliday R, 1999, J THEOR BIOL, V200, P339, DOI 10.1006/jtbi.1999.0995; HOLLIDAY R, 1975, SCIENCE, V187, P226, DOI 10.1126/science.1111098; Jin SG, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000013; Kangaspeska S, 2008, NATURE, V452, P112, DOI 10.1038/nature06640; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; Levenson JM, 2006, J BIOL CHEM, V281, P15763, DOI 10.1074/jbc.M511767200; LISMAN JE, 1985, P NATL ACAD SCI USA, V82, P3055, DOI 10.1073/pnas.82.9.3055; Lubin FD, 2008, J NEUROSCI, V28, P10576, DOI 10.1523/JNEUROSCI.1786-08.2008; Lubin FD, 2007, NEURON, V55, P942, DOI 10.1016/j.neuron.2007.07.039; Ma DKK, 2009, CELL CYCLE, V8, P1526, DOI 10.4161/cc.8.10.8500; Ma DK, 2009, SCIENCE, V323, P1074, DOI 10.1126/science.1166859; Mammen AL, 1997, J NEUROSCI, V17, P7351; Martinowich K, 2003, SCIENCE, V302, P890, DOI 10.1126/science.1090842; Metivier R, 2008, NATURE, V452, P45, DOI 10.1038/nature06544; Miller CA, 2008, NEUROBIOL LEARN MEM, V89, P599, DOI 10.1016/j.nlm.2007.07.016; Miller CA, 2007, NEURON, V53, P857, DOI 10.1016/j.neuron.2007.02.022; Miller CA, 2010, NAT NEUROSCI, V13, P664, DOI 10.1038/nn.2560; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Niehrs C, 2009, DIFFERENTIATION, V77, P1, DOI 10.1016/j.diff.2008.09.004; Ooi SKT, 2008, CELL, V133, P1145, DOI 10.1016/j.cell.2008.06.009; Razin A, 1981, Prog Nucleic Acid Res Mol Biol, V25, P33, DOI 10.1016/S0079-6603(08)60482-1; Roberson ED, 2001, REV NEUROSCIENCE, V12, P41; Roth TL, 2009, BIOL PSYCHIAT, V65, P760, DOI 10.1016/j.biopsych.2008.11.028; Sananbenesi F, 2009, BIOL CHEM, V390, P1145, DOI 10.1515/BC.2009.131; Santos KF, 2005, BRAZ J MED BIOL RES, V38, P1531, DOI 10.1590/S0100-879X2005001000010; SQUIRE LR, 1986, SCIENCE, V232, P1612, DOI 10.1126/science.3086978; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Swank MW, 2001, J NEUROSCI, V21, P3383, DOI 10.1523/JNEUROSCI.21-10-03383.2001; Szyf M, 2009, ANNU REV PHARMACOL, V49, P243, DOI 10.1146/annurev-pharmtox-061008-103102; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Thomson JP, 2010, NATURE, V464, P1082, DOI 10.1038/nature08924; Valinluck V, 2004, NUCLEIC ACIDS RES, V32, P4100, DOI 10.1093/nar/gkh739; Weaver ICG, 2005, J NEUROSCI, V25, P11045, DOI 10.1523/JNEUROSCI.3652-05.2005; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Wolffe AP, 1999, P NATL ACAD SCI USA, V96, P5894, DOI 10.1073/pnas.96.11.5894; Wood MA, 2006, LEARN MEMORY, V13, P241, DOI 10.1101/lm.278206; Wu H, 2010, SCIENCE, V329, P444, DOI 10.1126/science.1190485; Zhang Y, 2010, NUCLEIC ACIDS RES, V38, P4246, DOI 10.1093/nar/gkq147; Zhao XY, 2003, P NATL ACAD SCI USA, V100, P6777, DOI 10.1073/pnas.1131928100	50	325	338	3	72	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2010	13	11					1319	1323		10.1038/nn.2666	http://dx.doi.org/10.1038/nn.2666			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	673KI	20975755	Green Accepted			2022-12-28	WOS:000283658200008
J	Clapper, JR; Moreno-Sanz, G; Russo, R; Guijarro, A; Vacondio, F; Duranti, A; Tontini, A; Sanchini, S; Sciolino, NR; Spradley, JM; Hohmann, AG; Calignano, A; Mor, M; Tarzia, G; Piomelli, D				Clapper, Jason R.; Moreno-Sanz, Guillermo; Russo, Roberto; Guijarro, Ana; Vacondio, Federica; Duranti, Andrea; Tontini, Andrea; Sanchini, Silvano; Sciolino, Natale R.; Spradley, Jessica M.; Hohmann, Andrea G.; Calignano, Antonio; Mor, Marco; Tarzia, Giorgio; Piomelli, Daniele			Anandamide suppresses pain initiation through a peripheral endocannabinoid mechanism	NATURE NEUROSCIENCE			English	Article							ACID AMIDE HYDROLASE; CANNABINOID RECEPTORS; CB2 RECEPTORS; RAT MODEL; ANALGESIA; SYSTEM; FAAH; LOCALIZATION; ACTIVATION; INHIBITORS	Peripheral cannabinoid receptors exert a powerful inhibitory control over pain initiation, but the endocannabinoid signal that normally engages this intrinsic analgesic mechanism is unknown. To address this question, we developed a peripherally restricted inhibitor (URB937) of fatty acid amide hydrolase (FAAH), the enzyme responsible for the degradation of the endocannabinoid anandamide. URB937 suppressed FAAH activity and increased anandamide levels outside the rodent CNS. Despite its inability to access brain and spinal cord, URB937 attenuated behavioral responses indicative of persistent pain in rodent models of peripheral nerve injury and inflammation and prevented noxious stimulus-evoked neuronal activation in spinal cord regions implicated in nociceptive processing. CB1 cannabinoid receptor blockade prevented these effects. These results suggest that anandamide-mediated signaling at peripheral CB1 receptors controls the access of pain-related inputs to the CNS. Brain-impenetrant FAAH inhibitors, which strengthen this gating mechanism, might offer a new approach to pain therapy.	[Clapper, Jason R.; Moreno-Sanz, Guillermo; Guijarro, Ana; Piomelli, Daniele] Univ Calif Irvine, Dept Pharmacol, Irvine, CA 92717 USA; [Moreno-Sanz, Guillermo] Univ Complutense, Dept Biochem & Mol Biol 3, E-28040 Madrid, Spain; [Russo, Roberto; Calignano, Antonio] Univ Naples Federico II, Dept Expt Pharmacol, Naples, Italy; [Vacondio, Federica; Mor, Marco] Univ Parma, Dept Pharmaceut, I-43100 Parma, Italy; [Duranti, Andrea; Tontini, Andrea; Sanchini, Silvano; Tarzia, Giorgio] Univ Urbino Carlo Bo, Dept Hlth & Drug Sci, Urbino, Italy; [Sciolino, Natale R.; Hohmann, Andrea G.] Univ Georgia, Dept Psychol, Neurosci & Behav Program, Athens, GA 30602 USA; [Spradley, Jessica M.; Hohmann, Andrea G.] Univ Georgia, Program Neurosci, Biomed Hlth Sci Inst, Athens, GA 30602 USA; [Piomelli, Daniele] Italian Inst Technol, Genoa, Italy	University of California System; University of California Irvine; Complutense University of Madrid; University of Naples Federico II; University of Parma; University of Urbino; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; Istituto Italiano di Tecnologia - IIT	Piomelli, D (corresponding author), Univ Calif Irvine, Dept Pharmacol, Irvine, CA 92717 USA.	daniele.piomelli@iit.it	russo, roberto/A-3193-2012; Calignano, Antonio/K-2542-2018; Vacondio, Federica/C-1295-2009; Mor, Marco/D-2394-2009	russo, roberto/0000-0001-5950-1617; Mor, Marco/0000-0003-0199-1849; Sciolino, Natale/0000-0003-2794-1989; GUIJARRO ANTON, Ana Isabel/0000-0002-1595-2173; CALIGNANO, Antonio/0000-0002-1742-3179; Vacondio, Federica/0000-0002-0729-4385	National Institutes on Drug Abuse; University of Parma; Italian Ministry for Public Education, University and Research; Fulbright Commission; University of California; Agilent Foundation; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA012413] Funding Source: NIH RePORTER	National Institutes on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); University of Parma; Italian Ministry for Public Education, University and Research; Fulbright Commission; University of California(University of California System); Agilent Foundation; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank E. Dotsey for help with experiments. This research was supported by grants from the National Institutes on Drug Abuse (D.P. and A.G.H.), the University of Parma (M.M.) and the Italian Ministry for Public Education, University and Research (G.T., A.D and A.T.). G.M.-S. was partially supported by the Fulbright Commission and the Exchange Abroad Program, University of California. The support of the Agilent Foundation is gratefully acknowledged.	Agarwal N, 2007, NAT NEUROSCI, V10, P870, DOI 10.1038/nn1916; Ahluwalia J, 2003, J NEUROCHEM, V84, P585, DOI 10.1046/j.1471-4159.2003.01550.x; Alexander JP, 2005, CHEM BIOL, V12, P1179, DOI 10.1016/j.chembiol.2005.08.011; Anand P, 2009, BRAIN RES REV, V60, P255, DOI 10.1016/j.brainresrev.2008.12.003; BENNETT GJ, 1988, PAIN, V33, P87, DOI 10.1016/0304-3959(88)90209-6; Calignano A, 1998, NATURE, V394, P277, DOI 10.1038/28393; Clapper JR, 2009, CHEMMEDCHEM, V4, P1505, DOI 10.1002/cmdc.200900210; CODERRE TJ, 1992, J NEUROSCI, V12, P3665; Cravatt BF, 2001, P NATL ACAD SCI USA, V98, P9371, DOI 10.1073/pnas.161191698; Cravatt BF, 2004, P NATL ACAD SCI USA, V101, P10821, DOI 10.1073/pnas.0401292101; Dziadulewicz EK, 2007, J MED CHEM, V50, P3851, DOI 10.1021/jm070317a; Guindon J, 2008, BRIT J PHARMACOL, V153, P319, DOI 10.1038/sj.bjp.0707531; Hohmann AG, 1999, NEUROSCIENCE, V92, P1171, DOI 10.1016/S0306-4522(99)00220-1; Hohmann AG, 1999, NEUROSCIENCE, V90, P923, DOI 10.1016/S0306-4522(98)00524-7; Imai Y, 2003, MOL PHARMACOL, V64, P610, DOI 10.1124/mol.64.3.610; Kathuria S, 2003, NAT MED, V9, P76, DOI 10.1038/nm803; Kaufmann I, 2009, EUR SURG RES, V43, P325, DOI 10.1159/000235870; Kunos G, 2009, TRENDS PHARMACOL SCI, V30, P1, DOI 10.1016/j.tips.2008.10.001; Lever IJ, 2009, J NEUROSCI, V29, P3766, DOI 10.1523/JNEUROSCI.4071-08.2009; Liu J, 2006, P NATL ACAD SCI USA, V103, P13345, DOI 10.1073/pnas.0601832103; Loscher Wolfgang, 2005, NeuroRx, V2, P86, DOI 10.1007/BF03206645; LoVerme J, 2005, LIFE SCI, V77, P1685, DOI 10.1016/j.lfs.2005.05.012; LoVerme J, 2006, J PHARMACOL EXP THER, V319, P1051, DOI 10.1124/jpet.106.111385; Mitrirattanakul S, 2006, PAIN, V126, P102, DOI 10.1016/j.pain.2006.06.016; Nackley AG, 2003, NEUROSCIENCE, V117, P659, DOI 10.1016/S0306-4522(02)00870-9; Piomelli D, 2006, CNS DRUG REV, V12, P21, DOI 10.1111/j.1527-3458.2006.00021.x; Puig S, 1996, PAIN, V64, P345, DOI 10.1016/0304-3959(95)00121-2; Richardson D, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2401; Richardson JD, 1998, PAIN, V75, P111, DOI 10.1016/S0304-3959(97)00213-3; Russo R, 2007, J PHARMACOL EXP THER, V322, P236, DOI 10.1124/jpet.107.119941; Russo R, 2007, EUR J PHARMACOL, V566, P117, DOI 10.1016/j.ejphar.2007.03.007; Sagar DR, 2008, BRIT J PHARMACOL, V155, P1297, DOI 10.1038/bjp.2008.335; Schlosburg JE, 2009, AAPS J, V11, P39, DOI 10.1208/s12248-008-9075-y; Starowicz K, 2007, PHARMACOL THERAPEUT, V114, P13, DOI 10.1016/j.pharmthera.2007.01.005; Stein C, 2003, NAT MED, V9, P1003, DOI 10.1038/nm908; Stein Christoph, 2009, Handb Exp Pharmacol, P495, DOI 10.1007/978-3-540-79090-7_14; Tegeder I, 2003, BRAIN, V126, P1092, DOI 10.1093/brain/awg115	37	244	250	2	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2010	13	10					1265	1270		10.1038/nn.2632	http://dx.doi.org/10.1038/nn.2632			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	654MB	20852626	Green Submitted, Green Accepted			2022-12-28	WOS:000282171300019
J	Yamashita, T; Eguchi, K; Saitoh, N; von Gersdorff, H; Takahashi, T				Yamashita, Takayuki; Eguchi, Kohgaku; Saitoh, Naoto; von Gersdorff, Henrique; Takahashi, Tomoyuki			Developmental shift to a mechanism of synaptic vesicle endocytosis requiring nanodomain Ca2+	NATURE NEUROSCIENCE			English	Article							CLATHRIN-MEDIATED ENDOCYTOSIS; ADRENAL CHROMAFFIN CELLS; RETINAL BIPOLAR CELLS; FAST CNS SYNAPSE; TRANSMITTER RELEASE; CALCIUM-DEPENDENCE; RAPID ENDOCYTOSIS; SLOW ENDOCYTOSIS; NERVE-TERMINALS; DYNAMIN	Ca2+ is thought to be essential for the exocytosis and endocytosis of synaptic vesicles. However, the manner in which Ca2+ coordinates these processes remains unclear, particularly at mature synapses. Using membrane capacitance measurements from calyx of Held nerve terminals in rats, we found that vesicle endocytosis is initiated primarily in Ca2+ nanodomains around Ca2+ channels, where exocytosis is triggered. Bulk Ca2+ outside of the domain could also be involved in endocytosis at immature synapses, although only after extensive exocytosis at more mature synapses. This bulk Ca2+-dependent endocytosis required calmodulin and calcineurin activation at immature synapses, but not at more mature synapses. Similarly, GTP-independent endocytosis, which occurred after extensive exocytosis at immature synapses, became negligible after maturation. We propose that nanodomain Ca2+ simultaneously triggers exocytosis and endocytosis of synaptic vesicles and that the molecular mechanisms underlying Ca2+-dependent endocytosis undergo major developmental changes at this fast central synapse.	[Yamashita, Takayuki; Eguchi, Kohgaku; Takahashi, Tomoyuki] Okinawa Inst Sci & Technology Promot Corp, Initial Res Project, Cellular & Mol Synapt Funct Unit, Okinawa, Japan; [Saitoh, Naoto; Takahashi, Tomoyuki] Doshisha Univ, Fac Life & Med Sci, Dept Neurophysiol, Kyoto 602, Japan; [von Gersdorff, Henrique] Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97201 USA	Okinawa Institute of Science & Technology Graduate University; Doshisha University; Oregon Health & Science University	Takahashi, T (corresponding author), Okinawa Inst Sci & Technology Promot Corp, Initial Res Project, Cellular & Mol Synapt Funct Unit, Okinawa, Japan.	tyamashi@oist.jp; ttakahas@mail.doshisha.ac.jp	Takahashi, Tomoyuki/G-5951-2015; Yamashita, Takayuki/F-7589-2010; Eguchi, Kohgaku/C-1402-2015	Takahashi, Tomoyuki/0000-0002-8771-7666; Eguchi, Kohgaku/0000-0002-6170-2546; Yamashita, Takayuki/0000-0002-1849-9837	Core Research for Evolutional Science and Technology of Japan Science and Technology Agency; US National Institutes of Health [EY014043]; Japanese Ministry of Education, Culture, Sports, Science and Technology [20700357]; NATIONAL EYE INSTITUTE [R01EY014043] Funding Source: NIH RePORTER	Core Research for Evolutional Science and Technology of Japan Science and Technology Agency(Core Research for Evolutional Science and Technology (CREST)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank E. Johnson and S. Takamori for helpful comments. This work was supported by the Core Research for Evolutional Science and Technology of Japan Science and Technology Agency (T.T.), US National Institutes of Health grant EY014043 (H.v.G.) and Grant-in-Aid for Young Scientists from the Japanese Ministry of Education, Culture, Sports, Science and Technology #20700357 (T.Y.).	Artalejo CR, 1996, NEURON, V16, P195, DOI 10.1016/S0896-6273(00)80036-7; ARTALEJO CR, 1995, P NATL ACAD SCI USA, V92, P8328, DOI 10.1073/pnas.92.18.8328; Augustine GJ, 2003, NEURON, V40, P331, DOI 10.1016/S0896-6273(03)00639-1; Balaji J, 2008, J NEUROSCI, V28, P6742, DOI 10.1523/JNEUROSCI.1082-08.2008; Beutner D, 2001, NEURON, V29, P681, DOI 10.1016/S0896-6273(01)00243-4; Borst JGG, 1996, NATURE, V383, P431, DOI 10.1038/383431a0; Burgoyne RD, 2007, NAT REV NEUROSCI, V8, P182, DOI 10.1038/nrn2093; Chan SA, 2001, J PHYSIOL-LONDON, V537, P871; Chen Y, 2003, CELL, V115, P37, DOI 10.1016/S0092-8674(03)00726-8; Cousin MA, 2001, TRENDS NEUROSCI, V24, P659, DOI 10.1016/S0166-2236(00)01930-5; Daly C, 2002, J BIOL CHEM, V277, P9010, DOI 10.1074/jbc.M110815200; Engisch KL, 1998, J PHYSIOL-LONDON, V506, P591, DOI 10.1111/j.1469-7793.1998.591bv.x; Fedchyshyn MJ, 2005, J NEUROSCI, V25, P4131, DOI 10.1523/JNEUROSCI.0350-05.2005; Gad H, 1998, NEURON, V21, P607, DOI 10.1016/S0896-6273(00)80570-X; Granseth B, 2006, NEURON, V51, P773, DOI 10.1016/j.neuron.2006.08.029; Heidelberger R, 2001, J NEUROSCI, V21, P6467, DOI 10.1523/JNEUROSCI.21-17-06467.2001; HEUSER JE, 1973, J CELL BIOL, V57, P315, DOI 10.1083/jcb.57.2.315; Hosoi N, 2009, NEURON, V63, P216, DOI 10.1016/j.neuron.2009.06.010; JEWETT DL, 1972, BRAIN RES, V36, P101, DOI 10.1016/0006-8993(72)90769-X; Jockusch WJ, 2005, NEURON, V46, P869, DOI 10.1016/j.neuron.2005.05.004; Kawasaki F, 2000, NAT NEUROSCI, V3, P859, DOI 10.1038/78753; Kimura M, 2003, J PHYSIOL-LONDON, V553, P415, DOI 10.1113/jphysiol.2003.048371; KOENIG JH, 1989, J NEUROSCI, V9, P3844; Llinas RR, 2004, P NATL ACAD SCI USA, V101, P17855, DOI 10.1073/pnas.0408200101; Lou XL, 2008, P NATL ACAD SCI USA, V105, P17555, DOI 10.1073/pnas.0809621105; Marks B, 1998, CURR BIOL, V8, P740, DOI 10.1016/S0960-9822(98)70297-0; Nakamura T, 2008, J PHYSIOL-LONDON, V586, P2253, DOI 10.1113/jphysiol.2007.142521; Nakamura Y, 2007, NEUROSCI RES, V58, pS71, DOI 10.1016/j.neures.2007.06.415; Naraghi M, 1997, J NEUROSCI, V17, P6961; Neher E, 1998, NEURON, V20, P389, DOI 10.1016/S0896-6273(00)80983-6; Neves G, 2001, P NATL ACAD SCI USA, V98, P15282, DOI 10.1073/pnas.261311698; Newton AJ, 2006, P NATL ACAD SCI USA, V103, P17955, DOI 10.1073/pnas.0606212103; Poskanzer KE, 2003, NATURE, V426, P559, DOI 10.1038/nature02184; Renden R, 2007, J NEUROPHYSIOL, V98, P3349, DOI 10.1152/jn.00898.2007; Roos J, 1999, CURR BIOL, V9, P1411, DOI 10.1016/S0960-9822(00)80087-1; Shifman JM, 2006, P NATL ACAD SCI USA, V103, P13968, DOI 10.1073/pnas.0606433103; Slepnev VI, 1998, SCIENCE, V281, P821, DOI 10.1126/science.281.5378.821; Teng HB, 2000, J NEUROSCI, V20, P7986; Torok K, 1998, BIOCHEMISTRY-US, V37, P6188, DOI 10.1021/bi972773e; VONGERSDORFF H, 1994, NATURE, V370, P652, DOI 10.1038/370652a0; Watanabe H, 2010, J NEUROSCI, V30, P655, DOI 10.1523/JNEUROSCI.3214-09.2010; Wu LG, 2007, J NEUROSCI, V27, P11793, DOI 10.1523/JNEUROSCI.3471-07.2007; Wu W, 2005, J NEUROSCI, V25, P11676, DOI 10.1523/JNEUROSCI.2972-05.2005; Wu XS, 2009, NAT NEUROSCI, V12, P1003, DOI 10.1038/nn.2355; Wu Y, 2005, J NEUROPHYSIOL, V93, P2396, DOI 10.1152/jn.01108.2004; Xu JH, 2005, NEURON, V46, P633, DOI 10.1016/j.neuron.2005.03.024; Xu JH, 2008, NAT NEUROSCI, V11, P45, DOI 10.1038/nn2021; Yamashita T, 2005, SCIENCE, V307, P124, DOI 10.1126/science.1103631	48	69	69	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2010	13	7					838	U76		10.1038/nn.2576	http://dx.doi.org/10.1038/nn.2576			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	615YF	20562869	Green Accepted			2022-12-28	WOS:000279173900016
J	Hunt, LT; Kolling, N; Soltani, A; Woolrich, MW; Rushworth, MFS; Behrens, TEJ				Hunt, Laurence T.; Kolling, Nils; Soltani, Alireza; Woolrich, Mark W.; Rushworth, Matthew F. S.; Behrens, Timothy E. J.			Mechanisms underlying cortical activity during value-guided choice	NATURE NEUROSCIENCE			English	Article							NEURAL REPRESENTATION; PREFRONTAL CORTEX; DECISION-MAKING; PARIETAL CORTEX; WORKING-MEMORY; NEUROBIOLOGY; TIME; CINGULATE; BEHAVIOR; DORSAL	When choosing between two options, correlates of their value are represented in neural activity throughout the brain. Whether these representations reflect activity that is fundamental to the computational process of value comparison, as opposed to other computations covarying with value, is unknown. We investigated activity in a biophysically plausible network model that transforms inputs relating to value into categorical choices. A set of characteristic time-varying signals emerged that reflect value comparison. We tested these model predictions using magnetoencephalography data recorded from human subjects performing value-guided decisions. Parietal and prefrontal signals matched closely with model predictions. These results provide a mechanistic explanation of neural signals recorded during value-guided choice and a means of distinguishing computational roles of different cortical regions whose activity covaries with value.	[Hunt, Laurence T.; Kolling, Nils; Rushworth, Matthew F. S.] Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England; [Hunt, Laurence T.; Woolrich, Mark W.; Rushworth, Matthew F. S.; Behrens, Timothy E. J.] Univ Oxford, John Radcliffe Hosp, FMRIB Ctr, Oxford OX3 9DU, England; [Soltani, Alireza] Stanford Univ, Howard Hughes Med Inst, Sch Med, Stanford, CA 94305 USA; [Soltani, Alireza] Stanford Univ, Dept Neurobiol, Sch Med, Stanford, CA 94305 USA; [Woolrich, Mark W.] Warneford Hosp, Univ Dept Psychiat, Oxford Ctr Human Brain Activ OHBA, Oxford OX3 7JX, England; [Behrens, Timothy E. J.] UCL, Wellcome Trust Ctr Neuroimaging, London, England	University of Oxford; University of Oxford; Howard Hughes Medical Institute; Stanford University; Stanford University; University of Oxford; University of London; University College London	Hunt, LT (corresponding author), Univ Oxford, Dept Expt Psychol, S Parks Rd, Oxford OX1 3UD, England.	lhunt@fmrib.ox.ac.uk; behrens@fmrib.ox.ac.uk	Hunt, Laurence/ABA-1691-2021	Hunt, Laurence/0000-0002-8393-8533; Rushworth, Matthew/0000-0002-5578-9884; Woolrich, Mark/0000-0001-8460-8854; Kolling, Nils/0000-0002-0283-6966; Behrens, Timothy/0000-0003-0048-1177; Soltani, Alireza/0000-0003-4386-8486	Wellcome Trust [WT088312, WT080540]; Consortium Of Neuroimagers for Non-invasive Exploration of Brain Connectivity and Tracts (CONNECT); UK Medical Research Council; UK Engineering and Physical Sciences Research Council; European Commission [238292]; MRC [G0902373, G0700399] Funding Source: UKRI; Medical Research Council [G0700399, G0902373] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Consortium Of Neuroimagers for Non-invasive Exploration of Brain Connectivity and Tracts (CONNECT); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); European Commission(European CommissionEuropean Commission Joint Research Centre); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank V. Litvak and G. Barnes for many helpful discussions, C. Stagg and K. Friston for comments on the manuscript, T. Nichols for assistance implementing four-dimensional cluster-based permutation testing, and S. Braeutigam and A. Rao for help with data collection. This work was supported by the Wellcome Trust (L. T. H., N.K., M. W. W. and T.E.J.B., grant reference numbers WT088312 and WT080540), the Consortium Of Neuroimagers for Non-invasive Exploration of Brain Connectivity and Tracts (CONNECT; L. T. H. and T.E.J.B.), the UK Medical Research Council (M. F. S. R.) and the UK Engineering and Physical Sciences Research Council (M. W. W.). The project CONNECT acknowledges the financial support of the Future and Emerging Technologies (FET) program in the Seventh Framework Program for Research of the European Commission, under FET-Open grant number 238292.	Basten U, 2010, P NATL ACAD SCI USA, V107, P21767, DOI 10.1073/pnas.0908104107; BERG P, 1994, ELECTROEN CLIN NEURO, V90, P229, DOI 10.1016/0013-4694(94)90094-9; Blair K, 2006, J NEUROSCI, V26, P11379, DOI 10.1523/JNEUROSCI.1640-06.2006; Boorman ED, 2009, NEURON, V62, P733, DOI 10.1016/j.neuron.2009.05.014; Cai XY, 2011, NEURON, V69, P170, DOI 10.1016/j.neuron.2010.11.041; Compte A, 2000, CEREB CORTEX, V10, P910, DOI 10.1093/cercor/10.9.910; deCharms RC, 2000, ANNU REV NEUROSCI, V23, P613, DOI 10.1146/annurev.neuro.23.1.613; DICKINSON A, 1994, ANIM LEARN BEHAV, V22, P1, DOI 10.3758/BF03199951; Fellows LK, 2006, BRAIN, V129, P944, DOI 10.1093/brain/awl017; Gershman SJ, 2009, J NEUROSCI, V29, P13524, DOI 10.1523/JNEUROSCI.2469-09.2009; Haber SN, 2006, J NEUROSCI, V26, P8368, DOI 10.1523/JNEUROSCI.0271-06.2006; HAMALAINEN M, 1993, REV MOD PHYS, V65, P413, DOI 10.1103/RevModPhys.65.413; Hillebrand A, 2002, NEUROIMAGE, V16, P638, DOI 10.1006/nimg.2002.1102; Hsu M, 2009, J NEUROSCI, V29, P2231, DOI 10.1523/JNEUROSCI.5296-08.2009; Johnson PB, 1996, CEREB CORTEX, V6, P102, DOI 10.1093/cercor/6.2.102; Kable JW, 2007, NAT NEUROSCI, V10, P1625, DOI 10.1038/nn2007; Kable JW, 2009, NEURON, V63, P733, DOI 10.1016/j.neuron.2009.09.003; Kennerley SW, 2009, J COGNITIVE NEUROSCI, V21, P1162, DOI 10.1162/jocn.2009.21100; Kiebel SJ, 2009, HUM BRAIN MAPP, V30, P1866, DOI 10.1002/hbm.20775; Kim S, 2011, BIOL PSYCHIAT, V69, P1140, DOI 10.1016/j.biopsych.2010.07.005; Knutson B, 2005, J NEUROSCI, V25, P4806, DOI 10.1523/JNEUROSCI.0642-05.2005; Marinkovic K, 2004, Neurol Clin Neurophysiol, V2004, P30; Mars RB, 2011, J NEUROSCI, V31, P4087, DOI 10.1523/JNEUROSCI.5102-10.2011; Meltzer JA, 2008, CEREB CORTEX, V18, P1843, DOI 10.1093/cercor/bhm213; Milosavljevic M, 2010, JUDGM DECIS MAK, V5, P437; Muthukumaraswamy SD, 2009, P NATL ACAD SCI USA, V106, P8356, DOI 10.1073/pnas.0900728106; Noonan MP, 2010, P NATL ACAD SCI USA, V107, P20547, DOI 10.1073/pnas.1012246107; Padoa-Schioppa C, 2011, ANNU REV NEUROSCI, V34, P333, DOI 10.1146/annurev-neuro-061010-113648; Plassmann H, 2007, J NEUROSCI, V27, P9984, DOI 10.1523/JNEUROSCI.2131-07.2007; Platt ML, 1999, NATURE, V400, P233, DOI 10.1038/22268; Rangel A, 2008, NAT REV NEUROSCI, V9, P545, DOI 10.1038/nrn2357; Rolls ET, 2010, NEUROIMAGE, V53, P694, DOI 10.1016/j.neuroimage.2010.06.073; Rushworth MFS, 2008, NAT NEUROSCI, V11, P389, DOI 10.1038/nn2066; Scheperjans F, 2008, CEREB CORTEX, V18, P846, DOI 10.1093/cercor/bhm116; Serences JT, 2008, NEURON, V60, P1169, DOI 10.1016/j.neuron.2008.10.051; Shadlen MN, 2001, J NEUROPHYSIOL, V86, P1916, DOI 10.1152/jn.2001.86.4.1916; Sigman M, 2005, PLOS BIOL, V3, P334, DOI 10.1371/journal.pbio.0030037; Soltani A, 2006, J NEUROSCI, V26, P3731, DOI 10.1523/JNEUROSCI.5159-05.2006; Stephens D.W., 1986, pi; Sugrue LP, 2004, SCIENCE, V304, P1782, DOI 10.1126/science.1094765; TallonBaudry C, 1997, J NEUROSCI, V17, P722; Tom SM, 2007, SCIENCE, V315, P515, DOI 10.1126/science.1134239; Torrance G W, 1989, Int J Technol Assess Health Care, V5, P559; TVERSKY A, 1992, J RISK UNCERTAINTY, V5, P297, DOI 10.1007/BF00122574; Usher M, 2001, PSYCHOL REV, V108, P550, DOI 10.1037//0033-295X.108.3.550; VanVeen BD, 1997, IEEE T BIO-MED ENG, V44, P867, DOI 10.1109/10.623056; Wang XJ, 2002, NEURON, V36, P955, DOI 10.1016/S0896-6273(02)01092-9; Wong KF, 2006, J NEUROSCI, V26, P1314, DOI 10.1523/JNEUROSCI.3733-05.2006; Wong KF, 2007, FRONT COMPUT NEUROSC, V1, DOI 10.3389/neuro.10.006.2007	50	277	278	2	56	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2012	15	3					470	U169		10.1038/nn.3017	http://dx.doi.org/10.1038/nn.3017			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	899CY	22231429	Green Accepted			2022-12-28	WOS:000300793100022
J	Di Castro, MA; Chuquet, J; Liaudet, N; Bhaukaurally, K; Santello, M; Bouvier, D; Tiret, P; Volterra, A				Di Castro, Maria Amalia; Chuquet, Julien; Liaudet, Nicolas; Bhaukaurally, Khaleel; Santello, Mirko; Bouvier, David; Tiret, Pascale; Volterra, Andrea			Local Ca2+ detection and modulation of synaptic release by astrocytes	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; IN-SITU; HIPPOCAMPAL ASTROCYTES; POSTSYNAPTIC CURRENTS; GLUTAMATE EXOCYTOSIS; DENDRITIC SPINES; GRANULE CELLS; PLASTICITY; STIMULATION; TRANSMISSION	Astrocytes communicate with synapses by means of intracellular calcium ([Ca2+](i)) elevations, but local calcium dynamics in astrocytic processes have never been thoroughly investigated. By taking advantage of high-resolution two-photon microscopy, we identify the characteristics of local astrocyte calcium activity in the adult mouse hippocampus. Astrocytic processes showed intense activity, triggered by physiological transmission at neighboring synapses. They encoded synchronous synaptic events generated by sparse action potentials into robust regional (similar to 12 mu m) [Ca2+](i) elevations. Unexpectedly, they also sensed spontaneous synaptic events, producing highly confined (similar to 4 mu m), fast (millisecond-scale) miniature Ca2+ responses. This Ca2+ activity in astrocytic processes is generated through GTP- and inositol-1,4,5-trisphosphate-dependent signaling and is relevant for basal synaptic function. Thus, buffering astrocyte [Ca2+](i) or blocking a receptor mediating local astrocyte Ca2+ signals decreased synaptic transmission reliability in minimal stimulation experiments. These data provide direct evidence that astrocytes are integrated in local synaptic functioning in adult brain.	[Di Castro, Maria Amalia; Chuquet, Julien; Liaudet, Nicolas; Bhaukaurally, Khaleel; Santello, Mirko; Bouvier, David; Tiret, Pascale; Volterra, Andrea] Univ Lausanne, Dept Cell Biol & Morphol, Lausanne, Switzerland	University of Lausanne	Volterra, A (corresponding author), Univ Lausanne, Dept Cell Biol & Morphol, Lausanne, Switzerland.	andrea.volterra@unil.ch	Santello, Mirko/F-9007-2014; Di Castro, Maria Amalia/AGY-9938-2022; Chuquet, Julien/AAH-1615-2021; Bouvier, David S./E-3999-2014	Santello, Mirko/0000-0002-7709-4127; Di Castro, Maria Amalia/0000-0001-7480-1087; Bouvier, David S./0000-0002-8630-1044; Volterra, Andrea/0000-0003-1069-1602; Liaudet, Nicolas/0000-0002-0749-5857	Swiss National Science Foundation [3100A0-100850, 3100A0-120398]; MBF Foundation, Triesen; LI/Synapsis Foundation, Zurich; Swiss National Science Foundation National Center of Competence in Research; University of Lausanne Faculty of Biology and Medicine	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); MBF Foundation, Triesen; LI/Synapsis Foundation, Zurich; Swiss National Science Foundation National Center of Competence in Research; University of Lausanne Faculty of Biology and Medicine	We thank P. Bezzi for experiments in cultured astrocytes and critical comments, K. D. McCarthy (University of North Carolina, Chapel Hill) and P. G. Haydon (Tufts University) for providing Itpr2<SUP>-/-</SUP> mice, H. Kettenmann (Max Delbruck Center) for providing GFAP-EGFP mice, V. Crunelli, R. Schneggenburger and F. Helmchen for suggestions, and T. Oertner for critical reading of a previous manuscript version. This work was supported by grants from Swiss National Science Foundation (3100A0-100850 and 3100A0-120398) to A. V.; J.C. received a postdoctoral fellowship from MBF Foundation, Triesen, LI/Synapsis Foundation, Zurich; P. T., from Swiss National Science Foundation National Center of Competence in Research 'Synapsy'. M. S. received a University of Lausanne Faculty of Biology and Medicine PhD fellowship.	Agulhon C, 2010, SCIENCE, V327, P1250, DOI 10.1126/science.1184821; BERGERSEN LH, CEREB CORTE IN PRESS; Bezzi P, 2004, NAT NEUROSCI, V7, P613, DOI 10.1038/nn1246; Chao TI, 2002, TRIPARTITE SYNAPSE G, P3; Colonnese MT, 2005, J NEUROSCI, V25, P1291, DOI 10.1523/JNEUROSCI.4063-04.2005; Doengi M, 2009, P NATL ACAD SCI USA, V106, P17570, DOI 10.1073/pnas.0809513106; Domercq M, 2006, J BIOL CHEM, V281, P30684, DOI 10.1074/jbc.M606429200; Fellin T, 2004, NEURON, V43, P729, DOI 10.1016/j.neuron.2004.08.011; Fiacco TA, 2007, NEURON, V54, P611, DOI 10.1016/j.neuron.2007.04.032; Goldberg JH, 2003, NEURON, V40, P807, DOI 10.1016/S0896-6273(03)00714-1; Golovina VA, 2005, J PHYSIOL-LONDON, V564, P737, DOI 10.1113/jphysiol.2005.085035; Grosche J, 1999, NAT NEUROSCI, V2, P139, DOI 10.1038/5692; Halassa MM, 2010, ANNU REV PHYSIOL, V72, P335, DOI 10.1146/annurev-physiol-021909-135843; Hamilton NB, 2010, NAT REV NEUROSCI, V11, P227, DOI 10.1038/nrn2803; Henneberger C, 2010, NATURE, V463, P232, DOI 10.1038/nature08673; Hirase H, 2004, PLOS BIOL, V2, P494, DOI 10.1371/journal.pbio.0020096; Ikeda K, 2009, P NATL ACAD SCI USA, V106, P2945, DOI 10.1073/pnas.0811017106; Jourdain P, 2007, NAT NEUROSCI, V10, P331, DOI 10.1038/nn1849; Kang J, 1998, NAT NEUROSCI, V1, P683, DOI 10.1038/3684; Liu YB, 1996, J NEUROPHYSIOL, V76, P1074, DOI 10.1152/jn.1996.76.2.1074; Matsui K, 2003, NEURON, V40, P1173, DOI 10.1016/S0896-6273(03)00788-8; Matyash V, 2001, MOL CELL NEUROSCI, V18, P664, DOI 10.1006/mcne.2001.1047; McKinney RA, 1999, NAT NEUROSCI, V2, P44, DOI 10.1038/4548; Min MY, 1998, P NATL ACAD SCI USA, V95, P4702, DOI 10.1073/pnas.95.8.4702; Mori M, 2001, J PHYSIOL-LONDON, V535, P115, DOI 10.1111/j.1469-7793.2001.t01-1-00115.x; Murthy VN, 1999, NAT NEUROSCI, V2, P503, DOI 10.1038/9149; Navarrete M, 2008, NEURON, V57, P883, DOI 10.1016/j.neuron.2008.01.029; Nett WJ, 2002, J NEUROPHYSIOL, V87, P528, DOI 10.1152/jn.00268.2001; Nimmerjahn A, 2004, NAT METHODS, V1, P31, DOI 10.1038/nmeth706; Nolte C, 2001, GLIA, V33, P72; Palygin O, 2010, CELL CALCIUM, V48, P225, DOI 10.1016/j.ceca.2010.09.004; Pankratov Y, 2007, J GEN PHYSIOL, V129, P257, DOI 10.1085/jgp.200609693; Parri HR, 2001, NAT NEUROSCI, V4, P803, DOI 10.1038/90507; Perea G, 2007, SCIENCE, V317, P1083, DOI 10.1126/science.1144640; Perea G, 2009, TRENDS NEUROSCI, V32, P421, DOI 10.1016/j.tins.2009.05.001; Petravicz J, 2008, J NEUROSCI, V28, P4967, DOI 10.1523/JNEUROSCI.5572-07.2008; RAASTAD M, 1992, EUR J NEUROSCI, V4, P113, DOI 10.1111/j.1460-9568.1992.tb00114.x; Rosenmund C, 1996, NEURON, V16, P1197, DOI 10.1016/S0896-6273(00)80146-4; Santello M, 2011, NEURON, V69, P988, DOI 10.1016/j.neuron.2011.02.003; Soler-Llavina GJ, 2006, NAT NEUROSCI, V9, P798, DOI 10.1038/nn1698; Sutton MA, 2006, CELL, V125, P785, DOI 10.1016/j.cell.2006.03.040; Trommald M, 1997, J COMP NEUROL, V377, P15, DOI 10.1002/(SICI)1096-9861(19970106)377:1<15::AID-CNE3>3.0.CO;2-M; Ullian EM, 2001, SCIENCE, V291, P657, DOI 10.1126/science.291.5504.657; Wang SY, 2003, CELL SIGNAL, V15, P151, DOI 10.1016/S0898-6568(02)00085-2; Wang XH, 2006, NAT NEUROSCI, V9, P816, DOI 10.1038/nn1703; Witcher MR, 2007, GLIA, V55, P13, DOI 10.1002/glia.20415; Wu JQ, 2001, J PHYSIOL-LONDON, V533, P745, DOI 10.1111/j.1469-7793.2001.t01-1-00745.x; YASUDA R, 2004, SCI STKE, V219, P15, DOI DOI 10.1126/STKE.2192004P15; Zhou M, 2006, J NEUROPHYSIOL, V95, P134, DOI 10.1152/jn.00570.2005; Zhou Q, 2000, J PHYSIOL-LONDON, V525, P195, DOI 10.1111/j.1469-7793.2000.t01-1-00195.x	50	339	339	0	67	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2011	14	10					1276	U87		10.1038/nn.2929	http://dx.doi.org/10.1038/nn.2929			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	825EQ	21909085				2022-12-28	WOS:000295254200016
J	Chen, FY; Zha, DJ; Fridberger, A; Zheng, JF; Choudhury, N; Jacques, SL; Wang, RK; Shi, XR; Nuttall, AL				Chen, Fangyi; Zha, Dingjun; Fridberger, Anders; Zheng, Jiefu; Choudhury, Niloy; Jacques, Steven L.; Wang, Ruikang K.; Shi, Xiaorui; Nuttall, Alfred L.			A differentially amplified motion in the ear for near-threshold sound detection	NATURE NEUROSCIENCE			English	Article							BASILAR-MEMBRANE MOTION; HAIR-CELLS; MECHANOELECTRICAL TRANSDUCTION; REVERSE TRANSDUCTION; TECTORIAL MEMBRANE; ORGAN; COCHLEA; AMPLIFICATION; SENSITIVITY; POTENTIALS	The ear is a remarkably sensitive pressure fluctuation detector. In guinea pigs, behavioral measurements indicate a minimum detectable sound pressure of similar to 20 mu Pa at 16 kHz. Such faint sounds produce 0.1-nm basilar membrane displacements, a distance smaller than conformational transitions in ion channels. It seems that noise within the auditory system would swamp such tiny motions, making weak sounds imperceptible. Here we propose a new mechanism contributing to a resolution of this problem and validate it through direct measurement. We hypothesized that vibration at the apical side of hair cells is enhanced compared with that at the commonly measured basilar membrane side. Using in vivo optical coherence tomography, we demonstrated that apical-side vibrations peaked at a higher frequency, had different timing and were enhanced compared with those at the basilar membrane. These effects depend nonlinearly on the stimulus sound pressure level. The timing difference and enhancement of vibrations are important for explaining how the noise problem is circumvented.	[Chen, Fangyi; Zha, Dingjun; Fridberger, Anders; Zheng, Jiefu; Shi, Xiaorui; Nuttall, Alfred L.] Oregon Hlth & Sci Univ, Oregon Hearing Res Ctr, Portland, OR 97201 USA; [Zha, Dingjun] Fourth Mil Med Univ, Dept Otolaryngol Head & Neck Surg, Xijing Hosp, Xian, Peoples R China; [Fridberger, Anders] Karolinska Inst, Dept Clin Sci Intervent & Technol, Ctr Hearing & Commun Res, Stockholm, Sweden; [Choudhury, Niloy; Jacques, Steven L.; Nuttall, Alfred L.] Oregon Hlth & Sci Univ, Dept Biomed Engn, Portland, OR 97201 USA; [Jacques, Steven L.] Oregon Hlth & Sci Univ, Dept Dermatol, Portland, OR 97201 USA; [Wang, Ruikang K.] Univ Washington, Dept Bioengn, Seattle, WA 98195 USA; [Shi, Xiaorui] Peking Union Med Coll, Beijing 100021, Peoples R China; [Shi, Xiaorui] Chinese Acad Med Sci, Inst Microcirculat, Beijing 100037, Peoples R China; [Nuttall, Alfred L.] Univ Michigan, Kresge Hearing Res Inst, Ann Arbor, MI 48109 USA	Oregon Health & Science University; Air Force Military Medical University; Karolinska Institutet; Oregon Health & Science University; Oregon Health & Science University; University of Washington; University of Washington Seattle; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Microcirculation - CAMS; University of Michigan System; University of Michigan	Nuttall, AL (corresponding author), Oregon Hlth & Sci Univ, Oregon Hearing Res Ctr, Portland, OR 97201 USA.	nuttall@ohsu.edu	Wang, Ruikang/L-3889-2019; Fridberger, Anders/E-8977-2010; Chen, Fangyi/I-3497-2018	Wang, Ruikang/0000-0001-5169-8822; Fridberger, Anders/0000-0002-7960-1559; Chen, Fangyi/0000-0002-5024-6215	US National Institutes of Health, National Institute on Deafness and Other Communication Disorders [DC00141, DC010399, DC010201]; Swedish Research Council [K2008-63X-14061-08-3]; Tysta Skolan Foundation; Horselskadades Riksforbund; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC010399, R01DC010201, R01DC010844] Funding Source: NIH RePORTER	US National Institutes of Health, National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Swedish Research Council(Swedish Research CouncilEuropean Commission); Tysta Skolan Foundation; Horselskadades Riksforbund; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank E. de Boer, T. Ren, A. Magnusson and P. Gillespie for critical discussions and reading of the manuscript. This work was supported by US National Institutes of Health, National Institute on Deafness and Other Communication Disorders grants DC00141 (A.L.N.), DC010399 (A.L.N.) and DC010201 (R.K.W.); and Swedish Research Council grant K2008-63X-14061-08-3, the Tysta Skolan Foundation and Horselskadades Riksforbund (A.F.).	ALLEN JB, 1980, J ACOUST SOC AM, V68, P1660, DOI 10.1121/1.385198; BADENKRISTENSEN K, 1983, J PHYSIOL-LONDON, V335, P699, DOI 10.1113/jphysiol.1983.sp014559; Barral J, 2010, P NATL ACAD SCI USA, V107, P8079, DOI 10.1073/pnas.0913657107; BIALEK W, 1987, ANNU REV BIOPHYS BIO, V16, P455; BROWNELL WE, 1985, SCIENCE, V227, P194, DOI 10.1126/science.3966153; Chan DK, 2005, NAT NEUROSCI, V8, P149, DOI 10.1038/nn1385; Chen FY, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2717134; Choudhury N, 2006, HEARING RES, V220, P1, DOI 10.1016/j.heares.2006.06.006; Cooper NP, 2006, J PHYSIOL-LONDON, V576, P49, DOI 10.1113/jphysiol.2006.114991; COREY DP, 1979, NATURE, V281, P675, DOI 10.1038/281675a0; Dallos P, 2003, BIOPHYSICS OF THE COCHLEA: FROM MOLECULES TO MODELS, P97, DOI 10.1142/9789812704931_0013; de Boer E, 2000, J ACOUST SOC AM, V107, P1497, DOI 10.1121/1.428436; DENK W, 1989, PHYS REV LETT, V63, P207, DOI 10.1103/PhysRevLett.63.207; DENK W, 1992, HEARING RES, V60, P89, DOI 10.1016/0378-5955(92)90062-R; FLOCK A, 1965, COLD SPRING HARB SYM, V30, P133, DOI 10.1101/SQB.1965.030.01.016; Frank G, 1999, P NATL ACAD SCI USA, V96, P4420, DOI 10.1073/pnas.96.8.4420; Fridberger A, 2006, P NATL ACAD SCI USA, V103, P1918, DOI 10.1073/pnas.0507231103; Fridberger A, 2004, J NEUROSCI, V24, P10057, DOI 10.1523/JNEUROSCI.2711-04.2004; Fridberger A, 2003, NAT NEUROSCI, V6, P446, DOI 10.1038/nn1047; Gummer AW, 1996, P NATL ACAD SCI USA, V93, P8727, DOI 10.1073/pnas.93.16.8727; HEFFNER R, 1971, J ACOUST SOC AM, V49, P1888, DOI 10.1121/1.1912596; HOOD LJ, 1991, HEARING RES, V55, P109, DOI 10.1016/0378-5955(91)90097-S; Hu XT, 1999, J NEUROPHYSIOL, V82, P2798, DOI 10.1152/jn.1999.82.5.2798; HUDSPETH AJ, 1977, P NATL ACAD SCI USA, V74, P2407, DOI 10.1073/pnas.74.6.2407; Jaramillo F, 1998, NAT NEUROSCI, V1, P384, DOI 10.1038/1597; Kennedy HJ, 2005, NATURE, V433, P880, DOI 10.1038/nature03367; Khanna SM, 2000, HEARING RES, V149, P55, DOI 10.1016/S0378-5955(00)00162-3; KHANNA SM, 1982, SCIENCE, V215, P305, DOI 10.1126/science.7053580; Kolston PJ, 1999, P NATL ACAD SCI USA, V96, P3676, DOI 10.1073/pnas.96.7.3676; MAMMANO F, 1993, NATURE, V365, P838, DOI 10.1038/365838a0; Narayan SS, 1998, SCIENCE, V282, P1882, DOI 10.1126/science.282.5395.1882; NUTTALL AL, 1991, HEARING RES, V51, P203, DOI 10.1016/0378-5955(91)90037-A; Nuttall AL, 1995, HEARING RES, V92, P170, DOI 10.1016/0378-5955(95)00216-2; OLSON ES, 1991, J ACOUST SOC AM, V89, P1262, DOI 10.1121/1.400535; Pickles J. O, 1988, INTRO PHYSL HEARING; PROSEN CA, 1978, J ACOUST SOC AM, V63, P559, DOI 10.1121/1.381754; RHODE WS, 1971, J ACOUST SOC AM, V49, P1218, DOI 10.1121/1.1912485; Robles L, 2001, PHYSIOL REV, V81, P1305, DOI 10.1152/physrev.2001.81.3.1305; Ruggero MA, 2005, P NATL ACAD SCI USA, V102, P18614, DOI 10.1073/pnas.0509323102; RUGGERO MA, 1991, J NEUROSCI, V11, P1057; SELLICK PM, 1982, J ACOUST SOC AM, V72, P131, DOI 10.1121/1.387996; Tomo I, 2007, BIOPHYS J, V93, P3279, DOI 10.1529/biophysj.107.105072; van Netten SM, 2003, P NATL ACAD SCI USA, V100, P15510, DOI 10.1073/pnas.2632626100; Zheng J, 2000, NATURE, V405, P149, DOI 10.1038/35012009; ZWISLOCKI JJ, 1979, SCIENCE, V204, P639, DOI 10.1126/science.432671	45	149	152	0	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2011	14	6					770	U366		10.1038/nn.2827	http://dx.doi.org/10.1038/nn.2827			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	768SH	21602821	Green Accepted			2022-12-28	WOS:000290958000021
J	Cremona, ML; Matthies, HJG; Pau, K; Bowton, E; Speed, N; Lute, BJ; Anderson, M; Sen, N; Robertson, SD; Vaughan, RA; Rothman, JE; Galli, A; Javitch, JA; Yamamoto, A				Cremona, M. Laura; Matthies, Heinrich J. G.; Pau, Kelvin; Bowton, Erica; Speed, Nicole; Lute, Brandon J.; Anderson, Monique; Sen, Namita; Robertson, Sabrina D.; Vaughan, Roxanne A.; Rothman, James E.; Galli, Aurelio; Javitch, Jonathan A.; Yamamoto, Ai			Flotillin-1 is essential for PKC-triggered endocytosis and membrane microdomain localization of DAT	NATURE NEUROSCIENCE			English	Article							PROTEIN-KINASE-C; CLATHRIN-DEPENDENT MECHANISM; CELL-SURFACE EXPRESSION; DOPAMINE TRANSPORTER; GLUTAMATE TRANSPORTER; LIPID MICRODOMAINS; RAFT MICRODOMAINS; COCAINE BINDING; RECEPTOR; CHOLESTEROL	Plasmalemmal neurotransmitter transporters (NTTs) regulate the level of neurotransmitters, such as dopamine (DA) and glutamate, after their release at brain synapses. Stimuli including protein kinase C (PKC) activation can lead to the internalization of some NTTs and a reduction in neurotransmitter clearance capacity. We found that the protein Flotillin-1 (Flot1), also known as Reggie-2, was required for PKC-regulated internalization of members of two different NTT families, the DA transporter (DAT) and the glial glutamate transporter EAAT2, and we identified a conserved serine residue in Flot1 that is essential for transporter internalization. Further analysis revealed that Flot1 was also required to localize DAT within plasma membrane microdomains in stable cell lines, and was essential for amphetamine-induced reverse transport of DA in neurons but not for DA uptake. In sum, our findings provide evidence for a critical role of Flot1-enriched membrane microdomains in PKC-triggered DAT endocytosis and the actions of amphetamine.	[Cremona, M. Laura; Pau, Kelvin; Anderson, Monique; Yamamoto, Ai] Columbia Univ, Coll Phys & Surg, Dept Neurol, New York, NY 10027 USA; [Cremona, M. Laura; Pau, Kelvin; Anderson, Monique; Yamamoto, Ai] Columbia Univ, Coll Phys & Surg, Dept Pathol & Cell Biol, New York, NY USA; [Matthies, Heinrich J. G.; Bowton, Erica; Speed, Nicole; Lute, Brandon J.; Robertson, Sabrina D.; Galli, Aurelio] Vanderbilt Univ, Dept Mol Physiol & Biophys, Ctr Mol Neurosci, Kennedy Ctr, Nashville, TN 37232 USA; [Sen, Namita; Javitch, Jonathan A.] Columbia Univ, Coll Phys & Surg, Ctr Mol Recognit, New York, NY USA; [Sen, Namita; Javitch, Jonathan A.] Columbia Univ, Coll Phys & Surg, Dept Psychiat, New York, NY USA; [Sen, Namita; Javitch, Jonathan A.] Columbia Univ, Coll Phys & Surg, Dept Pharmacol, New York, NY USA; [Vaughan, Roxanne A.] Univ N Dakota, Sch Med & Hlth Sci, Grand Forks, ND 58201 USA; [Rothman, James E.] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06510 USA	Columbia University; Columbia University; Vanderbilt University; Columbia University; Columbia University; Columbia University; University of North Dakota Grand Forks; Yale University	Yamamoto, A (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Neurol, New York, NY 10027 USA.	ay46@columbia.edu	Yamamoto, Ai/D-1100-2011; Matthies, Heinrich/AAD-2375-2019; Matthies, Heinrich/B-7284-2017	Matthies, Heinrich/0000-0003-3615-7571; Matthies, Heinrich/0000-0003-3615-7571; Javitch, Jonathan/0000-0001-7395-2967; Robertson, Sabrina/0000-0003-4598-6929	US National Institute of Neurological Disorders and Stroke [RO1 NS050199]; Parkinson's Disease Foundation; US National Institute on Drug Abuse [PO1 DA12408, DA13975, K05 DA022413, DA13147]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050199] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K05DA022413, R01DA013975, P01DA012408, R01DA013147, R56DA013975] Funding Source: NIH RePORTER	US National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Parkinson's Disease Foundation; US National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank C. Karam, T. Melia, A. Pizzo, H. Stenmark and H. Yano for critical reading of this manuscript, and J. Rothstein (Johns Hopkins) for the Eaat2 cDNA. This work was supported by US National Institute of Neurological Disorders and Stroke research grant RO1 NS050199 and the Parkinson's Disease Foundation (A.Y.) and US National Institute on Drug Abuse research grants PO1 DA12408 (A. G. and J. A. J.), DA13975 (A. G.), K05 DA022413 (J. A. J.) and DA13147 (R. A. V.).	Adkins EM, 2007, BIOCHEMISTRY-US, V46, P10484, DOI 10.1021/bi700429z; Bauer M, 2006, FEBS LETT, V580, P5559, DOI 10.1016/j.febslet.2006.08.077; Baumann CA, 2000, NATURE, V407, P202, DOI 10.1038/35025089; Becart S, 2003, J CELL SCI, V116, P2565, DOI 10.1242/jcs.00449; Benlimame N, 1998, MOL BIOL CELL, V9, P1773, DOI 10.1091/mbc.9.7.1773; Bickel PE, 1997, J BIOL CHEM, V272, P13793, DOI 10.1074/jbc.272.21.13793; Buckley KM, 2000, J PHYSIOL-LONDON, V525, P11, DOI 10.1111/j.1469-7793.2000.t01-2-00011.x; Butchbach MER, 2004, J BIOL CHEM, V279, P34388, DOI 10.1074/jbc.M403938200; Chang MY, 2001, J NEUROCHEM, V77, P754, DOI 10.1046/j.1471-4159.2001.00284.x; Chen R, 2009, J PHARMACOL EXP THER, V328, P912, DOI 10.1124/jpet.108.147959; Damm EM, 2005, J CELL BIOL, V168, P477, DOI 10.1083/jcb.200407113; Deinhardt K, 2006, J CELL BIOL, V174, P459, DOI 10.1083/jcb.200508170; Di Guglielmo GM, 2003, NAT CELL BIOL, V5, P410, DOI 10.1038/ncb975; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; Escartin C, 2006, J NEUROSCI, V26, P5978, DOI 10.1523/JNEUROSCI.0302-06.2006; Filimonenko M, 2010, MOL CELL, V38, P265, DOI 10.1016/j.molcel.2010.04.007; Fog JU, 2006, NEURON, V51, P417, DOI 10.1016/j.neuron.2006.06.028; Foster JD, 2008, J NEUROCHEM, V105, P1683, DOI 10.1111/j.1471-4159.2008.05262.x; Frick M, 2007, CURR BIOL, V17, P1151, DOI 10.1016/j.cub.2007.05.078; Galbiati F, 1998, GENE, V210, P229, DOI 10.1016/S0378-1119(98)00064-X; Glebov OO, 2006, NAT CELL BIOL, V8, P46, DOI 10.1038/ncb1342; Gonzalez MI, 2005, J NEUROCHEM, V94, P1180, DOI 10.1111/j.1471-4159.2005.03330.x; Granas C, 2003, J BIOL CHEM, V278, P4990, DOI 10.1074/jbc.M205058200; Guillet BA, 2005, NEUROCHEM INT, V46, P337, DOI 10.1016/j.neuint.2004.10.006; Hong WC, 2010, J BIOL CHEM, V285, P32616, DOI 10.1074/jbc.M110.150565; Idkowiak-Baldys J, 2006, J BIOL CHEM, V281, P22321, DOI 10.1074/jbc.M512540200; Jacobowitz DM, 2004, NEUROTOX RES, V6, P245, DOI 10.1007/BF03033435; Kahlig KM, 2004, J BIOL CHEM, V279, P8966, DOI 10.1074/jbc.M303976200; Kalandadze A, 2002, J BIOL CHEM, V277, P45741, DOI 10.1074/jbc.M203771200; Kato N, 2006, J IMMUNOL, V177, P147, DOI 10.4049/jimmunol.177.1.147; Khoshbouei H, 2004, PLOS BIOL, V2, P387, DOI 10.1371/journal.pbio.0020078; Magnani F, 2004, J BIOL CHEM, V279, P38770, DOI 10.1074/jbc.M400831200; Melikian HE, 2004, PHARMACOL THERAPEUT, V104, P17, DOI 10.1016/j.pharmthera.2004.07.006; Miranda M, 2007, MOL BIOL CELL, V18, P313, DOI 10.1091/mbc.E06-08-0704; Morrow IC, 2005, TRAFFIC, V6, P725, DOI 10.1111/j.1600-0854.2005.00318.x; Morrow IC, 2002, J BIOL CHEM, V277, P48834, DOI 10.1074/jbc.M209082200; Pelkmans L, 2004, CELL, V118, P767, DOI 10.1016/j.cell.2004.09.003; Pike LJ, 2006, J LIPID RES, V47, P1597, DOI 10.1194/jlr.E600002-JLR200; Riento K, 2009, J CELL SCI, V122, P912, DOI 10.1242/jcs.039024; Robbins AK, 1998, BIOTECHNIQUES, V25, P240, DOI 10.2144/98252st04; Sen N, 2005, NEUROPHARMACOLOGY, V49, P780, DOI 10.1016/j.neuropharm.2005.08.014; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Sorkina T, 2005, TRAFFIC, V6, P157, DOI 10.1111/j.1600-0854.2005.00259.x; Stuermer CAO, 2011, J NEUROCHEM, V116, P708, DOI 10.1111/j.1471-4159.2010.07007.x; Sulzer D, 2005, PROG NEUROBIOL, V75, P406, DOI 10.1016/j.pneurobio.2005.04.003; Vaughan RA, 1996, J BIOL CHEM, V271, P21672, DOI 10.1074/jbc.271.35.21672; Wang LB, 2003, J LIPID RES, V44, P807, DOI 10.1194/jlr.M200449-JLR200; Wharton J, 2005, J BIOL CHEM, V280, P13483, DOI 10.1074/jbc.M413891200; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zhou JZ, 2004, J NEUROSCI, V24, P6301, DOI 10.1523/JNEUROSCI.1404-04.2004	50	139	142	0	50	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2011	14	4					469	U103		10.1038/nn.2781	http://dx.doi.org/10.1038/nn.2781			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	741FQ	21399631	Green Accepted			2022-12-28	WOS:000288849400018
J	Kleinlogel, S; Feldbauer, K; Dempski, RE; Fotis, H; Wood, PG; Bamann, C; Bamberg, E				Kleinlogel, Sonja; Feldbauer, Katrin; Dempski, Robert E.; Fotis, Heike; Wood, Phillip G.; Bamann, Christian; Bamberg, Ernst			Ultra light-sensitive and fast neuronal activation with the Ca2+-permeable channelrhodopsin CatCh	NATURE NEUROSCIENCE			English	Article							RESTORES VISUAL RESPONSES; SURFACE-CHARGE; PHOTOCYCLE; CHANNELS; CALCIUM; BACTERIORHODOPSIN; EXPRESSION; MEMBRANE; CELLS; MICE	The light-gated cation channel channelrhodopsin-2 (ChR2) has rapidly become an important tool in neuroscience, and its use is being considered in therapeutic interventions. Although wild-type and known variant ChR2s are able to drive light-activated spike trains, their use in potential clinical applications is limited by either low light sensitivity or slow channel kinetics. We present a new variant, calcium translocating channelrhodopsin (CatCh), which mediates an accelerated response time and a voltage response that is similar to 70-fold more light sensitive than that of wild-type ChR2. CatCh's superior properties stem from its enhanced Ca2+ permeability. An increase in [Ca2+](i) elevates the internal surface potential, facilitating activation of voltage-gated Na+ channels and indirectly increasing light sensitivity. Repolarization following light-stimulation is markedly accelerated by Ca2+-dependent BK channel activation. Our results demonstrate a previously unknown principle: shifting permeability from monovalent to divalent cations to increase sensitivity without compromising fast kinetics of neuronal activation. This paves the way for clinical use of light-gated channels.	[Kleinlogel, Sonja; Feldbauer, Katrin; Dempski, Robert E.; Fotis, Heike; Wood, Phillip G.; Bamann, Christian; Bamberg, Ernst] Max Planck Inst Biophys, Dept Biophys Chem, Frankfurt, Germany; [Bamberg, Ernst] Goethe Univ Frankfurt, Chem & Pharmaceut Sci Dept, Frankfurt, Germany	Max Planck Society; Goethe University Frankfurt	Bamberg, E (corresponding author), Max Planck Inst Biophys, Dept Biophys Chem, Frankfurt, Germany.	ernst.bamberg@biophys.mpg.de		Bamann, Christian/0000-0001-7473-438X	Deutsche Forschungsgemeinschaft [Sonderforschungsbereich 807]; Centre of Excellence Frankfurt Macromolecular Complexes; Federal Ministry of Education and Research of Germany [01GQ0815]; Max Planck Society	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Centre of Excellence Frankfurt Macromolecular Complexes; Federal Ministry of Education and Research of Germany(Federal Ministry of Education & Research (BMBF)); Max Planck Society(Max Planck SocietyFoundation CELLEX)	We would like to thank I. Bartnik for the preparation of the hippocampal neuron cultures, S. O'Shea for the help with the calcium imaging experiments, V. Busskamp for the support in recombinant adeno-associated virus construction, H. Biehl for excellent technical assistance, and K. Hartung, H. Spors, U. Terpitz and M. van Wyk for helpful discussions. The work was supported by grants from the Deutsche Forschungsgemeinschaft Sonderforschungsbereich 807, Centre of Excellence Frankfurt Macromolecular Complexes and the Federal Ministry of Education and Research of Germany (01GQ0815) to E.B., and by the Max Planck Society.	Allocca M, 2007, J VIROL, V81, P11372, DOI 10.1128/JVI.01327-07; Bamann C, 2008, J MOL BIOL, V375, P686, DOI 10.1016/j.jmb.2007.10.072; Bamann C, 2010, BIOCHEMISTRY-US, V49, P267, DOI 10.1021/bi901634p; Berndt A, 2009, NAT NEUROSCI, V12, P229, DOI 10.1038/nn.2247; Bi AD, 2006, NEURON, V50, P23, DOI 10.1016/j.neuron.2006.02.026; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Busskamp V, 2010, SCIENCE, V329, P413, DOI 10.1126/science.1190897; Cady C, 2001, BRAIN RES, V921, P1, DOI 10.1016/S0006-8993(01)03063-3; Caldwell JH, 2008, J BIOL CHEM, V283, P24300, DOI 10.1074/jbc.M802593200; de Felipe P, 2006, TRENDS BIOTECHNOL, V24, P68, DOI 10.1016/j.tibtech.2005.12.006; Faber ESL, 2003, NEUROSCIENTIST, V9, P181, DOI 10.1177/1073858403009003011; Feldbauer K, 2009, P NATL ACAD SCI USA, V106, P12317, DOI 10.1073/pnas.0905852106; FRANKENHAEUSER B, 1957, J PHYSIOL-LONDON, V137, P218, DOI 10.1113/jphysiol.1957.sp005808; Gunaydin LA, 2010, NAT NEUROSCI, V13, P387, DOI 10.1038/nn.2495; HILLE B, 1975, PHILOS T R SOC B, V270, P301, DOI 10.1098/rstb.1975.0011; HILLE B, 2001, ION CHANNELS EXCITAB, P649; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Joh NH, 2009, J AM CHEM SOC, V131, P10846, DOI 10.1021/ja904711k; Lagali PS, 2008, NAT NEUROSCI, V11, P667, DOI 10.1038/nn.2117; Lin JY, 2009, BIOPHYS J, V96, P1803, DOI 10.1016/j.bpj.2008.11.034; Lorenz L, 1996, P NATL ACAD SCI USA, V93, P13362, DOI 10.1073/pnas.93.23.13362; MULLER RU, 1972, J GEN PHYSIOL, V60, P285, DOI 10.1085/jgp.60.3.285; Nack M, 2010, PHOTOCH PHOTOBIO SCI, V9, P194, DOI 10.1039/b9pp00157c; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Nagel G, 2005, CURR BIOL, V15, P2279, DOI 10.1016/j.cub.2005.11.032; SUBRAMANIAM S, 1991, P NATL ACAD SCI USA, V88, P6873, DOI 10.1073/pnas.88.15.6873; Subramaniam S, 1997, P NATL ACAD SCI USA, V94, P1767, DOI 10.1073/pnas.94.5.1767; Thyagarajan S, 2010, J NEUROSCI, V30, P8745, DOI 10.1523/JNEUROSCI.4417-09.2010; Weber WM, 1999, BBA-BIOMEMBRANES, V1421, P213, DOI 10.1016/S0005-2736(99)00135-2; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744	30	280	303	0	48	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2011	14	4					513	U152		10.1038/nn.2776	http://dx.doi.org/10.1038/nn.2776			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	741FQ	21399632				2022-12-28	WOS:000288849400023
J	Di Marzo, V				Di Marzo, Vincenzo			Endocannabinoid signaling in the brain: biosynthetic mechanisms in the limelight	NATURE NEUROSCIENCE			English	Article							DIACYLGLYCEROL LIPASE-ALPHA; VANILLOID TYPE-1 RECEPTORS; MOUSE-BRAIN; IMMUNOHISTOCHEMICAL LOCALIZATION; INHIBITORY SYNAPSES; MULTIPLE MECHANISMS; CEREBELLAR CORTEX; DOPAMINE NEURONS; 2-ARACHIDONOYLGLYCEROL; SYSTEM	Studies of the endocannabinoid system in the CNS have been mostly focused on endocannabinoid receptors and inactivating mechanisms. Until recently, very little was known about the role of biosynthetic enzymes in endocannabinoid signaling. New data from the recent development of pharmacological and genetic tools for the study of these enzymes point to their fundamental role in determining where and when endocannabinoids function, and raise the possibility of new intriguing and previously unsuspected concepts in the general strategy of endocannabinoid signaling. However, even with these new tools, the cross-talk between anandamide and 2-arachidonoylglycerol biosynthesis makes it difficult to dissect one from the other, and data will need to be interpreted with this in mind.	CNR, Inst Biomol Chem, Endocannabinoid Res Grp, Pozzuoli, Italy	Consiglio Nazionale delle Ricerche (CNR)	Di Marzo, V (corresponding author), CNR, Inst Biomol Chem, Endocannabinoid Res Grp, Pozzuoli, Italy.	vdimarzo@icmib.na.cnr.it	Di Marzo, Vincenzo/AAD-7742-2019	Di Marzo, Vincenzo/0000-0002-1490-3070	US National Institutes of Health [DA-009789]; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA009789] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The author thanks T. Bisogno and S. Petrosino for their help. Support from the US National Institutes of Health (grant DA-009789) is also acknowledged.	Bisogno T, 2003, J CELL BIOL, V163, P463, DOI 10.1083/jcb.200305129; Bisogno T, 2006, BBA-MOL CELL BIOL L, V1761, P205, DOI 10.1016/j.bbalip.2005.12.009; Bisogno T, 2009, CHEMMEDCHEM, V4, P946, DOI 10.1002/cmdc.200800442; Chevaleyre V, 2003, NEURON, V38, P461, DOI 10.1016/S0896-6273(03)00235-6; Cristino L, 2008, NEUROSCIENCE, V151, P955, DOI 10.1016/j.neuroscience.2007.11.047; Cristino L, 2006, NEUROSCIENCE, V139, P1405, DOI 10.1016/j.neuroscience.2006.02.074; D'Asti E, 2010, ENDOCRINOLOGY, V151, P1685, DOI 10.1210/en.2009-1092; DEVANE WA, 1992, SCIENCE, V258, P1946, DOI 10.1126/science.1470919; Di Marzo V, 2008, NAT REV DRUG DISCOV, V7, P438, DOI 10.1038/nrd2553; Edwards DA, 2006, J NEUROPHYSIOL, V95, P67, DOI 10.1152/jn.00813.2005; Edwards DA, 2008, P NATL ACAD SCI USA, V105, P8142, DOI 10.1073/pnas.0803558105; Egertova M, 2008, J COMP NEUROL, V506, P604, DOI 10.1002/cne.21568; Fukaya M, 2008, EUR J NEUROSCI, V28, P1744, DOI 10.1111/j.1460-9568.2008.06495.x; Gao Y, 2010, J NEUROSCI, V30, P2017, DOI 10.1523/JNEUROSCI.5693-09.2010; Gomez O, 2010, GLIA, V58, P1913, DOI 10.1002/glia.21061; Goncalves MB, 2008, MOL CELL NEUROSCI, V38, P526, DOI 10.1016/j.mcn.2008.05.001; Harkany T, 2007, TRENDS PHARMACOL SCI, V28, P83, DOI 10.1016/j.tips.2006.12.004; Hashimotodani Y, 2008, NEUROPHARMACOLOGY, V54, P58, DOI 10.1016/j.neuropharm.2007.06.002; Hashimotodani Y, 2007, J NEUROSCI, V27, P1211, DOI 10.1523/JNEUROSCI.4159-06.2007; Hoover HS, 2008, BIOORG MED CHEM LETT, V18, P5838, DOI 10.1016/j.bmcl.2008.06.091; Katona I, 2006, J NEUROSCI, V26, P5628, DOI 10.1523/JNEUROSCI.0309-06.2006; Kim J, 2010, NAT NEUROSCI, V13, P592, DOI 10.1038/nn.2517; Lafourcade M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000709; Leung D, 2006, BIOCHEMISTRY-US, V45, P4720, DOI 10.1021/bi060163l; Maccarrone M, 2008, NAT NEUROSCI, V11, P152, DOI 10.1038/nn2042; Maejima T, 2005, J NEUROSCI, V25, P6826, DOI 10.1523/JNEUROSCI.0945-05.2005; Maione S, 2006, J PHARMACOL EXP THER, V316, P969, DOI 10.1124/jpet.105.093286; Marinelli S, 2009, NAT NEUROSCI, V12, P1488, DOI 10.1038/nn.2430; Marinelli S, 2008, J NEUROSCI, V28, P13532, DOI 10.1523/JNEUROSCI.0847-08.2008; Marrs WR, 2010, NAT NEUROSCI, V13, P951, DOI 10.1038/nn.2601; Melis M, 2004, J NEUROSCI, V24, P10707, DOI 10.1523/JNEUROSCI.3502-04.2004; Melis M, 2006, NEUROBIOL DIS, V24, P15, DOI 10.1016/j.nbd.2006.04.010; Min R, 2010, J NEUROSCI, V30, P2710, DOI 10.1523/JNEUROSCI.BC-3622-09.2010; Nomura DK, 2008, BIOORG MED CHEM LETT, V18, P5875, DOI 10.1016/j.bmcl.2008.08.007; Nomura S, 2007, EUR J NEUROSCI, V25, P659, DOI 10.1111/j.1460-9568.2007.05334.x; Nyilas R, 2008, J NEUROSCI, V28, P1058, DOI 10.1523/JNEUROSCI.5102-07.2008; Oddi S, 2008, CELL MOL LIFE SCI, V65, P840, DOI 10.1007/s00018-008-7494-7; Ortar G, 2008, J MED CHEM, V51, P6970, DOI 10.1021/jm800978m; Roloff AM, 2010, J NEUROSCI, V30, P3072, DOI 10.1523/JNEUROSCI.4603-09.2010; Safo PK, 2005, NEURON, V48, P647, DOI 10.1016/j.neuron.2005.09.020; Schlosburg JE, 2010, NAT NEUROSCI, V13, P1113, DOI 10.1038/nn.2616; Simon GM, 2010, MOL BIOSYST, V6, P1411, DOI 10.1039/c000237b; Starowicz K, 2007, PHARMACOL THERAPEUT, V114, P13, DOI 10.1016/j.pharmthera.2007.01.005; Straiker A, 2009, MOL PHARMACOL, V76, P1220, DOI 10.1124/mol.109.059030; Suarez J, 2008, J COMP NEUROL, V509, P400, DOI 10.1002/cne.21774; Szabo B, 2006, J PHYSIOL-LONDON, V577, P263, DOI 10.1113/jphysiol.2006.119362; Tanimura A, 2010, NEURON, V65, P320, DOI 10.1016/j.neuron.2010.01.021; van der Stelt M, 2005, EMBO J, V24, P3026, DOI 10.1038/sj.emboj.7600784; Wettschureck N, 2006, MOL CELL BIOL, V26, P5888, DOI 10.1128/MCB.00397-06; Yoshida T, 2006, J NEUROSCI, V26, P4740, DOI 10.1523/JNEUROSCI.0054-06.2006	50	126	127	1	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2011	14	1					9	15		10.1038/nn.2720	http://dx.doi.org/10.1038/nn.2720			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	699TE	21187849				2022-12-28	WOS:000285684900005
J	Dhawale, AK; Hagiwara, A; Bhalla, US; Murthy, VN; Albeanu, DF				Dhawale, Ashesh K.; Hagiwara, Akari; Bhalla, Upinder S.; Murthy, Venkatesh N.; Albeanu, Dinu F.			Non-redundant odor coding by sister mitral cells revealed by light addressable glomeruli in the mouse	NATURE NEUROSCIENCE			English	Article							RAT OLFACTORY-BULB; MITRAL/TUFTED CELLS; IN-VIVO; FUNCTIONAL-ORGANIZATION; OPTICAL INTERROGATION; NEURAL CIRCUITRY; TRANSGENIC MICE; CORTEX; INHIBITION; REPRESENTATIONS	Sensory inputs frequently converge on the brain in a spatially organized manner, often with overlapping inputs to multiple target neurons. Whether the responses of target neurons with common inputs become decorrelated depends on the contribution of local circuit interactions. We addressed this issue in the olfactory system using newly generated transgenic mice that express channelrhodopsin-2 in all of the olfactory sensory neurons. By selectively stimulating individual glomeruli with light, we identified mitral/tufted cells that receive common input (sister cells). Sister cells had highly correlated responses to odors, as measured by average spike rates, but their spike timing in relation to respiration was differentially altered. In contrast, non-sister cells correlated poorly on both of these measures. We suggest that sister mitral/tufted cells carry two different channels of information: average activity representing shared glomerular input and phase-specific information that refines odor representations and is substantially independent for sister cells.	[Hagiwara, Akari; Murthy, Venkatesh N.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Hagiwara, Akari; Murthy, Venkatesh N.] Harvard Univ, Ctr Brain Sci, Cambridge, MA 02138 USA; [Dhawale, Ashesh K.; Albeanu, Dinu F.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Dhawale, Ashesh K.; Bhalla, Upinder S.] Tata Inst Fundamental Res, Natl Ctr Biol Sci, Bangalore, Karnataka, India	Harvard University; Harvard University; Cold Spring Harbor Laboratory; Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS)	Murthy, VN (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.	vnmurthy@fas.harvard.edu; albeanu@cshl.edu		Murthy, Venkatesh/0000-0003-2443-4252; Dhawale, Ashesh/0000-0001-7438-1115; Albeanu, Dinu/0000-0001-7825-7744	Cold Spring Harbor Laboratory; International Society for Neurochemistry (Tata Institute of Fundamental Research); Merck; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC011291] Funding Source: NIH RePORTER	Cold Spring Harbor Laboratory; International Society for Neurochemistry (Tata Institute of Fundamental Research); Merck(Merck & Company); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank the Genome Manipulation Facility at Harvard University for help with generating the ORC mice. We are grateful to M. Meister, A. Kepecs, G. Turner, A. Khan, S. Kumari and P. Gupta for comments on the manuscript. B. Burbach, H. Cho, R. Eifert and M. Davis provided excellent technical support. We thank G. Otazu and S. Ranade for advice on building tetrodes and H. Oviedo and A. Zador for access to the laser-scanning photostimulation rig. Our special thanks go to Megabus for swift transportation and to the House of Marks. A. K. D. and D. F. A. were supported by the Cold Spring Harbor Laboratory Fellows Program. Additional support for A. K. D. was provided by the International Society for Neurochemistry, Sarojini Damodaran fellowship (Tata Institute of Fundamental Research) and Merck.	Adams Douglas, 1979, HITCHHIKERS GUIDE GA; Arenkiel BR, 2007, NEURON, V54, P205, DOI 10.1016/j.neuron.2007.03.005; Arganda-Carreras I, 2006, LECT NOTES COMPUT SC, V4241, P85; Aungst JL, 2003, NATURE, V426, P623, DOI 10.1038/nature02185; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Bozza T, 2004, NEURON, V42, P9, DOI 10.1016/S0896-6273(04)00144-8; BUONVISO N, 1990, J NEUROPHYSIOL, V63, P447, DOI 10.1152/jn.1990.63.3.447; Chen TW, 2009, P NATL ACAD SCI USA, V106, P2401, DOI 10.1073/pnas.0810151106; Christie JM, 2005, NEURON, V46, P761, DOI 10.1016/j.neuron.2005.04.030; DANCIGER E, 1989, P NATL ACAD SCI USA, V86, P8565, DOI 10.1073/pnas.86.21.8565; Egana JI, 2005, NEUROSCIENCE, V134, P1069, DOI 10.1016/j.neuroscience.2005.04.027; Engert F, 2002, NATURE, V419, P470, DOI 10.1038/nature00988; Fantana AL, 2008, NEURON, V59, P802, DOI 10.1016/j.neuron.2008.07.039; Gire DH, 2009, J NEUROSCI, V29, P13454, DOI 10.1523/JNEUROSCI.2368-09.2009; Gray CM, 1995, J NEUROSCI METH, V63, P43, DOI 10.1016/0165-0270(95)00085-2; Guo ZV, 2009, NAT METHODS, V6, P891, DOI 10.1038/nmeth.1397; Han X, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000299; Hartwich K, 2009, J NEUROSCI, V29, P9563, DOI 10.1523/JNEUROSCI.1397-09.2009; Holtmaat AJGD, 2005, NEURON, V45, P279, DOI 10.1016/j.neuron.2005.01.003; JAHR CE, 1980, SCIENCE, V207, P1473, DOI 10.1126/science.7361098; Kapoor V, 2006, J NEUROSCI, V26, P11709, DOI 10.1523/JNEUROSCI.3371-06.2006; Kashiwadani H, 1999, J NEUROPHYSIOL, V82, P1786, DOI 10.1152/jn.1999.82.4.1786; Kazama H, 2009, NAT NEUROSCI, V12, P1136, DOI 10.1038/nn.2376; Khan AG, 2008, NEURON, V57, P571, DOI 10.1016/j.neuron.2008.01.008; Kosaka T, 2004, NEUROSCI RES, V49, P373, DOI 10.1016/j.neures.2004.04.003; Luna VM, 2008, J NEUROSCI, V28, P8851, DOI 10.1523/JNEUROSCI.2385-08.2008; MACRIDES F, 1972, SCIENCE, V175, P84, DOI 10.1126/science.175.4017.84; MEREDITH M, 1986, J NEUROPHYSIOL, V56, P572, DOI 10.1152/jn.1986.56.3.572; Miyamichi K, 2005, J NEUROSCI, V25, P3586, DOI 10.1523/JNEUROSCI.0324-05.2005; Mombaerts P, 2006, ANNU REV CELL DEV BI, V22, P713, DOI 10.1146/annurev.cellbio.21.012804.093915; MONOD B, 1989, BEHAV BRAIN RES, V33, P51, DOI 10.1016/S0166-4328(89)80018-X; MOULY AM, 1986, BEHAV BRAIN RES, V21, P1, DOI 10.1016/0166-4328(86)90054-9; NICOLL RA, 1982, NATURE, V296, P441, DOI 10.1038/296441a0; Poo C, 2009, NEURON, V62, P850, DOI 10.1016/j.neuron.2009.05.022; Quirk MC, 2009, FRONT SYST NEUROSCI, V3, DOI 10.3389/neuro.06.013.2009; ROYET JP, 1988, J COMP NEUROL, V270, P559, DOI 10.1002/cne.902700409; Rubin BD, 1999, NEURON, V23, P499, DOI 10.1016/S0896-6273(00)80803-X; Schmitzer-Torbert N, 2005, NEUROSCIENCE, V131, P1, DOI 10.1016/j.neuroscience.2004.09.066; Schoppa NE, 2001, NEURON, V31, P639, DOI 10.1016/S0896-6273(01)00389-0; Shepherd G. M., 1998, SYNAPTIC ORG BRAIN; Shepherd GMG, 2003, NEURON, V38, P277, DOI 10.1016/S0896-6273(03)00152-1; Sigurdsson T, 2010, NATURE, V464, P763, DOI 10.1038/nature08855; Soucy ER, 2009, NAT NEUROSCI, V12, P210, DOI 10.1038/nn.2262; STEWART WB, 1979, J COMP NEUROL, V185, P715, DOI 10.1002/cne.901850407; Tan J, 2010, NEURON, V65, P912, DOI 10.1016/j.neuron.2010.02.011; Uchida N, 2003, NAT NEUROSCI, V6, P1224, DOI 10.1038/nn1142; Urban NN, 2002, J PHYSIOL-LONDON, V542, P355, DOI 10.1113/jphysiol.2001.013491; VASSAR R, 1994, CELL, V79, P981, DOI 10.1016/0092-8674(94)90029-9; Wachowiak M, 2004, P NATL ACAD SCI USA, V101, P9097, DOI 10.1073/pnas.0400438101; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744	50	150	151	1	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2010	13	11					1404	U183		10.1038/nn.2673	http://dx.doi.org/10.1038/nn.2673			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	673KI	20953197	Green Accepted			2022-12-28	WOS:000283658200022
J	Scott, CE; Wynn, SL; Sesay, A; Cruz, C; Cheung, M; Gaviro, MVG; Booth, S; Gao, B; Cheah, KSE; Lovell-Badge, R; Briscoe, J				Scott, Charlotte E.; Wynn, Sarah L.; Sesay, Abdul; Cruz, Catarina; Cheung, Martin; Gaviro, Maria-Victoria Gomez; Booth, Sarah; Gao, Bo; Cheah, Kathryn S. E.; Lovell-Badge, Robin; Briscoe, James			SOX9 induces and maintains neural stem cells	NATURE NEUROSCIENCE			English	Article							SONIC HEDGEHOG; SELF-RENEWAL; GENE-EXPRESSION; EPENDYMAL CELLS; CNS PRECURSOR; GLIAL-CELLS; IN-VITRO; MOUSE; DIFFERENTIATION; PROLIFERATION	Neural stem cells (NSCs) are uncommitted cells of the CNS defined by their multipotentiality and ability to self renew. We found these cells to not be present in substantial numbers in the CNS until after embryonic day (E) 10.5 in mouse and E5 in chick. This coincides with the induction of SOX9 in neural cells. Gain- and loss-of-function studies indicated that SOX9 was essential for multipotent NSC formation. Moreover, Sonic Hedgehog was able to stimulate precocious generation of NSCs by inducing Sox9 expression. SOX9 was also necessary for the maintenance of multipotent NSCs, as shown by in vivo fate mapping experiments in the adult subependymal zone and olfactory bulbs. In addition, loss of SOX9 led ependymal cells to adopt a neuroblast identity. These data identify a functional link between extrinsic and intrinsic mechanisms of NSCs specification and maintenance, and establish a central role for SOX9 in the process.	[Scott, Charlotte E.; Wynn, Sarah L.; Sesay, Abdul; Gaviro, Maria-Victoria Gomez; Booth, Sarah; Lovell-Badge, Robin] Natl Inst Med Res, Div Stem Cell Biol & Dev Genet, MRC, London NW7 1AA, England; [Scott, Charlotte E.; Cruz, Catarina; Cheung, Martin; Briscoe, James] Natl Inst Med Res, Div Dev Neurobiol, MRC, London NW7 1AA, England; [Wynn, Sarah L.; Cheung, Martin; Gao, Bo; Cheah, Kathryn S. E.] Univ Hong Kong, Dept Biochem, Hong Kong, Hong Kong, Peoples R China	MRC National Institute for Medical Research; MRC National Institute for Medical Research; University of Hong Kong	Lovell-Badge, R (corresponding author), Natl Inst Med Res, Div Stem Cell Biol & Dev Genet, MRC, Mill Hill, London NW7 1AA, England.	rlovell@nimr.mrc.ac.uk; jbrisco@nimr.mrc.ac.uk	cruz, catarina/I-1387-2013; Cheung, Martin Chi Hang/C-4235-2009	cruz, catarina/0000-0001-9139-8453; Lovell-Badge, Robin/0000-0001-9364-4179; Gomez-Gaviro, Maria Victoria/0000-0002-8683-5150; Gao, Bo/0000-0002-8684-5199; Cheung, Martin Chi Hang/0000-0002-3471-8534; Briscoe, James/0000-0002-1020-5240	UK Medical Research Council; US National Institutes of Health (National Institute of Biomedical Imaging and Bioengineering) [U117512772]; Hong Kong Research Grants Council; Medical Research Council [MC_U117562207] Funding Source: researchfish; MRC [MC_U117562207] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); US National Institutes of Health (National Institute of Biomedical Imaging and Bioengineering); Hong Kong Research Grants Council(Hong Kong Research Grants Council); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank A. Schedl (INSERM U636, Nice) for the conditional Sox9 mutant mice, A. Nagy (Samuel Lunenfeld Research Institute) for the pCall2 vector, W.C.W. Chan for blastocyst injections and production of Z/Sox9 mice and T. Caspary (Emory University) for the Arl13b antibody. The CMV:cre construct was a gift from S.O'Gorman (Salk Institute). Thank you to S. Guioli, F. Guillemot and L. Reynard for critical reading of the manuscript, to C. Andoniadou for advice and training in the ways of neurosphere cultures, to W. Han Yau in the photographics department at NIMR for help with illustrations, to T. Matabanadzo and other biological services staff at NIMR for help with the mouse colonies and other members of our laboratories for discussion and encouragement. This work was supported by the UK Medical Research Council (U117512772), a US National Institutes of Health (National Institute of Biomedical Imaging and Bioengineering) Quantum Grant (R.L.-B. and C.E.S.), and grants from the Hong Kong Research Grants Council and the Hong Kong University Grants Council Area of Excellence Scheme (S.L.W. and K.S.E.C.).	Ahn S, 2005, NATURE, V437, P894, DOI 10.1038/nature03994; Akiyama H, 2002, GENE DEV, V16, P2813, DOI 10.1101/gad.1017802; Akiyama H, 2004, P NATL ACAD SCI USA, V101, P6502, DOI 10.1073/pnas.0401711101; ANTON M, 1995, J VIROL, V69, P4600, DOI 10.1128/JVI.69.8.4600-4606.1995; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Bien-Willner GA, 2007, HUM MOL GENET, V16, P1143, DOI 10.1093/hmg/ddm061; Bonaguidi MA, 2008, J NEUROSCI, V28, P9194, DOI 10.1523/JNEUROSCI.3314-07.2008; Carlen M, 2009, NAT NEUROSCI, V12, P259, DOI 10.1038/nn.2268; Cheng LC, 2009, NAT NEUROSCI, V12, P399, DOI 10.1038/nn.2294; Cheung M, 2003, DEVELOPMENT, V130, P5681, DOI 10.1242/dev.00808; Cheung M, 2005, DEV CELL, V8, P179, DOI 10.1016/j.devcel.2004.12.010; Conti L, 2005, PLOS BIOL, V3, P1594, DOI 10.1371/journal.pbio.0030283; Doetsch F, 2003, NAT NEUROSCI, V6, P1127, DOI 10.1038/nn1144; Favaro R, 2009, NAT NEUROSCI, V12, P1248, DOI 10.1038/nn.2397; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Gulacsi AA, 2008, NAT NEUROSCI, V11, P1383, DOI 10.1038/nn.2226; HOUSTON CS, 1983, AM J MED GENET, V15, P3, DOI 10.1002/ajmg.1320150103; Kalani MYS, 2008, P NATL ACAD SCI USA, V105, P16970, DOI 10.1073/pnas.0808616105; Kempermann G, 2003, DEVELOPMENT, V130, P391, DOI 10.1242/dev.00203; Kordes U, 2006, J NEURO-ONCOL, V80, P151, DOI 10.1007/s11060-006-9180-7; Kordes U, 2005, DEV BRAIN RES, V157, P209, DOI 10.1016/j.devbrainres.2005.03.009; Lai K, 2003, NAT NEUROSCI, V6, P21, DOI 10.1038/nn983; Machold R, 2003, NEURON, V39, P937, DOI 10.1016/S0896-6273(03)00561-0; Miller SJ, 2006, CANCER RES, V66, P2584, DOI 10.1158/0008-5472.CAN-05-3330; Mizutani K, 2007, NATURE, V449, P351, DOI 10.1038/nature06090; Nowak JA, 2008, CELL STEM CELL, V3, P33, DOI 10.1016/j.stem.2008.05.009; Okubo T, 2005, DEVELOPMENT, V132, P1363, DOI 10.1242/dev.01678; Palma V, 2004, DEVELOPMENT, V131, P337, DOI 10.1242/dev.00930; Pevny L, 2005, CURR OPIN NEUROBIOL, V15, P7, DOI 10.1016/j.conb.2005.01.016; Poche RA, 2008, J COMP NEUROL, V510, P237, DOI 10.1002/cne.21746; Reynolds BA, 1996, DEV BIOL, V175, P1, DOI 10.1006/dbio.1996.0090; Rowitch DH, 1999, J NEUROSCI, V19, P8954, DOI 10.1523/JNEUROSCI.19-20-08954.1999; Shi YH, 2008, CRIT REV ONCOL HEMAT, V65, P43, DOI 10.1016/j.critrevonc.2007.06.004; Sottile V, 2006, BRAIN RES, V1099, P8, DOI 10.1016/j.brainres.2006.04.127; Spassky N, 2005, J NEUROSCI, V25, P10, DOI 10.1523/JNEUROSCI.1108-04.2005; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Stamataki D, 2005, GENE DEV, V19, P626, DOI 10.1101/gad.325905; Stolt CC, 2010, INT J BIOCHEM CELL B, V42, P437, DOI 10.1016/j.biocel.2009.07.014; Stolt CC, 2003, GENE DEV, V17, P1677, DOI 10.1101/gad.259003; Takaki M, 2006, STEM CELLS, V24, P1414, DOI 10.1634/stemcells.2005-0394; Takanaga H, 2009, STEM CELLS, V27, P165, DOI 10.1634/stemcells.2008-0580; Temple S, 2001, NATURE, V414, P112, DOI 10.1038/35102174; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Vidal VPI, 2005, CURR BIOL, V15, P1340, DOI 10.1016/j.cub.2005.06.064; Wood HB, 1999, MECH DEVELOP, V86, P197, DOI 10.1016/S0925-4773(99)00116-1	45	223	230	0	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2010	13	10					1181	1189		10.1038/nn.2646	http://dx.doi.org/10.1038/nn.2646			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	654MB	20871603	Green Submitted			2022-12-28	WOS:000282171300009
J	Reiff, DF; Plett, J; Mank, M; Griesbeck, O; Borst, A				Reiff, Dierk F.; Plett, Johannes; Mank, Marco; Griesbeck, Oliver; Borst, Alexander			Visualizing retinotopic half-wave rectified input to the motion detection circuitry of Drosophila	NATURE NEUROSCIENCE			English	Article							LARGE MONOPOLAR CELLS; FRUIT-FLY; CHLORIDE CHANNELS; COMPOUND EYE; LOBULA PLATE; OPTIC LOBE; WILD-TYPE; MELANOGASTER; RETINA; SYSTEM	In the visual system of Drosophila, photoreceptors R1-R6 relay achromatic brightness information to five parallel pathways. Two of them, the lamina monopolar cells L1 and L2, represent the major input lines to the motion detection circuitry. We devised a new method for optical recording of visually evoked changes in intracellular Ca(2+) in neurons using targeted expression of a genetically encoded Ca(2+) indicator. Ca(2+) in single terminals of L2 neurons in the medulla carried no information about the direction of motion. However, we found that brightness decrements (light-OFF) induced a strong increase in intracellular Ca(2+) but brightness increments (light-ON) induced only small changes, suggesting that half-wave rectification of the input signal occurs. Thus, L2 predominantly transmits brightness decrements to downstream circuits that then compute the direction of image motion.	[Reiff, Dierk F.; Plett, Johannes; Mank, Marco; Griesbeck, Oliver; Borst, Alexander] Max Planck Inst Neurobiol, Martinsried, Germany	Max Planck Society	Reiff, DF (corresponding author), Max Planck Inst Neurobiol, Martinsried, Germany.	reiff@neuro.mpg.de		Griesbeck, Oliver/0000-0001-5883-5594				ADELSON EH, 1985, J OPT SOC AM A, V2, P284, DOI 10.1364/JOSAA.2.000284; ANSTIS SM, 1975, VISION RES, V15, P957, DOI 10.1016/0042-6989(75)90236-9; BARLOW HB, 1965, J PHYSIOL-LONDON, V178, P477, DOI 10.1113/jphysiol.1965.sp007638; Borst A, 2002, J COMP PHYSIOL A, V188, P419, DOI 10.1007/s00359-002-0316-8; Borst A, 2010, ANNU REV NEUROSCI, V33, P49, DOI 10.1146/annurev-neuro-060909-153155; Buschbeck EK, 1996, J NEUROSCI, V16, P4563; Chalasani SH, 2007, NATURE, V450, P63, DOI 10.1038/nature06292; Clifford CWG, 2002, PROG NEUROBIOL, V68, P409, DOI 10.1016/S0301-0082(02)00154-5; COOMBE PE, 1986, J NEUROGENET, V3, P135, DOI 10.3109/01677068609106845; COOMBE PE, 1986, J COMP PHYSIOL A, V159, P655, DOI 10.1007/BF00612038; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; DOUGLASS JK, 1995, J NEUROSCI, V15, P5596; Douglass JK, 1996, J NEUROSCI, V16, P4551; EGELHAAF M, 1992, VISUAL NEUROSCI, V8, P151, DOI 10.1017/S0952523800009317; Euler T, 2002, NATURE, V418, P845, DOI 10.1038/nature00931; FISCHBACH KF, 1989, CELL TISSUE RES, V258, P441, DOI 10.1007/BF00218858; Franceschini N., 1989, P360; Gengs CX, 2002, J BIOL CHEM, V277, P42113, DOI 10.1074/jbc.M207133200; GOTZ KG, 1964, KYBERNETIK, V2, P77, DOI 10.1007/BF00288561; HARDIE RC, 1989, NATURE, V339, P704, DOI 10.1038/339704a0; HASSENSTEIN B, 1956, Z NATURFORSCH PT B, V11, P513; HASSENSTEIN B, 1952, VERH DTSCH ZOOL GES, V7, P95; HEISENBERG M, 1979, J COMP PHYSIOL, V130, P113, DOI 10.1007/BF00611046; JARVILEHTO M, 1973, Z ZELLFORSCH MIK ANA, V136, P291, DOI 10.1007/BF00307446; Joesch M, 2008, CURR BIOL, V18, P368, DOI 10.1016/j.cub.2008.02.022; Katsov AY, 2008, NEURON, V59, P322, DOI 10.1016/j.neuron.2008.05.022; LAUGHLIN SB, 1989, J EXP BIOL, V144, P113; Mank M, 2008, NAT METHODS, V5, P805, DOI 10.1038/NMETH.1243; MEINERTZHAGEN IA, 1991, J COMP NEUROL, V305, P232, DOI 10.1002/cne.903050206; Molnar A, 2009, J COMPUT NEUROSCI, V27, P569, DOI 10.1007/s10827-009-0170-6; Mronz M, 2008, J EXP BIOL, V211, P2026, DOI 10.1242/jeb.008268; Renteria RC, 2006, J NEUROSCI, V26, P11857, DOI 10.1523/JNEUROSCI.1718-06.2006; RIEHLE A, 1984, EXP BRAIN RES, V54, P390; Rister J, 2007, NEURON, V56, P155, DOI 10.1016/j.neuron.2007.09.014; Schnell B, 2010, J NEUROPHYSIOL, V103, P1646, DOI 10.1152/jn.00950.2009; SKINGSLEY DR, 1995, J COMP PHYSIOL A, V176, P611, DOI 10.1007/BF01021581; Strausfeld NJ., 1976, ATLAS INSECT BRAIN, DOI 10.1007/978-3-642-66179-2; Takemura SY, 2008, J COMP NEUROL, V509, P493, DOI 10.1002/cne.21757; Tammero LF, 2002, J EXP BIOL, V205, P2785; Tammero LF, 2002, J EXP BIOL, V205, P327; Ullman S., 1979, PROC R SOC SER B-BIO, DOI 10.7551/mitpress/3877.003.0009; VANDOORN AJ, 1982, EXP BRAIN RES, V45, P179, DOI 10.1007/BF00235777; VANSANTEN JPH, 1984, J OPT SOC AM A, V1, P451, DOI 10.1364/JOSAA.1.000451; Wassle H, 2004, NAT REV NEUROSCI, V5, P747, DOI 10.1038/nrn1497; WU CF, 1977, J GEN PHYSIOL, V69, P705, DOI 10.1085/jgp.69.6.705; ZETTLER F, 1973, J COMP PHYSIOL, V85, P89, DOI 10.1007/BF00694142; ZETTLER F, 1972, Z VERGL PHYSIOL, V76, P233, DOI 10.1007/BF00303230; ZETTLER F, 1987, J EXP BIOL, V131, P435; Zhu Y, 2009, CURR BIOL, V19, P613, DOI 10.1016/j.cub.2009.02.053	50	70	70	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2010	13	8					973	U92		10.1038/nn.2595	http://dx.doi.org/10.1038/nn.2595			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	632DK	20622873				2022-12-28	WOS:000280400600016
J	Anderson, CT; Sheets, PL; Kiritani, T; Shepherd, GMG				Anderson, Charles T.; Sheets, Patrick L.; Kiritani, Taro; Shepherd, Gordon M. G.			Sublayer-specific microcircuits of corticospinal and corticostriatal neurons in motor cortex	NATURE NEUROSCIENCE			English	Article							PRIMARY VISUAL-CORTEX; PYRAMIDAL NEURONS; FLAVOPROTEIN AUTOFLUORESCENCE; CALLOSAL PROJECTIONS; RAT; CONNECTIONS; ORGANIZATION; MORPHOLOGY; NEOCORTEX; CIRCUITS	The mammalian motor system is organized around distinct subcortical subsystems, suggesting that the intracortical circuits immediately upstream of spinal cord and basal ganglia might be functionally differentiated as well. We found that the main excitatory pathway in mouse motor cortex, layer 2/3 -> 5, is fractionated into distinct pathways targeting corticospinal and corticostriatal neurons, which are involved in motor control. However, connections were selective for neurons in certain sublayers: corticospinal neurons in upper layer 5B and corticostriatal neurons in lower 5A. A simple structural combinatorial principle accounts for this highly specific functional circuit architecture: potential connectivity is established by neuronal sublayer positioning and actual connectivity in this framework is determined by long-range axonal projection targets. Thus, intracortical circuits of these pyramidal neurons are specified not only by their long-range axonal targets or their layer or sublayer positions, but by both, in specific combinations.	[Anderson, Charles T.; Sheets, Patrick L.; Kiritani, Taro; Shepherd, Gordon M. G.] Northwestern Univ, Feinberg Sch Med, Dept Physiol, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Shepherd, GMG (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Physiol, Chicago, IL 60611 USA.	g-shepherd@northwestern.edu	Shepherd, Gordon/F-2679-2010	Anderson, Charles/0000-0003-3353-0182	Whitehall Foundation; National Institute of Neurological Disorders and Stroke at the US National Institutes of Health [NS061963]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS061963] Funding Source: NIH RePORTER	Whitehall Foundation; National Institute of Neurological Disorders and Stroke at the US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank L. Petreanu and K. Svoboda (Howard Hughes Medical Institute) for plasmids and comments, and D. Buxton for advice on retrograde labeling methods. The work was funded by grants from the Whitehall Foundation and the National Institute of Neurological Disorders and Stroke at the US National Institutes of Health (NS061963).	Alstermark B, 2004, J NEUROPHYSIOL, V92, P1958, DOI 10.1152/jn.00092.2004; Alstermark B, 2004, J NEUROPHYSIOL, V91, P1832, DOI 10.1152/jn.00820.2003; Ayling OGS, 2009, NAT METHODS, V6, P219, DOI [10.1038/NMETH.1303, 10.1038/nmeth.1303]; Ballion B, 2008, EUR J NEUROSCI, V27, P2313, DOI 10.1111/j.1460-9568.2008.06192.x; Binzegger T, 2004, J NEUROSCI, V24, P8441, DOI 10.1523/JNEUROSCI.1400-04.2004; Binzegger T, 2009, NEURAL NETWORKS, V22, P1071, DOI 10.1016/j.neunet.2009.07.011; Brown SP, 2009, CURR OPIN NEUROBIOL, V19, P415, DOI 10.1016/j.conb.2009.07.011; Brown SP, 2009, NATURE, V457, P1133, DOI 10.1038/nature07658; Cheatwood JL, 2005, BRAIN RES, V1036, P90, DOI 10.1016/j.brainres.2004.12.049; Chklovskii DB, 2004, NATURE, V431, P782, DOI 10.1038/nature03012; Dombeck DA, 2009, J NEUROSCI, V29, P13751, DOI 10.1523/JNEUROSCI.2985-09.2009; Douglas RJ, 2004, ANNU REV NEUROSCI, V27, P419, DOI 10.1146/annurev.neuro.27.070203.144152; Gao WJ, 2004, J COMP NEUROL, V476, P174, DOI 10.1002/cne.20224; GERFEN CR, 1989, SCIENCE, V246, P385, DOI 10.1126/science.2799392; Grinevich V, 2005, J NEUROSCI, V25, P8250, DOI 10.1523/JNEUROSCI.2235-05.2005; Groh A, 2010, CEREB CORTEX, V20, P826, DOI 10.1093/cercor/bhp152; Hattox AM, 2007, J NEUROPHYSIOL, V98, P3330, DOI 10.1152/jn.00397.2007; Hazan J, 1999, NAT GENET, V23, P296, DOI 10.1038/15472; Kaneko T, 2000, J COMP NEUROL, V423, P52, DOI 10.1002/1096-9861(20000717)423:1<52::AID-CNE5>3.0.CO;2-F; Larsen DD, 2008, FRONT NEURAL CIRCUIT, V1, DOI 10.3389/neuro.04.005.2007; Levesque M, 1996, BRAIN RES, V709, P311, DOI 10.1016/0006-8993(95)01333-4; LI CX, 1991, CAN J NEUROL SCI, V18, P28, DOI 10.1017/S0317167100031267; Llano DA, 2009, J NEUROPHYSIOL, V101, P3325, DOI 10.1152/jn.91291.2008; Lubke J, 2003, CEREB CORTEX, V13, P1051, DOI 10.1093/cercor/13.10.1051; Miller MN, 2008, J NEUROSCI, V28, P13716, DOI 10.1523/JNEUROSCI.2940-08.2008; Mizuno H, 2007, J NEUROSCI, V27, P6760, DOI 10.1523/JNEUROSCI.1215-07.2007; Molyneaux BJ, 2007, NAT REV NEUROSCI, V8, P427, DOI 10.1038/nrn2151; Morishima M, 2006, J NEUROSCI, V26, P4394, DOI 10.1523/JNEUROSCI.0252-06.2006; Nelson Sacha B., 2002, Neuron, V36, P19, DOI 10.1016/S0896-6273(02)00944-3; Otsuka T, 2008, J NEUROSCI, V28, P11186, DOI 10.1523/JNEUROSCI.1921-08.2008; Pasinelli P, 2006, NAT REV NEUROSCI, V7, P710, DOI 10.1038/nrn1971; Petreanu L, 2007, NAT NEUROSCI, V10, P663, DOI 10.1038/nn1891; Phillips C.G., 1977, MONOGR PHYSL SOC, V34; Rathelot JA, 2006, P NATL ACAD SCI USA, V103, P8257, DOI 10.1073/pnas.0602933103; Rathelot JA, 2009, P NATL ACAD SCI USA, V106, P918, DOI 10.1073/pnas.0808362106; Reiner A, 2003, J COMP NEUROL, V457, P420, DOI 10.1002/cne.10541; Shepherd GMG, 2005, NAT NEUROSCI, V8, P782, DOI 10.1038/nn1447; Shepherd GMG, 2009, FRONT NEUROSCI-SWITZ, V3, P337, DOI 10.3389/neuro.01.030.2009; Shibuki K, 2003, J PHYSIOL-LONDON, V549, P919, DOI 10.1113/jphysiol.2003.040709; Stepanyants A, 2005, TRENDS NEUROSCI, V28, P387, DOI 10.1016/j.tins.2005.05.006; Stepanyants A, 2008, CEREB CORTEX, V18, P13, DOI 10.1093/cercor/bhm027; Stevens CF, 1998, CURR BIOL, V8, pR708, DOI 10.1016/S0960-9822(98)70454-3; Striedter G. F., 2005, PRINCIPLES BRAIN EVO; Thomson AM, 2003, CEREB CORTEX, V13, P5, DOI 10.1093/cercor/13.1.5; Wang CL, 2007, J NEUROSCI, V27, P11334, DOI 10.1523/JNEUROSCI.3380-07.2007; Weiler N, 2008, NAT NEUROSCI, V11, P360, DOI 10.1038/nn2049; WILSON CJ, 1987, J COMP NEUROL, V263, P567, DOI 10.1002/cne.902630408; Wood L, 2009, J NEUROSCI, V29, P12440, DOI 10.1523/JNEUROSCI.3321-09.2009; Yu JN, 2008, FRONT NEURAL CIRCUIT, V2, DOI 10.3389/neuro.04.006.2008; Zarrinpar A, 2006, J NEUROPHYSIOL, V95, P1751, DOI 10.1152/jn.00974.2005	50	181	183	0	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2010	13	6					739	U116		10.1038/nn.2538	http://dx.doi.org/10.1038/nn.2538			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	600QY	20436481	Green Accepted			2022-12-28	WOS:000278003300019
